PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Das Thakur, M; Salangsang, F; Landman, AS; Sellers, WR; Pryer, NK; Levesque, MP; Dummer, R; McMahon, M; Stuart, DD				Das Thakur, Meghna; Salangsang, Fernando; Landman, Allison S.; Sellers, William R.; Pryer, Nancy K.; Levesque, Mitchell P.; Dummer, Reinhard; McMahon, Martin; Stuart, Darrin D.			Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance	NATURE			English	Article							RAF INHIBITOR RESISTANCE; BRAF; BRAF(V600E); SENESCENCE; PATHWAY; CANCER	Mutational activation of BRAF is the most prevalent genetic alteration in human melanoma, with >= 50% of tumours expressing the BRAF(V600E) oncoprotein(1,2). Moreover, the marked tumour regression and improved survival of late-stage BRAF-mutated melanoma patients in response to treatment with vemurafenib demonstrates the essential role of oncogenic BRAF in melanoma maintenance(3,4). However, as most patients relapse with lethal drug-resistant disease, understanding and preventing mechanism(s) of resistance is critical to providing improved therapy(5). Here we investigate the cause and consequences of vemurafenib resistance using two independently derived primary human melanoma xenograft models in which drug resistance is selected by continuous vemurafenib administration. In one of these models, resistant tumours show continued dependency on BRAF(V600E)-> MEK -> ERK signalling owing to elevated BRAF(V600E) expression. Most importantly, we demonstrate that vemurafenib-resistant melanomas become drug dependent for their continued proliferation, such that cessation of drug administration leads to regression of established drug-resistant tumours. We further demonstrate that a discontinuous dosing strategy, which exploits the fitness disadvantage displayed by drug-resistant cells in the absence of the drug, forestalls the onset of lethal drug-resistant disease. These data highlight the concept that drug-resistant cells may also display drug dependency, such that altered dosing may prevent the emergence of lethal drug resistance. Such observations may contribute to sustaining the durability of the vemurafenib response with the ultimate goal of curative therapy for the subset of melanoma patients with BRAF mutations.	[Das Thakur, Meghna; Salangsang, Fernando; Pryer, Nancy K.; Stuart, Darrin D.] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Landman, Allison S.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Landman, Allison S.; McMahon, Martin] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Levesque, Mitchell P.; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Novartis; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Novartis; University of Zurich; University Zurich Hospital	Stuart, DD (corresponding author), Novartis Inst Biomed Res, Emeryville, CA 94608 USA.	mcmahon@cc.ucsf.edu; darrin.stuart@novartis.com			NIBR Presidential Postdoctoral Fellowship; Melanoma Research Alliance; National Cancer Institute [R01-CA176839]; National Research Service Award T32 training grant [HL007185]; NATIONAL CANCER INSTITUTE [R01CA176839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER	NIBR Presidential Postdoctoral Fellowship; Melanoma Research Alliance; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the members of the Novartis Institutes for BioMedical Reseach (NIBR) Pharmacology department for technical support, comments and discussions during the course of this work. We thank C. Voliva, N. Aziz and E. Collisson for discussions. We thank B. Weisburd and the rest of the NIBR Bioinformatics department for assistance with exome sequencing data analysis. We thank S. Kaufman for sharing her knowledge of cell-based assays. We thank V. Marsh, N. Rosen, P. Poulikakos and D. Solit for providing additional advice and reagents. M.D.T. was supported by an NIBR Presidential Postdoctoral Fellowship. M.M. acknowledges support from the Melanoma Research Alliance and the National Cancer Institute (R01-CA176839). A.S.L. was supported by a National Research Service Award T32 training grant HL007185.	Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chmielecki J, 2012, J THORAC ONCOL, V7, P434, DOI 10.1097/JTO.0b013e31823c5aee; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Petti C, 2006, CANCER RES, V66, P6503, DOI 10.1158/0008-5472.CAN-05-4671; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tap WD, 2010, NEOPLASIA, V12, P637, DOI 10.1593/neo.10414; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	22	522	533	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					251	255		10.1038/nature11814	http://dx.doi.org/10.1038/nature11814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23302800	Green Accepted			2022-12-01	WOS:000315137700043
J	Miller, RA; Chu, QW; Xie, JX; Foretz, M; Viollet, B; Birnbaum, MJ				Miller, Russell A.; Chu, Qingwei; Xie, Jianxin; Foretz, Marc; Viollet, Benoit; Birnbaum, Morris J.			Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP	NATURE			English	Article							ADENYLATE-CYCLASE ACTIVITY; DIABETES-MELLITUS; RESPIRATORY-CHAIN; PROTEIN-KINASE; ENERGY-STATE; METFORMIN; ADENOSINE; LIVER; INHIBITION; GLUCOSE	Glucose production by the liver is essential for providing a substrate for the brain during fasting. The inability of insulin to suppress hepatic glucose output is a major aetiological factor in the hyperglycaemia of type-2 diabetes mellitus and other diseases of insulin resistance(1,2). For fifty years, one of the few classes of therapeutics effective in reducing glucose production has been the biguanides, which include phenformim and metformin, the latter the most frequently prescribed drug for type-2 diabetes(3). Nonetheless, the mechanism of action of biguanides remains imperfectly understood. The suggestion a decade ago that metformin reduces glucose synthesis through activation of the enzyme AMP-activated protein kinase (AMPK) has recently been challenged by genetic loss-of-function experiments(4). Here we provide a novel mechanism by which metformin antagonizes the action of glucagon, thus reducing fasting glucose levels. In mouse hepatocytes, metformin leads to the accumulation of AMP and related nucleotides, which inhibit adenylate cyclase, reduce levels of cyclic AMP and protein kinase A (PICA) activity, abrogate phosphorylation of critical protein targets of PICA, and block glucagon-dependent glucose output from hepatocytes. These data support a mechanism of action for metformin involving antagonism of glucagon, and suggest an approach for the development of antidiabetic drugs.	[Miller, Russell A.; Chu, Qingwei; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Xie, Jianxin] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, F-75006 Paris, France	University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Birnbaum, MJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu	FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health (NIH) [RO1 DK56886, PO1 DK49210, F32 DK079572]; Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM); Programme National de Recherche sur le Diabete (PNRD); Institut Benjamin Delessert; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, F32DK079572, P30DK019525, R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM); Programme National de Recherche sur le Diabete (PNRD); Institut Benjamin Delessert; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants RO1 DK56886 and PO1 DK49210 (M.J.B.) and F32 DK079572 (R.A.M.), the Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM) (to M.F.), the Programme National de Recherche sur le Diabete (PNRD) (to M.F. and B.V.) and the Institut Benjamin Delessert (to M.F.). Microscopy was performed in the University of Pennsylvania Cell and Developmental Biology Microscopy Core Facility. The Transgenic/Knockout, Mouse Phenotypipg, Viral Vector and Biomarker Cores of the University of Pennsylvania Diabetes and Endocrinology Research Center (NIH grant P30 DK19525) were instrumental in this work.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; BLUME AJ, 1975, J BIOL CHEM, V250, P5003; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FAIN JN, 1979, MOL CELL BIOCHEM, V25, P143; FAIN JN, 1972, J BIOL CHEM, V247, P6866; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GAWLER DJ, 1989, J ENDOCRINOL, V122, P207, DOI 10.1677/joe.0.1220207; Goodarzi MO, 2005, DIABETES OBES METAB, V7, P654, DOI 10.1111/j.1463-1326.2004.00448.x; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON RA, 1989, MOL PHARMACOL, V35, P681; LONDOS C, 1977, J BIOL CHEM, V252, P5951; MASSON S, 1992, BIOCHEMISTRY-US, V31, P7488, DOI 10.1021/bi00148a008; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Post Sr, 2000, METH MOL B, V136, P363; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STOLL B, 1992, BIOCHEM J, V287, P217, DOI 10.1042/bj2870217; Torres TP, 2011, J PHARMACOL EXP THER, V337, P610, DOI 10.1124/jpet.110.177899; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; YU B, 1994, BIOCHEM PHARMACOL, V48, P949, DOI 10.1016/0006-2952(94)90365-4; Zhang TT, 2009, J MOL ENDOCRINOL, V42, P57, DOI 10.1677/JME-08-0130; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	30	568	603	7	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					256	260		10.1038/nature11808	http://dx.doi.org/10.1038/nature11808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23292513	Green Accepted			2022-12-01	WOS:000315137700044
J	Lefaucheur, C; Loupy, A; Vernerey, D; Duong-Van-Huyen, JP; Suberbielle, C; Anglicheau, D; Verine, J; Beuscart, T; Nochy, D; Bruneval, P; Charron, D; Delahousse, M; Empana, JP; Hill, GS; Glotz, D; Legendre, C; Jouven, X				Lefaucheur, Carmen; Loupy, Alexandre; Vernerey, Dewi; Duong-Van-Huyen, Jean-Paul; Suberbielle, Caroline; Anglicheau, Dany; Verine, Jerome; Beuscart, Thibaut; Nochy, Dominique; Bruneval, Patrick; Charron, Dominique; Delahousse, Michel; Empana, Jean-Philippe; Hill, Gary S.; Glotz, Denis; Legendre, Christophe; Jouven, Xavier			Antibody-mediated vascular rejection of kidney allografts: a population-based study	LANCET			English	Article							ACUTE HUMORAL REJECTION; C4D DEPOSITION; TRANSPLANT RECIPIENTS; CLASSIFICATION; SURVIVAL; THERAPY; INJURY; PLASMAPHERESIS; VASCULOPATHY; PATHOLOGY	Background Rejection of allografts has always been the major obstacle to transplantation success. We aimed to improve characterisation of different kidney-allograft rejection phenotypes, identify how each one is associated with anti-HLA antibodies, and investigate their distinct prognoses. Methods Patients who underwent ABO-compatible kidney transplantations in Necker Hospital and Saint-Louis Hospital (Paris, France) between Jan 1, 1998, and Dec 31, 2008, were included in our population-based study. We assessed patients who provided biopsy samples for acute allograft rejection, which was defined as the association of deterioration in function and histopathological lesions. The main outcome was kidney allograft loss-ie, return to dialysis. To investigate distinct rejection patterns, we retrospectively assessed rejection episodes with review of graft histology, C4d in allograft biopsies, and donor-specific anti-HLA antibodies. Findings 2079 patients were included in the main analyses, of whom 302 (15%) had acute biopsy-proven rejection. We identified four distinct patterns of kidney allograft rejection: T cell-mediated vascular rejection (26 patients [9%]), antibody-mediated vascular rejection (64 [21%]), T cell-mediated rejection without vasculitis (139 [46%]), and antibody-mediated rejection without vasculitis (73 [24%]). Risk of graft loss was 9.07 times (95 CI 3.62-19.7) higher in antibody-mediated vascular rejection than in T cell-mediated rejection without vasculitis (p<0.0001), compared with an increase of 2.93 times (1.1-7.9; P=0.0237) in antibody-mediated rejection without vasculitis and no significant rise in T cell-mediated vascular rejection (hazard ratio [HR] 1.5, 95% CI 0.33-7.6; p=0.60). Interpretation We have identified a type of kidney rejection not presently included in classifications: antibody-mediated vascular rejection. Recognition of this distinct phenotype could lead to the development of new treatment strategies that could salvage many kidney allografts.	[Lefaucheur, Carmen; Charron, Dominique] Hop St Louis, AP HP, INSERM, Dept Immunol & Histocompatibil,U940, Paris, France; [Verine, Jerome] Hop St Louis, AP HP, INSERM, Dept Pathol,U940, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] Hop Necker Enfants Malad, AP HP, Dept Kidney Transplantat, F-75015 Paris, France; [Loupy, Alexandre; Vernerey, Dewi; Beuscart, Thibaut; Empana, Jean-Philippe; Jouven, Xavier] Univ Paris 05, Paris Cardiovasc Res Ctr, Biostat Unit, UMR S970, Paris, France; [Duong-Van-Huyen, Jean-Paul; Beuscart, Thibaut; Nochy, Dominique; Bruneval, Patrick; Hill, Gary S.] Georges Pompidou European Hosp, Dept Pathol, Paris, France; [Jouven, Xavier] Georges Pompidou European Hosp, Dept Cardiol, Paris, France; [Duong-Van-Huyen, Jean-Paul] Hop Foch, Dept Pathol, Suresnes, France; [Delahousse, Michel] Hop Foch, Dept Nephrol & Kidney Transplantat, Suresnes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Hospital Foch	Loupy, A (corresponding author), Hop Necker Enfants Malad, AP HP, Dept Kidney Transplantat, 149 Rue Sevres, F-75015 Paris, France.	alexandreloupy@gmail.com	lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Loupy, Alexandre/K-8512-2019; lefaucheur, carmen/F-3502-2013	Empana, Jean-Philippe/0000-0002-1469-7772; Glotz, Denis/0000-0001-5258-4237				Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; de Serrea NPM, 2008, AM J TRANSPLANT, V8, P1290, DOI 10.1111/j.1600-6143.2008.02221.x; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Everly MJ, 2008, TRANSPLANTATION, V86, P1754, DOI 10.1097/TP.0b013e318190af83; Faguer S, 2007, TRANSPLANTATION, V83, P1277, DOI 10.1097/01.tp.0000261113.30757.d1; Garcia GG, 2012, LANCET, V379, pE36, DOI 10.1016/S0140-6736(12)60202-5; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Herzenberg AM, 2002, J AM SOC NEPHROL, V13, P234, DOI 10.1681/ASN.V131234; Hill GS, 2011, J AM SOC NEPHROL, V22, P975, DOI 10.1681/ASN.2010070777; Hirohashi T, 2010, AM J TRANSPLANT, V10, P510, DOI 10.1111/j.1600-6143.2009.02958.x; Kaufman CL, 2012, AM J TRANSPLANT, V12, P1004, DOI 10.1111/j.1600-6143.2011.03915.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2007, AM J TRANSPLANT, V7, P832, DOI 10.1111/j.1600-6143.2006.01686.x; Lefaucheur C, 2009, AM J TRANSPLANT, V9, P1099, DOI 10.1111/j.1600-6143.2009.02591.x; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Loucaidou M, 2003, TRANSPLANTATION, V76, P1120, DOI 10.1097/01.TP.0000076474.76480.A4; Loupy A, 2011, AM J TRANSPLANT, V11, P1478, DOI 10.1111/j.1600-6143.2011.03563.x; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rocha PN, 2003, TRANSPLANTATION, V75, P1490, DOI 10.1097/01.TP.0000060252.57111.AC; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shimizu T, 2010, CLIN TRANSPLANT, V24, P22, DOI 10.1111/j.1399-0012.2010.01277.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Sis B, 2010, AM J TRANSPLANT, V10, P421, DOI 10.1111/j.1600-6143.2009.02938.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007	36	239	246	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					313	319		10.1016/S0140-6736(12)61265-3	http://dx.doi.org/10.1016/S0140-6736(12)61265-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23182298				2022-12-01	WOS:000314021800028
J	Lapi, F; Azoulay, L; Yin, H; Nessim, SJ; Suissa, S				Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Nessim, Sharon J.; Suissa, Samy			Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE-RENAL-FAILURE; PRACTICE RESEARCH DATABASE; EUROPEAN-SOCIETY; EPIDEMIOLOGY; VALIDITY; COMBINATIONS; PRESCRIPTION; DISEASE; DEATH; BIAS	Objectives To assess whether a double therapy combination consisting of diuretics, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-steroidal anti-inflammatory drugs (NSAIDs) and the triple therapy combination of two of the aforementioned antihypertensive drugs to which NSAIDs are added are associated with an increased risk of acute kidney injury. Design Retrospective cohort study using nested case-control analysis. Setting General practices contributing data to the UK Clinical Practice Research Datalink linked to the Hospital Episodes Statistics database. Participants A cohort of 487 372 users of antihypertensive drugs. Main outcome measures Rate ratios with 95% confidence intervals of acute kidney injury associated with current use of double and triple therapy combinations of antihypertensive drugs with NSAIDs. Results During a mean follow-up of 5.9 (SD 3.4) years, 2215 cases of acute kidney injury were identified (incidence rate 7/10 000 person years). Overall, current use of a double therapy combination containing either diuretics or angiotensin converting enzyme inhibitors or angiotensin receptor blockers with NSAIDs was not associated with an increased rate of acute kidney injury. In contrast, current use of a triple therapy combination was associated with an increased rate of acute kidney injury (rate ratio 1.31, 95% confidence interval 1.12 to 1.53). In secondary analyses, the highest risk was observed in the first 30 days of use (rate ratio 1.82, 1.35 to 2.46). Conclusions A triple therapy combination consisting of diuretics with angiotensin converting enzyme inhibitors or angiotensin receptor blockers and NSAIDs was associated with an increased risk of acute kidney injury. The risk was greatest at the start of treatment. Although antihypertensive drugs have cardiovascular benefits, vigilance may be warranted when they are used concurrently with NSAIDs.	[Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Lapi, Francesco; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Lapi, Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3G 1A4, Canada; [Nessim, Sharon J.] McGill Univ, Jewish Gen Hosp, Div Nephrol, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; University of Florence; McGill University; McGill University	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	Azoulay, Laurent/Z-4421-2019		Drug Safety and Effectiveness Network (DSEN); Canadian Institute of Health Research (CIHR); Canada Foundation for Innovation	Drug Safety and Effectiveness Network (DSEN); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was funded in part by infrastructure grants from the Drug Safety and Effectiveness Network (DSEN), the Canadian Institute of Health Research (CIHR), and the Canada Foundation for Innovation. The funding sources had no role in the design, analysis, or interpretation of the results, and thus the authors were independent from the funding sources. FL is the recipient of an LDI post-doctoral research award, LA is the recipient of a Chercheur-Boursier career award from the Fonds de recherche en sante du Quebec, and SS is the recipient of the James McGill chair award.	Adhiyaman V, 2001, J ROY SOC MED, V94, P512, DOI 10.1177/014107680109401005; Baraldi A, 1998, NEPHROL DIAL TRANSPL, V13, P25, DOI 10.1093/ndt/13.suppl_7.25; Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Feenstra H, 2001, ANN INTERN MED, V134, P569, DOI 10.7326/0003-4819-134-7-200104030-00010; Girman CJ, 2012, DIABETIC MED, V29, P614, DOI 10.1111/j.1464-5491.2011.03498.x; Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101; Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005; Han L, 2012, ANN EPIDEMIOL, V22, P9, DOI 10.1016/j.annepidem.2011.10.004; Hernandez-Diaz S, 2001, AM J MED S1, V110, P20, DOI DOI 10.1016/S0002-9343(00)00682-3; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Ishiguro C, 2008, J EPIDEMIOL, V18, P119, DOI 10.2188/jea.JE2007413; Kellum JA, 2002, CRIT CARE MED, V30, P2156, DOI 10.1097/00003246-200209000-00041; Kellum J, 2007, AM FAM PHYSICIAN, V76, P418; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Knauf H, 2006, EUR J CLIN PHARMACOL, V62, P885, DOI 10.1007/s00228-006-0190-3; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; LaCivita C, 2009, J AM PHARM ASSOC, V49, pE110, DOI 10.1331/JAPhA.2009.09005; Lafrance JP, 2009, PHARMACOEPIDEM DR S, V18, P923, DOI 10.1002/pds.1798; LaMarr B, 2010, AM J HEALTH-SYST PH, V67, P290, DOI 10.2146/ajhp090009; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; MATHEW TH, 1992, MED J AUSTRALIA, V156, P724, DOI 10.5694/j.1326-5377.1992.tb121517.x; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Morabito S, 2012, J NEPHROL, V25, P1098, DOI 10.5301/jn.5000101; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; NHS Information Centre for Health and Social Care, 2012, QOF 2009 10 DAT TABL; Olsen MH, 2010, J HYPERTENS, V28, P1593, DOI 10.1097/HJH.0b013e32833b7b08; Perez Gutthann S, 1996, ARCH INTERN MED, V156, P2433; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P897, DOI 10.1001/jama.2010.1205; Quartey G, 2011, PHARM STAT, V10, P539, DOI 10.1002/pst.528; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; Schneider V, 2006, AM J EPIDEMIOL, V164, P881, DOI 10.1093/aje/kwj331; SHUSTERMAN N, 1987, AM J MED, V83, P65, DOI 10.1016/0002-9343(87)90498-0; Smets HLE, 2008, PHARMACOEPIDEM DR S, V17, P1014, DOI 10.1002/pds.1641; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; Taber SS, 2008, EXPERT OPIN DRUG SAF, V7, P679, DOI [10.1517/14740330802410462, 10.1517/14740330802410462 ]; Thomas MC, 2000, MED J AUSTRALIA, V172, P184, DOI 10.5694/j.1326-5377.2000.tb125548.x; Thurman JM, 2008, KIDNEY INT, V73, P379, DOI 10.1038/sj.ki.5002739; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; World Health Organisation (WHO), DAT; Wu TY, 2010, J ROY SOC MED, V103, P239, DOI 10.1258/jrsm.2010.100113; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	55	189	191	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8525	10.1136/bmj.e8525	http://dx.doi.org/10.1136/bmj.e8525			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299844	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000313553800001
J	Mellen, M; Ayata, P; Dewell, S; Kriaucionis, S; Heintz, N				Mellen, Marian; Ayata, Pinar; Dewell, Scott; Kriaucionis, Skirmantas; Heintz, Nathaniel			MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; DNA METHYLATION; RETT-SYNDROME; HISTONE H1; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PHOSPHORYLATION; EXPRESSION; WIDE; QUANTIFICATION	The high level of 5-hydroxymethylcytosine (5hmC) present in neuronal genomes suggests that mechanisms interpreting 5hmC in the CNS may differ from those present in embryonic stem cells. Here, we present quantitative, genome-wide analysis of 5hmC, 5-methylcytosine (5mC), and gene expression in differentiated CNS cell types in vivo. We report that 5hmC is enriched in active genes and that, surprisingly, strong depletion of 5mC is observed over these regions. The contribution of these epigenetic marks to gene expression depends critically on cell type. We identify methyl-CpG-binding protein 2 (MeCP2) as the major 5hmC-binding protein in the brain and demonstrate that MeCP2 binds 5hmC- and 5mC-containing DNA with similar high affinities. The Rett-syndrome-causing mutation R133C preferentially inhibits 5hmC binding. These findings support a model in which 5hmC and MeCP2 constitute a cell-specific epigenetic mechanism for regulation of chromatin structure and gene expression.	[Kriaucionis, Skirmantas] Univ Oxford, ORCRB, Ludwig Inst Canc Res, Lab Epigenet Mech, Oxford OX3 7DQ, England; [Mellen, Marian; Ayata, Pinar; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	Ludwig Institute for Cancer Research; University of Oxford; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Kriaucionis, S (corresponding author), Univ Oxford, ORCRB, Ludwig Inst Canc Res, Lab Epigenet Mech, Oxford OX3 7DQ, England.	skirmantas.kriaucionis@ludwig.ox.ac.uk; heintz@rockefeller.edu	Kriaucionis, Skirmantas/A-2986-2015	Kriaucionis, Skirmantas/0000-0002-2273-5994; Mellen, Marian/0000-0003-1056-4371; Ayata, Pinar/0000-0001-7621-832X	Howard Hughes Medical Institute; Simons Foundation Autism Research Initiative; Conte Center PHS [MH090963]; Ludwig Institute for Cancer Research; Spanish MECD; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Autism Research Initiative; Conte Center PHS; Ludwig Institute for Cancer Research; Spanish MECD(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute (N.H.), Simons Foundation Autism Research Initiative (N.H.), Conte Center PHS MH090963 (N.H.), Ludwig Institute for Cancer Research (S.K.), and Spanish MECD (M.M.). We wish to thank Chun-Xiao Song and Chuan He for kindly providing 5hmC pull down reagents, Jim Selfridge and Adrian Bird for providing Mecp2-null mouse brains, and Brian Lang at GE Healthcare. We would further like to thank Beatriz Lopez and Betsy Gauthier for their assistance, and Jean-Pierre Roussarie, Anne Schaefer, Emmanuelle Jordi, and Ron Gejman for their advice. We also thank Connie Zhao, Christina Caserio, and Wenxiang Zhang from the Rockefeller University Genomics Resource Center; Svetlana Mazel, Selamawit Tadesse, Xiao Li, and Stanka Semova from the Rockefeller University Flow Cytometry Resource Center; and Henrik Molina, Joseph Fernandez, Milica Tesic Mark, and Susan Powell from The Rockefeller University Proteomics Resource Center.	Adkins NL, 2011, BIOCHEM CELL BIOL, V89, P1, DOI 10.1139/O10-112; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; CAMPOY FJ, 1995, J BIOL CHEM, V270, P26473, DOI 10.1074/jbc.270.44.26473; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Gonzales ML, 2012, MOL CELL BIOL, V32, P2894, DOI 10.1128/MCB.06728-11; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LANGE W, 1975, CELL TISSUE RES, V157, P115; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Palay S.L., 1974, CEREBELLAR CORTEX CY; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rutlin M, 2011, NEURON, V72, P3, DOI 10.1016/j.neuron.2011.09.017; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tao JF, 2009, INT REV NEUROBIOL, V89, P147, DOI 10.1016/S0074-7742(09)89007-7; Thambirajah AA, 2012, NUCLEIC ACIDS RES, V40, P2884, DOI 10.1093/nar/gkr1066; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	46	664	690	5	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1417	1430		10.1016/j.cell.2012.11.022	http://dx.doi.org/10.1016/j.cell.2012.11.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260135	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000312890300009
J	DeWeerdt, S				DeWeerdt, Sarah			PSYCHODERMATOLOGY An emotional response	NATURE			English	Editorial Material							PSORIASIS; STRESS											Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Fortune DG, 2002, BRIT J DERMATOL, V146, P458, DOI 10.1046/j.1365-2133.2002.04622.x; Heller M M, 2011, Skin Therapy Lett, V16, P1; Kleyn CE, 2008, J INVEST DERMATOL, V128, P1273, DOI 10.1038/sj.jid.5701144; Richards HL, 2005, BRIT J DERMATOL, V153, P1114, DOI 10.1111/j.1365-2133.2005.06817.x; Verhoeven EWM, 2009, BRIT J DERMATOL, V161, P295, DOI 10.1111/j.1365-2133.2009.09194.x	6	8	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					562	563		10.1038/492S62a	http://dx.doi.org/10.1038/492S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254976	Bronze			2022-12-01	WOS:000312488200008
J	Klein, BEK; Howard, KP; Gangnon, RE; Dreyer, JO; Lee, KE; Klein, R				Klein, Barbara E. K.; Howard, Kerri P.; Gangnon, Ronald E.; Dreyer, Jennifer O.; Lee, Kristine E.; Klein, Ronald			Long-term Use of Aspirin and Age-Related Macular Degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAVER-DAM EYE; LOW-DOSE ASPIRIN; VISUAL-ACUITY; INTRAOCULAR HEMORRHAGE; MACULOPATHY; POPULATION; ANTICOAGULANTS; PROGRESSION; PHYSICIANS; PERIOD	Context Aspirin is widely used for relief of pain and for cardioprotective effects. Its use is of concern to ophthalmologists when ocular surgery is being considered and also in the presence of age-related macular degeneration (AMD). Objective To examine the association of regular aspirin use with incidence of AMD. Design, Setting, and Participants The Beaver Dam Eye Study, a longitudinal population-based study of age-related eye diseases conducted in Wisconsin. Examinations were performed every 5 years over a 20-year period (1988-1990 through 20082010). Study participants (N=4926) were aged 43 to 86 years at the baseline examination. At subsequent examinations, participants were asked if they had regularly used aspirin at least twice a week for more than 3 months. Main Outcome Measure Incidence of early AMD, late AMD, and 2 subtypes of late AMD (neovascular AMD and pure geographic atrophy), assessed in retinal photographs according to the Wisconsin Age-Related Maculopathy Grading System. Results The median duration of follow-up was 14.8 years. There were 512 incident cases of early AMD (of 6243 person-visits at risk) and 117 incident cases of late AMD (of 8621 person-visits at risk) over the course of the study. Regular aspirin use 10 years prior to retinal examination was associated with late AMD (hazard ratio [HR], 1.63 [95% CI, 1.01-2.63]; P=.05), with estimated incidence of 1.76% (95% CI, 1.17%-2.64%) in regular users and 1.03% (95% CI, 0.70%-1.51%) in nonusers. For subtypes of late AMD, regular aspirin use 10 years prior to retinal examination was significantly associated with neovascular AMD (HR, 2.20 [95% CI, 1.20-4.15]; P=.01) but not pure geographic atrophy (HR, 0.66 [95% CI, 0.25-1.95]; P=.45). Aspirin use 5 years (HR, 0.86 [95% CI, 0.71-1.05]; P=.13) or 10 years (HR, 0.86 [95% CI, 0.65-1.13]; P=.28) prior to retinal examination was not associated with incident early AMD. Conclusions Among an adult cohort, aspirin use 5 years prior to observed incidence was not associated with incident early or late AMD. However, regular aspirin use 10 years prior was associated with a small but statistically significant increase in the risk of incident late and neovascular AMD. JAMA. 2012;308(23):2469-2478 www.jama.com	[Klein, Barbara E. K.; Howard, Kerri P.; Dreyer, Jennifer O.; Lee, Kristine E.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53726 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Klein, BEK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, 610 N Walnut St,4th Floor WARF, Madison, WI 53726 USA.	kleinb@epi.ophth.wisc.edu		Gangnon, Ronald/0000-0003-2587-6714; Klein, Ronald/0000-0002-4428-6237	National Institutes of Health (NIH) [EY06594]; National Eye Institute; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) grant EY06594 (Drs B. E. K. Klein, R. Klein). The National Eye Institute provided funding for the entire study, including for collection and analyses of data. Additional support was provided by Senior Scientific Investigator Awards from Research to Prevent Blindness (Drs B. E. K. Klein, R. Klein).	Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Christen WG, 2001, ARCH OPHTHALMOL-CHIC, V119, P1143, DOI 10.1001/archopht.119.8.1143; Christen WG, 2009, OPHTHALMOLOGY, V116, P2386, DOI 10.1016/j.ophtha.2009.05.031; de Jong PTVM, 2012, OPHTHALMOLOGY, V119, P112, DOI 10.1016/j.ophtha.2011.06.025; ELBABA F, 1986, OPHTHALMOLOGY, V93, P1581; Goertz O, 2011, BURNS, V37, P656, DOI 10.1016/j.burns.2011.01.004; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Kiernan DF, 2010, RETINA-J RET VIT DIS, V30, P1573, DOI 10.1097/IAE.0b013e3181e2266d; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 1996, OPHTHALMOLOGY, V103, P1169, DOI 10.1016/S0161-6420(96)30526-5; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2006, AM J OPHTHALMOL, V142, P539, DOI 10.1016/j.ajo.2006.06.015; RIDKER PM, 1991, AM HEART J, V122, P1588, DOI 10.1016/0002-8703(91)90275-M; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Scheck A, DAILY ASPIRIN USE AS; Singer JD, 2003, APPL LONGITUDINAL DA, P407; Tilanus MAD, 2000, GRAEF ARCH CLIN EXP, V238, P482, DOI 10.1007/PL00007887; US FOOD and Drug Administration (FDA), ASP QUEST ANSW	22	47	50	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2469	2478		10.1001/jama.2012.65406	http://dx.doi.org/10.1001/jama.2012.65406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288416	Bronze, Green Accepted			2022-12-01	WOS:000312441400023
J	Ashdown, HF; D'Souza, N; Karim, D; Stevens, RJ; Huang, A; Harnden, A				Ashdown, Helen F.; D'Souza, Nigel; Karim, Diallah; Stevens, Richard J.; Huang, Andrew; Harnden, Anthony			CHRISTMAS 2012: RESEARCH Pain over speed bumps in diagnosis of acute appendicitis: diagnostic accuracy study	BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS	Objective To assess the diagnostic accuracy of pain on travelling over speed bumps for the diagnosis of acute appendicitis. Design Prospective questionnaire based diagnostic accuracy study. Setting Secondary care surgical assessment unit at a district general hospital in the UK. Participants 101 patients aged 17-76 years referred to the on-call surgical team for assessment of possible appendicitis. Main outcome measures Sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios for pain over speed bumps in diagnosing appendicitis, with histological diagnosis of appendicitis as the reference standard. Results The analysis included 64 participants who had travelled over speed bumps on their journey to hospital. Of these, 34 had a confirmed histological diagnosis of appendicitis, 33 of whom reported increased pain over speed bumps. The sensitivity was 97% (95% confidence interval 85% to 100%), and the specificity was 30% (15% to 49%). The positive predictive value was 61% (47% to 74%), and the negative predictive value was 90% (56% to 100%). The likelihood ratios were 1.4 (1.1 to 1.8) for a positive test result and 0.1 (0.0 to 0.7) for a negative result. Speed bumps had a better sensitivity and negative likelihood ratio than did other clinical features assessed, including migration of pain and rebound tenderness. Conclusions Presence of pain while travelling over speed bumps was associated with an increased likelihood of acute appendicitis. As a diagnostic variable, it compared favourably with other features commonly used in clinical assessment. Asking about speed bumps may contribute to clinical assessment and could be useful in telephone assessment of patients.	[Ashdown, Helen F.; Stevens, Richard J.; Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [D'Souza, Nigel; Karim, Diallah; Huang, Andrew] Stoke Mandeville Hosp, Dept Surg, Aylesbury HP21 8AL, Bucks, England	University of Oxford	Ashdown, HF (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	helen.ashdown@phc.ox.ac.uk	D'Souza, Nigel/AAW-8195-2021	Ashdown, Helen/0000-0002-7758-7095; Stevens, Richard/0000-0002-9258-4060	National Institute for Health Research; University of Oxford; National Institute for Health Research [ACF-2010-13-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	No formal funding. HFA is an academic clinical fellow, which is a scheme partially funded by the National Institute for Health Research. The University of Oxford acted as study sponsor and had no role in the study design, data collection, analysis or interpretation, writing of the paper, or decision to submit for publication. All authors were independent from funders and sponsors.	Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Bickell NA, 2006, J AM COLL SURGEONS, V202, P401, DOI 10.1016/j.jamcollsurg.2005.11.016; Bunn F., 2009, COCHRANE DB SYST REV, V2003, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Department for Transport, 2007, 0107 DEP TRANSP; Golledge J, 1996, ANN ROY COLL SURG, V78, P11; Humes DJ, 2006, BMJ-BRIT MED J, V333, P530, DOI 10.1136/bmj.38940.664363.AE; Lewis SRR, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5976; Towner E, 2001, WHAT WORKS PREVENTIN; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156; WALKER SJ, 1995, ANN ROY COLL SURG, V77, P358	10	16	16	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8012	10.1136/bmj.e8012	http://dx.doi.org/10.1136/bmj.e8012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23247977	Green Published, hybrid			2022-12-01	WOS:000312698700002
J	Taubes, G				Taubes, Gary			Treat obesity as physiology, not physics	NATURE			English	Editorial Material									Nutr Sci Initiat, San Diego, CA USA		Taubes, G (corresponding author), Nutr Sci Initiat, San Diego, CA USA.	taubes@gmail.com							0	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					155	155		10.1038/492155a	http://dx.doi.org/10.1038/492155a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053GM	23235840	Bronze			2022-12-01	WOS:000312259300004
J	Prakash, GKS; Jog, PV; Batamack, PTD; Olah, GA				Prakash, G. K. Surya; Jog, Parag V.; Batamack, Patrice T. D.; Olah, George A.			Taming of Fluoroform: Direct Nucleophilic Trifluoromethylation of Si, B, S, and C Centers	SCIENCE			English	Article							CARBONYL-COMPOUNDS; ELECTROGENERATED BASE; EFFICIENT PRECURSOR; ALDEHYDES; REAGENTS; TRIFLUOROMETHYLTRIMETHYLSILANE; COMPLEXES; SULFIDES	Fluoroform (CF3H), a large-volume by-product of the manufacture of Teflon, refrigerants, polyvinylidene fluoride (PVDF), fire-extinguishing agents, and foams, is a potent and stable greenhouse gas that has found little practical use despite the growing importance of trifluoromethyl (CF3) functionality in more structurally elaborate pharmaceuticals, agrochemicals, and materials. Direct nucleophilic trifluoromethylation using CF3H has been a challenge. Here, we report on a direct trifluoromethylation protocol using close to stoichiometric amounts of CF3H in common organic solvents such as tetrahydrofuran (THF), diethyl ether, and toluene. The methodology is widely applicable to a variety of silicon, boron, and sulfur-based electrophiles, as well as carbon-based electrophiles.	[Prakash, G. K. Surya; Jog, Parag V.; Batamack, Patrice T. D.; Olah, George A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	University of Southern California	Prakash, GKS (corresponding author), Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA.	gprakash@usc.edu	Jog, Parag/AAJ-3401-2021; Prakash, Surya/AAF-1756-2022; Prakash, Surya/AFC-8224-2022		Loker Hydrocarbon Research Institute	Loker Hydrocarbon Research Institute	Support of our work by the Loker Hydrocarbon Research Institute is gratefully acknowledged.	Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; Banks R. E., 1982, PREPARATION PROPERTI; Barhdadi R, 1998, CHEM COMMUN, P1251, DOI 10.1039/a801406j; Billard T, 2001, EUR J ORG CHEM, V2001, P1467; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Folleas B, 1998, TETRAHEDRON LETT, V39, P2973, DOI 10.1016/S0040-4039(98)00391-8; Folleas B, 2000, TETRAHEDRON, V56, P275, DOI 10.1016/S0040-4020(99)00951-5; Forat G., 1996, Eur. Patent, Patent No. [735023, 735023A1]; GROBE J, 1995, SYNLETT, P641; Hagiwara T, 1997, NIPPON KAGAKU KAISHI, P869, DOI 10.1246/nikkashi.1997.869; Han WF, 2012, J FLUORINE CHEM, V140, P7, DOI 10.1016/j.jfluchem.2012.04.012; Hartwig J. F., 2012, [No title captured], Patent No. [US2012/0226041A1, 20120226041]; Khan BA, 2012, CHEM-EUR J, V18, P1577, DOI 10.1002/chem.201102652; Knauber T, 2011, CHEM-EUR J, V17, P2689, DOI 10.1002/chem.201002749; Kolomeitsev AA, 2003, TETRAHEDRON LETT, V44, P8273, DOI 10.1016/j.tetlet.2003.09.072; Langlois B.R., 2005, ACS SYM SER, V911, P57; Langlois BR, 2003, SYNTHESIS-STUTTGART, P185, DOI 10.1055/s-2003-36812; Large S, 2000, J ORG CHEM, V65, P8848, DOI 10.1021/jo000150s; Levin VV, 2011, TETRAHEDRON LETT, V52, P281, DOI 10.1016/j.tetlet.2010.11.025; Molander GA, 2003, ORGANOMETALLICS, V22, P3313, DOI 10.1021/om0302645; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Mukhopadhyay S, 2004, ORG PROCESS RES DEV, V8, P660, DOI 10.1021/op040007r; Novak P, 2012, J AM CHEM SOC, V134, P16167, DOI 10.1021/ja307783w; Novak P, 2012, ANGEW CHEM INT EDIT, V51, P7767, DOI 10.1002/anie.201201613; Olah G. A., 2009, SUPERACID CHEM, V2nd; PAWELKE G, 1989, J FLUORINE CHEM, V42, P429, DOI 10.1016/S0022-1139(00)83934-2; Popov I, 2011, J AM CHEM SOC, V133, P9286, DOI 10.1021/ja2041942; Prakash G. K. S., 2012, PCT Patent Appln., Patent No. [WO 2012/148772 A1, 2012148772, WO 2012/148772]; Prakash G. K. S., 2004, U.S. Patent, Patent No. [6,803,477, 6803477]; Prakash GKS, 1996, SYNLETT, P151; Prakash GKS, 2003, J ORG CHEM, V68, P4457, DOI 10.1021/jo030110z; Prakash GKS, 2001, J FLUORINE CHEM, V112, P123, DOI 10.1016/S0022-1139(01)00477-8; PRAKASH GKS, 1989, J AM CHEM SOC, V111, P393, DOI 10.1021/ja00183a073; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; RAMAIAH P, 1995, ORG SYNTH, V72, P232; Rijs NJ, 2012, DALTON T, V41, P3395, DOI 10.1039/c2dt12117d; RUPPERT I, 1984, TETRAHEDRON LETT, V25, P2195, DOI 10.1016/S0040-4039(01)80208-2; SHONO T, 1991, J ORG CHEM, V56, P2, DOI 10.1021/jo00001a002; Stahly G. P., 1989, U.S. Patents, Patent No. [4804774, 4804774A]; STAHLY GP, 1989, J ORG CHEM, V54, P2873, DOI 10.1021/jo00273a020; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P7153, DOI 10.1002/anie.201101691; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Ye YD, 2011, ORG LETT, V13, P5464, DOI 10.1021/ol202174a; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026	46	217	220	2	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1324	1327		10.1126/science.1227859	http://dx.doi.org/10.1126/science.1227859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224551				2022-12-01	WOS:000311991200061
J	Wang, WJ; Nossoni, Z; Berbasova, T; Watson, CT; Yapici, I; Lee, KSS; Vasileiou, C; Geiger, JH; Borhan, B				Wang, Wenjing; Nossoni, Zahra; Berbasova, Tetyana; Watson, Camille T.; Yapici, Ipek; Lee, Kin Sing Stephen; Vasileiou, Chrysoula; Geiger, James H.; Borhan, Babak			Tuning the Electronic Absorption of Protein-Embedded All-trans-Retinal	SCIENCE			English	Article							SCHIFF-BASE COUNTERION; BINDING PROTEINS; VISUAL PIGMENTS; RHODOPSIN; COLOR	Protein-chromophore interactions are a central component of a wide variety of critical biological processes such as color vision and photosynthesis. To understand the fundamental elements that contribute to spectral tuning of a chromophore inside the protein cavity, we redesigned human cellular retinol binding protein II (hCRBPII) to fully encapsulate all-trans-retinal and form a covalent bond as a protonated Schiff base. This system, using rational mutagenesis designed to alter the electrostatic environment within the binding pocket of the host protein, enabled regulation of the absorption maximum of the pigment in the range of 425 to 644 nanometers. With only nine point mutations, the hCRBPII mutants induced a systematic shift in the absorption profile of all-trans-retinal of more than 200 nanometers across the visible spectrum.	[Wang, Wenjing; Nossoni, Zahra; Berbasova, Tetyana; Watson, Camille T.; Yapici, Ipek; Lee, Kin Sing Stephen; Vasileiou, Chrysoula; Geiger, James H.; Borhan, Babak] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	geiger@chemistry.msu.edu; babak@chemistry.msu.edu	Wang, Wenjing/G-7318-2017; Lee, Kin Sing Stephen/I-9476-2012	Wang, Wenjing/0000-0001-6025-9848; Lee, Kin Sing Stephen/0000-0003-4541-3063; Geiger, James/0000-0002-9443-4488	NIH [R01-GM54082]; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division [DE-FG02-06ER15822]; DOE Office of Energy Research [W-31-109-ENG-38]; DOE, Office of Science, Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067311, R01GM054082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division; DOE Office of Energy Research; DOE, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01-GM54082. We thank the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division (grant DE-FG02-06ER15822 to J.H.G.) and the beamline staff at LS-CAT 21-ID (supported by the DOE Office of Energy Research under contract W-31-109-ENG-38). The Advanced Photon Source is supported by the DOE, Office of Science, Basic Energy Sciences, under contract W-31-109-ENG-38. PDB accession codes for the crystal structures used in this study: 4EXZ (Q108K:K40L); 4EEJ (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4R); 4GKC (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4A); 4EFG (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L); 4EDE (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:A33W). Michigan State University has applied for a patent titled "Colorimetric and Fluorescent Proteins" (U.S. patent pending, serial no. 13/636,499) related to the design methods and materials presented in this work.	BURGI HB, 1983, ACCOUNTS CHEM RES, V16, P153, DOI 10.1021/ar00089a002; Coto PB, 2006, P NATL ACAD SCI USA, V103, P17154, DOI 10.1073/pnas.0604048103; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Gunasekaran K, 2004, PROTEINS, V54, P179, DOI 10.1002/prot.10520; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Lee KSS, 2012, CHEMPLUSCHEM, V77, P273, DOI 10.1002/cplu.201100082; Li E, 1996, ANNU REV NUTR, V16, P205, DOI 10.1146/annurev.nu.16.070196.001225; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Nielsen MB, 2009, CHEM SOC REV, V38, P913, DOI 10.1039/b802068j; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Rajamani R, 2011, J COMPUT CHEM, V32, P854, DOI 10.1002/jcc.21663; Rajput J, 2010, ANGEW CHEM INT EDIT, V49, P1790, DOI 10.1002/anie.200905061; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Vasileiou C, 2007, J AM CHEM SOC, V129, P6140, DOI 10.1021/ja067546r	18	87	87	1	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1340	1343		10.1126/science.1226135	http://dx.doi.org/10.1126/science.1226135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224553	Green Accepted			2022-12-01	WOS:000311991200066
J	Kainer, MA; Reagan, DR; Nguyen, DB; Wiese, AD; Wise, ME; Ward, J; Park, BJ; Kanago, ML; Baumblatt, J; Schaefer, MK; Berger, BE; Marder, EP; Min, JY; Dunn, JR; Smith, RM; Dreyzehner, J; Jones, TF				Kainer, Marion A.; Reagan, David R.; Nguyen, Duc B.; Wiese, Andrew D.; Wise, Matthew E.; Ward, Jennifer; Park, Benjamin J.; Kanago, Meredith L.; Baumblatt, Jane; Schaefer, Melissa K.; Berger, Brynn E.; Marder, Ellyn P.; Min, Jea-Young; Dunn, John R.; Smith, Rachel M.; Dreyzehner, John; Jones, Timothy F.		Tennessee Fungal Meningitis Invest	Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASPERGILLUS MENINGITIS; EPIDURAL ABSCESS; SRI-LANKA; OUTBREAK; EXSEROHILUM; PHEOHYPHOMYCOSIS; VORICONAZOLE; MANAGEMENT; INJECTION	Background We investigated an outbreak of fungal infections of the central nervous system that occurred among patients who received epidural or paraspinal glucocorticoid injections of preservative-free methylprednisolone acetate prepared by a single compounding pharmacy. Methods Case patients were defined as patients with fungal meningitis, posterior circulation stroke, spinal osteomyelitis, or epidural abscess that developed after epidural or paraspinal glucocorticoid injections. Clinical and procedure data were abstracted. A cohort analysis was performed. Results The median age of the 66 case patients was 69 years (range, 23 to 91). The median time from the last epidural glucocorticoid injection to symptom onset was 18 days (range, 0 to 56). Patients presented with meningitis alone (73%), the cauda equina syndrome or focal infection (15%), or posterior circulation stroke with or without meningitis (12%). Symptoms and signs included headache (in 73% of the patients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff neck (in 29%). The median cerebrospinal fluid white-cell count on the first lumbar puncture among patients who presented with meningitis, with or without stroke or focal infection, was 648 per cubic millimeter (range, 6 to 10,140), with 78% granulocytes (range, 0 to 97); the protein level was 114 mg per deciliter (range, 29 to 440); and the glucose concentration was 44 mg per deciliter (range, 12 to 121) (2.5 mmol per liter [range, 0.7 to 6.7]). A total of 22 patients had laboratory confirmation of Exserohilum rostratum infection (21 patients) or Aspergillus fumigatus infection (1 patient). The risk of infection increased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translaminar approach to epidural glucocorticoid injection. Voriconazole was used to treat 61 patients (92%); 35 patients (53%) were also treated with liposomal amphotericin B. Eight patients (12%) died, seven of whom had stroke. Conclusions We describe an outbreak of fungal meningitis after epidural or paraspinal glucocorticoid injection with methylprednisolone from a single compounding pharmacy. Rapid recognition of illness and prompt initiation of therapy are important to prevent complications. (Funded by the Tennessee Department of Health and the Centers for Disease Control and Prevention.)	[Kainer, Marion A.] Tennessee Dept Hlth, Div Communicable & Environm Dis & Emergency Prepa, Nashville, TN 37243 USA; [Nguyen, Duc B.; Wise, Matthew E.; Schaefer, Melissa K.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Nguyen, Duc B.; Baumblatt, Jane; Smith, Rachel M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Park, Benjamin J.; Smith, Rachel M.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Tennessee Department Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kainer, MA (corresponding author), Tennessee Dept Hlth, Div Communicable & Environm Dis & Emergency Prepa, 1st Fl,Cordell Hull Bldg,425 5th Ave N, Nashville, TN 37243 USA.	marion.kainer@tn.gov	Wiese, Andrew D/U-9745-2017; Wiese, Andrew D/D-2200-2019	Wiese, Andrew D/0000-0002-0699-4224; Wiese, Andrew D/0000-0002-0699-4224; Pepe, Dana/0000-0002-5519-4506; Marder, Ellyn/0000-0003-3331-7920; Kainer, Marion/0000-0001-7678-8744	Tennessee Department of Health; Centers for Disease Control and Prevention [5U38HM000414-5]; Prevention and Public Health Fund: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology; Laboratory and Health Information Systems Capacity in State and Local Health Departments [3U5OCI000929-02S5]; Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components [1U5OCK000211-01]; Emerging Infections Program [1U5OCK000198-01]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U50CI000929] Funding Source: NIH RePORTER	Tennessee Department of Health; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Prevention and Public Health Fund: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology; Laboratory and Health Information Systems Capacity in State and Local Health Departments; Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components; Emerging Infections Program; National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Tennessee Department of Health, by an appointment to the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists and funded by the Centers for Disease Control and Prevention Cooperative Agreement 5U38HM000414-5, and by the Prevention and Public Health Fund 2012: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments Cooperative Agreement 3U5OCI000929-02S5; the Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components Cooperative Agreement 1U5OCK000211-01; and the Emerging Infections Program Cooperative Agreement 1U5OCK000198-01 (all, Centers for Disease Control and Prevention).	Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; AGARWAL A, 1995, MYCOPATHOLOGIA, V131, P9, DOI 10.1007/BF01103898; Anderson Shoana, 2012, Morbidity and Mortality Weekly Report, V61, P501; Carrino JA, 2002, RADIOLOGY, V225, P723, DOI 10.1148/radiol.2253011401; Centers for Disease Control and Prevention, INT TREATM GUID CENT; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; CLSI, 2008, MM18A CLSI; Food and Drug Administration, 2012, FDA FUNG MEN UPD 10; Frost BA, 2011, NEW ENGL J MED, V365, P2238, DOI 10.1056/NEJMc1105759; Gunaratne P. S., 2006, Ceylon Medical Journal, V51, P137; Gunaratne PS, 2007, NEW ENGL J MED, V356, P754, DOI 10.1056/NEJMc062547; Hooten WM, 2004, MAYO CLIN PROC, V79, P682, DOI 10.4065/79.5.682; Huang RC, 2004, SPINE, V29, pE7, DOI 10.1097/01.BRS.0000106764.40001.84; Jacobs F, 2012, EUR J CLIN MICROBIOL, V31, P1173, DOI 10.1007/s10096-011-1425-5; Jones TF, 2002, AM J MED, V112, P31, DOI 10.1016/S0002-9343(01)01032-4; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; LaSala PR, 2005, PEDIATR INFECT DIS J, V24, P939, DOI 10.1097/01.inf.0000180988.96528.5c; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; McPherson TB, 2006, J AM PHARM ASSOC, V46, P568, DOI 10.1331/1544-3191.46.5.568.McPherson; Muijsers RBR, 2002, DRUGS, V62, P2655, DOI 10.2165/00003495-200262180-00010; NG TTC, 1994, MICROBIOL-UK, V140, P2475, DOI 10.1099/13500872-140-9-2475; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Scott LJ, 2007, DRUGS, V67, P269, DOI 10.2165/00003495-200767020-00009; Sunenshine RH, 2007, CLIN INFECT DIS, V45, P527, DOI 10.1086/520664	28	119	120	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2194	2203		10.1056/NEJMoa1212972	http://dx.doi.org/10.1056/NEJMoa1212972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23131029	Green Accepted			2022-12-01	WOS:000311890600006
J	Scully, T				Scully, Tony			TO THE LIMIT	NATURE			English	Editorial Material																			0	39	40	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S2	S3		10.1038/492S2a	http://dx.doi.org/10.1038/492S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222671	Bronze			2022-12-01	WOS:000311893400002
J	Choat, B; Jansen, S; Brodribb, TJ; Cochard, H; Delzon, S; Bhaskar, R; Bucci, SJ; Feild, TS; Gleason, SM; Hacke, UG; Jacobsen, AL; Lens, F; Maherali, H; Martinez-Vilalta, J; Mayr, S; Mencuccini, M; Mitchell, PJ; Nardini, A; Pittermann, J; Pratt, RB; Sperry, JS; Westoby, M; Wright, IJ; Zanne, AE				Choat, Brendan; Jansen, Steven; Brodribb, Tim J.; Cochard, Herve; Delzon, Sylvain; Bhaskar, Radika; Bucci, Sandra J.; Feild, Taylor S.; Gleason, Sean M.; Hacke, Uwe G.; Jacobsen, Anna L.; Lens, Frederic; Maherali, Hafiz; Martinez-Vilalta, Jordi; Mayr, Stefan; Mencuccini, Maurizio; Mitchell, Patrick J.; Nardini, Andrea; Pittermann, Jarmila; Pratt, R. Brandon; Sperry, John S.; Westoby, Mark; Wright, Ian J.; Zanne, Amy E.			Global convergence in the vulnerability of forests to drought	NATURE			English	Article							HYDRAULIC ARCHITECTURE; TROPICAL FORESTS; XYLEM CAVITATION; WOODY-PLANTS; RAIN-FOREST; DIE-OFF; WATER; VEGETATION; MORTALITY; EMBOLISM	Shifts in rainfall patterns and increasing temperatures associated with climate change are likely to cause widespread forest decline in regions where droughts are predicted to increase in duration and severity(1). One primary cause of productivity loss and plant mortality during drought is hydraulic failure(2-4). Drought stress creates trapped gas emboli in the water transport system, which reduces the ability of plants to supply water to leaves for photosynthetic gas exchange and can ultimately result in desiccation and mortality. At present we lack a clear picture of how thresholds to hydraulic failure vary across a broad range of species and environments, despite many individual experiments. Here we draw together published and unpublished data on the vulnerability of the transport system to drought-induced embolism for a large number of woody species, with a view to examining the likely consequences of climate change for forest biomes. We show that 70% of 226 forest species from 81 sites worldwide operate with narrow (<1 megapascal) hydraulic safety margins against injurious levels of drought stress and therefore potentially face long-term reductions in productivity and survival if temperature and aridity increase as predicted for many regions across the globe(5,6). Safety margins are largely independent of mean annual precipitation, showing that there is global convergence in the vulnerability of forests to drought, with all forest biomes equally vulnerable to hydraulic failure regardless of their current rainfall environment. These findings provide insight into why drought-induced forest decline is occurring not only in arid regions but also in wet forests not normally considered at drought risk(7,8).	[Jansen, Steven] Ulm Univ, Inst Systemat Bot & Ecol, D-89081 Ulm, Germany; [Choat, Brendan] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW 2753, Australia; [Brodribb, Tim J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Cochard, Herve] INRA, PIAF UMR547, F-63100 Clermont Ferrand, France; [Delzon, Sylvain] Univ Bordeaux, INRA, UMR BIOGECO, F-33450 Talence, France; [Bhaskar, Radika] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Bucci, Sandra J.] Univ Nacl Patagonia San Juan Bosco, Dept Biol, Fac Ciencias Nat, RA-9000 Comodoro Rivadavia, Argentina; [Feild, Taylor S.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Gleason, Sean M.; Westoby, Mark; Wright, Ian J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Hacke, Uwe G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada; [Jacobsen, Anna L.; Pratt, R. Brandon] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Lens, Frederic] Leiden Univ, Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Martinez-Vilalta, Jordi] CREAF, Cerdanyola Del Valles 08193, Spain; [Mencuccini, Maurizio] Univ Autonoma Barcelona, ICREA, CREAF, Cerdanyola Del Valles 08193, Spain; [Mayr, Stefan] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria; [Mencuccini, Maurizio] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JN, Midlothian, Scotland; [Mitchell, Patrick J.] CSIRO, Sandy Bay, Tas 7005, Australia; [Nardini, Andrea] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Pittermann, Jarmila] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Sperry, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Zanne, Amy E.] Ctr Conservat & Sustainable Dev, Missouri Bot Garden, St Louis, MO 63166 USA; [Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Ulm University; Western Sydney University; University of Tasmania; INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Brown University; Universidad Nacional de la Patagonia San Juan Bosco; James Cook University; Macquarie University; University of Alberta; California State University System; California State University Bakersfield; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; University of Guelph; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA; University of Innsbruck; University of Edinburgh; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Trieste; University of California System; University of California Santa Cruz; Utah System of Higher Education; University of Utah; Missouri Botanical Gardens; George Washington University	Jansen, S (corresponding author), Ulm Univ, Inst Systemat Bot & Ecol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	steven.jansen@uni-ulm.de	Cochard, Hervé/P-7406-2015; Brodribb, Timothy John/C-6797-2013; Delzon, Sylvain/R-9538-2018; Jansen, Steven/A-9868-2012; Gleason, Sean M/AAZ-7685-2020; Martínez-Vilalta, Jordi/D-3385-2014; Mitchell, Patrick/D-7454-2011; Hacke, Uwe/M-7719-2015; Camarero, J. Julio/A-8602-2013; Mencuccini, Maurizio/B-9052-2011; Wright, Ian J/G-4979-2012; Dorman, Michael/F-7389-2010; Nardini, Andrea/C-6525-2009; Choat, Brendan/C-8445-2009; Lens, Frederic/B-8482-2011	Cochard, Hervé/0000-0002-2727-7072; Brodribb, Timothy John/0000-0002-4964-6107; Delzon, Sylvain/0000-0003-3442-1711; Jansen, Steven/0000-0002-4476-5334; Martínez-Vilalta, Jordi/0000-0002-2332-7298; Mitchell, Patrick/0000-0002-5016-7031; Hacke, Uwe/0000-0001-5983-3582; Camarero, J. Julio/0000-0003-2436-2922; Mencuccini, Maurizio/0000-0003-0840-1477; Wright, Ian J/0000-0001-8338-9143; Choat, Brendan/0000-0002-9105-640X; Lens, Frederic/0000-0002-5001-0149; Gleason, Sean/0000-0002-5607-4741; Bucci, Sandra Janet/0000-0003-1079-9277; Mayr, Stefan/0000-0002-3319-4396; Jacobsen, Anna/0000-0001-7830-5590; Westoby, Mark/0000-0001-7690-4530; Bhaskar, Radika/0000-0002-9191-3555	Alexander von Humboldt Foundation; ICREA Funding Source: Custom; NERC [NE/I011749/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 20852] Funding Source: researchfish; Natural Environment Research Council [NE/I011749/1] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ICREA(ICREA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the ARC-NZ Vegetation Function Network for hosting the original working group from which the data set was compiled. We are grateful to the Alexander von Humboldt Foundation for supporting B.C. during preparation of the manuscript.	Alder NN, 1996, OECOLOGIA, V105, P293, DOI 10.1007/BF00328731; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; [Anonymous], 2009, COPENHAGEN DIAGNOSIS; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Brodribb TJ, 2010, NEW PHYTOL, V188, P533, DOI 10.1111/j.1469-8137.2010.03393.x; Brodribb TJ, 2009, PLANT PHYSIOL, V149, P575, DOI 10.1104/pp.108.129783; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Delzon S, 2010, PLANT CELL ENVIRON, V33, P2101, DOI 10.1111/j.1365-3040.2010.02208.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Martinez-Vilalta J, 2004, PLANT ECOL, V171, P3, DOI 10.1023/B:VEGE.0000029378.87169.b1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meinzer FC, 2009, FUNCT ECOL, V23, P922, DOI 10.1111/j.1365-2435.2009.01577.x; Meir P, 2010, NEW PHYTOL, V187, P553, DOI 10.1111/j.1469-8137.2010.03390.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; Scholz FG, 2011, TREE PHYSIOL-NETH, V4, P341, DOI 10.1007/978-94-007-1242-3_13; Sperry JS, 2006, AM J BOT, V93, P1490, DOI 10.3732/ajb.93.10.1490; Sperry JS, 1998, PLANT CELL ENVIRON, V21, P347, DOI 10.1046/j.1365-3040.1998.00287.x; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Wortemann R, 2011, TREE PHYSIOL, V31, P1175, DOI 10.1093/treephys/tpr101; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	30	1492	1579	72	1628	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					752	+		10.1038/nature11688	http://dx.doi.org/10.1038/nature11688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23172141	Green Published			2022-12-01	WOS:000311606000044
J	Calabrese, JM; Sun, W; Song, LY; Mugford, JW; Williams, L; Yee, D; Starmer, J; Mieczkowski, P; Crawford, GE; Magnuson, T				Calabrese, J. Mauro; Sun, Wei; Song, Lingyun; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Crawford, Gregory E.; Magnuson, Terry			Site-Specific Silencing of Regulatory Elements as a Mechanism of X Inactivation	CELL			English	Article							TROPHOBLAST STEM-CELLS; CHROMOSOME INACTIVATION; XIST RNA; MOUSE; METHYLATION; SEQUENCES; GENOME; GENE; RECRUITMENT; INITIATION	The inactive X chromosome's (Xi) physical territory is microscopically devoid of transcriptional hallmarks and enriched in silencing-associated modifications. How these microscopic signatures relate to specific Xi sequences is unknown. Therefore, we profiled Xi gene expression and chromatin states at high resolution via allele-specific sequencing in mouse trophoblast stem cells. Most notably, X-inactivated transcription start sites harbored distinct epigenetic signatures relative to surrounding Xi DNA. These sites displayed H3-lysine27-trimethylation enrichment and DNaseI hypersensitivity, similar to autosomal Polycomb targets, yet excluded Pol II and other transcriptional hallmarks, similar to nontranscribed genes. CTCF bound X-inactivated and escaping genes, irrespective of measured chromatin boundaries. Escape from X inactivation occurred within, and X inactivation was maintained exterior to, the area encompassed by Xist in cells subject to imprinted and random X inactivation. The data support a model whereby inactivation of specific regulatory elements, rather than a simple chromosome-wide separation from transcription machinery, governs gene silencing over the Xi.	[Calabrese, J. Mauro; Sun, Wei; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC 27599 USA; [Calabrese, J. Mauro; Sun, Wei; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sun, Wei] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Magnuson, T (corresponding author), Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC 27599 USA.	trm4@med.unc.edu		Mieczkowski, Piotr/0000-0003-2418-0096	NIH [R01-GM101974]; UNC Cancer Research Fund; American Cancer Society postdoctoral fellowship [117571-PF-09-124-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074175, R01GM101974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Cancer Research Fund; American Cancer Society postdoctoral fellowship(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Magnuson lab members for critical comments, to Terry Furey and Darin London for DNase-Seq help, and to Victor Lobanenkov for kindly providing the CTCF antibody mixture. This work was supported by the NIH grant R01-GM101974 and UNC Cancer Research Fund. JMC was supported by the American Cancer Society postdoctoral fellowship 117571-PF-09-124-01-DDC.	Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Quinn J, 2006, METH MOLEC MED, V121, P125; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Song L, 2010, COLD SPRING HARB PRO, V2; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Williams LH, 2011, DEVELOPMENT, V138, P2049, DOI 10.1242/dev.061176; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	35	134	139	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					951	963		10.1016/j.cell.2012.10.037	http://dx.doi.org/10.1016/j.cell.2012.10.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178118	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000311423500010
J	Pencheva, N; Tran, H; Buss, C; Huh, D; Drobnjak, M; Busam, K; Tavazoie, SF				Pencheva, Nora; Tran, Hien; Buss, Colin; Huh, Doowon; Drobnjak, Marija; Busam, Klaus; Tavazoie, Sohail F.			Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis	CELL			English	Article							CANCER METASTASIS; TUMOR INVASION; MICRORNAS; GENE; SIGNATURES; SURVIVAL	Through in vivo selection of human cancer cell populations, we uncover a convergent and cooperative miRNA network that drives melanoma metastasis. We identify miR-1908, miR-199a-5p, and miR-199a-3p as endogenous promoters of metastatic invasion, angiogenesis, and colonization in melanoma. These miRNAs convergently target apolipoprotein E (ApoE) and the heat shock factor DNAJA4. Cancer-secreted ApoE suppresses invasion and metastatic endothelial recruitment (MER) by engaging melanoma cell LRP1 and endothelial cell LRP8 receptors, respectively, while DNAJA4 promotes ApoE expression. Expression levels of these miRNAs and ApoE correlate with human metastatic progression outcomes. Treatment of cells with locked nucleic acids (LNAs) targeting these miRNAs inhibits metastasis to multiple organs, and therapeutic delivery of these LNAs strongly suppresses melanoma metastasis. We thus identify miRNAs with dual cell-intrinsic/cell-extrinsic roles in cancer, reveal convergent cooperativity in a metastatic miRNA network, identify ApoE as an anti-angiogenic and metastasis-suppressive factor, and uncover multiple prognostic miRNAs with synergistic combinatorial therapeutic potential in melanoma.	[Pencheva, Nora; Tran, Hien; Buss, Colin; Huh, Doowon; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Drobnjak, Marija; Busam, Klaus] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685; Huh, Doowon/0000-0003-2722-0217; Drobnjak, Marija/0000-0003-0676-4709	Rita Allen foundation; Elizabeth foundation; Vincent Mayer foundation; DOD Era of Hope Scholar award; CTSA [5KL2 RR024142-04]; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024142] Funding Source: NIH RePORTER	Rita Allen foundation; Elizabeth foundation; Vincent Mayer foundation; DOD Era of Hope Scholar award; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the members of our laboratory for thoughtful comments on previous versions of this manuscript and Masoud Tavazoie for insightful discussions regarding melanoma. ApoE null mice were generously provided by Jan Breslow. We thank Jordana Ray-Kirton for tremendous help with clinical sample procurement and Yves Marcel for kindly providing ApoE neutralization antibody. S.F.T. was supported by the Rita Allen and the Elizabeth and Vincent Mayer foundations and a DOD Era of Hope Scholar award. H.T. was partially supported by an NIH/NCRR clinical scholar and CTSA awards 5KL2 RR024142-04. This work was also generously supported by the Melanoma Research Alliance and the Melanoma Research Foundation. S.F.T. is a cofounder and shareholder of Rgenix and a member of its scientific advisory board.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lucas R., 2006, ENV BURDEN DIS SERIE, V13; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; POLLACK VA, 1982, J NATL CANCER I, V69, P137; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6	28	258	276	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1068	1082		10.1016/j.cell.2012.10.028	http://dx.doi.org/10.1016/j.cell.2012.10.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23142051	Green Accepted, Bronze			2022-12-01	WOS:000311423500019
J	Dixson, DL; Hay, ME				Dixson, Danielle L.; Hay, Mark E.			Corals Chemically Cue Mutualistic Fishes to Remove Competing Seaweeds	SCIENCE			English	Article							REGION-WIDE DECLINES; OCEAN ACIDIFICATION; DWELLING GOBIES; GENUS GOBIODON; CLIMATE-CHANGE; BENTHIC ALGAE; REEFS; SPECIALIZATION; BIODIVERSITY; HERBIVORES	Corals in the genus Acropora generate much of the structural complexity upon which coral reefs depend, but they are susceptible to damage from toxic seaweeds. Acropora nasuta minimizes this damage by chemically cuing symbiotic goby fishes (Gobidon histrio or Paragobidon enchinocephalus) to remove the toxic seaweed Chlorodesmis fastigiata. Within minutes of seaweed contact, or contact from only seaweed chemical extract, the coral releases an odor that recruits gobies to trim the seaweed and dramatically reduce coral damage that would otherwise occur. In turn, chemically defended gobies become more toxic after consumption of this noxious alga. Mutualistic gobies and corals appear to represent a marine parallel to terrestrial ant-plants, in that the host provides shelter and food in return for protection from natural enemies.	[Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Aquat Chem Ecol Ctr, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011; Dixson, Danielle L/B-9253-2018	Hay, Mark E/0000-0002-6130-9349; Dixson, Danielle L/0000-0003-1493-1482	NSF [OCE-0929119]; NIH [U01-TW007401]; Teasley Endowment; FOGARTY INTERNATIONAL CENTER [U19TW007401, U01TW007401] Funding Source: NIH RePORTER; Division Of Ocean Sciences [0929119] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support provided by NSF grant OCE-0929119, NIH grant U01-TW007401, and the Teasley Endowment to the Georgia Institute of Technology. We thank the Fijian government and the Korolevu-i-wai district elders for collection and research permissions; B. Devine, J. White, G. Longo, R. Bonaldo, and D. Rasher for field, lab, or statistical assistance; J. Kubanek, D. Rasher, P. Munday, J. P. Hobbs, and anonymous reviewers for comments on the manuscript; and V. Bonito for assisting scientifically and culturally. The data reported in this manuscript are presented in the main paper and supplementary materials.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Brooker RM, 2010, J FISH BIOL, V76, P2578, DOI 10.1111/j.1095-8649.2010.02644.x; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HASHIMOTO Y, 1974, TOXICON, V12, P523, DOI 10.1016/0041-0101(74)90043-9; HAY ME, 1989, OECOLOGIA, V81, P418, DOI 10.1007/BF00377093; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; MEYER KD, 1994, CORAL REEFS, V13, P105, DOI 10.1007/BF00300770; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Riedlecker E, 2009, J ZOOL SYST EVOL RES, V47, P160, DOI 10.1111/j.1439-0469.2008.00497.x; Schubert M, 2003, ENVIRON BIOL FISH, V67, P359, DOI 10.1023/A:1025826829548; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Williams DE, 2012, CORAL REEFS, V31, P369, DOI 10.1007/s00338-011-0847-y	29	47	48	4	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					804	807		10.1126/science.1225748	http://dx.doi.org/10.1126/science.1225748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139333	Green Accepted			2022-12-01	WOS:000310839500046
J	Cardemil, CV; Cortese, MM; Medina-Marino, A; Jasuja, S; Desai, R; Leung, J; Rodriguez-Hart, C; Villarruel, G; Howland, J; Quaye, O; Tam, KI; Bowen, MD; Parashar, UD; Gerber, SI				Cardemil, Cristina V.; Cortese, Margaret M.; Medina-Marino, Andrew; Jasuja, Supriya; Desai, Rishi; Leung, Jessica; Rodriguez-Hart, Cristina; Villarruel, Gissela; Howland, Julia; Quaye, Osbourne; Tam, Ka Ian; Bowen, Michael D.; Parashar, Umesh D.; Gerber, Susan I.		Rotavirus Invest Team	Two Rotavirus Outbreaks Caused by Genotype G2P[4] at Large Retirement Communities Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME; GASTROENTERITIS; INFECTION; VACCINE; SEVERITY; CHILDREN; DIARRHEA; ADULTS; EPIDEMIOLOGY; SURVEILLANCE	Background: Outbreaks of rotavirus gastroenteritis in elderly adults are reported infrequently but are often caused by G2P[4] strains. In 2011, outbreaks were reported in 2 Illinois retirement facilities. Objective: To implement control measures, determine the extent and severity of illness, and assess risk factors for disease among residents and employees. Design: Cohort studies using surveys and medical chart abstraction. Setting: Two large retirement facilities in Cook County, Illinois. Patients: Residents and employees at both facilities and community residents with rotavirus disease. Measurements: Attack rates, hospitalization rates, and rotavirus genotype. Results: At facility A, 84 of 324 residents (26%) were identified with clinical or laboratory-confirmed rotavirus gastroenteritis (median age, 84 years) and 11 (13%) were hospitalized. The outbreak lasted 7 weeks. At facility B, 90 case patients among 855 residents (11%) were identified (median age, 88 years) and 19 (21%) were hospitalized. The facility B outbreak lasted 9.3 weeks. Ill employees were identified at both locations. In each facility, attack rates seemed to differ by residential setting, with the lowest rates among those in more separated settings or with high baseline level of infection control measures. The causative genotype for both outbreaks was G2P[4]. Some individuals shed virus detected by enzyme immunoassay or genotyping reverse transcription polymerase chain reaction for at least 35 days. G2P[4] was also identified in 17 of 19 (89%) samples from the older adult community but only 15 of 40 (38%) pediatric samples. Limitation: Medical or cognitive impairment among residents limited the success of some interviews. Conclusion: Rotavirus outbreaks can occur among elderly adults in residential facilities and can result in considerable morbidity. Among older adults, G2P[4] may be of unique importance. Health professionals should consider rotavirus as a cause of acute gastroenteritis in adults.	[Cortese, Margaret M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Cook Cty Dept Publ Hlth, Oak Forest, IL USA; Illinois Dept Publ Hlth, Chicago, IL USA	Centers for Disease Control & Prevention - USA	Cortese, MM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	mcortese@cdc.gov	Desai, Rishi/AAH-8988-2021	Quaye, Osbourne/0000-0002-0621-876X; , Andrew/0000-0002-0095-4141				ABBAS AMA, 1987, J HOSP INFECT, V9, P76, DOI 10.1016/0195-6701(87)90099-5; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Anderson EJ, 2012, J INFECTION, V64, P89, DOI 10.1016/j.jinf.2011.09.003; Banyai Krisztian, 2002, Orv Hetil, V143, P1347; Barnes GL, 2003, J PEDIATR-US, V142, P722, DOI 10.1067/mpd.2003.240; BARNES GL, 1992, J PAEDIATR CHILD H, V28, P54, DOI 10.1111/j.1440-1754.1992.tb02618.x; BERN C, 1992, J CLIN MICROBIOL, V30, P3234, DOI 10.1128/JCM.30.12.3234-3238.1992; Bishop RF, 1996, ARCH VIROL, P119; Sanz JC, 2009, ENFERM INFEC MICR CL, V27, P219, DOI 10.1016/j.eimc.2008.06.005; Cascio A, 2001, CLIN INFECT DIS, V32, P1126, DOI 10.1086/319744; Chimura Yuri, 2002, Kansenshogaku Zasshi, V76, P450; Clark HF, 2011, HUM VACCINES, V7, P1118, DOI 10.4161/hv.7.11.17820; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; CUBITT WD, 1980, J CLIN PATHOL, V33, P306, DOI 10.1136/jcp.33.3.306; de Rougemont A, 2011, PEDIATR INFECT DIS J, V30, P118, DOI 10.1097/INF.0b013e3181ef034e; Edmonson L M, 2000, J Am Med Dir Assoc, V1, P175; Fauvel M, 1980, CAN DIS WEEKLY REP, V6, P205; Feeney SA, 2006, J MED VIROL, V78, P1119, DOI 10.1002/jmv.20671; Fletcher M., 2000, Morbidity and Mortality Weekly Report, V49, P1131; Freeman MM, 2008, J MED VIROL, V80, P1489, DOI 10.1002/jmv.21228; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J INFECT DIS, V162, P362, DOI 10.1093/infdis/162.2.362; GREEN KY, 1990, J INFECT DIS, V161, P667, DOI 10.1093/infdis/161.4.667; Griffin DD, 2002, J INFECT DIS, V185, P1502, DOI 10.1086/340218; HALVORSRUD J, 1980, SCAND J INFECT DIS, V12, P161, DOI 10.3109/inf.1980.12.issue-3.01; HOLZEL H, 1980, J INFECTION, V2, P33, DOI 10.1016/S0163-4453(80)91750-8; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Iijima Y, 2006, SCAND J INFECT DIS, V38, P490, DOI 10.1080/00365540500532134; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Kapikian A.Z., 1996, FIELDS VIROLOGY, P1657; Kirk MD, 2010, CLIN INFECT DIS, V51, P907, DOI 10.1086/656406; LAMBERT M, 1991, CAN J PUBLIC HEALTH, V82, P351; Lederer P, 1995, Gesundheitswesen, V57, P326; LEWIS DC, 1989, J HOSP INFECT, V14, P9, DOI 10.1016/0195-6701(89)90128-X; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; MARRIE TJ, 1982, ARCH INTERN MED, V142, P313, DOI 10.1001/archinte.142.2.313; Marshall J, 2003, J CLIN VIROL, V28, P331, DOI 10.1016/S1386-6532(03)00081-7; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Mori I, 2002, J MED VIROL, V67, P613, DOI 10.1002/jmv.10147; National Institute of Infectious Diseases, 2000, OUTBR GROUP A ROT GA; Piednoir E, 2010, J HOSP INFECT, V75, P295, DOI 10.1016/j.jhin.2010.03.024; RAO GG, 1995, J HOSP INFECT, V30, P1, DOI 10.1016/0195-6701(95)90244-9; Ryan MJ, 1997, J INFECTION, V34, P49, DOI 10.1016/S0163-4453(97)80009-6; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Skaza A Trop, 2011, EURO SURVEILL, V16; SPRINGTHORPE VS, 1986, J HYG-CAMBRIDGE, V97, P139, DOI 10.1017/S0022172400064433; STEEL HM, 1992, J MED VIROL, V37, P132, DOI 10.1002/jmv.1890370211; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; WANDLESS I, 1981, AGE AGEING, V10, P36, DOI 10.1093/ageing/10.1.36; Yamagami Takaya, 2007, Kansenshogaku Zasshi, V81, P256; YOLKEN RH, 1978, NEW ENGL J MED, V299, P1156, DOI 10.1056/NEJM197811232992103	53	24	25	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					621	+		10.7326/0003-4819-157-9-201211060-00006	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128862				2022-12-01	WOS:000310783300003
J	Zimmermann, M; Lottersberger, F; Buonomo, SB; Sfeir, A; de Lange, T				Zimmermann, Michal; Lottersberger, Francisca; Buonomo, Sara B.; Sfeir, Agnel; de lange, Titia			53BP1 Regulates DSB Repair Using Rif1 to Control 5 ' End Resection	SCIENCE			English	Article							PROTEIN 53BP1; DNA; RECOMBINATION; TELOMERES; DOMAINS; CELLS; CTIP	The choice between double-strand break (DSB) repair by either homology-directed repair (HDR) or nonhomologous end joining (NHEJ) is tightly regulated. Defects in this regulation can induce genome instability and cancer. 53BP1 is critical for the control of DSB repair, promoting NHEJ, and inhibiting the 5' end resection needed for HDR. Using dysfunctional telomeres and genome-wide DSBs, we identify Rif1 as the main factor used by 53BP1 to impair 5' end resection. Rif1 inhibits resection involving CtIP, BLM, and Exo1; limits accumulation of BRCA1/BARD1 complexes at sites of DNA damage; and defines one of the mechanisms by which 53BP1 causes chromosomal abnormalities in Brca1-deficient cells. These data establish Rif1 as an important contributor to the control of DSB repair by 53BP1.	[Zimmermann, Michal; Lottersberger, Francisca; Sfeir, Agnel; de lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA; [Zimmermann, Michal] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Zimmermann, Michal] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Buonomo, Sara B.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy	Rockefeller University; Masaryk University Brno; Masaryk University Brno; European Molecular Biology Laboratory (EMBL)	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Buonomo, Sara/0000-0002-0177-2884; Lottersberger, Francisca/0000-0002-0677-8986	Brno Ph.D. talent fellowship; Czech Science Foundation [P205/12/0550]; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046] Funding Source: NIH RePORTER	Brno Ph.D. talent fellowship; Czech Science Foundation(Grant Agency of the Czech Republic); Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. White for expert mouse husbandry and M. Nussenzweig for providing mutant 53BP1 constructs. M.Z. was supported by a Brno Ph.D. talent fellowship and by a grant from the Czech Science Foundation to Ctirad Hofr (P205/12/0550) (see supplementary materials for detailed acknowledgement). This work was supported by a grant from the Breast Cancer Research Foundation to T.d.L. T.d.L. is an American Cancer Society Research Professor.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388	21	425	439	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					700	704		10.1126/science.1231573	http://dx.doi.org/10.1126/science.1231573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23306437	Green Accepted			2022-12-01	WOS:000314585600044
J	Lee, AM; Kanter, BR; Wang, D; Lim, JP; Zou, ME; Qiu, CC; McMahon, T; Dadgar, J; Fischbach-Weiss, SC; Messing, RO				Lee, Anna M.; Kanter, Benjamin R.; Wang, Dan; Lim, Jana P.; Zou, Mimi E.; Qiu, Chichen; McMahon, Thomas; Dadgar, Jahan; Fischbach-Weiss, Sarah C.; Messing, Robert O.			Prkcz null mice show normal learning and memory	NATURE			English	Article							KINASE M-ZETA; ANXIETY-LIKE BEHAVIOR; PKM-ZETA; DRUG REWARD; C-ZETA; MECHANISM; INHIBITION; PREFERENCE; 3-KINASE	Protein kinase M-zeta (PKM-zeta) is a constitutively active form of atypical protein kinase C that is exclusively expressed in the brain and implicated in the maintenance of long-term memory(1-9). Most studies that support a role for PKM-zeta in memory maintenance have used pharmacological PKM-zeta inhibitors such as the myristoylated zeta inhibitory peptide (ZIP) or chelerythrine. Here we use a genetic approach and target exon 9 of the Prkcz gene to generate mice that lack both protein kinase C-zeta (PKC-zeta) and PKM-zeta (Prkcz(-/-) mice). Prkcz(-/-) mice showed normal behaviour in a cage environment and in baseline tests of motor function and sensory perception, but displayed reduced anxiety-like behaviour. Notably, Prkcz(-/-) mice did not show deficits in learning or memory in tests of cued fear conditioning, novel object recognition, object location recognition, conditioned place preference for cocaine, or motor learning, when compared with wild-type littermates. ZIP injection into the nucleus accumbens reduced expression of cocaine-conditioned place preference in Prkcz(-/-) mice. In vitro, ZIP and scrambled ZIP inhibited PKM-zeta, PKC-iota and PKC-zeta with similar inhibition constant (K-i) values. Chelerythrine was a weak inhibitor of PKM-zeta (K-i = 76 mu M). Our findings show that absence of PKM-zeta does not impair learning and memory in mice, and that ZIP can erase reward memory even when PKM-zeta is not present.	[Lee, Anna M.; Kanter, Benjamin R.; Wang, Dan; Lim, Jana P.; Zou, Mimi E.; Qiu, Chichen; McMahon, Thomas; Dadgar, Jahan; Fischbach-Weiss, Sarah C.; Messing, Robert O.] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Messing, RO (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	romes@gallo.ucsf.edu	Kanter, Benjamin R./AAA-4781-2022; Messing, Robert/D-3642-2015; Lee, Anna/AAH-4598-2020	Messing, Robert/0000-0002-5345-4431; Lee, Anna/0000-0003-4551-0082; Kanter, Benjamin/0000-0003-4114-090X	National Institutes of Health [AA017072]; Canadian Institute of Health Research; State of California for medical research on alcohol and drug abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); State of California for medical research on alcohol and drug abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank V. N. Kharazia and A. J. Lean for assistance. This work was supported by National Institutes of Health grant AA017072 (R.O.M.), a Canadian Institute of Health Research Post-doctoral Fellowship (A. M. L.), and funds provided by the State of California for medical research on alcohol and drug abuse to UCSF.	Brabant C, 2005, PSYCHOPHARMACOLOGY, V180, P33, DOI 10.1007/s00213-004-2138-6; Chen J, 2007, GENES BRAIN BEHAV, V6, P776, DOI 10.1111/j.1601-183X.2007.00311.x; Choi DS, 2002, J NEUROSCI, V22, P9905; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Hardt O, 2010, HIPPOCAMPUS, V20, P691, DOI 10.1002/hipo.20708; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; Lisman J, 2012, HIPPOCAMPUS, V22, P648, DOI 10.1002/hipo.20980; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Parsons RG, 2011, NAT NEUROSCI, V14, P295, DOI 10.1038/nn.2745; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shabashov D, 2012, J MOL NEUROSCI, V47, P546, DOI 10.1007/s12031-011-9671-7; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	24	174	176	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					416	U163		10.1038/nature11803	http://dx.doi.org/10.1038/nature11803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283171	Green Accepted			2022-12-01	WOS:000313615900054
J	Fu, WQ; O'Connor, TD; Jun, G; Kang, HM; Abecasis, G; Leal, SM; Gabriel, S; Altshuler, D; Shendure, J; Nickerson, DA; Bamshad, MJ; Akey, JM				Fu, Wenqing; O'Connor, Timothy D.; Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo; Leal, Suzanne M.; Gabriel, Stacey; Altshuler, David; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.		NHLBI Exome Sequencing Project	Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants	NATURE			English	Article							POPULATION-GROWTH; RARE; MUTATIONS; DISEASE; GENE; EVOLUTION; HISTORY; EXCESS; AGE	Establishing the age of each mutation segregating in contemporary human populations is important to fully understand our evolutionary history(1,2) and will help to facilitate the development of new approaches for disease-gene discovery(3). Large-scale surveys of human genetic variation have reported signatures of recent explosive population growth(4-6), notable for an excess of rare genetic variants, suggesting that many mutations arose recently. To more quantitatively assess the distribution of mutation ages, we resequenced 15,336 genes in 6,515 individuals of European American and African American ancestry and inferred the age of 1,146,401 autosomal single nucleotide variants (SNVs). We estimate that approximately 73% of all protein-coding SNVs and approximately 86% of SNVs predicted to be deleterious arose in the past 5,000-10,000 years. The average age of deleterious SNVs varied significantly across molecular pathways, and disease genes contained a significantly higher proportion of recently arisen deleterious SNVs than other genes. Furthermore, European Americans had an excess of deleterious variants in essential and Mendelian disease genes compared to African Americans, consistent with weaker purifying selection due to the Out-of-Africa dispersal. Our results better delimit the historical details of human protein-coding variation, show the profound effect of recent human history on the burden of deleterious SNVs segregating in contemporary populations, and provide important practical information that can be used to prioritize variants in disease-gene discovery.	[Fu, Wenqing; O'Connor, Timothy D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gabriel, Stacey; Altshuler, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle	Fu, WQ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	wqfu@u.washington.edu; akeyj@u.washington.edu	Abecasis, Goncalo R/B-7840-2010; Singleton, Andrew B/C-3010-2009; de Bakker, Paul IW/B-8730-2009; Jun, Goo/F-1941-2017; Shendure, Jay/AAU-3684-2021; Jun, Goo/M-5235-2016; Altshuler, David M/A-4476-2009	de Bakker, Paul IW/0000-0001-7735-7858; Jun, Goo/0000-0003-0891-0204; Jun, Goo/0000-0003-0891-0204; Altshuler, David M/0000-0002-7250-4107; Ballantyne, Christie/0000-0002-6432-1730; Abecasis, Goncalo/0000-0003-1509-1825; Quinlan, Aaron/0000-0003-1756-0859; Caan, Bette/0000-0002-5803-310X; O'Connor, Timothy/0000-0002-0276-1896; Seshadri, Sudha/0000-0001-6135-2622; Turner, Emily/0000-0001-9040-9229; Akey, Joshua/0000-0002-4411-1330; Bustamante, Carlos D./0000-0002-4187-7920; Shendure, Jay/0000-0002-1516-1865	National Heart, Lung and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102925, RC2HL102924, RC2HL102923, RC2HL103010, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the support of the National Heart, Lung and Blood Institute (NHLBI), the contributions of the research institutions that participated in this study, the study investigators, field staff and study participants who created this resource for biomedical research, and the Population Genetics Project Team of the NHLBI. We thank J. Wilson and R. Do for critical feedback on the manuscript. Funding for the GO (Grand Opportunity) Exome Sequencing Project was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO) and RC2 HL-102924 (WHISP). The exome sequencing was was supported by NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Jia EZ, 2009, MOL BIOL REP, V36, P245, DOI 10.1007/s11033-007-9173-4; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; KIMURA M, 1973, GENETICS, V75, P199; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pyun JA, 2012, MATURITAS, V71, P402, DOI 10.1016/j.maturitas.2012.01.011; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782	27	650	658	4	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					216	220		10.1038/nature11690	http://dx.doi.org/10.1038/nature11690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201682	Green Accepted, Green Submitted			2022-12-01	WOS:000313259600038
J	Hodder, SL; Justman, J; Hughes, JP; Wang, J; Haley, DF; Adimora, AA; Del Rio, C; Golin, CE; Kuo, I; Rompalo, A; Soto-Torres, L; Mannheimer, SB; Johnson-Lewis, L; Eshleman, SH; El-Sadr, WM				Hodder, Sally L.; Justman, Jessica; Hughes, James P.; Wang, Jing; Haley, Danielle F.; Adimora, Adaora A.; Del Rio, Carlos; Golin, Carol E.; Kuo, Irene; Rompalo, Anne; Soto-Torres, Lydia; Mannheimer, Sharon B.; Johnson-Lewis, LeTanya; Eshleman, Susan H.; El-Sadr, Wafaa M.		Womens HIV SeroIncidence Study	HIV Acquisition Among Women From Selected Areas of the United States A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BEHAVIORAL SURVEILLANCE; RISK; MEN; SEX; INFECTION; BIAS	Background: Women account for 23% of newly diagnosed HIV infections in the United States, but there are few recent, well-characterized cohorts of U. S. women in whom behavior characteristics and HIV acquisition have been well-described. Objective: To evaluate HIV incidence and describe behaviors among U. S. women residing in areas of high HIV prevalence. Design: Multisite, longitudinal cohort of women who had HIV rapid testing and audio computer-assisted self-interviews at baseline and every 6 months for up to 12 months. (ClinicalTrials.gov: NCT00995176) Setting: 10 urban and periurban communities with high HIV prevalence and poverty rates, located in the northeastern and southeastern United States. Patients: Venue-based sampling was used to recruit women aged 18 to 44 years who recently had unprotected sex and had 1 or more additional personal or partner risk factors and no self-reported previous HIV diagnosis. Measurements: HIV prevalence and incidence, frequency of HIV risk behaviors, and health status perceptions. Results: Among 2099 high-risk women (85.9% black and 11.7% of Hispanic ethnicity), 32 (1.5%) were diagnosed with HIV infection at enrollment. Annual HIV incidence was 0.32% (95% CI, 0.14% to 0.74%). Older age, substance use, and knowing a partner had HIV were associated with HIV prevalence. Ten women died during the study (0.61% per year). Limitations: Longitudinal assessment of risk behaviors was limited to a maximum of 12 months. There were few incident HIV infections, precluding identification of characteristics predictive of HIV acquisition. Conclusion: This study enrolled a cohort of women with HIV incidence substantially higher than the Centers for Disease Control and Prevention national estimate in the general population of U. S. black women. Concerted efforts to improve preventive health care strategies for HIV and overall health status are needed for similar populations. Primary Funding Source: National Institutes of Health. Ann Intern Med. 2013;158:10-18.	[Hodder, Sally L.] Univ Med & Dent New Jersey, Dept Med, Div Infect Dis, Newark, NJ 07101 USA; Columbia Univ, Coll Phys & Surg, Int AIDS Care & Treatment Program, Joseph L Mailman Sch Publ Hlth, New York, NY USA; Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, New York, NY 10032 USA; Univ Washington, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; FHI 360, Durham, NC USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Ctr AIDS Res, Atlanta, GA 30322 USA; George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; NIAID, NIH, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; Columbia University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; Rollins School Public Health; Emory University; George Washington University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hodder, SL (corresponding author), Univ Med & Dent New Jersey, Dept Med, Div Infect Dis, 185 S Orange Ave,MSB I-506, Newark, NJ 07101 USA.	hoddersa@umdnj.edu	Justman, Jessica/AAA-3572-2020; del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517	National Institutes of Health; National Institute of Allergy and Infectious Diseases [UM1 AI068619, U01-AI068613, UM1-AI068613]; National Institute on Drug Abuse [UM1 AI068619, U01-AI068613, UM1-AI068613]; National Institute of Mental Health [UM1 AI068619, U01-AI068613, UM1-AI068613]; Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University [5UM1A1069466]; University of North Carolina Clinical Trials Unit [AI069423]; University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award [RR 025747]; University of North Carolina Center for AIDS Research [AI050410]; Emory University HIV/AIDS Clinical Trials Unit [5UO1AI069418]; Center for AIDS Research [P30 AI050409]; Clinical and Translational Science Award [UL1 RR025008, ULI RR025008]; Johns Hopkins Adult AIDS Clinical Trials Unit [AI069465]; Johns Hopkins Clinical and Translational Science Award [ULI RR025005]; Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR025008, UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069423, U01AI069418, UM1AI069465, UM1AI069466, U01AI068613, U01AI069465, U01AI069484, P30AI050409, P30AI050410, U01AI069423, UM1AI068619, UM1AI068613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University; University of North Carolina Clinical Trials Unit; University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award; University of North Carolina Center for AIDS Research; Emory University HIV/AIDS Clinical Trials Unit; Center for AIDS Research; Clinical and Translational Science Award; Johns Hopkins Adult AIDS Clinical Trials Unit; Johns Hopkins Clinical and Translational Science Award; Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health.; Grant Support: By the National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, and National Institute of Mental Health (cooperative agreement UM1 AI068619, U01-AI068613, and UM1-AI068613); Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University (5UM1A1069466); University of North Carolina Clinical Trials Unit (AI069423); University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award (RR 025747); University of North Carolina Center for AIDS Research (AI050410); Emory University HIV/AIDS Clinical Trials Unit (5UO1AI069418), Center for AIDS Research (P30 AI050409), and Clinical and Translational Science Award (UL1 RR025008); Johns Hopkins Adult AIDS Clinical Trials Unit (AI069465) and Clinical and Translational Science Award (ULI RR025008); Johns Hopkins Clinical and Translational Science Award (ULI RR025005); and The Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit.	Allen DR, 2009, PUBLIC HEALTH REP, V124, P26, DOI 10.1177/003335490912400106; Brookmeyer R, 1997, J ROY STAT SOC A STA, V160, P127, DOI 10.1111/1467-985X.00049; Centers for Disease Control and Prevention, 2011, HIV WOM; Centers for Disease Control and Prevention, HIV SURV WOM; DeNavas-Walt C., 2009, CURRENT POPULATION R, P60; DiClemente RJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e85; Dr Hodder, 1985, DROP; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; Eshleman SH, 2013, J INFECT DI IN PRESS; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Haley D.F., ADM TECHNICAL LOGIST; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hodder L., OBTAINING FUNDING; Hodder S.L., PROVISION STUDY MAT; Hodder S.L., CRITICAL REVISION AR; Hodder S.L., DRAFTING ARTICLE; Hodder S.L., CONCEPTION DESIGN; Hodder S.L., ANAL INTERPRETATION; Hodder SL, 2010, JAIDS-J ACQ IMM DEF, V55, pS69, DOI 10.1097/QAI.0b013e3181fbbdf9; Laeyendecker O, 2013, J INFECT DI IN PRESS; LOCKE SE, 1992, JAMA-J AM MED ASSOC, V268, P1301, DOI 10.1001/jama.268.10.1301; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; Masciotra S., 2010, 17 C RETR OPP INF SA; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Murphy SL, 2012, NATL VITAL STAT REPO, P60; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; UNAIDS, 2010, GLOB REP UNAIDS REP	34	73	74	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					10	U53		10.7326/0003-4819-158-1-201301010-00004	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277896	Green Accepted			2022-12-01	WOS:000313119900003
J	Li, ZY; Gadue, P; Chen, KF; Jiao, Y; Tuteja, G; Schug, J; Li, W; Kaestner, KH				Li, Zhaoyu; Gadue, Paul; Chen, Kaifu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Li, Wei; Kaestner, Klaus H.			Foxa2 and H2A.Z Mediate Nucleosome Depletion during Embryonic Stem Cell Differentiation	CELL			English	Article							TRANSCRIPTION FACTORS; DNA METHYLATION; HIGH-RESOLUTION; GENOME; ENDODERM; PLURIPOTENT; ENHANCER; GENES; LIVER; MAPS	Nucleosome occupancy is fundamental for establishing chromatin architecture. However, little is known about the relationship between nucleosome dynamics and initial cell lineage specification. Here, we determine the mechanisms that control global nucleosome dynamics during embryonic stem (ES) cell differentiation into endoderm. Both nucleosome depletion and de novo occupation occur during the differentiation process, with higher overall nucleosome density after differentiation. The variant histone H2A.Z and the winged helix transcription factor Foxa2 both act to regulate nucleosome depletion and gene activation, thus promoting ES cell differentiation, whereas DNA methylation promotes nucleosome occupation and suppresses gene expression. Nucleosome depletion during ES cell differentiation is dependent on Nap1l1-coupled SWI/SNF and INO80 chromatin remodeling complexes. Thus, both epigenetic and genetic regulators cooperate to control nucleosome dynamics during ES cell fate decisions.	[Li, Zhaoyu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Li, Zhaoyu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Gadue, Paul] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Chen, Kaifu; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu		Li, Zhaoyu/0000-0002-1136-2758; Li, Wei/0000-0001-9931-5990	National Institute of Diabetes and Digestive and Kidney Diseases [P01-DK049210]; National Science and Engineering Research Council of Canada; Juvenile Diabetes Research Foundation; Cancer Prevention Research Institute of Texas [RP110471-C3]; NATIONAL CANCER INSTITUTE [R00CA168983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK019525] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Shelley Berger for critical comments on the manuscript, and Alan Fox, Olga Smirnova, Matt Mansh, Aline Disimone, Karrie Brondell, Amber Riblett, and James LaRossa for excellent technical support. We thank Drs. Keji Zhao and Gangqing Hu (National Institutes of Health/National Heart, Lung, and Blood Institute) for helpful suggestions on computational analysis on our nucleosome data. We also thank Dr. Philip Streeter (Oregon) for kindly providing the ENDM1 (G10) antibody. This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (P01-DK049210 to K.H.K.). Z.L. was supported by National Science and Engineering Research Council of Canada and Juvenile Diabetes Research Foundation postdoctoral fellowship awards. This study was partially supported by the Cancer Prevention Research Institute of Texas (RP110471-C3 to W.L.). Z.L. and K.H.K. designed the experiments and wrote the manuscript. Z.L. performed the majority of experiments and computational analysis. P.G. and Y.J. did a part of the ES cell culture and sorting. K.C., W.L., G.T., and J.S. contributed to the computational analysis. K.H.K. directed the whole study.	Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2002, MOL CELL BIOL, V22, P856, DOI 10.1128/MCB.22.3.856-865.2002; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	29	148	151	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1608	1616		10.1016/j.cell.2012.11.018	http://dx.doi.org/10.1016/j.cell.2012.11.018			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260146	Green Accepted, Bronze			2022-12-01	WOS:000312890300023
J	Godlee, F				Godlee, Fiona			Withdraw approval for Tamiflu until NICE has full data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; METAANALYSIS; INFLUENZA					fgodlee@bmj.com						Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Godlee F., 2009, BMJ-BRIT MED J, V338, pb463; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350	9	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e8415	10.1136/bmj.e8415	http://dx.doi.org/10.1136/bmj.e8415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236047				2022-12-01	WOS:000312495100017
J	Fang, WW; Wang, X; Bracht, JR; Nowacki, M; Landweber, LF				Fang, Wenwen; Wang, Xing; Bracht, John R.; Nowacki, Mariusz; Landweber, Laura F.			Piwi-Interacting RNAs Protect DNA against Loss during Oxytricha Genome Rearrangement	CELL			English	Article							PARAMECIUM-TETRAURELIA; TETRAHYMENA-THERMOPHILA; C. ELEGANS; LYSINE-9 METHYLATION; EPIGENETIC MEMORY; 3' TERMINI; PIRNAS; GERMLINE; ELIMINATION; GENE	Genome duality in ciliated protozoa offers a unique system to showcase their epigenome as a model of inheritance. In Oxytricha, the somatic genome is responsible for vegetative growth, whereas the germline contributes DNA to the next sexual generation. Somatic nuclear development removes all transposons and other so-called "junk'' DNA, which comprise similar to 95% of the germline. We demonstrate that Piwi-interacting small RNAs (piRNAs) from the maternal nucleus can specify genomic regions for retention in this process. Oxytricha piRNAs map primarily to the somatic genome, representing the similar to 5% of the germline that is retained. Furthermore, injection of synthetic piRNAs corresponding to normally deleted regions leads to their retention in later generations. Our findings highlight small RNAs as powerful transgenerational carriers of epigenetic information for genome programming.	[Wang, Xing; Bracht, John R.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Fang, Wenwen] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Nowacki, Mariusz] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	Princeton University; Princeton University; University of Bern	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Nowacki, Mariusz/E-4485-2011; Wang, Xing/B-3682-2018; Fang, Wenwen/B-8422-2016	Nowacki, Mariusz/0000-0003-4894-2905; Wang, Xing/0000-0001-9930-3287; 	NIH [GM59708]; NSF [0923810, 0900544]; DOD [W81XWH-10-1-0122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708, F32GM099462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOD(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Perlman, B. Zee, and B. Garcia for mass spectrometry validation of the Otiwi1 antibody; J. Buckles, W. Wang, D. Storton, and L. Parsons for Illumina sequencing; L. Li and A. D. Goldman for assistance with phylogenetic analysis; X. Chen for searching the micronuclear genome assembly for junction-spanning piRNAs; A. Chen, K. Mochizuki, and M. Couvillion for sharing RNA IP protocols; E. Swart, J. Bloom, and P. Jiang for advice on computational analysis of deep-sequencing results; J. Postberg and J. Goodhouse for immunofluorescence advice; P. Andolfatto, J. Swan, J. Khurana, P. Schedl, and L. Beh for discussion or comments on the manuscript; and J. Wang for help with Oxytricha cell culture. We also thank three anonymous referees for valuable suggestions. This study was supported by NIH grant GM59708 and NSF grants 0923810 and 0900544 (to L.F.L.) and a DOD predoctoral fellowship W81XWH-10-1-0122 (to W.F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Coyne RS, 2012, METHOD CELL BIOL, V109, P53, DOI 10.1016/B978-0-12-385967-9.00004-9; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gan HY, 2011, RNA, V17, P1191, DOI 10.1261/rna.2648411; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Patzel V, 1999, NUCLEIC ACIDS RES, V27, P4328, DOI 10.1093/nar/27.22.4328; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Storici F, 2008, CURR OPIN MOL THER, V10, P224; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Zahler AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042371; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	71	98	99	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1243	1255		10.1016/j.cell.2012.10.045	http://dx.doi.org/10.1016/j.cell.2012.10.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217708	Green Accepted, Bronze			2022-12-01	WOS:000311999900014
J	Kyritsis, N; Kizil, C; Zocher, S; Kroehne, V; Kaslin, J; Freudenreich, D; Iltzsche, A; Brand, M				Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael			Acute Inflammation Initiates the Regenerative Response in the Adult Zebrafish Brain	SCIENCE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; IN-VIVO; INJURY; PROLIFERATION; TELENCEPHALON; ANTAGONIST; RECEPTOR-1; CELLS	The zebrafish regenerates its brain after injury and hence is a useful model organism to study the mechanisms enabling regenerative neurogenesis, which is poorly manifested in mammals. Yet the signaling mechanisms initiating such a regenerative response in fish are unknown. Using cerebroventricular microinjection of immunogenic particles and immunosuppression assays, we showed that inflammation is required and sufficient for enhancing the proliferation of neural progenitors and subsequent neurogenesis by activating injury-induced molecular programs that can be observed after traumatic brain injury. We also identified cysteinyl leukotriene signaling as an essential component of inflammation in the regenerative process of the adult zebrafish brain. Thus, our results demonstrate that in zebrafish, in contrast to mammals, inflammation is a positive regulator of neuronal regeneration in the central nervous system.	[Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael] Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, D-01307 Dresden, Germany; [Kaslin, Jan] Monash Univ, ARMI, Clayton, Vic 3800, Australia	Technische Universitat Dresden; Australian Regenerative Medicine Institute; Monash University	Brand, M (corresponding author), Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, Fetscherstasse 105, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kizil, Caghan/AFG-2073-2022; Brand, Michael/A-5509-2010; Kizil, Caghan/J-6923-2015; Kyritsis, Nikos/AAD-5187-2021	Kizil, Caghan/0000-0002-8164-9762; Brand, Michael/0000-0001-5711-6512; Kizil, Caghan/0000-0002-8164-9762; Kyritsis, Nikos/0000-0001-7801-5796; Kaslin, Jan/0000-0002-6207-1889; Zocher, Sara/0000-0001-8211-5490; Kroehne, Volker/0000-0002-5610-0866	Deutsche Forschungsgemeinschaft [SFB-655]; European Union (ZF Health, EC) [HEALTH-F4-2010-242048]; Technical University of Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health, EC); Technical University of Dresden	We thank A. Menge for cryosections and paraffin sections, G. Kempermann and C. L. Antos for useful discussions, T. Chavakis for discussions and critical reading on the manuscript, N. Trede for discussion and assistance with the immunosuppression assay, and M. Redd for kindly providing us the L-plastin antibody. This work was supported by research grants from the Deutsche Forschungsgemeinschaft (SFB-655), European Union (ZF Health, EC Grant Agreement HEALTH-F4-2010-242048), and Technical University of Dresden.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martin P, 2009, NATURE, V459, P921, DOI 10.1038/459921a; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Yu GL, 2005, BRAIN RES, V1053, P116, DOI 10.1016/j.brainres.2005.06.046; Zhang WP, 2002, ACTA PHARMACOL SIN, V23, P871	26	341	348	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1353	1356		10.1126/science.1228773	http://dx.doi.org/10.1126/science.1228773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138980				2022-12-01	WOS:000311991200070
J	Kumar, S				Kumar, Subrat			Extinction need not be forever	NATURE			English	Editorial Material									KIIT Univ, Sch Biotechnol, Bhubaneswar, India	Kalinga Institute of Industrial Technology (KIIT)	Kumar, S (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, India.	subrat_kumar@yahoo.com	Kumar, Subrat/P-4225-2014	Kumar, Subrat/0000-0002-0659-6381					0	13	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					9	9		10.1038/492009a	http://dx.doi.org/10.1038/492009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222570	Bronze			2022-12-01	WOS:000311893400014
J	Veronesi, G; Maisonneuve, P; Bellomi, M; Rampinelli, C; Durli, I; Bertolotti, R; Spaggiari, L				Veronesi, Giulia; Maisonneuve, Patrick; Bellomi, Massimo; Rampinelli, Cristiano; Durli, Iara; Bertolotti, Raffaella; Spaggiari, Lorenzo			Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-RISK INDIVIDUALS; NATURAL-HISTORY; GROWTH-RATES; CT; STAGE; TRIAL; CARCINOMA; NODULES; DESIGN; MODEL	Background: Lung cancer screening may detect cancer that will never become symptomatic (overdiagnosis), leading to overtreatment. Changes in size on sequential low-dose computed tomography (LDCT) screening, expressed as volume-doubling time (VDT), may help to distinguish aggressive cancer from cases that are unlikely to become symptomatic. Objective: To assess VDT for screening-detected lung cancer as an indicator of overdiagnosis. Design: Retrospective estimation of the VDT of cancer detected in a prospective LDCT screening cohort. Setting: Nonrandomized, single-center screening study involving persons at high risk for lung cancer enrolled between 2004 and 2005 who received LDCT annually for 5 years. Patients: 175 study patients diagnosed with primary lung cancer. Measurements: VDT was measured on LDCT and classified as fast-growing (<400 days), slow-growing (between 400 and 599 days), or indolent (>= 600 days). Results: Fifty-five cases of cancer were diagnosed at baseline, and 120 were diagnosed subsequently. Of the latter group, 19 cases (15.8%) were new (not visible on previous scans) and fast-growing (median VDT, 52 days); 101 (84.2%) were progressive, including 70 (58.3%) fast-growing and 31 (25.8%) slow-growing (15.0%) or indolent (10.8%) cases. Lung cancer-specific mortality was significantly higher (9.2% per year) in patients with new compared with slow-growing or indolent (0.9% per year) cancer. Sixty percent of fast-growing progressive cancer and 45% of new cancer were stage I, for which survival was good. Limitations: This is a retrospective study. Volume-doubling time can only indicate overdiagnosis and was estimated for new cancer from 1 measurement (a diameter of 2 mm assumed the previous year). Conclusion: Slow-growing or indolent cancer comprised approximately 25% of incident cases, many of which may have been overdiagnosed. To limit overtreatment in these cases, minimally invasive limited resection and nonsurgical treatments should be investigated.	[Veronesi, Giulia] European Inst Oncol, Div Thorac Surg, I-20141 Milan, Italy; Univ Milan, Sch Med, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Veronesi, G (corresponding author), European Inst Oncol, Div Thorac Surg, Via Ripamonti 435, I-20141 Milan, Italy.	giulia.veronesi@ieo.it	Maisonneuve, Patrick/U-9789-2018; Veronesi, Giulia/AAA-6327-2021; Bellomi, Massimo/AAM-4352-2020; Bertolotti, Raffaella/AAO-4674-2020; Spaggiari, Lorenzo/G-7915-2012	Maisonneuve, Patrick/0000-0002-5309-4704; Veronesi, Giulia/0000-0001-9032-1278; Spaggiari, Lorenzo/0000-0002-1068-3541	Italian Association for Cancer Research	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	By the Italian Association for Cancer Research.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Altorki N, 2010, J CLIN ONCOL, V28, P3131, DOI 10.1200/JCO.2009.23.9749; Bach PB, 2008, LANCET ONCOL, V9, P693, DOI 10.1016/S1470-2045(08)70176-1; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Beadsmoore CJ, 2003, EUR J RADIOL, V45, P8, DOI 10.1016/S0720-048X(02)00287-5; Berland Lincoln L, 2009, J Am Coll Radiol, V6, P14, DOI 10.1016/j.jacr.2008.06.018; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Carpagnano GE, 2008, AM J RESP CRIT CARE, V177, P337, DOI 10.1164/rccm.200707-1136OC; Detterbeck FC, 2008, J THORAC ONCOL, V3, P781, DOI 10.1097/JTO.0b013e31817c9230; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Fan J, 2012, ANN SURG ONCOL, V19, P661, DOI 10.1245/s10434-011-1931-9; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; GEDDES DM, 1979, BRIT J DIS CHEST, V73, P1, DOI 10.1016/0007-0971(79)90002-0; HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2011, LUNG CANCER, V71, P328, DOI 10.1016/j.lungcan.2010.10.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Leo F, 1999, THORAC CARDIOV SURG, V47, P53, DOI 10.1055/s-2007-1013110; Lindell RM, 2009, CHEST, V136, P1586, DOI 10.1378/chest.09-0915; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; McMahon PM, 2008, RADIOLOGY, V248, P278, DOI 10.1148/radiol.2481071446; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Raz DJ, 2007, CHEST, V132, P193, DOI 10.1378/chest.06-3096; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sone S, 2000, BRIT J RADIOL, V73, P137, DOI 10.1259/bjr.73.866.10884725; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; USUDA K, 1994, CANCER, V74, P2239, DOI 10.1002/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-P; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2010, ECANCERMEDICALSCIENC, V4, DOI 10.3332/ecancer.2010.186; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Veronesi G, 2011, J THORAC ONCOL, V6, P525, DOI 10.1097/JTO.0b013e318206dbcc; Veronesi G, 2011, CANCER PREV RES, V4, P34, DOI 10.1158/1940-6207.CAPR-10-0182; Veronesi G, 2010, J THORAC CARDIOV SUR, V140, P19, DOI 10.1016/j.jtcvs.2009.10.025; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zhong L, 2005, AM J RESP CRIT CARE, V172, P1308, DOI 10.1164/rccm.200505-830OC	45	127	134	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					776	+		10.7326/0003-4819-157-11-201212040-00005	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	23208167				2022-12-01	WOS:000312000100003
J	Sohi, SP				Sohi, Saran P.			Carbon Storage with Benefits	SCIENCE			English	Editorial Material							BIOCHAR; SOIL; CHARCOAL; UK		Univ Edinburgh, Sch Geosci, UK Biochar Res Ctr, Edinburgh EH9 3JN, Midlothian, Scotland	University of Edinburgh	Sohi, SP (corresponding author), Univ Edinburgh, Sch Geosci, UK Biochar Res Ctr, Edinburgh EH9 3JN, Midlothian, Scotland.	saran.sohi@ed.ac.uk	Sohi, Saran/K-1220-2019	Sohi, Saran/0000-0003-3207-8665				Bird MI, 2008, J ARCHAEOL SCI, V35, P2698, DOI 10.1016/j.jas.2008.04.018; Brewer CE, 2011, BIOENERG RES, V4, P312, DOI 10.1007/s12155-011-9133-7; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dias BO, 2010, BIORESOURCE TECHNOL, V101, P1239, DOI 10.1016/j.biortech.2009.09.024; Elad Y, 2011, PHYTOPATHOL MEDITERR, V50, P335; Hale SE, 2011, ENVIRON SCI TECHNOL, V45, P10445, DOI 10.1021/es202970x; Hammond J, 2011, ENERG POLICY, V39, P2646, DOI 10.1016/j.enpol.2011.02.033; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Prendergast-Miller MT, 2011, SOIL BIOL BIOCHEM, V43, P2243, DOI 10.1016/j.soilbio.2011.07.019; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P1, DOI 10.1016/j.palaeo.2010.03.044; Shackley S, 2011, CARBON MANAG, V2, P335, DOI 10.4155/CMT.11.22; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053	19	283	307	19	448	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1034	1035		10.1126/science.1225987	http://dx.doi.org/10.1126/science.1225987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180849				2022-12-01	WOS:000311390600028
J	Beletsky, L; Rich, JD; Walley, AY				Beletsky, Leo; Rich, Josiah D.; Walley, Alexander Y.			Prevention of Fatal Opioid Overdose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NALOXONE		[Beletsky, Leo] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Beletsky, Leo] Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Beletsky, Leo] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Rich, Josiah D.] Brown Med Sch, Providence, RI USA; [Rich, Josiah D.] Miriam Hosp, Providence, RI 02906 USA; [Walley, Alexander Y.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Walley, Alexander Y.] Boston Med Ctr, Boston, MA USA	Northeastern University; Northeastern University; University of California System; University of California San Diego; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Boston University; Boston Medical Center	Beletsky, L (corresponding author), Northeastern Univ, Sch Law, 400 Huntington Ave, Boston, MA 02115 USA.	l.beletsky@neu.edu		Walley, Alexander/0000-0002-8158-4882; Beletsky, Leo/0000-0003-0726-0676	NIAAA NIH HHS [U01AA11003] Funding Source: Medline; NIAID NIH HHS [P30 AI042853] Funding Source: Medline; NIDA NIH HHS [1R21DA029201, R21 DA029201, R37DA019829, 5K24DA022112, R25 DA013582, R01 DA032082, R25-DA13582, K24 DA022112, R01DA032082, R37 DA019829] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029201, R37DA019829, R25DA013582, K24DA022112, R01DA032082] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; American Medical Association, AMA AD NEW POL ANN M; Beletsky L, 2007, J URBAN HEALTH, V84, P126, DOI 10.1007/s11524-006-9120-z; Burris S., 2009, DREXEL LAW REV, V1, P273; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101	7	75	76	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1863	1864		10.1001/jama.2012.14205	http://dx.doi.org/10.1001/jama.2012.14205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150005	Green Accepted			2022-12-01	WOS:000310952700019
J	Alzu, A; Bermejo, R; Begnis, M; Lucca, C; Piccini, D; Carotenuto, W; Saponaro, M; Brambati, A; Cocito, A; Foiani, M; Liberi, G				Alzu, Amaya; Bermejo, Rodrigo; Begnis, Martina; Lucca, Chiara; Piccini, Daniele; Carotenuto, Walter; Saponaro, Marco; Brambati, Alessandra; Cocito, Andrea; Foiani, Marco; Liberi, Giordano			Senataxin Associates with Replication Forks to Protect Fork Integrity across RNA-Polymerase-II-Transcribed Genes	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; OCULOMOTOR APRAXIA TYPE-2; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GENOMIC INSTABILITY; MESSENGER-RNA; YEAST SEN1; HOMOLOGOUS RECOMBINATION; RESOLVING CONFLICTS	Transcription hinders replication fork progression and stability. The ATR checkpoint and specialized DNA helicases assist DNA synthesis across transcription units to protect genome integrity. Combining genomic and genetic approaches together with the analysis of replication intermediates, we searched for factors coordinating replication with transcription. We show that the Sen1/Senataxin DNA/RNA helicase associates with forks, promoting their progression across RNA polymerase II (RNAPII)-transcribed genes. sen1 mutants accumulate aberrant DNA structures and DNA-RNA hybrids while forks clash head-on with RNAPII transcription units. These replication defects correlate with hyper-recombination and checkpoint activation in sen1 mutants. The Sen1 function at the forks is separable from its role in RNA processing. Our data, besides unmasking a key role for Senataxin in coordinating replication with transcription, provide a framework for understanding the pathological mechanisms caused by Senataxin deficiencies and leading to the severe neurodegenerative diseases ataxia with oculomotor apraxia type 2 and amyotrophic lateral sclerosis 4.	[Alzu, Amaya; Bermejo, Rodrigo; Begnis, Martina; Lucca, Chiara; Piccini, Daniele; Carotenuto, Walter; Saponaro, Marco; Brambati, Alessandra; Cocito, Andrea; Foiani, Marco; Liberi, Giordano] FIRC Inst Mol Oncol IFOM Fdn, I-20139 Milan, Italy; [Brambati, Alessandra; Liberi, Giordano] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Milan	Liberi, G (corresponding author), FIRC Inst Mol Oncol IFOM Fdn, Via Adamello 16, I-20139 Milan, Italy.	giordano.liberi@igm.cnr.it	Bermejo, Rodrigo/S-2445-2019; Bermejo, Rodrigo/AAG-7830-2019; Foiani, Marco/M-8234-2014; LIBERI, GIORDANO/AAY-7273-2020; BRAMBATI, Alessandra/AAY-8195-2020; BRAMBATI, Alessandra/Q-1213-2018; Bermejo, Rodrigo/K-6613-2014; Saponaro, Marco/M-1854-2015	Foiani, Marco/0000-0003-4795-834X; LIBERI, GIORDANO/0000-0003-3160-2242; BRAMBATI, Alessandra/0000-0002-3816-425X; BRAMBATI, Alessandra/0000-0002-3816-425X; Bermejo, Rodrigo/0000-0002-2692-7045; Saponaro, Marco/0000-0002-9302-2553	Spanish Ministry of Science and Innovation [RYC-2010-07131, BFU2011-24909]; European Community [293770]; Associazione Italiana per la Ricerca sul Cancro (AIRC); Telethon-Italy [GGP08057]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon)	We thank Yuki Katou and Katsuhiko Shirahige for assistance with ChIP-chip map construction; Massimo Lopes, Ted Weinert, Michele Giannattasio, and all members of our labs for discussion; and Victor Gonzalez-Huici, Cheng-Fu Kao, Aurora Cerutti, Michael Culbertson, Rosella Visintin, Philip Hieter, and Hannah Klein for reagents, advice, and technical support. We also thank the Microarray Facility at the IFOM-IEO campus. A. B. is a student of the PhD program in Genetics, Molecular, and Cellular Biology of the University of Pavia. R. B. is supported by the Spanish Ministry of Science and Innovation (RYC-2010-07131 and BFU2011-24909) and the European Community's FP7 (under grant agreement 293770). This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) and Telethon-Italy (GGP08057) to G.L.	Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Clelland BW, 2010, TRANSCR-AUSTIN, V1, P115, DOI 10.4161/trns.1.3.13735; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conrad NK, 2000, GENETICS, V154, P557; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hu ZL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl142; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Olavarrieta L, 2002, MOL MICROBIOL, V46, P699, DOI 10.1046/j.1365-2958.2002.03217.x; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; SPENCER F, 1990, GENETICS, V124, P237; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yurov YB, 2011, THESCIENTIFICWORLDJO, V11, P2602, DOI 10.1100/2011/625690	79	152	156	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					835	846		10.1016/j.cell.2012.09.041	http://dx.doi.org/10.1016/j.cell.2012.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141540	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000310921200014
J	Kosuri, P; Alegre-Cebollada, J; Feng, J; Kaplan, A; Ingles-Prieto, A; Badilla, CL; Stockwell, BR; Sanchez-Ruiz, JM; Holmgren, A; Fernandez, JM				Kosuri, Pallav; Alegre-Cebollada, Jorge; Feng, Jason; Kaplan, Anna; Ingles-Prieto, Alvaro; Badilla, Carmen L.; Stockwell, Brent R.; Sanchez-Ruiz, Jose M.; Holmgren, Arne; Fernandez, Julio M.			Protein Folding Drives Disulfide Formation	CELL			English	Article							THIOREDOXIN-LIKE DOMAINS; ACTIVE-SITE CYSTEINE; ENDOPLASMIC-RETICULUM; MOLTEN GLOBULE; SINGLE PROTEIN; NMR-SPECTROSCOPY; LIVING CELLS; ISOMERASE; FORCE; BOND	PDI catalyzes the oxidative folding of disulfide-containing proteins. However, the sequence of reactions leading to a natively folded and oxidized protein remains unknown. Here we demonstrate a technique that enables independent measurements of disulfide formation and protein folding. We find that non-native disulfides are formed early in the folding pathway and can trigger misfolding. In contrast, a PDI domain favors native disulfides by catalyzing oxidation at a late stage of folding. We propose a model for cotranslational oxidative folding wherein PDI acts as a placeholder that is relieved by the pairing of cysteines caused by substrate folding. This general mechanism can explain how PDI catalyzes oxidative folding in a variety of structurally unrelated substrates.	[Kosuri, Pallav] Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10027 USA; [Kosuri, Pallav; Alegre-Cebollada, Jorge; Feng, Jason; Kaplan, Anna; Badilla, Carmen L.; Stockwell, Brent R.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA; [Ingles-Prieto, Alvaro; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, S-17177 Stockholm, Sweden	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of Granada; Karolinska Institutet	Kosuri, P (corresponding author), Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10027 USA.	pallav@caa.columbia.edu; jfernandez@columbia.edu	Ingles-Prieto, Alvaro/A-4365-2017; Sanchez-Ruiz, Jose/H-2849-2015; Kosuri, Pallav/J-8279-2012; Alegre-Cebollada, Jorge/I-4301-2014; Stockwell, Brent R/AAE-7200-2019	Ingles-Prieto, Alvaro/0000-0002-5409-8571; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Kosuri, Pallav/0000-0002-7025-3543; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Stockwell, Brent R/0000-0002-3532-3868	NIH [HL066030, HL061228, CA097061, CA161061, GM085081]; HHMI; Arnold and Mabel Beckman Foundation; Spanish Ministry of Education; Spanish Ministry of Science and Innovation [BIO2009-09562, CSD2009-00088]; FEDER; Fundacion Ibercaja; Training Program in Molecular Biophysics [T32GM008281]; Fulbright scholarship; NATIONAL CANCER INSTITUTE [R01CA097061, R01CA161061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM085081] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Arnold and Mabel Beckman Foundation; Spanish Ministry of Education(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Fundacion Ibercaja; Training Program in Molecular Biophysics; Fulbright scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (HL066030 and HL061228 to J.M.F.; CA097061, CA161061, and GM085081 to B. R. S.), HHMI (B. R. S.), the Arnold and Mabel Beckman Foundation (B. R. S.), the Spanish Ministry of Education (A. I.-P.), the Spanish Ministry of Science and Innovation (BIO2009-09562 and CSD2009-00088 to J.M.S.-R.), FEDER (J.M.S.-R.), Fundacion Ibercaja (J.A.-C.), and the Training Program in Molecular Biophysics (T32GM008281 to A. K.). P. K. was supported by a Fulbright scholarship. P. K., J.A.-C., and J.M.F. designed the experiments. P. K., J.A.-C., and J.F. performed the experiments and analyzed the data. A. K. and B. R. S. provided PDI A1. A. H. provided TRX. A. I.-P. and J.M.S.-R. provided TRX C35S. P. K., J.A.-C., and J.M.F. wrote the manuscript. We thank the members of the Fernandez lab for their illuminating feedback.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Baldwin RL, 2010, PROTEINS, V78, P2725, DOI 10.1002/prot.22803; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Berkovich R, 2010, BIOPHYS J, V98, P2692, DOI 10.1016/j.bpj.2010.02.053; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Chakravarthi Seema, 2009, P81; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI 10.1038/NCHEMBIO.467; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lappi AK, 2011, J MOL BIOL, V409, P238, DOI 10.1016/j.jmb.2011.03.024; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	58	125	126	2	95	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					794	806		10.1016/j.cell.2012.09.036	http://dx.doi.org/10.1016/j.cell.2012.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141538	Green Accepted, Bronze			2022-12-01	WOS:000310921200011
J	Barskey, AE; Schulte, C; Rosen, JB; Handschur, EF; Rausch-Phung, E; Doll, MK; Cummings, KP; Alleyne, EO; High, P; Lawler, J; Apostolou, A; Blog, D; Zimmerman, CM; Montana, B; Harpaz, R; Hickman, CJ; Rota, PA; Rota, JS; Bellini, WJ; Gallagher, KM				Barskey, Albert E.; Schulte, Cynthia; Rosen, Jennifer B.; Handschur, Elizabeth F.; Rausch-Phung, Elizabeth; Doll, Margaret K.; Cummings, Kisha P.; Alleyne, E. Oscar; High, Patricia; Lawler, Jacqueline; Apostolou, Andria; Blog, Debra; Zimmerman, Christopher M.; Montana, Barbara; Harpaz, Rafael; Hickman, Carole J.; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Gallagher, Kathleen M.			Mumps Outbreak in Orthodox Jewish Communities in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE EFFECTIVENESS; UNIVERSITY-STUDENTS; RECENT RESURGENCE; NETHERLANDS; INFECTION	Background By 2005, vaccination had reduced the annual incidence of mumps in the United States by more than 99%, with few outbreaks reported. However, in 2006, a large outbreak occurred among highly vaccinated populations in the United States, and similar outbreaks have been reported worldwide. The outbreak described in this report occurred among U. S. Orthodox Jewish communities during 2009 and 2010. Methods Cases of salivary-gland swelling and other symptoms clinically compatible with mumps were investigated, and demographic, clinical, laboratory, and vaccination data were evaluated. Results From June 28, 2009, through June 27, 2010, a total of 3502 outbreak-related cases of mumps were reported in New York City, two upstate New York counties, and one New Jersey county. Of the 1648 cases for which clinical specimens were available, 50% were laboratory-confirmed. Orthodox Jewish persons accounted for 97% of case patients. Adolescents 13 to 17 years of age (27% of all patients) and males (78% of patients in that age group) were disproportionately affected. Among case patients 13 to 17 years of age with documented vaccination status, 89% had previously received two doses of a mumps-containing vaccine, and 8% had received one dose. Transmission was focused within Jewish schools for boys, where students spend many hours daily in intense, face-to-face interaction. Orchitis was the most common complication (120 cases, 7% of male patients >= 12 years of age), with rates significantly higher among unvaccinated persons than among persons who had received two doses of vaccine. Conclusions The epidemiologic features of this outbreak suggest that intense exposures, particularly among boys in schools, facilitated transmission and overcame vaccine-induced protection in these patients. High rates of two-dose coverage reduced the severity of the disease and the transmission to persons in settings of less intense exposure.	[Barskey, Albert E.; Harpaz, Rafael; Hickman, Carole J.; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Gallagher, Kathleen M.] Ctr Res Dis Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Apostolou, Andria] Ctr Res Dis Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Schulte, Cynthia; Rausch-Phung, Elizabeth; Blog, Debra] New York State Dept Hlth, Albany, NY USA; [Rosen, Jennifer B.; Doll, Margaret K.; Cummings, Kisha P.; Zimmerman, Christopher M.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Alleyne, E. Oscar] Rockland Cty Dept Hlth, Pomona, NY USA; [Lawler, Jacqueline] Orange Cty Hlth Dept, Goshen, NY USA; [Handschur, Elizabeth F.; Montana, Barbara] New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; [High, Patricia] Ocean Cty Hlth Dept, Toms River, NJ USA	Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; New York City Department of Health & Mental Hygiene; New Jersey Department of Health & Senior Services	Barskey, AE (corresponding author), Ctr Res Dis Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop A-34, Atlanta, GA 30333 USA.	abarskey@cdc.gov	Doll, Margaret K./AAR-3987-2021; Rausch-Phung, Elizabeth/AGL-7956-2022	Doll, Margaret K./0000-0002-2125-7820; 				AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; Anis E, 2012, EPIDEMIOL INFECT, V140, P439, DOI 10.1017/S095026881100063X; [Anonymous], 2010, MMWR-MORBID MORTAL W, V59, P594; [Anonymous], 2012, MMWR-MORBID MORTAL W, V60, P1762; [Anonymous], 1967, MMWR-MORBID MORTAL W, V16, P430; Bangor-Jones RD, 2009, MED J AUSTRALIA, V191, P398, DOI 10.5694/j.1326-5377.2009.tb02850.x; Barskey AE, 2009, VACCINE, V27, P6186, DOI 10.1016/j.vaccine.2009.06.109; Boddicker JD, 2007, J CLIN MICROBIOL, V45, P2902, DOI 10.1128/JCM.00614-07; Capua I, 2004, AVIAN PATHOL, V33, P158, DOI 10.1080/03079450310001652077; Carr MJ, 2010, J CLIN MICROBIOL, V48, P3288, DOI 10.1128/JCM.00434-10; Centers for Disease Control and Prevention, STAT SURV VACC COV U; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P629; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cortese MM, 2008, CLIN INFECT DIS, V46, P1172, DOI 10.1086/529141; Cortese MM, 2011, J INFECT DIS, V204, P1413, DOI 10.1093/infdis/jir526; Council of State and Territorial Epidemiologists, CSTE POS STAT 09 ID; Davidkin I, 2010, EXPERT REV VACCINES, V9, P1045, DOI [10.1586/erv.10.99, 10.1586/ERV.10.99]; Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; ENNIS FA, 1969, J INFECT DIS, V119, P654, DOI 10.1093/infdis/119.6.654; Greenland K, 2012, VACCINE, V30, P4676, DOI 10.1016/j.vaccine.2012.04.083; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; High P., 2010, Morbidity and Mortality Weekly Report, V59, P125; Jin L, 2005, ARCH VIROL, V150, P1903, DOI 10.1007/s00705-005-0563-4; Kutty P, 2011, 45 NAT IMM C WASH DC; LeBaron CW, 2009, J INFECT DIS, V199, P552, DOI 10.1086/596207; Livingston KA, 2011, 45 NAT IMM C WASH DC; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; PLOTKIN SA, 2008, VACCINES, P435; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Roberts C, 2009, EUROSURVEILLANCE, V14; Rota JS, 2009, J MED VIROL, V81, P1819, DOI 10.1002/jmv.21557; Rubin SA, 2008, J INFECT DIS, V198, P508, DOI 10.1086/590115; SIMPSON REH, 1952, LANCET, V263, P549; Snijders BEP, 2012, VACCINE, V30, P2999, DOI 10.1016/j.vaccine.2012.02.035; STOKES J, 1946, J EXP MED, V84, P407, DOI 10.1084/jem.84.5.407; 1977, MMWR MORB MORTAL WKL, V26, P393	39	109	111	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1704	1713		10.1056/NEJMoa1202865	http://dx.doi.org/10.1056/NEJMoa1202865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113481	Bronze			2022-12-01	WOS:000310440800007
J	Acuna, GP; Moller, FM; Holzmeister, P; Beater, S; Lalkens, B; Tinnefeld, P				Acuna, G. P.; Moeller, F. M.; Holzmeister, P.; Beater, S.; Lalkens, B.; Tinnefeld, P.			Fluorescence Enhancement at Docking Sites of DNA-Directed Self-Assembled Nanoantennas	SCIENCE			English	Article							SINGLE-MOLECULE; NANOSCALE; EMISSION; ORIGAMI; LIGHT; MICROSCOPY; RESOLUTION; ANTENNAS; BIOLOGY; SURFACE	We introduce self-assembled nanoantennas to enhance the fluorescence intensity in a plasmonic hotspot of zeptoliter volume. The nanoantennas are prepared by attaching one or two gold nanoparticles (NPs) to DNA origami structures, which also incorporated docking sites for a single fluorescent dye next to one NP or in the gap between two NPs. We measured the dependence of the fluorescence enhancement on NP size and number and compare it to numerical simulations. A maximum of 117-fold fluorescence enhancement was obtained for a dye molecule positioned in the 23-nanometer gap between 100-nanometer gold NPs. Direct visualization of the binding and unbinding of short DNA strands, as well as the conformational dynamics of a DNA Holliday junction in the hotspot of the nanoantenna, show the compatibility with single-molecule assays.	[Acuna, G. P.; Moeller, F. M.; Holzmeister, P.; Beater, S.; Lalkens, B.; Tinnefeld, P.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, NanoBioSci Grp, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Acuna, GP (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, NanoBioSci Grp, Hans Sommer Str 10, D-38106 Braunschweig, Germany.	g.acuna@tu-bs.de; p.tinnefeld@tu-bs.de	Acuna, Guillermo/L-8169-2016	Acuna, Guillermo/0000-0001-8066-2677; Zumsande, Friederike/0000-0002-0902-7619	starting grant (SiMBA) of the European Research Council; Volkswagen Foundation; Center for NanoScience	starting grant (SiMBA) of the European Research Council; Volkswagen Foundation(Volkswagen); Center for NanoScience	We thank A. Gietl, J. J. Schmied, D. Grohmann, T. Liedl, and F. Stefani for fruitful discussion; A. Tiefnig for sample preparation; F. Demming for assistance with the numerical simulations; and S. Carregal Romero for the transmission electron microscopy images. This work was carried out at the NanoBioScience group, Braunschweig University of Technology, and was supported by a starting grant (SiMBA) of the European Research Council, the Volkswagen Foundation, and the Center for NanoScience. Technische Universitat Braunschweig, G.P.A., and P.T. have filed a provisional patent application, EP1260316.1., on the described method of creating hotspots using self-assembled DNA origami.	Acuna GP, 2012, ACS NANO, V6, P3189, DOI 10.1021/nn2050483; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Bek A, 2008, NANO LETT, V8, P485, DOI 10.1021/nl072602n; Busson MP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1964; Cang H, 2011, NATURE, V469, P385, DOI 10.1038/nature09698; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Coronado EA, 2011, NANOSCALE, V3, P4042, DOI 10.1039/c1nr10788g; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Di Fiori N, 2010, BIOPHYS J, V98, P2265, DOI 10.1016/j.bpj.2010.02.008; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Gietl A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks326; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lin HZ, 2012, CHEMPHYSCHEM, V13, P973, DOI 10.1002/cphc.201100743; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Ringler M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.203002; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518	28	503	515	25	564	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					506	510		10.1126/science.1228638	http://dx.doi.org/10.1126/science.1228638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112329				2022-12-01	WOS:000310195800052
J	Agee, CB; Wilson, NV; McCubbin, FM; Ziegler, K; Polyak, VJ; Sharp, ZD; Asmerom, Y; Nunn, MH; Shaheen, R; Thiemens, MH; Steele, A; Fogel, ML; Bowden, R; Glamoclija, M; Zhang, ZS; Elardo, SM				Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Ziegler, Karen; Polyak, Victor J.; Sharp, Zachary D.; Asmerom, Yemane; Nunn, Morgan H.; Shaheen, Robina; Thiemens, Mark H.; Steele, Andrew; Fogel, Marilyn L.; Bowden, Roxane; Glamoclija, Mihaela; Zhang, Zhisheng; Elardo, Stephen M.			Unique Meteorite from Early Amazonian Mars: Water-Rich Basaltic Breccia Northwest Africa 7034	SCIENCE			English	Article							OXYGEN-ISOTOPIC COMPOSITION; CHASSIGNY METEORITE; DIFFERENTIATION PROCESSES; MARTIAN METEORITES; UPPER-MANTLE; RB-SR; CONSTRAINTS; PETROGENESIS; SURFACE; ATMOSPHERE	We report data on the martian meteorite Northwest Africa (NWA) 7034, which shares some petrologic and geochemical characteristics with known martian meteorites of the SNC (i.e., shergottite, nakhlite, and chassignite) group, but also has some unique characteristics that would exclude it from that group. NWA 7034 is a geochemically enriched crustal rock compositionally similar to basalts and average martian crust measured by recent Rover and Orbiter missions. It formed 2.089 +/- 0.081 billion years ago, during the early Amazonian epoch in Mars' geologic history. NWA 7034 has an order of magnitude more indigenous water than most SNC meteorites, with up to 6000 parts per million extraterrestrial H2O released during stepped heating. It also has bulk oxygen isotope values of Delta O-17 = 0.58 +/- 0.05 per mil and a heat-released water oxygen isotope average value of Delta O-17 = 0.330 +/- 0.011 per mil, suggesting the existence of multiple oxygen reservoirs on Mars.	[Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Ziegler, Karen; Elardo, Stephen M.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Polyak, Victor J.; Sharp, Zachary D.; Asmerom, Yemane; Elardo, Stephen M.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Nunn, Morgan H.; Shaheen, Robina; Thiemens, Mark H.; Zhang, Zhisheng] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Steele, Andrew; Fogel, Marilyn L.; Bowden, Roxane; Glamoclija, Mihaela] Carnegie Inst Sci, Geophys Lab, Washington, DC 20005 USA; [Zhang, Zhisheng] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China	University of New Mexico; University of New Mexico; University of California System; University of California San Diego; Carnegie Institution for Science; Sun Yat Sen University	Agee, CB (corresponding author), Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA.	agee@unm.edu	Zhang, Zhisheng/W-5138-2019; Elardo, Stephen M/E-5865-2010; Steele, Andrew/A-3573-2013; Fogel, Marilyn L/M-2395-2015; McCubbin, Francis/D-1698-2009; McCubbin, Francis/AAG-1095-2020; Glamoclija, Mihaela/GWQ-3360-2022	Zhang, Zhisheng/0000-0002-3742-0880; Elardo, Stephen M/0000-0001-5730-8485; Steele, Andrew/0000-0001-9643-2841; Fogel, Marilyn L/0000-0002-1176-3818; Glamoclija, Mihaela/0000-0003-4327-6480	NASA Cosmochemistry Program [NNX11AH16G, NNX11AG76G]; New Mexico Space Grant Consortium; NASA Earth and Space Science Fellowship [NNX12AO15H]; NASA [NNX10AI77G]; NSF [ATM0960594]	NASA Cosmochemistry Program(National Aeronautics & Space Administration (NASA)); New Mexico Space Grant Consortium; NASA Earth and Space Science Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank J. Piatek for acquiring the NWA 7034 specimen and for his generous donation to the UNM Meteorite Museum, which has enabled this research and sample allocations for future research on NWA 7034. We also thank M. Spilde, V. Atudorei, and J. Connolly at the University of New Mexico for assistance with data collection. Supported by NASA Cosmochemistry Program grants NNX11AH16G (C. B. A.) and NNX11AG76G (F. M. M.). S. M. E. acknowledges support from the New Mexico Space Grant Consortium, NASA Earth and Space Science Fellowship NNX12AO15H, and NASA Cosmochemistry grant NNX10AI77G to Charles K. Shearer. M. H. T. and R. S. acknowledge NSF award ATM0960594, which allowed the development of an analytical technique to measure oxygen triple isotopic composition of small (<1 mu M) sulfate samples.	Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; Borg L, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002402; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Borg LE, 2002, GEOCHIM COSMOCHIM AC, V66, P2037, DOI 10.1016/S0016-7037(02)00835-9; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; Day JMD, 2006, METEORIT PLANET SCI, V41, P581, DOI 10.1111/j.1945-5100.2006.tb00484.x; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Farquhar J, 2000, J GEOPHYS RES-PLANET, V105, P11991, DOI 10.1029/1999JE001194; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; Filiberto J, 2008, GEOCHIM COSMOCHIM AC, V72, P690, DOI 10.1016/j.gca.2007.11.007; Franchi IA, 1999, METEORIT PLANET SCI, V34, P657, DOI 10.1111/j.1945-5100.1999.tb01371.x; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Grady M., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Herd CDK, 2003, METEORIT PLANET SCI, V38, P1793, DOI 10.1111/j.1945-5100.2003.tb00015.x; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; Lodders K., 1998, PLANETARY SCI COMPAN; McCubbin FM, 2008, AM MINERAL, V93, P676, DOI 10.2138/am.2008.2558; McCubbin FM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051711; McCubbin FM, 2010, EARTH PLANET SC LETT, V292, P132, DOI 10.1016/j.epsl.2010.01.028; McCubbin FM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003165; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; Mittlefehldt DW, 2008, REV MINERAL GEOCHEM, V68, P399, DOI 10.2138/rmg.2008.68.14; Nekvasil H, 2009, METEORIT PLANET SCI, V44, P853, DOI 10.1111/j.1945-5100.2009.tb00773.x; Nimmo F, 2008, NATURE, V453, P1220, DOI 10.1038/nature07025; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Norman MD, 1999, METEORIT PLANET SCI, V34, P439, DOI 10.1111/j.1945-5100.1999.tb01352.x; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Papike JJ, 2009, GEOCHIM COSMOCHIM AC, V73, P7443, DOI 10.1016/j.gca.2009.09.008; Reese CC, 2006, ICARUS, V184, P102, DOI 10.1016/j.icarus.2006.04.008; Riner MA, 2010, ICARUS, V209, P301, DOI 10.1016/j.icarus.2010.05.018; Romanek CS, 1998, METEORIT PLANET SCI, V33, P775, DOI 10.1111/j.1945-5100.1998.tb01683.x; Rumble D., 2009, P 40 LUN PLAN SCI C, V40, P2293; Sarbadhikari AB, 2011, GEOCHIM COSMOCHIM AC, V75, P6803, DOI 10.1016/j.gca.2011.09.001; Sarbadhikari AB, 2009, GEOCHIM COSMOCHIM AC, V73, P2190, DOI 10.1016/j.gca.2009.01.012; Sharp ZD, 2001, CHEM GEOL, V178, P197, DOI 10.1016/S0009-2541(01)00262-5; Shearer CK, 2011, AM MINERAL, V96, P1418, DOI 10.2138/am.2011.3860; SNYDER GA, 1992, GEOCHIM COSMOCHIM AC, V56, P3809, DOI 10.1016/0016-7037(92)90172-F; SNYDER GA, 1994, GEOCHIM COSMOCHIM AC, V58, P4795, DOI 10.1016/0016-7037(94)90209-7; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Till CB, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009044; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Wadwa M., 2004, ANTARCT METEORITE RE, V17, P97; WARREN PH, 1979, REV GEOPHYS, V17, P73, DOI 10.1029/RG017i001p00073; Wright SP, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003785; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Yung Y. L., 1999, PHOTOCHEMISTRY PLANE; Zipfel J, 2011, METEORIT PLANET SCI, V46, P1, DOI 10.1111/j.1945-5100.2010.01127.x	55	289	293	6	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					780	785		10.1126/science.1228858	http://dx.doi.org/10.1126/science.1228858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287721				2022-12-01	WOS:000314874400038
J	Hu, B; Margolin, W; Molineux, IJ; Liu, J				Hu, Bo; Margolin, William; Molineux, Ian J.; Liu, Jun			The Bacteriophage T7 Virion Undergoes Extensive Structural Remodeling During Infection	SCIENCE			English	Article							ESCHERICHIA-COLI; DNA EJECTION; TAIL FIBERS; INITIATION; MECHANISM; MACHINES; DELIVERY; PROTEIN	Adsorption and genome ejection are fundamental to the bacteriophage life cycle, yet their molecular mechanisms are not well understood. We used cryo-electron tomography to capture T7 virions at successive stages of infection of Escherichia coli minicells at similar to 4-nm resolution. The six phage tail fibers were folded against the capsid, extending and orienting symmetrically only after productive adsorption to the host cell surface. Receptor binding by the tail triggered conformational changes resulting in the insertion of an extended tail, which functions as the DNA ejection conduit into the cell cytoplasm. After ejection, the extended phage tail collapsed or disassembled, which allowed resealing of the infected cell membrane. These structural studies provide a detailed series of intermediates during phage infection.	[Hu, Bo; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Margolin, William] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Molineux, Ian J.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Austin	Molineux, IJ (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA.	molineux@austin.utexas.edu; jun.liu.1@uth.tmc.edu			National Institute on Allergy and Infection, NIH [R01AI087946]; Welch Foundation [AU-1714]; NIH [R01GM61074]; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110243, R01GM061074] Funding Source: NIH RePORTER	National Institute on Allergy and Infection, NIH; Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Leiman, S. Norris, and Y. W. Yin for comments. B. H. and J.L. were supported in part by grants R01AI087946 from the National Institute on Allergy and Infection, NIH, and AU-1714 from the Welch Foundation. W. M. was supported by NIH grant R01GM61074 and a grant from the Human Frontier Science Program. EM maps have been deposited in the EM Data Bank (www.ebi.ac.uk/pdbe/emdb/) with accession nos. EMD-5534, 5535, 5536, and 5537. J.L. and I.J.M. designed research; B. H. and W. M. constructed the E. coli mutants; B. H. and J. L. collected and analyzed data; and B. H., W. M., J. L., and I. J. M. wrote the paper.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; Kemp P, 2004, MOL MICROBIOL, V53, P1251, DOI 10.1111/j.1365-2958.2004.04204.x; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Rothenberg E, 2011, BIOPHYS J, V100, P2875, DOI 10.1016/j.bpj.2011.05.014; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Struthers-Schlinke JS, 2000, J MOL BIOL, V301, P35, DOI 10.1006/jmbi.2000.3940; ZIMKUS A Z, 1986, Molekulyarnaya Biologiya (Moscow), V20, P185	20	150	157	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					576	579		10.1126/science.1231887	http://dx.doi.org/10.1126/science.1231887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23306440	Green Accepted			2022-12-01	WOS:000314270000058
J	Wu, B; Peisley, A; Richards, C; Yao, H; Zeng, XH; Lin, C; Chu, FX; Walz, T; Hur, S				Wu, Bin; Peisley, Alys; Richards, Claire; Yao, Hui; Zeng, Xiaohui; Lin, Cecilie; Chu, Feixia; Walz, Thomas; Hur, Sun			Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5	CELL			English	Article							RIG-I HELICASE; RNA-RECOGNITION; PATTERN-RECOGNITION; SENSOR; MECHANISM; INSIGHTS; SYSTEM; DOMAIN; LGP2	MDA5, a viral double-stranded RNA (dsRNA) receptor, shares sequence similarity and signaling pathways with RIG-I yet plays essential functions in antiviral immunity through distinct specificity for viral RNA. Revealing the molecular basis for the functional divergence, we report here the crystal structure of MDA5 bound to dsRNA, which shows how, using the same domain architecture, MDA5 recognizes the internal duplex structure, whereas RIG-I recognizes the terminus of dsRNA. We further show that MDA5 uses direct protein-protein contacts to stack along dsRNA in a head-to-tail arrangement, and that the signaling domain (tandem CARD), which decorates the outside of the core MDA5 filament, also has an intrinsic propensity to oligomerize into an elongated structure that activates the signaling adaptor, MAVS. These data support a model in which MDA5 uses long dsRNA as a signaling platform to cooperatively assemble the core filament, which in turn promotes stochastic assembly of the tandem CARD oligomers for signaling.	[Wu, Bin; Peisley, Alys; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lin, Cecilie; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wu, Bin; Peisley, Alys; Richards, Claire; Hur, Sun] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yao, Hui] Nankai Univ, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China; [Zeng, Xiaohui; Chu, Feixia] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Walz, Thomas] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Nankai University; University System Of New Hampshire; University of New Hampshire; Howard Hughes Medical Institute	Hur, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	hur@idi.harvard.edu	Wu, Bin/C-4715-2015	Wu, Bin/0000-0002-0883-8006; Peisley, Alys/0000-0002-8999-5440; Walz, Thomas/0000-0003-2606-2835	NIFA/USDA [H00567]; UNH Karabelis Fund; Pew Scholarship	NIFA/USDA(United States Department of Agriculture (USDA)); UNH Karabelis Fund; Pew Scholarship	The authors thank the NE-CAT beamline scientists for their assistance during data collection. F.C. acknowledges NIFA/USDA H00567 and UNH Karabelis Fund. T.W. is an Investigator in the Howard Hughes Medical Institute. S.H. is the recipient of a Pew Scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Triantafilou K., 2012, J CELL SCI; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	25	355	359	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					276	289		10.1016/j.cell.2012.11.048	http://dx.doi.org/10.1016/j.cell.2012.11.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273991	Bronze			2022-12-01	WOS:000313719800023
J	Jonsson, T; Stefansson, H; Steinberg, S; Jonsdottir, I; Jonsson, PV; Snaedal, J; Bjornsson, S; Huttenlocher, J; Levey, AI; Lah, JJ; Rujescu, D; Hampel, H; Giegling, I; Andreassen, OA; Engedal, K; Ulstein, I; Djurovic, S; Ibrahim-Verbaas, C; Hofman, A; Ikram, MA; van Duijn, CM; Thorsteinsdottir, U; Kong, A; Stefansson, K				Jonsson, Thorlakur; Stefansson, Hreinn; Steinberg, Stacy; Jonsdottir, Ingileif; Jonsson, Palmi V.; Snaedal, Jon; Bjornsson, Sigurbjorn; Huttenlocher, Johanna; Levey, Allan I.; Lah, James J.; Rujescu, Dan; Hampel, Harald; Giegling, Ina; Andreassen, Ole A.; Engedal, Knut; Ulstein, Ingun; Djurovic, Srdjan; Ibrahim-Verbaas, Carla; Hofman, Albert; Ikram, M. Arfan; van Duijn, Cornelia M.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Variant of TREM2 Associated with the Risk of Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; CUTTING EDGE; MUTATIONS; RESPONSES; INFLAMMATION; EXPRESSION; FREQUENCY; DEMENTIA; SYSTEM	BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associated with the risk of the common late-onset form of Alzheimer's disease. Few rare variants affecting the risk of late-onset Alzheimer's disease have been found. METHODS We obtained the genome sequences of 2261 Icelanders and identified sequence variants that were likely to affect protein function. We imputed these variants into the genomes of patients with Alzheimer's disease and control participants and then tested for an association with Alzheimer's disease. We performed replication tests using case-control series from the United States, Norway, the Netherlands, and Germany. We also tested for a genetic association with cognitive function in a population of unaffected elderly persons. RESULTS A rare missense mutation (rs75932628-T) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which was predicted to result in an R47H substitution, was found to confer a significant risk of Alzheimer's disease in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42x10(-10)). The mutation had a frequency of 0.46% in controls 85 years of age or older. We observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1x10(-12) in combined discovery and replication samples). We also found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003). CONCLUSIONS Our findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease. Given the reported antiinflammatory role of TREM2 in the brain, the R47H substitution may lead to an increased predisposition to Alzheimer's disease through impaired containment of inflammatory processes. (Funded by the National Institute on Aging and others.)	[Jonsson, Thorlakur; Stefansson, Hreinn; Steinberg, Stacy; Jonsdottir, Ingileif; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Jonsdottir, Ingileif; Jonsson, Palmi V.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsson, Palmi V.; Snaedal, Jon; Bjornsson, Sigurbjorn] Landspitali Univ Hosp, Reykjavik, Iceland; [Huttenlocher, Johanna] Inst Human Genet, Dept Med Genet, Tubingen, Germany; Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-80539 Munich, Germany; [Rujescu, Dan; Giegling, Ina] Univ Halle Wittenberg, D-06108 Halle, Germany; [Hampel, Harald] Univ Frankfurt Main, Dept Psychiat, Frankfurt, Germany; [Levey, Allan I.; Lah, James J.] Emory Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, Atlanta, GA 30322 USA; [Andreassen, Ole A.; Djurovic, Srdjan] Univ Oslo, Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, Oslo, Norway; [Engedal, Knut; Ulstein, Ingun] Univ Oslo, Oslo Univ Hosp, Norwegian Ctr Aging & Hlth, Dept Geriatr, Oslo, Norway; [Andreassen, Ole A.; Engedal, Knut; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, Oslo, Norway; [Ibrahim-Verbaas, Carla; Hofman, Albert; Ikram, M. Arfan; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Iceland; Landspitali National University Hospital; Eberhard Karls University of Tubingen; University of Munich; Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Emory University; University of Oslo; University of Oslo; University of Oslo; Erasmus University Rotterdam; Erasmus MC	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Ikram, M. Arfan/AAM-5225-2021; Levey, Allan/F-2104-2011; Alexandrov, Boian/D-8815-2016; Andreassen, Ole A./AAY-7531-2020; Rujescu, Dan/GRS-3875-2022; Stefansson, Kari/AAE-7187-2019; Giegling, Ina/ABA-3677-2021; Babu, Sudarsanam/D-1694-2010	Levey, Allan/0000-0002-3153-502X; Kong, Augustine/0000-0001-8193-5438; Hampel, Harald/0000-0003-0894-8982; Djurovic, Srdjan/0000-0002-8140-8061; Andreassen, Ole A./0000-0002-4461-3568; Stefansson, Hreinn/0000-0002-9331-6666; Ikram, Mohammad Arfan/0000-0003-0372-8585; Ibrahim-verbaas, Carla/0000-0002-4325-0857; Van Duijn, Cornelia/0000-0002-2374-9204; Babu, Sudarsanam/0000-0002-3531-2579	National Institute on Aging [P50-AG025688, U01AG006781]; Research Council of Norway; South-Eastern Norway Health Authority; National Institutes of Health [U01HG004438]; National Human Genome Research Institute [U01HG004610]; eMERGE Administrative Coordinating Center [U01HG004603]; National Center for Biotechnology Information; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Research Institute for Diseases in the Elderly [014-93-015]; Stichting Alzheimer Onder-zoek; Hersenstichting Nederland; Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Seventh Framework Program; ENGAGE project [HEALTH-F4-2007-201413]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004610, U01HG006375, U01HG004603, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, U01AG006781, P50AG025688] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Council of Norway(Research Council of Norway); South-Eastern Norway Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); eMERGE Administrative Coordinating Center; National Center for Biotechnology Information; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Research Institute for Diseases in the Elderly; Stichting Alzheimer Onder-zoek; Hersenstichting Nederland; Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Seventh Framework Program(European Commission); ENGAGE project(General Electric); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (P50-AG025688, to Dr. Levey, for samples from the Alzheimer's Disease Center at Emory University; U01AG006781 for the Alzheimer's Disease Patient Registry and Adult Changes in Thought study; and the Division of Neuroscience for the NIA-LOAD study); a grant from the Research Council of Norway and South-Eastern Norway Health Authority for samples from Norway; a gift from 3M to expand the Adult Changes in Thought cohort; a grant from the National Institutes of Health (U01HG004438) for genotyping at Johns Hopkins University; cooperative agreements with the National Human Genome Research Institute (U01HG004610 for genomewide association analyses); by the eMERGE Administrative Coordinating Center (U01HG004603) for assistance with phenotype harmonization and genotype data cleaning; and by the National Center for Biotechnology Information. The Rotterdam Study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission; and the Municipality of Rotterdam; by a grant (014-93-015; RIDE2) from the Research Institute for Diseases in the Elderly, Stichting Alzheimer Onder-zoek, Hersenstichting Nederland, the Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging), the Seventh Framework Program (FP7/2007-2013), and the ENGAGE project (grant agreement HEALTH-F4-2007-201413).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Guerreiro RJ, 2012, ARCH NEUROL; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; ISHII T, 1984, ACTA NEUROPATHOL, V63, P296, DOI 10.1007/BF00687336; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Madry H, 2007, CLIN ORTHOP RELAT R, P262, DOI 10.1097/01.blo.0000229364.57985.df; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Montalbetti L, 2005, FUNCT NEUROL, V20, P71; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Paloneva, 2003, AM J HUM GENET, V72, P225; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; ROZEMULLER JM, 1986, VIRCHOWS ARCH B, V51, P247, DOI 10.1007/BF02899034; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Wunderlich P, 2010, GAMMA SECRETASE MEDI	51	1526	1561	5	204	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					107	116		10.1056/NEJMoa1211103	http://dx.doi.org/10.1056/NEJMoa1211103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23150908	Green Accepted			2022-12-01	WOS:000313238100001
J	Grumbine, RE; Pandit, MK				Grumbine, R. Edward; Pandit, Maharaj K.			Threats from India's Himalaya Dams	SCIENCE			English	Editorial Material									[Grumbine, R. Edward] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China; [Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Delhi	Grumbine, RE (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China.	ed.grumbine@gmail.com	Pandit, Maharaj K/A-4065-2014	Pandit, Maharaj K/0000-0001-6611-560X				[Anonymous], 2012, BP EN OUTL 2030; Centre for Interdisciplinary Studies of Mountain & Hill Environment, 2007, CARR CAP STUD TEEST; Choudhury Nirmalya, 2010, SUSTAINABLE DAM DEV; Dharmadikhary S., 2008, MOUNTAINS CONCRETE D; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Ebinger Charles K., 2011, ENERGY SECURITY S AS; Hennig T., 2012, HYDROPOWER PRACTICE, P293; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Mehta M. C., 2009, ECON POLIT WEEKLY, V2; Ministry of Water Resources Draft National Water Policy, 2012, NAT WAT POL IN PRESS; Nandimath O.V., 2009, OXFORD HDB ENV DECIS; Negi NS, 2011, 103 U BIEL CTR MIGR; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Press Information Bureau Government of India, 2012, 3 M NAT GANG RIV BAS; Rajaram T, 2011, J ENVIRON MANAGE, V92, P140, DOI 10.1016/j.jenvman.2010.08.024; Richter BD., 2010, WATER ALTERN INTERDI, V3, P14, DOI DOI 10.1007/S11195-009-9131-2; Sharma T., 2012, MEGA DAMS CAMPAIGNIN; Singh JS, 2006, CURR SCI INDIA, V90, P784; Sreedharan P, 2011, ELECT GRID EVOLUTION; Subramanian A., 2012, CAN INDIAS POWER PRO; Tollefson J, 2011, NATURE, V474, P430, DOI 10.1038/474430a; Wildlife Institute of India, 2012, ASS CUM IMP HYDR PRO; World Wildlife Fund, 2007, CLIM SOL WWFS VIS 20	24	138	142	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					36	37		10.1126/science.1227211	http://dx.doi.org/10.1126/science.1227211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288526				2022-12-01	WOS:000312985800039
J	Kamerow, D				Kamerow, Douglas			Does gay marriage improve health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSURANCE		RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Buffie WC, 2011, AM J PUBLIC HEALTH, V101, P986, DOI 10.2105/AJPH.2010.300112; Halkitis PN, 2012, AM J PUBLIC HEALTH, V102, P1628, DOI 10.2105/AJPH.2012.300940; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Parker-Pope Tara, 2010, NY TIMES MAGAZINE; Ponce NA, 2010, HEALTH AFFAIR, V29, P1539, DOI 10.1377/hlthaff.2009.0583; Wight RG, 2012, AM J PUBLIC HEALTH, V102, P503, DOI 10.2105/AJPH.2011.300384; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	7	1	1	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2012	345								e8586	10.1136/bmj.e8586	http://dx.doi.org/10.1136/bmj.e8586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23262572				2022-12-01	WOS:000312701700003
J	Kharazmi, E; Fallah, M; Sundquist, K; Hemminki, K				Kharazmi, E.; Fallah, M.; Sundquist, K.; Hemminki, K.			Familial risk of early and late onset cancer: nationwide prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIETARY FACTORS; LIFE-STYLE; UK; FRACTION; DATABASE; DISEASE	Objective To determine whether familial risk of cancer is limited to early onset cases. Design Nationwide prospective cohort study. Setting Nationwide Swedish Family-Cancer Database. Participants All Swedes born after 1931 and their biological parents, totalling >12.2 million individuals, including >1.1 million cases of first primary cancer. Main outcome measures Familial risks of the concordant cancers by age at diagnosis. Results The highest familial risk was seen for offspring whose parents were diagnosed at an early age. Familial risks were significantly increased for colorectal, lung, breast, prostate, and urinary bladder cancer and melanoma, skin squamous cell carcinoma, and non-Hodgkin's lymphoma, even when parents were diagnosed at age 70-79 or 80-89. When parents were diagnosed at more advanced ages (>= 90), the risk of concordant cancer in offspring was still significantly increased for skin squamous cell carcinoma (hazard ratio 1.9, 95% confidence interval 1.4 to 2.7), colorectal (1.6, 1.2 to 2.0), breast (1.3, 1.0 to 1.6), and prostate cancer (1.3, 1.1 to 1.6). For offspring with a cancer diagnosed at ages 60-76 whose parents were affected at age <50, familial risks were not significantly increased for nearly all cancers. Conclusion Though the highest familial risks of cancer are seen in offspring whose parents received a diagnosis of a concordant cancer at earlier ages, increased risks exist even in cancers of advanced ages. Familial cancers might not be early onset in people whose family members were affected at older ages and so familial cancers might have distinct early and late onset components.	[Kharazmi, E.; Fallah, M.; Hemminki, K.] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Sundquist, K.; Hemminki, K.] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, K.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Stanford University	Kharazmi, E (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany.	E.Kharazmi@dkfz.de	Fallah, Mahdi/A-8745-2008	Fallah, Mahdi/0000-0002-6639-065X; Kharazmi, Elham/0000-0003-4919-6641	Swedish Council for Working Life and Social Research; German Cancer Aid (Deutsche Krebshilfe)	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This study was supported by the Swedish Council for Working Life and Social Research and the German Cancer Aid (Deutsche Krebshilfe).	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Brandt A, 2008, ANN ONCOL, V19, P2084, DOI 10.1093/annonc/mdn527; Chang ET, 2006, JNCI-J NATL CANCER I, V98, P61, DOI 10.1093/jnci/djj005; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Engholm G, 2012, NORDCAN CANC INCIDEN; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Hampel H, 2004, J MED GENET, V41, P81, DOI 10.1136/jmg.2003.010918; Hemminki K, 2003, INT J CANCER, V103, P105, DOI 10.1002/ijc.10764; Hemminki K, 2002, INT J CANCER, V98, P316, DOI 10.1002/ijc.10195; Hemminki K, 2009, INT J CANCER, V124, P2250, DOI 10.1002/ijc.24301; Hemminki K, 2001, BRIT J CANCER, V84, P1466, DOI 10.1054/bjoc.2001.1811; Hemminki K, 2001, ACTA ONCOL, V40, P772; Hemminki K, 2005, HERED CANCER CLIN PR, V3, P7, DOI 10.1186/1897-4287-3-1-7; Hopper John L, 2011, Epidemiol Perspect Innov, V8, P2, DOI 10.1186/1742-5573-8-2; Kerber RA, 2005, CANCER-AM CANCER SOC, V103, P1906, DOI 10.1002/cncr.20989; Leu M, 2008, J NATL CANCER I, V100, P1318, DOI 10.1093/jnci/djn290; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Parkin DM, 2011, BRIT J CANCER, V105, pS27, DOI 10.1038/bjc.2011.479; Parkin DM, 2011, BRIT J CANCER, V105, pS24, DOI 10.1038/bjc.2011.478; Parkin DM, 2011, BRIT J CANCER, V105, pS2, DOI 10.1038/bjc.2011.474; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; Sundquist K, 2011, AM HEART J, V162, P317, DOI 10.1016/j.ahj.2011.05.013; The National Board of Health and Welfare, 2007, CANC INC SWED 2006; zur Hausen H, 1999, EUR J CANCER, V35, P1878, DOI 10.1016/S0959-8049(99)00291-9	28	46	48	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2012	345								e8076	10.1136/bmj.e8076	http://dx.doi.org/10.1136/bmj.e8076			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059JI	23257063	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000312700600001
J	Clement, R				Clement, Rhys			CHRISTMAS 2012: LIVES OF DOCTORS Is it time for an evidence based uniform for doctors?	BRITISH MEDICAL JOURNAL			English	Editorial Material							WHITE COATS; FLORA; BARE; INFECTIONS; FACEMASKS; PHYSICIAN; ATTIRE; ELBOWS		Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Clement, R (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland.	rhysclement@googlemail.com						[Anonymous], 2008, Naked Science Forum, Patent No. 5416929; Ardolino A, 2009, J HOSP INFECT, V71, P291, DOI 10.1016/j.jhin.2008.11.008; BARRETT TG, 1994, BRIT MED J, V309, P1710, DOI 10.1136/bmj.309.6970.1710; Baxter J, 2010, ANN R COLL SURG ENGL, V92, P248; Bianchi MT, 2008, J GEN INTERN MED, V23, P641, DOI 10.1007/s11606-008-0546-8; BLUMHAGEN DW, 1979, ANN INTERN MED, V91, P111, DOI 10.7326/0003-4819-91-1-111; Bond L, 2010, J LARYNGOL OTOL, V124, P963, DOI 10.1017/S0022215110001167; Brandt LJ, 2003, ARCH INTERN MED, V163, P1277, DOI 10.1001/archinte.163.11.1277; Braunstein, 1995, US patent, Patent No. [5 416 929, 7560399]; Brewer TL, 2004, AMBUL PEDIATR, V4, P257, DOI 10.1367/A03-097R1.1; Christoforidis JB, 2011, CURR DRUG TARGETS, V12, P221; Church J, 1986, Nursing (Lond), V3, P140; Davis L, 2008, BRIT DENT J, V204, P112, DOI 10.1038/bdj.2008.63; Department of Health Policy, 2010, UN WORKW GUID UN WOR; Department of Health Policy, 2007, UN WORKW EV BAS DEV; HILL J, 1974, LANCET, V2, P1131; Horwitz MD, 2010, BRIT J HOSP MED, V71, P124, DOI 10.12968/hmed.2010.71.3.46971; Jeans AR, 2010, J HOSP INFECT, V74, P16, DOI 10.1016/j.jhin.2009.06.032; K Ota, 2007, CAN J INFECT CONTROL, V22, P65; Lai ACK, 2012, J R SOC INTERFACE, V9, P938, DOI 10.1098/rsif.2011.0537; Li Y, 2008, J MULTIDISCIP HEALTH, V1, P17; Loh W, 2000, J HOSP INFECT, V45, P65, DOI 10.1053/jhin.1999.0702; Loveday H, 2007, J INFECT PREV, V8, P10; Magos A, 2007, BRIT MED J, V335, P684, DOI 10.1136/bmj.39353.427014.BE; Makary MA, 2007, NEW ENGL J MED, V356, P2693, DOI 10.1056/NEJMoa070378; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; MONTES LF, 1970, ARCH DERMATOL, V101, P145, DOI 10.1001/archderm.101.2.145; Rehman SU, 2005, AM J MED, V118, P1279, DOI 10.1016/j.amjmed.2005.04.026; Rock, 2009, CAN EV CLOTH STOP GE, Patent No. 7 560 399; Schoeffler L E, 1996, J Okla State Med Assoc, V89, P379; Scott Jude, 2010, Nurs Times, V106, P13; Shaposhnikov OK, 1981, VOEN MED ZH, V4, P58; Song J, 2012, ACS APPL MATER INTER, V4, P460, DOI 10.1021/am201563t; Usher B, 1928, ARCH DERMATOL SYPH, V18, P276, DOI 10.1001/archderm.1928.02380140100009; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; WIlson JA, 2007, J HOSP INFECT, V66, P301, DOI 10.1016/j.jhin.2007.03.026; WONG D, 1991, BRIT MED J, V303, P1602, DOI 10.1136/bmj.303.6817.1602; Yang L, 2011, ISRN NURS; Yoo HS, 2000, TEXT RES J, V70, P542, DOI 10.1177/004051750007000612	39	5	5	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 18	2012	345								e8286	10.1136/bmj.e8286	http://dx.doi.org/10.1136/bmj.e8286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249667				2022-12-01	WOS:000312698900013
J	Besnard, J; Ruda, GF; Setola, V; Abecassis, K; Rodriguiz, RM; Huang, XP; Norval, S; Sassano, MF; Shin, AI; Webster, LA; Simeons, FRC; Stojanovski, L; Prat, A; Seidah, NG; Constam, DB; Bickerton, GR; Read, KD; Wetsel, WC; Gilbert, IH; Roth, BL; Hopkins, AL				Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.			Automated design of ligands to polypharmacological profiles	NATURE			English	Article							DE-NOVO DESIGN; DRUG-DISCOVERY; SMALL-MOLECULE; IDENTIFICATION; OPTIMIZATION; PHARMACOLOGY; ANTAGONISTS; INHIBITORS; PREDICTION; PROGRAM	The clinical efficacy and safety of a drug is determined by its activity profile across many proteins in the proteome. However, designing drugs with a specific multi-target profile is both complex and difficult. Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery. Here we describe a new approach for the automated design of ligands against profiles of multiple drug targets. The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug into brain-penetrable ligands with either specific polypharmacology or exquisite selectivity profiles for G-protein-coupled receptors. Overall, 800 ligand-target predictions of prospectively designed ligands were tested experimentally, of which 75% were confirmed to be correct. We also demonstrate target engagement in vivo. The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacology.	[Besnard, Jeremy; Ruda, Gian Filippo; Abecassis, Keren; Norval, Suzanne; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Bickerton, G. Richard; Read, Kevin D.; Gilbert, Ian H.; Hopkins, Andrew L.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27759 USA; [Rodriguiz, Ramona M.; Shin, Antony I.; Wetsel, William C.] Duke Univ, Sch Med, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Sassano, Maria F.; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27759 USA; [Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal IRCM, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; [Constam, Daniel B.] Ecole Polytech Fed Lausanne EPFL SV ISREC, CH-1015 Lausanne, Switzerland; [Wetsel, William C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	University of Dundee; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Duke University; Duke University; Duke University	Hopkins, AL (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	bryan_roth@med.unc.edu; a.hopkins@dundee.ac.uk	Prat, Annik/S-6757-2018; Roth, Bryan L/F-3928-2010; Seidah, Nabil/I-3596-2013; Roth, Bryan/ABE-7032-2020; sassano, maria/G-4941-2013; Hopkins, Andrew/H-5138-2011	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Roth, Bryan/0000-0002-0561-6520; Besnard, Jeremy/0000-0001-5452-8183; Hopkins, Andrew/0000-0003-1977-018X; Gilbert, Ian/0000-0002-5238-1314; Constam, Daniel B./0000-0002-6256-3891; Ruda, Gian Filippo/0000-0001-6150-2715; /0000-0001-6426-0598; Setola, Vincent/0000-0002-9791-2270	SULSA [HR07019]; BBSRC Doctoral Training Programme; BBSRC Pathfinder [BB/FOF/PF/15/09]; BBSRC [BB/J010510/1]; University of Dundee's Pump Priming Fund for Translational Medical Research; National Institutes of Health (NIH) [MH082441]; Wellcome Trust [WT 083481]; North Carolina Biotechnology Center; Michael Hooker Chair of Pharmacology; Biotechnology and Biological Sciences Research Council [BB/J010510/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER	SULSA; BBSRC Doctoral Training Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Pathfinder(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Dundee's Pump Priming Fund for Translational Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); North Carolina Biotechnology Center; Michael Hooker Chair of Pharmacology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by SULSA (HR07019), the BBSRC Doctoral Training Programme, the BBSRC Pathfinder (BB/FOF/PF/15/09) and the BBSRC Follow On Fund schemes (BB/J010510/1) (A.L.H.), the University of Dundee's Pump Priming Fund for Translational Medical Research (I.H.G. and A.L.H.) and by grants from the National Institutes of Health (NIH) supporting drug discovery receptor pharmacology (B.L.R.) and the NIH grant MH082441 (W.C.W.). The chemical synthesis and informatics benefits from the infrastructure investments from the Wellcome Trust Strategic Award (WT 083481). We thank J. Overington for StARlite and ChEMBL. We wish to thank D. Murugesan for compound purification and C. Means and T. Rhodes for helping with the open field, hole-board and zero-maze tests. We also wish to thank C. Elms and J. Zhou for their support in the husbandry and generation of the mice used for behavioural testing. We also wish to thank F. Y. Li for customizing the software configuration for the hole-board tests. Some of the equipment used in the behavioural testing was purchased with a grant from the North Carolina Biotechnology Center. B.L.R. also received support from the Michael Hooker Chair of Pharmacology.	Alig L, 2008, J MED CHEM, V51, P2115, DOI 10.1021/jm701487t; Arnsten AFT, 2000, NEUROPSYCHOPHARMACOL, V23, P405, DOI 10.1016/S0893-133X(00)00133-0; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Bender A, 2007, COMB CHEM HIGH T SCR, V10, P719, DOI 10.2174/138620707782507313; Brotz-Oesterhelt H, 2008, CURR OPIN PHARMACOL, V8, P564, DOI 10.1016/j.coph.2008.06.008; Brown N, 2004, J COMPUT AID MOL DES, V18, P761, DOI 10.1007/s10822-004-6986-2; Brown N, 2004, J CHEM INF COMP SCI, V44, P1079, DOI 10.1021/ci034290p; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cannon EO, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-3; Deb K., 2006, INT J COMPUT INTELL, V2, P273, DOI DOI 10.5019/J.IJCIR.2006.67; Dey F, 2008, J CHEM INF MODEL, V48, P679, DOI 10.1021/ci700424b; Ertl P, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-8; Fanelli F., 2008, ANTITARGETS, P155; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GILLET V, 1993, J COMPUT AID MOL DES, V7, P127, DOI 10.1007/BF00126441; Gillet VJ, 2002, J MOL GRAPH MODEL, V20, P491, DOI 10.1016/S1093-3263(01)00150-4; Glick M, 2006, J CHEM INF MODEL, V46, P193, DOI 10.1021/ci050374h; Heikkila T, 2006, BIOORG MED CHEM LETT, V16, P88, DOI 10.1016/j.bmcl.2005.09.045; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hughes JD, 2008, BIOORG MED CHEM LETT, V18, P4872, DOI 10.1016/j.bmcl.2008.07.071; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Knowles J. D., 2007, P 9 ANN C GEN EV COM, P773; Kryssanov VV, 2001, ARTIF INTELL ENG, V15, P329, DOI 10.1016/S0954-1810(01)00023-1; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu Q, 2007, J MED CHEM, V50, P5392, DOI 10.1021/jm070750k; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Martin RE, 2007, J MED CHEM, V50, P6291, DOI 10.1021/jm701143p; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Nicolaou CA, 2007, CURR OPIN DRUG DISC, V10, P316; Nicolaou CA, 2009, J CHEM INF MODEL, V49, P295, DOI 10.1021/ci800308h; Obrezanova O, 2008, J COMPUT AID MOL DES, V22, P431, DOI 10.1007/s10822-008-9193-8; Obrezanova O, 2007, J CHEM INF MODEL, V47, P1847, DOI 10.1021/ci7000633; Ortega R, 2009, BIOORG MED CHEM LETT, V19, P1773, DOI 10.1016/j.bmcl.2009.01.067; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Porton B, 2010, GENES BRAIN BEHAV, V9, P257, DOI 10.1111/j.1601-183X.2009.00555.x; Ribeiz SRI, 2010, CNS DRUGS, V24, P303, DOI 10.2165/11530260-000000000-00000; Roche O, 2007, BIOORG MED CHEM LETT, V17, P3670, DOI 10.1016/j.bmcl.2007.04.056; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Ruda GF, 2010, J MED CHEM, V53, P6071, DOI 10.1021/jm1004754; Schneider, 2002, ADAPTIVE SYSTEMS DRU; Schneider G, 2000, J COMPUT AID MOL DES, V14, P487, DOI 10.1023/A:1008184403558; Schneider G, 2011, FUTURE MED CHEM, V3, P415, DOI [10.4155/FMC.11.8, 10.4155/fmc.11.8]; Schneider G, 2009, TRENDS BIOTECHNOL, V27, P18, DOI 10.1016/j.tibtech.2008.09.005; Stahl M, 2002, J COMPUT AID MOL DES, V16, P459, DOI 10.1023/A:1021242018286; Stewart KD, 2006, BIOORGAN MED CHEM, V14, P7011, DOI 10.1016/j.bmc.2006.06.024; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Vidal D, 2010, MOL INFORM, V29, P543, DOI 10.1002/minf.201000055; Vinkers HM, 2003, J MED CHEM, V46, P2765, DOI 10.1021/jm030809x; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Zhao W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-225	58	520	529	5	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					215	+		10.1038/nature11691	http://dx.doi.org/10.1038/nature11691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235874	Green Accepted, Green Submitted			2022-12-01	WOS:000312259300034
J	Sur, IK; Hallikas, O; Vaharautio, A; Yan, J; Turunen, M; Enge, M; Taipale, M; Karhu, A; Aaltonen, LA; Taipale, J				Sur, Inderpreet Kaur; Hallikas, Outi; Vaharautio, Anna; Yan, Jian; Turunen, Mikko; Enge, Martin; Taipale, Minna; Karhu, Auli; Aaltonen, Lauri A.; Taipale, Jussi			Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors	SCIENCE			English	Article							LONG-RANGE INTERACTION; C-MYC; PROSTATE-CANCER; 8Q24 PROSTATE; BETA-CATENIN; COLON-CANCER; VARIANT; TARGET; SUSCEPTIBILITY; INHIBITION	Multiple cancer-associated single-nucleotide polymorphisms (SNPs) have been mapped to conserved sequences within a 500-kilobase region upstream of the MYC oncogene on human chromosome 8q24. These SNPs may affect cancer development through altered regulation of MYC expression, but this hypothesis has been difficult to confirm. We generated mice deficient in Myc-335, a putative MYC regulatory element that contains rs6983267, a SNP accounting for more human cancer-related morbidity than any other genetic variant or mutation. In Myc-335 null mice, Myc transcripts were expressed in the intestinal crypts in a pattern similar to that in wild-type mice but at modestly reduced levels. The mutant mice displayed no overt phenotype but were markedly resistant to intestinal tumorigenesis induced by the APCmin mutation. These results establish that a cancer-associated SNP identified in human genome-wide association studies has a functional effect in vivo.	[Sur, Inderpreet Kaur; Vaharautio, Anna; Yan, Jian; Enge, Martin; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, Stockholm, Sweden; [Sur, Inderpreet Kaur] Karolinska Univ Hosp, Clin Res Ctr, Stockholm, Sweden; [Hallikas, Outi; Vaharautio, Anna; Turunen, Mikko; Taipale, Minna; Taipale, Jussi] Univ Helsinki, Biomedicum, Inst Biomed, Genome Scale Biol Program, FI-00014 Helsinki, Finland; [Karhu, Auli; Aaltonen, Lauri A.] Univ Helsinki, Biomedicum, Dept Med Genet, Genome Scale Biol Program, FI-00014 Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Helsinki	Taipale, J (corresponding author), Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, Stockholm, Sweden.	jussi.taipale@ki.se	Yan, Jian/B-2631-2018; Vähärautio, Anna/K-4279-2015; Aaltonen, Lauri/A-5375-2010; Enge, Martin/GYQ-5073-2022	Yan, Jian/0000-0002-1267-2870; Vähärautio, Anna/0000-0003-4721-3954; Aaltonen, Lauri/0000-0001-6839-4286; Karhu, Auli/0000-0002-7927-0796; Enge, Martin/0000-0001-8748-8931; Turunen, Mikko/0000-0001-5134-1559; Taipale, Minna/0000-0002-1905-2551; Sur, Inderpreet Kaur/0000-0001-5787-1040	Academy of Finland [140753]; Finnish Center of Excellence in Cancer Genetics Research [250345]; European Union Framework Program 7 project SYSCOL; European Research Council project GROWTHCONTROL; Sigrid Juselius Foundation; Finnish Cancer Society; Swedish Cancer Society; Center for Biosciences at Karolinska Institutet; Vetenskapsradet;  [134073]	Academy of Finland(Academy of Finland); Finnish Center of Excellence in Cancer Genetics Research; European Union Framework Program 7 project SYSCOL; European Research Council project GROWTHCONTROL; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Swedish Cancer Society(Swedish Cancer Society); Center for Biosciences at Karolinska Institutet(Karolinska Institutet); Vetenskapsradet(Swedish Research Council); 	We thank S. Miettinen and A. Zetterlund for technical assistance. This work was supported by the Academy of Finland grant 140753, postdoctoral researcher's project 134073, Finnish Center of Excellence in Cancer Genetics Research 250345, European Union Framework Program 7 project SYSCOL, European Research Council project GROWTHCONTROL, the Sigrid Juselius Foundation, the Finnish Cancer Society, the Swedish Cancer Society, the Center for Biosciences at Karolinska Institutet, and Vetenskapsradet.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen J Craig, 2004, BMC Dev Biol, V4, P4; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	28	163	166	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1360	1363		10.1126/science.1228606	http://dx.doi.org/10.1126/science.1228606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23118011				2022-12-01	WOS:000311991200072
J	Cote, GM; Sawyer, DB; Chabner, BA				Cote, Gregory M.; Sawyer, Douglas B.; Chabner, Bruce A.			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS ERBB2 Inhibition and Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTATIC BREAST-CANCER; DILATED CARDIOMYOPATHY; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; TRASTUZUMAB; SURVIVAL; REVEALS; SYSTEMS; PLUS; GENE		[Cote, Gregory M.; Chabner, Bruce A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Sawyer, Douglas B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Harvard University; Massachusetts General Hospital; Vanderbilt University	Cote, GM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.			Cote, Gregory/0000-0003-0181-886X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101425, R01HL068144] Funding Source: NIH RePORTER; NHLBI NIH HHS [P20 HL101425, R01 HL068144] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crone SA, 2002, ANN NY ACAD SCI, V971, P547, DOI 10.1111/j.1749-6632.2002.tb04525.x; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu FF, 2005, AM J PHYSIOL-HEART C, V289, pH660, DOI 10.1152/ajpheart.00268.2005; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	20	65	67	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2150	2153		10.1056/NEJMcibr1203156	http://dx.doi.org/10.1056/NEJMcibr1203156			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190227				2022-12-01	WOS:000311624400015
J	Jack, A				Jack, Andrew			Faking it	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], IPHARMACIST ME; Bate R, 2012, RES REP TROP MED, V3, P57, DOI 10.2147/RRTM.S33108; Bate R, 2012, RES REP TROP MED, V3, P63, DOI 10.2147/RRTM.S33690; Efpia, 2012, EUR STAK MOD; European Commission, 2011, REP EU CUST ENF INT; Gathigah M, 2011, KEN CIV SOC DEF ACC; Jack A., 2012, FINANCIAL TIMES; Jack A., 2008, FINANCIAL TIMES; Jack Andrew, 2011, FINANC TIMES; Organization W. H., 2012, MED SPUR FALS LAB FA; Pharmaceutical Security Institute, COUNT SIT; Tanne JH, 2008, BRIT MED J, V336, P412, DOI 10.1136/bmj.39496.419248.DB; WHO, 2006, COUNT MED FACTSH REV	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 20	2012	345								e7836	10.1136/bmj.e7836	http://dx.doi.org/10.1136/bmj.e7836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169809				2022-12-01	WOS:000311608200012
J	Ortega, FB; Silventoinen, K; Tynelius, P; Rasmussen, F				Ortega, Francisco B.; Silventoinen, Karri; Tynelius, Per; Rasmussen, Finn			Muscular strength in male adolescents and premature death: cohort study of one million participants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; ATTEMPTED-SUICIDE COHORT; CARDIORESPIRATORY FITNESS; MUSCLE STRENGTH; SELF-ESTEEM; DEPRESSIVE SYMPTOMS; PHYSICAL-ACTIVITY; EARLY ADULTHOOD; GRIP STRENGTH	Objectives To explore the extent to which muscular strength in adolescence is associated with all cause and cause specific premature mortality (<55 years). Design Prospective cohort study. Setting Sweden. Participants 1 142 599 Swedish male adolescents aged 16-19 years were followed over a period of 24 years. Main outcome measures Baseline examinations included knee extension, handgrip, and elbow flexion strength tests, as well as measures of diastolic and systolic blood pressure and body mass index. Cox regression was used to estimate hazard ratios for mortality according to muscular strength categories (tenths). Results During a median follow-up period of 24 years, 26 145 participants died. Suicide was a more frequent cause of death in young adulthood (22.3%) than was cardiovascular diseases (7.8%) or cancer (14.9%). High muscular strength in adolescence, as assessed by knee extension and handgrip tests, was associated with a 20-35% lower risk of premature mortality due to any cause or cardiovascular disease, independently of body mass index or blood pressure; no association was observed with mortality due to cancer. Stronger adolescents had a 20-30% lower risk of death from suicide and were 15-65% less likely to have any psychiatric diagnosis (such as schizophrenia and mood disorders). Adolescents in the lowest tenth of muscular strength showed by far the highest risk of mortality for different causes. All cause mortality rates (per 100 000 person years) ranged between 122.3 and 86.9 for the weakest and strongest adolescents; corresponding figures were 9.5 and 5.6 for mortality due to cardiovascular diseases and 24.6 and 16.9 for mortality due to suicide. Conclusions Low muscular strength in adolescents is an emerging risk factor for major causes of death in young adulthood, such as suicide and cardiovascular diseases. The effect size observed for all cause mortality was equivalent to that for well established risk factors such as elevated body mass index or blood pressure.	[Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden; [Ortega, Francisco B.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Ortega, Francisco B.] Karolinska Inst, Novum, Dept Biosci & Nutr, Stockholm, Sweden; [Ortega, Francisco B.] Univ Granada, Sch Med, Dept Med Physiol, E-18071 Granada, Spain; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland	Karolinska Institutet; University of Granada; Karolinska Institutet; University of Granada; University of Helsinki	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden.	Finn.Rasmussen@ki.se	Ortega, Francisco B/B-4002-2010; Ortega, Francisco B./AAG-5195-2021	Ortega, Francisco B/0000-0003-2001-1121; Ortega, Francisco B./0000-0003-2001-1121; Tynelius, Per/0000-0001-8155-7406; Silventoinen, Karri/0000-0003-1759-3079; Rasmussen, Finn/0000-0001-7915-7809	Swedish Research Council [2007-5942]; Spanish Ministry of Science and Innovation [RYC-2011-09011]; Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by a grant to FR from the Swedish Research Council (grant 2007-5942). FBO was supported by grants from the Spanish Ministry of Science and Innovation (RYC-2011-09011). The funding bodies had no role in the preparation of this manuscript.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: the study was supported by a grant to FR from the Swedish Research Council, and FBO was supported by grants from the Spanish Ministry of Science and Innovation; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Artero EG, 2011, J AM COLL CARDIOL, V57, P1831, DOI 10.1016/j.jacc.2010.12.025; Au ACY, 2009, ADOLESCENCE, V44, P851; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Batty GD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2506; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Beary M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1152; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P685; De Leo D, 2004, INT SUICIDE RATES PR; Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gale CR, 2012, ARCH GEN PSYCHIAT, V69, P823, DOI 10.1001/archgenpsychiatry.2011.2000; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Garaigordobil M, 2008, PSICOTHEMA, V20, P114; Greenleaf CA, 2010, RES Q EXERCISE SPORT, V81, pS65, DOI 10.1080/02701367.2010.10599695; Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koivukangas J, 2010, SCHIZOPHR RES, V116, P152, DOI 10.1016/j.schres.2009.10.022; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; National Board of Health and Welfare, 2010, CAUS DEATH HIST BACK; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1157/13078126; Ortega FB, 2010, AM J PREV MED, V39, P440, DOI 10.1016/j.amepre.2010.07.015; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Roberts JE, 1999, BRIT J CLIN PSYCHOL, V38, P425, DOI 10.1348/014466599162917; Romm KL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-136; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Sato M, 2009, EPIDEMIOLOGY, V20, P463, DOI 10.1097/EDE.0b013e31819ed09f; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Statistics Sweden. Multi-generation register, 2011, MULT REG 2010 DESCR; Sui XM, 2009, J PSYCHIATR RES, V43, P546, DOI 10.1016/j.jpsychires.2008.08.002; Sundstrom J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d643; VIITASALO JT, 1985, ERGONOMICS, V28, P1563, DOI 10.1080/00140138508963288; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639	46	326	334	3	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2012	345								e7279	10.1136/bmj.e7279	http://dx.doi.org/10.1136/bmj.e7279			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169869	Green Published, Green Submitted			2022-12-01	WOS:000311608200003
J	Groenen, MAM; Archibald, AL; Uenishi, H; Tuggle, CK; Takeuchi, Y; Rothschild, MF; Rogel-Gaillard, C; Park, C; Milan, D; Megens, HJ; Li, ST; Larkin, DM; Kim, H; Frantz, LAF; Caccamo, M; Ahn, H; Aken, BL; Anselmo, A; Anthon, C; Auvil, L; Badaoui, B; Beattie, CW; Bendixen, C; Berman, D; Blecha, F; Blomberg, J; Bolund, L; Bosse, M; Botti, S; Zhan, BJ; Bystrom, M; Capitanu, B; Carvalho-Silva, D; Chardon, P; Chen, C; Cheng, R; Choi, SH; Chow, W; Clark, RC; Clee, C; Crooijmans, RPMA; Dawson, HD; Dehais, P; De Sapio, F; Dibbits, B; Drou, N; Du, ZQ; Eversole, K; Fadista, J; Fairley, S; Faraut, T; Faulkner, GJ; Fowler, KE; Fredholm, M; Fritz, E; Gilbert, JGR; Giuffra, E; Gorodkin, J; Griffin, DK; Harrow, JL; Hayward, A; Howe, K; Hu, ZL; Humphray, SJ; Hunt, T; Hornshoj, H; Jeon, JT; Jern, P; Jones, M; Jurka, J; Kanamori, H; Kapetanovic, R; Kim, J; Kim, JH; Kim, KW; Kim, TH; Larson, G; Lee, K; Lee, KT; Leggett, R; Lewin, HA; Li, YR; Liu, WS; Loveland, JE; Lu, Y; Lunney, JK; Ma, J; Madsen, O; Mann, K; Matthews, L; McLaren, S; Morozumi, T; Murtaugh, MP; Narayan, J; Nguyen, DT; Ni, PX; Oh, SJ; Onteru, S; Panitz, F; Park, EW; Park, HS; Pascal, G; Paudel, Y; Perez-Enciso, M; Ramirez-Gonzalez, R; Reecy, JM; Rodriguez-Zas, S; Rohrer, GA; Rund, L; Sang, YM; Schachtschneider, K; Schraiber, JG; Schwartz, J; Scobie, L; Scott, C; Searle, S; Servin, B; Southey, BR; Sperber, G; Stadler, P; Sweedler, JV; Tafer, H; Thomsen, B; Wali, R; Wang, J; Wang, J; White, S; Xu, X; Yerle, M; Zhang, GJ; Zhang, JG; Zhang, J; Zhao, SH; Rogers, J; Churcher, C; Schook, LB				Groenen, Martien A. M.; Archibald, Alan L.; Uenishi, Hirohide; Tuggle, Christopher K.; Takeuchi, Yasuhiro; Rothschild, Max F.; Rogel-Gaillard, Claire; Park, Chankyu; Milan, Denis; Megens, Hendrik-Jan; Li, Shengting; Larkin, Denis M.; Kim, Heebal; Frantz, Laurent A. F.; Caccamo, Mario; Ahn, Hyeonju; Aken, Bronwen L.; Anselmo, Anna; Anthon, Christian; Auvil, Loretta; Badaoui, Bouabid; Beattie, Craig W.; Bendixen, Christian; Berman, Daniel; Blecha, Frank; Blomberg, Jonas; Bolund, Lars; Bosse, Mirte; Botti, Sara; Zhan Bujie; Bystrom, Megan; Capitanu, Boris; Carvalho-Silva, Denise; Chardon, Patrick; Chen, Celine; Cheng, Ryan; Choi, Sang-Haeng; Chow, William; Clark, Richard C.; Clee, Christopher; Crooijmans, Richard P. M. A.; Dawson, Harry D.; Dehais, Patrice; De Sapio, Fioravante; Dibbits, Bert; Drou, Nizar; Du, Zhi-Qiang; Eversole, Kellye; Fadista, Joao; Fairley, Susan; Faraut, Thomas; Faulkner, Geoffrey J.; Fowler, Katie E.; Fredholm, Merete; Fritz, Eric; Gilbert, James G. R.; Giuffra, Elisabetta; Gorodkin, Jan; Griffin, Darren K.; Harrow, Jennifer L.; Hayward, Alexander; Howe, Kerstin; Hu, Zhi-Liang; Humphray, Sean J.; Hunt, Toby; Hornshoj, Henrik; Jeon, Jin-Tae; Jern, Patric; Jones, Matthew; Jurka, Jerzy; Kanamori, Hiroyuki; Kapetanovic, Ronan; Kim, Jaebum; Kim, Jae-Hwan; Kim, Kyu-Won; Kim, Tae-Hun; Larson, Greger; Lee, Kyooyeol; Lee, Kyung-Tai; Leggett, Richard; Lewin, Harris A.; Li, Yingrui; Liu, Wansheng; Loveland, Jane E.; Lu, Yao; Lunney, Joan K.; Ma, Jian; Madsen, Ole; Mann, Katherine; Matthews, Lucy; McLaren, Stuart; Morozumi, Takeya; Murtaugh, Michael P.; Narayan, Jitendra; Dinh Truong Nguyen; Ni, Peixiang; Oh, Song-Jung; Onteru, Suneel; Panitz, Frank; Park, Eung-Woo; Park, Hong-Seog; Pascal, Geraldine; Paudel, Yogesh; Perez-Enciso, Miguel; Ramirez-Gonzalez, Ricardo; Reecy, James M.; Rodriguez-Zas, Sandra; Rohrer, Gary A.; Rund, Lauretta; Sang, Yongming; Schachtschneider, Kyle; Schraiber, Joshua G.; Schwartz, John; Scobie, Linda; Scott, Carol; Searle, Stephen; Servin, Bertrand; Southey, Bruce R.; Sperber, Goran; Stadler, Peter; Sweedler, Jonathan V.; Tafer, Hakim; Thomsen, Bo; Wali, Rashmi; Wang, Jian; Wang, Jun; White, Simon; Xu, Xun; Yerle, Martine; Zhang, Guojie; Zhang, Jianguo; Zhang, Jie; Zhao, Shuhong; Rogers, Jane; Churcher, Carol; Schook, Lawrence B.			Analyses of pig genomes provide insight into porcine demography and evolution	NATURE			English	Article							SEQUENCE; GENE; RECEPTOR; TASTE	For 10,000 years pigs and humans have shared a close and complex relationship. From domestication to modern breeding practices, humans have shaped the genomes of domestic pigs. Here we present the assembly and analysis of the genome sequence of a female domestic Duroc pig (Sus scrofa) and a comparison with the genomes of wild and domestic pigs from Europe and Asia. Wild pigs emerged in South East Asia and subsequently spread across Eurasia. Our results reveal a deep phylogenetic split between European and Asian wild boars similar to 1 million years ago, and a selective sweep analysis indicates selection on genes involved in RNA processing and regulation. Genes associated with immune response and olfaction exhibit fast evolution. Pigs have the largest repertoire of functional olfactory receptor genes, reflecting the importance of smell in this scavenging animal. The pig genome sequence provides an important resource for further improvements of this important livestock species, and our identification of many putative disease-causing variants extends the potential of the pig as a biomedical model.	[Groenen, Martien A. M.; Megens, Hendrik-Jan; Frantz, Laurent A. F.; Bosse, Mirte; Crooijmans, Richard P. M. A.; Dibbits, Bert; Madsen, Ole; Paudel, Yogesh] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6708 WD Wageningen, Netherlands; [Archibald, Alan L.; De Sapio, Fioravante; Faulkner, Geoffrey J.; Kapetanovic, Ronan] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Archibald, Alan L.; De Sapio, Fioravante; Faulkner, Geoffrey J.; Kapetanovic, Ronan] Univ Edinburgh, R D SVS, Easter Bush EH25 9RG, Midlothian, Scotland; [Uenishi, Hirohide; Kanamori, Hiroyuki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Tuggle, Christopher K.; Rothschild, Max F.; Bystrom, Megan; Cheng, Ryan; Du, Zhi-Qiang; Fritz, Eric; Hu, Zhi-Liang; Onteru, Suneel; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Tuggle, Christopher K.; Rothschild, Max F.; Bystrom, Megan; Cheng, Ryan; Du, Zhi-Qiang; Fritz, Eric; Hu, Zhi-Liang; Onteru, Suneel; Reecy, James M.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA; [Takeuchi, Yasuhiro] UCL, Div Infect & Immun, MRC, UCL Ctr Med Mol Virol, London WC1E 6BT, England; [Takeuchi, Yasuhiro] UCL, Div Infect & Immun, Wohl Vir Ctr, London WC1E 6BT, England; [Rogel-Gaillard, Claire; Chardon, Patrick; Giuffra, Elisabetta] INRA, Lab Anim Genet & Integrat Biol, Lab Radiobiol & Etud Genome, AgroParisTech,CEA,DSV,IRCM, F-78350 Jouy En Josas, France; [Park, Chankyu; Kim, Jaebum; Lee, Kyooyeol; Dinh Truong Nguyen] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; [Milan, Denis; Dehais, Patrice; Faraut, Thomas; Servin, Bertrand; Yerle, Martine] INRA, Lab Genet Cellulaire, F-31320 Castanet Tolosan, France; [Li, Shengting; Bolund, Lars; Li, Yingrui; Lu, Yao; Ni, Peixiang; Wang, Jian; Wang, Jun; Xu, Xun; Zhang, Guojie; Zhang, Jianguo] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Shengting; Bolund, Lars] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Larkin, Denis M.; Narayan, Jitendra] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DA, Ceredigion, Wales; [Kim, Heebal; Ahn, Hyeonju] Seoul Natl Univ, Dept Agr Biotechnol & C&K Genom, Seoul 151742, South Korea; [Caccamo, Mario; Drou, Nizar; Leggett, Richard; Ramirez-Gonzalez, Ricardo; Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Aken, Bronwen L.; Chow, William; Clark, Richard C.; Clee, Christopher; Fairley, Susan; Gilbert, James G. R.; Harrow, Jennifer L.; Howe, Kerstin; Humphray, Sean J.; Hunt, Toby; Jones, Matthew; Loveland, Jane E.; Matthews, Lucy; McLaren, Stuart; Scott, Carol; Searle, Stephen; White, Simon; Churcher, Carol] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Anselmo, Anna; Badaoui, Bouabid; Botti, Sara; Giuffra, Elisabetta] Parco Tecnol Padano, I-26900 Lodi, Italy; [Anthon, Christian; Fredholm, Merete; Gorodkin, Jan] IBHV Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Auvil, Loretta; Capitanu, Boris] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Beattie, Craig W.] Univ Illinois, Dept Surg, Chicago, IL 60612 USA; [Bendixen, Christian; Zhan Bujie; Fadista, Joao; Hornshoj, Henrik; Panitz, Frank; Thomsen, Bo] Aarhus Univ, Dept Mol Biol & Genet, DK-8830 Tjele, Denmark; [Berman, Daniel; Lunney, Joan K.; Mann, Katherine] USDA ARS, BARC Anim Parasit Dis Lab, Beltsville, MD 20705 USA; [Blecha, Frank; Sang, Yongming] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Acad Hosp, S-75185 Uppsala, Sweden; [Carvalho-Silva, Denise] European Bioinformat Inst, Hinxton CB10 1SD, Cambs, England; [Chen, Celine; Dawson, Harry D.] USDA, Immunol Lab, Beltsville Human Nutr Res Ctr, BARC E, Beltsville, MD 20705 USA; [Choi, Sang-Haeng; Park, Hong-Seog] Korean Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Eversole, Kellye] Eversole Associates, Bethesda, MD 20816 USA; [Eversole, Kellye] Alliance Anim Genome Res, Bethesda, MD 20816 USA; [Fowler, Katie E.; Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Hayward, Alexander; Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, BMC, SE-75123 Uppsala, Sweden; [Jeon, Jin-Tae] Gyeongsang Natl Univ, Coll Agr & Life Sci, Dept Anim Sci, Jinju 660701, South Korea; [Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kanamori, Hiroyuki; Morozumi, Takeya] Inst Japan Assoc Technoinnovat Agr Forestry & Fis, Tsukuba, Ibaraki 3050854, Japan; [Kim, Jaebum] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kim, Jae-Hwan] Natl Inst Anim Sci, Anim Genet Resources Stn, RDA, Namwon 590832, South Korea; [Kim, Kyu-Won] C&K Genom, Seoul 151742, South Korea; [Kim, Tae-Hun; Lee, Kyung-Tai; Park, Eung-Woo] Natl Inst Anim Sci, Anim Genom & Bioinformat Div, RDA, Suwon 441706, South Korea; [Larson, Greger] Univ Durham, Dept Archaeol, Durham DH1 3LE, England; [Lewin, Harris A.] Univ Calif Davis, UC Davis Genome Ctr, Dept Ecol & Evolut, Davis, CA 95618 USA; [Liu, Wansheng] Penn State Univ, Coll Agr Sci, CRBH, Dept Dairy & Anim Sci, University Pk, PA 16802 USA; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Ma, Jian] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Murtaugh, Michael P.; Schwartz, John] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Oh, Song-Jung] Jeju Natl Univ, Cheju 690756, South Korea; [Pascal, Geraldine] INRA, CNRS, UMR85, IFCE,Physiol Reprod & Comportements UMR7247, F-37380 Nouzilly, France; [Pascal, Geraldine] Univ Tours, F-37041 Tours, France; [Perez-Enciso, Miguel] CRAG, ICREA, E-08193 Bellaterra, Spain; [Perez-Enciso, Miguel] UAB, Fac Vet, E-08193 Bellaterra, Spain; [Rodriguez-Zas, Sandra; Rund, Lauretta; Schachtschneider, Kyle; Southey, Bruce R.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rohrer, Gary A.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Schraiber, Joshua G.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Scobie, Linda; Wali, Rashmi] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Sperber, Goran] Uppsala Univ, Biomed Ctr, Dept Neurosci, S-75124 Uppsala, Sweden; [Stadler, Peter; Tafer, Hakim] Univ Leipzig, Dept Comp Sci, Interdisciplinary Ctr Bioinformat, Bioinformat Grp, Leipzig, Germany; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Zhang, Guojie] BGI Europe, DK-2200 Copenhagen N, Denmark; [Zhang, Jie; Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China; [Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; National Institute of Agrobiological Sciences - Japan; Iowa State University; Iowa State University; University of London; University College London; University of London; University College London; AgroParisTech; CEA; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Konkuk University; INRAE; Beijing Genomics Institute (BGI); Aarhus University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Seoul National University (SNU); The Genome Analysis Centre (TGAC); Wellcome Trust Sanger Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Aarhus University; United States Department of Agriculture (USDA); Kansas State University; Uppsala University; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Kent; Uppsala University; Gyeongsang National University; University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Durham University; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Jeju National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); ICREA; Autonomous University of Barcelona; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Glasgow Caledonian University; Uppsala University; Leipzig University; University of Illinois System; University of Illinois Urbana-Champaign; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Huazhong Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Groenen, MAM (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Elst 1, NL-6708 WD Wageningen, Netherlands.	martien.groenen@wur.nl; alan.archibald@roslin.ed.ac.uk	PASCAL, Géraldine/A-7041-2008; Fadista, Joao/AAM-4870-2020; kapetanovic, ronan/G-8322-2012; Giuffra, Elisabetta/I-3201-2013; Badaoui, Bouabid/AAV-8968-2021; Schwartz, John/I-3002-2019; Madsen, Ole/E-3730-2012; Dawson, Harry/ABG-2734-2021; Giuffra, Elisabetta/J-8080-2014; Stadler, Peter F. F/L-7857-2015; Wang, Jun/A-7261-2013; Larkin, Denis/AAB-1633-2022; Groenen, Martien/D-8408-2012; Zhang, Guojie/B-6188-2014; Ramírez, Ricardo/H-4808-2019; PASCAL, Géraldine/L-4519-2013; Zhang, Guojie/J-7273-2019; Larkin, Denis/AAB-2249-2022; Park, Chankyu/D-8775-2011; Dawson, Harry/H-8242-2013; Eversole, Kellye/AAN-6141-2020; Nguyen, Dinh-Truong/AAI-5062-2021; Megens, Hendrik-Jan/E-9676-2010; Kim, Heebal/A-8889-2016; Li, Yingrui/K-1064-2015; Jern, Patric/AAR-2133-2021; Megens, Hendrik-Jan/M-5300-2019; Ma, Jian/A-9838-2008; Perez-Enciso, Miguel/H-6057-2015; Panitz, Frank/A-3281-2017; Jensen, Betina W/J-2207-2015; Faulkner, Geoffrey J/M-3168-2014; Servin, Bertrand/B-2206-2008; Crooijmans, Richard PMA/E-2492-2012; Pascal, Geraldine/P-8125-2019; Xu, Xun/AAI-6763-2020; Sweedler, Jonathan V/A-9405-2009; Kim, Kyu Won/AAJ-7213-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Fadista, Joao/0000-0003-2539-634X; kapetanovic, ronan/0000-0002-2908-1014; Schwartz, John/0000-0003-2057-1831; Madsen, Ole/0000-0001-8082-7881; Dawson, Harry/0000-0002-7648-9952; Stadler, Peter F. F/0000-0002-5016-5191; Larkin, Denis/0000-0001-7859-6201; Groenen, Martien/0000-0003-0484-4545; Zhang, Guojie/0000-0001-6860-1521; Ramírez, Ricardo/0000-0001-5745-7085; PASCAL, Géraldine/0000-0002-5250-6594; Zhang, Guojie/0000-0001-6860-1521; Eversole, Kellye/0000-0002-8784-4913; Nguyen, Dinh-Truong/0000-0002-6452-5573; Megens, Hendrik-Jan/0000-0002-3619-7533; Kim, Heebal/0000-0003-3064-1303; Jern, Patric/0000-0003-3393-5825; Megens, Hendrik-Jan/0000-0002-3619-7533; Ma, Jian/0000-0002-4202-5834; Perez-Enciso, Miguel/0000-0003-3524-995X; Panitz, Frank/0000-0002-6909-5162; Faulkner, Geoffrey J/0000-0001-5769-4494; Servin, Bertrand/0000-0001-5141-0913; Pascal, Geraldine/0000-0002-5250-6594; Xu, Xun/0000-0002-5338-5173; Sweedler, Jonathan V/0000-0003-3107-9922; Hunt, Toby/0000-0001-8377-0841; Leggett, Richard/0000-0003-3044-4297; Thomsen, Bo/0000-0001-9622-0929; Frantz, Laurent/0000-0001-8030-3885; Gorodkin, Jan/0000-0001-5823-4000; rund, laurie/0000-0003-0761-7196; Fairley, Susan/0000-0001-9425-0788; Carvalho-Silva, Dr D/0000-0001-5662-1840; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; CHENG, RYAN PEI YEN/0000-0002-2119-6431; Harrow, Jennifer/0000-0003-0338-3070; Howe, Kerstin/0000-0003-2237-513X; Mann, Katherine/0000-0001-8144-8170; Anthon, Christian/0000-0002-4336-1688; Chow, William/0000-0002-9056-201X; Loveland, Jane/0000-0002-7669-2934; Schook, Lawrence/0000-0002-6580-8364; Southey, Bruce/0000-0002-8959-7709; Schachtschneider, Kyle/0000-0002-7293-8642; Park, Chankyu/0000-0003-4855-2210; Tafer, Hakim/0000-0002-6252-9802; Rohrer, Gary/0000-0002-8252-9308; Zhang, Jianguo/0000-0003-0723-1701; fadista, joao/0000-0001-7558-7043; Giuffra, Elisabetta/0000-0001-9568-2056; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Harvey, Katie/0000-0003-0359-2390; Bosse, Mirte/0000-0003-2433-2483; Blomberg, Jonas/0000-0001-6492-2491; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Reecy, James/0000-0003-4602-0990; Archibald, Alan/0000-0001-9213-1830; Anselmo, Anna/0000-0002-5279-8670; Aken, Bronwen/0000-0002-3032-4095; Narayan, Jitendra/0000-0002-2065-2861; Fredholm, Merete/0000-0002-3563-7648; Hayward, Alexander/0000-0001-7413-718X; White, Simon/0000-0001-6375-2363; Gilbert, James/0000-0001-8079-3159; Ahn, Hyeonju/0000-0002-8922-972X	USDA CSREES/NIFA Swine Genome Coordination Program; College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI.; BBSRC [BB/E010520/1, BB/E010520/2, BB/I025328/1, BB/H005935/1, BB/G004013/1]; EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; Australian NHMRC [575585]; Next-Generation BioGreen 21 Program [PJ009019, PJ0081162012, PJ0080892011]; RDA, Republic of Korea; Ministry of Research (Spain); NIH [R13 RR020283A, NIH R13 RR032267A, ILLU 535-314, ILLU 538-379, ILLU-538-312, ILLU-538-34, 5 P41LM006252, P20-RR017686, 5 P41 LM006252]; CSREES; NIFA; MAFF [IRPPIAUGT-AG 1101/1201]; USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; USDA-ARS Project Plan [1235-51000-055-00D, 1265-32000-098-00D]; USDA AFRI NIFA/DHS [2010-39559-21860]; USDA ARS; USDA-NRSP8 Bioinformatics; NSFC [31025026]; Swedish Research Council FORMAS; Swedish Wenner-Gren Foundations; European Commission [LSHB-CT-2006-037377]; BioGreen21; RDA [PJ00622901, PJ00622902, PJ00622903, 20040301034467]; European Research Council under the European Community [249894]; NIH NIDA [P30 DA018310, R21 DA027548]; ANR [ANR07-GANI-001]; FTP/DFF [09-066598]; DSF/Strategic Growth Technologies [09-067036]; Lundbeck foundation [374/06]; DCSC (Scientific Computing); Funds for International Cooperation from the Ministry of Science and Technology of China [2002AA229061]; PL-Grid project: [POIG.02.03.00-00-007/08-00]; USDA-NIFA-CREES [AG 2006-35216-16668, AG 2002-34480-11828, AG 2003-34480-13172, AG 2004-34480-14417, AG 2005-34480-15939, AG 2006-34480-17150, AG 2008-34480-19328, AG 2009-34480-19875, AG 2002-35205-12712, AG 2008-35205-18769, AG 2009-65205-05642, AG 2004-3881-02193];  [USDA-NRI-2009-35205-05192];  [USDA-NRI-2006-35204-17337]; ICREA Funding Source: Custom; Biotechnology and Biological Sciences Research Council [BB/E010768/1, BB/I025360/1, BB/E010520/1, BB/H005935/1, BBS/E/D/20211550, BB/E010520/2, BB/I025506/1, BB/I025328/1, BB/G004013/1, BBS/E/D/05191130, BB/E011640/1] Funding Source: researchfish; Medical Research Council [G0900950, G0900950B] Funding Source: researchfish; Natural Environment Research Council [NE/F003382/2, NE/H005552/1, NE/H005269/1, NE/F003382/1] Funding Source: researchfish; Chief Scientist Office [ETM/32] Funding Source: researchfish; BBSRC [BB/I025360/1, BB/E010768/1, BB/E011640/1, BB/I025506/1, BBS/E/D/20211550, BBS/E/T/000PR5885, BBS/E/D/05191130] Funding Source: UKRI; MRC [G0900950] Funding Source: UKRI; NERC [NE/H005552/1, NE/F003382/2, NE/F003382/1, NE/H005269/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [R13RR032267, R13RR020283, P20RR017686] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, R21DA027548] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [P41LM006252] Funding Source: NIH RePORTER	USDA CSREES/NIFA Swine Genome Coordination Program; College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA, Republic of Korea; Ministry of Research (Spain); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; USDA-ARS Project Plan; USDA AFRI NIFA/DHS; USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-NRSP8 Bioinformatics; NSFC(National Natural Science Foundation of China (NSFC)); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Wenner-Gren Foundations; European Commission(European CommissionEuropean Commission Joint Research Centre); BioGreen21(Rural Development Administration (RDA), Republic of Korea); RDA(Rural Development Administration (RDA), Republic of Korea); European Research Council under the European Community(European Research Council (ERC)); NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ANR(French National Research Agency (ANR)); FTP/DFF; DSF/Strategic Growth Technologies; Lundbeck foundation(Lundbeckfonden); DCSC (Scientific Computing); Funds for International Cooperation from the Ministry of Science and Technology of China; PL-Grid project:; USDA-NIFA-CREES; ; ; ICREA(ICREA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors recognize the contributions of the following individuals towards the establishment of the Swine Genome Sequencing Consortium and their leadership in realizing this effort: J. Jen, P. J. Burfening, D. Hamernik, R. A. Easter, N. Merchen, R. D. Green, J. Cassady, B. Harlizius, M. Boggess and M. Stratton. Also the authors acknowledge A. Hernandez, C. Wright at the University of Illinois Keck Center for Comparative and Functional Genomics; N. Bruneau and Prof. Ning Li for their contribution to PERV studies; D. Goodband and D. Berman for their efforts in genome annotation; D. Grafham of the Welcome Trust Sanger Institute for his efforts in the genome assembly and J. Hedegaard, M. Nielsen and R. O. Nielsen for their contribution on the miRNA analysis. We also recognize contributions from the National Institute of Agrobiological Sciences and the Institute of Japan Association for Techno-innovation in Agriculture, Forestry and Fisheries, Tsukuba, Japan, H. Shinkai, T. Eguchi-Ogawa, K. Suzuki, D. Toki, T. Matsumoto, N. Fujishima-Kanaya, A. Mikawa, N. Okumura, M. Tanaka-Matsuda, K. Kurita, H. Sasaki, K. Kamiya, A. Kikuta, T. Bito and N. Fujitsuka. We acknowledge support from the USDA CSREES/NIFA Swine Genome Coordination Program, College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI. We are grateful to the genome team at NCBI for their assistance in checking the Sscrofa 10.2 assembly and for their independent annotation of the sequence. This project was also partially supported by grants: BBSRC grants (Ensembl): BB/E010520/1, BB/E010520/2, BB/I025328/1; EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; C. J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC (575585); BBSRC (BB/H005935/1); Next-Generation BioGreen 21 Program (PJ009019, PJ0081162012), RDA, Republic of Korea; Consolider programme from Ministry of Research (Spain); NIH R13 RR020283A; NIH R13 RR032267A; ILLU 535-314; ILLU 538-379; ILLU-538-312; ILLU-538-34; CSREES, NIFA for funding genome coordination activities; NIH grant 5 P41LM006252; MAFF grants (IRPPIAUGT-AG 1101/1201); USDA-NRI-2009-35205-05192; USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; Next-Generation BioGreen 21 (no. PJ0080892011) Program, RDA, Republic of Korea; USDA-ARS Project Plan 1235-51000-055-00D; USDA-ARS Project Plan 1265-32000-098-00D; USDA-NRI-2006-35204-17337 USDA AFRI NIFA/DHS 2010-39559-21860; NIH P20-RR017686; USDA ARS; USDA-NRSP8 Bioinformatics; USDA ARS Beltsville Area Summer Undergraduate Fellowships; BBSRC grant BB/G004013/1; NSFC Outstanding Youth grant (31025026); The Swedish Research Council FORMAS; The Swedish Wenner-Gren Foundations; European Commission FP6 funded project LSHB-CT-2006-037377; BioGreen21, RDA grant PJ00622901; BioGreen21, RDA grant PJ00622902; BioGreen21, RDA grant PJ00622903; BioGreen21, RDA grant PJ00622903. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no.; 249894 (SelSweep); NIH P20-RR017686; NIH NIDA P30 DA018310; NIH NIDA R21 DA027548; NIAS, RDA grant PJ001758; BioGreen21, RDA grant PJ006229; NIAS, RDA grant 20040301034467; ANR grant ANR07-GANI-001 DeliSus; Danish funding agencies: FTP/DFF (09-066598); DSF/Strategic Growth Technologies (09-067036); the Lundbeck foundation (374/06); DCSC (Scientific Computing); The Funds for International Cooperation from the Ministry of Science and Technology of China 2002AA229061; PL-Grid project: POIG.02.03.00-00-007/08-00 'Genome Assembly'; USDA-NIFA-CREES AG 2006-35216-16668; AG 2002-34480-11828; AG 2003-34480-13172; AG 2004-34480-14417; AG 2005-34480-15939; AG 2006-34480-17150; AG 2008-34480-19328; AG 2009-34480-19875; AG 2002-35205-12712; somatic cell genomics: Integrating QTL Discovery and Validation; AG 2008-35205-18769; AG 2009-65205-05642; AG 2004-3881-02193; AG 2011-67015-30229; AG 58-5438-2-313; AG 58-5438-7-317; and AG 58-0208-7-149; NIH grant 5 P41 LM006252.	Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Eguchi-Ogawa T, 2009, DEV COMP IMMUNOL, V33, P1111, DOI 10.1016/j.dci.2009.06.006; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fang X., GIGASCIENCE IN PRESS; Fischer A, 2005, MOL BIOL EVOL, V22, P432, DOI 10.1093/molbev/msi027; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hellekant G, 1999, J ANIM PHYSIOL AN N, V82, P8, DOI 10.1046/j.1439-0396.1999.00206.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kupsco JM, 2006, RNA, V12, P2103, DOI 10.1261/rna.186706; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murgiano L., BMC GENOMIC IN PRESS; Nelson SL, 1997, CHEM SENSES, V22, P129, DOI 10.1093/chemse/22.2.129; Nguyen D. T., BMC GENOMIC IN PRESS; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Rubin C. J., P NATL ACAD IN PRESS; Sambrook JG, 2006, IMMUNOGENETICS, V58, P481, DOI 10.1007/s00251-006-0110-9; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Schwartz JC, 2012, IMMUNOGENETICS, V64, P399, DOI 10.1007/s00251-011-0594-9; Schwartz JC, 2012, IMMUNOGENETICS, V64, P303, DOI 10.1007/s00251-011-0589-6; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Tanaka-Matsuda M, 2009, GENOMICS, V93, P261, DOI 10.1016/j.ygeno.2008.10.004; Tortereau F., BMC GENOMIC IN PRESS; Uenishi H, 2003, IMMUNOLOGY, V109, P515, DOI 10.1046/j.1365-2567.2003.01695.x; Uenishi H, 2009, MOL IMMUNOL, V46, P1212, DOI 10.1016/j.molimm.2008.11.010; VANDENBROECK K, 1993, EUR J BIOCHEM, V217, P45, DOI 10.1111/j.1432-1033.1993.tb18216.x; Walters E. M., BMC MED GEN IN PRESS; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	45	910	950	15	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					393	398		10.1038/nature11622	http://dx.doi.org/10.1038/nature11622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151582	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000311031600036
J	DeSantis, ME; Leung, EH; Sweeny, EA; Jackrel, ME; Cushman-Nick, M; Neuhaus-Follini, A; Vashist, S; Sochor, MA; Knight, MN; Shorter, J				DeSantis, Morgan E.; Leung, Eunice H.; Sweeny, Elizabeth A.; Jackrel, Meredith E.; Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Vashist, Shilpa; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James			Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients	CELL			English	Article							PLUS CHAPERONE CLPB; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; COMMON MECHANISM; YEAST PRIONS; CENTRAL PORE; THERMOTOLERANCE; PROPAGATION; INHERITANCE; DISORDERS	It is not understood how Hsp104, a hexameric AAA+ ATPase from yeast, disaggregates diverse structures, including stress-induced aggregates, prions, and a-synuclein conformers connected to Parkinson disease. Here, we establish that Hsp104 hexamers adapt different mechanisms of intersubunit collaboration to disaggregate stress-induced aggregates versus amyloid. To resolve disordered aggregates, Hsp104 subunits collaborate noncooperatively via probabilistic substrate binding and ATP hydrolysis. To disaggregate amyloid, several subunits cooperatively engage substrate and hydrolyze ATP. Importantly, Hsp104 variants with impaired intersubunit communication dissolve disordered aggregates, but not amyloid. Unexpectedly, prokaryotic ClpB subunits collaborate differently than Hsp104 and couple probabilistic substrate binding to cooperative ATP hydrolysis, which enhances disordered aggregate dissolution but sensitizes ClpB to inhibition and diminishes amyloid disaggregation. Finally, we establish that Hsp104 hexamers deploy more subunits to disaggregate Sup35 prion strains with more stable "cross-beta" cores. Thus, operational plasticity enables Hsp104 to robustly dissolve amyloid and nonamyloid clients, which impose distinct mechanical demands.	[DeSantis, Morgan E.; Leung, Eunice H.; Sweeny, Elizabeth A.; Jackrel, Meredith E.; Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Vashist, Shilpa; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [DeSantis, Morgan E.; Sweeny, Elizabeth A.; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Shorter, James] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Jackrel, Meredith/0000-0003-4406-9504; Sweeny, Elizabeth/0000-0001-7818-9112	NIH [T32GM071339, T32GM008275, T32AG000255, DP2OD002177]; NRSA [F31NS079009, F31NS067890]; AHA; Ellison Medical Foundation New Scholar in Aging Award; Penn Institute of Aging; Alzheimer Disease Core Center; Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079009, F31NS067890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); Penn Institute of Aging; Alzheimer Disease Core Center; Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Sue Lindquist, Sabine Kedzierska-Mieszkowska, and Virginia Lee for reagents. We thank Sandra Maday, Mark Lemmon, Aaron Gitler, Walter Englander, and Nancy Bonini for critiques and Lili Guo for artwork. Our work was funded by NIH training grant T32GM071339 and NRSA predoctoral fellowship F31NS079009 (M. E. D.); NIH training grant T32GM008275 (E. A. S. and M. A. S.); AHA predoctoral (E. A. S.) and postdoctoral fellowships (M.E.J.); NIH training grant T32AG000255 and NRSA predoctoral fellowship F31NS067890 (M.C.-N.); NIH Director's New Innovator Award (DP2OD002177), Ellison Medical Foundation New Scholar in Aging Award, Penn Institute of Aging, Alzheimer Disease Core Center, and Diabetes Research Center Awards (J.S.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346; Garrity SJ, 2010, P NATL ACAD SCI USA, V107, P10596, DOI 10.1073/pnas.0913280107; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/o09-121, 10.1139/O09-121]; Wang L, 2010, ANGEW CHEM INT EDIT, V49, P3904, DOI 10.1002/anie.201000068; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.17748, 10.4161/pri.5.4.17748]	45	128	129	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					778	793		10.1016/j.cell.2012.09.038	http://dx.doi.org/10.1016/j.cell.2012.09.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141537	Green Accepted, Bronze			2022-12-01	WOS:000310921200010
J	Gaudry, Q; Hong, EJ; Kain, J; de Bivort, BL; Wilson, RI				Gaudry, Quentin; Hong, Elizabeth J.; Kain, Jamey; de Bivort, Benjamin L.; Wilson, Rachel I.			Asymmetric neurotransmitter release enables rapid odour lateralization in Drosophila	NATURE			English	Article							OLFACTORY LOCAL INTERNEURONS; ANTENNAL LOBE; MELANOGASTER; CIRCUIT; NEURONS; OSMOTROPOTAXIS; INFORMATION; MARKER; SYSTEM; GENE	In Drosophila, most individual olfactory receptor neurons (ORNs) project bilaterally to both sides of the brain(1,2). Having bilateral rather than unilateral projections may represent a useful redundancy. However, bilateral ORN projections to the brain should also compromise the ability to lateralize odours. Nevertheless, walking or flying Drosophila reportedly turn towards the antenna that is more strongly stimulated by odour(3-5). Here we show that each ORN spike releases approximately 40% more neurotransmitter from the axon branch ipsilateral to the soma than from the contralateral branch. As a result, when an odour activates the antennae asymmetrically, ipsilateral central neurons begin to spike a few milliseconds before contralateral neurons, and at a 30 to 50% higher rate than contralateral neurons. We show that a walking fly can detect a 5% asymmetry in total ORN input to its left and right antennal lobes, and can turn towards the odour in less time than it requires the fly to complete a stride. These results demonstrate that neurotransmitter release properties can be tuned independently at output synapses formed by a single axon onto two target cells with identical functions and morphologies. Our data also show that small differences in spike timing and spike rate can produce reliable differences in olfactory behaviour.	[Gaudry, Quentin; Hong, Elizabeth J.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kain, Jamey; de Bivort, Benjamin L.] Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA; [de Bivort, Benjamin L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [de Bivort, Benjamin L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266	National Institutes of Health [R01DC008174]; Rowland Junior Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rowland Junior Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to M. Dickinson, V. Jayaraman, L. Luo, D. Tracey and L. Vosshall for gifts of fly stocks. A. Baker helped construct and improve the spherical treadmill apparatus. Members of the Wilson laboratory provided feedback on the manuscript. This work was supported by a research project grant from the National Institutes of Health (R01DC008174). R. I. W. is an HHMI Early Career Scientist. B.L.d.B. and J.K. were supported by the Rowland Junior Fellows Program.	Agarwal G, 2011, J NEUROPHYSIOL, V105, P1711, DOI 10.1152/jn.00591.2010; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; BORST A, 1982, J COMP PHYSIOL, V147, P479, DOI 10.1007/BF00612013; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; Duistermars BJ, 2009, CURR BIOL, V19, P1301, DOI 10.1016/j.cub.2009.06.022; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FLUGGE CHARLOTTE, 1934, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V20, P463; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HANGART.W, 1967, Z VERGL PHYSIOL, V57, P103, DOI 10.1007/BF00303068; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kazama H, 2011, J NEUROSCI, V31, P7619, DOI 10.1523/JNEUROSCI.5984-10.2011; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; KENNEDY JS, 1969, ENTOMOL EXP APPL, V12, P487, DOI 10.1007/BF00297080; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LOCKERY SR, 1990, J NEUROSCI, V10, P1816; MARTIN H, 1965, NATURE, V208, P59, DOI 10.1038/208059a0; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	36	86	86	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					424	U175		10.1038/nature11747	http://dx.doi.org/10.1038/nature11747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23263180	Green Accepted, Green Submitted			2022-12-01	WOS:000313615900056
J	Schwitalla, S; Fingerle, AA; Cammareri, P; Nebelsiek, T; Goktuna, SI; Ziegler, PK; Canli, O; Heijmans, J; Huels, DJ; Moreaux, G; Rupec, RA; Gerhard, M; Schmid, R; Barker, N; Clevers, H; Lang, R; Neumann, J; Kirchner, T; Taketo, MM; van den Brink, GR; Sansom, OJ; Arkan, MC; Greten, FR				Schwitalla, Sarah; Fingerle, Alexander A.; Cammareri, Patrizia; Nebelsiek, Tim; Goektuna, Serkan I.; Ziegler, Paul K.; Canli, Ozge; Heijmans, Jarom; Huels, David J.; Moreaux, Guenievre; Rupec, Rudolf A.; Gerhard, Markus; Schmid, Roland; Barker, Nick; Clevers, Hans; Lang, Roland; Neumann, Jens; Kirchner, Thomas; Taketo, Makoto M.; van den Brink, Gijs R.; Sansom, Owen J.; Arkan, Melek C.; Greten, Florian R.			Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties	CELL			English	Article							NF-KAPPA-B; BETA-CATENIN; PANCREATIC-CANCER; TUMOR PROGRESSION; MOUSE MODEL; IN-VIVO; INFLAMMATION; EXPRESSION; IKK; APC	Cell-type plasticity within a tumor has recently been suggested to cause a bidirectional conversion between tumor-initiating stem cells and nonstem cells triggered by an inflammatory stroma. NF-kappa B represents a key transcription factor within the inflammatory tumor microenvironment. However, NF-kappa B's function in tumor-initiating cells has not been examined yet. Using a genetic model of intestinal epithelial cell (IEC)-restricted constitutive Wnt-activation, which comprises the most common event in the initiation of colon cancer, we demonstrate that NF-kappa B modulates Wnt signaling and show that IEC-specific ablation of RelA/p65 retards crypt stem cell expansion. In contrast, elevated NF-kappa B signaling enhances Wnt activation and induces dedifferentiation of nonstem cells that acquire tumor-initiating capacity. Thus, our data support the concept of bidirectional conversion and highlight the importance of inflammatory signaling for dedifferentiation and generation of tumor-initiating cells in vivo.	[Schwitalla, Sarah; Nebelsiek, Tim; Goektuna, Serkan I.; Ziegler, Paul K.; Canli, Ozge; Arkan, Melek C.; Greten, Florian R.] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Fingerle, Alexander A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany; [Gerhard, Markus] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Schmid, Roland] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany; [Cammareri, Patrizia; Huels, David J.; Moreaux, Guenievre; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Heijmans, Jarom; van den Brink, Gijs R.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Rupec, Rudolf A.] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany; [Neumann, Jens; Kirchner, Thomas] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Barker, Nick] Inst Med Biol, Singapore 138648, Singapore; [Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Beatson Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich; University of Munich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Erlangen Nuremberg; Kyoto University	Greten, FR (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany.	florian.greten@lrz.tum.de	Barker, Nick/AAE-9833-2021; Greten, Florian R/AAF-5196-2020; Sch/AAA-9548-2021; Ziegler, Paul/AAO-4379-2021; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Gerhard, Markus/N-3387-2014; Lang, Roland/C-3287-2011; Gerhard, Markus/P-8996-2019	Barker, Nick/0000-0003-3566-4475; Greten, Florian R/0000-0002-3928-6080; Ziegler, Paul/0000-0002-7703-7747; Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Heijmans, Jarom/0000-0001-9615-7851; Sansom, Owen J./0000-0001-9540-3010; Huels, David/0000-0001-6154-1183; Goktuna, Serkan/0000-0001-6169-768X; Lang, Roland/0000-0003-0502-3677; Cammareri, Patrizia/0000-0002-5888-6903; Huels, Roland/0000-0002-1970-744X	European Research Council [ROSCAN-281967]; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Cancer Research UK [12481] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK)	We thank Kristin Retzlaff, Saskia Ettl, and Kerstin Burmeister for technical assistance; Jorg Mages and Angela Servatius for generation of microarray data; and Matthias Schiemann for FACS sorting as well as Michael Allgauer for help with in situ hybridization. We are grateful to Sylvie Robine for generously providing villin-creER<SUP>T2</SUP> mice. We thank Bert Vogelstein and Kenneth Kinzler for providing beta-catenin<SUP>S33Y</SUP> and TCF4 plasmids as well as TOPFLASH and FOPFLASH reporter constructs. We also thank Masayuki Miura for providing ERAI-transgenic mice and the pCAX-F-XBP1 Delta DBD-venus plasmid. This work was supported by grants from the European Research Council (ROSCAN-281967), Deutsche Forschungsgemeinschaft, and Deutsche Krebshilfe to F.R.G.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; COLE JW, 1963, CANCER, V16, P998, DOI 10.1002/1097-0142(196308)16:8<998::AID-CNCR2820160806>3.0.CO;2-C; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Preston SL, 2003, CANCER RES, V63, P3819; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	48	716	737	4	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					25	38		10.1016/j.cell.2012.12.012	http://dx.doi.org/10.1016/j.cell.2012.12.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273993	Bronze			2022-12-01	WOS:000313719800004
J	Spence, D				Spence, Des			A conspiracy of anonymity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								f32	10.1136/bmj.f32	http://dx.doi.org/10.1136/bmj.f32			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YU	23295249				2022-12-01	WOS:000313552300008
J	Cobb, KM; Westphal, N; Sayani, HR; Watson, JT; Di Lorenzo, E; Cheng, H; Edwards, RL; Charles, CD				Cobb, Kim M.; Westphal, Niko; Sayani, Hussein R.; Watson, Jordan T.; Di Lorenzo, Emanuele; Cheng, H.; Edwards, R. L.; Charles, Christopher D.			Highly Variable El Nino-Southern Oscillation Throughout the Holocene	SCIENCE			English	Article							TROPICAL PACIFIC CLIMATE; NINO/SOUTHERN-OSCILLATION; VARIABILITY; OCEAN; ENSO; MIDHOLOCENE	The El Nino-Southern Oscillation (ENSO) drives large changes in global climate patterns from year to year, yet its sensitivity to continued anthropogenic greenhouse forcing is uncertain. We analyzed fossil coral reconstructions of ENSO spanning the past 7000 years from the Northern Line Islands, located in the center of action for ENSO. The corals document highly variable ENSO activity, with no evidence for a systematic trend in ENSO variance, which is contrary to some models that exhibit a response to insolation forcing over this same period. Twentieth-century ENSO variance is significantly higher than average fossil coral ENSO variance but is not unprecedented. Our results suggest that forced changes in ENSO, whether natural or anthropogenic, may be difficult to detect against a background of large internal variability.	[Cobb, Kim M.; Sayani, Hussein R.; Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Westphal, Niko; Watson, Jordan T.; Charles, Christopher D.] Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Cheng, H.] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, H.; Edwards, R. L.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Cobb, KM (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	kcobb@eas.gatech.edu	Edwards, R. Lawrence/I-3124-2014; CHENG, HAI/H-3413-2017; Di Lorenzo, Emanuele/E-9107-2012; Watson, Jordan/U-9798-2019	Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458; Di Lorenzo, Emanuele/0000-0002-1935-7363; Watson, Jordan/0000-0002-1686-0377; Cobb, Kim/0000-0002-2125-9164	NSF-Division of Ocean Sciences [0752091]; National Natural Science Foundation of China [41230524]; NSF-Division of Atmospheric Sciences [1103403]; U.S. Department of Energy (DOE) [DOE-SC0005597]; Division Of Ocean Sciences [0752091] Funding Source: National Science Foundation	NSF-Division of Ocean Sciences(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF-Division of Atmospheric Sciences; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors acknowledge field support from the Norwegian Cruise Lines, the National Geographic Waitt program, and the Palmyra Atoll Research Consortium. The research was funded by NSF-Division of Ocean Sciences award 0752091 to K.M.C. and C.D.C., National Natural Science Foundation of China award 41230524 to H.C., NSF-Division of Atmospheric Sciences award 1103403 to R.L.E. and H.C., and U.S. Department of Energy (DOE) award DOE-SC0005597 to E.D.L. A. Wittenberg and C. Ammann generously provided the NINO3.4 time series from the long control runs of the NOAA-GFDL-CM2.1 and NCAR-CCSM4 models, respectively. Data availability: All data and metadata are archived at NCDC (ftp://ftp.ncdc.noaa.gov/pub/data/paleo/coral/east_pacific/line-islands2013.txt).	Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Brown J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001512; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Deser C, 2012, J CLIMATE, V25, P2622, DOI 10.1175/JCLI-D-11-00301.1; Evans MN, 1999, J GEOPHYS RES-OCEANS, V104, P13409, DOI 10.1029/1999JC900001; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; Koutavas A, 2006, GEOLOGY, V34, P993, DOI 10.1130/G22810A.1; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; McGregor HV, 2011, GEOCHIM COSMOCHIM AC, V75, P3930, DOI 10.1016/j.gca.2011.04.017; McGregor HV, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019972; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Nurhati IS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040270; Otto-Bliesner BL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018553; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stevenson S, 2012, J CLIMATE, V25, P2129, DOI 10.1175/JCLI-D-11-00252.1; Thompson DM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048224; Timmermann A, 2007, J CLIMATE, V20, P4147, DOI 10.1175/JCLI4240.1; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wang X, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031149; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1; Woodroffe CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015868; Zaunbrecher LK, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001788; Zheng W, 2008, CLIM DYNAM, V30, P745, DOI 10.1007/s00382-007-0320-3	30	293	299	17	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					67	70		10.1126/science.1228246	http://dx.doi.org/10.1126/science.1228246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288537				2022-12-01	WOS:000312985800052
J	Barry, ER; Morikawa, T; Butler, BL; Shrestha, K; de la Rosa, R; Yan, KS; Fuchs, CS; Magness, ST; Smits, R; Ogino, S; Kuo, CJ; Camargo, FD				Barry, Evan R.; Morikawa, Teppei; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Yan, Kelley S.; Fuchs, Charles S.; Magness, Scott T.; Smits, Ron; Ogino, Shuji; Kuo, Calvin J.; Camargo, Fernando D.			Restriction of intestinal stem cell expansion and the regenerative response by YAP	NATURE			English	Article							HIPPO SIGNALING PATHWAY; WNT/BETA-CATENIN; COLORECTAL-CANCER; IN-VITRO; MOUSE MODEL; EXPRESSION; HOMEOSTASIS; EPITHELIUM; CRYPT; LGR5	A remarkable feature of regenerative processes is their ability to halt proliferation once an organ's structure has been restored. The Wnt signalling pathway is the major driving force for homeostatic self-renewal and regeneration in the mammalian intestine. However, the mechanisms that counterbalance Wnt-driven proliferation are poorly understood. Here we demonstrate in mice and humans that yes-associated protein 1 (YAP; also known as YAP1)-a protein known for its powerful growth-inducing and oncogenic properties(1,2)-has an unexpected growth-suppressive function, restricting Wnt signals during intestinal regeneration. Transgenic expression of YAP reduces Wnt target gene expression and results in the rapid loss of intestinal crypts. In addition, loss of YAP results in Wnt hypersensitivity during regeneration, leading to hyperplasia, expansion of intestinal stem cells and niche cells, and formation of ectopic crypts and microadenomas. We find that cytoplasmic YAP restricts elevated Wnt signalling independently of the AXIN-APC-GSK-3 beta complex partly by limiting the activity of dishevelled (DVL). DVL signals in the nucleus of intestinal stem cells, and its forced expression leads to enhanced Wnt signalling in crypts. YAP dampens Wnt signals by restricting DVL nuclear translocation during regenerative growth. Finally, we provide evidence that YAP is silenced in a subset of highly aggressive and undifferentiated human colorectal carcinomas, and that its expression can restrict the growth of colorectal carcinoma xenografts. Collectively, our work describes a novel mechanistic paradigm for how proliferative signals are counterbalanced in regenerating tissues. Additionally, our findings have important implications for the targeting of YAP in human malignancies.	[Barry, Evan R.; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Barry, Evan R.; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Camargo, Fernando D.] Childrens Hosp, Dept Hematol Oncol, Boston, MA 02115 USA; [Barry, Evan R.; Butler, Brian L.; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Barry, Evan R.; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Smits, Ron] Erasmus MC, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	Fernando.camargo@childrens.harvard.edu		Kuo, Calvin/0000-0002-7427-5985; Magness, Scott/0000-0002-2746-1224; Ogino, Shuji/0000-0002-3909-2323; camargo, fernando/0000-0002-5630-5909	Stand Up to Cancer-AACR initiative; National Institutes of Health [R01 CA131426, AR064036]; Harvard Stem Cell Institute; American Cancer Society Illinois Division [PF-12-245-01-CCG]; CIRM [1K08DK096048];  [1U01DK085527];  [R01 CA151993];  [R01 DK091427];  [P01CA87969];  [P50CA127003]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA131426, R01CA151993, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK096048, U01DK085527, P30DK049216, R01DK091427] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; American Cancer Society Illinois Division(American Cancer Society); CIRM(California Institute for Regenerative Medicine); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Zon and Camargo laboratory members for critical review of this manuscript and X. He for Myc-DVL2 constructs. This work was supported by grants from the Stand Up to Cancer-AACR initiative (F. D. C.), National Institutes of Health R01 CA131426 and AR064036 (F. D. C.) and the Harvard Stem Cell Institute (F. D. C.). F. D. C. is a Pew Scholar in the Biomedical Sciences. E. R. B. is supported by a postdoctoral fellowship from the American Cancer Society Illinois Division (PF-12-245-01-CCG). This work has also benefited from support to K.S.Y. (CIRM, and 1K08DK096048), C.J.K. (1U01DK085527), S.O. (R01 CA151993 and R01 DK091427), S. T. M. (P01CA87969) and C. S. F. (P50CA127003).	Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Roth S, 2009, GENESIS, V47, P7, DOI 10.1002/dvg.20446; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	39	387	398	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					106	+		10.1038/nature11693	http://dx.doi.org/10.1038/nature11693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23178811	Green Submitted, Green Accepted			2022-12-01	WOS:000312933800040
J	Ohouo, PY; de Oliveira, FMB; Liu, Y; Ma, CJ; Smolka, MB				Ohouo, Patrice Y.; de Oliveira, Francisco M. Bastos; Liu, Yi; Ma, Chu Jian; Smolka, Marcus B.			DNA-repair scaffolds dampen checkpoint signalling by counteracting the adaptor Rad9	NATURE			English	Article							HOLLIDAY JUNCTION RESOLVASE; DAMAGE CHECKPOINT; PROTEIN-INTERACTION; REPLICATION STRESS; PHOSPHORYLATION; DPB11; SLX4; ACTIVATION; KINASE; DOMAIN	In response to genotoxic stress, a transient arrest in cell-cycle progression enforced by the DNA-damage checkpoint (DDC) signalling pathway positively contributes to genome maintenance(1). Because hyperactivated DDC signalling can lead to a persistent and detrimental cell-cycle arrest(2,3), cells must tightly regulate the activity of the kinases involved in this pathway. Despite their importance, the mechanisms for monitoring and modulating DDC signalling are not fully understood. Here we show that the DNA-repair scaffolding proteins Slx4 and Rtt107 prevent the aberrant hyperactivation of DDC signalling by lesions that are generated during DNA replication in Saccharomyces cerevisiae. On replication stress, cells lacking Slx4 or Rtt107 show hyperactivation of the downstream DDC kinase Rad53, whereas activation of the upstream DDC kinase Mec1 remains normal. An Slx4-Rtt107 complex counteracts the checkpoint adaptor Rad9 by physically interacting with Dpb11 and phosphorylated histone H2A, two positive regulators of Rad9-dependent Rad53 activation. A decrease in DDC signalling results from hypomorphic mutations in RAD53 and H2A and rescues the hypersensitivity to replication stress of cells lacking Slx4 or Rtt107. We propose that the Slx4-Rtt107 complex modulates Rad53 activation by a competition-based mechanism that balances the engagement of Rad9 at replication-induced lesions. Our findings show that DDC signalling is monitored and modulated through the direct action of DNA-repair factors.	[Ohouo, Patrice Y.; de Oliveira, Francisco M. Bastos; Liu, Yi; Ma, Chu Jian; Smolka, Marcus B.] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University	Smolka, MB (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	mbs266@cornell.edu	de Oliveira, Francisco Bastos/I-3540-2013; Bastos de Oliveira, Francisco/C-2349-2008	de Oliveira, Francisco Bastos/0000-0003-3314-3940; 	National Institutes of Health [RO1-GM097272, F31-GM093588]; Cornell Fleming Research Fellowship; HHMI Institutional Undergraduate Education Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM093588, R01GM097272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Fleming Research Fellowship; HHMI Institutional Undergraduate Education Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (RO1-GM097272 to M. B. S. and F31-GM093588 to P.Y.O.). F.M.B.O. was supported by a Cornell Fleming Research Fellowship. C.J.M. was supported by an HHMI Institutional Undergraduate Education Grant to Cornell. The authors thank B. Almeida for technical assistance and R. Weiss, S. Emr, A. Bretscher, G. Balmus and P. Russell for comments on the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Clerici M, 2001, EMBO J, V20, P6485, DOI 10.1093/emboj/20.22.6485; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Granata M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001047; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Li XX, 2012, J BIOL CHEM, V287, P9137, DOI 10.1074/jbc.M111.311860; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	30	73	73	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					120	+		10.1038/nature11658	http://dx.doi.org/10.1038/nature11658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23160493	Green Accepted			2022-12-01	WOS:000312933800043
J	Roberts, SA; Davidson, AJ; McLean, L; Beynon, RJ; Hurst, JL				Roberts, Sarah A.; Davidson, Amanda J.; McLean, Lynn; Beynon, Robert J.; Hurst, Jane L.			Pheromonal Induction of Spatial Learning in Mice	SCIENCE			English	Article							SEXUAL PHEROMONES; SIGNALS; MOUSE; SCENT; ENVIRONMENT; ATTRACTION; BEHAVIOR; MALES	Many mammals use scent marking for sexual and competitive advertisement, but little is known about the mechanism by which scents are used to locate mates and competitors. We show that darcin, an involatile protein sex pheromone in male mouse urine, can rapidly condition preference for its remembered location among females and competitor males so that animals prefer to spend time in the site even when scent is absent. Learned spatial preference is conditioned through contact with darcin in a single trial and remembered for approximately 14 days. This pheromone-induced learning allows animals to relocate sites of particular social relevance and provides proof that pheromones such as darcin can be highly potent stimuli for social learning.	[Roberts, Sarah A.; Davidson, Amanda J.; Hurst, Jane L.] Univ Liverpool, Mammalian Behav & Evolut Grp, Inst Integrat Biol, Neston CH64 7TE, England; [McLean, Lynn; Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Prot Funct Grp, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Hurst, JL (corresponding author), Univ Liverpool, Mammalian Behav & Evolut Grp, Inst Integrat Biol, Leahurst Campus, Neston CH64 7TE, England.	jane.hurst@liv.ac.uk	Beynon, Robert J/K-1408-2014; Roberts, Sarah/E-4936-2013; Hurst, Jane L/G-8793-2015	Beynon, Robert J/0000-0003-0857-495X; Hurst, Jane L/0000-0002-3728-9624; ROBERTS, SARAH/0000-0003-2193-5561	Biotechnology and Biological Science Research Council [BBC503897, BB/J002631/1]; Natural Environment Research Council [NE/G018650]; BBSRC [BB/J002631/1] Funding Source: UKRI; NERC [NE/G018650/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002631/1] Funding Source: researchfish; Natural Environment Research Council [NE/G018650/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Waters, R. Spencer, S. Jopson, and R. Humphries for technical help and members of the Mammalian Behavior & Evolution Group for helpful discussions. The study was funded by research grants to J. L. H. and R. J. B. from the Biotechnology and Biological Science Research Council (BBC503897 and BB/J002631/1) and the Natural Environment Research Council (NE/G018650). The data reported in this study are provided as raw data in the supplementary materials.	Bell MR, 2010, HORM BEHAV, V58, P410, DOI 10.1016/j.yhbeh.2010.05.017; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Gosling L. M., 1982, J COMP ETHOL, V60, P89; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; HARVEY S, 1989, J CHEM ECOL, V15, P2061, DOI 10.1007/BF01207438; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; LeMaster MP, 2001, ANIM BEHAV, V61, P827, DOI 10.1006/anbe.2000.1658; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Martinez-Ricos J, 2007, CHEM SENSES, V32, P139, DOI 10.1093/chemse/bjl039; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Pankevich DE, 2006, PHYSIOL BEHAV, V87, P781, DOI 10.1016/j.physbeh.2006.01.020; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Ramm SA, 2008, P ROY SOC B-BIOL SCI, V275, P1727, DOI 10.1098/rspb.2008.0302; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Wyatt T.D., 2003, PHEROMONES ANIMAL BE	22	116	116	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2012	338	6113					1462	1465		10.1126/science.1225638	http://dx.doi.org/10.1126/science.1225638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239735				2022-12-01	WOS:000312250800046
J	Clapier, CR; Cairns, BR				Clapier, Cedric R.; Cairns, Bradley R.			Regulation of ISWI involves inhibitory modules antagonized by nucleosomal epitopes	NATURE			English	Article							DNA TRANSLOCATION; CHROMATIN; MECHANISM; BINDING; RSC; IDENTIFICATION; RECOGNITION; DOMAIN	Chromatin-remodelling complexes (CRCs) mobilize nucleosomes to mediate the access of DNA-binding factors to their sites in vivo. These CRCs contain a catalytic subunit that bears an ATPase/DNA-translocase domain and flanking regions that bind nucleosomal epitopes(1). A central question is whether and how these flanking regions regulate ATP hydrolysis or the coupling of hydrolysis to DNA translocation, to affect nucleosome-sliding efficiency. ISWI-family CRCs contain the protein ISWI2, which uses its ATPase/DNA-translocase domain to pump DNA around the histone octamer to enable sliding(3-7). ISWI is positively regulated by two 'activating' nucleosomal epitopes: the 'basic patch' on the histone H4 tail, and extranucleosomal (linker) DNA(8-13). Previous work defined the HAND-SANT-SLIDE (HSS) domain at the ISWI carboxy terminus that binds linker DNA, needed for ISWI activity(14,15). Here we define two new, conserved and separate regulatory regions on Drosophila ISWI, termed AutoN and NegC, which negatively regulate ATP hydrolysis (AutoN) or the coupling of ATP hydrolysis to productive DNA translocation (NegC). The two aforementioned nucleosomal epitopes promote remodelling indirectly by preventing the negative regulation of AutoN and NegC. Notably, mutation or removal of AutoN and NegC enables marked nucleosome sliding without the H4 basic patch or extranucleosomal DNA, or the HSS domain, conferring on ISWI the biochemical attributes normally associated with SWI/SNF-family ATPases. Thus, the ISWI ATPase catalytic core is an intrinsically active DNA translocase that conducts nucleosome sliding, onto which selective 'inhibition-of-inhibition' modules are placed, to help ensure that remodelling occurs only in the presence of proper nucleosomal epitopes. This supports a general concept for the specialization of chromatin-remodelling ATPases, in which specific regulatory modules adapt an ancient active DNA translocase to conduct particular tasks only on the appropriate chromatin landscape.	[Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Sch Med, Salt Lake City, UT 84112 USA; [Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Howard Hughes Med Inst, Sch Med, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	cedric.clapier@hci.utah.edu; brad.cairns@hci.utah.edu			National Institutes of Health [GM60415, CA042014]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Tan for pST55-16 x NCP601a and G. Langst for pUC12 x 601. We thank C. Muller for experience gained by C. Clapier on structural aspects of ISWI protein. We thank T. Owen-Hughes for the S. cerevisiae strain TOH1358, T. Tsukiyama for the initial ISW1-containing plasmid, P. Gawu for technical assistance and B. Schackmann for DNA sequencing and peptide synthesis. This work was supported by National Institutes of Health grant GM60415 (supplies), Howard Hughes Medical Institute (support of C.R.C. and B.R.C.), and CA042014 (University of Utah core facilities).	Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Patel A, 2011, J BIOL CHEM, V286, P43984, DOI 10.1074/jbc.M111.282970; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	34	107	107	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					280	+		10.1038/nature11625	http://dx.doi.org/10.1038/nature11625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143334	Green Accepted			2022-12-01	WOS:000312259300048
J	Tottrup, AP; Klaassen, RHG; Kristensen, MW; Strandberg, R; Vardanis, Y; Lindstrom, A; Rahbek, C; Alerstam, T; Thorup, K				Tottrup, A. P.; Klaassen, R. H. G.; Kristensen, M. W.; Strandberg, R.; Vardanis, Y.; Lindstrom, A.; Rahbek, C.; Alerstam, T.; Thorup, K.			Drought in Africa Caused Delayed Arrival of European Songbirds	SCIENCE			English	Article							MIGRATORY BIRD		[Tottrup, A. P.; Kristensen, M. W.; Thorup, K.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum, DK-2100 Copenhagen, Denmark; [Klaassen, R. H. G.; Strandberg, R.; Vardanis, Y.; Lindstrom, A.; Alerstam, T.] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Klaassen, R. H. G.] Univ Groningen, Montagus Harrier Fdn, NL-9700 CC Groningen, Netherlands; [Klaassen, R. H. G.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, NL-9700 CC Groningen, Netherlands	University of Copenhagen; Lund University; University of Groningen; University of Groningen	Tottrup, AP (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum, Univ Pk 15, DK-2100 Copenhagen, Denmark.	aptottrup@bio.ku.dk	Rahbek, Carsten/D-9372-2013; Rahbek, Carsten/L-1129-2013; Klaassen, Raymond/K-3027-2013; Thorup, Kasper/A-4835-2013; Tøttrup, Anders P/N-3836-2013; Willemoes, Mikkel/J-9391-2012	Rahbek, Carsten/0000-0003-4585-0300; Thorup, Kasper/0000-0002-0320-0601; Tøttrup, Anders P/0000-0001-8776-9629; Willemoes, Mikkel/0000-0001-9363-6304	Swedish Research Council; Centre for Animal Movement Research; Villum Foundation; Swedish Environmental Protection Agency; Danish National Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research; Villum Foundation(Villum Fonden); Swedish Environmental Protection Agency; Danish National Research Foundation(Danmarks Grundforskningsfond)	Danish Nature Agency (J.nr.SN 302-009) and ethical committees in Malmo/Lund (M112-09) approved the studies. Swedish Research Council, Centre for Animal Movement Research, Villum Foundation, Swedish Environmental Protection Agency and Danish National Research Foundation financed this study. Contribution no. 259 from Ottenby Bird Observatory. Tracking data are available at www.movebank.org (digital object identifier: 10.5441/001/1.8jg3h6n7).	GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wilcove D. S., 2008, NO WAY HOME; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724	8	119	124	5	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1307	1307		10.1126/science.1227548	http://dx.doi.org/10.1126/science.1227548			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224549				2022-12-01	WOS:000311991200056
J	O'Dowd, A				O'Dowd, Adrian			Liverpool care pathway: doctors speak out	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@aol.com						[Anonymous], 2012, DAILY TELEGRAPH; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7511; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316	3	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7644	10.1136/bmj.e7644	http://dx.doi.org/10.1136/bmj.e7644			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152572				2022-12-01	WOS:000311336400012
J	Pak, J; Maniar, JM; Mello, CC; Fire, A				Pak, Julia; Maniar, Jay Mahesh; Mello, Cecilia Cabral; Fire, Andrew			Protection from Feed-Forward Amplification in an Amplified RNAi Mechanism	CELL			English	Article							GERM-LINE DEVELOPMENT; C-ELEGANS; CAENORHABDITIS-ELEGANS; POLYMERASE-II; INTERFERENCE; SIRNAS; ARGONAUTE; ROLES; RDE-1; DCR-1	The effectiveness of RNA interference (RNAi) in many organisms is potentiated through the signal-amplifying activity of a targeted RNA-directed RNA polymerase (RdRP) system that can convert a small population of exogenously-encountered dsRNA fragments into an abundant internal pool of small interfering RNA (siRNA). As for any biological amplification system, we expect an underlying architecture that will limit the ability of a randomly encountered trigger to produce an uncontrolled and self-escalating response. Investigating such limits in Caenorhabditis elegans, we find that feed-forward amplification is limited by biosynthetic and structural distinctions at the RNA level between (1) triggers that can produce amplification and (2) siRNA products of the amplification reaction. By assuring that initial (primary) siRNAs can act as triggers but not templates for activation, and that the resulting (secondary) siRNAs can enforce gene silencing on additional targets without unbridled trigger amplification, the system achieves substantial but fundamentally limited signal amplification.	[Pak, Julia; Mello, Cecilia Cabral; Fire, Andrew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Maniar, Jay Mahesh; Fire, Andrew] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fire, A (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	afire@stanford.edu		Fire, Andrew/0000-0001-6217-8312	NIGMS [R01GM37706]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Liu, L. Zhang, M. Stadler, A. Lamm, H. Zhang, D. Wu, L. Gracey, R. Li, I. Gabdank, K. Artiles, S. Gu, J. Gent, C. Kumsta, M. Hansen, P. Parameswaran, C. Smith, Z. Weng, R. Alcazar, W. Lui, P. Lacroute, A. Sidow, A. Jheon, O. Klein, anonymous reviewers and NIGMS (R01GM37706) for help and support.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bergstrom CT, 2003, P NATL ACAD SCI USA, V100, P11511, DOI 10.1073/pnas.1931639100; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; Boisvert MEL, 2008, CURR TOP MICROBIOL, V320, P21; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; FILES JG, 1983, J MOL BIOL, V164, P355, DOI 10.1016/0022-2836(83)90056-6; Fischer SEJ, 2010, INT J BIOCHEM CELL B, V42, P1306, DOI 10.1016/j.biocel.2010.03.006; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gent JI, 2009, GENETICS, V183, P1297, DOI 10.1534/genetics.109.109686; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Habig JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004052; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kumsta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035428; LANDEL CP, 1984, J MOL BIOL, V180, P497, DOI 10.1016/0022-2836(84)90024-X; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Okamura K, 2011, MOL CELL BIOL, V31, P884, DOI 10.1128/MCB.01141-10; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parrish S, 2001, RNA, V7, P1397; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Willis JH, 2006, MOL BIOL CELL, V17, P1051, DOI 10.1091/mbc.E05-09-0886; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	55	53	55	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					885	899		10.1016/j.cell.2012.10.022	http://dx.doi.org/10.1016/j.cell.2012.10.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141544	Green Accepted, Bronze			2022-12-01	WOS:000310921200018
J	Psakhye, I; Jentsch, S				Psakhye, Ivan; Jentsch, Stefan			Protein Group Modification and Synergy in the SUMO Pathway as Exemplified in DNA Repair	CELL			English	Article							UBIQUITIN E3 LIGASE; HOMOLOGOUS RECOMBINATION; RAD52 SUMOYLATION; DAMAGE-TOLERANCE; S-PHASE; REPLICATION; CHECKPOINT; COMPLEX; PCNA; EXO1	Protein modification by SUMO affects a wide range of protein substrates. Surprisingly, although SUMO pathway mutants display strong phenotypes, the function of individual SUMO modifications is often enigmatic, and SUMOylation-defective mutants commonly lack notable phenotypes. Here, we use DNA double-strand break repair as an example and show that DNA damage triggers a SUMOylation wave, leading to simultaneous multisite modifications of several repair proteins of the same pathway. Catalyzed by a DNA-bound SUMO ligase and triggered by single-stranded DNA, SUMOylation stabilizes physical interactions between the proteins. Notably, only wholesale elimination of SUMOylation of several repair proteins significantly affects the homologous recombination pathway by considerably slowing down DNA repair. Thus, SUMO acts synergistically on several proteins, and individual modifications only add up to efficient repair. We propose that SUMOylation may thus often target a protein group rather than individual proteins, whereas localized modification enzymes and highly specific triggers ensure specificity.	[Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Psakhye, Ivan/0000-0003-3877-133X	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Louis-Jeantet Foundation; EU Marie Curie Training Network	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Louis-Jeantet Foundation; EU Marie Curie Training Network(European Commission)	We thank S. Bergink, G. I. Karras, M. Kern, C. Lademann, B. Pfander, J. Renkawitz, and Z. Storchova for comments on the manuscript; C. Boulegue for mass spectrometry analysis; J. Rech for help with peptide array synthesis; K. Hofmann for help with bioinformatic analysis; and A. Strasser for technical assistance. I. P. was supported by a stipend from EU Marie Curie Training Network, and research by S. J. was supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, RUBICON EU Network of Excellence, and Louis-Jeantet Foundation.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Ohuchi T, 2009, DNA REPAIR, V8, P690, DOI 10.1016/j.dnarep.2009.01.018; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Westman BJ, 2011, NUCLEUS-AUSTIN, V2, P30, DOI 10.4161/nucl.2.1.14437; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	51	330	337	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					807	820		10.1016/j.cell.2012.10.021	http://dx.doi.org/10.1016/j.cell.2012.10.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23122649	Bronze			2022-12-01	WOS:000310921200012
J	Anbarasan, P; Baer, ZC; Sreekumar, S; Gross, E; Binder, JB; Blanch, HW; Clark, DS; Toste, FD				Anbarasan, Pazhamalai; Baer, Zachary C.; Sreekumar, Sanil; Gross, Elad; Binder, Joseph B.; Blanch, Harvey W.; Clark, Douglas S.; Toste, F. Dean			Integration of chemical catalysis with extractive fermentation to produce fuels	NATURE			English	Article							MICROBIAL-PRODUCTION; BUTANOL; RECOVERY; BIOMASS; HYDROCARBONS; CONVERSION; SUBSTRATE; BIOFUELS; ALKANES; ACETONE	Nearly one hundred years ago, the fermentative production of acetone by Clostridium acetobutylicum provided a crucial alternative source of this solvent for manufacture of the explosive cordite. Today there is a resurgence of interest in solventogenic Clostridium species to produce n-butanol and ethanol for use as renewable alternative transportation fuels(1-3). Acetone, a product of acetone-n-butanol-ethanol (ABE) fermentation, harbours a nucleophilic alpha-carbon, which is amenable to C-C bond formation with the electrophilic alcohols produced in ABE fermentation. This functionality can be used to form higher-molecular-mass hydrocarbons similar to those found in current jet and diesel fuels. Here we describe the integration of biological and chemocatalytic routes to convert ABE fermentation products efficiently into ketones by a palladium-catalysed alkylation. Tuning of the reaction conditions permits the production of either petrol or jet and diesel precursors. Glyceryl tributyrate was used for the in situ selective extraction of both acetone and alcohols to enable the simple integration of ABE fermentation and chemical catalysis, while reducing the energy demand of the overall process. This process provides a means to selectively produce petrol, jet and diesel blend stocks from lignocellulosic and cane sugars at yields near their theoretical maxima.	[Anbarasan, Pazhamalai; Sreekumar, Sanil; Gross, Elad; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Anbarasan, Pazhamalai; Baer, Zachary C.; Sreekumar, Sanil; Binder, Joseph B.; Blanch, Harvey W.; Clark, Douglas S.; Toste, F. Dean] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Baer, Zachary C.; Blanch, Harvey W.; Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Gross, Elad; Toste, F. Dean] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019; Anbarasan, Pazhamalai/E-7054-2011	Toste, F. Dean/0000-0001-8018-2198; Anbarasan, Pazhamalai/0000-0001-6049-5023	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Energy Biosciences Institute	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute	We are grateful to H.-J. Song for performing initial experiments on the catalytic alkylation of acetone, and V. Mitchell for analysing acid pretreatment hydrolysate inhibitors present in Miscanthus giganteus. F. D. T. and E. G. acknowledge funding from the Director, Office of Science of the US Department of Energy, under contract no. DE-AC02-05CH11231. This work was funded by the Energy Biosciences Institute.	Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Blommel PG, 2008, INT SUGAR J, V110, P672; Carlini C, 2004, J MOL CATAL A-CHEM, V212, P65, DOI 10.1016/j.molcata.2003.10.045; Corma A, 2011, ANGEW CHEM INT EDIT, V50, P2375, DOI 10.1002/anie.201007508; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Green EM, 2011, CURR OPIN BIOTECH, V22, P337, DOI 10.1016/j.copbio.2011.02.004; Guillena G, 2007, ANGEW CHEM INT EDIT, V46, P2358, DOI 10.1002/anie.200603794; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Gurbuz EI, 2010, GREEN CHEM, V12, P223, DOI 10.1039/b920369a; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; JEON YJ, 1987, ANN NY ACAD SCI, V506, P536, DOI 10.1111/j.1749-6632.1987.tb23848.x; Kraemer K, 2011, COMPUT CHEM ENG, V35, P949, DOI 10.1016/j.compchemeng.2011.01.028; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Kwon MS, 2005, ANGEW CHEM INT EDIT, V44, P6913, DOI 10.1002/anie.200502422; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Ren C, 2010, METAB ENG, V12, P446, DOI 10.1016/j.ymben.2010.05.002; ROFFLER SR, 1987, BIOPROCESS ENG, V2, P181, DOI 10.1007/BF00387326; ROFFLER SR, 1988, BIOTECHNOL BIOENG, V31, P135, DOI 10.1002/bit.260310207; SALVAPATI GS, 1989, J MOL CATAL, V54, P9, DOI 10.1016/0304-5102(89)80134-8; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tracy BP, 2012, CURR OPIN BIOTECH, V23, P364, DOI 10.1016/j.copbio.2011.10.008; Vane LM, 2008, BIOFUEL BIOPROD BIOR, V2, P553, DOI 10.1002/bbb.108; Wang C, 2011, METAB ENG, V13, P648, DOI 10.1016/j.ymben.2011.08.001; WAYMAN M, 1987, J FERMENT BIOENG, V65, P295, DOI 10.1016/0385-6380(87)90091-4; Xing R, 2010, GREEN CHEM, V12, P1933, DOI 10.1039/c0gc00263a	27	279	286	11	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					235	239		10.1038/nature11594	http://dx.doi.org/10.1038/nature11594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135469				2022-12-01	WOS:000310774300040
J	Chen, CE; Dhruva, SS; Redberg, RF				Chen, Connie E.; Dhruva, Sanket S.; Redberg, Rita F.			Inclusion of Comparative Effectiveness Data in High-Risk Cardiovascular Device Studies at the Time of Premarket Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chen, Connie E.] Stanford Hosp & Clin, Dept Med, Palo Alto, CA USA; [Dhruva, Sanket S.] Univ Calif Davis, Div Cardiovasc Med, Davis, CA 95616 USA; [Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA	Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco	Chen, CE (corresponding author), Stanford Hosp & Clin, Dept Med, Palo Alto, CA USA.	redberg@medicine.ucsf.edu						Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Food and Drug Administration, DET SAF EFF 860 7 VA; Food and Drug Administration, FDA SUMM SAF EFF DAT; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539	4	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1740	1742		10.1001/jama.2012.14491	http://dx.doi.org/10.1001/jama.2012.14491			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117769	Bronze			2022-12-01	WOS:000310726500015
J	Safford, MM; Brown, TM; Muntner, PM; Durant, RW; Glasser, S; Halanych, JH; Shikany, JM; Prineas, RJ; Samdarshi, T; Bittner, VA; Lewis, CE; Gamboa, C; Cushman, M; Howard, V; Howard, G				Safford, Monika M.; Brown, Todd M.; Muntner, Paul M.; Durant, Raegan W.; Glasser, Stephen; Halanych, Jewell H.; Shikany, James M.; Prineas, Ronald J.; Samdarshi, Tandaw; Bittner, Vera A.; Lewis, Cora E.; Gamboa, Christopher; Cushman, Mary; Howard, Virginia; Howard, George		REGARDS Investigators	Association of Race and Sex With Risk of Incident Acute Coronary Heart Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; UNIVERSAL DEFINITION; UNITED-STATES; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; MULTIPLE IMPUTATION; TRENDS; REVASCULARIZATION; STROKE; HEALTH	Context It is unknown whether long-standing disparities in incidence of coronary heart disease (CHD) among US blacks and whites persist. Objective To examine incident CHD by black and white race and by sex. Design, Setting, and Participants Prospective cohort study of 24 443 participants without CHD at baseline from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, who resided in the continental United States and were enrolled between 2003 and 2007 with follow-up through December 31, 2009. Main Outcome Measure Expert-adjudicated total (fatal and nonfatal) CHD, fatal CHD, and nonfatal CHD (definite or probable myocardial infarction [MI]; very small non-ST-elevation MI [NSTEMI] had peak troponin level <0.5 mu g/L). Results Over a mean (SD) of 4.2 (1.5) years of follow-up, 659 incident CHD events occurred (153 in black men, 138 in black women, 254 in white men, and 114 in white women). Among men, the age-standardized incidence rate per 1000 person-years for total CHD was 9.0 (95% CI, 7.5-10.8) for blacks vs 8.1 (95% CI, 6.9-9.4) for whites; fatal CHD: 4.0 (95% CI, 2.9-5.3) vs 1.9 (95% CI, 1.4-2.6), respectively; and nonfatal CHD: 4.9 (95% CI, 3.8-6.2) vs 6.2 (95% CI, 5.2-7.4). Among women, the age-standardized incidence rate per 1000 person-years for total CHD was 5.0 (95% CI, 4.2-6.1) for blacks vs 3.4 (95% CI, 2.8-4.2) for whites; fatal CHD: 2.0 (95% CI, 1.5-2.7) vs 1.0 (95% CI, 0.7-1.5), respectively; and nonfatal CHD: 2.8 (95% CI, 2.2-3.7) vs 2.2 (95% CI, 1.7-2.9). Age-and region-adjusted hazard ratios for fatal CHD among blacks vs whites was near 2.0 for both men and women and became statistically nonsignificant after multivariable adjustment. The multivariable-adjusted hazard ratio for incident nonfatal CHD for blacks vs whites was 0.68 (95% CI, 0.51-0.91) for men and 0.81 (95% CI, 0.58-1.15) for women. Of the 444 nonfatal CHD events, 139 participants (31.3%) had very small NSTEMIs. Conclusions The higher risk of fatal CHD among blacks compared with whites was associated with cardiovascular disease risk factor burden. These relationships may differ by sex.	[Safford, Monika M.; Brown, Todd M.; Durant, Raegan W.; Glasser, Stephen; Halanych, Jewell H.; Shikany, James M.; Bittner, Vera A.; Lewis, Cora E.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA; [Muntner, Paul M.; Gamboa, Christopher; Howard, Virginia; Howard, George] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Prineas, Ronald J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Samdarshi, Tandaw] Univ Mississippi, Sch Med, Oxford, MS USA; [Cushman, Mary] Univ Vermont, Sch Med, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Vermont	Safford, MM (corresponding author), Univ Alabama Birmingham, Sch Med, 1717 11th Ave S,MT643, Birmingham, AL 35294 USA.	msafford@uab.edu	Cushman, Mary/K-1157-2019	Cushman, Mary/0000-0002-7871-6143; Bittner, Vera/0000-0001-9456-850X; Howard, George/0000-0002-3068-5720; Brown, Todd/0000-0002-9820-5738	National Heart, Lung, and Blood Institute [R01 HL080477]; National Center for Research Resources [KL2 RR025776-04]; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; Amgen Corporation; Amgen; NovoNordisk; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025776] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111154, R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen Corporation(Amgen); Amgen(Amgen); NovoNordisk(Novo Nordisk); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Brown reported receiving grants from Amgen Pharmaceuticals not related to this article. Dr Muntner reported serving on an Amgen advisory board in 2011; serving as a consultant to Amgen; and receiving grants from Amgen. Dr Lewis reported receiving a grant from NovoNordisk for an obesity study. No other authors reported any disclosures.; This research project was supported by grant R01 HL080477 from the National Heart, Lung, and Blood Institute (Dr Safford); grant KL2 RR025776-04 from the National Center for Research Resources (Dr Brown); and cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services (Dr G Howard). Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corporation (Dr Safford).	Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Centers for Disease Control and Prevention, CDC WOND COMPR MORT; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Halim SA, 2009, CIRC-CARDIOVASC QUAL, V2, P199, DOI 10.1161/CIRCOUTCOMES.108.810127; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hochholzer W, 2008, AM J MED, V121, P399, DOI 10.1016/j.amjmed.2008.01.033; Howard VJ, 2010, J AM SOC HYPERTENS, V4, P32, DOI 10.1016/j.jash.2010.02.001; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jones DW, 2002, ARCH INTERN MED, V162, P2565, DOI 10.1001/archinte.162.22.2565; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Prineas R.J., 1982, MINNESOTA CODE MANUA; Prineas RJ, 2010, MINNESOTA CODE MANUA; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Ross JS, 2007, CIRCULATION, V115, P1012, DOI 10.1161/CIRCULATIONAHA.106.658377; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Soliman EZ, 2011, HEART, V97, P1597, DOI 10.1136/hrt.2010.215871; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Tate J, ANAL CHARACTERISTICS; Thygesen K, 2012, EUR HEART J; Thygesen K, 2008, CURR OPIN CRIT CARE, V14, P543, DOI 10.1097/MCC.0b013e32830d34b9; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Urban P, 2008, AM J MED, V121, P1065, DOI 10.1016/j.amjmed.2008.08.020; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	40	226	228	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1768	1774		10.1001/jama.2012.14306	http://dx.doi.org/10.1001/jama.2012.14306			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117777	Green Accepted, Bronze			2022-12-01	WOS:000310726500023
J	Aronin, N; Moore, M				Aronin, Neil; Moore, Melissa			Hunting Down Huntingtin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Aronin, Neil; Moore, Melissa] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Aronin, Neil; Moore, Melissa] Univ Massachusetts, Sch Med, Neurotherapeut Inst, Worcester, MA USA; [Moore, Melissa] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Aronin, N (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.				HHMI Funding Source: Medline	HHMI(Howard Hughes Medical Institute)		Bhide PG, 1996, J NEUROSCI, V16, P5523; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lu XH, 2012, NEURON, V74, P964, DOI 10.1016/j.neuron.2012.06.001; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	5	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1753	1754		10.1056/NEJMcibr1209595	http://dx.doi.org/10.1056/NEJMcibr1209595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113488				2022-12-01	WOS:000310440800015
J	Green, DJ; Alemseged, Z				Green, David J.; Alemseged, Zeresenay			Australopithecus afarensis Scapular Ontogeny, Function, and the Role of Climbing in Human Evolution	SCIENCE			English	Article							HOMININ SHOULDER; CHIMPANZEE; LOCOMOTION; PRIMATE; EMG; ETHIOPIA; BEHAVIOR; MUSCLES; WALKING; ANGLE	Scapular morphology is predictive of locomotor adaptations among primates, but this skeletal element is scarce in the hominin fossil record. Notably, both scapulae of the juvenile Australopithecus afarensis skeleton from Dikika, Ethiopia, have been recovered. These scapulae display several traits characteristic of suspensory apes, as do the few known fragmentary adult australopith representatives. Many of these traits change significantly throughout modern human ontogeny, but remain stable in apes. Thus, the similarity of juvenile and adult fossil morphologies implies that A. afarensis development was apelike. Additionally, changes in other scapular traits throughout African ape development are associated with shifts in locomotor behavior. This affirms the functional relevance of those characteristics, and their presence in australopith fossils supports the hypothesis that their locomotor repertoire included a substantial amount of climbing.	[Green, David J.] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA; [Alemseged, Zeresenay] Calif Acad Sci, Dept Anthropol, San Francisco, CA 94118 USA	Midwestern University; California Academy of Sciences	Green, DJ (corresponding author), Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA.	dgreen1@midwestern.edu			NSF IGERT grant [9987590]; NSF [BCS-0824552, BCS-0914687]; Leakey Foundation; Wenner-Gren Foundation; George Washington University; Midwestern University; California Academy of Sciences	NSF IGERT grant; NSF(National Science Foundation (NSF)); Leakey Foundation; Wenner-Gren Foundation; George Washington University; Midwestern University; California Academy of Sciences	We thank C. Kiarie and the staff at the National Museum of Ethiopia for help during the preparation of these fragile fossils. We greatly appreciate critical comments offered by B. Richmond, B. Wood, R. Bernstein, M. Hamrick, L.P. Hernandez, and three anonymous reviewers on this manuscript and A. Gordon for analytical assistance. We thank D. Hunt, L. Gordon, E. Westwig, I. Tattersall, G. Garcia, J. Chupasko, M. Omura, Y. Haile-Selassie, L. Jellema, M. Harman, A. Gill, E. Mbua, S. Muteti, M. Yilma, P.V. Tobias, B. Zipfel, S. Potze, and T. Perregil for coordinating museum visits. We also acknowledge the NSF IGERT grant (9987590), NSF Doctoral Dissertation Improvement Grant (BCS-0824552), NSF (BCS-0914687), The Leakey Foundation, the Wenner-Gren Foundation, The George Washington University, Midwestern University, and the California Academy of Sciences for funding support. This paper was written by D.J.G. and Z.A. Fossil data were collected and described by D.J.G. and Z.A. Extant primate data were collected and analyzed by D.J.G. The data reported in this paper are summarized in the supplementary materials; raw data are available on request to D.J.G.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; ASHTON E. H., 1964, PROC ZOOL SOC LONDON, V142, P49; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; Green D. J., 2012, J EXP ZOOL B; Green D. J., 2010, THESIS G WASHINGTON; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; Inman VT, 1944, J BONE JOINT SURG, V26, P1; Inouye SE, 1997, INT J PRIMATOL, V18, P629, DOI 10.1023/A:1026319424308; LARSON SG, 1986, AM J ANAT, V176, P171, DOI 10.1002/aja.1001760207; LARSON SG, 1995, AM J PHYS ANTHROPOL, V98, P13, DOI 10.1002/ajpa.1330980103; LARSON SG, 1991, AM J PHYS ANTHROPOL, V85, P71, DOI 10.1002/ajpa.1330850109; LARSON SG, 1987, J ZOOL, V212, P629, DOI 10.1111/j.1469-7998.1987.tb05961.x; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Latimer B., 1991, P169; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; MENSFORTH RP, 1990, AM J PHYS ANTHROPOL, V81, P267; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; OXNARD CE, 1967, AM J PHYS ANTHROPOL, V26, P219, DOI 10.1002/ajpa.1330260209; Roberts D., 1974, P171; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; Susman R.L., 1991, P121; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Young NM, 2008, AM J PHYS ANTHROPOL, V136, P247, DOI 10.1002/ajpa.20799; Young NM, 2002, THESIS HARVARD U	30	88	91	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					514	517		10.1126/science.1227123	http://dx.doi.org/10.1126/science.1227123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112331				2022-12-01	WOS:000310195800054
J	Pace, L; Tempez, A; Arnold-Schrauf, C; Lemaitre, F; Bousso, P; Fetler, L; Sparwasser, T; Amigorena, S				Pace, Luigia; Tempez, Andy; Arnold-Schrauf, Catharina; Lemaitre, Fabrice; Bousso, Philippe; Fetler, Luc; Sparwasser, Tim; Amigorena, Sebastian			Regulatory T Cells Increase the Avidity of Primary CD8(+) T Cell Responses and Promote Memory	SCIENCE			English	Article							DENDRITIC CELLS; IN-VIVO; PEPTIDE; REPERTOIRE; ANTIGEN; MHC; SELECTION; IMMUNITY; AUTOIMMUNITY; TOLERANCE	Although regulatory T cells (T-regs) are known to suppress self-reactive autoimmune responses, their role during T cell responses to nonself antigens is not well understood. We show that T-regs play a critical role during the priming of immune responses in mice. T-reg depletion induced the activation and expansion of a population of low-avidity CD8(+) T cells because of overproduction of CCL-3/4/5 chemokines, which stabilized the interactions between antigen-presenting dendritic cells and low-avidity T cells. In the absence of T-regs, the avidity of the primary immune response was impaired, which resulted in reduced memory to Listeria monocytogenes. These results suggest that T-regs are important regulators of the homeostasis of CD8(+) T cell priming and play a critical role in the induction of high-avidity primary responses and effective memory.	[Pace, Luigia; Tempez, Andy; Amigorena, Sebastian] Inst Curie, INSERM, U932, F-75248 Paris 05, France; [Arnold-Schrauf, Catharina; Sparwasser, Tim] TWINCORE, Ctr Expt & Clin Infect Res, Inst Infect Immunol, D-30625 Hannover, Germany; [Lemaitre, Fabrice; Bousso, Philippe] Inst Pasteur, INSERM, U668, Dept Immunol, F-75015 Paris, France; [Fetler, Luc] Inst Curie, CNRS, UMR 168, Lab Physicochim Curie, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center for Infection Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite	Amigorena, S (corresponding author), Inst Curie, INSERM, U932, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr	Fetler, luc/M-9034-2018; Sparwasser, Tim D/AAA-4306-2022; BOUSSO, Philippe/M-6547-2014; Sparwasser, Tim/AAF-7085-2019	BOUSSO, Philippe/0000-0002-6362-561X; Sparwasser, Tim/0000-0001-5645-902X; Amigorena, Sebastian/0000-0001-8583-8416	Institut Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de Recherche Contre le Cancer (ARC); EC [ENCITE, Health-F5-2008-201842, SFB 900]; ARC; Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine	Institut Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association de Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); EC(European CommissionEuropean Commission Joint Research Centre); ARC(Australian Research Council); Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine	We thank all the U932 and TWINCORE Sparwasser members; D. Raulet, A. Dielmann, P. Paul-Gilloteaux, O. Lantz, and M. Albert; the Nikon Imaging Center and flow cytometry platform; and the animal facilities of Institut Curie and TWINCORE for help with the experiments and helpful discussions. rLM-OVA was kindly provided by H. Shen. This work was supported by funding from the Institut Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de Recherche Contre le Cancer (ARC); EC grant ENCITE, Health-F5-2008-201842, SFB 900. L.P. has been supported by ARC, A.T. was a fellow of Ministere de l'Education et de la Recherche. C.A.-S. was supported by the Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine. The authors have no conflicting financial interests. The data are tabulated in the main paper and in the supplementary materials.	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Beltman JB, 2009, J IMMUNOL METHODS, V347, P54, DOI 10.1016/j.jim.2009.05.013; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dal Secco V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007696; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gottschalk RA, 2012, P NATL ACAD SCI USA, V109, P881, DOI 10.1073/pnas.1119763109; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Morlacchi S, 2011, J IMMUNOL, V186, P6807, DOI 10.4049/jimmunol.1003265; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	30	101	103	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					532	536		10.1126/science.1227049	http://dx.doi.org/10.1126/science.1227049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112334	Green Submitted			2022-12-01	WOS:000310195800059
J	Shoham, S; Marr, KA				Shoham, Shmuel; Marr, Kieren A.			Treatment of Iatrogenic Fungal Infections: A Black Mold Defines a New Gray Zone in Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VORICONAZOLE		[Shoham, Shmuel; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21212 USA	Johns Hopkins University	Marr, KA (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 720 Rutland Ave,Ross 1064, Baltimore, MD 21212 USA.	Kmarr4@jhmi.edu			NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, MULTISTATE FUNGAL ME; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P842; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kauffman CA, 2012, N ENGL J MED; Klont RR, 2004, CLIN INFECT DIS, V39, P1467, DOI 10.1086/425317; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Marr KA, 2012, PRESENTED AT 22ND EU; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; U.S. Food and Drug Administration, MULTISTATE OUTBREAK; U.S. Food and Drug Administration Antiviral Drugs Advisory Committee, 2001, BRIEFING DOCUMENT FO	11	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					208	+		10.7326/0003-4819-158-3-201302050-00572	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00572			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23147215	Green Accepted			2022-12-01	WOS:000314757900008
J	Arnon, TI; Horton, RM; Grigorova, IL; Cyster, JG				Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.			Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress	NATURE			English	Article							IMMUNE-COMPLEXES; LYMPHOCYTES; ANTIGEN; ABSENCE; ACTIVATION; EXPRESSION; RETENTION; TRANSPORT; SELECTION; CD19	The splenic marginal zone is a unique microenvironment where resident immune cells are exposed to the open blood circulation(1,2). Even though it has an important role in responses against bloodborne antigens, lymphocyte migration in the marginal zone has not been intravitally visualized due to challenges associated with achieving adequate imaging depth in this abdominal organ. Here we develop a two-photon microscopy procedure to study marginal zone and follicular B-cell movement in the live mouse spleen. We show that marginal zone B cells are highly motile and exhibit long membrane extensions. Marginal zone B cells shuttle between the marginal zone and follicles with at least one-fifth of the cells exchanging between compartments per hour, a behaviour that explains their ability to deliver antigens rapidly from the open blood circulation to the secluded follicles. Follicular B cells also transit from follicles to the marginal zone, but unlike marginal zone B cells, they fail to undergo integrin-mediated adhesion, become caught in fluid flow and are carried into the red pulp. Follicular B-cell egress via the marginal zone is sphingosine-1-phosphate receptor-1 (S1PR1)-dependent. This study shows that marginal zone B cells migrate continually between marginal zone and follicles and establishes the marginal zone as a site of S1PR1-dependent B-cell exit from follicles. The results also show how adhesive differences of similar cells critically influence their behaviour in the same microenvironment.	[Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu	Grigorova, Irina/AAR-8795-2020	Grigorova, Irina/0000-0002-4963-7403; Arnon, Tal/0000-0003-4629-5820	Jane Coffin Child's fellowship; National Institutes of Health [AI74847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Jane Coffin Child's fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Miller for help with the microscope stage mount, T. Phan for advice regarding mouse surgery, J. An for technical assistance and O. M Bannard, J. R. Muppidi, M. Barnes and A. Reboldi for comments on the manuscript. T. I. A. was supported by a Jane Coffin Child's fellowship and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health grant AI74847.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; KRAAL G, 1995, AM J PATHOL, V147, P763; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; KUMARARATNE DS, 1981, EUR J IMMUNOL, V11, P865, DOI 10.1002/eji.1830111104; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Morris MA, 2005, EUR J IMMUNOL, V35, P3570, DOI 10.1002/eji.200526218; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; You YY, 2009, J IMMUNOL, V182, P7343, DOI 10.4049/jimmunol.0804295	36	140	141	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					684	+		10.1038/nature11738	http://dx.doi.org/10.1038/nature11738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23263181	Green Accepted, Green Submitted			2022-12-01	WOS:000314219600059
J	Eulalio, A; Mano, M; Dal Ferro, M; Zentilin, L; Sinagra, G; Zacchigna, S; Giacca, M				Eulalio, Ana; Mano, Miguel; Dal Ferro, Matteo; Zentilin, Lorena; Sinagra, Gianfranco; Zacchigna, Serena; Giacca, Mauro			Functional screening identifies miRNAs inducing cardiac regeneration	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; DNA-SYNTHESIS; CELL-CYCLE; CARDIOMYOCYTE DEDIFFERENTIATION; MITOTIC DIVISION; GENE-EXPRESSION; HYPERTROPHY; MICRORNAS; PROLIFERATION; RNA	In mammals, enlargement of the heart during embryonic development is primarily dependent on the increase in cardiomyocyte numbers. Shortly after birth, however, cardiomyocytes stop proliferating and further growth of the myocardium occurs through hypertrophic enlargement of the existing myocytes. As a consequence of the minimal renewal of cardiomyocytes during adult life, repair of cardiac damage through myocardial regeneration is very limited. Here we show that the exogenous administration of selected microRNAs (miRNAs) markedly stimulates cardiomyocyte proliferation and promotes cardiac repair. We performed a high-content microscopy, high-throughput functional screening for human miRNAs that promoted neonatal cardiomyocyte proliferation using a whole-genome miRNA library. Forty miRNAs strongly increased both DNA synthesis and cytokinesis in neonatal mouse and rat cardiomyocytes. Two of these miRNAs (hsa-miR-590 and hsa-miR-199a) were further selected for testing and were shown to promote cell cycle re-entry of adult cardiomyocytes ex vivo and to promote cardiomyocyte proliferation in both neonatal and adult animals. After myocardial infarction in mice, these miRNAs stimulated marked cardiac regeneration and almost complete recovery of cardiac functional parameters. The miRNAs identified hold great promise for the treatment of cardiac pathologies consequent to cardiomyocyte loss.	[Eulalio, Ana; Mano, Miguel; Dal Ferro, Matteo; Zentilin, Lorena; Zacchigna, Serena; Giacca, Mauro] ICGEB, Mol Med Lab, I-34149 Trieste, Italy; [Dal Ferro, Matteo; Sinagra, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Dal Ferro, Matteo; Sinagra, Gianfranco] Azienda Osped Univ Osped Riuniti Trieste, Ctr Translat Cardiol, I-34129 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste	Giacca, M (corresponding author), ICGEB, Mol Med Lab, I-34149 Trieste, Italy.	giacca@icgeb.org	Mano, Miguel/A-4462-2013; Dal Ferro, Matteo/GPP-6060-2022; sinagra, gianfranco gs/P-7643-2014; Eulalio, Ana/D-3083-2013; Sinagra, Gianfranco/AAE-3943-2020; Giacca, Mauro/J-9287-2016; ZACCHIGNA, SERENA/E-9496-2017	Mano, Miguel/0000-0003-1922-4824; Dal Ferro, Matteo/0000-0002-2310-0448; Eulalio, Ana/0000-0002-7355-0674; Giacca, Mauro/0000-0003-2927-7225; SINAGRA, GIANFRANCO/0000-0003-2700-8478; ZACCHIGNA, SERENA/0000-0001-6705-3076	FEBS Long Term Fellowship; European Research Council (ERC) [250124]; Project CTC from the Fondazione CRTrieste, Trieste, Italy	FEBS Long Term Fellowship; European Research Council (ERC)(European Research Council (ERC)); Project CTC from the Fondazione CRTrieste, Trieste, Italy	The authors are grateful to M. Dapas and M. Zotti for technical support in AAV production, to M. Sturnega for help in animal experimentation and to S. Kerbavcic for editorial assistance. A. E. is recipient of a FEBS Long Term Fellowship. This work was supported by Advanced Grant 250124 from the European Research Council (ERC) to M. G. and from Project CTC from the Fondazione CRTrieste, Trieste, Italy.	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Fredj S, 2005, J CELL PHYSIOL, V202, P891, DOI 10.1002/jcp.20197; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAG AC, 1983, TISSUE CELL, V15, P597, DOI 10.1016/0040-8166(83)90010-1; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Pouliquin P, 2009, EUR BIOPHYS J BIOPHY, V39, P91, DOI 10.1007/s00249-009-0494-1; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; REISS K, 1993, EXP CELL RES, V207, P348, DOI 10.1006/excr.1993.1202; ROBLEDO M, 1956, AM J PATHOL, V32, P1215; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	50	699	736	12	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					376	+		10.1038/nature11739	http://dx.doi.org/10.1038/nature11739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222520				2022-12-01	WOS:000312488200045
J	Dolan, P; Kavetsos, G				Dolan, Paul; Kavetsos, Georgios			Educational interventions are unlikely to work because obese people aren't unhappy enough to lose weight	BRITISH MEDICAL JOURNAL			English	Editorial Material							VALUING HEALTH; BEHAVIOR		[Dolan, Paul; Kavetsos, Georgios] London Sch Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science	Kavetsos, G (corresponding author), London Sch Econ, London WC2A 2AE, England.	g.kavetsos@lse.ac.uk						Bradford WD, 2010, J HEALTH ECON, V29, P811, DOI 10.1016/j.jhealeco.2010.07.007; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Dolan P, 2008, ECON J, V118, P215, DOI 10.1111/j.1468-0297.2007.02110.x; Dolan P, 2012, MED DECIS MAKING, V32, P578, DOI 10.1177/0272989X11435173; Dolan P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2577; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Oswald A., 2007, IZA DISCUSSION PAPER, DOI DOI 10.1111/J.1468-0297.2007.02077_1.X; Oswald AJ, 2008, J PUBLIC ECON, V92, P1061; [No title captured], DOI DOI 10.1111/J.1468-0297.2008.02150.X	12	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8487	10.1136/bmj.e8487	http://dx.doi.org/10.1136/bmj.e8487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248082				2022-12-01	WOS:000312698700017
J	Redlener, I; Reilly, MJ				Redlener, Irwin; Reilly, Michael J.			Lessons from Sandy - Preparing Health Systems for Future Disasters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Redlener, Irwin; Reilly, Michael J.] Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Disaster Preparedness, New York, NY 10027 USA	Columbia University	Redlener, I (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Disaster Preparedness, New York, NY 10027 USA.							Clements BW, 2009, DISASTERS AND PUBLIC HEALTH: PLANNING AND RESPONSE, P1; Hartocollis A, 2012, NY TIMES, pA1; Hupert N, 2011, HLTH CARE EMERGENCY, P223; Redlener I, 2006, AM RISK; U.S. Environmental Protection Agency, 2012, GOW CAN HURR SAND SA	5	66	67	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2269	2271		10.1056/NEJMp1213486	http://dx.doi.org/10.1056/NEJMp1213486			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23171063	Green Published			2022-12-01	WOS:000312187700016
J	Cochella, L; Hobert, O				Cochella, Luisa; Hobert, Oliver			Embryonic Priming of a miRNA Locus Predetermines Postmitotic Neuronal Left/Right Asymmetry in C. elegans	CELL			English	Article							GENES	The mechanisms by which functional left/right asymmetry arises in morphologically symmetric nervous systems are poorly understood. Here, we provide a mechanistic framework for how functional asymmetry in a postmitotic neuron pair is specified in C. elegans. A key feature of this mechanism is a temporally separated, two-step activation of the lsy-6 miRNA locus. The lsy-6 locus is first "primed'' by chromatin decompaction in the precursor for the left neuron, but not the right neuron, several divisions before the neurons are born. lsy-6 expression is then "boosted'' to functionally relevant levels several divisions later in the mother of the left neuron, through the activity of a bilaterally expressed transcription factor that can only activate lsy-6 in the primed neuron. This study shows how cells can become committed during early developmental stages to execute a specific fate much later in development and provides a conceptual framework for understanding the generation of neuronal diversity.	[Cochella, Luisa; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Cochella, L (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	mlc2155@columbia.edu; or38@columbia.edu	Cochella, Luisa/B-6536-2016; Cochella, Luisa/AHD-8261-2022	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722; Hobert, Oliver/0000-0002-7634-2854	Helen Hay Whitney Foundation; National Institutes of Health [R01NS039996-05, R01NS050266-03]; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Greenwald, W. Grueber, R. Mann, and members of the Hobert lab for helpful discussions and comments on the manuscript. We thank P. Meister, S. Gasser, and S. Mango for advice and reagents; I. Topalidou for help with the smFISH; the CGC for strains; Q. Chen for assistance with microinjections; and A. Boyanov for help with obtaining integrated transgenes. L.C. was funded by a postdoctoral fellowship from the Helen Hay Whitney Foundation. This work was funded in part by the National Institutes of Health (R01NS039996-05 and R01NS050266-03) and by the HHMI.	Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Didiano D, 2010, RNA, V16, P349, DOI 10.1261/rna.1931510; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnston R, 2005, ENVIRON PLANN A, V37, P2, DOI 10.1068/a3811; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Ortiz CO, 2009, CURR BIOL, V19, P996, DOI 10.1016/j.cub.2009.05.043; Poole RJ, 2006, CURR BIOL, V16, P2279, DOI 10.1016/j.cub.2006.09.041; Poole RJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002109; Priess J R, 2005, NOTCH SIGNALING C EL; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Sarin S, 2009, DEVELOPMENT, V136, P2933, DOI 10.1242/dev.040204; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	28	55	55	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1229	1242		10.1016/j.cell.2012.10.049	http://dx.doi.org/10.1016/j.cell.2012.10.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201143	Green Accepted, Bronze			2022-12-01	WOS:000311999900013
J	Truman, AW; Kristjansdottir, K; Wolfgeher, D; Hasin, N; Polier, S; Zhang, H; Perrett, S; Prodromou, C; Jones, GW; Kron, SJ				Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Hasin, Naushaba; Polier, Sigrun; Zhang, Hong; Perrett, Sarah; Prodromou, Chrisostomos; Jones, Gary W.; Kron, Stephen J.			CDK-Dependent Hsp70 Phosphorylation Controls G1 Cyclin Abundance and Cell-Cycle Progression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CLN3 CYCLIN; GENE-EXPRESSION; CHAPERONE YDJ1; G(1) ARREST; PHO85; DEGRADATION; INHIBITOR; TARGETS	In budding yeast, the essential functions of Hsp70 chaperones Ssa1-4 are regulated through expression level, isoform specificity, and cochaperone activity. Suggesting a novel regulatory paradigm, we find that phosphorylation of Ssa1 T36 within a cyclin-dependent kinase (CDK) consensus site conserved among Hsp70 proteins alters cochaperone and client interactions. T36 phosphorylation triggers displacement of Ydj1, allowing Ssa1 to bind the G1 cyclin Cln3 and promote its degradation. The stress CDK Pho85 phosphorylates T36 upon nitrogen starvation or pheromone stimulation, destabilizing Cln3 to delay onset of S phase. In turn, the mitotic CDK Cdk1 phosphorylates T36 to block Cln3 accumulation in G2/M. Suggesting broad conservation from yeast to human, CDK-dependent phosphorylation of Hsc70 T38 similarly regulates Cyclin D1 binding and stability. These results establish an active role for Hsp70 chaperones as signal transducers mediating growth control of G1 cyclin abundance and activity.	[Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Kron, Stephen J.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Kron, Stephen J.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Hasin, Naushaba; Jones, Gary W.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Polier, Sigrun; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Zhang, Hong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Chicago; University of Chicago; Maynooth University; University of Sussex; Chinese Academy of Sciences; Institute of Biophysics, CAS	Kron, SJ (corresponding author), Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA.	skron@uchicago.edu	Kristjansdottir, Kolla/V-4952-2019; Truman, Andrew/I-8454-2019; Prodromou, Chrisostomos/ABA-9133-2021; Perrett, Sarah/AAS-9483-2020	Kristjansdottir, Kolla/0000-0001-7054-2444; Truman, Andrew/0000-0002-6409-3723; Prodromou, Chrisostomos/0000-0003-4320-1147; Perrett, Sarah/0000-0003-0137-0997; Jones, Gary/0000-0002-7565-934X; Kron, Stephen/0000-0003-1518-2436	NIGMS [GM60443]; NUI Maynooth John and Pat Hume postgraduate scholarship; Wellcome Trust [095605/Z11/Z]; 973 Program [2012CB911000/2013CB910700]; NATIONAL CANCER INSTITUTE [R01CA164492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060443] Funding Source: NIH RePORTER; Medical Research Council [G0801130B] Funding Source: researchfish	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NUI Maynooth John and Pat Hume postgraduate scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); 973 Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank M. Mollapour and S. Takahashi for insightful scientific discussion and A. Amon and P. Nash for helpful comments. We are grateful to E. Craig, M. Aldea, M. Polymenis, C. De Virgilio, D. Levin, P. Piper, B. Zetter, J. Buchner, S. Rospert, D. Klionsky, B. Andrews, and M. Tyers for providing materials used in this study. This work was supported by a generous gift from The Foglia Foundation and Mr. and Mrs. Vincent Foglia (A. W. T., S. J. K.) and NIGMS grant GM60443 (S. J. K.). N.H. was supported by a NUI Maynooth John and Pat Hume postgraduate scholarship. C. P. was funded by a Wellcome Trust Senior Investigator Award (095605/Z11/Z). S. P. and H.Z. were supported by the 973 Program (2012CB911000/2013CB910700).	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Benanti JA, 2012, SEMIN CELL DEV BIOL, V23, P492, DOI 10.1016/j.semcdb.2012.04.005; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Craig E.A., 2011, HSP70 CHAPERONES ELS; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; Jaiswal H, 2011, MOL CELL BIOL, V31, P1160, DOI 10.1128/MCB.00986-10; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kung C, 2005, P NATL ACAD SCI USA, V102, P3587, DOI 10.1073/pnas.0407170102; Mandal AK, 2008, MOL CELL BIOL, V28, P4434, DOI 10.1128/MCB.00543-08; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mazanka E, 2010, MOL BIOL CELL, V21, P2809, DOI 10.1091/mbc.E10-02-0174; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; Mollapour M, 2010, CELL CYCLE, V9, P2310, DOI 10.4161/cc.9.12.12054; Newcomb LL, 2003, EUKARYOT CELL, V2, P143, DOI 10.1128/EC.2.1.143-149.2003; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; SHERLOCK G, 1993, J GEN MICROBIOL, V139, P2531, DOI 10.1099/00221287-139-11-2531; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; Timblin BK, 1996, GENETICS, V143, P57; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wijnen H, 1999, GENETICS, V153, P1131; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yaglom JA, 1996, MOL CELL BIOL, V16, P3679; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033	47	92	94	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1308	1318		10.1016/j.cell.2012.10.051	http://dx.doi.org/10.1016/j.cell.2012.10.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217712	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000311999900019
J	Bourzac, K				Bourzac, Katherine			ANTI-AGEING Live long and prosper	NATURE			English	Editorial Material							CALORIC RESTRICTION											BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Stein PK, 2012, AGING CELL, V11, P644, DOI 10.1111/j.1474-9726.2012.00825.x	6	6	6	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S18	S20		10.1038/492S18a	http://dx.doi.org/10.1038/492S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222670	Bronze			2022-12-01	WOS:000311893400010
J	Perron, JT; Richardson, PW; Ferrier, KL; Lapotre, M				Perron, J. Taylor; Richardson, Paul W.; Ferrier, Ken L.; Lapotre, Mathieu			The root of branching river networks	NATURE			English	Article							TRIPLE JUNCTION REGION; EROSION RATES; MODEL; LANDSCAPE; BE-10; EVOLUTION; HILLSLOPE; BEDROCK; CREEP; AL-26	Branching river networks are one of the most widespread and recognizable features of Earth's landscapes and have also been discovered elsewhere in the Solar System(1,2). But the mechanisms that create these patterns and control their spatial scales are poorly understood. Theories based on probability(3-5) or optimality(3,6-8) have proven useful(9), but do not explain how river networks develop over time through erosion and sediment transport. Here we show that branching at the uppermost reaches of river networks is rooted in two coupled instabilities: first, valleys widen at the expense of their smaller neighbours, and second, side slopes of the widening valleys become susceptible to channel incision. Each instability occurs at a critical ratio of the characteristic timescales for soil transport and channel incision. Measurements from two field sites demonstrate that our theory correctly predicts the size of the smallest valleys with tributaries. We also show that the dominant control on the scale of landscape dissection in these sites is the strength of channel incision, which correlates with aridity and rock weakness, rather than the strength of soil transport. These results imply that the fine-scale structure of branching river networks is an organized signature of erosional mechanics, not a consequence of random topology.	[Perron, J. Taylor; Richardson, Paul W.; Ferrier, Ken L.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Lapotre, Mathieu] Univ Strasbourg, Ecole & Observ Sci Terre, F-67084 Strasbourg, France	Massachusetts Institute of Technology (MIT); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Perron, JT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	perron@mit.edu	Perron, J. Taylor/D-8983-2012; Lapotre, Mathieu/L-4910-2018	Perron, J. Taylor/0000-0002-0404-8701; Ferrier, Ken/0000-0003-4098-166X; Lapotre, Mathieu/0000-0001-9941-1552; Richardson, Paul/0000-0002-9418-1804	US National Science Foundation Geomorphology and Land Use Dynamics programme [EAR-0951672]; US Department of Defense through a National Defense Science and Engineering Graduate Fellowship; Division Of Earth Sciences [0951672] Funding Source: National Science Foundation	US National Science Foundation Geomorphology and Land Use Dynamics programme; US Department of Defense through a National Defense Science and Engineering Graduate Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the US National Science Foundation Geomorphology and Land Use Dynamics programme through award EAR-0951672 to J.T.P. and by the US Department of Defense through a National Defense Science and Engineering Graduate Fellowship to P. W. R. J.T.P. is a Scholar in the Canadian Institute for Advanced Research (CIFAR). The authors thank T. Clifton and G. Chmiel for assistance with sample preparation, and the Orradre family of San Ardo, California, and numerous landowners in Greene County, Pennsylvania, for granting access to their land.	[Anonymous], 1983, GEOL SOC AM BULL, V94, P1035; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Berg T, 1980, GEOLOGIC MAP PENNSYL; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; CULLING WEH, 1960, J GEOL, V68, P336, DOI 10.1086/626663; CULLING WEH, 1963, J GEOL, V71, P127, DOI 10.1086/626891; Dietrich W.E., 1993, CHANNEL NETWORK HYDR, P175; Ditchburn R.G, 1994, 3 WORKSH S PAC ENV R, P4; Dunne T., 1980, PROGR PHYSICAL GEOGR, V4, P211, DOI [DOI 10.1177/030913338000400204, 10.1177/030913338000400204.]; Durham D.L, 1974, PROF PAP US GEOL SUR, V819, P1; Fernandes NF, 1997, WATER RESOUR RES, V33, P1307, DOI 10.1029/97WR00534; Gilbert G. K., 1877, REPORT GEOLOGY HENRY, DOI DOI 10.5962/BHL.TITLE.51652; Gonzalez R., 2004, MATHWORKS MATLAB SIM; Granger DE, 1996, J GEOL, V104, P249, DOI 10.1086/629823; Hack J.T., 1957, 294B US GEOL SURV, V294-B, P1; HANKS TC, 1984, J GEOPHYS RES, V89, P5771, DOI 10.1029/JB089iB07p05771; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Hovius N, 1996, BASIN RES, V8, P29, DOI 10.1111/j.1365-2117.1996.tb00113.x; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1990, WATER RESOUR RES, V26, P2107, DOI 10.1029/WR026i009p02107; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; HOWARD AD, 1971, GEOGR ANAL, V3, P29; IZUMI N, 1995, J FLUID MECH, V283, P341, DOI 10.1017/S0022112095002357; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; KIRCHNER JW, 1993, GEOLOGY, V21, P591, DOI 10.1130/0091-7613(1993)021<0591:SIOHSL>2.3.CO;2; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Lashermes B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031140; Leopold L.B., 1962, 500A US GEOL SURV PR, P1; MCKEAN JA, 1993, GEOLOGY, V21, P343, DOI 10.1130/0091-7613(1993)021<0343:QOSPAD>2.3.CO;2; MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; MONAGHAN MC, 1992, EARTH PLANET SC LETT, V111, P483, DOI 10.1016/0012-821X(92)90198-5; MONTGOMERY DR, 1992, SCIENCE, V255, P826, DOI 10.1126/science.255.5046.826; NASH DB, 1980, J GEOL, V88, P353, DOI 10.1086/628513; Passalacqua P, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001254; Peckham S. D, 2011, GEOMORPHOMETRY 2011, P27; Perron JT, 2012, EARTH SURF PROC LAND, V37, P52, DOI 10.1002/esp.2205; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; Perron JT, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000977; RIGON R, 1993, WATER RESOUR RES, V29, P1635, DOI 10.1029/92WR02985; Rodriguez-Iturbe I., 2001, FRACTAL RIVER BASINS; ROSENBLOOM NA, 1994, J GEOPHYS RES-SOL EA, V99, P14013, DOI 10.1029/94JB00048; SCHUMM SA, 1956, GEOL SOC AM BULL, V67, P597, DOI 10.1130/0016-7606(1956)67[597:EODSAS]2.0.CO;2; Seidl M., 1992, CATENA S, V23, P101, DOI DOI 10.1029/2007WR006219; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; SHREVE RL, 1967, J GEOL, V75, P178, DOI 10.1086/627245; Small EE, 1999, GEOMORPHOLOGY, V27, P131, DOI 10.1016/S0169-555X(98)00094-4; SMITH TR, 1972, WATER RESOUR RES, V8, P1506, DOI 10.1029/WR008i006p01506; Snyder NP, 2000, GEOL SOC AM BULL, V112, P1250, DOI 10.1130/0016-7606(2000)112<1250:LRTTFD>2.3.CO;2; Snyder NP, 2003, GEOMORPHOLOGY, V53, P97, DOI 10.1016/S0169-555X(02)00349-5; Stock JD, 1999, J GEOPHYS RES-SOL EA, V104, P4983, DOI 10.1029/98JB02139; Strahler AN, 1957, T AM GEOPHYS UNION, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; SUN T, 1994, PHYS REV E, V49, P4865, DOI 10.1103/PhysRevE.49.4865; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Tucker GE, 1996, BASIN RES, V8, P329, DOI 10.1046/j.1365-2117.1996.00238.x; WILLGOOSE G, 1991, EARTH SURF PROC LAND, V16, P237, DOI 10.1002/esp.3290160305	57	87	91	5	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					100	+		10.1038/nature11672	http://dx.doi.org/10.1038/nature11672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222614				2022-12-01	WOS:000311893400053
J	Janes, CR; Corbett, KK; Jones, JH; Trostle, J				Janes, Craig R.; Corbett, Kitty K.; Jones, James H.; Trostle, James			Emerging infectious diseases: the role of social sciences	LANCET			English	Editorial Material							ECOLOGY; EMERGENCE; RESISTANCE; ZOONOSIS; BEHAVIOR		[Janes, Craig R.; Corbett, Kitty K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Jones, James H.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Jones, James H.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Trostle, James] Trinity Coll, Dept Anthropol, Hartford, CT 06106 USA	Simon Fraser University; Stanford University; Stanford University; Trinity College	Janes, CR (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	cjanes@sfu.ca		Trostle, James/0000-0002-6045-9521; Jones, James/0000-0003-1680-6757	NIAID NIH HHS [R01 AI050038] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050038] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aboud FE, 2012, SOC SCI MED, V75, P589, DOI 10.1016/j.socscimed.2012.04.009; Bharti N, 2010, EPIDEMIOL INFECT, V138, P1308, DOI 10.1017/S0950268809991385; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; Dowd JB, 2009, EPIDEMIOLOGY, V20, P902, DOI 10.1097/EDE.0b013e3181bb5302; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Frost LJ, 2008, ACCESS DO GOOD HLTH; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Kapan DD, 2006, ECOHEALTH, V3, P187, DOI 10.1007/s10393-006-0044-6; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; LEVINE MM, 1994, P NATL ACAD SCI USA, V91, P2390, DOI 10.1073/pnas.91.7.2390; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Phillipson J, 2009, J APPL ECOL, V46, P261, DOI 10.1111/j.1365-2664.2009.01625.x; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Quine CP, 2011, PHILOS T R SOC B, V366, P2010, DOI 10.1098/rstb.2010.0397; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Trostle JA, 2008, EPIDEMIOLOGY, V19, P384, DOI 10.1097/EDE.0b013e31816a9db0; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387	19	56	56	2	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1884	1886		10.1016/S0140-6736(12)61725-5	http://dx.doi.org/10.1016/S0140-6736(12)61725-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	046IK	23200487				2022-12-01	WOS:000311758500005
J	Lund, LH; Benson, L; Dahlstrom, U; Edner, M				Lund, Lars H.; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus			Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITOR; LEFT-VENTRICULAR FUNCTION; PROPENSITY SCORE; CARDIOVASCULAR EVENTS; CANDESARTAN; REDUCTION; MORBIDITY; TRIAL; METAANALYSIS; PERINDOPRIL	Context Heart failure with preserved ejection fraction (HFPEF) may be as common and as lethal as heart failure with reduced ejection fraction (HFREF). Three randomized trials of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ie, renin-angiotensin system [RAS] antagonists) did not reach primary end points but may have had selection bias or been underpowered. Objective To test the hypothesis that use of RAS antagonists is associated with reduced all-cause mortality in an unselected population with HFPEF. Design, Setting, and Patients Prospective study using the Swedish Heart Failure Registry of 41 791 unique patients registered from 64 hospitals and 84 outpatient clinics between 2000 and 2011. Of these, 16 216 patients with HFPEF (ejection fraction >= 40%; mean [SD] age, 75 [11] years; 46% women) were either treated (n=12 543) or not treated (n=3673) with RAS antagonists. Propensity scores for RAS antagonist use were derived from 43 variables. The association between use of RAS antagonists and all-cause mortality was assessed in a cohort matched 1: 1 based on age and propensity score and in the overall cohort with adjustment for propensity score as a continuous covariate. To assess consistency, separate age and propensity score-matched analyses were performed according to RAS antagonist dose in patients with HFPEF and in 20 111 patients with HFREF (ejection fraction <40%) in the same registry. Main Outcome Measure All-cause mortality. Results In the matched HFPEF cohort, 1-year survival was 77% (95% CI, 75%-78%) for treated patients vs 72% (95% CI, 70%-73%) for untreated patients, with a hazard ratio (HR) of 0.91 (95% CI, 0.85-0.98; P=.008). In the overall HFPEF cohort, crude 1-year survival was 86% (95% CI, 86%-87%) for treated patients vs 69% (95% CI, 68%-71%) for untreated patients, with a propensity score-adjusted HR of 0.90 (95% CI, 0.85-0.96; P=.001). In the HFPEF dose analysis, the HR was 0.85 (95% CI, 0.78-0.83) for 50% or greater of target dose vs no treatment (P<.001) and 0.94 (95% CI, 0.87-1.02) for less than 50% of target dose vs no treatment (P=.14). In the age and propensity score-matched HFREF analysis, the HR was 0.80 (95% CI, 0.74-0.86; P<.001). Conclusion Among patients with heart failure and preserved ejection fraction, the use of RAS antagonists was associated with lower all-cause mortality. JAMA. 2012;308(20):2108-2117 www.jama.com	[Lund, Lars H.] Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, S-17176 Stockholm, Sweden; [Lund, Lars H.; Edner, Magnus] Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden; [Benson, Lina] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ Hosp, Dept Cardiol, Cty Council Ostergotland, S-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Linkoping University; City Council Ostergotland; Linkoping University	Lund, LH (corresponding author), Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055	AstraZeneca; Thoratec; Heart-Ware; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation [20080409, 20100419]; Stockholm County Council [00556-2009, 20110120]	AstraZeneca(AstraZeneca); Thoratec; Heart-Ware; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lund reported receiving institutional research grants and speaker's and consulting fees from AstraZeneca, Thoratec, and Heart-Ware. No other disclosures were reported.; The Swedish Heart Failure Registry is funded by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, and the Swedish Heart-Lung Foundation. This study received no specific funding. Dr Lund was supported by grants 20080409 and 20100419 from the Swedish Heart-Lung Foundation, grants 00556-2009 and 20110120 from the Stockholm County Council, and an unrestricted research grant from AstraZeneca.	Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Desai A, 2007, CURR OPIN CARDIOL, V22, P578; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox KM, 2003, LANCET, V362, P782; Fu MQ, 2012, INT J CARDIOL, V155, P33, DOI 10.1016/j.ijcard.2011.01.081; Guyatt G., 2008, USERS GUIDES MEDICAL; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Henkel DM, 2008, CIRC-HEART FAIL, V1, P91, DOI 10.1161/CIRCHEARTFAILURE.107.743146; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray J, 2006, EUR HEART J, V27, P2257, DOI 10.1093/eurheartj/ehl249; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meune C, 2011, J CARDIOVASC PHARM T, V16, P368, DOI 10.1177/1074248410391667; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Shah NR, 2000, JAMA-J AM MED ASSOC, V284, P3127, DOI 10.1001/jama.284.24.3127; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Wright JW, 2008, HEART FAIL REV, V13, P367, DOI 10.1007/s10741-007-9060-z; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614	38	122	124	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2108	2117		10.1001/jama.2012.14785	http://dx.doi.org/10.1001/jama.2012.14785			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188027	Bronze			2022-12-01	WOS:000311537200025
J	Kirste, M; Wang, XA; Schewe, HC; Meijer, G; Liu, KP; van der Avoird, A; Janssen, LMC; Gubbels, KB; Groenenboom, GC; van de Meerakker, SYT				Kirste, Moritz; Wang, Xingan; Schewe, H. Christian; Meijer, Gerard; Liu, Kopin; van der Avoird, Ad; Janssen, Liesbeth M. C.; Gubbels, Koos B.; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.			Quantum-State Resolved Bimolecular Collisions of Velocity-Controlled OH with NO Radicals	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; INELASTIC-SCATTERING; MOLECULAR-BEAMS; ENERGY SURFACE; AR	Whereas atom-molecule collisions have been studied with complete quantum-state resolution, interactions between two state-selected molecules have proven much harder to probe. Here, we report the measurement of state-resolved inelastic scattering cross sections for collisions between two open-shell molecules that are both prepared in a single quantum state. Stark-decelerated hydroxyl (OH) radicals were scattered with hexapole-focused nitric oxide (NO) radicals in a crossed-beam configuration. Rotationally and spin-orbit inelastic scattering cross sections were measured on an absolute scale for collision energies between 70 and 300 cm(-1). These cross sections show fair agreement with quantum coupled-channels calculations using a set of coupled model potential energy surfaces based on ab initio calculations for the long-range nonadiabatic interactions and a simplistic short-range interaction. This comparison reveals the crucial role of electrostatic forces in complex molecular collision processes.	[van der Avoird, Ad; Janssen, Liesbeth M. C.; Gubbels, Koos B.; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Kirste, Moritz; Wang, Xingan; Schewe, H. Christian; Meijer, Gerard; van de Meerakker, Sebastiaan Y. T.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Liu, Kopin] Acad Sinica, IAMS, Taipei 10617, Taiwan	Radboud University Nijmegen; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Academia Sinica - Taiwan	Groenenboom, GC (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Heijendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	gerritg@theochem.ru.nl; basvdm@science.ru.nl	Groenenboom, Gerrit C/F-9692-2015; Groenenboom, Gerrit/S-8138-2019; Meijer, Gerard/D-2141-2009; van de Meerakker, Sebastiaan Y.T./D-4581-2012; Liu, Kopin/F-7929-2012	Groenenboom, Gerrit/0000-0002-0920-3707; Meijer, Gerard/0000-0001-9669-8340; Liu, Kopin/0000-0001-7499-2397; Janssen, Liesbeth/0000-0001-5283-1330	Alexander von Humboldt Foundation (AvHF); AvHF; Netherlands Organisation for Scientific Research (NWO);  [ERC-2009-AdG];  [247142-MolChip]	Alexander von Humboldt Foundation (AvHF); AvHF; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; 	S.Y.T.v.d.M. acknowledges support from the Netherlands Organisation for Scientific Research (NWO) via a VIDI grant. G. M. and K. B. G. acknowledge support from the ERC-2009-AdG under grant agreement 247142-MolChip. K. L. and A.v.d.A. acknowledge the Alexander von Humboldt Foundation (AvHF) for a Humboldt Research Award. X. W. acknowledges the AvHF for a research fellowship. We thank J. Blokland for her help setting up the narrowband laser system. We thank the referees for valuable and stimulating comments. The authors declare no competing financial interests.	BERNSTEIN RB, 1964, SCIENCE, V144, P141, DOI 10.1126/science.144.3615.141; Berteloite C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.203201; Chandler D. W., 2010, TUTORIALS MOL REACTI; CLARY DC, 1990, ANNU REV PHYS CHEM, V41, P61; Dagdigian PJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078386; Eyles CJ, 2011, NAT CHEM, V3, P597, DOI [10.1038/nchem.1071, 10.1038/NCHEM.1071]; Gilijamse JJ, 2006, SCIENCE, V313, P1617, DOI 10.1126/science.1131867; Hartogh P, 2011, NATURE, V478, P218, DOI 10.1038/nature10519; Kohguchi H, 2002, ANN RP CH C, V98, P421, DOI 10.1039/B111167C; Kohguchi H, 2001, SCIENCE, V294, P832, DOI 10.1126/science.1063774; Levine R.D., 1987, MOL REACTION DYNAMIC; Lorenz KT, 2001, SCIENCE, V293, P2063, DOI 10.1126/science.1062754; Nguyen MT, 1998, CHEM PHYS, V230, P1, DOI 10.1016/S0301-0104(97)00383-2; Paterson G, 2012, INT REV PHYS CHEM, V31, P69, DOI 10.1080/0144235X.2012.659046; Sawyer BC, 2011, PHYS CHEM CHEM PHYS, V13, P19059, DOI 10.1039/c1cp21203f; Scharfenberg L, 2011, EUR PHYS J D, V65, P189, DOI 10.1140/epjd/e2011-20009-4; Scharfenberg L, 2010, PHYS CHEM CHEM PHYS, V12, P10660, DOI 10.1039/c004422a; Scharfenberg L, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023410; SCHIFFMAN A, 1995, INT REV PHYS CHEM, V14, P371, DOI 10.1080/01442359509353315; Schreel K, 1996, J CHEM PHYS, V105, P4522, DOI 10.1063/1.472328; SHARKEY P, 1994, J CHEM SOC FARADAY T, V90, P3609, DOI 10.1039/ft9949003609; Smith IWM, 2011, ANNU REV ASTRON ASTR, V49, P29, DOI 10.1146/annurev-astro-081710-102533; STOLTE S, 1991, NATURE, V353, P391, DOI 10.1038/353391a0; Van De Meerakker SYT, 2008, NAT PHYS, V4, P595, DOI 10.1038/nphys1031; van de Meerakker SYT, 2012, CHEM REV, V112, P4828, DOI 10.1021/cr200349r; Vonk MT, 1997, J CHEM PHYS, V106, P1353, DOI 10.1063/1.473972; Watanabe D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.043201; WEINREB S, 1963, NATURE, V200, P829, DOI 10.1038/200829a0	28	104	104	5	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1060	1063		10.1126/science.1229549	http://dx.doi.org/10.1126/science.1229549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180857	Green Submitted			2022-12-01	WOS:000311390600038
J	Logothetis, NK; Eschenko, O; Murayama, Y; Augath, M; Steudel, T; Evrard, HC; Besserve, M; Oeltermann, A				Logothetis, N. K.; Eschenko, O.; Murayama, Y.; Augath, M.; Steudel, T.; Evrard, H. C.; Besserve, M.; Oeltermann, A.			Hippocampal-cortical interaction during periods of subcortical silence	NATURE			English	Article							SLOW-WAVE SLEEP; TRAINING REVERSIBLE INACTIVATION; MEMORY-SYSTEMS; DECLARATIVE MEMORY; SHARP WAVES; RIPPLES; OSCILLATION; CONSOLIDATION; REACTIVATION; STATE	Hippocampal ripples, episodic high-frequency field-potential oscillations primarily occurring during sleep and calmness, have been described in mice, rats, rabbits, monkeys and humans, and so far they have been associated with retention of previously acquired awake experience. Although hippocampal ripples have been studied in detail using neurophysiological methods, the global effects of ripples on the entire brain remain elusive, primarily owing to a lack of methodologies permitting concurrent hippocampal recordings and whole-brain activity mapping. By combining electrophysiological recordings in hippocampus with ripple-triggered functional magnetic resonance imaging, here we show that most of the cerebral cortex is selectively activated during the ripples, whereas most diencephalic, midbrain and brainstem regions are strongly and consistently inhibited. Analysis of regional temporal response patterns indicates that thalamic activity suppression precedes the hippocampal population burst, which itself is temporally bounded by massive activations of association and primary cortical areas. These findings suggest that during off-line memory consolidation, synergistic thalamocortical activity may be orchestrating a privileged interaction state between hippocampus and cortex by silencing the output of subcortical centres involved in sensory processing or potentially mediating procedural learning. Such a mechanism would cause minimal interference, enabling consolidation of hippocampus-dependent memory.	[Logothetis, N. K.; Eschenko, O.; Murayama, Y.; Augath, M.; Steudel, T.; Evrard, H. C.; Besserve, M.; Oeltermann, A.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, N. K.] Univ Manchester, Biomed Imaging Inst, Ctr Imaging Sci, Manchester M13 9PT, Lancs, England; [Besserve, M.] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany	Max Planck Society; University of Manchester; Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Nikos.Logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Eschenko, Oxana/N-7335-2013	Eschenko, Oxana/0000-0001-7482-5628; Evrard, Henry/0000-0001-8429-4699	Max Planck Society	Max Planck Society(Max Planck Society)	We thank D. Omer and M. Munk for reading the manuscript and for useful suggestions, D. Blaurock for English language corrections and editing, and P. Douay for help with the alert monkey experiments. This research was supported by the Max Planck Society. We apologize to those whose work we have not been able to cite for reasons of space.	Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Axmacher N, 2008, BEHAV BRAIN RES, V189, P1, DOI 10.1016/j.bbr.2007.12.018; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hasselmo M E, 1999, Prog Brain Res, V121, P3; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2002, J NEUROSCI, V22, P10941; MOURET J, 1963, J PHYSIOLOGY PARIS, V55, P305; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nadel L, 2011, NEUROPSYCHOPHARMACOL, V36, P251, DOI 10.1038/npp.2010.169; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV, P114; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; Pennartz CMA, 2002, PROG BRAIN RES, V138, P143, DOI 10.1016/S0079-6123(02)38076-2; Poldrack RA, 2004, NEUROBIOL LEARN MEM, V82, P324, DOI 10.1016/j.nlm.2004.05.003; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ramadan W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006697; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	50	235	236	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					547	553		10.1038/nature11618	http://dx.doi.org/10.1038/nature11618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172213				2022-12-01	WOS:000311339800042
J	Cook-Deegan, R				Cook-Deegan, Robert			Law and Science Collide Over Human Gene Patents	SCIENCE			English	Editorial Material							CANCER SUSCEPTIBILITY; ASCO STATEMENT		Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Collins FS, 1996, J CLIN ONCOL, V14, P1738; Conley J., 2012, GENOMIC LAW REP 0817; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; Holman Christopher M., 2009, KAN JL PUB POLY, V18, P215; Rai Arti K., 2011, YALE LAW J ONLINE, V121, P335; Skolnick M, 1996, J CLIN ONCOL, V14, P1737; Visco FM, 1996, J CLIN ONCOL, V14, P1737, DOI 10.1200/JCO.1996.14.5.1737	7	13	13	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					745	747		10.1126/science.1229854	http://dx.doi.org/10.1126/science.1229854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033ZI	23139317				2022-12-01	WOS:000310839500026
J	Woodworth, MB; Greig, LC; Kriegstein, AR; Macklis, JD				Woodworth, Mollie B.; Greig, Luciano Custo; Kriegstein, Arnold R.; Macklis, Jeffrey D.			SnapShot: Cortical Development	CELL			English	Editorial Material							CEREBRAL-CORTEX; SPECIFICATION; NEURONS		[Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Woodworth, MB (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.			Woodworth, Mollie/0000-0003-2130-2289; Greig, Luciano/0000-0002-0020-9379	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075998, F31NS064730, F31NS080343, R01NS045523, R01NS075672, R01NS049553, R37NS035710, R37NS041590, R01NS041590, R01NS072630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000222] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NINDS NIH HHS [R37 NS041590, R01 NS072630, R01 NS049553, R01 NS041590, R01 NS075672, F31 NS064730, F31 NS080343, R01 NS075998, R37 NS035710, R01 NS045523] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; MACDONALD JL, 2012, DEV NEUROSCIENCE COM, V1; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Shoemaker LD, 2010, BIOESSAYS, V32, P197, DOI 10.1002/bies.200900114	6	44	44	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					918	+		10.1016/j.cell.2012.10.004	http://dx.doi.org/10.1016/j.cell.2012.10.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141546	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000310921200023
J	Araki, R; Uda, M; Hoki, Y; Sunayama, M; Nakamura, M; Ando, S; Sugiura, M; Ideno, H; Shimada, A; Nifuji, A; Abe, M				Araki, Ryoko; Uda, Masahiro; Hoki, Yuko; Sunayama, Misato; Nakamura, Miki; Ando, Shunsuke; Sugiura, Mayumi; Ideno, Hisashi; Shimada, Akemi; Nifuji, Akira; Abe, Masumi			Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells	NATURE			English	Article							GROUND-STATE; C-MYC; MICE; GENERATION; FIBROBLASTS	The advantages of using induced pluripotent stem cells (iPSCs) instead of embryonic stem (ES) cells in regenerative medicine centre around circumventing concerns about the ethics of using ES cells and the likelihood of immune rejection of ES-cell-derived tissues(1,2). However, partial reprogramming and genetic instabilities in iPSCs(3-6) could elicit immune responses in transplant recipients even when iPSC-derived differentiated cells are transplanted. iPSCs are first differentiated into specific types of cells in vitro for subsequent transplantation. Although model transplantation experiments have been conducted using various iPSC-derived differentiated tissues(7-10) and immune rejections have not been observed, careful investigation of the immunogenicity of iPSC-derived tissue is becoming increasingly critical, especially as this has not been the focus of most studies done so far. A recent study reported immunogenicity of iPSC- but not ES-cell-derived teratomas(11) and implicated several causative genes. Nevertheless, some controversy has arisen regarding these findings(12). Here we examine the immunogenicity of differentiated skin and bone marrow tissues derived from mouse iPSCs. To ensure optimal comparison of iPSCs and ES cells, we established ten integration-free iPSC and seven ES-cell lines using an inbred mouse strain, C57BL/6. We observed no differences in the rate of success of transplantation when skin and bone marrow cells derived from iPSCs were compared with ES-cell-derived tissues. Moreover, we observed limited or no immune responses, including T-cell infiltration, for tissues derived from either iPSCs or ES cells, and no increase in the expression of the immunogenicity-causing Zg16 and Hormad1 genes in regressing skin and teratoma tissues. Our findings suggest limited immunogenicity of transplanted cells differentiated from iPSCs and ES cells.	[Araki, Ryoko; Uda, Masahiro; Hoki, Yuko; Sunayama, Misato; Nakamura, Miki; Ando, Shunsuke; Sugiura, Mayumi; Ideno, Hisashi; Nifuji, Akira; Abe, Masumi] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan; [Araki, Ryoko] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ideno, Hisashi; Shimada, Akemi; Nifuji, Akira] Tsurumi Univ, Sch Dent Med, Dept Pharmacol, Yokohama, Kanagawa 2308501, Japan	National Institutes for Quantum Science & Technology; Japan Science & Technology Agency (JST); Tsurumi University	Abe, M (corresponding author), Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan.	abemasum@nirs.go.jp	Nifuji, Akira/AAX-7907-2021	Nifuji, Akira/0000-0002-8182-4380; Abe, Masumi/0000-0003-1550-2006	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [22592053, 23592784] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Yamanaka for providing the 2A plasmid vectors; K. Ito, N. Nakajima and K. Kawabata for technical advice on the transplantation experiments; H. Yoshida, K. Nishikawa, A. Ishibashi, R. Watanabe, M. Nakamura and T. Maeda for technical assistance. This work was partially funded by a research grant from Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bubnic SJ, 2005, HEMATOLOGY, V10, P289, DOI 10.1080/10245330500093468; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jincho Y, 2010, J BIOL CHEM, V285, P26384, DOI 10.1074/jbc.M110.115915; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	30	349	370	2	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					100	104		10.1038/nature11807	http://dx.doi.org/10.1038/nature11807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23302801				2022-12-01	WOS:000314741200042
J	Volk, LJ; Bachman, JL; Johnson, R; Yu, YL; Huganir, RL				Volk, Lenora J.; Bachman, Julia L.; Johnson, Richard; Yu, Yilin; Huganir, Richard L.			PKM-zeta is not required for hippocampal synaptic plasticity, learning and memory	NATURE			English	Article							PROTEIN-KINASE-M; LONG-TERM POTENTIATION; C-ZETA; ZIP; MAINTENANCE; INHIBITOR; MECHANISM; ERASURE; CELLS	Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, has long been postulated as a cellular correlate of learning and memory. Although LTP can persist for long periods of time(1), the mechanisms underlying LTP maintenance, in the midst of ongoing protein turnover and synaptic activity, remain elusive. Sustained activation of the brain-specific protein kinase C (PKC) isoform protein kinase M-zeta (PKM-zeta) has been reported to be necessary for both LTP maintenance and long-term memory(2). Inhibiting PKM-zeta activity using a synthetic zeta inhibitory peptide (ZIP) based on the PKC-zeta pseudosubstrate sequence reverses established LTP in vitro and in vivo(3,4). More notably, infusion of ZIP eliminates memories for a growing list of experience-dependent behaviours, including active place avoidance(4), conditioned taste aversion(5), fear conditioning and spatial learning(6). However, most of the evidence supporting a role for PKM-zeta in LTP and memory relies heavily on pharmacological inhibition of PKM-zeta by ZIP. To further investigate the involvement of PKM-zeta in the maintenance of LTP and memory, we generated transgenic mice lacking PKC-zeta and PKM-zeta. We find that both conventional and conditional PKC zeta/PKM-zeta knockout mice show normal synaptic transmission and LTP at Schaffer collateral-CA1 synapses, and have no deficits in several hippocampal-dependent learning and memory tasks. Notably, ZIP still reverses LTP in PKC-zeta/PKM-zeta knockout mice, indicating that the effects of ZIP are independent of PKM-zeta.	[Volk, Lenora J.; Bachman, Julia L.; Johnson, Richard; Yu, Yilin; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Volk, Lenora/0000-0002-9074-4091	National Institute of Health [NS36715, T32MH15330]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, R01NS036715] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Schutz for providing the CaMKII Cre-ER<SUP>T2</SUP> mice, M. Gallagher and D. Smith for advice on behaviour and M. Coulter for technical support. We also thank all members of the Huganir lab for discussion and support. This work was supported by grants from the National Institute of Health (NS36715) and the Howard Hughes Medical Institute (to R. L. H.). L.J.V. is supported by a training grant from the National Institute of Health (T32MH15330).	Abraham WC, 2002, J NEUROSCI, V22, P9626; DENNY JB, 1990, BRAIN RES, V534, P201, DOI 10.1016/0006-8993(90)90130-4; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hirai T, 2003, NEUROSCI LETT, V348, P151, DOI 10.1016/S0304-3940(03)00780-8; Huang Y Y, 1994, Learn Mem, V1, P74; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Krotova K, 2006, BRIT J PHARMACOL, V148, P732, DOI 10.1038/sj.bjp.0706777; Kwapis JL, 2009, BEHAV NEUROSCI, V123, P844, DOI 10.1037/a0016343; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 2012, HIPPOCAMPUS, V22, P648, DOI 10.1002/hipo.20980; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Mei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021568; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sacktor TC, 2012, HIPPOCAMPUS, V22, P645, DOI 10.1002/hipo.20978; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2011, SCIENCE, V331, P1207, DOI 10.1126/science.1200215; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	28	217	222	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					420	U169		10.1038/nature11802	http://dx.doi.org/10.1038/nature11802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283174	Green Accepted			2022-12-01	WOS:000313615900055
J	Balbus, JM; Barouki, R; Birnbaum, LS; Etzel, RA; Gluckman, PD; Grandjean, P; Hancock, C; Hanson, MA; Heindel, JJ; Hoffman, K; Jensen, GK; Keeling, A; Neira, M; Rabadan-Diehl, C; Ralston, J; Tang, KC				Balbus, John M.; Barouki, Robert; Birnbaum, Linda S.; Etzel, Ruth A.; Gluckman, Peter D.; Grandjean, Philippe; Hancock, Christine; Hanson, Mark A.; Heindel, Jerrold J.; Hoffman, Kate; Jensen, Genon K.; Keeling, Ann; Neira, Maria; Rabadan-Diehl, Cristina; Ralston, Johanna; Tang, Kwok-Cho			Early-life prevention of non-communicable diseases	LANCET			English	Editorial Material							CHILDHOOD; HEALTH		[Balbus, John M.] NIEHS, NIH, Bethesda, MD 20892 USA; [Barouki, Robert] Univ Paris 05, Paris, France; [Birnbaum, Linda S.] NIEHS, Natl Technol Program, Res Triangle Pk, NC 27709 USA; [Heindel, Jerrold J.] NIEHS, Div Extramural Res & Training, Res Triangle Pk, NC 27709 USA; [Etzel, Ruth A.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Madison, WI 53706 USA; [Gluckman, Peter D.] Univ Auckland, Auckland 1, New Zealand; [Grandjean, Philippe] Univ So Denmark, Odense, Denmark; [Hancock, Christine] C3 Collaborating Hlth, London, England; [Hanson, Mark A.] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Hoffman, Kate] Social & Sci Syst, Durham, NC USA; [Hoffman, Kate] Univ N Carolina, Chapel Hill, NC USA; [Jensen, Genon K.] Hlth & Environm Alliance, Brussels, Belgium; [Keeling, Ann] Int Diabet Federat, Brussels, Belgium; [Neira, Maria; Tang, Kwok-Cho] WHO, CH-1211 Geneva, Switzerland; [Rabadan-Diehl, Cristina] NHLBI, NIH, Bethesda, MD 20892 USA; [Ralston, Johanna] World Heart Federat, Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin System; University of Wisconsin Madison; University of Auckland; University of Southern Denmark; University of Southampton; Social & Scientific Systems; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Balbus, JM (corresponding author), NIEHS, NIH, 31 Ctr Dr,Room B1CO2, Bethesda, MD 20892 USA.	john.balbus@nih.gov	Hanson, Mark/AAE-8236-2019; Etzel, Ruth A./N-5700-2019; Grandjean, Philippe/I-2962-2014	Hanson, Mark/0000-0002-6907-613X; Etzel, Ruth A./0000-0002-5236-3976; Birnbaum, Linda/0000-0001-5429-5658; hoffman, kate/0000-0001-8029-7710; Grandjean, Philippe/0000-0003-4046-9658	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018, R01ES012199] Funding Source: NIH RePORTER; NIEHS NIH HHS [T32 ES007018, R01 ES012199] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Gale CR, 2006, ARTERIOSCL THROM VAS, V26, P1877, DOI 10.1161/01.ATV.0000228819.13039.b8; Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; UN,, 2012, ARES66288 UN; United Nations, 2011, MILL DEV GOALS REP 2; United Nations, 2011, NCDS MDGS SUCC SYN; WHO, 2010, GLOB STAT REP NONC D	12	108	110	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					3	4		10.1016/S0140-6736(12)61609-2	http://dx.doi.org/10.1016/S0140-6736(12)61609-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064AW	23290956	Green Submitted, Green Accepted			2022-12-01	WOS:000313044300004
J	Milinkovitch, MC; Manukyan, L; Debry, A; Di-Poi, N; Martin, S; Singh, D; Lambert, D; Zwicker, M				Milinkovitch, Michel C.; Manukyan, Liana; Debry, Adrien; Di-Poi, Nicolas; Martin, Samuel; Singh, Daljit; Lambert, Dominique; Zwicker, Matthias			Crocodile Head Scales Are Not Developmental Units But Emerge from Physical Cracking	SCIENCE			English	Article							SURFACE MECHANICS; PATTERN-FORMATION; ORDER; HAIR	Various lineages of amniotes display keratinized skin appendages (feathers, hairs, and scales) that differentiate in the embryo from genetically controlled developmental units whose spatial organization is patterned by reaction-diffusion mechanisms (RDMs). We show that, contrary to skin appendages in other amniotes (as well as body scales in crocodiles), face and jaws scales of crocodiles are random polygonal domains of highly keratinized skin, rather than genetically controlled elements, and emerge from a physical self-organizing stochastic process distinct from RDMs: cracking of the developing skin in a stress field. We suggest that the rapid growth of the crocodile embryonic facial and jaw skeleton, combined with the development of a very keratinized skin, generates the mechanical stress that causes cracking.	[Milinkovitch, Michel C.; Manukyan, Liana; Debry, Adrien; Di-Poi, Nicolas] Univ Geneva, Lab Artificial & Nat Evolut, Dept Genet & Evolut, CH-1211 Geneva, Switzerland; [Martin, Samuel] La Ferme Crocodiles, Pierrelatte, France; [Singh, Daljit; Zwicker, Matthias] Univ Bern, Comp Graph Grp, CH-3012 Bern, Switzerland; [Lambert, Dominique] Univ Namur, Dept Math, Namur, Belgium; [Lambert, Dominique] Univ Namur, Namur Ctr Complex Syst, Namur, Belgium	University of Geneva; University of Bern; University of Namur; University of Namur	Milinkovitch, MC (corresponding author), Univ Geneva, Lab Artificial & Nat Evolut, Dept Genet & Evolut, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	michel.milinkovitch@unige.ch	Lambert, Dominique Jean-Marie/AAH-6865-2021; Di-Poi, Nicolas/O-6256-2019; Di-Poi, Nicolas/O-2378-2015	Lambert, Dominique Jean-Marie/0000-0002-6415-3175; Di-Poi, Nicolas/0000-0002-3313-3016; Di-Poi, Nicolas/0000-0002-3313-3016; Zwicker, Matthias/0000-0001-8630-5515; Milinkovitch, Michel/0000-0002-2553-0724	University of Geneva; Swiss National Science Foundation; Schmidheiny Foundation	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schmidheiny Foundation	This work was supported by the University of Geneva, the Swiss National Science Foundation, and the Schmidheiny Foundation. A. Tzika helped with in situs. H. Li assisted with nonrigid registration. We thank R. Pellet for assistance in mechanics design and A. Roux, M. Gonzalez-Gaitan, B. Chopard, U. Schibler, and anonymous reviewers for useful comments and suggestions.	Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P175; Bohn S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046215; Chang C, 2009, INT J DEV BIOL, V53, P813, DOI 10.1387/ijdb.072556cc; Dhouailly D, 2009, J ANAT, V214, P587, DOI 10.1111/j.1469-7580.2008.01041.x; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Furukawa Y, 2009, INT J COMPUT VISION, V84, P257, DOI 10.1007/s11263-009-0232-2; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Goehring L, 2005, EUROPHYS LETT, V69, P739, DOI 10.1209/epl/i2004-10408-x; Goehring L, 2010, SOFT MATTER, V6, P3562, DOI 10.1039/b922206e; Goehring L, 2009, P NATL ACAD SCI USA, V106, P387, DOI 10.1073/pnas.0805132106; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Herrmann HJ., 1990, STAT MODELS FRACTURE; Jagla EA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026203; Kazhdan Michael, 2006, P S GEOMETRY PROCESS, P61, DOI [DOI 10.2312/SGP/SGP06/061-070, DOI 10.1145/1364901.1364904]; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Li H, 2009, ACM T GRAPHIC, V28, DOI [10.1145/1618452.1618521, 10.1145/1618452.1618503]; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Shorlin KA, 2000, PHYS REV E, V61, P6950, DOI 10.1103/PhysRevE.61.6950; Snavely N, 2006, ACM T GRAPHIC, V25, P835, DOI 10.1145/1141911.1141964; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Thompson DW., 1917, GROWTH FORM, DOI [10.5962/bhl.title.11332, DOI 10.5962/BHL.TITLE.11332]; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; Weaire D., 1999, PHYS FOAMS	24	66	65	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					78	81		10.1126/science.1226265	http://dx.doi.org/10.1126/science.1226265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23196908				2022-12-01	WOS:000312985800055
J	Tucker, ME				Tucker, Miriam E.			US drug shortages: a disappearing problem?	BRITISH MEDICAL JOURNAL			English	Editorial Material												miriametucker@aol.com						American Society of Anesthesiologists, 2012, 2012 ASA DRUG SHORT; FDA, IMP AM SHUTD REC DRU; Generic Pharmaceutical Association, DRUG SHORT; Government Accountability Office, 2011, DRUG SHORT FDAS AB R; Silverman E, 2012, PHARMALOT       1211	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 21	2012	345								e8551	10.1136/bmj.e8551	http://dx.doi.org/10.1136/bmj.e8551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23261759				2022-12-01	WOS:000312701700024
J	Scott, G; Presswood, E				Scott, Gregory; Presswood, Edward			CHRISTMAS 2012: TOMORROW'S WORLD Case report of E.T.-The Extra-Terrestrial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEN		[Scott, Gregory] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England; [Presswood, Edward] Barnet & Chase Farm Hosp NHS Trust, Chase Farm Hosp, Enfield, Middx, England	Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust	Scott, G (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England.	gregory.scott99@imperial.ac.uk		Presswood, Edward/0000-0002-1429-0729; Berger, Marc Moritz/0000-0001-6771-3193; Scott, Gregory/0000-0001-8063-5871				Bierma, 2005, CHICAGO TRIBUNE; Kershner I., 1980, STAR WARS EPISODE 5; McGhee GR, 2011, VIENNA SER THEOR BIO, P1; Nolan JP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6122; Resuscitation Council, 2010, ADV LIF SUPP RES GUI; Spielberg S, 2005, ET EXTRA TERRESTRIAL; Spielberg Steven, 1982, ET EXTRA TERRESTRIAL; VANPRAAGH R, 1964, AM J CARDIOL, V13, P510, DOI 10.1016/0002-9149(64)90159-6; VanPraagh S, 1996, AM HEART J, V132, P382, DOI 10.1016/S0002-8703(96)90437-8; Wall TL, 1997, ANN INTERN MED, V127, P376, DOI 10.7326/0003-4819-127-5-199709010-00007; Williams SRP, 1997, EUR HEART J, V18, P376; World Health Organization, 2012, CHILD GROWTH STAND W	12	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2012	345								e8127	10.1136/bmj.e8127	http://dx.doi.org/10.1136/bmj.e8127			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249665				2022-12-01	WOS:000312698900011
J	Pacheco, AR; Curtis, MM; Ritchie, JM; Munera, D; Waldor, MK; Moreira, CG; Sperandio, V				Pacheco, Alline R.; Curtis, Meredith M.; Ritchie, Jennifer M.; Munera, Diana; Waldor, Matthew K.; Moreira, Cristiano G.; Sperandio, Vanessa			Fucose sensing regulates bacterial intestinal colonization	NATURE			English	Article							PHOSPHATE-TRANSPORT SYSTEM; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; CARBON NUTRITION; MEMBRANE-PROTEIN; UHP GENES; GROWTH; INDUCTION; MG1655; MUCIN	The mammalian gastrointestinal tract provides a complex and competitive environment for the microbiota(1). Successful colonization by pathogens requires scavenging nutrients, sensing chemical signals, competing with the resident bacteria and precisely regulating the expression of virulence genes(2). The gastrointestinal pathogen enterohaemorrhagic Escherichia coli (EHEC) relies on inter-kingdom chemical sensing systems to regulate virulence gene expression(3,4). Here we show that these systems control the expression of a novel two-component signal transduction system, named FusKR, where FusK is the histidine sensor kinase and FusR the response regulator. FusK senses fucose and controls expression of virulence and metabolic genes. This fucose-sensing system is required for robust EHEC colonization of the mammalian intestine. Fucose is highly abundant in the intestine(5). Bacteroides theta-iotaomicron produces multiple fucosidases that cleave fucose from host glycans, resulting in high fucose availability in the gut lumen(6). During growth in mucin, B. thetaiotaomicron contributes to EHEC virulence by cleaving fucose from mucin, thereby activating the FusKR signalling cascade, modulating the virulence gene expression of EHEC. Our findings suggest that EHEC uses fucose, a host-derived signal made available by the microbiota, to modulate EHEC pathogenicity and metabolism.	[Pacheco, Alline R.; Curtis, Meredith M.; Moreira, Cristiano G.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Pacheco, Alline R.; Curtis, Meredith M.; Moreira, Cristiano G.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ritchie, Jennifer M.; Munera, Diana; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sperandio, V (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	vanessa.sperandio@utsouthwestern.edu	Moreira, Cristiano/D-8694-2014; Moreira, Cristiano Gallina/AHB-1469-2022	Moreira, Cristiano/0000-0002-0689-4119; Moreira, Cristiano Gallina/0000-0002-0689-4119; Ritchie, Jennifer/0000-0002-1244-3082	National Institutes of Health (NIH) [AI053067, AI77853, AI077613]; Burroughs Wellcome Fund; NIH [AI42347, 5 T32 AI7520-14]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077853, T32AI007520, R01AI053067, R01AI077613, R01AI042347, R37AI042347] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Kendall for comments. We thank the microarray core facility. This work was supported by the National Institutes of Health (NIH) Grants AI053067, AI77853 and AI077613, and the Burroughs Wellcome Fund (to V. S.) and NIH Grant AI42347 and HHMI (to M. K. W.). M. M. C. was supported through NIH Training Grant 5 T32 AI7520-14. The contents are solely the responsibility of the authors and do not represent the official views of the NIH NIAID.	Autieri SM, 2007, INFECT IMMUN, V75, P5465, DOI 10.1128/IAI.00822-07; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHEN YM, 1987, J BACTERIOL, V169, P3712, DOI 10.1128/jb.169.8.3712-3719.1987; CHEN YM, 1987, MOL GEN GENET, V210, P331, DOI 10.1007/BF00325702; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Fox JT, 2009, J ANIM SCI, V87, P1304, DOI 10.2527/jas.2008-1166; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Janausch IG, 2004, MICROBIOL-SGM, V150, P877, DOI 10.1099/mic.0.26900-0; JASWAL VMS, 1988, BIOCHEM MED METAB B, V39, P105, DOI 10.1016/0885-4505(88)90064-3; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Ritchie K. M., 1989, INFECT IMMUN, V71, P7129; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sharp FC, 2007, INFECT IMMUN, V75, P2432, DOI 10.1128/IAI.02003-06; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2000, TRENDS MICROBIOL, V8, P544, DOI 10.1016/S0966-842X(00)01896-5; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; WESTON LA, 1987, J BACTERIOL, V169, P3546, DOI 10.1128/jb.169.8.3546-3555.1987; WESTON LA, 1988, J BACTERIOL, V170, P3375, DOI 10.1128/jb.170.8.3375-3383.1988; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; ZHU Y, 1986, J MOL EVOL, V23, P259, DOI 10.1007/BF02115582	38	313	324	6	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					113	+		10.1038/nature11623	http://dx.doi.org/10.1038/nature11623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23160491	Green Submitted, Green Accepted			2022-12-01	WOS:000311893400056
J	Eliasmith, C; Stewart, TC; Choo, X; Bekolay, T; DeWolf, T; Tang, C; Rasmussen, D				Eliasmith, Chris; Stewart, Terrence C.; Choo, Xuan; Bekolay, Trevor; DeWolf, Travis; Tang, Charlie; Rasmussen, Daniel			A Large-Scale Model of the Functioning Brain	SCIENCE			English	Article							ITEM; MEMORY	A central challenge for cognitive and systems neuroscience is to relate the incredibly complex behavior of animals to the equally complex activity of their brains. Recently described, large-scale neural models have not bridged this gap between neural activity and biological function. In this work, we present a 2.5-million-neuron model of the brain (called "Spaun") that bridges this gap by exhibiting many different behaviors. The model is presented only with visual image sequences, and it draws all of its responses with a physically modeled arm. Although simplified, the model captures many aspects of neuroanatomy, neurophysiology, and psychological behavior, which we demonstrate via eight diverse tasks.	[Eliasmith, Chris; Stewart, Terrence C.; Choo, Xuan; Bekolay, Trevor; DeWolf, Travis; Tang, Charlie; Rasmussen, Daniel] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2J 3G1, Canada	University of Waterloo	Eliasmith, C (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2J 3G1, Canada.	celiasmith@uwaterloo.ca	DeWolf, Travis/AAX-8363-2021	DeWolf, Travis/0000-0002-8780-5631; Bekolay, Trevor/0000-0001-5215-7999	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canadian Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	The development of Spaun was supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs program, the Canadian Foundation for Innovation, and the Ontario Innovation Trust. We thank M. van der Meer, B. Tripp, M. Laubach, and three anonymous reviewers for insightful comments on previous drafts. All models, scripts, and videos are deposited online at http://nengo.ca/ and http://models.nengo.ca/.	Ananthanarayanan R., 2007, P 2007 ACM IEEE C SU, P1, DOI DOI 10.1145/1362622.1362627; Chaaban I., 2007, TECHNICAL REPORT; de Garis H, 2010, NEUROCOMPUTING, V74, P3, DOI 10.1016/j.neucom.2010.08.004; Dosher BA, 1999, INT J PSYCHOL, V34, P276, DOI 10.1080/002075999399576; FORBES AR, 1964, BRIT J EDUC PSYCHOL, V34, P223, DOI 10.1111/j.2044-8279.1964.tb00632.x; Hadley RF, 2009, NEURAL COMPUT, V21, P510, DOI 10.1162/neco.2008.07-07-572; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JAHNKE JC, 1968, J EXP PSYCHOL, V76, P618, DOI 10.1037/h0025692; MacNeil D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022885; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; MURDOCK BB, 1993, PSYCHOL REV, V100, P183, DOI 10.1037/0033-295X.100.2.183; Orlov T, 2002, CEREB CORTEX, V12, P306, DOI 10.1093/cercor/12.3.306; Pasternak T., 2003, HDB PSYCHOL, V3, P139; Ranzato M., NIPS 07 P 20 INT C N, P1, DOI [10.1109/CVPR.2007.383157, DOI 10.1109/CVPR.2007.383157]; Raven J., 2004, MANUAL RAVENS PROGR; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Stewart TC, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00002; Todorov E, 2009, COGNITIVE NEUROSCIEN, V4; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586	20	472	489	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1202	1205		10.1126/science.1225266	http://dx.doi.org/10.1126/science.1225266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197532				2022-12-01	WOS:000311666200044
J	Brenchley, R; Spannagl, M; Pfeifer, M; Barker, GLA; D'Amore, R; Allen, AM; McKenzie, N; Kramer, M; Kerhornou, A; Bolser, D; Kay, S; Waite, D; Trick, M; Bancroft, I; Gu, Y; Huo, N; Luo, MC; Sehgal, S; Gill, B; Kianian, S; Anderson, O; Kersey, P; Dvorak, J; McCombie, WR; Hall, A; Mayer, KFX; Edwards, KJ; Bevan, MW; Hall, N				Brenchley, Rachel; Spannagl, Manuel; Pfeifer, Matthias; Barker, Gary L. A.; D'Amore, Rosalinda; Allen, Alexandra M.; McKenzie, Neil; Kramer, Melissa; Kerhornou, Arnaud; Bolser, Dan; Kay, Suzanne; Waite, Darren; Trick, Martin; Bancroft, Ian; Gu, Yong; Huo, Naxin; Luo, Ming-Cheng; Sehgal, Sunish; Gill, Bikram; Kianian, Sharyar; Anderson, Olin; Kersey, Paul; Dvorak, Jan; McCombie, W. Richard; Hall, Anthony; Mayer, Klaus F. X.; Edwards, Keith J.; Bevan, Michael W.; Hall, Neil			Analysis of the breadwheat genome using whole-genome shotgun sequencing	NATURE			English	Article							TRANSPOSABLE ELEMENTS; WHEAT GENOME; GENE; EVOLUTION; DIVERSITY; IDENTIFICATION; DUPLICATIONS; INTEGRATION; TRITICEAE; FLOW	Bread wheat (Triticum aestivum) is a globally important crop, accounting for 20 per cent of the calories consumed by humans. Major efforts are underway worldwide to increase wheat production by extending genetic diversity and analysing key traits, and genomic resources can accelerate progress. But so far the very large size and polyploid complexity of the bread wheat genome have been substantial barriers to genome analysis. Here we report the sequencing of its large, 17-gigabase-pair, hexaploid genome using 454 pyrosequencing, and comparison of this with the sequences of diploid ancestral and progenitor genomes. We identified between 94,000 and 96,000 genes, and assigned two-thirds to the three component genomes (A, B and D) of hexaploid wheat. High-resolution synteny maps identified many small disruptions to conserved gene order. We show that the hexaploid genome is highly dynamic, with significant loss of gene family members on polyploidization and domestication, and an abundance of gene fragments. Several classes of genes involved in energy harvesting, metabolism and growth are among expanded gene families that could be associated with crop productivity. Our analyses, coupled with the identification of extensive genetic variation, provide a resource for accelerating gene discovery and improving this major crop.	[McKenzie, Neil; Waite, Darren; Trick, Martin; Bancroft, Ian; Bevan, Michael W.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Brenchley, Rachel; D'Amore, Rosalinda; Kay, Suzanne; Hall, Anthony; Hall, Neil] Univ Liverpool, Ctr Genome Res, Liverpool L69 7ZB, Merseyside, England; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, MIPS IBIS, D-85764 Neuherberg, Germany; [Barker, Gary L. A.; Allen, Alexandra M.; Edwards, Keith J.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Kramer, Melissa; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kerhornou, Arnaud; Bolser, Dan; Kersey, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Gu, Yong; Huo, Naxin; Anderson, Olin] USDA, Western Reg Lab, Albany, CA 94710 USA; [Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Sehgal, Sunish; Gill, Bikram] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Kianian, Sharyar] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58018 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Liverpool; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bristol; Cold Spring Harbor Laboratory; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA); University of California System; University of California Davis; Kansas State University; North Dakota State University Fargo	Bevan, MW (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	Anthony.Hall@liverpool.ac.uk; k.mayer@helmholtz-muenchen.de; k.j.edwards@bristol.ac.uk; michael.bevan@jic.ac.uk; Neil.Hall@liverpool.ac.uk	Bancroft, Ian/AAH-3831-2020; Hall, Neil/A-8717-2013; Allen, alexandra/C-7562-2019; Luo, Ming-Cheng/C-5600-2011; Pfeifer, Matthias/GRJ-4579-2022; Bolser, Dan/AAE-3087-2019; Hall, Anthony/D-2844-2009; Mayer, Klaus FX/M-7941-2015	Hall, Neil/0000-0002-7995-3810; Luo, Ming-Cheng/0000-0002-9744-5887; Bolser, Dan/0000-0002-3991-0859; Hall, Anthony/0000-0002-1806-020X; Mayer, Klaus FX/0000-0001-6484-1077; Bancroft, Ian/0000-0001-7707-1171; Kerhornou, Arnaud/0000-0002-2890-295X; Kersey, Paul/0000-0002-7054-800X; Barker, Gary/0000-0002-9018-9526; McCombie, W. Richard/0000-0003-1899-0682; Brenchley, Rachel/0000-0003-4062-8217; Hall, Neil/0000-0003-2808-0009; Spannagl, Manuel/0000-0003-0701-7035	UK Biological and Biotechnological Sciences Research Council (BBSRC) [BB/G012865, BB/G013985/1, BB/G013004/1]; Wolfson Merit Award from the Royal Society; BBSRC Strategic Programme [B/J004588/1]; EC TriticeaeGenome grant [212019]; TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant [0315954C]; EC Transplant Grant [283496]; BBSRC Career Development Fellowship [BB/H022333/1]; US NSF [IOS-1032105, DBI-0923128, DBI-0701916, DBI-0822100]; USDA-NIFA [2008-35300-04588]; BBSRC [BB/G024650/1, BB/E004725/1, BB/H022333/1, BB/G013004/1, BB/I02347X/1, BB/G013985/1, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [G0900753] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G013004/1, BBS/E/T/000PR6193, BB/G024650/1, BB/I02347X/1, BB/E004725/1, BB/H022333/1, BB/G013985/1] Funding Source: researchfish; Medical Research Council [G0900753] Funding Source: researchfish; Division Of Integrative Organismal Systems [1032105] Funding Source: National Science Foundation	UK Biological and Biotechnological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wolfson Merit Award from the Royal Society; BBSRC Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC TriticeaeGenome grant; TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant; EC Transplant Grant; BBSRC Career Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US NSF(National Science Foundation (NSF)); USDA-NIFA(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DNA sequence was generated by The University of Liverpool Centre for Genomic Research (United Kingdom), 454 Life Sciences (United States), The Cold Spring Harbor Woodbury Genome Centre (United States) and The Genome Analysis Centre (United Kingdom). This work was supported by UK Biological and Biotechnological Sciences Research Council (BBSRC) grants BB/G012865, BB/G013985/1 and BB/G013004/1, to K.J.E., M.W.B. and N. Hall; a Wolfson Merit Award from the Royal Society, to N. Hall; BBSRC Strategic Programme grant B/J004588/1 (GRO), to M.W.B.; EC TriticeaeGenome grant number 212019, to K.F.X.M. and M.W.B.; The TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant number 0315954C, to K.F.X.M.; EC Transplant Grant 283496, to K.F.X.M. and P.K., a BBSRC Career Development Fellowship BB/H022333/1, to A.H., US NSF grants IOS-1032105 and DBI-0923128, to W.R.M.; USDA-NIFA grant 2008-35300-04588, to B.G.; and US NSF grants DBI-0701916, to J.D., and DBI-0822100, to S. Kianian.	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; JIN YK, 1994, PLANT CELL, V6, P1177, DOI 10.1105/tpc.6.8.1177; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nesbitt M, 1996, HULLED WHEATS, V4, P41; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sears E. R., 1966, CHROMOSOME MANIPULAT, P22; Shavrukov Y, 2009, BREEDING SCI, V59, P671, DOI 10.1270/jsbbs.59.671; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; United States Department of Agriculture, 2012, WASDE511 USDA; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang SW, 2011, BREEDING SCI, V61, P189, DOI 10.1270/jsbbs.61.189; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629	42	763	827	9	378	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					705	710		10.1038/nature11650	http://dx.doi.org/10.1038/nature11650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192148	hybrid, Green Published, Green Accepted			2022-12-01	WOS:000311606000034
J	Brandman, O; Stewart-Ornstein, J; Wong, D; Larson, A; Williams, CC; Li, GW; Zhou, S; King, D; Shen, PS; Weibezahn, J; Dunn, JG; Rouskin, S; Inada, T; Frost, A; Weissman, JS				Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Larson, Adam; Williams, Christopher C.; Li, Gene-Wei; Zhou, Sharleen; King, David; Shen, Peter S.; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Inada, Toshifumi; Frost, Adam; Weissman, Jonathan S.			A Ribosome-Bound Quality Control Complex Triggers Degradation of Nascent Peptides and Signals Translation Stress	CELL			English	Article							HEAT-SHOCK FACTOR-1; GENOME-WIDE ANALYSIS; PROTEIN-DEGRADATION; TRANSCRIPTION FACTOR; IN-VIVO; YEAST; KINASE; SYSTEM; SURVEILLANCE; ELONGATION	The conserved transcriptional regulator heat shock factor 1 (Hsf1) is a key sensor of proteotoxic and other stress in the eukaryotic cytosol. We surveyed Hsf1 activity in a genome-wide loss-of-function library in Saccaromyces cerevisiae as well as similar to 78,000 double mutants and found Hsf1 activity to be modulated by highly diverse stresses. These included disruption of a ribosome-bound complex we named the Ribosome Quality Control Complex (RQC) comprising the Ltn1 E3 ubiquitin ligase, two highly conserved but poorly characterized proteins (Tae2 and Rqc1), and Cdc48 and its cofactors. Electron microscopy and biochemical analyses revealed that the RQC forms a stable complex with 60S ribosomal subunits containing stalled polypeptides and triggers their degradation. A negative feedback loop regulates the RQC, and Hsf1 senses an RQC-mediated translation-stress signal distinctly from other stresses. Our work reveals the range of stresses Hsf1 monitors and elucidates a conserved cotranslational protein quality control mechanism.	[Shen, Peter S.; Frost, Adam] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Shen, Peter S.; Frost, Adam] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Zhou, Sharleen; King, David] Univ Calif Berkeley, HHMI Mass Spectrometry Lab, Berkeley, CA 94720 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Larson, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Tohoku University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Frost, A (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	frost@biochem.utah.edu; weissman@cmp.ucsf.edu	Inada, Toshifumi/AAE-1517-2019	Li, Gene-Wei/0000-0001-7036-8511; Rouskin, Silvi/0000-0003-2042-6642; Dunn, Joshua/0000-0003-4476-7257; Shen, Peter/0000-0002-6256-6910; Weissman, Jonathan/0000-0003-2445-670X; Frost, Adam/0000-0003-2231-2577	Helen Hay Whitney postdoctoral fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM105913, T32GM064337] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Helen Hay Whitney postdoctoral fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of the Weissman lab, M. Bassik, E. Boydston, L. Gilbert, A. Grenninger, C. Jan, M. Jonikas, M. Kampmann, Y. Liu, W. Luddington, M. McKeon, E. Oh, C. Reiger, M. Smith, N. Stern-Ginossar, and P. Walter for their valuable help with the manuscript and input on the project; T. Becker and R. Beckmann for help with EM; M. Larson and B. Toyama for help with graphic design; and M. Szeto for help in creating the fluorescent reporters. O.B. was supported by a Helen Hay Whitney postdoctoral fellowship. This work was funded by the Howard Hughes Medical Institute (to J.S.W.).	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Christians ES, 2006, HANDB EXP PHARM, V172, P139; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	45	370	382	3	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1042	1054		10.1016/j.cell.2012.10.044	http://dx.doi.org/10.1016/j.cell.2012.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178123	Green Accepted, Bronze			2022-12-01	WOS:000311423500017
J	Girotra, S; Nallamothu, BK; Spertus, JA; Li, Y; Krumholz, HM; Chan, PS				Girotra, Saket; Nallamothu, Brahmajee K.; Spertus, John A.; Li, Yan; Krumholz, Harlan M.; Chan, Paul S.		Amer Heart Assoc Get Guidelines	Trends in Survival after In-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; HEALTH-CARE-PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; NATIONAL-REGISTRY; DELAYED TIME; GUIDELINES; OUTCOMES; DEFIBRILLATION	BACKGROUND Despite advances in resuscitation care in recent years, it is not clear whether survival and neurologic function after in-hospital cardiac arrest have improved over time. METHODS We identified all adults who had an in-hospital cardiac arrest at 374 hospitals in the Get with the Guidelines-Resuscitation registry between 2000 and 2009. Using multivariable regression, we examined temporal trends in risk-adjusted rates of survival to discharge. Additional analyses explored whether trends were due to improved survival during acute resuscitation or postresuscitation care and whether they occurred at the expense of greater neurologic disability in survivors. RESULTS Among 84,625 hospitalized patients with cardiac arrest, 79.3% had an initial rhythm of asystole or pulseless electrical activity, and 20.7% had ventricular fibrillation or pulseless ventricular tachycardia. The proportion of cardiac arrests due to asystole or pulseless electrical activity increased over time (P<0.001 for trend). Risk-adjusted rates of survival to discharge increased from 13.7% in 2000 to 22.3% in 2009 (adjusted rate ratio per year, 1.04; 95% confidence interval [CI], 1.03 to 1.06; P<0.001 for trend). Survival improvement was similar in the two rhythm groups and was due to improvement in both acute resuscitation survival and postresuscitation survival. Rates of clinically significant neurologic disability among survivors decreased over time, with a risk- adjusted rate of 32.9% in 2000 and 28.1% in 2009 (adjusted rate ratio per year, 0.98; 95% CI, 0.97 to 1.00; P = 0.02 for trend). CONCLUSIONS Both survival and neurologic outcomes after in-hospital cardiac arrest have improved during the past decade at hospitals participating in a large national qualityimprovement registry. (Funded by the American Heart Association.)	[Girotra, Saket] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Dis, Iowa City, IA 52242 USA; [Nallamothu, Brahmajee K.] Res & Dev Ctr Excellence, Vet Affairs Ann Arbor Hlth Serv, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Spertus, John A.; Chan, Paul S.] Univ Missouri, Kansas City, MO USA; [Spertus, John A.; Li, Yan; Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, KS USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute; Yale University; Yale University; Yale University; Yale University	Girotra, S (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Dis, 200 Hawkins Dr,Suite 4430 RCP, Iowa City, IA 52242 USA.	saket-girotra@uiowa.edu	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Girotra, Saket/0000-0002-4784-4513	American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the American Heart Association.	Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aufderheide TP, 2010, HEART RHYTHM, V7, P1357, DOI 10.1016/j.hrthm.2010.04.022; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2010, JAMA-J AM MED ASSOC, V304, P2129, DOI 10.1001/jama.2010.1576; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Edelson DP, 2008, EMERG MED J, V168, P1063; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hinchey PR, 2010, ANN EMERG MED, V56, P348, DOI 10.1016/j.annemergmed.2010.01.036; Hunt EA, 2008, PEDIATRICS, V121, pE34, DOI 10.1542/peds.2007-0029; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kayser RG, 2008, RESUSCITATION, V78, P151, DOI 10.1016/j.resuscitation.2008.03.007; Meaney PA, 2010, CRIT CARE MED, V38, P101, DOI 10.1097/CCM.0b013e3181b43282; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Mhyre JM, 2010, ANESTHESIOLOGY, V113, P782, DOI 10.1097/ALN.0b013e3181eaa74f; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Pell JP, 2006, EUR HEART J, V27, P406, DOI 10.1093/eurheartj/ehi604; Raghunathan TE., 2002, IVEWARE IMPUTATION V; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	25	554	575	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1912	1920		10.1056/NEJMoa1109148	http://dx.doi.org/10.1056/NEJMoa1109148			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150959	Green Accepted, Bronze			2022-12-01	WOS:000311029300007
J	Grantham, J				Grantham, Jeremy			Be persuasive. Be brave. Be arrested (if necessary)	NATURE			English	Editorial Material									[Grantham, Jeremy] GMO, Boston, MA USA; [Grantham, Jeremy] Grantham Fdn Protect Environm, Boston, MA USA		Grantham, J (corresponding author), GMO, Boston, MA USA.	jeremy@granthamfoundation.org							0	23	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					303	303		10.1038/491303a	http://dx.doi.org/10.1038/491303a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151541	Bronze			2022-12-01	WOS:000311031600004
J	Jia, ZW; Mao, YR; Zhang, FJ; Ruan, YH; Ma, Y; Li, J; Guo, W; Liu, EW; Dou, ZH; Zhao, Y; Wang, L; Li, QQ; Xie, PY; Tang, HL; Han, J; Jin, X; Xu, J; Xiong, R; Zhao, DC; Li, P; Wang, X; Wang, LY; Qing, QQ; Ding, ZW; Chen, RY; Liu, ZF; Shao, YM				Jia, Zhongwei; Mao, Yurong; Zhang, Fujie; Ruan, Yuhua; Ma, Ye; Li, Jian; Guo, Wei; Liu, Enwu; Dou, Zhihui; Zhao, Yan; Wang, Lu; Li, Qianqian; Xie, Peiyan; Tang, Houlin; Han, Jing; Jin, Xia; Xu, Juan; Xiong, Ran; Zhao, Decai; Li, Ping; Wang, Xia; Wang, Liyan; Qing, Qianqian; Ding, Zhengwei; Chen, Ray Y.; Liu, Zhongfu; Shao, Yiming			Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; DISCORDANT COUPLES; DRUG-RESISTANCE; VIRAL LOAD; MORTALITY; PREVALENCE; INFECTION; FEMALE	Background On the basis of the results of the randomised clinical trial HPTN 052 and observational studies, WHO has recommended that antiretroviral therapy be off ered to all HIV-infected individuals with uninfected partners of the opposite sex (serodiscordant couples) to reduce the risk of transmission. Whether or not such a public health approach is feasible and the outcomes are sustainable at a large scale and in a developing country setting has not previously been assessed. Methods In this retrospective observational cohort study, we included treated and treatment-naive HIV-positive individuals with HIV-negative partners of the opposite sex who had been added to the national HIV epidemiology and treatment databases between Jan 1, 2003 and Dec 31, 2011. We analysed the annual rate of HIV infection in HIVnegative partners during follow-up, stratifi ed by treatment status of the index partner. Cox proportional hazards analyses were done to examine factors related to HIV transmission. Findings Based on data from 38 862 serodiscordant couples, with 101 295.1 person-years of follow-up for the seronegative partners, rates of HIV infection were 2.6 per 100 person-years (95% CI 2.4-2.8) among the 14 805 couples in the treatment-naive cohort (median baseline CD4 count for HIV-positive partners 441 cells per mu l [IQR 314-590]) and 1.3 per 100 person-years (1.2-1.3) among the 24 057 couples in the treated cohort (median baseline CD4 count for HIV-positive partners 168 cells per mu l [62-269]). We calculated a 26% relative reduction in HIV transmission (adjusted hazard ratio 0.74, 95% CI 0.65-0.84) in the treated cohort. The reduction in transmission was seen across almost all demographic subgroups and was signifi cant in the fi rst year (0.64, 0.54-0.76), and among couples in which the HIV-positive partner had been infected by blood or plasma transfusion (0.76, 0.59-0.99) or heterosexual intercourse (0.69, 0.56-0.84), but not among couples in which the HIV-positive partner was infected by injecting drugs (0.98, 0.71-1.36). Interpretation Antiretroviral therapy for HIV-positive individuals in serodiscordant couples reduced HIV transmission across China, which suggests that the treatment-as-prevention approach is a feasible public health prevention strategy on a national scale in a developing country context. The durability and generalisability of such protection, however, needs to be further studied.	[Jia, Zhongwei] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Mao, Yurong; Zhang, Fujie; Ruan, Yuhua; Ma, Ye; Li, Jian; Guo, Wei; Liu, Enwu; Dou, Zhihui; Zhao, Yan; Wang, Lu; Xie, Peiyan; Tang, Houlin; Han, Jing; Jin, Xia; Xu, Juan; Xiong, Ran; Zhao, Decai; Li, Ping; Wang, Xia; Qing, Qianqian; Ding, Zhengwei; Liu, Zhongfu; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China; [Ruan, Yuhua; Xie, Peiyan; Li, Ping; Wang, Xia; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Ruan, Yuhua; Wang, Xia; Shao, Yiming] Collaborat Innovat Ctr Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Jia, Zhongwei] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA; [Li, Qianqian] China Ocean Univ, Coll Math Sci, Qingdao, Peoples R China; [Xie, Peiyan; Li, Ping] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Chen, Ray Y.] NIAID, NIH, Bethesda, MD 20892 USA	Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Ocean University of China; Guangxi Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	zhongfuliu@163.com; yshao08@gmail.com	Liu, Enwu/AGC-4748-2022; Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019; tang, houlin/HGA-1502-2022; Wang, Xia/C-3298-2018	Liu, Enwu/0000-0003-2580-3523; Wang, Xia/0000-0002-1684-7076; Chen, Ray/0000-0001-6344-1442	Chinese Government's 12th Five-Year Plan; National Natural Science Foundation of China,; Canadian International Development Research Centre	Chinese Government's 12th Five-Year Plan; National Natural Science Foundation of China,(National Natural Science Foundation of China (NSFC)); Canadian International Development Research Centre	Chinese Government's 12th Five-Year Plan, the National Natural Science Foundation of China, and the Canadian International Development Research Centre.	Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153.pub2, 10.1002/14651858.CD009153]; [Anonymous], HIV TRANSM RISK; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Coburn BJ, 2011, LANCET INFECT DIS, V11, P263, DOI 10.1016/S1473-3099(11)70080-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu J, 2011, AIDS RES HUM RETROV, V27, P925, DOI [10.1089/AID.2010.0328, 10.1089/aid.2010.0328]; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; State Council AIDS Working Committee Office & UN Theme Group on AIDS in China, 2011, JOINT ASS HIV AIDS P; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHO, 2012, GUID OR PREEXP PROPH; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	31	100	120	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1195	1203		10.1016/S0140-6736(12)61898-4	http://dx.doi.org/10.1016/S0140-6736(12)61898-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	23206835				2022-12-01	WOS:000325209100024
J	Quoidbach, J; Gilbert, DT; Wilson, TD				Quoidbach, Jordi; Gilbert, Daniel T.; Wilson, Timothy D.			The End of History Illusion	SCIENCE			English	Article							MECHANICAL TURK; AVAILABILITY; CONSTRUCTION; FUTURE	We measured the personalities, values, and preferences of more than 19,000 people who ranged in age from 18 to 68 and asked them to report how much they had changed in the past decade and/or to predict how much they would change in the next decade. Young people, middle-aged people, and older people all believed they had changed a lot in the past but would change relatively little in the future. People, it seems, regard the present as a watershed moment at which they have finally become the person they will be for the rest of their lives. This "end of history illusion" had practical consequences, leading people to overpay for future opportunities to indulge their current preferences.	[Quoidbach, Jordi; Gilbert, Daniel T.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Quoidbach, Jordi] Natl Fund Sci Res, Brussels, Belgium; [Wilson, Timothy D.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Harvard University; Fonds de la Recherche Scientifique - FNRS; University of Virginia	Gilbert, DT (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gilbert@wjh.harvard.edu			NSF [BCS-0722132]; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the support of Research Grant BCS-0722132 from NSF to D.T.G. and T.D.W. Raw data from all studies are on deposit at the Inter-university Consortium for Political and Social Research (deposit no. 32668) and can be accessed at www.icpsr.umich.edu.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Lachman ME, 1997, MIDLIFE DEV INVENTOR; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195; Sedikides C, OXFORD HDB HUMAN MOT, P303; Swann W.B., 2011, HDB THEORIES SOCIAL, V2, P23, DOI DOI 10.4135/9781446249222.N27; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9	16	131	131	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					96	98		10.1126/science.1229294	http://dx.doi.org/10.1126/science.1229294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288539				2022-12-01	WOS:000312985800060
J	Ludwig, DS; Blumenthal, SJ; Willett, WC				Ludwig, David S.; Blumenthal, Susan J.; Willett, Walter C.			Opportunities to Reduce Childhood Hunger and Obesity Restructuring the Supplemental Nutrition Assistance Program (the Food Stamp Program)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Blumenthal, Susan J.] New Amer Fdn, Washington, DC USA; [Blumenthal, Susan J.] Georgetown Sch Med, Washington, DC USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blumenthal SJ., 2012, ACCESS, V28; Coleman-Jensen A, 2012, HOUSEHOLD FOOD SECUR; Kursmark M, 2009, CURR OPIN CLIN NUTR, V12, P310, DOI 10.1097/MCO.0b013e3283298e37; Nord M, 2009, USDA PUBLICATION, V28; POLHEMUS B, 2011, PEDIAT NUTR SURVEILL; Shenkin JD, 2010, AM J PUBLIC HEALTH, V100, P1562, DOI 10.2105/AJPH.2010.198549; Strayer M, 2012, CHARACTERISTICS SUPP; Zhang LN, 2012, PHYSIOL BEHAV, V105, P376, DOI 10.1016/j.physbeh.2011.08.035	8	31	31	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2567	2568		10.1001/jama.2012.45420	http://dx.doi.org/10.1001/jama.2012.45420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268513				2022-12-01	WOS:000312916600018
J	Pos, W; Sethi, DK; Call, MJ; Schulze, MSED; Anders, AK; Pyrdol, J; Wucherpfennig, KW				Pos, Wouter; Sethi, Dhruv K.; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Pyrdol, Jason; Wucherpfennig, Kai W.			Crystal Structure of the HLA-DM-HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection	CELL			English	Article							CLASS-II MHC; HLA-DR MOLECULES; INVARIANT-CHAIN; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGEN; SURFACE EXPRESSION; DM SUSCEPTIBILITY; BINDING; DISSOCIATION; MICE	HLA-DR molecules bind microbial peptides in an endosomal compartment and present them on the cell surface for CD4 T cell surveillance. HLA-DM plays a critical role in the endosomal peptide selection process. The structure of the HLA-DM-HLA-DR complex shows major rearrangements of the HLA-DR peptide-binding groove. Flipping of a tryptophan away from the HLA-DR1 P1 pocket enables major conformational changes that position hydrophobic HLA-DR residues into the P1 pocket. These conformational changes accelerate peptide dissociation and stabilize the empty HLA-DR peptide-binding groove. Initially, incoming peptides have access to only part of the HLA-DR groove and need to compete with HLA-DR residues for access to the P2 site and the hydrophobic P1 pocket. This energetic barrier creates a rapid and stringent selection process for the highest-affinity binders. Insertion of peptide residues into the P2 and P1 sites reverses the conformational changes, terminating selection through DM dissociation.	[Pos, Wouter; Sethi, Dhruv K.; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Pyrdol, Jason; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Anders, Anne-Kathrin; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu			National Institutes of Health [RO1 NS044914, PO1 AI045757]; National Multiple Sclerosis Society; American Diabetes Association; Ruth L. Kirschstein National Research Service Award; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8P41 GM103403-10]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA100265] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057493, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Diabetes Association(American Diabetes Association); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Drs. Eric Sundberg, Shannon Turley, Hao Wu, and Bana Jabri for reading the manuscript. This work was supported by grants from the National Institutes of Health (RO1 NS044914 and PO1 AI045757 to K.W.W.), postdoctoral fellowships from The National Multiple Sclerosis Society (D.K.S.) and the American Diabetes Association (W.P.), as well as a Ruth L. Kirschstein National Research Service Award (to M.J.C.). We thank the staff at the UCLA-DOE crystallization core and the CSIRO Collaborative Crystallization Centre, Melbourne, Australia, for setting up screens. Diffraction data were collected at the Advanced Photon Source using beamlines allocated to the Northeastern Collaborative Access Team. These beamlines are supported by grants from the National Center for Research Resources (5P41RR015301-10) and the National Institute of General Medical Sciences (8P41 GM103403-10) from the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; Busch R, 2002, J IMMUNOL METHODS, V263, P111, DOI 10.1016/S0022-1759(02)00034-0; Castellino F, 1998, J IMMUNOL, V161, P4048; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; Rupp B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018662; Sadegh-Nasseri S, 2008, TRENDS IMMUNOL, V29, P141, DOI 10.1016/j.it.2008.01.001; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Weber DA, 2001, J IMMUNOL, V167, P5167, DOI 10.4049/jimmunol.167.9.5167; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618	57	118	121	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1557	1568		10.1016/j.cell.2012.11.025	http://dx.doi.org/10.1016/j.cell.2012.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260142	Bronze, Green Accepted			2022-12-01	WOS:000312890300019
J	Ainsworth, C				Ainsworth, Claire			IMMUNOLOGY A many layered thing	NATURE			English	Editorial Material							PSORIASIS											Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Oh CJ, 2000, J AM ACAD DERMATOL, V42, P829, DOI 10.1067/mjd.2000.105948; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Valeyev NV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001024	6	6	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					552	554		10.1038/492S52a	http://dx.doi.org/10.1038/492S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254971	Bronze			2022-12-01	WOS:000312488200003
J	Zhang, C; Srinivasan, Y; Arlow, DH; Fung, JJ; Palmer, D; Zheng, YW; Green, HF; Pandey, A; Dror, RO; Shaw, DE; Weis, WI; Coughlin, SR; Kobilka, BK				Zhang, Cheng; Srinivasan, Yoga; Arlow, Daniel H.; Fung, Juan Jose; Palmer, Daniel; Zheng, Yaowu; Green, Hillary F.; Pandey, Anjali; Dror, Ron O.; Shaw, David E.; Weis, William I.; Coughlin, Shaun R.; Kobilka, Brian K.			High-resolution crystal structure of human protease-activated receptor 1	NATURE			English	Article							THROMBIN-RECEPTOR; AGONIST RECOGNITION; FORCE-FIELD; MEMBRANE-PROTEINS; OPIOID RECEPTOR; MECHANISM; BINDING; SODIUM; SPECIFICITY; TRAFFICKING	Protease-activated receptor 1 (PAR1) is the prototypical member of a family of G-protein-coupled receptors that mediate cellular responses to thrombin and related proteases. Thrombin irreversibly activates PAR1 by cleaving the amino-terminal exodomain of the receptor, which exposes a tethered peptide ligand that binds the heptahelical bundle of the receptor to affect G-protein activation. Here we report the 2.2 angstrom resolution crystal structure of human PAR1 bound to vorapaxar, a PAR1 antagonist. The structure reveals an unusual mode of drug binding that explains how a small molecule binds virtually irreversibly to inhibit receptor activation by the tethered ligand of PAR1. In contrast to deep, solvent-exposed binding pockets observed in other peptide-activated G-protein-coupled receptors, the vorapaxar-binding pocket is superficial but has little surface exposed to the aqueous solvent. Protease-activated receptors are important targets for drug development. The structure reported here will aid the development of improved PAR1 antagonists and the discovery of antagonists to other members of this receptor family.	[Srinivasan, Yoga; Palmer, Daniel; Zheng, Yaowu; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Zhang, Cheng; Fung, Juan Jose; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Arlow, Daniel H.; Green, Hillary F.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Pandey, Anjali] Portola Pharmaceut, San Francisco, CA 94080 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; D. E. Shaw Research; Stanford University	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,S452P, San Francisco, CA 94158 USA.	shaun.coughlin@ucsf.edu; kobilka@stanford.edu	Weis, William I/G-1437-2011; Zhang, Cheng/O-4372-2015; Palmer, Daniel/Q-7595-2016; Palmer, Daniel/J-2967-2014	Weis, William I/0000-0002-5583-6150; Zhang, Cheng/0000-0001-9042-4007; Palmer, Daniel/0000-0002-7954-9332; Palmer, Daniel/0000-0002-7954-9332; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, HL44907, HL65590]; Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065185, R01HL065590, R01HL044907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from the National Institutes of Health, grants NS028471 (B. K. K.), and HL44907 and HL65590 (S. R. C.), and from the Mathers Foundation (B.K.K. and W.I.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAHOU WF, 1994, BLOOD, V84, P4195, DOI 10.1182/blood.V84.12.4195.bloodjournal84124195; Blackhart BD, 2000, MOL PHARMACOL, V58, P1178, DOI 10.1124/mol.58.6.1178; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chackalamannil S, 2005, J MED CHEM, V48, P5884, DOI 10.1021/jm0502236; CHEN J, 1994, J BIOL CHEM, V269, P16041; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornelissen I, 2010, P NATL ACAD SCI USA, V107, P18605, DOI 10.1073/pnas.1013309107; COSTA T, 1990, MOL PHARMACOL, V37, P383; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Garcia-Lopez MT, 2010, CURR MED CHEM, V17, P109, DOI 10.2174/092986710790112639; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HEIN L, 1994, J BIOL CHEM, V269, P27719; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; ISHII K, 1993, J BIOL CHEM, V268, P9780; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kosoglou T, 2012, EUR J CLIN PHARMACOL, V68, P249, DOI 10.1007/s00228-011-1120-6; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Lindorff-Larsen K., 2009, P ACM IEEE C SUP POR, P1, DOI [10.1145/1654059.1654099, DOI 10.1145/1654059.1654099, DOI 10.1145/1654059.1654126]; LIU LW, 1991, J BIOL CHEM, V266, P16977; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; Neve KA, 2001, MOL PHARMACOL, V60, P373, DOI 10.1124/mol.60.2.373; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shapiro MJ, 1998, J BIOL CHEM, V273, P29009, DOI 10.1074/jbc.273.44.29009; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wilson MH, 2001, MOL PHARMACOL, V59, P929, DOI 10.1124/mol.59.4.929; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	70	336	350	3	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					387	+		10.1038/nature11701	http://dx.doi.org/10.1038/nature11701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222541	Green Submitted, Green Accepted			2022-12-01	WOS:000312488200047
J	Wilson, LE; Blythe, D; Sharfstein, JM				Wilson, Lucy E.; Blythe, David; Sharfstein, Joshua M.			Fungal Meningitis From Injection of Contaminated Steroids A Compounding Problem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilson, Lucy E.; Blythe, David; Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD 21202 USA	Maryland Department of Health & Mental Hygiene	Sharfstein, JM (corresponding author), Maryland Dept Hlth & Mental Hyg, 201 W Preston St, Baltimore, MD 21202 USA.	joshua.sharfstein@maryland.gov						[Anonymous], 2002, KANSAS CITY STA 1006; Centers for Disease Control and Prevention (CDC), MULT FUNG MEN OUTBR; Centers for Disease Control and Prevention (CDC), CAS DEF MEN SEPT ART; Food and Drug Administration (FDA), FUNG MEN OUTBR ARCH; Hallissy E, 2002, SAN FRANCISCO CHRONI; Kliff S, 2012, WASHINGTON POST; Professional Compounding Centers of America (PCCA), COMP PHARM PHARM AR	7	15	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2461	2462		10.1001/jama.2012.47932	http://dx.doi.org/10.1001/jama.2012.47932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23104261				2022-12-01	WOS:000312441400019
J	Liu, SM; Kandoth, PK; Warren, SD; Yeckel, G; Heinz, R; Alden, J; Yang, CL; Jamai, A; El-Mellouki, T; Juvale, PS; Hill, J; Baum, TJ; Cianzio, S; Whitham, SA; Korkin, D; Mitchum, MG; Meksem, K				Liu, Shiming; Kandoth, Pramod K.; Warren, Samantha D.; Yeckel, Greg; Heinz, Robert; Alden, John; Yang, Chunling; Jamai, Aziz; El-Mellouki, Tarik; Juvale, Parijat S.; Hill, John; Baum, Thomas J.; Cianzio, Silvia; Whitham, Steven A.; Korkin, Dmitry; Mitchum, Melissa G.; Meksem, Khalid			A soybean cyst nematode resistance gene points to a new mechanism of plant resistance to pathogens	NATURE			English	Article							SERINE HYDROXYMETHYLTRANSFERASE; HETERODERA-GLYCINES; RHG1 LOCUS; EXPRESSION; POLYMORPHISMS; REGISTRATION; RESPONSES; DENSITY; STRESS; VECTOR	Soybean (Glycine max (L.) Merr.) is an important crop that provides a sustainable source of protein and oil worldwide. Soybean cyst nematode (Heterodera glycines Ichinohe) is a microscopic roundworm that feeds on the roots of soybean and is a major constraint to soybean production. This nematode causes more than US$1 billion in yield losses annually in the United States alone(1), making it the most economically important pathogen on soybean. Although planting of resistant cultivars forms the core management strategy for this pathogen, nothing is known about the nature of resistance. Moreover, the increase in virulent populations of this parasite on most known resistance sources necessitates the development of novel approaches for control. Here we report the map-based cloning of a gene at the Rhg4 (for resistance to Heterodera glycines 4) locus, a major quantitative trait locus contributing to resistance to this pathogen. Mutation analysis, gene silencing and transgenic complementation confirm that the gene confers resistance. The gene encodes a serine hydroxymethyltransferase, an enzyme that is ubiquitous in nature and structurally conserved across kingdoms. The enzyme is responsible for interconversion of serine and glycine and is essential for cellular one-carbon metabolism. Alleles of Rhg4 conferring resistance or susceptibility differ by two genetic polymorphisms that alter a key regulatory property of the enzyme. Our discovery reveals an unprecedented plant resistance mechanism against a pathogen. The mechanistic knowledge of the resistance gene can be readily exploited to improve nematode resistance of soybean, an increasingly important global crop.	[Liu, Shiming; Jamai, Aziz; El-Mellouki, Tarik; Meksem, Khalid] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA; [Kandoth, Pramod K.; Yeckel, Greg; Heinz, Robert; Alden, John; Mitchum, Melissa G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Yeckel, Greg; Heinz, Robert; Alden, John; Mitchum, Melissa G.] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Warren, Samantha D.; Korkin, Dmitry] Univ Missouri, Christopher S Bond Life Sci Ctr, Dept Comp Sci, Columbia, MO 65211 USA; [Warren, Samantha D.; Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Yang, Chunling; Juvale, Parijat S.; Hill, John; Baum, Thomas J.; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Cianzio, Silvia] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Southern Illinois University System; Southern Illinois University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Iowa State University; Iowa State University	Meksem, K (corresponding author), So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA.	goellnerm@missouri.edu; meksemk@siu.edu	Liu, Shiming/AAG-9495-2020; Meksem, Khalid/AAD-3101-2022	Meksem, Khalid/0000-0002-9469-9718; /0000-0002-4613-8422	Illinois-Missouri Biotechnology Alliance [2005-3]; United Soybean Board [0253, 3253, 2268, 1251]; USDA-NIFA [2006-35300-17195]; National Science Foundation Plant Genome Research Program [0820642]; Illinois Soybean Association; North Central Soybean Research Program; Iowa Soybean Association; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; Div Of Biological Infrastructure [0845196] Funding Source: National Science Foundation	Illinois-Missouri Biotechnology Alliance; United Soybean Board; USDA-NIFA(United States Department of Agriculture (USDA)); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Illinois Soybean Association; North Central Soybean Research Program; Iowa Soybean Association; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank X. Yang for technical assistance with soybean hairy root propagation and M. Kroll for proofreading the manuscript. We thank R. Hussey, W. Gassmann, P. Gresshoff, A. Bendahmane, D. Xu and B. McClure for critical reading of the manuscript. We thank K. Sharma and S. Puthur for use of the HPLC facility and technical help. This work was supported by the Illinois-Missouri Biotechnology Alliance (project 2005-3 to M.G.M. and K.M.), United Soybean Board (project 0253 to K.M., S.C. and M.G.M.; project 3253 to K.M. and S.C.; project 2268 to K.M. and M.G.M; project 1251 to J.H. and S.A.W.), USDA-NIFA (grant 2006-35300-17195 to K.M.), the National Science Foundation Plant Genome Research Program (grant 0820642 to S.A.W., J.H., M. G. M. and T.J.B.), the National Science Foundation CAREER Program (DBI-0845196 to D.K.), Missouri Soybean Merchandising Council (project 258 to M.G.M.), Illinois Soybean Association, North Central Soybean Research Program, Iowa Soybean Association, and a Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship (to S.D.W.).	Alfadhli S, 2000, MOL BIOCHEM PARASIT, V110, P283, DOI 10.1016/S0166-6851(00)00282-6; Bagnyukova TV, 2008, BRAIN RES, V1237, P44, DOI 10.1016/j.brainres.2008.07.073; BERNARD RL, 1988, CROP SCI, V28, P1027; Brown S, 2010, J NEMATOL, V42, P201; CALDWELL B. E., 1960, AGRON JOUR, V52, P635; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dong K, 1997, GENETICS, V146, P1311; ENDO BY, 1965, PHYTOPATHOLOGY, V55, P375; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jefferson RA., 1987, PLANT MOL BIOL REP, V5, P387, DOI DOI 10.1007/BF02667740; Kandoth PK, 2011, PLANT PHYSIOL, V155, P1960, DOI 10.1104/pp.110.167536; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Koenning S. R., 2010, PLANT HLTH PROG; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; Liu XH, 2011, FUNCT INTEGR GENOMIC, V11, P539, DOI 10.1007/s10142-011-0225-4; MATSON ARNOLD L., 1965, CROP SCI, V5, P477, DOI 10.2135/cropsci1965.0011183X000500050032x; Meksem, 2008, HDB PLANT FUNCTIONAL, P251, DOI DOI 10.1002/9783527622542.CH12; Meksem K, 2000, THEOR APPL GENET, V101, P747, DOI 10.1007/s001220051540; Meksem K, 2001, THEOR APPL GENET, V103, P710, DOI 10.1007/s001220100597; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Niblack T. L., 2008, PLANT HLTH PROG; NIBLACK TL, 1993, J NEMATOL, V25, P880; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; SMITH TJ, 1973, CROP SCI, V13, P495, DOI 10.2135/cropsci1973.0011183X001300040033x; STAUFFER GV, 1981, GENE, V14, P63, DOI 10.1016/0378-1119(81)90148-7; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Xiao YL, 2005, PLANT PHYSIOL, V139, P1323, DOI 10.1104/pp.105.063479; Zhang CQ, 2010, PLANT PHYSIOL, V153, P52, DOI 10.1104/pp.109.151639; Zhang Y, 2008, ANAL BIOCHEM, V375, P367, DOI 10.1016/j.ab.2007.12.015	39	244	295	14	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					256	+		10.1038/nature11651	http://dx.doi.org/10.1038/nature11651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235880				2022-12-01	WOS:000312259300043
J	Redford, KH; Jensen, DB; Breheny, JJ				Redford, Kent H.; Jensen, Deborah B.; Breheny, James J.			Integrating the Captive and the Wild	SCIENCE			English	Editorial Material									[Redford, Kent H.] Archipelago Consulting, Irvington, NY 10533 USA; [Jensen, Deborah B.] Woodland Pk Zoo, Seattle, WA 98130 USA; [Breheny, James J.] Wildlife Conservat Soc, Bronx, NY 10460 USA	Wildlife Conservation Society	Redford, KH (corresponding author), Archipelago Consulting, Irvington, NY 10533 USA.							Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Lacy R., 2010, P 65 WAZA ANN C TECH; Lacy RC, 2013, ZOO BIOL, V32, P19, DOI 10.1002/zoo.21029; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Pritchard DJ, 2012, ORYX, V46, P18, DOI 10.1017/S0030605310001766; Randall DA, 2004, EMERG INFECT DIS, V10, P2214, DOI 10.3201/eid1012.040080; Redford KH, 2011, BIOSCIENCE, V61, P39, DOI 10.1525/bio.2011.61.1.9; Roman Joe, 2011, LISTED DISPATCHES AM; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Shepherdson D., 2004, P SPEC RISK 2004 PAT; SOULE M, 1986, ZOO BIOL, V5, P101, DOI 10.1002/zoo.1430050205; Valladares-Padua Claudio B., 2002, P301; Vander Haegen WM, 2009, J WILDLIFE MANAGE, V73, P1402, DOI 10.2193/2008-484; Volis S, 2010, BIODIVERS CONSERV, V19, P2441, DOI 10.1007/s10531-010-9849-2	15	43	52	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1157	1158		10.1126/science.1228899	http://dx.doi.org/10.1126/science.1228899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197520				2022-12-01	WOS:000311666200029
J	Ding, SY; Liu, YS; Zeng, YN; Himmel, ME; Baker, JO; Bayer, EA				Ding, Shi-You; Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Baker, John O.; Bayer, Edward A.			How Does Plant Cell Wall Nanoscale Architecture Correlate with Enzymatic Digestibility?	SCIENCE			English	Article							TRICHODERMA-REESEI; CORN STOVER; CRYSTAL-STRUCTURE; BINDING MODULES; CELLULOSE; SYSTEM; RECALCITRANCE; CELLULASES; MICROSCOPY; BIOFUELS	Greater understanding of the mechanisms contributing to chemical and enzymatic solubilization of plant cell walls is critical for enabling cost-effective industrial conversion of cellulosic biomass to biofuels. Here, we report the use of correlative imaging in real time to assess the impact of pretreatment, as well as the resulting nanometer-scale changes in cell wall structure, upon subsequent digestion by two commercially relevant cellulase systems. We demonstrate that the small, noncomplexed fungal cellulases deconstruct cell walls using mechanisms that differ considerably from those of the larger, multienzyme complexes (cellulosomes). Furthermore, high-resolution measurement of the microfibrillar architecture of cell walls suggests that digestion is primarily facilitated by enabling enzyme access to the hydrophobic cellulose face. The data support the conclusion that ideal pretreatments should maximize lignin removal and minimize polysaccharide modification, thereby retaining the essentially native microfibrillar structure.	[Ding, Shi-You; Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Baker, John O.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Weizmann Institute of Science	Ding, SY (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	shi.you.ding@nrel.gov	DING, SHIYOU/ABD-8519-2021; Ding, Shi-You/O-1209-2013	DING, SHIYOU/0000-0002-1102-1507; Zeng, Yining/0000-0002-0202-2479	U.S. Department of Energy (DOE) [DE-AC36-08-GO28308]; National Renewable Energy Laboratory; BioEnergy Science Center; DOE Bioenergy Research Center; Genomic Science Program [ER65258]; Office of Biological and Environmental Research in the DOE Office of Science	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); BioEnergy Science Center; DOE Bioenergy Research Center(United States Department of Energy (DOE)); Genomic Science Program; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. P. Tucker for the fungal cellulases; S. Xie for guidance regarding SRS microscopy; K. Ruckman for manuscript editing; and A. J. Ragauskas, C. E. Wyman, M. F. Davis, D. J. Johnson, and R. H. Atalla for valuable discussion. This work was supported by the U.S. Department of Energy (DOE) under contract no. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory. We acknowledge research support from the BioEnergy Science Center, a DOE Bioenergy Research Center, and the Genomic Science Program (ER65258), both supported by the Office of Biological and Environmental Research in the DOE Office of Science. S.-Y.D. conceptualized the project, conducted AFM, analyzed the data, and wrote the manuscript. Y.-S.L. conducted enzyme labeling, bright-field light microscopy, and CLSM. Y.Z. conducted SRS microscopy. E. A. B. purified the cellulosomes. S.-Y.D., M. E. H., J.O.B., and E. A. B. revised the manuscript. We declare no competing financial interests.	ATALLA RH, 1986, J RAMAN SPECTROSC, V17, P229, DOI 10.1002/jrs.1250170213; BERGHEM ER, 1973, EUR J BIOCHEM, V37, P21, DOI 10.1111/j.1432-1033.1973.tb02952.x; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Dagel DJ, 2011, J PHYS CHEM B, V115, P635, DOI 10.1021/jp109798p; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Donohoe BS, 2009, BIOTECHNOL BIOENG, V103, P480, DOI 10.1002/bit.22281; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Gritsch CS, 2005, ANN BOT-LONDON, V95, P619, DOI 10.1093/aob/mci068; Harris D, 2010, PLANT PHYSIOL, V153, P420, DOI 10.1104/pp.110.154203; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Jansen S, 1998, IAWA J, V19, P347, DOI 10.1163/22941932-90000658; JOHNSON EA, 1982, APPL ENVIRON MICROB, V43, P1125, DOI 10.1128/AEM.43.5.1125-1132.1982; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P1544, DOI 10.1002/bit.22203; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MORAG E, 1992, Enzyme and Microbial Technology, V14, P289, DOI 10.1016/0141-0229(92)90153-F; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; OOSHIMA H, 1990, BIOTECHNOL BIOENG, V36, P446, DOI 10.1002/bit.260360503; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Wise L. E., 1946, Paper Trade Journal, V122, P35; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zeng YN, 2010, BIOENERG RES, V3, P272, DOI 10.1007/s12155-010-9079-1	35	546	572	12	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1055	1060		10.1126/science.1227491	http://dx.doi.org/10.1126/science.1227491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180856				2022-12-01	WOS:000311390600037
J	Wee, LM; Flores-Jasso, CF; Salomon, WE; Zamore, PD				Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.			Argonaute Divides Its RNA Guide into Domains with Distinct Functions and RNA-Binding Properties	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; CRYSTAL-STRUCTURE; GENETIC INTERFERENCE; SITE ACCESSIBILITY; CODING REGION; NUCLEIC-ACID; MICRO RNAS; TARGET; RISC	MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) guide Argonaute proteins to silence mRNA expression. Argonaute binding alters the properties of an RNA guide, creating functional domains. We show that the domains established by Argonaute-the anchor, seed, central, 30 supplementary, and tail regions-have distinct biochemical properties that explain the differences between how animal miRNAs and siRNAs bind their targets. Extensive complementarity between an siRNA and its target slows the rate at which fly Argonaute2 (Ago2) binds to and dissociates from the target. Highlighting its role in antiviral defense, fly Ago2 dissociates so slowly from extensively complementary target RNAs that essentially every fully paired target is cleaved. Conversely, mouse AGO2, which mainly mediates miRNA directed repression, dissociates rapidly and with similar rates for fully paired and seed-matched targets. Our data narrow the range of biochemically reasonable models for how Argonaute-bound siRNAs and miRNAs find, bind, and regulate their targets.	[Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Wee, Liang Meng/U-2188-2017	Wee, Liang Meng/0000-0003-3870-8568; Flores-Jasso, C. Fabian/0000-0002-3745-495X; Flores-Jasso, Carlos Fabian/0000-0001-9096-0264; Zamore, Phillip/0000-0002-4505-9618	National Institutes of Health [GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R01GM065236, R37GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Turner, J. Chen, A. Carruthers, R. Gilmore, S. Ryder, B. Farley, O. Bilsel, S. Kathuria, and P. Gandhi for help and discussions; the Turner lab for use of equipment; A. Boucher, T. Covello, and G. Farley for technical support; and members of the Zamore lab for critical comments on the manuscript. This work was supported in part by National Institutes of Health grants GM62862 and GM65236. Phillip D. Zamore is a cofounder and scientific advisor to Alnylam Pharmaceuticals.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.bb.14.060185.001023; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; COHEN LS, 1967, J CELL PHYSIOL, V69, P331, DOI 10.1002/jcp.1040690309; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; HALL KB, 1992, NUCLEIC ACIDS RES, V20, P4283, DOI 10.1093/nar/20.16.4283; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammes G.G., 1970, ENZYMES, V2, P67; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lai EC, 1998, CELL, V93, P1103, DOI 10.1016/S0092-8674(00)81454-3; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schroeder SJ, 2009, METHOD ENZYMOL, V468, P371, DOI 10.1016/S0076-6879(09)68017-4; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	87	246	249	0	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1055	1067		10.1016/j.cell.2012.10.036	http://dx.doi.org/10.1016/j.cell.2012.10.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178124	Bronze, Green Accepted			2022-12-01	WOS:000311423500018
J	Mitra, D; Luo, X; Morgan, A; Wang, J; Hoang, MP; Lo, J; Guerrero, CR; Lennerz, JK; Mihm, MC; Wargo, JA; Robinson, KC; Devi, SP; Vanover, JC; D'Orazio, JA; McMahon, M; Bosenberg, MW; Haigis, KM; Haber, DA; Wang, YS; Fisher, DE				Mitra, Devarati; Luo, Xi; Morgan, Ann; Wang, Jin; Hoang, Mai P.; Lo, Jennifer; Guerrero, Candace R.; Lennerz, Jochen K.; Mihm, Martin C.; Wargo, Jennifer A.; Robinson, Kathleen C.; Devi, Suprabha P.; Vanover, Jillian C.; D'Orazio, John A.; McMahon, Martin; Bosenberg, Marcus W.; Haigis, Kevin M.; Haber, Daniel A.; Wang, Yinsheng; Fisher, David E.			An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background	NATURE			English	Article							STEM-CELL FACTOR; DNA LESIONS; MELANOCYTES; MICE; MUTATIONS; RISK; PIGMENTATION; SENESCENCE; EXPRESSION; DAMAGE	People with pale skin, red hair, freckles and an inability to tan-the 'red hair/fair skin' phenotype-are at highest risk of developing melanoma, compared to all other pigmentation types(1). Genetically, this phenotype is frequently the product of inactivating polymorphisms in the melanocortin 1 receptor (MC1R) gene. MC1R encodes a cyclic AMP-stimulating G-protein-coupled receptor that controls pigment production. Minimal receptor activity, as in red hair/fair skin polymorphisms, produces the red/yellow pheomelanin pigment, whereas increasing MC1R activity stimulates the production of black/brown eumelanin(2). Pheomelanin has weak shielding capacity against ultraviolet radiation relative to eumelanin, and has been shown to amplify ultraviolet-A-induced reactive oxygen species(3-5). Several observations, however, complicate the assumption that melanoma risk is completely ultraviolet-radiation-dependent. For example, unlike non-melanoma skin cancers, melanoma is not restricted to sun-exposed skin and ultraviolet radiation signature mutations are infrequently oncogenic drivers(6). Although linkage of melanoma risk to ultraviolet radiation exposure is beyond doubt, ultraviolet-radiation-independent events are likely to have a significant role(1,7). Here we introduce a conditional, melanocyte-targeted allele of the most common melanoma oncoprotein, BRAF(V600E), into mice carrying an inactivating mutation in the Mc1r gene (these mice have a phenotype analogous to red hair/fair skin humans). We observed a high incidence of invasive melanomas without providing additional gene aberrations or ultraviolet radiation exposure. To investigate the mechanism of ultraviolet-radiation-independent carcinogenesis, we introduced an albino allele, which ablates all pigment production on the Mc1r(e/e) background. Selective absence of pheomelanin synthesis was protective against melanoma development. In addition, normal Mc1r(e/e) mouse skin was found to have significantly greater oxidative DNA and lipid damage than albino Mc1r(e/e) mouse skin. These data suggest that the pheomelanin pigment pathway produces ultraviolet-radiation-independent carcinogenic contributions to melanomagenesis by a mechanism of oxidative damage. Although protection from ultraviolet radiation remains important, additional strategies may be required for optimal melanoma prevention.	[Mitra, Devarati; Morgan, Ann; Lo, Jennifer; Robinson, Kathleen C.; Devi, Suprabha P.; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Luo, Xi; Haigis, Kevin M.; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Wang, Jin; Guerrero, Candace R.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Hoang, Mai P.; Mihm, Martin C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lennerz, Jochen K.] Univ Ulm, Inst Pathol, D-89070 Ulm, Germany; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Vanover, Jillian C.; D'Orazio, John A.] Univ Kentucky, Sch Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of California System; University of California Riverside; Harvard University; Massachusetts General Hospital; Ulm University; Harvard University; Massachusetts General Hospital; University of Kentucky; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Yale University	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	dfisher3@partners.org	Fisher, David/AAH-2878-2019; Wang, Jin/AAE-3809-2022	Wang, Jin/0000-0001-5511-3983; Hoang, Mai/0000-0002-1406-7981; /0000-0002-9520-6874	National Institutes of Health [5R01 AR043369-16, R01-CA101864, F30 ES020663-01]; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [R01CA176839, R01CA129933, R01CA101864, R01CA131075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES020663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kunisada for generously sharing K14-SCF mice and C. L. Evans for help with mouse skin irradiation. We also thank A. P. Codgill for help with primary tumour cell culture and A. Piris for pathology consultation as well as M. Haigis and Z. Abdel-Malik for discussions. This work was supported by the following grants from the National Institutes of Health 5R01 AR043369-16 (D.E.F.), R01-CA101864 (Y.W.) and F30 ES020663-01 (D.M.), as well as support from the Dr Miriam and Sheldon G. Adelson Medical Research Foundation, the US-Israel Binational Science Foundation, and the Melanoma Research Alliance (D.E.F.).	Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; Hill HZ, 2000, PIGM CELL RES, V13, P140, DOI 10.1034/j.1600-0749.13.s8.25.x; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Kovacs D, 2012, J INVEST DERMATOL, V132, P1196, DOI 10.1038/jid.2011.457; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; NEUGUT AI, 1994, AM J PUBLIC HEALTH, V84, P1828, DOI 10.2105/AJPH.84.11.1828; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Rae J, 2012, J INVEST DERMATOL, V132, P488, DOI 10.1038/jid.2011.341; RHODES AR, 1987, JAMA-J AM MED ASSOC, V258, P3146, DOI 10.1001/jama.258.21.3146; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanover JC, 2009, PIGM CELL MELANOMA R, V22, P827, DOI 10.1111/j.1755-148X.2009.00617.x; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Wenczl E, 1998, J INVEST DERMATOL, V111, P678, DOI 10.1046/j.1523-1747.1998.00357.x; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159	30	308	314	3	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					449	+		10.1038/nature11624	http://dx.doi.org/10.1038/nature11624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123854	Green Accepted, Green Submitted			2022-12-01	WOS:000311031600047
J	Largeron, M; Fleury, MB				Largeron, Martine; Fleury, Maurice-Bernard			Bioinspired Oxidation Catalysts	SCIENCE			English	Editorial Material							AEROBIC OXIDATION; PRIMARY AMINES; IMINES; SYSTEM; ALCOHOLS; QUINONE		[Largeron, Martine; Fleury, Maurice-Bernard] Univ Paris 05, CNRS, Fac Sci Pharmaceut & Biol, UMR 8638, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Largeron, M (corresponding author), Univ Paris 05, CNRS, Fac Sci Pharmaceut & Biol, UMR 8638, F-75270 Paris 06, France.	martine.largeron@parisdescartes.fr; maurice.fleury@parisdescartes.fr	largeron, martine/AAW-4958-2020	largeron, martine/0000-0002-1725-8118				Gnanaprakasam B, 2010, ANGEW CHEM INT EDIT, V49, P1468, DOI 10.1002/anie.200907018; Hu ZZ, 2012, ORG BIOMOL CHEM, V10, P1618, DOI 10.1039/c2ob06670j; Largeron M, 2008, CHEM-EUR J, V14, P996, DOI 10.1002/chem.200700876; Largeron M, 2012, ANGEW CHEM INT EDIT, V51, P5409, DOI 10.1002/anie.201200587; MURAHASHI SI, 1995, ANGEW CHEM INT EDIT, V34, P2443, DOI 10.1002/anie.199524431; Mure M, 2004, ACCOUNTS CHEM RES, V37, P131, DOI 10.1021/ar9703342; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Patil RD, 2011, ADV SYNTH CATAL, V353, P1695, DOI 10.1002/adsc.201100100; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Samec JSM, 2005, CHEM-EUR J, V11, P2327, DOI 10.1002/chem.200401082; Tian HW, 2012, ADV SYNTH CATAL, V354, P2671, DOI 10.1002/adsc.201200574; Watson AJA, 2010, SCIENCE, V329, P635, DOI 10.1126/science.1191843; Wendlandt AE, 2012, ORG LETT, V14, P2850, DOI 10.1021/ol301095j; Yamaguchi K, 2003, ANGEW CHEM INT EDIT, V42, P1480, DOI 10.1002/anie.200250779; Yuan H, 2012, J AM CHEM SOC, V134, P13970, DOI 10.1021/ja306934b	15	110	111	7	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					43	44		10.1126/science.1232220	http://dx.doi.org/10.1126/science.1232220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288531				2022-12-01	WOS:000312985800044
J	Weaver, JF				Weaver, Jason F.			Entropies of Adsorbed Molecules Exceed Expectations	SCIENCE			English	Editorial Material									Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Weaver, JF (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	weaver@che.ufl.edu						Antony A, 2012, PHYS CHEM CHEM PHYS, V14, P12202, DOI 10.1039/c2cp41900a; Campbell CT, 2012, J AM CHEM SOC, V134, P18109, DOI 10.1021/ja3080117; Fichthorn KA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196103; Tait SL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400235	4	22	22	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					39	40		10.1126/science.1231552	http://dx.doi.org/10.1126/science.1231552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288528				2022-12-01	WOS:000312985800041
J	Duch, A; Felipe-Abrio, I; Barroso, S; Yaakov, G; Garcia-Rubio, M; Aguilera, A; de Nadal, E; Posas, F				Duch, Alba; Felipe-Abrio, Irene; Barroso, Sonia; Yaakov, Gilad; Garcia-Rubio, Maria; Aguilera, Andres; de Nadal, Eulalia; Posas, Francesc			Coordinated control of replication and transcription by a SAPK protects genomic integrity	NATURE			English	Article							DOUBLE-STRAND BREAKS; GENE-EXPRESSION; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; FORK PROGRESSION; CELL-CYCLE; STRESS; MRC1; PHASE; KINASE	Upon environmental changes or extracellular signals, cells are subjected to marked changes in gene expression (1,2). Dealing with high levels of transcription during replication is critical to prevent collisions between the transcription and replication pathways and avoid recombination events(3-5). In response to osmostress, hundreds of stress-responsive genes are rapidly induced by the stress-activated protein kinase (SAPK) Hog1 (ref.6), even during S phase(7). Here we show in Saccharomyces cerevisae that a single signalling molecule, Hog1, coordinates both replication and transcription upon osmostress. Hog1 interacts with and phosphorylates Mrc1, a component of the replication complex(8-11). Phosphorylation occurs at different sites to those targeted by Mec1 upon DNA damage(8,9). Mrc1 phosphorylation by Hog1 delays early and late origin firing by preventing Cdc45 loading, as well as slowing down replication-complex progression. Regulation of Mrc1 by Hog1 is completely independent of Mec1 and Rad53. Cells carrying a non-phosphorylatable allele of MRC1 (mrc1(3A)) do not delay replication upon stress and show a marked increase in transcription-associated recombination, genomic instability and Rad52 foci. In contrast, mrc1(3A) induces Rad53 and survival in the presence of hydroxyurea or methyl methanesulphonate. Therefore, Hog1 and Mrc1 define a novel S-phase checkpoint independent of the DNA-damage checkpoint that permits eukaryotic cells to prevent conflicts between DNA replication and transcription, which would otherwise lead to genomic instability when both phenomena are temporally coincident.	[Duch, Alba; Yaakov, Gilad; de Nadal, Eulalia; Posas, Francesc] Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain; [Felipe-Abrio, Irene; Barroso, Sonia; Garcia-Rubio, Maria; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Posas, F (corresponding author), Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain.	francesc.posas@upf.edu	Duch, Alba/AGI-1035-2022; Barroso, Sonia/F-2288-2016; de Nadal, Eulàlia/J-8178-2014; Posas, Francesc/K-1364-2013; Aguilera, Andres/L-1825-2014; Garcia-Rubio, Maria/C-2061-2017; FELIPE, IRENE/ABF-9743-2021	Duch, Alba/0000-0001-6041-1360; Barroso, Sonia/0000-0002-0062-2016; de Nadal, Eulàlia/0000-0003-0039-5607; Posas, Francesc/0000-0002-4164-7076; Aguilera, Andres/0000-0003-4782-1714; Garcia-Rubio, Maria/0000-0003-0981-0555; FELIPE, IRENE/0000-0001-7781-1459	Spanish Government [BIO2009-07762, BFU2012-33503, BFU2011-26722, BFU2010-16372, CSD2007-0015]; FP7 UNICELLSYS grant [201142]; Fundacion Marcelino Botin; ICREA Academia (Generalitat de Catalunya)	Spanish Government(Spanish GovernmentEuropean Commission); FP7 UNICELLSYS grant; Fundacion Marcelino Botin; ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya)	We thank L. Subirana, S. Ovejas and A. Fernandez for technical support. This work was supported by grants from the Spanish Government (BIO2009-07762 and BFU2012-33503 to F. P., BFU2011-26722 to E.d.N., BFU2010-16372 to A. A., and Consolider Ingenio 2010 programme CSD2007-0015 to F. P. and A. A.) and FP7 UNICELLSYS grant (no. 201142) and the Fundacion Marcelino Botin to F. P. F. P. and E.d.N. are recipients of an ICREA Academia (Generalitat de Catalunya).	Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bianco JN, 2012, METHODS, V57, P149, DOI 10.1016/j.ymeth.2012.04.007; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Garcia-Rubio M, 2008, MOL GENET GENOMICS, V279, P123, DOI 10.1007/s00438-007-0301-6; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Moriel-Carretero M, 2010, MOL CELL, V37, P690, DOI 10.1016/j.molcel.2010.02.008; Muers M, 2011, NAT REV GENET, V12, P156, DOI 10.1038/nrg2960; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; SPENCER F, 1990, GENETICS, V124, P237; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129	32	61	62	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					116	+		10.1038/nature11675	http://dx.doi.org/10.1038/nature11675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23178807				2022-12-01	WOS:000312933800042
J	Rogelj, J; McCollum, DL; Reisinger, A; Meinshausen, M; Riahi, K				Rogelj, Joeri; McCollum, David L.; Reisinger, Andy; Meinshausen, Malte; Riahi, Keywan			Probabilistic cost estimates for climate change mitigation	NATURE			English	Article							CARBON-CYCLE MODELS; ATMOSPHERE-OCEAN; SIMPLER MODEL; SCENARIOS; TARGETS	For more than a decade, the target of keeping global warming below 2 degrees C has been a key focus of the international climate debate(1). In response, the scientific community has published a number of scenario studies that estimate the costs of achieving such a target(2-5). Producing these estimates remains a challenge, particularly because of relatively well known, but poorly quantified, uncertainties, and owing to limited integration of scientific knowledge across disciplines(6). The integrated assessment community, on the one hand, has extensively assessed the influence of technological and socio-economic uncertainties on low-carbon scenarios and associated costs(2-4,7). The climate modelling community, on the other hand, has spent years improving its understanding of the geophysical response of the Earth system to emissions of greenhouse gases(8-12). This geophysical response remains a key uncertainty in the cost of mitigation scenarios but has been integrated with assessments of other uncertainties in only a rudimentary manner, that is, for equilibrium conditions(6,13). Here we bridge this gap between the two research communities by generating distributions of the costs associated with limiting transient global temperature increase to below specific values, taking into account uncertainties in four factors: geophysical, technological, social and political. Wefind that political choices that delay mitigation have the largest effect on the cost-risk distribution, followed by geophysical uncertainties, social factors influencing future energy demand and, lastly, technological uncertainties surrounding the availability of greenhouse gas mitigation options. Our information on temperature risk and mitigation costs provides crucial information for policy-making, because it clarifies the relative importance of mitigation costs, energy demand and the timing of global action in reducing the risk of exceeding a global temperature increase of 2 degrees C, or other limits such as 3 degrees C or 1.5 degrees C, across a wide range of scenarios.	[Rogelj, Joeri] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Rogelj, Joeri; McCollum, David L.; Riahi, Keywan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Reisinger, Andy] New Zealand Agr Greenhouse Gas Res Ctr, Palmerston North 4442, New Zealand; [Meinshausen, Malte] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Meinshausen, Malte] Potsdam Inst Climate Impact Res, PRIMAP Grp, D-14412 Potsdam, Germany; [Riahi, Keywan] Graz Univ Technol, A-8010 Graz, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; International Institute for Applied Systems Analysis (IIASA); University of Melbourne; Potsdam Institut fur Klimafolgenforschung; Graz University of Technology	Rogelj, J (corresponding author), ETH, Inst Atmospher & Climate Sci, Univ Str 16, CH-8092 Zurich, Switzerland.	joeri.rogelj@env.ethz.ch	Reisinger, Andy R/E-1201-2016; Meinshausen, Malte/A-7037-2011; Meinshausen, Malte/AAG-7985-2019; Rogelj, Joeri/I-7108-2012; Meinshausen, Malte/AAG-6505-2019; Riahi, Keywan/B-6426-2011	Reisinger, Andy R/0000-0002-6631-7188; Meinshausen, Malte/0000-0003-4048-3521; Rogelj, Joeri/0000-0003-2056-9061; Meinshausen, Malte/0000-0003-4048-3521; Riahi, Keywan/0000-0001-7193-3498; McCollum, David/0000-0003-1293-0179	Swiss National Science Foundation [200021-135067]; IIASA Peccei Award Grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); IIASA Peccei Award Grant	We thank V. Krey, P. Kolp and M. Strubegger for their support in developing the model set-up and extracting the results, R. Knutti and R. Socolow for comments and feedback during the writing process and S. Hatfield-Dodds, whose review comments substantially contributed to improving our manuscript. J.R. was supported by the Swiss National Science Foundation (project 200021-135067) and the IIASA Peccei Award Grant.	[Anonymous], 2000, IPCC SPECIAL REPORT; Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Bosetti V, 2009, CLIMATIC CHANGE, V96, P299, DOI 10.1007/s10584-009-9630-2; Clarke L, 2009, ENERG ECON, V31, pS64, DOI 10.1016/j.eneco.2009.10.013; den Elzen MGJ, 2010, CLIMATIC CHANGE, V99, P313, DOI 10.1007/s10584-010-9798-5; Edenhofer O, 2010, ENERG J, V31, P11; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Knutti R, 2008, J CLIMATE, V21, P2651, DOI 10.1175/2007JCLI2119.1; Krey V, 2009, ENERG ECON, V31, pS94, DOI 10.1016/j.eneco.2009.07.001; Mastrandrea M. D., 2010, GUIDANCE NOTE LEAD A, P3; Meehl G. A., 2007, IPCC CLIMATE CHANGE, P747; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1457, DOI 10.5194/acp-11-1457-2011; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P1011, DOI 10.1073/pnas.0903797106; Pachauri RK, 2007, CLIMATE CHANGE 2007; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Rao S, 2006, ENERG J, P177; Riahi K., 2012, ENERGY PATHWAYS SUST; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Schaeffer M, 2008, P NATL ACAD SCI USA, V105, P20621, DOI 10.1073/pnas.0802416106; Smith SM, 2012, NAT CLIM CHANGE, V2, P535, DOI 10.1038/NCLIMATE1496; Smith SJ, 2006, TELLUS B, V58, P586, DOI 10.1111/j.1600-0889.2006.00217.x; UNEP, 2011, BRIDG EM GAP 15 20; United Nations, 2009, WORLD POP PROSP 2008; Vaughan NE, 2009, CLIMATIC CHANGE, V96, P29, DOI 10.1007/s10584-009-9573-7	28	219	223	4	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					79	83		10.1038/nature11787	http://dx.doi.org/10.1038/nature11787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23282364				2022-12-01	WOS:000312933800034
J	Shi, XS; Bi, YC; Yang, W; Guo, XD; Jiang, Y; Wan, CJ; Li, LY; Bai, YB; Guo, J; Wang, YJ; Chen, XJ; Wu, B; Sun, HB; Liu, WL; Wang, JF; Xu, CQ				Shi, Xiaoshan; Bi, Yunchen; Yang, Wei; Guo, Xingdong; Jiang, Yan; Wan, Chanjuan; Li, Lunyi; Bai, Yibing; Guo, Jun; Wang, Yujuan; Chen, Xiangjun; Wu, Bo; Sun, Hongbin; Liu, Wanli; Wang, Junfeng; Xu, Chenqi			Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids	NATURE			English	Article							IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; CRAC CHANNEL; K+ CHANNEL; PROTEINS; BINDING; ORAI; PHOSPHORYLATION; RECOGNITION; SIGNALS	Ionic protein-lipid interactions are critical for the structure and function of membrane receptors, ion channels, integrins and many other proteins(1-7). However, the regulatory mechanism of these interactions is largely unknown. Here we show that Ca2+ can bind directly to anionic phospholipids and thus modulate membrane protein function. The activation of T-cell antigen receptor-CD3 complex (TCR), a key membrane receptor for adaptive immunity, is regulated by ionic interactions between positively charged CD3 epsilon/zeta cytoplasmic domains (CD3(CD)) and negatively charged phospholipids in the plasma membrane(1,8-10). Crucial tyrosines are buried in the membrane and are largely protected from phosphorylation in resting T cells. It is not clear how CD3CD dissociates from the membrane in antigen-stimulated T cells. The antigen engagement of even a single TCR triggers a Ca2+ influx(11) and TCR-proximal Ca2+ concentration is higher than the average cytosolic Ca2+ concentration(12). Our biochemical, live-cell fluorescence resonance energy transfer and NMR experiments showed that an increase in Ca2+ concentration induced the dissociation of CD3CD from the membrane and the solvent exposure of tyrosine residues. As a consequence, CD3 tyrosine phosphorylation was significantly enhanced by Ca2+ influx. Moreover, when compared with wild-type cells, Ca2+ channel-deficient T cells had substantially lower levels of CD3 phosphorylation after stimulation. The effect of Ca2+ on facilitating CD3 phosphorylation is primarily due to the charge of this ion, as demonstrated by the fact that replacing Ca2+ with the non-physiological ion Sr2+ resulted in the same feedback effect. Finally, P-31 NMR spectroscopy showed that Ca2+ bound to the phosphate group in anionic phospholipids at physiological concentrations, thus neutralizing the negative charge of phospholipids. Rather than initiating CD3 phosphorylation, this regulatory pathway of Ca2+ has a positive feedback effect on amplifying and sustaining CD3 phosphorylation and should enhance T-cell sensitivity to foreign antigens. Our study thus provides a new regulatory mechanism of Ca2+ to T-cell activation involving direct lipid manipulation.	[Bi, Yunchen; Wan, Chanjuan; Wang, Yujuan; Wu, Bo; Sun, Hongbin; Wang, Junfeng] Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China; [Shi, Xiaoshan; Yang, Wei; Guo, Xingdong; Jiang, Yan; Li, Lunyi; Bai, Yibing; Guo, Jun; Xu, Chenqi] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Shi, Xiaoshan; Yang, Wei; Guo, Xingdong; Jiang, Yan; Li, Lunyi; Bai, Yibing; Guo, Jun; Xu, Chenqi] Chinese Acad Sci, Natl Ctr Prot Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Chen, Xiangjun; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Wang, JF (corresponding author), Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, 350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China.	junfeng@hmfl.ac.cn; cqxu@sibcb.ac.cn	liu, wanli/H-5690-2011; Shi, Xiaoshan/AAH-7734-2021; Sun, Hongbin/C-9721-2015	liu, wanli/0000-0003-2624-6802; Shi, Xiaoshan/0000-0001-7931-8684; Sun, Hongbin/0000-0002-7712-0655; Liu, Wanli/0000-0003-0395-2800; Yang, Wei/0000-0001-9438-7215; Bai, Yibing/0000-0002-2944-5367; Xu, Chenqi/0000-0002-4968-6782; Wu, Bo/0000-0003-4556-0477	National Basic Research Program of China (973 Program) [2011CB910901, 2012CB910804, 2012CB917202]; National Science Foundation of China [31070738]; Chinese Academy of Sciences [KSCX2-EW-J-11]; Shanghai Municipal Commission for Science and Technology [10PJ1411500]; Young Talent Program of Shanghai Institutes for Biological Sciences, CAS [2010KIP101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; Young Talent Program of Shanghai Institutes for Biological Sciences, CAS	We would like to thank R. Lewis for his gift of CJ-1 Jurkat cell line; S.-c. Sun, A. Lin, D. Li, J. J. Chou, H. Gu and M. Lei for discussions. C. X. is funded by the National Basic Research Program of China (973 Program, no. 2011CB910901 and no. 2012CB910804), the National Science Foundation of China (no. 31070738), the Chinese Academy of Sciences (Hundred Talents Program and no. KSCX2-EW-J-11), the Shanghai Municipal Commission for Science and Technology (10PJ1411500) and the Young Talent Program of Shanghai Institutes for Biological Sciences, CAS (no. 2010KIP101). J. W. is funded by the National Basic Research Program of China (973 Program, no. 2012CB917202) and the Chinese Academy of Sciences (Hundred Talents Program).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kuhns MS, 2008, CELL, V135, P594, DOI 10.1016/j.cell.2008.10.033; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	31	155	167	12	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					111	+		10.1038/nature11699	http://dx.doi.org/10.1038/nature11699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23201688				2022-12-01	WOS:000312933800041
J	Goetz, L; Bethel, K; Topol, EJ				Goetz, Laura; Bethel, Kelly; Topol, Eric J.			Rebooting Cancer Tissue Handling in the Sequencing Era Toward Routine Use of Frozen Tumor Tissue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROMISE		[Goetz, Laura; Topol, Eric J.] Scripps Translat Sci Inst, Scripps Genom Med, La Jolla, CA 92037 USA; [Goetz, Laura] Scripps Clin, Div Gen Surg, La Jolla, CA 92037 USA; [Bethel, Kelly] Scripps Clin, Div Pathol, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Clin, Div Cardiovasc Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729; Bethel, Kelly/0000-0002-7005-8641				Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Klein C, 2012, JAMA-J AM MED ASSOC, V308, P1867, DOI 10.1001/2012.jama.10823; Kolata G, 2012, NY TIMES, pA1; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040	8	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					37	38		10.1001/jama.2012.70832	http://dx.doi.org/10.1001/jama.2012.70832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280221				2022-12-01	WOS:000319113000023
J	Lu, SJ; Zong, CH; Fan, W; Yang, MY; Li, JS; Chapman, AR; Zhu, P; Hu, XS; Xu, LY; Yan, LY; Bai, F; Qiao, J; Tang, FC; Li, RQ; Xie, XS				Lu, Sijia; Zong, Chenghang; Fan, Wei; Yang, Mingyu; Li, Jinsen; Chapman, Alec R.; Zhu, Ping; Hu, Xuesong; Xu, Liya; Yan, Liying; Bai, Fan; Qiao, Jie; Tang, Fuchou; Li, Ruiqiang; Xie, X. Sunney			Probing Meiotic Recombination and Aneuploidy of Single Sperm Cells by Whole-Genome Sequencing	SCIENCE			English	Article							HOT-SPOTS; RATES; MAP; AMPLIFICATION; PATTERNS; MEN	Meiotic recombination creates genetic diversity and ensures segregation of homologous chromosomes. Previous population analyses yielded results averaged among individuals and affected by evolutionary pressures. We sequenced 99 sperm from an Asian male by using the newly developed amplification method-multiple annealing and looping-based amplification cycles-to phase the personal genome and map recombination events at high resolution, which are nonuniformly distributed across the genome in the absence of selection pressure. The paucity of recombination near transcription start sites observed in individual sperm indicates that such a phenomenon is intrinsic to the molecular mechanism of meiosis. Interestingly, a decreased crossover frequency combined with an increase of autosomal aneuploidy is observable on a global per-sperm basis.	[Fan, Wei; Yang, Mingyu; Li, Jinsen; Zhu, Ping; Hu, Xuesong; Xu, Liya; Bai, Fan; Tang, Fuchou; Li, Ruiqiang; Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China; [Lu, Sijia; Zong, Chenghang; Chapman, Alec R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Yan, Liying; Qiao, Jie] Peking Univ, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China; [Yan, Liying; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China	Peking University; Harvard University; Harvard University; Peking University; Peking University	Li, RQ (corresponding author), Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China.	lirq@pku.edu.cn; xie@chemistry.harvard.edu	Zong, Chenghang/F-3243-2013; Xu, Liya/AAV-5387-2021; Galaxy, Yuuki/S-4013-2017	Galaxy, Yuuki/0000-0002-7135-520X; Zong, Chenghang/0000-0002-8337-8038; Zhu, Ping/0000-0002-4521-7524; Bai, Fan/0000-0001-6119-8936; Fan, Wei/0000-0001-5036-8733	U.S. NIH National Human Genome Research Institute [HG005097-1, HG005613-01]; Peking University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005613, R01HG005097] Funding Source: NIH RePORTER	U.S. NIH National Human Genome Research Institute; Peking University(Peking University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by U.S. NIH National Human Genome Research Institute grants (HG005097-1 and HG005613-01) to X. S. X. and by funding from Peking University to the Biodynamic Optical Imaging Center (BIOPIC). The computing was carried out at the National Supercomputer Center in Tianjin, China, and the calculations were performed on TianHe-1. We thank G. S. Young for assistance in sample prep and N. Kleckner and J. Zhang for critical comments on the manuscript. The sequencing data has been deposited with the National Center for Biotechnology Information; the accession number is SRA060945. C.Z., S.L., and X.S.X. are authors on a patent applied for by Harvard University that covers the MALBAC technology.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Downie SE, 1997, MOL HUM REPROD, V3, P815, DOI 10.1093/molehr/3.9.815; Epstein CJ., 2007, CONSEQUENCES CHROMOS; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/nmeth.1443, 10.1038/NMETH.1443]; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	36	218	255	2	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1627	1630		10.1126/science.1229112	http://dx.doi.org/10.1126/science.1229112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258895	Green Accepted, Green Submitted			2022-12-01	WOS:000312533100055
J	Teng, MW; Bolovan-Fritts, C; Dar, RD; Womack, A; Simpson, ML; Shenk, T; Weinberger, LS				Teng, Melissa W.; Bolovan-Fritts, Cynthia; Dar, Roy D.; Womack, Andrew; Simpson, Michael L.; Shenk, Thomas; Weinberger, Leor S.			An Endogenous Accelerator for Viral Gene Expression Confers a Fitness Advantage	CELL			English	Article							IMMEDIATE-EARLY PROMOTER; HUMAN CYTOMEGALOVIRUS; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; INFECTED CELLS; PROTEIN; TRANSCRIPTION; IE2; REPLICATION; BINDING	Many signaling circuits face a fundamental tradeoff between accelerating their response speed while maintaining final levels below a cytotoxic threshold. Here, we describe a transcriptional circuitry that dynamically converts signaling inputs into faster rates without amplifying final equilibrium levels. Using time-lapse microscopy, we find that transcriptional activators accelerate human cytomegalovirus (CMV) gene expression in single cells without amplifying steady-state expression levels, and this acceleration generates a significant replication advantage. We map the accelerator to a highly self-cooperative transcriptional negative-feedback loop (Hill coefficient similar to 7) generated by homomultimerization of the virus's essential transactivator protein IE2 at nuclear PML bodies. Eliminating the IE2-accelerator circuit reduces transcriptional strength through mislocalization of incoming viral genomes away from PML bodies and carries a heavy fitness cost. In general, accelerators may provide a mechanism for signal-transduction circuits to respond quickly to external signals without increasing steady-state levels of potentially cytotoxic molecules.	[Teng, Melissa W.; Bolovan-Fritts, Cynthia; Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Teng, Melissa W.; Weinberger, Leor S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Womack, Andrew; Shenk, Thomas] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego; Princeton University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu	Simpson, Michael/A-8410-2011	Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888	NSF; Center for Nanophase Materials Sciences; US Department of Energy; NIH [R01CA85786, K25GM083395]; NIH Center for Systems Biology at Princeton University [P50GM71508]; NATIONAL CANCER INSTITUTE [R01CA085786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, K25GM083395] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Center for Nanophase Materials Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Systems Biology at Princeton University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Ferrell, L. Fortunato, M. Elowitz, E. Mocarski, D. Spector, T. Hwa, A. Hoffmann, R. Tsien, J. Nelson, C. Lilley, M. Weitzman, and R. Everett for providing reagents, equipment, helpful discussion, and critical review of previous versions of this manuscript. We thank S. Thiberge and the Lewis-Sigler Imaging Core for invaluable technical expertise. M.W.T. and A.W. acknowledge support from NSF Graduate Research Fellowships. M.L.S. acknowledges support from the Center for Nanophase Materials Sciences, sponsored by the US Department of Energy. T.S. received support from the NIH (R01CA85786) and the NIH Center for Systems Biology at Princeton University (P50GM71508). This work was supported by NIH award K25GM083395 (L.S.W.). L.S.W. conceived and designed the study. M.W.T., C.B.-F., and L.S.W. designed and performed the experiments. M.W.T., C.B.F., R.D.D., M.L.S., T.S. and L.S.W. analyzed the data. A.W. and T.S. provided reagents. M.W.T., C.B.F., and L.S.W. wrote the paper.	Alon U., 2020, An introduction to systems biology: design principles of biological circuits ed., V2nd edn, P249; [Anonymous], 2006, CYTOMEGALOVIRUSES MO; Barrasa MI, 2005, J VIROL, V79, P1428, DOI 10.1128/JVI.79.3.1428-1437.2005; Black HS, 1999, P IEEE, V87, P379, DOI 10.1109/JPROC.1999.740032; Bolovan-Fritts C, 2001, J INFECT DIS, V184, P1252, DOI 10.1086/324010; Bolovan-Fritts CA, 2004, J VIROL, V78, P13173, DOI 10.1128/JVI.78.23.13173-13181.2004; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Carey M.F., 2009, TRANSCRIPTIONAL REGU; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; CHEN J, 1994, J BIOL CHEM, V269, P12482; CHIOU CJ, 1993, J VIROL, V67, P6201, DOI 10.1128/JVI.67.10.6201-6214.1993; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dwarakanath RS, 2001, VIROLOGY, V284, P297, DOI 10.1006/viro.2001.0924; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fan SS, 2005, J VIROL METHODS, V125, P23, DOI 10.1016/j.jviromet.2004.11.023; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gebert S, 1997, J VIROL, V71, P7048, DOI 10.1128/JVI.71.9.7048-7060.1997; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hummel M, 2002, J CLIN VIROL, V25, pS123; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MACIAS MP, 1993, P NATL ACAD SCI USA, V90, P707, DOI 10.1073/pnas.90.2.707; Mocarski E.S., 2006, FIELDS VIROLOGY, P2708; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nevels M, 2004, J VIROL, V78, P7803, DOI 10.1128/JVI.78.14.7803-7812.2004; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Rosenke K, 2004, J VIROL, V78, P7818, DOI 10.1128/JVI.78.14.7818-7822.2004; Roth J, 2006, NEUROL CLIN, V24, P421, DOI 10.1016/j.ncl.2006.03.004; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sanders RL, 2008, J VIROL, V82, P7059, DOI 10.1128/JVI.00675-08; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Sourvinos G, 2007, J VIROL, V81, P10123, DOI 10.1128/JVI.01009-07; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; Stinski MF, 2008, MED MICROBIOL IMMUN, V197, P223, DOI 10.1007/s00430-007-0069-7; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	47	42	44	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1569	1580		10.1016/j.cell.2012.11.051	http://dx.doi.org/10.1016/j.cell.2012.11.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260143	Green Accepted, Bronze			2022-12-01	WOS:000312890300020
J	Howard, S; Adams, J; White, M				Howard, Simon; Adams, Jean; White, Martin			CHRISTMAS 2012: RESEARCH Nutritional content of supermarket ready meals and recipes by television chefs in the United Kingdom: cross sectional study	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK	Objectives To compare the energy and macronutrient content of main meals created by television chefs with ready meals sold by supermarkets, and to compare both with nutritional guidelines published by the World Health Organization and UK Food Standards Agency. Design Cross sectional study. Setting Three supermarkets with the largest share of the grocery market in the United Kingdom, 2010. Samples 100 main meal recipes from five bestselling cookery books by UK television chefs and 100 own brand ready meals from the three leading UK supermarkets. Main outcome measures Number of meals for which the nutritional content complied with WHO recommendations, and the proportion of nutrients classified as red, amber, or green using the UK FSA's "traffic light" system for labelling food. Results No recipe or ready meal fully complied with the WHO recommendations. The ready meals were more likely to comply with the recommended proportions of energy derived from carbohydrate (18% v 6%, P = 0.01) and sugars (83% v 81%, P = 0.05) and fibre density (56% v 14% P < 0.01). The recipes were more likely to comply with the recommended sodium density (36% v 4%, P < 0.01), although salt used for seasoning was not assessed. The distributions of traffic light colours under the FSA's food labelling recommendations differed: the modal traffic light was red for the recipes (47%) and green for ready meals (42%). Overall, the recipes contained significantly more energy (2530 kJ v 2067 kJ), protein (37.5 g v 27.9 g), fat (27.1 g v 17.2 g), and saturated fat (9.2 g v 6.8 g; P < 0.01 for all) and significantly less fibre (3.3 g v 6.5 g, P < 0.01) per portion than the ready meals. Conclusions Neither recipes created by television chefs nor ready meals sold by three of the leading UK supermarkets complied with WHO recommendations. Recipes were less healthy than ready meals, containing significantly more energy, protein, fat, and saturated fat, and less fibre per portion than the ready meals.	[Howard, Simon] NHS Tees, Stockton On Tees TS17 6SG, England; [Adams, Jean; White, Martin] Newcastle Univ, UKCRC Ctr Translat Res Publ Hlth, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Howard, S (corresponding author), NHS Tees, Stockton On Tees TS17 6SG, England.	simonhoward@nhs.net	Howard, Simon/I-4976-2015; Adams, Jean/G-2402-2010	Howard, Simon/0000-0002-6317-0942; Adams, Jean/0000-0002-5733-7830; White, Martin/0000-0002-1861-6757	Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council [RES-590-38-0003]; Medical Research Council; National Institute for Health Research under the UKCRC; ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish	Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under the UKCRC; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	At the time this research was done, MW was partly and JA fully supported by Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Fuse receives funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (No RES-590-38-0003), Medical Research Council, and the National Institute for Health Research, under the auspices of UKCRC. Views expressed do not necessarily represent those of the funders.	Adams J, 2011, BRIT J NUTR, V105, P810, DOI 10.1017/S0007114510004435; Adams J, 2009, EUR J PUBLIC HEALTH, V19, P144, DOI 10.1093/eurpub/ckn132; Alexy U, 2011, EUR J CLIN NUTR, V65, P160, DOI 10.1038/ejcn.2010.254; [Anonymous], EATW PLAT; [Anonymous], 2010, BBC NEWS ONLINE; [Anonymous], 2010, GUARDIAN; Bittman M., 2012, NY TIMES; British Heart Foundation, 2012, POL STAT UNH FOOD DR; Broadcasters' Audience Research Board, WEEKL TOP 30 PROGR; Caraher M., 2000, J STUDY FOOD SOC, V4, P27, DOI 10.2752/152897900786690805; Chilled Food Association, 2010, HIST UK CHILL FOODS; Consensus Action on Salt and Health, 2012, FOOD IND PROGR; Corrigan T., 2010, IS AM READY BRIT REA; Department of Health, 2009, CHANGE4LIFE MARK STR; DUBBERT PM, 1984, J APPL BEHAV ANAL, V17, P85, DOI 10.1901/jaba.1984.17-85; Fearnley-Whittingstall H., 2009, RIVER COTTAGE EVERYD; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food Standards Agency, 2007, FRONT OF PACK TRAFF; Food Standards Agency, 2003, SALT READ MEALS SURV; Food Standards Agency, 2003, READ MEALS MARK; Garner E., 2009, TESCO SHARE TURNAROU; Harrison K, 2005, AM J PUBLIC HEALTH, V95, P1568, DOI 10.2105/AJPH.2004.048058; Hopkins J., 2008, Journal of Human Nutrition and Dietetics, V21, P389, DOI 10.1111/j.1365-277X.2008.00881_23.x; JOHNSON WG, 1990, ADDICT BEHAV, V15, P285, DOI 10.1016/0306-4603(90)90071-5; LACORS, 2010, UPD NUTR LAB TOL; Lawson N., 2010, KITCHEN RECIPES HEAR; Mintel Oxygen, 2010, CHILL FORZ READ MEAL; Morrisons, 2010, MARK OV ANN REP FIN; NHS Choices, 2010, QUICK HLTH MEALS; NHS Choices, 2011, 5 DAY RUN; Ofcom, 2010, HFSS ADV RESTR FIN R; Oliver J, 2010, JAMIES 30 MINUTE MEA; Oliver J., 2008, JAMIES MINISTRY FOOD; Oxford English Dictionary, 2008, TV DINN; Pascale L., 2011, BAKING MADE EASY; Reilly J, 2006, FRONT NUTR SCI, P201, DOI 10.1079/9780851990323.0201; RTS Resources, 2010, W EUR READ MEALS 201; Short F., 2003, Food Service Technology, V3, P177, DOI 10.1111/j.1471-5740.2003.00080.x; Sweney M., 2009, GUARDIAN; Triggle N., 2012, BBC NEWS ONLINE; UK Heart, 2012, CEL CHEFS TEA PART R; USDA, 2011, COOK MOR OFT HOM; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Windiets, 2012, WINDIETS DIET AN; World Health Organization, 2003, POP NUTR INT GOALS P, P54	45	61	62	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e7607	10.1136/bmj.e7607	http://dx.doi.org/10.1136/bmj.e7607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247976	Green Published, hybrid			2022-12-01	WOS:000312698700001
J	Al Mamun, AM; Lombardo, MJ; Shee, C; Lisewski, AM; Gonzalez, C; Lin, DX; Nehring, RB; Saint-Ruf, C; Gibson, JL; Frisch, RL; Lichtarge, O; Hastings, PJ; Rosenberg, SM				Al Mamun, Abu Amar M.; Lombardo, Mary-Jane; Shee, Chandan; Lisewski, Andreas M.; Gonzalez, Caleb; Lin, Dongxu; Nehring, Ralf B.; Saint-Ruf, Claude; Gibson, Janet L.; Frisch, Ryan L.; Lichtarge, Olivier; Hastings, P. J.; Rosenberg, Susan M.			Identity and Function of a Large Gene Network Underlying Mutagenic Repair of DNA Breaks	SCIENCE			English	Article							STRESS-INDUCED MUTATION; ESCHERICHIA-COLI; SIGMA-FACTOR; EXPRESSION; DATABASE; CANCERS; SWITCH; CELLS	Mechanisms of DNA repair and mutagenesis are defined on the basis of relatively few proteins acting on DNA, yet the identities and functions of all proteins required are unknown. Here, we identify the network that underlies mutagenic repair of DNA breaks in stressed Escherichia coli and define functions for much of it. Using a comprehensive screen, we identified a network of >= 93 genes that function in mutation. Most operate upstream of activation of three required stress responses (RpoS, RpoE, and SOS, key network hubs), apparently sensing stress. The results reveal how a network integrates mutagenic repair into the biology of the cell, show specific pathways of environmental sensing, demonstrate the centrality of stress responses, and imply that these responses are attractive as potential drug targets for blocking the evolution of pathogens.	[Al Mamun, Abu Amar M.; Lombardo, Mary-Jane; Shee, Chandan; Lisewski, Andreas M.; Gonzalez, Caleb; Lin, Dongxu; Nehring, Ralf B.; Gibson, Janet L.; Frisch, Ryan L.; Lichtarge, Olivier; Hastings, P. J.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Saint-Ruf, Claude] Univ Paris, INSERM, U1001, F-75730 Paris 15, France; [Lichtarge, Olivier; Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Rosenberg, Susan M./0000-0003-1444-473X	NSF [0905536, 1062455]; NIH [GM79656, GM66099, DP1-CA174424, R01-GM64022, R01-GM53158, F32-GM095267, F32-GM19909]; NATIONAL CANCER INSTITUTE [DP1CA174424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099, F32GM019909, R01GM064022, R25GM056929, F32GM095267, R01GM079656, R01GM053158] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0905536] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank R. Nichols and C. A. Gross for earlier bioinformatic analysis and discussion; S. Gottesman, C. Herman, J. D. Wang, and J. Weissman for discussions; J. Casadesus, S. Gottesman, C. Herman, G. Ira, X. Pan, E. Rogers, T. Silhavy, and J. D. Wang for comments on the manuscript; and D. Satory for help with strains. Bioinformatics supported by NSF 0905536, 1062455, and NIH GM79656 and GM66099 grants (O.L., A. M. L.). R.B.N. was supported by NIH Director's Pioneer Award DP1-CA174424 (S. M. R.). Supported by NIH grants R01-GM64022 (P. J. H.), R01-GM53158 (S. M. R.) and fellowships F32-GM095267 (R. L. F.) and F32-GM19909 (M.-J.L.). The genes of mutagenic repair of DNA breaks are accessible at http://wiki.porteco.org/tools/simnetwork.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gennis R. B., 1996, CELLULAR MOL BIOL, V1, P217; Gibson JL, 2010, MOL MICROBIOL, V77, P415, DOI 10.1111/j.1365-2958.2010.07213.x; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P463, DOI 10.1007/s12192-010-0205-y; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Prieto AI, 2006, GENETICS, V174, P575, DOI 10.1534/genetics.106.060889; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shee C, 2011, P NATL ACAD SCI USA, V108, P13659, DOI 10.1073/pnas.1104681108; STRATHERN JN, 1995, GENETICS, V140, P965; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973	28	138	140	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1344	1348		10.1126/science.1226683	http://dx.doi.org/10.1126/science.1226683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224554	Green Accepted			2022-12-01	WOS:000311991200067
J	Lindenmayer, DB; Laurance, WF; Franklin, JF				Lindenmayer, David B.; Laurance, William F.; Franklin, Jerry F.			Global Decline in Large Old Trees	SCIENCE			English	Editorial Material							LANDSCAPE; FUTURE; FIRE		[Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld 4878, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Franklin, Jerry F.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Australian National University; James Cook University; James Cook University; University of Washington; University of Washington Seattle	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, GPO Box 4, Canberra, ACT 0200, Australia.	david.lindenmayer@anu.edu.au	Lindenmayer, David B/P-7183-2017; Laurance, William F/B-2709-2012	Lindenmayer, David B/0000-0002-4766-4088; Laurance, William F/0000-0003-4430-9408				Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Jonsson MT, 2009, J VEG SCI, V20, P91, DOI 10.1111/j.1654-1103.2009.05394.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance W, 2012, NEW SCI, V213, P39, DOI 10.1016/S0262-4079(12)60248-6; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Mackey B, 2012, ECOL APPL, V22, P1852, DOI 10.1890/11-1479.1; Palik BJ, 2011, FOREST ECOL MANAG, V261, P128, DOI 10.1016/j.foreco.2010.09.041; Remm J, 2011, FOREST ECOL MANAG, V262, P579, DOI 10.1016/j.foreco.2011.04.028; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; VANPELT R, 2007, IDENTIFYING MATURE O	15	348	372	16	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1305	1306		10.1126/science.1231070	http://dx.doi.org/10.1126/science.1231070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224548	Green Published			2022-12-01	WOS:000311991200055
J	Schlimpert, S; Klein, EA; Briegel, A; Hughes, V; Kahnt, J; Bolte, K; Maier, UG; Brun, YV; Jensen, GJ; Gitai, Z; Thanbichler, M				Schlimpert, Susan; Klein, Eric A.; Briegel, Ariane; Hughes, Velocity; Kahnt, Joerg; Bolte, Kathrin; Maier, Uwe G.; Brun, Yves V.; Jensen, Grant J.; Gitai, Zemer; Thanbichler, Martin			General Protein Diffusion Barriers Create Compartments within Bacterial Cells	CELL			English	Article							CAULOBACTER-CRESCENTUS; NUTRIENT-UPTAKE; CROSSBANDS; STALKS; MEMBRANE; PEPTIDOGLYCAN; MORPHOGENESIS; LOCALIZATION; INDICATORS; DIVISION	In eukaryotes, the differentiation of cellular extensions such as cilia or neuronal axons depends on the partitioning of proteins to distinct plasma membrane domains by specialized diffusion barriers. However, examples of this compartmentalization strategy are still missing for prokaryotes, although complex cellular architectures are also widespread among this group of organisms. This study reveals the existence of a protein-mediated membrane diffusion barrier in the stalked bacterium Caulobacter crescentus. We show that the Caulobacter cell envelope is compartmentalized by macromolecular complexes that prevent the exchange of both membrane and soluble proteins between the polar stalk extension and the cell body. The barrier structures span the cross-sectional area of the stalk and comprise at least four proteins that assemble in a cell-cycle-dependent manner. Their presence is critical for cellular fitness because they minimize the effective cell volume, allowing faster adaptation to environmental changes that require de novo synthesis of envelope proteins.	[Schlimpert, Susan; Thanbichler, Martin] Max Planck Inst Terr Microbiol, Max Planck Res Grp Prokaryot Cell Biol, D-35043 Marburg, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Schlimpert, Susan; Thanbichler, Martin] Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany; [Bolte, Kathrin; Maier, Uwe G.] Univ Marburg, Dept Biol, Cell Biol Lab, D-35043 Marburg, Germany; [Klein, Eric A.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Hughes, Velocity; Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Maier, Uwe G.; Thanbichler, Martin] LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society; Philipps University Marburg; Philipps University Marburg; Princeton University; California Institute of Technology; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington; California Institute of Technology	Thanbichler, M (corresponding author), Max Planck Inst Terr Microbiol, Max Planck Res Grp Prokaryot Cell Biol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	thanbichler@mpi-marburg.mpg.de	Briegel, Ariane/AAC-1085-2021; Gitai, Zemer/AAI-6989-2021	Briegel, Ariane/0000-0003-3733-3725; Klein, Eric/0000-0003-3941-6233; Hughes, Velocity/0000-0002-3869-7726; Schlimpert, Susan/0000-0001-6364-8056; Brun, Yves/0000-0002-9289-1909	Max Planck Society; Human Frontier Science Program [RGY0069/2008-C]; National Institutes of Health (NIH) [DP2OD004389]; NRSA postdoctoral fellowship from National Institute of General Medical Sciences [F32GM906842]; NIH [GM51986, RO1 GM094800B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090684, R01GM094800, R01GM051986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004389] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA postdoctoral fellowship from National Institute of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephanie Wick for excellent technical assistance; Nikolay Ouzounov for helpful discussions; Juliane Kuhn, Patrick Viollier, and Grant Bowman for providing plasmids and strains; and Sarah Cheng for help with image segmentation. This work was supported by funds from the Max Planck Society to M. T., a Young Investigator Grant (RGY0069/2008-C) from the Human Frontier Science Program to Z.G. and M.T., a National Institutes of Health (NIH) Director's New Innovator Award (DP2OD004389) to Z.G., an NRSA postdoctoral fellowship (F32GM906842) from the National Institute of General Medical Sciences to E. A. K., NIH grant GM51986 to Y.V.B, and NIH grant RO1 GM094800B to G.J.J.	Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; Hughes HV, 2010, P NATL ACAD SCI USA, V107, P5599, DOI 10.1073/pnas.0909119107; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; JONES HC, 1973, J BACTERIOL, V116, P466, DOI 10.1128/JB.116.1.466-470.1973; Lang GI, 2009, P NATL ACAD SCI USA, V106, P5755, DOI 10.1073/pnas.0901620106; Le Blastier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014198; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Murat D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000422; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; PAERL HW, 1982, ADV MICROB ECOL, V6, P75; POINDEXTER JLS, 1964, J CELL BIOL, V23, P587; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; Poindexter JS, 1996, J BACTERIOL, V178, P3939, DOI 10.1128/jb.178.13.3939-3948.1996; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; SCHMIDT JM, 1973, ARCH MIKROBIOL, V89, P33, DOI 10.1007/BF00409397; SCHMIDT JM, 1975, J BACTERIOL, V124, P1601, DOI 10.1128/JB.124.3.1601-1603.1975; Seitz LC, 1998, J BACTERIOL, V180, P5235, DOI 10.1128/JB.180.19.5235-5239.1998; SMIT J, 1982, J CELL BIOL, V95, P41, DOI 10.1083/jcb.95.1.41; STALEY JT, 1973, NATURE, V246, P155, DOI 10.1038/246155a0; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Wagner JK, 2006, P NATL ACAD SCI USA, V103, P11772, DOI 10.1073/pnas.0602047103; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	33	51	51	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1270	1282		10.1016/j.cell.2012.10.046	http://dx.doi.org/10.1016/j.cell.2012.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201141	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000311999900016
J	Sandora, TJ; Goldmann, DA				Sandora, Thomas J.; Goldmann, Donald A.			Preventing Lethal Hospital Outbreaks of Antibiotic-Resistant Bacteria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sandora, Thomas J.; Goldmann, Donald A.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Sandora, Thomas J.; Goldmann, Donald A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Goldmann, Donald A.] Inst Healthcare Improvement, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement	Sandora, TJ (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA USA.							Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Ursprung R, 2005, QUAL SAF HEALTH CARE, V14, P284, DOI 10.1136/qshc.2004.012542; Zawacki A, 2004, INFECT CONT HOSP EP, V25, P1083, DOI 10.1086/502348	5	36	36	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2168	2170		10.1056/NEJMp1212370	http://dx.doi.org/10.1056/NEJMp1212370			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048DO	23215553	Bronze			2022-12-01	WOS:000311890600002
J	Bertelsen, M; Linneberg, A; Rosenberg, T; Christoffersen, N; Vorum, H; Gade, E; Larsen, M				Bertelsen, Mette; Linneberg, Allan; Rosenberg, Thomas; Christoffersen, Nynne; Vorum, Henrik; Gade, Else; Larsen, Michael			Comorbidity in patients with branch retinal vein occlusion: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; FOLLOW-UP; PLASMA HOMOCYSTEINE; POOLED DATA; POPULATION; PREVALENCE; MORTALITY; METAANALYSIS; MORBIDITY; COHORT	Objectives To evaluate comorbidity before and after the diagnosis of branch retinal vein occlusion to determine whether it is a consequence of arterial thickening and therefore could serve as a diagnostic marker for other comorbidities and to evaluate the risk factors for the development of such occlusion. Design Case-control study with prospective follow-up data from Danish national registries. Setting Four secondary referral centres covering about 80% of the Danish population (4.4 million). Participants 1168 patients with photographically verified branch retinal vein occlusion and 116 800 controls alive and aged >= 40 when the occlusion was diagnosed in the corresponding case. Main outcome measures The risk of comorbidity 10 years and 1 year before the diagnosis of branch retinal vein occlusion and the incident comorbidity in a mean period of seven years after the diagnosis, with odds ratios and incidence rate ratios adjusted for age, sex, and year of diagnosis. Results Risk factors present 10 years and 1 year before the diagnosis of branch retinal vein occlusion included peripheral artery disease (odds ratio 1.83, 95% confidence interval 1.14 to 2.95), diabetes (1.74, 1.40 to 2.17) and arterial hypertension (2.16, 1.86 to 2.51). After the diagnosis, patients had an increased risk of developing arterial hypertension (incidence rate ratio 1.37, 95% confidence interval 1.15 to 1.57), diabetes (1.51, 1.17 to 2.04), congestive heart failure (1.41, 1.12 to 1.68), and cerebrovascular disease (1.49, 1.27 to 1.76). Conclusion Diabetes, hypertension, and peripheral artery disease are associated with an increased risk of developing branch retinal vein occlusion up to a decade later. Branch retinal vein occlusion was associated with an increased risk of subsequently developing hypertension, diabetes, congestive heart failure, and cerebrovascular disease, emphasising the importance of preventive initiatives. These results fit the assumption that branch retinal vein occlusion is a consequence of arterial thickening and that the arteriovenous crossing signs that precede it are hallmarks of arterial disease.	[Bertelsen, Mette; Larsen, Michael] Glostrup Cty Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark; [Bertelsen, Mette; Rosenberg, Thomas; Christoffersen, Nynne; Larsen, Michael] Kennedy Ctr, Natl Eye Clin Visually Impaired, DK-2600 Glostrup, Denmark; [Bertelsen, Mette; Rosenberg, Thomas; Larsen, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Gade, Else] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital	Bertelsen, M (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Nordre Ringvej 57, DK-2600 Glostrup, Denmark.	mettebertelsen12@gmail.com	Larsen, Michael/E-9620-2010; Bertelsen, Mette/AFO-7185-2022	Larsen, Michael/0000-0002-5172-5891; Linneberg, Allan/0000-0002-0994-0184	Dag Lenards Foundation; Danish Diabetes Academy	Dag Lenards Foundation; Danish Diabetes Academy	We acknowledge the support of the Danish Diabetes Academy.; This study was funded by the Dag Lenards Foundation. The foundation had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the reports; or in the decision to submit the article for publication.	Andersen TF, 1999, DAN MED BULL, V46, P263; APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; Ariturk N, 1996, BRIT J OPHTHALMOL, V80, P633, DOI 10.1136/bjo.80.7.633; Cahill M, 2000, BRIT J OPHTHALMOL, V84, P154, DOI 10.1136/bjo.84.2.154; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Christoffersen N, 2007, OPHTHALMOLOGY, V114, P1186, DOI 10.1016/j.ophtha.2007.01.031; Chua B, 2005, AM J OPHTHALMOL, V139, P181, DOI 10.1016/j.ajo.2004.06.084; Cugati S, 2007, OPHTHALMOLOGY, V114, P520, DOI 10.1016/j.ophtha.2006.06.061; Eve Disease Case-Control Study Group, 1993, AM J OPHTHALMOL, V116, P286; FRUCHT J, 1984, BRIT J OPHTHALMOL, V68, P26, DOI 10.1136/bjo.68.1.26; Greiner K, 1999, AM J OPHTHALMOL, V128, P69, DOI 10.1016/S0002-9394(99)00074-4; Greiner Kathrin, 1999, International Ophthalmology, V23, P155, DOI 10.1023/A:1010639332737; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Janssen MCH, 2005, THROMB HAEMOSTASIS, V93, P1021, DOI 10.1160/TH04-11-0768; JOHNSTON RL, 1985, ARCH OPHTHALMOL-CHIC, V103, P1831; Kadayifcilar S, 2001, BRIT J OPHTHALMOL, V85, P1174, DOI 10.1136/bjo.85.10.1174; Kiire CA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e499; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kirwan JF, 1997, EYE, V11, P53, DOI 10.1038/eye.1997.11; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Kuhli C, 2004, AM J OPHTHALMOL, V137, P459, DOI 10.1016/j.ajo.2003.10.024; Kuo RN, 2011, MED CARE, V49, P1031, DOI 10.1097/MLR.0b013e31822ebe11; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lim LL, 2008, BRIT J OPHTHALMOL, V92, P1316, DOI 10.1136/bjo.2008.140640; Majji AB, 1997, RETINA-J RET VIT DIS, V17, P200, DOI 10.1097/00006982-199705000-00005; Martin SC, 2002, BRIT J OPHTHALMOL, V86, P774, DOI 10.1136/bjo.86.7.774; Munch IC, 2012, ACTA OPHTHALMOL, V90, P613, DOI 10.1111/j.1755-3768.2011.2148.x; Pedersen CB, 2006, DAN MED BULL, V53, P441; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2010.01.060, 10.1016/j.ophtha.2009.07.017]; RUBINSTEIN K, 1976, BRIT J OPHTHALMOL, V60, P148, DOI 10.1136/bjo.60.2.148; Singer Donald R.J., 2002, Eur J Intern Med, V13, P160, DOI 10.1016/S0953-6205(02)00024-9; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Weger M, 2005, OPHTHALMOLOGY, V112, P1910, DOI 10.1016/j.ophtha.2005.05.019; Werther W, 2011, ARCH OPHTHALMOL-CHIC, V129, P326, DOI 10.1001/archophthalmol.2011.2; Williamson TH, 1996, BRIT J OPHTHALMOL, V80, P203, DOI 10.1136/bjo.80.3.203; Wong TY, 2010, NEW ENGL J MED, V363, P2135, DOI 10.1056/NEJMcp1003934; Yasuda M, 2010, INVEST OPHTH VIS SCI, V51, P3205, DOI 10.1167/iovs.09-4453	45	57	58	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e7885	10.1136/bmj.e7885	http://dx.doi.org/10.1136/bmj.e7885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204001	Green Published, hybrid			2022-12-01	WOS:000311896500004
J	Yamamoto, S; Charng, WL; Rana, NA; Kakuda, S; Jaiswal, M; Bayat, V; Xiong, B; Zhang, K; Sandoval, H; David, G; Wang, H; Haltiwanger, RS; Bellen, HJ				Yamamoto, Shinya; Charng, Wu-Lin; Rana, Nadia A.; Kakuda, Shinako; Jaiswal, Manish; Bayat, Vafa; Xiong, Bo; Zhang, Ke; Sandoval, Hector; David, Gabriela; Wang, Hao; Haltiwanger, Robert S.; Bellen, Hugo J.			A Mutation in EGF Repeat-8 of Notch Discriminates Between Serrate/Jagged and Delta Family Ligands	SCIENCE			English	Article							DORSAL-VENTRAL BOUNDARY; FRINGE; ACTIVATION; BINDING; GLYCOSYLTRANSFERASE; MODULATION; DOMAIN; HEAD	Notch signaling affects many developmental and cellular processes and has been implicated in congenital disorders, stroke, and numerous cancers. The Notch receptor binds its ligands Delta and Serrate and is able to discriminate between them in different contexts. However, the specific domains in Notch responsible for this selectivity are poorly defined. Through genetic screens in Drosophila, we isolated a mutation, Notch(jigsaw), that affects Serrate-but not Delta-dependent signaling. Notch(jigsaw) carries a missense mutation in epidermal growth factor repeat-8 (EGFr-8) and is defective in Serrate binding. A homologous point mutation in mammalian Notch2 also exhibits defects in signaling of a mammalian Serrate homolog, Jagged1. Hence, an evolutionarily conserved valine in EGFr-8 is essential for ligand selectivity and provides a molecular handle to study numerous Notch-dependent signaling events.	[Yamamoto, Shinya; Charng, Wu-Lin; Bayat, Vafa; Xiong, Bo; David, Gabriela; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rana, Nadia A.; Kakuda, Shinako; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Jaiswal, Manish; Sandoval, Hector; Wang, Hao; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jaiswal, Manish; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bayat, Vafa] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Zhang, Ke; Bellen, Hugo J.] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.edu	Xiong, Bo/M-3605-2014; Yamamoto, Shinya/ABB-2837-2021; Bayat, Vafa/ABG-2774-2021; Zhang, Ke/B-8598-2018	Yamamoto, Shinya/0000-0003-2172-8036; Zhang, Ke/0000-0002-4794-8355; Xiong, Bo/0000-0002-2695-9100; Bayat, Vafa/0000-0002-1524-0520; Sandoval, Hector/0000-0002-9186-7384; Bellen, Hugo/0000-0001-5992-5989; Jaiswal, Manish/0000-0001-8360-8289	NIH [1RC4GM096355-01, 5R01GM061126-12, 5T32-HD055200, 5R01GM067858]; Intellectual and Developmental Disabilities Research Center [NIH 5P30HD024064]; Nakajima Foundation; Taiwan Merit Scholarships Program; National Science Council [NSC-095-SAF-I-564-015-TMS]; Edward and Josephine Hudson Scholarship Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund [1008200]; Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship [5K12GM084897]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858, RC4GM096355, R01GM061126, K12GM084897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center; Nakajima Foundation; Taiwan Merit Scholarships Program; National Science Council(Ministry of Science and Technology, Taiwan); Edward and Josephine Hudson Scholarship Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund; Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, and the Developmental Studies Hybridoma Bank for distribution of flies and antibodies. We are grateful to S. Artavanis-Tsakonas, G. Bornkamm, S. Bray, S. Chiba, P. Heitzler, H. Hiral, K. Irvine, H. Jafar-Nejad, A. Martinez-Arias, M. Milan, L. Strobl, G. Weinmaster, and C. Wesley for flies and reagents. We thank K. Schulze for critical reading and editing of the manuscript. We acknowledge S. Gibbs, A. Jawaid, Y. Chen, C. Benitez, B. McNulty, A. Lin-Moore, D. Bei, L. Wang, Y. Kawagishi, and T. Busby for technical assistance. We thank R. Kopan, S. Blacklow, M. Milan, K. Cook, N. Giagtzoglou, K. Venken, H. Tsuda, C. Yao, and H. Takeuchi for helpful comments and discussion. This research was supported in part by the NIH (1RC4GM096355-01 to H.J.B. and 5R01GM061126-12 to R. S. H). Confocal microscopy at Baylor College of Medicine is supported by the Intellectual and Developmental Disabilities Research Center (NIH 5P30HD024064). S. Y. was supported by a fellowship from the Nakajima Foundation. W.-L. C. was supported by Taiwan Merit Scholarships Program sponsored by the National Science Council (NSC-095-SAF-I-564-015-TMS). V. B. received support from the NIH (5T32-HD055200) and the Edward and Josephine Hudson Scholarship Fund. B. X. was supported by the Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund (grant 1008200). H. S. received support from a supplement to NIH 5R01GM067858 and the Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship 5K12GM084897. H.J.B. is a Howard Hughes Medical Institute Investigator.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Becam I, 2010, CURR BIOL, V20, P554, DOI 10.1016/j.cub.2010.01.058; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; deCelis JF, 1996, DEVELOPMENT, V122, P359; Haberman AS, 2003, DEV BIOL, V258, P443, DOI 10.1016/S0012-1606(03)00140-4; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1998, DEVELOPMENT, V125, P2951; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lindsley D.L., 1992, GENOME DROSOPHILA ME; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Pei ZF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-4; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	28	70	72	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1229	1232		10.1126/science.1228745	http://dx.doi.org/10.1126/science.1228745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197537	Green Accepted			2022-12-01	WOS:000311666200051
J	Ouyang, WM; Liao, W; Luo, CT; Yin, N; Huse, M; Kim, MV; Peng, M; Chan, P; Ma, Q; Mo, YF; Meijer, D; Zhao, KJ; Rudensky, AY; Atwal, G; Zhang, MQ; Li, MO				Ouyang, Weiming; Liao, Will; Luo, Chong T.; Yin, Na; Huse, Morgan; Kim, Myoungjoo V.; Peng, Min; Chan, Pamela; Ma, Qian; Mo, Yifan; Meijer, Dies; Zhao, Keji; Rudensky, Alexander Y.; Atwal, Gurinder; Zhang, Michael Q.; Li, Ming O.			Novel Foxo1-dependent transcriptional programs control T-reg cell function	NATURE			English	Article							FOXP3 EXPRESSION; GENE-EXPRESSION; TARGET GENES; DIFFERENTIATION; FOXO1; TOOL; AKT; MECHANISMS; INDUCTION; PROFILES	Regulatory T (T-reg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses(1-4). Foxp3 operates as a late-acting differentiation factor controlling T-reg cell homeostasis and function(5), whereas the early T-reg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors(6-10). However, whether Foxo proteins act beyond the T-reg-cell-commitment stage to control T-reg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of T-reg cell function. T-reg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with T-reg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of T-reg cells. Genome-wide analysis of Foxo1 binding sites reveals similar to 300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt-Foxo1 signalling module controls a novel genetic program indispensable for T-reg cell function.	[Ouyang, Weiming; Luo, Chong T.; Yin, Na; Huse, Morgan; Kim, Myoungjoo V.; Peng, Min; Chan, Pamela; Ma, Qian; Rudensky, Alexander Y.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Liao, Will; Mo, Yifan; Atwal, Gurinder] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Liao, Will; Mo, Yifan] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Luo, Chong T.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Meijer, Dies] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; [Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; Tsinghua University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	mzhang@cshl.edu; lim@mskcc.org	Peng, Min/O-3770-2017; Meijer, Dies/C-7786-2012	Peng, Min/0000-0002-5885-0660; Meijer, Dies/0000-0002-8461-6341; Luo, Chong/0000-0002-3477-5969; li, ming/0000-0002-1383-0535	Starr Cancer Consortium [13-A123]; Rita Allen Foundation; National Bio Resource Project (NBRPC) [2012CB316503]; National Institutes of Health [HG001696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	Starr Cancer Consortium; Rita Allen Foundation; National Bio Resource Project (NBRPC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Flavell for the Foxp3-IRES-RFP mouse strain, K. Rajewsky and C. Xiao for the Rosa26 targeting vector and T. Unterman for the HA-hFoxo1(AAA) construct. This work was supported by the Starr Cancer Consortium (13-A123 to M.O.L., M.Q.Z. and G. A.), the Rita Allen Foundation (M.O.L.), National Bio Resource Project (NBRPC) (2012CB316503 to M.Q.Z.) and National Institutes of Health (HG001696 to M.Q.Z.).	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li LP, 2009, J COMPUT BIOL, V16, P317, DOI 10.1089/cmb.2008.16TT; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	44	275	283	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					554	+		10.1038/nature11581	http://dx.doi.org/10.1038/nature11581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135404	Green Accepted			2022-12-01	WOS:000311339800043
J	Huang, JH; Ofek, G; Laub, L; Louder, MK; Doria-Rose, NA; Longo, NS; Imamichi, H; Bailer, RT; Chakrabarti, B; Sharma, SK; Alam, SM; Wang, T; Yang, YP; Zhang, BS; Migueles, SA; Wyatt, R; Haynes, BF; Kwong, PD; Mascola, JR; Connors, M				Huang, Jinghe; Ofek, Gilad; Laub, Leo; Louder, Mark K.; Doria-Rose, Nicole A.; Longo, Nancy S.; Imamichi, Hiromi; Bailer, Robert T.; Chakrabarti, Bimal; Sharma, Shailendra K.; Alam, S. Munir; Wang, Tao; Yang, Yongping; Zhang, Baoshan; Migueles, Stephen A.; Wyatt, Richard; Haynes, Barton F.; Kwong, Peter D.; Mascola, John R.; Connors, Mark			Broad and potent neutralization of HIV-1 by a gp41-specific human antibody	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN GP41; T-CELLS; EPITOPE; MEMBRANE; BINDING; 4E10; SPECIFICITIES	Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes similar to 98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site of vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical arginine or lysine just before the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 envelope glycoprotein.	[Huang, Jinghe; Laub, Leo; Imamichi, Hiromi; Migueles, Stephen A.; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Ofek, Gilad; Louder, Mark K.; Doria-Rose, Nicole A.; Longo, Nancy S.; Bailer, Robert T.; Wang, Tao; Yang, Yongping; Zhang, Baoshan; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Chakrabarti, Bimal; Sharma, Shailendra K.; Wyatt, Richard] Scripps Res Inst, Dept Immunol & Microbial Sci, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Alam, S. Munir; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); International AIDS Vaccine Initiative; Scripps Research Institute; Duke University	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.	mconnors@nih.gov	Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Huang, Jinghe/P-8068-2019; Huang, Jinghe/O-1986-2015	Huang, Jinghe/0000-0002-1968-871X	NIAID; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI005095, ZIAAI005022, ZIAAI000855] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. W. Hallahan for statistical analyses. We thank K. Lloyd. R. Parks, J. Eudailey and J. Blinn for performing autoantibody assays. We also thank M. Zwick for providing us with the HIV-1 JR2 MPER alanine mutant pseudovirus plasmids. HIV-2/HIV-1 chimaeras were provided by G. Shaw and L. Morris. We thank J. Stuckey for assistance with figures, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript. This project has been funded in part with federal funds from the Intramural Research Programs of NIAID and the National Cancer Institute, National Institutes of Health, under Contract no. HHSN261200800001E. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kabat EA, 1991, SEQUENCES PROTEINS I, V5th; Kershaw MH, 2001, CANCER RES, V61, P7920; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Rathinakumar R, 2012, J VIROL, V86, P1820, DOI 10.1128/JVI.05489-11; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	56	609	652	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					406	+		10.1038/nature11544	http://dx.doi.org/10.1038/nature11544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151583	Green Accepted			2022-12-01	WOS:000311031600038
J	Lederle, FA; Bloomfield, HE				Lederle, Frank A.; Bloomfield, Hanna E.			Drug Treatment of Asymptomatic Hypertriglyceridemia to Prevent Pancreatitis: Where Is the Evidence?	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; TRIGLYCERIDES; CHOLESTEROL; THERAPY		[Lederle, Frank A.; Bloomfield, Hanna E.] Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Lederle, FA (corresponding author), Vet Affairs Med Ctr 111O, Minneapolis, MN 55417 USA.	frank.lederle@va.gov		bloomfield, hanna/0000-0002-0756-7064				[Anonymous], 1984, JAMA, V251, P1196; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; CHAIT A, 1992, ADV INTERNAL MED, V37, P249; Christian JB, 2011, AM J CARDIOL, V107, P891, DOI 10.1016/j.amjcard.2010.11.008; DOMINGUEZMUNOZ JE, 1995, INT J PANCREATOL, V18, P101; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hall M F, 2010, NATL HLTH STAT REPOR, V29; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; MILLER A, 1979, ANN SURG, V190, P401, DOI 10.1097/00000658-197909000-00016; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nichols GA, 2011, AM J CARDIOL, V107, P225, DOI 10.1016/j.amjcard.2010.09.010; Sandhu S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-157; Veterans Health Administration Pharmacy Benefits Management Services Medical Advisory Panel Center for Medication Safety, 2009, NAT PBM B SAF HIGH D	18	14	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					662	+		10.7326/0003-4819-157-9-201211060-00011	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128864				2022-12-01	WOS:000310783300007
J	Kressler, D; Bange, G; Ogawa, Y; Stjepanovic, G; Bradatsch, B; Pratte, D; Amlacher, S; Strauss, D; Yoneda, Y; Katahira, J; Sinning, I; Hurt, E				Kressler, Dieter; Bange, Gert; Ogawa, Yutaka; Stjepanovic, Goran; Bradatsch, Bettina; Pratte, Dagmar; Amlacher, Stefan; Strauss, Daniela; Yoneda, Yoshihiro; Katahira, Jun; Sinning, Irmgard; Hurt, Ed			Synchronizing Nuclear Import of Ribosomal Proteins with Ribosome Assembly	SCIENCE			English	Article							EUKARYOTIC RIBOSOME; TRANSPORT; COMPLEX; RNA; BIOGENESIS; RESOLUTION; NUCLEOLUS; CYTOPLASM; SUBUNIT; PATHWAY	Ribosomal proteins are synthesized in the cytoplasm, before nuclear import and assembly with ribosomal RNA (rRNA). Little is known about coordination of nucleocytoplasmic transport with ribosome assembly. Here, we identify a transport adaptor, symportin 1 (Syo1), that facilitates synchronized coimport of the two 5S-rRNA binding proteins Rpl5 and Rpl11. In vitro studies revealed that Syo1 concomitantly binds Rpl5-Rpl11 and furthermore recruits the import receptor Kap104. The Syo1-Rpl5-Rpl11 import complex is released from Kap104 by RanGTP and can be directly transferred onto the 5S rRNA. Syo1 can shuttle back to the cytoplasm by interaction with phenylalanine-glycine nucleoporins. X-ray crystallography uncovered how the a-solenoid symportin accommodates the Rpl5 amino terminus, normally bound to 5S rRNA, in an extended groove. Symportin-mediated coimport of Rpl5-Rpl11 could ensure coordinated and stoichiometric incorporation of these proteins into pre-60S ribosomes.	[Kressler, Dieter; Bange, Gert; Stjepanovic, Goran; Bradatsch, Bettina; Amlacher, Stefan; Strauss, Daniela; Sinning, Irmgard; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Kressler, Dieter; Pratte, Dagmar] Univ Fribourg, Dept Biol, Unit Biochem, CH-1700 Fribourg, Switzerland; [Ogawa, Yutaka; Yoneda, Yoshihiro; Katahira, Jun] Osaka Univ, Grad Sch Frontier Biosci, Biomol Networks Labs, Suita, Osaka 5650871, Japan	Ruprecht Karls University Heidelberg; University of Fribourg; Osaka University	Kressler, D (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	dieter.kressler@unifr.ch; irmi.sinning@bzh.uni-heidelberg.de; ed.hurt@bzh.uni-heidelberg.de	Stjepanovic, Goran/A-7902-2010; Kressler, Dieter/C-2218-2012; Bange, Gert/AAB-3734-2021; Ed Hurt, Dr./AAE-8874-2019	Stjepanovic, Goran/0000-0002-4841-9949; Ed Hurt, Dr./0000-0002-4535-8255; Katahira, Jun/0000-0001-5188-0368; Bange, Gert/0000-0002-7826-0932; Kressler, Dieter/0000-0003-4855-3563	German Research Council [Hu363/9-4, SFB 638]; Swiss National Science Foundation [PP00P3_123341]; Japan Society for the Promotion of Science [21570195, 21247032]	German Research Council(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. Hendricks and C. Deforel for technical assistance, J. Kopp and C. Siegmann from the BZH Cluster of Excellence:CellNetworks crystallization platform, J. Lechner and his team for mass spectrometry, T. Ruppert and M. Mayer (Zentrum fur Molekulare Biologie Heidelberg) for access to the core facility for mass spectrometry for the HX-MS experiments, J. Woolford for sharing published rpl5 mutant plasmids, and L. Dimitrova (Hurt laboratory) for providing the full-length ctKAP104 clone. Data collection was performed at the European Synchrotron Radiation Facility, Grenoble. This work was funded by the German Research Council (Hu363/9-4 to E. H. and SFB 638 to I. S.), the Swiss National Science Foundation (PP00P3_123341 to D. K.), and the Japan Society for the Promotion of Science (no. 21570195 and no. 21247032 to J.K. and Y.Y., respectively). I. S. and E. H. are investigators of the Cluster of Excellence:CellNetworks, and G. B. is a fellow of the Peter and Traudl Engelhorn Foundation. D. K., G. B., I. S., and E. H. conceived the experiments. D. K., G. B., J.K., I. S., and E. H. analyzed the data. D. K., G. B., I. S., and E. H. wrote the paper. D. K. and D. S. constructed yeast strains and carried out all yeast genetic experiments. D. K., G. B., and S. A. constructed plasmids. D. K. carried out tandem-affinity purifications of yeast proteins. G. B. and D. K. performed binding assays. G. B. determined crystal structures. G. S. carried out the HX-MS experiments. D. P. and D. S. performed fluorescence microscopy of live yeast cells. B. B. performed in vitro FG-repeat binding assays. Y.O. performed in vitro import assays with permeabilized HeLa cells under the supervision of J.K. in the laboratory of Y.Y. J.K. measured binding constants by BIAcore. D. K. and G. B. contributed equally to this study. All authors commented on the manuscript. Atomic coordinates and structure factors for the reported crystal structures have been deposited with the Protein Data Bank (PDB) under accession codes 4GMNO (ctSyo1) and 4GMN (ctSyo1/ctL5-N). The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to D. K. (dieter. kressler@unifr.ch), I.S. (irmi.sinning@bzh.uni-heidelberg.de), or E.H. (ed.hurt@bzh.uni-heidelberg.de).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Claussen M, 1999, J BIOL CHEM, V274, P33951, DOI 10.1074/jbc.274.48.33951; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	31	76	81	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					666	671		10.1126/science.1226960	http://dx.doi.org/10.1126/science.1226960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118189	Green Submitted			2022-12-01	WOS:000310516000053
J	Ryan, A; O'Toole, L				Ryan, Andrea; O'Toole, Louise			Ochronosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ryan, Andrea; O'Toole, Louise] Mater Private Hosp, Dublin, Ireland	Mater Private Hospital	Ryan, A (corresponding author), Mater Private Hosp, Dublin, Ireland.	andrearyan11@gmail.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					E26	E26		10.1056/NEJMicm1111515	http://dx.doi.org/10.1056/NEJMicm1111515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113505				2022-12-01	WOS:000310440800012
J	Tulloch, J; David, B; Newman, RD; Meek, S				Tulloch, Jim; David, Benedict; Newman, Robert D.; Meek, Sylvia			Artemisinin-resistant malaria in the Asia-Pacific region	LANCET			English	Editorial Material									[Tulloch, Jim] Artemisinin Resistance Assessment Team, Adelaide, SA, Australia; [David, Benedict] Australian Agcy Int Dev, Canberra, ACT 2601, Australia; [Newman, Robert D.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Meek, Sylvia] Malaria Consortium, London, England	World Health Organization	David, B (corresponding author), Australian Agcy Int Dev, Canberra, ACT 2601, Australia.	benedict.david@ausaid.gov.au						Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008; Malaria Consortium National Malaria Centre Ministry of Health Cambodia WHO, 2011, MOV MAL EL TOOLS STR; Meek S, 2011, JOINT ASSESSMENT RES; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Roll Back Malaria, 2011, PROGR IMP SER, V7; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO - World Health Organization, 2012, UPD ART RES APR 2012; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Health Organization, 2011, GLOB PLAN ART RES CO	11	14	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					E16	E17		10.1016/S0140-6736(12)61820-0	http://dx.doi.org/10.1016/S0140-6736(12)61820-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23122219				2022-12-01	WOS:000320319500001
J	Stephansson, O; Kieler, H; Haglund, B; Artama, M; Engeland, A; Furu, K; Gissler, M; Norgaard, M; Nielsen, RB; Zoega, H; Valdimarsdottir, U				Stephansson, Olof; Kieler, Helle; Haglund, Bengt; Artama, Miia; Engeland, Anders; Furu, Kari; Gissler, Mika; Norgaard, Mette; Nielsen, Rikke Beck; Zoega, Helga; Valdimarsdottir, Unnur			Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERSISTENT PULMONARY-HYPERTENSION; POPULATION-BASED COHORT; ANTIDEPRESSANT TREATMENT; SPONTANEOUS-ABORTIONS; MAJOR DEPRESSION; NORDIC COUNTRIES; OUTCOMES; PREVALENCE; REGISTERS; NEWBORN	Importance Maternal psychiatric disease is associated with adverse pregnancy outcomes. Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn. However, the risk of stillbirth and infant mortality when accounting for previous maternal psychiatric disease remains unknown. Objective To study risk of stillbirth and infant mortality associated with use of SSRIs during pregnancy. Design, Setting, and Participants Population-based cohort study from all Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) at different periods from 1996 through 2007. The study included women with singleton births. We obtained information on maternal use of SSRIs from prescription registries. Maternal characteristics, pregnancy, and neonatal outcomes were obtained from patient and medical birth registries. Main Outcome Measures We used logistic regression to estimate relative risks of stillbirth, neonatal death, and postneonatal death associated with SSRI use during pregnancy taking into account maternal characteristics and previous psychiatric hospitalization. Results Among 1 633 877 singleton births in the study, 6054 were stillbirths; 3609, neonatal deaths; and 1578, postneonatal deaths. A total of 29 228 (1.79%) of mothers had filled a prescription for an SSRI during pregnancy. Women exposed to an SSRI presented with higher rates of stillbirth (4.62 vs 3.69 per 1000, P=.01) and postneonatal death (1.38 vs 0.96 per 1000, P=.03) than those who did not. The rate of neonatal death was similar between groups (2.54 vs 2.21 per 1000, P=.24). Yet in multivariable models, SSRI use was not associated with stillbirth (adjusted odds ratio [OR], 1.17; 95% CI, 0.96-1.41; P=.12), neonatal death (adjusted OR, 1.23; 95% CI, 0.96-1.57; P=.11), or postneonatal death (adjusted OR, 1.34; 95% CI, 0.97-1.86; P=.08). Estimates were further attenuated when stratified by previous hospitalization for psychiatric disease. The adjusted OR for stillbirth in women with a previous hospitalization for psychiatric disease was 0.92 (95% CI, 0.66-1.28; P=.62) and was 1.07 (95% CI, 0.84-1.36; P=.59) for those who had not been previously hospitalized. The corresponding ORs for neonatal death were 0.89 (95% CI, 0.58-1.39; P=.62) for women who were hospitalized and 1.14 (95% CI, 0.84-1.56; P=.39) for women who were not. For postneonatal death, the ORs were 1.02 (95% CI, 0.61-1.69; P=.95) for women who were hospitalized and 1.10 (95% CI, 0.71-1.72; P=.66) for women who were not. Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.	[Stephansson, Olof; Kieler, Helle; Haglund, Bengt] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Stephansson, Olof; Kieler, Helle; Haglund, Bengt] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Artama, Miia; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Engeland, Anders; Furu, Kari] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Div Epidemiol, Oslo, Norway; [Engeland, Anders] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Furu, Kari] Univ Tromso, Dept Pharm, Tromso, Norway; [Norgaard, Mette; Nielsen, Rikke Beck] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Zoega, Helga; Valdimarsdottir, Unnur] Univ Iceland, Sch Hlth Sci, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zoega, Helga] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); University of Bergen; UiT The Arctic University of Tromso; Aarhus University; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai	Stephansson, O (corresponding author), Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, SE-17176 Stockholm, Sweden.	olof.stephansson@ki.se	Zoega, Helga/M-1968-2015; Engeland, Anders/AAG-7437-2021	Kieler, Helle/0000-0001-9338-7133; Norgaard, Mette/0000-0001-6110-5891; Zoega, Helga/0000-0003-0761-9028; Gissler, Mika/0000-0001-8254-7525; Stephansson, Olof/0000-0003-1528-4563; Valdimarsdottir, Unnur/0000-0001-5382-946X	Swedish Pharmacy Company; Swedish Society of Medicine; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Swedish Pharmacy Company; Swedish Society of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Swedish Pharmacy Company and by the authors' affiliations. Olof Stephansson was supported by a postdoctorate scholarship from the Swedish Society of Medicine.	Agency DM, 2011, RISK DEATH SER SID E; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Chalmers JWT, 1998, BRIT MED J, V317, P539; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Colvin Lyn, 2012, CNS Drugs, V26, pe1, DOI 10.2165/11634190-000000000-00000; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gentile S, 2008, CNS SPECTRUMS, V13, P960, DOI 10.1017/S1092852900014012; Gissler M, 1997, EUR J EPIDEMIOL, V13, P169, DOI 10.1023/A:1007379029182; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nilsson E, 2008, BRIT J PSYCHIAT, V193, P311, DOI 10.1192/bjp.bp.107.045146; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1177/14034948020300020101; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1016/j.genhosppsych.2009.04.003, 10.1097/AOG.0b013e3181ba0632]	27	60	66	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					48	54		10.1001/jama.2012.153812	http://dx.doi.org/10.1001/jama.2012.153812			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280224	Bronze			2022-12-01	WOS:000319113000026
J	Ascano, M; Mukherjee, N; Bandaru, P; Miller, JB; Nusbaum, JD; Corcoran, DL; Langlois, C; Munschauer, M; Dewell, S; Hafner, M; Williams, Z; Ohler, U; Tuschl, T				Ascano, Manuel, Jr.; Mukherjee, Neelanjan; Bandaru, Pradeep; Miller, Jason B.; Nusbaum, Jeffrey D.; Corcoran, David L.; Langlois, Christine; Munschauer, Mathias; Dewell, Scott; Hafner, Markus; Williams, Zev; Ohler, Uwe; Tuschl, Thomas			FMRP targets distinct mRNA sequence elements to regulate protein expression	NATURE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; PAR-CLIP; SYNAPTIC FUNCTION; BINDING PROTEIN; CGG-REPEAT; GENE; IDENTIFICATION; MUTATION; AUTISM	Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1(-/-) mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.	[Ascano, Manuel, Jr.; Bandaru, Pradeep; Miller, Jason B.; Nusbaum, Jeffrey D.; Munschauer, Mathias; Hafner, Markus; Williams, Zev; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Mukherjee, Neelanjan; Corcoran, David L.; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Langlois, Christine; Williams, Zev] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Program Early & Recurrent Pregnancy Loss, Bronx, NY 10461 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Duke University; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA.	uwe.ohler@duke.edu; ttuschl@rockefeller.edu	Hafner, Markus/O-7100-2018; Munschauer, Mathias/AAK-2789-2020; Ascano, Manuel/ABA-3586-2020	Hafner, Markus/0000-0002-4336-6518; Munschauer, Mathias/0000-0001-6143-4548; Ascano, Manuel/0000-0002-9370-5493; Corcoran, David/0000-0001-7460-9247; Nusbaum, Jeffrey/0000-0001-5024-8256; Mukherjee, Neelanjan/0000-0003-0017-1400	NIH/NCRR/RU CCTS [UL1RR024143]; NSF [MCB-0822033]; Simons Foundation Autism Research Initiative [CEN5300891]; NIH [R01 MH080442, K08 HD068546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080442] Funding Source: NIH RePORTER	NIH/NCRR/RU CCTS; NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. We would like to thank the following members of the Tuschl laboratory for their support and assistance: G. Wardle, N. Renwick and I. Ben-Dov. We would like to thank J. Keene for his advice throughout the project. We would like to acknowledge M. Khorshid, L. Burger and M. Zavolan for analysing PAR-CLIP data at the initial stages of the project and discussions. We would like to thank the Memorial Sloan-Kettering Cancer Center in-situ core for their assistance with the mouse histology. Finally, we would like to express our appreciation to all members of the Tuschl laboratory for their assistance and collegiality. This work was supported, in part, by the following agencies: NIH/NCRR/RU CCTS (M. A., UL1RR024143), NSF (U.O., MCB-0822033), Simons Foundation Autism Research Initiative (T. T., CEN5300891) and NIH (T. T., R01 MH080442; Z.W., K08 HD068546).	Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P1101, DOI 10.1016/j.nbd.2011.12.028; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; De Rubeis S, 2012, ADV EXP MED BIOL, V970, P517, DOI 10.1007/978-3-7091-0932-8_23; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gross C, 2012, NEUROPSYCHOPHARMACOL, V37, P178, DOI 10.1038/npp.2011.137; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hagerman R, 2012, RESULTS PROBL CELL D, V54, P297, DOI 10.1007/978-3-642-21649-7_17; Hoell J., 2013, HDB RNA BIOCH, V1; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052	50	463	471	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					382	+		10.1038/nature11737	http://dx.doi.org/10.1038/nature11737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23235829	Green Accepted			2022-12-01	WOS:000312488200046
J	Zwiers, R; Zantvoord, FWA; Engelaer, FM; van Bodegom, D; van der Ouderaa, FJG; Westendorp, RGJ				Zwiers, R.; Zantvoord, F. W. A.; Engelaer, F. M.; van Bodegom, D.; van der Ouderaa, F. J. G.; Westendorp, R. G. J.			Mortality in former Olympic athletes: retrospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; LIFE EXPECTANCY; HEALTH-BENEFITS; SOCCER PLAYERS; LONGEVITY; SPORTS; DISEASE; EXERCISE; INJURIES	Objective To assess the mortality risk in subsequent years (adjusted for year of birth, nationality, and sex) of former Olympic athletes from disciplines with different levels of exercise intensity. Design Retrospective cohort study. Setting Former Olympic athletes. Participants 9889 athletes (with a known age at death) who participated in the Olympic Games between 1896 and 1936, representing 43 types of disciplines with different levels of cardiovascular, static, and dynamic intensity exercise; high or low risk of bodily collision; and different levels of physical contact. Main outcome measure All cause mortality. Results Hazard ratios for mortality among athletes from disciplines with moderate cardiovascular intensity (1.01, 95% confidence interval 0.96 to 1.07) or high cardiovascular intensity (0.98, 0.92 to 1.04) were similar to those in athletes from disciplines with low cardiovascular intensity. The underlying static and dynamic components in exercise intensity showed similar non-significant results. Increased mortality was seen among athletes from disciplines with a high risk of bodily collision (hazard ratio 1.11, 1.06 to 1.15) and with high levels of physical contact (1.16, 1.11 to 1.22). In a multivariate analysis, the effect of high cardiovascular intensity remained similar (hazard ratio 1.05, 0.89 to 1.25); the increased mortality associated with high physical contact persisted (hazard ratio 1.13, 1.06 to 1.21), but that for bodily collision became non-significant (1.03, 0.98 to 1.09) as a consequence of its close relation with physical contact. Conclusions Among former Olympic athletes, engagement in disciplines with high intensity exercise did not bring a survival benefit compared with disciplines with low intensity exercise. Those who engaged in disciplines with high levels of physical contact had higher mortality than other Olympians later in life.	[Zwiers, R.; Zantvoord, F. W. A.; Engelaer, F. M.; van Bodegom, D.; van der Ouderaa, F. J. G.; Westendorp, R. G. J.] Leyden Acad Vital & Ageing, NL-2333 AA Leiden, Netherlands; [Engelaer, F. M.; van Bodegom, D.; Westendorp, R. G. J.] Leiden Univ, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Engelaer, FM (corresponding author), Leyden Acad Vital & Ageing, Rijnsburgerweg 10, NL-2333 AA Leiden, Netherlands.	Engelaer@leydenacademy.nl	Van Der Ouderaa, Frans/AAA-8580-2020	van Bodegom, David/0000-0002-5691-8342				BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; BEAGLEHOLE R, 1983, NEW ZEAL MED J, V96, P513; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Bianco M, 2007, INT J SPORTS MED, V28, P697, DOI 10.1055/s-2007-964863; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; Blair SN, 1996, RES Q EXERCISE SPORT, V67, P193, DOI 10.1080/02701367.1996.10607943; Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hootman JM, 2007, J ATHL TRAINING, V42, P311; KARVONEN MJ, 1974, MED SCI SPORT EXER, V6, P49; Kokkinos P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/924945; KUJALA UM, 1994, METABOLISM, V43, P1255, DOI 10.1016/0026-0495(94)90219-4; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Kuss O, 2011, SCAND J MED SCI SPOR, V21, pE260, DOI 10.1111/j.1600-0838.2010.01269.x; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lippi G, 2006, CLIN CHEM LAB MED, V44, P322, DOI 10.1515/CCLM.2006.056; Melzer K, 2004, CURR OPIN CLIN NUTR, V7, P641, DOI 10.1097/00075197-200411000-00009; MENOTTI A, 1990, EUR J EPIDEMIOL, V6, P257, DOI 10.1007/BF00150429; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; SCHNOHR P, 1971, LANCET, V2, P1364; Sports Reference, 2011, OL STAT HIST; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Waterbor J, 1998, NEW ENGL J MED, V318, P1278; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; YAMAJI K, 1977, Journal of Human Ergology, V6, P15	35	30	30	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e7456	10.1136/bmj.e7456	http://dx.doi.org/10.1136/bmj.e7456			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241269	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000312495700002
J	Kagan, JC				Kagan, Jonathan C.			Signaling Organelles of the Innate Immune System	CELL			English	Review							TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; RIG-I; PATHOGEN RECOGNITION; ANTIVIRAL RESPONSES; PATTERN-RECOGNITION; ACCESSORY PROTEIN; ADAPTER MOLECULE; DROSOPHILA MYD88	There are at least five families of microbe-detection receptors that function to detect and eradicate potentially infectious microorganisms that enter multicellular eukaryotes. While a multitude of proteins regulating innate immune signal transduction have already been defined, continuous genetic screening for regulators of innate immunity may not yield as significant insight into the operation of these pathways as was obtained in the past. This diminished return on experimental investment suggests that we are approaching the asymptote of genetics-only approaches to study innate immunity. In contrast, it remains unclear how known regulators of innate immunity interact within the infrastructure of mammalian cells to execute their signaling functions. In this Perspective, I first highlight the locations within mammalian cells that permit innate immune signal transduction and then offer a model whereby structurally distinct proteins can be grouped functionally through their ability to assemble platforms of regulators on the signaling organelles of the innate immune system.	[Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kagan, Jonathan C.] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			National Institutes of Health [AI093589, AI072955]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955, R01AI093589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Perspective was not designed to comprehensively cover all aspects of innate immunity. As such, several important areas of host defense are not discussed or cited. The views expressed reflect my personal opinion and should not be considered a consensus in the field. I would like to thank members of my lab for helpful discussions during preparation of this manuscript. The National Institutes of Health grants AI093589 and AI072955 support the work performed in the laboratory of J.C.K. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Blanco AM, 2008, J NEUROCHEM, V106, P625, DOI 10.1111/j.1471-4159.2008.05425.x; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radons J, 2002, J BIOL CHEM, V277, P16456, DOI 10.1074/jbc.M201000200; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	105	72	74	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1168	1178		10.1016/j.cell.2012.11.011	http://dx.doi.org/10.1016/j.cell.2012.11.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217704	Bronze, Green Accepted			2022-12-01	WOS:000311999900008
J	Xu, YF; Xu, C; Kato, A; Tempel, W; Abreu, JG; Bian, CB; Hu, YG; Hu, D; Zhao, B; Cerovina, T; Diao, JB; Wu, FZ; He, HH; Cui, QY; Clark, E; Ma, C; Barbara, A; Veenstra, GJC; Xu, GL; Kaiser, UB; Liu, XS; Sugrue, SP; He, X; Min, JR; Kato, Y; Shi, YG				Xu, Yufei; Xu, Chao; Kato, Akiko; Tempel, Wolfram; Abreu, Jose Garcia; Bian, Chuanbing; Hu, Yeguang; Hu, Di; Zhao, Bin; Cerovina, Tanja; Diao, Jianbo; Wu, Feizhen; He, Housheng Hansen; Cui, Qingyan; Clark, Erin; Ma, Chun; Barbara, Andrew; Veenstra, Gert Jan C.; Xu, Guoliang; Kaiser, Ursula B.; Liu, X. Shirley; Sugrue, Stephen P.; He, Xi; Min, Jinrong; Kato, Yoichi; Shi, Yujiang Geno			Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development	CELL			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; MAMMALIAN DNA; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; MOUSE; 5-METHYLCYTOSINE; PROTEINS; GENOME; 5-CARBOXYLCYTOSINE	Ten-Eleven Translocation (Tet) family of dioxygenases dynamically regulates DNA methylation and has been implicated in cell lineage differentiation and oncogenesis. Yet their functions and mechanisms of action in gene regulation and embryonic development are largely unknown. Here, we report that Xenopus Tet3 plays an essential role in early eye and neural development by directly regulating a set of key developmental genes. Tet3 is an active 5mC hydroxylase regulating the 5mC/5hmC status at target gene promoters. Biochemical and structural studies further demonstrate that the Tet3 CXXC domain is critical for specific Tet3 targeting. Finally, we show that the enzymatic activity and CXXC domain are both crucial for Tet3's biological function. Together, these findings define Tet3 as a transcription regulator and reveal a molecular mechanism by which the 5mC hydroxylase and DNA binding activities of Tet3 cooperate to control target gene expression and embryonic development.	[Xu, Chao; Tempel, Wolfram; Bian, Chuanbing; Cerovina, Tanja; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Xu, Yufei; Hu, Yeguang; Hu, Di; Clark, Erin; Ma, Chun; Barbara, Andrew; Kaiser, Ursula B.; Shi, Yujiang Geno] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA; [Xu, Chao; Tempel, Wolfram; Bian, Chuanbing; Cerovina, Tanja; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Kato, Akiko; Kato, Yoichi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Hu, Di; Zhao, Bin; Diao, Jianbo; Wu, Feizhen; Ma, Chun] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China; [He, Housheng Hansen; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [He, Housheng Hansen; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cui, Qingyan; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Sugrue, Stephen P.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	University of Toronto; Structural Genomics Consortium; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; State University System of Florida; Florida State University; Harvard University; Boston Children's Hospital; Harvard Medical School; Fudan University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Radboud University Nijmegen; Harvard University; Dana-Farber Cancer Institute; State University System of Florida; University of Florida	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	jr.min@utoronto.ca; yoichi.kato@med.fsu.edu; yujiang_shi@hms.harvard.edu	Neurociencia, Inct/I-1011-2013; Wu, Feizhen/R-6415-2019; Wu, Feizhen/AGR-5215-2022; Veenstra, Gert Jan C./D-4963-2012; Xu, Chao/G-3885-2010; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021; Min, Jinrong/G-3449-2011; He, Hansen/ABD-8439-2020	Wu, Feizhen/0000-0002-1265-9887; Veenstra, Gert Jan C./0000-0002-7787-4940; Xu, Chao/0000-0003-0444-7080; Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755; Min, Jinrong/0000-0001-5210-3130; He, Hansen/0000-0003-2898-3363; Cui, Qingyan/0000-0002-5029-4436	NIH [GM078458, GM087641, GM074241]; Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education Project 985; CNPq (Brazil); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Eli Lilly; Pfizer; Novartis Research Foundation; Life Technologies; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Wellcome Trust; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [P30EY021721, R01EY007883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241, R01GM078458, R15GM087641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education Project 985; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Novartis Research Foundation; Life Technologies; Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Harland for helpful discussions, A Khorasani for critical reading of the manuscript and Q. Xu and L. Jiang for statistical analyses. We also thank R. Moon, W. Harris, J. Yang, X. Wang, M. Vetter and J.-P. Saint-Jeannet for valuable discussions and technical help. This work was supported by NIH grants GM078458 to Y.G.S., GM087641 to Y.K., and GM074241 to X.H., Brigham and Women's Hospital Biomedical Research Institute fund to sustain research excellence to Y.G.S., and Chinese Ministry of Education Project 985 to Biomedical Core Facility, Fudan University. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. J. G. A. was funded partially by CNPq (Brazil). Y.G.S. is a Pew Scholar. X. H. acknowledges support by Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD-18655). The Structural Genomics Consortium is a registered charity (No. 1097737) that receives funds from Canadian Institutes for Health Research, Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Eli Lilly, Pfizer, Novartis Research Foundation, Life Technologies, Ontario Innovation Trust, Ontario Ministry for Research and Innovation and Wellcome Trust (JM). Argonne National Laboratory is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; BESTOR TH, 1993, CURR BIOL, V3, P384, DOI 10.1016/0960-9822(93)90209-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sakano D, 2010, DEV CELL, V18, P450, DOI 10.1016/j.devcel.2009.12.023; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	30	184	204	0	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1200	1213		10.1016/j.cell.2012.11.014	http://dx.doi.org/10.1016/j.cell.2012.11.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217707	Green Accepted, Bronze			2022-12-01	WOS:000311999900011
J	Vahedi, G; Takahashi, H; Nakayamada, S; Sun, HW; Sartorelli, V; Kanno, Y; O'Shea, JJ				Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo; Sun, Hong-wei; Sartorelli, Vittorio; Kanno, Yuka; O'Shea, John J.			STATs Shape the Active Enhancer Landscape of T Cell Populations	CELL			English	Article							CHIP-SEQ DATA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; REGULATORY ELEMENTS; LINEAGE COMMITMENT; RNA-SEQ; BET; DIFFERENTIATION; IDENTIFICATION; ACCESSIBILITY	Signaling pathways are intimately involved in cellular differentiation, allowing cells to respond to their environment by regulating gene expression. Although enhancers are recognized as key elements that regulate selective gene expression, the interplay between signaling pathways and actively used enhancer elements is not clear. Here, we use CD4(+) T cells as a model of differentiation, mapping the activity of cell-type-specific enhancer elements in T helper 1 (Th1) and Th2 cells. Our data establish that STAT proteins have a major impact on the activation of lineage-specific enhancers and the suppression of enhancers associated with alternative cell fates. Transcriptome analysis further supports a functional role for enhancers regulated by STATs. Importantly, expression of lineage-defining master regulators in STAT-deficient cells fails to fully recover the chromatin signature of STAT-dependent enhancers. Thus, these findings point to a critical role of STATs as environmental sensors in dynamically molding the specialized enhancer architecture of differentiating cells.	[Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo; Kanno, Yuka; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kanno, Y (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov	Takahashi, Hayato/AAV-7707-2021; Kanno, Yuka/B-5802-2013	Takahashi, Hayato/0000-0001-6768-8821; Kanno, Yuka/0000-0001-5668-9319; Sartorelli, Vittorio/0000-0002-9284-3675	Intramural Research Programs of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041164, ZIAAR041159, Z01AR041159] Funding Source: NIH RePORTER	Intramural Research Programs of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. K. Zhao, A. Poholek, and K. Ghoreschi for critically reading this manuscript. We also thank G. Gutierrez-Cruz (Biodata Mining Core Facility, NIAMS), J. Simone, and J. Lay (Flow Cytometry Section, NIAMS) for their excellent technical support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of NIAMS.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smale ST, 2010, IMMUNITY, V32, P296, DOI 10.1016/j.immuni.2010.03.011; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	41	251	254	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					981	993		10.1016/j.cell.2012.09.044	http://dx.doi.org/10.1016/j.cell.2012.09.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178119	Green Accepted, Bronze			2022-12-01	WOS:000311423500012
J	Kalager, M; Tamimi, RM; Bretthauer, M; Adami, HO				Kalager, Mette; Tamimi, Rulla M.; Bretthauer, Michael; Adami, Hans-Olov			Prognosis in women with interval breast cancer: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCREENING-PROGRAM; TRUE INTERVAL; SURVIVAL; MAMMOGRAPHY; COMPLETENESS; FEATURES; REGISTRY; 10-YEAR; NORWAY; TIME	Objective To compare the prognosis in women with interval breast cancer (cancer detected after a normal screening mammogram and before the next scheduled mammogram) with breast cancer detected among women not yet invited to mammography screening (non-screened). Design Population based observational study. Setting Norwegian breast cancer screening programme, implemented in different counties from 1996 to 2005. Participants 7116 women with a diagnosis of breast cancer at age 50 to 72 years; 1816 had interval breast cancer and 5300 had a diagnosis of breast cancer but had not yet been invited to screening. Main outcome measures Characteristics of the breast tumours, and survival of the women using Kaplan Meier curves and multivariable Cox proportional hazard models. Results Although interval cancers on average were slightly larger than the cancers in women not invited to screening, the histological type or status of axilliary lymph nodes did not differ noticeably between the two groups. Among interval cancers, there were no appreciable trends in size, nodal status, grade, or hormone receptor positivity associated with time since the last normal mammogram as a marker of growth rate. After 10 years of follow-up, the survival rates were 79.1% (95% confidence interval 75.4% to 82.3%) among women with interval cancers and 76.8% (75.3% to 78.2%) among women in the non-screened cancer group (hazard ratio 0.98, 95% confidence interval 0.84 to 1.15; P=0.53). Analyses stratified by time since last normal mammogram, age at diagnosis, or screening round showed similar results. Conclusion The prognosis of women with interval breast cancers was the same as that of women with breast cancers diagnosed without mammography screening.	[Kalager, Mette; Tamimi, Rulla M.; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kalager, Mette; Bretthauer, Michael] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Kalager, Mette] Telemark Hosp, Dept Clin Res, Skien, Norway; [Tamimi, Rulla M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Bretthauer, Michael] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat, N-0027 Oslo, Norway; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Telemark Hospital Trust; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; National Hospital Norway; Karolinska Institutet	Kalager, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mkalager@hsph.harvard.edu			Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science	This study was funded by research grants from the Norwegian Research Council and Frontier Science. The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript.	ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Bordas P, 2007, BREAST, V16, P47, DOI 10.1016/j.breast.2006.05.006; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Collins S, 1998, BRIT MED J, V316, P832, DOI 10.1136/bmj.316.7134.832; Cowan WK, 2000, J CLIN PATHOL, V53, P140, DOI 10.1136/jcp.53.2.140; DEGROOTE R, 1983, SURGERY, V94, P543; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; Edge S. B., 2010, AJCC CANC STAGING MA, P291; ERZAAS A, 2003, QUALITY ASSURANCE MA; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; FRISELL J, 1992, BREAST CANCER RES TR, V24, P11, DOI 10.1007/BF01832353; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Hofvind S, 2008, ACTA RADIOL, V49, P975, DOI 10.1080/02841850802403730; Hofvind S, 2005, RADIOLOGY, V237, P437, DOI 10.1148/radiol.2372041174; HOLMBERG LH, 1986, LANCET, V2, P27; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kalager M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2331; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lawrence G, 2009, J MED SCREEN, V16, P186, DOI 10.1258/jms.2009.009040; PERRY NM, 1996, EUROPEAN GUIDELINES; Porter GJR, 2006, J MED SCREEN, V13, P115, DOI 10.1258/096914106778440572; Rayson D, 2011, CLIN BREAST CANCER, V11, P27, DOI 10.3816/CBC.2011.n.005; Schroen AA, 1996, J SURG ONCOL, V63, P141, DOI 10.1002/(SICI)1096-9098(199611)63:3<141::AID-JSO2>3.0.CO;2-D; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Vitak B, 1999, EUR RADIOL, V9, P460, DOI 10.1007/s003300050693; Vitak B, 1997, EUR J CANCER, V33, P1453, DOI 10.1016/S0959-8049(97)00185-8; Vitak B, 1998, EUR RADIOL, V8, P639, DOI 10.1007/s003300050452; Wang H, 2001, CANCER CAUSE CONTROL, V12, P39, DOI 10.1023/A:1008999403069; Wang HG, 2001, INT J CANCER, V94, P594, DOI 10.1002/ijc.1511; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239	34	27	28	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2012	345								e7536	10.1136/bmj.e7536	http://dx.doi.org/10.1136/bmj.e7536			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QI	23160783	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000311337500001
J	Schlipalius, DI; Valmas, N; Tuck, AG; Jagadeesan, R; Ma, L; Kaur, R; Goldinger, A; Anderson, C; Kuang, JJ; Zuryn, S; Mau, YS; Cheng, Q; Collins, PJ; Nayak, MK; Schirra, HJ; Hilliard, MA; Ebert, PR				Schlipalius, David I.; Valmas, Nicholas; Tuck, Andrew G.; Jagadeesan, Rajeswaran; Ma, Li; Kaur, Ramandeep; Goldinger, Anita; Anderson, Cameron; Kuang, Jujiao; Zuryn, Steven; Mau, Yosep S.; Cheng, Qiang; Collins, Patrick J.; Nayak, Manoj K.; Schirra, Horst Joachim; Hilliard, Massimo A.; Ebert, Paul R.			A Core Metabolic Enzyme Mediates Resistance to Phosphine Gas	SCIENCE			English	Article							DOMINICA F COLEOPTERA; LESSER GRAIN BORER; RHYZOPERTHA-DOMINICA; CAENORHABDITIS-ELEGANS; COMPARATIVE TOXICITY; DEHYDROGENASE; BOSTRYCHIDAE; STRAINS	Phosphine is a small redox-active gas that is used to protect global grain reserves, which are threatened by the emergence of phosphine resistance in pest insects. We find that polymorphisms responsible for genetic resistance cluster around the redox-active catalytic disulfide or the dimerization interface of dihydrolipoamide dehydrogenase (DLD) in insects (Rhyzopertha dominica and Tribolium castaneum) and nematodes (Caenorhabditis elegans). DLD is a core metabolic enzyme representing a new class of resistance factor for a redox-active metabolic toxin. It participates in four key steps of core metabolism, and metabolite profiles indicate that phosphine exposure in mutant and wild-type animals affects these steps differently. Mutation of DLD in C. elegans increases arsenite sensitivity. This specific vulnerability may be exploited to control phosphine-resistant insects and safeguard food security.	[Valmas, Nicholas; Hilliard, Massimo A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Kuang, Jujiao; Collins, Patrick J.; Nayak, Manoj K.] Agri Sci Queensland, Dept Agr Fisheries & Forestry, Ecosci Precinct, Brisbane, Qld 4001, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Jagadeesan, Rajeswaran; Ma, Li; Kaur, Ramandeep; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Collins, Patrick J.; Nayak, Manoj K.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT 2617, Australia; [Valmas, Nicholas; Goldinger, Anita; Anderson, Cameron; Zuryn, Steven; Mau, Yosep S.; Cheng, Qiang; Schirra, Horst Joachim; Ebert, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Mau, Yosep S.] Univ Nusa Cendana, Fac Agr, Kupang 85001, NTT, Indonesia; [Schirra, Horst Joachim] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; Queensland Department of Agriculture & Fisheries; University of Queensland; University of Queensland; Nippon Telegraph & Telephone Corporation; Universitas Nusa Cendana; University of Queensland	Hilliard, MA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	m.hilliard@uq.edu.au; p.ebert@uq.edu.au	Schirra, Horst Joachim/B-4210-2009; Mau, Yosep Seran/GNP-4795-2022; Zuryn, Steven/C-7967-2018; Schlipalius, David/B-8155-2011; Goldinger, Anita/K-9171-2018; Mau, Yosep Seran/AAC-4003-2021; Jagadeesan, Rajeswaran/K-8804-2019	Schirra, Horst Joachim/0000-0002-7541-246X; Mau, Yosep Seran/0000-0001-6654-5407; Zuryn, Steven/0000-0002-3551-6790; Schlipalius, David/0000-0002-8102-7031; Goldinger, Anita/0000-0002-7688-1823; Hilliard, Massimo A/0000-0001-7458-5812; Ebert, Paul/0000-0002-4435-0737; Kuang, Jujiao/0000-0002-1366-0089; Valmas, Nicholas/0000-0002-6925-9673; Jagadeesan, Rajeswaran/0000-0002-9890-5953	Cooperative Research Centre for National Plant Biosecurity [CRC20080, CRC50150]; Australian Research Council (ARC) [DP0558507]; Grains Research and Development Corporation [UQ00010]; National Institutes of Health [R01NS060129]; National Health and Medical Research Council [569500]; ARC Future Fellowship; Queensland Smart State Fellowship; Australian Postgraduate Award scholarships; University of Queensland Research Scholarship; AusAid scholarship; NIH National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129] Funding Source: NIH RePORTER	Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council (ARC)(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council); Queensland Smart State Fellowship; Australian Postgraduate Award scholarships; University of Queensland Research Scholarship(University of Queensland); AusAid scholarship; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Cooperative Research Centre for National Plant Biosecurity (CRC20080 and CRC50150) (D.I.S.); Australian Research Council (ARC) (DP0558507) and Grains Research and Development Corporation (UQ00010) (P.R.E.); National Institutes of Health (R01NS060129), National Health and Medical Research Council (PG# 569500), and ARC Future Fellowship (M.A.H.); Queensland Smart State Fellowship (H.J.S.); Australian Postgraduate Award scholarships (N.V., S.Z., and J.K.); University of Queensland Research Scholarship (Q.C., R.J., and R.K.); and AusAid scholarship (Y.S.M.). Sequence accession numbers (JX434596 to JX434608). We thank R. Tweedale, P. Bazzicalupo, and R. Tellam for comments and R. Barrero, H. Pavic, L. Bond, L. Kirszenblat, P. Mugno-Ramirez, A. Johnston, N. Mathew, and M. Mathew for technical assistance. Nematode strains provided by the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources. NMR data acquired at the Queensland NMR Network and University of Queensland-Institute of Molecular Bioscience NMR facilities. Author contribution statement: N.V., L.M., A.G.T., S.Z, J.K., Q.C., M.A.H., and P.R.E. provided data and analysis for C. elegans. R.J., R.K., A.G.T., and D.I.S. provided data and analysis for R. dominica and T. castaneum. H.J.S., A.G., and C.A. provided metabolomics data and analysis. H.J.S. performed homology modeling. P.J.C. and M.K.N. provided insect strains and phenotype data. D.I.S., N.V., H.J.S., M.A.H., and P.R.E. drafted the manuscript.	Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bergquist ER, 2009, J ORGANOMET CHEM, V694, P973, DOI 10.1016/j.jorganchem.2008.12.028; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; CHAUDHRY MQ, 1991, COMP BIOCHEM PHYS C, V99, P41, DOI 10.1016/0742-8413(91)90072-2; Chen WH, 2010, PLANT PHYSIOL, V153, P1385, DOI 10.1104/pp.110.153452; Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049; Collins PJ, 2005, J STORED PROD RES, V41, P373, DOI 10.1016/j.jspr.2004.05.002; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034027; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031541; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROBINSON JR, 1970, J STORED PROD RES, V6, P133, DOI 10.1016/0022-474X(70)90002-0; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	18	101	109	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					807	810		10.1126/science.1224951	http://dx.doi.org/10.1126/science.1224951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139334				2022-12-01	WOS:000310839500047
J	Nielsen, SF; Nordestgaard, BG; Bojesen, SE				Nielsen, Sune F.; Nordestgaard, Borge G.; Bojesen, Stig E.			Statin Use and Reduced Cancer-Related Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HMG-COA REDUCTASE; BREAST-CANCER; MEVALONATE PATHWAY; PROSPECTIVE COHORT; CELL-GROWTH; RISK; CHOLESTEROL; RECURRENCE; INHIBITORS; DRUGS	BACKGROUND A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality. METHODS We assessed mortality among patients from the entire Danish population who had received a diagnosis of cancer between 1995 and 2007, with follow-up until December 31, 2009. Among patients 40 years of age or older, 18,721 had used statins regularly before the cancer diagnosis and 277,204 had never used statins. RESULTS Multivariable-adjusted hazard ratios for statin users, as compared with patients who had never used statins, were 0.85 (95% confidence interval [CI], 0.83 to 0.87) for death from any cause and 0.85 (95% CI, 0.82 to 0.87) for death from cancer. Adjusted hazard ratios for death from any cause according to the defined daily statin dose (the assumed average maintenance dose per day) were 0.82 (95% CI, 0.81 to 0.85) for a dose of 0.01 to 0.75 defined daily dose per day, 0.87 (95% CI, 0.83 to 0.89) for 0.76 to 1.50 defined daily dose per day, and 0.87 (95% CI, 0.81 to 0.91) for higher than 1.50 defined daily dose per day; the corresponding hazard ratios for death from cancer were 0.83 (95% CI, 0.81 to 0.86), 0.87 (95% CI, 0.83 to 0.91), and 0.87 (95% CI, 0.81 to 0.92). The reduced cancer-related mortality among statin users as compared with those who had never used statins was observed for each of 13 cancer types. CONCLUSIONS Statin use in patients with cancer is associated with reduced cancer-related mortality. This suggests a need for trials of statins in patients with cancer.	[Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Bojesen, SE (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	stig.egil.bojesen@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Bojesen, Stig/0000-0002-4061-4133; Nordestgaard, Borge/0000-0002-1954-7220				Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Andersen TF, 1999, DAN MED BULL, V46, P263; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; BASERGA R, 1986, INT J RADIAT BIOL, V49, P219, DOI 10.1080/09553008514552511; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Boudreau DM, 2010, EXPERT OPIN DRUG SAF, V9, P603, DOI 10.1517/14740331003662620; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Cholesterol Treatment Trialists' (CTT) Collaborators, 2012, LANCET; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fritz G, 2005, INT J ONCOL, V27, P1401; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Garcia MJ, 2003, METHOD FIND EXP CLIN, V25, P457; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; HEROLD G, 1995, DIGESTION, V56, P57, DOI 10.1159/000201223; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2000.1716; Kusama T, 2001, CANCER RES, V61, P4885; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; LAMB E, 2009, PHARM TIMES     0515; Lamond AI, 2002, NATURE, V417, P383, DOI 10.1038/417383a; Mannello F, 2009, CANCER INVEST, V27, P466, DOI 10.1080/07357900802491444; Nielsen SF, 2012, CAN MED ASSOC J, V184, pE57, DOI 10.1503/cmaj.110167; Nielsen SF, 2011, BLOOD, V118, P4062, DOI 10.1182/blood-2011-02-337170; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Sobin LH., 2011, TNM CLASSIFICATION M; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Storm HH, 1997, DAN MED BULL, V44, P535; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476	40	681	693	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1792	1802		10.1056/NEJMoa1201735	http://dx.doi.org/10.1056/NEJMoa1201735			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134381				2022-12-01	WOS:000310773200006
J	Waldman, RJ; Mintz, ED; Papowitz, HE				Waldman, Ronald J.; Mintz, Eric D.; Papowitz, Heather E.			The Cure for Cholera - Improving Access to Safe Water and Sanitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Waldman, Ronald J.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Mintz, Eric D.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Papowitz, Heather E.] UNICEF, Hlth Sect, New York, NY USA	George Washington University; Centers for Disease Control & Prevention - USA; UNICEF	Waldman, RJ (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.		Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257				Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Hutton G, 2008, B WORLD HEALTH ORGAN, V86, P13, DOI 10.2471/BLT.07.046045; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; UNICEF/WHO Joint Monitoring, 2012, PROGR DRINK WAT SAN; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289	5	24	23	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					592	594		10.1056/NEJMp1214179	http://dx.doi.org/10.1056/NEJMp1214179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194VA	23301693				2022-12-01	WOS:000322659600003
J	Arora, S				Arora, Sonal			Surgeons in training may benefit from mental visualisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SKILLS		Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England	Imperial College London	Arora, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England.	sonal.arora06@imperial.ac.uk						Arora S, 2011, J AM COLL SURGEONS, V212, P225, DOI 10.1016/j.jamcollsurg.2010.09.025; Arora S, 2011, ANN SURG, V253, P265, DOI 10.1097/SLA.0b013e318207a789; Arora S, 2010, SURG ENDOSC, V24, P179, DOI 10.1007/s00464-009-0624-y; Bolles G., 2009, J DANCE ED, V9, P6, DOI [10.1080/15290824.2009.10387379, DOI 10.1080/15290824.2009.10387379]; Danzer Enrico, 2011, J Surg Educ, V68, P519, DOI 10.1016/j.jsurg.2011.06.004; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Geoffrion R, 2012, BJOG-INT J OBSTET GY, V119, P1040, DOI 10.1111/j.1471-0528.2012.03398.x; Komesu Y, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.008; Sanders CW, 2008, MED EDUC, V42, P607, DOI 10.1111/j.1365-2923.2007.02964.x; WEINBERG R., 2008, J IMAGERY RES SPORT, V3, P1, DOI DOI 10.2202/1932-0191.1025	10	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								e8611	10.1136/bmj.e8611	http://dx.doi.org/10.1136/bmj.e8611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YU	23295370				2022-12-01	WOS:000313552300007
J	Kaplan, HG; Malmgren, JA				Kaplan, Henry G.; Malmgren, Judith A.			The Breast Cancer Overdiagnosis Conundrum: An Oncologist's Viewpoint	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPACT		Swedish Canc Inst, Seattle, WA USA; HealthStat Consulting, Seattle, WA USA; Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA	Swedish Cancer Institute; Swedish Medical Center; University of Washington; University of Washington Seattle	Kaplan, HG (corresponding author), 1221 E Madison St, Seattle, WA 98104 USA.	hank.kaplan@swedish.org	kaplan, henry/ABI-4845-2020		Kaplan Cancer Research Fund	Kaplan Cancer Research Fund	By the Kaplan Cancer Research Fund.	Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Esserman LJ, 2011, BREAST CANCER RES TR, V130, P725, DOI 10.1007/s10549-011-1748-z; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kaplan HG, 2006, CLIN BREAST CANCER, V7, P133, DOI 10.3816/CBC.2006.n.022; Malmgren JA, 2012, RADIOLOGY, V262, P797, DOI 10.1148/radiol.11111734; Malmgren JA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-131; Smith RA, 2007, CANCER-AM CANCER SOC, V109, P2205, DOI 10.1002/cncr.22671; Smith RA, 2012, ONCOLOGY-NY, V26, P471	10	5	5	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					60	+		10.7326/0003-4819-158-1-201301010-00011	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23277900				2022-12-01	WOS:000313119900009
J	Partridge, L				Partridge, Linda			Diet and Healthy Aging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CALORIC RESTRICTION; RHESUS-MONKEYS		[Partridge, Linda] Max Planck Inst Biol Aging, Cologne, Germany; [Partridge, Linda] UCL, Inst Healthy Aging, Dept Genet Evolut & Environm, London, England	Max Planck Society; University of London; University College London	Partridge, L (corresponding author), Max Planck Inst Biol Aging, Cologne, Germany.		Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094				Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Weindruch R, 1988, RETARDATION AGING DI, P397	5	11	11	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2550	2551		10.1056/NEJMcibr1210447	http://dx.doi.org/10.1056/NEJMcibr1210447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268671				2022-12-01	WOS:000312714200017
J	Woodcock, J; Khan, M; Yu, LX				Woodcock, Janet; Khan, Mansoor; Yu, Lawrence X.			Withdrawal of Generic Budeprion for Nonbioequivalence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet; Khan, Mansoor; Yu, Lawrence X.] US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA.		/AAE-3713-2022; Yu, Lawrence/L-6280-2016	Khan, Mansoor/0000-0003-3649-3874				*FOOD DRUG ADM, 2003, GUIDANCE FOR INDUSTR, P77671	1	40	42	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2463	2465		10.1056/NEJMp1212969	http://dx.doi.org/10.1056/NEJMp1212969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23216549				2022-12-01	WOS:000312714200002
J	Webber, BJ; Seguin, PG; Burnett, DG; Clark, LL; Otto, JL				Webber, Bryant J.; Seguin, Peter G.; Burnett, Daniel G.; Clark, Leslie L.; Otto, Jean L.			Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY ATHEROSCLEROSIS; NATURAL-HISTORY; PUBLIC-HEALTH; DISEASE; MORTALITY; ASSOCIATIONS; SOLDIERS; TRENDS	Context Autopsies of US service members killed in the Korean and Vietnam wars demonstrated that atherosclerotic changes in the coronary arteries can appear early in the second and third decades of life, long before ischemic heart disease becomes clinically apparent. Objective To estimate the current prevalence of coronary and aortic atherosclerosis in the US armed forces. Design, Setting, and Participants Cross-sectional study of all US service members who died of combat or unintentional injuries in support of Operations Enduring Freedom and Iraqi Freedom/New Dawn between October 2001 and August 2011 and whose cardiovascular autopsy reports were available at the time of data collection in January 2012. Prevalence of atherosclerosis was analyzed by various demographic characteristics and medical history. Classifications of coronary atherosclerosis severity were determined prior to data analysis and designed to provide consistency with previous military studies: minimal (fatty streaking only), moderate (10%-49% luminal narrowing of >= 1 vessel), and severe (>= 50% narrowing >= 1 of vessel). Main Outcome Measures Prevalence of coronary and aortic atherosclerosis in the US armed forces and by age, sex, self-reported race/ethnicity, education, occupation, service branch and component, military rank, body mass index at military entrance, and International Classification of Diseases, Ninth Revision, Clinical Modification, diagnoses of cardiovascular risk factors. Results Of the 3832 service members included in the analysis, the mean age was 25.9 years (range, 18-59 years) and 98.3% were male. The prevalence of any coronary atherosclerosis was 8.5% (95% Cl, 7.6%-9.4%); severe coronary atherosclerosis was present in 2.3% (95% Cl, 1.8%-2.7%), moderate in 4.7% (95% CI,4.0%-5.3%), and minimal in 1.5% (95% Cl, 1.1%-1.9%). Service members with atherosclerosis were significantly older (mean [SD] age, 30.5 [8.1] years) than those without (mean [SD] age, 25.3 [5.6] years; P<.001). Comparing atherosclerosis prevalence among with those with no cardiovascular risk factor diagnoses (11.1% [95% Cl, 10.1%-12.1%]), there was a greater prevalence among those with a diagnosis of dyslipidemia (50.0% [95% Cl, 30.3%-69.7%]; age-adjusted prevalence ratio [PR], 2.09 [95% Cl, 1.43-3.06]), hypertension (43.6% [95% Cl, 27.3%-59.9%]; age-adjusted PR, 1.88 [95% Cl, 1.34-2.65]), or obesity (22.3% [95% Cl, 15.9%-28.7%]; age-adjusted PR, 1.47 [95% Cl, 1.10-1.96]), but smoking (14.1% [95% Cl, 8.0%-20.2%]) was not significantly associated with a higher prevalence of atherosclerosis (age-adjusted PR, 1.12 [95% Cl, 0.73-1.74]). Conclusion Among deployed US service members who died of combat or unintentional injuries and received autopsies, the prevalence of atherosclerosis varied by age and cardiovascular risk factors. JAMA. 2012;308(24):2577-2583 www.jama.com	[Webber, Bryant J.] Uniformed Serv Univ Hlth Sci, PMB, Bethesda, MD 20814 USA; [Seguin, Peter G.] Armed Forces Med Examiner Syst, Dover AFB, DE USA; [Clark, Leslie L.; Otto, Jean L.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Otto, Jean L.] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Air Force; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Webber, BJ (corresponding author), Uniformed Serv Univ Hlth Sci, PMB, 4301 Jones Bridge Rd,Room A1040A, Bethesda, MD 20814 USA.	bryant.webber@usuhs.edu	Webber, Bryant/ABI-7744-2020	Webber, Bryant/0000-0002-2099-2671; Burnett, Daniel/0000-0003-1277-0486	Uniformed Services University of the Health Sciences (USUHS); Armed Forces Medical Examiner System (AFMES); Armed Forces Health Surveillance Center (AFHSC)	Uniformed Services University of the Health Sciences (USUHS); Armed Forces Medical Examiner System (AFMES); Armed Forces Health Surveillance Center (AFHSC)	This study was supported by the Uniformed Services University of the Health Sciences (USUHS), Armed Forces Medical Examiner System (AFMES), and Armed Forces Health Surveillance Center (AFHSC).	[Anonymous], 1968, AG ADJ DEATH RAT 69, P1968; [Anonymous], 2004, DOD PHYS FITN BOD PR; Armed services exchange policy, 2005, ARM SERV EXCH POL IN; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BOOZE CF, 1987, AVIAT SPACE ENVIR MD, V58, P297; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Commander Submarine Force Atlantic Commander Submarine Force US Pacific Fleet, 2010, SUBM FORC TOB CESS P; ENOS WF, 1955, JAMA-J AM MED ASSOC, V158, P912, DOI 10.1001/jama.1955.02960110018005; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gardner JW, 2000, MIL MED, V165, P57, DOI 10.1093/milmed/165.suppl_2.57; Hatzfeld JJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110136; HOLME I, 1985, AM J CARDIOL, V55, P40, DOI 10.1016/0002-9149(85)90296-6; Hourani LL, 2008, 2008 DEP DEF SURV HL; Joseph A, 1993, J AM COLL CARDIOL, V22, P459, DOI 10.1016/0735-1097(93)90050-B; Joseph AM, 2005, MIL MED, V170, P874, DOI 10.7205/MILMED.170.10.874; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Long-term trends in diagnosed diabetes, 2012, LONG TERM TRENDS DIA; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; National Heart Lung and Blood Institute, EXP PAN INT GUID CAR; Ogden Cynthia L, 2004, Adv Data, P1; PETTYJOHN FS, 1975, AVIAT SPACE ENVIR MD, V46, P1299; QuickStats, 2009, MMWR-MORBID MORTAL W, V58, P1045; REED DM, 1987, AM J EPIDEMIOL, V126, P214, DOI 10.1093/aje/126.2.214; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Smoke-free DoD facilities, 2001, SMOK FREE DOD FAC IN; STRONG JP, 1986, JAMA-J AM MED ASSOC, V256, P2863, DOI 10.1001/jama.256.20.2863; STRONG JP, 1962, AM J PATHOL, V40, P37; Taneja N, 2002, AVIAT SPACE ENVIR MD, V73, P1025; TEJADA C, 1968, LAB INVEST, V18, P509; Tobacco use in the Air Force, 2012, TOB US AIR FORC INST; UEMURA K, 1964, B WORLD HEALTH ORGAN, V31, P297; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yoon Sung Sug Sarah, 2010, NCHS Data Brief, P1; Zhdanov VS, 1999, INT J CARDIOL, V68, P95, DOI 10.1016/S0167-5273(98)00339-8	43	85	92	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2577	2583		10.1001/jama.2012.70830	http://dx.doi.org/10.1001/jama.2012.70830			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268516	Bronze			2022-12-01	WOS:000312916600023
J	Crow, JM				Crow, James Mitchell			THERAPEUTICS Silencing psoriasis	NATURE			English	Editorial Material							MONOCLONAL-ANTIBODY; EFFICACY; SAFETY											Krueger G, 2001, ARCH DERMATOL, V137, P280; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Papp K, 2012, LANCET, V380, P738, DOI 10.1016/S0140-6736(12)60642-4; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112	7	26	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					558	559		10.1038/492S58a	http://dx.doi.org/10.1038/492S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254974	Bronze			2022-12-01	WOS:000312488200006
J	Kuehn, BM				Kuehn, Bridget M.			Center Takes Broader Look at Preterm Birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2448	2448		10.1001/jama.2012.90690	http://dx.doi.org/10.1001/jama.2012.90690			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23287891				2022-12-01	WOS:000312441400003
J	Hou, XW; Pedi, L; Diver, MM; Long, SB				Hou, Xiaowei; Pedi, Leanne; Diver, Melinda M.; Long, Stephen B.			Crystal Structure of the Calcium Release-Activated Calcium Channel Orai	SCIENCE			English	Article							CRAC CHANNEL; PLASMA-MEMBRANE; SUBUNIT STOICHIOMETRY; ION SELECTIVITY; MOLECULAR-BASIS; CA2+ SENSOR; I-CRAC; STIM1; STORE; CELLS	The plasma membrane protein Orai forms the pore of the calcium release-activated calcium (CRAC) channel and generates sustained cytosolic calcium signals when triggered by depletion of calcium from the endoplasmic reticulum. The crystal structure of Orai from Drosophila melanogaster, determined at 3.35 angstrom resolution, reveals that the calcium channel is composed of a hexameric assembly of Orai subunits arranged around a central ion pore. The pore traverses the membrane and extends into the cytosol. A ring of glutamate residues on its extracellular side forms the selectivity filter. A basic region near the intracellular side can bind anions that may stabilize the closed state. The architecture of the channel differs markedly from other ion channels and gives insight into the principles of selective calcium permeation and gating.	[Hou, Xiaowei; Pedi, Leanne; Diver, Melinda M.; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	longs@mskcc.org		Long, Stephen/0000-0002-8144-1398; Hou, Xiaowei/0000-0002-6668-1115; Diver, Melinda/0000-0001-5037-7322	NIH [GM094273]; Burroughs Wellcome Career Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Goldberg, M. B. Long, R. MacKinnon, and N. P. Pavletich for discussions and comments on the manuscript; C. D. Lima and members of the laboratory for discussions; E. Gouaux for green fluorescent protein fusion vectors; the staff of beamlines X25 and X29 (National Synchrotron Light Source, Brookhaven National Laboratory); the staff of the monoclonal antibody and proteomics and microchemistry facilities at MSKCC; the Keck Biophysics Resource at Yale University; and the Center for Applied Isotope Studies at the University of Georgia for protein analysis. This work was supported by the NIH (grant GM094273) and by a Burroughs Wellcome Career Award (to S. B. L). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4HKR (wild type) and 4HKS (K163W mutant).	Aussel C, 1996, BIOCHEM J, V313, P909, DOI 10.1042/bj3130909; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HILLE B, 1992, IONIC CHANNELS EXCIT, pR13; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1995, PFLUG ARCH EUR J PHY, V430, P315, DOI 10.1007/BF00373905; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; James BD, 1996, INORG CHIM ACTA, V247, P169, DOI 10.1016/0020-1693(95)04955-X; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P297; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	43	422	430	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1308	1313		10.1126/science.1228757	http://dx.doi.org/10.1126/science.1228757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23180775	Green Accepted			2022-12-01	WOS:000311991200057
J	Fanfair, RN; Benedict, K; Bos, J; Bennett, SD; Lo, YC; Adebanjo, T; Etienne, K; Deak, E; Derado, G; Shieh, WJ; Drew, C; Zaki, S; Sugerman, D; Gade, L; Thompson, EH; Sutton, DA; Engelthaler, DM; Schupp, JM; Brandt, ME; Harris, JR; Lockhart, SR; Turabelidze, G; Park, BJ				Fanfair, Robyn Neblett; Benedict, Kaitlin; Bos, John; Bennett, Sarah D.; Lo, Yi-Chun; Adebanjo, Tolu; Etienne, Kizee; Deak, Eszter; Derado, Gordana; Shieh, Wun-Ju; Drew, Clifton; Zaki, Sherif; Sugerman, David; Gade, Lalitha; Thompson, Elizabeth H.; Sutton, Deanna A.; Engelthaler, David M.; Schupp, James M.; Brandt, Mary E.; Harris, Julie R.; Lockhart, Shawn R.; Turabelidze, George; Park, Benjamin J.			Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOPHYSOMYCES-ELEGANS; SOFT-TISSUE; TSUNAMI SURVIVOR; ZYGOMYCOSIS; OUTBREAK; INFECTIONS; EPIDEMIOLOGY; MANAGEMENT; FASCIITIS; RHIZOPUS	BACKGROUND Mucormycosis is a fungal infection caused by environmentally acquired molds. We investigated a cluster of cases of cutaneous mucormycosis among persons injured during the May 22, 2011, tornado in Joplin, Missouri. METHODS We defined a case as a soft-tissue infection in a person injured during the tornado, with evidence of a mucormycete on culture or immunohistochemical testing plus DNA sequencing. We conducted a case-control study by reviewing medical records and conducting interviews with case patients and hospitalized controls. DNA sequencing and whole-genome sequencing were performed on clinical specimens to identify species and assess strain-level differences, respectively. RESULTS A total of 13 case patients were identified, 5 of whom (38%) died. The patients had a median of 5 wounds (range, 1 to 7); 11 patients (85%) had at least one fracture, 9 (69%) had blunt trauma, and 5 (38%) had penetrating trauma. All case patients had been located in the zone that sustained the most severe damage during the tornado. On multivariate analysis, infection was associated with penetrating trauma (adjusted odds ratio for case patients vs. controls, 8.8; 95% confidence interval [CI], 1.1 to 69.2) and an increased number of wounds (adjusted odds ratio, 2.0 for each additional wound; 95% CI, 1.2 to 3.2). Sequencing of the D1-D2 region of the 28S ribosomal DNA yielded Apophysomyces trapeziformis in all 13 case patients. Whole-genome sequencing showed that the apophysomyces isolates were four separate strains. CONCLUSIONS We report a cluster of cases of cutaneous mucormycosis among Joplin tornado survivors that were associated with substantial morbidity and mortality. Increased awareness of fungi as a cause of necrotizing soft-tissue infections after a natural disaster is warranted.	[Fanfair, Robyn Neblett; Benedict, Kaitlin; Bennett, Sarah D.; Adebanjo, Tolu; Etienne, Kizee; Deak, Eszter; Gade, Lalitha; Brandt, Mary E.; Harris, Julie R.; Lockhart, Shawn R.; Park, Benjamin J.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Derado, Gordana] Ctr Dis Control & Prevent, Biostat Off, Atlanta, GA USA; [Fanfair, Robyn Neblett; Bennett, Sarah D.; Lo, Yi-Chun] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Shieh, Wun-Ju; Drew, Clifton; Zaki, Sherif] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Sugerman, David] Ctr Dis Control & Prevent, Div Injury Response, Atlanta, GA USA; [Bos, John; Lo, Yi-Chun; Turabelidze, George] Missouri Dept Hlth & Senior Serv, Jefferson, AR USA; [Thompson, Elizabeth H.; Sutton, Deanna A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Engelthaler, David M.; Schupp, James M.] Translat Genom Res Inst, Flagstaff, AZ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health San Antonio; Translational Genomics Research Institute	Park, BJ (corresponding author), 1600 Clifton Rd,MS C-09, Atlanta, GA 30333 USA.	bpark1@cdc.gov						Alexander BD, 2010, AM J TRANSPLANT, V10, P2161, DOI 10.1111/j.1600-6143.2010.03216.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andresen D, 2005, LANCET, V365, P876, DOI 10.1016/S0140-6736(05)71046-1; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P992; [Anonymous], 2005, EM WOUND MAN HEALTHC; [Anonymous], 2003, TORN BEING PREP; Antoniadou A, 2009, CLIN MICROBIOL INFEC, V15, P55, DOI 10.1111/j.1469-0691.2009.02982.x; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; Christiaens G, 2005, J HOSP INFECT, V61, P88, DOI 10.1016/j.jhin.2004.12.011; Daley WR, 2005, AM J EPIDEMIOL, V161, P1144, DOI 10.1093/aje/kwi142; Etienne K, 2011, PLOS ONE IN PRESS; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Guarner J, 2011, CLIN MICROBIOL REV, V24, P247, DOI 10.1128/CMR.00053-10; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HUFFNAGLE KE, 1992, J MED VET MYCOL, V30, P83; Ibrahim AS, 2008, CURR OPIN INFECT DIS, V21, P620, DOI 10.1097/QCO.0b013e3283165fd1; Ivers LC, 2006, CURR OPIN INFECT DIS, V19, P408, DOI 10.1097/01.qco.0000244044.85393.9e; Jain D, 2006, MODERN PATHOL, V19, P1221, DOI 10.1038/modpathol.3800639; Kimura M, 1999, ARCH PATHOL LAB MED, V123, P386; Kindo A J, 2007, Indian J Med Microbiol, V25, P285; Kontoyiannis DP, 2011, BLOOD, V118, P1216, DOI 10.1182/blood-2011-03-316430; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; LeMaile-Williams M, 2006, CLIN INFECT DIS, V43, pE83, DOI 10.1086/508277; Maravi-Poma E, 2004, INTENS CARE MED, V30, P724, DOI 10.1007/s00134-003-2132-1; Meis JF, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.02973.x; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; National Weather Service. Springfield MO, 2011, JOPL TORN EV SUMM; Oklahoma State Department of Health, 2006, TORN MORT QUEST MED; PATINO JF, 1991, WORLD J SURG, V15, P240, DOI 10.1007/BF01659059; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Skiada A, 2009, CLIN MICROBIOL INFEC, V15, P41, DOI 10.1111/j.1469-0691.2009.02979.x; Snell BJ, 2007, PLAST RECONSTR SURG, V119, P448, DOI 10.1097/01.prs.0000233624.34950.f8; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Sun HY, 2011, LANCET INFECT DIS, V11, P301, DOI 10.1016/S1473-3099(10)70316-9; U.S. Army Corps of Engineers, JOPL MISS TORN PATH; Wang Jue, 2002, Surg Infect (Larchmt), V3, P283, DOI 10.1089/109629602761624243; Weddle G, 2011, 49 ANN M INF DIS SOC; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	39	212	213	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2214	2225		10.1056/NEJMoa1204781	http://dx.doi.org/10.1056/NEJMoa1204781			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215557				2022-12-01	WOS:000311890600008
J	Gilliam, JC; Chang, JT; Sandoval, IM; Zhang, YW; Li, TS; Pittler, SJ; Chiu, W; Wensel, TG				Gilliam, Jared C.; Chang, Juan T.; Sandoval, Ivette M.; Zhang, Youwen; Li, Tiansen; Pittler, Steven J.; Chiu, Wah; Wensel, Theodore G.			Three-Dimensional Architecture of the Rod Sensory Cilium and Its Disruption in Retinal Neurodegeneration	CELL			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; BARDET-BIEDL-SYNDROME; CGMP-GATED CHANNEL; ACID-RICH PROTEINS; CRYOELECTRON TOMOGRAPHY; CILIARY ROOTLET; BETA-SUBUNIT; BASAL BODY; DISK MORPHOGENESIS; OUTER SEGMENTS	Defects in primary cilia lead to devastating disease because of their roles in sensation and developmental signaling but much is unknown about ciliary structure and mechanisms of their formation and maintenance. We used cryo-electron tomography to obtain 3D maps of the connecting cilium and adjacent cellular structures of a modified primary cilium, the rod outer segment, from wild-type and genetically defective mice. The results reveal the molecular architecture of the cilium and provide insights into protein functions. They suggest that the ciliary rootlet is involved in cellular transport and stabilizes the axoneme. A defect in the BBSome membrane coat caused defects in vesicle targeting near the base of the cilium. Loss of the proteins encoded by the Cngb1 gene disrupted links between the disk and plasma membranes. The structures of the outer segment membranes support a model for disk morphogenesis in which basal disks are enveloped by the plasma membrane.	[Gilliam, Jared C.; Chang, Juan T.; Sandoval, Ivette M.; Chiu, Wah; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chang, Juan T.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Zhang, Youwen; Pittler, Steven J.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35924 USA; [Li, Tiansen] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	twensel@bcm.edu	; Pittler, Steven/J-7091-2013	Wensel, Theodore/0000-0003-3518-9352; Pittler, Steven/0000-0002-8464-9303	NIH [EY011900, EY07981, P41RR002250, EY018143, EY10309, EY10581, EY011731, T32EY007001, EY002520]; Robert Welch Foundation [Q-0035, Q1242]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250, P41RR006009] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010581, T32EY007001, R29EY010581, R01EY018143, R01EY010309, R01EY011900, R01EY007981, P30EY003039, ZIAEY000490, R01EY011731, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, R25GM056929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the NIH (EY011900 and EY07981 to T.G.W., P41RR002250 to W. C., EY018143 to S.J.P., EY10309 and EY10581 to T.L., support for I.M.S. by EY011731, an NIH NRSA trainee appointment on grant T32EY007001 to J.C.G., and Vision Research Core Grant EY002520) and by the Robert Welch Foundation (Q-0035 to T.G.W. and Q1242 to W.C.). We thank Mr. Ralph Nichols for help with electron microscopy of fixed samples, Dr. Vera Moiseenkova-Bell for help in the early stages of the project, and Dr. Alecia Gross for helpful suggestions and pilot experiments.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams NA, 2007, OPHTHALMIC GENET, V28, P113, DOI 10.1080/13816810701537424; ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Ardell MD, 2000, GENE, V245, P311, DOI 10.1016/S0378-1119(00)00023-8; Batra-Safferling R, 2006, J BIOL CHEM, V281, P1449, DOI 10.1074/jbc.M505012200; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chaitin M H, 1989, Prog Clin Biol Res, V314, P265; CHAITIN MH, 1984, J CELL BIOL, V99, P239, DOI 10.1083/jcb.99.1.239; CHAITIN MH, 1986, INVEST OPHTH VIS SCI, V27, P1764; CHAITIN MH, 1992, EXP EYE RES, V54, P261, DOI 10.1016/S0014-4835(05)80216-7; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Clarke R.D., 1946, J I ACTUARIES, V72, P481, DOI [DOI 10.1017/S0020268100035435, 10.1017/S0020268100035435]; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; DELPRIORE LV, 1987, INVEST OPHTH VIS SCI, V28, P633; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Moser JJ, 2010, SEMIN CELL DEV BIOL, V21, P148, DOI 10.1016/j.semcdb.2009.06.006; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Ozanics V., 1982, OCULAR ANATOMY EMBRY, P462; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; RENTHAL R, 1973, EXP EYE RES, V17, P511, DOI 10.1016/0014-4835(73)90081-X; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; SPIRA AW, 1979, AM J ANAT, V155, P319, DOI 10.1002/aja.1001550304; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	53	106	110	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1029	1041		10.1016/j.cell.2012.10.038	http://dx.doi.org/10.1016/j.cell.2012.10.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178122	Bronze, Green Accepted			2022-12-01	WOS:000311423500016
J	Yang, YWJ; Baltus, AE; Mathew, RS; Murphy, EA; Evrony, GD; Gonzalez, DM; Wang, EP; Marshall-Walker, CA; Barry, BJ; Murn, J; Tatarakis, A; Mahajan, MA; Samuels, HH; Shi, Y; Golden, JA; Mahajnah, M; Shenhav, R; Walsh, CA				Yang, Yawei J.; Baltus, Andrew E.; Mathew, Rebecca S.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Murn, Jernej; Tatarakis, Antonis; Mahajan, Muktar A.; Samuels, Herbert H.; Shi, Yang; Golden, Jeffrey A.; Mahajnah, Muhammad; Shenhav, Ruthie; Walsh, Christopher A.			Microcephaly Gene Links Trithorax and REST/NRSF to Control Neural Stem Cell Proliferation and Differentiation	CELL			English	Article							HISTONE MODIFICATIONS; SELF-RENEWAL; CHROMATIN; NEUROGENESIS; REST; COMPLEX; TRANSCRIPTION; PROTEINS; NEURONS; STATES	Microcephaly is a neurodevelopmental disorder causing significantly reduced cerebral cortex size. Many known microcephaly gene products localize to centrosomes, regulating cell fate and proliferation. Here, we identify and characterize a nuclear zinc finger protein, ZNF335/NIF-1, as a causative gene for severe microcephaly, small somatic size, and neonatal death. Znf335 null mice are embryonically lethal, and conditional knockout leads to severely reduced cortical size. RNA-interference and postmortem human studies show that ZNF335 is essential for neural progenitor self-renewal, neurogenesis, and neuronal differentiation. ZNF335 is a component of a vertebrate-specific, trithorax H3K4-methylation complex, directly regulating REST/NRSF, a master regulator of neural gene expression and cell fate, as well as other essential neural-specific genes. Our results reveal ZNF335 as an essential link between H3K4 complexes and REST/NRSF and provide the first direct genetic evidence that this pathway regulates human neurogenesis and neuronal differentiation.	[Yang, Yawei J.; Baltus, Andrew E.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Yang, Yawei J.; Baltus, Andrew E.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Murn, Jernej; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Yang, Yawei J.; Evrony, Gilad D.; Wang, Estee P.; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yang, Yawei J.; Evrony, Gilad D.; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Yang, Yawei J.; Evrony, Gilad D.] Harvard Univ, Sch Med, Harvard MD PhD MSTP Program, Boston, MA 02115 USA; [Mathew, Rebecca S.; Murn, Jernej; Tatarakis, Antonis; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yang, Yawei J.; Baltus, Andrew E.; Mathew, Rebecca S.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Tatarakis, Antonis; Walsh, Christopher A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Yang, Yawei J.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Murphy, Elisabeth A.] Northeastern Univ, Dept Neurosci, Boston, MA 02115 USA; [Wang, Estee P.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Mahajan, Muktar A.; Samuels, Herbert H.] NYU, Sch Med, Dept Pharmacol & Med, New York, NY 10016 USA; [Golden, Jeffrey A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mahajnah, Muhammad] Hillel Yaffe Med Ctr, IL-38100 Hadera, Israel; [Mahajnah, Muhammad] Technion Israel Inst Technol, IL-32000 Haifa, Israel; [Shenhav, Ruthie] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Northeastern University; Harvard University; Harvard School of Dental Medicine; New York University; Harvard University; Brigham & Women's Hospital; Technion Israel Institute of Technology; Rabin Medical Center	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Murn, Jernej/ABD-3624-2020	Walsh, Christopher/0000-0002-0156-2238; Mahajan, Muktar/0000-0003-1024-6808; Golden, Jeffrey/0000-0001-9933-5502; Gonzalez, Dilenny/0000-0003-0661-5930; Evrony, Gilad/0000-0001-7621-2630	Stuart H.Q. and Victoria Quan Fellowship; NIH MSTP [T32GM007753]; NIH [T32 HD007466, GM058012, GM071004, CA118487]; Damon Runyon Cancer Research Foundation [DRG-2042-10]; HHMI Medical Research Fellows Program; NINDS [RO1 NS032457, R01 NS35129]; Manton Center for Orphan Disease Research;  [RO1 DK16636]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058012, T32GM007753, R01GM071004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457, R01NS035129] Funding Source: NIH RePORTER	Stuart H.Q. and Victoria Quan Fellowship; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; HHMI Medical Research Fellows Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Manton Center for Orphan Disease Research; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Moazed, M.E. Hatten, B. Ren, D.M. Ferrero, and members of the Walsh laboratory for helpful discussions; L. Shechtman for tissue; N. Dwyer for early mapping; G. Mandel for DN-REST construct; E.E. Govek for help with cerebellar slices; K. S. Krishnamoorthy for control MRIs; and D.J. Tischfield, L.B. Hills, K.D. Atabay, P.P. Wang, J. Wortzel, D.G. Tierney, and J.M. Felie for technical assistance. This work was supported by a Stuart H.Q. and Victoria Quan Fellowship (Y.J.Y.); a NIH MSTP grant T32GM007753 (Y.J.Y. and G.D.E.); a NIH T32 HD007466 (A.E.B.); The Damon Runyon Cancer Research Foundation DRG-2042-10 (R.S.M.); HHMI Medical Research Fellows Program (E.P.W.); RO1 DK16636 (H.H.S.); NIH grants (GM058012, GM071004, and CA118487) (Y.S.); grants from the NINDS (RO1 NS032457 and R01 NS35129); and the Manton Center for Orphan Disease Research (C.A.W.). C.A.W. is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BARKOVICH A, 2007, DIAGNOSTIC IMAGING P; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dredge BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021585; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Paro R, 1998, CIBA F SYMP, V214, P51; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Zheng JN, 2006, LIFE SCI, V78, P724, DOI 10.1016/j.lfs.2005.05.064	33	113	128	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1097	1112		10.1016/j.cell.2012.10.043	http://dx.doi.org/10.1016/j.cell.2012.10.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178126	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000311423500021
J	Wodak, A				Wodak, Alex			Drug law reform: when bad policy is good politics	LANCET			English	Editorial Material									St Vincents Hosp, Darlinghurst, NSW 2010, Australia	St Vincents Hospital Sydney	Wodak, A (corresponding author), St Vincents Hosp, Darlinghurst, NSW 2010, Australia.	alex.wodak@gmail.com						Bewley-Taylor D. R., 1999, US INT DRUG CONTROL; Cave D., 2012, NY TIMES; Commission on Narcotic Drugs, 2008, ECN72008CRP17 COMM N; Douglas B., 2012, ALTERNATIVES PROHIBI; Global Commission on Drug Policy, 2012, WAR DRUGS HIV AIDS C; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Rau B, 2006, INT AFF, V82, P285, DOI 10.1111/j.1468-2346.2006.00531.x; Rolles Stephen, 2010, BMJ, V341, pc3360, DOI 10.1136/bmj.c3360; The Global Commission on Drug Policy, 2011, WAR DRUGS; UNODC, 2008, 51 SESS COMM NARC DR; Youngers C., 2012, DRUG LAW REFORM GENI	12	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1624	1626		10.1016/S0140-6736(12)61847-9	http://dx.doi.org/10.1016/S0140-6736(12)61847-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035MN	23134835				2022-12-01	WOS:000310951400005
J	Tye, KM; Mirzabekov, JJ; Warden, MR; Ferenczi, EA; Tsai, HC; Finkelstein, J; Kim, SY; Adhikari, A; Thompson, KR; Andalman, AS; Gunaydin, LA; Witten, IB; Deisseroth, K				Tye, Kay M.; Mirzabekov, Julie J.; Warden, Melissa R.; Ferenczi, Emily A.; Tsai, Hsing-Chen; Finkelstein, Joel; Kim, Sung-Yon; Adhikari, Avishek; Thompson, Kimberly R.; Andalman, Aaron S.; Gunaydin, Lisa A.; Witten, Ilana B.; Deisseroth, Karl			Dopamine neurons modulate neural encoding and expression of depression-related behaviour	NATURE			English	Article							STRESS-INDUCED ANHEDONIA; VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT; ANIMAL-MODEL; AVERSIVE STIMULI; REWARD CIRCUIT; GABA NEURONS; SUSCEPTIBILITY; MICE; INHIBITION	Major depression is characterized by diverse debilitating symptoms that include hopelessness and anhedonia(1). Dopamine neurons involved in reward and motivation(2-9) are among many neural populations that have been hypothesized to be relevant(10), and certain antidepressant treatments, including medications and brain stimulation therapies, can influence the complex dopamine system. Until now it has not been possible to test this hypothesis directly, even in animal models, as existing therapeutic interventions are unable to specifically target dopamine neurons. Here we investigated directly the causal contributions of defined dopamine neurons to multidimensional depression-like phenotypes induced by chronic mild stress, by integrating behavioural, pharmacological, optogenetic and electrophysiological methods in freely moving rodents. We found that bidirectional control (inhibition or excitation) of specified midbrain dopamine neurons immediately and bidirectionally modulates (induces or relieves) multiple independent depression symptoms caused by chronic stress. By probing the circuit implementation of these effects, we observed that optogenetic recruitment of these dopamine neurons potently alters the neural encoding of depression-related behaviours in the downstream nucleus accumbens of freely moving rodents, suggesting that processes affecting depression symptoms may involve alterations in the neural encoding of action in limbic circuitry.	[Tye, Kay M.] MIT, Picower Inst Learning & Memory Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tye, Kay M.; Mirzabekov, Julie J.; Warden, Melissa R.; Ferenczi, Emily A.; Tsai, Hsing-Chen; Finkelstein, Joel; Kim, Sung-Yon; Adhikari, Avishek; Thompson, Kimberly R.; Andalman, Aaron S.; Gunaydin, Lisa A.; Witten, Ilana B.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ferenczi, Emily A.; Tsai, Hsing-Chen; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tye, KM (corresponding author), MIT, Picower Inst Learning & Memory Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kaytye@mit.edu; deissero@stanford.edu	Adhikari, Avishek/A-3339-2012; Tye, Kay/J-6158-2013; Andalman, Aaron S/C-7694-2011; Adhikari, Avishek/AAF-4444-2021; Kim, Sung-Yon/AAO-8405-2020; Core, Vector/CAF-4832-2022; Adhikari, Avishek/N-1284-2015; Warden, Melissa R/M-9300-2016	Adhikari, Avishek/0000-0002-9187-9211; Tye, Kay/0000-0002-2435-0182; Adhikari, Avishek/0000-0002-9187-9211; Kim, Sung-Yon/0000-0003-0791-7308; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997	Helen Hay Whitney Foundation; NRSA [F32 MH880102]; JPB Foundation; NARSAD; Wiegers Family Fund; NIMH; NIDA; DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NARSAD(NARSAD); Wiegers Family Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Davidson, S. Pak, C. Ramakrishnan, L. Grosenick, Z. Chen and the members of the Deisseroth Laboratory for support. I. B. W. was supported by the Helen Hay Whitney Foundation; K. M. T was supported by NRSA fellowship F32 MH880102 and the JPB Foundation; K. R. T., M. R. W. and K. D. are NARSAD grant awardees. K. D. was supported by the Wiegers Family Fund and by the NIMH, the NIDA, the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Gatsby Charitable Foundation, the Snyder Foundation, the Woo Foundation and the Albert Yu and Mary Bechman Foundation. All tools and methods described are distributed and supported freely (http://www.optogenetics.org).	Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FREEMAN AS, 1987, BRAIN RES, V405, P46, DOI 10.1016/0006-8993(87)90988-7; Friedman A, 2008, J MOL NEUROSCI, V34, P201, DOI 10.1007/s12031-007-9016-8; GRACE AA, 1984, J NEUROSCI, V4, P2877; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 2004, NEUROPHARMACOLOGY, V47, P190, DOI 10.1016/j.neuropharm.2004.07.012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Koob GF, 1996, MOL PSYCHIATR, V1, P186; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S., 2012, NATURE; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Lemos J.C., 2012, NATURE          0919; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tanaka K, 2012, J NEUROSCI, V32, P4319, DOI 10.1523/JNEUROSCI.5952-11.2012; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Willner P., 1991, EUR NEUROPSYCHOPHARM, V1, P295; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	34	636	664	21	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					537	+		10.1038/nature11740	http://dx.doi.org/10.1038/nature11740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235822	Green Published, Green Accepted			2022-12-01	WOS:000313871400039
J	Peters, SE; Kelly, DC; Fraass, AJ				Peters, Shanan E.; Kelly, Daniel C.; Fraass, Andrew J.			Oceanographic controls on the diversity and extinction of planktonic foraminifera	NATURE			English	Article							GLOBAL DISTRIBUTION; SPECIES-DIVERSITY; ORIGINATION; MACROSTRATIGRAPHY; HISTORY; TRENDS; RECORD	Understanding the links between long-term biological evolution, the ocean-atmosphere system and plate tectonics is a central goal of Earth science. Although environmental perturbations of many different kinds are known to have affected long-term biological evolution, particularly during major mass extinction events(1,2), the relative importance of physical environmental factors versus biological interactions in governing rates of extinction and origination through geological time remains unknown(2). Here we use macrostratigraphic data from the Atlantic Ocean basin to show that changes in global species diversity and rates of extinction among planktonic foraminifera have been linked to tectonically and climatically forced changes in ocean circulation and chemistry from the Jurassic period to the present. Transient environmental perturbations, such as those that occurred after the asteroid impact at the end of the Cretaceous period(1) approximately 66 million years ago, and the Eocene/Oligocene greenhouse-icehouse transition(3,4) approximately 34 million years ago, are superimposed on this general long-term relationship. Rates of species origination, by contrast, are not correlated with corresponding macrostratigraphic quantities, indicating that physiochemical changes in the ocean-atmosphere system affect evolution principally by driving the synchronous extinction of lineages that originated owing to more protracted and complex interactions between biological and environmental factors.	[Peters, Shanan E.; Kelly, Daniel C.; Fraass, Andrew J.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Peters, SE (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	peters@geology.wisc.edu	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317; Fraass, Andrew/0000-0002-2007-3616; Kelly, Clay/0000-0002-3241-1635	National Science Foundation Division of Earth Sciences (NSF EAR) [EAR 0819931]; NSF [EAR 0628719]	National Science Foundation Division of Earth Sciences (NSF EAR); NSF(National Science Foundation (NSF))	We thank M. Foote and B. Wilkinson for feedback on our analyses and this manuscript, and N. A. Heim for help in drafting the maps herein. This work was partially supported by National Science Foundation Division of Earth Sciences (NSF EAR) EAR 0819931 to S.E.P. and NSF EAR 0628719 subcontract to D.C.K.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Be A. W. H., 1971, MICROPALEONTOLOGY OC, P1025; BE AWH, 1977, OCEANIC MICROPALEONT, V1, P1; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BERGGREN WA, 1977, TECTONOPHYSICS, V38, P11, DOI 10.1016/0040-1951(77)90199-8; CIFELLI R, 1969, SYST ZOOL, V18, P154, DOI 10.2307/2412601; CLIMAP Project Members, 1976, Science, V191, P1131; CLIMAP Project Members, 1994, CLIMAP 18K DAT; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; D'Hondt S, 1998, PALEOBIOLOGY, V24, P512, DOI 10.1017/S0094837300020133; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Georgescu MD, 2008, J FORAMIN RES, V38, P157, DOI 10.2113/gsjfr.38.2.157; HALLOCK P, 1991, PALAEOGEOGR PALAEOCL, V83, P49, DOI 10.1016/0031-0182(91)90075-3; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hannisdal B, 2010, J GEOL, V118, P111, DOI 10.1086/650180; HAQ BU, 1977, J GEOPHYS RES-OC ATM, V82, P3861, DOI 10.1029/JC082i027p03861; Hemleben Ch, 1989, MODERN PLANKTONIC FO, DOI DOI 10.1016/S0016-6995(89)80108-1; HOLLAND SM, 1995, PALEOBIOLOGY, V21, P92, DOI 10.1017/S0094837300013099; Holland SM, 2000, PALEOBIOLOGY, V26, P148, DOI 10.1666/0094-8373(2000)26[148:TQOTFR]2.0.CO;2; Huber B.T., 2006, MESOZOIC PLANKTONIC; Kauffman E.G., 1993, 39 GEOL ASS CAN, P1; KELLER G, 1987, GEOLOGY, V15, P199, DOI 10.1130/0091-7613(1987)15<199:GDOLPH>2.0.CO;2; Kennett J.P., 1983, NEOGENE PLANKTONIC F; LIPPS JH, 1970, EVOLUTION, V24, P1, DOI 10.1111/j.1558-5646.1970.tb01737.x; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lyle M., 1995, SCI RESULTS, V138, P821, DOI [DOI 10.2973/0DP.PR0C.SR.138.157.1995, 10.2973/odp.proc.sr.138.157.1995, DOI 10.2973/ODP.PROC.SR.138.157.1995]; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Milliman J. D., 1974, RECENT SEDIMENTARY C; Moore Jr T. C., 1978, MICROPALEONTOL SP PU, V3, P113; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Norris RD, 2001, GEOL SOC SPEC PUBL, V183, P23, DOI 10.1144/GSL.SP.2001.183.01.02; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P344; Olsson R. K., 1999, ATLAS PALEOCENE PLAN; Parker F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Pearson P.N., 2006, CUSHMAN FDN FORAMINI, V41; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2006, PALEOBIOLOGY, V32, P387, DOI 10.1666/05081.1; Peters SE, 2011, GEOLOGY, V39, P259, DOI 10.1130/G31442.1; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; PROTHERO DR, 1980, SYST ZOOL, V29, P119, DOI 10.2307/2412642; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Saito T, 1981, SYSTEMATIC INDEX REC; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Stewart D. R. M., 2000, PLANKRANGE DATABASE; Sverdrup H. U., 1942, OCEANS THEIR PHYS CH; Thierstein H. R., 1979, DEEP DRILLING RESULT, P249; Thunell R., 1986, TERMINAL EOCENE EVEN, P363, DOI [10.1016/s0920-5446(08)70140-7, DOI 10.1016/S0920-5446(08)70140-7]; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Vincent E., 1981, OCEAN LITHOSPHERE SE, V7, P1025; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	56	31	32	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					398	U140		10.1038/nature11815	http://dx.doi.org/10.1038/nature11815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23302802				2022-12-01	WOS:000313615900050
J	Schloissnig, S; Arumugam, M; Sunagawa, S; Mitreva, M; Tap, J; Zhu, A; Waller, A; Mende, DR; Kultima, JR; Martin, J; Kota, K; Sunyaev, SR; Weinstock, GM; Bork, P				Schloissnig, Siegfried; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Mitreva, Makedonka; Tap, Julien; Zhu, Ana; Waller, Alison; Mende, Daniel R.; Kultima, Jens Roat; Martin, John; Kota, Karthik; Sunyaev, Shamil R.; Weinstock, George M.; Bork, Peer			Genomic variation landscape of the human gut microbiome	NATURE			English	Article							SALT HYDROLASE ACTIVITY; IV SECRETION SYSTEMS; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; POPULATION-GENETICS; HUMAN FECES; DIVERSITY; BACTERIAL; EVOLUTION; RECONSTRUCTION	Whereas large-scale efforts have rapidly advanced the understanding and practical impact of human genomic variation, the practical impact of variation is largely unexplored in the human microbiome. We therefore developed a framework for metagenomic variation analysis and applied it to 252 faecal metagenomes of 207 individuals from Europe and North America. Using 7.4 billion reads aligned to 101 reference species, we detected 10.3 million single nucleotide polymorphisms (SNPs), 107,991 short insertions/deletions, and 1,051 structural variants. The average ratio of non-synonymous to synonymous polymorphism rates of 0.11 was more variable between gut microbial species than across human hosts. Subjects sampled at varying time intervals exhibited individuality and temporal stability of SNP variation patterns, despite considerable composition changes of their gut microbiota. This indicates that individual-specific strains are not easily replaced and that an individual might have a unique metagenomic genotype, which may be exploitable for personalized diet or drug intake.	[Schloissnig, Siegfried; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Tap, Julien; Zhu, Ana; Waller, Alison; Mende, Daniel R.; Kultima, Jens Roat; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Mitreva, Makedonka; Martin, John; Kota, Karthik; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gweinsto@genome.wustl.edu; bork@embl.de	Powell, Sean/B-2374-2009; Bork, Peer/F-1813-2013; ravegnini, gloria/K-1330-2016; Arumugam, Manimozhiyan/AAJ-2394-2020; Tap, Julien/E-5760-2010; Weinstock, George M/C-6314-2013; Sunagawa, Shinichi/Q-5950-2019; Mende, Daniel R/I-3662-2019; Arumugam, Manimozhiyan/E-1211-2011	Powell, Sean/0000-0002-0994-5911; Bork, Peer/0000-0002-2627-833X; ravegnini, gloria/0000-0002-7774-402X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Tap, Julien/0000-0001-8998-5413; Weinstock, George M/0000-0002-2997-4592; Sunagawa, Shinichi/0000-0003-3065-0314; Mende, Daniel R/0000-0001-6831-4557; Arumugam, Manimozhiyan/0000-0002-0886-9101; Mitreva, Makedonka/0000-0001-9572-3436; Schloissnig, Siegfried/0000-0003-4574-8330	EMBL; European Community [HEALTH-F4-2007-201052]; IHMS [HEALTH-F4-2010-261376]; National Institutes of Health [U54HG003079, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER	EMBL; European Community(European Commission); IHMS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors are grateful to J. Korbel and the members of the Bork group at EMBL for discussions and assistance, especially S. Powell for performing some of the computations. We thank the EMBL IT core facility and Y. Yuan for managing the high-performance computing resources. We would like to thank J. I. Gordon for providing three of the samples used. We are also grateful to the European MetaHIT consortium and the NIH Common Fund Human Microbiome Project Consortium for generating and making available the data sets used in this study. The research leading to these results has received funding from EMBL, the European Community's Seventh Framework Programme via the MetaHIT (HEALTH-F4-2007-201052) and IHMS (HEALTH-F4-2010-261376) grants as well as from the National Institutes of Health grants U54HG003079 and U54HG004968.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P1615, DOI [10.1099/ijs.0.02143-0, 10.1099/00207713-52-5-1615]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; KUNZ BA, 1983, GENETICS, V105, P489; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	48	521	555	11	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					45	50		10.1038/nature11711	http://dx.doi.org/10.1038/nature11711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23222524	Green Submitted, Green Accepted			2022-12-01	WOS:000312933800027
J	Metzger, ML; Billett, A; Link, MP				Metzger, Monika L.; Billett, Amy; Link, Michael P.			The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Metzger, Monika L.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Metzger, Monika L.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Billett, Amy] Dana Farber Canc Inst, Boston, MA 02115 USA; [Billett, Amy] Boston Childrens Hosp, Boston, MA USA; [Link, Michael P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Link, Michael P.] Lucile Packard Childrens Hosp, Stanford, CA USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Stanford University; Lucile Packard Children's Hospital (LPCH)	Metzger, ML (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.							Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Link MP, 2012, J CLIN ONCOL, V30, P692, DOI 10.1200/JCO.2011.41.0936	3	61	61	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2461	2463		10.1056/NEJMp1212468	http://dx.doi.org/10.1056/NEJMp1212468			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268661				2022-12-01	WOS:000312714200001
J	Warden, MR; Selimbeyoglu, A; Mirzabekov, JJ; Lo, M; Thompson, KR; Kim, SY; Adhikari, A; Tye, KM; Frank, LM; Deisseroth, K				Warden, Melissa R.; Selimbeyoglu, Aslihan; Mirzabekov, Julie J.; Lo, Maisie; Thompson, Kimberly R.; Kim, Sung-Yon; Adhikari, Avishek; Tye, Kay M.; Frank, Loren M.; Deisseroth, Karl			A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge	NATURE			English	Article							COGNITIVE CONTROL; LATERAL HABENULA; DEPRESSION; RAT; DISORDERS; STIMULATION; MOOD	The prefrontal cortex (PFC) is thought to participate in high-level control of the generation of behaviours (including the decision to execute actions(1)); indeed, imaging and lesion studies in human beings have revealed that PFC dysfunction can lead to either impulsive states with increased tendency to initiate action(2), or to amotivational states characterized by symptoms such as reduced activity, hopelessness and depressed mood(3). Considering the opposite valence of these two phenotypes as well as the broad complexity of other tasks attributed to PFC, we sought to elucidate the PFC circuitry that favours effortful behavioural responses to challenging situations. Here we develop and use a quantitative method for the continuous assessment and control of active response to a behavioural challenge, synchronized with single-unit electrophysiology and optogenetics in freely moving rats. In recording from the medial PFC (mPFC), we observed that many neurons were not simply movement-related in their spike-firing patterns but instead were selectively modulated from moment to moment, according to the animal's decision to act in a challenging situation. Surprisingly, we next found that direct activation of principal neurons in the mPFC had no detectable causal effect on this behaviour. We tested whether this behaviour could be causally mediated by only a subclass of mPFC cells defined by specific downstream wiring. Indeed, by leveraging optogenetic projection-targeting to control cells with specific efferent wiring patterns, we found that selective activation of those mPFC cells projecting to the brainstem dorsal raphe nucleus (DRN), a serotonergic nucleus implicated in major depressive disorder(4), induced a profound, rapid and reversible effect on selection of the active behavioural state. These results may be of importance in understanding the neural circuitry underlying normal and pathological patterns of action selection and motivation in behaviour.	[Warden, Melissa R.; Selimbeyoglu, Aslihan; Mirzabekov, Julie J.; Thompson, Kimberly R.; Kim, Sung-Yon; Adhikari, Avishek; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Selimbeyoglu, Aslihan; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lo, Maisie] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Warden, MR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mwarden@stanford.edu; deissero@stanford.edu	Kim, Sung-Yon/AAO-8405-2020; Adhikari, Avishek/AAF-4444-2021; Tye, Kay/J-6158-2013; Adhikari, Avishek/A-3339-2012; Warden, Melissa R/M-9300-2016; Adhikari, Avishek/N-1284-2015	Kim, Sung-Yon/0000-0003-0791-7308; Adhikari, Avishek/0000-0002-9187-9211; Tye, Kay/0000-0002-2435-0182; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; Adhikari, Avishek/0000-0002-9187-9211; Frank, Loren/0000-0002-1752-5677	Wiegers Family Fund; NARSAD; Stanford Graduate Fellowship; Samsung Scholarship; Berry Foundation Fellowship; NIMH [1F32MH088010-01]; NIMH; NIDA; DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Yu Foundation; Snyder Foundation; Tarlton Foundation; Alice Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, F32MH088010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER	Wiegers Family Fund; NARSAD(NARSAD); Stanford Graduate Fellowship(Stanford University); Samsung Scholarship(Samsung); Berry Foundation Fellowship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Yu Foundation; Snyder Foundation; Tarlton Foundation; Alice Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank H. Mayberg, R. Malenka, L. Gunaydin, J. Mattis, I. Ellwood and I. Witten for helpful comments on the manuscript; I. Ellwood, I. Witten, R. Airan, L. Meltzer, M. Roy, V. Gradinaru, A. Andalman, T. Davidson, R. Durand, M. Bower and M. Carr for useful discussions; and all members of the K. D. laboratory for their support. We are grateful to S. Pak, C. Ramakrishnan and C. Perry for technical assistance. This work was supported by the Wiegers Family Fund (K.D.), NARSAD (M.R.W. and K.R.T.), Stanford Graduate Fellowship (A.S.), Samsung Scholarship (S.-Y.K.), Berry Foundation Fellowship (A.A.), NIMH (1F32MH088010-01, K.M.T.), and NIMH, NIDA, the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Yu, Snyder, Tarlton and Alice Woo Foundations, and the Gatsby Charitable Foundation (K.D.).	Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; DALGLEISH T, 1990, CLIN PSYCHOL REV, V10, P589, DOI 10.1016/0272-7358(90)90098-U; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Goncalves L, 2009, BRAIN RES BULL, V78, P240, DOI 10.1016/j.brainresbull.2008.11.012; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; INGRAM RE, 1994, COGNITIVE THER RES, V18, P317, DOI 10.1007/BF02357508; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kim U, 2012, EUR J NEUROSCI, V35, P1253, DOI 10.1111/j.1460-9568.2012.08030.x; Maes Michael, 1995, P933; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	27	397	406	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					428	432		10.1038/nature11617	http://dx.doi.org/10.1038/nature11617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160494	Green Accepted			2022-12-01	WOS:000312488200056
J	Vos, T; Flaxman, AD; Naghavi, M; Lozano, R; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basanez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabe, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, SA; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, GR; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, HL; Cheng, ATA; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; de Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; De Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fevre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Franklin, R; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gosselin, R; Grainger, R; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Ma, JX; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KMV; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O'Donnell, M; O'Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; De Leon, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJC; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JRA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; van der Werf, MJ; van Os, J; Vavilala, MS; Venketasubramanian, N; Wang, MR; Wang, WZ; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SRM; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AKM; Zheng, ZJ; Zonies, D; Lopez, AD; Murray, CJL				Vos, Theo; Flaxman, Abraham D.; Naghavi, Mohsen; Lozano, Rafael; Michaud, Catherine; Ezzati, Majid; Shibuya, Kenji; Salomon, Joshua A.; Abdalla, Safa; Aboyans, Victor; Abraham, Jerry; Ackerman, Ilana; Aggarwal, Rakesh; Ahn, Stephanie Y.; Ali, Mohammed K.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Bahalim, Adil N.; Barker-Collo, Suzanne; Barrero, Lope H.; Bartels, David H.; Basanez, Maria-Gloria; Baxter, Amanda; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bernabe, Eduardo; Bhalla, Kavi; Bhandari, Bishal; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Black, James A.; Blencowe, Hannah; Blore, Jed D.; Blyth, Fiona; Bolliger, Ian; Bonaventure, Audrey; Boufous, Soufi Ane; Bourne, Rupert; Boussinesq, Michel; Braithwaite, Tasanee; Brayne, Carol; Bridgett, Lisa; Brooker, Simon; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Buckle, Geoff Rey; Budke, Christine M.; Burch, Michael; Burney, Peter; Burstein, Roy; Calabria, Bianca; Campbell, Benjamin; Canter, Charles E.; Carabin, Helene; Carapetis, Jonathan; Carmona, Loreto; Cella, Claudia; Charlson, Fiona; Chen, Honglei; Cheng, Andrew Tai-Ann; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; de Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahiya, Manu; Dahodwala, Nabila; Damsere-Derry, James; Danaei, Goodarz; Davis, Adrian; De Leo, Diego; Degenhardt, Louisa; Dellavalle, Robert; Delossantos, Allyne; Denenberg, Julie; Derrett, Sarah; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Torne, Cesar; Dolk, Helen; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Edmond, Karen; Elbaz, Alexis; Ali, Suad Eltahir; Erskine, Holly; Erwin, Patricia J.; Espindola, Patricia; Ewoigbokhan, Stalin E.; Farzadfar, Farshad; Feigin, Valery; Felson, David T.; Ferrari, Alize; Ferri, Cleusa P.; Fevre, Eric M.; Finucane, Mariel M.; Flaxman, Seth; Flood, Louise; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Franklin, Richard; Fransen, Marlene; Freeman, Michael K.; Gabbe, Belinda J.; Gabriel, Sherine E.; Gakidou, Emmanuela; Ganatra, Hammad A.; Garcia, Bianca; Gaspari, Flavio; Gillum, Richard F.; Gmel, Gerhard; Gosselin, Richard; Grainger, Rebecca; Groeger, Justina; Guillemin, Francis; Gunnell, David; Gupta, Ramyani; Haagsma, Juanita; Hagan, Holly; Halasa, Yara A.; Hall, Wayne; Haring, Diana; Maria Haro, Josep; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Higashi, Hideki; Hill, Catherine; Hoen, Bruno; Hoffman, Howard; Hotez, Peter J.; Hoy, Damian; Huang, John J.; Ibeanusi, Sydney E.; Jacobsen, Kathryn H.; James, Spencer L.; Jarvis, Deborah; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Jonas, Jost B.; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kawakami, Norito; Keren, Andre; Khoo, Jon-Paul; King, Charles H.; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Lalloo, Ratilal; Laslett, Laura L.; Lathlean, Tim; Leasher, Janet L.; Lee, Yong Yi; Leigh, James; Lim, Stephen S.; Limb, Elizabeth; Lin, John Kent; Lipnick, Michael; Lipshultz, Steven E.; Liu, Wei; Loane, Maria; Ohno, Summer Lockett; Lyons, Ronan; Ma, Jixiang; Mabweijano, Jacqueline; MacIntyre, Michael F.; Malekzadeh, Reza; Mallinger, Leslie; Manivannan, Sivabalan; Marcenes, Wagner; March, Lyn; Margolis, David J.; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGill, Neil; McGrath, John; Elena Medina-Mora, Maria; Meltzer, Michele; Mensah, George A.; Merriman, Tony R.; Meyer, Ana-Claire; Miglioli, Valeria; Miller, Matthew; Miller, Ted R.; Mitchell, Philip B.; Mocumbi, Ana Olga; Moffitt, Terrie E.; Mokdad, Ali A.; Monasta, Lorenzo; Montico, Marcella; Moradi-Lakeh, Maziar; Moran, Andrew; Morawska, Lidia; Mori, Rintaro; Murdoch, Michele E.; Mwaniki, Michael K.; Naidoo, Kovin; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nelson, Paul K.; Nelson, Robert G.; Nevitt, Michael C.; Newton, Charles R.; Nolte, Sandra; Norman, Paul; Norman, Rosana; O'Donnell, Martin; O'Hanlon, Simon; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Page, Andrew; Pahari, Bishnu; Pandian, Jeyaraj Durai; Rivero, Andrea Panozo; Patten, Scott B.; Pearce, Neil; Perez Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Phillips, Michael R.; Pierce, Kelsey; Pion, Sebastien; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. Arden, III; Popova, Svetlana; Porrini, Esteban; Pourmalek, Farshad; Prince, Martin; Pullan, Rachel L.; Ramaiah, Kapa D.; Ranganathan, Dharani; Razavi, Homie; Regan, Mathilda; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Richardson, Kathryn; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; De Leon, Felipe Rodriguez; Ronfani, Luca; Room, Robin; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Schwebel, David C.; Scott, James Graham; Segui-Gomez, Maria; Shahraz, Saeid; Shepard, Donald S.; Shin, Hwashin; Shivakoti, Rupak; Singh, David; Singh, Gitanjali M.; Singh, Jasvinder A.; Singleton, Jessica; Sleet, David A.; Sliwa, Karen; Smith, Emma; Smith, Jennifer L.; Stapelberg, Nicolas J. C.; Steer, Andrew; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Syed, Sana; Tamburlini, Giorgio; Tavakkoli, Mohammad; Taylor, Hugh R.; Taylor, Jennifer A.; Taylor, William J.; Thomas, Bernadette; Thomson, W. Murray; Thurston, George D.; Tleyjeh, Imad M.; Tonelli, Marcello; Towbin, Jeff Rey A.; Truelsen, Thomas; Tsilimbaris, Miltiadis K.; Ubeda, Clotilde; Undurraga, Eduardo A.; van der Werf, Marieke J.; van Os, Jim; Vavilala, Monica S.; Venketasubramanian, N.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weatherall, David J.; Weinstock, Martin A.; Weintraub, Robert; Weisskopf, Marc G.; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Sean R. M.; Witt, Emma; Wolfe, Frederick; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Zaidi, Anita K. M.; Zheng, Zhi-Jie; Zonies, David; Lopez, Alan D.; Murray, Christopher J. L.			Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							IRON-DEFICIENCY ANEMIA; DEPRESSIVE DISORDER; HEARING IMPAIRMENT; COGNITIVE FUNCTION; MENTAL-DISORDERS; LIFE EXPECTANCY; 187 COUNTRIES; PREVALENCE; HEALTH; POPULATION	Background Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs). Methods Of the 291 diseases and injuries in the GBD cause list, 289 cause disability. For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality. Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies. For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources. For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates). Disability weights for 220 unique health states were used to capture the severity of health loss. YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods. We included uncertainty estimates at all stages of the analysis. Findings Global prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350 000 cases per 1 million people. Prevalence and severity of health loss were weakly correlated (correlation coefficient -0.37). In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990. The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases. The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls. Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010. Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality. Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa. Interpretation Rates of YLDs per 100 000 people have remained largely constant over time but rise steadily with age. Population growth and ageing have increased YLD numbers and crude rates over the past two decades. Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased. Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality. Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges. Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.	[Baxter, Amanda; Erskine, Holly; Ferrari, Alize; Khoo, Jon-Paul; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Higashi, Hideki; Lee, Yong Yi; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James Graham] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Flaxman, Abraham D.; Naghavi, Mohsen; Lozano, Rafael; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Campbell, Benjamin; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen S.; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Salomon, Joshua A.; Danaei, Goodarz; Lin, John Kent; Miller, Matthew; Singh, Gitanjali M.; Sudfeld, Christopher; Tavakkoli, Mohammad; Weisskopf, Marc G.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Wei] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Colan, Steven D.] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Bhalla, Kavi] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, San Antonio, TX USA; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, H. Ross; Gupta, Ramyani; Limb, Elizabeth] St Georges Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Bell, Michelle L.; Huang, John J.; Ozgediz, Doruk] Yale Univ, New Haven, CT USA; [Felson, David T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Hay, Roderick J.] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Dahiya, Manu] Queen Mary Univ London, Inst Dent, London, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Black, James A.] MRC, Epidemiol Unit, Cambridge, England; [Blencowe, Hannah; Brooker, Simon; Edmond, Karen; Pearce, Neil; Pullan, Rachel L.; Smith, Jennifer L.] London Sch Hyg & Trop Med, London WC1, England; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim; Leigh, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bonaventure, Audrey; Elbaz, Alexis] INSERM, Paris, France; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Bucello, Chiara; Mitchell, Philip B.] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Brayne, Carol; Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buckle, Geoff Rey; Manivannan, Sivabalan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Canter, Charles E.] Washington Univ, St Louis, MO USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Carmona, Loreto] Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [Cella, Claudia; Cortinovis, Monica; Gaspari, Flavio; Miglioli, Valeria; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Havmoeller, Rasmus] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [de Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.; Denenberg, Julie] Univ Calif San Diego, San Diego, CA 92103 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Dellavalle, Robert] Denver VA Med Ctr, Denver, CO USA; [Derrett, Sarah; Grainger, Rebecca; Merriman, Tony R.; Taylor, William J.; Thomson, W. Murray] Univ Otago, Dunedin, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dolk, Helen; Loane, Maria] Univ Ulster, Ulster, Ireland; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ewoigbokhan, Stalin E.] Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Feigin, Valery] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Polanczyk, Guilherme V.] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Franklin, Richard] Royal Life Saving Soc, Sydney, NSW, Australia; [Franklin, Richard; Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Nevitt, Michael C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Groeger, Justina] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Guillemin, Francis] Univ Lorraine, Nancy, France; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Halasa, Yara A.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, St Bio De Llobregat, Spain; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hill, Catherine] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Hoen, Bruno] Univ Franche Comte, F-25030 Besancon, France; [Hoen, Bruno] Ctr Hosp Reg Univ Besancon, Besancon, France; [Hoffman, Howard] NIDCD, NIH, Bethesda, MD USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [King, Charles H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Laslett, Laura L.] Univ Tasmania, Hobart, Tas 7001, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Ma, Jixiang] China Ctr Dis Control, Natl Ctr Noncommunicable Dis Control & Prevent, Beijing, Peoples R China; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Mwaniki, Michael K.] Kemri Wellcome Trust, Kilifi, Kenya; [Naidoo, Kovin] Univ KwaZulu Natal, AVRI, Durban, South Africa; [Naldi, Luigi] Ctr Studi GISED, Bergamo, Italy; [Nolte, Sandra] Charite, D-13353 Berlin, Germany; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Rivero, Andrea Panozo] Hosp Joan 23, La Paz, Bolivia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Perez Padilla, Rogelio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porrini, Esteban] Hosp Univ Canarias, Tenerif, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Ramaiah, Kapa D.] Vector Control Res Ctr, Pondicherry, India; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Regan, Mathilda] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rein, David B.] Univ Chicago, NORC, Chicago, IL 60637 USA; [De Leon, Felipe Rodriguez] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Shin, Hwashin] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Syed, Sana; Zaidi, Anita K. M.] Agwa Khan Univ, Karachi, Pakistan; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Tonelli, Marcello] Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Towbin, Jeff Rey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Iraklion, Greece; [Ubeda, Clotilde] ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [van Os, Jim] Maastricht Univ Med Ctr, Maastricht, Netherlands; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Sean R. M.] Univ Western Sydney, Campbelltown, NSW, Australia; [Wolfe, Frederick] Arthrit Res, Wichita, KS USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Nelson, Robert G.] NIDDK, NIH, Bethesda, MD USA	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Emory University; Emory University; St Georges University London; Mayo Clinic; University of Auckland; Pontificia Universidad Javeriana; Yale University; Boston University; University of Oxford; University of Oxford; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Flinders University South Australia; Cabrini Health; Monash University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Camilo Jose Cela University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Pennsylvania; Griffith University; Griffith University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Ulster University; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); Carnegie Mellon University; James Cook University; Howard University; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centers for Disease Control & Prevention - USA; Universite de Lorraine; University of Bristol; New York University; Brandeis University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska University Hospital; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine; University of Port Harcourt; George Mason University; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Case Western Reserve University; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of Tasmania; Nova Southeastern University; University of Miami; Swansea University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Mulago National Referral Hospital; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Duke University; IRCCS Burlo Garofolo; Columbia University; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; Watford General Hospital; University of Kwazulu Natal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; University of Calgary; Hospital Universitario Cruces; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidad de la Laguna; University of British Columbia; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of California System; University of California Berkeley; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Turning Point Alcohol & Drug Centre - Australia; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Health Canada; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); Drexel University; University of Alberta; Cincinnati Children's Hospital Medical Center; University of Copenhagen; University of Crete; KNCV Tuberculosis Foundation; Maastricht University; Maastricht University Medical Centre (MUMC); National University of Singapore; Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; Western Sydney University; National Data Bank for Rheumatic Diseases; Royal Cornwall Hospital; University of London; London School Economics & Political Science; Landstuhl Regional Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Cheng, Andrew/O-1159-2018; Salomon, Joshua/S-1929-2019; Truelsen, Thomas/AAY-1549-2020; Degenhardt, Louisa J/D-4515-2012; Newton, Charles RJC/B-7578-2014; Pope, C. Arden/ABD-5522-2021; SHIN, HS/AAE-5381-2022; Thomson, William Murray/A-4971-2008; Jayaraman, Sudha/AAH-3059-2019; Naldi, Luigi/K-6343-2016; Dellavalle, Robert/L-2020-2013; Brugha, Traolach/T-9326-2019; Monasta, Lorenzo/B-1388-2012; Courville, Karen/AAW-1462-2021; PACELLA, ROSANA E./F-2774-2010; Bikbov, Boris/I-4594-2013; Carapetis, Jonathan R/H-8933-2014; Ebel, Beth/F-4544-2014; Phillips, Michael Robert/AAE-7585-2021; Salomon, Joshua A/D-3898-2009; Schwebel, David/GXH-9944-2022; Bernabe, Eduardo/R-3441-2017; Colan, Steven/ABB-4580-2020; Krishnamurthi, Rita/AAU-7841-2021; Ortblad, Katrina/ABF-9070-2020; Ferrari, Alize J/G-1746-2011; Polanczyk, Guilherme V/C-2345-2012; Sacco, Ralph/Y-9278-2019; Moradi-Lakeh, Maziar/ABC-9793-2021; Pourmalek, Farshad/A-8188-2010; Elbaz, Alexis/F-8952-2017; Aboyans, Victor/AAN-8308-2020; Pandian, Jeyaraj Durai/AAV-5591-2020; Perico, Norberto/ABH-3222-2020; Boussinesq, Michel/J-7256-2016; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Moffitt, Terrie E/D-5295-2011; Naidoo, Kovin Shunmugam/AAF-5914-2020; Bolliger, Ian W/C-4207-2016; Montico, Marcella/B-5290-2013; Polanczyk, Guilherme V./AAF-6142-2021; Nolte, Sandra/B-7498-2008; Newton, Charles/V-7872-2019; Lopez, Alan D/F-1487-2010; Díaz-Torné, César/AAG-2419-2020; Laslett, Laura/G-3973-2011; Ganatra, Hammad A/P-8652-2019; Lalloo, Ratilal/O-5624-2014; Steer, Andrew C/C-2840-2013; Bennett, Derrick/AAH-1220-2022; Bennett, Derrick/AFL-9254-2022; Hill, Catherine L/AAE-7152-2019; Higashi, Hideki/D-3797-2011; Bell, Michelle/Y-4608-2018; Coffeng, Luc/AAL-6631-2021; Charlson, Fiona/R-8963-2019; Bin Abdulhak, Aref/AAK-4348-2020; Matzopoulos, Richard/AAL-9965-2021; Patten, Scott/B-4434-2011; Oliveira, Claudia DL/G-8618-2011; Stovner, Lars Jacob/D-5025-2014; Pesudovs, Konrad/T-9403-2019; Aggarwal, Rakesh/D-1583-2009; Ali, Mohammed K/N-9833-2013; Tonelli, Marcello/B-3028-2009; Carabin, Helene/B-7600-2016; Zonies, David/B-6497-2011; Buchbinder, Rachelle/G-2952-2011; Osborne, Richard H/A-9447-2010; Medina-Mora, María Elena I/T-5937-2018; Condon, John R/N-2281-2013; Charlson, Fiona J/F-5290-2011; Anderson, Hugh R/A-7417-2016; Thomson, William Murray/AAC-8575-2019; Gunnell, David/ABE-6653-2020; Jacobsen, Kathryn H./B-5857-2008; Lopez, Alan/AAA-2734-2022; van Os, Jim/V-8884-2019; Erskine, Holly/K-5244-2012; Cowie, Benjamin/HFZ-9941-2022; Lozano, Rafael/T-5352-2018; Singh, Jasvinder/R-6172-2019; Black, James A/A-5917-2010; Feigin, Valery/AAF-2313-2019; , Bennett/O-7998-2019; Lathlean, Tim/K-3653-2013; Bin Abdulhak, Aref/AAM-9492-2020; Marks, Guy B./F-5058-2013; Ronfani, Luca/B-6668-2013; Room, Robin/ABH-8505-2020; Sudfeld, Christopher/AAW-3856-2021; Harrison, James/B-8958-2009; Thurston, George/ABB-1359-2021; Braithwaite, Tasanee/AAZ-1118-2020; Naldi, Luigi/AFM-8982-2022; Room, Robin/ABF-7460-2021; Carmona, Loreto/A-2748-2014; Davis, Adrian C/E-6022-2015; Hall, Wayne D/A-3283-2008; Mokdad, Ali H./AAD-1232-2022; Ferri, Cleusa Pinheiro/B-2922-2010; PEREZ-RUIZ, FERNANDO/E-4844-2012; Lee, Yong Yi/C-1373-2015; Haro, Josep Maria/D-1423-2011; Grainger, Rebecca/I-1866-2012; Baxter, Amanda/E-5449-2011; Brayne, Carol/AAA-4285-2020; O'Donnell, Martin/ABE-7459-2020; Prince, Martin J/A-9170-2010; Malekzadeh, Reza/U-1382-2017; Norman, Paul E/C-5485-2013; Narayan, K.M. Venkat/J-9819-2012; Whiteford, Harvey A/A-4840-2009; Scott, James/D-5900-2012; Karthikeyan, Ganesan/D-5767-2012; Jarvis, Deborah/E-6494-2011; Choobkar, Saeed/AAA-3212-2020; McGrath, John Joseph/G-5493-2010; van Os, Jim/C-2113-2014; Saha, Sukanta/K-3774-2012; Franklin, Richard Charles/H-1731-2012; RUIZ, FERNANDO PEREZ/X-1980-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Benjamin, Emelia/E-7103-2011; Undurraga, Eduardo A./I-3739-2014; Morawska, Lidia/B-4140-2011; Blore, Jed/K-6331-2012; Remuzzi, Giuseppe/V-9766-2017; Watt, Kerrianne/G-2520-2010; Leasher, Janet/B-8889-2016	Cheng, Andrew/0000-0002-2698-0516; Salomon, Joshua/0000-0003-3929-5515; Degenhardt, Louisa J/0000-0002-8513-2218; Newton, Charles RJC/0000-0002-6999-5507; SHIN, HS/0000-0002-7263-6257; Thomson, William Murray/0000-0003-0588-6843; Jayaraman, Sudha/0000-0003-1094-5836; Naldi, Luigi/0000-0002-3160-2835; Dellavalle, Robert/0000-0001-8132-088X; Brugha, Traolach/0000-0002-9786-9591; Monasta, Lorenzo/0000-0001-7774-548X; Courville, Karen/0000-0002-4182-6736; PACELLA, ROSANA E./0000-0002-9742-1957; Bikbov, Boris/0000-0002-1925-7506; Carapetis, Jonathan R/0000-0002-1182-9792; Phillips, Michael Robert/0000-0002-5973-2439; Salomon, Joshua A/0000-0003-3929-5515; Bernabe, Eduardo/0000-0002-1858-3713; Krishnamurthi, Rita/0000-0003-0869-2083; Ortblad, Katrina/0000-0002-5675-8836; Ferrari, Alize J/0000-0002-7863-9117; Polanczyk, Guilherme V/0000-0003-2311-3289; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Pourmalek, Farshad/0000-0002-2134-0771; Elbaz, Alexis/0000-0001-9724-5490; Perico, Norberto/0000-0002-3147-4327; Boussinesq, Michel/0000-0001-6312-0681; Moffitt, Terrie E/0000-0002-8589-6760; Bolliger, Ian W/0000-0001-8055-297X; Montico, Marcella/0000-0003-0377-8232; Polanczyk, Guilherme V./0000-0003-2311-3289; Nolte, Sandra/0000-0001-6185-9423; Newton, Charles/0000-0002-6999-5507; Lopez, Alan D/0000-0001-5818-6512; Díaz-Torné, César/0000-0001-6275-7699; Laslett, Laura/0000-0002-4336-0095; Ganatra, Hammad A/0000-0001-9534-2780; Lalloo, Ratilal/0000-0001-5822-1269; Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Hill, Catherine L/0000-0001-8289-4922; Higashi, Hideki/0000-0002-5534-0905; Bell, Michelle/0000-0002-3965-1359; Coffeng, Luc/0000-0002-4425-2264; Charlson, Fiona/0000-0003-2876-5040; Matzopoulos, Richard/0000-0001-9063-6210; Patten, Scott/0000-0001-9871-4041; Pesudovs, Konrad/0000-0002-6322-9369; Aggarwal, Rakesh/0000-0001-9689-494X; Tonelli, Marcello/0000-0002-0846-3187; Buchbinder, Rachelle/0000-0002-0597-0933; Osborne, Richard H/0000-0002-9081-2699; Medina-Mora, María Elena I/0000-0001-9300-0752; Condon, John R/0000-0003-4952-0990; Charlson, Fiona J/0000-0003-2876-5040; Gunnell, David/0000-0002-0829-6470; Jacobsen, Kathryn H./0000-0002-4198-6246; van Os, Jim/0000-0002-7245-1586; Erskine, Holly/0000-0003-3119-9211; Cowie, Benjamin/0000-0002-7087-5895; Lozano, Rafael/0000-0002-7356-8823; Singh, Jasvinder/0000-0003-3485-0006; Black, James A/0000-0002-2200-3179; Bin Abdulhak, Aref/0000-0001-9988-8609; Marks, Guy B./0000-0002-8976-8053; Ronfani, Luca/0000-0001-5710-3914; Sudfeld, Christopher/0000-0002-3203-3638; Harrison, James/0000-0001-9893-8491; Braithwaite, Tasanee/0000-0002-3025-4066; Naldi, Luigi/0000-0002-3160-2835; Room, Robin/0000-0002-5618-385X; Carmona, Loreto/0000-0002-4401-2551; Davis, Adrian C/0000-0001-7134-7528; Hall, Wayne D/0000-0003-1984-0096; Mokdad, Ali H./0000-0002-4994-3339; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Lee, Yong Yi/0000-0003-2359-6823; Haro, Josep Maria/0000-0002-3984-277X; Grainger, Rebecca/0000-0001-9201-8678; Baxter, Amanda/0000-0001-8198-9022; Brayne, Carol/0000-0001-5307-663X; O'Donnell, Martin/0000-0002-7347-7761; Prince, Martin J/0000-0003-1379-7146; Malekzadeh, Reza/0000-0002-9820-6335; Norman, Paul E/0000-0003-3406-0506; Narayan, K.M. Venkat/0000-0001-8621-5405; Whiteford, Harvey A/0000-0003-4667-6623; Scott, James/0000-0002-0744-0688; Karthikeyan, Ganesan/0000-0002-2073-2917; McGrath, John Joseph/0000-0002-4792-6068; Franklin, Richard Charles/0000-0003-1864-4552; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Mayosi, Bongani/0000-0001-6641-8950; Duber, Herbert/0000-0002-5077-3170; O'donnell, Colm/0000-0002-8004-450X; Budke, Christine/0000-0002-4750-0905; Shibuya, Kenji/0000-0003-2528-7530; Benjamin, Emelia/0000-0003-4076-2336; Ali, Mohammed/0000-0001-7266-2503; Farzadfar, Farshad/0000-0001-8288-4046; Mori, Rintaro/0000-0001-7656-6156; Ebel, Beth/0000-0001-9310-8325; Colquhoun, Samantha/0000-0002-6750-1147; Weissman, Myrna/0000-0003-3490-3075; Miller, Ted/0000-0002-0958-2639; williams, hywel/0000-0002-5646-3093; Aboyans, Victor/0000-0002-0322-9818; Ackerman, Ilana/0000-0002-6028-1612; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Derrett, Sarah/0000-0003-2867-0498; Chen, Honglei/0000-0003-3446-7779; Buckle, Geoffrey/0000-0001-7721-0397; Undurraga, Eduardo A./0000-0002-4425-1253; WILKINSON, JAMES/0000-0003-1945-5622; Phillips, David/0000-0003-2569-1015; Basanez, Maria-Gloria/0000-0001-5031-3361; Mocumbi, Ana/0000-0002-9564-2860; Woolf, Anthony/0000-0001-8482-8056; Feigin, Valery L./0000-0002-6372-1740; Fevre, Eric/0000-0001-8931-4986; Loane, Maria/0000-0002-1206-3637; Gabbe, Belinda/0000-0001-7096-7688; Morawska, Lidia/0000-0002-0594-9683; Burney, Peter/0000-0001-8635-5678; Stolk, Wilma/0000-0001-9509-1328; Mock, Charles/0000-0002-0564-568X; King, Charles/0000-0001-8349-9270; Blencowe, Hannah/0000-0003-1556-3159; Wolfe, Frederick/0000-0002-2801-6413; Johns, Nicole/0000-0003-4513-4582; Bonaventure, Audrey/0000-0001-6665-8145; Blore, Jed/0000-0002-3649-8686; O'Hanlon, Simon/0000-0002-6852-3911; Porrini, Esteban/0000-0002-3056-4662; Tleyjeh, Imad/0000-0002-5551-0353; Pullan, Rachel/0000-0001-9844-1362; Dherani, Mukesh/0000-0002-3055-9636; Barrero, Lope/0000-0003-1503-0264; Syed, Sana/0000-0003-0954-0583; Felson, David/0000-0002-2668-2447; Pion, Sebastien/0000-0002-9468-7020; Kobusingye, Olive/0000-0003-2413-599X; White, Richard Aubrey/0000-0002-6747-1726; Jarvis, Deborah/0000-0002-1753-3896; Remuzzi, Giuseppe/0000-0002-6194-3446; Rein, David/0000-0002-1271-5789; Hotez, Peter/0000-0001-8770-1042; Mensah, George/0000-0002-0387-5326; Sanchez Riera, Lidia/0000-0003-0774-2480; Calabria, Bianca/0000-0001-6444-4696; Groeger, Justina/0000-0003-0324-3385; Pearce, Neil/0000-0002-9938-7852; Smith, Emma/0000-0001-6510-2583; Alvarado, Miriam/0000-0003-2864-9410; Lin, John/0000-0003-2490-4453; Watt, Kerrianne/0000-0002-2275-081X; Mitchell, Philip/0000-0002-7954-5235; Knowlton, Lisa Marie/0000-0001-6046-5035; Lathlean, Timothy/0000-0001-7340-1567; Merriman, Tony/0000-0003-0844-8726; Taylor, Hugh/0000-0002-9437-784X; Leasher, Janet/0000-0002-8779-5162; Cooper, Leslie/0000-0003-1002-3313; Cella, Claudia/0000-0002-9210-0775; Gmel, Gerhard/0000-0001-9403-9405; Boufous, Soufiane/0000-0002-5686-1729; Shivakoti, Rupak/0000-0002-2773-9310; Pandian, Jeyaraj/0000-0003-0028-1968; Razavi, Homie/0000-0002-2658-6930; Malekzadeh, Reza/0000-0003-1043-3814	Berlin Heart Honoraria; Lundbeck; Medtronic; Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm; CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine; Societe Francaise de Negma-Lerads; Pfizer; Pierre Fabre Medicaments; Sanofi-Aventis France; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Novartis; National Council for Scientific and Technological Development (CNPq, Brazil); European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); Takeda; Savient; Ardea; Regeneron; Allergan; URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Cancer Institute (NCI); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology; Wellcome Trust [098045, 085308]; Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; NIH, the National Institute of Environmental Health Sciences; Africa Programme for Onchocerciasis Control (WHO/APOC); NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; US Department of Veterans Affairs; Health Research Council of New Zealand; University of Otago; National Institute for Stroke and Applied Neurosciences; Swedish Research Council [2011-1071]; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council; World Health Organization; World Mental Health Japan (WMH-J); Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Australian Government; National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences; South African Medical Research Council Burden of Disease Research Unit; University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant [ES015459]; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; National Institute of Environmental Health Sciences [ES00260]; Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; AUT University; MRC [G0901214] Funding Source: UKRI; Medical Research Council [G0901214, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, P30ES000260, T32ES015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Berlin Heart Honoraria; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine(Region Grand-Est); Societe Francaise de Negma-Lerads; Pfizer(Pfizer); Pierre Fabre Medicaments; Sanofi-Aventis France(Sanofi-Aventis); Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Novartis(Novartis); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Ardea; Regeneron(Regeneron); Allergan(AbbVieAllergan); URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology; Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; NIH, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Africa Programme for Onchocerciasis Control (WHO/APOC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US Department of Veterans Affairs(US Department of Veterans Affairs); Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; National Institute for Stroke and Applied Neurosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Health Organization(World Health Organization); World Mental Health Japan (WMH-J); Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare; Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences(Tehran University of Medical Sciences); South African Medical Research Council Burden of Disease Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; AUT University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C E Canter has worked as an Optum Health consultant, Blue Cross Blue Shield consultant, and received Berlin Heart Honoraria and travel fees. E R Dorsey has received payments for consulting services from Lundbeck and Medtronic and research support from Lundbeck and Prana Biotechnology. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other remuneration. F Guillemin did a study on osteoarthritis epidemiology in an institution that received grants from public sources: Assurance-Maladie (CNAMTS) InVS, Inserm, CHU de Nancy, CHU de Nice, Conseil Regional de Lorraine, Societe Francaise de Negma-Lerads, Pfizer, Pierre Fabre Medicaments, Sanofi-Aventis France. H J Hoffman is a US Federal Government employee of the National Institutes of Health (NIH). P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G A Mensah is a former employee of PepsiCo. F Perez-Ruiz was an advisor for Ardea, Menarini, Novartis, Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an advisor for educational issues for Savient; led investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea. G V Polanczyk has served as a speaker or consultant to Eli-Lily, Novartis, Janssen-Cilag, and Shire Pharmaceuticals, developed educational material for Janssen-Cilag, and received an independent investigator grant from Novartis and from the National Council for Scientific and Technological Development (CNPq, Brazil). L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and received research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). J A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals, and Novartis. J A Singh is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. J A Singh is supported by research grants from the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institute on Aging (NIA), National Cancer Institute (NCI) and the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs) and is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease Study 2010 in various capacities. We would also like to specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also wish to express our gratitude to the following organizations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Lori M Newman, Jordis Ott, Poul Erik Petersen, Shekhar Saxena, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support in order to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalog as much data as possible to inform the estimates; Erin C Mullany for her systematic efforts in organizing drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript; Brad Bell for his review, critiques, and insights about the DisMod-MR software which helped to improve its performance and results; and Jiaji Du for his work developing the user interface for the DisMod-MR software so that multiple expert groups could use it and easily assess the results. The following individuals would like to acknowledge various forms of institutional support. J P Abraham, B Bartels, and P Yeh recognize the support of the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the World Health Organization Violence and Injury Prevention. B Bikbov acknowledges support from the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology. R Bourne acknowledges the Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. S Brooker is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). T S Brugha received funding from the Department of Health London, for the National Health Service Information Centre, by the University of Leicester. R Buchbinder is partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University and Cabrini Health. P Burney and D Jarvis acknowledge that the Chronic Respiratory Disease Group received support from the BUPA Foundation, who had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. C Cella, M Cortinovis, F Gaspari, V Miglioli, and N Perico on behalf of the entire Genitourinary Expert Group acknowledge the International Society of Nephrology (ISN).; H Chen acknowledges that his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng and W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for their work on onchocerciasis. B C Cowie received institutional support from the Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support her work for illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, Australia. R Dellavalle was supported by the US Department of Veterans Affairs while contributing to this study. S Derrett acknowledges the Health Research Council of New Zealand and the University of Otago for their support. V Feigin and R Krishnamurthi were supported by the National Institute for Stroke and Applied Neurosciences, AUT University. E Fevre acknowledges the Wellcome Trust for grant 085308. W Hall was supported by an NHMRC Australia Fellowship. R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill and Melinda Gates Foundation and the Australian National Health and Medical Research Council. K H Jacobsen was supported by the World Health Organization for her work on hepatitis A. N Kawakami notes that the collection of data ultimately used in this study was supported by the following grants: The World Mental Health Japan (WMH-J) is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He would like to thank staff members, field coordinators, and interviewers of the WMH Japan 2002-2004 Survey. L L Laslett is supported by an Australian Government Australian Postgraduate Award. She also notes that the TasOAC study, the results of which were used in this research, was supported by the National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation, and University of Tasmania Institutional Research Grants Scheme. R Malekzadeh funding from research grant of Tehran University of Medical Sciences to do the related studies. R Matzopoulos acknowledges the two institutions that support his research work: South African Medical Research Council Burden of Disease Research Unit; and the University of Cape Town School of Public Health and Family Medicine. T Merriman acknowledges the Health Research Council of New Zealand. K Naidoo was supported by the Brien Holden Vision Institute. P Nelson was supported by the National Drug and Alcohol Research Centre (UNSW, Australia). R G Nelson acknowledges his research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. C Olives was funded in part by the Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant (ES015459).; D Ozgediz acknowledges the staff and collaborators at the Mulago Hospital and Makerere University in Kampala, Uganda. K Pesudovs received institutional support from Flinders University. R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson received funding support from the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funds from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD). G D Thurston was supported in part by Center grant ES00260 from the National Institute of Environmental Health Sciences. D J Weatherall was supported by the Wellcome Trust UK, the Medical Research Council UK and the Anthony Cerami and Ann Dunne Research Trust.	Agency for Healthcare Research and Quality, US MED EXP PAN SURV; ALTER G, 1989, POP STUD-J DEMOG, V43, P25, DOI 10.1080/0032472031000143836; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; [Anonymous], 2021, CANC INCIDENCE 5 CON; [Anonymous], 2002, WORLD HLTH REP 2002; [Anonymous], 2004, WORLD HLTH REP 2004; [Anonymous], 2002, CANC INCIDENCE 5 CON; Australian Bureau of Statistics A, NAT SURV MENT HLTH W; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bhidayasiri R, 2011, NEUROEPIDEMIOLOGY, V37, P222, DOI 10.1159/000334440; Brody J A, 1990, Aging (Milano), V2, P283; Brooker S, 2001, TROP MED INT HEALTH, V6, P998, DOI 10.1046/j.1365-3156.2001.00798.x; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Brooks PM, 2004, APLAR J RHEUMATOL, V7, P272; Canadian Institute of Health Information, 2011, NAT AMB CAR REP SYST; CDC National Center for Health Statistics, 1993, NAT AMB MED CAR SURV; CDC National Center for Health Statistics, 1992, NAT HOSP AMB MED CAR; Chen Wan-qing, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P374; Clements ACA, 2009, B WORLD HEALTH ORGAN, V87, P921, DOI 10.2471/BLT.08.058933; Cohen A., 2002, WORLD MENTAL HLTH CA; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Doll R, 1970, CANC INCIDENCE 5 CON, VII; Eaton WW, 2007, ACTA PSYCHIAT SCAND, V116, P182, DOI 10.1111/j.1600-0447.2007.01017.x; Eppig C, 2010, P ROY SOC B-BIOL SCI, V277, P3801, DOI 10.1098/rspb.2010.0973; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gates GA, 2002, J AM GERIATR SOC, V50, P482, DOI 10.1046/j.1532-5415.2002.50114.x; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Goldman LS, 1999, J GEN INTERN MED, V14, P569, DOI 10.1046/j.1525-1497.1999.03478.x; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Health organization, 2001, WORLD HLTH REPORT 20; Hickman M., 2002, B NARCOTICS, VLIV, P15, DOI DOI 10.1016/J.DRUGOPO.2005.02.05; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hsairi M, 2003, Sante Publique, V15, P25; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Iwata N, 2002, PSYCHIAT RES, V110, P281, DOI 10.1016/S0165-1781(02)00102-6; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1080/j.1440-1614.2000.00728.x; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johansson S R, 1991, Health Transit Rev, V1, P39; Kapteyn A, 2007, AM ECON REV, V97, P461, DOI 10.1257/aer.97.1.461; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Kristensen N, 2008, LABOUR ECON, V15, P96, DOI 10.1016/j.labeco.2006.11.001; Leonard H, 2003, PAEDIATR PERINAT EP, V17, P58, DOI 10.1046/j.1365-3016.2003.00469.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathers Colin D, 2006, Popul Health Metr, V4, P4, DOI 10.1186/1478-7954-4-4; Mayr WT, 2003, NEUROLOGY, V61, P1373, DOI 10.1212/01.WNL.0000094316.90240.EB; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; MUIR C, 1987, IARC SCI PUBLICATION, V88; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Murray C. J. L., 1996, GLOBAL HLTH STAT COM; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, GLOBAL BURDEN DIS CO; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; New York Heart Association, 1964, DIS HEART BLOOD VESS; Olshansky SJ, 1991, J AGING HEALTH, V312, P194, DOI DOI 10.1177/089826439100300205; PARKIN DM, 1992, IARC SCI PUBLICATION, V120; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; RCGP Research & Surveillance Centre, 2009, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2005, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2008, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2007, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2010, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2006, WEEKL RET SERV ANN R; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; Schur N, 2013, ACTA TROP, V128, P365, DOI 10.1016/j.actatropica.2011.10.006; Simeon DT, 1995, W INDIAN MED J, P27; Soriano JB, 2003, INT J TUBERC LUNG D, V7, P415; Strickland D, 2004, MOVEMENT DISORD, V19, P318, DOI 10.1002/mds.10619; Sugawara N, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-27; UNAIDS, 2011, SPECTR EPP 2011; US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism, NAT EP SURV ALC REL; van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Wallhagen MI, 2008, RES GERONTOL NURS, V1, P80, DOI 10.3928/19404921-20080401-08; WALTER T, 1989, PEDIATRICS, V84, P7; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; Waterhouse JA, 1982, IARC SCI PUBLICATION, VIV; Watkins WE, 1996, T ROY SOC TROP MED H, V90, P156, DOI 10.1016/S0035-9203(96)90121-2; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2010, WOR HEALT REP, P1; Woolf AD, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.2.81; Woolf AD, 2001, BMJ-BRIT MED J, V322, P1079, DOI 10.1136/bmj.322.7294.1079; World Health Organization, 2003, INTRO DRUG UTILIZATI; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	108	4488	4725	51	1429	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2163	2196		10.1016/S0140-6736(12)61729-2	http://dx.doi.org/10.1016/S0140-6736(12)61729-2			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245607	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000312387000015
J	Chamberlain, JS				Chamberlain, Jeffrey S.			A Genetic Intervention Stands a Skip Away from Clinical Tests	SCIENCE			English	Editorial Material							DUCHENNE MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; EXPRESSION		[Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Sch Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Sch Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chamberlain, JS (corresponding author), Univ Washington, Dept Neurol, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	Jsc5@u.washington.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	NIAMS NIH HHS [R37 AR040864] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040864] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BERTORINI TE, 1991, MUSCLE NERVE, V14, P503, DOI 10.1002/mus.880140603; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; KOENIG M, 1989, AM J HUM GENET, V45, P498; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Nicolas A, 2012, ORPHANET J RARE DIS, V7, DOI [10.1186/1750-1172-7-45, 10.1186/1750-1172-7-42]; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Schmajuk G, 1999, J BIOL CHEM, V274, P21783, DOI 10.1074/jbc.274.31.21783	15	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1431	1432		10.1126/science.1233074	http://dx.doi.org/10.1126/science.1233074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239725				2022-12-01	WOS:000312250800036
J	Werner, EW; Mei, TS; Burckle, AJ; Sigman, MS				Werner, Erik W.; Mei, Tian-Sheng; Burckle, Alexander J.; Sigman, Matthew S.			Enantioselective Heck Arylations of Acyclic Alkenyl Alcohols Using a Redox-Relay Strategy	SCIENCE			English	Article							WACKER-TYPE OXIDATION; ALLYLIC ALCOHOLS; ASYMMETRIC HECK; DIAZONIUM SALTS; CATALYST; DIFUNCTIONALIZATION; KETONES; GAMMA	Progress in the development of asymmetric Heck couplings of arenes and acyclic olefins has been limited by a tenuous understanding of the factors that dictate selectivity in migratory insertion and beta-hydride elimination. On the basis of key mechanistic insight recently garnered in the exploration of selective Heck reactions, we report here an enantioselective variant that delivers beta-, gamma-, or delta-aryl carbonyl products from acyclic alkenol substrates. The catalyst system imparts notable regioselectivity during migratory insertion and promotes the migration of the alkene's unsaturation toward the alcohol to ultimately form the ketone product. The reaction uses aryldiazonium salts as the arene source, yields enantiomeric products from opposite starting alkene configurations, and uses a readily accessible ligand. The racemic nature of the alkenol substrate does not bias the enantioselection.	[Werner, Erik W.; Mei, Tian-Sheng; Burckle, Alexander J.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu	Mei, Tian-Sheng/Y-3266-2019; mei, tiansheng/H-5293-2011	Mei, Tian-Sheng/0000-0002-4985-1071; 	NIH [R01GM063540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01GM063540.	AYYAR KS, 1968, CAN J CHEMISTRY, V46, P1467, DOI 10.1139/v68-242; Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; Berthiol F, 2006, TETRAHEDRON, V62, P4372, DOI 10.1016/j.tet.2006.02.061; Bouquillon S, 2001, J ORGANOMET CHEM, V634, P153, DOI 10.1016/S0022-328X(01)01149-4; Burns NZ, 2009, ANGEW CHEM INT EDIT, V48, P2854, DOI 10.1002/anie.200806086; Calo V, 2007, J ORG CHEM, V72, P2596, DOI 10.1021/jo070005f; Dounay AB, 2003, CHEM REV, V103, P2945, DOI 10.1021/cr020039h; Harper KC, 2012, NAT CHEM, V4, P366, DOI [10.1038/NCHEM.1297, 10.1038/nchem.1297]; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Jensen KH, 2010, J AM CHEM SOC, V132, P17471, DOI 10.1021/ja108106h; Jensen KH, 2009, J AM CHEM SOC, V131, P17074, DOI 10.1021/ja909030c; KIKUKAWA K, 1981, TETRAHEDRON, V37, P31, DOI 10.1016/S0040-4020(01)97711-7; Kikushima K, 2011, J AM CHEM SOC, V133, P6902, DOI 10.1021/ja200664x; LAROCK RC, 1989, TETRAHEDRON LETT, V30, P6629, DOI 10.1016/S0040-4039(00)70636-8; Mc Cartney D, 2011, CHEM SOC REV, V40, P5122, DOI 10.1039/c1cs15101k; McDonald RI, 2011, ORG LETT, V13, P2830, DOI 10.1021/ol200784y; MELPOLDER JB, 1976, J ORG CHEM, V41, P265, DOI 10.1021/jo00864a017; Michel BW, 2011, J AM CHEM SOC, V133, P8317, DOI 10.1021/ja2017043; Michel BW, 2009, J AM CHEM SOC, V131, P6076, DOI 10.1021/ja901212h; Richter JM, 2008, J AM CHEM SOC, V130, P17938, DOI 10.1021/ja806981k; Roglans A, 2006, CHEM REV, V106, P4622, DOI 10.1021/cr0509861; Shibasaki M, 2004, ADV SYNTH CATAL, V346, P1533, DOI 10.1002/adsc.200404203; Sigman MS, 2012, ACCOUNTS CHEM RES, V45, P874, DOI 10.1021/ar200236v; Smith SW, 2009, J AM CHEM SOC, V131, P14231, DOI 10.1021/ja9061823; Tanaka K, 1999, CHEM PHARM BULL, V47, P1053; Taylor JG, 2011, EUR J ORG CHEM, V2011, P1403, DOI 10.1002/ejoc.201001620; Urkalan KB, 2009, ANGEW CHEM INT EDIT, V48, P3146, DOI 10.1002/anie.200900218; Werner EW, 2011, J AM CHEM SOC, V133, P9692, DOI 10.1021/ja203164p; Werner EW, 2010, J AM CHEM SOC, V132, P13981, DOI 10.1021/ja1060998; Yonehara K, 2000, J ORGANOMET CHEM, V603, P40, DOI 10.1016/S0022-328X(00)00069-3; Yoo KS, 2007, ORG LETT, V9, P3933, DOI 10.1021/ol701584f; Yoo KS, 2010, J ORG CHEM, V75, P95, DOI 10.1021/jo901977n; Zultanski SL, 2011, J AM CHEM SOC, V133, P15362, DOI 10.1021/ja2079515	34	331	330	10	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1455	1458		10.1126/science.1229208	http://dx.doi.org/10.1126/science.1229208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239733	Green Accepted			2022-12-01	WOS:000312250800044
J	Ofri, D				Ofri, Danielle			The Storm and the Aftermath	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10003 USA; [Ofri, Danielle] Bellevue Hosp, New York, NY USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10003 USA.			Ofri, Danielle/0000-0001-9865-7104					0	16	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2265	2267		10.1056/NEJMp1213843	http://dx.doi.org/10.1056/NEJMp1213843			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23151281				2022-12-01	WOS:000312187700014
J	Shaughnessy, AF				Shaughnessy, Allen F.			Monoclonal antibodies: magic bullets with a hefty price tag	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED PHASE-3 TRIAL; MULTIPLE-SCLEROSIS; ALEMTUZUMAB		Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	Allen.Shaughnessy@Tufts.edu						[Anonymous], 2012, LANCET, V380, P1792; Bourgoin AF, WHAT YOU NEED KNOW F; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Fanneau de La Horie GC, MAKING BIOL DRUGS MO; Herper M, WORLDS MOST EXPENSIV; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Staton T, SANOFI PULLS CAMPATH; U.S. Food and Drug Administration, BIOS	9	71	76	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8346	10.1136/bmj.e8346	http://dx.doi.org/10.1136/bmj.e8346			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236036				2022-12-01	WOS:000312495100013
J	Han, ZJ; Qiu, F; Eisenberg, R; Holland, PL; Krauss, TD				Han, Zhiji; Qiu, Fen; Eisenberg, Richard; Holland, Patrick L.; Krauss, Todd D.			Robust Photogeneration of H-2 in Water Using Semiconductor Nanocrystals and a Nickel Catalyst	SCIENCE			English	Article							PHOTOCATALYTIC HYDROGEN-PRODUCTION; ARTIFICIAL PHOTOSYNTHESIS; REDUCTION; COMPLEX; LIGHT; LIGANDS	Homogeneous systems for light-driven reduction of protons to H-2 typically suffer from short lifetimes because of decomposition of the light-absorbing molecule. We report a robust and highly active system for solar hydrogen generation in water that uses CdSe nanocrystals capped with dihydrolipoic acid (DHLA) as the light absorber and a soluble Ni2+-DHLA catalyst for proton reduction with ascorbic acid as an electron donor at pH = 4.5, which gives >600,000 turnovers. Under appropriate conditions, the precious-metal-free system has undiminished activity for at least 360 hours under illumination at 520 nanometers and achieves quantum yields in water of over 36%.	[Han, Zhiji; Qiu, Fen; Eisenberg, Richard; Holland, Patrick L.; Krauss, Todd D.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester	Eisenberg, R (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	eisenberg@chem.rochester.edu; holland@chem.rochester.edu; krauss@chem.rochester.edu	Qiu, Fen/H-9479-2016; Krauss, Todd/GQA-6399-2022; Eisenberg, Robert/P-6070-2019	Krauss, Todd/0000-0002-4860-874X; Eisenberg, Richard/0000-0003-1762-535X	Office of Basic Energy Sciences, U.S. Department of Energy [DE-FG02-09ER16121, DE-SC0002106]	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Z.H. led the effort for hydrogen generation and catalysis, and F. Q. for nanocrystal synthesis and characterization. This work was supported by the Office of Basic Energy Sciences, U.S. Department of Energy, grant DE-FG02-09ER16121 and DE-SC0002106. The authors acknowledge the University of Rochester Medical Center and the Department of Environmental Medicine for the analytical support and R. M. Gelein for the cadmium and nickel AAS measurements.	Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; Amirav L, 2010, J PHYS CHEM LETT, V1, P1051, DOI 10.1021/jz100075c; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; BONOMI F, 1992, INORG CHIM ACTA, V192, P237, DOI 10.1016/S0020-1693(00)80765-3; BROWN GM, 1979, J AM CHEM SOC, V101, P1298, DOI 10.1021/ja00499a051; Brown KA, 2012, J AM CHEM SOC, V134, P5627, DOI 10.1021/ja2116348; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; DiSalle BF, 2011, J AM CHEM SOC, V133, P11819, DOI 10.1021/ja201514e; Eckenhoff WT, 2012, DALTON T, V41, P13004, DOI 10.1039/c2dt30823a; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Han ZJ, 2012, ANGEW CHEM INT EDIT, V51, P1667, DOI 10.1002/anie.201107329; Jasieniak J, 2011, ACS NANO, V5, P5888, DOI 10.1021/nn201681s; Kockerling M, 2000, INORG CHEM COMMUN, V3, P117; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; McCormick TM, 2010, J AM CHEM SOC, V132, P15480, DOI 10.1021/ja1057357; McNamara WR, 2012, P NATL ACAD SCI USA, V109, P15594, DOI 10.1073/pnas.1120757109; Probst B, 2011, INORG CHEM, V50, P3404, DOI 10.1021/ic102317u; Shemesh Y, 2011, ANGEW CHEM INT EDIT, V50, P1185, DOI 10.1002/anie.201006407; SLETTEN J, 1994, ACTA CHEM SCAND, V48, P929, DOI 10.3891/acta.chem.scand.48-0929; Streich D, 2010, CHEM-EUR J, V16, P60, DOI 10.1002/chem.200902489; Talapin DV, 2004, J PHYS CHEM B, V108, P18826, DOI 10.1021/jp046481g; TREMEL W, 1988, INORG CHEM, V27, P3886, DOI 10.1021/ic00295a004; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P3193, DOI 10.1002/anie.201006352; White TA, 2011, J AM CHEM SOC, V133, P15332, DOI 10.1021/ja206782k	27	632	643	31	923	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1321	1324		10.1126/science.1227775	http://dx.doi.org/10.1126/science.1227775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138979				2022-12-01	WOS:000311991200060
J	Kohl, KP; Jones, CD; Sekelsky, J				Kohl, Kathryn P.; Jones, Corbin D.; Sekelsky, Jeff			Evolution of an MCM Complex in Flies That Promotes Meiotic Crossovers by Blocking BLM Helicase	SCIENCE			English	Article							STRAND BREAK REPAIR; GENETIC-ANALYSIS; DROSOPHILA BLM; CROSSING-OVER; MUTS HOMOLOG; RECOMBINATION	Generation of meiotic crossovers in many eukaryotes requires the elimination of anti-crossover activities by using the Msh4-Msh5 heterodimer to block helicases. Msh4 and Msh5 have been lost from the flies Drosophila and Glossina, but we identified a complex of minichromosome maintenance (MCM) proteins that functionally replace Msh4-Msh5. We found that REC, an ortholog of MCM8 that evolved under strong positive selection in flies, interacts with MEI-217 and MEI-218, which arose from a previously undescribed metazoan-specific MCM protein. Meiotic crossovers were reduced in Drosophila rec, mei-217, and mei-218 mutants; however, removal of the Bloom syndrome helicase (BLM) ortholog restored crossovers. Thus, MCMs were co-opted into a novel complex that replaced the meiotic pro-crossover function of Msh4-Msh5 in flies.	[Kohl, Kathryn P.; Sekelsky, Jeff] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Sekelsky, Jeff] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Sekelsky, Jeff] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sekelsky, J (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	sekelsky@unc.edu	Chun, Jongsik/R-8458-2017; Kim, Bong-Soo/L-4779-2013; Kang, Hojeong/C-7208-2011	Chun, Jongsik/0000-0003-3385-5171; Kim, Bong-Soo/0000-0003-1243-8280; Sekelsky, Jeff/0000-0002-4424-677X	NIH [GM061252, 5T32GM007092]; NSF [MCB-0618691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R01GM061252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. McKim for helpful discussions and for sharing unpublished results, and N. Crown and other members of the Sekelsky laboratory for helpful comments on the manuscript. Supported by NIH grant GM061252 (J.S.), NSF grant MCB-0618691 (J.S., C.D.J., and G. C. Copenhaver), and NIH grant 5T32GM007092 (K. P. K.). Alignments and trees were submitted to TreeBASE (http://purl.org/phylo/treebase/phylows/study/TB2:S13435).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; BAKER BS, 1972, GENETICS, V71, P255; Blanton HL, 2005, PLOS GENET, V1, P343, DOI 10.1371/journal.pgen.0010040; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lake CM, 2007, GENETICS, V176, P2151, DOI 10.1534/genetics.107.073551; Liu H, 2000, GENETICS, V154, P1735; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Manheim EA, 2002, MOL BIOL CELL, V13, P84, DOI 10.1091/mbc.01-06-0318; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Morgan T. H., 1912, Science New York N S, V36; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040	18	44	48	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1363	1365		10.1126/science.1228190	http://dx.doi.org/10.1126/science.1228190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224558	Green Submitted, Green Accepted			2022-12-01	WOS:000311991200073
J	Abbott, A				Abbott, Alison			COGNITION The brain's decline	NATURE			English	Editorial Material																			0	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S4	S5		10.1038/492S4a	http://dx.doi.org/10.1038/492S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222672	Bronze			2022-12-01	WOS:000311893400003
J	Rose, J; Parashar, UD				Rose, Johnie; Parashar, Umesh D.			Should India launch a national immunisation programme against rotavirus? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; VACCINE; MORTALITY; EFFICACY; DIARRHEA; INFANTS; SAFETY; IMPACT		[Rose, Johnie] Case Western Reserve Univ, Div Res, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA; [Parashar, Umesh D.] Ctr Dis Control & Prevent, Atlanta, GA USA	Case Western Reserve University; Centers for Disease Control & Prevention - USA	Rose, J (corresponding author), Case Western Reserve Univ, Div Res, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA.	johnie.rose@case.edu	/AHA-3700-2022; /AAB-7864-2021	/0000-0001-7458-9303; /0000-0001-7458-9303	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2009, WKLY EPIDEMIOL REC; Babji S, 2012, CURR OPIN VIROL, V2, P443, DOI 10.1016/j.coviro.2012.05.005; Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094; International Institute for Population Sciences Macro International, 2007, NAT FAM HLTH SURV NF, V1, P242; Morris SK, 2012, B WORLD HEALTH ORGAN, V90, P720, DOI 10.2471/BLT.12.101873; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rose J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3653; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WHO - World Health Organization, 2010, STAT ROT ROT VACC IN	15	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e7818	10.1136/bmj.e7818	http://dx.doi.org/10.1136/bmj.e7818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23203999	Green Accepted			2022-12-01	WOS:000311896500002
J	Armstrong, K				Armstrong, Katrina			Genomics and Health Care Disparities The Role of Statistical Discrimination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Ctr Comparat Effectiveness Genom Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Armstrong, K (corresponding author), Univ Penn, Ctr Comparat Effectiveness Genom Med, Perelman Sch Med, 1220 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	karmstro@mail.med.upenn.edu			NCI NIH HHS [UC2CA148310] Funding Source: Medline; NATIONAL CANCER INSTITUTE [UC2CA148310] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agency for Healthcare Research and Quality, 2010 NAT HEALTHC QUA; Bickell NA, 2006, J CLIN ONCOL, V24, P1357, DOI 10.1200/JCO.2005.04.5799; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Harman JS, 2004, PSYCHIAT SERV, V55, P1379, DOI 10.1176/appi.ps.55.12.1379; *I MED, 2002, UN TREATM CONFR RAC; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; Valenzuela JM, 2011, PEDIATR DIABETES, V12, P696, DOI 10.1111/j.1399-5448.2011.00766.x	10	5	5	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1979	1980		10.1001/2012.jama.10820	http://dx.doi.org/10.1001/2012.jama.10820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23138130				2022-12-01	WOS:000311291400019
J	Gruen, RL; Reade, MC				Gruen, Russell L.; Reade, Michael C.			Administer tranexamic acid early to injured patients at risk of substantial bleeding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRAUMA PATIENTS; HEMORRHAGE; CRASH-2; MORTALITY		[Gruen, Russell L.] Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Gruen, Russell L.] Monash Univ, Melbourne, Vic 3004, Australia; [Reade, Michael C.] Univ Queensland, Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld 4129, Australia; [Reade, Michael C.] Australian Def Force Joint Hlth Command, Canberra, ACT 2600, Australia; [Reade, Michael C.] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld 4129, Australia; [Gruen, Russell L.] The Alfred, Melbourne, Vic 3004, Australia	Monash University; Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital	Gruen, RL (corresponding author), Natl Trauma Res Inst, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	r.gruen@alfred.org.au	Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707				Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	14	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2012	345								e7133	10.1136/bmj.e7133	http://dx.doi.org/10.1136/bmj.e7133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044GQ	23165649				2022-12-01	WOS:000311607800001
J	Cohen, JM; Woolsey, AM; Sabot, OJ; Gething, PW; Tatem, AJ; Moonen, B				Cohen, Justin M.; Woolsey, Aaron M.; Sabot, Oliver J.; Gething, Peter W.; Tatem, Andrew J.; Moonen, Bruno			Optimizing Investments in Malaria Treatment and Diagnosis	SCIENCE			English	Editorial Material							SUB-SAHARAN AFRICA; COUNTRIES; FEVERS; POLICY		[Cohen, Justin M.; Woolsey, Aaron M.; Sabot, Oliver J.; Moonen, Bruno] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA	University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cohen, JM (corresponding author), Clinton Hlth Access Initiat, Boston, MA 02127 USA.	jcohen@clinton-healthaccess.org	Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022	Gething, Peter/0000-0001-6759-5449; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2008, GLOB MAL ACT PLAN MA; Arnold F., 2012, PRELIMINARY REP IND; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; Clinton Health Access Initiative, 2011, MAINT GAINS GLOB MAL; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Johnston G., 1996, REPEATED MEASURES AN; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Larson BA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-314; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization (WHO), 2010, GUID TREATM MAL; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	24	38	38	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					612	614		10.1126/science.1229045	http://dx.doi.org/10.1126/science.1229045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118172				2022-12-01	WOS:000310516000033
J	Paull, D; Emmanuele, V; Weiss, KA; Treff, N; Stewart, L; Hua, HQ; Zimmer, M; Kahler, DJ; Goland, RS; Noggle, SA; Prosser, R; Hirano, M; Sauer, MV; Egli, D				Paull, Daniel; Emmanuele, Valentina; Weiss, Keren A.; Treff, Nathan; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Goland, Robin S.; Noggle, Scott A.; Prosser, Robert; Hirano, Michio; Sauer, Mark V.; Egli, Dieter			Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants	NATURE			English	Article							MEIOTIC SPINDLE; HUMAN EMBRYOS; CELL-LINES; STEM-CELLS; MOUSE; SEGREGATION; MTDNA; VITRIFICATION; MICROTUBULES; DEFICIENCY	Mitochondrial DNA mutations transmitted maternally within the oocyte cytoplasm often cause life-threatening disorders. Here we explore the use of nuclear genome transfer between unfertilized oocytes of two donors to prevent the transmission of mitochondrial mutations. Nuclear genome transfer did not reduce developmental efficiency to the blastocyst stage, and genome integrity was maintained provided that spontaneous oocyte activation was avoided through the transfer of incompletely assembled spindle-chromosome complexes. Mitochondrial DNA transferred with the nuclear genome was initially detected at levels below 1%, decreasing in blastocysts and stem-cell lines to undetectable levels, and remained undetectable after passaging for more than one year, clonal expansion, differentiation into neurons, cardiomyocytes or beta-cells, and after cellular reprogramming. Stem cells and differentiated cells had mitochondrial respiratory chain enzyme activities and oxygen consumption rates indistinguishable from controls. These results demonstrate the potential of nuclear genome transfer to prevent the transmission of mitochondrial disorders in humans.	[Paull, Daniel; Weiss, Keren A.; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Noggle, Scott A.; Egli, Dieter] New York Stem Cell Fdn Lab, New York, NY 10032 USA; [Emmanuele, Valentina; Hirano, Michio] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Treff, Nathan] Reprod Med Associates New Jersey, Morristown, NJ 07960 USA; [Hua, Haiqing; Goland, Robin S.] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Prosser, Robert; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA; [Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA	The New York Stem Cell Foundation; Columbia University; Reproductive Medicine Associates of New Jersey; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Lab, New York, NY 10032 USA.	mvs9@columbia.edu; d.egli@nyscf.org	Kahler, David J/I-9275-2019	Kahler, David J/0000-0002-7144-2215; Noggle, Scott/0000-0002-0374-2240	New York Stem Cell Foundation; New York State Stem Cell Science award [C026184]; Bernard and Anne Spitzer Fund	New York Stem Cell Foundation; New York State Stem Cell Science award; Bernard and Anne Spitzer Fund	We thank S. Chang and K. Eggan for discussions, Z. Hall for critical reading of the manuscript, and L. Yu and O. Nahum for SNP-array preparation. We thank anonymous oocyte donors for participating in research, and M. Spencer for a Lykos laser system. This work was supported by the New York Stem Cell Foundation, the New York State Stem Cell Science award C026184, and the Bernard and Anne Spitzer Fund.	ASRM, 2012, FERTIL STERIL; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bianchi V, 2005, HUM REPROD, V20, P1078, DOI 10.1093/humrep/deh736; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GOOK DA, 1994, HUM REPROD, V9, P684, DOI 10.1093/oxfordjournals.humrep.a138572; Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124; INOUE S, 1975, BIOPHYS J, V15, P725, DOI 10.1016/S0006-3495(75)85850-4; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Larman MG, 2007, REPROD BIOMED ONLINE, V15, P692, DOI 10.1016/S1472-6483(10)60537-8; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Meirelles FV, 1998, GENETICS, V148, P877; Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Rosenwaks Z, 2010, NAT MED, V16, P645, DOI 10.1038/nm0610-645; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Soc As Reprod Tech Amer Reprod Med, 2004, FERTIL STERIL, V81, P1207, DOI 10.1016/j.fertnstert.2004.01.017; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang Jing, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1906s68	47	172	185	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					632	+		10.1038/nature11800	http://dx.doi.org/10.1038/nature11800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23254936	Green Accepted			2022-12-01	WOS:000314219600048
J	Hackett, JA; Sengupta, R; Zylicz, JJ; Murakami, K; Lee, C; Down, TA; Surani, MA				Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Down, Thomas A.; Surani, M. Azim			Germline DNA Demethylation Dynamics and Imprint Erasure Through 5-Hydroxymethylcytosine	SCIENCE			English	Article							TET PROTEINS; MOUSE; METHYLATION; GENOME; CELL; 5-METHYLCYTOSINE; SPECIFICATION; MECHANISMS; CONVERSION; GENES	Mouse primordial germ cells (PGCs) undergo sequential epigenetic changes and genome-wide DNA demethylation to reset the epigenome for totipotency. Here, we demonstrate that erasure of CpG methylation (5mC) in PGCs occurs via conversion to 5-hydroxymethylcytosine (5hmC), driven by high levels of TET1 and TET2. Global conversion to 5hmC initiates asynchronously among PGCs at embryonic day (E) 9.5 to E10.5 and accounts for the unique process of imprint erasure. Mechanistically, 5hmC enrichment is followed by its protracted decline thereafter at a rate consistent with replication-coupled dilution. The conversion to 5hmC is an important component of parallel redundant systems that drive comprehensive reprogramming in PGCs. Nonetheless, we identify rare regulatory elements that escape systematic DNA demethylation in PGCs, providing a potential mechanistic basis for transgenerational epigenetic inheritance.	[Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Down, Thomas A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QN, England; [Zylicz, Jan J.; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Murakami, Kazuhiro/AAC-4569-2019	Murakami, Kazuhiro/0000-0003-1759-9542; Hackett, Jamie/0000-0002-6237-3684; Surani, Azim/0000-0002-8640-4318; Zylicz, Jan/0000-0001-9622-5658	Wellcome Trust [RG49135, RG44593, 083563]; Human Frontier Science Program	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank N. Miller for fluorescence-activated cell sorting analysis, F. Tang and W. Tang for experimental support, and G-L. Xu for reagents. This work was funded by the Wellcome Trust (RG49135, RG44593, and 083563) and the Human Frontier Science Program. Sequencing data have been deposited in the Sequence Read Archive (SRA060914).	Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Qin CH, 2010, MOL CARCINOGEN, V49, P54, DOI 10.1002/mc.20576; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	25	529	548	1	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					448	452		10.1126/science.1229277	http://dx.doi.org/10.1126/science.1229277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23223451	Green Accepted			2022-12-01	WOS:000313960700044
J	Menting, JG; Whittaker, J; Margetts, MB; Whittaker, LJ; Kong, GKW; Smith, BJ; Watson, CJ; Zakova, L; Kletvikova, E; Jiracek, J; Chan, SJ; Steiner, DF; Dodson, GG; Brzozowski, AM; Weiss, MA; Ward, CW; Lawrence, MC				Menting, John G.; Whittaker, Jonathan; Margetts, Mai B.; Whittaker, Linda J.; Kong, Geoffrey K. -W.; Smith, Brian J.; Watson, Christopher J.; Zakova, Lenka; Kletvikova, Emilia; Jiracek, Jiri; Chan, Shu Jin; Steiner, Donald F.; Dodson, Guy G.; Brzozowski, Andrzej M.; Weiss, Michael A.; Ward, Colin W.; Lawrence, Michael C.			How insulin engages its primary binding site on the insulin receptor	NATURE			English	Article							1ST 3 DOMAINS; DIABETES-ASSOCIATED MUTATIONS; LIGAND-INDUCED ACTIVATION; MOLECULAR REPLACEMENT; PROTEIN; AFFINITY; MODEL; REFINEMENT; PEPTIDE; ELEMENT	Insulin receptor signalling has a central role in mammalian biology, regulating cellular metabolism, growth, division, differentiation and survival(1,2). Insulin resistance contributes to the pathogenesis of type 2 diabetes mellitus and the onset of Alzheimer's disease(3); aberrant signalling occurs in diverse cancers, exacerbated by crosstalk with the homologous type 1 insulin-like growth factor receptor (IGF1R)(4). Despite more than three decades of investigation, the three-dimensional structure of the insulin-insulin receptor complex has proved elusive, confounded by the complexity of producing the receptor protein. Here we present the first view, to our knowledge, of the interaction of insulin with its primary binding site on the insulin receptor, on the basis of four crystal structures of insulin bound to truncated insulin receptor constructs. The direct interaction of insulin with the first leucine-rich-repeat domain (L1) of insulin receptor is seen to be sparse, the hormone instead engaging the insulin receptor carboxy-terminal alpha-chain (alpha CT) segment, which is itself remodelled on the face of L1 upon insulin binding. Contact between insulin and L1 is restricted to insulin B-chain residues. The aCT segment displaces the B-chain C-terminal beta-strand away from the hormone core, revealing the mechanism of a long-proposed conformational switch in insulin upon receptor engagement. This mode of hormone-receptor recognition is novel within the broader family of receptor tyrosine kinases(5). We support these findings by photo-crosslinking data that place the suggested interactions into the context of the holoreceptor and by isothermal titration calorimetry data that dissect the hormone-insulin receptor interface. Together, our findings provide an explanation for a wealth of biochemical data from the insulin receptor and IGF1R systems relevant to the design of therapeutic insulin analogues.	[Menting, John G.; Margetts, Mai B.; Kong, Geoffrey K. -W.; Smith, Brian J.; Ward, Colin W.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Whittaker, Jonathan; Whittaker, Linda J.; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem, Melbourne, Vic 3086, Australia; [Watson, Christopher J.; Dodson, Guy G.; Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zakova, Lenka; Kletvikova, Emilia; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague, Czech Republic; [Chan, Shu Jin; Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Case Western Reserve University; La Trobe University; University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Chicago; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	michael.weiss@case.edu; lawrence@wehi.edu.au	Smith, Brian J/F-8282-2011; Jiracek, Jiri/Y-6703-2019; Zakova, Lenka/Y-6234-2019; Jiracek, Jiri/A-7124-2008; Zakova, Lenka/A-7119-2008; Lawrence, Michael C/A-5357-2009	Smith, Brian J/0000-0003-0498-1910; Jiracek, Jiri/0000-0003-3848-2773; Zakova, Lenka/0000-0001-6439-2574; Jiracek, Jiri/0000-0003-3848-2773; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801	Australian National Health and Medical Research Council (NHMRC) [516729, 575539, 1005896]; Hazel and Pip Appel Fund; NHMRC [361646]; Victorian State Government; NIH [DK40949, DK13914, DK20595]; American Diabetes Association [1-11INI-31]; Grant Agency of the Czech Republic [P207/11/P430]; Research Project of the Academy of Sciences of the Czech Republic [RVO: 61388963]; BBSRC; UoY Research Priming Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013914, R01DK013914, P30DK020595, P60DK020595, R01DK040949] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UoY Research Priming Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This Letter is dedicated to our co-author, the late Guy Dodson, in recognition of his lifetime contribution to the study of the structure of insulin. This work was supported by Australian National Health and Medical Research Council (NHMRC) Project grants 516729, 575539 and 1005896 and the Hazel and Pip Appel Fund (to M. C. L.), NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute of Medical Research), NIH grant no. DK40949(to M. A. W. and J.W.) and American Diabetes Association grant no. 1-11INI-31 (to J.W.), Grant Agency of the Czech Republic grant P207/11/P430 (to L.Z.), Research Project of the Academy of Sciences of the Czech Republic RVO: 61388963 (to the Institute of Organic Chemistry and Biochemistry), NIH grants DK13914 and DK20595 (to D. F. S.), a BBSRC PhD studentship (to C. J.W.) and the UoY Research Priming Fund(to the York Structural Biology Laboratory). Part of this research was undertaken on the MX2 beamline at the Australian Synchrotron (AS), Victoria, Australia. We thank the DLS for access to beamline I24 and the Australian International Synchrotron Access Program for travel funds. We thank P. Colman and J. Gulbis, our colleagues at CSIRO and the AS beam line staff for their support; J. Turkenburg for assistance in collecting data at DLS; K. Huang for assistance with midi-receptor photo-crosslinking; Q.-X. Hua and Y. Yang for discussion of NMR studies of insulin; S.-Q. Hu, S. H. Nakagawa, N. F. Phillips and S. Wang for assistance with insulin analogue synthesis; P. G. Katsoyannis for advice about the synthesis of photo-reactive insulin analogues and for providing an initial set of Pap analogues; K. Siddle for supplying the 83-7 and 83-14 hybridomas; L. Lu and the fermentation group CSIRO Materials Science and Engineering for large-scale cell culture.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G., 2011, BUSTER VERSION 2 10; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARKUSSEN J, 1991, J BIOL CHEM, V266, P18814; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w	52	261	282	4	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					241	U276		10.1038/nature11781	http://dx.doi.org/10.1038/nature11781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302862	Green Accepted			2022-12-01	WOS:000313259600043
J	Holt, B; Lessard, JP; Borregaard, MK; Fritz, SA; Araujo, MB; Dimitrov, D; Fabre, PH; Graham, CH; Graves, GR; Jonsson, KA; Nogues-Bravo, D; Wang, ZH; Whittaker, RJ; Fjeldsa, J; Rahbek, C				Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Dimitrov, Dimitar; Fabre, Pierre-Henri; Graham, Catherine H.; Graves, Gary R.; Jonsson, Knud A.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Fjeldsa, Jon; Rahbek, Carsten			An Update of Wallace's Zoogeographic Regions of the World	SCIENCE			English	Article							GLOBAL PATTERNS; CLIMATE-CHANGE; DISTRIBUTIONS; CONSERVATION; DIVERSITY; VELOCITY; ENDEMISM	Modern attempts to produce biogeographic maps focus on the distribution of species, and the maps are typically drawn without phylogenetic considerations. Here, we generate a global map of zoogeographic regions by combining data on the distributions and phylogenetic relationships of 21,037 species of amphibians, birds, and mammals. We identify 20 distinct zoogeographic regions, which are grouped into 11 larger realms. We document the lack of support for several regions previously defined based on distributional data and show that spatial turnover in the phylogenetic composition of vertebrate assemblages is higher in the Southern than in the Northern Hemisphere. We further show that the integration of phylogenetic information provides valuable insight on historical relationships among regions, permitting the identification of evolutionarily unique regions of the world.	[Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Graves, Gary R.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Rahbek, Carsten] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, DK-2100 Copenhagen O, Denmark; [Fritz, Susanne A.] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Fritz, Susanne A.] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany; [Araujo, Miguel B.] CSIC, Dept Biogeog & Global Change, Natl Museum Nat Sci, Madrid 28006, Spain; [Araujo, Miguel B.] Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, P-7000 Evora, Portugal; [Dimitrov, Dimitar; Fabre, Pierre-Henri; Jonsson, Knud A.; Fjeldsa, Jon] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark; [Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Graves, Gary R.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20013 USA; [Whittaker, Robert J.] Univ Oxford, Biodivers Res Grp, Sch Geog & Environm, Ctr Environm, Oxford OX1 3QY, England	University of Copenhagen; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; University of Copenhagen; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford	Lessard, JP (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, DK-2100 Copenhagen O, Denmark.	jplessard@bio.ku.dk	Rahbek, Carsten/L-1129-2013; Graham, Catherine/A-9560-2011; Fjeldså, Jon/A-9699-2013; Graves, Gary R/P-1003-2017; Rahbek, Carsten/D-9372-2013; Jonsson, Knud A/F-6902-2012; Jønsson, Knud/GMW-5310-2022; Whittaker, Robert J/H-1548-2015; Dimitrov, Dimitar/A-9563-2009; Wang, Zhiheng/G-1750-2010; Araújo, Miguel B/B-6117-2008; Borregaard, Michael/B-8442-2008; Graham, Catherine/AAN-1237-2020; Fritz, Susanne/M-9872-2014	Rahbek, Carsten/0000-0003-4585-0300; Graham, Catherine/0000-0001-9267-7948; Fjeldså, Jon/0000-0003-0790-3600; Graves, Gary R/0000-0003-1406-5246; Jønsson, Knud/0000-0002-1875-9504; Whittaker, Robert J/0000-0001-7775-3383; Dimitrov, Dimitar/0000-0001-5830-5702; Wang, Zhiheng/0000-0003-0808-7780; Araújo, Miguel B/0000-0002-5107-7265; Borregaard, Michael/0000-0002-8146-8435; Graham, Catherine/0000-0001-9267-7948; Fritz, Susanne/0000-0002-4085-636X; Pierre-Henri, Fabre/0000-0002-3414-5625; Nogues-Bravo, David/0000-0002-4060-0153; Holt, Ben G./0000-0003-0831-9684	Danish National Research Foundation; Marie Curie Actions under the Seventh Framework Programme [PIEF-GA-2009-252888]; Spanish Research Council (CSIC)	Danish National Research Foundation(Danmarks Grundforskningsfond); Marie Curie Actions under the Seventh Framework Programme; Spanish Research Council (CSIC)	We thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution, and Climate. B.G.H. also thanks the Marie Curie Actions under the Seventh Framework Programme (PIEF-GA-2009-252888). M.B.A. also thanks the Spanish Research Council (CSIC) for support, and S.A.F. thanks the Landes-Offensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz program of Hesse's Ministry of Higher Education, Research, and the Arts. We thank L. Hansen for help with data and reference compilations. We thank the International Union for Conservation of Nature and Natural Resources for making the amphibian and mammal range data available. Data are archived at http://macroecology.ku.dk/resources/wallace.	Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lomolino M.V., 2010, BIOGEOGRAPHY; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sclater P.L., 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI [10.1111/j.1096-3642.1858.tb02549.x, DOI 10.1111/J.1096-3642.1858.TB02549.X]; Udvardy MDF, 1975, 18 INT UN CONS NAT; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Wallace A. R, 1894, GEOGRAPHICAL J; Weber M, 1902, INDOAUSTRALISCHE ARC; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; [No title captured]	26	785	840	18	614	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					74	78		10.1126/science.1228282	http://dx.doi.org/10.1126/science.1228282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23258408				2022-12-01	WOS:000312985800054
J	Boj, SF; van Es, JH; Huch, M; Li, VSW; Jose, A; Hatzis, P; Mokry, M; Haegebarth, A; van den Born, M; Chambon, P; Voshol, P; Dor, Y; Cuppen, E; Fillat, C; Clevers, H				Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Jose, Anabel; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Chambon, Pierre; Voshol, Peter; Dor, Yuval; Cuppen, Edwin; Fillat, Cristina; Clevers, Hans			Diabetes Risk Gene and Wnt Effector Tcf7l2/TCF4 Controls Hepatic Response to Perinatal and Adult Metabolic Demand	CELL			English	Article							BETA-CATENIN; LIVER; POLYMORPHISMS; EXPRESSION; GLUCOSE; CORRELATE; RECEPTOR	Most studies on TCF7L2 SNP variants in the pathogenesis of type 2 diabetes (T2D) focus on a role of the encoded transcription factor TCF4 in beta cells. Here, a mouse genetics approach shows that removal of TCF4 from beta cells does not affect their function, whereas manipulating TCF4 levels in the liver has major effects on metabolism. In Tcf7l2(-/-) mice, the immediate postnatal surge in liver metabolism does not occur. Consequently, pups die due to hypoglycemia. By combining chromatin immunoprecipitation with gene expression profiling, we identify a TCF4-controlled metabolic gene program that is acutely activated in the postnatal liver. In concordance, adult liver-specific Tcf7l2 knockout mice show reduced hepatic glucose production during fasting and display improved glucose homeostasis when maintained on high-fat diet. Furthermore, liver-specific TCF4 overexpression increases hepatic glucose production. These observations imply that TCF4 directly activates metabolic genes and that inhibition of Wnt signaling may be beneficial in metabolic disease.	[Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Cuppen, Edwin; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Jose, Anabel; Fillat, Cristina] CIBERER, Barcelona 08036, Spain; [Jose, Anabel; Fillat, Cristina] IDIBAPS, Barcelona 08036, Spain; [Chambon, Pierre] Univ Strasbourg 1, IGBMC, F-67404 Illkirch Graffenstaden, France; [Voshol, Peter] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Hebrew University of Jerusalem	Clevers, H (corresponding author), KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Mokry, Michal/AAN-3809-2021; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; van+Es, Johan/ABD-5411-2021; Fillat, Cristina/ABH-1674-2020	Mokry, Michal/0000-0002-5298-4852; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Li, Vivian/0000-0003-2041-0085; Fillat, Cristina/0000-0002-0801-3338	Stichting Diabetes Onderzoek Nederland; Diabetes Fonds; EMBO [ALT-835-2007]; KWF/PF HUBR [2007-3956]; CGCII; long-term Marie Curie fellowship; Ti Pharm [T3-106]; MINECO [BIO2011-30299-C02-02]; Instituto de Salud Carlos III [IIS10/00014];  [EU/232814-stemcellmark];  [EU/236954-ICSC LGR5]	Stichting Diabetes Onderzoek Nederland; Diabetes Fonds; EMBO(European Molecular Biology Organization (EMBO)); KWF/PF HUBR; CGCII; long-term Marie Curie fellowship; Ti Pharm; MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ; 	We thank H. Begthel, J. Korving, L. van Gurp, C. Kroon-Veenboer, and B. El Haddouti for technical assistance and T. Mahmoudi and J.D. Mul for their helpful discussions. This work was supported by Stichting Diabetes Onderzoek Nederland and the Diabetes Fonds. S.F.B. is supported by EMBO long-term fellowship (ALT-835-2007) and by EU/232814-stemcellmark; J.H.E. is supported by EU/232814-stemcellmark; V.S.W.L. is supported by KWF/PF HUBR 2007-3956; P.H. was supported by CGCII; A.H. was supported by KWF/PF HUBR 2007-3956; M.H. is supported by long-term Marie Curie fellowship and EU/236954-ICSC LGR5; M.B. is supported by Ti Pharm/T3-106; and A.J. and C.F. are supported by BIO2011-30299-C02-02 from MINECO and IIS10/00014 from Instituto de Salud Carlos III.	Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DASHTI N, 1979, BIOCHEM MED METAB B, V22, P365, DOI 10.1016/0006-2944(79)90024-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; FERRE P, 1986, REPROD NUTR DEV, V26, P619, DOI 10.1051/rnd:19860413; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Gustafsson J, 2009, INDIAN J MED RES, V130, P618; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187	38	165	172	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1595	1607		10.1016/j.cell.2012.10.053	http://dx.doi.org/10.1016/j.cell.2012.10.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260145	Bronze			2022-12-01	WOS:000312890300022
J	Yamaguchi, S; Hong, K; Liu, R; Shen, L; Inoue, A; Diep, D; Zhang, K; Zhang, Y				Yamaguchi, Shinpei; Hong, Kwonho; Liu, Rui; Shen, Li; Inoue, Azusa; Diep, Dinh; Zhang, Kun; Zhang, Yi			Tet1 controls meiosis by regulating meiotic gene expression	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; EPIGENETIC EVENTS; MAMMALIAN DNA; MOUSE; MICE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; SPECIFICATION; PLURIPOTENCY	Meiosis is a germ-cell-specific cell division process through which haploid gametes are produced for sexual reproduction(1). Before the initiation of meiosis, mouse primordial germ cells undergo a series of epigenetic reprogramming steps(2,3), including the global erasure of DNA methylation at the 5-position of cytosine (5mC) in CpG-rich DNA(4,5). Although several epigenetic regulators, such as Dnmt3l and the histone methyltransferases G9a and Prdm9, have been reported to be crucial for meiosis(6), little is known about how the expression of meiotic genes is regulated and how their expression contributes to normal meiosis. Using a loss-of-function approach in mice, here we show that the 5mC-specific dioxygenase Tet1 has an important role in regulating meiosis in mouse oocytes. Tet1 deficiency significantly reduces female germ-cell numbers and fertility. Univalent chromosomes and unresolved DNA double-strand breaks are also observed in Tet1-deficient oocytes. Tet1 deficiency does not greatly affect the genome-wide demethylation that takes place in primordial germ cells, but leads to defective DNA demethylation and decreased expression of a subset of meiotic genes. Our study thus establishes a function for Tet1 in meiosis and meiotic gene activation in female germ cells.	[Liu, Rui; Diep, Dinh; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	kzhang@bioeng.ucsd.edu; yzhang@genetics.med.harvard.edu	Zhang, Kun/ABE-6349-2020; Yamaguchi, Shinpei/HCH-5553-2022	Zhang, Kun/0000-0002-7596-5224; Yamaguchi, Shinpei/0000-0002-9377-4835; Zhang, Yi/0000-0002-2789-0811; Hong, Kwonho/0000-0001-7479-4091	National Institutes of Health [U01DK089565]; CIRM [BRB3-05083];  [R01GM097253]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wang and W. Jiang for FACS sorting, A. Adey and J. Shendure for sharing reagents and protocols for Tn5mC-seq, and H.-L. Fung for Illumina sequencing. This work was partially supported by U01DK089565 (National Institutes of Health) (to Y.Z.), R01GM097253 and CIRM BRB3-05083 (to K.Z.). Y.Z. is an Investigator of the Howard Hughes Medical Institute. D.D. is a CIRM-UCSD pre-doctoral fellow.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/NMETH.1871, 10.1038/nmeth.1871]; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Wang H, 2006, J CELL BIOL, V173, P485, DOI 10.1083/jcb.200512077; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934	29	196	207	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					443	+		10.1038/nature11709	http://dx.doi.org/10.1038/nature11709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23151479	Green Submitted, Green Accepted			2022-12-01	WOS:000312488200059
J	Shakur, H; Roberts, I; Piot, P; Horton, R; Krug, E; Mersch, J				Shakur, Haleema; Roberts, Ian; Piot, Peter; Horton, Richard; Krug, Etienne; Mersch, Jeannot			A promise to save 100 000 trauma patients	LANCET			English	Editorial Material									[Shakur, Haleema; Roberts, Ian; Piot, Peter] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Horton, Richard] The Lancet, London NW1 7BY, England; [Krug, Etienne] WHO, CH-1211 Geneva, Switzerland; [Mersch, Jeannot] European Federat Rd Traff Victims, Luxembourg, Luxembourg	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X				Aeron-Thomas A, 2004, INVOLVEMENT IMPACT R; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peden M., 2004, WORLD REPORT ROAD TR; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	9	13	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2062	2063		10.1016/S0140-6736(12)62037-6	http://dx.doi.org/10.1016/S0140-6736(12)62037-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245601				2022-12-01	WOS:000312387000008
J	Rawlins, M				Rawlins, Michael			We are asking more questions about NICE appraisal of Tamiflu	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; NICE, 2011, TECHN APPR PROC GUID; NICE, 2002, SYST REV EFF COST EF	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8420	10.1136/bmj.e8420	http://dx.doi.org/10.1136/bmj.e8420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236048				2022-12-01	WOS:000312495100018
J	Liu, Y; Rutlin, M; Huang, SY; Barrick, CA; Wang, F; Jones, KR; Tessarollo, L; Ginty, DD				Liu, Yin; Rutlin, Michael; Huang, Siyi; Barrick, Colleen A.; Wang, Fan; Jones, Kevin R.; Tessarollo, Lino; Ginty, David D.			Sexually Dimorphic BDNF Signaling Directs Sensory Innervation of the Mammary Gland	SCIENCE			English	Article							CELL-DEATH; NERVOUS-SYSTEM; IN-VIVO; TRKB; RECEPTOR; NEURONS; MOUSE; DIFFERENTIATION; ORGANIZATION; GENE	How neural circuits associated with sexually dimorphic organs are differentially assembled during development is unclear. Here, we report a sexually dimorphic pattern of mouse mammary gland sensory innervation and the mechanism of its formation. Brain-derived neurotrophic factor (BDNF), emanating from mammary mesenchyme and signaling through its receptor TrkB on sensory axons, is required for establishing mammary gland sensory innervation of both sexes at early developmental stages. Subsequently, in males, androgens promote mammary mesenchymal expression of a truncated form of TrkB, which prevents BDNF-TrkB signaling in sensory axons and leads to a rapid loss of mammary gland innervation independent of neuronal apoptosis. Thus, sex hormone regulation of a neurotrophic factor signal directs sexually dimorphic axonal growth and maintenance, resulting in generation of a sex-specific neural circuit.	[Liu, Yin; Rutlin, Michael; Huang, Siyi; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Barrick, Colleen A.; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; University of Colorado System; University of Colorado Boulder	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Liu, Yin/0000-0002-2377-2703; JONES, KEVIN/0000-0002-3802-7562	NIH [NS34814, EY014998, DE019440]; NATIONAL CANCER INSTITUTE [ZIABC010390, ZIABC010391] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, R37NS034814, R01NS034814, R29NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ginty laboratory for assistance and discussions throughout the course of this project, and A. Kolodkin and R. Kuruvilla for comments on the manuscript. This work was supported by NIH grants NS34814 (D. D. G.), EY014998 (K.R.J.), and DE019440 (F. W.). D. D. G. is an investigator of the Howard Hughes Medical Institute. BDNFlox mice are covered under U. S. patent no. 4,959,317, which is licensed to Bristol-Myer Squibb Company, with the right to grant sublicenses. The mice are available for noncommercial biomedical research under a Material Transfer Agreement with the University of Colorado.	Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Forger NG, 2006, NEUROSCIENCE, V138, P929, DOI 10.1016/j.neuroscience.2005.07.006; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Gorski JA, 2003, J NEUROSCI, V23, P6856; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; NORDEEN EJ, 1985, SCIENCE, V229, P671, DOI 10.1126/science.4023706; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; WRIGHT LL, 1987, INT J DEV NEUROSCI, V5, P305, DOI 10.1016/0736-5748(87)90005-0	21	47	47	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1357	1360		10.1126/science.1228258	http://dx.doi.org/10.1126/science.1228258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224557	Green Accepted			2022-12-01	WOS:000311991200071
J	Sipp, D; Turner, L				Sipp, Douglas; Turner, Leigh			US Regulation of Stem Cells as Medical Products	SCIENCE			English	Editorial Material							FDA REGULATION; ENCEPHALOMYELITIS; RULES; TEXAS		[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 12345, Japan; [Turner, Leigh] Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA; [Turner, Leigh] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Turner, Leigh] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA	RIKEN; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 12345, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Turner, Leigh/0000-0001-7283-6809				Alderazi YJ, 2012, J CHILD NEUROL, V27, P632, DOI 10.1177/0883073811422831; Carpenter D, 2010, PRINC STUD AM POLIT, P73; Cyranoski D, 2012, NATURE, V484, P149, DOI 10.1038/484149a; Cyranoski D, 2011, NATURE, V477, P377; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Giannakopoulou A, 2011, EXP NEUROL, V230, P16, DOI 10.1016/j.expneurol.2010.04.011; Gottlieb S., 2012, WALL STREET J, pA13; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Ikegaya H, 2012, NATURE, V489, P33, DOI 10.1038/489033c; Johnson L., 2012, HOUSTON PUBLIC  1026; Kaiser J, 2012, SCIENCE, V336, P284, DOI 10.1126/science.336.6079.284; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Levine AD, 2012, REGEN MED, V7, P451, DOI [10.2217/RME.12.43, 10.2217/rme.12.43]; Patra P.K., 2010, LAW TECHNOL SCI, V7, P295; Pera MF, 2012, SUBMISSION NHMRC PUB; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Steeves JD, 2011, YONSEI MED J, V52, P701, DOI 10.3349/ymj.2011.52.5.701; Thirabanjasak D, 2010, J AM SOC NEPHROL, V21, P1218, DOI 10.1681/ASN.2009111156; von Eschenbach Andrew, 2012, WALL STREET J, pA19	20	37	38	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1296	1297		10.1126/science.1229918	http://dx.doi.org/10.1126/science.1229918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	049NZ	23224541				2022-12-01	WOS:000311991200048
J	Luk, KC; Kehm, V; Carroll, J; Zhang, B; O'Brien, P; Trojanowski, JQ; Lee, VMY				Luk, Kelvin C.; Kehm, Victoria; Carroll, Jenna; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M. -Y.			Pathological alpha-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice	SCIENCE			English	Article							LEWY BODIES; DISEASE; BRAIN; DEATH	Parkinson's disease is characterized by abundant alpha-synuclein (alpha-Syn) neuronal inclusions, known as Lewy bodies and Lewy neurites, and the massive loss of midbrain dopamine neurons. However, a cause-and-effect relationship between Lewy inclusion formation and neurodegeneration remains unclear. Here, we found that in wild-type nontransgenic mice, a single intrastriatal inoculation of synthetic alpha-Syn fibrils led to the cell-to-cell transmission of pathologic alpha-Syn and Parkinson's-like Lewy pathology in anatomically interconnected regions. Lewy pathology accumulation resulted in progressive loss of dopamine neurons in the substantia nigra pars compacta, but not in the adjacent ventral tegmental area, and was accompanied by reduced dopamine levels culminating in motor deficits. This recapitulation of a neurodegenerative cascade thus establishes a mechanistic link between transmission of pathologic alpha-Syn and the cardinal features of Parkinson's disease.	[Lee, Virginia M. -Y.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA.	vmylee@upenn.edu	Luk, Kelvin/AAZ-4202-2020	Luk, Kelvin/0000-0002-6591-6269	NIH [NS053488]; JPB Foundation; RJG Foundation; Parkinson Council; Jeff and Anne Keefer Fund; University of Pennsylvania Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; RJG Foundation; Parkinson Council; Jeff and Anne Keefer Fund; University of Pennsylvania Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Byrne, J. Levitan, I. Song, and J. Yeh for technical assistance, and L. Kwong, H. Tran, and K. Brunden for their comments. This work was funded by NIH NS053488, the JPB and RJG Foundations, the Parkinson Council, and the Jeff and Anne Keefer Fund. K. C. L. is supported in part by the University of Pennsylvania Institute for Translational Medicine and Therapeutics. The data reported in this paper are presented in the main text and supplementary materials. Materials and methods are available as supplementary materials on Science Online.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Baba M, 1998, AM J PATHOL, V152, P879; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033	24	1507	1542	11	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					949	953		10.1126/science.1227157	http://dx.doi.org/10.1126/science.1227157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161999	Green Accepted			2022-12-01	WOS:000311083600044
J	Murray, B				Murray, Barbara			Liverpool care pathway: doctors have always aimed to ease distress in dying	BRITISH MEDICAL JOURNAL			English	Editorial Material									Manor Med Practice, Stockport SK1 3PZ, Lancs, England		Murray, B (corresponding author), Manor Med Practice, Stockport SK1 3PZ, Lancs, England.	barby@doctors.org.uk						European Federation of National Associations of Orthopaedics and Traumatology, 2012, CONSENSUS STATEMENT; General Medical Council, 2010, TREATM CAR END LIFE; Marie Curie Palliative Care Institute Liverpool, 2010, WHAT IS LIV CAR PATH; Morrow A., 2009, WHAT IS HOSPICE COMF; National Institute for Health and Clinical Excellence, 2010, PALL CAR NEEDS	5	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7606	10.1136/bmj.e7606	http://dx.doi.org/10.1136/bmj.e7606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152571				2022-12-01	WOS:000311336400008
J	Zhang, F; Wang, J; Xu, J; Zhang, Z; Koppetsch, BS; Schultz, N; Vreven, T; Meignin, C; Davis, I; Zamore, PD; Weng, ZP; Theurkauf, WE				Zhang, Fan; Wang, Jie; Xu, Jia; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Vreven, Thom; Meignin, Carine; Davis, Ilan; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			UAP56 Couples piRNA Clusters to the Perinuclear Transposon Silencing Machinery	CELL			English	Article							MESSENGER-RNA EXPORT; DROSOPHILA-MELANOGASTER; MAGO NASHI; AXIS SPECIFICATION; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; VASA PROTEIN; GERM PLASM; LOCALIZATION; HELICASE	piRNAs silence transposons during germline development. In Drosophila, transcripts from heterochromatic clusters are processed into primary piRNAs in the perinuclear nuage. The nuclear DEAD box protein UAP56 has been previously implicated in mRNA splicing and export, whereas the DEAD box protein Vasa has an established role in piRNA production and localizes to nuage with the piRNA binding PIWI proteins Ago3 and Aub. We show that UAP56 colocalizes with the cluster-associated HP1 variant Rhino, that nuage granules containing Vasa localize directly across the nuclear envelope from cluster foci containing UAP56 and Rhino, and that cluster transcripts immunoprecipitate with both Vasa and UAP56. Significantly, a charge-substitution mutation that alters a conserved surface residue in UAP56 disrupts colocalization with Rhino, germline piRNA production, transposon silencing, and perinuclear localization of Vasa. We therefore propose that UAP56 and Vasa function in a piRNA-processing compartment that spans the nuclear envelope.	[Wang, Jie; Xu, Jia; Vreven, Thom; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Zhang, Fan; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA 01655 USA; [Zhang, Fan; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Meignin, Carine] Univ Strasbourg, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, CNRS, F-67084 Strasbourg, France; [Davis, Ilan] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Xu, Jia/F-7750-2012; Zamore, Phillip D/A-8941-2013	Xu, Jia/0000-0003-3921-018X; Meignin, Carine/0000-0002-6588-9045; Davis, Ilan/0000-0002-5385-3053; Theurkauf, William/0000-0001-7342-1912; Zamore, Phillip/0000-0002-4505-9618	NIH [HD049116]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Thanks to members of the Theurkauf and Weng labs for critical discussions and constructive criticisms, to Dr. Paul Lasko for antibodies, and to the Bloomington Drosophila Stock Center for strains. Special thanks to Melissa Moore for sharing her insights into DEAD box proteins. This work was supported by NIH grant HD049116.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Eberl DF, 1997, GENETICS, V146, P951; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; EDDY EM, 1975, INT REV CYTOL, V43, P229; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1990, DEVELOPMENT, V109, P425; Hedges DJ, 2011, ADV GENET, V73, P219, DOI 10.1016/B978-0-12-380860-8.00006-9; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jang JK, 2003, J CELL SCI, V116, P3069, DOI 10.1242/jcs.00614; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meignin C, 2008, DEV BIOL, V315, P89, DOI 10.1016/j.ydbio.2007.12.004; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr SE, 2001, GENE DEV, V15, P2886; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Siomi MC, 2010, SEMIN CELL DEV BIOL, V21, P754, DOI 10.1016/j.semcdb.2010.01.011; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006	49	158	165	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					871	884		10.1016/j.cell.2012.09.040	http://dx.doi.org/10.1016/j.cell.2012.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141543	Green Accepted, Bronze			2022-12-01	WOS:000310921200017
J	Gkogkas, CG; Khoutorsky, A; Ran, I; Rampakakis, E; Nevarko, T; Weatherill, DB; Vasuta, C; Yee, S; Truitt, M; Dallaire, P; Major, F; Lasko, P; Ruggero, D; Nader, K; Lacaille, JC; Sonenberg, N				Gkogkas, Christos G.; Khoutorsky, Arkady; Ran, Israeli; Rampakakis, Emmanouil; Nevarko, Tatiana; Weatherill, Daniel B.; Vasuta, Cristina; Yee, Stephanie; Truitt, Morgan; Dallaire, Paul; Major, Francois; Lasko, Paul; Ruggero, Davide; Nader, Karim; Lacaille, Jean-Claude; Sonenberg, Nahum			Autism-related deficits via dysregulated eIF4E-dependent translational control	NATURE			English	Article							FRAGILE-X-SYNDROME; COPY-NUMBER VARIATION; TUBEROUS-SCLEROSIS; ULTRASONIC VOCALIZATIONS; INHIBITORY SYNAPSES; SYNAPTIC PLASTICITY; SPECTRUM DISORDERS; LEARNING-DEFICITS; REPRESSOR 4E-BP2; MOUSE MODELS	Hyperconnectivity of neuronal circuits due to increased synaptic protein synthesis is thought to cause autism spectrum disorders (ASDs). The mammalian target of rapamycin (mTOR) is strongly implicated in ASDs by means of upstream signalling; however, downstream regulatory mechanisms are ill-defined. Here we show that knockout of the eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2)-an eIF4E repressor downstream of mTOR-or eIF4E overexpression leads to increased translation of neuroligins, which are postsynaptic proteins that are causally linked to ASDs. Mice that have the gene encoding 4E-BP2 (Eif4ebp2) knocked out exhibit an increased ratio of excitatory to inhibitory synaptic inputs and autistic-like behaviours (that is, social interaction deficits, altered communication and repetitive/stereotyped behaviours). Pharmacological inhibition of eIF4E activity or normalization of neuroligin 1, but not neuroligin 2, protein levels restores the normal excitation/inhibition ratio and rectifies the social behaviour deficits. Thus, translational control by eIF4E regulates the synthesis of neuroligins, maintaining the excitation-to-inhibition balance, and its dysregulation engenders ASD-like phenotypes.	[Gkogkas, Christos G.; Khoutorsky, Arkady; Rampakakis, Emmanouil; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Gkogkas, Christos G.; Khoutorsky, Arkady; Rampakakis, Emmanouil; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ran, Israeli; Weatherill, Daniel B.; Vasuta, Cristina; Lacaille, Jean-Claude] Univ Montreal, GRSNC, Montreal, PQ H3C 3J7, Canada; [Ran, Israeli; Weatherill, Daniel B.; Vasuta, Cristina; Lacaille, Jean-Claude] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Rampakakis, Emmanouil] JSS Med Res Inc, Montreal, PQ H4S 1N8, Canada; [Yee, Stephanie; Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Sch Med, San Francisco, CA 94158 USA; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Dallaire, Paul; Major, Francois] Univ Montreal, Dept Comp Sci, Montreal, PQ H3C 3J7, Canada; [Dallaire, Paul; Major, Francois] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universite de Montreal; Universite de Montreal; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	jean-claude.lacaille@umontreal.ca; nahum.sonenberg@mcgill.ca	Lasko, Paul/C-6761-2014; Gkogkas, Christos/GLR-5348-2022; Gkogkas, Christos/GQH-2659-2022; Ran, Israeli/B-2432-2009	Lasko, Paul/0000-0002-4037-3501; Gkogkas, Christos/0000-0001-6281-3419; Ran, Israeli/0000-0003-4824-6416; Rampakakis, Emmanouil/0000-0002-7427-8246; Khoutorsky, Arkady/0000-0003-3846-8728	Canadian Institutes of Health Research [MOP-114994, MOP-10848, MOP-93679, MOP-44050]; Autism Speaks [7109]; Fonds de la Recherche en Sante du Quebec (FRSQ; Groupe de Recherche sur le Systeme Nerveux Central); National Institutes of Health [NIH RO1 CA154916, NIH RO1 CA140456]; Canada Research Chair in Cellular and Molecular Neurophysiology; Savoy Foundation; NATIONAL CANCER INSTITUTE [R01CA140456, R01CA154916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088813] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Autism Speaks; Fonds de la Recherche en Sante du Quebec (FRSQ; Groupe de Recherche sur le Systeme Nerveux Central); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair in Cellular and Molecular Neurophysiology(Canada Research Chairs); Savoy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institutes of Health Research (N.S., MOP-114994; J.-C.L., MOP-10848; P.D. and F.M., MOP-93679; and P.L. and N.S., MOP-44050), Autism Speaks (Grant 7109 to N.S.), and the Fonds de la Recherche en Sante du Quebec (J.-C.L. FRSQ; Groupe de Recherche sur le Systeme Nerveux Central), and the National Institutes of Health (D.R.; NIH RO1 CA154916 and NIH RO1 CA140456). D.R. is a Leukemia & Lymphoma Society Scholar. J.-C.L. is the recipient of the Canada Research Chair in Cellular and Molecular Neurophysiology. I.R. was supported by a Fellowship of the Savoy Foundation. We thank Y. Svitkin, A. Parsyan, E. Petroulakis, R. Karni and V. Polunovski for advice; K. Gamache, A. Sylvestre, S. Perreault, C. Lister and I. Harvey for technical assistance; T. Alain for assistance with lentiviral titration; S. Hamdani for assistance with USVs; and W. Sossin and P. Skehel for critical reading of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cornew L, 2012, J AUTISM DEV DISORD, V42, P1884, DOI 10.1007/s10803-011-1431-6; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Jeste SS, 2008, J CHILD NEUROL, V23, P520, DOI 10.1177/0883073807309788; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parada LF, 2012, CURR OPIN NEUROBIOL; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	46	347	354	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					371	U113		10.1038/nature11628	http://dx.doi.org/10.1038/nature11628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23172145	Green Published, Green Accepted			2022-12-01	WOS:000313615900044
J	Kretz, M; Siprashvili, Z; Chu, C; Webster, DE; Zehnder, A; Qu, K; Lee, CS; Flockhart, RJ; Groff, AF; Chow, J; Johnston, D; Kim, GE; Spitale, RC; Flynn, RA; Zheng, GXY; Aiyer, S; Raj, A; Rinn, JL; Chang, HY; Khavari, PA				Kretz, Markus; Siprashvili, Zurab; Chu, Ci; Webster, Dan E.; Zehnder, Ashley; Qu, Kun; Lee, Carolyn S.; Flockhart, Ross J.; Groff, Abigail F.; Chow, Jennifer; Johnston, Danielle; Kim, Grace E.; Spitale, Robert C.; Flynn, Ryan A.; Zheng, Grace X. Y.; Aiyer, Subhadra; Raj, Arjun; Rinn, John L.; Chang, Howard Y.; Khavari, Paul A.			Control of somatic tissue differentiation by the long non-coding RNA TINCR	NATURE			English	Article							GENE; CHROMATIN; COMPLEXES; REPRESSION; EXPRESSION; MUTATIONS; STAUFEN; SUITE; SHAPE	Several of the thousands of human long non-coding RNAs (lncRNAs) have been functionally characterized(1-4); however, potential roles for lncRNAs in somatic tissue differentiation remain poorly understood. Here we show that a 3.7-kilobase lncRNA, terminal differentiation-induced ncRNA (TINCR), controls human epidermal differentiation by a post-transcriptional mechanism. TINCR is required for high messenger RNA abundance of key differentiation genes, many of which are mutated in human skin diseases, including FLG, LOR, ALOXE3, ALOX12B, ABCA12, CASP14 and ELOVL3. TINCR-deficient epidermis lacked terminal differentiation ultrastructure, including keratohyalin granules and intact lamellar bodies. Genome-scale RNA interactome analysis revealed that TINCR interacts with a range of differentiation mRNAs. TINCR-mRNA interaction occurs through a 25-nucleotide 'TINCR box' motif that is strongly enriched in interacting mRNAs and required for TINCR binding. A high-throughput screen to analyse TINCR binding capacity to approximately 9,400 human recombinant proteins revealed direct binding of TINCR RNA to the staufen1 (STAU1) protein. STAU1-deficient tissue recapitulated the impaired differentiation seen with TINCR depletion. Loss of UPF1 and UPF2, both of which are required for STAU1-mediated RNA decay, however, did not have differentiation effects. Instead, the TINCR-STAU1 complex seems to mediate stabilization of differentiation mRNAs, such as KRT80. These data identify TINCR as a key lncRNA required for somatic tissue differentiation, which occurs through lncRNA binding to differentiation mRNAs to ensure their expression.	[Kretz, Markus; Siprashvili, Zurab; Chu, Ci; Webster, Dan E.; Zehnder, Ashley; Qu, Kun; Lee, Carolyn S.; Flockhart, Ross J.; Groff, Abigail F.; Chow, Jennifer; Johnston, Danielle; Kim, Grace E.; Spitale, Robert C.; Flynn, Ryan A.; Zheng, Grace X. Y.; Chang, Howard Y.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Aiyer, Subhadra; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chang, Howard Y.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; University of Pennsylvania; Harvard University; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chang, HY (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; khavari@stanford.edu	Qu, Kun/G-3359-2012; Kretz, Markus/ABB-8490-2021	Webster, Dan/0000-0001-6874-8451; Lee, Carolyn/0000-0002-6511-3757; Rinn, John/0000-0002-7231-7539; Raj, Arjun/0000-0002-2915-6960; Flynn, Ryan/0000-0001-5013-0442	US Veterans Affairs Office of Research and Development; National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [AR49737]; NIH [R01-HG004361]; California Institute for Regenerative Medicine; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737, T32AR007422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US Veterans Affairs Office of Research and Development funding to P. A. K. and National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) grant AR49737 to P. A. K., and by NIH R01-HG004361 and California Institute for Regenerative Medicine to H.Y.C. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; O'Driscoll J, 2002, CLIN EXP DERMATOL, V27, P243, DOI 10.1046/j.1365-2230.2002.01031.x; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sakai K, 2009, J INVEST DERMATOL, V129, P2306, DOI 10.1038/jid.2009.23; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Virtanen M, 2003, J INVEST DERMATOL, V121, P1013, DOI 10.1046/j.1523-1747.2003.12534.x; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	655	697	6	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					231	U245		10.1038/nature11661	http://dx.doi.org/10.1038/nature11661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201690	Green Accepted			2022-12-01	WOS:000313259600041
J	Bagdonaite, J; Jansen, P; Henkel, C; Bethlem, HL; Menten, KM; Ubachs, W				Bagdonaite, Julija; Jansen, Paul; Henkel, Christian; Bethlem, Hendrick L.; Menten, Karl M.; Ubachs, Wim			A Stringent Limit on a Drifting Proton-to-Electron Mass Ratio from Alcohol in the Early Universe	SCIENCE			English	Article							FINE-STRUCTURE CONSTANT; RADIO-SOURCE PKS1830-211; PKS 1830-211; MOLECULAR ABSORPTION; HYPERFINE-STRUCTURE; GRAVITATIONAL LENS; REST FREQUENCIES; METHANOL; REDSHIFT; Z=0.89	The standard model of physics is built on the fundamental constants of nature, but it does not provide an explanation for their values, nor require their constancy over space and time. Here we set a limit on a possible cosmological variation of the proton-to-electron mass ratio m by comparing transitions in methanol observed in the early universe with those measured in the laboratory. From radio-astronomical observations of PKS1830-211, we deduced a constraint of Delta mu/mu = (0.0 +/- 1.0) x 10(-7) at redshift z = 0.89, corresponding to a look-back time of 7 billion years. This is consistent with a null result.	[Bagdonaite, Julija; Jansen, Paul; Bethlem, Hendrick L.; Ubachs, Wim] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Henkel, Christian; Menten, Karl M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Henkel, Christian] King Abdulaziz Univ, Dept Astron, Jeddah 21413, Saudi Arabia	Vrije Universiteit Amsterdam; Max Planck Society; King Abdulaziz University	Ubachs, W (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	w.m.g.ubachs@vu.nl	Ubachs, Wim/F-5649-2011; Bethlem, Hendrick Lucas/B-2831-2008; Ubachs, W./K-3256-2019	Ubachs, Wim/0000-0001-7840-3756; Bethlem, Hendrick Lucas/0000-0003-4575-8512; Ubachs, W./0000-0001-7840-3756	Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants"; Netherlands Organization for Scientific Research via a VIDI grant; European Research Council via a Starting Grant	Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants"; Netherlands Organization for Scientific Research via a VIDI grant; European Research Council via a Starting Grant	This work is supported by the Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants." H. L. B. acknowledges support from the Netherlands Organization for Scientific Research via a VIDI grant and by the European Research Council via a Starting Grant. We thank the staff of the Effelsberg radio telescope for their hospitality and support. The raw data of the radioastronomical observations are available upon request from the Max Planck Institute for Radio Astronomy at Bonn (kmenten@mpifr-bonn.mpg.de).	Barrow JD, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.043521; BRECKENRIDGE SM, 1995, ASTROPHYS J, V438, P504, DOI 10.1086/175095; Chengalur JN, 1999, ASTRON ASTROPHYS, V343, pL79; Ellingsen SP, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L7; Henkel C, 2009, ASTRON ASTROPHYS, V500, P725, DOI 10.1051/0004-6361/200811475; HEUVEL JEM, 1973, J MOL SPECTROSC, V45, P282, DOI 10.1016/0022-2852(73)90159-8; Jansen P, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062505; Jansen P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.100801; JAUNCEY DL, 1991, NATURE, V352, P132, DOI 10.1038/352132a0; Kanekar N, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L12; King JA, 2012, MON NOT R ASTRON SOC, V422, P3370, DOI 10.1111/j.1365-2966.2012.20852.x; Leurini S, 2004, ASTRON ASTROPHYS, V422, P573, DOI 10.1051/0004-6361:20047046; Levshakov SA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/26; Lidman C, 1999, ASTROPHYS J, V514, pL57, DOI 10.1086/311949; LIN CC, 1959, REV MOD PHYS, V31, P841, DOI 10.1103/RevModPhys.31.841; Lovas FJ, 2004, J PHYS CHEM REF DATA, V33, P177, DOI 10.1063/1.1633275; Malec AL, 2010, MON NOT R ASTRON SOC, V403, P1541, DOI 10.1111/j.1365-2966.2009.16227.x; Menten KM, 2008, ASTRON ASTROPHYS, V492, P725, DOI 10.1051/0004-6361:200810041; Muller HSP, 2004, ASTRON ASTROPHYS, V428, P1019, DOI 10.1051/0004-6361:20041384; Muller S, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117096; Muller S, 2008, ASTRON ASTROPHYS, V491, P739, DOI 10.1051/0004-6361:200810392; Murphy MT, 2008, SCIENCE, V320, P1611, DOI 10.1126/science.1156352; Murphy MT, 2003, MON NOT R ASTRON SOC, V345, P609, DOI 10.1046/j.1365-8711.2003.06970.x; Reinhold E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.151101; Smolin L, 2004, PHYSICA A, V340, P705, DOI 10.1016/j.physa.2004.05.021; van Veldhoven J, 2004, EUR PHYS J D, V31, P337, DOI 10.1140/epjd/e2004-00160-9; van Weerdenburg F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180802; Webb JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191101; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884; Wiklind T, 1996, NATURE, V379, P139, DOI 10.1038/379139a0	30	98	98	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					46	48		10.1126/science.1224898	http://dx.doi.org/10.1126/science.1224898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239626	Green Submitted			2022-12-01	WOS:000312985800046
J	Doerfel, LK; Wohlgemuth, I; Kothe, C; Peske, F; Urlaub, H; Rodnina, MV				Doerfel, Lili K.; Wohlgemuth, Ingo; Kothe, Christina; Peske, Frank; Urlaub, Henning; Rodnina, Marina V.			EF-P Is Essential for Rapid Synthesis of Proteins Containing Consecutive Proline Residues	SCIENCE			English	Article							ELONGATION-FACTOR-P; PEPTIDE-BOND FORMATION; TRANSFER-RNA; TRANSLATION ELONGATION; POSTTRANSLATIONAL MODIFICATION; RIBOSOME-RESCUE; SSRA; TERMINATION; VIRULENCE; HYPUSINE	Elongation factor P (EF-P) is a translation factor of unknown function that has been implicated in a great variety of cellular processes. Here, we show that EF-P prevents ribosome from stalling during synthesis of proteins containing consecutive prolines, such as PPG, PPP, or longer proline strings, in natural and engineered model proteins. EF-P promotes peptide-bond formation and stabilizes the peptidyl-transfer RNA in the catalytic center of the ribosome. EF-P is posttranslationally modified by a hydroxylated beta-lysine attached to a lysine residue. The modification enhances the catalytic proficiency of the factor mainly by increasing its affinity to the ribosome. We propose that EF-P and its eukaryotic homolog, eIF5A, are essential for the synthesis of a subset of proteins containing proline stretches in all cells.	[Doerfel, Lili K.; Wohlgemuth, Ingo; Kothe, Christina; Peske, Frank; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Wohlgemuth, Ingo; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Goettingen, Dept Clin Chem, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Wohlgemuth, Ingo/0000-0001-9121-7675	Max Planck Society; Deutsche Forschungsgemeinschaft	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank W. Wintermeyer for critically reading the manuscript; W. Holtkamp and J. Mittelstaet for the translation assay and M1 and M2 peptide markers; D. Gorlich and C. Enke for the antibody against EF-P; and O. Geintzer, S. Kappler, T. Wiles, M. Zimmermann, T. Uhlendorf, A. Bursy, and U. Plessmann for expert technical assistance. The work was funded by the Max Planck Society and by grants from the Deutsche Forschungsgemeinschaft.	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sunohara T, 2002, RNA, V8, P1416, DOI 10.1017/S1355838202020198; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	26	303	311	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					85	88		10.1126/science.1229017	http://dx.doi.org/10.1126/science.1229017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239624	Green Submitted			2022-12-01	WOS:000312985800057
J	Haider, B; Hausser, M; Carandini, M				Haider, Bilal; Haeusser, Michael; Carandini, Matteo			Inhibition dominates sensory responses in the awake cortex	NATURE			English	Article							LOCAL CORTICAL NETWORKS; PRIMARY VISUAL-CORTEX; NEURONS IN-VIVO; ORIENTATION SELECTIVITY; NEOCORTICAL NEURONS; HZ OSCILLATION; BARREL CORTEX; MECHANISMS; INTERNEURONS; SPARSE	The activity of the cerebral cortex is thought to depend on the precise relationship between synaptic excitation and inhibition(1-4). In the visual cortex, in particular, intracellular measurements have related response selectivity to coordinated increases in excitation and inhibition(5-9). These measurements, however, have all been made during anaesthesia, which strongly influences cortical state(10) and therefore sensory processing(7,11-15). The synaptic activity that is evoked by visual stimulation during wakefulness is unknown. Here we measured visually evoked responses-and the underlying synaptic conductances-in the visual cortex of anaesthetized and awake mice. Under anaesthesia, responses could be elicited from a large region of visual space(16) and were prolonged. During wakefulness, responses were more spatially selective and much briefer. Whole-cell patch-clamp recordings of synaptic conductances(5,17) showed a difference in synaptic inhibition between the two conditions. Under anaesthesia, inhibition tracked excitation in amplitude and spatial selectivity. By contrast, during wakefulness, inhibition was much stronger than excitation and had extremely broad spatial selectivity. We conclude that during wakefulness, cortical responses to visual stimulation are dominated by synaptic inhibition, restricting the spatial spread and temporal persistence of neural activity. These results provide a direct glimpse of synaptic mechanisms that control sensory responses in the awake cortex.	[Haider, Bilal; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Haider, B (corresponding author), UCL, UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	b.haider@ucl.ac.uk	Hausser, Michael/AAW-6827-2020; Carandini, Matteo/ABD-8296-2021	Hausser, Michael/0000-0002-2673-8957; Carandini, Matteo/0000-0003-4880-7682; Haider, Bilal/0000-0002-6382-1426	National Science Foundation; European Research Council; Wellcome Trust; Medical Research Council; Gatsby Charitable Foundation; MRC [G0800791] Funding Source: UKRI; Medical Research Council [G0800791] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Sato, A. Saleem and A. Ayaz for help with procedures; S. L. Smith, C. Schmidt-Hieber and K. Powell for advice on recordings, and A. Roth, M. Scanziani and D. McCormick for comments. We are grateful to the National Science Foundation, the European Research Council, the Wellcome Trust, the Medical Research Council and the Gatsby Charitable Foundation for financial support. M. C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Cardin JA, 2010, J NEUROSCI, V30, P3652, DOI 10.1523/JNEUROSCI.5279-09.2010; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	36	345	347	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					97	+		10.1038/nature11665	http://dx.doi.org/10.1038/nature11665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23172139	Green Accepted			2022-12-01	WOS:000312933800038
J	Huang, GN; Thatcher, JE; McAnally, J; Kong, YL; Qi, XX; Tan, W; DiMaio, JM; Amatruda, JF; Gerard, RD; Hill, JA; Bassel-Duby, R; Olson, EN				Huang, Guo N.; Thatcher, Jeffrey E.; McAnally, John; Kong, Yongli; Qi, Xiaoxia; Tan, Wei; DiMaio, J. Michael; Amatruda, James F.; Gerard, Robert D.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			C/EBP Transcription Factors Mediate Epicardial Activation During Heart Development and Injury	SCIENCE			English	Article							RETINOIC ACID; BINDING PROTEIN; GRAINY-HEAD; MOUSE HEART; REGENERATION; ZEBRAFISH; CELLS; DROSOPHILA; INTEGRITY; IMMUNITY	The epicardium encapsulates the heart and functions as a source of multipotent progenitor cells and paracrine factors essential for cardiac development and repair. Injury of the adult heart results in reactivation of a developmental gene program in the epicardium, but the transcriptional basis of epicardial gene expression has not been delineated. We established a mouse embryonic heart organ culture and gene expression system that facilitated the identification of epicardial enhancers activated during heart development and injury. Epicardial activation of these enhancers depends on a combinatorial transcriptional code centered on CCAAT/enhancer binding protein (C/EBP) transcription factors. Disruption of C/EBP signaling in the adult epicardium reduced injury-induced neutrophil infiltration and improved cardiac function. These findings reveal a transcriptional basis for epicardial activation and heart injury, providing a platform for enhancing cardiac regeneration.	[Huang, Guo N.; McAnally, John; Qi, Xiaoxia; Amatruda, James F.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Thatcher, Jeffrey E.; DiMaio, J. Michael] Univ Texas SW Med Ctr Dallas, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA; [Kong, Yongli; Tan, Wei; Amatruda, James F.; Gerard, Robert D.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Tan, Weihong/A-5412-2008; Tan, Weihong/AAA-4536-2020	Tan, Weihong/0000-0002-8066-1524; Huang, Guo/0000-0002-4335-9123	O'Donnell Foundation Fellow of the Life Sciences Research Foundation; NIH Pathway [1K99HL114738]; NIH [HL100401-01]; Donald W. Reynolds Center for Clinical Cardiovascular Research; American Heart Association; Jon Holden DeHaan Foundation; Leducq Foundation; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL114738, R01HL077439, R01HL093039, R01HL111665, K99HL114738, U01HL100401] Funding Source: NIH RePORTER	O'Donnell Foundation Fellow of the Life Sciences Research Foundation; NIH Pathway; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; American Heart Association(American Heart Association); Jon Holden DeHaan Foundation; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Cabrera for graphical assistance; J. Shelton and J. A. Richardson for histology; A. Mobley for assistance with fluorescence-activated cell sorting; the UT Southwestern microarray core facility; and K. Kangasniemi, K. Sagiyama, and M. Takahashi for cardiac magnetic resonance imaging. We are grateful to G. Begemann, S. Jane, P. Johnson, C. Lagman, R. MacDonald, R. Roeder, J. Rosen, G. Stark, C. Vinson, M. Wolfgang, and C. Zahnow for plasmids and reagents. We thank J. Chen, N. Munshi, P. Yi, and members of the Olson laboratory for scientific discussion and critical reading of the manuscript. G. N. H. is an O'Donnell Foundation Fellow of the Life Sciences Research Foundation and a recipient of the NIH Pathway to Independence Award (1K99HL114738). Supported by NIH grant HL100401-01, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the American Heart Association, the Jon Holden DeHaan Foundation, the Leducq Foundation, and the Robert A. Welch Foundation (grant 1-0025) (E.N.O.). Microarray data have been deposited in Gene Expession Omnibus (accession no. GSE41959).	Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Didon L, 2011, AM J RESP CRIT CARE, V184, P233, DOI 10.1164/rccm.201007-1113OC; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kim CH, 2011, VITAM HORM, V86, P83, DOI 10.1016/B978-0-12-386960-9.00004-6; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Osada S, 1996, J BIOL CHEM, V271, P3891; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Serluca FC, 2008, DEV BIOL, V315, P18, DOI 10.1016/j.ydbio.2007.10.007; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sucov HM, 2009, PEDIATR CARDIOL, V30, P617, DOI 10.1007/s00246-009-9391-8; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	28	148	154	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1599	1603		10.1126/science.1229765	http://dx.doi.org/10.1126/science.1229765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160954	Green Accepted			2022-12-01	WOS:000312533100047
J	Thorsteinsdottir, H; Saenz, TW				Thorsteinsdottir, Halla; Saenz, Tirso W.			Tackling Meningitis in Africa	SCIENCE			English	Editorial Material									[Thorsteinsdottir, Halla] Small Globe, Toronto, ON, Canada; [Saenz, Tirso W.] Univ Brasilia, Ctr Sustainable Dev, Brasilia, DF, Brazil	Universidade de Brasilia	Thorsteinsdottir, H (corresponding author), Small Globe, Toronto, ON, Canada.	halla@smallglobe.org			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brautigam D., 2009, THE DRAGONS GIFT; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8; Grogg P., 2010, CUBA BRAZIL UNITE AF; IRIN, 2007, AFR FIGHT MEN RAC TI; Kapoor A. K., 2012, S S COLLABORATION HL, P233; Love Patrick, 2012, OECD INSIGHTS; Padron F. Sotolongo, 2007, MEDICC REV, V9, P18; Reid-Henry S. M., 2010, CUBAN CURE; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Saenz T. W., 2012, S S COLLABORATION HL; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC19, DOI 10.1038/nbt1204supp-DC19; Undesa (Departamento de Asuntos Economicos y Sociales de las Naciones Unidas), 2010, DEV COOP MDGS MAX RE	13	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1546	1547		10.1126/science.1233318	http://dx.doi.org/10.1126/science.1233318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057AE	23258878				2022-12-01	WOS:000312533100034
J	Kakkar, M				Kakkar, Manish			Dengue fever is massively under-reported in India, hampering our response	BRITISH MEDICAL JOURNAL			English	Editorial Material							THAILAND; BURDEN		Publ Hlth Fdn India, Delhi 110070, India	Public Health Foundation of India	Kakkar, M (corresponding author), Publ Hlth Fdn India, Communicable Dis ISID Campus,4 Inst Area Vasant K, Delhi 110070, India.	manish.kakkar@phfi.org						[Anonymous], DENG CAS DEATHS COUN; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Central Bureau of Health Intelligence, 2012, NAT HLTH PROF 2011; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Harris G., 2012, NY TIMES; Ministry of Statistics and Programme Implementation Government of India, 2006, MORB HLTH CAR COND A, P507; National Vector Borne Disease Control Programme, 2012, MAL SIT IND; Organization WH, 2010, SIT UPD DENG SEA REG; Sudarshan MK, 2007, INT J INFECT DIS, V11, P29, DOI 10.1016/j.ijid.2005.10.007; The National Vector Borne Disease Control Programme, DISTR DENG DENG HAEM; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; World Health Organization, 2009, DENG GUID DIAGN TREA	14	29	31	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8574	10.1136/bmj.e8574	http://dx.doi.org/10.1136/bmj.e8574			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23255584				2022-12-01	WOS:000312700100008
J	Ince, C; van Kuijen, AM; Milstein, DMJ; Yuruk, K; Folkow, LP; Fokkens, WJ; Blix, AS				Ince, Can; van Kuijen, Anne-Marije; Milstein, Dan M. J.; Yuruk, Koray; Folkow, Lars P.; Fokkens, Wytske J.; Blix, Arnoldus S.			CHRISTMAS 2012: RESEARCH Why Rudolph's nose is red: observational study	BRITISH MEDICAL JOURNAL			English	Editorial Material							LASER-DOPPLER FLOWMETRY; NASAL HEAT-EXCHANGE; MUCOSAL MICROCIRCULATION; SEPTIC SHOCK; BLOOD-FLOW; REINDEER; RHINOSTEREOMETRY; CONGESTION	Objective To characterise the functional morphology of the nasal microcirculation in humans in comparison with reindeer as a means of testing the hypothesis that the luminous red nose of Rudolph, one of the most well known reindeer pulling Santa Claus's sleigh, is due to the presence of a highly dense and rich nasal microcirculation. Design Observational study. Setting Tromso, Norway (near the North Pole), and Amsterdam, the Netherlands. Participants Five healthy human volunteers, two adult reindeer, and a patient with grade 3 nasal polyposis. Main outcome measures Architecture of the microvasculature of the nasal septal mucosa and head of the inferior turbinates, kinetics of red blood cells, and real time reactivity of the microcirculation to topical medicines. Results Similarities between human and reindeer nasal microcirculation were uncovered. Hairpin-like capillaries in the reindeers' nasal septal mucosa were rich in red blood cells, with a perfused vessel density of 20 (SD 0.7) mm/mm(2). Scattered crypt or gland-like structures surrounded by capillaries containing flowing red blood cells were found in human and reindeer noses. In a healthy volunteer, nasal microvascular reactivity was demonstrated by the application of a local anaesthetic with vasoconstrictor activity, which resulted in direct cessation of capillary blood flow. Abnormal microvasculature was observed in the patient with nasal polyposis. Conclusions The nasal microcirculation of reindeer is richly vascularised, with a vascular density 25% higher than that in humans. These results highlight the intrinsic physiological properties of Rudolph's legendary luminous red nose, which help to protect it from freezing during sleigh rides and to regulate the temperature of the reindeer's brain, factors essential for flying reindeer pulling Santa Claus's sleigh under extreme temperatures.	[Ince, Can] Erasmus Univ, Dept Intens Care Med, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [van Kuijen, Anne-Marije; Fokkens, Wytske J.] Univ Amsterdam, Dept Otorhinolaryngol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Milstein, Dan M. J.; Yuruk, Koray] Univ Amsterdam, Dept Translat Physiol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Folkow, Lars P.; Blix, Arnoldus S.] Univ Tromso, Dept Arctic & Marine Biol, N-9001 Tromso, Norway	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; UiT The Arctic University of Tromso	Ince, C (corresponding author), Erasmus Univ, Dept Intens Care Med, Erasmus Med Ctr, S Gravendijkwal 230,POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.ince@erasmusmc.nl	Milstein, Dan M.J./H-2821-2019; Fokkens, Wytske WJ/ABF-2185-2020	Milstein, Dan M.J./0000-0003-1335-5516; 				Aas-Hansen O, 2000, AM J PHYSIOL-REG I, V279, pR1190; Abrams Don-Carlos, 1997, Rhinology (Utrecht), V35, P22; Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Blix AS, 2011, J EXP BIOL, V214, P3850, DOI 10.1242/jeb.057455; Blix AS, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-42; BLIX AS, 1983, J PHYSIOL-LONDON, V340, P445, DOI 10.1113/jphysiol.1983.sp014772; Blix AS, 2005, ARCTIC ANIMALS; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; Cervin A, 2001, RHINOLOGY, V39, P13; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; DRUCE HM, 1989, MICROVASC RES, V38, P175, DOI 10.1016/0026-2862(89)90026-5; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Grudemo H, 1997, ORL-J OTO-RHIN-LARYN, V59, P50, DOI 10.1159/000276905; Grudemo H, 1999, AM J RHINOL, V13, P1, DOI 10.2500/105065899781389911; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JOHNSEN HK, 1985, AM J PHYSIOL, V249, pR617, DOI 10.1152/ajpregu.1985.249.5.R617; Mathura KR, 2001, LANCET, V358, P1698, DOI 10.1016/S0140-6736(01)06722-8; Meinders AJ, 2009, NEW ENGL J MED, V360, pE9, DOI 10.1056/NEJMicm066261; Milstein DMJ, 2010, ORAL SURG ORAL MED O, V109, P91, DOI 10.1016/j.tripleo.2009.08.041; Philpott CM, 2005, CLIN OTOLARYNGOL, V30, P373, DOI 10.1111/j.1365-2273.2005.00985.x; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6	23	8	8	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8311	10.1136/bmj.e8311	http://dx.doi.org/10.1136/bmj.e8311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23247980	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000312698700003
J	McCarthy, M				McCarthy, Michael			Containing the opioid overdose epidemic	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		LocalHealthGuide Com, Seattle, WA USA		McCarthy, M (corresponding author), LocalHealthGuide Com, Seattle, WA USA.	mxmc@mac.com						Agency Medical Directors Group, 2010, INT GUID OP DOS CHRO; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487	4	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2012	345								e8340	10.1136/bmj.e8340	http://dx.doi.org/10.1136/bmj.e8340			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056NE	23241432				2022-12-01	WOS:000312496200001
J	Sheth, R; Marcon, L; Bastida, MF; Junco, M; Quintana, L; Dahn, R; Kmita, M; Sharpe, J; Ros, MA				Sheth, Rushikesh; Marcon, Luciano; Felix Bastida, M.; Junco, Marisa; Quintana, Laura; Dahn, Randall; Kmita, Marie; Sharpe, James; Ros, Maria A.			Hox Genes Regulate Digit Patterning by Controlling the Wavelength of a Turing-Type Mechanism	SCIENCE			English	Article							REACTION-DIFFUSION MODEL; SONIC-HEDGEHOG; LIMB; GLI3; EXPRESSION; NUMBER; FINS; DOWNSTREAM; REVEALS; HOXD-13	The formation of repetitive structures (such as stripes) in nature is often consistent with a reaction-diffusion mechanism, or Turing model, of self-organizing systems. We used mouse genetics to analyze how digit patterning (an iterative digit/nondigit pattern) is generated. We showed that the progressive reduction in Hoxa13 and Hoxd11-Hoxd13 genes (hereafter referred to as distal Hox genes) from the Gli3-null background results in progressively more severe polydactyly, displaying thinner and densely packed digits. Combined with computer modeling, our results argue for a Turing-type mechanism underlying digit patterning, in which the dose of distal Hox genes modulates the digit period or wavelength. The phenotypic similarity with fish-fin endoskeleton patterns suggests that the pentadactyl state has been achieved through modification of an ancestral Turing-type mechanism.	[Kmita, Marie] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Sharpe, James] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Sheth, Rushikesh; Felix Bastida, M.; Junco, Marisa; Ros, Maria A.] Univ Cantabria, Soc El Desarrollo Reg Cantabria, Consejo Super Invest Cient, Fac Med,Inst Biomed Biotecnol, Santander 39011, Spain; [Marcon, Luciano; Quintana, Laura; Sharpe, James] CRG, EMBL, Syst Biol Res Unit, Barcelona 08003, Spain; [Marcon, Luciano; Quintana, Laura; Sharpe, James] Univ Pompeu Fabra, Barcelona 08003, Spain; [Felix Bastida, M.; Ros, Maria A.] Univ Cantabria, Dept Anat & Biol Celular, Santander 39011, Spain	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Universidad de Cantabria	Kmita, M (corresponding author), Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	marie.kmita@ircm.qc.ca; james.sharpe@crg.eu; marian.ros@unican.es	kmita, marie/AAU-9620-2020; Sharpe, James/AAB-7948-2019; Marcon, Luciano LM/X-9975-2018; Sharpe, James/L-1150-2014; Marcon, Luciano/AAK-5535-2020; Ros, Maria A./K-8160-2014	Marcon, Luciano LM/0000-0003-0957-9170; Sharpe, James/0000-0002-1434-9743; Marcon, Luciano/0000-0003-0957-9170; Ros, Maria A./0000-0002-1224-7671; Kmita, Marie/0000-0003-4021-0478	Spanish Ministry of Science and Innovation [BFU2011-24972]; Canadian Institutes of Health Research [MOP-82880]; Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; EMBL-CRG Systems Biology Program; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; EMBL-CRG Systems Biology Program; ICREA(ICREA)	We thank D. Duboule and P. Chambon for the mutant mice, A. Munteanu for comments on the mathematical analysis, and M. Torres and M. Towers for critical reading of the manuscript. This work was supported by grant BFU2011-24972 from the Spanish Ministry of Science and Innovation to M. A. R. and by grant MOP-82880 from the Canadian Institutes of Health Research to M. K. R. S. was supported by a Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; L. M. was supported by a fellowship from the EMBL-CRG Systems Biology Program.	Bastida MF, 2008, CURR OPIN GENET DEV, V18, P374, DOI 10.1016/j.gde.2008.06.009; Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis AP, 1996, DEVELOPMENT, V122, P1175; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Goff DJ, 1997, DEVELOPMENT, V124, P627; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; MAINI PK, 1991, INT REV CYTOL, V129, P91; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Miura T, 2004, B MATH BIOL, V66, P627, DOI 10.1016/j.bulm.2003.09.009; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Newman SA, 1996, BIOESSAYS, V18, P171, DOI 10.1002/bies.950180302; Schneider I, 2011, P NATL ACAD SCI USA, V108, P12782, DOI 10.1073/pnas.1109993108; Sheth R, 2007, DEV BIOL, V310, P430, DOI 10.1016/j.ydbio.2007.07.023; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	31	237	238	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1476	1480		10.1126/science.1226804	http://dx.doi.org/10.1126/science.1226804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239739	Green Accepted			2022-12-01	WOS:000312250800050
J	Bhaskaran, K; Armstrong, B; Hajat, S; Haines, A; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Armstrong, Ben; Hajat, Shakoor; Haines, Andy; Wilkinson, Paul; Smeeth, Liam			Heat and risk of myocardial infarction: hourly level case-crossover analysis of MINAP database	BRITISH MEDICAL JOURNAL			English	Article							EASTERN UNITED-STATES; AIR-POLLUTION; TIME-SERIES; AMBIENT-TEMPERATURE; 11 CITIES; MORTALITY; ENGLAND; DEATHS; WALES; ADMISSIONS	Objective To quantify the association between exposure to higher temperatures and the risk of myocardial infarction at an hourly temporal resolution. Design Case-crossover study. Setting England and Wales Myocardial Ischaemia National Audit Project (MINAP) database. Participants 24 861 hospital admissions for myocardial infarction occurring in 11 conurbations during the warmest months (June to August) of the years 2003-09. Main outcome measure Odds ratio of myocardial infarction for a 1 degrees C increase in temperature. Results Strong evidence was found for an effect of heat acting 1-6 hours after exposure to temperatures above an estimated threshold of 20 degrees C (95% confidence interval 16 degrees C to 25 degrees C). For each 1 C increase in temperature above this threshold, the risk of myocardial infarction increased by 1.9% (0.5% to 3.3%, P=0.009). Later reductions in risk seemed to offset early increases in risk: the cumulative effect of a 1 degrees C rise in temperature above the threshold was 0.2% (-2.1% to 2.5%) by the end of the third day after exposure. Conclusions Higher ambient temperatures above a threshold of 20 degrees C seem to be associated with a transiently increased risk of myocardial infarction 1-6 hours after exposure. Reductions in risk at longer lags are consistent with heat triggering myocardial infarctions early in highly vulnerable people who would otherwise have had a myocardial infarction some time later ("short term displacement"). Policies aimed at reducing the health effects of hot weather should include consideration of effects operating at sub-daily timescales.	[Bhaskaran, Krishnan; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Armstrong, Ben; Hajat, Shakoor; Haines, Andy; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Haines, Andy/0000-0002-8053-4605; Smeeth, Liam/0000-0002-9168-6022; Bhaskaran, Krishnan/0000-0001-5364-8757; Wilkinson, Paul/0000-0001-7456-259X; armstrong, benedict/0000-0003-4407-0409	British Heart Foundation [FS/04/045]; Wellcome Trust [086091/Z/08/Z]; Garfield Weston Foundation; National Institute for Health Research postdoctoral fellowship [NIHR-PDF-2011-04-007]; Wellcome Trust senior research fellowship in clinical science [098504/Z/12/Z]; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Garfield Weston Foundation; National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); Wellcome Trust senior research fellowship in clinical science(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (grant number FS/04/045), the Wellcome Trust (grant number 086091/Z/08/Z), and the Garfield Weston Foundation. KB is supported by a National Institute for Health Research postdoctoral fellowship (grant number NIHR-PDF-2011-04-007). LS is supported by a Wellcome Trust senior research fellowship in clinical science (grant number 098504/Z/12/Z). The British Heart Foundation, the Garfield Weston Foundation, the National Institute for Health Research, and the Wellcome Trust had no role in the design or conduct of this study, or in the preparation, review, approval, or decision to submit the manuscript. All authors carried out this research independently of the funding bodies.	Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5531; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Curriero FC, 2003, AM J EPIDEMIOL, V158, P93, DOI 10.1093/aje/kwg105; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Department for Environment Food and Rural Affairs, 2011, UK AIR DAT ARCH; Department of Health, 2011, HEATW PLAN ENGL PROT; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Halonen JI, 2011, ENVIRON RES, V111, P281, DOI 10.1016/j.envres.2010.12.001; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Loughnan ME, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-41; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Met Office, 2012, MET OFF INT DAT ARCH; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Nayha Simo, 2005, Int J Circumpolar Health, V64, P451; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stryhn H, 2003, INT S VET EP EC ISVE; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; WOOLHISER DA, 1979, J APPL METEOROL, V18, P34, DOI 10.1175/1520-0450(1979)018<0034:MLEOFC>2.0.CO;2; Yu WW, 2011, HEART, V97, P1089, DOI 10.1136/hrt.2010.217166	36	69	70	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2012	345								e8050	10.1136/bmj.e8050	http://dx.doi.org/10.1136/bmj.e8050			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23243290	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-01	WOS:000312495700003
J	Lekomtsev, S; Su, KC; Pye, VE; Blight, K; Sundaramoorthy, S; Takaki, T; Collinson, LM; Cherepanov, P; Divecha, N; Petronczki, M				Lekomtsev, Sergey; Su, Kuan-Chung; Pye, Valerie E.; Blight, Ken; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Collinson, Lucy M.; Cherepanov, Peter; Divecha, Nullin; Petronczki, Mark			Centralspindlin links the mitotic spindle to the plasma membrane during cytokinesis	NATURE			English	Article							CONTRACTILE RING; BINDING DOMAIN; RHOGEF ECT2; PROTEIN; COMPLEX; ABSCISSION; GTPASE; ACTIN; MICROTUBULES; PI(4,5)P-2	At the end of cell division, cytokinesis splits the cytoplasm of nascent daughter cells and partitions segregated sister genomes(1,2). To coordinate cell division with chromosome segregation, the mitotic spindle controls cytokinetic events at the cell envelope. The spindle midzone stimulates the actomyosin-driven contraction of the cleavage furrow, which proceeds until the formation of a microtubule-rich intercellular bridge with the midbody at its centre. The midbody directs the final membrane abscission reaction(1,2) and has been proposed to attach the cleavage furrow to the intercellular bridge(3). How the mitotic spindle is connected to the plasma membrane during cytokinesis is not understood. Here we identify a plasma membrane tethering activity in the centralspindlin protein complex, a conserved component of the spindle midzone and midbody(4). We demonstrate that the C1 domain of the centralspindlin subunit MgcRacGAP associates with the plasma membrane by interacting with polyanionic phosphoinositide lipids. Using X-ray crystallography we determine the structure of this atypical C1 domain. Mutations in the hydrophobic cap and in basic residues of the C1 domain of MgcRacGAP prevent association of the protein with the plasma membrane, and abrogate cytokinesis in human and chicken cells. Artificial membrane tethering of centralspindlin restores cell division in the absence of the C1 domain of MgcRacGAP. Although C1 domain function is dispensable for the formation of the midzone and midbody, it promotes contractility and is required for the attachment of the plasma membrane to the midbody, a long-postulated function of this organelle(3). Our analysis suggests that centralspindlin links the mitotic spindle to the plasma membrane to secure the final cut during cytokinesis in animal cells.	[Lekomtsev, Sergey; Su, Kuan-Chung; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, S Mimms EN6 3LD, Herts, England; [Lekomtsev, Sergey; Su, Kuan-Chung; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Aneuploidy Lab, S Mimms EN6 3LD, Herts, England; [Pye, Valerie E.; Cherepanov, Peter] Canc Res UK London Res Inst, Clare Hall Labs, Chromatin Struct & Mobile DNA Lab, S Mimms EN6 3LD, Herts, England; [Blight, Ken; Collinson, Lucy M.] Canc Res UK London Res Inst, Electron Microscopy Unit, London WC2A 3PX, England; [Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Inositide Lab, Manchester M20 4BX, Lancs, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Petronczki, M (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, Blanche Lane, S Mimms EN6 3LD, Herts, England.	mark.petronczki@cancer.org.uk	Cherepanov, Peter P/F-6859-2010; Sundaramoorthy, Sriramkumar/AAS-2912-2021	Cherepanov, Peter P/0000-0002-0634-538X; Collinson, Lucy/0000-0003-0260-613X; divecha, nullin/0000-0001-9695-6039; Pye, Valerie E/0000-0001-9616-2992; Petronczki, Mark/0000-0003-0139-5692	Cancer Research UK; EMBO; Cancer Research UK [15272] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	We would like to thank W. Bement, W. Earnshaw, J. Gannon, D. Gerlich, M. Glotzer, G. Hammond, M. Hikida, H. Hochegger, R. Irvine, M. Kurosaki, B. Larijani, P. Parker, A. Piekny, R. Prekeris, E. Sahai, K. Samejima and M. Symons for reagents and advice. Work in the Petronczki laboratory is supported by Cancer Research UK and the EMBO Young Investigator Programme. S.L. acknowledges support from an EMBO Long-Term Fellowship.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Loria A, 2012, CURR BIOL, V22, P213, DOI 10.1016/j.cub.2011.12.019; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Simon GC, 2008, EMBO J, V27, P1791, DOI 10.1038/emboj.2008.112; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	44	102	103	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					276	+		10.1038/nature11773	http://dx.doi.org/10.1038/nature11773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235882				2022-12-01	WOS:000312259300047
J	Ruas, JL; White, JP; Rao, RR; Kleiner, S; Brannan, KT; Harrison, BC; Greene, NP; Wu, J; Estall, JL; Irving, BA; Lanza, IR; Rasbach, KA; Okutsu, M; Nair, KS; Yan, Z; Leinwand, LA; Spiegelman, BM				Ruas, Jorge L.; White, James P.; Rao, Rajesh R.; Kleiner, Sandra; Brannan, Kevin T.; Harrison, Brooke C.; Greene, Nicholas P.; Wu, Jun; Estall, Jennifer L.; Irving, Brian A.; Lanza, Ian R.; Rasbach, Kyle A.; Okutsu, Mitsuharu; Nair, K. Sreekumaran; Yan, Zhen; Leinwand, Leslie A.; Spiegelman, Bruce M.			A PGC-1 alpha Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy	CELL			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MICE; GROWTH; MASS; HOMEOSTASIS; EXPRESSION; PROTECTS; ATROPHY; FIBERS; DRIVES	PGC-1 alpha is a transcriptional coactivator induced by exercise that gives muscle many of the best known adaptations to endurance-type exercise but has no effects on muscle strength or hypertrophy. We have identified a form of PGC-1 alpha (PGC-1 alpha 4) that results from alternative promoter usage and splicing of the primary transcript. PGC-1 alpha 4 is highly expressed in exercised muscle but does not regulate most known PGC-1 alpha targets such as the mitochondrial OXPHOS genes. Rather, it specifically induces IGF1 and represses myostatin, and expression of PGC-1 alpha 4 in vitro and in vivo induces robust skeletal muscle hypertrophy. Importantly, mice with skeletal muscle-specific transgenic expression of PGC-1 alpha 4 show increased muscle mass and strength and dramatic resistance to the muscle wasting of cancer cachexia. Expression of PGC-1 alpha 4 is preferentially induced in mouse and human muscle during resistance exercise. These studies identify a PGC-1 alpha protein that regulates and coordinates factors involved in skeletal muscle hypertrophy.	[Ruas, Jorge L.; White, James P.; Rao, Rajesh R.; Kleiner, Sandra; Brannan, Kevin T.; Wu, Jun; Estall, Jennifer L.; Rasbach, Kyle A.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA; [Harrison, Brooke C.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Greene, Nicholas P.; Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Irving, Brian A.; Lanza, Ian R.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol, Endocrine Res Unit, Rochester, MN 55905 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of Virginia; Mayo Clinic	Ruas, JL (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	jorge.ruas@ki.se; bruce_spiegelman@dfci.harvard.edu	Ruas, Jorge/AAE-6094-2019; Greene, Nicholas/G-7399-2015; Greene, Nicholas/A-6076-2013; Irving, Brian/B-9683-2016	Ruas, Jorge/0000-0002-1110-2606; Greene, Nicholas/0000-0002-9504-9362; Irving, Brian/0000-0002-4131-9523; Greene, Nicholas/0000-0001-9621-2005; Lanza, Ian/0000-0002-9858-3384; LEINWAND, LESLIE/0000-0003-1470-4810; Yan, Zhen/0000-0002-4826-9813; Estall, Jennifer/0000-0002-9838-1440	NIH [DK061562, 5K01AR55676-2, T32HL07284, AR050429, GM29090]; Novartis; Wenner-Gren Foundations, Sweden; AHA [09POST2010078, 12SDG8070003]; Novartis, Inc.;  [RR024151];  [AG09531]; Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284, R01HL119937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055676, R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061562, K01DK094824, R56DK054477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Wenner-Gren Foundations, Sweden; AHA(American Heart Association); Novartis, Inc.; ; ; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Srikripa Devarakonda and Sibylle Jager for valuable discussions. ERR alpha and ERR gamma KO myoblasts were a kind gift from Dr. Zhidan Wu (Novartis Institutes for Biomedical Research). The MEF2C/Myogenin promoter cassette was kindly provided by Dr. Eric Olson (University of Texas Southwestern Medical Center). LLC cells were kindly donated by Dr. Jose M. Garcia (Baylor College of Medicine). This project was supported by grants (DK061562) from the NIH and from Novartis to B.M.S. J.L.R. was supported in part by a grant from the Wenner-Gren Foundations, Sweden. This research was supported in part by grants to B. C. H. (NIH, 5K01AR55676-2), N.P.G. (NIH, T32HL07284), J.W. (AHA, 09POST2010078 and 12SDG8070003), B.A.I. (RR024151 and AG09531), Z.Y. (NIH, AR050429), and L. A. L. (NIH, GM29090). B. M. S. is a shareholder and consultant to Ember Therapeutics and has received funding in the form of sponsored research from Novartis, Inc.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dinchuk JE, 2010, ENDOCRINOLOGY, V151, P4123, DOI 10.1210/en.2010-0032; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702; Gentry B, 2011, MUSCLE NERVE, V43, P49, DOI 10.1002/mus.21796; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MCMILLAN DN, 1992, J ANIM SCI, V70, P3014, DOI 10.2527/1992.70103014x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	40	433	453	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1319	1331		10.1016/j.cell.2012.10.050	http://dx.doi.org/10.1016/j.cell.2012.10.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217713	Bronze, Green Accepted			2022-12-01	WOS:000311999900020
J	Stensmyr, MC; Dweck, HKM; Farhan, A; Ibba, I; Strutz, A; Mukunda, L; Linz, J; Grabe, V; Steck, K; Lavista-Llanos, S; Wicher, D; Sachse, S; Knaden, M; Becher, PG; Seki, Y; Hansson, BS				Stensmyr, Marcus C.; Dweck, Hany K. M.; Farhan, Abu; Ibba, Irene; Strutz, Antonia; Mukunda, Latha; Linz, Jeanine; Grabe, Veit; Steck, Kathrin; Lavista-Llanos, Sofia; Wicher, Dieter; Sachse, Silke; Knaden, Markus; Becher, Paul G.; Seki, Yoichi; Hansson, Bill S.			A Conserved Dedicated Olfactory Circuit for Detecting Harmful Microbes in Drosophila	CELL			English	Article							ANTENNAL LOBE; SENSORY INPUT; NEURONS; GEOSMIN; PHEROMONE; BEHAVIOR; SYSTEM; REPRESENTATIONS; INTERNEURONS; ORGANIZATION	Flies, like all animals, need to find suitable and safe food. Because the principal food source for Drosophila melanogaster is yeast growing on fermenting fruit, flies need to distinguish fruit with safe yeast from yeast covered with toxic microbes. We identify a functionally segregated olfactory circuit in flies that is activated exclusively by geosmin. This microbial odorant constitutes an ecologically relevant stimulus that alerts flies to the presence of harmful microbes. Geosmin activates only a single class of sensory neurons expressing the olfactory receptor Or56a. These neurons target the DA2 glomerulus and connect to projection neurons that respond exclusively to geosmin. Activation of DA2 is sufficient and necessary for aversion, overrides input from other olfactory pathways, and inhibits positive chemotaxis, oviposition, and feeding. The geosmin detection system is a conserved feature in the genus Drosophila that provides flies with a sensitive, specific means of identifying unsuitable feeding and breeding sites.	[Stensmyr, Marcus C.; Dweck, Hany K. M.; Farhan, Abu; Ibba, Irene; Strutz, Antonia; Mukunda, Latha; Linz, Jeanine; Grabe, Veit; Steck, Kathrin; Lavista-Llanos, Sofia; Wicher, Dieter; Sachse, Silke; Knaden, Markus; Seki, Yoichi; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany; [Becher, Paul G.] Swedish Univ Agr Sci, Div Chem Ecol, S-23053 Alnarp, Sweden	Max Planck Society; Swedish University of Agricultural Sciences	Stensmyr, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoll Str 8, D-07745 Jena, Germany.	mstensmyr@ice.mpg.de; hansson@ice.mpg.de	Becher, Paul/ABF-4450-2020; Knaden, Markus/E-2151-2015; Sachse, Silke/M-8484-2014; Abu, Farhan/AAH-8596-2020; Hansson, Bill S/G-2774-2013	Becher, Paul/0000-0001-5058-2668; Knaden, Markus/0000-0002-6710-1071; Sachse, Silke/0000-0002-9769-8067; Abu, Farhan/0000-0002-7385-5590; Hansson, Bill S/0000-0002-4811-1223; Steck, Kathrin/0000-0003-2711-2873; Grabe, Veit/0000-0002-0736-2771; Seki, Yoichi/0000-0002-3337-4768; Stensmyr, Marcus/0000-0003-4009-9212	Max Planck Society; German Federal Ministry of Education and Research; Swedish research council Formas	Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Max Planck Society, the German Federal Ministry of Education and Research (A. S., V. G., and S. S.), and the Swedish research council Formas (P. G. B.). We wish to thank S. Caron and F. Maderspacher for valuable comments on the manuscript, E. Wheeler for editorial assistance, and R. Stieber, K. Weniger, and S. Kaltofen for technical support. We thank I. Urru for assisting with odor collections, S. Koczsan and J. Rybak for morphological analysis, and M. Thoma for providing help with the Flywalk experiments.	Arndt C, 1999, MICROBIOL-SGM, V145, P1989, DOI 10.1099/13500872-145-8-1989; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Castillo MA, 1999, J AGR FOOD CHEM, V47, P2120, DOI 10.1021/jf981010a; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Juttner F, 2007, APPL ENVIRON MICROB, V73, P4395, DOI 10.1128/AEM.02250-06; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; MATTHEIS JP, 1992, APPL ENVIRON MICROB, V58, P3170, DOI 10.1128/AEM.58.9.3170-3172.1992; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinbergen N., 1951, STUDY INSTINCT; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yoshida T., 2000, Drosophila Information Service, V83, P18; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5	47	358	369	12	176	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1345	1357		10.1016/j.cell.2012.09.046	http://dx.doi.org/10.1016/j.cell.2012.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217715	Bronze			2022-12-01	WOS:000311999900022
J	Abitua, PB; Wagner, E; Navarrete, IA; Levine, M				Abitua, Philip Barron; Wagner, Eileen; Navarrete, Ignacio A.; Levine, Michael			Identification of a rudimentary neural crest in a non-vertebrate chordate	NATURE			English	Article							MESODERMAL TISSUES; CELL FATE; LINEAGE; GENE; PLASTICITY; INDUCTION; EVOLUTION; INSIGHTS; ORIGIN; GENOME	Neural crest arises at the neural plate border, expresses a core set of regulatory genes and produces a diverse array of cell types, including ectomesenchyme derivatives that elaborate the vertebrate head(1,2). The evolution of neural crest has been proposed to be a key event leading to the appearance of new cell types that fostered the transition from filter feeding to active predation in ancestral vertebrates(3). However, the origin of neural crest remains controversial, as homologous cell types have not been unambiguously identified in non-vertebrate chordates(1,4). Here we show that the tunicate Ciona intestinalis possesses a cephalic melanocyte lineage (a9.49) similar to neural crest that can be reprogrammed into migrating 'ectomesenchyme' by the targeted misexpression of Twist (also known as twist-like 2). Our results suggest that the neural crest melanocyte regulatory network pre-dated the divergence of tunicates and vertebrates. We propose that the co-option of mesenchyme determinants, such as Twist, into the neural plate ectoderm was crucial to the emergence of the vertebrate 'new head'(3).	[Abitua, Philip Barron; Wagner, Eileen; Navarrete, Ignacio A.; Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu		Levine, Michael/0000-0001-7629-0081; Navarrete, Ignacio/0000-0001-6644-1616; Abitua, Philip/0000-0002-8264-0807	US National Science Foundation; US National Institutes of Health [NS 076542]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Stolfi for his continued support and guidance, Y. Satou for isolating the Twist enhancer, N. Ellis for cloning Dmbx > Twist and B. Gainous for critical reading of the manuscript. P. B. A is supported by a graduate fellowship from the US National Science Foundation. This work was supported by a grant from the US National Institutes of Health (NS 076542).	Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jeffery WR, 2006, J EXP ZOOL PART B, V306B, P470, DOI 10.1002/jez.b.21109; Jeffery WR, 2008, DEV BIOL, V324, P152, DOI 10.1016/j.ydbio.2008.08.022; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; NISHIDA H, 1989, DEV BIOL, V132, P355, DOI 10.1016/0012-1606(89)90232-7; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Shi W, 2008, DEVELOPMENT, V135, P931, DOI 10.1242/dev.011940; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Tassy O, 2010, GENOME RES, V20, P1459, DOI 10.1101/gr.108175.110; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Tokuoka M, 2005, DEV BIOL, V288, P387, DOI 10.1016/j.ydbio.2005.09.018; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Vlaeminck-Guillem V, 2000, MECH DEVELOP, V91, P331, DOI 10.1016/S0925-4773(99)00272-5; Wada H, 2006, INT J BIOL SCI, V2, P133; Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108	30	146	147	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					104	+		10.1038/nature11589	http://dx.doi.org/10.1038/nature11589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23135395	Green Accepted			2022-12-01	WOS:000311893400054
J	Spano, S; Galan, JE				Spano, Stefania; Galan, Jorge E.			A Rab32-Dependent Pathway Contributes to Salmonella Typhi Host Restriction	SCIENCE			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; SECRETORY LYSOSOMES; BACTERIAL SURVIVAL; PUDIAK-SYNDROME; SYNDROME GENES; III SECRETION; MURINE; PATHOGENESIS; TYPHIMURIUM	Unlike other Salmonellae, the intracellular bacterial human pathogen Salmonella Typhi exhibits strict host specificity. The molecular bases for this restriction are unknown. Here we found that the expression of a single type III secretion system effector protein from broad-host Salmonella Typhimurium allowed Salmonella Typhi to survive and replicate within macrophages and tissues from mice, a nonpermissive host. This effector proteolytically targeted Rab32, which controls traffic to lysosome-related organelles in conjunction with components of the biogenesis of lysosome-related organelle complexes (BLOCs). RNA interference-mediated depletion of Rab32 or of an essential component of a BLOC complex was sufficient to allow S. Typhi to survive within mouse macrophages. Furthermore, S. Typhi was able to survive in macrophages from mice defective in BLOC components.	[Spano, Stefania; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Spanò, Stefania/F-4951-2011	Spanò, Stefania/0000-0001-9154-7463	National Institute of Allergy and Infectious Diseases [AI079022, AI055472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079022, R01AI055472, R56AI079022] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Mothes for providing primary bone-marrow-derived macrophages from pa/co/le mice, which had been provided to him by R. Swank. We also thank C. Roy's laboratory for providing various Rab GTPase constructs and members of the Galan laboratory for critical reading of the manuscript. This work was supported by National Institute of Allergy and Infectious Diseases grants AI079022 and AI055472 (to J.E.G.).	Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Chan WT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002713; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; EDSALL G, 1960, J EXP MED, V112, P143, DOI 10.1084/jem.112.1.143; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; VLADOIANU IR, 1990, MICROB PATHOGENESIS, V8, P83, DOI 10.1016/0882-4010(90)90072-X; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	36	100	99	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					960	963		10.1126/science.1229224	http://dx.doi.org/10.1126/science.1229224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162001	Green Accepted			2022-12-01	WOS:000311083600047
J	Weinberg, DS; Schoen, RE				Weinberg, David S.; Schoen, Robert E.			Colorectal Cancer Screening: America's Next Top Model?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TASK-FORCE; COLONOSCOPY; POLYPS		[Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, DS (corresponding author), Fox Chase Canc Ctr, Dept Med, 333 Cottman Ave, Philadelphia, PA 19111 USA.	david.weinberg@fccc.edu						Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Knudsen AB, 2012, ANN INTERN MED, V157, P611, DOI 10.7326/0003-4819-157-9-201211060-00005; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Penn E, 2010, ARCH INTERN MED, V170, P1127, DOI 10.1001/archinternmed.2010.152; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245	9	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					673	+		10.7326/0003-4819-157-9-201211060-00017	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00017			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128867				2022-12-01	WOS:000310783300012
J	Spence, D				Spence, Des			How the Liverpool care pathway has transformed end of life care	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Bowater D., 2012, TELEGRAPH; Doughty, 2012, DAILY MAIL	2	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7308	10.1136/bmj.e7308	http://dx.doi.org/10.1136/bmj.e7308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114070				2022-12-01	WOS:000310778900012
J	Payne, D				Payne, David			Tamiflu: the battle for secret drug data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; INFLUENZA					dpayne@bmj.com						Centers for Disease Control and Prevention, REC INFL ANT MED REM; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3513; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7168; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374	7	12	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2012	345								e7303	10.1136/bmj.e7303	http://dx.doi.org/10.1136/bmj.e7303			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109482	Bronze			2022-12-01	WOS:000310778000010
J	Chojnacki, J; Staudt, T; Glass, B; Bingen, P; Engelhardt, J; Anders, M; Schneider, J; Muller, B; Hell, SW; Krausslich, HG				Chojnacki, Jakub; Staudt, Thorsten; Glass, Baerbel; Bingen, Pit; Engelhardt, Johann; Anders, Maria; Schneider, Jale; Mueller, Barbara; Hell, Stefan W.; Kraeusslich, Hans-Georg			Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN INCORPORATION; GP41 CYTOPLASMIC TAIL; INFLUENZA-VIRUS; TYPE-1; VIRIONS; FUSION; ENV; ORGANIZATION; TOMOGRAPHY	Human immunodeficiency virus type 1 (HIV-1) buds from the cell as an immature particle requiring subsequent proteolysis of the main structural polyprotein Gag for morphological maturation and infectivity. Visualization of the viral envelope (Env) glycoprotein distribution on the surface of individual HIV-1 particles with stimulated emission depletion (STED) superresolution fluorescence microscopy revealed maturation-induced clustering of Env proteins that depended on the Gag-interacting Env tail. Correlation of Env surface clustering with the viral entry efficiency revealed coupling between the viral interior and exterior: Rearrangements of the inner protein lattice facilitated the alteration of the virus surface in preparation for productive entry. We propose that Gag proteolysis-dependent clustering of the sparse Env trimers on the viral surface may be an essential aspect of HIV-1 maturation.	[Chojnacki, Jakub; Glass, Baerbel; Anders, Maria; Mueller, Barbara; Kraeusslich, Hans-Georg] Univ Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Schneider, Jale; Hell, Stefan W.] German Canc Res Ctr, Opt Nanoscopy Div, D-69120 Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Schneider, Jale; Hell, Stefan W.] BIOQUANT, D-69120 Heidelberg, Germany; [Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Krausslich, HG (corresponding author), Univ Heidelberg, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Chojnacki, Jakub/AAL-8170-2021; Muller, Barbara/AAC-4483-2020	Krausslich, Hans-Georg/0000-0002-8756-329X; Chojnacki, Jakub/0000-0002-4457-8096; Muller, Barbara/0000-0001-5726-5585	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	We are grateful to J. Mak (Burnet Institute, Melbourne) for purified recombinant HIV-1 Gag and to P. Guardado-Calves (Institut Pasteur, Paris) for monomeric and trimeric Env gp140. We thank L. Castillo for purified recombinant HIV-1 CA, V. Bosch (DKFZ Heidelberg) for HIV-1 gp120 and CD4 antisera as well as HIV-1 Env expression plasmids, R. Doms (University of Pennsylvania) for SupT1R5 cells, C. Aiken (Vanderbilt University Medical Center) for infectious HIV-1 variant plasmids, and T. Hope (Northwestern University Chicago) for the eGFP. Vpr construct. H.-G.K. is an investigator of the Excellence Cluster CellNetworks funded by the German Research Foundation (DFG). S.W.H. holds a patent on STED microscopy in several European countries and the United States, which has been licensed to Leica, a microscope manufacturer.	Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHENG RH, 1995, CELL, V80, P621; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Endress T, 2008, EUR BIOPHYS J BIOPHY, V37, P1291, DOI 10.1007/s00249-008-0322-z; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Holtkotte D, 2006, AIDS RES HUM RETROV, V22, P57, DOI 10.1089/aid.2006.22.57; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	26	188	192	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					524	528		10.1126/science.1226359	http://dx.doi.org/10.1126/science.1226359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112332				2022-12-01	WOS:000310195800057
J	Blakemore, SJ				Blakemore, Sarah-Jayne			Teenage kicks: cannabis and the adolescent brain	LANCET			English	Editorial Material									UCL Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Blakemore, SJ (corresponding author), UCL Inst Cognit Neurosci, London WC1N 3AR, England.	s.blakemore@ucl.ac.uk	Blakemore, Sarah-Jayne/A-1792-2010	Blakemore, Sarah-Jayne/0000-0002-1690-2805				Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Steinberg L, 2010, ADOLESCENCE; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136	11	13	13	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					888	889		10.1016/S0140-6736(12)61578-5	http://dx.doi.org/10.1016/S0140-6736(12)61578-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23117180				2022-12-01	WOS:000316069700010
J	Zhou, HH; Sun, LT; Yang, XL; Schimmel, P				Zhou, Huihao; Sun, Litao; Yang, Xiang-Lei; Schimmel, Paul			ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase	NATURE			English	Article							HALOFUGINONE; ADENYLATE; ASSAYS	Febrifugine is the active component of the Chinese herb Chang Shan (Dichroa febrifuga Lour.)(1,2), which has been used for treating malaria-induced fever for about 2,000 years. Halofuginone (HF), the halogenated derivative of febrifugine, has been tested in clinical trials for potential therapeutic applications in cancer and fibrotic disease(3-6). Recently, HF was reported to inhibit T(H)17 cell differentiation by activating the amino acid response pathway(7), through inhibiting human prolyl-transfer RNA synthetase (ProRS) to cause intracellular accumulation of uncharged tRNA(8,9). Curiously, inhibition requires the presence of unhydrolysed ATP. Here we report an unusual 2.0 angstrom structure showing that ATP directly locks onto and orients two parts of HF onto human ProRS, so that one part of HF mimics bound proline and the other mimics the 3' end of bound tRNA. Thus, HF is a new type of ATP-dependent inhibitor that simultaneously occupies two different substrate binding sites on ProRS. Moreover, our structure indicates a possible similar mechanism of action for febrifugine in malaria treatment. Finally, the elucidation here of a two-site modular targeting activity of HF raises the possibility that substrate-directed capture of similar inhibitors might be a general mechanism that could be applied to other synthetases.	[Zhou, Huihao; Sun, Litao; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007; SUN, LITAO/0000-0002-8415-989X; Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM15539, GM23562, GM88278]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562, R01GM088278, R01GM015539, R37GM015539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Musier-Forsyth for providing the ProRS gene plasmid and Pro-SA, staff at beamline 7-1 of Stanford Synchrotron Radiation Lightsource for assistance in X-ray diffraction data collection, and M. Guo for comments. This work was supported by National Institutes of Health grants GM15539, GM23562 and GM88278 and by a fellowship from the National Foundation for Cancer Research.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Coatney G. R., 1950, Journal of the National Malaria Society, V9, P183; de Jonge MJA, 2006, EUR J CANCER, V42, P1768, DOI 10.1016/j.ejca.2005.12.027; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hill JM, 1998, U. S. Patent, Patent No. [5,824,657, 5824657]; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KOEPFLI JB, 1947, J AM CHEM SOC, V69, P1837, DOI 10.1021/ja01199a513; Koon HB, 2011, JAIDS-J ACQ IMM DEF, V56, P64, DOI 10.1097/QAI.0b013e3181fc0141; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1177/108705710100600609; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhu SR, 2009, BIOORGAN MED CHEM, V17, P4496, DOI 10.1016/j.bmc.2009.05.011	21	104	115	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					121	124		10.1038/nature11774	http://dx.doi.org/10.1038/nature11774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23263184	Green Accepted			2022-12-01	WOS:000314741200046
J	Acquaviva, L; Szekvolgyi, L; Dichtl, B; Dichtl, BS; Saint Andre, CD; Nicolas, A; Geli, V				Acquaviva, Laurent; Szekvoelgyi, Lorant; Dichtl, Bernhard; Dichtl, Beatriz Solange; Saint Andre, Christophe de La Roche; Nicolas, Alain; Geli, Vincent			The COMPASS Subunit Spp1 Links Histone Methylation to Initiation of Meiotic Recombination	SCIENCE			English	Article							STRAND BREAK FORMATION; H3 TRIMETHYLATION; GENE-EXPRESSION; SITES; PROMOTER; FEATURES; HOTSPOTS; COMPLEX; PRDM9; ONSET	During meiosis, combinatorial associations of genetic traits arise from homologous recombination between parental chromosomes. Histone H3 lysine 4 trimethylation marks meiotic recombination hotspots in yeast and mammals, but how this ubiquitous chromatin modification relates to the initiation of double-strand breaks (DSBs) dependent on Spo11 remains unknown. Here, we show that the tethering of a PHD-containing protein, Spp1 (a component of the COMPASS complex), to recombinationally cold regions is sufficient to induce DSB formation. Furthermore, we found that Spp1 physically interacts with Mer2, a key protein of the differentiated chromosomal axis required for DSB formation. Thus, by interacting with H3K4me3 and Mer2, Spp1 promotes recruitment of potential meiotic DSB sites to the chromosomal axis, allowing Spo11 cleavage at nearby nucleosome-depleted regions.	[Acquaviva, Laurent; Saint Andre, Christophe de La Roche; Geli, Vincent] Aix Marseille Univ, Inst Paoli Calmettes, Marseille Canc Res Ctr CRCM, INSERM,CNRS,U1068,UMR7258, F-13009 Marseille, France; [Szekvoelgyi, Lorant; Nicolas, Alain] Univ Paris 06, CNRS, Inst Curie, Ctr Rech,UMR3244, F-75248 Paris, France; [Dichtl, Bernhard; Dichtl, Beatriz Solange] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia; [Szekvoelgyi, Lorant] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Deakin University; University of Debrecen	Dichtl, B (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia.	b.dichtl@deakin.edu.au; laroche@ifr88.cnrs-mrs.fr; alain.nicolas@curie.fr; geli@ifr88.cnrs-mrs.fr	Székvölgyi, Lóránt/AAC-1600-2021	Székvölgyi, Lóránt/0000-0002-7529-0319; Dichtl, Bernhard/0000-0001-5514-4982; Acquaviva, Laurent/0000-0001-5080-3619	"Ligue contre le Cancer" (Equipe Labelisees); Swiss National Science Foundation; Fondation ARC; European Union; Hungarian Research Fund	"Ligue contre le Cancer" (Equipe Labelisees); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation ARC; European Union(European Commission); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank F. Klein and V. Borde for materials, J. B. Boule for his help, and S. Kowalczykowski for reading of the manuscript. Work in the V. G. and A.N. laboratories is supported by the "Ligue contre le Cancer" (Equipe Labelisees). Work in the laboratory of B. D. was supported by the Swiss National Science Foundation. L. A. was supported by grants from the Fondation ARC and L.Sz. by the European Union and the Hungarian Research Fund.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Murton BL, 2010, J MOL BIOL, V398, P481, DOI 10.1016/j.jmb.2010.03.036; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Tischfield SE, 2012, CELL CYCLE, V11, P1496, DOI 10.4161/cc.19733; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	24	132	133	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					215	218		10.1126/science.1225739	http://dx.doi.org/10.1126/science.1225739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23160953				2022-12-01	WOS:000313328200047
J	Riffell, JA; Lei, H; Abrell, L; Hildebrand, JG				Riffell, Jeffrey A.; Lei, Hong; Abrell, Leif; Hildebrand, John G.			Neural Basis of a Pollinator's Buffet: Olfactory Specialization and Learning in Manduca sexta	SCIENCE			English	Article							FLORAL SCENT; MODULATION; HAWKMOTH; MEMORY; EVOLUTION; HONEYBEE; FLOWERS; INSECT; SYSTEM; ODORS	Pollinators exhibit a range of innate and learned behaviors that mediate interactions with flowers, but the olfactory bases of these responses in a naturalistic context remain poorly understood. The hawkmoth Manduca sexta is an important pollinator for many night-blooming flowers but can learn-through olfactory conditioning-to visit other nectar resources. Analysis of the flowers that are innately attractive to moths shows that the scents all have converged on a similar chemical profile that, in turn, is uniquely represented in the moth's antennal (olfactory) lobe. Flexibility in visitation to nonattractive flowers, however, is mediated by octopamine-associated modulation of antennal-lobe neurons during learning. Furthermore, this flexibility does not extinguish the innate preferences. Such processing of stimuli through two olfactory channels, one involving an innate bias and the other a learned association, allows the moths to exist within a dynamic floral environment while maintaining specialized associations.	[Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lei, Hong; Hildebrand, John G.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA	University of Washington; University of Washington Seattle; University of Arizona; University of Arizona; University of Arizona	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu	Lei, Hong/ABH-1356-2020; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Lei, Hong/0000-0002-5619-3097; Abrell, Leif/0000-0003-2490-1180	NSF [IOS 0822709, CHE 0216226]; NIH [R01-DC-02751]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002751] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank C. Reisenman, R. Alarcon, A. Dacks, G. Davidowitz, and J. Bronstein for advice and assistance; C. Hedgcock and F. van Breugal for images of flowers and moths; and M. Dickinson and H. Bradshaw for manuscript comments. This work was supported by NSF grants IOS 0822709 to J.A.R. and CHE 0216226 to L. A., and NIH grant R01-DC-02751 to J.G.H.	Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Dacks AM, 2012, J NEUROPHYSIOL, V108, P539, DOI 10.1152/jn.00159.2012; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; Farooqui T, 2003, J NEUROSCI, V23, P5370; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Knudsen JT, 1998, BRITTONIA, V50, P174, DOI 10.2307/2807848; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Menzel R., 1985, EXPT BEHAV ECOLOGY, V1, P55; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Raguso RA, 1998, OIKOS, V81, P238, DOI 10.2307/3547045; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	22	102	104	3	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					200	204		10.1126/science.1225483	http://dx.doi.org/10.1126/science.1225483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223454				2022-12-01	WOS:000313328200043
J	Knobloch, M; Braun, SMG; Zurkirchen, L; von Schoultz, C; Zamboni, N; Arauzo-Bravo, MJ; Kovacs, WJ; Karalay, O; Suter, U; Machado, RAC; Roccio, M; Lutolf, MP; Semenkovich, CF; Jessberger, S				Knobloch, Marlen; Braun, Simon M. G.; Zurkirchen, Luis; von Schoultz, Carolin; Zamboni, Nicola; Arauzo-Bravo, Marcos J.; Kovacs, Werner J.; Karalay, Oezlem; Suter, Ueli; Machado, Raquel A. C.; Roccio, Marta; Lutolf, Matthias P.; Semenkovich, Clay F.; Jessberger, Sebastian			Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis	NATURE			English	Article							FATTY-ACID SYNTHASE; TRANSGENIC MICE; SPOT 14; NEUROGENESIS; HOMEOSTASIS; GLUCOSE	Mechanisms controlling the proliferative activity of neural stem and progenitor cells (NSPCs) have a pivotal role to ensure life-long neurogenesis in the mammalian brain(1). How metabolic programs are coupled with NSPC activity remains unknown. Here we show that fatty acid synthase (Fasn), the key enzyme of de novo lipogenesis(2), is highly active in adult NSPCs and that conditional deletion of Fasn in mouse NSPCs impairs adult neurogenesis. The rate of de novo lipid synthesis and subsequent proliferation of NSPCs is regulated by Spot14, a gene previously implicated in lipid metabolism(3-5), that we found to be selectively expressed in low proliferating adult NSPCs. Spot14 reduces the availability of malonyl-CoA(6), which is an essential substrate for Fasn to fuel lipogenesis. Thus, we identify here a functional coupling between the regulation of lipid metabolism and adult NSPC proliferation.	[Knobloch, Marlen; Braun, Simon M. G.; Machado, Raquel A. C.; Jessberger, Sebastian] Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland; [Knobloch, Marlen; Braun, Simon M. G.; Zurkirchen, Luis; von Schoultz, Carolin; Kovacs, Werner J.; Karalay, Oezlem; Suter, Ueli; Machado, Raquel A. C.; Jessberger, Sebastian] Swiss Fed Inst Technol, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Zamboni, Nicola] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Roccio, Marta; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Washington University (WUSTL)	Jessberger, S (corresponding author), Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland.	jessberger@hifo.uzh.ch	Knobloch, Marlen/A-9565-2015; Kovacs, Werner/AAD-1107-2019; Zamboni, Nicola/K-3042-2012; Suter, Ueli/A-1624-2010; Jessberger, Sebastian/AAJ-4032-2020; Lutolf, Matthias P/E-5914-2010; Marcos, Arauzo-Bravo/A-1706-2011	Knobloch, Marlen/0000-0002-7490-0285; Kovacs, Werner/0000-0002-4440-4344; Zamboni, Nicola/0000-0003-1271-1021; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Jessberger, Sebastian/0000-0002-0056-8275; Semenkovich, Clay/0000-0003-1163-1871; Martinez Machado, Raquel Arminda/0000-0001-5912-2991; Braun, Simon/0000-0003-2622-9914; Roccio, Marta/0000-0001-7568-9429	NCCR Neural Plasticity and Repair; Swiss National Science Foundation; TH grant [ETH-01 08-1]; Zurich Neuroscience Center (ZNZ); Novartis Foundation; Theodore Ott Foundation; EMBO Young Investigator program; Janggen-Pohn foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076729, R01DK088083, P30DK020579] Funding Source: NIH RePORTER	NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TH grant; Zurich Neuroscience Center (ZNZ); Novartis Foundation(Novartis); Theodore Ott Foundation; EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); Janggen-Pohn foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Aigner, D. C. Lie, F. H. Gage and members of the Jessberger group for conceptual input; S. Kobel, C. Fischer, K. Walter, P. Sidiropoulos, T. Buch, B. Becher, P. Pelczar, P. Lotscher, A. J. Eisch and D. C. Lagace for experimental help or reagents; and the Light Microscopy and Screening Center (LMSC) of the ETH Zurich and the BioImaging and Optics Platform (BIOP) of the EPFL for help with imaging. This study was supported by the NCCR Neural Plasticity and Repair, Swiss National Science Foundation, TH grant (ETH-01 08-1), Zurich Neuroscience Center (ZNZ), Novartis Foundation, Theodore Ott Foundation, and the EMBO Young Investigator program (to S. J.). M. K. was supported by the Janggen-Pohn foundation.	Aipoalani DL, 2010, ENDOCRINOLOGY, V151, P2071, DOI 10.1210/en.2009-1058; Campbell MC, 2003, ENDOCRINOLOGY, V144, P5242, DOI 10.1210/en.2002-0008; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Johansson T, 2010, GENESIS, V48, P264, DOI 10.1002/dvg.20612; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Moncur JT, 1998, P NATL ACAD SCI USA, V95, P6989, DOI 10.1073/pnas.95.12.6989; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu QH, 2001, ENDOCRINOLOGY, V142, P4363, DOI 10.1210/en.142.10.4363	20	314	325	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					226	230		10.1038/nature11689	http://dx.doi.org/10.1038/nature11689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201681	Green Accepted			2022-12-01	WOS:000313259600040
J	Jakobsen, L; Ratcliffe, JM; Surlykke, A				Jakobsen, Lasse; Ratcliffe, John M.; Surlykke, Annemarie			Convergent acoustic field of view in echolocating bats	NATURE			English	Article							SOUND BEAM; BROWN BAT; PREY; VESPERTILIONIDAE; PURSUIT; SIZE	Most echolocating bats exhibit a strong correlation between body size and the frequency of maximum energy in their echolocation calls (peak frequency), with smaller species using signals of higher frequency than larger ones(1,2). Size-signal allometry or acoustic detection constraints imposed on wavelength by preferred prey size have been used to explain this relationship(1,3). Here we propose the hypothesis that smaller bats emit higher frequencies to achieve directional sonar beams, and that variable beam width is critical for bats. Shorter wavelengths relative to the size of the emitter translate into more directional sound beams(4). Therefore, bats that emit their calls through their mouths should show a relationship between mouth size and wavelength, driving smaller bats to signals of higher frequency. We found that in a flight room mimicking a closed habitat, six aerial hawking vespertilionid species (ranging in size from 4 to 21 g, ref. 5) produced sonar beams of extraordinarily similar shape and volume. Each species had a directivity index of 11 +/- 1 dB (a half-amplitude angle of approximately 37 degrees) and an on-axis sound level of 108 +/- 4 dB sound pressure level referenced to 20 mu Pa root mean square at 10 cm. Thus all bats adapted their calls to achieve similar acoustic fields of view. We propose that the necessity for high directionality has been a key constraint on the evolution of echolocation, which explains the relationship between bat size and echolocation call frequency. Our results suggest that echolocation is a dynamic system that allows different species, regardless of their body size, to converge on optimal fields of view in response to habitat and task.	[Jakobsen, Lasse; Ratcliffe, John M.; Surlykke, Annemarie] Univ So Denmark, Sound Commun Grp, Inst Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Surlykke, A (corresponding author), Univ So Denmark, Sound Commun Grp, Inst Biol, DK-5230 Odense M, Denmark.	ams@biology.sdu.dk		Jakobsen, Lasse/0000-0002-8496-5576	Danish Council for Natural Sciences (FNU), Carlsberg, Oticon; European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies [215370]	Danish Council for Natural Sciences (FNU), Carlsberg, Oticon; European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies	We thank H. Baagoe and B. Fenton for access to the bat collections at the Natural History Museum of Denmark and the Royal Ontario Museum, respectively, and R. Fisher and J. Hallam for providing gape heights of bats in flight. S. Brinklov, C. Elemans, B. Falk, B. Fenton, J. Galef, P. Madsen, C. Moss, H.-U. Schnitzler and M. Wahlberg provided detailed comments that improved the manuscript. This study was funded by the Danish Council for Natural Sciences (FNU), Carlsberg, Oticon and the European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies Contract 215370. Animal capture and experimentation was approved by Skov-og Naturstyrelsen (Denmark).	ANSI standard S1, 1995, S1261995ASA1131995 A; BAAGOE HJ, 1987, RECENT ADV STUDY BAT, P57; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bruel & Kj&AELIG;r, 1982, DAT HDB; Dietz C., 2007, HDB FLEDERMAUSE EURO; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; Houston R, 2004, ECHOLOCATION BATS DO, P339, DOI DOI 10.1016/0370-1573(95)00083-6; Hulva P, 2004, MOL PHYLOGENET EVOL, V32, P1023, DOI 10.1016/j.ympev.2004.04.007; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; KALLEN FC, 1972, J MORPHOL, V136, P385, DOI 10.1002/jmor.1051360402; Land MF, 2012, OXF ANIMAL BIOL SER, P1; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; MOGENSEN F, 1979, J COMP PHYSIOL, V134, P165, DOI 10.1007/BF00610475; Moss CF, 2011, CURR OPIN NEUROBIOL, V21, P645, DOI 10.1016/j.conb.2011.05.028; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Pye J. David, 1993, Bioacoustics, V4, P271; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Suthers RA, 2004, AN ACAD BRAS CIENC, V76, P247, DOI 10.1590/S0001-37652004000200009; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271	29	82	85	2	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					93	96		10.1038/nature11664	http://dx.doi.org/10.1038/nature11664			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23172147				2022-12-01	WOS:000312933800037
J	Retallack, GJ				Retallack, Gregory J.			Ediacaran life on land	NATURE			English	Article							COMPACTION; PALEOSOLS; MORAINES; FOSSILS; GROWTH; SOILS	Ediacaran (635-542 million years ago) fossils have been regarded as early animal ancestors of the Cambrian evolutionary explosion of marine invertebrate phyla(1), as giant marine protists(2) and as lichenized fungi(3). Recent documentation of palaeosols in the Ediacara Member of the Rawnsley Quartzite of South Australia(4) confirms past interpretations of lagoonal-aeolian deposition based on synsedimentary ferruginization and loessic texture(5,6). Further evidence for palaeosols comes from non-marine facies, dilation cracks, soil nodules, sand crystals, stable isotopic data and mass balance geochemistry(4). Here I show that the uppermost surfaces of the palaeosols have a variety of fossils in growth position, including Charniodiscus, Dickinsonia, Hallidaya, Parvancorina, Phyllozoon, Praecambridium, Rugoconites, Tribrachidium and 'old-elephant skin' (ichnogenus Rivularites(7)). These fossils were preserved as ferruginous impressions, like plant fossils(8), and biological soil crusts(9,10) of Phanerozoic eon sandy palaeosols. Sand crystals after gypsum(11) and nodules of carbonate(12) are shallow within the palaeosols(4), even after correcting for burial compaction(13). Periglacial involutions and modest geochemical differentiation of the palaeosols are evidence of a dry, cold temperate Ediacaran palaeoclimate in South Australia(4). This new interpretation of some Ediacaran fossils as large sessile organisms of cool, dry soils, is compatible with observations that Ediacaran fossils were similar in appearance and preservation to lichens and other microbial colonies of biological soil crusts(3), rather than marine animals(1), or protists(2).	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Retallack, GJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	gregr@uoregon.edu			PRF fund of the American Chemical Society	PRF fund of the American Chemical Society	K. Lloyd, P. Coulthard, A. Coulthard, K. Anderson and D. Crawford facilitated permission to undertake research in Flinders Ranges National Park. B. Logan and M. Willison aided sampling of drill core at PIRSA, Glenside. T. Palmer and D. Atkins provided mathematical advice. Fieldwork was funded by the PRF fund of the American Chemical Society, and aided by C. Metzger and J. Gehling.	Antcliffe JB, 2008, PALAEONTOLOGY, V51, P11, DOI 10.1111/j.1475-4983.2007.00738.x; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; DAN J, 1982, GEODERMA, V28, P173, DOI 10.1016/0016-7061(82)90002-7; DAN J, 1973, ISR J EARTH SCI, V22, P211; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Ewing SA, 2006, GEOCHIM COSMOCHIM AC, V70, P5293, DOI 10.1016/j.gca.2006.08.020; Food & Agriculture Organization, 1978, SOIL MAP WORLD, VVIII; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; GLAESSNER M, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0361-72; Grazhdankin D, 2007, LETHAIA, V40, P201, DOI 10.1111/j.1502-3931.2007.00025.x; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Jenkins RJF, 2011, GEOL SOC MEM, V36, P693, DOI 10.1144/M36.68; JENKINS RJF, 1983, J GEOL SOC AUST, V30, P101, DOI 10.1080/00167618308729240; Matthews JA, 2005, HOLOCENE, V15, P1, DOI 10.1191/0959683605hl779rp; Mawson D., 1949, T ROY SOC SOUTH AUST, V72, P276; Retallack G.J., 2012, SOC EC PALEONTOLOGIS, V101, P136; Retallack GJ, 2005, GEOLOGY, V33, P333, DOI 10.1130/G21263.1; Retallack GJ, 2007, ALCHERINGA, V31, P215, DOI 10.1080/03115510701484705; Retallack GJ, 2012, SEDIMENTOLOGY, V59, P1208, DOI 10.1111/j.1365-3091.2011.01302.x; Retallack GJ, 2012, PALAEOGEOGR PALAEOCL, V329, P47, DOI 10.1016/j.palaeo.2012.02.017; Retallack GJ, 2010, GEOLOGY, V38, P403, DOI 10.1130/G30514.1; Retallack GJ, 2009, ALCHERINGA, V33, P355, DOI 10.1080/03115510903271066; Seilacher A, 2005, PALAEOGEOGR PALAEOCL, V227, P323, DOI 10.1016/j.palaeo.2005.06.003; Sheldon ND, 2001, GEOLOGY, V29, P247, DOI 10.1130/0091-7613(2001)029<0247:EFCOPD>2.0.CO;2; Simpson WS, 2010, SEDIMENT GEOL, V230, P139, DOI 10.1016/j.sedgeo.2010.07.004; Solomina O, 2003, ARCT ANTARCT ALP RES, V35, P129, DOI 10.1657/1523-0430(2003)035[0129:LAATMI]2.0.CO;2; Sprigg R. C., 1947, Transactions of the Royal Society of South Australia, V71, P212; Vickers-Rich, 2008, RISE ANIMALS EVOLUTI; Yin Z, 2011, PRECAMBR RES; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	30	102	107	1	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					89	92		10.1038/nature11777	http://dx.doi.org/10.1038/nature11777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23235827				2022-12-01	WOS:000312933800036
J	Azzolin, L; Zanconato, F; Bresolin, S; Forcato, M; Basso, G; Bicciato, S; Cordenonsi, M; Piccolo, S				Azzolin, Luca; Zanconato, Francesca; Bresolin, Silvia; Forcato, Mattia; Basso, Giuseppe; Bicciato, Silvio; Cordenonsi, Michelangelo; Piccolo, Stefano			Role of TAZ as Mediator of Wnt Signaling	CELL			English	Article							PATHWAY; INHIBITION; PROTEIN; YAP; DEGRADATION; COMPONENTS; STABILITY; COMPLEX; TARGETS; LATS	Wnt growth factors are fundamental regulators of cell fate, but how the Wnt signal is translated into biological responses is incompletely understood. Here, we report that TAZ, a biologically potent transcriptional coactivator, serves as a downstream element of the Wnt/beta-catenin cascade. This function of TAZ is independent from its well-established role as mediator of Hippo signaling. In the absence of Wnt activity, the components of the beta-catenin destruction complex-APC, Axin, and GSK3-are also required to keep TAZ at low levels. TAZ degradation depends on phosphorylated beta-catenin that bridges TAZ to its ubiquitin ligase beta-TrCP. Upon Wnt signaling, escape of beta-catenin from the destruction complex impairs TAZ degradation and leads to concomitant accumulation of beta-catenin and TAZ. At the genome-wide level, a substantial portion of Wnt transcriptional responses is mediated by TAZ. TAZ activation is a general feature of Wnt signaling and is functionally relevant to mediate Wnt biological effects.	[Azzolin, Luca; Zanconato, Francesca; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Biomed Sci, I-35126 Padua, Italy; [Bresolin, Silvia; Basso, Giuseppe] Univ Padua, Dept Woman & Child Hlth, I-35128 Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy	University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Biomed Sci, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Azzolin, Luca/K-8012-2016; Cordenonsi, Michelangelo/K-7692-2016; Bicciato, Silvio/C-9825-2009; BICCIATO, Silvio/J-4466-2019; Forcato, Mattia/B-7733-2015; Bresolin, Silvia/K-6576-2016	Azzolin, Luca/0000-0002-2425-6153; Cordenonsi, Michelangelo/0000-0002-8253-5724; Bicciato, Silvio/0000-0002-1944-7078; BICCIATO, Silvio/0000-0002-1944-7078; Forcato, Mattia/0000-0002-7383-6576; Bresolin, Silvia/0000-0001-7677-7084; PICCOLO, STEFANO/0000-0002-2037-0004; BASSO, GIUSEPPE/0000-0002-2634-9302	Italian Welfare Ministry; AIRC-MFAG; Fondazione Citta della Speranza Grant; AIRC; HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur grants	Italian Welfare Ministry; AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza Grant; AIRC(Fondazione AIRC per la ricerca sul cancro); HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur grants	We thank O. Wessely and S. Dupont for comments; S. Zanotti for ST-2 differentiation protocol; G. Martello, M.C. Faux, A.R. Clarke, H. Miyoshi, and L. Naldini for gifts of reagents; and Tito Panciera for helping with RNA preparations. Plasmids purchased from Addgene were kindly deposited by K. Hochedlinger and W. Harper. This work is supported by "Young Italian Researchers" grants from the Italian Welfare Ministry and AIRC-MFAG to M.C.; from Fondazione Citta della Speranza Grant to G.B.; from AIRC Special Program Molecular Clinical Oncology "5 per mille" to S.P. and S.B.; and from HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S.P.	Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Ben-Ze'Ev A, 1999, ANN NY ACAD SCI, V886, P37, DOI 10.1111/j.1749-6632.1999.tb09398.x; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	32	345	359	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1443	1456		10.1016/j.cell.2012.11.027	http://dx.doi.org/10.1016/j.cell.2012.11.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23245942	Bronze			2022-12-01	WOS:000312890300011
J	Ragusa, MJ; Stanley, RE; Hurley, JH				Ragusa, Michael J.; Stanley, Robin E.; Hurley, James H.			Architecture of the Atg17 Complex as a Scaffold for Autophagosome Biogenesis	CELL			English	Article							SMALL-ANGLE SCATTERING; SACCHAROMYCES-CEREVISIAE; MONITORING AUTOPHAGY; MEMBRANE CURVATURE; PROTEIN-KINASE; EARLY STEPS; YEAST; FIP200; MACROMOLECULES; TUMORIGENESIS	Macroautophagy is a bulk clearance mechanism in which the double-membraned phagophore grows and engulfs cytosolic material. In yeast, the phagophore nucleates from a cluster of 20-30 nm diameter Atg9-containing vesicles located at a multiprotein assembly known as the preautophagosomal structure (PAS). The crystal structure of a 2:2:2 complex of the earliest acting PAS proteins, Atg17, Atg29, and Atg31, was solved at 3.05 angstrom resolution. Atg17 is crescent shaped with a 10 nm radius of curvature. Dimerization of the Atg17-Atg31-Atg29 complex is critical for both PAS formation and autophagy, and each dimer contains two separate and complete crescents. Upon induction of autophagy, Atg17-Atg31-Atg29 assembles with Atg1 and Atg13, which in turn initiates the formation of the phagophore. The C-terminal EAT domain of Atg1 was shown to sense membrane curvature, dimerize, and tether lipid vesicles. These data suggest a structural mechanism for the organization of Atg9 vesicles into the early phagophore.	[Ragusa, Michael J.; Stanley, Robin E.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Stanley, Robin/M-3008-2019; Stanley, Robin E/C-7128-2019	Stanley, Robin/0000-0002-2106-3102; Stanley, Robin E/0000-0002-2106-3102	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; U.S. DOE [DE-AC02-06CH11357]; NIH, NIDDK; Damon Runyon Cancer Research Fellowship; Ruth Kirschtein NRSA fellowship [GM099319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099319] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Damon Runyon Cancer Research Fellowship; Ruth Kirschtein NRSA fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Klionsky and W. Prinz for strains, constructs, and technical advice; X. Zuo for assistance with SAXS; X.-F. Ren and R. Ghirlando for light scattering assistance; B. Canagarajah for assistance with Figure 7; and T.R. Serio for a vector. Crystallographic data were collected at the Southeast Regional Collaborative Access Team 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. SAXS data were collected at NCI beamline 12ID-B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38 and was supported by the U.S. DOE under contract number DE-AC02-06CH11357. This research was supported by the Intramural Program of the NIH, NIDDK (J.H.H.), a Damon Runyon Cancer Research Fellowship (R.E.S.), and a Ruth Kirschtein NRSA fellowship GM099319 (M.J.R.).	Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Choi JD, 2012, ONCOGENE; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbrc.2007.02.150; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klionsky Daniel J., 2007, V390, P363; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yeh YY, 2011, J BIOL CHEM, V286, P28931, DOI 10.1074/jbc.M111.250324; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	50	170	173	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1501	1512		10.1016/j.cell.2012.11.028	http://dx.doi.org/10.1016/j.cell.2012.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23219485	Bronze, Green Accepted			2022-12-01	WOS:000312890300015
J	Abyzov, A; Mariani, J; Palejev, D; Zhang, Y; Haney, MS; Tomasini, L; Ferrandino, AF; Belmaker, LAR; Szekely, A; Wilson, M; Kocabas, A; Calixto, NE; Grigorenko, EL; Huttner, A; Chawarska, K; Weissman, S; Urban, AE; Gerstein, M; Vaccarino, FM				Abyzov, Alexej; Mariani, Jessica; Palejev, Dean; Zhang, Ying; Haney, Michael Seamus; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Szekely, Anna; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Huttner, Anita; Chawarska, Katarzyna; Weissman, Sherman; Urban, Alexander Eckehart; Gerstein, Mark; Vaccarino, Flora M.			Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells	NATURE			English	Article							GENOMIC STRUCTURAL VARIANTS; NUCLEOTIDE-RESOLUTION; RETROTRANSPOSITION; FIBROBLASTS; FRAMEWORK; REGIONS; BRAIN; NANOG	Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) has been suspected of causing de novo copy number variation(1-4). To explore this issue, here we performa whole-genome and transcriptome analysis of 20 human iPSC lines derived from the primary skin fibroblasts of seven individuals using next-generation sequencing. We find that, on average, an iPSC line manifests two copy number variants (CNVs) not apparent in the fibroblasts from which the iPSC was derived. Using PCR and digital droplet PCR, we show that at least 50% of those CNVs are present as low-frequency somatic genomic variants in parental fibroblasts (that is, the fibroblasts from which each corresponding human iPSC line is derived), and are manifested in iPSC lines owing to their clonal origin. Hence, reprogramming does not necessarily lead to de novo CNVs in iPSCs, because most of the line-manifested CNVs reflect somatic mosaicism in the human skin. Moreover, our findings demonstrate that clonal expansion, and iPSC lines in particular, can be used as a discovery tool to reliably detect low-frequency CNVs in the tissue of origin. Overall, we estimate that approximately 30% of the fibroblast cells have somatic CNVs in their genomes, suggesting widespread somatic mosaicism in the human body. Our study paves the way to understanding the fundamental question of the extent to which cells of the human body normally acquire structural alterations in their DNA post-zygotically.	[Abyzov, Alexej; Mariani, Jessica; Palejev, Dean; Zhang, Ying; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Szekely, Anna; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Huttner, Anita; Chawarska, Katarzyna; Weissman, Sherman; Urban, Alexander Eckehart; Gerstein, Mark; Vaccarino, Flora M.] Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA; [Abyzov, Alexej; Wilson, Michael; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Abyzov, Alexej; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Mariani, Jessica; Palejev, Dean; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Chawarska, Katarzyna; Vaccarino, Flora M.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Zhang, Ying; Szekely, Anna; Weissman, Sherman] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Haney, Michael Seamus; Urban, Alexander Eckehart] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Haney, Michael Seamus; Urban, Alexander Eckehart] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Szekely, Anna] Yale Univ, Dept Neurol, New Haven, CT 06520 USA; [Grigorenko, Elena L.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Grigorenko, Elena L.] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Huttner, Anita] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Vaccarino, Flora M.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Stanford University; Stanford University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Vaccarino, FM (corresponding author), Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA.	aeurban@stanford.edu; mark.gerstein@yale.edu; flora.vaccarino@yale.edu	Abyzov, Alexej/M-4284-2013; Abyzov, Alexej/AAT-4615-2020	Vaccarino, Flora/0000-0003-2167-981X; Abyzov, Alexej/0000-0001-5405-6729; Wilson, Michael/0000-0001-5892-6074; Palejev, Dean/0000-0002-0563-6636; Calixto, Nathaniel/0000-0002-0948-7607	National Institutes of Health (NIH); AL Williams Professorship fund; Harris Professorship fund; NIMH [MH089176, MH087879]; Simons Foundation [SFARI 137055]; State of Connecticut; NIH [RR19895]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087879, P50MH081756, R01MH089176, R33MH087879] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AL Williams Professorship fund; Harris Professorship fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; State of Connecticut; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge support from the National Institutes of Health (NIH) and from the AL Williams Professorship fund and the Harris Professorship fund. We also acknowledge the Yale University Biomedical High Performance Computing Center and its support team(in particular, R. Bjornson and N. Carriero). We thank A. Klin for help with family recruitment. We thank M. V. Simonini for technical help, I.-H. Park for advice in the characterization of iPSC lines and the gift of the iPSC PGP1-1, and S. A. Duncan for the gift of the K3 iPSC line. We acknowledge the following grant support: NIMH MH089176 and MH087879, the Simons Foundation (SFARI 137055 F. V.) and the State of Connecticut, which funded the hiPSC generation and characterization; and NIH grant RR19895, which funded the instrumentation. We acknowledge the Yale Center for Clinical Investigation for clinical support in obtaining the biopsy specimens. We thank J. Overton for advice in carrying out DNA and RNA sequencing. Finally, we thank M. O'Huallachain and J. Li-Pook-Than for their advice on planning, carrying out and analysing the ddPCR experiments.	Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Arlt MF, 2011, P NATL ACAD SCI USA, V108, P17360, DOI 10.1073/pnas.1109272108; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Brennand KJ, 2011, STEM CELLS, V29, P1915, DOI 10.1002/stem.762; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elliott AM, 2010, MOL BIOTECHNOL, V46, P234, DOI 10.1007/s12033-010-9294-1; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mkrtchyan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009591; O'Huallachain M., 2012, P NATL ACAD SCI US; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaccarino FM, 2011, J CHILD PSYCHOL PSYC, V52, P504, DOI 10.1111/j.1469-7610.2010.02348.x; Wang LY, 2009, GENOME RES, V19, P106, DOI 10.1101/gr.080069.108; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	48	272	286	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					438	+		10.1038/nature11629	http://dx.doi.org/10.1038/nature11629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160490	Green Accepted			2022-12-01	WOS:000312488200058
J	Brown, MTC; Tan, KR; O'Connor, EC; Nikonenko, I; Muller, D; Luscher, C				Brown, Matthew T. C.; Tan, Kelly R.; O'Connor, Eoin C.; Nikonenko, Irina; Muller, Dominique; Luescher, Christian			Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning	NATURE			English	Article							TONICALLY ACTIVE NEURONS; DOPAMINERGIC-NEURONS; NUCLEUS-ACCUMBENS; REWARD; ACTIVATION; STRIATUM; RELEASE; COCAINE	The ventral tegmental area (VTA) and nucleus accumbens (NAc) are essential for learning about environmental stimuli associated with motivationally relevant outcomes. The task of signalling such events, both rewarding and aversive, from the VTA to the NAc has largely been ascribed to dopamine neurons(1-3). The VTA also contains GABA (gamma-aminobutyric acid)-releasing neurons, which provide local inhibition(4,5) and also project to the NAc6,7. However, the cellular targets and functional importance of this long-range inhibitory projection have not been ascertained. Here we show that GABA-releasing neurons of the VTA that project to the NAc (VTA GABA projection neurons) inhibit accumbal cholinergic interneurons (CINs) to enhance stimulus-outcome learning. Combining optogenetics with structural imaging and electrophysiology, we found that VTA GABA projection neurons selectively target NAc CINs, forming multiple symmetrical synaptic contacts that generated inhibitory postsynaptic currents. This is remarkable considering that CINs represent a very small population of all accumbal neurons, and provide the primary source of cholinergic tone in the NAc. Brief activation of this projection was sufficient to halt the spontaneous activity of NAc CINs, resembling the pause recorded in animals learning stimulus-outcome associations(8-12). Indeed, we found that forcing CINs to pause in behaving mice enhanced discrimination of a motivationally important stimulus that had been associated with an aversive outcome. Our results demonstrate that VTA GABA projection neurons, through their selective targeting of accumbal CINs, provide a novel route through which the VTA communicates saliency to the NAc. VTA GABA projection neurons thus emerge as orchestrators of dopaminergic and cholinergic modulation in the NAc.	[Brown, Matthew T. C.; Tan, Kelly R.; O'Connor, Eoin C.; Nikonenko, Irina; Muller, Dominique; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Brown, Matthew/0000-0001-6983-962X; O'Connor, Eoin/0000-0002-7810-1915	Swiss National Science Foundation; National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation	We thank the members of the Luscher laboratory for discussion and comments on the manuscript. This work was funded by a grant of the Swiss National Science Foundation to C.L. and the National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation. fTom<SUP>PVALBcre</SUP> mice were provided by A. Holtmaat.	AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Apicella P, 2011, J NEUROSCI, V31, P1507, DOI 10.1523/JNEUROSCI.4880-10.2011; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Inokawa H, 2010, NEUROSCIENCE, V168, P395, DOI 10.1016/j.neuroscience.2010.03.062; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Ligorio M, 2009, J CHEM NEUROANAT, V37, P33, DOI 10.1016/j.jchemneu.2008.08.003; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771	30	222	223	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					452	456		10.1038/nature11657	http://dx.doi.org/10.1038/nature11657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23178810				2022-12-01	WOS:000312488200061
J	Losos, JB; Hillis, DM; Greene, HW				Losos, Jonathan B.; Hillis, David M.; Greene, Harry W.			Who Speaks with a Forked Tongue?	SCIENCE			English	Editorial Material							PHYLOGENY; MOLECULES; SELECTION; GENES		[Losos, Jonathan B.] Harvard Univ, Harvard Museum Comparat Zool, Cambridge, MA 02138 USA; [Hillis, David M.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Greene, Harry W.] Cornell Univ, Ithaca, NY 14853 USA	Harvard University; University of Texas System; University of Texas Austin; Cornell University	Losos, JB (corresponding author), Harvard Univ, Harvard Museum Comparat Zool, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu; dhillis@austin.utexas.edu; hwg5@cornell.edu	Hillis, David/L-5421-2019					Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Edwards SV, 2009, P NATL ACAD SCI USA, V106, P8799, DOI 10.1073/pnas.0904103106; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703	14	57	60	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1428	1429		10.1126/science.1232455	http://dx.doi.org/10.1126/science.1232455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239723				2022-12-01	WOS:000312250800034
J	Xu, NL; Harnett, MT; Williams, SR; Huber, D; O'Connor, DH; Svoboda, K; Magee, JC				Xu, Ning-long; Harnett, Mark T.; Williams, Stephen R.; Huber, Daniel; O'Connor, Daniel H.; Svoboda, Karel; Magee, Jeffrey C.			Nonlinear dendritic integration of sensory and motor input during an active sensing task	NATURE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CORTICAL-NEURONS; OBJECT LOCALIZATION; PYRAMIDAL NEURONS; NEURAL ACTIVITY; CIRCUITS; ORGANIZATION; DYNAMICS; WHISKING; MOTION	Active dendrites provide neurons with powerful processing capabilities. However, little is known about the role of neuronal dendrites in behaviourally related circuit computations. Here we report that a novel global dendritic nonlinearity is involved in the integration of sensory and motor information within layer 5 pyramidal neurons during an active sensing behaviour. Layer 5 pyramidal neurons possess elaborate dendritic arborizations that receive functionally distinct inputs, each targeted to spatially separate regions(1,2). At the cellular level, coincident input from these segregated pathways initiates regenerative dendritic electrical events that produce bursts of action potential output(3,4) and circuits featuring this powerful dendritic nonlinearity can implement computations based on input correlation(5). To examine this in vivo we recorded dendritic activity in layer 5 pyramidal neurons in the barrel cortex using two-photon calcium imagingin mice performing an object-localization task. Large-amplitude, global calcium signals were observed throughout the apical tuft dendrites when active touch occurred at particular object locations or whisker angles. Such global calcium signals are produced by dendritic plateau potentials that require both vibrissal sensory input and primary motor cortex activity. These data provide direct evidence of nonlinear dendritic processing of correlated sensory and motor information in the mammalian neocortex during active sensation.	[Xu, Ning-long; Harnett, Mark T.; Huber, Daniel; O'Connor, Daniel H.; Svoboda, Karel; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Williams, Stephen R.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia	Howard Hughes Medical Institute; University of Queensland	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Xu, Ning-long/U-8665-2019; Huber, Daniel/C-2932-2013	Xu, Ning-long/0000-0002-1651-401X; Williams, Stephen/0000-0001-5352-7947; Huber, Daniel/0000-0002-0744-7679	Australian research council [FT100100502]; Australian National Health and Medical Research Council [APP1004575]	Australian research council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank L. Tian and L. Looger for GCaMP3 constructs; J. Chandrashekar, N. Ryba and C. Zuker for GCaMP3 transgenic mice; W. Denk for comments on the manuscript; N. Clack, G. Myers, T. Zhao, V. Iyer, S. Peron and S. Drukmann for help with software and analysis; and L. Petreanu for help with experimental apparatus. S.R.W. is supported by the Australian research council (FT100100502) and Australian National Health and Medical Research Council (APP1004575).	Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chen X., 2011, NATURE; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Iyer V., 2009, 2009 NEUR M PLANN SO; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L., 2012, NATURE; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhao T, 2011, NEUROINFORMATICS, V9, P247, DOI 10.1007/s12021-011-9120-3	38	306	309	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					247	+		10.1038/nature11601	http://dx.doi.org/10.1038/nature11601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143335				2022-12-01	WOS:000312259300041
J	Zhu, WQ; London, NR; Gibson, CC; Davis, CT; Tong, ZZ; Sorensen, LK; Shi, DS; Guo, JP; Smith, MCP; Grossmann, AH; Thomas, KR; Li, DY				Zhu, Weiquan; London, Nyall R.; Gibson, Christopher C.; Davis, Chadwick T.; Tong, Zongzhong; Sorensen, Lise K.; Shi, Dallas S.; Guo, Jinping; Smith, Matthew C. P.; Grossmann, Allie H.; Thomas, Kirk R.; Li, Dean Y.			Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability	NATURE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; ANTI-TNF-ALPHA; ENDOTHELIAL PERMEABILITY; INFLAMMATION; MECHANISMS; PROTEIN; GENE; MICE	The innate immune response is essential for combating infectious disease. Macrophages and other cells respond to infection by releasing cytokines, such as interleukin-1 beta (IL-1 beta), which in turn activate a well-described, myeloid-differentiation factor 88 (MYD88)-mediated, nuclear factor-kappa B (NF-kappa B)-dependent transcriptional pathway that results in inflammatory-cell activation and recruitment(1-4). Endothelial cells, which usually serve as a barrier to the movement of inflammatory cells out of the blood and into tissue, are also critical mediators of the inflammatory response(5,6). Paradoxically, the cytokines vital to a successful immune defence also have disruptive effects on endothelial cell-cell interactions and can trigger degradation of barrier function and dissociation of tissue architecture(7-9). The mechanism of this barrier dissolution and its relationship to the canonical NF-kappa B pathway remain poorly defined. Here we show that the direct, immediate and disruptive effects of IL-1 beta on endothelial stability in a human in vitro cell model are NF-kappa B independent and are instead the result of signalling through the small GTPase ADP-ribosylation factor 6 (ARF6) and its activator ARF nucleotide binding site opener (ARNO; also known as CYTH2). Moreover, we show that ARNO binds directly to the adaptor protein MYD88, and thus propose MYD88-ARNO-ARF6 as a proximal IL-1 beta signalling pathway distinct from that mediated by NF-kappa B. Finally, we show that SecinH3, an inhibitor of ARF guanine nucleotide-exchange factors such as ARNO, enhances vascular stability and significantly improves outcomes in animal models of inflammatory arthritis and acute inflammation.	[Zhu, Weiquan; London, Nyall R.; Guo, Jinping; Smith, Matthew C. P.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Zhu, Weiquan; London, Nyall R.; Gibson, Christopher C.; Davis, Chadwick T.; Sorensen, Lise K.; Shi, Dallas S.; Guo, Jinping; Smith, Matthew C. P.; Grossmann, Allie H.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [London, Nyall R.; Smith, Matthew C. P.; Li, Dean Y.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Gibson, Christopher C.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Davis, Chadwick T.; Shi, Dallas S.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Tong, Zongzhong] Navigen Inc, Salt Lake City, UT 84112 USA; [Guo, Jinping] Second Mil Med Univ, Dept Anat, Shanghai 200433, Peoples R China; [Grossmann, Allie H.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Li, Dean Y.] VA Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Sichuan Acad Med Sci, Inst Lab Med, Key Lab Human Dis Gene Study Sichuan Prov, Chengdu 610072, Sichuan, Peoples R China; [Li, Dean Y.] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Naval Medical University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Li, DY (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	dean.li@u2m2.utah.edu		Sorensen, Lise K./0000-0003-3250-4564	National Heart, Lung, and Blood Institute; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; American Asthma Foundation; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA163970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311, R01HL084516, R01HL065648] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; American Asthma Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Lim and T. Mleynek for graphical assistance, G. Zimmerman and J. Kaplan for reading the manuscript, S. Odelberg for reading the manuscript and statistical analysis, J. Ling for help with immunostaining, R. Campbell and A. Weyrich for providing primary human blood cells, C. Rodesch and the University of Utah Cell Imaging/Fluorescence Facility as well as the University of Utah Flow Cytometry Facility, and M. P. Revelo for help with pathology. D.Y.L. and his laboratory were funded by grants from the National Heart, Lung, and Blood Institute; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; the American Asthma Foundation; and the Department of Defense. D.Y.L. is the HA and Edna Benning Endowed Professor of Medicine and Cardiology.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; London NR, 2009, ANGIOGENESIS, V12, P149, DOI 10.1007/s10456-009-9130-z; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matthews JS, 1999, CYTOKINE, V11, P643, DOI 10.1006/cyto.1998.0478; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Riley KN, 2003, MOL BIOL CELL, V14, P4155, DOI 10.1091/mbc.e02-11-0726; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI 10.2217/IMT.10.67; Szekanecz Z, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2515; VANDENBERG WB, 1994, CLIN EXP IMMUNOL, V95, P237; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WOOLEY PH, 1993, J IMMUNOL, V151, P6602; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	30	113	121	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					252	255		10.1038/nature11603	http://dx.doi.org/10.1038/nature11603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143332	Green Accepted			2022-12-01	WOS:000312259300042
J	Jetz, W; Thomas, GH; Joy, JB; Hartmann, K; Mooers, AO				Jetz, W.; Thomas, G. H.; Joy, J. B.; Hartmann, K.; Mooers, A. O.			The global diversity of birds in space and time	NATURE			English	Article							MOLECULAR PHYLOGENIES; DIVERSIFICATION RATES; NORTH-AMERICAN; FOSSIL RECORD; EVOLUTION; RADIATIONS; PATTERNS; HISTORY; BIOGEOGRAPHY; EXTINCTION	Current global patterns of biodiversity result from processes that operate over both space and time and thus require an integrated macroecological and macroevolutionary perspective(1-4). Molecular time trees have advanced our understanding of the tempo and mode of diversification(5-7) and have identified remarkable adaptive radiations across the tree of life(8-10). However, incomplete joint phylogenetic and geographic sampling has limited broad-scale inference. Thus, the relative prevalence of rapid radiations and the importance of their geographic settings in shaping global biodiversity patterns remain unclear. Here we present, analyse and map the first complete dated phylogeny of all 9,993 extant species of birds, a widely studied group showing many unique adaptations. We find that birds have undergone a strong increase in diversification rate from about 50 million years ago to the near present. This acceleration is due to a number of significant rate increases, both within songbirds and within other young and mostly temperate radiations including the waterfowl, gulls and woodpeckers. Importantly, species characterized with very high past diversification rates are interspersed throughout the avian tree and across geographic space. Geographically, the major differences in diversification rates are hemispheric rather than latitudinal, with bird assemblages in Asia, North America and southern South America containing a disproportionate number of species from recent rapid radiations. The contribution of rapidly radiating lineages to both temporal diversification dynamics and spatial distributions of species diversity illustrates the benefits of an inclusive geographical and taxonomical perspective. Overall, whereas constituent clades may exhibit slowdowns(10,11), the adaptive zone into which modern birds have diversified since the Cretaceous may still offer opportunities for diversification.	[Jetz, W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Thomas, G. H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Joy, J. B.; Mooers, A. O.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Hartmann, K.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia	Yale University; University of Sheffield; Simon Fraser University; University of Tasmania	Jetz, W (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06520 USA.	walter.jetz@yale.edu; amooers@sfu.ca	Thomas, Gavin/AAE-8959-2019; Jetz, Walter/ABF-1517-2020	Joy, Jeffrey/0000-0002-7013-1482; Jetz, Walter/0000-0002-1971-7277; Thomas, Gavin/0000-0002-1982-6051	NSF [DBI 0960550, DEB 1026764]; NASA [NNX11AP72G]; Natural Environment Research Council [NE/G012938/1]; NERC (Centre for Population Biology); NSERC Canada; Wissenschaftskolleg zu Berlin; Yale Institute for Biospheric Sciences; Simon Fraser University; NERC [NE/G012938/2, NE/G012938/1] Funding Source: UKRI; Natural Environment Research Council [NE/G012938/2] Funding Source: researchfish; Division Of Environmental Biology [1026764] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC (Centre for Population Biology)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); Yale Institute for Biospheric Sciences; Simon Fraser University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Redding for critical input in the early stages of this project; A. Mimoto, F. Ronqvist and M. Teslenko for help modifying MrBayes; I. Martyn for coding; R. Bowie, J. McGuire, A. Cooper, K. Burns and M. Sorenson among others, for unpublished phylogenetic material or information; M. Benton, T. Ezard, T. Price, M. Donoghue, J. Beaulieu, J. Belmaker, P. M. Hull, D. Field, N. Longrich, V. Saranathan, M. Steel, H. Morlon, J. Brown, A. Phillimore, R. Fitzjohn, R. Etienne, W. Stein and especially T. Stadler for data, important input and/or discussion; G. Smith, C. Schank, D. Thiele, T. M. Lee, F. La Sorte, C. Edwards, K. Ashton and J. Hazelhurst for help with spatial and phylogenetic data collection and management; C. Schank for help preparing the tree visualizations. This work was carried out using the BlueFern Supercomputing Facilities (http://www.bluefern.canterbury.ac.nz), University of Canterbury, the Advanced Computing Research Centre, University of Bristol (http://www.bris.ac.uk/acrc/) and the Interdisciplinary Research in Mathematics and Computer Sciences Centre, Simon Fraser University (http://www.irmacs.sfu.ca). This work was partly supported by NSF grants DBI 0960550 and DEB 1026764 and NASA Biodiversity Grant NNX11AP72G (W. J.); the Natural Environment Research Council (Postdoctoral Fellowship grant number NE/G012938/1 and the NERC Centre for Population Biology) (G.H.T.); and NSERC Canada, the Wissenschaftskolleg zu Berlin, the Yale Institute for Biospheric Sciences and Simon Fraser University (A.O.M.). Most importantly, we thank the many avian systematists and phylogeneticists who have contributed their data to public databases and so made our study possible.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Derryberry EP, 2011, EVOLUTION, V65, P2973, DOI 10.1111/j.1558-5646.2011.01374.x; Ericson PGP, 2012, J BIOGEOGR, V39, P813, DOI 10.1111/j.1365-2699.2011.02650.x; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Grant P. R., 2011, WHY SPECIES MULTIPLY; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price T, 2000, AM NAT, V156, P354, DOI 10.1086/303397; Price T., 2008, SPECIATION BIRDS; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Simpson G.G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842	30	1974	2015	33	1097	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					444	448		10.1038/nature11631	http://dx.doi.org/10.1038/nature11631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123857				2022-12-01	WOS:000311031600046
J	Manavella, PA; Hagmann, J; Ott, F; Laubinger, S; Franz, M; Macek, B; Weigel, D				Manavella, Pablo A.; Hagmann, Joerg; Ott, Felix; Laubinger, Sascha; Franz, Mirita; Macek, Boris; Weigel, Detlef			Fast-Forward Genetics Identifies Plant CPL Phosphatases as Regulators of miRNA Processing Factor HYL1	CELL			English	Article							RNA-POLYMERASE-II; SMALL INTERFERING RNA; CAP-BINDING COMPLEX; C-TERMINAL DOMAIN; ARABIDOPSIS-THALIANA; MICRORNA BIOGENESIS; ABSCISIC-ACID; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-PHOSPHORYLATION; PRI-MIRNA	MicroRNAs (miRNAs) are processed from primary transcripts that contain partially self-complementary foldbacks. As in animals, the core microprocessor in plants is a Dicer protein, DICER-LIKE1 (DCL1). Processing accuracy and strand selection is greatly enhanced through the RNA binding protein HYPONASTIC LEAVES 1 (HYL1) and the zinc finger protein SERRATE (SE). We have combined a luciferase-based genetic screen with whole-genome sequencing for rapid identification of new regulators of miRNA biogenesis and action. Among the first six mutants analyzed were three alleles of C-TERMINAL DOMAIN PHOSPHATASE-LIKE 1 (CPL1)/FIERY2 (FRY2). In the miRNA processing complex, SE functions as a scaffold to mediate CPL1 interaction with HYL1, which needs to be dephosphorylated for optimal activity. In the absence of CPL1, HYL1 dephosphorylation and hence accurate processing and strand selection from miRNA duplexes are compromised. Our findings thus define a new regulatory step in plant miRNA biogenesis.	[Manavella, Pablo A.; Hagmann, Joerg; Ott, Felix; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Laubinger, Sascha] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Franz, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Macek, Boris/N-1442-2015; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Macek, Boris/0000-0002-1206-2458; Weigel, Detlef/0000-0002-2114-7963; Manavella, Pablo/0000-0003-3589-4414; Laubinger, Sascha/0000-0002-6682-0728	European Community IP SIROCCO [LSHG-CT-2006-037900]; Deutsche Forschungsgemeinschaft; Max Planck Society	European Community IP SIROCCO; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank S. Grant and J. Dangl for cpl2 seeds, M. Christie, E. Izaurralde, I. Rubio-Somoza and R. Schwab for comments, C. Becker for help with RNA-seq analyses, and N. Camomilli for technical assistance. We are grateful to an anonymous reviewer for pointing out the miRNA* effects. Supported by a Human Frontier Science Program Long-Term Fellowship (P. A. M.), by European Community IP SIROCCO (contract LSHG-CT-2006-037900), a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and the Max Planck Society.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bezerra IC, 2004, PLANT J, V40, P112, DOI 10.1111/j.1365-313X.2004.02194.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; de Felippes FF, 2010, METHODS MOL BIOL, V592, P255, DOI 10.1007/978-1-60327-005-2_17; de Felippes FF, 2011, NUCLEIC ACIDS RES, V39, P2880, DOI 10.1093/nar/gkq1240; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Isono E, 2010, METHODS MOL BIOL, V655, P377, DOI 10.1007/978-1-60761-765-5_25; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim S, 2008, PLANT CELL PHYSIOL, V49, P1634, DOI 10.1093/pcp/pcn146; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lesicka-Gorecka J, 2008, ACTA BIOCHIM POL, V55, P517; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Olsen Jesper V., 2009, V492, P131, DOI 10.1007/978-1-59745-493-3_7; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tagami Y, 2009, RNA, V15, P450, DOI 10.1261/rna.1297109; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang W, 2011, PLANT CELL, V23, P3565, DOI 10.1105/tpc.111.091058; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x	70	153	159	2	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					859	870		10.1016/j.cell.2012.09.039	http://dx.doi.org/10.1016/j.cell.2012.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141542	Bronze			2022-12-01	WOS:000310921200016
J	Weinstock, JV				Weinstock, Joel V.			The worm returns	NATURE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; TRICHURIS-SUIS THERAPY; CROHNS-DISEASE; COLITIS		[Weinstock, Joel V.] Tufts Univ, Boston, MA 02111 USA; [Weinstock, Joel V.] Tufts Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Weinstock, JV (corresponding author), Tufts Univ, Boston, MA 02111 USA.	jweinstock2@tuftsmedicalcenter.org			NIDDK NIH HHS [R01 DK091987] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091987] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Blum AM, 2012, J IMMUNOL, V189, P2512, DOI 10.4049/jimmunol.1102892; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Weinstock JV, 2004, GUT, V53, P7, DOI 10.1136/gut.53.1.7; World Health Organization, 2007, ACT WORMS	10	60	69	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					183	185		10.1038/491183a	http://dx.doi.org/10.1038/491183a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135449	Bronze, Green Accepted			2022-12-01	WOS:000310774300014
J	de Wijn, AG				de Wijn, Alfred G.			Measuring Solar Magnetism	SCIENCE			English	Editorial Material							DYNAMICS-OBSERVATORY SDO; FIELD; MISSION		Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	de Wijn, AG (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.	dwijn@ucar.edu		de Wijn, Alfred/0000-0002-5084-4661				AUER LH, 1977, SOL PHYS, V55, P47, DOI 10.1007/BF00150873; Borrero JM, 2011, SOL PHYS, V273, P267, DOI 10.1007/s11207-010-9515-6; Casini R, 2003, ASTROPHYS J, V598, pL67, DOI 10.1086/380496; DeRosa ML, 2009, ASTROPHYS J, V696, P1780, DOI 10.1088/0004-637X/696/2/1780; Hale GE, 1908, ASTROPHYS J, V28, P315, DOI 10.1086/141602; Hathaway DH, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-1; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kuckein C, 2009, ASTRON ASTROPHYS, V501, P1113, DOI 10.1051/0004-6361/200911800; LITES BW, 1982, ASTROPHYS J SUPPL S, V49, P293, DOI 10.1086/190800; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; SKUMANICH A, 1987, ASTROPHYS J, V322, P473, DOI 10.1086/165743; STENFLO JO, 1973, SOL PHYS, V32, P41, DOI 10.1007/BF00152728; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Zeeman P., 1896, VERSL GEW VERG AFD N, P181	15	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					476	477		10.1126/science.1226336	http://dx.doi.org/10.1126/science.1226336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112318				2022-12-01	WOS:000310195800040
J	Ernst, A; Avvakumov, G; Tong, JF; Fan, YH; Zhao, YL; Alberts, P; Persaud, A; Walker, JR; Neculai, AM; Neculai, D; Vorobyov, A; Garg, P; Beatty, L; Chan, PK; Juang, YC; Landry, MC; Yeh, C; Zeqiraj, E; Karamboulas, K; Allali-Hassani, A; Vedadi, M; Tyers, M; Moffat, J; Sicheri, F; Pelletier, L; Durocher, D; Raught, B; Rotin, D; Yang, JH; Moran, MF; Dhe-Paganon, S; Sidhu, SS				Ernst, Andreas; Avvakumov, George; Tong, Jiefei; Fan, Yihui; Zhao, Yanling; Alberts, Philipp; Persaud, Avinash; Walker, John R.; Neculai, Ana-Mirela; Neculai, Dante; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Chan, Pak-Kei; Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Karamboulas, Konstantina; Allali-Hassani, Abdellah; Vedadi, Masoud; Tyers, Mike; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Raught, Brian; Rotin, Daniela; Yang, Jianhua; Moran, Michael F.; Dhe-Paganon, Sirano; Sidhu, Sachdev S.			A Strategy for Modulation of Enzymes in the Ubiquitin System	SCIENCE			English	Article							DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; SPECIFICITY; LIGASE; CANCER; TRAFFICKING; RECOGNITION; ENDOCYTOSIS; INHIBITION; PROTEASES	The ubiquitin system regulates virtually all aspects of cellular function. We report a method to target the myriad enzymes that govern ubiquitination of protein substrates. We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallography. We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity. Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains. Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymatic steps in the ubiquitin system.	[Ernst, Andreas; Neculai, Ana-Mirela; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Karamboulas, Konstantina; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Avvakumov, George; Walker, John R.; Neculai, Dante; Allali-Hassani, Abdellah; Vedadi, Masoud; Dhe-Paganon, Sirano] MaRS Ctr, Struct Genom Consortium, 101 Coll St,Suite 700, Toronto, ON M5G 1L7, Canada; [Tong, Jiefei; Alberts, Philipp; Persaud, Avinash; Rotin, Daniela; Moran, Michael F.] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Fan, Yihui; Zhao, Yanling; Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Persaud, Avinash; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Chan, Pak-Kei; Tyers, Mike] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Tyers, Mike; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Yeh, Christina; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Moran, Michael F.; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Moffat, Jason; Moran, Michael F.; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Moffat, Jason; Raught, Brian; Sidhu, Sachdev S.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Moffat, Jason; Raught, Brian; Sidhu, Sachdev S.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine; Texas Children's Cancer Center; University of Toronto; Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Sidhu, SS (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	sachdev.sidhu@utoronto.ca	Ernst, Andreas/M-3013-2019; Durocher, Daniel/A-7733-2010; Pelletier, Laurence/F-8858-2013; Moffat, Jason/AAC-1110-2020; Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021; Neculai, Dante/A-9923-2011; Neculai, Dante/M-2884-2013; Moran, Michael/GYD-3631-2022	Durocher, Daniel/0000-0003-3863-8635; Moffat, Jason/0000-0002-5663-8586; Neculai, Dante/0000-0001-8887-9168; /0000-0002-5255-895X; Zeqiraj, Elton/0000-0003-0239-5926	Canadian Institutes for Health Research [MOP-111149, MOP-13494, MOP-57795, MOP-102536, 1097737]; NIH-National Institute of Neurological Disorders and Stroke [1R01NS072420-01]; Canada Research Chairs in Structural Principles of Signal Transduction; Canadian Foundation for Innovation, Systems and Synthetic Biology; Molecular Signatures; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072420] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Research Chairs in Structural Principles of Signal Transduction(Canada Research Chairs); Canadian Foundation for Innovation, Systems and Synthetic Biology; Molecular Signatures; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank I. Pot and J.J. Adams for helpful comments on the manuscript and Y. Li for cloning protease constructs. This project was supported by operating grants from the Canadian Institutes for Health Research to S. S. S. (MOP-111149), D. R. (MOP-13494), F. S., M. T. (MOP-57795), and M. F. M. (MOP-102536). J.Y. receives funding from a NIH-National Institute of Neurological Disorders and Stroke grant (1R01NS072420-01). F. S., D. R., M. T., and M. F. M. hold Canada Research Chairs (Tier 1) in Structural Principles of Signal Transduction, Canadian Foundation for Innovation, Systems and Synthetic Biology, and Molecular Signatures, respectively. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. E., G. A., S. D., and S. S. S. designed the study. A. E., A. V., P. G., and L. B. performed phage display selections, protein purification, and in vitro inhibition assays. G. A., A.-M.N., D.N., J.W., Y.-C.J., and S. D. purified proteins used in this study and solved all the crystal structures. J.T. and M. F. M. performed intracellular USP8 inhibition experiments. Y. F., Y.Z., and J.Y. performed intracellular USP21 inhibition experiments. Y.-C.J., M.-C. L., C. Y., E.Z, F. S., L. P., M. T., and D. D. purified proteins used as targets for phage display selections. K. K. and J.M. performed initial intracellular characterizations of Ub variants. A. A.-H. and M. V. performed in vitro enzymatic assays. P.-K.C. and B. R. provided Ub variants expressing stable cell lines and performed mass spectrometry experiments. P. A., A. P., and D. R. performed NEDD4 ubiquitination experiments; A. E. and S. S. S. analyzed data, prepared figures, and wrote the paper. S. S. S., L. B., and A. E. are inventors on a pending patent, "Specific Active Site Inhibitors of Enzymes or Substrate Binding Partners and Methods of Producing the Same" (PCT/US11/39601).	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fellouse F. A., 2005, PHAGE DISPLAY BIIOTE, V3, P111; Grunda JM, 2006, J NEURO-ONCOL, V80, P261, DOI 10.1007/s11060-006-9191-4; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Meijer IMJ, 2011, CELL SIGNAL, V23, P458, DOI 10.1016/j.cellsig.2010.10.023; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125	46	194	206	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					590	595		10.1126/science.1230161	http://dx.doi.org/10.1126/science.1230161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23287719	Green Accepted			2022-12-01	WOS:000314270000062
J	Chakraborty, S; Gruber, T; Barry, CE; Boshoff, HI; Rhee, KY				Chakraborty, Sumit; Gruber, Todd; Barry, Clifton E., III; Boshoff, Helena I.; Rhee, Kyu Y.			Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis	SCIENCE			English	Article							DIHYDROPTEROATE SYNTHASE; THYMIDYLATE SYNTHASE; ESCHERICHIA-COLI; LIGAND-BINDING; RESISTANCE; METHOTREXATE; INHIBITION; DEPLETION; THYX	Folate biosynthesis is an established anti-infective target, and the antifolate para-aminosalicylic acid (PAS) was one of the first anti-infectives introduced into clinical practice on the basis of target-based drug discovery. Fifty years later, PAS continues to be used to treat tuberculosis. PAS is assumed to inhibit dihydropteroate synthase (DHPS) in Mycobacterium tuberculosis by mimicking the substrate p-aminobenzoate (PABA). However, we found that sulfonamide inhibitors of DHPS inhibited growth of M. tuberculosis only weakly because of their intracellular metabolism. In contrast, PAS served as a replacement substrate for DHPS. Products of PAS metabolism at this and subsequent steps in folate metabolism inhibited those enzymes, competing with their substrates. PAS is thus a prodrug that blocks growth of M. tuberculosis when its active forms are generated by enzymes in the pathway they poison.	[Chakraborty, Sumit; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chakraborty, Sumit; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Gruber, Todd; Barry, Clifton E., III; Boshoff, Helena I.] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rhee, KY (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	kyr9001@med.cornell.edu	Barry, Clifton E/ABE-7992-2020; Barry, Clifton E/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	Burroughs Wellcome Career Award in the Biomedical Sciences; William Randolph Hearst Foundation; Bill and Melinda Gates TB Drug Accelerator Program [OPP1024050]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); William Randolph Hearst Foundation; Bill and Melinda Gates TB Drug Accelerator Program; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nathan for critical discussions and reading of the manuscript, D. Garboczi for assistance in preparing purified FolP1 and FolC, R. Lee and M. Serono for the generous gifts of pure folate intermediates and pteroate analogs, S. Fischer for expert mass spectrometric support, a Burroughs Wellcome Career Award in the Biomedical Sciences to K.Y.R., the William Randolph Hearst Foundation, and the Bill and Melinda Gates TB Drug Accelerator Program (OPP1024050) for support. This work was supported in part by the Intramural Research Program of NIAID, NIH. Primary data are deposited in Dryad; the provisional doi is 10.5061/dryad.vh36n.	ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; ELION GERTRUDE B., 1965, ADVANCE CHEMOTHERAP, V2, P91; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Huang TS, 2012, J ANTIMICROB CHEMOTH, V67, P633, DOI 10.1093/jac/dkr501; Hunter JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002237; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Long E. R, 1958, CHEM CHEMOTHERAPY TU, P347; Lu WY, 2007, J AM SOC MASS SPECTR, V18, P898, DOI 10.1016/j.jasms.2007.01.017; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; Nopponpunth V, 1999, J BACTERIOL, V181, P6814, DOI 10.1128/JB.181.21.6814-6821.1999; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; ROSDAHL K. -G, 1948, SVENSK KEMISK TIDSKR, V60, P12; Schuessler DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034471; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108	22	138	141	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					88	91		10.1126/science.1228980	http://dx.doi.org/10.1126/science.1228980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23118010	Green Accepted			2022-12-01	WOS:000312985800058
J	Wakamoto, Y; Dhar, N; Chait, R; Schneider, K; Signorino-Gelo, F; Leibler, S; McKinney, JD				Wakamoto, Yuichi; Dhar, Neeraj; Chait, Remy; Schneider, Katrin; Signorino-Gelo, Francois; Leibler, Stanislas; McKinney, John D.			Dynamic Persistence of Antibiotic-Stressed Mycobacteria	SCIENCE			English	Article							BACTERIAL PERSISTENCE; PHENOTYPIC VARIABILITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; MECHANISM; ENVIRONMENTS; TOLERANCE; GROWTH; NOISE; CELLS	Exposure of an isogenic bacterial population to a cidal antibiotic typically fails to eliminate a small fraction of refractory cells. Historically, fractional killing has been attributed to infrequently dividing or nondividing "persisters." Using microfluidic cultures and time-lapse microscopy, we found that Mycobacterium smegmatis persists by dividing in the presence of the drug isoniazid (INH). Although persistence in these studies was characterized by stable numbers of cells, this apparent stability was actually a dynamic state of balanced division and death. Single cells expressed catalase-peroxidase (KatG), which activates INH, in stochastic pulses that were negatively correlated with cell survival. These behaviors may reflect epigenetic effects, because KatG pulsing and death were correlated between sibling cells. Selection of lineages characterized by infrequent KatG pulsing could allow nonresponsive adaptation during prolonged drug exposure.	[Wakamoto, Yuichi; Dhar, Neeraj; Schneider, Katrin; Signorino-Gelo, Francois; McKinney, John D.] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Chait, Remy; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	McKinney, JD (corresponding author), Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland.	john.mckinney@epfl.ch	Dhar, Neeraj/K-8171-2013	Dhar, Neeraj/0000-0002-5887-8137; Chait, Remy/0000-0003-0876-3187	Charles H. Revson Foundation; New York Community Trust; Harvey L. Karp Discovery Fellowship; JST PRESTO Program; Bill and Melinda Gates Foundation; NIH [HL088906]; Swiss National Science Foundation [310030_135639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088906] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24657014] Funding Source: KAKEN	Charles H. Revson Foundation; New York Community Trust; Harvey L. Karp Discovery Fellowship; JST PRESTO Program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by fellowships from the Charles H. Revson Foundation and the Heiser Program for Research in Leprosy and Tuberculosis of the New York Community Trust (N.D.); a Harvey L. Karp Discovery Fellowship and the JST PRESTO Program (Y.W.); and the Bill and Melinda Gates Foundation, NIH grant HL088906, and Swiss National Science Foundation grant 310030_135639 (J.D.M.).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bigger JW, 1944, LANCET, V2, P497; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Coates ARM, 2008, TRENDS PHARMACOL SCI, V29, P143, DOI 10.1016/j.tips.2007.12.001; Cogan NG, 2006, J THEOR BIOL, V238, P694, DOI 10.1016/j.jtbi.2005.06.017; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hobby GL, 1944, P SOC EXP BIOL MED, V56, P181, DOI 10.3181/00379727-56-14643; Hobby GL, 1942, P SOC EXP BIOL MED, V50, P281, DOI 10.3181/00379727-50-13773; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Iuchi S, 1996, J BIOCHEM-TOKYO, V120, P1055; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; KUBITSCHEK HE, 1964, MUTAT RES, V1, P113, DOI 10.1016/0027-5107(64)90013-2; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12	39	355	363	4	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					91	95		10.1126/science.1229858	http://dx.doi.org/10.1126/science.1229858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288538				2022-12-01	WOS:000312985800059
J	Neria, Y; Shultz, JM				Neria, Yuval; Shultz, James M.			Mental Health Effects of Hurricane Sandy Characteristics, Potential Aftermath, and Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; TERRORIST ATTACKS		[Neria, Yuval] New York State Psychiat Inst & Hosp, Unit 69, New York, NY 10032 USA; [Neria, Yuval] Columbia Univ, Dept Psychiat, New York, NY USA; [Neria, Yuval] Columbia Univ, Dept Epidemiol, New York, NY USA; [Shultz, James M.] Univ Miami, Miller Sch Med, Ctr Disaster & Extreme Event Preparedness DEEP Ct, Miami, FL 33136 USA	New York State Psychiatry Institute; Columbia University; Columbia University; University of Miami	Neria, Y (corresponding author), New York State Psychiat Inst & Hosp, Unit 69, 1051 Riverside Dr, New York, NY 10032 USA.	ny126@columbia.edu			NIMH NIH HHS [R01 MH072833] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072833] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; [Anonymous], NY TIMES; Foa EB, 2005, NEUROPSYCHOPHARMACOL, V30, P1806, DOI 10.1038/sj.npp.1300815; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Sandy Hurricane, 2012, HURR SAND; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Walsh MW, NY TIMES	9	98	99	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2571	2572		10.1001/jama.2012.110700	http://dx.doi.org/10.1001/jama.2012.110700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23160987	Green Accepted			2022-12-01	WOS:000312916600020
J	Goode, J				Goode, Jamie			VITICULTURE Fruity with a hint of drought	NATURE			English	Editorial Material												jamie@wineanorak.com							0	8	8	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					351	353		10.1038/492351a	http://dx.doi.org/10.1038/492351a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257865	Bronze			2022-12-01	WOS:000312488200063
J	Bomers, MK; van Agtmael, MA; Luik, H; van Veen, MC; Vandenbroucke-Grauls, CMJE; Smulders, YM				Bomers, Marije K.; van Agtmael, Michiel A.; Luik, Hotsche; van Veen, Merk C.; Vandenbroucke-Grauls, Christina M. J. E.; Smulders, Yvo M.			Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANINE SCENT DETECTION; LABORATORY DIAGNOSIS; EPIDEMIOLOGY; INFECTION; CANCER; COLONIZATION; ACQUISITION; OUTBREAK; DIARRHEA; DELAYS	Objective To investigate whether a dog's superior olfactory sensitivity can be used to detect Clostridium difficile in stool samples and hospital patients. Design Proof of principle study, using a case-control design. Setting Two large Dutch teaching hospitals. Participants A 2 year old beagle trained to identify the smell of C difficile and tested on 300 patients (30 with C difficile infection and 270 controls). Intervention The dog was guided along the wards by its trainer, who was blinded to the participants' infection status. Each detection round concerned 10 patients (one case and nine controls). The dog was trained to sit or lie down when C difficile was detected. Main outcome measures Sensitivity and specificity for detection of C difficile in stool samples and in patients. Results The dog's sensitivity and specificity for identifying C difficile in stool samples were both 100% (95% confidence interval 91% to 100%). During the detection rounds, the dog correctly identified 25 of the 30 cases (sensitivity 83%, 65% to 94%) and 265 of the 270 controls (specificity 98%, 95% to 99%). Conclusion A trained dog was able to detect C difficile with high estimated sensitivity and specificity, both in stool samples and in hospital patients infected with C difficile.	[Bomers, Marije K.; van Agtmael, Michiel A.; Smulders, Yvo M.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands; [Luik, Hotsche] HL&HONDEN, Edam, Netherlands; [van Veen, Merk C.] St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Sint Lucas Andreas Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bomers, MK (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	m.bomers@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020; Smulders, YM/AAG-7506-2021	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Bomers, Marije/0000-0003-0399-6926				BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Burdette SD, 2007, CLIN INFECT DIS, V44, P1142, DOI 10.1086/513033; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Delmee M, 2001, CLIN MICROBIOL INFEC, V7, P411, DOI 10.1046/j.1198-743x.2001.00294.x; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Frenz MB, 2003, QJM-INT J MED, V96, P579, DOI 10.1093/qjmed/hcg098; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Hensgens MPM, 2011, EUR J CLIN MICROBIOL, V30, P587, DOI 10.1007/s10096-010-1127-4; Horvath G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-643; IsselTarver L, 1997, GENETICS, V145, P185; Johansen A, 2002, AGE AGEING, V31; Karre T, 2011, J CLIN MICROBIOL, V49, P725, DOI 10.1128/JCM.01028-10; Kufelnicka AM, 2011, CLIN INFECT DIS, V52, P1451, DOI 10.1093/cid/cir201; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lefebvre SL, 2008, AM J INFECT CONTROL, V36, P78, DOI 10.1016/j.ajic.2007.09.005; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Scheurer D, 2008, J HOSP MED, V3, P156, DOI 10.1002/jhm.277; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; WILLIAMS H, 1989, LANCET, V1, P734; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712	34	63	67	0	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e7396	10.1136/bmj.e7396	http://dx.doi.org/10.1136/bmj.e7396			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241268	hybrid, Green Submitted, Green Published			2022-12-01	WOS:000312495700001
J	Nagano, AJ; Sato, Y; Mihara, M; Antonio, BA; Motoyama, R; Itoh, H; Nagamura, Y; Izawa, T				Nagano, Atsushi J.; Sato, Yutaka; Mihara, Motohiro; Antonio, Baltazar A.; Motoyama, Ritsuko; Itoh, Hironori; Nagamura, Yoshiaki; Izawa, Takeshi			Deciphering and Prediction of Transcriptome Dynamics under Fluctuating Field Conditions	CELL			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; ARABIDOPSIS; RICE; PHYTOCHROME; REGULATORS	Determining the drivers of gene expression patterns is more straightforward in laboratory conditions than in the complex fluctuating environments where organisms typically live. We gathered transcriptome data from the leaves of rice plants in a paddy field along with the corresponding meteorological data and used them to develop statistical models for the endogenous and external influences on gene expression. Our results indicate that the transcriptome dynamics are predominantly governed by endogenous diurnal rhythms, ambient temperature, plant age, and solar radiation. The data revealed diurnal gates for environmental stimuli to influence transcription and pointed to relative influences exerted by circadian and environmental factors on different metabolic genes. The model also generated predictions for the influence of changing temperatures on transcriptome dynamics. We anticipate that our models will help translate the knowledge amassed in laboratories to problems in agriculture and that our approach to deciphering the transcriptome fluctuations in complex environments will be applicable to other organisms.	[Nagano, Atsushi J.; Itoh, Hironori; Izawa, Takeshi] Natl Inst Agrobiol Sci, Photosynthesis & Photobiol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Sato, Yutaka; Antonio, Baltazar A.; Motoyama, Ritsuko; Nagamura, Yoshiaki] Natl Inst Agrobiol Sci, Genome Resource Ctr, Tsukuba, Ibaraki 3058602, Japan; [Mihara, Motohiro; Izawa, Takeshi] Natl Inst Agrobiol Sci, Plant Genom Res Unit, Tsukuba, Ibaraki 3058602, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Nagamura, Y (corresponding author), Natl Inst Agrobiol Sci, Genome Resource Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	nagamura@affrc.go.jp; tizawa@nias.affrc.go.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049; Izawa, Takeshi/0000-0001-5109-0024	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [RTR-0004, GPN0001, RTR-0002]	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan)	We thank M. Ebihara for her experimental assistance; M. Fukata for maintaining the FiT-DB database and registration of some microarray data to GEO; Dr. S. Ishida for useful advice on the annotation enrichment analysis; H. Minami, K. Kamatsuki, N. Namiki for assistance in analysis of microarray data and registration to GEO; and Dr. N. Sakurai for providing the gene lists in KaPPA-View4. This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation; RTR-0004 and GPN0001 to T. I. and RTR-0002 to Y.N.).	Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2012, PLANT CELL ENVIRON, V35, P1729, DOI 10.1111/j.1365-3040.2012.02555.x; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Morita S., 2009, Bulletin of the National Agricultural Research Center for Kyushu Okinawa Region, P1; Parry M.L., 2007, CONTRIBUTION WORKING; Richards CL, 2012, PLOS GENET, V8, P482, DOI 10.1371/journal.pgen.1002662; Ronald P, 2011, GENETICS, V188, P11, DOI 10.1534/genetics.111.128553; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147	17	137	141	2	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1358	1369		10.1016/j.cell.2012.10.048	http://dx.doi.org/10.1016/j.cell.2012.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217716	Bronze			2022-12-01	WOS:000311999900023
J	Stensola, H; Stensola, T; Solstad, T; Froland, K; Moser, MB; Moser, EI				Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.			The entorhinal grid map is discretized	NATURE			English	Article							SPATIAL REPRESENTATION; FUNCTIONAL ARCHITECTURE; THETA OSCILLATIONS; PATH-INTEGRATION; SINGLE NEURONS; CELLS; INTERFERENCE; DIRECTION; CORTEX; MONKEY	The medial entorhinal cortex (MEC) is part of the brain's circuit for dynamic representation of self-location. The metric of this representation is provided by grid cells, cells with spatial firing fields that tile environments in a periodic hexagonal pattern. Limited anatomical sampling has obscured whether the grid system operates as a unified system or a conglomerate of independent modules. Here we show with recordings from up to 186 grid cells in individual rats that grid cells cluster into a small number of layer-spanning anatomically overlapping modules with distinct scale, orientation, asymmetry and theta-frequency modulation. These modules can respond independently to changes in the geometry of the environment. The discrete topography of the grid-map, and the apparent autonomy of the modules, differ from the graded topography of maps for continuous variables in several sensory systems, raising the possibility that the modularity of the grid map is a product of local self-organizing network dynamics.	[Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7491 Trondheim, Norway; [Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Ctr Biol Memory, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	hanne.stensola@ntnu.no; tor.stensola@ntnu.no; edvard.moser@ntnu.no		Stensola, Tor/0000-0002-5485-6141; Stensola, Hanne/0000-0002-5823-944X	European Research Council ('CIRCUIT') [232608]; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	European Research Council ('CIRCUIT'); Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	We thank A. M. Amundgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng, and H. Waade for technical assistance, J. Whitlock for implanting an animal in the tangential group, and T. Bonhoeffer, B. Dunn, B. McNaughton, Y. Roudi, A. Treves and A. Witoelar for helpful discussion. The work was supported by an Advanced Investigator Grant from the European Research Council ('CIRCUIT', Grant Agreement no. 232608), the Kavli Foundation and the Centre of Excellence scheme of the Research Council of Norway.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Couey J.J., 2012, SOC NEC ABSTR, V702.06; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; HEVNER RF, 1992, J COMP NEUROL, V326, P451, DOI 10.1002/cne.903260310; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IKEDA J, 1989, BRAIN RES, V505, P176, DOI 10.1016/0006-8993(89)90134-0; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sperry RW, 1943, J COMP NEUROL, V79, P33, DOI 10.1002/cne.900790104; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; TOLHURST DJ, 1981, EXP BRAIN RES, V44, P340; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	50	361	367	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					72	78		10.1038/nature11649	http://dx.doi.org/10.1038/nature11649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222610				2022-12-01	WOS:000311893400047
J	McArdle, C				McArdle, Ciarstan			PERSONAL VIEW Patients with melanoma are avoiding follow-up to get insurance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MELANOMA		James Cook Univ Hosp, Dept Plast Surg, Middlesbrough TS4 3BW, Cleveland, England	James Cook University Hospital	McArdle, C (corresponding author), James Cook Univ Hosp, Dept Plast Surg, Middlesbrough TS4 3BW, Cleveland, England.	ciarstanmcardle@gmail.com						American Cancer Society, 2012, LEARN CANC MAL SKIN; Cancer Research UK, 2012, SKIN CANC INC STAT T; DiFronzo LA, 1999, ANN SURG ONCOL, V6, P705, DOI 10.1007/s10434-999-0705-0; Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1016/j.bjps.2010.07.006, 10.1111/j.1365-2133.2010.09883.x]	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e7803	10.1136/bmj.e7803	http://dx.doi.org/10.1136/bmj.e7803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23208251				2022-12-01	WOS:000312188700004
J	Stern-Ginossar, N; Weisburd, B; Michalski, A; Vu, TKL; Hein, MY; Huang, SX; Ma, M; Shen, B; Qian, SB; Hengel, H; Mann, M; Ingolia, NT; Weissman, JS				Stern-Ginossar, Noam; Weisburd, Ben; Michalski, Annette; Vu Thuy Khanh Le; Hein, Marco Y.; Huang, Sheng-Xiong; Ma, Ming; Shen, Ben; Qian, Shu-Bing; Hengel, Hartmut; Mann, Matthias; Ingolia, Nicholas T.; Weissman, Jonathan S.			Decoding Human Cytomegalovirus	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; PROTEIN	The human cytomegalovirus (HCMV) genome was sequenced 20 years ago. However, like those of other complex viruses, our understanding of its protein coding potential is far from complete. We used ribosome profiling and transcript analysis to experimentally define the HCMV translation products and follow their temporal expression. We identified hundreds of previously unidentified open reading frames and confirmed a fraction by means of mass spectrometry. We found that regulated use of alternative transcript start sites plays a broad role in enabling tight temporal control of HCMV protein expression and allowing multiple distinct polypeptides to be generated from a single genomic locus. Our results reveal an unanticipated complexity to the HCMV coding capacity and illustrate the role of regulated changes in transcript start sites in generating this complexity.	[Michalski, Annette; Hein, Marco Y.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Stern-Ginossar, Noam; Weisburd, Ben; Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisico, CA 94158 USA; [Vu Thuy Khanh Le; Hengel, Hartmut] Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Huang, Sheng-Xiong; Ma, Ming; Shen, Ben] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Nat Prod Lib Initiat, Jupiter, FL 33458 USA; [Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Cornell University	Michalski, A (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany.	michalsk@biochem.mpg.de; weissman@cmp.ucsf.edu	Mann, Matthias/A-3454-2013; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020; Hein, Marco/C-2994-2014	Mann, Matthias/0000-0003-1292-4799; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; Hein, Marco/0000-0002-9490-2261; Weissman, Jonathan/0000-0003-2445-670X; , Noam/0000-0003-3583-5932; Huang, Sheng-Xiong/0000-0002-3616-8556; Weisburd, Ben/0000-0001-9898-9109	human frontier science program postdoctoral fellowship; Howard Hughes Medical Institute; Max Planck Society; NATIONAL CANCER INSTITUTE [R01CA106150] Funding Source: NIH RePORTER	human frontier science program postdoctoral fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank O. Mandelboim, D. Wolf, M. Trilling, A. Lauring, S. Karniely, and Weissman lab members for critical reading of the manuscript; C. Chu for assistance with sequencing; and J. Pelletier for providing Pateamine A. N.S.-G. is supported by a human frontier science program postdoctoral fellowship. This work was supported by the Howard Hughes Medical Institute (J. S. W.) and the Max Planck Society (M. M.). The Gene Expression Omnibus accession number for the data is GSE41605.	Biegalke BJ, 2004, J VIROL, V78, P9579, DOI 10.1128/JVI.78.17.9579-9583.2004; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; Gatherer D, 2011, P NATL ACAD SCI USA, V108, P19755, DOI 10.1073/pnas.1115861108; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Joachim T., 1998, MAKING LARGE SCALE S, P169, DOI DOI 10.17877/DE290R-5098; LEACH FS, 1989, J VIROL, V63, P1783, DOI 10.1128/JVI.63.4.1783-1791.1989; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; LORD PCW, 1989, J GEN VIROL, V70, P2383, DOI 10.1099/0022-1317-70-9-2383; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Qian ZK, 2008, J VIROL, V82, P3452, DOI 10.1128/JVI.01964-07; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stamminger T, 2002, J VIROL, V76, P4836, DOI 10.1128/JVI.76.10.4836-4847.2002; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Zhang GJ, 2007, J VIROL, V81, P11267, DOI 10.1128/JVI.00007-07	24	407	415	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1088	1093		10.1126/science.1227919	http://dx.doi.org/10.1126/science.1227919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180859	Green Accepted			2022-12-01	WOS:000311390600046
J	Sienski, G; Donertas, D; Brennecke, J				Sienski, Grzegorz; Doenertas, Derya; Brennecke, Julius			Transcriptional Silencing of Transposons by Piwi and Maelstrom and Its Impact on Chromatin State and Gene Expression	CELL			English	Article							PRIMARY PIRNA BIOGENESIS; SMALL RNAS; EPIGENETIC MEMORY; DROSOPHILA; HETEROCHROMATIN; PROTEIN; METHYLATION; GERMLINE; PATHWAY; ROLES	Eukaryotic genomes are colonized by transposons whose uncontrolled activity causes genomic instability. The piRNA pathway silences transposons in animal gonads, yet how this is achieved molecularly remains controversial. Here, we show that the HMG protein Maelstrom is essential for Piwi-mediated silencing in Drosophila. Genome-wide assays revealed highly correlated changes in RNA polymerase II recruitment, nascent RNA output, and steady-state RNA levels of transposons upon loss of Piwi or Maelstrom. Our data demonstrate piRNA-mediated trans-silencing of hundreds of transposon copies at the transcriptional level. We show that Piwi is required to establish heterochromatic H3K9me3 marks on transposons and their genomic surroundings. In contrast, loss of Maelstrom affects transposon H3K9me3 patterns only mildly yet leads to increased heterochromatin spreading, suggesting that Maelstrom acts downstream of or in parallel to H3K9me3. Our work illustrates the widespread influence of transposons and the piRNA pathway on chromatin patterns and gene expression.	[Sienski, Grzegorz; Doenertas, Derya; Brennecke, Julius] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Brennecke, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/T-5883-2019; Brennecke, Julius/C-1626-2015	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814	Austrian Academy of Sciences; European Community's 7th Framework Programme [FP7/2007-2013]; ERC grant [260711EU]; Austrian Science Fund (FWF) [Y 510-B12]; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community's 7th Framework Programme; ERC grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank K. Adelman for alpha-Rbp3; M. Siomi for OSCs and alpha-Armi; M. Madalinski for antibody purifications; S. Lopez for fly injections; the VDRC; A. Pelisson and H. Ruohola-Baker for fly strains; D. Jurczak, A. Stark, D. Gerlach, R. Maier and R. Sachidanandam for help with bioinformatics; and the CSF NGS unit for deep sequencing. We thank S. Grewal and D. Moazed for inspiring discussions and comments on the manuscript. The Brennecke laboratory is supported by the Austrian Academy of Sciences, the European Community's 7th Framework Programme (FP7/2007-2013; ERC grant # 260711EU), and the Austrian Science Fund (FWF; Y 510-B12). G.S. is supported by the Boehringer Ingelheim Fonds. G.S., D.D., and J.B. designed the experiments. G.S. and D.D. performed the experiments. G.S. performed the computational analysis. G.S., D.D., and JB analyzed the data and wrote the paper.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dufourt J, 2011, DNA RES, V18, P451, DOI 10.1093/dnares/dsr031; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moshkovich N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000880; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	39	405	421	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					964	980		10.1016/j.cell.2012.10.040	http://dx.doi.org/10.1016/j.cell.2012.10.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23159368	Green Published, hybrid			2022-12-01	WOS:000311423500011
J	Alexander, GC; Kruszewski, SP; Webster, DW				Alexander, G. Caleb; Kruszewski, Stefan P.; Webster, Daniel W.			Rethinking Opioid Prescribing to Protect Patient Safety and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION; PAIN		[Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, Baltimore, MD 21205 USA; [Alexander, G. Caleb] Johns Hopkins Med, Dept Med, Sect Gen Internal Med, Baltimore, MD USA; [Alexander, G. Caleb] Univ Illinois, Sch Pharm, Dept Pharm Practice, Chicago, IL USA; [Kruszewski, Stefan P.] Stefan P Kruszewski MD & Associates, Harrisburg, PA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,W6035, Baltimore, MD 21205 USA.	galexand@jhsph.edu			AHRQ HHS [R01 HS0189960] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		American College of Emergency Physicians Opioid Guideline Writing Panel, CLIN POL CRIT ISS PR; Baucus, 2012, GRASSLEY SEEK ANSWER; Centers for Disease Control and Prevention (CDC), 2011, CDC VIT SIGNS PRESCR; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; National Center for Injury Prevention and Control Division of Unintentional Injury Centers for Disease Control and Prevention, 2011, POL IMP PRESCR PAIN; University of Wisconsin Pain and Policy Group, CENTR PRINC BAL	8	70	70	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1865	1866		10.1001/jama.2012.14282	http://dx.doi.org/10.1001/jama.2012.14282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150006				2022-12-01	WOS:000310952700020
J	Santos, ME; Salzburger, W				Santos, M. Emilia; Salzburger, Walter			How Cichlids Diversify	SCIENCE			English	Editorial Material							ADAPTIVE RADIATION; EVOLUTION; SPECIATION; SELECTION; FISHES		[Santos, M. Emilia; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of Basel	Santos, ME (corresponding author), Univ Basel, Inst Zool, Vesalgasse 1, CH-4051 Basel, Switzerland.	emilia.santos@unibas.ch; walter.salzburger@unibas.ch	Salzburger, Walter/G-1598-2011	Salzburger, Walter/0000-0002-9988-1674; Santos, M. Emilia/0000-0003-3158-7935				Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Barlow G.W., 2000, CICHLID FISHES NATUR; Colombo M, 2013, MOL ECOL, V22, P670, DOI 10.1111/mec.12029; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Fryer G., 1972, CICHLID FISHES GREAT; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Kidd MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031236; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; Manousaki T, 2013, MOL ECOL, V22, P650, DOI 10.1111/mec.12034; Miyagi R, 2012, MOL BIOL EVOL, V29, P3281, DOI 10.1093/molbev/mss139; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144	17	42	43	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					619	621		10.1126/science.1224818	http://dx.doi.org/10.1126/science.1224818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118176				2022-12-01	WOS:000310516000037
J	Bolker, J				Bolker, Jessica			There's more to life than rats and flies	NATURE			English	Editorial Material							MODEL; MICE; BIOLOGY		Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Bolker, J (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	jessica.bolker@unh.edu						Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; BOLKER JA, 1995, BIOESSAYS, V17, P451, DOI 10.1002/bies.950170513; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Geerts H, 2009, CNS DRUGS, V23, P915, DOI 10.2165/11310890-000000000-00000; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/NMETH.1500, 10.1038/nmeth.1500]; Kohler RobertE., 1994, LORDS FLY DROSOPHILA; Maher B, 2009, NATURE, V458, P695, DOI 10.1038/458695a; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224	10	113	116	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					31	33		10.1038/491031a	http://dx.doi.org/10.1038/491031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128209	Bronze			2022-12-01	WOS:000310434500013
J	Prota, AE; Bargsten, K; Zurwerra, D; Field, JJ; Diaz, JF; Altmann, KH; Steinmetz, MO				Prota, Andrea E.; Bargsten, Katja; Zurwerra, Didier; Field, Jessica J.; Fernando Diaz, Jose; Altmann, Karl-Heinz; Steinmetz, Michel O.			Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents	SCIENCE			English	Article							ALPHA-BETA-TUBULIN; EPOTHILONE-A; BINDING MODE; GDP-TUBULIN; COMPLEX; TAXOL; DIMER	Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical applications and basic research, their molecular mechanisms of action on tubulin and microtubules remain elusive. We determined high-resolution crystal structures of ab-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A. Both compounds were bound to the taxane pocket of beta-tubulin and used their respective side chains to induce structuring of the M-loop into a short helix. Because the M-loop establishes lateral tubulin contacts in microtubules, these findings explain how taxane-site MSAs promote microtubule assembly and stability. Further, our results offer fundamental structural insights into the control mechanisms of microtubule dynamics.	[Prota, Andrea E.; Bargsten, Katja; Steinmetz, Michel O.] Paul Scherrer Inst, Villigen, Switzerland; [Zurwerra, Didier; Altmann, Karl-Heinz] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Field, Jessica J.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Fernando Diaz, Jose] CSIC, CIB, Madrid, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Victoria University Wellington; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Steinmetz, MO (corresponding author), Paul Scherrer Inst, Villigen, Switzerland.	michel.steinmetz@psi.ch	Díaz, J. Fernando/U-3532-2017; Steinmetz, Michel O/AAA-3349-2022; Díaz, J. Fernando/M-6853-2019; Prota, Andrea Enrico/R-9526-2019	Díaz, J. Fernando/0000-0003-2743-3319; Steinmetz, Michel O/0000-0001-6157-3687; Díaz, J. Fernando/0000-0003-2743-3319; Prota, Andrea Enrico/0000-0003-0875-5339	European Molecular Biology Organization; Genesis Oncology Trust; Ministerio de Economia y Competitividad [BIO2010-16351]; Comunidad Autonoma de Madrid [S2010/BMD-2457]; Roche Research Foundation; Swiss National Science Foundation [310030B_138659]; Swiss SystemsX.ch initiative [BIP-2011/122]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Genesis Oncology Trust; Ministerio de Economia y Competitividad(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss SystemsX.ch initiative	We thank R. Kammerer, F. Winkler, and Y. Barral for critical reading of the manuscript; V. de Lucas de Segovia for providing calf brains for tubulin purification; and V. Olieric and M. Wang for excellent technical assistance with the collection of x-ray data at beamline X06SA and X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland). J.J.F. received a short-term fellowship from the European Molecular Biology Organization and a Professional Development Grant from the Genesis Oncology Trust. This work was supported by grants from the Ministerio de Economia y Competitividad (BIO2010-16351) and the Comunidad Autonoma de Madrid (S2010/BMD-2457) (to J.F.D.), a Ph.D. fellowship from the Roche Research Foundation (to D.Z.), and grants from the Swiss National Science Foundation (310030B_138659) and the Swiss SystemsX.ch initiative (BIP-2011/122) (to M.O.S.). Coordinates have been deposited at the Protein Data Bank (PDB) under identification (ID) nos. 4I4T (T<INF>2</INF>R-TTL-Zampa), 4I50 (T<INF>2</INF>R-TTL-EpoA), and 4I55 (T<INF>2</INF>R-TTL).	Altmann KH, 2007, CHEMMEDCHEM, V2, P396, DOI 10.1002/cmdc.200600206; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Field JJ, 2012, CHEM BIOL, V19, P686, DOI 10.1016/j.chembiol.2012.05.008; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Lechleider RJ, 2008, CLIN CANCER RES, V14, P4378, DOI 10.1158/1078-0432.CCR-08-0015; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mitra A, 2008, BIOPHYS J, V95, P3252, DOI 10.1529/biophysj.108.133884; Nettles JH, 2009, TOP CURR CHEM, V286, P209, DOI 10.1007/128_2008_24; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Reese M, 2007, ANGEW CHEM INT EDIT, V46, P1864, DOI 10.1002/anie.200604505; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Zurwerra D, 2012, CHEM-EUR J, V18, P16868, DOI 10.1002/chem.201202553	21	344	351	13	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					587	590		10.1126/science.1230582	http://dx.doi.org/10.1126/science.1230582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23287720	Green Submitted, Green Accepted			2022-12-01	WOS:000314270000061
J	Efeyan, A; Zoncu, R; Chang, S; Gumper, I; Snitkin, H; Wolfson, RL; Kirak, O; Sabatini, DD; Sabatini, DM				Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Gumper, Iwona; Snitkin, Harriet; Wolfson, Rachel L.; Kirak, Oktay; Sabatini, David D.; Sabatini, David M.			Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival	NATURE			English	Article							INDUCTION; MECHANISM; LYSOSOME; REVEALS; KINASE; SENSES	The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates organismal growth in response to many environmental cues, including nutrients and growth factors(1). Cell-based studies showed that mTORC1 senses amino acids through the RagA-D family of GTPases(2,3) (also known as RRAGA, B, C and D), but their importance in mammalian physiology is unknown. Here we generate knock-in mice that express a constitutively active form of RagA (RagA(GTP)) from its endogenous promoter. RagA(GTP/GTP) mice develop normally, but fail to survive postnatal day 1. When delivered by Caesarean section, fasted RagA(GTP/GTP) neonates die almost twice as rapidly as wild-type littermates. Within an hour of birth, wild-type neonates strongly inhibit mTORC1, which coincides with profound hypoglycaemia and a decrease in plasma amino-acid concentrations. In contrast, mTORC1 inhibition does not occur in RagA(GTP/GTP) neonates, despite identical reductions in blood nutrient amounts. With prolonged fasting, wild-type neonates recover their plasma glucose concentrations, but RagA(GTP/GTP) mice remain hypoglycaemic until death, despite using glycogen at a faster rate. The glucose homeostasis defect correlates with the inability of fasted RagA(GTP/GTP) neonates to trigger autophagy and produce amino acids for de novo glucose production. Because profound hypoglycaemia does not inhibit mTORC1 inRagA(GTP/GTP) neonates, we considered the possibility that the Rag pathway signals glucose as well as amino-acid sufficiency to mTORC1. Indeed, mTORC1 is resistant to glucose deprivation in RagA(GTP/GTP) fibroblasts, and glucose, like amino acids, controls its recruitment to the lysosomal surface, the site of mTORC1 activation. Thus, the Rag GTPases signal glucose and amino-acid concentrations to mTORC1, and have an unexpectedly key role in neonates in autophagy induction and thus nutrient homeostasis and viability.	[Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Kirak, Oktay; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Seven Cambridge Ctr, Cambridge, MA 02142 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gumper, Iwona; Snitkin, Harriet; Sabatini, David D.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); New York University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Kirak, Oktay/H-6347-2013; Efeyan, Alejo/J-8197-2016	Kirak, Oktay/0000-0002-6524-4685; Efeyan, Alejo/0000-0002-3806-6799; /0000-0002-1446-7256	National Institutes of Health [R01 CA129105, R01 CA103866, R37 AI047389]; American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation; Human Frontiers Science Program; Jane Coffin Childs Memorial Fund for Medical Research; LAM Foundation; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontiers Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund for Medical Research; LAM Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini laboratory for suggestions, and A. Hutchins for technical assistance. We thank R. Shaw for providing the AMPK-DKO MEFs, D. Ron for the GCN2-KO MEFs and M. Barbacid for the transcriptional STOP cassette. This work was supported by grants from the National Institutes of Health (R01 CA129105, R01 CA103866 and R37 AI047389) and awards from the American Federation for Aging, Starr Foundation, Koch Institute Frontier Research Program, and the Ellison Medical Foundation to D. M. S., fellowships from the Human Frontiers Science Program to A. E., and the Jane Coffin Childs Memorial Fund for Medical Research and the LAM Foundation to R.Z. D. M. S. in an investigator of Howard Hughes Medical Institute.	Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hirose E, 1998, J CELL SCI, V111, P11; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	23	294	302	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					679	+		10.1038/nature11745	http://dx.doi.org/10.1038/nature11745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23263183	Green Submitted, Green Accepted			2022-12-01	WOS:000314219600058
J	Chang, HH; Larson, J; Blencowe, H; Spong, CY; Howson, CP; Cairns-Smith, S; Lackritz, EM; Lee, SK; Mason, E; Serazin, AC; Walani, S; Simpson, JL; Lawn, JE				Chang, Hannah H.; Larson, Jim; Blencowe, Hannah; Spong, Catherine Y.; Howson, Christopher P.; Cairns-Smith, Sarah; Lackritz, Eve M.; Lee, Shoo K.; Mason, Elizabeth; Serazin, Andrew C.; Walani, Salimah; Simpson, Joe Leigh; Lawn, Joy E.		Born Too Soon Preterm Prevention A	Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index	LANCET			English	Article							PREGNANT-WOMEN; SYSTEMATIC ANALYSIS; CERVICAL PESSARY; TIME TRENDS; SMOKING; RATES; RISK; PROGESTERONE; OUTCOMES; METAANALYSIS	Background Every year, 1.1 million babies die from prematurity, and many survivors are disabled. Worldwide, 15 million babies are born preterm (<37 weeks' gestation), with two decades of increasing rates in almost all countries with reliable data. The understanding of drivers and potential benefit of preventive interventions for preterm births is poor. We examined trends and estimate the potential reduction in preterm births for countries with very high human development index (VHHDI) if present evidence-based interventions were widely implemented. This analysis is to inform a rate reduction target for Born Too Soon. Methods Countries were assessed for inclusion based on availability and quality of preterm prevalence data (2000-10), and trend analyses with projections undertaken. We analysed drivers of rate increases in the USA, 1989-2004. For 39 countries with VHHDI with more than 10 000 births, we did country-by-country analyses based on target population, incremental coverage increase, and intervention efficacy. We estimated cost savings on the basis of reported costs for preterm care in the USA adjusted using World Bank purchasing power parity. Findings From 2010, even if all countries with VHHDI achieved annual preterm birth rate reductions of the best performers for 1990-2010 (Estonia and Croatia), 2000-10 (Sweden and Netherlands), or 2005-10 (Lithuania, Estonia), rates would experience a relative reduction of less than 5% by 2015 on average across the 39 countries. Our analysis of preterm birth rise 1989-2004 in USA suggests half the change is unexplained, but important drivers include non-medically indicated labour induction and caesarean delivery and assisted reproductive technologies. For all 39 countries with VHHDI, five interventions modelling at high coverage predicted a 5% relative reduction of preterm birth rate from 9.59% to 9.07% of livebirths: smoking cessation (0.01 rate reduction), decreasing multiple embryo transfers during assisted reproductive technologies (0.06), cervical cerclage (0.15), progesterone supplementation (0.01), and reduction of non-medically indicated labour induction or caesarean delivery (0.29). These findings translate to roughly 58 000 preterm births averted and total annual economic cost savings of about US$3 billion. Interpretation We recommend a conservative target of a relative reduction in preterm birth rates of 5% by 2015. Our findings highlight the urgent need for research into underlying mechanisms of preterm births, and development of innovative interventions. Furthermore, the highest preterm birth rates occur in low-income settings where the causes of prematurity might differ and have simpler solutions such as birth spacing and treatment of infections in pregnancy than in high-income countries. Urgent focus on these settings is also crucial to reduce preterm births worldwide.	[Chang, Hannah H.; Larson, Jim; Cairns-Smith, Sarah] Boston Consulting Grp Inc, Boston, MA USA; [Blencowe, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Howson, Christopher P.; Walani, Salimah; Simpson, Joe Leigh] March Dimes Fdn, White Plains, NY USA; [Lackritz, Eve M.] Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Lee, Shoo K.] Canadian Inst Hlth Res, Inst Human Dev Child & Youth Hlth, Toronto, ON, Canada; [Mason, Elizabeth] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Serazin, Andrew C.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA; [Lawn, Joy E.] Save Children, Saving Newborn Lives, London, England	Boston Consulting Group (BCG); University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institute for Work & Health; World Health Organization; Bill & Melinda Gates Foundation; Save the Children	Lawn, JE (corresponding author), Save Children, Saving Newborn Lives, London, England.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020; Lee, Shoo K/P-3016-2015	Lawn, Joy/0000-0002-4573-1443; Lackritz, Eve/0000-0002-5397-7291; Blencowe, Hannah/0000-0003-1556-3159	March of Dimes, USA; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health, USA; March of Dimes; Bill & Melinda Gates Foundation	March of Dimes, USA(March of Dimes); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	March of Dimes, USA, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institutes of Health, USA.; The time of HHC, JL, and SC-S was funded by the March of Dimes and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. JEL's time was funded by a grant from the Bill & Melinda Gates Foundation to Save the Children's Saving Newborn Lives programme. HB's time was funded by a grant from the Bill & Melinda Gates Foundation to the Child Health Epidemiology Reference Group. We thank Simon Cousens of the London School of Hygiene and Tropical Medicine and Craig Rubens of the Global Alliance to Prevent Prematurity and Stillbirth for technical review. We are grateful to Lori McDougall of the Partnership for Maternal Newborn and Child Health, Lily Kak of USAID, Tola Ladejobi of Boston Consulting Group, Judith Palais, and Rachel Diamond of the March of Dimes for support.	Aly H, 2010, J PERINATOL, V30, P447, DOI 10.1038/jp.2009.117; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Behrman RE, 2007, PRETERM BIRTH CAUSES, V6; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brose LS, 2011, THORAX, V66, P924, DOI 10.1136/thoraxjnl-2011-200251; Centers for Disease Control and Prevention American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, 2009, 2009 ASS REPR TECHN; Centers for Disease Control and Prevention ASfRM Society for Assisted Reproductive Technology, 2011, 2009 ASS REPR TECHN; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cobb NK, 2005, NICOTINE TOB RES, V7, P207, DOI 10.1080/14622200500055319; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Declercq E, 2006, AM J PUBLIC HEALTH, V96, P867, DOI 10.2105/AJPH.2004.052381; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Donovan EF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.044; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Filion KB, 2011, BJOG-INT J OBSTET GY, V118, P1422, DOI 10.1111/j.1471-0528.2011.03065.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Fritz MA, 2009, FERTIL STERIL, V92, P1518, DOI 10.1016/j.fertnstert.2009.08.059; Gibbons L, 2010, WORLD HEALTH REPORT; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Houda M, 2012, LANCET, V380, P886, DOI 10.1016/S0140-6736(12)61503-7; Howson CP, 2012, MARCH DIMES PMNCH SA; Hui ASY, 2012, LANCET, V380, P887, DOI 10.1016/S0140-6736(12)61504-9; Kim SY, 2009, AM J PUBLIC HEALTH, V99, P893, DOI 10.2105/AJPH.2008.144485; Kramer MS, 2012, AM J OBSTET GYNECOL, V206, P108, DOI 10.1016/j.ajog.2011.10.864; Lanting CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008363; Laughon SK, 2010, OBSTET GYNECOL, V116, P1047, DOI 10.1097/AOG.0b013e3181f73f97; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Melendez J, 2012, LANCET, V380, P886, DOI 10.1016/S0140-6736(12)61502-5; Mugo M, 2005, CURR HYPERTENS REP, V7, P348, DOI 10.1007/s11906-005-0068-2; Murphy HR, 2011, DIABETIC MED, V28, P1060, DOI 10.1111/j.1464-5491.2011.03333.x; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Norman JE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-79; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Osterman Michelle J K, 2011, Natl Vital Stat Rep, V59, P1; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; TESTART J, 1992, HUM REPROD, V7, P362, DOI 10.1093/oxfordjournals.humrep.a137651; US Census Bureau, 2012, STAT ABSTR US 2012; van der Klis KAM, 2002, AUST NZ J PUBL HEAL, V26, P125, DOI 10.1111/j.1467-842X.2002.tb00904.x; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Zhang X, 2012, BJOG-INT J OBSTET GY, V119, P1309, DOI 10.1111/j.1471-0528.2012.03453.x	54	352	375	3	116	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					223	234		10.1016/S0140-6736(12)61856-X	http://dx.doi.org/10.1016/S0140-6736(12)61856-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23158883	Green Accepted			2022-12-01	WOS:000313887600034
J	Bondy-Denomy, J; Pawluk, A; Maxwell, KL; Davidson, AR				Bondy-Denomy, Joe; Pawluk, April; Maxwell, Karen L.; Davidson, Alan R.			Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system	NATURE			English	Article							GENOME SEQUENCE; PSEUDOMONAS; RNA; RESISTANCE; PHAGE; INTERFERENCE; DEFENSE; DNA	A widespread system used by bacteria for protection against potentially dangerous foreign DNA molecules consists of the clustered regularly interspaced short palindromic repeats (CRISPR) coupled with cas (CRISPR-associated) genes(1). Similar to RNA interference in eukaryotes(2), these CRISPR/Cas systems use small RNAs for sequence-specific detection and neutralization of invading genomes(3). Here we describe the first examples of genes that mediate the inhibition of a CRISPR/Cas system. Five distinct 'anti-CRISPR' genes were found in the genomes of bacteriophages infecting Pseudomonas aeruginosa. Mutation of the anti-CRISPR gene of a phage rendered it unable to infect bacteria with a functional CRISPR/Cas system, and the addition of the same gene to the genome of a CRISPR/Cas-targeted phage allowed it to evade the CRISPR/Cas system. Phage-encoded anti-CRISPR genes may represent a widespread mechanism for phages to overcome the highly prevalent CRISPR/Cas systems. The existence of anti-CRISPR genes presents new avenues for the elucidation of CRISPR/Cas functional mechanisms and provides new insight into the co-evolution of phages and bacteria.	[Bondy-Denomy, Joe; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pawluk, April; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480; Pawluk, April/0000-0002-6136-2086	Canadian Institutes for Health Research [MOP- 6279, XNE86943]; CIHR Canada Graduate Scholarship Doctoral Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR))	We thank D. Guttman, Y.-H. Cho, K. Cady and G. O'Toole for providing P. aeruginosa strains and phages. We also thank K. Severinov for providing the M13 phage and E. coli strains required for assaying the type 1-E system. We thank J. Brumell, A. Spence and W. Navarre for reading the manuscript. We also thank D. Bona for technical assistance. This work was supported by an Operating Grant to K. L. M. (fund number MOP- 6279) and an Emerging Team Grant to A. R. D. and K. L. M. (fund number XNE86943), both of which were from the Canadian Institutes for Health Research. J. B. D. was supported by a CIHR Canada Graduate Scholarship Doctoral Award.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Brouns S. J. J., 2012, COLD SPRING HARB PER, V4; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Chung IY, 2012, J VIROL, V86, P8336, DOI 10.1128/JVI.01127-12; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heo YJ, 2007, MICROBIOL-SGM, V153, P2885, DOI 10.1099/mic.0.2007/007260-0; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Wang PW, 2004, J BACTERIOL, V186, P400, DOI 10.1128/JB.186.2.400-410.2004; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	31	468	496	29	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					429	U181		10.1038/nature11723	http://dx.doi.org/10.1038/nature11723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23242138	Green Accepted			2022-12-01	WOS:000313615900057
J	Thomas, BC; Neal, DE				Thomas, Benjamin C.; Neal, David E.			Androgen deprivation treatment in prostate cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCREASED SURVIVAL; COST-EFFECTIVENESS; PHASE-III; THERAPY; SUPPRESSION; MEN; MONOTHERAPY; CASTRATION; DEGARELIX; RISK		[Thomas, Benjamin C.] Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England; [Thomas, Benjamin C.; Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Thomas, BC (corresponding author), Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England.	bct26@cam.ac.uk	Shah, Syed Imran Ali/D-1324-2012	Shah, Syed Imran Ali/0000-0002-0833-0771; Neal, David/0000-0002-6033-5086	MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adler A, 2012, ABIRATERONE CASTRATI; [Anonymous], 1997, Br J Urol, V79, P235; Bayoumi AM, 2000, JNCI-J NATL CANCER I, V92, P1731, DOI 10.1093/jnci/92.21.1731; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Bubley GJ, 2001, UROLOGY, V58, P5, DOI 10.1016/S0090-4295(01)01235-3; Crawford ED, 2011, J UROLOGY, V186, P889, DOI 10.1016/j.juro.2011.04.083; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Derweesh IH, 2007, BJU INT, V100, P1060, DOI 10.1111/j.1464-410X.2007.07184.x; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Heidenreich A, 2012, GUIDELINES PROSTATE; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Lawton CA, 2005, J CLIN ONCOL, V23, P800, DOI 10.1200/JCO.2005.08.141; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; Lu LT, 2012, BJU INT, V109, P1183, DOI 10.1111/j.1464-410X.2011.10434.x; MOFFAT LEF, 1990, EUR UROL, V18, P26; National Institute for Health and Clinical Excellence, 2008, PROST CANC DIAGN TRE; Potosky AL, 2001, J CLIN ONCOL, V19, P3750, DOI 10.1200/JCO.2001.19.17.3750; Ryan CJ, 2003, UROLOGY, V62, P87, DOI 10.1016/j.urology.2003.10.002; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Strum SB, 1997, BRIT J UROL, V79, P933, DOI 10.1046/j.1464-410X.1997.00234.x; The Veterans Administration Co-operative Urological Research Group, 1967, SURG GYNECOL OBSTET, V124, P1011; Tyrrell CJ, 1998, EUR UROL, V33, P447, DOI 10.1159/000019634	29	9	9	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								e8555	10.1136/bmj.e8555	http://dx.doi.org/10.1136/bmj.e8555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZR	23303885				2022-12-01	WOS:000313554900010
J	Jost, TS				Jost, Timothy Stoltzfus			Religious Freedom and Women's Health - The Litigation on Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Guttmacher Institute, 2012, STATE POLICIES IN BR; Institute of Medicine, 2011, CLINICAL PREVENTIVE; The Becket Fund for Religious Liberty, 2012, THE BECKET FUND FOR	3	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					4	6		10.1056/NEJMp1214605	http://dx.doi.org/10.1056/NEJMp1214605			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PA	23252500				2022-12-01	WOS:000312930600014
J	Hawkes, N				Hawkes, Nigel			MEDICINE IN DEVELOPING COUNTRIES Deworming debunked	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESCHOOL-CHILDREN; TRIAL					nigel.hawkes1@btinternet.com						Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; [Anonymous], COPENHAGEN CONSENSUS; [Anonymous], 2008, TIME; [Anonymous], 2012, COCHRANES INCOMPLETE; Awasthi S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000223; Baird S, 2011, WORMS AT WORK LONG R; Barrett W, 2011, FORBES; Bundy D, TRENDS PARASITOL FOR; Bundy D, 2011, NEW REASONS WHY SCHO; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Disease Control Priorities Project, 2008, DEWORMING CHILDREN B; GiveWell, COMBINATION DEWORMIN; GiveWell, 2011, ERRORS IN DCP2 COST; Ozier O, 2011, EXPLOITING EXTERNALI; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; WHO, 2005, THE EVIDENCE IS IN D	16	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8558	10.1136/bmj.e8558	http://dx.doi.org/10.1136/bmj.e8558			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284157				2022-12-01	WOS:000313236300014
J	Igonet, S; Rey, FA				Igonet, Sebastien; Rey, Felix A.			SnapShot: Viral and Eukaryotic Protein Fusogens	CELL			English	Editorial Material							FUSION		[Igonet, Sebastien; Rey, Felix A.] Inst Pasteur, CNRS, URA 3015, Unite Virol Struct, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Igonet, S (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.			Rey, Felix/0000-0002-9953-7988				Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108	4	14	14	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1634	U264		10.1016/j.cell.2012.11.041	http://dx.doi.org/10.1016/j.cell.2012.11.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260148	Bronze			2022-12-01	WOS:000312890300026
J	O'Roak, BJ; Vives, L; Fu, WQ; Egertson, JD; Stanaway, IB; Phelps, IG; Carvill, G; Kumar, A; Lee, C; Ankenman, K; Munson, J; Hiatt, JB; Turner, EH; Levy, R; O'Day, DR; Krumm, N; Coe, BP; Martin, BK; Borenstein, E; Nickerson, DA; Mefford, HC; Doherty, D; Akey, JM; Bernier, R; Eichler, EE; Shendure, J				O'Roak, Brian J.; Vives, Laura; Fu, Wenqing; Egertson, Jarrett D.; Stanaway, Ian B.; Phelps, Ian G.; Carvill, Gemma; Kumar, Akash; Lee, Choli; Ankenman, Katy; Munson, Jeff; Hiatt, Joseph B.; Turner, Emily H.; Levy, Roie; O'Day, Diana R.; Krumm, Niklas; Coe, Bradley P.; Martin, Beth K.; Borenstein, Elhanan; Nickerson, Deborah A.; Mefford, Heather C.; Doherty, Dan; Akey, Joshua M.; Bernier, Raphael; Eichler, Evan E.; Shendure, Jay			Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders	SCIENCE			English	Article							DE-NOVO MUTATIONS; DYRK1A; AMPLIFICATION; RISK	Exome sequencing studies of autism spectrum disorders (ASDs) have identified many de novo mutations but few recurrently disrupted genes. We therefore developed a modified molecular inversion probe method enabling ultra-low-cost candidate gene resequencing in very large cohorts. To demonstrate the power of this approach, we captured and sequenced 44 candidate genes in 2446 ASD probands. We discovered 27 de novo events in 16 genes, 59% of which are predicted to truncate proteins or disrupt splicing. We estimate that recurrent disruptive mutations in six genes-CHD8, DYRK1A, GRIN2B, TBR1, PTEN, and TBL1XR1-may contribute to 1% of sporadic ASDs. Our data support associations between specific genes and reciprocal subphenotypes (CHD8-macrocephaly and DYRK1A-microcephaly) and replicate the importance of a beta-catenin-chromatin-remodeling network to ASD etiology.	[O'Roak, Brian J.; Vives, Laura; Fu, Wenqing; Egertson, Jarrett D.; Stanaway, Ian B.; Kumar, Akash; Lee, Choli; Hiatt, Joseph B.; Turner, Emily H.; Levy, Roie; Krumm, Niklas; Coe, Bradley P.; Martin, Beth K.; Borenstein, Elhanan; Nickerson, Deborah A.; Akey, Joshua M.; Eichler, Evan E.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Phelps, Ian G.; Carvill, Gemma; O'Day, Diana R.; Mefford, Heather C.; Doherty, Dan] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Phelps, Ian G.; Carvill, Gemma; Mefford, Heather C.; Doherty, Dan] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Ankenman, Katy; Munson, Jeff; Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021; Coe, Bradley/A-2878-2009	Coe, Bradley/0000-0001-8471-4016; Martin, Beth/0000-0002-9661-014X; O'Roak, Brian/0000-0002-4141-0095; Shendure, Jay/0000-0002-1516-1865; Kumar, Akash/0000-0001-9442-3597; Akey, Joshua/0000-0002-4411-1330; Turner, Emily/0000-0001-9040-9229	National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Simons Foundation [SFARI 137578, 191889]; NIH [HD065285, NS069605, R01 NS064077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102925, RC2HL103010, RC2HL102923, RC2HL102926, UC2HL102923, UC2HL102924, UC2HL102926, RC2HL102925, UC2HL103010, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605, R01NS064077, R56NS069605] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010); we also thank B. Vernot, M. Dennis, T. Brown, and other members of the Eichler and Shendure labs for helpful discussions. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E. Wijsman). We appreciate obtaining access to phenotypic data on the Simons Foundation Autism Research Initiative (SFARI) Base. Approved researchers can obtain the SSC population dataset described in this study (https://ordering.base.sfari.org/similar to browse_collection/archive[ssc_v13]/ui:view) by applying at https://base.sfari.org. This work was supported by grants from the Simons Foundation (SFARI 137578, 191889 to E. E. E., J.S., and R. B.), NIH HD065285 (E. E. E. and J.S.), NIH NS069605 (H. C. M.), and R01 NS064077 (D. D.). E. B. is an Alfred P. Sloan Research Fellow. E. E. E. is an Investigator of the Howard Hughes Medical Institute. Scientific advisory boards or consulting affiliations: Ariosa Diagnostics (J.S.), Stratos Genomics (J.S.), Good Start Genetics (J.S.), Adaptive Biotechnologies (J. S.), Pacific Biosciences (E. E. E.), SynapDx (E. E. E.), DNAnexus (E. E. E.), and SFARI GENE (H. C. M.). B.J.O. is an inventor on patent PCT/US2009/30620: Mutations in contactin associated protein 2 are associated with increased risk for idiopathic autism. Raw sequencing data available at the National Database for Autism Research, NDARCOL1878.	Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Williams CA, 2008, AM J MED GENET A, V146A, P2023, DOI 10.1002/ajmg.a.32434; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	21	860	898	6	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1619	1622		10.1126/science.1227764	http://dx.doi.org/10.1126/science.1227764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160955	Green Accepted			2022-12-01	WOS:000312533100053
J	Rosenzweig, A				Rosenzweig, Anthony			Cardiac Regeneration	SCIENCE			English	Editorial Material							PRESERVED EJECTION FRACTION; RANDOMIZED PHASE-1 TRIAL; CARDIOMYOCYTE PROLIFERATION; HEART-FAILURE; STEM-CELLS; MYOCARDIAL-INFARCTION; FIBROBLASTS; APOPTOSIS; MYOCYTES; THERAPY		[Rosenzweig, Anthony] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiovasc, Boston, MA 02215 USA; [Rosenzweig, Anthony] Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Rosenzweig, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiovasc, Boston, MA 02215 USA.	arosenzw@bidmc.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019		NHLBI NIH HHS [R01 HL122987] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; DeFrances Carol J, 2006, Adv Data, P1; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278	27	24	28	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1549	1550		10.1126/science.1228951	http://dx.doi.org/10.1126/science.1228951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258880				2022-12-01	WOS:000312533100036
J	Paterson, AH; Wendel, JF; Gundlach, H; Guo, H; Jenkins, J; Jin, DC; Llewellyn, D; Showmaker, KC; Shu, SQ; Udall, J; Yoo, MJ; Byers, R; Chen, W; Doron-Faigenboim, A; Duke, MV; Gong, L; Grimwood, J; Grover, C; Grupp, K; Hu, GJ; Lee, TH; Li, JP; Lin, LF; Liu, T; Marler, BS; Page, JT; Roberts, AW; Romanel, E; Sanders, WS; Szadkowski, E; Tan, X; Tang, HB; Xu, CM; Wang, JP; Wang, ZN; Zhang, D; Zhang, L; Ashrafi, H; Bedon, F; Bowers, JE; Brubaker, CL; Chee, PW; Das, S; Gingle, AR; Haigler, CH; Harker, D; Hoffmann, LV; Hovav, R; Jones, DC; Lemke, C; Mansoor, S; Rahman, MU; Rainville, LN; Rambani, A; Reddy, UK; Rong, JK; Saranga, Y; Scheffler, BE; Scheffler, JA; Stelly, DM; Triplett, BA; Van Deynze, A; Vaslin, MFS; Waghmare, VN; Walford, SA; Wright, RJ; Zaki, EA; Zhang, TZ; Dennis, ES; Mayer, KFX; Peterson, DG; Rokhsar, DS; Wang, XY; Schmutz, J				Paterson, Andrew H.; Wendel, Jonathan F.; Gundlach, Heidrun; Guo, Hui; Jenkins, Jerry; Jin, Dianchuan; Llewellyn, Danny; Showmaker, Kurtis C.; Shu, Shengqiang; Udall, Joshua; Yoo, Mi-jeong; Byers, Robert; Chen, Wei; Doron-Faigenboim, Adi; Duke, Mary V.; Gong, Lei; Grimwood, Jane; Grover, Corrinne; Grupp, Kara; Hu, Guanjing; Lee, Tae-ho; Li, Jingping; Lin, Lifeng; Liu, Tao; Marler, Barry S.; Page, Justin T.; Roberts, Alison W.; Romanel, Elisson; Sanders, William S.; Szadkowski, Emmanuel; Tan, Xu; Tang, Haibao; Xu, Chunming; Wang, Jinpeng; Wang, Zining; Zhang, Dong; Zhang, Lan; Ashrafi, Hamid; Bedon, Frank; Bowers, John E.; Brubaker, Curt L.; Chee, Peng W.; Das, Sayan; Gingle, Alan R.; Haigler, Candace H.; Harker, David; Hoffmann, Lucia V.; Hovav, Ran; Jones, Donald C.; Lemke, Cornelia; Mansoor, Shahid; Rahman, Mehboob Ur; Rainville, Lisa N.; Rambani, Aditi; Reddy, Umesh K.; Rong, Jun-kang; Saranga, Yehoshua; Scheffler, Brian E.; Scheffler, Jodi A.; Stelly, David M.; Triplett, Barbara A.; Van Deynze, Allen; Vaslin, Maite F. S.; Waghmare, Vijay N.; Walford, Sally A.; Wright, Robert J.; Zaki, Essam A.; Zhang, Tianzhen; Dennis, Elizabeth S.; Mayer, Klaus F. X.; Peterson, Daniel G.; Rokhsar, Daniel S.; Wang, Xiyin; Schmutz, Jeremy			Repeated polyploidization of Gossypium genomes and the evolution of spinnable cotton fibres	NATURE			English	Article							DNA; SEQUENCE; RECOMBINATION; ARABIDOPSIS; PLANTS; ORGANIZATION; BARBADENSE; PATHWAYS; ANCIENT; PROTEIN	Polyploidy often confers emergent properties, such as the higher fibre productivity and quality of tetraploid cottons than diploid cottons bred for the same environments(1). Here we show that an abrupt five-to sixfold ploidy increase approximately 60 million years (Myr) ago, and allopolyploidy reuniting divergent Gossypium genomes approximately 1-2 Myr ago(2), conferred about 30-36-fold duplication of ancestral angiosperm (flowering plant) genes in elite cottons (Gossypium hirsutum and Gossypium barbadense), genetic complexity equalled only by Brassica(3) among sequenced angiosperms. Nascent fibre evolution, before allopolyploidy, is elucidated by comparison of spinnable-fibred Gossypium herbaceum A and non-spinnable Gossypium longicalyx F genomes to one another and the outgroup D genome of non-spinnable Gossypium raimondii. The sequence of a G. hirsutum A(t)D(t) (in which 't' indicates tetraploid) cultivar reveals many non-reciprocal DNA exchanges between subgenomes that may have contributed to phenotypic innovation and/or other emergent properties such as ecological adaptation by polyploids. Most DNA-level novelty in G. hirsutum recombines alleles from the D-genome progenitor native to its New World habitat and the Old World A-genome progenitor in which spinnable fibre evolved. Coordinated expression changes in proximal groups of functionally distinct genes, including a nuclear mitochondrial DNA block, may account for clusters of cotton-fibre quantitative trait loci affecting diverse traits. Opportunities abound for dissecting emergent properties of other polyploids, particularly angiosperms, by comparison to diploid progenitors and outgroups.	[Paterson, Andrew H.; Guo, Hui; Lee, Tae-ho; Li, Jingping; Lin, Lifeng; Marler, Barry S.; Tan, Xu; Tang, Haibao; Wang, Zining; Zhang, Dong; Bowers, John E.; Das, Sayan; Gingle, Alan R.; Lemke, Cornelia; Mansoor, Shahid; Rainville, Lisa N.; Rong, Jun-kang; Wang, Xiyin] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wendel, Jonathan F.; Yoo, Mi-jeong; Gong, Lei; Grover, Corrinne; Grupp, Kara; Hu, Guanjing; Szadkowski, Emmanuel; Xu, Chunming] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Gundlach, Heidrun; Mayer, Klaus F. X.] German Res Ctr Environm Hlth GmbH, MIPS IBIS Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Jenkins, Jerry; Shu, Shengqiang; Grimwood, Jane; Rokhsar, Daniel S.; Schmutz, Jeremy] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94595 USA; [Jenkins, Jerry; Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Jin, Dianchuan; Chen, Wei; Liu, Tao; Wang, Jinpeng; Zhang, Lan; Wang, Xiyin] Hebei United Univ, Sch Life Sci, Ctr Genom & Computat Biol, Tangshan 063000, Hebei, Peoples R China; [Jin, Dianchuan; Chen, Wei; Liu, Tao; Wang, Jinpeng; Zhang, Lan; Wang, Xiyin] Hebei United Univ, Sch Sci, Tangshan 063000, Hebei, Peoples R China; [Llewellyn, Danny; Bedon, Frank; Brubaker, Curt L.; Walford, Sally A.; Dennis, Elizabeth S.] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Showmaker, Kurtis C.; Sanders, William S.; Peterson, Daniel G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Udall, Joshua; Byers, Robert; Page, Justin T.; Harker, David; Rambani, Aditi] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Doron-Faigenboim, Adi; Hovav, Ran] Agr Res Org, Inst Plant Sci, Dept Field Crops, IL-50250 Bet Dagan, Israel; [Duke, Mary V.; Scheffler, Brian E.; Scheffler, Jodi A.] USDA ARS, Jamie Whitten Delta States Res Ctr, Stoneville, MS 38776 USA; [Roberts, Alison W.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Romanel, Elisson] Univ Fed Rio de Janeiro, Dept Genet, BR-21941901 Rio De Janeiro, Brazil; [Tang, Haibao] J Craig Venter Inst, Rockville, MD 20850 USA; [Xu, Chunming] NE Normal Univ, Inst Cytol & Genet, Unit Plant Epigenet, Key Lab Mol Epigenet MOE, Changchun 5268, Peoples R China; [Ashrafi, Hamid; Van Deynze, Allen] Univ Calif Davis, Plant Reprod Biol Extens Ctr, Davis, CA 95616 USA; [Brubaker, Curt L.] Bayer CropSci, B-9052 Ghent, Belgium; [Chee, Peng W.] Univ Georgia, Coastal Plain Expt Stn, Tifton, GA 31793 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Hoffmann, Lucia V.] EMBRAPA, Ctr Nacl Pesquisa Algodao, BR-75375000 Santo Antonio De Goias, Go, Brazil; [Jones, Donald C.] Cotton Inc, Cary, NC 27513 USA; [Mansoor, Shahid; Rahman, Mehboob Ur] Natl Inst Biotechnol & Genet Engn, Faisalabad 38000, Pakistan; [Reddy, Umesh K.] W Virginia State Univ, Dept Biol, Institute, WV 25112 USA; [Saranga, Yehoshua] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Triplett, Barbara A.] USDA ARS, New Orleans, LA 70124 USA; [Vaslin, Maite F. S.] Univ Fed Rio de Janeiro, Dept Microbiol, BR-21941971 Rio De Janeiro, Brazil; [Waghmare, Vijay N.] Cent Inst Cotton Res, Nagpur 440010, Maharashtra, India; [Wright, Robert J.] Texas Tech Univ, Dept Plant Sci, Lubbock, TX 79415 USA; [Zaki, Essam A.] Genet Engn & Biotechnol Res Inst, Nucle Acids Dept, Alexandria 21934, Egypt; [Zhang, Tianzhen] Nanjing Agr Univ, Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China	University System of Georgia; University of Georgia; Iowa State University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; North China University of Science & Technology; North China University of Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Mississippi State University; Brigham Young University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; United States Department of Agriculture (USDA); University of Rhode Island; Universidade Federal do Rio de Janeiro; J. Craig Venter Institute; Northeast Normal University - China; University of California System; University of California Davis; Bayer AG; Bayer CropScience; University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cotton Incorporated; Pakistan Institute of Engineering & Applied Science; West Virginia State University; Hebrew University of Jerusalem; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); Universidade Federal do Rio de Janeiro; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Cotton Research; Texas Tech University System; Texas Tech University; Nanjing Agricultural University	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@plantbio.uga.edu; jschmutz@hudsonalpha.org	Tang, Haibao/A-6715-2011; Chen, Wei/O-6774-2017; Stelly, David/ABC-7400-2020; Mayer, Klaus FX/M-7941-2015; Bowers, John/B-9245-2009; Walford, Sally/B-5488-2011; Rahman, Mehboob-ur-/I-7983-2015; Chen, Wei/W-8311-2019; Romanel, Elisson AC/E-5888-2019; Grimwood, Jane/ABD-5737-2021; Dennis, Elizabeth S/A-6074-2008; Yoo, Mi-Jeong/ABH-9752-2020; Vaslin, Maite F/G-5074-2011; Zaki, Essam/K-8456-2015; Romanel, Elisson AC/F-1933-2013; Bowers, John/AAD-7601-2019; Llewellyn, Danny J/D-5230-2009; Schmutz, Jeremy/N-3173-2013; Saranga, Yehoshua/GXV-3347-2022; Hoffmann, Lucia Vieira/C-1161-2013; Rambani, Aditi/I-2573-2019; Grover, Corrinne E/K-3194-2019; Jenkins, Jerry/ABE-6479-2020; Hu, Guanjing/AAA-4497-2020; Yoo, Michelle/L-3668-2019; Bedon, Frank/B-5497-2011	Tang, Haibao/0000-0002-3460-8570; Chen, Wei/0000-0002-6857-7696; Stelly, David/0000-0002-3468-4119; Mayer, Klaus FX/0000-0001-6484-1077; Bowers, John/0000-0001-8984-9796; Romanel, Elisson AC/0000-0002-4794-4215; Dennis, Elizabeth S/0000-0002-7850-591X; Yoo, Mi-Jeong/0000-0003-4991-2636; Vaslin, Maite F/0000-0002-7252-7050; Zaki, Essam/0000-0002-3906-623X; Romanel, Elisson AC/0000-0002-4794-4215; Llewellyn, Danny J/0000-0001-9535-8707; Schmutz, Jeremy/0000-0001-8062-9172; Hoffmann, Lucia Vieira/0000-0003-2150-1990; Rambani, Aditi/0000-0002-3691-6737; Grover, Corrinne E/0000-0003-3878-5459; Jenkins, Jerry/0000-0002-7943-3997; Hu, Guanjing/0000-0001-8552-7394; Bedon, Frank/0000-0002-9940-5926; Gundlach, Heidrun/0000-0002-6757-0943; Peterson, Daniel/0000-0002-0274-5968; Scheffler, Brian/0000-0003-1968-8952; Guo, Hui/0000-0001-7830-8564; Ashrafi, Hamid/0000-0002-2094-2367; Haigler, Candace/0000-0001-7810-4035; Mansoor, Shahid/0000-0001-7418-1826; Rokhsar, Daniel/0000-0002-8704-2224; Showmaker, Kurt/0000-0002-6317-9402; Shu, Shengqiang/0000-0002-4336-8994; Xu, Chunming/0000-0002-0986-0993; Bowers, John/0000-0001-5693-2796	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US National Science Foundation [DBI 98-72630, DBI 02-11700, DBI 02-08311, IIP-0917856, IIP-1127755, IOS 1025947]; USDA [ARS-58-6402-7-241, 58-6402-1-644, 58-6402-1-645, ARS 6402-21310-003-00, NRI 00-52100-9685, 02-35301-12045]; Bayer CropScience; Consortium for Plant Biotechnology Research; Cotton, Inc.; Georgia State Support Committee; Texas State Support Committee; Pakistan-US Science and Technology Cooperation Program; US-Egypt Science and Technology Cooperation Program; Fulbright Scholar Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PDJ150690/2012-6]; Fundacao de Amparo a Pesquisa Pensa Rio [E-26/110.324/2010]; Texas AgriLife; Brigham Young University (BYU); Direct For Biological Sciences [1025947] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0841821] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Bayer CropScience(Bayer AG); Consortium for Plant Biotechnology Research; Cotton, Inc.(Cotton R&D Corp); Georgia State Support Committee; Texas State Support Committee; Pakistan-US Science and Technology Cooperation Program; US-Egypt Science and Technology Cooperation Program(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); Fulbright Scholar Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa Pensa Rio; Texas AgriLife; Brigham Young University (BYU); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work, conducted by the US Department of Energy Joint Genome Institute, is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. The authors appreciate financial support from the US National Science Foundation (DBI 98-72630 to A.H.P., J.F.W., A.R.G.; DBI 02-11700 to J.F.W., A.H.P., J.U., A.R.G.; DBI 02-08311, IIP-0917856; IIP-1127755 to A.H.P.; IOS 1025947 to C.H.H.), USDA (ARS-58-6402-7-241, 58-6402-1-644 and 58-6402-1-645 to D.G.P.; ARS 6402-21310-003-00 to B.E.S.; NRI 00-52100-9685 and 02-35301-12045 to A.H.P.), Bayer CropScience and The Consortium for Plant Biotechnology Research (A.H.P.), Cotton, Inc. (P.W.C., D.C.J., A.H.P., D.M.S., A.V.-D., J.F.W.), Georgia State Support Committee (P.W.C., A.H.P.), Texas State Support Committee (R.J.W.), Pakistan-US Science and Technology Cooperation Program (P.W.C., S.M., A.H.P., M.u.R.), US-Egypt Science and Technology Cooperation Program (A.H.P., E.A.Z.), Fulbright Scholar Program (S.M., E.A.Z.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico PDJ150690/2012-6 (E.R.), Fundacao de Amparo a Pesquisa Pensa Rio E-26/110.324/2010 (M.F.S.V.), Texas AgriLife (D.M.S.), and Brigham Young University (BYU) Mentored Environment Grants (J.U.). RNA-seq reads were mapped by students on Marylou at the Fulton Supercomputer Center at BYU. We thank L.S. Dure III, G.O. Myers, J. McD Stewart, T.A. Wilkins and J. Zhu for co-endorsing the sequencing of G. raimondii by the US Department of Energy.	ADKISSON PL, 1982, SCIENCE, V216, P19, DOI 10.1126/science.216.4541.19; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Flagel LE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-302; GEEVER RF, 1989, THEOR APPL GENET, V77, P553, DOI 10.1007/BF00274278; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; KADIR ZBA, 1976, CHROMOSOMA, V56, P85, DOI 10.1007/BF00293732; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Lin LF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-395; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Muravenko OV, 1998, GENOME, V41, P616, DOI 10.1139/gen-41-4-616; REINISCH AJ, 1994, GENETICS, V138, P829; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rong J, 2005, GENOME RES, V15, P1198, DOI 10.1101/gr.3907305; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; WALBOT V, 1976, J MOL BIOL, V101, P503, DOI 10.1016/0022-2836(76)90242-4; WANG GL, 1995, THEOR APPL GENET, V91, P1153, DOI 10.1007/BF00223934; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479	42	825	898	12	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					423	+		10.1038/nature11798	http://dx.doi.org/10.1038/nature11798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257886	Green Published, hybrid			2022-12-01	WOS:000312488200055
J	Murray, CJL; Vos, T; Lozano, R; Naghavi, M; Flaxman, AD; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basanez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabe, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, SA; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, G; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, HL; Cheng, ATA; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; De Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; De Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fevre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gonzalez-Medina, D; Gosselin, R; Grainger, R; Grant, B; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Laden, F; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Levinson, D; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mock, C; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KMV; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O'Donnell, M; O'Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; De Leon, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJC; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JRA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; van der Werf, MJ; van Os, J; Vavilala, MS; Venketasubramanian, N; Wang, MR; Wang, WZ; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiebe, N; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SRM; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AKM; Zheng, ZJ; Zonies, D; Lopez, AD				Murray, Christopher J. L.; Vos, Theo; Lozano, Rafael; Naghavi, Mohsen; Flaxman, Abraham D.; Michaud, Catherine; Ezzati, Majid; Shibuya, Kenji; Salomon, Joshua A.; Abdalla, Safa; Aboyans, Victor; Abraham, Jerry; Ackerman, Ilana; Aggarwal, Rakesh; Ahn, Stephanie Y.; Ali, Mohammed K.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Bahalim, Adil N.; Barker-Collo, Suzanne; Barrero, Lope H.; Bartels, David H.; Basanez, Maria-Gloria; Baxter, Amanda; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bernabe, Eduardo; Bhalla, Kavi; Bhandari, Bishal; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Black, James A.; Blencowe, Hannah; Blore, Jed D.; Blyth, Fiona; Bolliger, Ian; Bonaventure, Audrey; Boufous, Soufi Ane; Bourne, Rupert; Boussinesq, Michel; Braithwaite, Tasanee; Brayne, Carol; Bridgett, Lisa; Brooker, Simon; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Buckle, Geoffrey; Budke, Christine M.; Burch, Michael; Burney, Peter; Burstein, Roy; Calabria, Bianca; Campbell, Benjamin; Canter, Charles E.; Carabin, Helene; Carapetis, Jonathan; Carmona, Loreto; Cella, Claudia; Charlson, Fiona; Chen, Honglei; Cheng, Andrew Tai-Ann; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; De Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahiya, Manu; Dahodwala, Nabila; Damsere-Derry, James; Danaei, Goodarz; Davis, Adrian; De Leo, Diego; Degenhardt, Louisa; Dellavalle, Robert; Delossantos, Allyne; Denenberg, Julie; Derrett, Sarah; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Torne, Cesar; Dolk, Helen; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Edmond, Karen; Elbaz, Alexis; Ali, Suad Eltahir; Erskine, Holly; Erwin, Patricia J.; Espindola, Patricia; Ewoigbokhan, Stalin E.; Farzadfar, Farshad; Feigin, Valery; Felson, David T.; Ferrari, Alize; Ferri, Cleusa P.; Fevre, Eric M.; Finucane, Mariel M.; Flaxman, Seth; Flood, Louise; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Fransen, Marlene; Freeman, Michael K.; Gabbe, Belinda J.; Gabriel, Sherine E.; Gakidou, Emmanuela; Ganatra, Hammad A.; Garcia, Bianca; Gaspari, Flavio; Gillum, Richard F.; Gmel, Gerhard; Gonzalez-Medina, Diego; Gosselin, Richard; Grainger, Rebecca; Grant, Bridget; Groeger, Justina; Guillemin, Francis; Gunnell, David; Gupta, Ramyani; Haagsma, Juanita; Hagan, Holly; Halasa, Yara A.; Hall, Wayne; Haring, Diana; Maria Haro, Josep; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Higashi, Hideki; Hill, Catherine; Hoen, Bruno; Hoffman, Howard; Hotez, Peter J.; Hoy, Damian; Huang, John J.; Ibeanusi, Sydney E.; Jacobsen, Kathryn H.; James, Spencer L.; Jarvis, Deborah; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Jonas, Jost B.; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kawakami, Norito; Keren, Andre; Khoo, Jon-Paul; King, Charles H.; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Laden, Francine; Lalloo, Ratilal; Laslett, Laura L.; Lathlean, Tim; Leasher, Janet L.; Lee, Yong Yi; Leigh, James; Levinson, Daphna; Lim, Stephen S.; Limb, Elizabeth; Lin, John Kent; Lipnick, Michael; Lipshultz, Steven E.; Liu, Wei; Loane, Maria; Ohno, Summer Lockett; Lyons, Ronan; Mabweijano, Jacqueline; MacIntyre, Michael F.; Malekzadeh, Reza; Mallinger, Leslie; Manivannan, Sivabalan; Marcenes, Wagner; March, Lyn; Margolis, David J.; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGill, Neil; McGrath, John; Elena Medina-Mora, Maria; Meltzer, Michele; Mensah, George A.; Merriman, Tony R.; Meyer, Ana-Claire; Miglioli, Valeria; Miller, Matthew; Miller, Ted R.; Mitchell, Philip B.; Mock, Charles; Mocumbi, Ana Olga; Moffitt, Terrie E.; Mokdad, Ali A.; Monasta, Lorenzo; Montico, Marcella; Moradi-Lakeh, Maziar; Moran, Andrew; Morawska, Lidia; Mori, Rintaro; Murdoch, Michele E.; Mwaniki, Michael K.; Naidoo, Kovin; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nelson, Paul K.; Nelson, Robert G.; Nevitt, Michael C.; Newton, Charles R.; Nolte, Sandra; Norman, Paul; Norman, Rosana; O'Donnell, Martin; O'Hanlon, Simon; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Page, Andrew; Pahari, Bishnu; Pandian, Jeyaraj Durai; Panozo Rivero, Andrea; Patten, Scott B.; Pearce, Neil; Perez Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Phillips, Michael R.; Pierce, Kelsey; Pion, Sebastien; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. Arden, III; Popova, Svetlana; Porrini, Esteban; Pourmalek, Farshad; Prince, Martin; Pullan, Rachel L.; Ramaiah, Kapa D.; Ranganathan, Dharani; Razavi, Homie; Regan, Mathilda; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Richardson, Kathryn; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; Rodriguez De Leon, Felipe; Ronfani, Luca; Room, Robin; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Schwebel, David C.; Scott, James Graham; Segui-Gomez, Maria; Shahraz, Saeid; Shepard, Donald S.; Shin, Hwashin; Shivakoti, Rupak; Singh, David; Singh, Gitanjali M.; Singh, Jasvinder A.; Singleton, Jessica; Sleet, David A.; Sliwa, Karen; Smith, Emma; Smith, Jennifer L.; Stapelberg, Nicolas J. C.; Steer, Andrew; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Syed, Sana; Tamburlini, Giorgio; Tavakkoli, Mohammad; Taylor, Hugh R.; Taylor, Jennifer A.; Taylor, William J.; Thomas, Bernadette; Thomson, W. Murray; Thurston, George D.; Tleyjeh, Imad M.; Tonelli, Marcello; Towbin, Jeff Rey A.; Truelsen, Thomas; Tsilimbaris, Miltiadis K.; Ubeda, Clotilde; Undurraga, Eduardo A.; van der Werf, Marieke J.; van Os, Jim; Vavilala, Monica S.; Venketasubramanian, N.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weatherall, David J.; Weinstock, Martin A.; Weintraub, Robert; Weisskopf, Marc G.; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiebe, Natasha; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Sean R. M.; Witt, Emma; Wolfe, Frederick; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Zaidi, Anita K. M.; Zheng, Zhi-Jie; Zonies, David; Lopez, Alan D.			Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							PUBLIC-HEALTH UTILITY; ECONOMIC COST; RISK-FACTORS; MORTALITY; POPULATION; COUNTRIES; EXPECTANCY; AUSTRALIA; COPD; LOST	Background Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. Methods We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. Findings Global DALYs remained stable from 1990 (2.503 billion) to 2010 (2.490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. Interpretation Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results.	[Baxter, Amanda; Erskine, Holly; Ferrari, Alize; Khoo, Jon-Paul; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Higashi, Hideki; Lee, Yong Yi; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James Graham] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Murray, Christopher J. L.; Lozano, Rafael; Naghavi, Mohsen; Flaxman, Abraham D.; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Campbell, Benjamin; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Gonzalez-Medina, Diego; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen S.; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Salomon, Joshua A.; Danaei, Goodarz; Laden, Francine; Lin, John Kent; Miller, Matthew; Singh, Gitanjali M.; Sudfeld, Christopher; Tavakkoli, Mohammad; Weisskopf, Marc G.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Wei] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Colan, Steven D.] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Bhalla, Kavi] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, San Antonio, TX USA; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, H. Ross; Gupta, Ramyani; Limb, Elizabeth] St Georges Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Bell, Michelle L.; Huang, John J.; Ozgediz, Doruk] Yale Univ, New Haven, CT USA; [Felson, David T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Hay, Roderick J.] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Dahiya, Manu] Queen Mary Univ London, Inst Dent, London, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Black, James A.] MRC, Epidemiol Unit, Cambridge, England; [Blencowe, Hannah; Brooker, Simon; Edmond, Karen; Pearce, Neil; Pullan, Rachel L.; Smith, Jennifer L.] London Sch Hyg & Trop Med, London WC1, England; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim; Leigh, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bonaventure, Audrey; Elbaz, Alexis] INSERM, Paris, France; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Bucello, Chiara; Mitchell, Philip B.] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Brayne, Carol; Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buckle, Geoffrey; Manivannan, Sivabalan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Canter, Charles E.] Washington Univ, St Louis, MO USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Carmona, Loreto] Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [Cella, Claudia; Cortinovis, Monica; Gaspari, Flavio; Miglioli, Valeria; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Havmoeller, Rasmus] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fevre, Eric M.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [De Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.; Denenberg, Julie] Univ Calif San Diego, San Diego, CA 92103 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Dellavalle, Robert] Denver VA Med Ctr, Denver, VA USA; [Derrett, Sarah; Grainger, Rebecca; Merriman, Tony R.; Taylor, William J.; Thomson, W. Murray] Univ Otago, Dunedin, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dolk, Helen; Loane, Maria] Univ Ulster, Ulster, Ireland; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ewoigbokhan, Stalin E.] Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Feigin, Valery] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Polanczyk, Guilherme V.] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Nevitt, Michael C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Groeger, Justina] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Guillemin, Francis] Univ Lorraine, Nancy, France; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Halasa, Yara A.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, St Boi De Llobregat, Spain; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hill, Catherine] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Hoen, Bruno] Univ Franche Comte, F-25030 Besancon, France; [Hoen, Bruno] Ctr Hosp Reg Univ Besancon, Besancon, France; [Hoffman, Howard] NIDCD, NIH, Bethesda, MD USA; [Nelson, Robert G.] NIDDK, NIH, Bethesda, MD USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [King, Charles H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Laslett, Laura L.] Univ Tasmania, Hobart, Tas 7001, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Levinson, Daphna] Minist Hlth, Jerusalem, Israel; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Mwaniki, Michael K.] Kemri Wellcome Trust, Kilifi, Kenya; [Naidoo, Kovin] Univ KwaZulu Natal, AVRI, Durban, South Africa; [Naldi, Luigi] Ctr Studi GISED, Bergamo, Italy; [Nolte, Sandra] Charite, D-13353 Berlin, Germany; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Panozo Rivero, Andrea] Hosp Joan 23, La Paz, Bolivia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Perez Padilla, Rogelio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porrini, Esteban] Hosp Univ Canarias, Tenerif, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Ramaiah, Kapa D.] Vector Control Res Ctr, Pondicherry, India; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Regan, Mathilda] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rein, David B.] Univ Chicago, NORC, Chicago, IL 60637 USA; [Rodriguez De Leon, Felipe] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Shin, Hwashin] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Syed, Sana; Zaidi, Anita K. M.] Aga Khan Univ, Karachi, Pakistan; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Tonelli, Marcello] Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Towbin, Jeff Rey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Iraklion, Greece; [Ubeda, Clotilde] ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [van Os, Jim] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Sean R. M.] Hollywood Orthopaed Grp, Perth, WA, Australia; [Wolfe, Frederick] Arthrit Res, Wichita, KS USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Emory University; Emory University; St Georges University London; Mayo Clinic; University of Auckland; Pontificia Universidad Javeriana; Yale University; Boston University; University of Oxford; University of Oxford; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Flinders University South Australia; Cabrini Health; Monash University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Camilo Jose Cela University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Pennsylvania; Griffith University; Griffith University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Ulster University; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); Carnegie Mellon University; James Cook University; Howard University; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centers for Disease Control & Prevention - USA; Universite de Lorraine; University of Bristol; New York University; Brandeis University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska University Hospital; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; University of Port Harcourt; George Mason University; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Case Western Reserve University; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of Tasmania; Nova Southeastern University; University of Miami; Swansea University; Mulago National Referral Hospital; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Duke University; IRCCS Burlo Garofolo; Columbia University; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; Watford General Hospital; University of Kwazulu Natal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; University of Calgary; Hospital Universitario Cruces; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidad de la Laguna; University of British Columbia; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of California System; University of California Berkeley; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Turning Point Alcohol & Drug Centre - Australia; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Health Canada; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); Aga Khan University; Drexel University; University of Alberta; Cincinnati Children's Hospital Medical Center; University of Copenhagen; University of Crete; KNCV Tuberculosis Foundation; Maastricht University; National University of Singapore; Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; National Data Bank for Rheumatic Diseases; Royal Cornwall Hospital; University of London; London School Economics & Political Science; Landstuhl Regional Medical Center	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Medina-Mora, María Elena I/T-5937-2018; Pesudovs, Konrad/T-9403-2019; Polanczyk, Guilherme V/C-2345-2012; Thomson, William Murray/A-4971-2008; Black, James A/A-5917-2010; Jacobsen, Kathryn H./B-5857-2008; Carabin, Helene/B-7600-2016; Narayan, K.M. Venkat/J-9819-2012; Bennett, Derrick/AAH-1220-2022; Prince, Martin J/A-9170-2010; Courville, Karen/AAW-1462-2021; Jayaraman, Sudha/AAH-3059-2019; Lathlean, Tim/K-3653-2013; Colan, Steven/ABB-4580-2020; Ferri, Cleusa Pinheiro/B-2922-2010; Montico, Marcella/B-5290-2013; Osborne, Richard H/A-9447-2010; Buchbinder, Rachelle/G-2952-2011; Hall, Wayne D/A-3283-2008; Lopez, Alan D/F-1487-2010; Charlson, Fiona/R-8963-2019; Sudfeld, Christopher/AAW-3856-2021; Saha, Sukanta/K-3774-2012; Wiebe, Natasha/V-7803-2019; Ronfani, Luca/B-6668-2013; Polanczyk, Guilherme V./AAF-6142-2021; Steer, Andrew C/C-2840-2013; Charlson, Fiona J/F-5290-2011; Bernabe, Eduardo/R-3441-2017; Scott, James/D-5900-2012; Laslett, Laura/G-3973-2011; Davis, Adrian C/E-6022-2015; Zonies, David/B-6497-2011; Cowie, Benjamin/HFZ-9941-2022; McGrath, John Joseph/G-5493-2010; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Anderson, Hugh R/A-7417-2016; Naidoo, Kovin Shunmugam/AAF-5914-2020; Lopez, Alan/AAA-2734-2022; Sacco, Ralph/Y-9278-2019; Newton, Charles RJC/B-7578-2014; Krishnamurthi, Rita/AAU-7841-2021; Aggarwal, Rakesh/D-1583-2009; , Bennett/O-7998-2019; Condon, John R/N-2281-2013; Haro, Josep Maria/D-1423-2011; Ferrari, Alize J/G-1746-2011; Lozano, Rafael/T-5352-2018; Ortblad, Katrina/ABF-9070-2020; Moffitt, Terrie E/D-5295-2011; Higashi, Hideki/D-3797-2011; Hill, Catherine L/AAE-7152-2019; Karthikeyan, Ganesan/D-5767-2012; Truelsen, Thomas/AAY-1549-2020; Bikbov, Boris/I-4594-2013; Salomon, Joshua A/D-3898-2009; van Os, Jim/C-2113-2014; PEREZ-RUIZ, FERNANDO/E-4844-2012; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Room, Robin/ABF-7460-2021; Naldi, Luigi/K-6343-2016; Thomson, William Murray/AAC-8575-2019; Bell, Michelle/Y-4608-2018; Grainger, Rebecca/I-1866-2012; Malekzadeh, Reza/U-1382-2017; Tonelli, Marcello/B-3028-2009; Ali, Mohammed K/N-9833-2013; Feigin, Valery/AAF-2313-2019; Norman, Paul E/C-5485-2013; Harrison, James/B-8958-2009; Room, Robin/ABH-8505-2020; Elbaz, Alexis/F-8952-2017; Brugha, Traolach/T-9326-2019; Bin Abdulhak, Aref/AAM-9492-2020; Stovner, Lars Jacob/D-5025-2014; Coffeng, Luc/AAL-6631-2021; Bennett, Derrick/AFL-9254-2022; Patten, Scott/B-4434-2011; RUIZ, FERNANDO PEREZ/X-1980-2019; Carmona, Loreto/A-2748-2014; O'Donnell, Martin/ABE-7459-2020; Bin Abdulhak, Aref/AAK-4348-2020; Brayne, Carol/AAA-4285-2020; Schwebel, David/GXH-9944-2022; Perico, Norberto/ABH-3222-2020; Boussinesq, Michel/J-7256-2016; Ganatra, Hammad A/P-8652-2019; Braithwaite, Tasanee/AAZ-1118-2020; Phillips, Michael Robert/AAE-7585-2021; Pandian, Jeyaraj Durai/AAV-5591-2020; Monasta, Lorenzo/B-1388-2012; Nolte, Sandra/B-7498-2008; Baxter, Amanda/E-5449-2011; Erskine, Holly/K-5244-2012; Singh, Jasvinder/R-6172-2019; PACELLA, ROSANA E./F-2774-2010; Whiteford, Harvey A/A-4840-2009; Aboyans, Victor/AAN-8308-2020; Pope, C. Arden/ABD-5522-2021; Cheng, Andrew/O-1159-2018; Moradi-Lakeh, Maziar/ABC-9793-2021; Naldi, Luigi/AFM-8982-2022; Matzopoulos, Richard/AAL-9965-2021; Dellavalle, Robert/L-2020-2013; Newton, Charles/V-7872-2019; Bolliger, Ian W/C-4207-2016; Carapetis, Jonathan R/H-8933-2014; Pourmalek, Farshad/A-8188-2010; Jarvis, Deborah/E-6494-2011; van Os, Jim/V-8884-2019; Degenhardt, Louisa J/D-4515-2012; Thurston, George/ABB-1359-2021; Marks, Guy B./F-5058-2013; Díaz-Torné, César/AAG-2419-2020; Mokdad, Ali H./AAD-1232-2022; Gunnell, David/ABE-6653-2020; Salomon, Joshua/S-1929-2019; Lee, Yong Yi/C-1373-2015; SHIN, HS/AAE-5381-2022; Lalloo, Ratilal/O-5624-2014; Undurraga, Eduardo A./I-3739-2014; Benjamin, Emelia/E-7103-2011; Leasher, Janet/B-8889-2016; Morawska, Lidia/B-4140-2011; Watt, Kerrianne/G-2520-2010; Blore, Jed/K-6331-2012; Remuzzi, Giuseppe/V-9766-2017	Medina-Mora, María Elena I/0000-0001-9300-0752; Pesudovs, Konrad/0000-0002-6322-9369; Polanczyk, Guilherme V/0000-0003-2311-3289; Thomson, William Murray/0000-0003-0588-6843; Black, James A/0000-0002-2200-3179; Jacobsen, Kathryn H./0000-0002-4198-6246; Narayan, K.M. Venkat/0000-0001-8621-5405; Bennett, Derrick/0000-0002-9170-8447; Prince, Martin J/0000-0003-1379-7146; Courville, Karen/0000-0002-4182-6736; Jayaraman, Sudha/0000-0003-1094-5836; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Montico, Marcella/0000-0003-0377-8232; Osborne, Richard H/0000-0002-9081-2699; Buchbinder, Rachelle/0000-0002-0597-0933; Hall, Wayne D/0000-0003-1984-0096; Lopez, Alan D/0000-0001-5818-6512; Charlson, Fiona/0000-0003-2876-5040; Sudfeld, Christopher/0000-0002-3203-3638; Wiebe, Natasha/0000-0002-5613-1582; Ronfani, Luca/0000-0001-5710-3914; Polanczyk, Guilherme V./0000-0003-2311-3289; Charlson, Fiona J/0000-0003-2876-5040; Bernabe, Eduardo/0000-0002-1858-3713; Scott, James/0000-0002-0744-0688; Laslett, Laura/0000-0002-4336-0095; Davis, Adrian C/0000-0001-7134-7528; Cowie, Benjamin/0000-0002-7087-5895; McGrath, John Joseph/0000-0002-4792-6068; Newton, Charles RJC/0000-0002-6999-5507; Krishnamurthi, Rita/0000-0003-0869-2083; Aggarwal, Rakesh/0000-0001-9689-494X; Condon, John R/0000-0003-4952-0990; Haro, Josep Maria/0000-0002-3984-277X; Ferrari, Alize J/0000-0002-7863-9117; Lozano, Rafael/0000-0002-7356-8823; Ortblad, Katrina/0000-0002-5675-8836; Moffitt, Terrie E/0000-0002-8589-6760; Higashi, Hideki/0000-0002-5534-0905; Hill, Catherine L/0000-0001-8289-4922; Karthikeyan, Ganesan/0000-0002-2073-2917; Bikbov, Boris/0000-0002-1925-7506; Salomon, Joshua A/0000-0003-3929-5515; Room, Robin/0000-0002-5618-385X; Naldi, Luigi/0000-0002-3160-2835; Bell, Michelle/0000-0002-3965-1359; Grainger, Rebecca/0000-0001-9201-8678; Malekzadeh, Reza/0000-0002-9820-6335; Tonelli, Marcello/0000-0002-0846-3187; Norman, Paul E/0000-0003-3406-0506; Harrison, James/0000-0001-9893-8491; Elbaz, Alexis/0000-0001-9724-5490; Brugha, Traolach/0000-0002-9786-9591; Bin Abdulhak, Aref/0000-0001-9988-8609; Coffeng, Luc/0000-0002-4425-2264; Bennett, Derrick/0000-0002-9170-8447; Patten, Scott/0000-0001-9871-4041; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Carmona, Loreto/0000-0002-4401-2551; O'Donnell, Martin/0000-0002-7347-7761; Brayne, Carol/0000-0001-5307-663X; Perico, Norberto/0000-0002-3147-4327; Boussinesq, Michel/0000-0001-6312-0681; Ganatra, Hammad A/0000-0001-9534-2780; Braithwaite, Tasanee/0000-0002-3025-4066; Phillips, Michael Robert/0000-0002-5973-2439; Monasta, Lorenzo/0000-0001-7774-548X; Nolte, Sandra/0000-0001-6185-9423; Baxter, Amanda/0000-0001-8198-9022; Erskine, Holly/0000-0003-3119-9211; Singh, Jasvinder/0000-0003-3485-0006; PACELLA, ROSANA E./0000-0002-9742-1957; Whiteford, Harvey A/0000-0003-4667-6623; Cheng, Andrew/0000-0002-2698-0516; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Naldi, Luigi/0000-0002-3160-2835; Matzopoulos, Richard/0000-0001-9063-6210; Dellavalle, Robert/0000-0001-8132-088X; Newton, Charles/0000-0002-6999-5507; Bolliger, Ian W/0000-0001-8055-297X; Carapetis, Jonathan R/0000-0002-1182-9792; Pourmalek, Farshad/0000-0002-2134-0771; van Os, Jim/0000-0002-7245-1586; Degenhardt, Louisa J/0000-0002-8513-2218; Marks, Guy B./0000-0002-8976-8053; Díaz-Torné, César/0000-0001-6275-7699; Mokdad, Ali H./0000-0002-4994-3339; Gunnell, David/0000-0002-0829-6470; Salomon, Joshua/0000-0003-3929-5515; Lee, Yong Yi/0000-0003-2359-6823; SHIN, HS/0000-0002-7263-6257; Lalloo, Ratilal/0000-0001-5822-1269; Calabria, Bianca/0000-0001-6444-4696; Colquhoun, Samantha/0000-0002-6750-1147; Blencowe, Hannah/0000-0003-1556-3159; Knowlton, Lisa Marie/0000-0001-6046-5035; Pandian, Jeyaraj/0000-0003-0028-1968; O'Hanlon, Simon/0000-0002-6852-3911; Fevre, Eric/0000-0001-8931-4986; Farzadfar, Farshad/0000-0001-8288-4046; williams, hywel/0000-0002-5646-3093; Barrero, Lope/0000-0003-1503-0264; Shivakoti, Rupak/0000-0002-2773-9310; King, Charles/0000-0001-8349-9270; Porrini, Esteban/0000-0002-3056-4662; Undurraga, Eduardo A./0000-0002-4425-1253; Miller, Ted/0000-0002-0958-2639; Burney, Peter/0000-0001-8635-5678; Benjamin, Emelia/0000-0003-4076-2336; Sanchez Riera, Lidia/0000-0003-0774-2480; Rein, David/0000-0002-1271-5789; Ali, Mohammed/0000-0001-7266-2503; Chen, Honglei/0000-0003-3446-7779; Phillips, David/0000-0003-2569-1015; Mayosi, Bongani/0000-0001-6641-8950; Pearce, Neil/0000-0002-9938-7852; Pion, Sebastien/0000-0002-9468-7020; Smith, Emma/0000-0001-6510-2583; Merriman, Tony/0000-0003-0844-8726; Pullan, Rachel/0000-0001-9844-1362; Mocumbi, Ana/0000-0002-9564-2860; Taylor, William/0000-0001-6075-8479; Gmel, Gerhard/0000-0001-9403-9405; Bonaventure, Audrey/0000-0001-6665-8145; Basanez, Maria-Gloria/0000-0001-5031-3361; Ebel, Beth/0000-0001-9310-8325; Razavi, Homie/0000-0002-2658-6930; Taylor, Hugh/0000-0002-9437-784X; Loane, Maria/0000-0002-1206-3637; Jarvis, Deborah/0000-0002-1753-3896; Malekzadeh, Reza/0000-0003-1043-3814; Kobusingye, Olive/0000-0003-2413-599X; Alvarado, Miriam/0000-0003-2864-9410; Lathlean, Timothy/0000-0001-7340-1567; Leasher, Janet/0000-0002-8779-5162; Mock, Charles/0000-0002-0564-568X; Sleet, David/0000-0002-6165-3289; WILKINSON, JAMES/0000-0003-1945-5622; Stolk, Wilma/0000-0001-9509-1328; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Shibuya, Kenji/0000-0003-2528-7530; Buckle, Geoffrey/0000-0001-7721-0397; Groeger, Justina/0000-0003-0324-3385; Tleyjeh, Imad/0000-0002-5551-0353; Morawska, Lidia/0000-0002-0594-9683; Mitchell, Philip/0000-0002-7954-5235; White, Richard Aubrey/0000-0002-6747-1726; Aboyans, Victor/0000-0002-0322-9818; Boufous, Soufiane/0000-0002-5686-1729; Weissman, Myrna/0000-0003-3490-3075; O'donnell, Colm/0000-0002-8004-450X; Gabbe, Belinda/0000-0001-7096-7688; Hotez, Peter/0000-0001-8770-1042; Watt, Kerrianne/0000-0002-2275-081X; Syed, Sana/0000-0003-0954-0583; Duber, Herbert/0000-0002-5077-3170; Blore, Jed/0000-0002-3649-8686; Ackerman, Ilana/0000-0002-6028-1612; Felson, David/0000-0002-2668-2447; Cooper, Leslie/0000-0003-1002-3313; Cella, Claudia/0000-0002-9210-0775; Wolfe, Frederick/0000-0002-2801-6413; Budke, Christine/0000-0002-4750-0905; Lin, John/0000-0003-2490-4453; Feigin, Valery L./0000-0002-6372-1740; Mensah, George/0000-0002-0387-5326; Woolf, Anthony/0000-0001-8482-8056; Mori, Rintaro/0000-0001-7656-6156; Johns, Nicole/0000-0003-4513-4582; Remuzzi, Giuseppe/0000-0002-6194-3446; Dherani, Mukesh/0000-0002-3055-9636; Derrett, Sarah/0000-0003-2867-0498	Berlin Heart Honoraria; Lundbeck; Medtronic; Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm; CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine; Societe Francaise de Negma-Lerads; Pfizer; Pierre Fabre Medicaments; Sanofi-Afentis France; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Novartis; National Council for Scientific and Technological Development (CNPq, Brazil); Takeda; Savient; Ardea; Regeneron; Allergan; URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Aging (NIA); National Cancer Institute (NCI); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Wellcome Trust [098045, 085308]; Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; NIH; National Institute of Environmental Health Sciences; Africa Programme for Onchocerciasis Control (WHO/APOC); Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; US Department of Veterans Affairs; Health Research Council of New Zealand; University of Otago; National Institute for Stroke and Applied Neurosciences; AUT University; NHMRC; Swedish Research Council [2011-1071]; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council; World Health Organization; World Mental Health Japan (WMH-J); Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Australian Government; National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences; South African Medical Research Council Burden of Disease Research Unit; University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant [ES015459]; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia); European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing; Commonwealth Government of Australia; Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); National Institute of Environmental Health Sciences [ES00260]; Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; MRC [G0901214] Funding Source: UKRI; Medical Research Council [G0901214, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, ZIAES101986, T32ES015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Berlin Heart Honoraria; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine(Region Grand-Est); Societe Francaise de Negma-Lerads; Pfizer(Pfizer); Pierre Fabre Medicaments; Sanofi-Afentis France; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Novartis(Novartis); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Ardea; Regeneron(Regeneron); Allergan(AbbVieAllergan); URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Aging (NIA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Africa Programme for Onchocerciasis Control (WHO/APOC); Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US Department of Veterans Affairs(US Department of Veterans Affairs); Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; National Institute for Stroke and Applied Neurosciences; AUT University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Health Organization(World Health Organization); World Mental Health Japan (WMH-J); Japan Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences(Tehran University of Medical Sciences); South African Medical Research Council Burden of Disease Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia); European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Commonwealth Government of Australia(Australian Government); Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C E Canter has worked as an Optum Health consultant, Blue Cross Blue Shield consultant, and received Berlin Heart Honoraria and travel fees. E R Dorsey has received payments for consulting services from Lundbeck and Medtronic and research support from Lundbeck and Prana Biotechnology. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other remuneration. F Guillemin conducted a study on osteoarthritis epidemiology in an institution that received grants from public sources: Assurance-Maladie (CNAMTS) InVS, Inserm, CHU de Nancy, CHU de Nice, Conseil Regional de Lorraine, Societe Francaise de Negma-Lerads, Pfizer, Pierre Fabre Medicaments, Sanofi-Afentis France. H J Hoffman is a US Federal Government employee of the National Institutes of Health (NIH). P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G Mensah is a former employee of PepsiCo. F Perez-Ruiz was an advisor for Ardea, Menarini, Novartis, Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an advisor for educational issues for Savient; led investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea. G V Polanczyk has served as a speaker and/or consultant to Eli-Lily, Novartis, Janssen-Cilag, and Shire Pharmaceuticals, developed educational material for Janssen-Cilag, and received an independent investigator grant from Novartis and from the National Council for Scientific and Technological Development (CNPq, Brazil). L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and received research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). J A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis. J A Singh is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. J A Singh is supported by research grants from the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Aging (NIA), National Cancer Institute (NCI), and the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs) and is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, AL, USA.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease 2010 study in various capacities. We would like to specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also wish to express our gratitude to the following organisations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Lori M Newman, Jordis Ott, Poul Erik Petersen, Shekhar Saxena, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support in order to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalog as much data as possible to inform the estimates; and Erin C Mullany for her systematic efforts in organising drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript. The following individuals would like to acknowledge various forms of institutional support. J P Abraham, B Bartels, and P Yeh recognise the support of the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the World Health Organization Violence and Injury Prevention. B Bikbov acknowledges support from the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V I Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology. R Bourne acknowledges the Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. S Brooker is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). T S Brugha received funding from the Department of Health London, for the National Health Service Information Centre, by the University of Leicester. R Buchbinder is partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University, and Cabrini Health. P Burney and D Jarvis acknowledge the Chronic Respiratory Disease group received funding from the BUPA Foundation. They had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. C Cella, M Cortinovis, F Gaspari, V Miglioli, and N Perico, on behalf of the entire Genitourinary Expert Group, acknowledge the International Society of Nephrology (ISN). H Chen acknowledges that his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng, and W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for their work on onchocerciasis.; B C Cowie received institutional support from the Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support her work for illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, Australia. R Dellavalle was supported by the US Department of Veterans Affairs while contributing to this study. S Derrett acknowledges the Health Research Council of New Zealand and the University of Otago for their support. V Feigin and R Krishnamurthi were supported by the National Institute for Stroke and Applied Neurosciences, AUT University. E Fevre acknowledges the Wellcome Trust for grant 085308. W Hall was supported by an NHMRC Australia Fellowship. R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill and Melinda Gates Foundation and the Australian National Health and Medical Research Council. K H Jacobsen was supported by the World Health Organization for her work on hepatitis A. N Kawakami notes that the collection of data ultimately used in this study was supported by the following grants: The World Mental Health Japan (WMH-J) is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He would like to thank staff members, field coordinators, and interviewers of the WMH Japan 2002-2004 Survey. L L Laslett is supported by an Australian Government Australian Postgraduate Award. She also notes that the TasOAC study, the results of which were used in this research, was supported by the National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation, and University of Tasmania Institutional Research Grants Scheme. R Malekzadeh received funding from a research grant of Tehran University of Medical Sciences to do the related studies. R Matzopoulos acknowledges the two institutions that support his research work: South African Medical Research Council Burden of Disease Research Unit; and the University of Cape Town School of Public Health and Family Medicine. T Merriman acknowledges the Health Research Council of New Zealand. K Naidoo was supported by the Brien Holden Vision Institute. P Nelson was supported by the National Drug and Alcohol Research Centre (UNSW, Australia). R G Nelson acknowledges his research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. C Olives was funded in part by the Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant (ES015459). D Ozgediz acknowledges the staff and collaborators at the Mulago Hospital and Makerere University in Kampala, Uganda. K Pesudovs received institutional support from Flinders University.; R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson received funding support from the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funds from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD). G D Thurston was supported in part by Center grant ES00260 from the National Institute of Environmental Health Sciences. D J Weatherall was supported by the Wellcome Trust UK, the Medical Research Council UK and the Anthony Cerami and Ann Dunne Research Trust.	Adair T, 2012, INT J TUBERC LUNG D, V16, P1699, DOI 10.5588/ijtld.12.0251; Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; [Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], WORLD HLTH REP 2004; [Anonymous], 2006, HIGHL HLTH EST 2005; [Anonymous], 2011, VIET NAM BURD DIS IN; [Anonymous], 2003, HLTH SYSTEMS PERFORM; [Anonymous], 2005, NCMH BACKGR PAP BURD; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bowie C., 2007, MALAWI MED J, V18, P104; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Bundhamcharoen K, 2002, THAI WORKING GROUP B; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Carp FM, 2000, ELDER ABUSE FAMILY I; Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI 10.1590/s1135-57272009000100011; Chalk R, 1998, VIOLENCE FAMILIES AS; CHAMIE M, 1995, DISABIL REHABIL, V17, P323, DOI 10.3109/09638289509166718; Chapman G, 2006, TROP MED INT HEALTH, V11, P660, DOI 10.1111/j.1365-3156.2006.01601.x; Coyte PC, 1998, ARTHRIT CARE RES, V11, P315, DOI 10.1002/art.1790110503; de Salud M, 2004, ESTUDIO CARGA ENFERM; Departamento de Epidemiologia MINSAL, 2007, EST CARG ENF CARG AT; Dgedge M, 2001, B WORLD HEALTH ORGAN, V79, P546; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Escobar M, 1994, CARGA ENFERMEDAD COL; Fouad D, 2007, ECOMOD2007 C; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; Fukuda Y, 1999, J HLTH WELFARE STAT, V46, P28; Gadelha AMJ, 1998, PROJETO CARGA DOENCA; Genova-Maleras R, 2012, PUBLIC HEALTH, V126, P1024, DOI 10.1016/j.puhe.2012.08.012; Green S., 2007, BURDEN DIS ILLNESS U; Grosse SD, 2009, PUBLIC HEALTH REP, V124, P197, DOI 10.1177/003335490912400206; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hsairi M, 2003, Sante Publique, V15, P25; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Hurley Susan F, 2007, Cost Eff Resour Alloc, V5, P2, DOI 10.1186/1478-7547-5-2; Hyder AA, 1998, AM J PUBLIC HEALTH, V88, P196, DOI 10.2105/AJPH.88.2.196; Hyder AA, 2000, AM J PUBLIC HEALTH, V90, P1235, DOI 10.2105/AJPH.90.8.1235; Hyder AA, 2012, AM J PUBLIC HEALTH, V102, P1061, DOI 10.2105/AJPH.2011.300563; Ikeda S, 1998, J HLTH CARE SOC, V8, P83; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; Kosen S, 1998, ESTIMATION NATL BURD; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lai T, 2009, EUR J PUBLIC HEALTH, V19, P541, DOI 10.1093/eurpub/ckp038; Lapostolle A, 2008, EUR J PUBLIC HEALTH, V18, P195, DOI 10.1093/eurpub/ckm109; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Logan WPD, 1950, POP STUD-J DEMOG, V4, P132, DOI 10.2307/2172133; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozada P, 1999, PESO ENFERMEDAD ECUA; Lozano R, 2009, CARGA ENFERMEDAD MUN; Lozano R., 1995, J INT DEV, V7, P555, DOI DOI 10.1002/JID.3380070314; Lozano R., 1997, PESO ENFERMEDAD MEXI, P23; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206; Marks G, 1997, HLTH ADULT BRITAIN 1; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathur P., 2011, INDIAN J COMMUNITY M, V36, pS72, DOI [10.4103/0970-0218.94713, DOI 10.4103/0970-0218.94713]; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Ministerio de Salud de Costa Rica, 2008, MED CARG ENF COST RI; Ministry of Health, 2004, BURD DIS FIN REP; Ministry of Health, 2001, MIN HLTH PUBL HLTH I; Murray C. J. L., 1996, GLOBAL HLTH STAT COM; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Murray CJL, 2002, SUMMARY MEASURES POP; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Norman R., 2006, REVISED BURDEN DIS E; Oh IH, 2011, J KOREAN MED ASSOC, V54, P646, DOI 10.5124/jkma.2011.54.6.646; Peden M., 2004, WORLD REPORT ROAD TR; Peterson S, 1998, SJUKDOMSBORDAN SVERI; Phua HP, 2009, SINGAP MED J, V50, P468; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reiss A, 1993, VIOLENCE FAMILIES UN; Rodriguez J, 2008, CARGA ENFERMEDAD COL; Rodriguez J, 2000, CARGA GLOBAL ENFERME; Salas Vergara J, 1996, ESTUDIO PRIORIDADES; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Samutharuk B., 1999, MEASUREMENT DIS BURD; Schiamberg LB, 1999, J ELDER ABUSE NEGL, V11, P79, DOI 10.1300/J084v11n01_05; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; Seuc AH, 2010, CAD SAUDE PUBLICA, V26, P615, DOI 10.1590/S0102-311X2010000300018; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; The Thai Working Group on Burden of Disease and Injury, 2004, J HEALTH SCI, V13, P239; Thomas C, 2004, DISABIL SOC, V19, P569, DOI 10.1080/0968759042000252506; United Nations, UN ROAD SAF; Velasquez Valdivia A., 2006, ANALISIS ESTUDIO CAR; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; *WHO, WORLD HLTH REP 1999; World Bank, 1993, WORLD DEV REP 1993 I, V1; World Health Organization, WORLD HLTH REP 2002; World Health Organization, WORLD HLTH REP 2001; World Health Organization, REG BURD DIS EST 200; World Health Organization, 2010, VIOLENCE PREVENTION; World Health Organization, WORLD HLTH REP 2000; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Yusoff AF, MALAYSIAN BURDEN DIS; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	112	5493	5723	56	1487	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2197	2223		10.1016/S0140-6736(12)61689-4	http://dx.doi.org/10.1016/S0140-6736(12)61689-4			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245608	Green Submitted			2022-12-01	WOS:000312387000016
J	Basset, Y; Cizek, L; Cuenoud, P; Didham, RK; Guilhaumon, F; Missa, O; Novotny, V; Odegaard, F; Roslin, T; Schmidl, J; Tishechkin, AK; Winchester, NN; Roubik, DW; Aberlenc, HP; Bail, J; Barrios, H; Bridle, JR; Castano-Meneses, G; Corbara, B; Curletti, G; da Rocha, WD; de Bakker, D; Delabie, JHC; Dejean, A; Fagan, LL; Floren, A; Kitching, RL; Medianero, E; Miller, SE; de Oliveira, EG; Orivel, J; Pollet, M; Rapp, M; Ribeiro, SP; Roisin, Y; Schmidt, JB; Sorensen, L; Leponce, M				Basset, Yves; Cizek, Lukas; Cuenoud, Philippe; Didham, Raphael K.; Guilhaumon, Francois; Missa, Olivier; Novotny, Vojtech; Odegaard, Frode; Roslin, Tomas; Schmidl, Juergen; Tishechkin, Alexey K.; Winchester, Neville N.; Roubik, David W.; Aberlenc, Henri-Pierre; Bail, Johannes; Barrios, Hector; Bridle, Jon R.; Castano-Meneses, Gabriela; Corbara, Bruno; Curletti, Gianfranco; da Rocha, Wesley Duarte; de Bakker, Domir; Delabie, Jacques H. C.; Dejean, Alain; Fagan, Laura L.; Floren, Andreas; Kitching, Roger L.; Medianero, Enrique; Miller, Scott E.; de Oliveira, Evandro Gama; Orivel, Jerome; Pollet, Marc; Rapp, Mathieu; Ribeiro, Servio P.; Roisin, Yves; Schmidt, Jesper B.; Sorensen, Line; Leponce, Maurice			Arthropod Diversity in a Tropical Forest	SCIENCE			English	Article							HOST-SPECIFICITY; SPECIES RICHNESS; HERBIVOROUS INSECTS; BETA-DIVERSITY; ANT FAUNA; BIODIVERSITY	Most eukaryotic organisms are arthropods. Yet, their diversity in rich terrestrial ecosystems is still unknown. Here we produce tangible estimates of the total species richness of arthropods in a tropical rainforest. Using a comprehensive range of structured protocols, we sampled the phylogenetic breadth of arthropod taxa from the soil to the forest canopy in the San Lorenzo forest, Panama. We collected 6144 arthropod species from 0.48 hectare and extrapolated total species richness to larger areas on the basis of competing models. The whole 6000-hectare forest reserve most likely sustains 25,000 arthropod species. Notably, just 1 hectare of rainforest yields >60% of the arthropod biodiversity held in the wider landscape. Models based on plant diversity fitted the accumulated species richness of both herbivore and nonherbivore taxa exceptionally well. This lends credence to global estimates of arthropod biodiversity developed from plant models.	[Basset, Yves; Roubik, David W.] Smithsonian Trop Res Inst, Panama City, Panama; [Basset, Yves; Cizek, Lukas; Novotny, Vojtech] Univ S Bohemia, Ceske Budejovice 37005, Czech Republic; [Basset, Yves] Univ Panama, Panama City, Panama; [Cizek, Lukas; Novotny, Vojtech] Acad Sci Czech Republ, Ceske Budejovice 37005, Czech Republic; [Cuenoud, Philippe] Museum Hist Nat Ville Geneve, CH-1208 Geneva, Switzerland; [Didham, Raphael K.] Univ Western Australia, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Ecosyst Sci, Perth, WA 6009, Australia; [Guilhaumon, Francois] Univ Evora, Catedra Rui Nabeiro, P-7004516 Evora, Portugal; [Missa, Olivier] Univ York, York YO10 5DD, N Yorkshire, England; [Odegaard, Frode] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Roslin, Tomas] Univ Helsinki, FIN-00014 Helsinki, Finland; [Schmidl, Juergen; Bail, Johannes] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Tishechkin, Alexey K.] Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; [Winchester, Neville N.] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Aberlenc, Henri-Pierre] Cirad, F-34988 Montferrier Sur Lez, France; [Bridle, Jon R.] Univ Bristol, Bristol BS8 1UD, Avon, England; [Castano-Meneses, Gabriela] Univ Nacl Autonoma Mexico, Mexico City 0510, DF, Mexico; [Corbara, Bruno] Univ Blaise Pascal, F-63000 Clermont Ferrand, France; [Curletti, Gianfranco] Museo Civico Storia Nat, I-10022 Carmagnola, Italy; [da Rocha, Wesley Duarte; Delabie, Jacques H. C.] Ctr Pesquisas Cacau, BR-45600000 Itabuna, Brazil; [da Rocha, Wesley Duarte; Delabie, Jacques H. C.] Univ Estadual Santa Cruz, BR-45662900 Ilheus, Brazil; [de Bakker, Domir] Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; [Dejean, Alain] Univ Toulouse 3, F-31062 Toulouse, France; [Floren, Andreas] Univ Wurzburg, D-97070 Wurzburg, Germany; [Kitching, Roger L.] Griffith Univ, Nathan, Qld 4111, Australia; [Miller, Scott E.] Natl Museum Nat Hist, Washington, DC 20008 USA; [de Oliveira, Evandro Gama] Ctr Univ UNA, Belo Horizonte, MG, Brazil; [Orivel, Jerome] CNRS, F-97379 Kourou, France; [Pollet, Marc] Res Inst Nat & Forest, B-1070 Brussels, Belgium; [Rapp, Mathieu] Museum Hist Nat, CH-2000 Neuchatel, Switzerland; [Ribeiro, Servio P.] Univ Fed Ouro Preto, BR-35400000 Ouro Preto, MG, Brazil; [Roisin, Yves] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Schmidt, Jesper B.; Sorensen, Line] Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Universidad de Panama; Czech Academy of Sciences; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Evora; University of York - UK; Norwegian Institute Nature Research; University of Helsinki; University of Erlangen Nuremberg; University of Victoria; CIRAD; University of Bristol; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universidade Estadual de Santa Cruz; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Wurzburg; Griffith University; Smithsonian Institution; Smithsonian National Museum of Natural History; Centro Universitario UNA; Centre National de la Recherche Scientifique (CNRS); Research Institute for Nature & Forest; Universidade Federal de Ouro Preto; Universite Libre de Bruxelles	Basset, Y (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	bassety@si.edu	Guilhaumon, francois/GPX-7180-2022; Didham, Raphael K/B-5953-2011; Ribeiro, Sérvio Pontes/AAG-1146-2020; Ribeiro, Sérvio/G-1887-2012; Novotny, Vojtech/G-9434-2014; Cizek, Lukas/G-7905-2014; Roslin, Tomas/E-8648-2016; Delabie, Jacques H C/F-3405-2010; Basset, Yves F/B-6642-2014; Cizek, Lukas/K-7111-2015; Missa, Olivier/G-2687-2012; Guilhaumon, François/C-3240-2009	Guilhaumon, francois/0000-0003-4707-8932; Ribeiro, Sérvio Pontes/0000-0002-0191-8759; Ribeiro, Sérvio/0000-0002-0191-8759; Novotny, Vojtech/0000-0001-7918-8023; Cizek, Lukas/0000-0002-6447-2002; Roslin, Tomas/0000-0002-2957-4791; Delabie, Jacques H C/0000-0002-2695-1061; Basset, Yves F/0000-0002-1942-5717; Cizek, Lukas/0000-0002-6447-2002; Missa, Olivier/0000-0002-4330-5192; Roisin, Yves/0000-0001-6635-3552; Miller, Scott/0000-0002-4138-1378; Orivel, Jerome/0000-0002-5636-3228; CORBARA, Bruno/0000-0003-4232-8234; Bridle, Jonathan/0000-0002-5999-0307; Dejean, Alain/0000-0002-3561-2248	STRI; United Nations Environment Programme; Smithsonian Institution (Walcott Fund); European Science Foundation; Global Canopy Programme; SolVin-Solvay SA	STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); United Nations Environment Programme; Smithsonian Institution (Walcott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); European Science Foundation(European Science Foundation (ESF)European Commission); Global Canopy Programme; SolVin-Solvay SA	IBISCA-Panama is an initiative of Pro-Natura International, Ocean Vert, the universities Blaise Pascal and of Panama, and the Smithsonian Tropical Research Institute (STRI), with core funding from SolVin-Solvay SA, STRI, the United Nations Environment Programme, the Smithsonian Institution (Walcott Fund), the European Science Foundation, and the Global Canopy Programme. J. Herrera, E. Andrade, M. Samaniego, S. J. Wright, N. Baiben, S. Bechet, J. Belleguic, T. Aubert, K. Jordan, G. Ebersolt, D. Cleyet-Marrel, L. Pyot, O. Pascal, P. Basset, and E. Bauhaus helped with logistics in the field. A. Barba, R. Cabrera, A. Cornejo, I. Diaz, A. F. R. do Carmo, I. C. do Nascimento, E. A. dos Santos, M. Gonzalez, A. Hernandez, M. Manumbor, M. Mogia, S. Pinzon, B. Perez, L. S. Ramos-Lacau, and O. Valdez helped with initial sorting of the arthropod and plant material. Data (as of 10 May 2012) have been deposited in the Dryad repository: http://dx.doi.org/10.5061/dryad.f3p75.	Basset Y, 2001, PLANT ECOL, V153, P87, DOI 10.1023/A:1017581406101; Basset Y., 2003, ARTHROPODS TROPICAL; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamilton AJ, 2011, AM NAT, V177, P544, DOI 10.1086/659643; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Kitching Roger L., 2011, Memoirs of the Queensland Museum, V55, P235; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; May RM, 2004, PHILOS T ROY SOC B, V359, P733, DOI 10.1098/rstb.2003.1455; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2006, BIODIVERS CONSERV, V15, P83, DOI 10.1007/s10531-004-3106-5; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Strong D.R., 1984, INSECTS PLANTS COMMU; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	24	318	352	12	574	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1481	1484		10.1126/science.1226727	http://dx.doi.org/10.1126/science.1226727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239740	Green Submitted			2022-12-01	WOS:000312250800051
J	Mills, E				Mills, Evan			The Greening of Insurance	SCIENCE			English	Editorial Material							CLIMATE; RESPONSES		Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mills, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	emills@lbl.gov						Bordoff J. E., 2008, PAY AS YOU DRIVE AUT; ClimateWise, 2011, CLIMATEWISE PRINC 4; Kron W, 2012, NAT HAZARD EARTH SYS, V12, P535, DOI 10.5194/nhess-12-535-2012; Leggett J., 1993, EUROPEAN ENV, V3, P3; Lloyd's, 2006, CLIM CHANG AD BUST, V360; Lloyd's, 2008, DIR DOCK; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Mills E, 2005, SCIENCE, V309, P1040, DOI 10.1126/science.1112121; Mills E., 1996, J SOC INSUR RES, V1996, P15; Mills E, 2012, B ATOM SCI, V68, P67, DOI 10.1177/0096340212464362; Mills E, 2009, GENEVA PAP R I-ISS P, V34, P323, DOI 10.1057/gpp.2009.14; Munich Reinsurance Co, 1973, FLOOD IN; Patton L., 2008, EUR BUS REV, V2008, P3005; Phelan L, 2011, ENVIRON POLICY GOV, V21, P112, DOI 10.1002/eet.565; Schmidt S, 2009, ENVIRON IMPACT ASSES, V29, P359, DOI 10.1016/j.eiar.2009.03.003; Swiss Reinsurance Co, 2011, HIDD RISK CLIM CHANG; Swiss Reinsurance Co, 2012, WORLD INS 2011; Tran S. M., 2008, J SCI TECHNOL LAW, V14, P73	18	35	35	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1424	1425		10.1126/science.1229351	http://dx.doi.org/10.1126/science.1229351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053DN	23239720				2022-12-01	WOS:000312250800031
J	Rincon-Arano, H; Halow, J; Delrow, JJ; Parkhurst, SM; Groudine, M				Rincon-Arano, Hector; Halow, Jessica; Delrow, Jeffrey J.; Parkhurst, Susan M.; Groudine, Mark			UpSET Recruits HDAC Complexes and Restricts Chromatin Accessibility and Acetylation at Promoter Regions	CELL			English	Article							SET-DOMAIN PROTEIN; RNA-POLYMERASE-II; NUCLEOSOME ORGANIZATION; DROSOPHILA GENOME; INACTIVE GENES; IN-VIVO; MLL5; METHYLTRANSFERASE; METHYLATION; H3K4	Developmental gene expression results from the orchestrated interplay between genetic and epigenetic mechanisms. Here, we describe upSET, a transcriptional regulator encoding a SET domain-containing protein recruited to active and inducible genes in Drosophila. However, unlike other Drosophila SET proteins associated with gene transcription, UpSET is part of an Rpd3/Sin3-containing complex that restricts chromatin accessibility and histone acetylation to promoter regions. In the absence of UpSET, active chromatin marks and chromatin accessibility increase and spread to genic and flanking regions due to destabilization of the histone deacetylase complex. Consistent with this, transcriptional noise increases, as manifest by activation of repetitive elements and off-target genes. Interestingly, upSET mutant flies are female sterile due to upregulation of key components of Notch signaling during oogenesis. Thus UpSET defines a class of metazoan transcriptional regulators required to fine tune transcription by preventing the spread of active chromatin.	[Rincon-Arano, Hector; Halow, Jessica; Parkhurst, Susan M.; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Groudine, Mark] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Groudine, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	markg@fhcrc.org	Halow, Jessica/GQO-7562-2022	Parkhurst, Susan/0000-0001-5806-9930	NIH [GM073021, GM097083, DK44746, HL65440]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746, R01DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073021, R01GM097083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jorja Henikoff, Steve Henikoff, and Galina Filippova for their interest, advice and comments on the manuscript. We thank Jorja Henikoff, Ryan Basom and Janet Young for bioinformatic help. We also thank Erika Bach, Al Courey, Barry Honda, Steven Hou, Lori Pile, Liz Wayner, the Harvard Exelixis Collection, the Bloomington/Kyoto Stock Centers, and the Developmental Studies Hybridoma Bank for antibodies, flies and other reagents used in this study. This work was supported by NIH grants GM073021 and GM097083 (to SMP) and DK44746 and HL65440 (to MG).	Abed M, 2009, METHODS MOL BIOL, V567, P155, DOI 10.1007/978-1-60327-414-2_11; Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Hallson G, 2012, GENETICS, V190, P91, DOI 10.1534/genetics.111.135863; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; KAMINKER JS, 2002, GENOME BIOL, V0003; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	46	38	40	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1214	1228		10.1016/j.cell.2012.11.009	http://dx.doi.org/10.1016/j.cell.2012.11.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23177352	Green Accepted, Bronze			2022-12-01	WOS:000311999900012
J	Curtis, BA; Tanifuji, G; Burki, F; Gruber, A; Irimia, M; Maruyama, S; Arias, MC; Ball, SG; Gile, GH; Hirakawa, Y; Hopkins, JF; Kuo, A; Rensing, SA; Schmutz, J; Symeonidi, A; Elias, M; Eveleigh, RJM; Herman, EK; Klute, MJ; Nakayama, T; Obornik, M; Reyes-Prieto, A; Armbrust, EV; Aves, SJ; Beiko, RG; Coutinho, P; Dacks, JB; Durnford, DG; Fast, NM; Green, BR; Grisdale, CJ; Hempel, F; Henrissat, B; Hoppner, MP; Ishida, KI; Kim, E; Koreny, LK; Kroth, PG; Liu, Y; Malik, SB; Maier, UG; McRose, D; Mock, T; Neilson, JAD; Onodera, NT; Poole, AM; Pritham, EJ; Richards, TA; Rocap, G; Roy, SW; Sarai, C; Schaack, S; Shirato, S; Slamovits, CH; Spencer, DF; Suzuki, S; Worden, AZ; Zauner, S; Barry, K; Bell, C; Bharti, AK; Crow, JA; Grimwood, J; Kramer, R; Lindquist, E; Lucas, S; Salamov, A; McFadden, GI; Lane, CE; Keeling, PJ; Gray, MW; Grigoriev, IV; Archibald, JM				Curtis, Bruce A.; Tanifuji, Goro; Burki, Fabien; Gruber, Ansgar; Irimia, Manuel; Maruyama, Shinichiro; Arias, Maria C.; Ball, Steven G.; Gile, Gillian H.; Hirakawa, Yoshihisa; Hopkins, Julia F.; Kuo, Alan; Rensing, Stefan A.; Schmutz, Jeremy; Symeonidi, Aikaterini; Elias, Marek; Eveleigh, Robert J. M.; Herman, Emily K.; Klute, Mary J.; Nakayama, Takuro; Obornik, Miroslav; Reyes-Prieto, Adrian; Armbrust, E. Virginia; Aves, Stephen J.; Beiko, Robert G.; Coutinho, Pedro; Dacks, Joel B.; Durnford, Dion G.; Fast, Naomi M.; Green, Beverley R.; Grisdale, Cameron J.; Hempel, Franziska; Henrissat, Bernard; Hoeppner, Marc P.; Ishida, Ken-Ichiro; Kim, Eunsoo; Koreny, Lude. K.; Kroth, Peter G.; Liu, Yuan; Malik, Shehre-Banoo; Maier, Uwe G.; McRose, Darcy; Mock, Thomas; Neilson, Jonathan A. D.; Onodera, Naoko T.; Poole, Anthony M.; Pritham, Ellen J.; Richards, Thomas A.; Rocap, Gabrielle; Roy, Scott W.; Sarai, Chihiro; Schaack, Sarah; Shirato, Shu; Slamovits, Claudio H.; Spencer, David F.; Suzuki, Shigekatsu; Worden, Alexandra Z.; Zauner, Stefan; Barry, Kerrie; Bell, Callum; Bharti, Arvind K.; Crow, John A.; Grimwood, Jane; Kramer, Robin; Lindquist, Erika; Lucas, Susan; Salamov, Asaf; McFadden, Geoffrey I.; Lane, Christopher E.; Keeling, Patrick J.; Gray, Michael W.; Grigoriev, Igor V.; Archibald, John M.			Algal genomes reveal evolutionary mosaicism and the fate of nucleomorphs	NATURE			English	Article							GENE-TRANSFER; NUCLEUS; CHLORARACHNIOPHYTE; PROTEINS; SEQUENCE; GREEN; RED; CRYPTOPHYTES; EUKARYOTES; HISTORY	Cryptophyte and chlorarachniophyte algae are transitional forms in the widespread secondary endosymbiotic acquisition of photosynthesis by engulfment of eukaryotic algae. Unlike most secondary plastid-bearing algae, miniaturized versions of the endosymbiont nuclei (nucleomorphs) persist in cryptophytes and chlorarachniophytes. To determine why, and to address other fundamental questions about eukaryote-eukaryote endosymbiosis, we sequenced the nuclear genomes of the cryptophyte Guillardia theta and the chlorarachniophyte Bigelowiella natans. Both genomes have >21,000 protein genes and are intron rich, and B. natans exhibits unprecedented alternative splicing for a single-celled organism. Phylogenomic analyses and subcellular targeting predictions reveal extensive genetic and biochemical mosaicism, with both host-and endosymbiont-derived genes servicing the mitochondrion, the host cell cytosol, the plastid and the remnant endosymbiont cytosol of both algae. Mitochondrion-to-nucleus gene transfer still occurs in both organisms but plastid-to-nucleus and nucleomorph-to-nucleus transfers do not, which explains why a small residue of essential genes remains locked in each nucleomorph.	[Curtis, Bruce A.; Tanifuji, Goro; Maruyama, Shinichiro; Gile, Gillian H.; Hopkins, Julia F.; Eveleigh, Robert J. M.; Malik, Shehre-Banoo; Onodera, Naoko T.; Slamovits, Claudio H.; Spencer, David F.; Grigoriev, Igor V.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Curtis, Bruce A.; Tanifuji, Goro; Maruyama, Shinichiro; Nakayama, Takuro; Onodera, Naoko T.; Spencer, David F.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada; [Curtis, Bruce A.; Tanifuji, Goro; Burki, Fabien; Maruyama, Shinichiro; Nakayama, Takuro; Reyes-Prieto, Adrian] Univ British Columbia, Integrated Microbial Biodivers Program, Canadian Inst Adv Res, Vancouver, BC V6T 1Z4, Canada; [Burki, Fabien; Hirakawa, Yoshihisa] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Gruber, Ansgar] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Irimia, Manuel] Univ Toronto, Dept Med Res, Toronto, ON M5S 3E1, Canada; [Arias, Maria C.; Ball, Steven G.] Banting & Best Sci & Technol Lille, F-59655 Villeneuve Dascq, France; [Kuo, Alan] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rensing, Stefan A.; Schmutz, Jeremy] Univ Freiburg, Fac Biol, D-79085 Freiburg, Germany; [Schmutz, Jeremy] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Elias, Marek] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic; [Eveleigh, Robert J. M.] Genome Quebec, Montreal, PQ H3A 1A4, Canada; [Herman, Emily K.; Klute, Mary J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Obornik, Miroslav] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Univ S Bohemia, Biol Ctr, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Reyes-Prieto, Adrian] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 5A3, Canada; [Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Aves, Stephen J.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 4R2, Canada; [Coutinho, Pedro] Aix Marseille Univ, CNRS UMR 7257, F-13228 Marseille, France; [Hempel, Franziska] LOEWE Zentrum Synthet Mikrobiol Synmikro, D-35032 Marburg, Germany; [Hoeppner, Marc P.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Ishida, Ken-Ichiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kim, Eunsoo] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Liu, Yuan] Nat Hist Museum, London SW7 5BD, England; [McRose, Darcy] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Pritham, Ellen J.] Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Roy, Scott W.] San Francisco State Univ, San Francisco, CA 94132 USA; [Schaack, Sarah] Reed Coll, Portland, OR 97202 USA; [Kramer, Robin] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Lane, Christopher E.] Univ Rhode Isl, Kingston, RI 02881 USA	Dalhousie University; Dalhousie University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of British Columbia; University of Konstanz; University of Toronto; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Freiburg; HudsonAlpha Institute for Biotechnology; University of Ostrava; University of Alberta; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of New Brunswick; University of Washington; University of Washington Seattle; University of Exeter; Dalhousie University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; University of Tsukuba; American Museum of Natural History (AMNH); Natural History Museum London; Monterey Bay Aquarium Research Institute; University of East Anglia; University of Canterbury; California State University System; San Francisco State University; Reed College - Oregon; National Center for Genome Resources (NCGR); University of Melbourne; University of Rhode Island	Archibald, JM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.	john.archibald@dal.ca	Henrissat, Bernard/J-2475-2012; Dacks, Joel/AAE-3308-2021; Mock, Thomas/A-3127-2008; Kroth, Peter G/A-9728-2008; Obornik, Miroslav/G-9350-2014; Elias, Marek/D-6851-2014; Maruyama, Shinichiro/AAO-4764-2021; Slamovits, Claudio/E-2591-2011; Barry, Kerrie Whitelaw/AAA-5500-2020; Koreny, Ludek/G-9766-2014; NAKAYAMA, Takuro/AAT-9444-2020; McFadden, Geoffrey McFadden I/F-7667-2014; Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; Arias, Maria Cecilia/H-4886-2012; Hirakawa, Yoshihisa/A-6119-2012; Worden, Alexandra Z./AAD-6567-2019; Irimia, Manuel/E-3040-2010; Tanifuji, Goro/O-9172-2015; Green, Beverley R./AAJ-5199-2021; Burki, Fabien/F-4818-2010; Gruber, Ansgar/B-9587-2008	Henrissat, Bernard/0000-0002-3434-8588; Dacks, Joel/0000-0003-4520-5694; Mock, Thomas/0000-0001-9604-0362; Kroth, Peter G/0000-0003-4734-8955; Elias, Marek/0000-0003-0066-6542; Slamovits, Claudio/0000-0003-3050-1474; Barry, Kerrie Whitelaw/0000-0002-8999-6785; NAKAYAMA, Takuro/0000-0001-5135-0156; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Schmutz, Jeremy/0000-0001-8062-9172; Irimia, Manuel/0000-0002-2179-2567; Green, Beverley R./0000-0002-4021-9387; Gruber, Ansgar/0000-0002-5876-4391; Keeling, Patrick/0000-0002-7644-0745; Richards, Thomas/0000-0002-9692-0973; Aves, Stephen/0000-0002-5600-900X; Worden, Alexandra/0000-0002-9888-9324; Malik, Shehre-Banoo/0000-0003-0833-0648; McRose, Darcy/0000-0001-9637-7176; Rocap, Gabrielle/0000-0001-7253-611X; Grigoriev, Igor/0000-0002-3136-8903; Ball, Steven/0000-0003-1629-1650; Poole, Anthony/0000-0001-9940-2824; Hirakawa, Yoshihisa/0000-0002-3780-354X; Grisdale, Cameron/0000-0003-1923-6972; Koreny, Ludek/0000-0002-9979-3172; Gray, Michael/0000-0001-7125-2625; Burki, Fabien/0000-0002-8248-8462	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Natural Sciences and Engineering Research Council of Canada; BBSRC [BB/G00885X/2, BB/G00885X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00885X/2, BB/G00885X/1] Funding Source: researchfish; Alberta Innovates [201001324] Funding Source: researchfish	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alberta Innovates	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. RNA-seq data used in the paper were generated by the National Center for Genome Resources as part of the Gordon and Betty Moore Foundation's Marine Microbial Eukaryote Transcriptome Project. B. A. C. and J.F.H. were supported by a Special Research Opportunities Grant from the Natural Sciences and Engineering Research Council of Canada awarded to J.M.A. and M. W. G. J.M.A., P.J.K., M. W. G. and C. H. S. are members of the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. G. I. M. is an Australian Research Council Federation Fellow and a Howard Hughes International Scholar. We thank R. A. Andersen (Bigelow Laboratories) for assistance with single-cell isolations, C. X. Chan for a tree-sorting PERL script, H. Gutierrez for help with SM protein family annotation, and B. Read for permission to analyse the Emiliania huxleyi genome sequenced by the JGI.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Burki F, 2012, GENOME BIOL EVOL, V4, P738, DOI 10.1093/gbe/evs049; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Curtis BA, 2010, CURR BIOL, V20, pR919, DOI 10.1016/j.cub.2010.09.038; Deschamps P, 2006, EUKARYOT CELL, V5, P954, DOI 10.1128/EC.00380-05; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Gile GH, 2008, MOL BIOL EVOL, V25, P1967, DOI 10.1093/molbev/msn147; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; HILL DRA, 1986, PHYCOLOGIA, V25, P521, DOI 10.2216/i0031-8884-25-4-521.1; Hirakawa Y, 2011, MOL MICROBIOL, V80, P1439, DOI 10.1111/j.1365-2958.2011.07643.x; Hirakawa Y, 2010, MOL BIOL EVOL, V27, P1538, DOI 10.1093/molbev/msq038; Irimia M, 2008, MOL BIOL EVOL, V25, P375, DOI 10.1093/molbev/msm262; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kugrens Paul, 2003, P715, DOI 10.1016/B978-012741550-5/50022-2; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; McFadden G. I., 1997, Phycological Research, V45, P145, DOI 10.1111/j.1440-1835.1997.tb00087.x; Moog D, 2011, GENOME BIOL EVOL, V3, P375, DOI 10.1093/gbe/evr031; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Ota S, 2011, PHYCOLOGIA, V50, P317, DOI 10.2216/09-102.1; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr068, 10.1093/gbe/evr001]; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Stiller JW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-484; Tanifuji G, 2011, GENOME BIOL EVOL, V3, P44, DOI 10.1093/gbe/evq082; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	50	263	270	1	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					59	65		10.1038/nature11681	http://dx.doi.org/10.1038/nature11681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201678	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-01	WOS:000311893400045
J	Wehrwein, P				Wehrwein, Peter			STEM CELLS Repeat to fade	NATURE			English	Editorial Material																		Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2011, AGING-US, V3, P555, DOI 10.18632/aging.100333; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	7	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S12	S13		10.1038/492S12a	http://dx.doi.org/10.1038/492S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222667	Bronze			2022-12-01	WOS:000311893400007
J	Okuda, S; Freinkman, E; Kahne, D				Okuda, Suguru; Freinkman, Elizaveta; Kahne, Daniel			Cytoplasmic ATP Hydrolysis Powers Transport of Lipopolysaccharide Across the Periplasm in E-coli	SCIENCE			English	Article							OUTER-MEMBRANE; INNER-MEMBRANE; GENETIC-CODE; FUNCTIONAL-ANALYSIS; PROTEIN COMPLEX; CELL-ENVELOPE; IDENTIFICATION; MECHANISM; SURFACE; EXPORT	Millions of molecules of lipopolysaccharide (LPS) must be assembled on the Escherichia coli cell surface each time the cell divides. The biogenesis of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane through the periplasm to the cell surface. However, no intermediate transport states have been observed. We developed methods to observe intermediate LPS molecules bound to Lpt proteins in the process of being transported in vivo. Movement of individual LPS molecules along these binding sites required multiple rounds of adenosine triphosphate (ATP) hydrolysis in vitro, which suggests that ATP is used to push a continuous stream of LPS through a transenvelope bridge in discrete steps against a concentration gradient.	[Okuda, Suguru; Freinkman, Elizaveta; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Okuda, Suguru/K-6571-2017	Okuda, Suguru/0000-0002-9184-5601	NIH [AI081059, GM066174]; Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The plasmid pSup-BpaRS-6TRN was a gift from P. G. Schultz (Scripps Research Institute). We thank C. Hagan for valuable discussion. Supported by NIH grants AI081059 and GM066174 (D.K.) and a Fannie and John Hertz Foundation graduate fellowship (E.F.).	Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Kaback H., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; KIM YJ, 1994, CELL, V78, P845; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576	27	139	141	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1214	1217		10.1126/science.1228984	http://dx.doi.org/10.1126/science.1228984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23138981	Green Accepted			2022-12-01	WOS:000311666200047
J	Shepherd, A; Ivins, ER; Geruo, A; Barletta, VR; Bentley, MJ; Bettadpur, S; Briggs, KH; Bromwich, DH; Forsberg, R; Galin, N; Horwath, M; Jacobs, S; Joughin, I; King, MA; Lenaerts, JTM; Li, JL; Ligtenberg, SRM; Luckman, A; Luthcke, SB; McMillan, M; Meister, R; Milne, G; Mouginot, J; Muir, A; Nicolas, JP; Paden, J; Payne, AJ; Pritchard, H; Rignot, E; Rott, H; Sorensen, LS; Scambos, TA; Scheuchl, B; Schrama, EJO; Smith, B; Sundal, AV; van Angelen, JH; van de Berg, WJ; van den Broeke, MR; Vaughan, DG; Velicogna, I; Wahr, J; Whitehouse, PL; Wingham, DJ; Yi, DH; Young, D; Zwally, HJ				Shepherd, Andrew; Ivins, Erik R.; Geruo, A.; Barletta, Valentina R.; Bentley, Mike J.; Bettadpur, Srinivas; Briggs, Kate H.; Bromwich, David H.; Forsberg, Rene; Galin, Natalia; Horwath, Martin; Jacobs, Stan; Joughin, Ian; King, Matt A.; Lenaerts, Jan T. M.; Li, Jilu; Ligtenberg, Stefan R. M.; Luckman, Adrian; Luthcke, Scott B.; McMillan, Malcolm; Meister, Rakia; Milne, Glenn; Mouginot, Jeremie; Muir, Alan; Nicolas, Julien P.; Paden, John; Payne, Antony J.; Pritchard, Hamish; Rignot, Eric; Rott, Helmut; Sorensen, Louise Sandberg; Scambos, Ted A.; Scheuchl, Bernd; Schrama, Ernst J. O.; Smith, Ben; Sundal, Aud V.; van Angelen, Jan H.; van de Berg, Willem J.; van den Broeke, Michiel R.; Vaughan, David G.; Velicogna, Isabella; Wahr, John; Whitehouse, Pippa L.; Wingham, Duncan J.; Yi, Donghui; Young, Duncan; Zwally, H. Jay			A Reconciled Estimate of Ice-Sheet Mass Balance	SCIENCE			English	Article							PINE ISLAND GLACIER; RELATIVE SEA-LEVEL; ISOSTATIC-ADJUSTMENT; ANTARCTIC PENINSULA; WEST ANTARCTICA; GREENLAND; MODEL; CLIMATE; SURFACE; SHELF	We combined an ensemble of satellite altimetry, interferometry, and gravimetry data sets using common geographical regions, time intervals, and models of surface mass balance and glacial isostatic adjustment to estimate the mass balance of Earth's polar ice sheets. We find that there is good agreement between different satellite methods-especially in Greenland and West Antarctica-and that combining satellite data sets leads to greater certainty. Between 1992 and 2011, the ice sheets of Greenland, East Antarctica, West Antarctica, and the Antarctic Peninsula changed in mass by -142 +/- 49, +14 +/- 43, -65 +/- 26, and -20 +/- 14 gigatonnes year(-1), respectively. Since 1992, the polar ice sheets have contributed, on average, 0.59 +/- 0.20 millimeter year(-1) to the rate of global sea-level rise.	[Shepherd, Andrew; Briggs, Kate H.; Sundal, Aud V.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Ivins, Erik R.; Velicogna, Isabella] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Geruo, A.; Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Barletta, Valentina R.; Forsberg, Rene; Sorensen, Louise Sandberg] Tech Univ Denmark, DTU SPACE, Geodynam Dept, Natl Space Inst, DK-2880 Lyngby, Denmark; [Bentley, Mike J.; Whitehouse, Pippa L.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Bettadpur, Srinivas] Univ Texas Austin, Ctr Space Res, Austin, TX 78759 USA; [Bromwich, David H.; Nicolas, Julien P.] Ohio State Univ, Byrd Polar Res Ctr, Polar Meteorol Grp, Columbus, OH 43210 USA; [Bromwich, David H.; Nicolas, Julien P.] Ohio State Univ, Dept Geog, Atmospher Sci Program, Columbus, OH 43210 USA; [Galin, Natalia; Meister, Rakia; Muir, Alan; Wingham, Duncan J.] UCL, Dept Earth Sci, Ctr Polar Observat & Modelling, London WC1E 6BT, England; [Horwath, Martin] Tech Univ Munich, Inst Astron & Phys Geodasie, D-80333 Munich, Germany; [Jacobs, Stan] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Joughin, Ian; Smith, Ben] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [King, Matt A.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lenaerts, Jan T. M.; Ligtenberg, Stefan R. M.; van Angelen, Jan H.; van de Berg, Willem J.; van den Broeke, Michiel R.] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [Li, Jilu; Paden, John] Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; [Luckman, Adrian] Swansea Univ, Coll Sci, Dept Geog, Swansea SA2 8PP, W Glam, Wales; [Luthcke, Scott B.] NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Greenbelt, MD 20771 USA; [Milne, Glenn] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Mouginot, Jeremie; Rignot, Eric; Velicogna, Isabella] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Payne, Antony J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Pritchard, Hamish; Vaughan, David G.] British Antarctic Survey, Cambridge CB3 0ET, England; [Rott, Helmut] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Scambos, Ted A.] Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Schrama, Ernst J. O.] Delft Univ Technol, Fac Aerosp Engn, NL-2629 HS Delft, Netherlands; [Yi, Donghui] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, SGT Inc, Greenbelt, MD 20771 USA; [Young, Duncan] Univ Texas Austin, Inst Geophys, Austin, TX 78759 USA; [Zwally, H. Jay] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, Greenbelt, MD 20771 USA; [King, Matt A.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia	University of Leeds; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; Technical University of Denmark; Durham University; University of Texas System; University of Texas Austin; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of London; University College London; Technical University of Munich; Columbia University; University of Washington; University of Washington Seattle; Newcastle University - UK; Utrecht University; University of Kansas; Swansea University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Ottawa; University of California System; University of California Irvine; University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Innsbruck; University of Colorado System; University of Colorado Boulder; Delft University of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stinger Ghaffarian Technologies, Inc. (SGT); University of Texas System; University of Texas Austin; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Tasmania	Shepherd, A (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	ashepherd@leeds.ac.uk; erik.r.ivins@jpl.nasa.gov	Pritchard, Hamish Daniel/AAU-4696-2021; Vaughan, David/C-8348-2011; Rignot, Eric/A-4560-2014; Luckman, Adrian/GVS-1716-2022; Joughin, Ian R/A-2998-2008; McMillan, Malcolm/K-7712-2014; King, Matt/B-4622-2008; Joughin, Ian/AAR-7778-2021; van de Berg, Willem Jan/H-4385-2011; Horwath, Martin/ABH-4320-2020; Velicogna, Isabella/R-5561-2018; Bromwich, David/C-9225-2016; Bettadpur, Srinivas/M-3744-2014; Van den Broeke, Michiel R./F-7867-2011; Mouginot, Jeremie/G-7045-2015; Lenaerts, Jan/D-9423-2012; Horwath, Martin/F-9239-2011; Young, Duncan A./G-6256-2010; Luthcke, Scott B/D-6283-2012; Sørensen, Louise Sandberg/E-5282-2014; payne, antony/A-8916-2008; A, Geruo/AAP-3565-2020; Bentley, Michael J/F-7386-2011; Ligtenberg, Stefan/AAF-8290-2020	Rignot, Eric/0000-0002-3366-0481; Joughin, Ian R/0000-0001-6229-679X; King, Matt/0000-0001-5611-9498; Joughin, Ian/0000-0001-6229-679X; van de Berg, Willem Jan/0000-0002-8232-2040; Velicogna, Isabella/0000-0002-9020-1898; Van den Broeke, Michiel R./0000-0003-4662-7565; Mouginot, Jeremie/0000-0001-9155-5455; Lenaerts, Jan/0000-0003-4309-4011; Horwath, Martin/0000-0001-5797-244X; Young, Duncan A./0000-0002-6866-8176; Sørensen, Louise Sandberg/0000-0002-3771-4061; payne, antony/0000-0001-8825-8425; A, Geruo/0000-0001-5714-402X; Bentley, Michael J/0000-0002-2048-0019; Vaughan, David/0000-0002-9065-0570; Yi, Donghui/0000-0001-6363-5538; Shepherd, Andrew/0000-0002-4914-1299; Whitehouse, Pippa/0000-0002-9092-3444; Bettadpur, Srinivas/0000-0003-3885-2228; Forsberg, Rene/0000-0002-7288-9545; Luckman, Adrian/0000-0002-9618-5905; McMillan, Malcolm/0000-0002-5113-0177; Muir, Alan/0000-0001-7754-088X; SCHRAMA, ERNST/0000-0002-9654-4082; Barletta, Valentina Roberta/0000-0003-4427-0830	Phillip Leverhulme Prize award; European Union [125]; NASA [NNX09AE47G, NNX08AD64G]; Netherlands Organization for Scientific Research; Netherlands Polar Program; UK Natural Environment Research Council; NSF; Lamont Doherty Earth Observatory; NERC [cpom20001, NE/E004806/1, NE/I010874/1, NE/E007023/1, NE/F014260/1, NE/E014089/1] Funding Source: UKRI; Natural Environment Research Council [NE/E014089/1, NE/E007023/1, NE/E004806/1, NE/F014260/1, bas0100027, cpom20001, earth010006, NE/I010874/1] Funding Source: researchfish	Phillip Leverhulme Prize award; European Union(European Commission); NASA(National Aeronautics & Space Administration (NASA)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Polar Program; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Lamont Doherty Earth Observatory; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This Ice Sheet Mass Balance Exercise (IMBIE) was facilitated by the European Space Agency and NASA and by a Phillip Leverhulme Prize awarded to A. S. The work was additionally supported by the European Union Framework Programme 7 ice2sea program (ice2sea publication 125), the Lamont Doherty Earth Observatory, NASA (grants NNX09AE47G and NNX08AD64G), the Netherlands Organization for Scientific Research, the Netherlands Polar Program, the UK Natural Environment Research Council, and the NSF. Antarctic glacier ice thickness data used in the IOM calculations were acquired by NASA IceBridge and the Centro de Estudios Cientifico Chile, and additional estimates were provided by J. Bamber and J. Griggs. E. van Meijgaard provided assistance with the RACMO model.	Ackert RP, 2011, EARTH PLANET SC LETT, V307, P83, DOI 10.1016/j.epsl.2011.04.015; Berthier E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051755; Bevis M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002642; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Chen JL, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007789; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Ettema J, 2010, CRYOSPHERE, V4, P511, DOI 10.5194/tc-4-511-2010; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fettweis X, 2011, CRYOSPHERE, V5, P359, DOI 10.5194/tc-5-359-2011; Fleming K, 2004, QUATERNARY SCI REV, V23, P1053, DOI 10.1016/j.quascirev.2003.11.001; Giovinetto MB, 2000, ANN GLACIOL-SER, V31, P171, DOI 10.3189/172756400781820200; Gogineni S, 2001, J GEOPHYS RES-ATMOS, V106, P33761, DOI 10.1029/2001JD900183; Goodwin I., 2003, J GEOPHYS RES, V108, P16; Gunter B, 2009, J GEODESY, V83, P1051, DOI 10.1007/s00190-009-0323-4; Hein AS, 2011, EARTH PLANET SC LETT, V307, P211, DOI 10.1016/j.epsl.2011.04.037; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Ivins ER, 2005, ANTARCT SCI, V17, P541, DOI 10.1017/S0954102005002968; Ivins ER, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007607; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/ngeo1188, 10.1038/NGEO1188]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Krinner G, 2007, CLIM DYNAM, V28, P215, DOI 10.1007/s00382-006-0177-x; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016145; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Li J, 2011, ANN GLACIOL, V52, P1, DOI 10.3189/172756411799096321; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI [10.1038/ngeo1061, 10.1038/NGEO1061]; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Munneke PK, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015113; OHMURA A, 1991, J GLACIOL, V37, P140; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Riva REM, 2009, EARTH PLANET SC LETT, V288, P516, DOI 10.1016/j.epsl.2009.10.013; Rott H, 2011, CRYOSPHERE, V5, P125, DOI 10.5194/tc-5-125-2011; Rott H, 1996, SCIENCE, V271, P788, DOI 10.1126/science.271.5250.788; Schrama EJO, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2009JB006847; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; Shuman CA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025227; Simpson MJR, 2009, QUATERNARY SCI REV, V28, P1631, DOI 10.1016/j.quascirev.2009.03.004; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tarasov L, 2002, GEOPHYS J INT, V150, P198, DOI 10.1046/j.1365-246X.2002.01702.x; Tedesco M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014005; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Todd C, 2010, QUATERNARY SCI REV, V29, P1328, DOI 10.1016/j.quascirev.2010.02.001; Turner J., 2009, ANTARCTIC CLIMATE CH; Uotila P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007482; van de Berg W. J., 2008, THESIS UTRECHT U UTR; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van Meijgaard E., 2008, KNMI REGIONAL ATMOSP; Vaughan DG, 1999, J CLIMATE, V12, P933, DOI 10.1175/1520-0442(1999)012<0933:RONSMB>2.0.CO;2; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Wahr J, 2000, J GEOPHYS RES-SOL EA, V105, P16279, DOI 10.1029/2000JB900113; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wingham DJ, 2006, PHILOS T R SOC A, V364, P1627, DOI 10.1098/rsta.2006.1792; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Wingham DJ, 1998, SCIENCE, V282, P456, DOI 10.1126/science.282.5388.456; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682; ZWALLY HJ, 1989, SCIENCE, V246, P1587, DOI 10.1126/science.246.4937.1587; [No title captured]	93	990	1008	15	588	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1183	1189		10.1126/science.1228102	http://dx.doi.org/10.1126/science.1228102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197528	Green Submitted			2022-12-01	WOS:000311666200039
J	Hernandez, AF; Mi, XJ; Hammill, BG; Hammill, SC; Heidenreich, PA; Masoudi, FA; Qualls, LG; Peterson, ED; Fonarow, GC; Curtis, LH				Hernandez, Adrian F.; Mi, Xiaojuan; Hammill, Bradley G.; Hammill, Stephen C.; Heidenreich, Paul A.; Masoudi, Frederick A.; Qualls, Laura G.; Peterson, Eric D.; Fonarow, Gregg C.; Curtis, Lesley H.			Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CLINICAL-TRIALS; OLDER PATIENTS; SPIRONOLACTONE; HYPERKALEMIA; STATES; RATES; CARE	Context Aldosterone antagonist therapy for heart failure and reduced ejection fraction has been highly efficacious in randomized trials. However, questions remain regarding the effectiveness and safety of the therapy in clinical practice. Objective To examine the clinical effectiveness of newly initiated aldosterone antagonist therapy among older patients hospitalized with heart failure and reduced ejection fraction. Design, Setting, and Participants Using clinical registry data linked to Medicare claims from 2005 through 2010, we examined outcomes of eligible patients hospitalized with heart failure and reduced ejection fraction. We used Cox proportional hazards models and inverse-weighted estimates of the probability of treatment to adjust for treatment selection bias. Main Outcome Measures All-cause mortality, cardiovascular readmission, and heart failure readmission at 3 years, and hyperkalemia readmission at 30 days and 1 year. Results Among 5887 patients who met the inclusion criteria, the mean age was 77.6 years; of those 1070 (18.2%) started aldosterone antagonist therapy at discharge. Cumulative incidence rates among treated and untreated patients were 49.9% vs 51.2% (P=.62) for mortality; 63.8% vs 63.9% (P=.65) for cardiovascular readmission; and 38.7% vs 44.9% (P<.001) for heart failure readmission at 3 years; and 2.9% vs 1.2% (P<.001) for hyperkalemia readmission within 30 days and 8.9% vs 6.3% (P=.002) within 1 year. After inverse weighting for the probability of treatment, there were no significant differences in mortality (hazard ratio [HR], 1.04; 95% CI, 0.96-1.14; P=.32) and cardiovascular readmission (HR, 1.00; 95% CI, 0.91-1.09; P=.94). Heart failure readmission was lower among treated patients at 3 years (HR, 0.87; 95% CI, 0.77-0.98; P=.02). Readmission associated with hyperkalemia was higher with aldosterone antagonist therapy at 30 days (HR, 2.54; 95% CI, 1.51-4.29; P<.001) and 1 year (HR, 1.50; 95% CI, 1.23-1.84; P<.001). Conclusions Initiation of aldosterone antagonist therapy at hospital discharge was not independently associated with improved mortality or cardiovascular readmission but was associated with improved heart failure readmission among eligible older patients with heart failure and reduced ejection fraction. There was a significant increase in the risk of readmission with hyperkalemia, predominantly within 30 days after discharge. JAMA. 2012;308(20):2097-2107 www.jama.com	[Hernandez, Adrian F.; Mi, Xiaojuan; Qualls, Laura G.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Heidenreich, Paul A.] VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Masoudi, Frederick A.] Univ Colorado Anschutz Med Campus, Aurora, CO USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA	Duke University; Duke University; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021; Masoudi, Frederick/Q-7467-2019; Hernandez, Adrian F/A-7818-2016; Heidenreich, Paul/AAU-6864-2021	Fonarow, Gregg C/0000-0002-3192-8093; Hernandez, Adrian F/0000-0003-3387-9616; Heidenreich, Paul/0000-0001-7730-8490	Amylin Pharmaceutical; Johnson Johnson; American College of Cardiology; Oklahoma Foundation for Medical Quality; American Heart Association; Massachusetts Medical Society; Eli Lilly Co; GlaxoSmithKline; Ahmanson Foundation; National Heart, Lung, and Blood Institute; (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA29020050032I]; Agency for Healthcare Research and Quality [U19HS021092]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021092] Funding Source: NIH RePORTER	Amylin Pharmaceutical(Bristol-Myers Squibb); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); American College of Cardiology(General Electric); Oklahoma Foundation for Medical Quality; American Heart Association(American Heart Association); Massachusetts Medical Society; Eli Lilly Co(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Ahmanson Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hernandez reported receiving grant funding from Amylin Pharmaceutical and Johnson & Johnson; and receiving honoraria from AstraZeneca, Corthera, and sanofi-aventis. Dr Masoudi reported receiving salary support through his institution from the American College of Cardiology and the Oklahoma Foundation for Medical Quality; and receiving payment for editorial board service from the American Heart Association and the Massachusetts Medical Society. Dr Peterson reported receiving grant funding from Eli Lilly& Co and Johnson & Johnson. Dr Fonarow reported receiving grant funding and other research support from GlaxoSmithKline; receiving honoraria from Boston Scientific/Guidant, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, and St Jude Medical; and serving as a consultant for Amgen, Gambro, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Relypsa, Scios, and St Jude Medical. Dr Fonarow holds the Eliot Corday Chair of Cardiovascular Medicine at UCLA and is also supported by the Ahmanson Foundation. Dr Curtis reported receiving grant funding from GlaxoSmithKline, Johnson & Johnson, and the National Heart, Lung, and Blood Institute. Drs Hernandez, Setoguchi, Peterson, and Curtis have made available online detailed listings of financial disclosures (https://www.dcri.org/about-us/conflict-of-interest).; This study was funded under contract number HHSA29020050032I (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Dr Peterson was supported in part by grant number U19HS021092 from the Agency for Healthcare Research and Quality. Get With the Guidelines-Heart Failure is provided by the American Heart Association; is currently supported in part by Medtronic, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable; and had been funded through support from GlaxoSmithKline.	Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Curtis LH, 2012, AM HEART J, V163, P946, DOI 10.1016/j.ahj.2012.03.007; Dreyer NA, 2010, AM J MANAG CARE, V16, P467; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Fonarow GC, 2012, J AM HEART ASSOC, V1, P16, DOI 10.1161/JAHA.111.000018; Fonarow GC, 2011, AM HEART J, V161, P1024, DOI 10.1016/j.ahj.2011.01.027; Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632; Ghali JK, 2010, J AM COLL CARDIOL, V56, P2077, DOI 10.1016/j.jacc.2010.07.013; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamaguchi S, 2010, AM HEART J, V160, P1156, DOI 10.1016/j.ahj.2010.08.036; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hernandez AF, 2010, AM HEART J, V159, P406, DOI 10.1016/j.ahj.2009.12.024; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Levine M, 2008, USERS GUIDES MED LIT, P363; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; MANTEL N, 1974, J AM STAT ASSOC, V69, P81, DOI 10.2307/2285503; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	32	99	101	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2097	2107		10.1001/jama.2012.14795	http://dx.doi.org/10.1001/jama.2012.14795			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188026	Bronze			2022-12-01	WOS:000311537200024
J	LeGates, TA; Altimus, CM; Wang, H; Lee, HK; Yang, SG; Zhao, HQ; Kirkwood, A; Weber, ET; Hattar, S				LeGates, Tara A.; Altimus, Cara M.; Wang, Hui; Lee, Hey-Kyoung; Yang, Sunggu; Zhao, Haiqing; Kirkwood, Alfredo; Weber, E. Todd; Hattar, Samer			Aberrant light directly impairs mood and learning through melanopsin-expressing neurons	NATURE			English	Article							RETINAL GANGLION-CELLS; LONG-TERM DEPRESSION; MORRIS WATER MAZE; BEHAVIORAL DESPAIR; MEMORY; CLOCK; RATS; PROJECTIONS; FLUOXETINE; ANXIETY	The daily solar cycle allows organisms to synchronize their circadian rhythms and sleep-wake cycles to the correct temporal niche(1). Changes in day-length, shift-work, and transmeridian travel lead to mood alterations and cognitive function deficits(2). Sleep deprivation and circadian disruption underlie mood and cognitive disorders associated with irregular light schedules(2). Whether irregular light schedules directly affect mood and cognitive functions in the context of normal sleep and circadian rhythms remains unclear. Here we show, using an aberrant light cycle that neither changes the amount and architecture of sleep nor causes changes in the circadian timing system, that light directly regulates mood-related behaviours and cognitive functions in mice. Animals exposed to the aberrant light cycle maintain daily corticosterone rhythms, but the overall levels of corticosterone are increased. Despite normal circadian and sleep structures, these animals show increased depression-like behaviours and impaired hippocampal long-term potentiation and learning. Administration of the antidepressant drugs fluoxetine or desipramine restores learning in mice exposed to the aberrant light cycle, suggesting that the mood deficit precedes the learning impairments. To determine the retinal circuits underlying this impairment of mood and learning, we examined the behavioural consequences of this light cycle in animals that lack intrinsically photosensitive retinal ganglion cells. In these animals, the aberrant light cycle does not impair mood and learning, despite the presence of the conventional retinal ganglion cells and the ability of these animals to detect light for image formation. These findings demonstrate the ability of light to influence cognitive and mood functions directly through intrinsically photosensitive retinal ganglion cells.	[LeGates, Tara A.; Altimus, Cara M.; Zhao, Haiqing; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Wang, Hui; Lee, Hey-Kyoung; Yang, Sunggu; Kirkwood, Alfredo; Hattar, Samer] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Weber, E. Todd] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA	Johns Hopkins University; Johns Hopkins University; Rider University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	shattar@jhu.edu	Hattar, Samer/W-6927-2019	Lee, Hey-Kyoung/0000-0002-5554-983X; Yang, Sunggu/0000-0002-7567-9949; LeGates, Tara/0000-0002-6005-4786	David and Lucile Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034606] Funding Source: NIH RePORTER	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. Gould, G. Ball and A. Sawa for their expert advice on the behavioural tests. We would like to thank R. Kuruvilla for her critical reading and advice on this manuscript. We would also like to thank the mouse tri-laboratory for suggestions and advice. This work was supported by the David and Lucile Packard Foundation grant to S.H.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baldi E, 2003, PHYSIOL BEHAV, V78, P785, DOI 10.1016/S0031-9384(03)00064-7; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Fonken LK, 2009, BEHAV BRAIN RES, V205, P349, DOI 10.1016/j.bbr.2009.07.001; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Honey RC, 1998, J NEUROSCI, V18, P2226; Iyilikci O, 2009, BEHAV BRAIN RES, V203, P65, DOI 10.1016/j.bbr.2009.04.013; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lockley SW, 2006, SLEEP, V29, P161; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; McDermott CM, 2003, J NEUROSCI, V23, P9687; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; Tataroglu O, 2004, BRAIN RES, V1001, P118, DOI 10.1016/j.brainres.2003.11.063; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Warthen DM, 2011, P NATL ACAD SCI USA, V108, P13788, DOI 10.1073/pnas.1103214108	27	313	323	9	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					594	+		10.1038/nature11673	http://dx.doi.org/10.1038/nature11673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23151476	Green Accepted			2022-12-01	WOS:000311339800052
J	Milucka, J; Ferdelman, TG; Polerecky, L; Franzke, D; Wegener, G; Schmid, M; Lieberwirth, I; Wagner, M; Widdel, F; Kuypers, MMM				Milucka, Jana; Ferdelman, Timothy G.; Polerecky, Lubos; Franzke, Daniela; Wegener, Gunter; Schmid, Markus; Lieberwirth, Ingo; Wagner, Michael; Widdel, Friedrich; Kuypers, Marcel M. M.			Zero-valent sulphur is a key intermediate in marine methane oxidation	NATURE			English	Article							MEDIATING ANAEROBIC OXIDATION; IN-SITU HYBRIDIZATION; MOSBY MUD VOLCANO; SULFATE REDUCTION; ELEMENTAL SULFUR; EQUILIBRIUM DISTRIBUTION; OLIGONUCLEOTIDE PROBES; MICROBIAL COMMUNITIES; AQUEOUS-SOLUTIONS; POLYSULFIDE IONS	Emissions of methane, a potent greenhouse gas, from marine sediments are controlled by anaerobic oxidation of methane coupled primarily to sulphate reduction (AOM). Sulphate-coupled AOM is believed to be mediated by a consortium of methanotrophic archaea (ANME) and sulphate-reducing Deltaproteobacteria but the underlying mechanism has not yet been resolved. Here we show that zero-valent sulphur compounds (S-0) are formed during AOM through a new pathway for dissimilatory sulphate reduction performed by the methanotrophic archaea. Hence, AOM might not be an obligate syntrophic process but may be carried out by the ANME alone. Furthermore, we show that the produced S-0-in the form of disulphide-is disproportionated by the Deltaproteobacteria associated with the ANME. Our observations expand the diversity of known microbially mediated sulphur transformations and have significant implications for our understanding of the biogeochemical carbon and sulphur cycles.	[Milucka, Jana; Ferdelman, Timothy G.; Polerecky, Lubos; Franzke, Daniela; Wegener, Gunter; Widdel, Friedrich; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Wegener, Gunter] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Schmid, Markus; Wagner, Michael] Univ Vienna, A-1090 Vienna, Austria; [Lieberwirth, Ingo] Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Vienna; Max Planck Society	Milucka, J (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jmilucka@mpi-bremen.de	Polerecky, Lubos/E-1134-2014; Lieberwirth, Ingo/Q-5862-2017; Ferdelman, Timothy G/A-3758-2013; Schmid, Markus C/D-2669-2012; Wagner, Michael/A-7801-2011	Polerecky, Lubos/0000-0003-4425-585X; Ferdelman, Timothy G/0000-0002-9701-3793; Wagner, Michael/0000-0002-9778-7684; Wegener, Gunter/0000-0002-6819-373X	Max Planck Society; ERC [294343]	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission)	We want to thank G. Klockgether, K. Imhoff, S. Littmann and T. Vagner for technical support, G. Lavik and M. Formolo for analytical support and discussions, M. Schuler and T. Keil for assistance with cryosectioning, A. Boetius for providing samples, and T. Holler for the initial enrichment and maintenance of the Isis culture. This work was financially supported by the Max Planck Society and the ERC Advanced Grant 294343 (to M.W.).	Alperin M, 2010, SCIENCE, V329, P288, DOI 10.1126/science.1189966; Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; Basen M, 2011, ENVIRON MICROBIOL, V13, P1370, DOI 10.1111/j.1462-2920.2011.02443.x; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; FUSELER K, 1995, ARCH MICROBIOL, V164, P104, DOI 10.1007/BF02525315; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holmkvist L, 2011, DEEP-SEA RES PT I, V58, P493, DOI 10.1016/j.dsr.2011.02.009; House Christopher H., 2011, Life-Basel, V1, P19, DOI 10.3390/life1010019; Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x; Johnson EF, 2008, MICROBIAL SULFUR METABOLISM, P202, DOI 10.1007/978-3-540-72682-1_16; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kamyshny A, 2006, ANAL CHEM, V78, P2631, DOI 10.1021/ac051854a; Kamyshny A, 2004, ENVIRON SCI TECHNOL, V38, P6633, DOI 10.1021/es049514e; Kamyshny A, 2009, GEOCHIM COSMOCHIM AC, V73, P6022, DOI 10.1016/j.gca.2009.07.003; Kamyshny A, 2007, ENVIRON SCI TECHNOL, V41, P2395, DOI 10.1021/es062637+; Kamyshny A, 2009, GEOSTAND GEOANAL RES, V33, P415, DOI 10.1111/j.1751-908X.2009.00907.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; KRAMER M, 1989, ARCH MICROBIOL, V151, P232, DOI 10.1007/BF00413135; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Mastalerz V, 2007, CHEM GEOL, V246, P87, DOI 10.1016/j.chemgeo.2007.09.005; Meulepas RJW, 2010, APPL MICROBIOL BIOT, V87, P1499, DOI 10.1007/s00253-010-2597-0; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Meysman FJR, 2005, MAR CHEM, V97, P206, DOI 10.1016/j.marchem.2005.08.005; Milucka J., 2012, ENV MICROBIOL; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Pasteris JD, 2001, CHEM GEOL, V180, P3, DOI 10.1016/S0009-2541(01)00302-3; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; SALEH AM, 1964, J APPL BACTERIOL, V27, P281, DOI 10.1111/j.1365-2672.1964.tb04914.x; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; STEUDEL R, 1988, Z NATURFORSCH B, V43, P203; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; Stumm W., 1996, AQUAT CHEM, P990; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; THODE HG, 1961, GEOCHIM COSMOCHIM AC, V25, P159, DOI 10.1016/0016-7037(61)90074-6; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Treude T, 2007, APPL ENVIRON MICROB, V73, P2271, DOI 10.1128/AEM.02685-06; Trofimov BA, 2009, J SULFUR CHEM, V30, P518, DOI 10.1080/17415990902998579; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; Wegener G, 2008, ENVIRON MICROBIOL, V10, P2287, DOI 10.1111/j.1462-2920.2008.01653.x; Widdel F, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P265, DOI 10.1017/CBO9780511541490.010; Zopfi J., 2004, GEOLOGICAL SOC AM SP, P97, DOI [10.1130/0-8137-2379-5.97, DOI 10.1130/0-8137-2379-5.97]	73	373	396	15	475	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					541	+		10.1038/nature11656	http://dx.doi.org/10.1038/nature11656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135396				2022-12-01	WOS:000311339800041
J	Sheffield, J; Wood, EF; Roderick, ML				Sheffield, Justin; Wood, Eric F.; Roderick, Michael L.			Little change in global drought over the past 60 years	NATURE			English	Article							PAN EVAPORATION; SEVERITY INDEX; SOIL-MOISTURE; CLIMATE; PRECIPITATION; DATASET; WATER	Drought is expected to increase in frequency and severity in the future as a result of climate change, mainly as a consequence of decreases in regional precipitation but also because of increasing evaporation driven by global warming(1-3). Previous assessments of historic changes in drought over the late twentieth and early twenty-first centuries indicate that this may already be happening globally. In particular, calculations of the Palmer Drought Severity Index (PDSI) show a decrease in moisture globally since the 1970s with a commensurate increase in the area in drought that is attributed, in part, to global warming(4,5). The simplicity of the PDSI, which is calculated from a simple water-balance model forced by monthly precipitation and temperature data, makes it an attractive tool in large-scale drought assessments, but may give biased results in the context of climate change(6). Here we show that the previously reported increase in global drought is overestimated because the PDSI uses a simplified model of potential evaporation(7) that responds only to changes in temperature and thus responds incorrectly to global warming in recent decades. More realistic calculations, based on the underlying physical principles(8) that take into account changes in available energy, humidity and wind speed, suggest that there has been little change in drought over the past 60 years. The results have implications for how we interpret the impact of global warming on the hydrological cycle and its extremes, and may help to explain why palaeoclimate drought reconstructions based on tree-ring data diverge from the PDSI-based drought record in recent years(9,10).	[Sheffield, Justin; Wood, Eric F.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Roderick, Michael L.] Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Climate Sys, Canberra, ACT 0200, Australia; [Roderick, Michael L.] Australian Natl Univ, Res Sch Biol, Australian Res Council Ctr Excellence Climate Sys, Canberra, ACT 0200, Australia	Princeton University; Australian National University; Australian National University	Sheffield, J (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	justin@princeton.edu	Roderick, Michael/C-9621-2009	Roderick, Michael/0000-0002-3630-7739; Sheffield, Justin/0000-0003-2400-0630; Wood, Eric/0000-0001-7037-9675	US National Oceanic and Atmospheric Agency [NA10OAR4310130, NA11OAR4310097]; NASA [NNX08AN40A]; Australian Research Council [DP0879763, DP110105376, CE11E0098]	US National Oceanic and Atmospheric Agency; NASA(National Aeronautics & Space Administration (NASA)); Australian Research Council(Australian Research Council)	J.S. acknowledges support from the US National Oceanic and Atmospheric Agency (NA10OAR4310130, NA11OAR4310097) and NASA (NNX08AN40A). M.L.R. acknowledges the support of the Australian Research Council (DP0879763, DP110105376, CE11E0098).	ALLEY WM, 1984, J CLIM APPL METEOROL, V23, P1100, DOI 10.1175/1520-0450(1984)023<1100:TPDSIL>2.0.CO;2; [Anonymous], 1993, HDB HYDROLOGY; Briffa KR, 2009, INT J CLIMATOL, V29, P1894, DOI 10.1002/joc.1836; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL039902, 10.1029/2009GL037604]; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; DAI AG, 2011, WILEY INTERDISCIP RE, V2, P45, DOI [10.1002/wcc.81, DOI 10.1002/WCC.81]; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; De Grandpre L, 2011, CAN J FOREST RES, V41, P1242, DOI [10.1139/X11-051, 10.1139/x11-051]; Donohue RJ, 2010, J HYDROL, V386, P186, DOI 10.1016/j.jhydrol.2010.03.020; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Gupta SK, 2006, GEWEX NEWS, V16, P12; Hirschi M, 2011, NAT GEOSCI, V4, P17, DOI [10.1038/ngeo1032, 10.1038/NGEO1032]; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jensen M.E., 1973, CONSUMPTIVE USE WATE, P215; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lockart N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040598; McCabe GJ, 2006, INT J CLIMATOL, V26, P849, DOI 10.1002/joc.1289; Milly PCD, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI363.1; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monteith J. L., 1964, S SOC EXP BIOL, V19, P205; Mu QZ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000179; Palmer WC, 1965, METEOROLOGICAL DROUG, V30, DOI DOI 10.1111/J.1467-9523.2006.00307.X; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Roderick ML, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031166; Roderick ML, 2009, GEOGR COMPASS, V3, P761, DOI 10.1111/j.1749-8198.2008.00214.x; Roderick ML, 2004, INT J CLIMATOL, V24, P1077, DOI 10.1002/joc.1061; Schneider U., 2008, WEATHER CLIMATE DTSC; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Shaw SB, 2011, HYDROL PROCESS, V25, P1466, DOI 10.1002/hyp.7913; Sheffield J, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008288; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sheffield J, 2010, J HYDROMETEOROL, V11, P253, DOI 10.1175/2009JHM1176.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sternberg T, 2011, NATURE, V472, P169, DOI 10.1038/472169d; Svoboda M, 2002, B AM METEOROL SOC, V83, P1181, DOI 10.1175/1520-0477(2002)083&lt;1181:TDM&gt;2.3.CO;2; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; van der Schrier G, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006745; van der Schrier G, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015001; Wang JS, 2010, CLIM RES, V41, P51, DOI 10.3354/cr00837; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Willmott C. J., 2010, GLOBAL AIR TEMPERATU; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	47	1206	1259	55	766	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					435	+		10.1038/nature11575	http://dx.doi.org/10.1038/nature11575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151587				2022-12-01	WOS:000311031600044
J	Straub, AC; Lohman, AW; Billaud, M; Johnstone, SR; Dwyer, ST; Lee, MY; Bortz, PS; Best, AK; Columbus, L; Gaston, B; Isakson, BE				Straub, Adam C.; Lohman, Alexander W.; Billaud, Marie; Johnstone, Scott R.; Dwyer, Scott T.; Lee, Monica Y.; Bortz, Pamela Schoppee; Best, Angela K.; Columbus, Linda; Gaston, Benjamin; Isakson, Brant E.			Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling	NATURE			English	Article							RELAXING FACTOR; SMOOTH-MUSCLE; NO; PROPYLTHIOURACIL; NITROSYLATION; HEMOPROTEINS; MYOGLOBIN; OXIDATION; REDUCTASE; PROTEINS	Models of unregulated nitric oxide (NO) diffusion do not consistently account for the biochemistry of NO synthase (NOS)-dependent signalling in many cell systems(1-3). For example, endothelial NOS controls blood pressure, blood flow and oxygen delivery through its effect on vascular smooth muscle tone(4), but the regulation of these processes is not adequately explained by simple NO diffusion from endothelium to smooth muscle(3,5). Here we report a new model for the regulation of NO signalling by demonstrating that haemoglobin (Hb) alpha (encoded by the HBA1 and HBA2 genes in humans) is expressed in human and mouse arterial endothelial cells and enriched at the myoendothelial junction, where it regulates the effects of NO on vascular reactivity. Notably, this function is unique to Hb alpha and is abrogated by its genetic depletion. Mechanistically, endothelial Hb alpha haem iron in the Fe3+ state permits NO signalling, and this signalling is shut off when Hb alpha is reduced to the Fe2+ state by endothelial cytochrome b5 reductase 3 (CYB5R3, also known as diaphorase 1)(6). Genetic and pharmacological inhibition of CYB5R3 increases NO bioactivity in small arteries. These data reveal a new mechanism by which the regulation of the intracellular Hb alpha oxidation state controls NOS signalling in non-erythroid cells. This model may be relevant to haem-containing globins in a broad range of NOS-containing somatic cells(7-13).	[Straub, Adam C.; Lohman, Alexander W.; Billaud, Marie; Johnstone, Scott R.; Lee, Monica Y.; Bortz, Pamela Schoppee; Best, Angela K.; Isakson, Brant E.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lohman, Alexander W.; Billaud, Marie; Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Dwyer, Scott T.; Gaston, Benjamin] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA; [Columbus, Linda] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Isakson, BE (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	brant@virginia.edu	Columbus, Linda/F-5877-2010; Billaud, Marie/N-7609-2017; Johnstone, Scott R/E-5032-2013	Columbus, Linda/0000-0002-2574-0561; Billaud, Marie/0000-0002-7591-0362; Johnstone, Scott R/0000-0003-1920-5033; Straub, Adam/0000-0003-0542-9466	American Heart Association; National Institutes of Health [HL088554, HL107963, HL059337, HL101871, HL112904, HL007284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112904, P01HL101871, R00HL112904, R56HL059337, R01HL088554, T32HL007284, R01HL059337, R21HL107963] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Advanced Microscopy and Histology core at the University of Virginia and the Yale Proteomic Facility. We acknowledge V. Balasubramaniam, S. Lewis and D. Singel for discussions of the data and B. Duling for critical evaluation of experiments and the manuscript. We also thank M. Weiss for the Hb alpha-stabilizing protein antibody and for discussions. This work was supported by an American Heart Association Scientist Development Grant (B. E. I.), National Institutes of Health grants HL088554 (B. E. I.), HL107963 (B. E. I.) HL059337 (B. G.), HL101871 (B. G.), HL112904 (A. C. S.) and HL007284 (A. W. L. and A. C. S.). M. B. and S.R.J. were supported by American Heart Association postdoctoral fellowships, and A. W. L. and M.Y.L. were supported by American Heart Association predoctoral fellowships.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Davalos A, 2010, MOL CELL PROTEOMICS, V9, P2109, DOI 10.1074/mcp.M110.001289; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; FREGLY MJ, 1959, CIRC RES, V7, P486, DOI 10.1161/01.RES.7.3.486; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Heberlein KR, 2010, CIRC RES, V106, P1092, DOI 10.1161/CIRCRESAHA.109.215723; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Lam YH, 2002, PRENATAL DIAG, V22, P56; LEE E, 1986, FEBS LETT, V209, P49, DOI 10.1016/0014-5793(86)81082-1; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927	30	206	212	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					473	477		10.1038/nature11626	http://dx.doi.org/10.1038/nature11626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123858	Green Accepted			2022-12-01	WOS:000311031600052
J	Levin, GP; Robinson-Cohen, C; de Boer, IH; Houston, DK; Lohman, K; Liu, YM; Kritchevsky, SB; Cauley, JA; Tanaka, T; Ferrucci, L; Bandinelli, S; Patel, KV; Hagstrom, E; Michaelsson, K; Melhus, H; Wang, T; Wolf, M; Psaty, BM; Siscovick, D; Kestenbaum, B				Levin, Gregory P.; Robinson-Cohen, Cassianne; de Boer, Ian H.; Houston, Denise K.; Lohman, Kurt; Liu, Yongmei; Kritchevsky, Stephen B.; Cauley, Jane A.; Tanaka, Toshiko; Ferrucci, Luigi; Bandinelli, Stefania; Patel, Kushang V.; Hagstrom, Emil; Michaelsson, Karl; Melhus, Hakan; Wang, Thomas; Wolf, Myles; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan			Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D-RECEPTOR GENE; VITAMIN-D; SERUM 25-HYDROXYVITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; SEASONAL-VARIATION; FRACTURE RISK; HIP FRACTURE; OLDER-ADULTS; POLYMORPHISMS; CANCER	Context Lower serum 25-hydroxyvitamin D concentrations are associated with greater risks of many chronic diseases across large, prospective community-based studies. Substrate 25-hydroxyvitamin D must be converted to 1,25-dihydroxyvitamin D for full biological activity, and complex metabolic pathways suggest that interindividual variability in vitamin D metabolism may alter the clinical consequences of measured serum 25-hydroxyvitamin D. Objective To investigate whether common variation within genes encoding the vitamin D-binding protein, megalin, cubilin, CYP27B1, CYP24A1, and the vitamin D receptor (VDR) modify associations of low 25-hydroxyvitamin D with major clinical outcomes. Design, Setting, and Participants Examination of 141 single-nucleotide polymorphisms in a discovery cohort of 1514 white participants (who were recruited from 4 US regions) from the community-based Cardiovascular Health Study. Participants had serum 25-hydroxyvitamin D measurements in 1992-1993 and were followed up for a median of 11 years (through 2006). Replication meta-analyses were conducted across the independent, community-based US Health, Aging, and Body Composition (n=922; follow-up: 1998-1999 through 2005), Italian Invecchiare in Chianti (n=835; follow-up: 1998-2000 through 2006), and Swedish Uppsala Longitudinal Study of Adult Men (n=970; follow-up: 1991-1995 through 2008) cohort studies. Main Outcome Measure Composite outcome of incident hip facture, myocardial infarction, cancer, and mortality over long-term follow-up. Results Interactions between 5 single-nucleotide polymorphisms and low 25-hydroxyvitamin D concentration were identified in the discovery phase and 1 involving a variant in the VDR gene replicated in independent meta-analysis. Among Cardiovascular Health Study participants, low 25-hydroxyvitamin D concentration was associated with hazard ratios for risk of the composite outcome of 1.40 (95% CI, 1.12-1.74) for those who had 1 minor allele at rs7968585 and 1.82 (95% CI, 1.31-2.54) for those with 2 minor alleles at rs7968585. In contrast, there was no evidence of an association (estimated hazard ratio, 0.93 [95% CI, 0.70-1.24]) among participants who had 0 minor alleles at this single-nucleotide polymorphism. Conclusion Known associations of low 25-hydroxyvitamin D with major health outcomes may vary according to common genetic differences in the vitamin D receptor. JAMA. 2012;308(18):1898-1905 www.jama.com	[Levin, Gregory P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Robinson-Cohen, Cassianne; de Boer, Ian H.; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [de Boer, Ian H.; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Dept Anasthesiol & Pain Med, Seattle, WA 98195 USA; [de Boer, Ian H.; Kestenbaum, Bryan] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [de Boer, Ian H.; Kestenbaum, Bryan] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Ctr Pain Res Impact Measurement & Effectiveness, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Grp Hlth Res Inst & Cooperat, Seattle, WA 98195 USA; [Houston, Denise K.; Kritchevsky, Stephen B.] Wake Forest Univ, Dept Internal Med, Winston Salem, NC 27109 USA; [Lohman, Kurt] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Lohman, Kurt; Liu, Yongmei] Wake Forest Univ, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Houston, Denise K.; Lohman, Kurt; Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy; [Hagstrom, Emil; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Wang, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA; [Wolf, Myles] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Azienda Sanitaria di Firenze; Uppsala University; Uppsala University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Miami	Levin, GP (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.	glevin11@uw.edu	Michaelsson, Karl/AAM-9094-2021; Hagstrom, Emil/AAE-8361-2021; Robinson-Cohen, Cassianne/ABB-4985-2021; bandinelli, stefania/AAL-4570-2020; de Boer, Ian/GYJ-3282-2022	Michaelsson, Karl/0000-0003-2815-1217; Houston, Denise/0000-0002-3355-4304; Robinson-Cohen, Cassianne/0000-0003-4783-7046; Cauley, Jane A/0000-0003-0752-4408; Wang, Thomas/0000-0003-4063-6508; Kritchevsky, Stephen/0000-0003-3336-6781	Abbott Laboratories; National Institute on Aging, National Institutes of Health; American Society for Nutrition; Department of Veteran Affairs; Abbott Nutrition Health Institute; National Institutes of Health; Shire; Amgen; Abbott; Genzyme; Medtronic; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC075150, N01HC015103, N01HC055222, N01HC085079, N01HC045133, N01HC085086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084443, R01HL096875, R01HL087652, R01HL105756, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062106, N01AG012111, R01AG027002, R01AG029364, P30AG021332, R01AG032098, N01AG062103, K01AG030506, N01AG062101] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Society for Nutrition; Department of Veteran Affairs(US Department of Veterans Affairs); Abbott Nutrition Health Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shire; Amgen(Amgen); Abbott(Abbott Laboratories); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr de Boer reported receiving research grant funding from Abbott Laboratories. Dr Houston reported pending institutional grant support from the National Institute on Aging, National Institutes of Health; and receiving payment for lectures from the American Society for Nutrition, the Department of Veteran Affairs, and Abbott Nutrition Health Institute. Dr Wang reported serving as a consultant to Diasorin; receiving an investigatorinitiated grant from Diasorin; and receiving payment for lectures from Diasorin. Dr Wolf reported serving as a consultant to Abbott, Genzyme, Luitpold, Mitsubishi, Cytochroma, Astellas, and Kai; receiving institutional grants from the National Institutes of Health, Shire, and Amgen; receiving payment for lectures from Abbott, Genzyme, and Shire; and having a pending patent. Dr Psaty reported serving on a data and safety monitoring board for a clinical trial of a device funded by Zoll ZifeCor; and serving on a steering committee for the Yale Open Data Access Project funded by Medtronic. Dr Kestenbaum reported receiving institutional grant support from Amgen. No other authors reported disclosures.	Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gong G, 1999, OSTEOPOROSIS INT, V9, P55, DOI 10.1007/s001980050116; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Ji GR, 2010, BONE, V47, P681, DOI 10.1016/j.bone.2010.06.024; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007013; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Li YC, 2002, J CLIN INVEST, V110, P229, DOI 10.1172/JCI0215219; Liu CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S10; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Lurie G, 2007, CANCER EPIDEM BIOMAR, V16, P2566, DOI 10.1158/1055-9965.EPI-07-0753; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Morrison NA, 2005, PHARMACOGENET GENOM, V15, P127, DOI 10.1097/01213011-200502000-00008; Onen IH, 2008, EXP BIOL MED, V233, P1608, DOI 10.3181/0803-RM-110; Penna-Martinez M, 2009, THYROID, V19, P623, DOI 10.1089/thy.2008.0388; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; SHERMAN SS, 1990, J CLIN ENDOCR METAB, V71, P405, DOI 10.1210/jcem-71-2-405; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Smith NL, 2009, THROMB RES, V123, pS25, DOI 10.1016/S0049-3848(09)70139-2; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398	46	132	139	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1898	1905		10.1001/jama.2012.17304	http://dx.doi.org/10.1001/jama.2012.17304			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150009	Green Accepted, Bronze			2022-12-01	WOS:000310952700026
J	Byers, J; Dunn, S				Byers, John; Dunn, Stacey			Bateman in Nature: Predation on Offspring Reduces the Potential for Sexual Selection	SCIENCE			English	Article							MATE CHOICE; MATING SUCCESS; VARIANCE	Sexual selection is driven by competition for mates, and the advantage of a competitor is determined by the number of offspring it produces. Early experiments by Angus Bateman characterized this interaction, and the quantitative relationship between a male's number of mates and number of offspring is known as the Bateman slope. Sexual dimorphism, one of the most obvious results of sexual selection, largely requires a positive Bateman relationship, and the slope provides an estimate of the potential for sexual selection. However, natural selection from the environment can also influence male success, as can random effects, and some have argued for inclusion of the latter in calculations of mate success. Data from pronghorn (Antilocapra americana) reveal the presence of a positive Bateman slope in each year of a 10-year study. We found no evidence that random effects skewed male mating success; however, substantial yearly variation in the Bateman slope due to predation on fawns was evident. These results support the validity of the Bateman relationship, yet they also demonstrate that environmental or extrinsic influences can limit the potential for sexual selection.	[Byers, John; Dunn, Stacey] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Idaho; University of Idaho	Byers, J (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	jbyers@uidaho.edu			U.S. Fish and Wildlife Service; NSF [9808377, 0097115, 0738012]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); NSF(National Science Foundation (NSF))	We thank the dozens of field volunteers who helped build our data set, L. Waits for laboratory guidance, S. Nuismer for statistical consultation, and the U.S. Fish and Wildlife Service for access permits and support. Supported by NSF grants 9808377, 0097115, and 0738012 to J.B. Data location: Dryad Digital Repository (http://datadryad.org/handle/10255/dryad.34974).	ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; Barnowe-Meyer KK, 2010, J MAMMAL, V91, P712, DOI 10.1644/09-MAMM-A-057.1; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Byers J.A., 1997, AM PRONGHORN SOCIAL; Byers J. A., 2006, P 22 BIENN PRONGH WO, V22, P27; Byers JA, 1997, J MAMMAL, V78, P894, DOI 10.2307/1382948; BYERS JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P147, DOI 10.1007/BF00293804; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; HUBBELL SP, 1987, AM NAT, V130, P91, DOI 10.1086/284700; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; SUTHERLAND WJ, 1985, ANIM BEHAV, V33, P1349, DOI 10.1016/S0003-3472(85)80197-4; Wade MJ, 2010, HEREDITY, V105, P507, DOI 10.1038/hdy.2010.8	14	23	23	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					802	804		10.1126/science.1224660	http://dx.doi.org/10.1126/science.1224660			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139332				2022-12-01	WOS:000310839500045
J	Clement, JP; Aceti, M; Creson, TK; Ozkan, ED; Shi, YL; Reish, NJ; Almonte, AG; Miller, BH; Wiltgen, BJ; Miller, CA; Xu, XM; Rumbaugh, G				Clement, James P.; Aceti, Massimiliano; Creson, Thomas K.; Ozkan, Emin D.; Shi, Yulin; Reish, Nicholas J.; Almonte, Antoine G.; Miller, Brooke H.; Wiltgen, Brian J.; Miller, Courtney A.; Xu, Xiangmin; Rumbaugh, Gavin			Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NMDA RECEPTOR; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; SILENT SYNAPSES; IN-VIVO; CRITICAL PERIOD; VISUAL-CORTEX; ANIMAL-MODEL; AUTISM	Mutations that cause intellectual disability (ID) and autism spectrum disorder (ASD) are commonly found in genes that encode for synaptic proteins. However, it remains unclear how mutations that disrupt synapse function impact intellectual ability. In the SYNGAP1 mouse model of ID/ASD, we found that dendritic spine synapses develop prematurely during the early postnatal period. Premature spine maturation dramatically enhanced excitability in the developing hippocampus, which corresponded with the emergence of behavioral abnormalities. Inducing SYNGAP1 mutations after critical developmental windows closed had minimal impact on spine synapse function, whereas repairing these pathogenic mutations in adulthood did not improve behavior and cognition. These data demonstrate that SynGAP protein acts as a critical developmental repressor of neural excitability that promotes the development of life-long cognitive abilities. We propose that the pace of dendritic spine synapse maturation in early life is a critical determinant of normal intellectual development.	[Clement, James P.; Aceti, Massimiliano; Creson, Thomas K.; Ozkan, Emin D.; Miller, Brooke H.; Miller, Courtney A.; Rumbaugh, Gavin] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Miller, Courtney A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Shi, Yulin; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Reish, Nicholas J.; Almonte, Antoine G.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Wiltgen, Brian J.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Irvine; University of Alabama System; University of Alabama Birmingham; University of Virginia	Rumbaugh, G (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	grumbaug@scripps.edu	Miller, Courtney A/E-8651-2010; Reish, Nicholas/ACC-7587-2022; Ozkan, Emin Deniz/A-5752-2009; Clement, James/Q-5628-2019; Wiltgen, Brian/D-2947-2013	Miller, Courtney A/0000-0001-8628-4902; Ozkan, Emin Deniz/0000-0002-1073-6703; Aceti, Massimiliano/0000-0002-6632-1398; Almonte, Antoine/0000-0002-8778-2724; Reish, Nicholas/0000-0001-5677-3895; Clement, James/0000-0001-7625-6430	National Institute for Neurological Disorders and Stroke [R01NS064079]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R03HD060672]; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute for Drug Abuse [DA023700-04S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023700, K99DA023700] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Ronald Davis, Damon Page, and Fadi Hamdan, as well as members of the Rumbaugh Laboratory, for their helpful comments on this manuscript. We also thank Zachary Collier, Samuel Bacharach, Bryce Grier, and Gopi Patel for assistance in context discrimination studies. This work was supported by grants to G. R. from the National Institute for Neurological Disorders and Stroke (R01NS064079), The Eunice Kennedy Shriver National Institute for Child Health and Human Development (R03HD060672), and the National Alliance for Research on Schizophrenia and Depression (NARSAD). The laser photostimulation and voltage-sensitive dye imaging part of this work was performed in X.X.'s laboratory, supported by a grant from the National Institute for Drug Abuse (DA023700-04S1). J.P.C. and E.D.O. performed electrophysiological recordings; M. A. performed multiphoton imaging studies and spine analysis; T. K. C., N.J.R., A. G. A., and B.J.W. performed behavioral studies; Y.S. and X. X. performed laser photo-stimulation and imaging studies; G. R., C. A. M., T. K. C., J.P.C., M. A., B.J.W., X. X. designed experiments; B. M. and T. K. C. performed protein/mRNA studies; G. R. conceived the study and wrote the manuscript; G. R., C. A. M., J.P.C., and T. K. C. edited the manuscript.	Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bender RA, 2004, ADV EXP MED BIOL, V548, P213; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Daenen EWPM, 2002, BEHAV BRAIN RES, V131, P67, DOI 10.1016/S0166-4328(01)00350-3; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dvorkin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000027; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Krepischi ACV, 2010, AM J MED GENET A, V152A, P2376, DOI 10.1002/ajmg.a.33554; Lau CG, 2012, J NEUROSCI, V32, P8521, DOI 10.1523/JNEUROSCI.1245-12.2012; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; Muhia M, 2010, EUR J NEUROSCI, V31, P529, DOI 10.1111/j.1460-9568.2010.07079.x; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pilpel N, 2009, J NEUROSCI METH, V182, P55, DOI 10.1016/j.jneumeth.2009.05.020; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Porter K, 2005, EUR J NEUROSCI, V21, P351, DOI 10.1111/j.1460-9568.2005.03874.x; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	56	213	220	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					709	723		10.1016/j.cell.2012.08.045	http://dx.doi.org/10.1016/j.cell.2012.08.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141534	Green Accepted, Bronze			2022-12-01	WOS:000310921200005
J	Knudsen, AB; Hur, C; Gazelle, GS; Schrag, D; McFarland, EG; Kuntz, KM				Knudsen, Amy B.; Hur, Chin; Gazelle, G. Scott; Schrag, Deborah; McFarland, Elizabeth G.; Kuntz, Karen M.			Rescreening of Persons With a Negative Colonoscopy Result: Results From a Microsimulation Model	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL OCCULT-BLOOD; AMERICAN-CANCER-SOCIETY; RANDOMIZED CONTROLLED-TRIAL; ON-COLORECTAL-CANCER; SERVICES TASK-FORCE; CT COLONOGRAPHY; SCREENING COLONOSCOPY; MEDICARE POPULATION; LARGE-INTESTINE; LARGE-BOWEL	Background: Persons with a negative result on screening colonoscopy are recommended to repeat the procedure in 10 years. Objective: To assess the effectiveness and costs of colonoscopy versus other rescreening strategies after an initial negative colonoscopy result. Design: Microsimulation model. Data Sources: Literature and data from the Surveillance, Epidemiology, and End Results program. Target Population: Persons aged 50 years who had no adenomas or cancer detected on screening colonoscopy. Time Horizon: Lifetime. Perspective: Societal. Intervention: No further screening or rescreening starting at age 60 years with colonoscopy every 10 years, annual highly sensitive guaiac fecal occult blood testing (HSFOBT), annual fecal immuno-chemical testing (FIT), or computed tomographic colonography (CTC) every 5 years. Outcome Measures: Lifetime cases of colorectal cancer, life expectancy, and lifetime costs per 1000 persons, assuming either perfect or imperfect adherence. Results of Base-Case Analysis: Rescreening with any method substantially reduced the risk for colorectal cancer compared with no further screening (range, 7.7 to 12.6 lifetime cases per 1000 persons [perfect adherence] and 17.7 to 20.9 lifetime cases per 1000 persons [imperfect adherence] vs. 31.3 lifetime cases per 1000 persons with no further screening). In both adherence scenarios, the differences in life-years across rescreening strategies were small (range, 30 893 to 30 902 life-years per 1000 persons [perfect adherence] vs. 30 865 to 30 869 life-years per 1000 persons [imperfect adherence]). Rescreening with HSFOBT, FIT, or CTC had fewer complications and was less costly than continuing colonoscopy. Results of Sensitivity Analysis: Results were sensitive to test-specific adherence rates. Limitation: Data on adherence to rescreening were limited. Conclusion: Compared with the currently recommended strategy of continuing colonoscopy every 10 years after an initial negative examination, rescreening at age 60 years with annual HSFOBT, annual FIT, or CTC every 5 years provides approximately the same benefit in life-years with fewer complications at a lower cost. Therefore, it is reasonable to use other methods to rescreen persons with negative colonoscopy results.	[Knudsen, Amy B.] Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Inst Technol Assessment, Boston, MA 02114 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; SSM St Joseph Hosp, St Charles, MO USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; University of Minnesota System; University of Minnesota Twin Cities	Knudsen, AB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Inst Technol Assessment, 101 Merrimac St,10th Floor, Boston, MA 02114 USA.	aknudsen@mgh-ita.org		Hur, Chin/0000-0002-2819-7576	National Cancer Institute, National Institutes of Health [RC1CA147256, U01CA088204, U01CA152959]; National Cancer Institute; NATIONAL CANCER INSTITUTE [RC1CA147256, U01CA152959, U01CA088204] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By award RC1CA147256 and grants U01CA088204 and U01CA152959 from the National Cancer Institute, National Institutes of Health.; Primary Funding Source: National Cancer Institute.	Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Medicare & Medicaid Services (CMS) HHS, 2006, FED REG, V71, P69623; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Ding A, 2011, RADIOL CLIN N AM, V49, P257, DOI 10.1016/j.rcl.2010.11.004; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Ho W, 2010, AM J ROENTGENOL, V195, P393, DOI 10.2214/AJR.09.3500; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Jonas DE, 2007, AM J GASTROENTEROL, V102, P2401, DOI 10.1111/j.1572-0241.2007.01387.x; Klabunde CN, 2011, CANCER EPIDEM BIOMAR, V20, P1611, DOI 10.1158/1055-9965.EPI-11-0220; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Kuntz KM, 2011, MED DECIS MAKING, V31, P530, DOI 10.1177/0272989X11408730; Lansdorp-Vogelaar I, 2010, ANN INTERN MED, V153, P368, DOI 10.7326/0003-4819-153-6-201009210-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Moawad FJ, 2010, AM J ROENTGENOL, V195, P1118, DOI 10.2214/AJR.10.4921; National Center for Health Statistics Centers for Disease Control and Prevention, 2009, 2008 NAT HLTH INT SU; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Population Division U.S. Census Bureau, 2009, NCEST200801 US CENS; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Schwartz DC, 2008, AM J GASTROENTEROL, V103, P346, DOI 10.1111/j.1572-0241.2007.01586.x; SEER Program, SEER STAT DAT INC SE; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Thomson PDR, 2010, RED BOOK PHARM FUNDA; US Bureau of Labor Statistics, 2011, NAT COMP SURV OCC EA; US Census Bureau, 2012, STAT ABSTR US 2012; van Ballegooijen M, 2011, MED DECIS MAKING, V31, P540, DOI 10.1177/0272989X11408915; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yabroff KR, 2005, MED CARE, V43, P640, DOI 10.1097/01.mlr.0000167177.45020.4a; Zauber AG, 2007, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	64	23	23	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					611	+		10.7326/0003-4819-157-9-201211060-00005	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128861	Green Accepted			2022-12-01	WOS:000310783300002
J	McCartney, M				McCartney, Margaret			The assault on the Liverpool care pathway	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2010, DAILY MAIL; [Anonymous], 2004, DAILY MAIL; [Anonymous], 2012, DAILY MAIL; Boggan S., 2009, DAILY MAIL; Catholic Herald, 2010, CATHOLIC HERALD 0423; Christian Medical Comment, 2012, LIVERPOOL CARE PATHW; Clarke N., DIS NHS KILL MY MOTH; Doughty, 2012, DAILY MAIL; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6654; Maes N., 2011, DAILY MAIL; Marie Curie Palliative Care Institute Liverpool, 2010, WHAT IS LIV CAR PATH; Phillips M., 2012, DAILY MAIL; Preston M, 2007, END LIFE CARE, V1, P1	13	14	14	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 30	2012	345								e7316	10.1136/bmj.e7316	http://dx.doi.org/10.1136/bmj.e7316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EY	23112122				2022-12-01	WOS:000310778200019
J	Heneka, MT; Kummer, MP; Stutz, A; Delekate, A; Schwartz, S; Vieira-Saecker, A; Griep, A; Axt, D; Remus, A; Tzeng, TC; Gelpi, E; Halle, A; Korte, M; Latz, E; Golenbock, DT				Heneka, Michael T.; Kummer, Markus P.; Stutz, Andrea; Delekate, Andrea; Schwartz, Stephanie; Vieira-Saecker, Ana; Griep, Angelika; Axt, Daisy; Remus, Anita; Tzeng, Te-Chen; Gelpi, Ellen; Halle, Annett; Korte, Martin; Latz, Eicke; Golenbock, Douglas T.			NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice	NATURE			English	Article							LONG-TERM POTENTIATION; AMYLOID CLEARANCE; BETA; MICROGLIA; CNS; INTERLEUKIN-1-BETA; EXPRESSION; IL-1-BETA; ENZYME; MEMORY	Alzheimer's disease is the world's most common dementing illness. Deposition of amyloid-beta peptide drives cerebral neuroinflammation by activating microglia(1,2). Indeed, amyloid-beta activation of the NLRP3 inflammasome in microglia is fundamental for interleukin-1 beta maturation and subsequent inflammatory events(3). However, it remains unknown whether NLRP3 activation contributes to Alzheimer's disease in vivo. Here we demonstrate strongly enhanced active caspase-1 expression in human mild cognitive impairment and brains with Alzheimer's disease, suggesting a role for the inflammasome in this neurodegenerative disease. Nlrp3(-/-) or Casp1(-/-) mice carrying mutations associated with familial Alzheimer's disease were largely protected from loss of spatial memory and other sequelae associated with Alzheimer's disease, and demonstrated reduced brain caspase-1 and interleukin-1 beta activation as well as enhanced amyloid-beta clearance. Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of amyloid-beta in the APP/PS1 model of Alzheimer's disease. These results show an important role for the NLRP3/caspase-1 axis in the pathogenesis of Alzheimer's disease, and suggest that NLRP3 inflammasome inhibition represents a new therapeutic intervention for the disease.	[Heneka, Michael T.; Kummer, Markus P.; Schwartz, Stephanie; Vieira-Saecker, Ana; Griep, Angelika; Axt, Daisy] Univ Bonn, Dept Neurol, Clin Neurosci Unit, D-53127 Bonn, Germany; [Heneka, Michael T.; Latz, Eicke] DZNE, D-53175 Bonn, Germany; [Stutz, Andrea; Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Delekate, Andrea; Remus, Anita; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany; [Tzeng, Te-Chen; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Tzeng, Te-Chen; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Gelpi, Ellen] Univ Barcelona, Hosp Clin, IDIBAPS, Neurol Tissue Bank, E-08036 Barcelona, Spain; [Halle, Annett] Ctr Adv European Studies & Res CAESAR, D-53175 Bonn, Germany; [Korte, Martin] AG NIND, HZI, Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Braunschweig University of Technology; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Helmholtz-Center for Infection Research	Latz, E (corresponding author), DZNE, D-53175 Bonn, Germany.	michael.Heneka@ukb.uni-bonn.de; eicke.latz@uni-bonn.de; douglas.golenbock@umassmed.edu	Latz, Eicke/H-3951-2014; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Latz, Eicke/0000-0003-1488-5666; Kummer, Markus P./0000-0002-0993-2918; Heneka, Michael/0000-0003-4996-1630	Dana Foundation; National Institutes of Health; Deutsche Forschungsgemeinschaft; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084048, R01AI083713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060] Funding Source: NIH RePORTER	Dana Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Dana Foundation (E. L.), the National Institutes of Health (E. L., D. T. G.) and the Deutsche Forschungsgemeinschaft (E. L., M. T. H.). We thank G. Nunez and V. M. Dixit for providing anti-caspase-1 Abs. We thank B. De Strooper and L. Serneels for the BACE1 knockout mice and discussion. We also thank H. Jacobsen for the BACE1 transgenic mice.	Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Murray CA, 1998, J NEUROSCI, V18, P2974; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004	30	1533	1625	28	481	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					674	+		10.1038/nature11729	http://dx.doi.org/10.1038/nature11729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23254930	Green Accepted, Green Submitted			2022-12-01	WOS:000314219600057
J	Juncadella, IJ; Kadl, A; Sharma, AK; Shim, YM; Hochreiter-Hufford, A; Borish, L; Ravichandran, KS				Juncadella, Ignacio J.; Kadl, Alexandra; Sharma, Ashish K.; Shim, Yun M.; Hochreiter-Hufford, Amelia; Borish, Larry; Ravichandran, Kodi S.			Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation	NATURE			English	Article							DUST MITE ALLERGEN; ASTHMA; RESPONSES; FAMILY; ENGULFMENT; MECHANISM; MIMICRY; PROTEIN; INNATE; MOUSE	Lung epithelial cells can influence immune responses to airway allergens(1,2). Airway epithelial cells also undergo apoptosis after encountering environmental allergens(3); yet, relatively little is known about how these are cleared, and their effect on airway inflammation. Here we show that airway epithelial cells efficiently engulf apoptotic epithelial cells and secrete anti-inflammatory cytokines, dependent upon intracellular signalling by the small GTPase Rac1. Inducible deletion of Rac1 expression specifically in airway epithelial cells in a mouse model resulted in defective engulfment by epithelial cells and aberrant anti-inflammatory cytokine production. Intranasal priming and challenge of these mice with house dust mite extract or ovalbumin as allergens led to exacerbated inflammation, augmented Th2 cytokines and airway hyper-responsiveness, with decreased interleukin (IL)-10 in bronchial lavages. Rac1-deficient epithelial cells produced much higher IL-33 upon allergen or apoptotic cell encounter, with increased numbers of nuocyte-like cells(1,4,5). Administration of exogenous IL-10 'rescued' the airway inflammation phenotype in Rac1-deficient mice, with decreased IL-33. Collectively, these genetic and functional studies suggest a new role for Rac1-dependent engulfment by airway epithelial cells and in establishing the anti-inflammatory environment, and that defects in cell clearance in the airways could contribute to inflammatory responses towards common allergens.	[Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Borish, Larry; Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Kadl, Alexandra; Shim, Yun M.; Borish, Larry] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Sharma, Ashish K.] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA; [Borish, Larry] Univ Virginia, Ctr Asthma & Allerg Dis, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Shim, Yun Michael/N-2049-2017; Kadl, Alexandra/AAV-3395-2021	Shim, Yun Michael/0000-0002-3780-3371; Sharma, Ashish/0000-0002-1234-6039; Ravichandran, Kodi/0000-0001-9049-1410	Immunology Training Grant; NHLBI; American Asthma Foundation; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI057438, U01AI100799] Funding Source: NIH RePORTER	Immunology Training Grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Asthma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Ravichandran laboratory for their suggestions, especially J. Kinchen and P. Trampont. We thank J. Whitsett for the rtTA-CCSP/Cre mice, X. Liu for the TGF-beta responsive cell line PE25, and J. Steinke and J. Kennedy for providing human nasal epithelial cells. This work was supported by an Immunology Training Grant (I. J. J.), a F32 postdoctoral fellowship from the NHLBI (I. J. J.), and grants from the American Asthma Foundation and the National Institutes of Health (K. S. R.). K. S. R. has been a William Benter Senior Fellow of the American Asthma Foundation.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fahy JV, 2011, AM J RESP CRIT CARE, V184, P390, DOI 10.1164/rccm.201107-1258ED; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Jyonouchi H, 1999, APOPTOSIS, V4, P407, DOI 10.1023/A:1009607607603; Kirsch T, 2007, BLOOD, V109, P2854, DOI 10.1182/blood-2006-06-026187; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Thomas WR, 2009, EXPERT REV CLIN IMMU, V5, P233, DOI [10.1586/eci.09.5, 10.1586/ECI.09.5]; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; White Steven R, 2011, J Allergy (Cairo), V2011, P948406, DOI 10.1155/2011/948406; Yamada Y, 2004, PEDIAT ALLERG IMM-UK, V15, P159, DOI 10.1111/j.1399-3038.2004.00155.x	30	195	205	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					547	+		10.1038/nature11714	http://dx.doi.org/10.1038/nature11714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235830	Green Accepted			2022-12-01	WOS:000313871400041
J	Yamanaka, S; Mehta, S; Reyes-Turcu, FE; Zhuang, FL; Fuchs, RT; Rong, YK; Robb, GB; Grewal, SIS				Yamanaka, Soichiro; Mehta, Sameet; Reyes-Turcu, Francisca E.; Zhuang, Fanglei; Fuchs, Ryan T.; Rong, Yikang; Robb, Gregory B.; Grewal, Shiv I. S.			RNAi triggered by specialized machinery silences developmental genes and retrotransposons	NATURE			English	Article							MEIOTIC MESSENGER-RNAS; FISSION YEAST; ELIMINATION; PROMOTES; COMPLEX; TRANSCRIPTOME; SURVEILLANCE; MAINTENANCE; METHYLATION; NUCLEATION	RNA interference (RNAi) is a conserved mechanism in which small interfering RNAs (siRNAs) guide the degradation of cognate RNAs, but also promote heterochromatin assembly at repetitive DNA elements such as centromeric repeats(1,2). However, the full extent of RNAi functions and its endogenous targets have not been explored. Here we show that, in the fission yeast Schizosaccharomyces pombe, RNAi and heterochromatin factors cooperate to silence diverse loci, including sexual differentiation genes, genes encoding transmembrane proteins, and retrotransposons that are also targeted by the exosome RNA degradation machinery. In the absence of the exosome, transcripts are processed preferentially by the RNAi machinery, revealing siRNA clusters and a corresponding increase in heterochromatin modifications across large domains containing genes and retrotransposons. We show that the generation of siRNAs and heterochromatin assembly by RNAi is triggered by a mechanism involving the canonical poly(A) polymerase Pla1 and an associated RNA surveillance factor Red1, which also activate the exosome. Notably, siRNA production and heterochromatin modifications at these target loci are regulated by environmental growth conditions, and by developmental signals that induce gene expression during sexual differentiation. Our analyses uncover an interaction between RNAi and the exosome that is conserved in Drosophila, and show that differentiation signals modulate RNAi silencing to regulate developmental genes.	[Yamanaka, Soichiro; Mehta, Sameet; Reyes-Turcu, Francisca E.; Rong, Yikang; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhuang, Fanglei; Fuchs, Ryan T.; Robb, Gregory B.] New England Biolabs Inc, Ipswich, MA 01938 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New England Biolabs	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Mehta, Sameet/A-1936-2011	Mehta, Sameet/0000-0002-3029-3217; Robb, Gregory Brett/0000-0002-2382-2256; Grewal, Shiv/0000-0002-4552-9261	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523, ZIABC010446] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Zofall and K. Zhang for contributions, J. Barrowman for editing the manuscript, M. Yamamoto for the pla1-37 strain, E. Lei for the Drosophila rrp6 mutant, B. Walker and M. Pineda for their help in sequencing, and Grewal laboratory members for discussions. This study used the Helix Systems and the Biowulf Linux cluster at the National Institutes of Health. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Munafo DB, 2010, RNA, V16, P2537, DOI 10.1261/rna.2242610; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tarailo-Graovac Maja, 2009, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s25; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	32	101	105	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					557	+		10.1038/nature11716	http://dx.doi.org/10.1038/nature11716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23151475	Green Accepted			2022-12-01	WOS:000313871400043
J	Coelho, PS; Brustad, EM; Kannan, A; Arnold, FH				Coelho, Pedro S.; Brustad, Eric M.; Kannan, Arvind; Arnold, Frances H.			Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes	SCIENCE			English	Article							STEREOSELECTIVE CYCLOPROPANATION; IRON; PROMISCUITY	Transition metal-catalyzed transfers of carbenes, nitrenes, and oxenes are powerful methods for functionalizing C = C and C-H bonds. Nature has evolved a diverse toolbox for oxene transfers, as exemplified by the myriad monooxygenation reactions catalyzed by cytochrome P450 enzymes. The isoelectronic carbene transfer to olefins, a widely used C-C bond-forming reaction in organic synthesis, has no biological counterpart. Here we report engineered variants of cytochrome P450(BM3) that catalyze highly diastereo- and enantioselective cyclopropanation of styrenes from diazoester reagents via putative carbene transfer. This work highlights the capacity to adapt existing enzymes for the catalysis of synthetically important reactions not previously observed in nature.	[Coelho, Pedro S.; Kannan, Arvind; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Brustad, Eric M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Brustad, Eric M.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Arnold, Frances H./0000-0002-4027-364X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-06ER15762]; Ruth M. Kirschstein National Institutes of Health (NIH) from the National Institute of General Medical Sciences [F32GM087102]; University of North Carolina Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087102] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Ruth M. Kirschstein National Institutes of Health (NIH) from the National Institute of General Medical Sciences; University of North Carolina Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-06ER15762. E.M.B. was supported by a Ruth M. Kirschstein National Institutes of Health (NIH) postdoctoral fellowship, award number F32GM087102, from the National Institute of General Medical Sciences and a generous startup fund from the University of North Carolina Chapel Hill. P.S.C., E.M.B., and F.H.A. have filed through the California Institute of Technology a provisional patent application that is based on the results presented here. The authors thank Z. J. Wang for helpful discussions during the preparation of the manuscript.	Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Breslow R, 2009, J BIOL CHEM, V284, P1337, DOI 10.1074/jbc.X800011200; Caballero A, 2009, EUR J INORG CHEM, P1137, DOI 10.1002/ejic.200800944; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Lewis JC, 2009, CHIMIA, V63, P309, DOI 10.2533/chimia.2009.309; Morandi B, 2012, SCIENCE, V335, P1471, DOI 10.1126/science.1218781; Nicolas I, 2008, COORDIN CHEM REV, V252, P727, DOI 10.1016/j.ccr.2007.09.003; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Wessjohann LA, 2003, CHEM REV, V103, P1625, DOI 10.1021/cr0100188; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; WOLF JR, 1995, J AM CHEM SOC, V117, P9194, DOI 10.1021/ja00141a011	16	494	507	21	583	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					307	310		10.1126/science.1231434	http://dx.doi.org/10.1126/science.1231434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23258409				2022-12-01	WOS:000313622000040
J	Boden, WE; Franklin, BA; Wenger, NK				Boden, William E.; Franklin, Barry A.; Wenger, Nanette K.			Physical Activity and Structured Exercise for Patients With Stable Ischemic Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL THERAPY; CORONARY; PREVENTION; INTENSITY		[Boden, William E.] Samuel Stratton VA Med Ctr, Dept Med, Albany, NY 12208 USA; [Boden, William E.] Albany Med Coll, Albany, NY 12208 USA; [Franklin, Barry A.] William Beaumont Hosp, Dept Prevent Cardiol Rehabil, Royal Oak, MI 48072 USA; [Franklin, Barry A.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Wenger, Nanette K.] Grady Mem Hosp, Dept Med, Div Cardiol, Atlanta, GA USA; [Wenger, Nanette K.] Emory Univ, Sch Med, Atlanta, GA USA	Albany Medical College; Beaumont Health; Oakland University; Emory University	Boden, WE (corresponding author), Samuel Stratton VA Med Ctr, Dept Med, 113 Holland Ave, Albany, NY 12208 USA.	william.boden@va.gov						Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2009, NEW ENGL J MED, V360, P2570, DOI 10.1056/NEJMe0904090; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Myers J, 2008, CLIN INVEST MED, V31, pE400; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Wen CP, 2012, LANCET, V380, P192, DOI 10.1016/S0140-6736(12)60954-4	10	33	35	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					143	144		10.1001/jama.2012.128367	http://dx.doi.org/10.1001/jama.2012.128367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299603				2022-12-01	WOS:000313517000020
J	Alonzo, F; Kozhaya, L; Rawlings, SA; Reyes-Robles, T; DuMont, AL; Myszka, DG; Landau, NR; Unutmaz, D; Torres, VJ				Alonzo, Francis, III; Kozhaya, Lina; Rawlings, Stephen A.; Reyes-Robles, Tamara; DuMont, Ashley L.; Myszka, David G.; Landau, Nathaniel R.; Unutmaz, Derya; Torres, Victor J.			CCR5 is a receptor for Staphylococcus aureus leukotoxin ED	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTORS; CHEMOKINE RECEPTORS; HIV-1 INFECTION; BIOSENSOR TECHNOLOGY; SMALL-MOLECULE; CORECEPTOR; RESISTANT; CELLS; IDENTIFICATION	Pore-forming toxins are critical virulence factors for many bacterial pathogens and are central to Staphylococcus aureus-mediated killing of host cells. S. aureus encodes pore-forming bi-component leukotoxins that are toxic towards neutrophils, but also specifically target other immune cells. Despite decades since the first description of staphylococcal leukocidal activity, the host factors responsible for the selectivity of leukotoxins towards different immune cells remain unknown. Here we identify the human immunodeficiency virus (HIV) co-receptor CCR5 as a cellular determinant required for cytotoxic targeting of subsets of myeloid cells and T lymphocytes by the S. aureus leukotoxin ED (LukED). We further demonstrate that LukED-dependent cell killing is blocked by CCR5 receptor antagonists, including the HIV drug maraviroc. Remarkably, CCR5-deficient mice are largely resistant to lethal S. aureus infection, highlighting the importance of CCR5 targeting in S. aureus pathogenesis. Thus, depletion of CCR5(+) leukocytes by LukED suggests a new immune evasion mechanism of S. aureus that can be therapeutically targeted.	[Alonzo, Francis, III; Kozhaya, Lina; Rawlings, Stephen A.; Reyes-Robles, Tamara; DuMont, Ashley L.; Landau, Nathaniel R.; Unutmaz, Derya; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Myszka, David G.] Biosensor Tools LLC, Salt Lake City, UT 84103 USA	New York University; New York University; New York University	Torres, VJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	derya.unutmaz@nyumc.org; victor.torres@nyumc.org	Rawlings, Stephen/ABA-6797-2020	Rawlings, Stephen/0000-0003-3637-1447; Torres, Victor/0000-0002-7126-0489; Unutmaz, Derya/0000-0001-8898-6633	New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant [09SDG2060036]; National Institutes of Health (NIH) [R56-AI091856-01A1]; NIH [T32-AI007180, R42-MH084372-02A1, R21-AI087973, R01-AI065303]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091856, F32AI098395, R21AI087973, T32AI007180, R01AI065303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R42MH084372] Funding Source: NIH RePORTER	New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Torres laboratory, D. R. Littman, M. Lu, and A. Darwin for reading this manuscript. We also thank V. KewalRamani for providing reagents, and S. Polsky for assistance with purification of PBMCs. This research was supported by New York University School of Medicine Development Funds, an American Heart Association Scientist Development Grant (09SDG2060036) to V.J.T. and National Institutes of Health (NIH) grants R56-AI091856-01A1 to V.J.T., NIH training grant T32-AI007180 to F. A., A. L. D. and S. A. R., NIH R42-MH084372-02A1 to D. G. M., and NIH R21-AI087973 and R01-AI065303 grants to D.U.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Caccuri F, 2012, P NATL ACAD SCI USA, V109, P14580, DOI 10.1073/pnas.1206605109; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Didigu CA, 2012, VIRUSES-BASEL, V4, P309, DOI 10.3390/v4020309; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Giagulli C, 2012, BLOOD, V119, P2274, DOI 10.1182/blood-2011-06-364083; Golding H, 2003, BLOOD, V102, P3280, DOI 10.1182/blood-2003-04-1096; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hedrick PW, 2006, TRENDS GENET, V22, P293, DOI 10.1016/j.tig.2006.04.007; Hummel S, 2005, GENES IMMUN, V6, P371, DOI 10.1038/sj.gene.6364172; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lucotte G, 2002, INFECT GENET EVOL, V1, P201, DOI 10.1016/S1567-1348(02)00027-8; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Moore PCL, 2002, J MED MICROBIOL, V51, P516, DOI 10.1099/0022-1317-51-6-516; Morner A, 1999, J VIROL, V73, P2343; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Navratilova I, 2006, ANAL BIOCHEM, V353, P278, DOI 10.1016/j.ab.2006.03.049; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Panton PN, 1932, LANCET, V1, P506; Rahbar R, 2009, J VIROL, V83, P2226, DOI 10.1128/JVI.01655-08; Rich RL, 2009, ANAL BIOCHEM, V386, P98, DOI 10.1016/j.ab.2008.12.011; Saita Y, 2007, INT IMMUNOPHARMACOL, V7, P1528, DOI 10.1016/j.intimp.2007.07.019; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Van de Velde H., 1894, CELLULE, V10, P403; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	44	205	212	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					51	+		10.1038/nature11724	http://dx.doi.org/10.1038/nature11724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23235831	Green Accepted			2022-12-01	WOS:000312933800028
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: sexual health medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION					destwo@yahoo.co.uk						Centers for Disease Control and Prevention, 2012, HIV TRANSM RISK; Centers for Disease Control and Prevention, 2010, CDC AN NAT HERP PREV; Centers for Disease Control and Prevention, 2012, GEN HPV INF FACT SHE; ClinicalTrials.gov, 2012, HOM SELF TEST HIV IN; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Health Protection Agency, 2011, HIV UK 2011 REP; Scoular A, 2002, BRIT MED J, V324, P1366, DOI 10.1136/bmj.324.7350.1366; Spence Des, 2010, BMJ, V340, pc2547, DOI 10.1136/bmj.c2547; van Valkengoed IGM, 2004, INT J EPIDEMIOL, V33, P416, DOI 10.1093/ije/dyh029; Wallace LA, 2008, SEX TRANSM INFECT, V84, P171, DOI 10.1136/sti.2007.026047; Ward H, 2005, BRIT MED J, V330, P1173, DOI 10.1136/bmj.330.7501.1173	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8643	10.1136/bmj.e8643	http://dx.doi.org/10.1136/bmj.e8643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284162				2022-12-01	WOS:000313236300001
J	Arnheim-Dahlstrom, L; Hallgren, J; Weibull, CE; Sparen, P				Arnheim-Dahlstrom, Lisen; Hallgren, Jonas; Weibull, Caroline E.; Sparen, Par			Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; YOUNG-CHILDREN; UNITED-STATES; A H1N1; IMMUNIZATION; CONVULSIONS; MORTALITY; MEASLES; MUMPS	Objective To assess the risk of epileptic seizures in people with and without epilepsy after vaccination with a monovalent AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix; Glaxo SmithKline, Sweden). Design Register based self controlled case series. Setting Three Swedish counties (source population 750 000). Participants 373 398 people (age 0-106, median 41.2) who were vaccinated. Vaccinated people with epileptic seizures, diagnosed as inpatients or outpatients, at any time from 90 days before until 90 days after any dose of vaccine. Main outcome measures Endpoints were admission to hospital or outpatient hospital care with epileptic seizures as the main diagnosis. The effect estimate of relative incidence was calculated as the incidence of epileptic seizures in period after exposure relative to the incidence of epileptic seizures in two control periods, one before and one after vaccination. Results 859 people experienced epileptic seizures during the study period. There was no increased risk of seizures in people with previously diagnosed epilepsy (relative incidence 1.01, 95% confidence interval 0.74 to 1.39) and a non-significant decrease in risk for people without epilepsy (0.67, 0.27 to 1.65) during the day 1-7 risk period (where day 1 is the day of vaccination). In a second risk period (day 8-30), there was a non-significant increased risk of seizures in people without epilepsy (1.11, 0.73 to 1.70) but no increase in risk for those with epilepsy (1.00, 0.83 to 1.21). Conclusions This study found no evidence of an increase in risk of presentation to hospital with epileptic seizures after vaccination with a monovalent AS03 adjuvanted pandemic H1N1 influenza vaccine.	[Arnheim-Dahlstrom, Lisen; Hallgren, Jonas; Weibull, Caroline E.; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden	Karolinska Institutet	Arnheim-Dahlstrom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se	Weibull, Caroline/AAJ-5755-2020	Sparen, Par/0000-0002-5184-8971	GlaxoSmithKline Biologicals in Belgium; GlaxoSmithKline	GlaxoSmithKline Biologicals in Belgium; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by a grant from GlaxoSmithKline Biologicals in Belgium. The authors had full access to all the data in the study and had the full responsibility to submit the report for publication. The opinions presented in the report do not necessarily reflect those of the funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that all the authors received unconditional grants from GlaxoSmithKline for the submitted study.	[Anonymous], 1993, EPILEPSIA, V34, P592; Brown NJ, 2007, CURR OPIN NEUROL, V20, P181, DOI 10.1097/WCO.0b013e3280555160; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Epilepsy Foundation America, 2010, SEC EP FDN AM 2010; European Medicines Agency, 13 PAND PHARM UPD; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; GALE JL, 1994, JAMA-J AM MED ASSOC, V271, P37, DOI 10.1001/jama.271.1.37; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; KULENKAMPFF M, 1974, ARCH DIS CHILD, V49, P46, DOI 10.1136/adc.49.1.46; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Leroy Z, 2012, VACCINE, V30, P2020, DOI 10.1016/j.vaccine.2011.12.042; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mayet A, 2011, VACCINE, V29, P2576, DOI 10.1016/j.vaccine.2011.01.056; Mitrakrishnan S, 2011, VACCINE, V29, P6369, DOI 10.1016/j.vaccine.2011.04.126; Munch JS, 2010, INT MARIT HEALTH, V61, P246; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Polkinghorne BG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-291; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Shorvon S, 2008, EPILEPSIA, V49, P219, DOI 10.1111/j.1528-1167.2007.01478.x; Stowe J, 2011, VACCINE, V29, P9467, DOI 10.1016/j.vaccine.2011.10.029; Tomson T, 2000, J NEUROL, V247, P15, DOI 10.1007/s004150050004; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; van Puijenbroek EP, 2010, DRUG SAFETY, V33, P1097, DOI 10.2165/11539270-000000000-00000; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	27	15	15	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2012	345								e7594	10.1136/bmj.e7594	http://dx.doi.org/10.1136/bmj.e7594			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PQ	23274350	Green Published, hybrid			2022-12-01	WOS:000312932200001
J	Merkin, J; Russell, C; Chen, P; Burge, CB				Merkin, Jason; Russell, Caitlin; Chen, Ping; Burge, Christopher B.			Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues	SCIENCE			English	Article							TIGHT JUNCTIONS; TRANSCRIPTOME; CONSERVATION; EXPRESSION; ERK	Most mammalian genes produce multiple distinct messenger RNAs through alternative splicing, but the extent of splicing conservation is not clear. To assess tissue-specific transcriptome variation across mammals, we sequenced complementary DNA from nine tissues from four mammals and one bird in biological triplicate, at unprecedented depth. We find that while tissue-specific gene expression programs are largely conserved, alternative splicing is well conserved in only a subset of tissues and is frequently lineage-specific. Thousands of previously unknown, lineage-specific, and conserved alternative exons were identified; widely conserved alternative exons had signatures of binding by MBNL, PTB, RBFOX, STAR, and TIA family splicing factors, implicating them as ancestral mammalian splicing regulators. Our data also indicate that alternative splicing often alters protein phosphorylatability, delimiting the scope of kinase signaling.	[Merkin, Jason; Russell, Caitlin; Chen, Ping; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Chen, Ping] Univ Helsinki, Syst Biol Lab, Res Programs Unit, FIN-00014 Helsinki, Finland; [Chen, Ping] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00014 Helsinki, Finland	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Helsinki; University of Helsinki	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020; Chen, Ping/AAL-8264-2020	Chen, Ping/0000-0002-8068-1891	Broad Institute SPARC grant; NIH training grant; Academy of Finland (Center of Excellence in Cancer Genetics Research); Sigrid Juselius Foundation; FICS; NIH [OD011092]; NSF [0821391]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Broad Institute SPARC grant; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland (Center of Excellence in Cancer Genetics Research); Sigrid Juselius Foundation(Sigrid Juselius Foundation); FICS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.M. and C. B. B. designed the study and wrote the manuscript. J.M. collected tissue samples, extracted RNA, conducted computational analyses, and prepared figures. C. R. prepared RNA-Seq libraries and developed protocols. P. C. contributed computational analyses. We thank A. Robertson for analysis of coding potential of alternative isoforms; E. Wang for help with the Mbnl1 CLIP analysis; D. Treacy for assistance with library preparation; S. McGeary, D. Page, A. Pai, C. Lin, and members of the Burge lab for comments on the manuscript; and the MIT BioMicro Center for assistance with sequencing. This work was supported by a Broad Institute SPARC grant (C. B. B.), by an NIH training grant (J.M.), by a fellowship from the Academy of Finland (Center of Excellence in Cancer Genetics Research), Sigrid Juselius Foundation and FICS (P. C.), by NIH grant OD011092 to the Oregon National Primate Research Center, by grant 0821391 from the NSF, and by grants from the NIH (to C. B. B.). Sequence data associated with this manuscript have been submitted to NCBI Gene Expession Omnibus (accession no. GSE41637).	Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Ladd AN, 2002, GENOME BIOL, V3; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Samak G, 2011, AM J PHYSIOL-GASTR L, V301, pG50, DOI 10.1152/ajpgi.00494.2010; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	30	559	579	5	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1593	1599		10.1126/science.1228186	http://dx.doi.org/10.1126/science.1228186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258891	Green Accepted, Green Submitted			2022-12-01	WOS:000312533100046
J	Price, RM				Price, Rebecca M.			How We Got Here: An Inquiry-Based Activity About Human Evolution	SCIENCE			English	Editorial Material									Univ Washington, Bothell, WA 98011 USA	University of Washington; University of Washington Bothell	Price, RM (corresponding author), Univ Washington, Box 358530,18115 Campus Way NE, Bothell, WA 98011 USA.	becca.price@uwb.edu						Bransford JD., 2000, PEOPLE LEARN BRAIN M; Bybee R.W., 1997, ACHIEVING SCI LITERA; DeHaan RL, 2011, SCIENCE, V334, P1499, DOI 10.1126/science.1207918; Handelsman J., 2007, SCI TEACHING; Karukstis Kerry K, 2007, DEV SUSTAINING RES S; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Meikle W. E., 2010, EVOLUTION ED OUTREAC, V3, P573; Price RM, 2012, AM BIOL TEACH, V74, P106, DOI 10.1525/abt.2012.74.2.8	8	3	3	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1554	1555		10.1126/science.1215221	http://dx.doi.org/10.1126/science.1215221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258884				2022-12-01	WOS:000312533100040
J	Lariviere, L; Plaschka, C; Seizl, M; Wenzeck, L; Kurth, F; Cramer, P				Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick			Structure of the Mediator head module	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION INITIATION; PREINITIATION COMPLEX; MAXIMUM-LIKELIHOOD; YEAST; RECRUITMENT; PROTEIN; CTD; ARCHITECTURE; HOLOENZYME	Gene transcription by RNA polymerase (Pol) II requires the coactivator complex Mediator. Mediator connects transcriptional regulators and Pol II, and is linked to human disease(1-4). Mediator from the yeast Saccharomyces cerevisiae has a molecular mass of 1.4 megadaltons and comprises 25 subunits that form the head, middle, tail and kinase modules(5-7). The head module constitutes one-half of the essential Mediator core(8), and comprises the conserved(9) subunits Med6, Med8, Med11, Med17, Med18, Med20 and Med22. Recent X-ray analysis of the S. cerevisiae head module at 4.3 angstrom resolution led to a partial architectural model with three submodules called neck, fixed jaw and moveable jaw(10). Here we determine de novo the crystal structure of the head module from the fission yeast Schizosaccharomyces pombe at 3.4 angstrom resolution. Structure solution was enabled by new structures of Med6 and the fixed jaw, and previous structures of the moveable jaw(11) and part of the neck(12), and required deletion of Med20. The S. pombe head module resembles the head of a crocodile with eight distinct elements, of which at least four are mobile. The fixed jaw comprises tooth and nose domains, whereas the neck submodule contains a helical spine and one limb, with shoulder, arm and finger elements. The arm and the essential shoulder contact other parts of Mediator. The jaws and a central joint are implicated in interactions with Pol II and its carboxy-terminal domain, and the joint is required for transcription in vitro. The S. pombe head module structure leads to a revised model of the S. cerevisiae module, reveals a high conservation and flexibility, explains knownmutations, and provides the basis for unravelling a central mechanism of gene regulation.	[Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick] Univ Munich, CIPSM, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Lariviere, L (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	larivier@genzentrum.lmu.de; cramer@genzentrum.lmu.de		Plaschka, Clemens/0000-0002-6020-9514	Boehringer Ingelheim fellowship; Elite Network of Bavaria; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMU innovativ project Bioimaging Network; Vallee Foundation; Jung-Stiftung	Boehringer Ingelheim fellowship(Boehringer Ingelheim); Elite Network of Bavaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMU innovativ project Bioimaging Network; Vallee Foundation; Jung-Stiftung	We thank S. Baumli, A. C. Cheung, A. Imhof and C. Schmidt for help. We acknowledge the crystallization facility at the Max Planck Institute of Biochemistry, Martinsried. Diffraction data were collected at the Swiss Light Source, Villigen, Switzerland. M.S. was supported by a Boehringer Ingelheim fellowship and the Elite Network of Bavaria. P.C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMU innovativ project Bioimaging Network, the Vallee Foundation, and the Jung-Stiftung.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W., 2011, SEMIN CELL DEV BIOL; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1914, DOI 10.1107/S0907444903020511; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; Knablein J, 1997, J MOL BIOL, V270, P1, DOI 10.1006/jmbi.1997.1074; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Lariviere L., 2012, CURR OPIN CELL BIOL; Lariviere L, 2008, GENE DEV, V22, P872, DOI 10.1101/gad.465108; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; NONET ML, 1989, GENETICS, V123, P715; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; SCHNEIDER G, 1994, ACTA CRYSTALLOGR D, V50, P186, DOI 10.1107/S0907444993009679; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tan Q, 2000, GENE DEV, V14, P339; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpps.20, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	48	76	78	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					448	+		10.1038/nature11670	http://dx.doi.org/10.1038/nature11670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23123849	Green Published			2022-12-01	WOS:000312488200060
J	Stagnaro-Green, A; Sullivan, S; Pearce, EN				Stagnaro-Green, Alex; Sullivan, Scott; Pearce, Elizabeth N.			Iodine Supplementation During Pregnancy and Lactation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; POSTPARTUM; MANAGEMENT		[Stagnaro-Green, Alex] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Sullivan, Scott] Med Univ S Carolina, Dept Obstet Gynecol, Charleston, SC 29425 USA; [Pearce, Elizabeth N.] Boston Univ, Sch Med, Endocrinol Sect, Boston, MA 02118 USA	George Washington University; Medical University of South Carolina; Boston University	Stagnaro-Green, A (corresponding author), George Washington Univ, Sch Med & Hlth Sci, 2300 1 St,Ross Hall,Ste 712, Washington, DC 20037 USA.	alexsg@gwu.edu		Stagnaro-Green, Alex/0000-0003-2434-3852; Pearce, Elizabeth/0000-0003-3799-0354				[Anonymous], 2007, ASS IOD DEF DIS MON; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Food and Nutrition Board, 2006, DIET REF INT, P320; Glinoer D, 2007, PUBLIC HEALTH NUTR, V10, P1542, DOI 10.1017/S1368980007360886; Gregory CO, 2009, THYROID, V19, P1019, DOI 10.1089/thy.2009.0166; Leung AM, 2009, NEW ENGL J MED, V360, P939, DOI 10.1056/NEJMc0807851; Obican SG, 2012, BIRTH DEFECTS RES A, V94, P677, DOI 10.1002/bdra.23051; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Zimmermann MB, 2012, CURR OPIN ENDOCRINOL, V19, P382, DOI 10.1097/MED.0b013e328357271a	10	26	31	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2463	2464		10.1001/jama.2012.45423	http://dx.doi.org/10.1001/jama.2012.45423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288022				2022-12-01	WOS:000312441400020
J	Sobczak, JPJ; Martin, TG; Gerling, T; Dietz, H				Sobczak, Jean-Philippe J.; Martin, Thomas G.; Gerling, Thomas; Dietz, Hendrik			Rapid Folding of DNA into Nanoscale Shapes at Constant Temperature	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ORIGAMI; PROTEINS; STATE	We demonstrate that, at constant temperature, hundreds of DNA strands can cooperatively fold a long template DNA strand within minutes into complex nanoscale objects. Folding occurred out of equilibrium along nucleation-driven pathways at temperatures that could be influenced by the choice of sequences, strand lengths, and chain topology. Unfolding occurred in apparent equilibrium at higher temperatures than those for folding. Folding at optimized constant temperatures enabled the rapid production of three-dimensional DNA objects with yields that approached 100%. The results point to similarities with protein folding in spite of chemical and structural differences. The possibility for rapid and high-yield assembly will enable DNA nanotechnology for practical applications.	[Sobczak, Jean-Philippe J.; Martin, Thomas G.; Gerling, Thomas; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany	Technical University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Walter Schottky Inst, Coulombwall 4A, D-85748 Garching, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662	Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM; Deutsche Forschungsgemeinschaft [SFB863]; Technische Universitat Munchen Institute for Advanced Study; European Research Council [256270]	Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Munchen Institute for Advanced Study; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM and the SFB863, the Technische Universitat Munchen Institute for Advanced Study, and a European Research Council Starting Grant to H. D. (GA no. 256270). We thank E. Lin Shiao for preliminary experiments, M. Schickinger for the design of the gearlike object, C. Castro for the design of the hinged-bar object, F. Praetorius for preparing scaffold DNA, and B. Wei and P. Yin for supplying DNA strands for tile-based DNA objects. Additional data described in this work can be found in the online supplementary materials.	Alberts B., 2002, MOL BIOL CELL; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Jungmann R, 2008, J AM CHEM SOC, V130, P10062, DOI 10.1021/ja8030196; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/NNANO.2010.107, 10.1038/nnano.2010.107]; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; Martin TG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2095; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Wei RS, 2012, ANGEW CHEM INT EDIT, V51, P4864, DOI 10.1002/anie.201200688; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	30	192	194	2	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1458	1461		10.1126/science.1229919	http://dx.doi.org/10.1126/science.1229919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239734				2022-12-01	WOS:000312250800045
J	Shen, K; Arslan, S; Akopian, D; Ha, T; Shan, SO				Shen, Kuang; Arslan, Sinan; Akopian, David; Ha, Taekjip; Shan, Shu-ou			Activated GTPase movement on an RNA scaffold drives co-translational protein targeting	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; SINGLE-MOLECULE FRET; SRP RNA; CRYSTAL-STRUCTURE; RECEPTOR; RIBOSOME; COMPLEX; MECHANISM; TRANSLOCATION; COMPONENTS	Approximately one-third of the proteome is initially destined for the eukaryotic endoplasmic reticulum or the bacterial plasma membrane(1). The proper localization of these proteins is mediated by a universally conserved protein-targeting machinery, the signal recognition particle (SRP), which recognizes ribosomes carrying signal sequences(2-4) and, through interactions with the SRP receptor(5,6), delivers them to the protein-translocation machinery on the target membrane(7). The SRP is an ancient ribonucleoprotein particle containing an essential, elongated SRP RNA for which precise functions have remained elusive. Here we used single-molecule fluorescence microscopy to show that the Escherichia coli SRP-SRP receptor GTPase complex, after initial assembly at the tetra-loop end of SRP RNA, travels over 100 angstrom to the distal end of this RNA, where rapid GTP hydrolysis occurs. This movement is negatively regulated by the translating ribosome and, at a later stage, positively regulated by the SecYEG translocon, providing an attractive mechanism for ensuring the productive exchange of the targeting and translocation machineries at the ribosome exit site with high spatial and temporal accuracy. Our results show that large RNAs can act as molecular scaffolds that enable the easy exchange of distinct factors and precise timing of molecular events in a complex cellular process; this concept may be extended to similar phenomena in other ribonucleoprotein complexes.	[Shen, Kuang; Akopian, David; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Arslan, Sinan; Ha, Taekjip] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu	Shen, Kuang/H-9441-2016; Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Arslan, Sinan/0000-0001-7270-8372	National Institutes of Health (NIH) [GM078024, GM45162, GM065367]; Caltech [350270]; Beckman Young Investigator award; David and Lucile Packard Fellowship in Science and Engineering; Henry Dreyfus Teacher-Scholar award; National Science Foundation Physics Frontiers Centers program [08222613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R37GM045162, R01GM078024, R01GM045162] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech; Beckman Young Investigator award; David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar award; National Science Foundation Physics Frontiers Centers program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Ban and members of the Shan group for comments on the manuscript, C. Richards, L. Cai, T. Zhiyentayev, K. Lee and R. Zhou for help with RNClabelling and the instrument and software setup, and C.L. Guo, S. Kouand H. Lester for discussions. This work is supported by National Institutes of Health (NIH) grant GM078024 to S.-o.S., an NIH instrument supplement to grant GM45162 to D.C. Rees, and Caltech matching fund 350270 for the single-molecule instruments. S.-o.S. was supported by the Beckman Young Investigator award, the David and Lucile Packard Fellowship in Science and Engineering, and the Henry Dreyfus Teacher-Scholar award. T.H. was supported by National Science Foundation Physics Frontiers Centers program (08222613) and NIH grant GM065367.	ALTHOFF S, 1994, NUCLEIC ACIDS RES, V22, P1933, DOI 10.1093/nar/22.11.1933; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hoskins AA, 2011, CURR OPIN CHEM BIOL, V15, P864, DOI 10.1016/j.cbpa.2011.10.010; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; YUAN R, 1981, ANNU REV BIOCHEM, V50, P285, DOI 10.1146/annurev.bi.50.070181.001441; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	38	62	63	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					271	+		10.1038/nature11726	http://dx.doi.org/10.1038/nature11726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235881	Green Accepted			2022-12-01	WOS:000312259300046
J	Nikfardjam, M				Nikfardjam, Mariam			Omega-3 fatty acids and cardioprotection-IIb or not IIb?	LANCET			English	Editorial Material									Med Univ Vienna, A-1090 Vienna, Austria	Medical University of Vienna	Nikfardjam, M (corresponding author), Med Univ Vienna, A-1090 Vienna, Austria.	mariam.nikfardjam@meduniwien.ac.at						Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; ClinicalTrials.gov, RISK PREV STUD EV EF; ClinicalTrials.gov, VIT D OM 3 TRIAL VIT; ClinicalTrials.gov, STUD CARD EV IN DIAB; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					1976	1977		10.1016/S0140-6736(12)62039-X	http://dx.doi.org/10.1016/S0140-6736(12)62039-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23217853				2022-12-01	WOS:000312124900008
J	McMorran, BJ; Wieczorski, L; Drysdale, KE; Chan, JA; Huang, HM; Smith, C; Mitiku, C; Beeson, JG; Burgio, G; Foote, SJ				McMorran, Brendan J.; Wieczorski, Laura; Drysdale, Karen E.; Chan, Jo-Anne; Huang, Hong Ming; Smith, Clare; Mitiku, Chalachew; Beeson, James G.; Burgio, Gaetan; Foote, Simon J.			Platelet Factor 4 and Duffy Antigen Required for Platelet Killing of Plasmodium falciparum	SCIENCE			English	Article							ERYTHROCYTE CHEMOKINE RECEPTOR; SEVERE MALARIA; MICROBICIDAL PROTEINS; STAPHYLOCOCCUS-AUREUS; AFRICAN CHILDREN; BLOOD-CELLS; THROMBOCYTOPENIA; INFECTION; CHOLESTEROL; INHIBITION	Platelets restrict the growth of intraerythrocytic malaria parasites by binding to parasitized cells and killing the parasite within. Here, we show that the platelet molecule platelet factor 4 (PF4 or CXCL4) and the erythrocyte Duffy-antigen receptor (Fy) are necessary for platelet-mediated killing of Plasmodium falciparum parasites. PF4 is released by platelets on contact with parasitized red cells, and the protein directly kills intraerythrocytic parasites. This function for PF4 is critically dependent on Fy, which binds PF4. Genetic disruption of Fy expression inhibits binding of PF4 to parasitized cells and concomitantly prevents parasite killing by both human platelets and recombinant human PF4. The protective function afforded by platelets during a malarial infection may therefore be compromised in Duffy-negative individuals, who do not express Fy.	[McMorran, Brendan J.; Huang, Hong Ming; Burgio, Gaetan; Foote, Simon J.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [McMorran, Brendan J.; Wieczorski, Laura; Drysdale, Karen E.; Smith, Clare; Mitiku, Chalachew; Burgio, Gaetan; Foote, Simon J.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Chan, Jo-Anne; Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia	Macquarie University; University of Tasmania; Burnet Institute	McMorran, BJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	brendan.mcmorran@mq.edu.au	Burgio, Gaetan/B-6722-2015; Foote, Simon J/F-2802-2013	Burgio, Gaetan/0000-0002-7434-926X; McMorran, Brendan/0000-0003-1845-8872; Foote, Simon/0000-0002-9142-2107; Smith, Clare M./0000-0003-2601-0955	National Health and Medical Research Council of Australia [605524, 490037]; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia; Bill and Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute; Australian Research Council [DP120100061]; Victorian State Government Operational Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Bill and Melinda Gates Foundation Grand Challenges Explorations(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support Scheme	We thank the Australian Red Cross Blood Services in Hobart and Brisbane for providing red blood cells and antibodies, the platelet donors, and C. Flowers and R. McWhirter for phlebotomy. We also acknowledge funding support from the National Health and Medical Research Council of Australia (grants 605524 and 490037), the Australian Cancer Research Foundation, the National Collaborative Research Infrastructure Strategy of Australia, The Bill and Melinda Gates Foundation Grand Challenges Explorations, The Howard Hughes Medical Institute, Australian Research Council (grant DP120100061 and Future Fellowship to J.G.B.), and the Victorian State Government Operational Infrastructure Support Scheme. Ethics approval for the platelet donations was received from the Human Research Ethics Committee (Tasmania) Network (H0009004). Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.8sb5h	Adedapo Aduragbenro D., 2007, Journal of Vector Borne Diseases, V44, P266; Akimitsu N, 2004, PARASITOL RES, V93, P499, DOI 10.1007/s00436-004-1165-x; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HORSTMANN RD, 1981, BLUT, V42, P157, DOI 10.1007/BF01026385; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Kashiwazaki M, 2003, INT IMMUNOL, V15, P1219, DOI 10.1093/intimm/dxg121; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; LU ZH, 1995, J BIOL CHEM, V270, P26239; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Peterson JE, 2010, AM J HEMATOL, V85, P487, DOI 10.1002/ajh.21732; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; Polack B, 1997, HAEMOSTASIS, V27, P278; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xiong YQ, 2002, J INFECT DIS, V185, P348, DOI 10.1086/338514; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; ZUCKER MB, 1991, P SOC EXP BIOL MED, V198, P693	32	110	110	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1348	1351		10.1126/science.1228892	http://dx.doi.org/10.1126/science.1228892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224555	Green Published			2022-12-01	WOS:000311991200068
J	Sebastian, C; Zwaans, BMM; Silberman, DM; Gymrek, M; Goren, A; Zhong, L; Ram, O; Truelove, J; Guimaraes, AR; Toiber, D; Cosentino, C; Greenson, JK; MacDonald, AI; McGlynn, L; Maxwell, F; Edwards, J; Giacosa, S; Guccione, E; Weissleder, R; Bernstein, BE; Regev, A; Shiels, PG; Lombard, DB; Mostoslavsky, R				Sebastian, Carlos; Zwaans, Bernadette M. M.; Silberman, Dafne M.; Gymrek, Melissa; Goren, Alon; Zhong, Lei; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Toiber, Debra; Cosentino, Claudia; Greenson, Joel K.; MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Giacosa, Sofia; Guccione, Ernesto; Weissleder, Ralph; Bernstein, Bradley E.; Regev, Aviv; Shiels, Paul G.; Lombard, David B.; Mostoslavsky, Raul			The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; C-MYC; GENE-EXPRESSION; RIBOSOMAL DNA; TUMORIGENESIS; TRANSCRIPTION; GLYCOLYSIS; PHYSIOLOGY; INTEGRITY; MUTATION	Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.	[Zwaans, Bernadette M. M.; Greenson, Joel K.; Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Sebastian, Carlos; Silberman, Dafne M.; Goren, Alon; Zhong, Lei; Ram, Oren; Toiber, Debra; Cosentino, Claudia; Giacosa, Sofia; Bernstein, Bradley E.; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gymrek, Melissa; Bernstein, Bradley E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gymrek, Melissa] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Goren, Alon; Ram, Oren; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Weissleder, Ralph; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Shiels, Paul G.] Univ Glasgow, MVLS, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Guccione, Ernesto] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Silberman, Dafne M.] CEFyBO UBA CONICET, Sch Med, Dept Human Biochem, Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of Glasgow; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Lombard, DB (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	davidlom@umich.edu; rmostoslavsky@mgh.harvard.edu	Sebastian, Carlos/H-8014-2018; Sebastian, Carlos/CAG-6271-2022; Cosentino, Claudia/AAF-1100-2019; Edwards, Joanne/J-1903-2015	Sebastian, Carlos/0000-0001-6623-8028; Edwards, Joanne/0000-0002-7192-6906; /0000-0003-0828-4143; Gymrek, Melissa/0000-0002-6086-3903; Lombard, David/0000-0002-4292-0185; Goren, Alon/0000-0001-5669-9357; Shiels, Paul/0000-0002-7577-9843	NIH [GM093072-01, DK088190-01A1, GM101171]; Sidney Kimmel Cancer Research Foundation; Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center; Nathan Shock Center [AG013283]; Pardee Foundation; Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya); National Defense Science and Engineering Graduate Fellowship; Brain Power for Israel Foundation; Fondazione Umberto Veronesi; NHGRI Center of Excellence in Genome Science [P50HG006193]; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072, R01GM101171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Research Foundation; Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center; Nathan Shock Center; Pardee Foundation; Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya)(Generalitat de Catalunya); National Defense Science and Engineering Graduate Fellowship; Brain Power for Israel Foundation; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NHGRI Center of Excellence in Genome Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH awards GM093072-01 and DK088190-01A1 (R.M.) and GM101171 (D.B.L.), the Sidney Kimmel Cancer Research Foundation (R.M.), the Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center (D.B.L.), the Nathan Shock Center (AG013283; D.B.L.), and the Pardee Foundation (D.B.L.). R.M. is a Howard Goodman Scholar and an MGH Research Scholar. D.B.L. is a New Scholar in Aging of the Ellison Medical Foundation. C.S. is the recipient of a Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya). M.G. is supported by a National Defense Science and Engineering Graduate Fellowship. D.T. is the recipient of the Brain Power for Israel Foundation. C.C. is supported by a Fellowship from the Fondazione Umberto Veronesi. A.R. is supported by a P50HG006193 from the NHGRI Center of Excellence in Genome Science. D.B.L. would like to thank Dr. Chuxia Deng (NIDDK/NIH) for the floxed SIRT6 mouse strain. We thank Nabeel Bardeesy, Eric Fearon, Alexandros Tzatsos, Polina Paskaleva, Kevin Haigis, Agustina D'Urso, Marco Bezzi, and the Mostoslavsky and Lombard labs for technical advice, reagents, and helpful discussions. We thank the ENCODE Chromatin Project at the Broad Institute for data sharing. R.M. is a member of Sirtris scientific advisory board.	Anders M., 2011, MOL CARCINOG; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Martinez-Pastor B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00022; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; YAMAMOTO T, 1990, BIOCHEM BIOPH RES CO, V170, P223, DOI 10.1016/0006-291X(90)91263-R; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Younes M, 1996, CANCER RES, V56, P1164; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	44	481	502	0	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1185	1199		10.1016/j.cell.2012.10.047	http://dx.doi.org/10.1016/j.cell.2012.10.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217706	Green Accepted, Bronze			2022-12-01	WOS:000311999900010
J	Eisenstein, M				Eisenstein, Michael			CENTENARIANS Great expectations	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION											Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848	7	8	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S6	S8		10.1038/492S6a	http://dx.doi.org/10.1038/492S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222673				2022-12-01	WOS:000311893400004
J	Bleyer, A; Welch, HG				Bleyer, Archie; Welch, H. Gilbert			Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; THERAPY	Background To reduce mortality, screening must detect life-threatening disease at an earlier, more curable stage. Effective cancer-screening programs therefore both increase the incidence of cancer detected at an early stage and decrease the incidence of cancer presenting at a late stage. Methods We used Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 in the incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. Results The introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year, from 112 to 234 cases per 100,000 women - an absolute increase of 122 cases per 100,000 women. Concomitantly, the rate at which women present with late-stage cancer has decreased by 8%, from 102 to 94 cases per 100,000 women - an absolute decrease of 8 cases per 100,000 women. With the assumption of a constant underlying disease burden, only 8 of the 122 additional early-stage cancers diagnosed were expected to progress to advanced disease. After excluding the transient excess incidence associated with hormone-replacement therapy and adjusting for trends in the incidence of breast cancer among women younger than 40 years of age, we estimated that breast cancer was overdiagnosed (i.e., tumors were detected on screening that would never have led to clinical symptoms) in 1.3 million U.S. women in the past 30 years. We estimated that in 2008, breast cancer was overdiagnosed in more than 70,000 women; this accounted for 31% of all breast cancers diagnosed. Conclusions Despite substantial increases in the number of cases of early-stage breast cancer detected, screening mammography has only marginally reduced the rate at which women present with advanced cancer. Although it is not certain which women have been affected, the imbalance suggests that there is substantial overdiagnosis, accounting for nearly a third of all newly diagnosed breast cancers, and that screening is having, at best, only a small effect on the rate of death from breast cancer.	[Bleyer, Archie] St Charles Hlth Syst, Qual Dept, Cent Oregon, OR USA; [Bleyer, Archie] Oregon Hlth & Sci Univ, Dept Radiat Med, Portland, OR 97201 USA; [Bleyer, Archie] Univ Texas Med Sch Houston, Houston, TX USA; [Welch, H. Gilbert] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Oregon Health & Science University; University of Texas System; University of Texas Health Science Center Houston; Dartmouth College	Bleyer, A (corresponding author), 2500 NE Neff Rd, Bend, OR 97701 USA.	ableyer@gmail.com	wang, edwin/G-5372-2010	Welch, H. Gilbert/0000-0002-3448-1207				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; [Anonymous], 2005, SEER DAT 1973 2009 I; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Breen N, 2007, CANCER DETECT PREV, V31, P220, DOI 10.1016/j.cdp.2007.04.006; CHU KC, 1991, JNCI-J NATL CANCER I, V83, P1636, DOI 10.1093/jnci/83.22.1636; De P, 2010, JNCI-J NATL CANCER I, V102, P1489, DOI 10.1093/jnci/djq345; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gager J.G., 1992, BATTLEFIELDS KNOWLED, P3; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kopans DB, 2011, RADIOLOGY, V260, P616, DOI 10.1148/radiol.11110716; Ries LAG, 2007, SEER SURVIVAL MONOGR, P105; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT DAT BAS IN; United States Census Bureau, POP EST; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG, 1997, J GEN INTERN MED, V12, P118, DOI 10.1046/j.1525-1497.1997.00017.x; Welch HG, 2011, OVERDIAGNOSED MAKING, P84; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	21	891	911	0	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1998	2005		10.1056/NEJMoa1206809	http://dx.doi.org/10.1056/NEJMoa1206809			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171096	Bronze			2022-12-01	WOS:000311340200007
J	Firth, P; Ttendo, S				Firth, Paul; Ttendo, Stephen			Intensive Care in Low-Income Countries - A Critical Need	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFRICA		[Firth, Paul] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ttendo, Stephen] Mbarara Reg Referral Hosp, Dept Anaesthesia & Crit Care, Mbarara, Uganda	Harvard University; Massachusetts General Hospital	Firth, P (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.			Firth, Paul/0000-0003-1909-5225				[Anonymous], 2011, BMJ-BRIT MED J, DOI DOI 10.1136/bmj.d7031; Central Intelligence Agency, WORLD FACTB; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Towey RM, 2008, AFR HEALTH SCI, V8, P61	5	47	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1974	1976		10.1056/NEJMp1204957	http://dx.doi.org/10.1056/NEJMp1204957			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171093				2022-12-01	WOS:000311340200003
J	Bintu, L; Ishibashi, T; Dangkulwanich, M; Wu, YY; Lubkowska, L; Kashlev, M; Bustamante, C				Bintu, Lacramioara; Ishibashi, Toyotaka; Dangkulwanich, Manchuta; Wu, Yueh-Yi; Lubkowska, Lucyna; Kashlev, Mikhail; Bustamante, Carlos			Nucleosomal Elements that Control the Topography of the Barrier to Transcription	CELL			English	Article							RNA-POLYMERASE-II; HISTONE TAIL DOMAINS; DNA TRANSLOCATION; KINETIC-MODEL; ELONGATION; CHROMATIN; ACETYLATION; STABILITY; DYNAMICS; ARREST	The nucleosome represents a mechanical barrier to transcription that operates as a general regulator of gene expression. We investigate how each nucleosomal component-the histone tails, the specific histone-DNA contacts, and the DNA sequence-contributes to the strength of the barrier. Removal of the tails favors progression of RNA polymerase II into the entry region of the nucleosome by locally increasing the wrapping-unwrapping rates of the DNA around histones. In contrast, point mutations that affect histone-DNA contacts at the dyad abolish the barrier to transcription in the central region by decreasing the local wrapping rate. Moreover, we show that the nucleosome amplifies sequence-dependent transcriptional pausing, an effect mediated through the structure of the nascent RNA. Each of these nucleosomal elements controls transcription elongation by affecting distinctly the density and duration of polymerase pauses, thus providing multiple and alternative mechanisms for control of gene expression by chromatin remodeling and transcription factors.	[Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Ishibashi, Toyotaka; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Dangkulwanich, Manchuta; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wu, Yueh-Yi; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Lubkowska, Lucyna; Kashlev, Mikhail] NCI Ctr Canc Res, Frederick, MD 21702 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustamante, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Ishibashi, Toyotaka/AAW-2687-2020	Ishibashi, Toyotaka/0000-0001-8015-2319; Dangkulwanich, Manchuta/0000-0001-8927-0952; Bustamante, Carlos/0000-0002-2970-0073	NIH [R01-GM032543-31]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; JSPS; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Hodges, S. Kassube, S. Sternberg, B. Zamft, and members of the Bustamante laboratory for assistance and discussions. T. I. is supported by a fellowship from JSPS. This work was supported by NIH grant R01-GM032543-31 (C. B.) and by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract No. DE-AC02-05CH11231 (C.B.).	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Greive SJ, 2011, BIOPHYS J, V101, P1155, DOI 10.1016/j.bpj.2011.07.042; Greive SJ, 2011, BIOPHYS J, V101, P1166, DOI 10.1016/j.bpj.2011.07.043; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Protacio RU, 2000, MOL CELL BIOL, V20, P8866, DOI 10.1128/MCB.20.23.8866-8878.2000; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Ujvari A, 2008, J BIOL CHEM, V283, P32236, DOI 10.1074/jbc.M806636200; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Xu F, 2010, NUCLEIC ACIDS RES, V38, P6872, DOI 10.1093/nar/gkq506; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	41	124	130	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					738	749		10.1016/j.cell.2012.10.009	http://dx.doi.org/10.1016/j.cell.2012.10.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141536	Green Accepted, Bronze			2022-12-01	WOS:000310921200007
J	Gire, SK; Stremlau, M; Andersen, KG; Schaffner, SF; Bjornson, Z; Rubins, K; Hensley, L; McCormick, JB; Lander, ES; Garry, RF; Happi, C; Sabeti, PC				Gire, Stephen K.; Stremlau, Matthew; Andersen, Kristian G.; Schaffner, Stephen F.; Bjornson, Zach; Rubins, Kathleen; Hensley, Lisa; McCormick, Joseph B.; Lander, Eric. S.; Garry, Robert F.; Happi, Christian; Sabeti, Pardis C.			Emerging Disease or Diagnosis?	SCIENCE			English	Editorial Material							LASSA FEVER; EBOLA-VIRUS; NIGERIA					sgire@oeb.harvard.edu; psabeti@oeb.harvard.edu	Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011; Andersen, Kristian/D-5006-2009	Andersen, Kristian/0000-0001-6431-5982; Schaffner, Stephen/0000-0001-6699-3568; Hensley, Lisa/0000-0003-1188-4342; Happi, Christian/0000-0002-3056-6705; Garry, Robert/0000-0002-5683-3250; McCormick, Joseph/0000-0002-5844-8102	NIAID NIH HHS [AI2009061, AI2008031] Funding Source: Medline; NIH HHS [DP2 OD006514, 1DP2OD006514-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Ehichioya DU, 2011, J CLIN MICROBIOL, V49, P1157, DOI 10.1128/JCM.01891-10; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Oaks J, 1992, EMERGING INFECT MICR; Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371	17	23	24	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					750	752		10.1126/science.1225893	http://dx.doi.org/10.1126/science.1225893			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033ZI	23139320				2022-12-01	WOS:000310839500029
J	Rafelski, SM; Viana, MP; Zhang, Y; Chan, YHM; Thorn, KS; Yam, P; Fung, JC; Li, H; Costa, LD; Marshall, WF				Rafelski, Susanne M.; Viana, Matheus P.; Zhang, Yi; Chan, Yee-Hung M.; Thorn, Kurt S.; Yam, Phoebe; Fung, Jennifer C.; Li, Hao; Costa, Luciano da F.; Marshall, Wallace F.			Mitochondrial Network Size Scaling in Budding Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; INHERITANCE; DAUGHTER; DIVISION; GROWTH	Mitochondria must grow with the growing cell to ensure proper cellular physiology and inheritance upon division. We measured the physical size of mitochondrial networks in budding yeast and found that mitochondrial network size increased with increasing cell size and that this scaling relation occurred primarily in the bud. The mitochondria-to-cell size ratio continually decreased in aging mothers over successive generations. However, regardless of the mother's age or mitochondrial content, all buds attained the same average ratio. Thus, yeast populations achieve a stable scaling relation between mitochondrial content and cell size despite asymmetry in inheritance.	[Rafelski, Susanne M.; Zhang, Yi; Chan, Yee-Hung M.; Thorn, Kurt S.; Li, Hao; Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Rafelski, Susanne M.; Chan, Yee-Hung M.; Li, Hao; Marshall, Wallace F.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA; [Viana, Matheus P.; Costa, Luciano da F.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Zhang, Yi] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Zhang, Yi] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Yam, Phoebe; Fung, Jennifer C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Sao Paulo; Peking University; Peking University; University of California System; University of California San Francisco	Rafelski, SM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	susanner@uci.edu; wallace.marshall@ucsf.edu	da F. Costa, Luciano/H-5475-2011; Viana, Matheus/A-7137-2012	da F. Costa, Luciano/0000-0001-5203-4366; Viana, Matheus/0000-0001-9288-2108; Thorn, Kurt/0000-0001-9310-288X; Zhang, Yi/0000-0001-6609-8635	Sandler Postdoctoral Fellowship; Herbert Boyer Junior Faculty Endowed Chair Award; NIH [R01GM097017, R01GM070808, R01GM026259, P50Gm081879, 5RO1GM097213-02]; NIH National Research Service Award fellowship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [05/00587-5, 07/50882-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301303/06-1]; Packard Fellowship; China Scholarship Council (CSC) scholarship; Boyer Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097017, R01GM097213, R01GM070808, R01GM026259, P50GM081879] Funding Source: NIH RePORTER	Sandler Postdoctoral Fellowship; Herbert Boyer Junior Faculty Endowed Chair Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Packard Fellowship(The David & Lucile Packard Foundation); China Scholarship Council (CSC) scholarship(China Scholarship Council); Boyer Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nunnari, J. Shaw, and A. Lewandowska for plasmids, strains, and discussions; G. Pesce for sharing unpublished results and discussions; and A. Caudy, E. Hong, K. C. Huang, A. Rosebrock, and the Marshall laboratory for reading the manuscript. Microscopy was performed at the UCSF Nikon Imaging Center. This work was supported by Sandler and Boyer Postdoctoral Fellowships (S. M. R.); the Herbert Boyer Junior Faculty Endowed Chair Award and NIH grant R01GM097017 (W. F. M.); an NIH National Research Service Award fellowship (Y.-H.M.C.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (05/00587-5, 07/50882-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (301303/06-1) grants (L.d.F.C. and M. P. V.); NIH grants R01GM070808, R01GM026259, P50Gm081879, and a Packard Fellowship (Y.Z. and H. L.); a China Scholarship Council (CSC) scholarship (Y.Z.); and NIH grant 5RO1GM097213-02 (P.Y. and J. C. F.). Image analysis algorithms are described in detail in methods (6). The data are included in the main and supplementary figures.	Devin A, 2004, TOXICOL MECH METHOD, V14, P271, DOI 10.1080/15376520490479620; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; TANAKA K, 1985, J CELL SCI, V73, P207; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; WOLDRINGH CL, 1993, J BACTERIOL, V175, P3174, DOI 10.1128/JB.175.10.3174-3181.1993	11	111	113	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					822	824		10.1126/science.1225720	http://dx.doi.org/10.1126/science.1225720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139336	Green Accepted			2022-12-01	WOS:000310839500051
J	Schubeler, D				Schuebeler, Dirk			Epigenetic Islands in a Genetic Ocean	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; DNA METHYLATION; BASE-RESOLUTION; IN-VIVO; TRANSCRIPTION; 5-HYDROXYMETHYLCYTOSINE; REGIONS; BINDING; STATES		Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	dirk@fmi.ch						Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	25	38	40	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					756	757		10.1126/science.1227243	http://dx.doi.org/10.1126/science.1227243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139324				2022-12-01	WOS:000310839500033
J	Shyh-Chang, N; Locasale, JW; Lyssiotis, CA; Zheng, YX; Teo, RY; Ratanasirintrawoot, S; Zhang, J; Onder, T; Unternaehrer, JJ; Zhu, H; Asara, JM; Daley, GQ; Cantley, LC				Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Asara, John M.; Daley, George Q.; Cantley, Lewis C.			Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; MOUSE; GLYCINE; CANCER; CHROMATIN	Threonine is the only amino acid critically required for the pluripotency of mouse embryonic stem cells (mESCs), but the detailed mechanism remains unclear. We found that threonine and S-adenosylmethionine (SAM) metabolism are coupled in pluripotent stem cells, resulting in regulation of histone methylation. Isotope labeling of mESCs revealed that threonine provides a substantial fraction of both the cellular glycine and the acetyl-coenzyme A (CoA) needed for SAM synthesis. Depletion of threonine from the culture medium or threonine dehydrogenase (Tdh) from mESCs decreased accumulation of SAM and decreased trimethylation of histone H3 lysine 4 (H3K4me3), leading to slowed growth and increased differentiation. Thus, abundance of SAM appears to influence H3K4me3, providing a possible mechanism by which modulation of a metabolic pathway might influence stem cell fate.	[Ng Shyh-Chang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Ng Shyh-Chang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ng Shyh-Chang; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ng Shyh-Chang; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ng Shyh-Chang; Daley, George Q.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA; [Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; lewis_cantley@hms.harvard.edu	Locasale, Jason W/ABE-6505-2020; Onder, Tamer T/H-3330-2013; Cantley, Lewis C/D-1800-2014; Zhu, Hao/L-5114-2013; Onder, Tamer/O-3669-2019; ZHANG, JIN/D-1435-2013; Lyssiotis, Costas A/AAI-1923-2019	Locasale, Jason W/0000-0002-7766-3502; Onder, Tamer T/0000-0002-2372-9158; Cantley, Lewis C/0000-0002-1298-7653; Zhu, Hao/0000-0002-8417-9698; Onder, Tamer/0000-0002-2372-9158; Lyssiotis, Costas A/0000-0001-9309-6141; Shyh-Chang, Ng/0000-0003-3138-9525; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	NSS Scholarship from the Agency for Science, Technology and Research, Singapore; American Cancer Society; NIH [4R00CA168997-02, RC2HL102815, U01 HL100001, R01 GM56203]; Damon Runyon Cancer Research Foundation Amgen fellowship; iPierian Inc.; NATIONAL CANCER INSTITUTE [R00CA168997, K08CA157727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NSS Scholarship from the Agency for Science, Technology and Research, Singapore; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation Amgen fellowship; iPierian Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Daley and Cantley labs for helpful discussions. Supported by the NSS Scholarship from the Agency for Science, Technology and Research, Singapore (N.S.-C.), the American Cancer Society and NIH grant 4R00CA168997-02 (J.W.L.), a Damon Runyon Cancer Research Foundation Amgen fellowship (C. A. L.), NIH grants RC2HL102815 and U01 HL100001 (G. Q. D.), and NIH grant R01 GM56203 (L. C. C.). G. Q. D. is an investigator of the HHMI. G. Q. D., as a co-founder and scientific advisory board member, holds stock options and receives consulting fees from iPierian Inc., a biopharmaceutical company that uses iPS cells in drug discovery against neurologic disease. L. C. C. is the founder and a member of the board of directors of Agios Pharmaceuticals, a company that targets metabolic enzymes for cancer treatment.	Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BACKLUND PS, 1986, EUR J BIOCHEM, V160, P245, DOI 10.1111/j.1432-1033.1986.tb09963.x; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; EAGLE H, 1961, J BIOL CHEM, V236, P2039; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; McMillan JM, 2005, J PHARM PHARMACOL, V57, P599, DOI 10.1211/0022357056082; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	24	424	431	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					222	226		10.1126/science.1226603	http://dx.doi.org/10.1126/science.1226603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23118012	Green Accepted			2022-12-01	WOS:000313328200049
J	Boumil, MM				Boumil, Marcia M.			Off-Label Marketing and the First Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University	Boumil, MM (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.								0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					103	105		10.1056/NEJMp1214926	http://dx.doi.org/10.1056/NEJMp1214926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066RO	23234470				2022-12-01	WOS:000313238100014
J	Gu, WF; Lee, HC; Chaves, D; Youngman, EM; Pazour, GJ; Conte, D; Mello, CC				Gu, Weifeng; Lee, Heng-Chi; Chaves, Daniel; Youngman, Elaine M.; Pazour, Gregory J.; Conte, Darryl, Jr.; Mello, Craig C.			CapSeq and CIP-TAP Identify Pol II Start Sites and Reveal Capped Small RNAs as C. elegans piRNA Precursors	CELL			English	Article							POLYMERASE-II; DIVERGENT TRANSCRIPTION; EPIGENETIC MEMORY; PRIMAL RNAS; PIWI; GERMLINE; PROMOTER; COMPLEX; IDENTIFICATION; BIOGENESIS	Piwi-interacting (pi) RNAs are germline-expressed small RNAs linked to epigenetic programming. C. elegans piRNAs are thought to be transcribed as independent gene-like loci. To test this idea and to identify potential transcription start (TS) sites for piRNA precursors, we developed CapSeq, an efficient enzymatic method for 5' anchored RNA profiling. Using CapSeq, we identify candidate TS sites, defined by 70-90 nt sequence tags, for >50% of annotated Pol II loci. Surprisingly, however, these CapSeq tags failed to identify the overwhelming majority of piRNA loci. Instead, we show that the likely piRNA precursors are similar to 26 nt capped small (cs) RNAs that initiate precisely 2 nt upstream of mature piRNAs and that piRNA processing or stability requires a U at the csRNA +3 position. Finally, we identify a heretofore unrecognized class of piRNAs processed from csRNAs that are expressed at promoters genome wide, nearly doubling the number of piRNAs available for genome surveillance.	[Gu, Weifeng; Lee, Heng-Chi; Chaves, Daniel; Youngman, Elaine M.; Pazour, Gregory J.; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Youngman, Elaine/E-7072-2013; Youngman, Elaine/O-7449-2019	Pazour, Gregory/0000-0002-6285-8796; Lee, Heng-Chi/0000-0001-8154-906X	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, F32GM099372, R01GM060992, R01GM058800] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Mello lab for useful discussions, Tom Blumenthal for providing spliced leader sequences, Stephen Jones for providing mouse sample, Zhiping Weng for providing information about the mouse database, and Ellen Kittler for deep sequencing. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grant GM058800.	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Blumenthal T., 1997, RNA PROCESSING GENE; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRENNER S, 1974, GENETICS, V77, P71; Cecere G, 2012, MOL CELL, V47, P734, DOI 10.1016/j.molcel.2012.06.021; Chen CY, 2009, P NATL ACAD SCI USA, V106, P127, DOI 10.1073/pnas.0811689106; Conte D, 2010, CELL, V140, P452, DOI 10.1016/j.cell.2010.02.005; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu WF, 2011, METHODS MOL BIOL, V725, P251, DOI 10.1007/978-1-61779-046-1_17; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lamm AT, 2011, GENOME RES, V21, P265, DOI 10.1101/gr.108845.110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Morton JJ, 2011, RNA, V17, P327, DOI 10.1261/rna.2447111; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67	57	132	136	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1488	1500		10.1016/j.cell.2012.11.023	http://dx.doi.org/10.1016/j.cell.2012.11.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260138	Bronze, Green Accepted			2022-12-01	WOS:000312890300014
J	Li, JH; Cone, JE; Kahn, AR; Brackbill, RM; Farfel, MR; Greene, CM; Hadler, JL; Stayner, LT; Stellman, SD				Li, Jiehui; Cone, James E.; Kahn, Amy R.; Brackbill, Robert M.; Farfel, Mark R.; Greene, Carolyn M.; Hadler, James L.; Stayner, Leslie T.; Stellman, Steven D.			Association Between World Trade Center Exposure and Excess Cancer Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTER HEALTH REGISTRY; YORK-CITY FIREFIGHTERS; MULTIPLE-MYELOMA; CENTER DISASTER; PROSTATE-CANCER; COLLAPSE; COHORT; WORKERS; MORTALITY; SYMPTOMS	Context The terrorist attacks of September 11, 2001, resulted in the release of known and suspected carcinogens into the environment. There is public concern that exposures may have resulted in increased cancers. Objective To evaluate cancer incidence among persons enrolled in the World Trade Center Health Registry. Design, Setting, and Participants Observational study of 55 778 New York State residents enrolled in the World Trade Center Health Registry in 2003-2004, including rescue/recovery workers (n=21 850) and those not involved in rescue/recovery (n=33 928), who were followed up from enrollment through December 31, 2008. Within-cohort comparisons using Cox proportional hazards models assessed the relationship between intensity of World Trade Center exposure and selected cancers. Main Outcome Measures Cases were identified through linkage with 11 state cancer registries. Standardized incidence ratios (SIRs) adjusted for age, race/ethnicity, and sex were computed with 2003-2008 New York State rates as the reference, focusing on cancers diagnosed in 2007-2008 as being most likely to be related to exposure during September 11 and its aftermath. The total and site-specific incidence rate differences (RDs) per 100 000 person-years between the study population and the New York State population in 2007-2008 also were calculated. Results There were 1187 incident cancers diagnosed, with an accumulated 253 269 person-years (439 cancers among rescue/recovery workers and 748 among those not involved in rescue/recovery). The SIR for all cancer sites combined in 2007-2008 was not significantly elevated (SIR, 1.14 [95% CI, 0.99 to 1.30]; RD, 67 [95% CI, -6 to 126] per 100 000 person-years among rescue/recovery workers vs SIR, 0.92 [95% CI, 0.83 to 1.03]; RD, -45 [95% CI, -106 to 15] per 100 000 person-years among those not involved in rescue/recovery). Among rescue/recovery workers, the SIRs had significantly increased by 2007-2008 for 3 cancer sites and were 1.43 (95% CI, 1.11 to 1.82) for prostate cancer (n=67; RD, 61 [95% CI, 20 to 91] per 100 000 person-years), 2.02 (95% CI, 1.07 to 3.45) for thyroid cancer (n=13; RD, 16 [95% CI, 2 to 23] per 100 000 person-years), and 2.85 (95% CI, 1.15 to 5.88) for multiple myeloma (n=7; RD, 11 [95% CI, 2 to 14] per 100 000 person-years). No increased incidence was observed in 2007-2008 among those not involved in rescue/recovery. Using within-cohort comparisons, the intensity of World Trade Center exposure was not significantly associated with cancer of the lung, prostate, thyroid, non-Hodgkin lymphoma, or hematological cancer in either group. Conclusions Among persons enrolled in the World Trade Center Health Registry, there was an excess risk for prostate cancer, thyroid cancer, and myeloma in 20072008 compared with that for New York State residents; however, these findings were based on a small number of events and multiple comparisons. No significant associations were observed with intensity of World Trade Center exposures. Longer follow-up for typically long-latency cancers and attention to specific cancer sites are needed. JAMA. 2012;308(23):2479-2488 www.jama.com	[Li, Jiehui] New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, Long Isl City, NY 11101 USA; [Kahn, Amy R.] New York State Dept Hlth, Bur Canc Epidemiol, Albany, NY USA; [Stayner, Leslie T.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Stellman, Steven D.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; State University of New York (SUNY) System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University	Li, JH (corresponding author), New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, 42-09 28th St,7th Floor, Long Isl City, NY 11101 USA.	jli3@health.nyc.gov			National Institute for Occupational Safety and Health [1U50/OH009739]; Agency for Toxic Substances and Disease Registry [U50/ATU272750]; National Center for Environmental Health of the Centers for Disease Control and Prevention; New York City Department of Health and Mental Hygiene; New York State Department of Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U50OH009739] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Agency for Toxic Substances and Disease Registry(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Environmental Health of the Centers for Disease Control and Prevention; New York City Department of Health and Mental Hygiene; New York State Department of Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was supported by cooperative agreement 1U50/OH009739 from the National Institute for Occupational Safety and Health and cooperative agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry, which included support from the National Center for Environmental Health of the Centers for Disease Control and Prevention, and the New York City Department of Health and Mental Hygiene. Ms Kahn was supported by the New York State Department of Health.	Ahmed S, 2010, AM J ROENTGENOL, V195, P1066, DOI 10.2214/AJR.10.4506; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; ARMENIAN HK, 1974, AM J EPIDEMIOL, V99, P92, DOI 10.1093/oxfordjournals.aje.a121599; BOFFETTA P, 1989, INT J CANCER, V43, P554, DOI 10.1002/ijc.2910430404; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Breslow N. E., 1987, STATISTICAL METHODS, V2, P69; Cahill TA, 2004, AEROSOL SCI TECH, V38, P165, DOI 10.1080/02786820490250836; DEMERS PA, 1993, AM J IND MED, V23, P629, DOI 10.1002/ajim.4700230410; Edelman P, 2003, ENVIRON HEALTH PERSP, V111, P1906, DOI 10.1289/ehp.6315; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Horii Y, 2010, ENVIRON SCI TECHNOL, V44, P5188, DOI 10.1021/es100282d; HOWE GR, 1990, AM J EPIDEMIOL, V132, P1039, DOI 10.1093/oxfordjournals.aje.a115745; Jordan HT, 2011, LANCET, V378, P879, DOI 10.1016/S0140-6736(11)60966-5; Kipen HM, 2005, TXB CLIN OCCUPATIONA; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Moline JM, 2009, J OCCUP ENVIRON MED, V51, P896, DOI 10.1097/JOM.0b013e3181ad49c8; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; National Cancer Institute, SEER SIT REC ICD O 3; New York State Department of Health, 1976, PERC CANC DIAGN EARL; Perlman SE, 2011, LANCET, V378, P925, DOI 10.1016/S0140-6736(11)60967-7; Pleil JD, 2004, P NATL ACAD SCI USA, V101, P11685, DOI 10.1073/pnas.0404499101; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Rinsky RA, 2002, AM J IND MED, V42, P474, DOI 10.1002/ajim.10138; Russi MB, 2005, TXB CLIN OCCUPATIONA; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; SHORE RE, 1985, J NATL CANCER I, V74, P1177; Stellman SD, 2006, ENV OCCUPATIONAL MED, P1236; Weakley J, 2011, PREV MED, V53, P364, DOI 10.1016/j.ypmed.2011.09.001; Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860; Wisnivesky JP, 2011, LANCET, V378, P888, DOI 10.1016/S0140-6736(11)61180-X; Zeig-Owens R, 2011, LANCET, V378, P898, DOI 10.1016/S0140-6736(11)60989-6	34	79	79	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2479	2488		10.1001/jama.2012.110980	http://dx.doi.org/10.1001/jama.2012.110980			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288447	Green Published			2022-12-01	WOS:000312441400024
J	Spiegelhalter, D				Spiegelhalter, David			CHRISTMAS 2012: THOUGHTS FOR TODAY Using speed of ageing and "microlives" to communicate the effects of lifetime habits and environment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; HEALTH; TIME		Univ Cambridge, Stat Lab, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, D (corresponding author), Univ Cambridge, Stat Lab, Cambridge CB3 0WB, England.	d.spiegelhalter@statslab.cam.ac.uk						Chapman GB, 1996, J EXP PSYCHOL LEARN, V22, P771, DOI 10.1037/0278-7393.22.3.771; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [DOI 10.1111/J.1539-6053.2008.00033.X, 10.1111/j.1539-6053.2008.00033.x]; Haybittle JL, 1998, INT J EPIDEMIOL, V27, P885, DOI 10.1093/ije/27.5.885; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Nichols M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000957; Office of National Statistics, 2011, INT LIF TABL 2008 20; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Shaw M, 2000, BRIT MED J, V320, P53, DOI 10.1136/bmj.320.7226.53; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; Wells S, 2010, HEART, V96, P708, DOI 10.1136/hrt.2009.191320	12	10	10	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8223	10.1136/bmj.e8223	http://dx.doi.org/10.1136/bmj.e8223			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247978	Green Submitted			2022-12-01	WOS:000312698700018
J	Gayathri, P; Fujii, T; Moller-Jensen, J; van den Ent, F; Namba, K; Lowe, J				Gayathri, P.; Fujii, T.; Moller-Jensen, J.; van den Ent, F.; Namba, K.; Loewe, J.			A Bipolar Spindle of Antiparallel ParM Filaments Drives Bacterial Plasmid Segregation	SCIENCE			English	Article							DYNAMIC INSTABILITY; STRUCTURAL BASIS; DNA SEGREGATION; F-ACTIN; VISUALIZATION; MECHANISM	To ensure their stable inheritance by daughter cells during cell division, bacterial low-copy-number plasmids make simple DNA segregating machines that use an elongating protein filament between sister plasmids. In the ParMRC system of the Escherichia coli R1 plasmid, ParM, an actinlike protein, forms the spindle between ParRC complexes on sister plasmids. By using a combination of structural work and total internal reflection fluorescence microscopy, we show that ParRC bound and could accelerate growth at only one end of polar ParM filaments, mechanistically resembling eukaryotic formins. The architecture of ParM filaments enabled two ParRC-bound filaments to associate in an antiparallel orientation, forming a bipolar spindle. The spindle elongated as a bundle of at least two antiparallel filaments, thereby pushing two plasmid clusters toward the poles.	[Gayathri, P.; Moller-Jensen, J.; van den Ent, F.; Loewe, J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fujii, T.; Namba, K.] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Namba, K.] Riken Quantitat Biol Ctr, Suita, Osaka 5650871, Japan	MRC Laboratory Molecular Biology; Osaka University; RIKEN	Lowe, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Namba, Keiichi/A-9406-2016; Møller-Jensen, Jakob/AAO-8480-2020	Møller-Jensen, Jakob/0000-0002-6008-3771; Lowe, Jan/0000-0002-5218-6615; Gayathri, Pananghat/0000-0002-2242-4619	MRC [U105184326]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21227006]; FP7-IIF-2008 fellowship; Medical Research Council [MC_U105184326] Funding Source: researchfish; MRC [MC_U105184326] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FP7-IIF-2008 fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge N. Barry and C. Johnson (MRC-LMB, help with TIRF microscopy and isothermal titration calorimetry); T. Kato (Osaka University, technical support with cryo-EM); beamline support at ID29, ID14-2 (European Synchrotron Radiation Facility, France), and I02 (Diamond Light Source, UK); L. Amos, S. Bullock, A. Carter, and R. Gasper-Schonenbrucher (MRC-LMB, critical reading of the manuscript); and K. Gerdes (Newcastle University) and A. Toste Rego (MRC-LMB) (provision of reagents). Support by the MRC (U105184326 to J.L.), Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (21227006 to K. N.), and FP7-IIF-2008 fellowship (P. G.) is acknowledged. Protein Data Bank (PDB) accession codes: ParM-AMPPNP, 4A61; ParM-AMPPNP-ParR<INF>pept</INF>, 4A62. The EM reconstruction has been deposited in the Electron Microscopy Data Bank (EMD-1980), fitted coordinates in the PDB (4A6J).	Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Sun SX, 2010, CURR BIOL, V20, pR649, DOI 10.1016/j.cub.2010.07.004; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	22	63	65	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1334	1337		10.1126/science.1229091	http://dx.doi.org/10.1126/science.1229091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23112295	Green Accepted			2022-12-01	WOS:000311991200064
J	Zhuravleva, A; Clerico, EM; Gierasch, LM				Zhuravleva, Anastasia; Clerico, Eugenia M.; Gierasch, Lila M.			An Interdomain Energetic Tug-of-War Creates the Allosterically Active State in Hsp70 Molecular Chaperones	CELL			English	Article							SUBSTRATE-BINDING DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; WEIGHT PROTEINS; METHYL-GROUPS; DNAK; ATPASE; MUTATIONS; MECHANISM; INSIGHTS	The allosteric mechanism of Hsp70 molecular chaperones enables ATP binding to the N-terminal nucleotide-binding domain (NBD) to alter substrate affinity to the C-terminal substrate-binding domain (SBD) and substrate binding to enhance ATP hydrolysis. Cycling between ATP-bound and ADP/substrate-bound states requires Hsp70s to visit a state with high ATPase activity and fast on/off kinetics of substrate binding. We have trapped this "allosterically active'' state for the E. coli Hsp70, DnaK, and identified how interactions among the NBD, the beta subdomain of the SBD, the SBD alpha-helical lid, and the conserved hydrophobic interdomain linker enable allosteric signal transmission between ligand-binding sites. Allostery in Hsp70s results from an energetic tug-of-war between domain conformations and formation of two orthogonal interfaces: between the NBD and SBD, and between the helical lid and the beta subdomain of the SBD. The resulting energetic tension underlies Hsp70 functional properties and enables them to be modulated by ligands and cochaperones and "tuned'' through evolution.	[Zhuravleva, Anastasia; Clerico, Eugenia M.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu		Zhuravleva, Anastasia/0000-0001-6165-8509	NIH [GM027616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM027616. We thank Fabian Romano and Alejandro Heuck for assistance with the time-resolved fluorescence measurements.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keller R, 2004, THESIS ETH ZURICH; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	52	186	187	0	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1296	1307		10.1016/j.cell.2012.11.002	http://dx.doi.org/10.1016/j.cell.2012.11.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217711	Green Accepted, Bronze			2022-12-01	WOS:000311999900018
J	Rao, V				Rao, Veena			Law on infant foods inhibits the marketing of complementary foods for infants, furthering undernutrition in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India		Rao, V (corresponding author), Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India.	nobel_6@hotmail.com						Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Government of India Ministry of Health and Family Welfare, 2005, NAT FAM HLTH SURV 3, V3; Unicef, IND CHILDR; WHO, 2001, COMPL FEED REP GLOB; World Health Organization, 1981, INT COD MARK BREAST; World Health Organization (WHO), 2001, GLOB STRAT INF YOUNG; Zeigler J, 2006, CHILDRENS RIGHTS UN	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e8131	10.1136/bmj.e8131	http://dx.doi.org/10.1136/bmj.e8131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23204041	Green Submitted			2022-12-01	WOS:000311896500008
J	Misegades, LK; Winter, K; Harriman, K; Talarico, J; Messonnier, NE; Clark, TA; Martin, SW				Misegades, Lara K.; Winter, Kathleen; Harriman, Kathleen; Talarico, John; Messonnier, Nancy E.; Clark, Thomas A.; Martin, Stacey W.			Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EFFICACY; DIPHTHERIA; TETANUS	Context In 2010, California experienced its largest pertussis epidemic in more than 60 years; a substantial burden of disease was noted in the 7- to 10-year-old age group despite high diphtheria, tetanus, and acellular pertussis vaccine (DTaP) coverage, indicating the possibility of waning protection. Objective To evaluate the association between pertussis and receipt of 5 DTaP doses by time since fifth DTaP dose. Design, Setting, and Participants Case-control evaluation conducted in 15 California counties. Cases (n=682) were all suspected, probable, and confirmed pertussis cases among children aged 4 to 10 years reported from January through December 14, 2010; controls (n=2016) were children in the same age group who received care from the clinicians reporting the cases. Three controls were selected per case. Vaccination histories were obtained from medical records and immunization registries. Main Outcome Measures Primary outcomes were (1) odds ratios (ORs) for the association between pertussis and receipt of the 5-dose DTaP series and (2) ORs for the association between pertussis and time since completion (<12, 12-23, 24-35, 36-47, 48-59, or >= 60 months) of the 5-dose DTaP series. Logistic regression was used to calculate ORs, accounting for clustering by county and clinician, and vaccine effectiveness (VE) was estimated as (1-OR) x 100%. Results Among cases and controls, 53 (7.8%) and 19 (0.9%) had not received any pertussis-containing vaccines, respectively. Compared with controls, children with pertussis had a lower odds of having received all 5 doses of DTaP (OR, 0.11; 95% CI, 0.06-0.21 [estimated VE, 88.7%; 95% CI, 79.4%-93.8%]). When children were categorized by time since completion of the DTaP series, using an unvaccinated reference group, children with pertussis compared with controls were less likely to have received their fifth dose within the prior 12 months (19 [2.8%] vs 354 [17.6%], respectively; OR, 0.02; 95% CI, 0.01-0.04 [estimated VE, 98.1%; 95% CI, 96.1%-99.1%]). This association was evident with longer time since vaccination, with ORs increasing with time since the fifth dose. At 60 months or longer (n=231 cases [33.9%] and n=288 controls [14.3%]), the OR was 0.29 (95% CI, 0.15-0.54 [estimated VE, 71.2%; 95% CI, 45.8%-84.8%]). Accordingly, the estimated VE declined each year after receipt of the fifth dose of DTaP. Conclusion Among children in 15 California counties, children with pertussis, compared with controls, had lower odds of having received the 5-dose DTaP series; as time since last DTaP dose increased, the odds increased, which is consistent with a progressive decrease in estimated vaccine effectiveness each year after the final dose of pertussis vaccine. JAMA. 2012;308(20):2126-2132 www.jama.com	[Misegades, Lara K.; Messonnier, Nancy E.; Clark, Thomas A.; Martin, Stacey W.] US Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Misegades, Lara K.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Winter, Kathleen; Harriman, Kathleen; Talarico, John] Calif Dept Publ Hlth, Immunizat Branch, Richmond, VA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Misegades, LK (corresponding author), US Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,MS C25, Atlanta, GA 30329 USA.	lmisegades@cdc.gov						[Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2011, R LANG ENV STAT COMP; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; California Department of Health Services Immunization Branch, 2011, PERT REP; California Department of Public Health, 2010, PERT CDPH CAS DEF; Centers for Disease Control and Prevention, 2010, COV IND VACC VACC SE; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Clark T, 2011, NAT IMM C MARCH 30 W; CODY CL, 1981, PEDIATRICS, V68, P650; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Division of Integrated Surveillance Systems and Services National Center for Public Health Informatics Coordinating Center for Health Information and Service Centers for Disease Control and Prevention US Department of Health and Human Services, NAT NOT DIS SURV SYS; EDWARDS KM, 2004, VACCINES, P471; FINE PEM, 1987, REV INFECT DIS, V9, P866; Fitzmaurice G, 2000, NUTRITION, V16, P1114, DOI 10.1016/S0899-9007(00)00437-8; Friedrich MJ, 2011, JAMA-J AM MED ASSOC, V306, P27, DOI 10.1001/jama.2011.888; GROB PR, 1981, BRIT MED J, V282, P1925, DOI 10.1136/bmj.282.6280.1925; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; LONG SS, 1990, PEDIATRICS, V85, P294; Mieszkowski Katharine, 2010, NY TIMES; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Winter K, 2012, J PEDIAT, V2012, P20; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	31	180	181	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2126	2132		10.1001/jama.2012.14939	http://dx.doi.org/10.1001/jama.2012.14939			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188029	Bronze			2022-12-01	WOS:000311537200027
J	Fuglie, K; Heisey, P; King, J; Pray, CE; Schimmelpfennig, D				Fuglie, Keith; Heisey, Paul; King, John; Pray, Carl E.; Schimmelpfennig, David			The Contribution of Private Industry to Agricultural Innovation	SCIENCE			English	Editorial Material							PRODUCTIVITY; WILL		[Fuglie, Keith; Heisey, Paul; Schimmelpfennig, David] Econ Res Serv, USDA, Washington, DC 20472 USA; [King, John] USDA, Off Chief Scientist, Washington, DC 20250 USA; [Pray, Carl E.] Rutgers State Univ, New Brunswick, NJ 08901 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Rutgers State University New Brunswick	Schimmelpfennig, D (corresponding author), Econ Res Serv, USDA, Washington, DC 20472 USA.	des@ers.usda.gov		Fuglie, Keith/0000-0002-7601-0542; King, John/0000-0003-4947-0241				Alston J. M., 2004, California Agriculture, V58, P80, DOI 10.3733/ca.v058n02p80; Alston JM, 2010, NAT RES MANAG POLICY, V34, P1, DOI 10.1007/978-1-4419-0658-8; Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; Cohen JI, 2005, NAT BIOTECHNOL, V23, P27, DOI 10.1038/nbt0105-27; DASGUPTA P, 1980, ECON J, V90, P266, DOI 10.2307/2231788; Fuglie K., 2011, EC RES REP USDA; Fuglie K.O., 2001, J AGR APPL EC, V33, P459; Huffman W.E., 2006, SCI AGR LONG TERM PE, V2nd ed.; Klotz C., 1995, AGES9525 USDA EC RES; McDougall P., 2011, COST TIME INVOLVED D; McDougall P., 2016, COST NEW AGROCHEMICA; Pardey P. G., 2006, Agricultural research: a growing global divide?; Piesse J, 2010, PHILOS T R SOC B, V365, P3035, DOI 10.1098/rstb.2010.0140; Pingali PL, 2002, FOOD POLICY, V27, P223, DOI 10.1016/S0306-9192(02)00012-X; Pray C. E, 2007, HDB AGR EC, V3; Pray CE, 1998, WORLD DEV, V26, P1127, DOI 10.1016/S0305-750X(98)00040-0; Rubenstein KD, 2006, CROP SCI, V46, P1021, DOI 10.2135/cropsci2005.0129; SCHILDOW DV, 2004, CLIN RESP MED, P19; Wang CG, 2009, AM J AGR ECON, V91, P374, DOI 10.1111/j.1467-8276.2008.01246.x; World Bank, 2007, WORLD DEV REPORT 200	20	29	29	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1031	1032		10.1126/science.1226294	http://dx.doi.org/10.1126/science.1226294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180847				2022-12-01	WOS:000311390600026
J	Sprunck, S; Rademacher, S; Vogler, F; Gheyselinck, J; Grossniklaus, U; Dresselhaus, T				Sprunck, Stefanie; Rademacher, Svenja; Vogler, Frank; Gheyselinck, Jacqueline; Grossniklaus, Ueli; Dresselhaus, Thomas			Egg Cell-Secreted EC1 Triggers Sperm Cell Activation During Double Fertilization	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; ARABIDOPSIS; PLANTS; FUSION	Double fertilization is the defining characteristic of flowering plants. However, the molecular mechanisms regulating the fusion of one sperm with the egg and the second sperm with the central cell are largely unknown. We show that gamete interactions in Arabidopsis depend on small cysteine-rich EC1 (EGG CELL 1) proteins accumulating in storage vesicles of the egg cell. Upon sperm arrival, EC1-containing vesicles are exocytosed. The sperm endomembrane system responds to exogenously applied EC1 peptides by redistributing the potential gamete fusogen HAP2/GCS1 (HAPLESS 2/GENERATIVE CELL SPECIFIC 1) to the cell surface. Furthermore, fertilization studies with ec1 quintuple mutants show that successful male-female gamete interactions are necessary to prevent multiple-sperm cell delivery. Our findings provide evidence that mutual gamete activation, regulated exocytosis, and sperm plasma membrane modifications govern flowering plant gamete interactions.	[Sprunck, Stefanie; Rademacher, Svenja; Vogler, Frank; Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany; [Gheyselinck, Jacqueline; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Gheyselinck, Jacqueline; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	University of Regensburg; University of Zurich; University of Zurich	Sprunck, S (corresponding author), Univ Regensburg, Biochem Zentrum Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	stefanie.sprunck@biologie.uni-regensburg.de	Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974	Deutsche Forschungsgemeinschaft [SP 686/1-2, SFB924, DR 334/5]; Universitat Bayern e.V.; Australian Grains Research Development Corporation; Swiss National Science Foundation [3100AO-112489]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universitat Bayern e.V.; Australian Grains Research Development Corporation(Grains R&D Corp); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Seeds were kindly provided by M. Johnson (HAP2p:HAP2-YFP) and F. Berger (HTR10p:HTR10-mRFP1). We thank M. Gebert for her help in in situ hybridization, M. Gahrtz for providing plasmids, M. Kammerer and B. Bellmann for technical assistance, and F. Sprenger for his support in spinning disc microscopy. This work was supported by the Deutsche Forschungsgemeinschaft (grants SP 686/1-2 and SFB924 to S. S. and DR 334/5 to T. D.), by a graduate scholarship of Universitat Bayern e.V. (to S. R.), and, in part, by the Australian Grains Research Development Corporation (to T. D.) and the Swiss National Science Foundation (grant 3100AO-112489 to U. G.). S. S. and T. D. are inventors on a patent (WO 2007/092992) related to the EC1 promoter sequences. Accession numbers and author contributions are listed in the supplementary materials.	Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Gebert M, 2008, PLANT CELL, V20, P2798, DOI 10.1105/tpc.108.061028; Grote E, 2010, J CELL SCI, V123, P1902, DOI 10.1242/jcs.066662; Guignard M.L., 1899, REV G N BOT, V11, P129; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Hirohashi N, 2008, DEV GROWTH DIFFER, V50, pS221, DOI 10.1111/j.1440-169X.2008.01017.x; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Inoue N, 2011, ASIAN J ANDROL, V13, P81, DOI 10.1038/aja.2010.70; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Liu Y, 2008, ACTA METEOROL SIN, V22, P22; McCue AD, 2011, J EXP BOT, V62, P1621, DOI 10.1093/jxb/err032; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; Neill AT, 2004, REPRODUCTION, V127, P141, DOI 10.1530/rep.1.00085; Pan JM, 2000, CURR OPIN MICROBIOL, V3, P596, DOI 10.1016/S1369-5274(00)00146-6; Parrington J, 2007, DEV DYNAM, V236, P2027, DOI 10.1002/dvdy.21255; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Sprunck S, 2010, BIOCHEM SOC T, V38, P635, DOI 10.1042/BST0380635; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	23	204	221	9	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1093	1097		10.1126/science.1223944	http://dx.doi.org/10.1126/science.1223944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180860				2022-12-01	WOS:000311390600047
J	Davis, JG; Gierszal, KP; Wang, P; Ben-Amotz, D				Davis, Joel G.; Gierszal, Kamil P.; Wang, Ping; Ben-Amotz, Dor			Water structural transformation at molecular hydrophobic interfaces	NATURE			English	Article							HYDRATION; METHANE	Hydrophobic hydration is considered to have a key role in biological processes ranging from membrane formation to protein folding and ligand binding(1). Historically, hydrophobic hydration shells were thought to resemble solid clathrate hydrates(2-4), with solutes surrounded by polyhedral cages composed of tetrahedrally hydrogen-bonded water molecules. But more recent experimental(5-8) and theoretical(9-16) studies have challenged this view and emphasized the importance of the length scales involved. Here we report combined polarized, isotopic and temperature-dependent Raman scattering measurements with multivariate curve resolution (Raman-MCR)(17-19) that explore hydrophobic hydration by mapping the vibrational spectroscopic features arising from the hydrophobic hydration shells of linear alcohols ranging from methanol to heptanol. Our data, covering the entire 0-100 degrees C temperature range, show clear evidence that at low temperatures the hydration shells have a hydrophobically enhanced water structure with greater tetrahedral order and fewer weak hydrogen bonds than the surrounding bulk water. This structure disappears with increasing temperature and is then, for hydrophobic chains longer than similar to 1 nm, replaced by a more disordered structure with weaker hydrogen bonds than bulk water. These observations support our current understanding of hydrophobic hydration, including the thermally induced water structural transformation that is suggestive of the hydrophobic crossover predicted to occur at lengths of similar to 1 nm (refs 5, 9, 10, 14).	[Davis, Joel G.; Gierszal, Kamil P.; Wang, Ping; Ben-Amotz, Dor] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ben-Amotz, D (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	bendor@purdue.edu			National Science Foundation [CHE-0847928]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (CHE-0847928). We thank B. Widom, D. Chandler, M. Fayer and S. Granick for comments and suggestions; D. Wilcox for writing the SMCR code used in this work; B. Rankin for performing molecular dynamics simulations to determine the number of water molecules in the first hydration shells of n-alcohols (as further described in Supplementary Methods); and D. L. McCaffrey, S. Zukowski and C. DeShaw (undergraduate research students) for assistance in collecting experimental results relevant to this work.	Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Ben-Amotz D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121648; Buchanan P, 2005, CHEM PHYS LETT, V415, P89, DOI 10.1016/j.cplett.2005.08.064; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; FRANK HS, 1945, J CHEM PHYS, V13, P507, DOI 10.1063/1.1723985; Friesen AD, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633478; Garde S, 1996, PHYS REV LETT, V77, P4966, DOI 10.1103/PhysRevLett.77.4966; Garde S, 2011, P NATL ACAD SCI USA, V108, P16491, DOI 10.1073/pnas.1113256108; Gierszal KP, 2011, J PHYS CHEM LETT, V2, P2930, DOI 10.1021/jz201373e; GILL SJ, 1985, J PHYS CHEM-US, V89, P3758, DOI 10.1021/j100263a034; GLEW DN, 1962, J PHYS CHEM-US, V66, P605, DOI 10.1021/j100810a008; Laage D, 2009, J PHYS CHEM B, V113, P2428, DOI 10.1021/jp809521t; LAWTON WH, 1971, TECHNOMETRICS, V13, P617, DOI 10.2307/1267173; Li F, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3516460; Li ITS, 2011, P NATL ACAD SCI USA, V108, P16527, DOI 10.1073/pnas.1105450108; Liu CL, 2011, SPECTROSC SPECT ANAL, V31, P1524, DOI 10.3964/j.issn.1000-0593(2011)06-1524-05; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Matysiak S, 2011, J PHYS CHEM B, V115, P14859, DOI 10.1021/jp2079633; Perera PN, 2009, P NATL ACAD SCI USA, V106, P12230, DOI 10.1073/pnas.0903675106; Perera P, 2008, J AM CHEM SOC, V130, P4576, DOI 10.1021/ja077333h; Petersen C, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142861; Raschke TM, 2005, P NATL ACAD SCI USA, V102, P6777, DOI 10.1073/pnas.0500225102; ROSSKY PJ, 1982, FARADAY SYMP CHEM S, P69, DOI 10.1039/fs9821700069; Smith JD, 2005, P NATL ACAD SCI USA, V102, P14171, DOI 10.1073/pnas.0506899102; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; Tomlinson-Phillips J, 2011, J PHYS CHEM A, V115, P6177, DOI 10.1021/jp111346s; Torii H, 2006, J PHYS CHEM A, V110, P9469, DOI 10.1021/jp062033s; Yang M, 2010, PHYS CHEM CHEM PHYS, V12, P982, DOI 10.1039/b918314k; Zhang XY, 2002, SCIENCE, V295, P663, DOI 10.1126/science.1066854	30	378	379	19	655	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					582	585		10.1038/nature11570	http://dx.doi.org/10.1038/nature11570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172216				2022-12-01	WOS:000311339800049
J	Berman, AJ; Cech, TR				Berman, Andrea J.; Cech, Thomas R.			SnapShot: Telomeres and Telomerase	CELL			English	Editorial Material									[Berman, Andrea J.; Cech, Thomas R.] Univ Colorado, HHMI, BioFrontiers Inst, Boulder, CO 80309 USA; [Berman, Andrea J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, BioFrontiers Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Berman, AJ (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.							Du H.-Y., 2008, TELOMERES TELOMERASE; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700	3	6	6	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5								10.1016/j.cell.2012.11.008	http://dx.doi.org/10.1016/j.cell.2012.11.008			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178129	Bronze			2022-12-01	WOS:000311423500024
J	Nadelman, RB; Hanincova, K; Mukherjee, P; Liveris, D; Nowakowski, J; McKenna, D; Brisson, D; Cooper, D; Bittker, S; Madison, G; Holmgren, D; Schwartz, I; Wormser, GP				Nadelman, Robert B.; Hanincova, Klara; Mukherjee, Priyanka; Liveris, Dionysios; Nowakowski, John; McKenna, Donna; Brisson, Dustin; Cooper, Denise; Bittker, Susan; Madison, Gul; Holmgren, Diane; Schwartz, Ira; Wormser, Gary P.			Differentiation of Reinfection from Relapse in Recurrent Lyme Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BURGDORFERI SENSU-STRICTO; BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; IXODES-SCAPULARIS; HEMATOGENOUS DISSEMINATION; GENETIC DIVERSITY; CULTURE; INFECTION; FAILURE; OSPC	BACKGROUND Erythema migrans is the most common manifestation of Lyme disease. Recurrences are not uncommon, and although they are usually attributed to reinfection rather than relapse of the original infection, this remains somewhat controversial. We used molecular typing of Borrelia burgdorferi isolates obtained from patients with culture-confirmed episodes of erythema migrans to distinguish between relapse and reinfection. Methods We determined the genotype of the gene encoding outer-surface protein C (ospC) of B. burgdorferi strains detected in cultures of skin or blood specimens obtained from patients with consecutive episodes of erythema migrans. After polymerase-chain-reaction amplification, ospC genotyping was performed by means of reverse line-blot analysis or DNA sequencing of the nearly full-length gene. Most strains were further analyzed by determining the genotype according to the 16S-23S ribosomal RNA intergenic spacer type, multilocus sequence typing, or both. Patients received standard courses of antibiotics for erythema migrans. RESULTS B. burgdorferi isolates obtained from 17 patients who received a diagnosis of erythema migrans between 1991 and 2011 and who had 22 paired episodes of this lesion (initial and second episodes) were available for testing. The ospC genotype was found to be different at each initial and second episode. Apparently identical genotypes were identified on more than one occasion in only one patient, at the first and third episodes, 5 years apart, but different genotypes were identified at the second and fourth episodes. CONCLUSIONS None of the 22 paired consecutive episodes of erythema migrans were associated with the same strain of B. burgdorferi on culture. Our data show that repeat episodes of erythema migrans in appropriately treated patients were due to reinfection and not relapse. (Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.)	[Nadelman, Robert B.; Nowakowski, John; McKenna, Donna; Cooper, Denise; Bittker, Susan; Madison, Gul; Holmgren, Diane; Wormser, Gary P.] New York Med Coll, Div Infect Dis, Dept Med, Valhalla, NY 10595 USA; [Hanincova, Klara; Mukherjee, Priyanka; Liveris, Dionysios; Schwartz, Ira] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Brisson, Dustin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	New York Medical College; New York Medical College; University of Pennsylvania	Nadelman, RB (corresponding author), New York Med Coll, Div Infect Dis, Dept Med, Rm 245, Valhalla, NY 10595 USA.	robert_nadelman@nymc.edu	Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579; Madison, Guy/0000-0001-5366-1169	National Institutes of Health; William and Sylvia Silberstein Foundation; Guide-point Global and Decision Resources; Baxter; Bio-Rad; DiaSorin; Immunetics; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Sylvia Silberstein Foundation; Guide-point Global and Decision Resources; Baxter; Bio-Rad; DiaSorin; Immunetics; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.; Supported in part by grants from the National Institutes of Health (AR41511 and AI45801) and the William and Sylvia Silberstein Foundation, to Dr. Schwartz.; Dr. Nadelman reports receiving consulting fees from Guide-point Global and Decision Resources and serving as an expert witness in medical malpractice cases regarding Lyme disease. Dr. Wormser reports receiving consulting fees from Baxter, serving as an expert witness in medical malpractice cases regarding Lyme disease, holding stock in Abbott, and receiving grant support to his institution from Bio-Rad, DiaSorin, Immunetics, and bioMerieux. No other potential conflict of interest relevant to this article was reported.	BERGER BW, 1992, J AM ACAD DERMATOL, V27, P34, DOI 10.1016/0190-9622(92)70152-6; Brisson D, 2006, AM J TROP MED HYG, V74, P615, DOI 10.4269/ajtmh.2006.74.615; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2010, EMERG INFECT DIS, V16, P911, DOI 10.3201/eid1606.090329; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Dandache P, 2008, INFECT DIS CLIN N AM, V22, P235, DOI 10.1016/j.idc.2007.12.012; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P5008, DOI 10.1128/AEM.00479-08; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; MALANE MS, 1991, ANN INTERN MED, V114, P490, DOI 10.7326/0003-4819-114-6-490; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; MELSKI JW, 1993, ARCH DERMATOL, V129, P709, DOI 10.1001/archderm.129.6.709; NADELMAN RB, 1993, AM J MED, V94, P583, DOI 10.1016/0002-9343(93)90208-7; Nadelman RB, 2008, CLIN INFECT DIS, V46, P950, DOI 10.1086/528872; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Nowakowski J, 2000, ARCH FAM MED, V9, P563, DOI 10.1001/archfami.9.6.563; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Nowakowski J, 2001, CLIN INFECT DIS, V33, P2023, DOI 10.1086/324490; Probert WS, 1997, J INFECT DIS, V175, P400, DOI 10.1093/infdis/175.2.400; Qiu WG, 2002, GENETICS, V160, P833; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Vaz A, 2001, INFECT IMMUN, V69, P7437, DOI 10.1128/IAI.69.12.7437-7444.2001; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922	38	62	63	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1883	1890		10.1056/NEJMoa1114362	http://dx.doi.org/10.1056/NEJMoa1114362			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150958	Green Accepted, Bronze			2022-12-01	WOS:000311029300004
J	Drucker, E				Drucker, Ernest			Drugs: the third rail of US politics	LANCET			English	Editorial Material									[Drucker, Ernest] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Drucker, Ernest] CUNY, John Jay Coll Criminal Justice, New York, NY 10021 USA	Columbia University; City University of New York (CUNY) System	Drucker, E (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	emdrucker@earthlink.net						[Anonymous], 2010, BARS 2 SUBST AB AM P; Baker P., 2012, NY TIMES; Drucker E., 2011, PLAGUE PRISONS EPIDE; Drucker E, 2012, J PUBLIC HEALTH POL, V33, P309, DOI 10.1057/jphp.2012.16; Drug Policy Alliance, 2012, REF MAR LAWS; European Commission Eurostat, 1998, EU27 EUR COMM EUR; Guillermoprieto A., 2012, NEW YORK REV BOOKS; Kain E., 2012, FORBES; OECD, 2012, HLTH GLANC EUR 2010; Onishi N, 2012, NY TIMES; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; The Disaster Center, 2011, 2011 US CRIM RAT 196; Thoumi FE, 2005, J DRUG ISSUES, V35, P185, DOI 10.1177/002204260503500109; UN Office on Drugs and Crime, 2011, GLOB STUD HOM 2011; US Centers for Disease Control and Prevention, 2012, HOM RECR SAF UN POIS	15	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1626	1628		10.1016/S0140-6736(12)61889-3	http://dx.doi.org/10.1016/S0140-6736(12)61889-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035MN	23138110				2022-12-01	WOS:000310951400006
J	Clowney, EJ; LeGros, MA; Mosley, CP; Clowney, FG; Markenskoff-Papadimitriou, EC; Myllys, M; Barnea, G; Larabell, CA; Lomvardas, S				Clowney, E. Josephine; LeGros, Mark A.; Mosley, Colleen P.; Clowney, Fiona G.; Markenskoff-Papadimitriou, Eirene C.; Myllys, Markko; Barnea, Gilad; Larabell, Carolyn A.; Lomvardas, Stavros			Nuclear Aggregation of Olfactory Receptor Genes Governs Their Monogenic Expression	CELL			English	Article							ORGANIZATION; CHROMATIN; CHOICE; MORPHOLOGY; PROMOTER; LAMINA; GENOME; MICE	Gene positioning and regulation of nuclear architecture are thought to influence gene expression. Here, we show that, in mouse olfactory neurons, silent olfactory receptor (OR) genes from different chromosomes converge in a small number of heterochromatic foci. These foci are OR exclusive and form in a cell-type-specific and differentiation-dependent manner. The aggregation of OR genes is developmentally synchronous with the downregulation of lamin b receptor (LBR) and can be reversed by ectopic expression of LBR in mature olfactory neurons. LBR-induced reorganization of nuclear architecture and disruption of OR aggregates perturbs the singularity of OR transcription and disrupts the targeting specificity of the olfactory neurons. Our observations propose spatial sequestering of heterochromatinized OR family members as a basis of monogenic and monoallelic gene expression.	[Clowney, E. Josephine; Lomvardas, Stavros] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [LeGros, Mark A.; Mosley, Colleen P.; Clowney, Fiona G.; Larabell, Carolyn A.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Markenskoff-Papadimitriou, Eirene C.; Lomvardas, Stavros] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [LeGros, Mark A.; Larabell, Carolyn A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Myllys, Markko] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Jyvaskyla; Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Clowney, Eleanor/0000-0002-9150-9464; Lomvardas, Stavros/0000-0002-7668-3026	National Science Foundation (NSF GRFP); Roadmap for Epigenomics grant [5R01DA030320-02]; McKnight Endowment for Neurosciences; National Center for Research Resources [5P41RR019664-08]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103445-08]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NIH [5R01MH086920]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER	National Science Foundation (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Roadmap for Epigenomics grant; McKnight Endowment for Neurosciences; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. Nicholas Ryba for the G gamma 8 tTA transgenic mice; Drs. Monica Zwerger and Harald Herrmann for the anti-LBR antibody; David Lyons and Drs. Richard Axel, Keith Yamamoto, and David Agard for input and suggestions; and Dr. Nirao Shah and the Lomvardas lab for critical reading of the manuscript. Also, we are grateful to Dr. Allan Basbaum for making the Shidduch between S.L. and C.A.L. E.J.C. and E.C.M.-P. are supported by fellowships from the National Science Foundation (NSF GRFP). This project was funded by the Roadmap for Epigenomics grant 5R01DA030320-02 and the McKnight Endowment for Neurosciences. National Center for X-Ray Tomography is funded by grants from the National Center for Research Resources (5P41RR019664-08) and the National Institute of General Medical Sciences (8 P41 GM103445-08) from the National Institutes of Health and US Department of Energy, Office of Biological and Environmental Research (DE-AC02-05CH11231). G.B. is a Pew scholar and is supported, in part, by NIH grant 5R01MH086920.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Eskiw CH, 2010, COLD SH Q B, V75, P501, DOI 10.1101/sqb.2010.75.046; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GOLDOWITZ D, 1982, DEV BIOL, V89, P261, DOI 10.1016/0012-1606(82)90313-X; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; ZACHARIAS H, 1995, GENETICS, V141, P7; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	35	220	222	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					724	737		10.1016/j.cell.2012.09.043	http://dx.doi.org/10.1016/j.cell.2012.09.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141535	Bronze, Green Accepted			2022-12-01	WOS:000310921200006
J	Bascom-Slack, CA; Arnold, AE; Strobel, SA				Bascom-Slack, Carol A.; Arnold, A. Elizabeth; Strobel, Scott A.			Student-Directed Discovery of the Plant Microbiome and Its Products	SCIENCE			English	Editorial Material							ENDOPHYTES; DIVERSITY		[Bascom-Slack, Carol A.; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA	Yale University; University of Arizona	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	scott.strobel@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Stone JK, 2000, BOOK SOIL P, P3; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356	8	43	45	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					485	486		10.1126/science.1215227	http://dx.doi.org/10.1126/science.1215227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112324				2022-12-01	WOS:000310195800046
J	Barzilay, EJ; Schaad, N; Magloire, R; Mung, KS; Boncy, J; Dahourou, GA; Mintz, ED; Steenland, MW; Vertefeuille, JF; Tappero, JW				Barzilay, Ezra J.; Schaad, Nicolas; Magloire, Roc; Mung, Kam S.; Boncy, Jacques; Dahourou, Georges A.; Mintz, Eric D.; Steenland, Maria W.; Vertefeuille, John F.; Tappero, Jordan W.			Cholera Surveillance during the Haiti Epidemic - The First 2 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; OUTBREAK; DISEASE	BACKGROUND In October 2010, nearly 10 months after a devastating earthquake, Haiti was stricken by epidemic cholera. Within days after detection, the Ministry of Public Health and Population established a National Cholera Surveillance System (NCSS). METHODS The NCSS used a modified World Health Organization case definition for cholera that included acute watery diarrhea, with or without vomiting, in persons of all ages residing in an area in which at least one case of Vibrio cholerae O1 infection had been confirmed by culture. RESULTS Within 29 days after the first report, cases of V. cholerae O1 (serotype Ogawa, biotype El Tor) were confirmed in all 10 administrative departments (similar to states or provinces) in Haiti. Through October 20, 2012, the public health ministry reported 604,634 cases of infection, 329,697 hospitalizations, and 7436 deaths from cholera and isolated V. cholerae O1 from 1675 of 2703 stool specimens tested (62.0%). The cumulative attack rate was 5.1% at the end of the first year and 6.1% at the end of the second year. The cumulative case fatality rate consistently trended downward, reaching 1.2% at the close of year 2, with departmental cumulative rates ranging from 0.6% to 4.6% (median, 1.4%). Within 3 months after the start of the epidemic, the rolling 14-day case fatality rate was 1.0% and remained at or below this level with few, brief exceptions. Overall, the cholera epidemic in Haiti accounted for 57% of all cholera cases and 53% of all cholera deaths reported to the World Health Organization in 2010 and 58% of all cholera cases and 37% of all cholera deaths in 2011. CONCLUSIONS A review of NCSS data shows that during the first 2 years of the cholera epidemic in Haiti, the cumulative attack rate was 6.1%, with cases reported in all 10 departments. Within 3 months after the first case was reported, there was a downward trend in mortality, with a 14-day case fatality rate of 1.0% or less in most areas.	[Barzilay, Ezra J.; Schaad, Nicolas; Dahourou, Georges A.; Mintz, Eric D.; Steenland, Maria W.; Vertefeuille, John F.; Tappero, Jordan W.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Magloire, Roc] Minist Sante Publ & Populat, Direct Epidemiol Lab & Rech, Port Au Prince, Haiti; [Mung, Kam S.] Pan Amer Hlth Org, Port Au Prince, Haiti; [Boncy, Jacques] Minist Sante Publ & Populat, Lab Natl Sante Publ, Port Au Prince, Haiti; [Dahourou, Georges A.; Vertefeuille, John F.] Ctr Dis Control & Prevent, Haiti Off, Port Au Prince, Haiti	Centers for Disease Control & Prevention - USA; Pan American Health Organization	Barzilay, EJ (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A-05, Atlanta, GA 30329 USA.	ebarzilay@cdc.gov						Abrams JY, 2012, EPIDEMIOL INFECT, V1, P1; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; [Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P325; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P933; [Anonymous], 2011, HAITI CHOLERA TRAINI; [Anonymous], 2011, HAIT CHOL OUTBR SIT; [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P639; Bauernfeind A, 2004, CHOLERA GUIDELINES; Brunkard Joan M., 2012, Morbidity and Mortality Weekly Report, V61, P309; Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Ernst S, 2011, EMERG INFECT DIS, V17, P2155, DOI 10.3201/eid1711.110815; European Centre for Disease Prevention and Control, 2012, OUTBR CHOL CUB POT R; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Gerard JA, 2012, AM SOC TROP MED HYG; German R R, 2001, MMWR Recomm Rep, V50, P1; Global Task force on Cholera Control, 2004, WHOCDSCPEZFK20044; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Jackson BR, 2012, SERO EPIDEMIOLOGIC S; Jenson D, 2011, EMERG INFECT DIS, V17, P2130, DOI 10.3201/eid1711.110958; Koo D, 1996, Bull Pan Am Health Organ, V30, P134; Jimenez ML, 2011, EMERG INFECT DIS, V17, P2172, DOI 10.3201/eid1711.111263; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; NALIN DR, 1978, LANCET, V2, P856; Newton AE, 2011, EMERG INFECT DIS, V17, P2166, DOI 10.3201/eid1711.110808; PALMER DL, 1976, J INFECT DIS, V134, P8, DOI 10.1093/infdis/134.1.8; Pan American Health Organization, 2012, CHOL SIT UPD; Pan American Health Organization Division of Vaccines and Immunization, 2012, 20 M TECHN ADV GROUP; Periago MR, 2012, LANCET, V379, pE12, DOI 10.1016/S0140-6736(12)60031-2; Piarroux R, 2011, EMERG INFECT DIS, V17, P1161, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Rapid establishment of an internally displaced persons disease surveillance system after an earthquake-Haiti, 2010, MMWR MORB MORTAL WKL, V59, P939; Routh JA, 2011, EMERG INFECT DIS, V17, P2139, DOI 10.3201/eid1711.110747; Ryan ET, 2011, EMERG INFECT DIS, V17, P2175, DOI 10.3201/eid1711.110849; Shikanga OT, 2009, AM J TROP MED HYG, V81, P1085, DOI 10.4269/ajtmh.2009.09-0400; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; SWERDLOW DL, 1994, J INFECT DIS, V170, P468, DOI 10.1093/infdis/170.2.468; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Talkington DF, 2012, 2012 AM SOC MICR GEN; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; Tauxe Robert, 1994, P321; Tauxe RV, 2011, EMERG INFECT DIS, V17, P2094, DOI 10.3201/eid1711.110857; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, 1993, GUID CHOL CONTR	48	143	147	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					599	609		10.1056/NEJMoa1204927	http://dx.doi.org/10.1056/NEJMoa1204927			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23301694	Bronze			2022-12-01	WOS:000322659600005
J	Redecke, L; Nass, K; DePonte, DP; White, TA; Rehders, D; Barty, A; Stellato, F; Liang, MN; Barends, TRM; Boutet, S; Williams, GJ; Messerschmidt, M; Seibert, MM; Aquila, A; Arnlund, D; Bajt, S; Barth, T; Bogan, MJ; Caleman, C; Chao, TC; Doak, RB; Fleckenstein, H; Frank, M; Fromme, R; Galli, L; Grotjohann, I; Hunter, MS; Johansson, LC; Kassemeyer, S; Katona, G; Kirian, RA; Koopmann, R; Kupitz, C; Lomb, L; Martin, AV; Mogk, S; Neutze, R; Shoeman, RL; Steinbrener, J; Timneanu, N; Wang, DJ; Weierstall, U; Zatsepin, NA; Spence, JCH; Fromme, P; Schlichting, I; Duszenko, M; Betzel, C; Chapman, HN				Redecke, Lars; Nass, Karol; DePonte, Daniel P.; White, Thomas A.; Rehders, Dirk; Barty, Anton; Stellato, Francesco; Liang, Mengning; Barends, Thomas R. M.; Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Seibert, M. Marvin; Aquila, Andrew; Arnlund, David; Bajt, Sasa; Barth, Torsten; Bogan, Michael J.; Caleman, Carl; Chao, Tzu-Chiao; Doak, R. Bruce; Fleckenstein, Holger; Frank, Matthias; Fromme, Raimund; Galli, Lorenzo; Grotjohann, Ingo; Hunter, Mark S.; Johansson, Linda C.; Kassemeyer, Stephan; Katona, Gergely; Kirian, Richard A.; Koopmann, Rudolf; Kupitz, Chris; Lomb, Lukas; Martin, Andrew V.; Mogk, Stefan; Neutze, Richard; Shoeman, Robert L.; Steinbrener, Jan; Timneanu, Nicusor; Wang, Dingjie; Weierstall, Uwe; Zatsepin, Nadia A.; Spence, John C. H.; Fromme, Petra; Schlichting, Ilme; Duszenko, Michael; Betzel, Christian; Chapman, Henry N.			Natively Inhibited Trypanosoma brucei Cathepsin B Structure Determined by Using an X-ray Laser	SCIENCE			English	Article							PROTEIN-STRUCTURE DETERMINATION; HUMAN AFRICAN TRYPANOSOMIASIS; CYSTEINE PROTEASES; OCCLUDING LOOP; ACTIVE-SITE; PROPEPTIDE; PAPAIN; NANOCRYSTALLOGRAPHY; CRYSTALLOGRAPHY; DISEASE	The Trypanosoma brucei cysteine protease cathepsin B (TbCatB), which is involved in host protein degradation, is a promising target to develop new treatments against sleeping sickness, a fatal disease caused by this protozoan parasite. The structure of the mature, active form of TbCatB has so far not provided sufficient information for the design of a safe and specific drug against T. brucei. By combining two recent innovations, in vivo crystallization and serial femtosecond crystallography, we obtained the room-temperature 2.1 angstrom resolution structure of the fully glycosylated precursor complex of TbCatB. The structure reveals the mechanism of native TbCatB inhibition and demonstrates that new biomolecular information can be obtained by the "diffraction-before-destruction" approach of x-ray free-electron lasers from hundreds of thousands of individual microcrystals.	[Redecke, Lars; Rehders, Dirk] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-22607 Hamburg, Germany; [Redecke, Lars; Rehders, Dirk] Deutsch Elekt Synchrotron DESY, Med Univ Lubeck, Inst Biochem, D-22607 Hamburg, Germany; [Redecke, Lars] Med Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany; [Barends, Thomas R. M.; Kassemeyer, Stephan; Lomb, Lukas; Shoeman, Robert L.; Steinbrener, Jan; Schlichting, Ilme] DESY, Ctr Free Elect Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Nass, Karol; Galli, Lorenzo; Chapman, Henry N.] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Barends, Thomas R. M.; Kassemeyer, Stephan; Lomb, Lukas; Shoeman, Robert L.; Steinbrener, Jan; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Seibert, M. Marvin] Natl Accelerator Lab, Stanford Linear Accelerator Ctr SLAC, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Arnlund, David; Johansson, Linda C.; Katona, Gergely; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Barth, Torsten; Koopmann, Rudolf; Mogk, Stefan; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Bogan, Michael J.] SLAC Natl Accelerator Lab, Photon Ultrafast Laser Sci & Engn PULSE Inst, Menlo Pk, CA 94025 USA; [Chao, Tzu-Chiao; Fromme, Raimund; Grotjohann, Ingo; Hunter, Mark S.; Kupitz, Chris; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Doak, R. Bruce; Kirian, Richard A.; Wang, Dingjie; Weierstall, Uwe; Zatsepin, Nadia A.; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Timneanu, Nicusor] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Betzel, Christian] DESY, Univ Hamburg, Inst Biochem & Mol Biol, D-22607 Hamburg, Germany	University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck; German Center for Infection Research; University of Lubeck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Hamburg; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Gothenburg; Eberhard Karls University of Tubingen; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Uppsala University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Betzel, C (corresponding author), DESY, Univ Hamburg, Inst Biochem & Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	christian.betzel@uni-hamburg.de; henry.chapman@desy.de	Barty, Anton/K-5137-2014; Katona, Gergely/B-3491-2008; Fromme, Raimund/C-8885-2012; Fromme, Raimund/AAG-6578-2019; Bajt, Sasa/O-4695-2019; Kirian, Richard/M-3750-2013; Messerschmidt, Marc/F-3796-2010; Schlichting, Ilme/I-1339-2013; Frank, Matthias/O-9055-2014; Nass, Karol/K-1970-2012; Johansson, Linda/O-6893-2019; Messerschmidt, Marc/Y-8929-2019; Timneanu, Nicusor/C-7691-2012; Neutze, Richard/A-7573-2010; Johansson, Linda/B-1240-2011; Bajt, Sasa/G-2228-2010; FRS, Henry N Chapman/G-2153-2010; Zatsepin, Nadia/AAF-2451-2019; Fromme, Raimund/W-5838-2019; Chao, Tzu-Chiao/A-6400-2013; Betzel, Christian/G-8105-2018; Stellato, Francesco/AAZ-4379-2020	Barty, Anton/0000-0003-4751-2727; Katona, Gergely/0000-0002-2031-8716; Fromme, Raimund/0000-0003-4835-1080; Bajt, Sasa/0000-0002-7163-7602; Messerschmidt, Marc/0000-0002-8641-3302; Nass, Karol/0000-0001-8843-1566; Johansson, Linda/0000-0003-4776-5142; Messerschmidt, Marc/0000-0002-8641-3302; Timneanu, Nicusor/0000-0001-7328-0400; Neutze, Richard/0000-0003-0986-6153; Johansson, Linda/0000-0003-4776-5142; FRS, Henry N Chapman/0000-0002-4655-1743; Fromme, Raimund/0000-0003-4835-1080; Betzel, Christian/0000-0002-3879-5019; Aquila, Andrew/0000-0003-0358-2774; Chao, Tzu-Chiao/0000-0001-8781-6958; Frank, Matthias/0000-0002-5244-0791; MARTIN, ANDREW/0000-0003-3704-1829; White, Thomas/0000-0002-8407-0270; Kirian, Richard/0000-0001-7197-3086; Zatsepin, Nadia/0000-0003-1757-0205; Johansson, Linda/0000-0002-8931-0683; Seibert, Mark Marvin/0000-0003-0251-0744	German Federal Ministry for Education and Research [01KX0806, 01KX0807]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research; Hamburg School for Structure and Dynamics in Infection (SDI); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces" [EXC 306]; DFG; Landesgraduiertenforderung Baden-Wurttemberg; Max Planck Society; Swedish Research Council; Swedish Strategic Research Foundation; Swedish Foundation for International Cooperation in Research and Higher Education; U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC; U.S. Department of Energy through Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; University of California Office of the President Lab Fee Program [118036]; NSF [MCB-1021557, MCB-1120997]; NIH [1R01GM095583]; Div Of Molecular and Cellular Bioscience [1021557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583, U54GM094599] Funding Source: NIH RePORTER	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Hamburg Ministry of Science and Research; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research; Hamburg School for Structure and Dynamics in Infection (SDI); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg; Max Planck Society(Max Planck SocietyFoundation CELLEX); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Swedish Foundation for International Cooperation in Research and Higher Education; U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC(United States Department of Energy (DOE)); U.S. Department of Energy through Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); University of California Office of the President Lab Fee Program(University of California System); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out in February 2011 at the LCLS, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. This work was supported by the following agencies: the German Federal Ministry for Education and Research (grants 01KX0806 and 01KX0807), the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research and the Hamburg School for Structure and Dynamics in Infection (SDI), the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces" (EXC 306), the DFG, the Landesgraduiertenforderung Baden-Wurttemberg, the Max Planck Society, the Swedish Research Council, the Swedish Strategic Research Foundation, the Swedish Foundation for International Cooperation in Research and Higher Education, the U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC, the U.S. Department of Energy through Lawrence Livermore National Laboratory under the contract DE-AC52-07NA27344 and supported by the University of California Office of the President Lab Fee Program (award no. 118036), the NSF (award MCB-1021557 and MCB-1120997), and the NIH (award 1R01GM095583).	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Bryant C, 2009, BIOORG MED CHEM LETT, V19, P6218, DOI 10.1016/j.bmcl.2009.08.098; Chagas JR, 1996, FEBS LETT, V392, P233, DOI 10.1016/0014-5793(96)00822-8; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chen YM, 1996, FEBS LETT, V393, P24, DOI 10.1016/0014-5793(96)00847-2; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Tomoo K, 2010, CURR TOP MED CHEM, V10, P696, DOI 10.2174/156802610791113441; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamamoto Y, 2002, CURR PROTEIN PEPT SC, V3, P231, DOI 10.2174/1389203024605331	29	329	340	1	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					227	230		10.1126/science.1229663	http://dx.doi.org/10.1126/science.1229663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23196907	Green Accepted			2022-12-01	WOS:000313328200050
J	Allen, VG; Mitterni, L; Seah, C; Rebbapragada, A; Martin, IE; Lee, C; Siebert, H; Towns, L; Melano, RG; Low, DE				Allen, Vanessa G.; Mitterni, Leo; Seah, Christine; Rebbapragada, Anuradha; Martin, Irene E.; Lee, Colin; Siebert, Heather; Towns, Lynn; Melano, Roberto G.; Low, Donald E.			Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PENICILLIN-BINDING PROTEIN-2; DISEASES-TREATMENT-GUIDELINES; REDUCED SUSCEPTIBILITY; DECREASED SUSCEPTIBILITY; CEFTRIAXONE; MUTATIONS; PENA; TIME; RESISTANCE; EMERGENCE	Importance Although cephalosporins are the cornerstone of treatment of Neisseria gonorrhoeae infections, cefixime is the only oral antimicrobial option. Increased minimum inhibitory concentrations (MICs) to cefixime have been identified worldwide and have been associated with reports of clinical failure. Objective To assess the risk of clinical treatment failure of N gonorrhoeae infections associated with the use of cefixime. Design, Setting, and Population A retrospective cohort study of culture-positive N gonorrhoeae infections at a single sexual health clinic in Toronto, Canada, that routinely performs test of cure. The cohort comprised N gonorrhoeae culture-positive individuals identified between May 1, 2010, and April 30, 2011, treated with cefixime as recommended by Public Health Agency of Canada guidelines. Main Outcome Measures Cefixime treatment failure, defined as the repeat isolation of N gonorrhoeae at the test-of-cure visit identical to the pretreatment isolate by molecular typing and explicit denial of reexposure. Results There were 291 N gonorrhoeae culture-positive individuals identified. Of 133 who returned for test of cure, 13 were culture positive; 9 patients were determined to have experienced cefixime treatment failure, involving urethral (n=4), pharyngeal (n=2), and rectal (n=3) sites. The overall rate of clinical treatment failure among those who had a test of cure was 6.77% (95% CI, 3.14%-12.45%; 9/133). The rate of clinical failure associated with a cefixime MIC of 0.12 mu g/mL or greater was 25.0% (95% CI, 10.69%-44.87%; 7/28) compared with 1.90% (95% CI, 0.23%-6.71%; 2/105) of infections with cefixime MICs less than 0.12 mu g/mL, with a relative risk of 13.13 (95% CI, 2.88-59.72; P < .001). Conclusion and Relevance The rate of clinical failure following treatment of N gonorrhoeae infections with cefixime was relatively high at a Toronto clinic and was associated with elevated MICs. JAMA. 2013; 309(2):163-170	[Allen, Vanessa G.; Seah, Christine; Rebbapragada, Anuradha; Lee, Colin; Siebert, Heather; Towns, Lynn; Melano, Roberto G.] Publ Hlth Ontario, Toronto, ON, Canada; [Allen, Vanessa G.; Rebbapragada, Anuradha; Melano, Roberto G.; Low, Donald E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lee, Colin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mitterni, Leo] Hassle Free Clin, Toronto, ON, Canada; [Martin, Irene E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Low, Donald E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; Public Health Agency of Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Allen, VG (corresponding author), Publ Hlth Ontario Labs, 81 Resources Rd, Toronto, ON M9P 3T1, Canada.	vanessa.allen@oahpp.ca	Allen, Vanessa/AAE-2756-2022	Allen, Vanessa/0000-0001-9802-9730				Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], SEX TRANSM DIS FIG H; [Anonymous], VOL TYP LAB TEST MET; Bignell C, 2011, INT J STD AIDS, V22, P541, DOI 10.1258/ijsa.2011.011267; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P873; Chisholm SA, 2011, J ANTIMICROB CHEMOTH, V66, P2509, DOI 10.1093/jac/dkr332; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Deguchi Takashi, 2003, Journal of Infection and Chemotherapy, V9, P35, DOI 10.1007/s10156-002-0204-8; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Forsyth S, 2011, INT J STD AIDS, V22, P296, DOI 10.1258/ijsa.2009.009191; HANDSFIELD HH, 1992, CLIN INFECT DIS, V15, pS123, DOI 10.1093/clind/15.Supplement_1.S123; Ison CA, 2011, EURO SURVEILL, V16; Kelsey J., 1996, METHODS OBSERVATIONA; Lee SG, 2010, J ANTIMICROB CHEMOTH, V65, P669, DOI 10.1093/jac/dkp505; Lewis DA, 2010, SEX TRANSM INFECT, V86, P415, DOI 10.1136/sti.2010.042648; Liao MM, 2011, J ANTIMICROB CHEMOTH, V66, P1016, DOI 10.1093/jac/dkr021; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Martin I, 2012, SEX TRANSM DIS, V39, P316, DOI 10.1097/OLQ.0b013e3182401b69; Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Osaka Kazuyoshi, 2008, Journal of Infection and Chemotherapy, V14, P195, DOI 10.1007/s10156-008-0610-7; PLOURDE PJ, 1992, J INFECT DIS, V166, P919, DOI 10.1093/infdis/166.4.919; Public Health Agency of Canada, IMP NOT PUBL HLTH IN; Public Health Agency of Canada, CAN GUID SEX TRANSM; Sathia L, 2007, INT J STD AIDS, V18, P647, DOI 10.1258/095646207781568556; Takahata S, 2006, ANTIMICROB AGENTS CH, V50, P3638, DOI 10.1128/AAC.00626-06; Tapsall J, ANTIMICROBIAL RESIST; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2011, EURO SURVEILL, V16; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P2543, DOI 10.1093/jac/dkq377; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, GLOB ACT PLAN CONTR; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275; Zhao SQ, 2009, ANTIMICROB AGENTS CH, V53, P3744, DOI 10.1128/AAC.00304-09	41	149	152	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					163	170		10.1001/jama.2012.176575	http://dx.doi.org/10.1001/jama.2012.176575			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299608	Bronze			2022-12-01	WOS:000313517000025
J	Al-Khatib, SM; Hellkamp, A; Bardy, GH; Hammill, S; Hall, WJ; Mark, DB; Anstrom, KJ; Curtis, J; Al-Khalidi, H; Curtis, LH; Heidenreich, P; Peterson, ED; Sanders, G; Clapp-Channing, N; Lee, KL; Moss, AJ				Al-Khatib, Sana M.; Hellkamp, Anne; Bardy, Gust H.; Hammill, Stephen; Hall, W. Jackson; Mark, Daniel B.; Anstrom, Kevin J.; Curtis, Jeptha; Al-Khalidi, Hussein; Curtis, Lesley H.; Heidenreich, Paul; Peterson, Eric D.; Sanders, Gillian; Clapp-Channing, Nancy; Lee, Kerry L.; Moss, Arthur J.			Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICARE BENEFICIARIES; HEART-FAILURE; GENERALIZABILITY; OUTCOMES; REGISTRY; DISEASE	Importance Randomized clinical trials have shown that implantable cardioverter-defibrillator (ICD) therapy saves lives. Whether the survival of patients who received an ICD in primary prevention clinical trials differs from that of trial-eligible patients receiving a primary prevention ICD in clinical practice is unknown. Objective To determine whether trial-eligible patients who received a primary prevention ICD as documented in a large national registry have a survival rate that differs from the survival rate of similar patients who received an ICD in the 2 largest primary prevention clinical trials, MADIT-II (n = 742) and SCD-HeFT (n = 829). Design, Setting, and Patients Retrospective analysis of data for patients enrolled in the National Cardiovascular Data Registry ICD Registry between January 1, 2006, and December 31, 2007, meeting the MADIT-II criteria (2464 propensity score-matched patients) or the SCD-HeFT criteria (3352 propensity score-matched patients). Mortality data for the registry patients were collected through December 31, 2009. Main Outcome Measures Cox proportional hazards models were used to compare mortality from any cause. Results The median follow-up time in MADIT-II, SCD-HeFT, and the ICD Registry was 19.5, 46.1, and 35.2 months, respectively. Compared with patients enrolled in the clinical trials, patients in the ICD Registry were significantly older and had a higher burden of comorbidities. In the matched cohorts, there was no significant difference in survival between MADIT-II-like patients in the registry and MADIT-II patients randomized to receive an ICD (2-year mortality rates: 13.9% and 15.6%, respectively; adjusted ICD Registry vs trial hazard ratio, 1.06; 95% CI, 0.85-1.31; P = .62). Likewise, the survival among SCD-HeFT-like patients in the registry was not significantly different from survival among patients randomized to receive ICD therapy in SCD-HeFT (3-year mortality rates: 17.3% and 17.4%, respectively; adjusted registry vs trial hazard ratio, 1.16; 95% CI, 0.97-1.38; P = .11). Conclusions and Relevance There was no significant difference in survival between clinical trial patients randomized to receive an ICD and a similar group of clinical registry patients who received a primary prevention ICD. Our findings support the continued use of primary prevention ICDs in similar patients seen in clinical practice.	[Al-Khatib, Sana M.; Hellkamp, Anne; Mark, Daniel B.; Anstrom, Kevin J.; Al-Khalidi, Hussein; Curtis, Lesley H.; Peterson, Eric D.; Sanders, Gillian; Clapp-Channing, Nancy; Lee, Kerry L.] Duke Clin Res Inst, Durham, NC 27715 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Ctr Clin & Genet Econ, Durham, NC 27710 USA; [Al-Khatib, Sana M.; Mark, Daniel B.; Peterson, Eric D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; [Bardy, Gust H.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Hammill, Stephen] Mayo Clin, Rochester, MN USA; [Hall, W. Jackson; Moss, Arthur J.] Univ Rochester, Rochester, NY USA; [Curtis, Jeptha] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Heidenreich, Paul] Stanford Univ, Palo Alto Vet Hlth Care Syst, Palo Alto, CA 94304 USA	Duke University; Duke University; Duke University; Duke University; University of Washington; University of Washington Seattle; Mayo Clinic; University of Rochester; Yale University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Heidenreich, Paul/AAU-6864-2021; Peterson, Eric David/ABF-5033-2021	Heidenreich, Paul/0000-0001-7730-8490; Mark, Daniel/0000-0001-6340-8087	Cameron Health; Eli Lilly; Medtronic; AstraZeneca; Gilead Sciences; American College of Cardiology Foundation; Center for Medicare & Medicaid Services; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI); Johnson Johnson; GlaxoSmithKline; Agency for Healthcare Research and Quality; NHLBI; Boston Scientific; St Jude; Biotronic; National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	Cameron Health; Eli Lilly(Eli Lilly); Medtronic(Medtronic); AstraZeneca(AstraZeneca); Gilead Sciences(Gilead Sciences); American College of Cardiology Foundation(General Electric); Center for Medicare & Medicaid Services; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); GlaxoSmithKline(GlaxoSmithKline); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Biotronic; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bardy reported consulting fees, equity, and intellectual property rights in Cameron Health. Dr Mark reported receiving research grants from Eli Lilly, Medtronic, AstraZeneca, and Gilead Sciences. Dr Anstrom reported receiving research support from AstraZeneca, Eli Lilly, and Medtronic; having served as a consultant for Abbott Vascular, AstraZeneca, Bristol Meyer Squibb, and Ikaria; and having served on data monitoring committees for Pfizer and Vertex. Dr J. Curtis reported owning stock in Medtronic and receiving salary support from the American College of Cardiology Foundation, Center for Medicare & Medicaid Services, and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI). Dr L. Curtis reported receiving research and salary support from Johnson & Johnson, GlaxoSmithKline, Agency for Healthcare Research and Quality, and NHLBI. Dr Curtis has made available online a detailed listing of financial disclosures (http://www.dcri.duke.edu/research/coi.jsp). Dr Heidenreich reported receiving research support from Medtronic. Dr Lee reported receiving modest consulting fees from Medtronic. Dr Moss reported receiving research grants from Boston Scientific and salary support from Boston Scientific, Medtronic, St Jude, and Biotronic. No other disclosures were reported.; This analysis was funded by a grant (1R01-HL093071-01A1) from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Al-Khatib SM, 2012, HEART RHYTHM S, V9, pS381; Badano Luigi P, 2003, Ital Heart J, V4, P84; Bahit MC, 2003, AM HEART J, V145, P109, DOI 10.1067/mhj.2003.43; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cardinal H, 2004, CAN J CARDIOL, V20, P417; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Keitner GI, 2003, J CLIN PSYCHIAT, V64, P1091, DOI 10.4088/JCP.v64n0915; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pedone C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-24; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Walsh CR, 2000, AM J CARDIOL, V86, P908, DOI 10.1016/S0002-9149(00)01120-6	16	69	70	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					55	62		10.1001/jama.2012.157182	http://dx.doi.org/10.1001/jama.2012.157182			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280225	Green Accepted			2022-12-01	WOS:000319113000027
J	Arranz, R; Coloma, R; Chichon, FJ; Conesa, JJ; Carrascosa, JL; Valpuesta, JM; Ortin, J; Martin-Benito, J				Arranz, Rocio; Coloma, Rocio; Javier Chichon, Francisco; Javier Conesa, Jose; Carrascosa, Jose L.; Valpuesta, Jose M.; Ortin, Juan; Martin-Benito, Jaime			The Structure of Native Influenza Virion Ribonucleoproteins	SCIENCE			English	Article							A VIRUS NUCLEOPROTEIN; RNA; LOCALIZATION; NUCLEAR; REPLICATION; COMPLEXES; OLIGOMERIZATION; RECONSTRUCTION; POLYMERASE; PARTICLES	The influenza viruses cause annual epidemics of respiratory disease and occasional pandemics, which constitute a major public-health issue. The segmented negative-stranded RNAs are associated with the polymerase complex and nucleoprotein (NP), forming ribonucleoproteins (RNPs), which are responsible for virus transcription and replication. We describe the structure of native RNPs derived from virions. They show a double-helical conformation in which two NP strands of opposite polarity are associated with each other along the helix. Both strands are connected by a short loop at one end of the particle and interact with the polymerase complex at the other end. This structure will be relevant for unraveling the mechanisms of nuclear import of parental virus RNPs, their transcription and replication, and the encapsidation of progeny RNPs into virions.	[Coloma, Rocio; Ortin, Juan] Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid, Spain; [Arranz, Rocio; Javier Chichon, Francisco; Javier Conesa, Jose; Carrascosa, Jose L.; Valpuesta, Jose M.; Martin-Benito, Jaime] CSIC, Dept Macromol Struct, Ctr Nacl Biotecnol, Madrid, Spain; [Coloma, Rocio; Ortin, Juan] Inst Natl Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Valpuesta, Jose M.] Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid, Spain.	jortin@cnb.csic.es; jmartinb@cnb.csic.es	García, Francisco Javier Chichón/R-2167-2019; Valpuesta, Jose M/AAA-6002-2019; Ortin, Juan/L-3622-2013; Chichón García, Francisco Javier/B-6029-2011; Conesa, Jose Javier/J-5878-2017; Valpuesta, José M/T-1977-2017; Chichón García, Francisco Javier/K-5117-2012	García, Francisco Javier Chichón/0000-0003-2766-0327; Chichón García, Francisco Javier/0000-0003-2766-0327; Conesa, Jose Javier/0000-0002-8440-5691; Valpuesta, José M/0000-0001-7468-8053; Chichón García, Francisco Javier/0000-0003-2766-0327; Ortin, Juan/0000-0002-6200-4678; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Arranz, Rocio/0000-0001-5321-0915	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC, BFU2011-25090/BMC]; FLUPHARM strep project [FP7-259751]; Fundacion Marcelino Botin	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FLUPHARM strep project; Fundacion Marcelino Botin	The technical assistance of Y. Fernandez and N. Zamarreno is gratefully acknowledged. We thank D. Luque for help with the generation of movies. This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) grants BFU2010-17540/BMC (J.O.) and BFU2011-25090/BMC (J.M.-B.), by the FLUPHARM strep project (FP7-259751) (J.O.), and by Fundacion Marcelino Botin (J.O.). J.M.-B. and J.O. designed the experiments. R.A., J.M-B, R.C. F.J.C. and J.J.C. carried out the experiments. J.O. and J.M.-B. wrote the paper with contributions from R.A., R.C., F.J.C., and J.J.C. and discussions with J.L.C. and J.M.V. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. EM maps have been deposited in the EM Data Bank (www.ebi.ac.uk/pdbe/emdb/), accession numbers EMD-2205, 2206, 2207, and 2208. The atomic coordinates of the docking have been deposited in the Protein Data Bank (www.rcsb.org/), accession code 4bbl.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bullido R, 2000, J GEN VIROL, V81, P135, DOI 10.1099/0022-1317-81-1-135; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; JENNINGS PA, 1983, CELL, V34, P619, DOI 10.1016/0092-8674(83)90394-X; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Noda T, 2012, P NATL ACAD SCI USA, V109, P8797, DOI 10.1073/pnas.1206736109; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.jmb.2007.10.022; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	29	214	219	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1634	1637		10.1126/science.1228172	http://dx.doi.org/10.1126/science.1228172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180776				2022-12-01	WOS:000312533100057
J	Hastings, G; de Andrade, M; Moodie, C				Hastings, Gerard; de Andrade, Marisa; Moodie, Crawford			Tobacco harm reduction: the devil is in the deployment	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard; de Andrade, Marisa; Moodie, Crawford] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland	University of Stirling	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk		Moodie, Crawford/0000-0002-1805-2509	Cancer Research UK [15192] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		[Anonymous], 2012, PRESCR COST AN ENGL; [Anonymous], 2009, NRT SMOK CESS AIDS U; British American Tobacco, 2011, SUST REP 2011; British American Tobacco, 2011, SUST REP 2011 HARM R; Buck D., 2012, CLUSTERING UNHEALTHY; Committee on Safety of Medicines, REP WORK GROUP NIC R; Davis RM, 2009, NCI TOBACCO CONTROL; Euromonitor, 2009, TOB UK COUNTR MARK I; Medsafe (Regulatory Information), GUID COD CAT EL CIG; MHRA, DRUG SAF UPD NIC REP; MHRA (Medicines Healthcare products Regulatory Agency), 2009, PUBL ASS REP US NIC; National Institute for Health and Clinical Excellence, 2012, TOB HARM RED APPR SM; Nicoventures, 2012, WHAT IS NIC; O'Reilly D, 2009, TOBACCO HARM REDUCTI; Oxfam, POL PRACT MUGG POV Y; Yeaman A, 1963, IMPLICATIONS BATTELL	16	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8412	10.1136/bmj.e8412	http://dx.doi.org/10.1136/bmj.e8412			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248081	Green Submitted			2022-12-01	WOS:000312698700016
J	Prockop, DJ				Prockop, Darwin J.			New Targets for Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MESENCHYMAL STEM-CELLS		Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Prockop, DJ (corresponding author), Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX USA.							Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fuchs S, 2012, VITAM HORM, V88, P491, DOI 10.1016/B978-0-12-394622-5.00022-5; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229	5	4	5	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2353	2354		10.1056/NEJMcibr1210178	http://dx.doi.org/10.1056/NEJMcibr1210178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234518				2022-12-01	WOS:000312187700013
J	Rollauer, SE; Tarry, MJ; Graham, JE; Jaaskelainen, M; Jager, F; Johnson, S; Krehenbrink, M; Liu, SM; Lukey, MJ; Marcoux, J; McDowell, MA; Rodriguez, F; Roversi, P; Stansfeld, PJ; Robinson, CV; Sansom, MSP; Palmer, T; Hogbom, M; Berks, BC; Lea, SM				Rollauer, Sarah E.; Tarry, Michael J.; Graham, James E.; Jaaskelainen, Mari; Jaeger, Franziska; Johnson, Steven; Krehenbrink, Martin; Liu, Sai-Man; Lukey, Michael J.; Marcoux, Julien; McDowell, Melanie A.; Rodriguez, Fernanda; Roversi, Pietro; Stansfeld, Phillip J.; Robinson, Carol V.; Sansom, Mark S. P.; Palmer, Tracy; Hogbom, Martin; Berks, Ben C.; Lea, Susan M.			Structure of the TatC core of the twin-arginine protein transport system	NATURE			English	Article							SEC-INDEPENDENT PROTEIN; CYSTEINE SCANNING MUTAGENESIS; SIGNAL PEPTIDE; TRANSLOCASE COMPONENT; PATHWAY; TOPOLOGY; BINDING; FORM; COMPLEXES; EFFICIENT	The twin-arginine translocation (Tat) pathway is one of two general protein transport systems found in the prokaryotic cytoplasmic membrane and is conserved in the thylakoid membrane of plant chloroplasts. The defining, and highly unusual, property of the Tat pathway is that it transports folded proteins, a task that must be achieved without allowing appreciable ion leakage across the membrane. The integral membrane TatC protein is the central component of the Tat pathway. TatC captures substrate proteins by binding their signal peptides. TatC then recruits TatA family proteins to form the active translocation complex. Here we report the crystal structure of TatC from the hyperthermophilic bacterium Aquifex aeolicus. This structure provides a molecular description of the core of the Tat translocation system and a framework for understanding the unique Tat transport mechanism.	[Rollauer, Sarah E.; Graham, James E.; Krehenbrink, Martin; Liu, Sai-Man; Lukey, Michael J.; Rodriguez, Fernanda; Stansfeld, Phillip J.; Sansom, Mark S. P.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rollauer, Sarah E.; Graham, James E.; Johnson, Steven; Liu, Sai-Man; Lukey, Michael J.; McDowell, Melanie A.; Roversi, Pietro; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Tarry, Michael J.; Jaaskelainen, Mari; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Jaeger, Franziska; Palmer, Tracy] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Marcoux, Julien; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Oxford; University of Oxford; Stockholm University; University of Dundee; University of Oxford	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ben.berks@bioch.ox.ac.uk; susan.lea@path.ox.ac.uk	Rollauer, Sarah/L-4576-2016; Roversi, Pietro/AAK-4241-2021; Jaeger, Franziska/AGY-9260-2022; Johnson, Steven J/F-9182-2016; Sansom, Mark S.P./C-5157-2009; Marcoux, Julien/I-3908-2012; Stansfeld, Phillip James/AAA-9228-2020; Jaeger, Franziska/I-4764-2017; Lea, Susan M/B-7678-2009; Roversi, Pietro/F-8925-2011; Stansfeld, Phill/C-6213-2011	Rollauer, Sarah/0000-0002-2116-3170; Roversi, Pietro/0000-0001-9280-9437; Jaeger, Franziska/0000-0002-6823-4589; Johnson, Steven J/0000-0002-7877-3543; Sansom, Mark S.P./0000-0001-6360-7959; Stansfeld, Phillip James/0000-0001-8800-7669; Jaeger, Franziska/0000-0002-6823-4589; Lea, Susan M/0000-0001-9287-8053; Roversi, Pietro/0000-0001-9280-9437; Stansfeld, Phill/0000-0001-8800-7669; McDowell, Melanie/0000-0002-5231-8809; Hogbom, Martin/0000-0001-5574-9383; Marcoux, Julien/0000-0001-7321-7436; robinson, carol/0000-0001-7829-5505; Palmer, Tracy/0000-0001-9043-2592; Graham, James/0000-0002-8639-7592; Lukey, Michael/0000-0003-3608-3883; Berks, Ben/0000-0001-9685-4067	Wellcome Trust [083599, 092970MA]; Swedish Foundation for Strategic Research; Swedish Research Council [2010-5061]; E.P. Abrahams Cephalosporin Trust; Biotechnology and Biological Sciences Research Council [BB/E023347/1, BB/1019855/1]; Medical Research Council [G1001640, G0900888]; European Research Council; James Martin 21st Century School Vaccine Design Institute; BBSRC [BB/H000267/1, BB/F02150X/1, BB/I019855/1, BB/E023347/1] Funding Source: UKRI; MRC [G1001640] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [B19456, BB/F02150X/1, BBS/B/16011, BB/H000267/1, BB/I019855/1, BEP17032] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); E.P. Abrahams Cephalosporin Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); James Martin 21st Century School Vaccine Design Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Byrne, G. Orriss and R. Owens for their contributions to the early stages of this project; R. Keller for advice; and J. Willemde Gier, D. Daley and R. Huber for providing strains and reagents. This work was supported by the Wellcome Trust (studentships to S.E.R., J.E.G. and M.A.M.; grant 083599, P.R.; grant 092970MA, M.S.P.S.), the Swedish Foundation for Strategic Research ('Future research leaders 4' to M.H.), the Swedish Research Council (grant 2010-5061 to M.H.), the E.P. Abrahams Cephalosporin Trust (M.K. and F.R.), the Biotechnology and Biological Sciences Research Council (studentship, M.J.L.; grant BB/E023347/1, S-M.L.; grant BB/1019855/1, P.J.S.), the Medical Research Council (grant G1001640, F.J.; grant G0900888, S.J.), and the European Research Council (Advanced Grant IMPRESS, J.M. and C.V.R.). Work in S.M.L.'s group is funded by the James Martin 21st Century School Vaccine Design Institute.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARKAN A, 1986, EMBO J, V5, P1421, DOI 10.1002/j.1460-2075.1986.tb04378.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G. B. E., 2011, BUSTER 2 11 2; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Celedon J. M., 2012, BIOCH BIOPHYS ACTA; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fritsch MJ, 2012, MOL MICROBIOL, V84, P1108, DOI 10.1111/j.1365-2958.2012.08080.x; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gouffi K, 2002, FEBS LETT, V525, P65, DOI 10.1016/S0014-5793(02)03069-7; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-402312, 10.1146/annurev-biophys-050511-102312]; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	63	128	129	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					210	+		10.1038/nature11683	http://dx.doi.org/10.1038/nature11683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201679	Green Accepted			2022-12-01	WOS:000312259300033
J	Borne, RT; Krantz, MJ				Borne, Ryan T.; Krantz, Mori J.			Lixivaptan for Hyponatremia-The Numbers Game	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOLVAPTAN		[Borne, Ryan T.; Krantz, Mori J.] Denver Hlth Hosp & Author, Dept Internal Med, Denver, CO USA; [Krantz, Mori J.] Div Cardiol, Denver, CO USA	Denver Health Medical Center	Borne, RT (corresponding author), Denver Hlth Med Ctr, 660 Bannock St,MC 4000, Denver, CO 80204 USA.	ryan.borne@dhha.org						FDA, CARD REN DRUGS ADV C; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2345	2346		10.1001/jama.2012.54515	http://dx.doi.org/10.1001/jama.2012.54515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232892				2022-12-01	WOS:000312132400023
J	Spencer, FA; Iorio, A; You, J; Murad, MH; Schunemann, HJ; Vandvik, PO; Crowther, MA; Pottie, K; Lang, ES; Meerpohl, JJ; Falck-Ytter, Y; Alonso-Coello, P; Guyatt, GH				Spencer, Frederick A.; Iorio, Alfonso; You, John; Murad, M. Hassad; Schuenemann, Holger J.; Vandvik, Per O.; Crowther, Mark A.; Pottie, Kevin; Lang, Eddy S.; Meerpohl, Joerg J.; Falck-Ytter, Yngve; Alonso-Coello, Pablo; Guyatt, Gordon H.			Uncertainties in baseline risk estimates and confidence in treatment effects	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATRIAL-FIBRILLATION; GRADE; QUALITY; RECOMMENDATIONS; ANTICOAGULATION; PUBLICATION		[Spencer, Frederick A.; Iorio, Alfonso; You, John; Schuenemann, Holger J.; Crowther, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada; [Iorio, Alfonso; You, John; Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 4A6, Canada; [Murad, M. Hassad] Mayo Clin, Div Prevent Med, Rochester, MN USA; [Vandvik, Per O.] Inlandet Hosp Trust, Dept Med, Gjovik, Norway; [Vandvik, Per O.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Crowther, Mark A.] McMaster Univ, Dept Mol Med, Hamilton, ON L8N 4A6, Canada; [Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Pottie, Kevin] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Lang, Eddy S.] Univ Calgary, Div Emergency Med, Calgary, AB, Canada; [Meerpohl, Joerg J.] Univ Med Ctr, Inst Med Biometry & Med Informat, German Cochrane Ctr, Freiburg, Germany; [Falck-Ytter, Yngve] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Alonso-Coello, Pablo] CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain	McMaster University; McMaster University; Mayo Clinic; Innlandet Hospital Trust; Norwegian Knowledge Centre for Health Services; McMaster University; University of Ottawa; University of Ottawa; University of Calgary; University of Freiburg; Case Western Reserve University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Spencer, FA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada.	fspence@mcmaster.ca	Meerpohl, Joerg J/J-4224-2013; Pottie, Kevin/ABC-4385-2020; Yngve Falck-Ytter, AGAF/AAC-5362-2019; Iorio, Alfonso/B-9478-2013; Murad, M. Hassan/AAW-4367-2020; Falck-Ytter, Yngve/GZH-0993-2022; Lang, Eddy/AAS-2080-2020; Lang, Eddy/I-4759-2014	Meerpohl, Joerg J/0000-0002-1333-5403; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Iorio, Alfonso/0000-0002-3331-8766; Alonso-Coello, Pablo/0000-0002-8001-8504; Crowther, Mark/0000-0003-4986-4873; Schunemann, Holger/0000-0003-3211-8479; Lang, Eddy/0000-0003-0850-4337; Murad, Mohammad Hassan/0000-0001-5502-5975				Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Danish SF, 2005, NEUROSURGERY, V56, P92; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Mara M, 2004, Ceska Gynekol, V69, P312; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	20	36	40	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2012	345								e7401	10.1136/bmj.e7401	http://dx.doi.org/10.1136/bmj.e7401			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040PZ	23152569	Green Submitted, Bronze			2022-12-01	WOS:000311336400019
J	Attaran, A; Barry, D; Basheer, S; Bate, R; Benton, D; Chauvin, J; Garrett, L; Kickbusch, I; Kohler, JC; Midha, K; Newton, PN; Nishtar, S; Orhii, P; McKee, M				Attaran, Amir; Barry, Donna; Basheer, Shamnad; Bate, Roger; Benton, David; Chauvin, James; Garrett, Laurie; Kickbusch, Ilona; Kohler, Jillian Clare; Midha, Kamal; Newton, Paul N.; Nishtar, Sania; Orhii, Paul; McKee, Martin			How to achieve international action on falsified and substandard medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUG QUALITY		[Attaran, Amir] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Barry, Donna] Partners Hlth, Boston, MA USA; [Basheer, Shamnad] Natl Univ Jurid Sci, Kolkata, India; [Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC USA; [Benton, David] Int Council Nurses, Geneva, Switzerland; [Chauvin, James] World Federat Publ Hlth Assoc, Geneva, Switzerland; [Garrett, Laurie] Council Foreign Relat, New York, NY USA; [Kickbusch, Ilona] Grad Inst, Global Hlth Programme, Geneva, Switzerland; [Kohler, Jillian Clare] Univ Toronto, Toronto, ON, Canada; [Midha, Kamal] Int Pharmaceut Federat, The Hague, Netherlands; [Newton, Paul N.] Univ Oxford, Oxford, England; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Orhii, Paul] Natl Agcy Food & Drug Adm & Control, Abuja, Nigeria; [McKee, Martin] London Sch Hyg & Trop Med, London WC1, England	University of Ottawa; Partners Healthcare System; American Enterprise Institute for Public Policy Research; University of Toronto; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Attaran, A (corresponding author), Univ Ottawa, 1 Stewart St, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca	benton, david/AAC-5298-2020; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	benton, david/0000-0001-8418-8618; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Benton, David/0000-0002-4068-8124; Newton, Paul/0000-0002-4608-6431	Wellcome Trust [089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmad K, 2004, LANCET, V363, P713, DOI 10.1016/S0140-6736(04)15670-5; [Anonymous], 2011, LANCET, V377, P1626, DOI 10.1016/S0140-6736(11)60656-9; [Anonymous], 2010, BERKELEY DECLARATION; [Anonymous], 2011, HIV AIDS KENYA MAJOR; Attaran A, 2011, J INT CRIM JUSTICE, V9, P325, DOI 10.1093/jicj/mqr005; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Bate R, 2010, LANCET, V376, P1446, DOI 10.1016/S0140-6736(10)61416-X; Beni S, 2011, ANAL BIOANAL CHEM, V399, P527, DOI 10.1007/s00216-010-4121-x; Callard C, 2010, TOB CONTROL, V19, P285, DOI 10.1136/tc.2009.035071; China State Council, 2012, NAT 12 5 YEAR PLAN D; Choudary A., 2012, POLICE BODY RECOMMEN; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; Council of Europe, 2011, CONV COUNT MED PROD; Erhun WO., 2001, J HLTH POPULATION DE, V4, P23; European Commission, 2011, REP EU CUST ENF INT; Fitz-Maurice E, 1932, AM J INT LAW, V26, P533, DOI 10.2307/2190203; Garrett L, ENSURING SAFETY INTE; India Parliamentary Standing Committee on Health and Family Welfare, 2012, 59 IND PARL STAND CO; Kubic TT, 2010, J BIOLAW BUS, V13, P38; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2002, BRIT MED J, V324, P800, DOI 10.1136/bmj.324.7341.800; Nordt SP, 2010, AM J CARDIOVASC DRUG, V10, P261, DOI 10.2165/11537640-000000000-00000; Okie S, 2009, NEW ENGL J MED, V361, P737, DOI 10.1056/NEJMp0903870; Oxfam, 2011, EYE BALL MED REG NOT; People's Health Movement, 2011, IT CONS 64 WHA; Pew Charitable Trusts, 2011, HEP PROT CONS RISKS; Schep LJ, 2009, CLIN TOXICOL, V47, P525, DOI 10.1080/15563650903086444; Third World Network, 2010, WHOS COUNT PROGR LEG; United Nations Office on Drugs and Crime, 2010, GLOBALIZATION CRIME; Von Braun J, 2010, AFR J INT COMP LAW, V18, P238, DOI 10.3366/ajicl.2010.0007; Weaver CM, 2012, WALL STREET J; WHO, 2011, WHOS ROL PREV CONTR; WHO, 2011, WHO PREQ MED PROGR F; WHO, 2011, FALS LAM ZID NEV TAB; WHO and IMPACT, 2006, COUNT MED UPD EST; World Health Organization, 2010, COUNT MED PROD REP S; World Health Organization, 2011, REP WORK GROUP MEMB; World Health Organization, INT PHARM; World Trade Organization, 1994, TRAD REL ASP INT PRO; [No title captured]	43	65	65	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2012	345								e7381	10.1136/bmj.e7381	http://dx.doi.org/10.1136/bmj.e7381			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PU	23149211	Green Submitted, Bronze			2022-12-01	WOS:000311335800015
J	Gu, S; Jin, L; Zhang, Y; Huang, Y; Zhang, FJ; Valdmanis, PN; Kay, MA				Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.			The Loop Position of shRNAs and Pre-miRNAs Is Critical for the Accuracy of Dicer Processing In Vivo	CELL			English	Article							RNA-INTERFERENCE; STRUCTURAL BASIS; HELICASE DOMAIN; MESSENGER-RNAS; RECOGNITION; EXPRESSION; MICRORNAS; BIOGENESIS; EFFICIENT; TERMINI	Short hairpin RNA (shRNA)-induced RNAi is used for biological discovery and therapeutics. Dicer, whose normal role is to liberate endogenous miRNAs from their precursors, processes shRNAs into different biologically active siRNAs, affecting their efficacy and potential for off-targeting. We found that, in cells, Dicer induced imprecise cleavage events around the expected sites based on the previously described 50/30 counting rules. These promiscuous noncanonical cleavages were abrogated when the cleavage site was positioned 2 nt from a bulge or loop. Interestingly, we observed that the similar to 1/3 of mammalian endogenous pre-miRNAs that contained such structures were more precisely processed by Dicer. Implementing a "loop-counting rule," we designed potent anti-HCV shRNAs with substantially reduced off-target effects. Our results suggest that Dicer recognizes the loop/bulge structure in addition to the ends of shRNAs/pre-miRNAs for accurate processing. This has important implications for both miRNA processing and future design of shRNAs for RNAi-based genetic screens and therapies.	[Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	markay@stanford.edu	Gu, Shuo/K-5404-2016	Valdmanis, Paul/0000-0001-8840-6969; Kay, Mark/0000-0002-2799-2615; Gu, Shuo/0000-0002-7924-5363	NIH [DK 078424, AI071068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK 078424 (M. A. K.) and NIH AI071068 (M. A. K.). We thank Dr. Grace Zheng for the Dicer KO ES cells and Dr. George Mias for helpful discussions on statistical methods.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mcintyre GJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-34; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pan QW, 2012, TRENDS BIOTECHNOL, V30, P206, DOI 10.1016/j.tibtech.2012.01.002; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Sawh AN, 2012, NAT STRUCT MOL BIOL, V19, P365, DOI 10.1038/nsmb.2275; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	48	193	205	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					900	911		10.1016/j.cell.2012.09.042	http://dx.doi.org/10.1016/j.cell.2012.09.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141545	Green Accepted, Bronze			2022-12-01	WOS:000310921200019
J	Zhou, XX; Chung, HK; Lam, AJ; Lin, MZ				Zhou, Xin X.; Chung, Hokyung K.; Lam, Amy J.; Lin, Michael Z.			Optical Control of Protein Activity by Fluorescent Protein Domains	SCIENCE			English	Article							SPATIOTEMPORAL CONTROL; LIGHT; ACTIVATION; INDUCTION; GTPASES; CELLS	Fluorescent proteins (FPs) are widely used as optical sensors, whereas other light-absorbing domains have been used for optical control of protein localization or activity. Here, we describe light-dependent dissociation and association in a mutant of the photochromic FP Dronpa, and we used it to control protein activities with light. We created a fluorescent light-inducible protein design in which Dronpa domains are fused to both termini of an enzyme domain. In the dark, the Dronpa domains associate and cage the protein, but light induces Dronpa dissociation and activates the protein. This method enabled optical control over guanine nucleotide exchange factor and protease domains without extensive screening. Our findings extend the applications of FPs from exclusively sensing functions to also encompass optogenetic control.	[Zhou, Xin X.; Chung, Hokyung K.; Lam, Amy J.; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University	Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mzlin@stanford.edu		Chung, H. Kay/0000-0002-7028-2432; Lin, Michael/0000-0002-0492-1961; Zhou, Xin/0000-0002-8198-2856	Stanford School of Engineering; Stanford Graduate Fellowship; Siebel Foundation Scholarship; Lucille Packard Children's Health Initiative; Burroughs Wellcome Career Award for Medical Scientists; NIH [R01NS076860]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076860] Funding Source: NIH RePORTER	Stanford School of Engineering; Stanford Graduate Fellowship(Stanford University); Siebel Foundation Scholarship; Lucille Packard Children's Health Initiative; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Davidson (Florida State University) for pcDNA3-mNeptune-Fascin, N. Shaner and R. Tsien (University of California San Diego) for pBAD-tdTomato, M. Yazawa and R. Dolmetsch (Stanford University) for cell lines and advice, Y. Geng in the Lin laboratory for assistance with plasmid design, and other members of the Lin laboratory. This work was funded by the Stanford School of Engineering and a Stanford Graduate Fellowship (X.X.Z.); a Siebel Foundation Scholarship (A.J.L.); and the Lucille Packard Children's Health Initiative, a Burroughs Wellcome Career Award for Medical Scientists, and NIH grant R01NS076860 (M.Z.L.). M.Z.L. is a Rita Allen Foundation Scholar. X.X.Z. and M.Z.L. are inventors on a patent application filed by Stanford University covering the construct design described in the paper. X.X.Z. designed, executed, and analyzed experiments and cowrote the manuscript. H.K.C. designed, executed, and analyzed experiments. A.J.L. assisted with experimental design. M.Z.L. conceived of the study, directed the project, provided advice, analyzed experiments, and cowrote the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Fan HY, 2011, BIOCHEMISTRY-US, V50, P1226, DOI 10.1021/bi101432p; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI [10.1038/nmeth.1524, 10.1038/NMETH.1524]; Krauss U, 2011, CHEM-EUR J, V17, P2552, DOI 10.1002/chem.201002716; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Leonard TA, 2007, CELL, V129, P1037, DOI 10.1016/j.cell.2007.06.001; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Mizuno H, 2010, PHOTOCH PHOTOBIO SCI, V9, P239, DOI 10.1039/b9pp00124g; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Muller J, 2008, CHEMBIOCHEM, V9, P2029, DOI 10.1002/cbic.200800190; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Powers Hilary J, 2012, Subcell Biochem, V56, P229, DOI 10.1007/978-94-007-2199-9_12; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riggsbee CW, 2010, TRENDS BIOTECHNOL, V28, P468, DOI 10.1016/j.tibtech.2010.06.001; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/nmeth.1473, 10.1038/NMETH.1473]; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	31	202	208	2	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					810	814		10.1126/science.1226854	http://dx.doi.org/10.1126/science.1226854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139335	Green Accepted			2022-12-01	WOS:000310839500048
J	Shaughnessy, AF				Shaughnessy, Allen F.			Meningitis outbreak shines light on compounding pharmacies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	Allen.Shaughnessy@Tufts.edu						Ballentine Carol, 1981, FDA CONSUMER MAG JUN; Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; EMLab P& K, 2011, USP 797 STAND GUID U; Lam Carol, PHARM COMPOUNDING RE; Lamb E, EARN PHARM COMPOUNDI; Pharmaceutical Commerce, 2012, DRUG SHORT 2012 WORS; Silverman E., 2012, PHARMALOT       1005; US Food and Drug Administration, 2012, QUEST ANSW FUNG MEN	8	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 5	2012	345								e7432	10.1136/bmj.e7432	http://dx.doi.org/10.1136/bmj.e7432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036KY	23129491				2022-12-01	WOS:000311026000005
J	Ling, QH; Huang, WH; Baldwin, A; Jarvis, P				Ling, Qihua; Huang, Weihua; Baldwin, Amy; Jarvis, Paul			Chloroplast Biogenesis Is Regulated by Direct Action of the Ubiquitin-Proteasome System	SCIENCE			English	Article							MITOCHONDRIAL E3; IMPORT RECEPTOR; ARABIDOPSIS; LIGASE; PROTEINS; PLASTIDS; DEGRADATION; PATHWAYS; DYNAMICS; NUCLEUS	Development of chloroplasts and other plastids depends on the import of thousands of nucleus-encoded proteins from the cytosol. Import is initiated by TOC (translocon at the outer envelope of chloroplasts) complexes in the plastid outer membrane that incorporate multiple, client-specific receptors. Modulation of import is thought to control the plastid's proteome, developmental fate, and functions. Using forward genetics, we identified Arabidopsis SP1, which encodes a RING-type ubiquitin E3 ligase of the chloroplast outer membrane. The SP1 protein associated with TOC complexes and mediated ubiquitination of TOC components, promoting their degradation. Mutant sp1 plants performed developmental transitions that involve plastid proteome changes inefficiently, indicating a requirement for reorganization of the TOC machinery. Thus, the ubiquitin-proteasome system acts on plastids to control their development.	[Ling, Qihua; Huang, Weihua; Baldwin, Amy; Jarvis, Paul] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Jarvis, P (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	rpj3@le.ac.uk	Huang, Weihua/GVS-4853-2022	Ling, Qihua/0000-0002-6984-9921; Baldwin, Amy/0000-0002-2162-3771; Jarvis, Paul/0000-0003-2127-5671	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D016541/1, BB/H008039/1]; Royal Society Rosenheim Research Fellowship; Royal Society International Incoming Fellowship; BBSRC [BB/D016541/1, BB/H008039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008039/1, BB/D016541/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Rosenheim Research Fellowship; Royal Society International Incoming Fellowship(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Rashbrooke for assistance with initial phenotype analyses and rough mapping of sp1; U. Ranganathan for her contribution to the analysis of SPL1; R. Patel and R. Berkeley for excellent technical assistance; N. Allcock and S. Hyman for electron microscopy (EM) carried out within the EM Laboratory, University of Leicester; C. Dean and R. Trosch for helpful comments on the manuscript; U. Flores-Perez for antigen preparation (atToc132 and atToc34); M. Boutry (PMA2), N. E. Hoffman (LHCP), K. Inoue (OEP80), F. Kessler (atToc159), and G. Thorlby (SFR2) for antibodies; C. E. Stebbins for the AtUBC8 clone; and the Salk Institute Genomic Analysis Laboratory (SIGnAL) and the Nottingham Arabidopsis Stock Centre (NASC) for the sp1-2 and sp1-3 alleles. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/D016541/1 and BB/H008039/1) to P.J., by the Royal Society Rosenheim Research Fellowship to P.J., and by a Royal Society International Incoming Fellowship to W. H. This work is the subject of patent application number GB 1216090.9, which covers the role of the ubiquitin-proteasome system in the control of plastid development. The data are presented in the manuscript and in the supplementary materials.	Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Basnayake BMVS, 2011, PLANT CELL REP, V30, P37, DOI 10.1007/s00299-010-0941-6; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Huang WH, 2006, PLANT CELL, V18, P2479, DOI 10.1105/tpc.106.045013; Huang WH, 2011, PLANT PHYSIOL, V157, P147, DOI 10.1104/pp.111.181891; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee S, 2009, PLANT CELL, V21, P3984, DOI 10.1105/tpc.109.071548; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Mochizuki N, 1996, PLANT PHYSIOL, V112, P1465, DOI 10.1104/pp.112.4.1465; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shen GX, 2007, PLANT J, V52, P309, DOI 10.1111/j.1365-313X.2007.03239.x; Stanga JP, 2009, PLANT PHYSIOL, V149, P1896, DOI 10.1104/pp.109.135301; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	29	164	176	7	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					655	659		10.1126/science.1225053	http://dx.doi.org/10.1126/science.1225053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118188				2022-12-01	WOS:000310516000050
J	Smith, RM; Schaefer, MK; Kainer, MA; Wise, M; Finks, J; Duwve, J; Fontaine, E; Chu, A; Carothers, B; Reilly, A; Fiedler, J; Wiese, AD; Feaster, C; Gibson, L; Griese, S; Purfield, A; Cleveland, AA; Benedict, K; Harris, JR; Brandt, ME; Blau, D; Jernigan, J; Weber, JT; Park, BJ				Smith, Rachel M.; Schaefer, Melissa K.; Kainer, Marion A.; Wise, Matthew; Finks, Jennie; Duwve, Joan; Fontaine, Elizabeth; Chu, Alvina; Carothers, Barbara; Reilly, Amy; Fiedler, Jay; Wiese, Andrew D.; Feaster, Christine; Gibson, Lex; Griese, Stephanie; Purfield, Anne; Cleveland, Angela A.; Benedict, Kaitlin; Harris, Julie R.; Brandt, Mary E.; Blau, Dianna; Jernigan, John; Weber, J. Todd; Park, Benjamin J.		Multistate Fungal Infection	Fungal Infections Associated with Contaminated Methylprednisolone Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACET JOINT INJECTION; LOW-BACK-PAIN; ASPERGILLUS MENINGITIS; CLADOSPORIUM-CLADOSPORIOIDES; CORTICOSTEROID INJECTION; MULTISTATE OUTBREAK; STEROID INJECTIONS; EPIDURAL ABSCESS; UNITED-STATES; SRI-LANKA	BackgroundFungal infections are rare complications of injections for treatment of chronic pain. In September 2012, we initiated an investigation into fungal infections associated with injections of preservative-free methylprednisolone acetate that was purchased from a single compounding pharmacy. MethodsThree lots of methylprednisolone acetate were recalled by the pharmacy; examination of unopened vials later revealed fungus. Notification of all persons potentially exposed to implicated methylprednisolone acetate was conducted by federal, state, and local public health officials and by staff at clinical facilities that administered the drug. We collected clinical data on standardized case-report forms, and we tested for the presence of fungi in isolates and specimens by examining cultures and performing polymerase-chain-reaction assays and histopathological and immunohistochemical testing. ResultsBy October 19, 2012, more than 99% of 13,534 potentially exposed persons had been contacted. As of July 1, 2013, there were 749 reported cases of infection in 20 states, with 61 deaths (8%). Laboratory evidence of Exserohilum rostratum was present in specimens from 153 case patients (20%). Additional data were available for 728 case patients (97%); 229 of these patients (31%) had meningitis with no other documented infection. Case patients had received a median of 1 injection (range, 1 to 6) of implicated methylprednisolone acetate. The median age of the patients was 64 years (range, 15 to 97), and the median incubation period (the number of days from the last injection to the date of the first diagnosis) was 47 days (range, 0 to 249); 40 patients (5%) had a stroke. ConclusionsAnalysis of data from a large, multistate outbreak of fungal infections showed substantial morbidity and mortality. The infections were associated with injection of a contaminated glucocorticoid medication from a single compounding pharmacy. Rapid public health actions included prompt recall of the implicated product, notification of exposed persons, and early outreach to clinicians.	[Smith, Rachel M.; Griese, Stephanie; Purfield, Anne] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Smith, Rachel M.; Purfield, Anne; Cleveland, Angela A.; Benedict, Kaitlin; Harris, Julie R.; Brandt, Mary E.; Park, Benjamin J.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA; [Schaefer, Melissa K.; Wise, Matthew; Jernigan, John; Weber, J. Todd] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Blau, Dianna] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Kainer, Marion A.; Wiese, Andrew D.] Tennessee Dept Hlth, Nashville, TN USA; [Finks, Jennie; Fiedler, Jay] Bur Epidemiol, Michigan Dept Community Hlth, Lansing, MI USA; [Duwve, Joan; Feaster, Christine] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Fontaine, Elizabeth; Gibson, Lex] Virginia Dept Hlth, Richmond, VA USA; [Chu, Alvina] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Carothers, Barbara] New Jersey Dept Hlth, Trenton, NJ USA; [Reilly, Amy] Florida Dept Hlth, Tallahassee, FL USA; [Griese, Stephanie] North Carolina Div Publ Hlth, Raleigh, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Tennessee Department Health; MDHHS - Michigan Department of Health & Human Services; Maryland Department of Health & Mental Hygiene; New Jersey Department of Health & Senior Services; Florida Department of Health	Park, BJ (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA.	bpark1@cdc.gov	Wiese, Andrew D/D-2200-2019; Cleveland, Angela Ahlquist/Q-2778-2019; Wiese, Andrew D/U-9745-2017	Wiese, Andrew D/0000-0002-0699-4224; Cleveland, Angela Ahlquist/0000-0003-1375-8964; Wiese, Andrew D/0000-0002-0699-4224; Jernigan, John/0000-0001-8163-925X; Kainer, Marion/0000-0001-7678-8744				ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; [Anonymous], 2012, ARCH UPD FUNG MEN; [Anonymous], 2012, CDC FDA JOINT TEL IN; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P310; Chew FLM, 2009, JPN J OPHTHALMOL, V53, P657, DOI 10.1007/s10384-009-0722-3; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; Clinical and Laboratory Standards Institute, 2008, MM18A CLSI; Cooper AB, 1996, CAN J ANAESTH, V43, P471, DOI 10.1007/BF03018109; DOUER D, 1987, J MED VET MYCOL, V25, P235; Duquia RP, 2010, MYCOSES, V53, P541, DOI 10.1111/j.1439-0507.2009.01745.x; Gade L, 2013, EUKARYOT CELL, V12, P677, DOI 10.1128/EC.00046-13; Gaul C, 2005, PAIN, V116, P407, DOI 10.1016/j.pain.2005.05.032; GRAY RG, 1981, SEMIN ARTHRITIS RHEU, V10, P231, DOI 10.1016/0049-0172(81)90001-9; Gunaratne PS, 2007, NEW ENGL J MED, V356, P754, DOI 10.1056/NEJMc062547; Hoelzer BC, 2008, EUR J PAIN, V12, P261, DOI 10.1016/j.ejpain.2007.05.005; Hooten WM, 2004, MAYO CLIN PROC, V79, P682, DOI 10.4065/79.5.682; Kabbara Abdallah, 2004, Pain Physician, V7, P269; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Lalueza A, 2011, ENDOSCOPY, V43, pE9, DOI 10.1055/s-0030-1255804; Lockhart SR, J CLIN MICR IN PRESS; Main Street Family Pharmacy, 2013, LLC ISS VOL NAT REC; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; Medprep Consulting Inc, 2013, ANN VOL NAT REC ALL; OSTENSSON A, 1991, BRIT J RHEUMATOL, V30, P35; Park MS, 2007, YONSEI MED J, V48, P711, DOI 10.3349/ymj.2007.48.4.711; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Ritter JM, 2013, AM J PATHOL, V183, P881, DOI 10.1016/j.ajpath.2013.05.007; Saigal G, 2004, AM J NEURORADIOL, V25, P642; Simopoulos Thomas T, 2008, Pain Physician, V11, P693; Smith RM, 2013, NEW ENGL J MED, V368, P2535, DOI 10.1056/NEJMc1306560; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558; Terr AI, 2001, ANN ALLERG ASTHMA IM, V87, P57, DOI 10.1016/S1081-1206(10)62343-5; Verweij PE, 1999, J CLIN MICROBIOL, V37, P1186, DOI 10.1128/JCM.37.4.1186-1189.1999; Viscoli C, 2002, J CLIN MICROBIOL, V40, P1496, DOI 10.1128/JCM.40.4.1496-1499.2002	39	128	132	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1598	1609		10.1056/NEJMoa1213978	http://dx.doi.org/10.1056/NEJMoa1213978			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	23252499				2022-12-01	WOS:000326031100009
J	Kokkinos, PF; Faselis, C; Myers, J; Panagiotakos, D; Doumas, M				Kokkinos, Peter F.; Faselis, Charles; Myers, Jonathan; Panagiotakos, Demosthenes; Doumas, Michael			Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study	LANCET			English	Article							ALL-CAUSE MORTALITY; 20-YEAR FOLLOW-UP; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; PRIMARY PREVENTION; MEN; CHOLESTEROL; PREDICTORS; AMERICAN; EVENTS	Background Statins are commonly prescribed for management of dyslipidaemia and cardiovascular disease. Increased fitness is also associated with low mortality and is recommended as an essential part of promoting health. However, little information exists about the combined effects of fitness and statin treatment on all-cause mortality. We assessed the combined effects of statin treatment and fitness on all-cause mortality risk. Methods In this prospective cohort study, we included dyslipidaemic veterans from Veterans Affairs Medical Centers in Palo Alto, CA, and Washington DC, USA, who had had an exercise tolerance test between 1986, and 2011. We assigned participants to one of four fitness categories based on peak metabolic equivalents (MET) achieved during exercise test and eight categories based on fitness status and statin treatment. The primary endpoint was all-cause mortality adjusted for age, body-mass index, ethnic origin, sex, history of cardiovascular disease, cardiovascular drugs, and cardiovascular risk factors. We assessed mortality from Veteran's Affairs' records on Dec 31, 2011. We compared groups with Cox proportional hazard model. Findings We assessed 10 043 participants (mean age 58.8 years, SD 10.9 years). During a median follow-up of 10.0 years (IQR 6.0-14.2), 2318 patients died, with an average yearly mortality rate of 22 deaths per 1000 person-years. Mortality risk was 18.5% (935/5046) in people taking statins versus 27.7% (1386/4997) in those not taking statins (p<0.0001). In patients who took statins, mortality risk decreased as fitness increased; for highly fit individuals (>9 MET; n=694), the hazard ratio (HR) was 0.30 (95% CI 0.21-0.41; p<0.0001) compared with least fit (<= 5 METs) patients (HR 1; n=1060). For those not treated with statins, the HR for least fit participants (n=1024) was 1.35 (95% CI 1.17-1.54; p<0.0001) and progressively decreased to 0.53 (95% CI 0.44-0.65; p<0.0001) for those in the highest fitness category (n=1498). Interpretation Statin treatment and increased fitness are independently associated with low mortality among dyslipidaemic individuals. The combination of statin treatment and increased fitness resulted in substantially lower mortality risk than either alone, reinforcing the importance of physical activity for individuals with dyslipidaemia.	[Kokkinos, Peter F.; Faselis, Charles; Panagiotakos, Demosthenes; Doumas, Michael] Vet Affairs Med Ctr, Dept Cardiol, Washington, DC 20422 USA; [Kokkinos, Peter F.] Georgetown Univ, Sch Med, Washington, DC USA; [Kokkinos, Peter F.; Faselis, Charles] George Washington Univ, Sch Med, Washington, DC USA; [Myers, Jonathan] Vet Affairs Palo Alto Hlth Care Syst, Div Cardiol, Palo Alto, CA USA; [Myers, Jonathan] Stanford Univ, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Kokkinos, PF (corresponding author), Vet Affairs Med Ctr, Div Cardiol, 50 Irving St NW, Washington, DC 20422 USA.	peter.kokkinos@va.gov	Panagiotakos, Demosthenes/C-9776-2013; Panagiotakos, Demosthenes/K-8294-2019; Panagiotakos, Demosthenes/M-9167-2019	Panagiotakos, Demosthenes/0000-0001-8583-153X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Faselis, Charles/0000-0001-9895-0327; Doumas, Michael/0000-0002-7269-8044	RRD VA [IK6 RX002477] Funding Source: Medline; Veterans Affairs [IK6RX002477] Funding Source: NIH RePORTER	RRD VA; Veterans Affairs(US Department of Veterans Affairs)		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Kizer KW, 2000, MED CARE, V38, pS7; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Kokkinos P, 2009, HYPERTENSION, V53, P494, DOI 10.1161/HYPERTENSIONAHA.108.127027; Kokkinos P, 2009, DIABETES CARE, V32, P623, DOI 10.2337/dc08-1876; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mascitelli L, 2009, INT J CARDIOL, V134, P136, DOI 10.1016/j.ijcard.2007.12.048; McAuley PA, 2007, DIABETES CARE, V30, P1539, DOI 10.2337/dc06-2397; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Packard CJ, 1998, CIRCULATION, V97, P1440; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sacks FM, 1998, CIRCULATION, V97, P1446; Selim AJ, 2002, MED CARE, V40, P237, DOI 10.1097/00005650-200203000-00007; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6	31	131	133	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					394	399		10.1016/S0140-6736(12)61426-3	http://dx.doi.org/10.1016/S0140-6736(12)61426-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23199849				2022-12-01	WOS:000314578900036
J	Chaudhury, D; Walsh, JJ; Friedman, AK; Juarez, B; Ku, SM; Koo, JW; Ferguson, D; Tsai, HC; Pomeranz, L; Christoffel, DJ; Nectow, AR; Ekstrand, M; Domingos, A; Mazei-Robison, MS; Mouzon, E; Lobo, MK; Neve, RL; Friedman, JM; Russo, SJ; Deisseroth, K; Nestler, EJ; Han, MH				Chaudhury, Dipesh; Walsh, Jessica J.; Friedman, Allyson K.; Juarez, Barbara; Ku, Stacy M.; Koo, Ja Wook; Ferguson, Deveroux; Tsai, Hsing-Chen; Pomeranz, Lisa; Christoffel, Daniel J.; Nectow, Alexander R.; Ekstrand, Mats; Domingos, Ana; Mazei-Robison, Michelle S.; Mouzon, Ezekiell; Lobo, Mary Kay; Neve, Rachael L.; Friedman, Jeffrey M.; Russo, Scott J.; Deisseroth, Karl; Nestler, Eric J.; Han, Ming-Hu			Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT STRESS; ANTIDEPRESSANT ACTION; REWARD CIRCUIT; IN-VIVO; SUSCEPTIBILITY; STIMULATION; INHIBITION; EXPRESSION; RESPONSES	Ventral tegmental area(VTA) dopamine neurons in the brain's reward circuit have a crucial role in mediating stress responses(1-4), including determining susceptibility versus resilience to social-stress-induced behavioural abnormalities(5). VTA dopamine neurons show two in vivo patterns of firing: low frequency tonic firing and high frequency phasic firing(6-8). Phasic firing of the neurons, which is well known to encode reward signals(6,7,9), is upregulated by repeated social-defeat stress, a highly validated mouse model of depression(5,8,10-13). Surprisingly, this pathophysiological effect is seen in susceptible mice only, with no apparent change in firing rate in resilient individuals(5,8). However, direct evidence-in real time-linking dopamine neuron phasic firing in promoting the susceptible (depression-like) phenotype is lacking. Here we took advantage of the temporal precision and cell-type and projection-pathway specificity of optogenetics to show that enhanced phasic firing of these neurons mediates susceptibility to social-defeat stress in freely behaving mice. We show that optogenetic induction of phasic, but not tonic, firing in VTA dopamine neurons of mice undergoing a subthreshold social-defeat paradigm rapidly induced a susceptible phenotype as measured by social avoidance and decreased sucrose preference. Optogenetic phasic stimulation of these neurons also quickly induced a susceptible phenotype in previously resilient mice that had been subjected to repeated social-defeat stress. Furthermore, we show differences in projection-pathway specificity in promoting stress susceptibility: phasic activation of VTA neurons projecting to the nucleus accumbens (NAc), but not to the medial prefrontal cortex (mPFC), induced susceptibility to social-defeat stress. Conversely, optogenetic inhibition of the VTA-NAc projection induced resilience, whereas inhibition of the VTA-mPFC projection promoted susceptibility. Overall, these studies reveal novel firing-pattern-and neural-circuit-specific mechanisms of depression.	[Chaudhury, Dipesh; Walsh, Jessica J.; Friedman, Allyson K.; Juarez, Barbara; Ku, Stacy M.; Nestler, Eric J.; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Koo, Ja Wook; Ferguson, Deveroux; Christoffel, Daniel J.; Mazei-Robison, Michelle S.; Mouzon, Ezekiell; Lobo, Mary Kay; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Tsai, Hsing-Chen; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tsai, Hsing-Chen; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Pomeranz, Lisa; Nectow, Alexander R.; Ekstrand, Mats; Domingos, Ana; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10056 USA; [Neve, Rachael L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Stanford University; Howard Hughes Medical Institute; Rockefeller University; Massachusetts Institute of Technology (MIT)	Han, MH (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Lobo, Mary Kay/K-7734-2015; Core, Vector/CAF-4832-2022; Han, Ming-Hu/G-8836-2012; Mazei-Robison, Michelle/I-4304-2017; Russo, Scott/R-7107-2019	Lobo, Mary Kay/0000-0002-9419-2079; Mazei-Robison, Michelle/0000-0002-2372-1420; Russo, Scott/0000-0002-6470-1805; Juarez, Barbara/0000-0001-7897-8031; Pomeranz, Lisa/0000-0002-8117-7355; Ferguson, Deveroux/0000-0001-9302-5992; Friedman, Allyson/0000-0002-8190-3011; Domingos, Ana/0000-0002-7938-4814; Christoffel, Dan/0000-0002-6303-5134; Ekstrand, Mats/0000-0003-0019-9462; Walsh, Jessica/0000-0001-8466-8451	National Institute of Mental Health [R01 MH092306]; Johnson & Johnson IMHRO Rising Star Translational Research Award; National Research Service Awards [F31 MH095425, F32 MH096464]; Mount Sinai PREP [R25 GM064118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, T32MH096678, F31MH095425, F32MH096464, R01MH092306, T32MH087004, T32MH020016, F31MH108326, K99MH094405] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson IMHRO Rising Star Translational Research Award; National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai PREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (R01 MH092306 to D. C. and M. H. H.), Johnson & Johnson IMHRO Rising Star Translational Research Award (M. H. H.), the National Research Service Awards (F31 MH095425 to J.J.W. and F32 MH096464 to A. K. F) and the Mount Sinai PREP R25 GM064118 (B.J.). We would like to thank K. Roy for help with some of the schematics in the figures, and we thank R. Cachope and J. Cheer for help with chronic fibre implantation techniques.	Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Giacobbe P, 2009, EXP NEUROL, V219, P44, DOI 10.1016/j.expneurol.2009.04.028; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han H. M., 2011, 50 ANN M ACNP; Hemmeter UM, 2010, EXPERT REV NEUROTHER, V10, P1101, DOI [10.1586/ern.10.83, 10.1586/ERN.10.83]; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Iniguez SD, 2010, J NEUROSCI, V30, P7652, DOI 10.1523/JNEUROSCI.0951-10.2010; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; Krishnan V, 2008, AM J PSYCHIAT, V165, P1109, DOI 10.1176/appi.ajp.2008.08071076; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Radulescu AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012695; Razzoli M, 2011, BEHAV BRAIN RES, V218, P253, DOI 10.1016/j.bbr.2010.11.050; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; Venzala E., 2012, EUR NEUROPSYCHOPHARM, DOI 10.1016/jeuroneuro.2012.05.010; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; Yadid G, 2008, PROG BRAIN RES, V172, P265, DOI 10.1016/S0079-6123(08)00913-8	37	691	710	15	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					532	+		10.1038/nature11713	http://dx.doi.org/10.1038/nature11713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235832	Green Accepted			2022-12-01	WOS:000313871400038
J	DuBois, RM; Vaney, MC; Tortorici, MA; Al Kurdi, R; Barba-Spaeth, G; Krey, T; Rey, FA				DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.			Functional and evolutionary insight from the crystal structure of rubella virus protein E1	NATURE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; FUSION PROTEIN; GLYCOPROTEIN; RECEPTOR; RESPONSES; SURFACE; DOMAIN; ENTRY; FORM	Little is known about the three-dimensional organization of rubella virus, which causes a relatively mild measles-like disease in children but leads to serious congenital health problems when contracted in utero(1). Although rubella virus belongs to the same family as the mosquito-borne alphaviruses, in many respects it is more similar to other aerosol-transmitted human viruses such as the agents of measles and mumps. Although the use of the triple MMR (measles, mumps and rubella) live vaccine has limited its incidence in western countries, congenital rubella syndrome remains an important health problem in the developing world. Here we report the 1.8 angstrom resolution crystal structure of envelope glycoprotein E1, the main antigen and sole target of neutralizing antibodies against rubella virus. E1 is the main player during entry into target cells owing to its receptor-binding and membrane-fusion functions. The structure reveals the epitope and the neutralization mechanism of an important category of protecting antibodies against rubella infection. It also shows that rubella virus E1 is a class II fusion protein, which had hitherto only been structurally characterized for the arthropod-borne alphaviruses and flaviviruses. In addition, rubella virus E1 has an extensive membrane-fusion surface that includes a metal site, reminiscent of the T-cell immunoglobulin and mucin family of cellular proteins that bind phosphatidylserine lipids at the plasma membrane of cells undergoing apoptosis. Such features have not been seen in any fusion protein crystallized so far. Structural comparisons show that the class II fusion proteins from alphaviruses and flaviviruses, despite belonging to different virus families, are closer to each other than they are to rubella virus E1. This suggests that the constraints on arboviruses imposed by alternating cycles between vertebrates and arthropods resulted in more conservative evolution. By contrast, in the absence of this constraint, the strictly human rubella virus seems to have drifted considerably into a unique niche as sole member of the Rubivirus genus.	[DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.	rey@pasteur.fr		Barba Spaeth, Giovanna/0000-0003-2069-9501; DuBois, Rebecca/0000-0003-4185-5673; Rey, Felix/0000-0002-9953-7988; Tortorici, M. Alejandra/0000-0002-2260-2577	'Pasteur-Howard' fellowship; Merck-Serono from the French Government [ANR-10-LABX-62-IBEID];  [ANR-05-MIIM-012-02-Dentry]	'Pasteur-Howard' fellowship; Merck-Serono from the French Government; 	We thank A. Haouz of Institut Pasteur and the PXI beam line staff at the Swiss Light Source and PROXIMA 1 beam line at SOLEIL synchrotron facilities for assistance; C. Vonrhein at Global Phasing for expertise in phase determination; G. Bricogne for input, G. Dupras and J.M. Mallet at Ecole Normale Superieure in Paris for the synthesis of galactose-3-sulphate used in co-crystallization trials; and J. Casasnovas, L. Chernomordik, Y. Gaudin, S. Harrison, F. Heinz, M. Kielian and J. Lepault for discussion. R. M. D. was supported by a 'Pasteur-Howard' fellowship. This work was mainly funded by grant ANR-05-MIIM-012-02-Dentry to F. A. R., who also acknowledges support from Merck-Serono from the French Government's Investissements d'Avenir program: Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant no. ANR-10-LABX-62-IBEID).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battisti AJ, 2012, J VIROL, V86, P11078, DOI 10.1128/JVI.01390-12; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2009, BUSTER VERSION 2 8 0; Castile JD, 1999, INT J PHARM, V188, P87, DOI 10.1016/S0378-5173(99)00207-0; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Goldstein D. A., 1990, CLIN METHODS HIST PH, P677; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hobman T., 2007, FIELDS VIROLOGY, P1069; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; KATOW S, 1988, J GEN VIROL, V69, P2797, DOI 10.1099/0022-1317-69-11-2797; KATOW S, 1985, J CLIN MICROBIOL, V21, P449, DOI 10.1128/JCM.21.3.449-451.1985; Kee SH, 2004, MICROBIOL IMMUNOL, V48, P823, DOI 10.1111/j.1348-0421.2004.tb03614.x; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; MASTROMARINO P, 1990, MED MICROBIOL IMMUN, V179, P105; MITCHELL LA, 1992, J CLIN MICROBIOL, V30, P1841, DOI 10.1128/JCM.30.7.1841-1847.1992; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Petruzziello R, 1996, J GEN VIROL, V77, P303, DOI 10.1099/0022-1317-77-2-303; Qiu ZY, 2000, J VIROL, V74, P6637, DOI 10.1128/JVI.74.14.6637-6642.2000; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stiasny K, 2004, J VIROL, V78, P3178, DOI 10.1128/JVI.78.6.3178-3183.2004; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; WOLINSKY JS, 1993, J VIROL, V67, P961, DOI 10.1128/JVI.67.2.961-968.1993	41	71	78	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					552	+		10.1038/nature11741	http://dx.doi.org/10.1038/nature11741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23292515				2022-12-01	WOS:000313871400042
J	Ruark, E; Snape, K; Humburg, P; Loveday, C; Bajrami, I; Brough, R; Rodrigues, DN; Renwick, A; Seal, S; Ramsay, E; Duarte, SD; Rivas, MA; Warren-Perry, M; Zachariou, A; Campion-Flora, A; Hanks, S; Murray, A; Pour, NA; Douglas, J; Gregory, L; Rimmer, A; Walker, NM; Yang, TP; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Brice, G; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Eccles, D; Evans, DG; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Shanley, S; Walker, L; Gore, M; Houlston, R; Brown, MA; Caufield, MJ; Deloukas, P; McCarthy, MI; Todd, JA; Turnbull, C; Reis, JS; Ashworth, A; Antoniou, AC; Lord, CJ; Donnelly, P; Rahman, N				Ruark, Elise; Snape, Katie; Humburg, Peter; Loveday, Chey; Bajrami, Ilirjana; Brough, Rachel; Rodrigues, Daniel Nava; Renwick, Anthony; Seal, Sheila; Ramsay, Emma; Duarte, Silvana Del Vecchio; Rivas, Manuel A.; Warren-Perry, Margaret; Zachariou, Anna; Campion-Flora, Adriana; Hanks, Sandra; Murray, Anne; Pour, Naser Ansari; Douglas, Jenny; Gregory, Lorna; Rimmer, Andrew; Walker, Neil M.; Yang, Tsun-Po; Adlard, Julian W.; Barwell, Julian; Berg, Jonathan; Brady, Angela F.; Brewer, Carole; Brice, Glen; Chapman, Cyril; Cook, Jackie; Davidson, Rosemarie; Donaldson, Alan; Douglas, Fiona; Eccles, Diana; Evans, D. Gareth; Greenhalgh, Lynn; Henderson, Alex; Izatt, Louise; Kumar, Ajith; Lalloo, Fiona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Paterson, Joan; Porteous, Mary; Rogers, Mark T.; Shanley, Susan; Walker, Lisa; Gore, Martin; Houlston, Richard; Brown, Matthew A.; Caufield, Mark J.; Deloukas, Panagiotis; McCarthy, Mark I.; Todd, John A.; Turnbull, Clare; Reis-Filho, Jorge S.; Ashworth, Alan; Antoniou, Antonis C.; Lord, Christopher J.; Donnelly, Peter; Rahman, Nazneen		Breast Ovarian Canc Susceptibility; Wellcome Trust Case Control Consor	Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer	NATURE			English	Article							DETECTABLE CLONAL MOSAICISM; CONFER SUSCEPTIBILITY; GERMLINE MUTATIONS; TUMOR-SUPPRESSOR; RARE VARIANTS; WIP1; PHOSPHATASE; PROTEIN; AMPLIFICATION; INHIBITOR	Improved sequencing technologies offer unprecedented opportunities for investigating the role of rare genetic variation in common disease. However, there are considerable challenges with respect to study design, data analysis and replication(1). Using pooled next-generation sequencing of 507 genes implicated in the repair of DNA in 1,150 samples, an analytical strategy focused on protein-truncating variants (PTVs) and a large-scale sequencing case-control replication experiment in 13,642 individuals, here we show that rare PTVs in the p53-inducible protein phosphatase PPM1D are associated with predisposition to breast cancer and ovarian cancer. PPM1D PTV mutations were present in 25 out of 7,781 cases versus 1 out of 5,861 controls (P = 1.12 x 10(-5)), including 18 mutations in 6,912 individuals with breast cancer (P = 2.42 x 10(-4)) and 12 mutations in 1,121 individuals with ovarian cancer (P = 3.10 x 10(-9)). Notably, all of the identified PPM1D PTVs were mosaic in lymphocyte DNA and clustered within a 370-base-pair region in the final exon of the gene, carboxy-terminal to the phosphatase catalytic domain. Functional studies demonstrate that the mutations result in enhanced suppression of p53 in response to ionizing radiation exposure, suggesting that the mutant alleles encode hyperactive PPM1D isoforms. Thus, although the mutations cause premature protein truncation, they do not result in the simple loss-of-function effect typically associated with this class of variant, but instead probably have a gain-of-function effect. Our results have implications for the detection and management of breast and ovarian cancer risk. More generally, these data provide new insights into the role of rare and of mosaic genetic variants in common conditions, and the use of sequencing in their identification.	[Ruark, Elise; Snape, Katie; Loveday, Chey; Renwick, Anthony; Seal, Sheila; Ramsay, Emma; Duarte, Silvana Del Vecchio; Warren-Perry, Margaret; Zachariou, Anna; Hanks, Sandra; Murray, Anne; Pour, Naser Ansari; Douglas, Jenny; Houlston, Richard; Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Humburg, Peter; Rivas, Manuel A.; Gregory, Lorna; Rimmer, Andrew] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bajrami, Ilirjana; Brough, Rachel; Rodrigues, Daniel Nava; Campion-Flora, Adriana; Reis-Filho, Jorge S.; Ashworth, Alan; Lord, Christopher J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Brough, Rachel] Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England; [Rivas, Manuel A.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7LD, England; [Walker, Neil M.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [Yang, Tsun-Po] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Adlard, Julian W.] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Barwell, Julian] Univ Hosp Leicester NHS Trust, Leicestershire Genet Ctr, Leicester LE1 5WW, Leics, England; [Berg, Jonathan] Univ Dundee, Div Med Sci, Dundee DD1 9SY, Scotland; [Brady, Angela F.] Kennedy Galton Ctr, NW Thames Reg Genet Serv, London HA1 3UJ, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Reg Genet Serv, Exeter EX1 2ED, Devon, England; [Brice, Glen] St George Hosp, SW Thames Reg Genet Serv, London SW17 0RE, England; [Chapman, Cyril] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Cook, Jackie] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Davidson, Rosemarie] So Gen Hosp, Lab Med, W Scotland Reg Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, SW Reg Genet Serv, Bristol BS2 8EG, Avon, England; [Douglas, Fiona; Henderson, Alex] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Eccles, Diana] Univ Southampton, Southampton Univ Hosp NHS Trust, Fac Med, Southampton SO16 5YA, Hants, England; [Evans, D. Gareth] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Greenhalgh, Lynn] Liverpool Womens NHS Fdn Trust, Merseyside & Cheshire Clin Genet Serv, Liverpool L8 7SS, Merseyside, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, SE Thames Reg Genet Serv, London SE1 9RT, England; [Kumar, Ajith] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Lalloo, Fiona] St Marys Hosp, Univ Dept Med Genet & Reg Genet Serv, Manchester M13 9WL, Lancs, England; [Miedzybrodzka, Zosia] Aberdeen Royal Infirm, Aberdeen & N Scotland Clin Genet Serv, Aberdeen AB25 2ZA, Scotland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast HSC Trust, No Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, E Anglian Reg Genet Serv, Cambridge CB2 0QQ, England; [Porteous, Mary] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Rogers, Mark T.] Univ Wales Hosp, All Wales Med Genet Serv, Cardiff CF14 4XW, S Glam, Wales; [Shanley, Susan] Royal Marsden NHS Fdn Trust, Dept Canc Genet, Sutton SM2 5PT, Surrey, England; [Walker, Lisa] Oxford Univ Hosp NHS Trust, Oxford Reg Genet Serv, Oxford OX3 7LJ, England; [Gore, Martin] Royal Marsden NHS Fdn, Dept Gynaecol Oncol, London SW3 6JJ, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Caufield, Mark J.] Queen Mary Univ London, London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LI, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LI, England; [Antoniou, Antonis C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Chapel Allerton Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; University of Dundee; University of Exeter; St Georges University London; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; University of Glasgow; University of Bristol; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Aberdeen; Queens University Belfast; University of Cambridge; University of Edinburgh; Cardiff University; Royal Marsden NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Queensland; University of London; Queen Mary University London; University of Oxford; University of Cambridge; University of Oxford	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Turnbull, Clare/AAA-6596-2019; Humburg, Peter/A-4191-2009; Breen, Gerome D/A-5540-2010; Evans, D Gareth/AAB-4308-2022; Eccles, Diana/K-6327-2019; Lord, Christopher/AAX-7130-2021; Deloukas, Panos/B-2922-2013; eyre, stephen/K-3776-2017; Brown, Matthew A/E-5749-2010; Rivas, Manuel/ABE-8173-2020; Lord, Christopher J/B-3295-2012; Snape, Katie/AAA-8101-2022; Dominiczak, Anna F/P-9390-2017; Hemingway, Harry/C-1219-2009; Todd, John/A-3542-2010; McCarthy, Mark/M-3763-2015; Rahman, Nazneen/D-2802-2013; Lucassen, Anneke/D-7764-2017	Humburg, Peter/0000-0002-3331-6496; Breen, Gerome D/0000-0003-2053-1792; Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Deloukas, Panos/0000-0001-9251-070X; eyre, stephen/0000-0002-1251-6974; Brown, Matthew A/0000-0003-0538-8211; Rivas, Manuel/0000-0003-1457-9925; Lord, Christopher J/0000-0002-3226-0515; Dominiczak, Anna F/0000-0003-4913-3608; Donnelly, Peter/0000-0001-9495-3408; Wain, Louise/0000-0003-4951-1867; Zeggini, Eleftheria/0000-0003-4238-659X; Walker, Neil/0000-0001-9796-7688; Hattersley, Andrew/0000-0001-5620-473X; Houlston, Richard/0000-0002-5268-0242; Forbes, Alastair/0000-0001-7416-9843; Lindgren, Cecilia/0000-0002-4903-9374; Hemingway, Harry/0000-0003-2279-0624; Eeles, Rosalind/0000-0002-3698-6241; Hocking, Lynne J/0000-0002-2414-2826; Ouwehand, Willem/0000-0002-7744-1790; Todd, John/0000-0003-2740-8148; Plagnol, Vincent/0000-0002-5597-9215; McCarthy, Mark/0000-0002-4393-0510; Yang, Tsun-Po/0000-0002-9077-4434; Ansari-Pour, Naser/0000-0003-0908-0484; Lango Allen, Hana/0000-0002-7803-8688; Campbell, James/0000-0001-6756-8766; Munroe, Patricia/0000-0002-4176-2947; Mentzer, Alexander/0000-0002-4502-2209; Harrison, Pille/0000-0003-4117-6910; Turnbull, Clare/0000-0002-1734-5772; Newman, William/0000-0002-6382-4678; Adlard, Julian/0000-0002-1693-0435; Rahman, Nazneen/0000-0003-4376-0440; Weedon, Michael/0000-0002-6174-6135; Lucassen, Anneke/0000-0003-3324-4338	Wellcome Trust [090532/Z/09/Z]; Medical Research Council (MRC) Hub grant [G0900747 91070]; Institute of Cancer Research; Cancer Research UK; RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer; MRC [G0000934]; Cancer Research UK Senior Cancer Research Fellow [C12292/A11174]; Wolfson-Royal Society Merit Award; Michael and Betty Kadoorie Cancer Genetics Research Programme; Cancer Research UK [14276, 15106, 11174] Funding Source: researchfish; Medical Research Council [G0000934, G0800675, MR/K006584/1, G0600329, G0800759, G0700491, G9521010] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219, NF-SI-0508-10275] Funding Source: researchfish; Chief Scientist Office [ETM/137, CZB/4/540, ETM/75] Funding Source: researchfish; MRC [G9521010, G0800675, G0800759, G0600329, G0700491] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC) Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Senior Cancer Research Fellow; Wolfson-Royal Society Merit Award(Royal Society of London); Michael and Betty Kadoorie Cancer Genetics Research Programme; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the subjects and families that participated in the research and D. Dudakia, J. Bull and R. Linger for their assistance in recruitment. We are indebted to M. Stratton for discussions of the data and to A. Strydom for editorial assistance. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics, Oxford (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council (MRC) Hub grant G0900747 91070) for the generation of the phase 1 sequencing data. This work was funded by the Institute of Cancer Research, The Wellcome Trust, Cancer Research UK and Breakthrough Breast Cancer. We acknowledge support by the RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer. We acknowledge the use of DNA from the British 1958 Birth Cohort collection funded by the MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow (C12292/A11174). P. Do. is supported by a Wolfson-Royal Society Merit Award. K. S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme.	[Anonymous], 2002, IARC Sci Publ, P1; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gayther SA, 2010, CURR OPIN GENET DEV, V20, P231, DOI 10.1016/j.gde.2010.03.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hayashi R, 2011, BIOCHEMISTRY-US, V50, P4537, DOI 10.1021/bi101949t; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rimmer A, 2012, PLATYPUS INTEGRATED; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Snape K, 2012, BREAST CANCER RES TR, V134, P429, DOI 10.1007/s10549-012-2057-x; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Tavassoli F, 2003, WHO CLASSIFICATION T; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	40	186	192	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					406	U152		10.1038/nature11725	http://dx.doi.org/10.1038/nature11725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23242139	Green Accepted			2022-12-01	WOS:000313615900052
J	Han, MS; Jung, DY; Morel, C; Lakhani, SA; Kim, JK; Flavell, RA; Davis, RJ				Han, Myoung Sook; Jung, Dae Young; Morel, Caroline; Lakhani, Saquib A.; Kim, Jason K.; Flavell, Richard A.; Davis, Roger J.			JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation	SCIENCE			English	Article							ADIPOSE-TISSUE; ACTIVATION; CELLS; POLARIZATION; SENSITIVITY; DIFFERENTIATION	The cJun NH2-terminal kinase (JNK) signaling pathway contributes to inflammation and plays a key role in the metabolic response to obesity, including insulin resistance. Macrophages are implicated in this process. To test the role of JNK, we established mice with selective JNK deficiency in macrophages. We report that feeding a high-fat diet to control and JNK-deficient mice caused similar obesity, but only mice with JNK-deficient macrophages remained insulin-sensitive. The protection of mice with macrophage-specific JNK deficiency against insulin resistance was associated with reduced tissue infiltration by macrophages. Immunophenotyping demonstrated that JNK was required for pro-inflammatory macrophage polarization. These studies demonstrate that JNK in macrophages is required for the establishment of obesity-induced insulin resistance and inflammation.	[Han, Myoung Sook; Morel, Caroline; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Han, Myoung Sook; Jung, Dae Young; Morel, Caroline; Kim, Jason K.; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Lakhani, Saquib A.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT USA; [Lakhani, Saquib A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University; Yale University; University of Massachusetts System; University of Massachusetts Worcester	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Lakhani, Sunil R/I-1970-2018	Lakhani, Sunil R/0000-0003-4067-2760; Kim, Jason/0000-0002-7185-042X; Lakhani, Saquib/0000-0003-3235-3460; Han, Myoung Sook/0000-0002-7226-2590; Davis, Roger/0000-0002-0130-1652	National Institutes of Health [DK090963, DK080756, CA065861]; American Diabetes Association [7-10-BETA-02];  [DK093000]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK093000, R01DK080756, R24DK090963, P30DK032520, U2CDK093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Barrett, V. Benoit, Y. Lee, and J.-H. Liu for technical assistance; S. Vernia for designing Taqman probes; and K. Gemme for administrative assistance. These studies were supported by grants from the National Institutes of Health (DK090963, DK080756, and CA065861). The University of Massachussetts Mouse Metabolic Phenotyping Center is supported by grant DK093000. M. S. H. was supported by a postdoctoral fellowship (7-10-BETA-02) from the American Diabetes Association. R.J.D. and J.K.K. are members of the University of Massachussetts Diabetes and Endocrinology Research Center (DK032520). R.J.D. and R. A. F. are Investigators of the Howard Hughes Medical Institute. Mouse strains described are available to qualified investigators upon completion of a standard institutional materials transfer agreement. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; WANG J, 1994, CLIN EXP IMMUNOL, V95, P263, DOI 10.1111/j.1440-1681.1994.tb02511.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	24	455	483	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					218	222		10.1126/science.1227568	http://dx.doi.org/10.1126/science.1227568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223452	Green Accepted			2022-12-01	WOS:000313328200048
J	Downer, NJ; Ali, NJ; Au-Yong, ITH				Downer, Nicola J.; Ali, Nabeel J.; Au-Yong, Iain T. H.			Investigating pleural thickening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIFFERENTIAL-DIAGNOSIS; THORACOSCOPY; CT; DISEASE; MANAGEMENT		[Downer, Nicola J.; Ali, Nabeel J.] Kings Mill Hosp, Dept Resp Med, Mansfield NG17 4JL, Sutton In Ashfi, England; [Au-Yong, Iain T. H.] Kings Mill Hosp, Dept Radiol, Mansfield NG17 4JL, Sutton In Ashfi, England		Au-Yong, ITH (corresponding author), Kings Mill Hosp, Dept Radiol, Mansfield NG17 4JL, Sutton In Ashfi, England.	iauyong@doctors.org.uk						British Thoracic Society, 2011, PLEUR PLAQ INF HLTH; Duysinx B, 2004, CHEST, V125, P489, DOI 10.1378/chest.125.2.489; Hansell D, 2009, IMAGING DIS CHEST; Hansen M, 1998, RESP MED, V92, P228, DOI 10.1016/S0954-6111(98)90100-7; HARRIS RJ, 1995, CHEST, V107, P845, DOI 10.1378/chest.107.3.845; Hierholzer J, 2000, CHEST, V118, P604, DOI 10.1378/chest.118.3.604; LEUNG AN, 1990, AM J ROENTGENOL, V154, P487, DOI 10.2214/ajr.154.3.2106209; Manhire A, 2003, THORAX, V58, P920, DOI 10.1136/thorax.58.11.920; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; MCLOUD TC, 1991, AM J ROENTGENOL, V156, P1145, DOI 10.2214/ajr.156.6.2028857; Miles Susan E, 2008, J Occup Med Toxicol, V3, P20, DOI 10.1186/1745-6673-3-20; Qureshi NR, 2009, THORAX, V64, P139, DOI 10.1136/thx.2008.100545; Rahman NM, 2007, BRIT MED J, V334, P206, DOI 10.1136/bmj.39061.503866.0B; Rahman NM, 2010, THORAX, V65, P54, DOI 10.1136/thx.2010.137018; Rodriguez-Panadero F, 2006, EUR RESPIR J, V28, P409, DOI 10.1183/09031936.06.00013706; Rusch V W, 1995, Chest, V108, P1122; Sharif S, 2011, INTERACT CARDIOV TH, V12, P806, DOI 10.1510/icvts.2010.255901; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Wiggins J, 2007, THORAX, V62, P1, DOI 10.1136/thx.2007.087619	19	9	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2013	346								e8376	10.1136/bmj.e8376	http://dx.doi.org/10.1136/bmj.e8376			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066QZ	23287997				2022-12-01	WOS:000313236600004
J	Li, XC; Dang, SY; Yan, CY; Gong, XQ; Wang, JW; Shi, YG				Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong			Structure of a presenilin family intramembrane aspartate protease	NATURE			English	Article							GAMMA-SECRETASE REVEALS; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CATALYTIC PORE; TRANSMEMBRANE DOMAIN-4; COMPLEX; PROTEOLYSIS; BINDING; PEN-2; MODEL	Presenilin and signal peptide peptidase (SPP) are intramembrane aspartyl proteases that regulate important biological functions in eukaryotes. Mechanistic understanding of presenilin and SPP has been hamperedby lack of relevant structural information. Here we report the crystal structure of a presenilin/SPP homologue (PSH) from the archaeon Methanoculleus marisnigri JR1. The protease, comprising nine transmembrane segments (TMs), adopts a previously unreported protein fold. The amino-terminal domain, consisting of TM1-6, forms a horseshoe-shaped structure, surrounding TM7-9 of the carboxy-terminal domain. The two catalytic aspartate residues are located on the cytoplasmic side of TM6 and TM7, spatially close to each other and approximately 8 angstrom into the lipid membrane surface. Water molecules gain constant access to the catalytic aspartates through a large cavity between the amino-and carboxy-terminal domains. Structural analysis reveals insights into the presenilin/SPP family of intramembrane proteases.	[Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Sch Life Sci,Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Sch Life Sci,Ctr Struct Biol, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Dang, Shangyu/0000-0001-9141-1865; Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048; Li, Xiaochun/0000-0002-0177-0803	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation of China [30888001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J. He and Q. Wang at Shanghai Synchrotron Radiation Facility beamline BL17U and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU for assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2009CB918801), and National Natural Science Foundation of China project 30888001.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chiang PM, 2012, NEUROBIOL AGING, V33, P277, DOI 10.1016/j.neurobiolaging.2009.12.028; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyashita H, 2011, J BIOL CHEM, V286, P26188, DOI 10.1074/jbc.M111.260273; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	60	158	160	2	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					56	+		10.1038/nature11801	http://dx.doi.org/10.1038/nature11801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254940				2022-12-01	WOS:000312933800029
J	Mick, DU; Dennerlein, S; Wiese, H; Reinhold, R; Pacheu-Grau, D; Lorenzi, I; Sasarman, F; Weraarpachai, W; Shoubridge, EA; Warscheid, B; Rehling, P				Mick, David U.; Dennerlein, Sven; Wiese, Heike; Reinhold, Robert; Pacheu-Grau, David; Lorenzi, Isotta; Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.; Warscheid, Bettina; Rehling, Peter			MITRAC Links Mitochondrial Protein Translocation to Respiratory-Chain Assembly and Translational Regulation	CELL			English	Article							CYTOCHROME-C-OXIDASE; F1F0-ATP SYNTHASE; COX I; COMPLEX; YEAST; SUPERCOMPLEX; BIOGENESIS; DEFICIENCY; EXPRESSION; MUTATIONS	Mitochondrial respiratory-chain complexes assemble from subunits of dual genetic origin assisted by specialized assembly factors. Whereas core subunits are translated on mitochondrial ribosomes, others are imported after cytosolic translation. How imported subunits are ushered to assembly intermediates containing mitochondria-encoded subunits is unresolved. Here, we report a comprehensive dissection of early cytochrome c oxidase assembly intermediates containing proteins required for normal mitochondrial translation and reveal assembly factors promoting biogenesis of human respiratory-chain complexes. We find that TIM21, a subunit of the inner-membrane presequence translocase, is also present in the major assembly intermediates containing newly mitochondria-synthesized and imported respiratory-chain subunits, which we term MITRAC complexes. Human TIM21 is dispensable for protein import but required for integration of early-assembling, presequence-containing subunits into respiratory-chain intermediates. We establish an unexpected molecular link between the TIM23 transport machinery and assembly of respiratory-chain complexes that regulate mitochondrial protein synthesis in response to their assembly state.	[Mick, David U.; Dennerlein, Sven; Reinhold, Robert; Pacheu-Grau, David; Lorenzi, Isotta; Rehling, Peter] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Wiese, Heike; Warscheid, Bettina] Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; [Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Gottingen; University of Freiburg; McGill University; McGill University; Max Planck Society	Rehling, P (corresponding author), Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany.	peter.rehling@medizin.uni-goettingen.de	Mick, David/AAW-3726-2021; Pacheu-Grau, David/A-9074-2017	Pacheu-Grau, David/0000-0003-2645-3983; Mick, David/0000-0003-1427-9412; Warscheid, Bettina/0000-0001-5096-1975; Wiese, Heike/0000-0002-8941-3762	Deutsche Forschungsgemeinschaft [SFB860]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State, Government [EXC 294 BIOSS]; CIHR; Max-Planck-Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State, Government; CIHR(Canadian Institutes of Health Research (CIHR)); Max-Planck-Society(Max Planck Society)	We thank C. Schulz, M. Deckers, and B. Schrul for helpful discussion; J. Melin for critical reading of the manuscript; D. Gorlich for his support; and M. Balleininger, M. Wissel, B. Knapp, and K. Lobenwein for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, SFB860, Excellence Initiative of the German Federal & State, Governments (EXC 294 BIOSS) (B.W.), operating grant from the CIHR (E.A.S.), and the Max-Planck-Society (P.R.). E.A.S. is an HHMI international scholar.	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Peralta S, 2012, J BIOL CHEM, V287, P24174, DOI 10.1074/jbc.M112.343764; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wagner K, 2009, J MOL BIOL, V392, P855, DOI 10.1016/j.jmb.2009.07.059; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	32	147	156	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1528	1541		10.1016/j.cell.2012.11.053	http://dx.doi.org/10.1016/j.cell.2012.11.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260140	Bronze			2022-12-01	WOS:000312890300017
J	Latos, PA; Pauler, FM; Koerner, MV; Senergin, HB; Hudson, QJ; Stocsits, RR; Allhoff, W; Stricker, SH; Klement, RM; Warczok, KE; Aumayr, K; Pasierbek, P; Barlow, DP				Latos, Paulina A.; Pauler, Florian M.; Koerner, Martha V.; Senergin, H. Basak; Hudson, Quanah J.; Stocsits, Roman R.; Allhoff, Wolfgang; Stricker, Stefan H.; Klement, Ruth M.; Warczok, Katarzyna E.; Aumayr, Karin; Pasierbek, Pawel; Barlow, Denise P.			Airn Transcriptional Overlap, But Not Its lncRNA Products, Induces Imprinted Igf2r Silencing	SCIENCE			English	Article							RNA; EXPRESSION; GROWTH	Mammalian imprinted genes often cluster with long noncoding (lnc) RNAs. Three lncRNAs that induce parental-specific silencing show hallmarks indicating that their transcription is more important than their product. To test whether Airn transcription or product silences the Igf2r gene, we shortened the endogenous lncRNA to different lengths. The results excluded a role for spliced and unspliced Airn lncRNA products and for Airn nuclear size and location in silencing Igf2r. Instead, silencing only required Airn transcriptional overlap of the Igf2r promoter, which interferes with RNA polymerase II recruitment in the absence of repressive chromatin. Such a repressor function for lncRNA transcriptional overlap reveals a gene silencing mechanism that may be widespread in the mammalian genome, given the abundance of lncRNA transcripts.	[Latos, Paulina A.; Pauler, Florian M.; Koerner, Martha V.; Senergin, H. Basak; Hudson, Quanah J.; Allhoff, Wolfgang; Stricker, Stefan H.; Klement, Ruth M.; Warczok, Katarzyna E.; Barlow, Denise P.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Stocsits, Roman R.; Aumayr, Karin] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Pasierbek, Pawel] Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pauler, FM (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14, A-1090 Vienna, Austria.	fpauler@cemm.oeaw.ac.at; dbarlow@cemm.oeaw.ac.at	Stricker, Stefan H/A-4930-2015; Hudson, Quanah/I-9837-2014; Stricker, Stefan/A-7410-2013	Stricker, Stefan H/0000-0002-5488-8530; Hudson, Quanah/0000-0002-3407-4388; 	Austrian Science Fund FWF [F4302-B09, W1207-B09]; Genome Research in Austria [GEN-AU 820980]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Genome Research in Austria	We thank E. F. Wagner and A. Wutz for the R2 Delta and D3 ES cell lines, and G. Superti-Furga, C. Bock, and A. P. Bird for comments on the manuscript. Array data (GSE41444) are available at www.ncbi.nlm.nih.gov/geo. Supported by grants from Austrian Science Fund FWF (F4302-B09 and W1207-B09) and Genome Research in Austria (GEN-AU 820980).	Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Hudson QJ, 2011, DEV BIOL, V353, P420, DOI 10.1016/j.ydbio.2011.02.017; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Wutz A, 2001, DEVELOPMENT, V128, P1881; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	19	329	341	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1469	1472		10.1126/science.1228110	http://dx.doi.org/10.1126/science.1228110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239737				2022-12-01	WOS:000312250800048
J	Grenon, SM; Saary, J; Gray, G; Vanderploeg, JM; Hughes-Fulford, M				Grenon, S. Marlene; Saary, Joan; Gray, Gary; Vanderploeg, James M.; Hughes-Fulford, Millie			Can I take a space flight? Considerations for doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPACEFLIGHT	Commercial investment is bringing space tourism closer to reality. Marlene Grenon and colleagues outline what doctors will need to know Although perhaps unfamiliar with the specific physiological changes associated with commercial air travel, most physicians will have travelled by plane and many will have attended a passenger in need of medical assistance while on a commercial flight. They are, however, unlikely to have experience of space travel. Numerous commercial enterprises exist that will eventually provide competitively priced access to spaceflight experiences for paying customers. With spaceports construction under way, bookings are already taking place. Physicians can in future expect patients to ask questions and request clearance processes (such as fitness to fly certificates) for space travel as they do for commercial airplane flights today. Here, we provide some background to the field of space medicine for non-experts and point to resources for clinicians when a patient presents with requests related to space travel.	[Grenon, S. Marlene] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94121 USA; [Grenon, S. Marlene] San Francisco VA Med Ctr, Dept Surg, San Francisco, CA USA; [Saary, Joan] Univ Toronto, Dept Occupat Med, Toronto, ON, Canada; [Saary, Joan] Canadian Forces Environm Med Estab, Toronto, ON, Canada; [Gray, Gary] Canadian Space Agcy, Montreal, PQ, Canada; [Vanderploeg, James M.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Aerosp Med Program, Galveston, TX USA; [Hughes-Fulford, Millie] Vet Affairs Med Ctr, Hughes Fulford Lab, San Francisco, CA 94121 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Toronto; Canadian Space Agency; University of Texas System; University of Texas Medical Branch Galveston; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Grenon, SM (corresponding author), Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94121 USA.	marlene.grenon@ucsfmedctr.org		Hughes-Fulford, Millie/0000-0002-0756-068X	NCRR NIH HHS [KL2RR024130] Funding Source: Medline; NIA NIH HHS [UH3 AG037628] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antunano MJ, 2001, AVIAT SPACE ENVIR MD, V72, P948; BEZDEK RH, 1992, NATURE, V355, P105, DOI 10.1038/355105a0; Blue RS, 2012, AVIAT SPACE ENVIR MD, V83, P929, DOI 10.3357/ASEM.3351.2012; Bogomolov VV, 2007, AVIAT SPACE ENVIR MD, V78, P1162, DOI 10.3357/ASEM.2175.2007; Center of Excellence for Commercial Space Transportation, FLIGHT CREW MED STAN; FAA Office of Commercial Space Transportation, REG; Federal Aviation Administration, 2006, GUID MED SCREEN COMM; Federal Aviation Administration, FOR SUB REUS VEH 10; Gray G, 2008, PRINCIPLES CLIN MED, P59; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; International Academy of Astronautics, 2009, MED SAF LIAB ISS SHO; Jennings RT, 2006, AVIAT SPACE ENVIR MD, V77, P475; Launius RD, 2003, SPACE POLICY, V19, P163, DOI 10.1016/S0265-9646(03)00039-0; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Pandya S, 2009, J NEUROSURG, V111, P1141, DOI 10.3171/2009.2.JNS081334; Rayman RB, 2002, AVIAT SPACE ENVIR MD, V73, P1132; Thirsk R, 2009, CAN MED ASSOC J, V180, P1324, DOI 10.1503/cmaj.090815; Thirsk R, 2009, CAN MED ASSOC J, V180, P1216, DOI 10.1503/cmaj.081125; Vanderploeg J, 2011, AVIAT SPACE ENVIR MD, V82, P475, DOI 10.3357/ASEM.3015.2011; Wilhelm M. J., 2001, Journal of Heart and Lung Transplantation, V20, P201, DOI 10.1016/S1053-2498(00)00427-7; Williams D, 2009, CAN MED ASSOC J, V180, P1317, DOI 10.1503/cmaj.090628; Williams D, 2009, CAN MED ASSOC J, V180, P1292, DOI 10.1503/cmaj.090925	22	22	22	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e8124	10.1136/bmj.e8124	http://dx.doi.org/10.1136/bmj.e8124			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241271	Green Published			2022-12-01	WOS:000312495700005
J	Hughes, AL; Gottschling, DE				Hughes, Adam L.; Gottschling, Daniel E.			An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; H+-ATPASE; PROTEINS; MECHANISMS; MEMBRANE; INHERITANCE; MORPHOLOGY; EXCHANGER; INSIGHTS	Mitochondria have a central role in ageing. They are considered to be both a target of the ageing process and a contributor to it(1). Alterations in mitochondrial structure and function are evident during ageing in most eukaryotes(2), but how this occurs is poorly understood. Here we identify a functional link between the lysosome-like vacuole and mitochondria in Saccharomyces cerevisiae, and show that mitochondrial dysfunction in replicatively aged yeast arises from altered vacuolar pH. We found that vacuolar acidity declines during the early asymmetric divisions of a mother cell, and that preventing this decline suppresses mitochondrial dysfunction and extends lifespan. Surprisingly, changes in vacuolar pH do not limit mitochondrial function by disrupting vacuolar protein degradation, but rather by reducing pH-dependent amino acid storage in the vacuolar lumen. We also found that calorie restriction promotes lifespan extension at least in part by increasing vacuolar acidity via conserved nutrient-sensing pathways(3). Interestingly, although vacuolar acidity is reduced in aged mother cells, acidic vacuoles are regenerated in newborn daughters, coinciding with daughter cells having a renewed lifespan potential(4). Overall, our results identify vacuolar pH as a critical regulator of ageing and mitochondrial function, and outline a potentially conserved mechanism by which calorie restriction delays the ageing process. Because the functions of the vacuole are highly conserved throughout evolution(5), we propose that lysosomal pH may modulate mitochondrial function and lifespan in other eukaryotic cells.	[Hughes, Adam L.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	dgottsch@fhcrc.org		Hughes, Adam/0000-0002-7095-3793	National Institutes of Health [AG037512, AG023779]; Glenn Award for Research in Biological Mechanisms of Aging; Helen Hay Whitney Foundation; Genetic Approaches to Aging Training Grant [T32 AG000057]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037512, R01AG023779, T32AG000057, R37AG023779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Award for Research in Biological Mechanisms of Aging; Helen Hay Whitney Foundation; Genetic Approaches to Aging Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Pallanck and members of the Gottschling laboratory for reviewing the manuscript; K. Henderson for helpful discussions; G. Miesenbock, D. Lindstromand J. Hsu for reagents; and L. Dimitrov for technical assistance. This work was supported by National Institutes of Health grants AG037512 and AG023779, and a Glenn Award for Research in Biological Mechanisms of Aging to D.E.G., and by fellowships from the Helen Hay Whitney Foundation and Genetic Approaches to Aging Training Grant (T32 AG000057) to A.L.H.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.e05-07-0678; Baker B, 1998, INTERNET WORLD, V9, P14; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; MORANO KA, 1994, J CELL SCI, V107, P2813; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539	41	327	331	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					261	+		10.1038/nature11654	http://dx.doi.org/10.1038/nature11654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23172144	Green Accepted			2022-12-01	WOS:000312259300044
J	Jangi, S				Jangi, Sushrut			Facing Uncertainty - Dispatch from Beth Israel Medical Center, Manhattan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Jangi, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2267	2269		10.1056/NEJMp1213844	http://dx.doi.org/10.1056/NEJMp1213844			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23151280				2022-12-01	WOS:000312187700015
J	Hernandez, AR; Klein, AM; Kirschner, MW				Hernandez, Ana R.; Klein, Allon M.; Kirschner, Marc W.			Kinetic Responses of beta-Catenin Specify the Sites of Wnt Control	SCIENCE			English	Article							AXIN; PHOSPHORYLATION	Despite more than 30 years of work on the Wnt signaling pathway, the basic mechanism of how the extracellular Wnt signal increases the intracellular concentration of beta-catenin is still contentious. Circumventing much of the detailed biochemistry, we used basic principles of chemical kinetics coupled with quantitative measurements to define the reactions on beta-catenin directly affected by the Wnt signal. We conclude that the core signal transduction mechanism is relatively simple, with only two regulated phosphorylation steps. Their partial inhibition gives rise to the full dynamics of the response and subsequently maintains a steady state in which the concentration of beta-catenin is increased.	[Hernandez, Ana R.; Klein, Allon M.; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu			Novartis Institutes for Biomedical Research; Career Award at the Scientific Interface from the Burroughs Welcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125603] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; Career Award at the Scientific Interface from the Burroughs Welcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Gerhart, M. Springer, X. He, W. Fontana, J. Gunawardena, J. Gray, F. Cong, and R. Deibler for discussions and comments on the manuscript; Y. Ben-Neriah for plasmids; and the Novartis Institutes for Biomedical Research for support of this work. A. M. K. holds a Career Award at the Scientific Interface from the Burroughs Welcome Fund. M. W. K. serves as a paid consultant on the scientific review board of Novartis.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; CHANCE B, 1958, NATURE, V182, P1190, DOI 10.1038/1821190a0; HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Peacocke AR, 1996, J THEOR BIOL, V182, P219, DOI 10.1006/jtbi.1996.0158; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200	16	89	89	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1337	1340		10.1126/science.1228734	http://dx.doi.org/10.1126/science.1228734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138978				2022-12-01	WOS:000311991200065
J	Fujiwara, Y; Dixon, JA; O'Hara, F; Funder, ED; Dixon, DD; Rodriguez, RA; Baxter, RD; Herle, B; Sach, N; Collins, MR; Ishihara, Y; Baran, PS				Fujiwara, Yuta; Dixon, Janice A.; O'Hara, Fionn; Funder, Erik Daa; Dixon, Darryl D.; Rodriguez, Rodrigo A.; Baxter, Ryan D.; Herle, Bart; Sach, Neal; Collins, Michael R.; Ishihara, Yoshihiro; Baran, Phil S.			Practical and innate carbon-hydrogen functionalization of heterocycles	NATURE			English	Article							AROMATIC-COMPOUNDS; TRIFLUOROMETHYLATION; ARYL; STRATEGIES; CHEMISTRY; FLUORINE; REAGENT; ARENES	Nitrogen-rich heterocyclic compounds have had a profound effect on human health because these chemical motifs are found in a large number of drugs used to combat a broad range of diseases and pathophysiological conditions. Advances in transition-metal-mediated cross-coupling have simplified the synthesis of such molecules; however, C-H functionalization of medicinally important heterocycles that does not rely on pre-functionalized starting materials is an underdeveloped area(1-9). Unfortunately, the innate properties of heterocycles that make them so desirable for biological applications-such as aqueous solubility and their ability to act as ligands-render them challenging substrates for direct chemical functionalization. Here we report that zinc sulphinate salts can be used to transfer alkyl radicals to heterocycles, allowing for the mild (moderate temperature, 50 degrees C or less), direct and operationally simple formation of medicinally relevant C-C bonds while reacting in a complementary fashion to other innate C-H functionalization methods(2-6) (Minisci, borono-Minisci, electrophilic aromatic substitution, transition-metal-mediated C-H insertion and C-H deprotonation). We prepared a toolkit of these reagents and studied their reactivity across a wide range of heterocycles (natural products, drugs and building blocks) without recourse to protecting-group chemistry. The reagents can even be used in tandem fashion in a single pot in the presence of water and air.	[Fujiwara, Yuta; Dixon, Janice A.; O'Hara, Fionn; Funder, Erik Daa; Dixon, Darryl D.; Rodriguez, Rodrigo A.; Baxter, Ryan D.; Herle, Bart; Sach, Neal; Collins, Michael R.; Ishihara, Yoshihiro; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sach, Neal; Collins, Michael R.] Pfizer Inc, La Jolla Labs, Dept Chem, San Diego, CA 92121 USA	Scripps Research Institute; Pfizer	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu		Dixon, Darryl D./0000-0002-3904-9587	US NIH/NIGMS [GM-073949]; Uehara Memorial Foundation; US-UK Fulbright Commission; Aarhus University; OChem Graduate School; CDNA; CFIN; NABIIT; US NIH; Pfizer Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073949] Funding Source: NIH RePORTER	US NIH/NIGMS; Uehara Memorial Foundation(Uehara Memorial Foundation); US-UK Fulbright Commission; Aarhus University; OChem Graduate School; CDNA; CFIN; NABIIT; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D.-H. Huang and L. Pasternack for NMR spectroscopic assistance, A. Schuyler and W. Uritboonthai for mass spectrometry assistance and D. Cayer for the analysis of the beta-lactamase activity. Financial support for this work was provided by the US NIH/NIGMS (GM-073949), the Uehara Memorial Foundation (postdoctoral fellowship for Y.F.), the US-UK Fulbright Commission (postdoctoral fellowship for F.O.), Aarhus University, OChem Graduate School, CDNA, CFIN and NABIIT (fellowship for E. D. F.), the US NIH (graduate fellowship for R. A. R.) and Pfizer Inc. (postdoctoral fellowship for R.D.B.).	Bruckl T, 2012, ACCOUNTS CHEM RES, V45, P826, DOI 10.1021/ar200194b; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Duncton MAJ, 2011, MEDCHEMCOMM, V2, P1135, DOI 10.1039/c1md00134e; Fier PS, 2012, J AM CHEM SOC, V134, P5524, DOI 10.1021/ja301013h; Fujiwara Y, 2012, J AM CHEM SOC, V134, P1494, DOI 10.1021/ja211422g; Fujiwara Y, 2011, J AM CHEM SOC, V133, P3292, DOI 10.1021/ja111152z; Han C, 2009, J AM CHEM SOC, V131, P7532, DOI 10.1021/ja902046m; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; KAMIGATA N, 1994, J CHEM SOC PERK T 1, P1339, DOI 10.1039/p19940001339; Kino T, 2010, J FLUORINE CHEM, V131, P98, DOI 10.1016/j.jfluchem.2009.09.007; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; LANGLOIS BR, 1991, TETRAHEDRON LETT, V32, P7525, DOI 10.1016/0040-4039(91)80524-A; Li Y, 2006, ORG LETT, V8, P1693, DOI 10.1021/ol060322t; Ma JA, 2007, J FLUORINE CHEM, V128, P975, DOI 10.1016/j.jfluchem.2007.04.026; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Molander GA, 2011, ORG LETT, V13, P1852, DOI 10.1021/ol2003572; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Qi QQ, 2012, J FLUORINE CHEM, V133, P115, DOI 10.1016/j.jfluchem.2011.07.005; Raymond J. I., 1971, J PHYS CHEM-US, V75, P3235; RUSSELL GA, 1985, J ORG CHEM, V50, P3423, DOI 10.1021/jo00218a041; Seiple IB, 2010, J AM CHEM SOC, V132, P13194, DOI 10.1021/ja1066459; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Zhao YC, 2012, ANGEW CHEM INT EDIT, V51, P1033, DOI 10.1002/anie.201106742	30	653	656	7	440	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					95	+		10.1038/nature11680	http://dx.doi.org/10.1038/nature11680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201691	Green Accepted			2022-12-01	WOS:000311893400052
J	Salazar, RF; Dotson, NM; Bressler, SL; Gray, CM				Salazar, R. F.; Dotson, N. M.; Bressler, S. L.; Gray, C. M.			Content-Specific Fronto-Parietal Synchronization During Visual Working Memory	SCIENCE			English	Article							SHORT-TERM-MEMORY; PRIMATE PREFRONTAL CORTEX; POSTERIOR PARIETAL CORTICES; NEURAL MECHANISMS; RHESUS-MONKEY; TOP-DOWN; OSCILLATIONS; ATTENTION; NEURONS; NETWORKS	Lateral prefrontal and posterior parietal cortical areas exhibit task-dependent activation during working memory tasks in humans and monkeys. Neurons in these regions become synchronized during attention-demanding tasks, but the contribution of these interactions to working memory is largely unknown. Using simultaneous recordings of neural activity from multiple areas in both regions, we find widespread, task-dependent, and content-specific synchronization of activity across the fronto-parietal network during visual working memory. The patterns of synchronization are prevalent among stimulus-selective neurons and are governed by influences arising in parietal cortex. These results indicate that short-term memories are represented by large-scale patterns of synchronized activity across the fronto-parietal network.	[Salazar, R. F.; Dotson, N. M.; Gray, C. M.] Montana State Univ, Bozeman, MT 59717 USA; [Bressler, S. L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; Florida Atlantic University	Gray, CM (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	cmgray@cns.montana.edu		Salazar, Rodrigo/0000-0003-3530-666X; Dotson, Nicholas/0000-0002-0885-2182	National Institute of Mental Health [MH069374, MH081162]; National Institute of Neurological Disorders and Stroke [NS059312]; Swiss National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069374, R01MH081162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059312] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Mental Health (MH069374, MH081162), the National Institute of Neurological Disorders and Stroke (NS059312), and the Swiss National Science Foundation. We thank B. Goodell for the design and development of the microdrive systems used in this study and U. Koster for technical support in the computational procedures. We also thank two anonymous reviewers for helpful comments on an earlier version of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hebb D.O., 2002, CLIN PSYCHOL; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Miller EK, 1996, J NEUROSCI, V16, P5154; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; QUINTANA J, 1989, BRAIN RES, V503, P100, DOI 10.1016/0006-8993(89)91709-5; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	31	233	236	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1097	1100		10.1126/science.1224000	http://dx.doi.org/10.1126/science.1224000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23118014	Green Accepted			2022-12-01	WOS:000311390600048
J	Palm-Meinders, IH; Koppen, H; Terwindt, GM; Launer, LJ; Konishi, J; Moonen, JME; Bakkers, JTN; Hofman, PAM; van Lew, B; Middelkoop, HAM; van Buchem, MA; Ferrari, MD; Kruit, MC				Palm-Meinders, Inge H.; Koppen, Hille; Terwindt, Gisela M.; Launer, Lenore J.; Konishi, Junya; Moonen, Juliette M. E.; Bakkers, Jacobus T. N.; Hofman, Paul A. M.; van Lew, Baldur; Middelkoop, Huub A. M.; van Buchem, Mark A.; Ferrari, Michel D.; Kruit, Mark C.			Structural Brain Changes in Migraine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WHITE-MATTER HYPERINTENSITIES; SMALL-VESSEL DISEASE; CARDIOVASCULAR-DISEASE; COGNITIVE FUNCTION; VERBAL FLUENCY; POPULATION; LESIONS; RISK; HEADACHE; INFARCTS	Context A previous cross-sectional study showed an association of migraine with a higher prevalence of magnetic resonance imaging (MRI)-measured ischemic lesions in the brain. Objective To determine whether women or men with migraine (with and without aura) have a higher incidence of brain lesions 9 years after initial MRI, whether migraine frequency was associated with progression of brain lesions, and whether progression of brain lesions was associated with cognitive decline. Design, Setting, and Participants In a follow-up of the 2000 Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis cohort, a prospective population-based observational study of Dutch participants with migraine and an age-and sex-matched control group, 203 of the 295 baseline participants in the migraine group and 83 of 140 in the control group underwent MRI scan in 2009 to identify progression of MRI-measured brain lesions. Comparisons were adjusted for age, sex, hypertension, diabetes, and educational level. The participants in the migraine group were a mean 57 years (range, 43-72 years), and 71% were women. Those in the control group were a mean 55 years (range, 44-71 years), and 69% were women. Main Outcome Measures Progression of MRI-measured cerebral deep white matter hyperintensities, infratentorial hyperintensities, and posterior circulation territory infarctlike lesions. Change in cognition was also measured. Results Of the 145 women in the migraine group, 112 (77%) vs 33 of 55 women (60%) in the control group had progression of deep white matter hyperintensities (adjusted odds ratio [OR], 2.1; 95% CI, 1.0-4.1; P = .04). There were no significant associations of migraine with progression of infratentorial hyperintensities: 21 participants (15%) in the migraine group and 1 of 57 participants (2%) in the control group showed progression (adjusted OR, 7.7; 95% CI, 1.0-59.5; P = .05) or new posterior circulation territory infarctlike lesions: 10 of 203 participants (5%) in the migraine group but none of 83 in the control group (P = .07). There was no association of number or frequency of migraine headaches with progression of lesions. There was no significant association of high vs nonhigh deep white matter hyperintensity load with change in cognitive scores (-3.7 in the migraine group vs 1.4 in the control group; 95% CI, -4.4 to 0.2; adjusted P = .07). Conclusions In a community-based cohort followed up after 9 years, women with migraine had a higher incidence of deep white matter hyperintensities but did not have significantly higher progression of other MRI-measured brain changes. There was no association of migraine with progression of any MRI-measured brain lesions in men. JAMA. 2012;308(18):1889-1897 www.jama.com	[Palm-Meinders, Inge H.; Konishi, Junya; Moonen, Juliette M. E.; van Buchem, Mark A.; Kruit, Mark C.] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands; [van Lew, Baldur] Leiden Univ, Med Ctr, Div Image Proc, NL-2300 RC Leiden, Netherlands; [Koppen, Hille; Terwindt, Gisela M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; [Middelkoop, Huub A. M.] Leiden Univ, Med Ctr, Dept Neuropsychol, NL-2300 RC Leiden, Netherlands; [Koppen, Hille] Haga Hosp, Dept Neurol, The Hague, Netherlands; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Bakkers, Jacobus T. N.] Slingeland Hosp, Dept Radiol, Doetinchem, Netherlands; [Hofman, Paul A. M.] Acad Hosp Maastricht, Dept Radiol, Maastricht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; Maastricht University Medical Centre (MUMC)	Kruit, MC (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands.	m.c.kruit@lumc.nl	Ferrari, Michel D./ABE-3758-2021; Kruit, Mark C/K-2431-2012; van Buchem, Mark/AAC-9843-2022	Ferrari, Michel D./0000-0001-9691-9449; Kruit, Mark C/0000-0002-4319-834X; van Buchem, Mark/0000-0003-1881-1998; Dichgans, Martin/0000-0002-0654-387X	Almirall; Coherex; Colucid; Eisai; GlaxoSmithKline; Linde; MAP; Medtronic; Menarini; Merck; Minster; Pfizer; St Jude; National Institutes of Health [1R01NS061382-01]; Netherlands Heart Foundation [2007B016]; Netherlands Organisation for Scientific Research [903-52-291, VICI 918-56-602]; National Institute on Aging [907-00-217, Vidi 917-11-319]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061382] Funding Source: NIH RePORTER	Almirall(Almirall); Coherex; Colucid; Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Linde; MAP; Medtronic(Medtronic); Menarini(Menarini Group); Merck(Merck & Company); Minster; Pfizer(Pfizer); St Jude(St. Jude Medical); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ferrari reported receiving grants and consultancy or industry support from Almirall, Coherex, Colucid, Eisai, GlaxoSmithKline, Linde, MAP, Medtronic, Menarini, Merck, Minster, Pfizer, and St Jude, and independent support from the Netherlands Organisation for Scientific Research (NOW). Dr Terwindt reported receiving consultancy support from Merck, Janssen-Cilag, Almirall, and Menarini. Dr Koppen reported consultancy or industry support from Allergan, Benecke congres, Pfizer, and In circulation website. The other authors reported no financial disclosures.; This work was supported by grants 1R01NS061382-01 from the National Institutes of Health, 2007B016 from the Netherlands Heart Foundation, and 903-52-291, VICI 918-56-602, and Spinoza 2009 from the Netherlands Organisation for Scientific Research, and 907-00-217 and Vidi 917-11-319 from the Intramural Research Program at the National Institute on Aging.	Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Kruit MC, 2006, STROKE, V37, P1109, DOI 10.1161/01.STR.0000206446.26702.e9; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Kurth Tobias, 2006, Curr Pain Headache Rep, V10, P214, DOI 10.1007/s11916-006-0048-5; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Le Pira F, 2004, FUNCT NEUROL, V19, P101; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rey A, 1985, EXAMIN CLIN PSYCHOL; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2010, HEADACHE, V50, P588, DOI 10.1111/j.1526-4610.2009.01570.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schwedt TJ, 2008, CEPHALALGIA, V28, P531, DOI 10.1111/j.1468-2982.2008.01554.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tietjen GE, 2009, STROKE, V40, P2977, DOI 10.1161/STROKEAHA.109.547901; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Waldie KE, 2002, NEUROLOGY, V59, P904, DOI 10.1212/WNL.59.6.904; Wechsler, 1981, WECHSLER ADULT INTEL; Wolf ME, 2011, NEUROLOGY, V76, P1911, DOI 10.1212/WNL.0b013e31821d74d5	35	137	144	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1889	1897		10.1001/jama.2012.14276	http://dx.doi.org/10.1001/jama.2012.14276			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150008	Green Accepted			2022-12-01	WOS:000310952700025
J	Buesseler, KO				Buesseler, Ken O.			Fishing for Answers off Fukushima	SCIENCE			English	Editorial Material							RADIONUCLIDES; RADIOCESIUM; JAPAN		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu						Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029295; International Atomic Energy Agency, 2004, TECHN REP SER, V422; Japan Ministry of Agriculture, 2012, RES INSP RAD MAT FIS; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Ministry of Education, 2012, READ MAR SOIL MON SE; Rowan DJ, 1995, J APPL ECOL, V32, P739, DOI 10.2307/2404813; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; Tokyo Electric Power Company, 2012, NUCL AN RES FISH SHE; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493	11	88	96	7	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					480	482		10.1126/science.1228250	http://dx.doi.org/10.1126/science.1228250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112321	Green Submitted			2022-12-01	WOS:000310195800043
J	Garrison, JL; Macosko, EZ; Bernstein, S; Pokala, N; Albrecht, DR; Bargmann, CI				Garrison, Jennifer L.; Macosko, Evan Z.; Bernstein, Samantha; Pokala, Navin; Albrecht, Dirk R.; Bargmann, Cornelia I.			Oxytocin/Vasopressin-Related Peptides Have an Ancient Role in Reproductive Behavior	SCIENCE			English	Article							MALE MATING-BEHAVIOR; CAENORHABDITIS-ELEGANS; C-ELEGANS; OXYTOCIN	Many biological functions are conserved, but the extent to which conservation applies to integrative behaviors is unknown. Vasopressin and oxytocin neuropeptides are strongly implicated in mammalian reproductive and social behaviors, yet rodent loss-of-function mutants have relatively subtle behavioral defects. Here we identify an oxytocin/vasopressin-like signaling system in Caenorhabditis elegans, consisting of a peptide and two receptors that are expressed in sexually dimorphic patterns. Males lacking the peptide or its receptors perform poorly in reproductive behaviors, including mate search, mate recognition, and mating, but other sensorimotor behaviors are intact. Quantitative analysis indicates that mating motor patterns are fragmented and inefficient in mutants, suggesting that oxytocin/vasopressin peptides increase the coherence of mating behaviors. These results indicate that conserved molecules coordinate diverse behavioral motifs in reproductive behavior.	[Garrison, Jennifer L.; Macosko, Evan Z.; Bernstein, Samantha; Pokala, Navin; Albrecht, Dirk R.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Garrison, JL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.		Macosko, Evan/X-4664-2019; Pokala, Navin/AAH-5719-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618	G. Harold and Leila Y. Mathers Foundation; Harvey Karp and Helen Hay Whitney Fellowships; NIH [K99GM092859, GM07739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, K99GM092859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Harvey Karp and Helen Hay Whitney Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Strains bearing ntc-1, ntr-1, and ntr-2 mutations are available through the C. elegans National BioResource Project (NBRP), subject to a materials transfer agreement. Sequence accession numbers are as follows: NM_001038459.1 (ntc-1), NM_060792 (ntr-1), NM_078076 (ntr-2). We thank S. Emmons for sharing the male wiring diagram before publication; D. Anderson, S. Emmons, S. Flavell, A. Gordus, W. Kristan, T. Maniar, P. McGrath, L. Vosshall, and Y. Xu for discussions; S. Chalasani for plasmids; S. Mitani and the National Bioresource Project for ntc-1, ntr-1, and ntr-2 mutants; and the Rockefeller Proteomics Facility, the Rockefeller Bioimaging Facility, and the Rockefeller High Throughput Screening Facility for technical support. This work was supported by a grant from the G. Harold and Leila Y. Mathers Foundation, by Harvey Karp and Helen Hay Whitney Fellowships to J.L.G., by NIH grant K99GM092859 to J.L.G., and by NIH grant GM07739 to E.Z.M. C.I.B. is an Investigator of the Howard Hughes Medical Institute.	Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; HODGKIN J, 1987, ANNU REV GENET, V21, P133, DOI 10.1146/annurev.ge.21.120187.001025; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Wagenaar DA, 2010, CURR BIOL, V20, P487, DOI 10.1016/j.cub.2010.02.027; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909	16	162	165	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					540	543		10.1126/science.1226201	http://dx.doi.org/10.1126/science.1226201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112335	Green Accepted			2022-12-01	WOS:000310195800061
J	LaRue, CC; Padilla, PA				LaRue, Candace C.; Padilla, Pamela A.			A Mutant Search-Caenorhabditis elegans and Gene Discovery	SCIENCE			English	Editorial Material									[LaRue, Candace C.; Padilla, Pamela A.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Padilla, PA (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	pamela.padilla@unt.edu			Division Of Integrative Organismal Systems [0747391] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BRENNER S, 1974, GENETICS, V77, P71; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	4	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					487	488		10.1126/science.1215229	http://dx.doi.org/10.1126/science.1215229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112325				2022-12-01	WOS:000310195800047
J	Cong, L; Ran, FA; Cox, D; Lin, SL; Barretto, R; Habib, N; Hsu, PD; Wu, XB; Jiang, WY; Marraffini, LA; Zhang, F				Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Barretto, Robert; Habib, Naomi; Hsu, Patrick D.; Wu, Xuebing; Jiang, Wenyan; Marraffini, Luciano A.; Zhang, Feng			Multiplex Genome Engineering Using CRISPR/Cas Systems	SCIENCE			English	Article							STREPTOCOCCUS-THERMOPHILUS; IMMUNE-SYSTEM; TAL EFFECTORS; CAS SYSTEMS; SMALL RNAS; DNA; BACTERIA; ENDONUCLEASE; NUCLEASES; DEFENSE	Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage. We engineered two different type II CRISPR/Cas systems and demonstrate that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. Cas9 can also be converted into a nicking enzyme to facilitate homology-directed repair with minimal mutagenic activity. Lastly, multiple guide sequences can be encoded into a single CRISPR array to enable simultaneous editing of several sites within the mammalian genome, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.	[Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Habib, Naomi; Hsu, Patrick D.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Habib, Naomi; Hsu, Patrick D.; Zhang, Feng] MIT, Dept Biol Engn, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cong, Le] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Cox, David] Harvard Univ, Sch Med, Harvard MIT Hlth Sci & Technol, Boston, MA 02115 USA; [Ran, F. Ann; Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lin, Shuailiang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Barretto, Robert] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jiang, Wenyan; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Tsinghua University; Columbia University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Rockefeller University	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Wu, Xuebing/C-9152-2013; Habib, Naomi/AAA-8937-2020; Lin, Shuailiang/O-3272-2016; Cong, Le/M-9981-2013; Macrae, Rhiannon/AAX-1536-2020; Hsu, Patrick/ABD-5749-2021	Wu, Xuebing/0000-0003-0369-5269; Cong, Le/0000-0003-4725-8714; Hsu, Patrick/0000-0002-9380-2648	Zhang lab; Medical Scientist Training Program; NIH [R01-GM34277, R01-CA133404]; NIH Director's New Innovator Award [DP2AI104556]; NIH Director's Pioneer Award [DP1MH100706]; Keck foundation; McKnight foundation; Gates foundation; Damon Runyon foundation; Searle Scholars foundation; Klingenstein foundation; Simons foundation; NATIONAL CANCER INSTITUTE [R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073124] Funding Source: NIH RePORTER	Zhang lab; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck foundation(W.M. Keck Foundation); McKnight foundation; Gates foundation(Bill & Melinda Gates Foundation); Damon Runyon foundation; Searle Scholars foundation; Klingenstein foundation(Klingenstein Philanthropies); Simons foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the entire Zhang lab for their support and advice; P. A. Sharp for generous help with Northern blot analysis; C. Jennings, R. Desimone, and M. Kowalczyk for helpful comments; and X. Ye for help with confocal imaging. L. C. and X. W. are Howard Hughes Medical Institute International Student Research Fellows. D. C. is supported by the Medical Scientist Training Program. P. D. H. is a James Mills Pierce Fellow. X. W. is supported by NIH grants R01-GM34277 and R01-CA133404 to P. A. Sharp, X.W.'s thesis adviser. L. A. M. is supported by Searle Scholars, R. Allen, an Irma T. Hirschl Award, and a NIH Director's New Innovator Award (DP2AI104556). F.Z. is supported by a NIH Director's Pioneer Award (DP1MH100706); the Keck, McKnight, Gates, Damon Runyon, Searle Scholars, Klingenstein, and Simons foundations; R. Metcalfe; M. Boylan; and J. Pauley. The authors have no conflicting financial interests. A patent application has been filed relating to this work, and the authors plan on making the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab Web site (www.genome-engineering.org).	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Wood A. J., 2011, WOOD SCI, V333, P307; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	29	9164	10624	358	8119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					819	823		10.1126/science.1231143	http://dx.doi.org/10.1126/science.1231143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287718	Green Accepted, Green Submitted			2022-12-01	WOS:000314874400049
J	Chen, Q; Chen, YB; Bian, CJ; Fujiki, R; Yu, XC				Chen, Qiang; Chen, Yibin; Bian, Chunjing; Fujiki, Ryoji; Yu, Xiaochun			TET2 promotes histone O-GlcNAcylation during gene transcription	NATURE			English	Article							EMBRYONIC STEM-CELLS; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; 5-HYDROXYMETHYLCYTOSINE; GENOME; 5-METHYLCYTOSINE; PROTEINS; NUCLEAR; DNA; DIFFERENTIATION	Ten eleven translocation (TET) enzymes, including TET1, TET2 and TET3, convert 5-methylcytosine to 5-hydroxymethylcytosine(1) and regulate gene transcription(2-5). However, the molecular mechanism by which TET family enzymes regulate gene transcription remains elusive(5,6). Using protein affinity purification, here we search for functional partners of TET proteins, and find that TET2 and TET3 associate with O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT), an enzyme that by itself catalyses the addition of O-GlcNAc onto serine and threonine residues (O-GlcNAcylation) in vivo(7,8). TET2 directly interacts with OGT, which is important for the chromatin association of OGT in vivo. Although this specific interaction does not regulate the enzymatic activity of TET2, it facilitates OGT-dependent histone O-GlcNAcylation. Moreover, OGT associates with TET2 at transcription start sites. Downregulation of TET2 reduces the amount of histone 2B Ser 112 GlcNAc marks in vivo, which are associated with gene transcription regulation. Taken together, these results reveal a TET2-dependent O-GlcNAcylation of chromatin. The double epigenetic modifications on both DNA and histones by TET2 and OGT coordinate together for the regulation of gene transcription.	[Chen, Qiang; Chen, Yibin; Bian, Chunjing; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Fujiki, Ryoji] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Fujiki, Ryoji] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Michigan System; University of Michigan; University of Tokyo; Japan Science & Technology Agency (JST)	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 1150 W Med Ctr Dr,5560A MSRBII, Ann Arbor, MI 48109 USA.	xiayu@med.umich.edu	chen, qiang/G-5031-2016; Chen, Yibin/A-3019-2015; Chen, Yibin/L-3533-2014	Chen, Yibin/0000-0003-1060-9373; 	National Institutes of Health [CA132755, CA130899]; University of Michigan Cancer Center; GI Peptide Research Center; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); GI Peptide Research Center; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Kuang for proofreading the manuscript and J. Hutchins for research support. This work was supported by the National Institutes of Health (CA132755 and CA130899 to X.Y.), the University of Michigan Cancer Center and GI Peptide Research Center. X.Y. is a recipient of the Era of Hope Scholar Award from the Department of Defense.	Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	35	366	383	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					561	+		10.1038/nature11742	http://dx.doi.org/10.1038/nature11742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23222540	Green Accepted			2022-12-01	WOS:000313871400044
J	Lin, CQ; Garruss, AS; Luo, ZJ; Guo, FL; Shilatifard, A				Lin, Chengqi; Garruss, Alexander S.; Luo, Zhuojuan; Guo, Fengli; Shilatifard, Ali			The RNA Pol II Elongation Factor EII3 Marks Enhancers in ES Cells and Primes Future Gene Activation	CELL			English	Article							EMBRYONIC STEM-CELLS; CIS-REGULATORY SIGNATURE; POLYMERASE-II; COMPLEX SEC; TRANSCRIPTION ELONGATION; CHROMATIN INTERACTIONS; GENOME; EXPRESSION; DROSOPHILA; COHESIN	Enhancers play a central role in precisely regulating the expression of developmentally regulated genes. However, the machineries required for enhancer-promoter communication have remained largely unknown. We have found that EII3, a member of the Ell (eleven-nineteen lysine-rich leukemia gene) family of RNA Pol II elongation factors, occupies enhancers in embryonic stem cells. EII3's association with enhancers is required for setting up proper Pol II occupancy at the promoter-proximal regions of developmentally regulated genes and for the recruitment of the super elongation complex ( SEC) to these loci following differentiation signals. Furthermore, EII3 binding to inactive or poised enhancers is essential for stem cell specification. We have also detected the presence of Pol II and EII3 in germ cell nuclei. These findings raise the possibility that transcription factors could prime gene expression by marking enhancers in ES cells or even as early as in the germ cell state.	[Lin, Chengqi; Garruss, Alexander S.; Luo, Zhuojuan; Guo, Fengli; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Shilatifard, A (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ash@stowers.org		Lin, Chengqi/0000-0002-2121-584X	Alex's Lemonade Stand Foundation; National Institute of Health [R01CA89455, R01CA150265]; NATIONAL CANCER INSTITUTE [R01CA150265, R01CA089455] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr. Edwin Smith for conversations and for critical reading of the manuscript. We also thank Boris Rubenstein for mathematical support and Michael Durnin, Stacy Marshall, and Ka Chun Lai for technical assistance. We are also thankful to Laura Shilatifard for editorial assistance. This work was performed to fulfill, in part, requirements for C.L.'s PhD. thesis research as a student registered with the Open University. Studies in this manuscript were supported, in part, by funds provided by the Alex's Lemonade Stand Foundation and from the National Institute of Health (R01CA89455 and R01CA150265 to A.S.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Elmendorf BJ, 2001, J BIOL CHEM, V276, P23109, DOI 10.1074/jbc.M101445200; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khoueiry P, 2010, CURR BIOL, V20, P792, DOI 10.1016/j.cub.2010.03.063; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Markstein M, 2002, CURR OPIN GENET DEV, V12, P601, DOI 10.1016/S0959-437X(02)00345-3; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Newman JJ, 2010, COLD SH Q B, V75, P227, DOI 10.1101/sqb.2010.75.016; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raschke EE, 1999, J IMMUNOL, V163, P4375; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith ER, 2011, MOL CELL, V44, P954, DOI 10.1016/j.molcel.2011.12.008; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	55	74	76	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					144	156		10.1016/j.cell.2012.12.015	http://dx.doi.org/10.1016/j.cell.2012.12.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273992	Green Accepted, Bronze			2022-12-01	WOS:000313719800013
J	Krumholz, HM				Krumholz, Harlan M.			Post-Hospital Syndrome - An Acquired, Transient Condition of Generalized Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							READMISSION		[Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Martin, Carmel Mary/B-6358-2011	Martin, Carmel Mary/0000-0001-8174-7859	NHLBI NIH HHS [U01 HL105270] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714, DOI 10.1093/ajcn/65.6.1714; Jencks SF, 2009, NEW ENGL J MED, V360, P1418; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515	3	751	758	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					100	102		10.1056/NEJMp1212324	http://dx.doi.org/10.1056/NEJMp1212324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066RO	23301730	Green Accepted			2022-12-01	WOS:000313238100013
J	Yancey, AK; Sallis, RE; Bastani, R				Yancey, Antronette K.; Sallis, Robert E.; Bastani, Roshan			Changing Physical Activity Participation for the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WALKING; TALK; CARE		[Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA; [Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90095 USA; [Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Kaiser Permanente Ctr Hlth Equ, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Kaiser Permanente; University of California System; University of California Los Angeles	Yancey, AK (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, 650 Charles Young Dr,South Room 31-235 CHS, Los Angeles, CA 90095 USA.	ayancey@ucla.edu						Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Boyle M, 2009, PEDIATRICS, V123, pS293, DOI 10.1542/peds.2008-2780H; Collins L, 2005, J NUTR EDUC BEHAV, V37, pS121, DOI 10.1016/S1499-4046(06)60212-1; Crawford PB, 2004, AM J PUBLIC HEALTH, V94, P1480, DOI 10.2105/AJPH.94.9.1480; Frank Erica, 2003, J Am Med Womens Assoc (1972), V58, P178; Frank E, 2009, CAN FAM PHYSICIAN, V55, P810; Lesser LI, 2012, JAMA-J AM MED ASSOC, V308, P983, DOI 10.1001/2012.jama.10427; Yancey AK, 2010, INSTANT RECESS BUILD	9	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					141	142		10.1001/jama.2012.127989	http://dx.doi.org/10.1001/jama.2012.127989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299602				2022-12-01	WOS:000313517000019
J	Renata, H; Zhou, QH; Baran, PS				Renata, Hans; Zhou, Qianghui; Baran, Phil S.			Strategic Redox Relay Enables A Scalable Synthesis of Ouabagenin, A Bioactive Cardenolide	SCIENCE			English	Article							CROSS-COUPLING REACTIONS; STEROID GLYCOSIDES; NATURAL-PRODUCTS; BUFADIENOLIDES; OXIDATION; ALCOHOLS; OLEFINS; OUABAIN; OXYGEN	Here, we report on a scalable route to the polyhydroxylated steroid ouabagenin with an unusual take on the age-old practice of steroid semisynthesis. The incorporation of both redox and stereochemical relays during the design of this synthesis resulted in efficient access to more than 500 milligrams of a key precursor toward ouabagenin-and ultimately ouabagenin itself-and the discovery of innovative methods for carbon-hydrogen (C-H) and carbon-carbon activation and carbon-oxygen bond homolysis. Given the medicinal relevance of the cardenolides in the treatment of congestive heart failure, a variety of ouabagenin analogs could potentially be generated from the key intermediate as a means of addressing the narrow therapeutic index of these molecules. This synthesis also showcases an approach to bypass the historically challenging problem of selective C-H oxidation of saturated carbon centers in a controlled fashion.	[Renata, Hans; Zhou, Qianghui; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Zhou, Qianghui/U-8879-2019; Zhou, Qianghui/D-8258-2016	Zhou, Qianghui/0000-0002-8125-0380; Zhou, Qianghui/0000-0002-8125-0380	LEO Pharma; TEVA; NIH/NCI [CA134785]; Bristol-Myers Squibb; Shanghai Institute of Organic Chemistry; NATIONAL CANCER INSTITUTE [R01CA134785] Funding Source: NIH RePORTER	LEO Pharma(LEO Pharma); TEVA(Teva Pharmaceutical Industries); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bristol-Myers Squibb(Bristol-Myers Squibb); Shanghai Institute of Organic Chemistry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by LEO Pharma and an unrestricted grant from TEVA. Early studies were supported by the NIH/NCI (CA134785). Bristol-Myers Squibb supported a graduate fellowship to H. R., and the Shanghai Institute of Organic Chemistry supported a postdoctoral fellowship to Q.Z. We are grateful to A. Rheingold and C. E. Moore (University of California, San Diego) for x-ray crystallographic analysis and G. Siuzdak (the Scripps Research Institute) for mass spectrometry assistance. We thank J. Felding, H. Bladh, and R. Shenvi for valuable discussions. Metrical parameters for the structures of compounds 7 and 11' are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-909412 and 909413, respectively.	Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Barker TJ, 2012, J AM CHEM SOC, V134, P13588, DOI 10.1021/ja3063716; Barluenga J, 2004, CHEM-EUR J, V10, P4206, DOI 10.1002/chem.200400136; BARTON DHR, 1962, J CHEM SOC, P470, DOI 10.1039/jr9620000470; BARTON DHR, 1982, J CHEM SOC PERK T 1, P2085, DOI 10.1039/p19820002085; CHUNG SK, 1979, J ORG CHEM, V44, P1014, DOI 10.1021/jo01320a033; Corey E. J., 1989, LOGIC CHEM SYNTHESIS, P17; COREY EJ, 1959, J AM CHEM SOC, V81, P5209, DOI 10.1021/ja01528a046; Egner U, 1999, TETRAHEDRON, V55, P11267, DOI 10.1016/S0040-4020(99)00638-9; ERHARDT PW, 1987, J MED CHEM, V30, P231, DOI 10.1021/jm00385a001; Fortner KC, 2010, J AM CHEM SOC, V132, P275, DOI 10.1021/ja906996c; Furstner A, 2008, CHEM COMMUN, P2873, DOI 10.1039/b805299a; Hanson JR, 2005, NAT PROD REP, V22, P104, DOI 10.1039/b415086b; Heasley B, 2012, CHEM-EUR J, V18, P3092, DOI 10.1002/chem.201103733; Hollingworth GJ, 1996, J CHEM SOC PERK T 1, P1913, DOI 10.1039/p19960001913; HRYCKO S, 1988, J ORG CHEM, V53, P1515, DOI 10.1021/jo00242a032; IMHOF R, 1972, HELV CHIM ACTA, V55, P1151, DOI 10.1002/hlca.19720550410; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Ishihara Y, 2010, SYNLETT, P1733, DOI 10.1055/s-0030-1258123; Jana CK, 2011, ANGEW CHEM INT EDIT, V50, P8407, DOI 10.1002/anie.201101869; Kamano Y, 1998, BIOORGAN MED CHEM, V6, P1103, DOI 10.1016/S0968-0896(98)00067-4; Kawamura A, 1999, P NATL ACAD SCI USA, V96, P6654, DOI 10.1073/pnas.96.12.6654; Larock R. C., 1989, COMPREHENSIVE ORGANI, P505; MCDONALD CE, 1990, TETRAHEDRON LETT, V31, P6283, DOI 10.1016/S0040-4039(00)97043-6; Narayan S, 2005, ANGEW CHEM INT EDIT, V44, P3275, DOI 10.1002/anie.200462883; Newhouse T, 2009, CHEM SOC REV, V38, P3010, DOI 10.1039/b821200g; Ng D, 2004, ORG LETT, V6, P645, DOI 10.1021/ol0499250; Rousseau G, 2011, ANGEW CHEM INT EDIT, V50, P2450, DOI 10.1002/anie.201006139; Samojlowicz C, 2008, CHEM COMMUN, P6282, DOI 10.1039/b816567j; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Shi J, 2011, J AM CHEM SOC, V133, P8014, DOI 10.1021/ja202103e; Szent-Gyorgyi A, 1953, CHEM PHYSL CONTRACTI, P86; TSCHESCHE R, 1972, PROC R SOC SER B-BIO, V180, P187, DOI 10.1098/rspb.1972.0014; VIJAYARAHAVAN B, 1990, TETRAHEDRON LETT, V31, P6223, DOI 10.1016/S0040-4039(00)97030-8; WEHRLI H, 1961, HELV CHIM ACTA, V44, P2162, DOI 10.1002/hlca.19610440745; WIESNER K, 1986, PURE APPL CHEM, V58, P799, DOI 10.1351/pac198658050799; Wietzerbin K, 2000, EUR J INORG CHEM, P1391; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014; YOSHII E, 1978, J ORG CHEM, V43, P3946, DOI 10.1021/jo00414a031; Zhang HX, 2008, ANGEW CHEM INT EDIT, V47, P1272, DOI 10.1002/anie.200704959	41	114	115	3	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					59	63		10.1126/science.1230631	http://dx.doi.org/10.1126/science.1230631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288535	Green Accepted			2022-12-01	WOS:000312985800050
J	Srivastava, M; Nambiar, M; Sharma, S; Karki, SS; Goldsmith, G; Hegde, M; Kumar, S; Pandey, M; Singh, RK; Ray, P; Natarajan, R; Kelkar, M; De, A; Choudhary, B; Raghavan, SC				Srivastava, Mrinal; Nambiar, Mridula; Sharma, Sheetal; Karki, Subhas S.; Goldsmith, G.; Hegde, Mahesh; Kumar, Sujeet; Pandey, Monica; Singh, Ram K.; Ray, Pritha; Natarajan, Renuka; Kelkar, Madhura; De, Abhijit; Choudhary, Bibha; Raghavan, Sathees C.			An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression	CELL			English	Article							DNA-LIGASE IV; EMBRYONIC LETHALITY; XRCC4-LIGASE IV; UP-REGULATION; CELL-LINES; PROTEINS; GENES; P53	DNA Ligase IV is responsible for sealing of double-strand breaks (DSBs) during nonhomologous end-joining (NHEJ). Inhibiting Ligase IV could result in amassing of DSBs, thereby serving as a strategy toward treatment of cancer. Here, we identify a molecule, SCR7 that inhibits joining of DSBs in cell-free repair system. SCR7 blocks Ligase IV-mediated joining by interfering with its DNA binding but not that of T4 DNA Ligase or Ligase I. SCR7 inhibits NHEJ in a Ligase IV-dependent manner within cells, and activates the intrinsic apoptotic pathway. More importantly, SCR7 impedes tumor progression in mouse models and when coadministered with DSB-inducing therapeutic modalities enhances their sensitivity significantly. This inhibitor to target NHEJ offers a strategy toward the treatment of cancer and improvement of existing regimens.	[Srivastava, Mrinal; Nambiar, Mridula; Sharma, Sheetal; Hegde, Mahesh; Pandey, Monica; Choudhary, Bibha; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Karki, Subhas S.; Kumar, Sujeet] KLE Univ, Coll Pharm, Dept Pharmaceut Chem, Bangalore 560010, Karnataka, India; [Goldsmith, G.; Natarajan, Renuka; Choudhary, Bibha] Inst Bioinformat & Appl Biotechnol, Bangalore 560100, Karnataka, India; [Singh, Ram K.; Ray, Pritha; Kelkar, Madhura; De, Abhijit] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, India	Indian Institute of Science (IISC) - Bangalore; K.L.E. Academy of Higher Education & Research; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	DE, ABHIJIT/AAR-5631-2021; Hegde, Mahesh/ABE-2057-2020; karki, subhas s/AAH-6451-2020; KUMAR, SUJEET/AAD-5081-2019; Srivastava, Mrinal/AAM-5013-2020	DE, ABHIJIT/0000-0002-5818-0206; Hegde, Mahesh/0000-0002-7853-6281; karki, subhas s/0000-0002-5599-3594; KUMAR, SUJEET/0000-0002-0833-158X; Singh, Ram Kumar/0000-0002-7654-1212	Indian Institute of Science, Bangalore; Leukemia Research Foundation, USA; CSIR; IISc; DBT (India)	Indian Institute of Science, Bangalore; Leukemia Research Foundation, USA; CSIR(Council of Scientific & Industrial Research (CSIR) - India); IISc; DBT (India)(Department of Biotechnology (DBT) India)	We are thankful to Prof. N. Yathindra for modeling and docking studies. We also thank P. Ajitkumar and B. Tharakan for suggestions; P. Kuppusamy for help; K.K. Chiruvella for reagents; and S.R. Ranganatha, D. Iyer, S. Javadekar, and members of SCR laboratory for critical reading of the manuscript. We thank Strides ARCOLAB Bangalore for Doxorubicin. Ligase IV/XRCC4 plasmid was a gift from M. Modesti (France). pETDuet-1 was from B. Gopal (India); Ligase I and Ligase III alpha/XRCC1 plasmids were from A. Tomkinson (USA) and K.W. Caldecott (UK), respectively. pREP-hLIGIV was from C. Campbell (USA), I-SceI vector from R. Scully (USA), and pcDNA3.1 RFP from Arun Kumar (India); pJS296 was gifted by J. Stark (USA). We thank V. Hegde for NMR (IISc). Animal, NMR, confocal, microtome and FACS facilities of IISc, and FACS facilities of C-CAMP, NCBS, are also acknowledged. We thank R. Malhotra for mouse imaging (ACTREC). A start-up grant from the Indian Institute of Science, Bangalore, and financial assistance from Leukemia Research Foundation, USA, for S.C.R. are acknowledged. Financial support from R. Varadarajan is also acknowledged. M.S. and M.P. are supported by CSIR, M.N. by IISc Research Associate fellowship, and S.S. by DBT (India).	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Jayaram S, 2008, NUCLEIC ACIDS RES, V36, P5773, DOI 10.1093/nar/gkn552; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pucci S, 2001, ONCOGENE, V20, P739, DOI 10.1038/sj.onc.1204148; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; Sharma S, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/389129; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; Shintani S, 2003, CANCER SCI, V94, P894, DOI 10.1111/j.1349-7006.2003.tb01372.x; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sirzen F, 1999, EUR J CANCER, V35, P111, DOI 10.1016/S0959-8049(98)00289-5; Zapata JM, 1998, BREAST CANCER RES TR, V47, P129, DOI 10.1023/A:1005940832123; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	33	257	267	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1474	1487		10.1016/j.cell.2012.11.054	http://dx.doi.org/10.1016/j.cell.2012.11.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260137	Bronze			2022-12-01	WOS:000312890300013
J	O'Connor, TJ; Boyd, D; Dorer, MS; Isberg, RR				O'Connor, Tamara J.; Boyd, Dana; Dorer, Marion S.; Isberg, Ralph R.			Aggravating Genetic Interactions Allow a Solution to Redundancy in a Bacterial Pathogen	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA GENOME; RAB GTPASE FUNCTION; ENDOPLASMIC-RETICULUM; IDENTIFICATION; MACROPHAGES; SYSTEM	Interactions between hosts and pathogens are complex, so understanding the events that govern these interactions requires the analysis of molecular mechanisms operating in both organisms. Many pathogens use multiple strategies to target a single event in the disease process, confounding the identification of the important determinants of virulence. We developed a genetic screening strategy called insertional mutagenesis and depletion (iMAD) that combines bacterial mutagenesis and RNA interference, to systematically dissect the interplay between a pathogen and its host. We used this technique to resolve the network of proteins secreted by the bacterium Legionella pneumophila to promote intracellular growth, a critical determinant of pathogenicity of this organism. This strategy is broadly applicable, allowing the dissection of any interface between two organisms involving numerous interactions.	[O'Connor, Tamara J.; Dorer, Marion S.; Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [O'Connor, Tamara J.; Dorer, Marion S.; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Microbiol & Microbiol, Boston, MA 02111 USA; [Boyd, Dana] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Harvard Medical School	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Howard Hughes Med Inst, 150 Harrison Ave, Boston, MA 02111 USA.	ralph.isberg@tufts.edu			Howard Hughes Medical Institute; Natalie V. Zucker Fellowship; NIH [GMO41883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natalie V. Zucker Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Rubin and C. Sassetti for helpful advice regarding the TraSH protocol, plasmids, and equipment use; J. Vogel for plasmids; K. Bodi, TUCF genomics core facility, and A. Ensminger for scientific advice with genome sequencing protocols and analyses; and A. Camilli for equipment use. We thank D. Daigle, K. Davis, E. Haenssler, A. Hempstead, D. DeJesus, S. Mohammadi, and E. Creasey for reviewing the manuscript. This work was supported by the Howard Hughes Medical Institute (T.J.O. and M. S. D.), a Natalie V. Zucker Fellowship (T.J.O.), and NIH grant GMO41883 (D. B.). R. R. I. is an investigator of the Howard Hughes Medical Institute.	Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BRAND BC, 1994, MOL MICROBIOL, V14, P797, DOI 10.1111/j.1365-2958.1994.tb01316.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Swanson MS, 1996, INFECT IMMUN, V64, P2585, DOI 10.1128/IAI.64.7.2585-2594.1996; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	27	86	86	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1440	1444		10.1126/science.1229556	http://dx.doi.org/10.1126/science.1229556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239729	Green Accepted			2022-12-01	WOS:000312250800040
J	Tougher, S; Ye, Y; Amuasi, JH; Kourgueni, IA; Thomson, R; Goodman, C; Mann, AG; Ren, RL; Willey, BA; Adegoke, CA; Amin, A; Ansong, D; Bruxvoort, K; Diallo, DA; Diap, G; Festo, C; Johanes, B; Juma, E; Kalolella, A; Malam, O; Mberu, B; Ndiaye, S; Nguah, SB; Seydou, M; Taylor, M; Rueda, ST; Wamukoya, M; Arnold, F; Hanson, K				Tougher, Sarah; Ye, Yazoume; Amuasi, John H.; Kourgueni, Idrissa A.; Thomson, Rebecca; Goodman, Catherine; Mann, Andrea G.; Ren, Ruilin; Willey, Barbara A.; Adegoke, Catherine A.; Amin, Abdinasir; Ansong, Daniel; Bruxvoort, Katia; Diallo, Diadier A.; Diap, Graciela; Festo, Charles; Johanes, Boniface; Juma, Elizabeth; Kalolella, Admirabilis; Malam, Oumarou; Mberu, Blessing; Ndiaye, Salif; Nguah, Samuel B.; Seydou, Moctar; Taylor, Mark; Rueda, Sergio Torres; Wamukoya, Marilyn; Arnold, Fred; Hanson, Kara		ACTwatch Grp	Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data	LANCET			English	Article							GLOBAL SUBSIDY; TANZANIA; ACT	Background Malaria is one of the greatest causes of mortality worldwide. Use of the most effective treatments for malaria remains inadequate for those in need, and there is concern over the emergence of resistance to these treatments. In 2010, the Global Fund launched the Affordable Medicines Facility-malaria (AMFm), a series of national-scale pilot programmes designed to increase the access and use of quality-assured artemisinin based combination therapies (QAACTs) and reduce that of artemisinin monotherapies for treatment of malaria. AMFm involves manufacturer price negotiations, subsidies on the manufacturer price of each treatment purchased, and supporting interventions such as communications campaigns. We present findings on the effect of AMFm on QAACT price, availability, and market share, 6-15 months after the delivery of subsidised ACTs in Ghana, Kenya, Madagascar, Niger, Nigeria, Uganda, and Tanzania (including Zanzibar). Methods We did nationally representative baseline and endpoint surveys of public and private sector outlets that stock antimalarial treatments. QAACTs were identified on the basis of the Global Fund's quality assurance policy. Changes in availability, price, and market share were assessed against specified success benchmarks for 1 year of AMFm implementation. Key informant interviews and document reviews recorded contextual factors and the implementation process. Findings In all pilots except Niger and Madagascar, there were large increases in QAACT availability (25.8-51.9 percentage points), and market share (15.9-40.3 percentage points), driven mainly by changes in the private for-profit sector. Large falls in median price for QAACTs per adult equivalent dose were seen in the private for-profit sector in six pilots, ranging from US$1.28 to $4.82. The market share of oral artemisinin monotherapies decreased in Nigeria and Zanzibar, the two pilots where it was more than 5% at baseline. Interpretation Subsidies combined with supporting interventions can be effective in rapidly improving avail ability, price, and market share of QAACTs, particularly in the private for-profit sector. Decisions about the future of AMFm should also consider the effect on use in vulnerable populations, access to malaria diagnostics, and cost-effectiveness.	[Tougher, Sarah; Thomson, Rebecca; Goodman, Catherine; Mann, Andrea G.; Willey, Barbara A.; Bruxvoort, Katia; Diallo, Diadier A.; Taylor, Mark; Rueda, Sergio Torres; Hanson, Kara] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Amuasi, John H.] Univ Minnesota, Sch Publ Hlth, PhD Program, Div Hlth Policy & Management, Minneapolis, MN USA; [Amuasi, John H.; Ansong, Daniel; Nguah, Samuel B.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Kourgueni, Idrissa A.] Ctr Int Etud & Rech Populat Africaines, Niamey, Niger; [Kourgueni, Idrissa A.; Malam, Oumarou; Seydou, Moctar] Inst Natl Stat, Niamey, Niger; [Diap, Graciela] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Thomson, Rebecca; Bruxvoort, Katia; Festo, Charles; Johanes, Boniface; Kalolella, Admirabilis; Taylor, Mark] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Ansong, Daniel] Kwame Nkrumah Univ Sci & Technol, Dept Child Hlth, Sch Med Sci, Kumasi, Ghana; [Mberu, Blessing] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Ndiaye, Salif] Ctr Rech Dev Humain, Dakar, Senegal; [Juma, Elizabeth] Ctr Global Hlth Res, Kenya Med Res Inst, Nairobi, Kenya; [Taylor, Mark] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Exeter EX4 4QJ, Devon, England	University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Kwame Nkrumah University Science & Technology; Ifakara Health Institute; Kwame Nkrumah University Science & Technology; African Population & Health Research Centre; Kenya Medical Research Institute; University of Exeter	Tougher, S (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	sarah.tougher@lshtm.ac.uk	Nguah, Samuel/AAQ-9725-2020	Goodman, Catherine/0000-0002-2241-3485; Amuasi, John/0000-0002-8640-2662; Bruxvoort, Katia/0000-0001-8277-2431; Taylor, Mark/0000-0002-7646-7905; Tougher, Sarah/0000-0001-7990-4368; Wamukoya, Marylene/0000-0002-2900-9178; ANSONG, Daniel/0000-0003-1328-9117; Thomson, Rebecca/0000-0001-9683-9457	Global Fund; Tuberculosis and Malaria; Bill & Melinda Gates Foundation; Tuberculosis; Malaria; Bill & Melinda Gates Foundation for ACTwatch Central; ACTwatch surveys [058992]; Bill and Melinda Gates Foundation; European Regional Development Fund; European Social Fund Convergence Programme for Cornwall; Isles of Scilly	Global Fund; Tuberculosis and Malaria; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Tuberculosis; Malaria; Bill & Melinda Gates Foundation for ACTwatch Central; ACTwatch surveys; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Regional Development Fund(European Commission); European Social Fund Convergence Programme for Cornwall; Isles of Scilly	The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Bill & Melinda Gates Foundation.; We thank the large number of people from many different organisations who assisted with data analysis, data processing, and primary data collection. We acknowledge the contributions of Noureddine Abderrahim, Mwenda Gitonga, and David Muturi with data entry programmes; Ronnette Nolasco with project arrangements; Adrienne Keen with support to data analysis and processing, and Barry Dewitt, Dan Hamilton, Zhuzhi Moore, Falgunee Parekh, Yuan Cheng, and Ashley Garley with outlet survey table preparation. We also thank Immo Kleinschmidt, Milly Marston, Neal Alexander, Karim Anaya-Izquierdo and John Bradley for statistical advice; Meghna Ranganathan, Olivia Nuccio, Angela Camilleri, Edna Ogada, Emily Carter, Emily Harris, Tsione Solomon, Yohannes Kinfu, and Iarimalanto Rabary for research assistance; and Ohene Buabeng, Isaac Boakye, Raymond Atiemo Danso and other staff of the Research and Development Unit at Komfo Ankye Teaching Hospital who assisted technically and logistically with the field surveys in Ghana. We thank the following members of the AMFm Secretariat for their advice and support: Melisse Murray, Silas Holland, Fabienne Jourberton, Lloyd Matowe, and Orion Yeandel. Finally, we acknowledge the contribution of all the respondents who participated in the surveys and interviews. The evaluation was funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria, with support from the Bill & Melinda Gates Foundation for ACTwatch Central and ACTwatch surveys in three countries (#058992). Sarah Tougher, Rebecca Thomson, Catherine Goodman, Andrea G Mann, Barbara Willey, Katia Bruxvoort, Sergio Torres Rueda, Kara Hanson, and Benjamin Palafox are members of the LSHTM Malaria Centre. Catherine Goodman, Rebecca Thomson, Katia Bruxvoort, Charles Festo, Boniface Johanes, Admirabilis Kalolella, and Mark Taylor work with the IMPACT2 project, part of the ACT Consortium (http://www.actconsortium.org/) which is funded by the Bill and Melinda Gates Foundation. Mark Taylor now works with the European Centre for Environment and Human Health (part of the University of Exeter Medical School) which is supported by investment from the European Regional Development Fund and the European Social Fund Convergence Programme for Cornwall and the Isles of Scilly.	ACTwatch Group, 2012, ACTWATCH HOUS SURV; ACTwatch Group and Association Beninoise pour le Marketing Social (ABMS)/Benin, 2011, OUTL SURV REP BEN 20; ACTwatch Group and Association Beninoise pour le Marketing Social (ABMS)/Benin, 2009, OUTL SURV REP BEN 20; ACTwatch Group and Population Services International (PSI)/Madagascar, 2009, MAD OUTL SURV 2008 R; ACTwatch Group and Society for Family Health (SFH)/Zambia, 2009, OUTL SURV REP ZAMB 2; ACTwatch Group and Society for Family Health (SFH)/Zambia, 2011, OUTL SURV REP ZAM 20; ACTwatch Group and the Program for Accessible Health CEPU, 2009, UG OUTL SURV 2009 RE; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; Arrow KJ, 2004, SAVING LIVES BUYING; Craig P, 2008, DEV EVALUATING COMPL; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Government of India Department of Customs, 2009, IND CHEM IMP EXP DAT; ICF International LSHTM, 2012, INF EV PHAS 1 AFF ME; Kamal-Yanni M, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60048-7; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Measure DHS, 2012, DEM HLTH SURV MAL RW; Measure DHS, 2012, MAL IND SURV ANG KEN; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Roll Back Malaria, 2011, UPD ACT PRIC AFF MED; Sabot O, 2009, DISTRIBUTION ARTEMIS; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Schaferhoff M, 2010, ESTIMATING BENCHMARK; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2008, AFF MED FAC MAL; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOB FUND QUAL ASS P; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yadav P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-299; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	33	114	115	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1916	1926		10.1016/S0140-6736(12)61732-2	http://dx.doi.org/10.1016/S0140-6736(12)61732-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23122217				2022-12-01	WOS:000311758500028
J	Helm, D				Helm, Dieter			The Kyoto approach has failed	NATURE			English	Editorial Material									Univ Oxford, New Coll, Oxford OX1 2JD, England	University of Oxford	Helm, D (corresponding author), Univ Oxford, New Coll, Oxford OX1 2JD, England.	dieter.helm@new.ox.ac.uk						[Anonymous], 2011, MED TERM COAL MARK R; BP, 2021, BPS STAT REV WORLD E; European Commission, 2008, 20 20 2020 EUR CLIM; European Parliament and the Council of the European Union, 2003, OFF J EUR UNION, VL275, P32; Helm D., 2007, TOO GOOD BE TRUE UKS; Helm D., 2012, 80 GRANTH RES I CLIM; Helm D., 2012, CARBON CRUNCH WERE G, P40; MacKay D., 2008, SUSTAINABLE ENERGY W; US Energy Information Administration, 2012, MONTHLY ENERGY R OCT	9	25	26	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					663	665		10.1038/491663a	http://dx.doi.org/10.1038/491663a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	044FY	23192129	Bronze			2022-12-01	WOS:000311606000016
J	Huang, SD; Holzel, M; Knijnenburg, T; Schlicker, A; Roepman, P; McDermott, U; Garnett, M; Grernrum, W; Sun, C; Prahallad, A; Groenendijk, FH; Mittempergher, L; Nijkamp, W; Neefjes, J; Salazar, R; ten Dijke, P; Uramoto, H; Tanaka, F; Beijersbergen, RL; Wessels, LFA; Bernards, R				Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Roepman, Paul; McDermott, Ultan; Garnett, Mathew; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Neefjes, Jacques; Salazar, Ramon; ten Dijke, Peter; Uramoto, Hidetaka; Tanaka, Fumihiro; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene			MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-beta Receptor Signaling	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; CELL LUNG-CANCER; COLORECTAL-CANCER; RESISTANCE; MUTATIONS; SENSITIVITY; INHIBITION; PATHWAY; THERAPY; SCREEN	Inhibitors of the ALK and EGF receptor tyrosine kinases provoke dramatic but short-lived responses in lung cancers harboring EML4-ALK translocations or activating mutations of EGFR, respectively. We used a large-scale RNAi screen to identify MED12, a component of the transcriptional MEDIATOR complex that is mutated in cancers, as a determinant of response to ALK and EGFR inhibitors. MED12 is in part cytoplasmic where it negatively regulates TGF-beta R2 through physical interaction. MED12 suppression therefore results in activation of TGF-beta R signaling, which is both necessary and sufficient for drug resistance. TGF-beta signaling causes MEK/ERK activation, and consequently MED12 suppression also confers resistance to MEK and BRAF inhibitors in other cancers. MED12 loss induces an EMT-like phenotype, which is associated with chemotherapy resistance in colon cancer patients and to gefitinib in lung cancer. Inhibition of TGF-beta R signaling restores drug responsiveness in MED12(KD) cells, suggesting a strategy to treat drug-resistant tumors that have lost MED12.	[Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene] Netherlands Canc Inst, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Roepman, Paul; Bernards, Rene] Agendia Inc, Irvine, CA 92618 USA; [Roepman, Paul; Bernards, Rene] Agendia NV, NL-1098 XH Amsterdam, Netherlands; [McDermott, Ultan; Garnett, Mathew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Salazar, Ramon] Inst Catala Oncol IDIBELL, Lhospitalet De Llobregat 08908, Spain; [ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Uramoto, Hidetaka; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Dept Surg 2, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Agendia; Agendia; Wellcome Trust Sanger Institute; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Occupational & Environmental Health - Japan	Bernards, R (corresponding author), Netherlands Canc Inst, Canc Genom Ctr, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Dijke, Peter ten/AAG-4660-2021; Neefjes, Jacques J.C./H-8780-2017; Sun, Chong/AAB-4859-2021	Dijke, Peter ten/0000-0002-7234-342X; Neefjes, Jacques J.C./0000-0001-6763-2211; Sun, Chong/0000-0001-9008-2158; Bernards, Rene/0000-0001-8677-3423; Mittempergher, Lorenza/0000-0003-3425-3965; McDermott, Ultan/0000-0001-9032-4700; Beijersbergen, Roderick/0000-0003-0116-4130; Schlicker, Andreas/0000-0002-6588-7883; Huang, Sidong/0000-0002-2838-4726	Dutch Cancer Society; European Research Council grant; Cancer Systems Biology Center grant by NWO; Netherlands Genomics Initiative (NGI); Spanish BAE FIS travel grant by Instituto Carlos III	Dutch Cancer Society(KWF Kankerbestrijding); European Research Council grant(European Research Council (ERC)); Cancer Systems Biology Center grant by NWO; Netherlands Genomics Initiative (NGI); Spanish BAE FIS travel grant by Instituto Carlos III	We thank the members of the NKI Genomics Core Facility, Maarten van Dinther, Jelle Wesseling, Ingrid Hofland, Ian Majewski, Kylie Greig, Johan Kuiken, and Erik Voets for technical support and discussion. We are grateful to Cinzia Pochet for support. This work was supported by grants from the Dutch Cancer Society, a European Research Council grant, The Cancer Systems Biology Center grant by NWO, The Netherlands Genomics Initiative (NGI), and a Spanish BAE FIS travel grant by Instituto Carlos III (to R.S.). P.R. and R.B. are employees and shareholders of Agendia Inc.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	31	307	331	1	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					937	950		10.1016/j.cell.2012.10.035	http://dx.doi.org/10.1016/j.cell.2012.10.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178117	Bronze, Green Accepted			2022-12-01	WOS:000311423500009
J	Osmundson, J; Montero-Diez, C; Westblade, LF; Hochschild, A; Darst, SA				Osmundson, Joseph; Montero-Diez, Cristina; Westblade, Lars F.; Hochschild, Ann; Darst, Seth A.			Promoter-Specific Transcription Inhibition in Staphylococcus aureus by a Phage Protein	CELL			English	Article							RNA-POLYMERASE HOLOENZYME; PRIMARY SIGMA-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ALPHA-SUBUNIT; BACTERIOPHAGE-T7 DNA; RIBOSOME SYNTHESIS; BACTERIAL; RECOGNITION; INITIATION	Phage G1 gp67 is a 23 kDa protein that binds to the Staphylococcus aureus (Sau) RNA polymerase (RNAP) sigma(A) subunit and blocks cell growth by inhibiting transcription. We show that gp67 has little to no effect on transcription from most promoters but is a potent inhibitor of ribosomal RNA transcription. A 2.0-angstrom-resolution crystal structure of the complex between gp67 and Sau sigma(A) domain 4 (sigma(A)(4)) explains how gp67 joins the RNAP promoter complex through sigma(A)(4) without significantly affecting sigma(A)(4) function. Our results indicate that gp67 forms a complex with RNAP at most, if not all, sigma(A)-dependent promoters, but selectively inhibits promoters that depend on an interaction between upstream DNA and the RNAP alpha-subunit C-terminal domain (alpha CTD). Thus, we reveal a promoter-specific transcription inhibition mechanism by which gp67 interacts with the RNAP promoter complex through one subunit (sigma(A)), and selectively affects the function of another subunit (alpha CTD) depending on promoter usage.	[Osmundson, Joseph; Westblade, Lars F.; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA; [Montero-Diez, Cristina; Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Rockefeller University; Harvard University; Harvard Medical School	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	darst@rockefeller.edu			Office of Basic Energy Sciences, U.S. Department of Energy; National Center for Research Resources, National Institutes of Health (NIH) [RR-15301]; NIH [RO1 GM044025, RO1 GM053759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025, R01GM053759] Funding Source: NIH RePORTER	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.A. Campbell, R. Gourse, W. Ross, and P. Deighan for helpful discussions; K.R. Rajashankar and F. Murphy at APS NE-CAT beamline 24ID, and W. Shi at NSLS beamline X3A for support with synchrotron data collection; S. Wigneshweraraj for gifts of plasmids and helpful advice; and C. Zhao and S. Dewell of The Rockefeller University Genomics Resource Center for assistance with RNA-seq. We also thank all members of the Darst and Hochschild laboratories for helpful discussions. This work was based in part on research conducted at the APS and NSLS, supported by the Office of Basic Energy Sciences, U.S. Department of Energy. The NE-CAT beamlines at the APS are supported by award RR-15301 from the National Center for Research Resources, National Institutes of Health (NIH). This work was supported by NIH grants RO1 GM044025 to A. H. and RO1 GM053759 to S. A. D.	Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Datta I, 2005, J BIOCHEM MOL BIOL, V38, P97; Dehbi M, 2009, J BACTERIOL, V191, P3763, DOI 10.1128/JB.00241-09; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Dove Simon L, 2004, Methods Mol Biol, V261, P231; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Fox K R, 1997, Methods Mol Biol, V90, P1; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Hinton DM, 2005, MICROBIOL-SGM, V151, P1729, DOI 10.1099/mic.0.27972-0; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; KADESCH TR, 1982, J MOL BIOL, V155, P1, DOI 10.1016/0022-2836(82)90489-2; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nechaev S, 2003, ANNU REV MICROBIOL, V57, P301, DOI 10.1146/annurev.micro.57.030502.090942; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Ptashne M, 1992, GENETIC SWITCH PHAGE; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROSENBERG S, 1982, J MOL BIOL, V155, P31, DOI 10.1016/0022-2836(82)90490-9; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; STEVENS A, 1977, NUCLEIC ACIDS RES, V4, P877, DOI 10.1093/nar/4.4.877; Tiemann B, 2004, J BACTERIOL, V186, P7262, DOI 10.1128/JB.186.21.7262-7272.2004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WADE HE, 1964, BIOCHEM J, V93, P121, DOI 10.1042/bj0930121; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Yano ST, 2011, MOL MICROBIOL, V79, P1325, DOI 10.1111/j.1365-2958.2010.07526.x	64	17	19	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1005	1016		10.1016/j.cell.2012.10.034	http://dx.doi.org/10.1016/j.cell.2012.10.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178120	Green Accepted, Bronze			2022-12-01	WOS:000311423500014
J	Wu, BR; Zhang, Z; Lui, W; Chen, XJ; Wang, YD; Chamberlain, AA; Moreno-Rodriguez, RA; Markwald, RR; O'Rourke, BP; Sharp, DJ; Zheng, DY; Lenz, J; Baldwin, HS; Chang, CP; Zhou, B				Wu, Bingruo; Zhang, Zheng; Lui, Wendy; Chen, Xiangjian; Wang, Yidong; Chamberlain, Alyssa A.; Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.; O'Rourke, Brian P.; Sharp, David J.; Zheng, Deyou; Lenz, Jack; Baldwin, H. Scott; Chang, Ching-Pin; Zhou, Bin			Endocardial Cells Form the Coronary Arteries by Angiogenesis through Myocardial-Endocardial VEGF Signaling	CELL			English	Article							SMOOTH-MUSCLE-CELLS; CARDIAC MORPHOGENESIS; TRANSCRIPTION FACTOR; VESSEL DEVELOPMENT; ENDOTHELIAL-CELLS; NF-ATC; MOUSE; EXPRESSION; LINEAGE; ORIGIN	The origins and developmental mechanisms of coronary arteries are incompletely understood. We show here by fate mapping, clonal analysis, and immunohistochemistry that endocardial cells generate the endothelium of coronary arteries. Dye tracking, live imaging, and tissue transplantation also revealed that ventricular endocardial cells are not terminally differentiated; instead, they are angiogenic and form coronary endothelial networks. Myocardial Vegf-a or endocardial Vegfr-2 deletion inhibited coronary angiogenesis and arterial formation by ventricular endocardial cells. In contrast, lineage and knockout studies showed that endocardial cells make a small contribution to the coronary veins, the formation of which is independent of myocardialto-endocardial Vegf signaling. Thus, contrary to the current view of a common source for the coronary vessels, our findings indicate that the coronary arteries and veins have distinct origins and are formed by different mechanisms. This information may help develop better cell therapies for coronary artery disease.	[Wu, Bingruo; Zhang, Zheng; Lui, Wendy; Chen, Xiangjian; Wang, Yidong; Chamberlain, Alyssa A.; Lenz, Jack; Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [O'Rourke, Brian P.; Sharp, David J.] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Zheng, Deyou] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Wu, Bingruo; Baldwin, H. Scott; Zhou, Bin] Vanderbilt Univ, Dept Pediat, Nashville, TN 37322 USA; [Zhang, Zheng; Wang, Yidong] Sichuan Univ, State Key Lab Biotherapy, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China; [Chen, Xiangjian; Zhou, Bin] Jiangsu Prov Hosp, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China; [Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29403 USA; [Chang, Ching-Pin] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Sichuan University; Nanjing Medical University; Medical University of South Carolina; Stanford University	Zhou, B (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	bin.zhou@einstein.yu.edu	moreno, ricardo/AAS-5868-2021; Moreno-Rodriguez, Ricardo/GPT-4006-2022; Zhang, Zheng/G-7187-2016	Moreno Rodriguez, Ricardo Alberto/0000-0002-5420-4231; Zheng, Deyou/0000-0003-4354-5337	NIH [HL078881, HL100398, HL85345]; AHA [0435128N]; Tuner-Hazinski Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078881, R01HL085345, U01HL100398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Tuner-Hazinski Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Napoleone Ferrara, Janet Rossant, Kyunghee Choi, and Gordon Fishell for Vegf-a<SUP>f/f</SUP>, Vegfr-2<SUP>f/f</SUP>, RCE<SUP>fsEGFP</SUP> mice. We thank Drs. Bernice Morrow and Richard Kitsis for critical reading of the manuscript and Tatyana Harris for the illustration. B.Z. was supported by NIH (HL078881), AHA (0435128N) and Tuner-Hazinski Research Award. H.S.B. and C.-P.C. were supported by NIH (HL100398 and HL85345, respectively).	Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gustafsson E, 2001, J CELL SCI, V114, P671; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Majesky MW, 2004, CURR TOP DEV BIOL, V62, P225; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Sugi Y, 1996, DEV BIOL, V175, P66, DOI 10.1006/dbio.1996.0096; Tomanek RJ, 2006, CIRC RES, V98, P947, DOI 10.1161/01.RES.0000216974.75994.da; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wada AM, 2003, ARTERIOSCL THROM VAS, V23, P2138, DOI 10.1161/01.ATV.0000098645.38676.CC; Wikenheiser J, 2006, DEV DYNAM, V235, P115, DOI 10.1002/dvdy.20499; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	45	256	263	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1083	1096		10.1016/j.cell.2012.10.023	http://dx.doi.org/10.1016/j.cell.2012.10.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178125	Green Accepted, Bronze			2022-12-01	WOS:000311423500020
J	Wang, RC; Wei, YJ; An, ZY; Zou, ZJ; Xiao, GH; Bhagat, G; White, M; Reichelt, J; Levine, B				Wang, Richard C.; Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Xiao, Guanghua; Bhagat, Govind; White, Michael; Reichelt, Julia; Levine, Beth			Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation	SCIENCE			English	Article							MAMMALIAN AUTOPHAGY; INHIBITION; GROWTH; CANCER; TUMORS; CELLS	Aberrant signaling through the class I phosphatidylinositol 3-kinase (PI3K)-Akt axis is frequent in human cancer. Here, we show that Beclin 1, an essential autophagy and tumor suppressor protein, is a target of the protein kinase Akt. Expression of a Beclin 1 mutant resistant to Akt-mediated phosphorylation increased autophagy, reduced anchorage-independent growth, and inhibited Akt-driven tumorigenesis. Akt-mediated phosphorylation of Beclin 1 enhanced its interactions with 14-3-3 and vimentin intermediate filament proteins, and vimentin depletion increased autophagy and inhibited Akt-driven transformation. Thus, Akt-mediated phosphorylation of Beclin 1 functions in autophagy inhibition, oncogenesis, and the formation of an autophagy-inhibitory Beclin 1/14-3-3/vimentin intermediate filament complex. These findings have broad implications for understanding the role of Akt signaling and intermediate filament proteins in autophagy and cancer.	[Wang, Richard C.; Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Wang, Richard C.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bhagat, Govind] New York Presbyterian Hosp, New York, NY 10032 USA; [White, Michael] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Reichelt, Julia] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; NewYork-Presbyterian Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Wang, Richard/AAW-3066-2021; An, Zhenyi/H-9061-2016; Reichelt, Julia/AAP-1842-2021; Bhagat, Govind/AAE-9493-2021	Wang, Richard/0000-0003-4543-8295; Reichelt, Julia/0000-0002-4358-7011; Bhagat, Govind/0000-0001-6250-048X	NIH/National Cancer Institute [ROI CA84254-S1, RO1 CA109618, ROI CA129451, KO8 CA164047]; Dermatology Foundation Career Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists; German Research Foundation [RE2673/1-1]; NATIONAL CANCER INSTITUTE [K08CA164047, P30CA142543, R01CA109618, R01CA071443, R01CA129451, R01CA084254] Funding Source: NIH RePORTER	NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation Career Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. De Berardinis, W. Hahn, D. Lev, P. Mischel, N. Mizushima, B. Omary, G. Pearson, W. Sellers, R. Weinberg, and M. Yaffe for providing critical reagents and A. Diehl and H. Harrington for help with manuscript preparation. This work was supported by NIH/National Cancer Institute grants ROI CA84254-S1 and RO1 CA109618 to B. L., ROI CA129451 to M. W., KO8 CA164047 to R. W., a Dermatology Foundation Career Development Award, a Burroughs Wellcome Fund Career Award for Medical Scientists to R. W., and German Research Foundation grant RE2673/1-1 to J.R.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	21	508	546	8	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					956	959		10.1126/science.1225967	http://dx.doi.org/10.1126/science.1225967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23112296	Green Accepted			2022-12-01	WOS:000311083600046
J	Koerte, IK; Ertl-Wagner, B; Reiser, M; Zafonte, R; Shenton, ME				Koerte, Inga K.; Ertl-Wagner, Birgit; Reiser, Maximilian; Zafonte, Ross; Shenton, Martha E.			White Matter Integrity in the Brains of Professional Soccer Players Without a Symptomatic Concussion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Koerte, Inga K.] Harvard Univ, Sch Med, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Ertl-Wagner, Birgit; Reiser, Maximilian] Univ Munich, Inst Clin Radiol, Munich, Germany; [Shenton, Martha E.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Munich; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Koerte, IK (corresponding author), Harvard Univ, Sch Med, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.	ikoerte@bwh.harvard.edu	Ertl-Wagner, Birgit/AAD-5708-2020; Koerte, Inga Katharina/AAW-3031-2021	Ertl-Wagner, Birgit/0000-0002-7896-7049	NINDS NIH HHS [R01 NS078337] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078337] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024	5	161	162	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1859	1861		10.1001/jama.2012.13735	http://dx.doi.org/10.1001/jama.2012.13735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150002	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000310952700016
J	Nissen, SE				Nissen, Steven E.			Cardiovascular Effects of Diabetes Drugs: Emerging From the Dark Ages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYOCARDIAL-INFARCTION; DEATH; ROSIGLITAZONE; MELLITUS; RISK		Cleveland Clin, Dept Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOLDNER MG, 1971, J AMER MED ASSOC, V218, P1400, DOI 10.1001/jama.218.9.1400; Meier JJ, 2004, HEART, V90, P9, DOI 10.1136/heart.90.1.9; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; US Department of Health and Human Services Food and Drug Administration, 2008, GUID IND DIAB MELL E	11	20	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					671	672		10.7326/0003-4819-157-9-201211060-00016	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128866				2022-12-01	WOS:000310783300011
J	Elli, L				Elli, Luca			Where's the evidence for gluten sensitivity?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Osped Maggiore Policlin, Ctr Prevent & Diag Coeliac Dis, Fdn IRCCS Ca Granda, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Elli, L (corresponding author), Osped Maggiore Policlin, Ctr Prevent & Diag Coeliac Dis, Fdn IRCCS Ca Granda, Via Francesco Sforza 35, I-20122 Milan, Italy.	lucelli@yahoo.com	Elli, Luca/K-6084-2016	Elli, Luca/0000-0002-0873-0759				Elli L, 2003, TOXICOL LETT, V146, P1, DOI 10.1016/j.toxlet.2003.09.004; Enck P, 2010, EUR J GASTROEN HEPAT, V22, P1402, DOI 10.1097/MEG.0b013e3283405a17; Painter K, 2008, US TODAY; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15	7	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 2	2012	345								e7360	10.1136/bmj.e7360	http://dx.doi.org/10.1136/bmj.e7360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033FL	23125126				2022-12-01	WOS:000310779500001
J	Godlee, F				Godlee, Fiona			Open letter to Roche about oseltamivir trial data	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITORS; ACUTE INFLUENZA; COMPLICATIONS; EFFICACY; SAFETY					fgodlee@bmj.com						Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016	7	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7305	10.1136/bmj.e7305	http://dx.doi.org/10.1136/bmj.e7305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109484	Bronze			2022-12-01	WOS:000310778000012
J	Qin, J; Wu, SP; Creighton, CJ; Dai, FY; Xie, X; Cheng, CM; Frolov, A; Ayala, G; Lin, X; Feng, XH; Ittmann, MM; Tsai, SJ; Tsai, MJ; Tsai, SY				Qin, Jun; Wu, San-Pin; Creighton, Chad J.; Dai, Fangyan; Xie, Xin; Cheng, Chiang-Min; Frolov, Anna; Ayala, Gustavo; Lin, Xia; Feng, Xin-Hua; Ittmann, Michael M.; Tsai, Shaw-Jenq; Tsai, Ming-Jer; Tsai, Sophia Y.			COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis	NATURE			English	Article							TRANSCRIPTION FACTOR-II; GENE-EXPRESSION; CANCER; ORPHAN; ANGIOGENESIS; SUPPRESSION; METASTASIS; RECURRENCE; MOUSE	Mutations in phosphatase and tensin homologue (PTEN) or genomic alterations in the phosphatidylinositol-3-OH kinase-signalling pathway are the most common genetic alterations reported in human prostate cancer(1-4). However, the precise mechanism underlying how indolent tumours with PTEN alterations acquire metastatic potential remains poorly understood. Recent studies suggest that upregulation of transforming growth factor (TGF)-beta signalling triggered by PTEN loss will form a growth barrier as a defence mechanism to constrain prostate cancer progression(5), underscoring that TGF-beta signalling might represent a pre-invasive checkpoint to prevent PTEN-mediated prostate tumorigenesis. Here we show that COUP transcription factor II (COUP-TFII, also known as NR2F2)(6-9), a member of the nuclear receptor superfamily, serves as a key regulator to inhibit SMAD4-dependent transcription, and consequently overrides the TGF-beta-dependent checkpoint for PTEN-null indolent tumours. Overexpression of COUP-TFII in the mouse prostate epithelium cooperates with PTEN deletion to augment malignant progression and produce an aggressive metastasis-prone tumour. The functional counteraction between COUP-TFII and SMAD4 is reinforced by genetically engineered mouse models in which conditional loss of SMAD4 diminishes the inhibitory effects elicited by COUP-TFII ablation. The biological significance of COUP-TFII in prostate carcinogenesis is substantiated by patient sample analysis, in which COUP-TFII expression or activity is tightly correlated with tumour recurrence and disease progression, whereas it is inversely associated with TGF-beta signalling. These findings reveal that the destruction of the TGF-beta-dependent barrier by COUP-TFII is crucial for the progression of PTEN-mutant prostate cancer into a life-threatening disease, and supports COUP-TFII as a potential drug target for the intervention of metastatic human prostate cancer.	[Qin, Jun; Wu, San-Pin; Dai, Fangyan; Xie, Xin; Cheng, Chiang-Min; Feng, Xin-Hua; Tsai, Shaw-Jenq; Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Dai, Fangyan; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Frolov, Anna; Ayala, Gustavo; Ittmann, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Dept Physiol, Coll Med, Tainan 701, Taiwan; [Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Cheng Kung University; Baylor College of Medicine	Tsai, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.edu; stsai@bcm.edu	Dai, Fangyan/J-8927-2016; , San Pin Wu/AAF-8371-2020; Tsai, Shaw-Jenq/AAG-6569-2019; Ayala, Gustavo/ABC-6625-2020	, San Pin Wu/0000-0001-9626-784X; TSAI, SHAW-JENQ/0000-0002-3569-5813	DERC Center [P30 DK079638]; National Institutes of Health [DK62434, DK59820, DK45641, HL76448]; Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, R01DK045641, U19DK062434, R37DK045641, P30DK079638] Funding Source: NIH RePORTER	DERC Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Wu for the Pten<SUP>flox/flox</SUP> mice, F. Wang for ARR2PB-Cre (PB-Cre) transgenic mice and E. J. Robertson for the Smad4<SUP>flox/flox</SUP> mice. We thank H. K. Graves and L.-Y. Yu-Lee for editorial assistance and S. Elledge for comments. We also thank the Baylor Microarray Core supported by the DERC Center (P30 DK079638) for the microarray analysis. This work was supported by grants from the National Institutes of Health DK62434, DK59820 (S.Y.T. and M.-J.T.), DK45641 (M.-J.T.) and HL76448 (S.Y.T.), and the Dan L. Duncan Cancer Center.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Nagasaki S, 2009, CANCER SCI, V100, P639, DOI 10.1111/j.1349-7006.2008.01078.x; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2010, CANCER RES, V70, P8812, DOI 10.1158/0008-5472.CAN-10-0551; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; Shin SW, 2009, ONCOL REP, V21, P101, DOI 10.3892/or_00000195; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	37	129	137	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					236	U252		10.1038/nature11674	http://dx.doi.org/10.1038/nature11674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201680	Green Accepted			2022-12-01	WOS:000313259600042
J	Powell, T; Hanfling, D; Gostin, LO				Powell, Tia; Hanfling, Dan; Gostin, Lawrence O.			Emergency Preparedness and Public Health The Lessons of Hurricane Sandy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Powell, Tia] Albert Einstein Coll Med, Montefiore Einstein Ctr Bioeth, Bronx, NY 10467 USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA; [Hanfling, Dan] Georgetown Univ, Dept Emergency Med, Washington, DC 20001 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Yeshiva University; Albert Einstein College of Medicine; Inova Health System; Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Hartocollis A, 2012, NY TIMES; Institute of Medicine, 2012, CRIS STAND CAR SYST, DOI DOI 10.17226/13351; Katz C, 2012, NYC             1027; Kolker Robert, 2021, NEW YORK TIMES MAGAZ; Ofri D, 2012, NEW ENGL J MED, V367, P2265, DOI 10.1056/NEJMp1213843; Shapiro J, BELLEVUE HOSP EVACUA	6	85	86	0	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2569	2570		10.1001/jama.2012.108940	http://dx.doi.org/10.1001/jama.2012.108940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23281545				2022-12-01	WOS:000312916600019
J	Tsai, NP; Wilkerson, JR; Guo, WR; Maksimova, MA; DeMartino, GN; Cowan, CW; Huber, KM				Tsai, Nien-Pei; Wilkerson, Julia R.; Guo, Weirui; Maksimova, Marina A.; DeMartino, George N.; Cowan, Christopher W.; Huber, Kimberly M.			Multiple Autism-Linked Genes Mediate Synapse Elimination via Proteasomal Degradation of a Synaptic Scaffold PSD-95	CELL			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; OL-PROTOCADHERIN; TRANSLATION; MEF2; ENDOCYTOSIS; TRAFFICKING; EXPRESSION; DIVERSITY	The activity-dependent transcription factor myocyte enhancer factor 2 (MEF2) induces excitatory synapse elimination in mouse neurons, which requires fragile X mental retardation protein (FMRP), an RNA-binding protein implicated in human cognitive dysfunction and autism. We report here that protocadherin 10 (Pcdh10), an autism-spectrum disorders gene, is necessary for this process. MEF2 and FMRP cooperatively regulate the expression of Pcdh10. Upon MEF2 activation, PSD-95 is ubiquitinated by the ubiquitin E3 ligase murine double minute 2 (Mdm2) and then binds to Pcdh10, which links it to the proteasome for degradation. Blockade of the Pcdh10-proteasome interaction inhibits MEF2-induced PSD-95 degradation and synapse elimination. In FMRP-lacking neurons, elevated protein levels of eukaryotic translation elongation factor 1 alpha (EF1 alpha), an Mdm2-interacting protein and FMRP target mRNA, sequester Mdm2 and prevent MEF2-induced PSD-95 ubiquitination and synapse elimination. Together, our findings reveal roles for multiple autism-linked genes in activity-dependent synapse elimination.	[Tsai, Nien-Pei; Wilkerson, Julia R.; Guo, Weirui; Maksimova, Marina A.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Guo, Weirui/G-2868-2015; Cowan, Christopher W/I-2497-2014; Huber, Kimberly/X-5534-2019; Litvinova, Marina/C-6154-2017	WILKERSON, JULIA/0000-0002-7497-2270; Litvinova, Marina/0000-0002-2622-6548	National Institutes of Health [NS045711, HD052731, F32HD069111, F32HD062120]; Simons Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731, F32HD069111] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institutes of Health NS045711, HD052731 (K.M.H.), F32HD069111 (N.-P.T.), F32HD062120 (J.R.W.) and from the Simons Foundations (K.M.H. and C.W.C.). We would also like to thank L. Ormazabal, N. Cabalo, F. Niere, K. Loerwald, T. Zang, D. Thompson, X. Li, and B. Chen for technical assistance; Dr. M. Rosen for the GST-Pcdh10 constructs; Dr. J. Gibson for helpful discussions; and Drs. Robert and Jennifer Darnell for sharing their FMRP-CLIP target list prior to publication.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Dolezelova P, 2012, CELL CYCLE, V11, P953, DOI 10.4161/cc.11.5.19445; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frum R, 2007, J PROTEOME RES, V6, P1410, DOI 10.1021/pr060584p; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Haas KF, 2007, MOL CELL NEUROSCI, V35, P64, DOI 10.1016/j.mcn.2007.02.002; Hirano S, 1999, J NEUROSCI, V19, P995; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Woods GF, 2011, J NEUROSCI, V31, P12129, DOI 10.1523/JNEUROSCI.6662-10.2011; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104	41	186	189	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1581	1594		10.1016/j.cell.2012.11.040	http://dx.doi.org/10.1016/j.cell.2012.11.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260144	Green Accepted, Bronze			2022-12-01	WOS:000312890300021
J	Ko, F; Vitale, S; Chou, CF; Cotch, MF; Saaddine, J; Friedman, DS				Ko, Fang; Vitale, Susan; Chou, Chiu-Fang; Cotch, Mary Frances; Saaddine, Jinan; Friedman, David S.			Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 DIABETES-MELLITUS; UNITED-STATES; TEMPORAL TRENDS; RETINOPATHY; CHILDREN; ADOLESCENTS; PERSPECTIVE; HEALTH	Context Over the past decade, chronic illnesses with ophthalmic sequelae such as diabetes and diabetic retinopathy have increased. Objectives To estimate prevalence of nonrefractive visual impairment and to describe its relationship with demographic and systemic risk factors including diagnosed diabetes. Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) examined a representative sample of the US noninstitutionalized population. In 1999-2002 and 2005-2008, 9471 and 10 480 participants aged 20 years or older received questionnaires, laboratory tests, and physical examinations. Visual acuity of less than 20/40 aided by autorefractor was classified as nonrefractive visual impairment. Main Outcome Measure Nonrefractive visual impairment. Results Weighted prevalence of nonrefractive visual impairment increased 21% among US adults aged 20 years and older from 1.4% in 1999-2002 to 1.7% in 2005-2008 (P=.03); and increased 40% among non-Hispanic whites aged 20-39 years from 0.5% to 0.7% (P=.008). In multivariable analyses, statistically significant risk factors for nonrefractive visual impairment in 1999-2002 included age (per year odds ratio [OR], 1.07; 95% CI, 1.05-1.09), poverty (OR, 2.18; 95% CI, 1.31-3.64), lack of insurance (OR, 1.85; 95% CI, 1.16-2.95), and diabetes with 10 or more years since diagnosis (OR, 1.93; 95% CI, 1.15-3.25). In 2005-2008, risk factors included age (OR, 1.05; 95% CI, 1.04-1.07), poverty (OR, 2.23; 95% CI, 1.55-3.22), education less than high school (OR, 2.11; 95% CI, 1.54-2.90), and diabetes with 10 or more years since diagnosis (OR, 2.67; 95% CI, 1.64-4.37). Prevalence of diabetes with 10 or more years since diagnosis increased 22% overall from 2.8% to 3.6% (P=.02); and 133% among non-Hispanic whites aged 20-39 years from 0.3% to 0.7% (P<.001). Conclusion Prevalence of nonrefractive visual impairment was significantly higher in 2005-2008 than in 1999-2002 and may be attributable, in part, to higher prevalence of diabetes, an associated risk factor that increased in prevalence during this time period. JAMA. 2012;308(22):2361-2368 www.jama.com	[Ko, Fang; Friedman, David S.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21205 USA; [Friedman, David S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vitale, Susan; Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Chou, Chiu-Fang; Saaddine, Jinan] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Centers for Disease Control & Prevention - USA	Friedman, DS (corresponding author), Wilmer 120,600 N Wolfe St, Baltimore, MD 21287 USA.	david.friedman@jhu.edu		Friedman, David/0000-0002-2055-5797; vitale, susan/0000-0002-5972-6848; Cotch, Mary Frances/0000-0002-2046-4350	National Eye Institute (ARVO); Pepose; David Friedman Research Grant Award; Centers for Disease Control and Prevention (CDC) [1U58DP002653-01]; National Center for Health Statistics (NCHS); CDC; National Institutes of Health (NIH) [Z01EY000402]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002653] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [Z01EY000402, ZIAEY000402] Funding Source: NIH RePORTER	National Eye Institute (ARVO); Pepose; David Friedman Research Grant Award; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Health Statistics (NCHS); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Friedman reports having consulted for Alcon, Bausch and Lomb, Merck, Pfizer, Allergan, Nidek, and QLT. Dr Ko reports receipt of support for travel to meetings for the study or other purposes from the National Eye Institute (ARVO travel grant), a Pepose travel grant, and a David Friedman Research Grant Award for provision of writing assistance, medicines, equipment, or administratrive support. The remaining authors report no disclosures.; This study was supported by the Centers for Disease Control and Prevention (CDC) grant 1U58DP002653-01 and the David Friedman Research Grant Award. The National Health and Nutrition Examination Survey (NHANES) is sponsored by the National Center for Health Statistics (NCHS), CDC. Funding for the vision component was provided by the National Eye Institute (NEI), National Institutes of Health (NIH), Intramural Research Program grant Z01EY000402.	Acton KJ, 2002, AM J PUBLIC HEALTH, V92, P1485, DOI 10.2105/AJPH.92.9.1485; Berglund PA., 2009, SAS GLOB FOR 2009 MA, P246; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Burrows Nilka R., 2011, Morbidity and Mortality Weekly Report, V60, P1549; Centers for Disease Control and Prevention, 2011, ED SERV UDOHAH; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cugati S, 2006, DIABETES RES CLIN PR, V74, P301, DOI 10.1016/j.diabres.2006.04.002; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Kaufman FR, 2002, J PEDIATR ENDOCR MET, V15, P737; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN R, 1991, DIABETES CARE, V14, P914, DOI 10.2337/diacare.14.10.914; Klein R., 1995, DIABETES AM, V2nd ed., P293, DOI DOI 10.1063/1.1522643; Klein R, 2010, DIABETES, V59, P1853, DOI 10.2337/db09-1904; Klein R, 2010, OPHTHALMOLOGY, V117, P63, DOI 10.1016/j.ophtha.2009.06.051; LeCaire T, 2006, AM J EPIDEMIOL, V164, P143, DOI 10.1093/aje/kwj166; Lytle LA, 2012, ABDOM IMAGING, V37, P719, DOI 10.1007/s00261-012-9861-y; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; *NAT HLTH NUTR EX, PUBL US DAT FIL; *NAT HLTH NUTR EX, VIS PROC MAN; National Health and Nutrition Examination Survey, LAB PROC MAN; National Health and Nutrition Examination Survey, HYP TEST; National Health and Nutrition Examination Survey, AN REP GUID; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Roberts CB, 2010, ARCH OPHTHALMOL-CHIC, V128, P766, DOI 10.1001/archophthalmol.2010.86; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Yuan YC., 2000, MULTIPLE IMPUTATION; Zambelli-Weiner A, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2012.03 .018, DOI 10.1016/J.AJO.2012.03]; Zhang XZ, 2008, ARCH OPHTHALMOL-CHIC, V126, P1421, DOI 10.1001/archopht.126.10.1421; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	37	56	57	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2361	2368		10.1001/jama.2012.85685	http://dx.doi.org/10.1001/jama.2012.85685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232894	Green Accepted			2022-12-01	WOS:000312132400026
J	Soldner, F; Jaenisch, R				Soldner, Frank; Jaenisch, Rudolf			iPSC Disease Modeling	SCIENCE			English	Editorial Material							PLURIPOTENT; GENERATION		[Soldner, Frank; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Soldner, F (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NCI NIH HHS [R01 CA084198] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	21	116	121	0	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1155	1156		10.1126/science.1227682	http://dx.doi.org/10.1126/science.1227682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197518				2022-12-01	WOS:000311666200027
J	Jones, JL; Esber, GR; McDannald, MA; Gruber, AJ; Hernandez, A; Mirenzi, A; Schoenbaum, G				Jones, Joshua L.; Esber, Guillem R.; McDannald, Michael A.; Gruber, Aaron J.; Hernandez, Alex; Mirenzi, Aaron; Schoenbaum, Geoffrey			Orbitofrontal Cortex Supports Behavior and Learning Using Inferred But Not Cached Values	SCIENCE			English	Article							PREFRONTAL CORTEX; VENTRAL STRIATUM; REWARD VALUE; LESIONS; AMYGDALA; INACTIVATION; DEVALUATION; RESPONSES; REVERSAL; NEURONS	Computational and learning theory models propose that behavioral control reflects value that is both cached (computed and stored during previous experience) and inferred (estimated on the fly on the basis of knowledge of the causal structure of the environment). The latter is thought to depend on the orbitofrontal cortex. Yet some accounts propose that the orbitofrontal cortex contributes to behavior by signaling "economic" value, regardless of the associative basis of the information. We found that the orbitofrontal cortex is critical for both value-based behavior and learning when value must be inferred but not when a cached value is sufficient. The orbitofrontal cortex is thus fundamental for accessing model-based representations of the environment to compute value rather than for signaling value per se.	[Jones, Joshua L.; Hernandez, Alex; Schoenbaum, Geoffrey] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA; [Esber, Guillem R.; McDannald, Michael A.; Mirenzi, Aaron; Schoenbaum, Geoffrey] NIDA, Behav Neurophysiol Res Sect, Cellular Neurobiol Res Branch, Intramural Res Program, Baltimore, MD 21201 USA; [Gruber, Aaron J.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Lethbridge	Jones, JL (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Sch Med, 20 Penn St, Baltimore, MD 21201 USA.	josh.jones@nih.gov; geoffrey.schoenbaum@nih.gov	Esber, Guillem/AAL-9246-2020	Esber, Guillem/0000-0001-8874-4255; Hernandez, Alex/0000-0002-2267-4781; Gruber, Aaron/0000-0003-2700-5429	National Institute on Drug Abuse (NIDA), NIH [F32-031517]; NIDA [R01-DA015718]; Natural Sciences and Engineering Research Council of Canada; Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, R01DA015718, F32DA031517] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse (NIDA), NIH, F32-031517 to J.L.J., NIDA R01-DA015718 to G. S., funding from Natural Sciences and Engineering Research Council of Canada to A.J.G., and by the Intramural Research Program at NIDA. The opinions expressed in this article are the authors' own and do not reflect the view of the NIH or U.S. Department of Health and Human Services. The authors declare that they have no conflicts of interest related to the data presented in this manuscript.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Barto A, 1998, REINFORCEMENT LEARNI, V1st; Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Burke KA, 2009, EUR J NEUROSCI, V30, P1941, DOI 10.1111/j.1460-9568.2009.06992.x; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kamin LJ, 1969, PUNISHMENT AVERSIVE, P242; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Machado CJ, 2007, EUR J NEUROSCI, V25, P2885, DOI 10.1111/j.1460-9568.2007.05525.x; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pickens CL, 2005, BEHAV NEUROSCI, V119, P317, DOI 10.1037/0735-7044.119.1.317; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; West EA, 2011, J NEUROSCI, V31, P15128, DOI 10.1523/JNEUROSCI.3295-11.2011	30	185	186	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					953	956		10.1126/science.1227489	http://dx.doi.org/10.1126/science.1227489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162000	Green Accepted			2022-12-01	WOS:000311083600045
J	Moynihan, R				Moynihan, Ray			Too much medicine, not enough mirth	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDER		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], ONION; [Anonymous], 2002, BMJ, V324; Gotzsche PC, 2002, BRIT MED J, V324, P890; Lenzer J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6230; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Payer L, 2006, DIS MONGERS DOCTORS; Schwarz A., 2012, NY TIMES	9	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7116	10.1136/bmj.e7116	http://dx.doi.org/10.1136/bmj.e7116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114064				2022-12-01	WOS:000310778900009
J	Beets, I; Janssen, T; Meelkop, E; Temmerman, L; Suetens, N; Rademakers, S; Jansen, G; Schoofs, L				Beets, Isabel; Janssen, Tom; Meelkop, Ellen; Temmerman, Liesbet; Suetens, Nick; Rademakers, Suzanne; Jansen, Gert; Schoofs, Liliane			Vasopressin/Oxytocin-Related Signaling Regulates Gustatory Associative Learning in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; OXYTOCIN RECEPTORS; IDENTIFICATION; PLASTICITY; MOTIVATION; SEROTONIN; DOPAMINE; CUES	Vasopressin- and oxytocin-related neuropeptides are key regulators of animal physiology, including water balance and reproduction. Although these neuropeptides also modulate social behavior and cognition in mammals, the mechanism for influencing behavioral plasticity and the evolutionary origin of these effects are not well understood. Here, we present a functional vasopressin- and oxytocin-like signaling system in the nematode Caenorhabditis elegans. Through activation of its receptor NTR-1, a vasopressin/oxytocin-related neuropeptide, designated nematocin, facilitates the experience-driven modulation of salt chemotaxis, a type of gustatory associative learning in C. elegans. Our study suggests that vasopressin and oxytocin neuropeptides have ancient roles in modulating sensory processing in neural circuits that underlie behavioral plasticity.	[Beets, Isabel; Janssen, Tom; Meelkop, Ellen; Temmerman, Liesbet; Suetens, Nick; Schoofs, Liliane] Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote Unit, B-3000 Louvain, Belgium; [Rademakers, Suzanne; Jansen, Gert] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands	KU Leuven; Erasmus University Rotterdam; Erasmus MC	Schoofs, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote Unit, B-3000 Louvain, Belgium.	liliane.schoofs@bio.kuleuven.be	Jansen, Gert/HCI-8852-2022; Janssen, Tom/AAC-1849-2020; Meelkop, Ellen/G-3052-2012; schoofs, liliane/ABD-2943-2020; Beets, Isabel/I-6386-2012; Schoofs, Liliane/F-2815-2010	Schoofs, Liliane/0000-0002-1673-432X; Jansen, Gert/0000-0002-7524-171X; Beets, Isabel/0000-0002-0968-4360; Temmerman, Liesbet/0000-0002-1249-3995	Fund for Scientific Research-Flanders (FWO); KU Leuven Faculty Research Fund; KU Leuven [GOA/11/002]; FWO [G.0767.09, G.0601.11]	Fund for Scientific Research-Flanders (FWO)(FWO); KU Leuven Faculty Research Fund; KU Leuven(KU Leuven); FWO(FWO)	We thank the Caenorhabditis Genetics Center, S. Mitani, C. Bargmann, and M. Alkema for strains and reagents; L. Vanden Bosch, M. Vanhove, and W. De Haes for technical assistance. I.B., T.J., and L.T. benefit from the Fund for Scientific Research-Flanders (FWO) and E.M. from the KU Leuven Faculty Research Fund. This work was supported by the KU Leuven concerted research grant GOA/11/002 and FWO grants G.0767.09 and G.0601.11. GenBank accession numbers of ntc-1, ntr-1, and ntr-2 sequences are JQ277480, JQ277731, and JQ277479. Strains carrying the tm2385, tm2765, and tm2243 alleles are available through the C. elegans National BioResource Project (NBRP), subject to a materials transfer agreement.	Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; CULOTTI JG, 1978, GENETICS, V90, P243; DEWIED D, 1993, FRONT NEUROENDOCRIN, V14, P251, DOI 10.1006/frne.1993.1009; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Izquierdo A, 2012, BEHAV BRAIN RES, V233, P494, DOI 10.1016/j.bbr.2012.05.032; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Janssen T, 2010, ANN NY ACAD SCI, V1200, P1, DOI 10.1111/j.1749-6632.2010.05506.x; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Orcel H, 2009, MOL PHARMACOL, V75, P637, DOI 10.1124/mol.108.049031; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SCHUMACHER M, 1990, SCIENCE, V250, P691, DOI 10.1126/science.2173139; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; VANKESTEREN RE, 1995, NEURON, V15, P897, DOI 10.1016/0896-6273(95)90180-9; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	20	114	117	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					543	545		10.1126/science.1226860	http://dx.doi.org/10.1126/science.1226860			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112336	Green Accepted			2022-12-01	WOS:000310195800062
J	Bieniossek, C; Papai, G; Schaffitzel, C; Garzoni, F; Chaillet, M; Scheer, E; Papadopoulos, P; Tora, L; Schultz, P; Berger, I				Bieniossek, Christoph; Papai, Gabor; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Scheer, Elisabeth; Papadopoulos, Petros; Tora, Laszlo; Schultz, Patrick; Berger, Imre			The architecture of human general transcription factor TFIID core complex	NATURE			English	Article							CRYSTAL-STRUCTURE; TERMINAL DOMAIN; YEAST; IDENTIFICATION; SUBCOMPLEX; SUBUNIT; OCTAMER; TAFS	The initiation of gene transcription by RNA polymerase II is regulated by a plethora of proteins in human cells. The first general transcription factor to bind gene promoters is transcription factor IID (TFIID). TFIID triggers pre-initiation complex formation, functions as a coactivator by interacting with transcriptional activators and reads epigenetic marks(1-3). TFIID is a megadalton-sized multiprotein complex composed of TATA-box-binding protein (TBP) and 13 TBP-associated factors (TAFs)(3). Despite its crucial role, the detailed architecture and assembly mechanism of TFIID remain elusive. Histone fold domains are prevalent in TAFs, and histone-like tetramer and octamer structures have been proposed in TFIID4-6. A functional core-TFIID subcomplex was revealed in Drosophila nuclei, consisting of a subset of TAFs (TAF4, TAF5, TAF6, TAF9 and TAF12)(7). These core subunits are thought to be present in two copies in holo-TFIID, in contrast to TBP and other TAFs that are present in a single copy(8), conveying a transition from symmetry to asymmetry in the TFIID assembly pathway. Here we present the structure of human core-TFIID determined by cryoelectron microscopy at 11.6 angstrom resolution. Our structure reveals a two-fold symmetric, interlaced architecture, with pronounced protrusions, that accommodates all conserved structural features of the TAFs including the histone folds. We further demonstrate that binding of one TAF8-TAF10 complex breaks the original symmetry of core-TFIID. We propose that the resulting asymmetric structure serves as a functional scaffold to nucleate holo-TFIID assembly, by accreting one copy each of the remaining TAFs and TBP.	[Bieniossek, Christoph; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Berger, Imre] UJF CNRS EMBL, Unite Mixte Int UMI 3265, European Mol Biol Lab EMBL Grenoble Outstn, F-38042 Grenoble 9, France; [Bieniossek, Christoph; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Berger, Imre] UJF CNRS EMBL, Unite Mixte Int UMI 3265, Unit Virus Host Cell Interact UVHCI, F-38042 Grenoble 9, France; [Papai, Gabor; Schultz, Patrick] IGBMC, Dept Integrated Struct Biol, F-67404 Illkirch Graffenstaden, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] INSERM, U964, F-67400 Paris, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] CNRS Illkirch, UMR7104, F-67000 Strasbourg, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] Univ Strasbourg, F-67000 Strasbourg, France; [Scheer, Elisabeth; Tora, Laszlo] IGBMC, Dept Funct Genom & Canc, F-67404 Illkirch Graffenstaden, France; [Papadopoulos, Petros] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Erasmus University Rotterdam; Erasmus MC	Schultz, P (corresponding author), IGBMC, Dept Integrated Struct Biol, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	patrick.schultz@igbmc.fr; iberger@embl.fr	Tora, Laszlo/E-9999-2018; Papadopoulos, Petros/B-1913-2015	Tora, Laszlo/0000-0001-7398-2250; Papadopoulos, Petros/0000-0002-8342-329X; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760; Papai, Gabor/0000-0002-2779-8679; Berger, Imre/0000-0001-7518-9045; Chaillet, Maxime/0000-0001-6812-4147; schultz, patrick/0000-0002-7310-6186	European Research Council (ERC); Agence Nationale de la Recherche (ANR); EC Marie Curie Action; EC; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National pour la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM); ANR; ChromAct; TFIID-Complexes	European Research Council (ERC)(European Research Council (ERC)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); EC Marie Curie Action(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); ChromAct; TFIID-Complexes	We thank all members of the Berger, Schultz and Tora laboratories for advice and discussions. We are grateful to C. Romier for providing the X-ray structure of the TAF6 C-terminal domain before publication. We thank J. Demmers for mass spectrometric analyses and F. Grosveld for discussions. The EMBL, IBS and IGBMC core facilities are acknowledged for services. We are indebted to G. Schoehn for maintaining the electron microscopes in Grenoble. T. J. Richmond is acknowledged for advice and support. C. B. is a fellow of the joint European Commission (EC)/EMBL interdisciplinary research opportunities program (EIPOD). C. S. is recipient of a European Research Council (ERC) Starting Grant and an Agence Nationale de la Recherche (ANR) Jeunes Chercheuses award. I. B. acknowledges support from the EC Marie Curie Action and the EC Framework Programme (FP) 7 projects INSTRUCT, PCUBE, BioSTRUCT-X, 4D-CellFate and ComplexINC. P. S. acknowledges support from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National pour la Recherche Scientifique (CNRS), the Association pour la Recherche sur le Cancer (ARC) and the Fondation pour la Recherche Medicale (FRM). This work was supported by the ANR Projets Blancs puzzle-fit (to P. S.), ChromAct (to P. S. and L. T.) and TFIID-Complexes (to L.T., P.S. and I.B.).	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Muller F, 2010, CURR OPIN GENET DEV, V20, P533, DOI 10.1016/j.gde.2010.06.004; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Scheer E, 2012, J BIOL CHEM, V287, P27580, DOI 10.1074/jbc.M112.379206; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Soutoglou E, 2005, MOL CELL BIOL, V25, P4092, DOI 10.1128/MCB.25.10.4092-4104.2005; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	30	110	114	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					699	702		10.1038/nature11791	http://dx.doi.org/10.1038/nature11791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23292512				2022-12-01	WOS:000314219600062
J	Ma, C; Su, LJ; Seven, AB; Xu, YB; Rizo, J				Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep			Reconstitution of the Vital Functions of Munc18 and Munc13 in Neurotransmitter Release	SCIENCE			English	Article							DEPENDENT MEMBRANE-FUSION; SYNAPTIC VESICLE FUSION; NEURONAL SNARE COMPLEX; CRYSTAL-STRUCTURE; ALPHA-SNAP; C2B DOMAIN; SYNAPTOTAGMIN; EXOCYTOSIS; DOCKING; CALCIUM	Neurotransmitter release depends critically on Munc18-1, Munc13, the Ca2+ sensor synaptotagmin-1, and the soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptors (SNAREs) syntaxin-1, synaptobrevin, and SNAP-25. In vitro reconstitutions have shown that syntaxin-1-SNAP-25 liposomes fuse efficiently with synaptobrevin liposomes in the presence of synaptotagmin-1-Ca2+, but neurotransmitter release also requires Munc18-1 and Munc13 in vivo. We found that Munc18-1 could displace SNAP-25 from syntaxin-1 and that fusion of syntaxin-1-Munc18-1 liposomes with synaptobrevin liposomes required Munc13, in addition to SNAP-25 and synaptotagmin-1-Ca2+. Moreover, when starting with syntaxin-1-SNAP-25 liposomes, NSF-alpha-SNAP disassembled the syntaxin-1-SNAP-25 heterodimers and abrogated fusion, which then required Munc18-1 and Munc13. We propose that fusion does not proceed through syntaxin-1-SNAP-25 heterodimers but starts with the syntaxin-1-Munc18-1 complex; Munc18-1 and Munc13 then orchestrate membrane fusion together with the SNAREs and synaptotagmin-1-Ca2+ in an NSF- and SNAP-resistant manner.	[Ma, Cong] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Ma, Cong] Huazhong Univ Sci & Technol, Inst Biochem & Biophys, Wuhan 430074, Peoples R China; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ma, C (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	cong.ma7@gmail.com; jose@arnie.swmed.edu			Welch Foundation [I-1304]; National Science Foundation of China [31200618]; NIH [NS37200, NS40944]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944, R01NS037200] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Sun for expert technical assistance; Y. Liu for initial efforts to reconstitute syntaxin-1-Munc18-1 complexes; and W. Li, W. Wickner, and M. Brown for fruitful discussions. This work was supported by grant I-1304 from the Welch Foundation (to J.R.), grant 31200618 from the National Science Foundation of China (to C. M.), and grants NS37200 and NS40944 from the NIH (to J.R.).	Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508	35	257	260	7	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					421	425		10.1126/science.1230473	http://dx.doi.org/10.1126/science.1230473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23258414	Green Accepted			2022-12-01	WOS:000313960700036
J	Simakov, O; Marletaz, F; Cho, SJ; Edsinger-Gonzales, E; Havlak, P; Hellsten, U; Kuo, DH; Larsson, T; Lv, J; Arendt, D; Savage, R; Osoegawa, K; de Jong, P; Grimwood, J; Chapman, JA; Shapiro, H; Aerts, A; Otillar, RP; Terry, AY; Boore, JL; Grigoriev, IV; Lindberg, DR; Seaver, EC; Weisblat, DA; Putnam, NH; Rokhsar, DS				Simakov, Oleg; Marletaz, Ferdinand; Cho, Sung-Jin; Edsinger-Gonzales, Eric; Havlak, Paul; Hellsten, Uffe; Kuo, Dian-Han; Larsson, Tomas; Lv, Jie; Arendt, Detlev; Savage, Robert; Osoegawa, Kazutoyo; de Jong, Pieter; Grimwood, Jane; Chapman, Jarrod A.; Shapiro, Harris; Aerts, Andrea; Otillar, Robert P.; Terry, Astrid Y.; Boore, Jeffrey L.; Grigoriev, Igor V.; Lindberg, David R.; Seaver, Elaine C.; Weisblat, David A.; Putnam, Nicholas H.; Rokhsar, Daniel S.			Insights into bilaterian evolution from three spiralian genomes	NATURE			English	Article							SCHMIDTEA-MEDITERRANEA; SCHISTOSOMA-MANSONI; GENES; TREE; REPERTOIRE; RESOLUTION; ORGANISM; LIFE	Current genomic perspectives on animal diversity neglect two prominent phyla, the molluscs and annelids, that together account for nearly one-third of known marine species and are important both ecologically and as experimental systems in classical embryology(1-3). Here we describe the draft genomes of the owl limpet (Lottia gigantea), a marine polychaete (Capitella teleta) and a freshwater leech (Helobdella robusta), and compare them with other animal genomes to investigate the origin and diversification of bilaterians from a genomic perspective. We find that the genome organization, gene structure and functional content of these species are more similar to those of some invertebrate deuterostome genomes (for example, amphioxus and sea urchin) than those of other protostomes that have been sequenced to date (flies, nematodes and flatworms). The conservation of these genomic features enables us to expand the inventory of genes present in the last common bilaterian ancestor, establish the tripartite diversification of bilaterians using multiple genomic characteristics and identify ancient conserved long-and short-range genetic linkages across metazoans. Superimposed on this broadly conserved pan-bilaterian background we find examples of lineage-specific genome evolution, including varying rates of rearrangement, intron gain and loss, expansions and contractions of gene families, and the evolution of clade-specific genes that produce the unique content of each genome.	[Simakov, Oleg; Marletaz, Ferdinand; Larsson, Tomas; Arendt, Detlev] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Simakov, Oleg; Cho, Sung-Jin; Edsinger-Gonzales, Eric; Kuo, Dian-Han; Weisblat, David A.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Havlak, Paul; Lv, Jie; Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Hellsten, Uffe; Grimwood, Jane; Chapman, Jarrod A.; Shapiro, Harris; Aerts, Andrea; Otillar, Robert P.; Terry, Astrid Y.; Boore, Jeffrey L.; Grigoriev, Igor V.; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Savage, Robert] Williams Coll, Dept Biol, Thompson Biol Lab, Williamstown, MA 01267 USA; [Osoegawa, Kazutoyo; de Jong, Pieter] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Grimwood, Jane] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Seaver, Elaine C.] Univ Hawaii Manoa, Kewalo Marine Lab, Honolulu, HI 96813 USA; [Putnam, Nicholas H.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Rokhsar, Daniel S.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; Rice University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Williams College; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; University of Hawaii System; University of Hawaii Manoa; Rice University; Okinawa Institute of Science & Technology Graduate University	Putnam, NH (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, POB 1892, Houston, TX 77251 USA.	nputnam@gmail.com; dsrokhsar@gmail.com	Simakov, Oleg/G-4572-2015; Terry, Astrid Y/A-2538-2011; Grimwood, Jane/ABD-5737-2021; Putnam, Nicholas/B-9968-2008; Marlétaz, Ferdinand/H-3018-2019; Lindberg, David R/D-8138-2011; Simakov, Oleg/AAV-2494-2020; LU, JIE/AAP-6595-2020	Simakov, Oleg/0000-0002-3585-4511; Terry, Astrid Y/0000-0002-5234-1224; Putnam, Nicholas/0000-0002-1315-782X; Marlétaz, Ferdinand/0000-0001-8124-4266; Simakov, Oleg/0000-0002-3585-4511; LU, JIE/0000-0001-5071-8959; Rokhsar, Daniel/0000-0002-8704-2224; Edsinger, Eric/0000-0002-1012-1506; Grigoriev, Igor/0000-0002-3136-8903; Kuo, Dian-Han/0000-0002-6461-2562	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Gordon and Betty Moore Foundation; National Science Foundation (NSF) [EF-0850294, I0S-0922792]; National Institutes of Health (NIH) [RO1 GM 074619]; Boehringer Ingelheim Fonds; US National Human Genome Research Institute; Direct For Biological Sciences [0850294] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074619] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. Early work on the analysis of these genomes was also supported by the Gordon and Betty Moore Foundation through a grant to the Center for Integrative Genomics at the University of California. D. S. R. thanks R. Melmon for a grant in support of this project. N.H.P. is supported by the National Science Foundation (NSF) under grant EF-0850294; D. A. W. is supported by the National Institutes of Health (NIH; RO1 GM 074619) and NSF (I0S-0922792); and O.S. is supported by Boehringer Ingelheim Fonds. E.E-G. was supported by a training grant from the US National Human Genome Research Institute. We thank A. Meyer and J. Gerhart for helpful discussions.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Conklin EG, 1897, EMBRYOLOGY CREPIDULA; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Frobius AC, 2006, GENE EXPR PATTERNS, V6, P985, DOI 10.1016/j.modgep.2006.04.002; Henry JQ, 2007, INTEGR COMP BIOL, V47, P865, DOI 10.1093/icb/icm035; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Purschke G, 2005, HYDROBIOLOGIA, V535, P53, DOI 10.1007/s10750-004-4358-5; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Roy SW, 2008, MOL BIOL EVOL, V25, P620, DOI 10.1093/molbev/msn035; Roy SW, 2005, P NATL ACAD SCI USA, V102, P4403, DOI 10.1073/pnas.0409891102; Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium, 2009, NATURE, V460, P345; Shimeld SM, 2010, DEV BIOL, V340, P234, DOI 10.1016/j.ydbio.2010.01.015; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Telford MJ, 2011, TRENDS GENET, V27, P186, DOI 10.1016/j.tig.2011.02.003; Wilson EB, 1892, J MORPHOL, V6, P361; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596	28	406	419	8	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					526	531		10.1038/nature11696	http://dx.doi.org/10.1038/nature11696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23254933	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-01	WOS:000313871400037
J	Senyo, SE; Steinhauser, ML; Pizzimenti, CL; Yang, VK; Cai, L; Wang, M; Wu, TD; Guerquin-Kern, JL; Lechene, CP; Lee, RT				Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Wang, Mei; Wu, Ting-Di; Guerquin-Kern, Jean-Luc; Lechene, Claude P.; Lee, Richard T.			Mammalian heart renewal by pre-existing cardiomyocytes	NATURE			English	Article							STEM-CELLS; MOUSE; REGENERATION; TURNOVER	Although recent studies have revealed that heart cells are generated in adult mammals, the frequency of generation and the source of new heart cells are not yet known. Some studies suggest a high rate of stem cell activity with differentiation of progenitors to cardiomyocytes(1). Other studies suggest that new cardiomyocytes are born at a very low rate(2-4), and that they may be derived from the division of pre-existing cardiomyocytes. Here we show, by combining two different pulse-chase approaches-genetic fate-mapping with stable isotope labelling, and multi-isotope imaging mass spectrometry-that the genesis of cardiomyocytes occurs at a low rate by the division of pre-existing cardiomyocytes during normal ageing, a process that increases adjacent to areas of myocardial injury. We found that cell cycle activity during normal ageing and after injury led to polyploidy and multinucleation, but also to new diploid, mononucleate cardiomyocytes. These data reveal pre-existing cardiomyocytes as the dominant source of cardiomyocyte replacement in normal mammalian myocardial homeostasis as well as after myocardial injury.	[Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA; [Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Wang, Mei; Lechene, Claude P.; Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] INSERM, U759, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France; [Wang, Mei; Lechene, Claude P.] Natl Resource Imaging Mass Spectrometry, Cambridge, MA 02139 USA; [Wang, Mei; Lechene, Claude P.] Brigham & Womens Hosp, Dept Med, Div Genet, Cambridge, MA 02139 USA; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Harvard University; Brigham & Women's Hospital; Harvard University	Lee, RT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA.	rlee@partners.org	Steinhauser, Matthew L./GVT-6393-2022; Guerquin-Kern, Jean-Luc/M-5000-2018	Steinhauser, Matthew L./0000-0001-5287-9246; Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; Senyo, Samuel/0000-0002-9206-6845; Lee, Richard/0000-0003-4687-1381; WU, Ting-Di/0000-0002-6398-0363	National Institutes of Health (NIH) [F32 HL108570, K08 DK090147, EB001974, AG034641, AG032977, AG040019]; American Heart Association (AHA FTF); Future Leaders in Cardiovascular Medicine; Watkins Cardiovascular Leadership Award; Ellison Medical Foundation [AG-SS-2215-08]; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL108570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974, P20EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R21AG034641, R01AG032977] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA FTF)(American Heart Association); Future Leaders in Cardiovascular Medicine; Watkins Cardiovascular Leadership Award; Ellison Medical Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Gannon for surgical assistance; J. Lammerding and P. Isserman for assistance with microscopy and IP Lab software; and C. MacGillivray for histology; and J. C. Poczatek and Z. Kaufman for assistance with OpenMIMS Data Analysis and image data processing. S. E. S. is funded by the National Institutes of Health (NIH; F32 HL108570). M. L. S. is funded by the American Heart Association (AHA FTF), Future Leaders in Cardiovascular Medicine, Watkins Cardiovascular Leadership Award and the NIH (K08 DK090147). C. P. L. is funded by the NIH (EB001974 and AG034641) and the Ellison Medical Foundation (AG-SS-2215-08). R. T. L. is funded by the NIH (AG032977 and AG040019) and the Harvard Stem Cell Institute.	ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Hosoda T, 2011, J THROMB HAEMOST, V9, P151, DOI 10.1111/j.1538-7836.2011.04363.x; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Hu VW, 2002, FASEB J, V16, P1456, DOI 10.1096/fj.02-0142fje; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; KATZBERG AA, 1977, AM J ANAT, V149, P489, DOI 10.1002/aja.1001490406; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; KLEIN PD, 1986, J CLIN PHARMACOL, V26, P378, DOI 10.1002/j.1552-4604.1986.tb03544.x; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	27	860	902	6	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					433	U186		10.1038/nature11682	http://dx.doi.org/10.1038/nature11682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23222518	Green Submitted, Green Accepted			2022-12-01	WOS:000313615900058
J	Ma, MM; Guo, L; Anderson, DG; Langer, R				Ma, Mingming; Guo, Liang; Anderson, Daniel G.; Langer, Robert			Bio-Inspired Polymer Composite Actuator and Generator Driven by Water Gradients	SCIENCE			English	Article							SHAPE-MEMORY POLYMERS; BIOMEDICAL APPLICATIONS; ARTIFICIAL MUSCLES; POLYPYRROLE; LIGHT; SYSTEMS; RANGE; GEL; PH	Here we describe the development of a water-responsive polymer film. Combining both a rigid matrix (polypyrrole) and a dynamic network (polyol-borate), strong and flexible polymer films were developed that can exchange water with the environment to induce film expansion and contraction, resulting in rapid and continuous locomotion. The film actuator can generate contractile stress up to 27 megapascals, lift objects 380 times heavier than itself, and transport cargo 10 times heavier than itself. We have assembled a generator by associating this actuator with a piezoelectric element. Driven by water gradients, this generator outputs alternating electricity at similar to 0.3 hertz, with a peak voltage of similar to 1.0 volt. The electrical energy is stored in capacitors that could power micro-and nanoelectronic devices.	[Ma, Mingming; Guo, Liang; Anderson, Daniel G.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Anderson, Daniel G.; Langer, Robert] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rlanger@mit.edu	Guo, Liang/B-8413-2012; Ma, Mingming/G-1703-2011	Guo, Liang/0000-0003-4738-4366; Ma, Mingming/0000-0002-7967-8927	National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award [HHSN268201000045C]; National Cancer Institute [CA151884]; Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0034]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Armed Forces Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.M. and R.L. conceived the idea and designed the experiments. M. M. and L. G. performed the experiments. M. M., L. G., D. G. A., and R. L. contributed materials and/or tools, analyzed the data, and wrote the paper. This research was supported in part by a National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award, contract no. HHSN268201000045C; National Cancer Institute grant CA151884; and Armed Forces Institute of Regenerative Medicine Award no. W81XWH-08-2-0034. Experimental procedures, additional data for materials characterization, and the device test are presented in the supplementary materials. We thank D. Bong for thoughtful discussion and N. Zhang for help in the preparation of figures.	Baughman RH, 2005, SCIENCE, V308, P63, DOI 10.1126/science.1099010; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177; Caldorera-Moore ME, 2011, ACCOUNTS CHEM RES, V44, P1061, DOI 10.1021/ar2001777; Camacho-Lopez M, 2004, NAT MATER, V3, P307, DOI 10.1038/nmat1118; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Hara S, 2004, POLYM J, V36, P151, DOI 10.1295/polymj.36.151; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Madden JD, 2002, MATER RES SOC SYMP P, V698, P137; Minko S, 2006, RESPONSIVE POLYM MAT; Okuzaki H, 1998, J POLYM SCI POL PHYS, V36, P2237, DOI 10.1002/(SICI)1099-0488(19980915)36:12<2237::AID-POLB20>3.0.CO;2-#; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Park T, 2006, J AM CHEM SOC, V128, P13986, DOI 10.1021/ja064116s; Qin Y, 2008, NATURE, V451, P809, DOI [10.1038/nature06601, 10.1038/nature066O1]; REN XM, 1993, J PHYS CHEM-US, V97, P5356, DOI 10.1021/j100122a029; SHIBAYAMA M, 1988, POLYMER, V29, P336, DOI 10.1016/0032-3861(88)90343-6; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; SZAFRAN M, 1994, J MOL STRUCT, V321, P57, DOI 10.1016/0022-2860(93)08206-J; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; van Oosten CL, 2009, NAT MATER, V8, P677, DOI [10.1038/NMAT2487, 10.1038/nmat2487]; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a	26	602	622	43	1282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					186	189		10.1126/science.1230262	http://dx.doi.org/10.1126/science.1230262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307738	Green Accepted, Green Submitted			2022-12-01	WOS:000313328200039
J	McAleenan, A; Clemente-Blanco, A; Cordon-Preciado, V; Sen, N; Esteras, M; Jarmuz, A; Aragon, L				McAleenan, Alexandra; Clemente-Blanco, Andres; Cordon-Preciado, Violeta; Sen, Nicholas; Esteras, Miguel; Jarmuz, Adam; Aragon, Luis			Post-replicative repair involves separase-dependent removal of the kleisin subunit of cohesin	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; CLEAVAGE; PATHWAY; DAMAGE; EXO1; HELICASE	DNA double-strand break repair is critical for cell viability and involves highly coordinated pathways to restore DNA integrity at the lesion. An early event during homology-dependent repair is resection of the break to generate progressively longer 3' single-strand tails that are used to identify suitable templates for repair(1). Sister chromatids provide near-perfect sequence homology and are therefore the preferred templates during homologous recombination(2,3). To provide a bias for the use of sisters as donors, cohesin-the complex that tethers sister chromatids together(4)-is recruited to the break(5,6) to enforce physical proximity. Here we show that DNA breaks promote dissociation of cohesin loaded during the previous S phase in budding yeast, and that damage-induced dissociation of cohesin requires separase, the protease that dissolves cohesion in anaphase(7). Moreover, a separase-resistant allele of the gene coding for the alpha-kleisin subunit of cohesin, Mcd1 (also known as Scc1), reduces double-strand break resection and compromises the efficiency of repair even when loaded during DNA damage. We conclude that post-replicative DNA repair involves cohesin dissociation by separase to promote accessibility to repair factors during the coordinated cellular response to restore DNA integrity.	[McAleenan, Alexandra; Clemente-Blanco, Andres; Cordon-Preciado, Violeta; Sen, Nicholas; Esteras, Miguel; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England	Imperial College London	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Blanco, Andrés Clemente/D-4255-2014	Blanco, Andrés Clemente/0000-0002-3674-0671; Esteras Bejar, Miguel/0000-0001-6697-3890	Intramural Research Program of the Medical Research Council UK; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: researchfish	Intramural Research Program of the Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank D. Koshland, E. Unal, J. Haber, G. Ira and K. Nasmyth for providing valuable strains. We thank members of the Aragon laboratory, P. Ullal, S. Farmer, K. Pegram, J. Torres-Rosell and M. Merkenschlager for discussions and reading of the manuscript. This work was funded by the Intramural Research Program of the Medical Research Council UK.	Baskerville C, 2008, GENETICS, V178, P2361, DOI 10.1534/genetics.107.085308; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	19	37	37	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					250	U270		10.1038/nature11630	http://dx.doi.org/10.1038/nature11630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23178808				2022-12-01	WOS:000313259600045
J	Lauschke, VM; Tsiairis, CD; Francois, P; Aulehla, A				Lauschke, Volker M.; Tsiairis, Charisios D.; Francois, Paul; Aulehla, Alexander			Scaling of embryonic patterning based on phase-gradient encoding	NATURE			English	Article							SOMITE SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; MORPHOGEN GRADIENTS; MOUSE EMBRYO; SOMITOGENESIS; DYNAMICS; OSCILLATION; INITIATION; SYSTEMS; NUMBER	A fundamental feature of embryonic patterning is the ability to scale and maintain stable proportions despite changes in overall size, for instance during growth(1-6). A notable example occurs during vertebrate segment formation: after experimental reduction of embryo size, segments form proportionally smaller, and consequently, a normal number of segments is formed(1,7,8). Despite decades of experimental(1,7) and theoretical work(9-11), the underlying mechanism remains unknown. More recently, ultradian oscillations in gene activity have been linked to the temporal control of segmentation(12); however, their implication in scaling remains elusive. Here we show that scaling of gene oscillation dynamics underlies segment scaling. To this end, we develop a new experimental model, an ex vivo primary cell culture assay that recapitulates mouse mesoderm patterning and segment scaling, in a quasi-monolayer of presomitic mesoderm cells (hereafter termed monolayer PSM or mPSM). Combined with real-time imaging of gene activity, this enabled us to quantify the gradual shift in the oscillation phase and thus determine the resulting phase gradient across the mPSM. Crucially, we show that this phase gradient scales by maintaining a fixed amplitude across mPSM of different lengths. We identify the slope of this phase gradient as a single predictive parameter for segment size, which functions in a size-and temperature-independent manner, revealing a hitherto unrecognized mechanism for scaling. Notably, in contrast to molecular gradients, a phase gradient describes the distribution of a dynamical cellular state. Thus, our phase-gradient scaling findings reveal a new level of dynamic information-processing, and provide evidence for the concept of phase-gradient encoding during embryonic patterning and scaling.	[Lauschke, Volker M.; Tsiairis, Charisios D.; Aulehla, Alexander] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Francois, Paul] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	European Molecular Biology Laboratory (EMBL); McGill University	Aulehla, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	aulehla@embl.de	Francois, Paul/G-5673-2010; Tsiairis, Charisios/A-9145-2018; Lauschke, Volker/O-3014-2017	Francois, Paul/0000-0002-2223-839X; Lauschke, Volker/0000-0002-1140-6204; Tsiairis, Charisios/0000-0002-9788-9875; Aulehla, Alexander/0000-0003-3487-9239	Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN 401950-11]; Regroupement Quebecois pour les materiaux de pointe (RQMP); McGill University	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regroupement Quebecois pour les materiaux de pointe (RQMP); McGill University	We thank members of the Aulehla laboratory for discussion and comments on the manuscript. We thank M. Snaebjornsson for providing Supplementary Video 1. We thank F. Peri, D. Gilmour, T. Hiiragi and F. Spitz for comments on the manuscript and P. Riedinger for artwork. This work was supported by EMBL Imaging and Laboratory animal resource core facilities. The Mesp2-GFP line was provided by Y. Saga. P. F. was supported by Natural Science and Engineering Research Council of Canada (NSERC), Discovery Grant program RGPIN 401950-11, Regroupement Quebecois pour les materiaux de pointe (RQMP) and McGill University.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; COOKE J, 1975, NATURE, V254, P196, DOI 10.1038/254196a0; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GOODWIN BC, 1969, J THEOR BIOL, V25, P49, DOI 10.1016/S0022-5193(69)80017-2; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KOPELL N, 1973, SCIENCE, V180, P1171, DOI 10.1126/science.180.4091.1171; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; McHale P, 2006, PHYS BIOL, V3, P107, DOI 10.1088/1478-3975/3/2/003; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; Meinhardt H., 1982, MODELS BIOL PATTERN; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morimoto M, 2006, DEV BIOL, V300, P687, DOI 10.1016/j.ydbio.2006.08.043; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Restrepo S, 2011, CURR BIOL, V21, pR815, DOI 10.1016/j.cub.2011.08.041; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Roeling D, 2011, CELL, V145, P800, DOI 10.1016/j.cell.2011.05.007; ROSS J, 1988, SCIENCE, V240, P460, DOI 10.1126/science.240.4851.460; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	34	118	118	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					101	+		10.1038/nature11804	http://dx.doi.org/10.1038/nature11804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254931				2022-12-01	WOS:000312933800039
J	Pan, LP; Blanck, HM; Sherry, B; Dalenius, K; Grummer-Strawn, LM				Pan, Liping; Blanck, Heidi M.; Sherry, Bettylou; Dalenius, Karen; Grummer-Strawn, Laurence M.			Trends in the Prevalence of Extreme Obesity Among US Preschool-Aged Children Living in Low-Income Families, 1998-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RISK-FACTORS; CHILDHOOD		[Pan, Liping; Blanck, Heidi M.; Sherry, Bettylou; Dalenius, Karen; Grummer-Strawn, Laurence M.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Pan, LP (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30329 USA.	lpan@cdc.gov		Pan, Liping/0000-0003-0926-8719	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Polhamus B., PEDIAT NUTR SURVEILL; Sen Y, 2008, EUR J PEDIATR, V167, P1183, DOI 10.1007/s00431-007-0658-x; Sharma A. J., 2009, Morbidity and Mortality Weekly Report, V58, P769; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	6	107	108	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2563	2565		10.1001/jama.2012.108099	http://dx.doi.org/10.1001/jama.2012.108099			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268509	Green Accepted, Bronze			2022-12-01	WOS:000312916600014
J	Zong, CH; Lu, SJ; Chapman, AR; Xie, XS				Zong, Chenghang; Lu, Sijia; Chapman, Alec R.; Xie, X. Sunney			Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell	SCIENCE			English	Article							GENETIC-ANALYSIS; MUTATION-RATES; HUMAN CANCERS; TUMOR-CELLS; AMPLIFICATION; DNA; EVOLUTION; POLYMERASE; PRIMER; PCR	Kindred cells can have different genomes because of dynamic changes in DNA. Single-cell sequencing is needed to characterize these genomic differences but has been hindered by whole-genome amplification bias, resulting in low genome coverage. Here, we report on a new amplification method-multiple annealing and looping-based amplification cycles (MALBAC)-that offers high uniformity across the genome. Sequencing MALBAC-amplified DNA achieves 93% genome coverage >= 1x for a single human cell at 25x mean sequencing depth. We detected digitized copy-number variations (CNVs) of a single cancer cell. By sequencing three kindred cells, we were able to identify individual single-nucleotide variations (SNVs), with no false positives detected. We directly measured the genome-wide mutation rate of a cancer cell line and found that purine-pyrimidine exchanges occurred unusually frequently among the newly acquired SNVs.	[Zong, Chenghang; Lu, Sijia; Chapman, Alec R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Zong, Chenghang/F-3243-2013	Zong, Chenghang/0000-0002-8337-8038	U.S. National Institutes of Health National Human Genome Research Institute [HG005097-1, HG005613-01]; Bill & Melinda Gates Foundation [OPP42867]; NIH [NIH/NIGMS T32 GM008313]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005613, R01HG005097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health National Human Genome Research Institute grants (HG005097-1 and HG005613-01) and in part by Bill & Melinda Gates Foundation OPP42867 to X.S.X. A.R.C. was supported by an NIH Molecular Biophysics Training grant (NIH/NIGMS T32 GM008313). We thank P. Choi for his involvement in the early stage of the project and J. Lu and L. Song for their assistance on the experiments. We thank J. Yong for his help on single-cell expansion and isolation and Y. Zhang at Biodynamic and Optical Imaging Center (BIOPIC) at Peking University for assistance on sequencing. The sequencing data are deposited at the National Center for Biotechnology Information with accession no. SRA060929. C.Z., S.L., and X.S.X. are authors on a patent applied for by Harvard University that covers the MALBAC technology.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Drake JW, 1998, GENETICS, V148, P1667; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949; Hanson EK, 2005, ANAL BIOCHEM, V346, P246, DOI 10.1016/j.ab.2005.08.017; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lao Kaiqin, 2008, Biotechnol J, V3, P378, DOI 10.1002/biot.200700253; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; MacArthur D, 2012, NATURE, V487, P427, DOI 10.1038/487427a; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	31	706	874	12	441	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1622	1626		10.1126/science.1229164	http://dx.doi.org/10.1126/science.1229164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258894	Green Accepted, Green Submitted			2022-12-01	WOS:000312533100054
J	van der Harst, P; Zhang, WH; Leach, IM; Rendon, A; Verweij, N; Sehmi, J; Paul, DS; Elling, U; Allayee, H; Li, XZ; Radhakrishnan, A; Tan, ST; Voss, K; Weichenberger, CX; Albers, CA; Al-Hussani, A; Asselbergs, FW; Ciullo, M; Danjou, F; Dina, C; Esko, T; Evans, DM; Franke, L; Goegele, M; Hartiala, J; Hersch, M; Holm, H; Hottenga, JJ; Kanoni, S; Kleber, ME; Lagou, V; Langenberg, C; Lopez, LM; Lyytikainen, LP; Melander, O; Murgia, F; Nolte, IM; O'Reilly, PF; Padmanabhan, S; Parsa, A; Pirastu, N; Porcu, E; Portas, L; Prokopenko, I; Ried, JS; Shin, SY; Tang, CS; Teumer, A; Traglia, M; Ulivi, S; Westra, HJ; Yang, J; Zhao, JH; Anni, F; Abdellaoui, A; Attwood, A; Balkau, B; Bandinelli, S; Bastardot, F; Benyamin, B; Boehm, BO; Cookson, WO; Das, D; de Bakker, PIW; de Boer, RA; de Geus, EJC; de Moor, MH; Dimitriou, M; Domingues, FS; Doring, A; Engstrom, G; Eyjolfsson, GI; Ferrucci, L; Fischer, K; Galanello, R; Garner, SF; Genser, B; Gibson, QD; Girotto, G; Gudbjartsson, DF; Harris, SE; Hartikainen, AL; Hastie, CE; Hedblad, B; Illig, T; Jolley, J; Kahonen, M; Kema, IP; Kemp, JP; Liang, LM; Lloyd-Jones, H; Loos, RJF; Meacham, S; Medland, SE; Meisinger, C; Memari, Y; Mihailov, E; Miller, K; Moffatt, MF; Nauck, M; Novatchkova, M; Nutile, T; Olafsson, I; Onundarson, PT; Parracciani, D; Penninx, BW; Perseu, L; Piga, A; Pistis, G; Pouta, A; Puc, U; Raitakari, O; Ring, SM; Robino, A; Ruggiero, D; Ruokonen, A; Saint-Pierre, A; Sala, C; Salumets, A; Sambrook, J; Schepers, H; Schmidt, CO; Sillje, HHW; Sladek, R; Smit, JH; Starr, JM; Stephens, J; Sulem, P; Tanaka, T; Thorsteinsdottir, U; Tragante, V; van Gilst, WH; van Pelt, LJ; van Veldhuisen, DJ; Volker, U; Whitfield, JB; Willemsen, G; Winkelmann, BR; Wirnsberger, G; Algra, A; Cucca, F; d'Adamo, AP; Danesh, J; Deary, IJ; Dominiczak, AF; Elliott, P; Fortina, P; Froguel, P; Gasparini, P; Greinacher, A; Hazen, SL; Jarvelin, MR; Khaw, KT; Lehtimaki, T; Maerz, W; Martin, NG; Metspalu, A; Mitchell, BD; Montgomery, GW; Moore, C; Navis, G; Pirastu, M; Pramstaller, PP; Ramirez-Solis, R; Schadt, E; Scott, J; Shuldiner, AR; Smith, GD; Smith, JG; Snieder, H; Sorice, R; Spector, TD; Stefansson, K; Stumvoll, M; Tang, WHW; Toniolo, D; Tonjes, A; Visscher, PM; Vollenweider, P; Wareham, NJ; Wolffenbuttel, BHR; Boomsma, DI; Beckmann, JS; Dedoussis, GV; Deloukas, P; Ferreira, MA; Sanna, S; Uda, M; Hicks, AA; Penninger, JM; Gieger, C; Kooner, JS; Ouwehand, WH; Soranzo, N; Chambers, JC				van der Harst, Pim; Zhang, Weihua; Leach, Irene Mateo; Rendon, Augusto; Verweij, Niek; Sehmi, Joban; Paul, Dirk S.; Elling, Ulrich; Allayee, Hooman; Li, Xinzhong; Radhakrishnan, Aparna; Tan, Sian-Tsung; Voss, Katrin; Weichenberger, Christian X.; Albers, Cornelis A.; Al-Hussani, Abtehale; Asselbergs, Folkert W.; Ciullo, Marina; Danjou, Fabrice; Dina, Christian; Esko, Tonu; Evans, David M.; Franke, Lude; Goegele, Martin; Hartiala, Jaana; Hersch, Micha; Holm, Hilma; Hottenga, Jouke-Jan; Kanoni, Stavroula; Kleber, Marcus E.; Lagou, Vasiliki; Langenberg, Claudia; Lopez, Lorna M.; Lyytikainen, Leo-Pekka; Melander, Olle; Murgia, Federico; Nolte, Ilja M.; O'Reilly, Paul F.; Padmanabhan, Sandosh; Parsa, Afshin; Pirastu, Nicola; Porcu, Eleonora; Portas, Laura; Prokopenko, Inga; Ried, Janina S.; Shin, So-Youn; Tang, Clara S.; Teumer, Alexander; Traglia, Michela; Ulivi, Sheila; Westra, Harm-Jan; Yang, Jian; Zhao, Jing Hua; Anni, Franco; Abdellaoui, Abdel; Attwood, Antony; Balkau, Beverley; Bandinelli, Stefania; Bastardot, Francois; Benyamin, Beben; Boehm, Bernhard O.; Cookson, William O.; Das, Debashish; de Bakker, Paul I. W.; de Boer, Rudolf A.; de Geus, Eco J. C.; de Moor, Marleen H.; Dimitriou, Maria; Domingues, Francisco S.; Doering, Angela; Engstrom, Gunnar; Eyjolfsson, Gudmundur Ingi; Ferrucci, Luigi; Fischer, Krista; Galanello, Renzo; Garner, Stephen F.; Genser, Bernd; Gibson, Quince D.; Girotto, Giorgia; Gudbjartsson, Daniel Fannar; Harris, Sarah E.; Hartikainen, Anna-Liisa; Hastie, Claire E.; Hedblad, Bo; Illig, Thomas; Jolley, Jennifer; Kahonen, Mika; Kema, Ido P.; Kemp, John P.; Liang, Liming; Lloyd-Jones, Heather; Loos, Ruth J. F.; Meacham, Stuart; Medland, Sarah E.; Meisinger, Christa; Memari, Yasin; Mihailov, Evelin; Miller, Kathy; Moffatt, Miriam F.; Nauck, Matthias; Novatchkova, Maria; Nutile, Teresa; Olafsson, Isleifur; Onundarson, Pall T.; Parracciani, Debora; Penninx, Brenda W.; Perseu, Lucia; Piga, Antonio; Pistis, Giorgio; Pouta, Anneli; Puc, Ursula; Raitakari, Olli; Ring, Susan M.; Robino, Antonietta; Ruggiero, Daniela; Ruokonen, Aimo; Saint-Pierre, Aude; Sala, Cinzia; Salumets, Andres; Sambrook, Jennifer; Schepers, Hein; Schmidt, Carsten Oliver; Sillje, Herman H. W.; Sladek, Rob; Smit, Johannes H.; Starr, John M.; Stephens, Jonathan; Sulem, Patrick; Tanaka, Toshiko; Thorsteinsdottir, Unnur; Tragante, Vinicius; van Gilst, Wiek H.; van Pelt, L. Joost; van Veldhuisen, Dirk J.; Voelker, Uwe; Whitfield, John B.; Willemsen, Gonneke; Winkelmann, Bernhard R.; Wirnsberger, Gerald; Algra, Ale; Cucca, Francesco; d'Adamo, Adamo Pio; Danesh, John; Deary, Ian J.; Dominiczak, Anna F.; Elliott, Paul; Fortina, Paolo; Froguel, Philippe; Gasparini, Paolo; Greinacher, Andreas; Hazen, Stanley L.; Jarvelin, Marjo-Riitta; Khaw, Kay Tee; Lehtimaki, Terho; Maerz, Winfried; Martin, Nicholas G.; Metspalu, Andres; Mitchell, Braxton D.; Montgomery, Grant W.; Moore, Carmel; Navis, Gerjan; Pirastu, Mario; Pramstaller, Peter P.; Ramirez-Solis, Ramiro; Schadt, Eric; Scott, James; Shuldiner, Alan R.; Smith, George Davey; Smith, J. Gustav; Snieder, Harold; Sorice, Rossella; Spector, Tim D.; Stefansson, Kari; Stumvoll, Michael; Tang, W. H. Wilson; Toniolo, Daniela; Toenjes, Anke; Visscher, Peter M.; Vollenweider, Peter; Wareham, Nicholas J.; Wolffenbuttel, Bruce H. R.; Boomsma, Dorret I.; Beckmann, Jacques S.; Dedoussis, George V.; Deloukas, Panos; Ferreira, Manuel A.; Sanna, Serena; Uda, Manuela; Hicks, Andrew A.; Penninger, Josef Martin; Gieger, Christian; Kooner, Jaspal S.; Ouwehand, Willem H.; Soranzo, Nicole; Chambers, John C.			Seventy-five genetic loci influencing the human red blood cell	NATURE			English	Article							GENOME-WIDE ASSOCIATION; HEMOGLOBIN LEVELS; VARIANTS; EXPRESSION; PROTEIN; COHORT; DOMAIN; LEVEL; MOUSE; STEM	Anaemia is a chief determinant of global ill health, contributing to cognitive impairment, growth retardation and impaired physical capacity. To understand further the genetic factors influencing red blood cells, we carried out a genome-wide association study of haemoglobin concentration and related parameters in up to 135,367 individuals. Here we identify 75 independent genetic loci associated with one or more red blood cell phenotypes at P < 10(-8), which together explain 4-9% of the phenotypic variance per trait. Using expression quantitative trait loci and bioinformatic strategies, we identify 121 candidate genes enriched in functions relevant to red blood cell biology. The candidate genes are expressed preferentially in red blood cell precursors, and 43 have haematopoietic phenotypes in Mus musculus or Drosophila melanogaster. Through open-chromatin and coding-variant analyses we identify potential causal genetic variants at 41 loci. Our findings provide extensive new insights into genetic mechanisms and biological pathways controlling red blood cell formation and function.	[Zhang, Weihua; Al-Hussani, Abtehale; O'Reilly, Paul F.; Elliott, Paul; Jarvelin, Marjo-Riitta; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [van der Harst, Pim; Leach, Irene Mateo; Verweij, Niek; de Boer, Rudolf A.; Sillje, Herman H. W.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [van der Harst, Pim; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Zhang, Weihua; Sehmi, Joban; Tan, Sian-Tsung; Miller, Kathy; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp NHS Trust, Uxbridge UB1 3HW, Middx, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Albers, Cornelis A.; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Albers, Cornelis A.; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Rendon, Augusto] Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 2SR, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Sehmi, Joban; Tan, Sian-Tsung; Cookson, William O.; Moffatt, Miriam F.; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Paul, Dirk S.; Radhakrishnan, Aparna; Albers, Cornelis A.; Kanoni, Stavroula; Shin, So-Youn; Attwood, Antony; Meacham, Stuart; Memari, Yasin; Ramirez-Solis, Ramiro; Deloukas, Panos; Ouwehand, Willem H.; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Elling, Ulrich; Novatchkova, Maria; Puc, Ursula; Wirnsberger, Gerald; Penninger, Josef Martin] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Allayee, Hooman; Hartiala, Jaana] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Li, Xinzhong] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London W12 0NN, England; [Li, Xinzhong; Chambers, John C.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Li, Xinzhong; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, London SW3 6NP, England; [Weichenberger, Christian X.; Goegele, Martin; Domingues, Francisco S.; Saint-Pierre, Aude; Pramstaller, Peter P.; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Asselbergs, Folkert W.; Tragante, Vinicius] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3508 Utrecht, Netherlands; [Asselbergs, Folkert W.; de Bakker, Paul I. W.; Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 Utrecht, Netherlands; [Asselbergs, Folkert W.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 Utrecht, Netherlands; [Ciullo, Marina; Mihailov, Evelin; Nutile, Teresa; Ruggiero, Daniela; Sorice, Rossella] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Danjou, Fabrice; Anni, Franco; Galanello, Renzo] Univ Cagliari, Osped Reg Microcitemie ASL8, Dipartimento Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Dina, Christian] INSERM, UMR 1087, F-44007 Nantes 1, France; [Dina, Christian] CNRS, UMR 6291, F-44007 Nantes 1, France; [Dina, Christian] Univ Nantes, Sch Med, F-44000 Nantes, France; [Esko, Tonu; Fischer, Krista; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Evans, David M.; Kemp, John P.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Hersch, Micha; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Hersch, Micha] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Holm, Hilma; Gudbjartsson, Daniel Fannar; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Hottenga, Jouke-Jan; Abdellaoui, Abdel; de Geus, Eco J. C.; de Moor, Marleen H.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Kleber, Marcus E.; Genser, Bernd; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, D-68167 Mannheim, Germany; [Kleber, Marcus E.] LURIC Study Nonprofit LLC, D-79098 Freiburg, Germany; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Langenberg, Claudia; Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Lopez, Lorna M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lopez, Lorna M.; Harris, Sarah E.; Starr, John M.; Deary, Ian J.; Visscher, Peter M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Tampere Univ Hosp, Fimlab Labs, Dept Clin Chem, FIN-33521 Tampere, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33521 Tampere, Finland; [Melander, Olle; Engstrom, Gunnar; Hedblad, Bo; Smith, J. Gustav] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Murgia, Federico; Portas, Laura; Pirastu, Mario] Natl Res Council Italy, Inst Populat Genet, I-07100 Sassari, Italy; [Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Padmanabhan, Sandosh; Hastie, Claire E.; Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Parsa, Afshin; Gibson, Quince D.; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pirastu, Nicola; Girotto, Giorgia; Robino, Antonietta; d'Adamo, Adamo Pio; Gasparini, Paolo] Univ Trieste, IRCCS Burlo Garofolo Trieste, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Porcu, Eleonora; Perseu, Lucia; Cucca, Francesco; Sanna, Serena; Uda, Manuela] Cittadella Univ Monserrato, CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Ried, Janina S.; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Tang, Clara S.; Benyamin, Beben; Medland, Sarah E.; Whitfield, John B.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.; Ferreira, Manuel A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Teumer, Alexander; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Traglia, Michela; Pistis, Giorgio; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Balkau, Beverley] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, F-94807 Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50125 Florence, Italy; [Bastardot, Francois; Vollenweider, Peter] Univ Lausanne, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Benyamin, Beben; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Boehm, Bernhard O.] Univ Hosp, Dept Med, Div Endocrinol & Diabet, D-89075 Ulm, Germany; [Das, Debashish] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Dimitriou, Maria; Dedoussis, George V.] Harokopio Univ, Athens 17671, Greece; [Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Doering, Angela; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Eyjolfsson, Gudmundur Ingi] Lab Mjodd, IS-108 Reykjavik, Iceland; [Ferrucci, Luigi; Tanaka, Toshiko] NIA, Clin Res Branch, Baltimore, MD 21250 USA; [Gibson, Quince D.] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Sci Obstet & Gynecol, FIN-90220 Oulu, Finland; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, FIN-33521 Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33521 Tampere, Finland; [Kema, Ido P.; van Pelt, L. Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Dept Epidemiol, Boston, MA 02115 USA; [Memari, Yasin] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.] Landspitali Univ Hosp, Hematol Lab, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.] Landspitali Univ Hosp, Coagulat Disorder Ctr, IS-101 Reykjavik, Iceland; [Parracciani, Debora] Genet Pk Ogliastra, Perdasdefogu, Sardinia, Italy; [Penninx, Brenda W.; Smit, Johannes H.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2333 Leiden, Netherlands; [Piga, Antonio] Univ Turin, Dept Clin & Biol Sci, Div Pediat, I-10043 Turin, Italy; [Piga, Antonio] Univ Turin, Dept Clin & Biol Sci, Thalassemia Ctr, I-10043 Turin, Italy; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FIN-90220 Oulu, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, FIN-90101 Oulu, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20521 Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20521 Turku, Finland; [Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, FIN-90014 Oulu, Finland; [Salumets, Andres] Competence Ctr Reprod Med & Biol, EE-50410 Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Gen & Mol Pathol, EE-51014 Tartu, Estonia; [Schepers, Hein] Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, NL-9700 RB Groningen, Netherlands; [Schepers, Hein] Univ Groningen, Univ Med Ctr Groningen, Dept Stem Cell Biol, NL-9700 RB Groningen, Netherlands; [Schmidt, Carsten Oliver] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Sladek, Rob] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Sladek, Rob] McGill Univ, Fac Med, Dept Med, Montreal, PQ H3A 1B1, Canada; [Starr, John M.] Univ Edinburgh, Western Gen Hosp, Geriatr Med Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Winkelmann, Bernhard R.] ClinPhen Study Ctr, D-60594 Frankfurt, Germany; [Algra, Ale] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, NL-3584 CG Utrecht, Netherlands; [Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Danesh, John; Moore, Carmel] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Fortina, Paolo] Thomas Jefferson Univ, Coll Med, Dept Canc Biol, Philadelphia, PA 19107 USA; [Fortina, Paolo] Univ Roma La Sapienza, Dipartimento Med Mol, I-00161 Rome, Italy; [Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, F-59100 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London W2 1PG, England; [Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17487 Greifswald, Germany; [Hazen, Stanley L.; Tang, W. H. Wilson] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse snd Serv, FIN-90101 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, FIN-90220 Oulu, Finland; [Khaw, Kay Tee] Addenbrookes Hosp, Clin Gerontol Unit, Cambridge CB2 2QQ, England; [Maerz, Winfried] Synlab Acad, D-68165 Mannheim, Germany; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Schadt, Eric] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21201 USA; [Smith, J. Gustav] Lund Univ, Dept Cardiol, S-22185 Lund, Sweden; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, IFB Adipos Dis, D-04103 Leipzig, Germany; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England	Imperial College London; University of Groningen; University of Groningen; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; Imperial College London; Wellcome Trust Sanger Institute; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Southern California; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; European Academy of Bozen-Bolzano; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Cagliari; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; University of Tartu; University of Tartu; University of Bristol; University of Lausanne; Swiss Institute of Bioinformatics; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; University of Edinburgh; Tampere University; Tampere University Hospital; Tampere University; Lund University; Consiglio Nazionale delle Ricerche (CNR); University of Groningen; University of Glasgow; University System of Maryland; University of Maryland Baltimore; IRCCS Burlo Garofolo; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; QIMR Berghofer Medical Research Institute; Greifswald Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Azienda Sanitaria di Firenze; University of Lausanne; University of Queensland; Ulm University; University of London; University College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harokopio University Athens; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade Federal da Bahia; University of Edinburgh; University of Oulu; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Tampere University; Tampere University Hospital; Tampere University; University of Groningen; Harvard University; Harvard T.H. Chan School of Public Health; University of London; King's College London; Greifswald Medical School; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turin; University of Turin; University of Oulu; Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Bristol; University of Oulu; University of Tartu; University of Groningen; University of Groningen; Greifswald Medical School; McGill University; McGill University; University of Edinburgh; Utrecht University; Utrecht University Medical Center; University of Sassari; University of Cambridge; Imperial College London; Jefferson University; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Greifswald Medical School; Cleveland Clinic Foundation; Finland National Institute for Health & Welfare; University of Oulu; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; SYNLAB Group; University of Groningen; Krankenhaus Bozen; University of Lubeck; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lund University; University of London; King's College London; Leipzig University; Leipzig University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Groningen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England.	p.van.der.harst@umcg.nl; christian.gieger@helmholtz-muenchen.de; j.kooner@ic.ac.uk; who1000@cam.ac.uk; ns6@sanger.ac.uk; john.chambers@ic.ac.uk	Pirastu, Nicola/G-4358-2011; de Boer, Rudolf/ABE-9879-2020; Fortina, Paolo/ABE-8350-2020; de Bakker, Paul IW/B-8730-2009; Bastardot, François/P-7809-2019; Uda, Manuela/AAC-2645-2019; Medland, Sarah/AAT-7595-2020; Albers, Kees/A-4170-2015; Yang, Jian/A-5852-2010; Stumvoll, Michael/ABE-1121-2021; Verweij, Niek/ABC-6249-2021; Langenberg, Claudia/ABG-9067-2021; Lehtimäki, Terho/AAD-1094-2022; sanna, serena/H-3009-2019; Dedoussis, George/AAN-7252-2021; Verweij, Niek/A-4499-2017; Prokopenko, Inga/H-3241-2014; Schmidt, Carsten Oliver/AAH-2778-2019; Hicks, Andrew Anthony/E-9518-2017; Austin, Eric Douglas/A-6070-2013; Ciullo, Marina/AAE-3041-2020; Penninger, Josef M/I-6860-2013; Evans, David M/H-6325-2013; zhang, weihua/GXV-1334-2022; Boomsma, Dorret I/AAX-4470-2020; Pirastu, Nicola/AHB-6226-2022; Montgomery, Grant W/B-7148-2008; Ulivi, Sheila/H-3700-2013; Kanoni, Stavroula/AAN-7161-2021; Medland, Sarah E/C-7630-2013; Prokopenko, Inga/AAU-9895-2020; Pramstaller, Peter P/C-2357-2008; van Veldhuisen, Dirk Jan/E-8967-2014; d'Adamo, Adamo Pio/G-4064-2011; Deary, Ian J/C-6297-2009; FROGUEL, Philippe/O-6799-2017; Deloukas, Panos/B-2922-2013; Boehm, Bernhard Otto/F-8750-2015; Khaw, Kay-Tee/AAZ-3209-2021; Lopez, Lorna/AAR-4912-2020; Mitchell, Braxton/CAF-0876-2022; Stefansson, Kari/AAE-7187-2019; Franke, Lude/P-7036-2016; bandinelli, stefania/AAL-4570-2020; Tang, Wai Hong Wilson/I-1238-2013; Asselbergs, Folkert W./ABD-6752-2021; Hartiala, Jaana A/GLR-1825-2022; Toniolo, Daniela/AAE-2969-2019; Loos, Ruth J F/Q-2862-2016; Ferreira, Manuel A R/D-3609-2013; Colaus, PsyColaus/K-6607-2013; ruggiero, daniela/K-5638-2016; de Geus, Eco J.C./M-9318-2015; Raitakari, Olli/AAQ-7389-2021; Paul, Dirk S./H-3469-2019; Salumets, Andres/J-2278-2015; Hazen, Stanley L/ABD-5845-2021; Gasparini, Paolo/B-6173-2014; Sala, Cinzia Felicita/AAN-1900-2020; Kemp, John P./R-3091-2018; Sladek, Robert/R-2391-2019; Davey Smith, George/A-7407-2013; Teumer, Alexander/S-7438-2019; Padmanabhan, Sandosh/S-3963-2016; Dominiczak, Anna F/P-9390-2017; Wolffenbuttel, Bruce/A-8419-2011; van Gilst, Wiek/R-1806-2019; Lyytikäinen, Leo-Pekka/C-8544-2016; Traglia, Michela/AAX-5816-2020; Beckmann, Jacques Simon/A-9772-2008; Penninx, Brenda WJH/S-7627-2017; Martin, Nicholas/R-9235-2019; Loos, Ruth/GON-5877-2022; Benyamin, Beben/D-9195-2012; Danjou, Fabrice/D-1563-2014; Dina, Christian R/D-3535-2015; Meisinger, Christine/B-5358-2014; Bastardot, Francois/J-4013-2017; Visscher, Peter/ABB-6151-2020; de Moor, Marleen/J-7434-2019; Onundarson, Pall T./AAJ-1037-2020; Lagou, Vasiliki/N-8451-2013; Girotto, Giorgia/I-9452-2018; Robino, Antonietta/K-9398-2016	de Bakker, Paul IW/0000-0001-7735-7858; Bastardot, François/0000-0003-4060-0353; Uda, Manuela/0000-0002-4890-6456; Medland, Sarah/0000-0003-1382-380X; Albers, Kees/0000-0003-4115-3727; Yang, Jian/0000-0003-2001-2474; Stumvoll, Michael/0000-0001-6225-8240; Verweij, Niek/0000-0002-4303-7685; Langenberg, Claudia/0000-0002-5017-7344; Lehtimäki, Terho/0000-0002-2555-4427; sanna, serena/0000-0002-3768-1749; Dedoussis, George/0000-0002-7798-6221; Prokopenko, Inga/0000-0003-1624-7457; Schmidt, Carsten Oliver/0000-0001-5266-9396; Hicks, Andrew Anthony/0000-0001-6320-0411; Austin, Eric Douglas/0000-0002-1709-9022; Ciullo, Marina/0000-0002-9621-9984; Penninger, Josef M/0000-0002-8194-3777; Evans, David M/0000-0003-0663-4621; Montgomery, Grant W/0000-0002-4140-8139; Ulivi, Sheila/0000-0003-3606-835X; Kanoni, Stavroula/0000-0002-1691-9615; Medland, Sarah E/0000-0003-1382-380X; d'Adamo, Adamo Pio/0000-0001-9367-4909; Deary, Ian J/0000-0002-1733-263X; FROGUEL, Philippe/0000-0003-2972-0784; Deloukas, Panos/0000-0001-9251-070X; Lopez, Lorna/0000-0002-0241-9783; Franke, Lude/0000-0002-5159-8802; Asselbergs, Folkert W./0000-0002-1692-8669; Hartiala, Jaana A/0000-0003-4883-9318; Toniolo, Daniela/0000-0001-9545-6032; Loos, Ruth J F/0000-0002-8532-5087; Ferreira, Manuel A R/0000-0001-9059-1825; ruggiero, daniela/0000-0003-3898-7827; de Geus, Eco J.C./0000-0001-6022-2666; Paul, Dirk S./0000-0002-8230-0116; Salumets, Andres/0000-0002-1251-8160; Kemp, John P./0000-0002-9105-2249; Sladek, Robert/0000-0002-2730-1204; Davey Smith, George/0000-0002-1407-8314; Teumer, Alexander/0000-0002-8309-094X; Dominiczak, Anna F/0000-0003-4913-3608; Wolffenbuttel, Bruce/0000-0001-9262-6921; van Gilst, Wiek/0000-0003-2968-8585; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Beckmann, Jacques Simon/0000-0002-9741-1900; Penninx, Brenda WJH/0000-0001-7779-9672; Martin, Nicholas/0000-0003-4069-8020; Benyamin, Beben/0000-0001-5608-2293; Danjou, Fabrice/0000-0002-4976-2327; Dina, Christian R/0000-0002-7722-7348; Bastardot, Francois/0000-0003-4060-0353; Visscher, Peter/0000-0002-2143-8760; de Moor, Marleen/0000-0001-7177-5637; Meacham, Stuart/0000-0002-3667-6059; Murgia, Federico/0000-0002-3608-845X; Soranzo, Nicole/0000-0003-1095-3852; Melander, Olle/0000-0002-2581-484X; Kahonen, Mika/0000-0002-4510-7341; Pramstaller, Peter P/0000-0002-9831-8302; Gudbjartsson, Daniel/0000-0002-5222-9857; Willemsen, Gonneke/0000-0003-3755-0236; Esko, Tonu/0000-0003-1982-6569; s, hema/0000-0002-3440-9475; Fortina, Paolo/0000-0002-5898-2081; Rendon, Augusto/0000-0001-8994-0039; Tang, Clara/0000-0003-0265-2638; Padmanabhan, Sandosh/0000-0003-3869-5808; CUCCA, Francesco/0000-0002-7414-1995; Gasparini, Paolo/0000-0002-0859-0856; Pirastu, Nicola/0000-0002-5363-3886; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Stephens, Jonathan/0000-0003-2020-9330; Shuldiner, Alan/0000-0001-9921-4305; van Pelt, Joost/0000-0001-5538-1806; Portas, Laura/0000-0003-1789-1893; Gogele, Martin/0000-0003-4785-4348; Volker, Uwe/0000-0002-5689-3448; Domingues, Francisco/0000-0003-4567-4562; Lagou, Vasiliki/0000-0003-3165-8940; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Girotto, Giorgia/0000-0003-4507-6589; Ouwehand, Willem/0000-0002-7744-1790; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Schepers, Hein/0000-0002-7731-3318; Memari, Yasin/0000-0002-1747-542X; Meisinger, Christa/0000-0002-9026-6544; O'Reilly, Paul/0000-0001-7515-0845; Genser, Bernd/0000-0001-5787-0902; Kleber, Marcus/0000-0003-0663-7275; Tang, W. H. Wilson/0000-0002-8335-735X; Gieger, Christian/0000-0001-6986-9554; Engstrom, Gunnar/0000-0002-8618-9152; Radhakrishnan, Aparna/0000-0002-8153-9037; Weichenberger, Christian X./0000-0002-2176-0274; Robino, Antonietta/0000-0003-2152-2353; NUTILE, TERESA/0000-0001-7062-8352; Whitfield, John/0000-0002-1103-0876; Mitchell, Braxton/0000-0003-4920-4744	MRC [G0801056, G0600705, MC_U106188470, G1002084, G0700704] Funding Source: UKRI; Austrian Science Fund FWF [I 434] Funding Source: Medline; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: Medline; Cancer Research UK [14136] Funding Source: Medline; Medical Research Council [G1000143, G0700704, G9815508, G0600705, G0401527, MC_U106188470, G0801056, G1002084, MC_U106179471] Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NCI NIH HHS [R01 CA165001] Funding Source: Medline; NCRR NIH HHS [U54 RR020278, UL1 RR025005, K12 RR023250] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [HHSN268201100006C, P01 HL076491, R01 HL086694, HHSN268201100011C, R01 HL103866, HHSN268201100007C, R01 HL087679, HHSN268201100008C, HHSN268201100010C, R01 HL103931, HHSN268201100012C, R01 HL088119, P01 HL098055, U01 HL084756, P20 HL113452, R01 HL059367, R01 HL087641, HHSN268201100005C, HHSN268201100009C, U01 HL072515] Funding Source: Medline; NIA NIH HHS [N01AG12109, R01 AG018728] Funding Source: Medline; NICHD NIH HHS [R01 HD042157] Funding Source: Medline; NIDA NIH HHS [HHSN271201100005C] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488] Funding Source: Medline; NIGMS NIH HHS [R01 GM053275, U01 GM074518] Funding Source: Medline; NIMH NIH HHS [U24 MH068457, R01 MH081802, RL1 MH083268] Funding Source: Medline; NLM NIH HHS [R01 LM010098] Funding Source: Medline; Wellcome Trust [092731, 097117] Funding Source: Medline; Department of Health [RP-PG-0310-1002] Funding Source: Medline; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA165001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, UL1RR025005, K12RR023250] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, P01HL098055, P20HL113452, P01HL076491, R01HL086694, R01HL087679, R01HL088119, R01HL059367, U01HL084756, R01HL103931, R01HL103866, U01HL072515] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081802, U24MH068457, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 434] Funding Source: researchfish; Medical Research Council [G0801056B, G0700704B] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1002, NF-SI-0611-10275, NF-SI-0611-10136] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); Department of Health; Chief Scientist Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; ANDERSON RJ, 1990, J TRAUMA, V30, P1059, DOI 10.1097/00005373-199009000-00001; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Berhane S, 2011, VIROLOGY, V421, P149, DOI 10.1016/j.virol.2011.09.025; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Galanello R, 2009, BLOOD, V114, P3935, DOI 10.1182/blood-2009-04-217901; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Scanlon KS, 2000, OBSTET GYNECOL, V96, P741, DOI 10.1016/S0029-7844(00)00982-0; Shah RC, 2011, NEUROLOGY, V77, P219, DOI 10.1212/WNL.0b013e318225aaa9; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; van Wijk R, 2003, BLOOD, V101, P345, DOI 10.1182/blood-2002-06-1851; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	47	236	237	0	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					369	+		10.1038/nature11677	http://dx.doi.org/10.1038/nature11677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222517	Green Published, Green Accepted			2022-12-01	WOS:000312488200044
J	Xu, KX; Wu, ZJ; Groner, AC; He, HSHS; Cai, CM; Lis, RT; Wu, XQ; Stack, EC; Loda, M; Liu, T; Xu, H; Cato, L; Thornton, JE; Gregory, RI; Morrissey, C; Vessella, RL; Montironi, R; Magi-Galluzzi, C; Kantoff, PW; Balk, SP; Liu, XS; Brown, M				Xu, Kexin; Wu, Zhenhua Jeremy; Groner, Anna C.; He, Housheng Hansen; Cai, Changmeng; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Liu, Tao; Xu, Han; Cato, Laura; Thornton, James E.; Gregory, Richard I.; Morrissey, Colm; Vessella, Robert L.; Montironi, Rodolfo; Magi-Galluzzi, Cristina; Kantoff, Philip W.; Balk, Steven P.; Liu, X. Shirley; Brown, Myles			EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent	SCIENCE			English	Article							GENE-EXPRESSION; HISTONE METHYLTRANSFERASE; SUPPRESSES METHYLATION; PHOSPHORYLATION; LYSINE-27; COMPLEX; PROGRESSION; PROTEIN; AKT	Epigenetic regulators represent a promising new class of therapeutic targets for cancer. Enhancer of zeste homolog 2 (EZH2), a subunit of Polycomb repressive complex 2 (PRC2), silences gene expression via its histone methyltransferase activity. We found that the oncogenic function of EZH2 in cells of castration-resistant prostate cancer is independent of its role as a transcriptional repressor. Instead, it involves the ability of EZH2 to act as a coactivator for critical transcription factors including the androgen receptor. This functional switch is dependent on phosphorylation of EZH2 and requires an intact methyltransferase domain. Hence, targeting the non-PRC2 function of EZH2 may have therapeutic efficacy for treating metastatic, hormone-refractory prostate cancer.	[Xu, Kexin; Wu, Zhenhua Jeremy; Groner, Anna C.; He, Housheng Hansen; Liu, Tao; Xu, Han; Cato, Laura; Liu, X. Shirley; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Xu, Kexin; Groner, Anna C.; He, Housheng Hansen; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Cato, Laura; Kantoff, Philip W.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Xu, Kexin; Groner, Anna C.; He, Housheng Hansen; Cai, Changmeng; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Cato, Laura; Kantoff, Philip W.; Balk, Steven P.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Wu, Zhenhua Jeremy; He, Housheng Hansen; Liu, Tao; Xu, Han; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Wu, Zhenhua Jeremy; He, Housheng Hansen; Liu, Tao; Xu, Han; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Cai, Changmeng; Balk, Steven P.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Lis, Rosina T.; Stack, Edward C.; Loda, Massimo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Loda, Massimo] Kings Coll London, Div Canc Studies, London SE1 8UB, England; [Thornton, James E.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thornton, James E.; Gregory, Richard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Morrissey, Colm; Vessella, Robert L.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Vessella, Robert L.] Puget Sound VA Hlth Care Syst, Seattle, WA 98108 USA; [Montironi, Rodolfo] Polytech Univ Marche Reg, United Hosp, Sect Pathol Anat, I-60126 Ancona, Italy; [Magi-Galluzzi, Cristina] Cleveland Clin, Pathol & Lab Med Inst, Glickman Urol & Kidney Inst, Dept Canc Biol,Taussig Canc Inst, Cleveland, OH 44195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; King's College London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; Marche Polytechnic University; Cleveland Clinic Foundation	Liu, XS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.	xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu	Liu, Tao/G-3585-2010; Magi-Galluzzi, Cristina/AAW-6484-2020; Brown, Myles/AAX-5332-2021; Liu, Tao/AAO-6310-2021; Brown, Myles/B-6906-2008; Cai, Changmeng/AAE-6835-2020; He, Hansen/ABD-8439-2020	Liu, Tao/0000-0002-8818-8313; Brown, Myles/0000-0002-8213-1658; Liu, Tao/0000-0002-8818-8313; He, Hansen/0000-0003-2898-3363; Cai, Changmeng/0000-0002-8701-2586; Liu, Tao/0000-0003-0446-9001; Kantoff, Philip/0000-0001-7275-0597	Prostate Cancer Foundation (PCF); Swiss National Science Foundation; NSF; A. David Mazzone Project Development Award; PCF Challenge Awards; U.S. Department of Defense Idea Development Award [PC100950]; National Cancer Institute [CA131945, CA89021, CA90381]; NIH [CA166507, CA111803, CA090381, GM99409, CA85859, CA097186]; NATIONAL CANCER INSTITUTE [P01CA089021, R01CA111803, R00CA166507, P50CA097186, P50CA090381, R01CA131945, P01CA085859, K99CA166507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099409] Funding Source: NIH RePORTER	Prostate Cancer Foundation (PCF); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF)); A. David Mazzone Project Development Award; PCF Challenge Awards; U.S. Department of Defense Idea Development Award(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Huang, A. Chinnaiyan, Y. Shang, and D. Reinberg for sharing their reagents, and Y. Qiu, X. Yang, J. Xu, and M. Ni for technical support and advice. Supported by a Prostate Cancer Foundation (PCF) Young Investigator Award (K. X.); a Swiss National Science Foundation prospective researcher fellowship (A. C. G.); a NSF graduate research fellowship (J. E. T.); an A. David Mazzone Project Development Award (M. B.); PCF Challenge Awards (S. P. B. and M. B.); U.S. Department of Defense Idea Development Award PC100950 (S. P. B.); National Cancer Institute grants CA131945, CA89021, and CA90381 (M. L.); and NIH grants CA166507 (C. C.), CA111803 (S. P. B.), CA090381 (M. B., S. P. B., P. W. K.), GM99409 (X. S. L.), and CA85859 and CA097186 (C. M., R. L. V.). All data sets have been deposited in the Gene Expression Omnibus database (GSE39461). M. B. serves as a consultant to Novartis Pharmaceuticals.	Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	22	570	590	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1465	1469		10.1126/science.1227604	http://dx.doi.org/10.1126/science.1227604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239736	Green Accepted			2022-12-01	WOS:000312250800047
J	Yardimci, H; Wang, XD; Loveland, AB; Tappin, I; Rudner, DZ; Hurwitz, J; van Oijen, AM; Walter, JC				Yardimci, Hasan; Wang, Xindan; Loveland, Anna B.; Tappin, Inger; Rudner, David Z.; Hurwitz, Jerard; van Oijen, Antoine M.; Walter, Johannes C.			Bypass of a protein barrier by a replicative DNA helicase	NATURE			English	Article							SIMIAN-VIRUS-40 T-ANTIGEN; LARGE-TUMOR-ANTIGEN; SINGLE-STRANDED-DNA; HEXAMERIC HELICASE; VIRAL ORIGIN; SV40 ORIGIN; IN-VITRO; MECHANISM; FORK; TRANSLOCATION	Replicative DNA helicases generally unwind DNA as a single hexamer that encircles and translocates along one strand of the duplex while excluding the complementary strand (known as steric exclusion). By contrast, large T antigen, the replicative DNA helicase of the simian virus 40 (SV40), is reported to function as a pair of stacked hexamers that pumps double-stranded DNA through its central channel while laterally extruding single-stranded DNA. Here we use single-molecule and ensemble assays to show that large T antigen assembled on the SV40 origin unwinds DNA efficiently as a single hexamer that translocates on single-stranded DNA in the 3'-to-5' direction. Unexpectedly, large T antigen unwinds DNA past a DNA-protein crosslink on the translocation strand, suggesting that the large T antigen ring can open to bypass bulky adducts. Together, our data underscore the profound conservation among replicative helicase mechanisms, and reveal a new level of plasticity in the interactions of replicative helicases with DNA damage.	[van Oijen, Antoine M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Yardimci, Hasan; Loveland, Anna B.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Xindan; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	University of Groningen; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	van Oijen, AM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.	a.m.van.oijen@rug.nl; johannes_walter@hms.harvard.edu	Institute, Zernike/W-7033-2019; Wang, Xindan/P-3967-2014; Wang, Xindan/Q-6600-2019; van Oijen, Antoine/I-3167-2014	Wang, Xindan/0000-0001-6458-180X; van Oijen, Antoine/0000-0002-1794-5161; Loveland, Anna B./0000-0001-9172-7747; Yardimci, Hasan/0000-0001-5009-1391; Walter, Johannes/0000-0002-4186-7570	National Institutes of Health (NIH) [GM62267, HL098316, GM077248, GM5 R01 GM034559, GM086466]; American Cancer Society (ACS) [RSG0823401GMC]; Netherlands Organization for Scientific Research (NWO) [Vici 680-47-607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM034559, R01GM077248, R01GM086466] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Richardson for critical reading of the manuscript, and C. Etson for help in the preparation of lambda ori DNA. J.C.W. was supported by grants from the National Institutes of Health (NIH) (GM62267 and HL098316) and American Cancer Society (ACS) (RSG0823401GMC). A.M.v.O. was supported by grants from the NIH (GM077248), ACS (RSG0823401GMC), and the Netherlands Organization for Scientific Research (NWO; Vici 680-47-607). J.H. was funded by NIH grant GM5 R01 GM034559. X.W. was a long-term postdoctoral fellow of the Human Frontier Science Program; D.Z.R. was supported by NIH grant GM086466.	Alexandrov AI, 2002, J BIOL CHEM, V277, P44886, DOI 10.1074/jbc.M207022200; Anand RP, 2012, NUCLEIC ACIDS RES, V40, P1091, DOI 10.1093/nar/gkr836; Barbaro BA, 2000, J VIROL, V74, P8601, DOI 10.1128/JVI.74.18.8601-8613.2000; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; EKI T, 1992, J BIOL CHEM, V267, P7284; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fanning E, 2009, VIROLOGY, V384, P352, DOI 10.1016/j.virol.2008.11.038; Fanning Ellen, 2009, P1, DOI 10.1007/978-0-387-68945-6_1; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GOETZ GS, 1988, J BIOL CHEM, V263, P383; Gomez-Lorenzo MG, 2003, EMBO J, V22, P6205, DOI 10.1093/emboj/cdg612; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kuhn H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn107; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; MACMILLAN AM, 1992, J ORG CHEM, V57, P2989, DOI 10.1021/jo00037a006; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sclafani RA, 2004, GENE DEV, V18, P2039, DOI 10.1101/gad.1240604; Seinsoth S, 2003, EMBO REP, V4, P263, DOI 10.1038/sj.embor.embor770; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; Smelkova NV, 1997, J VIROL, V71, P8766, DOI 10.1128/JVI.71.11.8766-8773.1997; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tanner NA, 2010, SINGLE MOL TOOLS B, P259; Thomason Lynn C., 2009, V501, P239, DOI 10.1007/978-1-60327-164-6_21; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Weisshart K, 1999, J VIROL, V73, P2201, DOI 10.1128/JVI.73.3.2201-2211.1999; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Wu CX, 2001, J VIROL, V75, P2839, DOI 10.1128/JVI.75.6.2839-2847.2001; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027	46	68	68	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					205	+		10.1038/nature11730	http://dx.doi.org/10.1038/nature11730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201686	Green Accepted, Green Submitted, Green Published			2022-12-01	WOS:000312259300032
J	Campbell-Thompson, M; Wasserfall, C; Montgomery, EL; Atkinson, MA; Kaddis, JS				Campbell-Thompson, Martha; Wasserfall, Clive; Montgomery, Emily L.; Atkinson, Mark A.; Kaddis, John S.			Pancreas Organ Weight in Individuals With Disease-Associated Autoantibodies at Risk for Type 1 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MELLITUS		[Campbell-Thompson, Martha; Wasserfall, Clive; Montgomery, Emily L.; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Kaddis, John S.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA	State University System of Florida; University of Florida; City of Hope	Campbell-Thompson, M (corresponding author), Univ Florida, Dept Pathol, Gainesville, FL 32611 USA.	jkaddis@coh.org	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020; Campbell-Thompson, Martha/A-7584-2010	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; Kaddis, John/0000-0002-6752-7670; Campbell-Thompson, Martha/0000-0001-6878-1235	NIDDK NIH HHS [DP3 DK101120] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Loftin LB, 1991, ADV ED RES SUBSTANTI, V1, P133; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081	6	96	96	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2337	2339		10.1001/jama.2012.15008	http://dx.doi.org/10.1001/jama.2012.15008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232891	Bronze			2022-12-01	WOS:000312132400020
J	Bar-Peled, L; Sabatini, DM				Bar-Peled, Liron; Sabatini, David M.			SnapShot: mTORC1 Signaling at the Lysosomal Surface	CELL			English	Editorial Material							GROWTH-CONTROL; UPSTREAM; TOR		[Bar-Peled, Liron; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Bar-Peled, L (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.			/0000-0002-1446-7256				Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230	10	30	30	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1390	+	1390.e1	10.1016/j.cell.2012.11.038	http://dx.doi.org/10.1016/j.cell.2012.11.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217718	Bronze			2022-12-01	WOS:000311999900027
J	Geu-Flores, F; Sherden, NH; Courdavault, V; Burlat, V; Glenn, WS; Wu, C; Nims, E; Cui, YH; O'Connor, SE				Geu-Flores, Fernando; Sherden, Nathaniel H.; Courdavault, Vincent; Burlat, Vincent; Glenn, Weslee S.; Wu, Cen; Nims, Ezekiel; Cui, Yuehua; O'Connor, Sarah E.			An alternative route to cyclic terpenes by reductive cyclization in iridoid biosynthesis	NATURE			English	Article							IRIDANE SKELETON FORMATION; PROGESTERONE 5-BETA-REDUCTASE; CATHARANTHUS-ROSEUS; ALKALOID BIOSYNTHESIS; METABOLISM; MECHANISM; GENES; SECOIRIDOIDS; VINDOLINE; P5-BETA-R	The iridoids comprise a large family of distinctive bicyclic monoterpenes that possess a wide range of pharmacological activities, including anticancer, anti-inflammatory, antifungal and antibacterial activities(1-4). Additionally, certain iridoids are used as sex pheromones in agriculturally important species of aphids, a fact that has underpinned innovative and integrated pest management strategies(5). To harness the biotechnological potential of this natural product class, the enzymes involved in the biosynthetic pathway must be elucidated. Here we report the discovery of iridoid synthase, a plant-derived enzyme that generates the iridoid ring scaffold, as evidenced by biochemical assays, gene silencing, co-expression analysis and localization studies. In contrast to all known monoterpene cyclases, which use geranyl diphosphate as substrate and invoke a cationic intermediate, iridoid synthase uses the linear monoterpene 10-oxogeranial as substrate and probably couples an initial NAD(P) H-dependent reduction step with a subsequent cyclization step via a Diels-Alder cycloaddition or a Michael addition. Our results illustrate how a short-chain reductase was recruited as cyclase for the production of iridoids in medicinal plants. Furthermore, we highlight the prospects of using unrelated reductases to generate artificial cyclic scaffolds. Beyond the recognition of an alternative biochemical mechanism for the biosynthesis of cyclic terpenes, we anticipate that our work will enable the large-scale heterologous production of iridoids in plants and microorganisms for agricultural(5-8) and pharmaceutical(1-4,9) applications.	[Geu-Flores, Fernando; Sherden, Nathaniel H.; Glenn, Weslee S.; O'Connor, Sarah E.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Courdavault, Vincent] Univ Tours, Biomol & Biotechnol Vegetales EA2106, F-37200 Tours, France; [Burlat, Vincent] Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Burlat, Vincent] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Glenn, Weslee S.; Nims, Ezekiel] MIT, Dept Chem, Cambridge, MA 02139 USA; [Wu, Cen; Cui, Yuehua] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [O'Connor, Sarah E.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Massachusetts Institute of Technology (MIT); Michigan State University; University of East Anglia	O'Connor, SE (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	sarah.o'connor@jic.ac.uk	Cui, Yuehua/A-3529-2008; Geu-Flores, Fernando/B-2737-2015; Courdavault, Vincent/AAK-1117-2020; burlat, vincent/J-6831-2015; O'Connor, Sarah Ellen/X-2893-2019; burlat, vincent/ABB-1802-2021; Cui, Yuehua/E-8004-2010; O'Connor, Sarah/O-5850-2016	Cui, Yuehua/0000-0001-8099-1753; Geu-Flores, Fernando/0000-0002-5735-9810; burlat, vincent/0000-0002-0897-6011; burlat, vincent/0000-0002-0897-6011; Cui, Yuehua/0000-0001-8099-1753; Courdavault, Vincent/0000-0001-8902-4532; O'Connor, Sarah/0000-0003-0356-6213	Danish Council for Independent Research (Natural Sciences) [10-082858]; NIH [GM074820]; John Innes Foundation; National Science Foundation; NSF [DMS-1209112]; John Innes Centre; University of East Anglia;  [j004561SRC (BB/J004561/1)];  [BB/J009091/1]; BBSRC [BB/J009091/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J009091/1] Funding Source: researchfish	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Innes Foundation; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); John Innes Centre; University of East Anglia; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The present study was funded by the Danish Council for Independent Research (Natural Sciences) through Postdoctoral Fellowship 10-082858 granted to F.G.-F. Additional funding was received from the NIH (GM074820), the j004561SRC (BB/J004561/1 and BB/J009091/1) and the John Innes Foundation. This work was conducted under Defra Plant Health Licence PHSI 449/6612(07/2011). W. S. G. gratefully acknowledges a National Science Foundation Predoctoral Fellowship. Y.C. would like to thank the NSF for grant DMS-1209112. K. R. Chauhan is acknowledged for providing initial nepetalactol samples. We thank S. Fairhurst, L. Hill and A. Jones for NMR, LC-MS and GC-MS assistance, respectively. J. Ward and N. Hawkins are acknowledged for the GC-MS-based high-resolution mass spectra (HRMS) of synthesized compounds. R. Buell and E. Gongora-Castillo provided many helpful discussions on the transcriptome data. The purified EasA protein was provided J. Z. Cheng, to whom we are deeply indebted. S.E.O. receives salary support through a synergy initiative between the John Innes Centre and the University of East Anglia.	Bauer P, 2010, PHYTOCHEMISTRY, V71, P1495, DOI 10.1016/j.phytochem.2010.06.004; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cheng JZ, 2010, J AM CHEM SOC, V132, P1776, DOI 10.1021/ja910193p; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dewhirst SY, 2010, VITAM HORM, V83, P551, DOI 10.1016/S0083-6729(10)83022-5; Dinda B, 2007, CHEM PHARM BULL, V55, P689, DOI 10.1248/cpb.55.689; Dinda B, 2011, CHEM PHARM BULL, V59, P803, DOI 10.1248/cpb.59.803; Dinda B, 2009, CHEM PHARM BULL, V57, P765, DOI 10.1248/cpb.57.765; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Guirimand G, 2011, J PLANT PHYSIOL, V168, P549, DOI 10.1016/j.jplph.2010.08.018; Guirimand G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-182; Guirimand G, 2009, PLANT CELL REP, V28, P1215, DOI 10.1007/s00299-009-0722-2; INOUYE H, 1978, PLANTA MED, V33, P193, DOI 10.1055/s-0028-1097377; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d; Liscombe DK, 2011, PHYTOCHEMISTRY, V72, P1969, DOI 10.1016/j.phytochem.2011.07.001; Mahroug S, 2006, PLANTA, V223, P1191, DOI 10.1007/s00425-005-0167-y; McElvain SM, 1942, J AM CHEM SOC, V64, P1828, DOI 10.1021/ja01260a025; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Soe ARB, 2004, ISOT ENVIRON HEALT S, V40, P175, DOI 10.1080/10256010410001674994; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Tundis R, 2008, MINI-REV MED CHEM, V8, P399, DOI 10.2174/138955708783955926; UESATO S, 1987, TETRAHEDRON LETT, V28, P4431, DOI 10.1016/S0040-4039(00)96530-4; UESATO S, 1984, CHEM PHARM BULL, V32, P3764, DOI 10.1248/cpb.32.3764; UESATO S, 1984, CHEM PHARM BULL, V32, P1671; UESATO S, 1983, CHEM PHARM BULL, V31, P4185; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	33	225	238	8	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					138	+		10.1038/nature11692	http://dx.doi.org/10.1038/nature11692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23172143				2022-12-01	WOS:000311893400061
J	Lee, GS; Subramanian, N; Kim, AI; Aksentijevich, I; Goldbach-Mansky, R; Sacks, DB; Germain, RN; Kastner, DL; Chae, JJ				Lee, Geun-Shik; Subramanian, Naeha; Kim, Andrew I.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela; Sacks, David B.; Germain, Ronald N.; Kastner, Daniel L.; Chae, Jae Jin			The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP	NATURE			English	Article							NALP3 INFLAMMASOME; ACTIVATION; ATP; LIPOPOLYSACCHARIDE; SECRETION; CRYSTALS	Mutations in the gene encoding NLRP3 cause a spectrum of auto-inflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS)(1). NLRP3 is a key component of one of several distinct cytoplasmic multiprotein complexes (inflammasomes) that mediate the maturation of the proinflammatory cytokine interleukin-1 beta (IL-1 beta) by activating caspase-1. Although several models for inflammasome activation, such as K+ efflux(2), generation of reactive oxygen species(3) and lysosomal destabilization(4), have been proposed, the precise molecular mechanism of NLRP3 inflammasome activation, as well as the mechanism by which CAPS-associated mutations activate NLRP3, remain to be elucidated. Here we show that the murine calcium-sensing receptor (CASR) activates the NLRP3 inflammasome, mediated by increased intracellular Ca2+ and decreased cellular cyclic AMP(cAMP). Ca2+ or other CASR agonists activate the NLRP3 inflammasome in the absence of exogenous ATP, whereas knockdown of CASR reduces inflammasome activation in response to known NLRP3 activators. CASR activates the NLRP3 inflammasome through phospholipase C, which catalyses inositol-1,4,5-trisphosphate production and thereby induces release of Ca2+ from endoplasmic reticulum stores. The increased cytoplasmic Ca2+ promotes the assembly of inflammasome components, and intracellular Ca2+ is required for spontaneous inflammasome activity in cells from patients with CAPS. CASR stimulation also results in reduced intracellular cAMP, which independently activates the NLRP3 inflammasome. cAMP binds to NLRP3 directly to inhibit inflammasome assembly, and downregulation of cAMP relieves this inhibition. The binding affinity of cAMP for CAPS-associated mutant NLRP3 is substantially lower than for wild-type NLRP3, and the uncontrolled mature IL-1 beta production from CAPS patients' peripheral blood mononuclear cells is attenuated by increasing cAMP. Taken together, these findings indicate that Ca2+ and cAMP are two key molecular regulators of the NLRP3 inflammasome that have critical roles in the molecular pathogenesis of CAPS.	[Lee, Geun-Shik; Kim, Andrew I.; Aksentijevich, Ivona; Kastner, Daniel L.; Chae, Jae Jin] NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Lee, Geun-Shik] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea; [Subramanian, Naeha; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Goldbach-Mansky, Raphaela] NIAMSD, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Sacks, David B.] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kastner, DL (corresponding author), NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov; chaej@mail.nih.gov	Germain, Ronald N./Z-1945-2019; Aksentijevich, Ivona/AAF-1335-2019; Goldbach-Mansky, Raphaela/N-5917-2017; Germain, Ronald/ABE-7090-2020	Sacks, David/0000-0003-3100-0735; Chae, Jae Jin/0000-0003-0719-4349; Subramanian, Naeha/0000-0003-3754-0521	NIAMS; NHGRI; NIAID, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373, ZIAHG200372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIEAR041176, ZIAAR041138] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CLINICAL CENTER	This work was supported by the Intramural Research Programs of the NIAMS, NHGRI, and NIAID, NIH. We thank E. Remmers for discussion and a thorough review of this manuscript.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; COCKCROFT S, 1979, J PHYSIOL-LONDON, V296, P229, DOI 10.1113/jphysiol.1979.sp013002; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Menkin V., 1981, BIOCH MECH INFLAMMAT; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Osawa Y, 2006, AM J PHYSIOL-CELL PH, V290, pC143, DOI 10.1152/ajpcell.00171.2005; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Ross PE, 1997, J CELL BIOL, V138, P987, DOI 10.1083/jcb.138.5.987; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Xi YH, 2010, MOL CELL BIOCHEM, V342, P233, DOI 10.1007/s11010-010-0489-3; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	24	609	634	10	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					123	+		10.1038/nature11588	http://dx.doi.org/10.1038/nature11588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23143333	Green Accepted			2022-12-01	WOS:000311893400058
J	Sotomayor, M; Weihofen, WA; Gaudet, R; Corey, DP				Sotomayor, Marcos; Weihofen, Wilhelm A.; Gaudet, Rachelle; Corey, David P.			Structure of a force-conveying cadherin bond essential for inner-ear mechanotransduction	NATURE			English	Article							USHER-SYNDROME; HAIR-CELLS; MOLECULAR-DYNAMICS; SENSORY TRANSDUCTION; HEARING-LOSS; ADHESION; MUTATIONS; PCDH15; CDH23; STEREOCILIA	Hearing and balance use hair cells in the inner ear to transform mechanical stimuli into electrical signals(1). Mechanical force from sound waves or head movements is conveyed to hair-cell transduction channels by tip links(2,3), fine filaments formed by two atypical cadherins known as protocadherin 15 and cadherin 23 (refs 4, 5). These two proteins are involved in inherited deafness(6-10) and feature long extracellular domains that interact tip-to-tip(5,11) in a Ca2+-dependent manner. However, the molecular architecture of this complex is unknown. Here we combine crystallography, molecular dynamics simulations and binding experiments to characterize the protocadherin 15-cadherin 23 bond. We find a unique cadherin interaction mechanism, in which the two most amino-terminal cadherin repeats (extracellular cadherin repeats 1 and 2) of each protein interact to form an overlapped, antiparallel heterodimer. Simulations predict that this tip-link bond is mechanically strong enough to resist forces in hair cells. In addition, the complex is shown to become unstable in response to Ca2+ removal owing to increased flexure of Ca2+-free cadherin repeats. Finally, we use structures and biochemical measurements to study the molecular mechanisms by which deafness mutations disrupt tip-link function. Overall, our results shed light on the molecular mechanics of hair-cell sensory transduction and on new interaction mechanisms for cadherins, a large protein family implicated in tissue and organ morphogenesis(12,13), neural connectivity(14) and cancer(15).	[Sotomayor, Marcos; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Sotomayor, Marcos; Corey, David P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Weihofen, Wilhelm A.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University	Corey, DP (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	gaudet@mcb.harvard.edu; dcorey@hms.harvard.edu	Gaudet, Rachelle/I-4133-2014; Sotomayor, Marcos/T-2411-2019; Sotomayor, Marcos/J-4898-2012; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805; Gaudet, Rachelle/0000-0002-9177-054X; Corey, David/0000-0003-4497-6016	NIH [R01 DC02281, RC2GM093307, RR-15301]; National Science Foundation through TeraGrid/XSEDE [TRAC MCB080015]; Department of Energy (DOE) [DE-AC02-06CH11357]; DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation through TeraGrid/XSEDE; Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Derfler for assistance with mutagenesis, V. D'Souza and her laboratory for advice on calorimetry, and the Corey and Gaudet laboratories for discussions. Full-length complementary DNAs of Cdh23 and Pcdh15 used as template for some of our constructs were provided by U. Muller (The Scripps Research Institute) and T. B. Friedman (National Institutes of Health (NIH)). This work was supported by the NIH (R01 DC02281 to D. P. C.; RC2GM093307 to National Resource for Biomedical Supercomputing/Pittsburgh Supercomputing Center) and the National Science Foundation through TeraGrid/XSEDE (TRAC MCB080015). Simulations were performed at the NCSA-Abe, NICS-Kraken, TACC-Ranger and PSC-Anton supercomputers. Use of Advanced Photon Source beamlines was supported by NIH award RR-15301 and Department of Energy (DOE) contract no. DE-AC02-06CH11357. Use of Advanced Light Source beamline 4.2.2 was supported by DOE contract no. DE-AC02-05CH11231. M. S. was a Howard Hughes Medical Institute (HHMI) Fellow of the Helen Hay Whitney Foundation and D. P. C. is an HHMI Investigator.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2008, HUM GENET, V124, P215, DOI 10.1007/s00439-008-0543-3; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marchand S, 1998, PROTEINS, V33, P265, DOI 10.1002/(SICI)1097-0134(19981101)33:2<265::AID-PROT10>3.0.CO;2-I; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rouget-Quermalet V, 2006, ONCOGENE, V25, P2807, DOI 10.1038/sj.onc.1209301; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thomson J.A., 2004, BIOCALORIMETRY, P37; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6	46	102	108	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					128	+		10.1038/nature11590	http://dx.doi.org/10.1038/nature11590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23135401	Green Submitted, Green Accepted			2022-12-01	WOS:000311893400059
J	Ke, YG; Ong, LL; Shih, WM; Yin, P				Ke, Yonggang; Ong, Luvena L.; Shih, William M.; Yin, Peng			Three-Dimensional Structures Self-Assembled from DNA Bricks	SCIENCE			English	Article							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI; RNA; LATTICES; NANOTECHNOLOGY; CRYSTAL; DESIGN; MOTOR	We describe a simple and robust method to construct complex three-dimensional (3D) structures by using short synthetic DNA strands that we call "DNA bricks." In one-step annealing reactions, bricks with hundreds of distinct sequences self-assemble into prescribed 3D shapes. Each 32-nucleotide brick is a modular component; it binds to four local neighbors and can be removed or added independently. Each 8-base pair interaction between bricks defines a voxel with dimensions of 2.5 by 2.5 by 2.7 nanometers, and a master brick collection defines a "molecular canvas" with dimensions of 10 by 10 by 10 voxels. By selecting subsets of bricks from this canvas, we constructed a panel of 102 distinct shapes exhibiting sophisticated surface features, as well as intricate interior cavities and tunnels.	[Ke, Yonggang; Ong, Luvena L.; Shih, William M.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ke, Yonggang; Shih, William M.] Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ke, Yonggang; Shih, William M.] Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ong, Luvena L.] MIT, Harvard Massachusetts Inst Technol MIT Div Hlth S, Cambridge, MA 02139 USA; [Yin, Peng] Harvard Univ, Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu		/0000-0001-5317-3018	Office of Naval Research (ONR) Young Investigator Program award [N000141110914]; ONR grant [N000141010827, N000014091118, N000141010241]; Army Research Office [W911NF1210238]; NSF [CCF1054898]; NIH [1DP2OD007292, 1DP2OD004641]; Wyss Institute Faculty Startup Fund; Wyss Institute Faculty Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641, DP2OD007292] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1054898] Funding Source: National Science Foundation	Office of Naval Research (ONR) Young Investigator Program award(Office of Naval Research); ONR grant; Army Research Office; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute Faculty Startup Fund; Wyss Institute Faculty Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors thank M. Dai for technical assistance; E. Winfree, B. Wei, and S. Woo for discussions; and D. Pastuszak for assistance in draft preparation. This work is supported by an Office of Naval Research (ONR) Young Investigator Program award N000141110914, an ONR grant N000141010827, an Army Research Office grant W911NF1210238, an NSF CAREER award CCF1054898, an NIH Director's New Innovator award 1DP2OD007292, and a Wyss Institute Faculty Startup Fund to P.Y., and by a Wyss Institute Faculty Grant, ONR grants N000014091118 and N000141010241, and an NIH Director's New Innovator award 1DP2OD004641 to W.M.S.. L.L.O. is supported by an NSF graduate research fellowship. Y.K. conceived the project, designed and performed the experiments, analyzed the data, and wrote the paper; L.L.O. designed and performed the experiments, analyzed the data, and wrote the paper; W.M.S. conceived the project, discussed the results, and wrote the paper; P.Y. conceived, designed, and supervised the study, interpreted the data, and wrote the paper. The DNA sequences for the nanostructures can be found in the supplementary materials. A provisional patent has been filed based on this work.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2012, NATURE, V485, P584, DOI 10.1038/485584a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schulman R, 2012, P NATL ACAD SCI USA, V109, P6405, DOI 10.1073/pnas.1117813109; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shih WM, 2010, CURR OPIN STRUC BIOL, V20, P276, DOI 10.1016/j.sbi.2010.03.009; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	43	819	847	20	707	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1177	1183		10.1126/science.1227268	http://dx.doi.org/10.1126/science.1227268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197527	Green Accepted			2022-12-01	WOS:000311666200038
J	Manosas, M; Perumal, SK; Croquette, V; Benkovic, SJ				Manosas, Maria; Perumal, Senthil K.; Croquette, Vincent; Benkovic, Stephen J.			Direct Observation of Stalled Fork Restart via Fork Regression in the T4 Replication System	SCIENCE			English	Article							MAMMALIAN-CELLS; DNA-REPLICATION; UVSW PROTEIN; BACTERIOPHAGE-T4; REPAIR; MODEL; HELICASE; RECOMBINATION; REPLISOME; REVERSAL	The restart of a stalled replication fork is a major challenge for DNA replication. Depending on the nature of the damage, different repair processes might be triggered; one is template switching, which is a bypass of a leading-strand lesion via fork regression. Using magnetic tweezers to study the T4 bacteriophage enzymes, we have reproduced in vitro the complete process of template switching. We show that the UvsW DNA helicase in cooperation with the T4 holoenzyme can overcome leading-strand lesion damage by a pseudostochastic process, periodically forming and migrating a four-way Holliday junction. The initiation of the repair process requires partial replisome disassembly via the departure of the replicative helicase. The results support the role of fork regression pathways in DNA repair.	[Manosas, Maria; Croquette, Vincent] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, F-75005 Paris, France; [Manosas, Maria] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Croquette, Vincent] Ecole Normale Super, Dept Biol, F-75005 Paris, France; [Perumal, Senthil K.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Manosas, Maria] Inst Sanidad Carlos III, CIBER BBN Bioingn Biomat & Nanomed, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; University of Barcelona; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Croquette, V (corresponding author), Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, 24 Rue Lhomond, F-75005 Paris, France.	vincent.croquette@lps.ens.fr; sjb1@psu.edu		Manosas Castejon, Maria/0000-0001-8001-4055; Croquette, Vincent/0000-0003-1400-0039	Human Frontier Science Program; U.S. National Institutes of Health [GM013306]; ERC [Magreps 267 862]; Juan de la Cierva Program MICINN-JDC; EPSRC [EP/H006702/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H006702/1] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Juan de la Cierva Program MICINN-JDC; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank B. Michel and D. Bensimon for useful comments on the manuscript and M. M. Spiering for DNA substrates. This work was supported by a Human Frontier Science Program grant (to V.C. and S.J.B.), U.S. National Institutes of Health grant GM013306 (to S.J.B.), ERC grant Magreps 267 862 (to V.C.), and Juan de la Cierva Program MICINN-JDC (to M.M). M.M. conducted single-molecule assays and performed the analysis. S.K.P. conducted ensemble assays, analyzed data, and prepared DNA and proteins. V.C. built the magnetic tweezers. M.M., S.K.P., V.C., and S.J.B. wrote the paper. Materials and methods are available as supplementary materials.	Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6174, DOI 10.1093/nar/gks253; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111	19	62	63	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1217	1220		10.1126/science.1225437	http://dx.doi.org/10.1126/science.1225437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197534	Green Accepted			2022-12-01	WOS:000311666200048
J	Choy, A; Dancourt, J; Mugo, B; O'Connor, TJ; Isberg, RR; Melia, TJ; Roy, CR				Choy, Augustine; Dancourt, Julia; Mugo, Brian; O'Connor, Tamara J.; Isberg, Ralph R.; Melia, Thomas J.; Roy, Craig R.			The Legionella Effector RavZ Inhibits Host Autophagy Through Irreversible Atg8 Deconjugation	SCIENCE			English	Article							PNEUMOPHILA GENOME; SYSTEM; PATHWAY	Eukaryotic cells can use the autophagy pathway to defend against microbes that gain access to the cytosol or reside in pathogen-modified vacuoles. It remains unclear if pathogens have evolved specific mechanisms to manipulate autophagy. Here, we found that the intracellular pathogen Legionella pneumophila could interfere with autophagy by using the bacterial effector protein RavZ to directly uncouple Atg8 proteins attached to phosphatidylethanolamine on autophagosome membranes. RavZ hydrolyzed the amide bond between the carboxyl-terminal glycine residue and an adjacent aromatic residue in Atg8 proteins, producing an Atg8 protein that could not be reconjugated by Atg7 and Atg3. Thus, intracellular pathogens can inhibit autophagy by irreversibly inactivating Atg8 proteins during infection.	[Dancourt, Julia; Mugo, Brian; Melia, Thomas J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Choy, Augustine; Roy, Craig R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [O'Connor, Tamara J.; Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [O'Connor, Tamara J.; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Yale University; Yale University; Howard Hughes Medical Institute; Tufts University; Tufts University	Melia, TJ (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	thomas.melia@yale.edu; craig.roy@yale.edu	Dancourt, Julia/U-1533-2017	Dancourt, Julia/0000-0002-6237-1566; Roy, Craig/0000-0003-4490-440X	Science, Technology and Research Scholars Program at Yale University; Howard Hughes Medical Institute; NIH [AI007019, NS063973, AI041699, AI048770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R01AI041699, R29AI041699, R01AI048770, R37AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973] Funding Source: NIH RePORTER	Science, Technology and Research Scholars Program at Yale University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Mizushima and A. Iwasaki for providing GFP-LC3 and Atg5-deficient mice and S. Shin for providing the plasmid encoding BlaM-RalF. Support for this research came from the Science, Technology and Research Scholars Program at Yale University (B. M.); the Howard Hughes Medical Institute (T.J.O. and R. R. I.); and NIH Awards AI007019 (A. C.), NS063973 (T.J.M.), AI041699, and AI048770 (C. R. R.). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Hayward AP, 2011, ANNU REV PHYTOPATHOL, V49, P557, DOI 10.1146/annurev-phyto-072910-095333; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jotwani A, 2012, METHOD CELL BIOL, V108, P93, DOI 10.1016/B978-0-12-386487-1.00005-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	15	314	325	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1072	1076		10.1126/science.1227026	http://dx.doi.org/10.1126/science.1227026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23112293	Green Accepted			2022-12-01	WOS:000311390600042
J	Lichtenstein, P; Halldner, L; Zetterqvist, J; Sjolander, A; Serlachius, E; Fazel, S; Langstrom, N; Larsson, H				Lichtenstein, Paul; Halldner, Linda; Zetterqvist, Johan; Sjolander, Arvid; Serlachius, Eva; Fazel, Seena; Langstrom, Niklas; Larsson, Henrik			Medication for Attention Deficit-Hyperactivity Disorder and Criminality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELEASE METHYLPHENIDATE TREATMENT; FOLLOW-UP; DEFICIT/HYPERACTIVITY DISORDER; ADHD; CHILDREN; SAFETY; MTA; PREVALENCE; EFFICACY; ADULTS	Background Attention deficit-hyperactivity disorder (ADHD) is a common disorder that has been associated with criminal behavior in some studies. Pharmacologic treatment is available for ADHD and may reduce the risk of criminality. Methods Using Swedish national registers, we gathered information on 25,656 patients with a diagnosis of ADHD, their pharmacologic treatment, and subsequent criminal convictions in Sweden from 2006 through 2009. We used stratified Cox regression analyses to compare the rate of criminality while the patients were receiving ADHD medication, as compared with the rate for the same patients while not receiving medication. Results As compared with nonmedication periods, among patients receiving ADHD medication, there was a significant reduction of 32% in the criminality rate for men (adjusted hazard ratio, 0.68; 95% confidence interval [CI], 0.63 to 0.73) and 41% for women (hazard ratio, 0.59; 95% CI, 0.50 to 0.70). The rate reduction remained between 17% and 46% in sensitivity analyses among men, with factors that included different types of drugs (e.g., stimulant vs. nonstimulant) and outcomes (e.g., type of crime). Conclusions Among patients with ADHD, rates of criminality were lower during periods when they were receiving ADHD medication. These findings raise the possibility that the use of medication reduces the risk of criminality among patients with ADHD. (Funded by the Swedish Research Council and others.)	[Lichtenstein, Paul; Halldner, Linda; Zetterqvist, Johan; Sjolander, Arvid; Langstrom, Niklas; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Serlachius, Eva] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford, England	Karolinska Institutet; Karolinska Institutet; University of Oxford	Lichtenstein, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	paul.lichtenstein@ki.se	Sjölander, Arvid/AAR-2993-2021; Langstrom, Niklas/C-5615-2009; Fazel, Seena/B-5307-2008; Larsson, Henrik/GYD-5161-2022; Serlachius, Eva/E-8956-2013	Langstrom, Niklas/0000-0002-2686-6799; Fazel, Seena/0000-0002-5383-5365; Serlachius, Eva/0000-0001-7115-6422; Halldner Henriksson, Linda/0000-0003-0561-5998; lichtenstein, paul/0000-0003-3037-5287; Larsson, Henrik/0000-0002-6851-3297	Swedish Research Council; Swedish Council for Working Life and Social Research; Swedish Prison and Probation Services; National Institute of Child Health and Human Development [HD061817]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061817] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Prison and Probation Services; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Swedish Research Council and others.; Supported in part by grants from the Swedish Research Council, the Swedish Council for Working Life and Social Research, the Swedish Prison and Probation Services, the National Institute of Child Health and Human Development (HD061817), and the Wellcome Trust (to Dr. Fazel).	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; Allison PaulD., 2009, FIXED EFFECTS REGRES; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; [Anonymous], 2011, KRIM 2010 CRIM STAT; Arnold LE, 2004, J ABNORM CHILD PSYCH, V32, P39, DOI 10.1023/B:JACP.0000007579.61289.31; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Barkley RA, 2004, J CHILD PSYCHOL PSYC, V45, P195, DOI 10.1111/j.1469-7610.2004.00214.x; Biederman J, 2010, PSYCHIAT RES, V177, P299, DOI 10.1016/j.psychres.2009.12.010; Chamberlain SR, 2007, BIOL PSYCHIAT, V61, P1317, DOI 10.1016/j.biopsych.2007.04.009; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; DOLMEN L, 2001, BROTTSLIGHETEN OLIKA; FARRINGTON D, 2004, CROSS NATL STUDIES C; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Findling RL, 2008, CLIN THER, V30, P942, DOI 10.1016/j.clinthera.2008.05.006; Gibbons RD, 2010, ANNU REV PUBL HEALTH, V31, P419, DOI 10.1146/annurev.publhealth.012809.103649; Graham J, 2008, CNS DRUGS, V22, P213, DOI 10.2165/00023210-200822030-00003; Greenhill, 2007, J AM ACAD CHILD PSY, V46, P141; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Koesters M, 2009, J PSYCHOPHARMACOL, V23, P733, DOI 10.1177/0269881108092338; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Lee EW, 1992, SURVIVAL ANAL STATE, P237, DOI [10.1007/978-94-015-7983-4_14, DOI 10.1007/978-94-015-7983-4_14]; Lindevall O., 2009, PASTILL COMPREHENSIV; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McCarthy S, 2009, BRIT J PSYCHIAT, V194, P273, DOI 10.1192/bjp.bp.107.045245; Molina BSG, 2007, J AM ACAD CHILD PSY, V46, P1028, DOI 10.1097/chi.0b013e3180686d96; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Satterfield JH, 2007, J AM ACAD CHILD PSY, V46, P601, DOI 10.1097/chi.0b013e318033ff59; Scheffler RM, 2007, HEALTH AFFAIR, V26, P450, DOI 10.1377/hlthaff.26.2.450; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Winhusen TM, 2011, J CHILD ADOL PSYCHOP, V21, P455, DOI 10.1089/cap.2011.0014; Zetterqvist J, 2012, ACTA PSYCHIAT SCAND; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x	40	317	325	1	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2006	2014		10.1056/NEJMoa1203241	http://dx.doi.org/10.1056/NEJMoa1203241			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171097	Bronze, Green Accepted			2022-12-01	WOS:000311340200008
J	Tokinaga, H; Xie, SP; Deser, C; Kosaka, Y; Okumura, YM				Tokinaga, Hiroki; Xie, Shang-Ping; Deser, Clara; Kosaka, Yu; Okumura, Yuko M.			Slowdown of the Walker circulation driven by tropical Indo-Pacific warming	NATURE			English	Article							ASIAN CLIMATE; PRECIPITATION; SENSITIVITY; SIMULATION; SHIFT	Global mean sea surface temperature (SST) has risen steadily over the past century(1,2), but the overall pattern contains extensive and often uncertain spatial variations, with potentially important effects on regional precipitation(3,4). Observations suggest a slowdown of the zonal atmospheric overturning circulation above the tropical Pacific Ocean (the Walker circulation) over the twentieth century(1,5). Although this change has been attributed to a muted hydrological cycle forced by global warming(5,6), the effect of SST warming patterns has not been explored and quantified(1,7,8). Here we perform experiments using an atmospheric model, and find that SST warming patterns are the main cause of the weakened Walker circulation over the past six decades (1950-2009). The SST trend reconstructed from bucket-sampled SST and night-time marine surface air temperature features a reduced zonal gradient in the tropical Indo-Pacific Ocean, a change consistent with subsurface temperature observations(8). Model experiments with this trend pattern robustly simulate the observed changes, including the Walker circulation slowdown and the eastward shift of atmospheric convection from the Indonesian maritime continent to the central tropical Pacific. Our results cannot establish whether the observed changes are due to natural variability or anthropogenic global warming, but they do show that the observed slowdown in the Walker circulation is presumably driven by oceanic rather than atmospheric processes.	[Tokinaga, Hiroki; Xie, Shang-Ping] Univ Hawaii Manoa, SOEST, Dept Meteorol, Int Pacific Res Ctr, 1680 EW Rd, Honolulu, HI 96822 USA; [Xie, Shang-Ping] Ocean Univ China, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Deser, Clara] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Okumura, Yuko M.] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA	University of Hawaii System; University of Hawaii Manoa; Ocean University of China; National Center Atmospheric Research (NCAR) - USA; University of Texas System; University of Texas Austin	Tokinaga, H (corresponding author), Univ Hawaii Manoa, SOEST, Dept Meteorol, Int Pacific Res Ctr, 1680 EW Rd, Honolulu, HI 96822 USA.	tokinaga@hawaii.edu; xie@hawaii.edu	Kosaka, Yu/C-2792-2009; Okumura, Yuko/A-9742-2012; Xie, Shang-Ping/C-1254-2009; Tokinaga, Hiroki/K-6813-2012	Kosaka, Yu/0000-0001-5575-4668; Xie, Shang-Ping/0000-0002-3676-1325; Tokinaga, Hiroki/0000-0002-2734-1820; Okumura, Yuko/0000-0002-1874-3465	JAMSTEC; National Basic Research Program of China [2012CB955600]; NASA; NSF; NOAA	JAMSTEC; National Basic Research Program of China(National Basic Research Program of China); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank A. Timmermann for discussions, and X. T. Zheng and J. Ma for data processing. The work was supported by JAMSTEC, the National Basic Research Program of China (2012CB955600), NASA, NSF and NOAA. NCAR is sponsored by NSF.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Anderson JL, 2004, J CLIMATE, V17, P4641, DOI 10.1175/JCLI-3223.1; Bunge L, 2009, J CLIMATE, V22, P3979, DOI 10.1175/2009JCLI2724.1; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Clement A, 2011, J CLIMATE, V24, P4056, DOI 10.1175/2011JCLI3973.1; Collins WD, 2006, J CLIMATE, V19, P2144, DOI 10.1175/JCLI3760.1; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Deser C, 2006, J CLIMATE, V19, P6170, DOI 10.1175/JCLI3963.1; Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; DiNezio P. N., 2010, EOS T AM GEOPHYS UN, V91, P141, DOI DOI 10.1029/2010EO160001; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI [10.1038/ngeo1008, 10.1038/NGEO1008]; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kennedy JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015218; Kennedy J. J., 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Mann-Kendall G., 1975, RANK CORRELATION MET; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meehl GA, 2009, J CLIMATE, V22, P780, DOI 10.1175/2008JCLI2552.1; Meng QJ, 2012, CLIM DYNAM, V38, P1757, DOI 10.1007/s00382-011-1047-8; Neale R. B., J CLIM UNPUB; Power SB, 2011, J CLIMATE, V24, P6501, DOI 10.1175/2011JCLI4101.1; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Roeckner E., 2003, 349 MPI; Schneider U., 2008, GLOBAL PRECIPITATION; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shin SI, 2011, CLIM DYNAM, V36, P1577, DOI 10.1007/s00382-009-0732-3; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Tokinaga H, 2012, J CLIMATE, V25, P1689, DOI 10.1175/JCLI-D-11-00263.1; Tokinaga H, 2011, J CLIMATE, V24, P267, DOI 10.1175/2010JCLI3789.1; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; WILLMOTT CJ, 1995, INT J CLIMATOL, V15, P221, DOI 10.1002/joc.3370150207; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Xie SP, 2010, J CLIMATE, V23, P3352, DOI 10.1175/2010JCLI3429.1; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1	38	246	261	5	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					439	443		10.1038/nature11576	http://dx.doi.org/10.1038/nature11576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151588				2022-12-01	WOS:000311031600045
J	Antman, EM; Harrington, RA				Antman, Elliott M.; Harrington, Robert A.			Transforming Clinical Trials in Cardiovascular Disease Mission Critical for Health and Economic Well-being	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DESIGN		[Antman, Elliott M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Harrington, Robert A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Stanford University	Antman, EM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu						Antman E, 2012, WIRES SYST BIOL MED, V4, P367, DOI 10.1002/wsbm.1173; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Meurer WJ, 2012, JAMA-J AM MED ASSOC, V307, P2377, DOI 10.1001/jama.2012.4174; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; US Food and Drug Administration Center for Drug Evaluation and Research, 2011, CDER SCI PRIOR REV C	8	33	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1743	1744		10.1001/jama.2012.14841	http://dx.doi.org/10.1001/jama.2012.14841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117771				2022-12-01	WOS:000310726500017
J	Arnett, DK; Claas, SA				Arnett, Donna K.; Claas, Steven A.			Preventing and Controlling Hypertension in the Era of Genomic Innovation and Environmental Transformation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Arnett, Donna K.; Claas, Steven A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Arnett, DK (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, RPHB 220E,1530 3rd Ave S, Birmingham, AL USA.	arnett@ms.soph.uab.edu		Claas, Steven/0000-0001-9789-8395				Bloom D., 2011, GLOBAL EC BURDEN NON; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Konner M, 2010, NUTR CLIN PRACT, V25, P594, DOI 10.1177/0884533610385702; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; World Health Organization, 2012, CARD DIS CVDS FACT S	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1745	1746		10.1001/jama.2012.28747	http://dx.doi.org/10.1001/jama.2012.28747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117772				2022-12-01	WOS:000310726500018
J	Califf, RM; Sanderson, I; Miranda, ML				Califf, Robert M.; Sanderson, Iain; Miranda, Marie Lynn			The Future of Cardiovascular Clinical Research Informatics, Clinical Investigators, and Community Engagement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA; [Miranda, Marie Lynn] Univ Michigan, Dept Pediat, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, England; [Sanderson, Iain] Duke Hlth Technol Solut, Durham, England	Duke University; University of Michigan System; University of Michigan	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, 200 Trent Dr,1117 Davison Bldg, Durham, NC 27710 USA.	robert.califf@duke.edu		Miranda, Marie Lynn/0000-0002-5670-0837				CALIFF RM, 1981, WESTERN J MED, V135, P321; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Grossman C, 2011, I MED NAT AC ENG WOR; Health Care Systems (HCS) Research Collaboratory, NIH COMM FUND OFF ST; Jha AK, 2010, HEALTH AFFAIR, V29, P1951, DOI 10.1377/hlthaff.2010.0502; Miranda Marie Lynn, 2011, N C Med J, V72, P132; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	9	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1747	1748		10.1001/jama.2012.28745	http://dx.doi.org/10.1001/jama.2012.28745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117773				2022-12-01	WOS:000310726500019
J	Stevenson, DG				Stevenson, David G.			Growing Pains for the Medicare Hospice Benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PALLIATIVE CARE		Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							Byock I, 1998, J Palliat Med, V1, P165, DOI 10.1089/jpm.1998.1.165; Groninger H, 2012, HEALTH AFFAIR, V31, P452, DOI [10.1377/hlthaff.2011.0473, 10.1377/HLTHAFF.2011.0473]; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Waldman P, 2011, WASHINGTON POST	5	16	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1683	1685		10.1056/NEJMp1208465	http://dx.doi.org/10.1056/NEJMp1208465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113479				2022-12-01	WOS:000310440800004
J	Hawkes, N				Hawkes, Nigel			Bright lights and big city health problems	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7226	10.1136/bmj.e7226	http://dx.doi.org/10.1136/bmj.e7226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109328				2022-12-01	WOS:000310778000003
J	Sainsbury, S; Niesser, J; Cramer, P				Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick			Structure and function of the initially transcribing RNA polymerase II-TFIIB complex	NATURE			English	Article							TRANSCRIPTION FACTOR IIB; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; PROMOTER CLEARANCE; IN-VIVO; INITIATION; MECHANISM; DNA; ARCHITECTURE	The general transcription factor (TF) IIB is required for RNA polymerase (Pol) II initiation and extends with its B-reader element into the Pol II active centre cleft. Low-resolution structures of the Pol II-TFIIB complex(1,2) indicated how TFIIB functions in DNA recruitment, but they lacked nucleic acids and half of the B-reader, leaving other TFIIB functions(3,4) enigmatic. Here we report crystal structures of the Pol II-TFIIB complex from the yeast Saccharomyces cerevisiae at 3.4 angstrom resolution and of an initially transcribing complex that additionally contains the DNA template and a 6-nucleotide RNA product. The structures reveal the entire B-reader and protein-nucleic acid interactions, and together with functional data lead to a more complete understanding of transcription initiation. TFIIB partially closes the polymerase cleft to position DNA and assist in its opening. The B-reader does not reach the active site but binds the DNA template strand upstream to assist in the recognition of the initiator sequence and in positioning the transcription start site. TFIIB rearranges active-site residues, induces binding of the catalytic metal ion B, and stimulates initial RNA synthesis allosterically. TFIIB then prevents the emerging DNA-RNA hybrid duplex from tilting, which would impair RNA synthesis. When the RNA grows beyond 6 nucleotides, it is separated from DNA and is directed to its exit tunnel by the B-reader loop. Once the RNA grows to 12-13 nucleotides, it clashes with TFIIB, triggering TFIIB displacement and elongation complex formation. Similar mechanisms may underlie all cellular transcription because all eukaryotic and archaeal RNA polymerases use TFIIB-like factors(5), and the bacterial initiation factor sigma has TFIIB-like topology(1,2) and contains the loop region 3.2 that resembles the B-reader loop in location, charge and function(6-8). TFIIB and its counterparts may thus account for the two fundamental properties that distinguish RNA from DNA polymerases: primer-independent chain initiation and product separation from the template.	[Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de			Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation	We thank C. Bajen, A. Cheung, S. Etzold, F. Hog, D. Kostrewa, N. Pirkl and other members of the Cramer laboratory. Part of this work was performed at the Swiss Light Source (SLS) at the Paul Scherrer Institut, Villigen, Switzerland. S. S. was supported by a postdoctoral fellowship from the Alexander-von-Humboldt Foundation. P. C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMUinnovativ project Bioimaging Network, the Jung-Stiftung, and the Vallee Foundation.	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hawkes NA, 1999, J BIOL CHEM, V274, P14337, DOI 10.1074/jbc.274.20.14337; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; SIKORSKI RS, 1989, GENETICS, V122, P19; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Yang C, 2012, NUCLEIC ACIDS RES, V40, P6495, DOI 10.1093/nar/gks323; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	34	129	131	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					437	U191		10.1038/nature11715	http://dx.doi.org/10.1038/nature11715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23151482	Green Published			2022-12-01	WOS:000313615900059
J	Shimazu, T; Hirschey, MD; Newman, J; He, WJ; Shirakawa, K; Le Moan, N; Grueter, CA; Lim, H; Saunders, LR; Stevens, RD; Newgard, CB; Farese, RV; de Cabo, R; Ulrich, S; Akassoglou, K; Verdin, E				Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Le Moan, Natacha; Grueter, Carrie A.; Lim, Hyungwook; Saunders, Laura R.; Stevens, Robert D.; Newgard, Christopher B.; Farese, Robert V., Jr.; de Cabo, Rafael; Ulrich, Scott; Akassoglou, Katerina; Verdin, Eric			Suppression of Oxidative Stress by beta-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor	SCIENCE			English	Article							KETONE-BODIES; METABOLISM; EXPRESSION; CELLS	Concentrations of acetyl-coenzyme A and nicotinamide adenine dinucleotide (NAD(+)) affect histone acetylation and thereby couple cellular metabolic status and transcriptional regulation. We report that the ketone body D-beta-hydroxybutyrate (beta OHB) is an endogenous and specific inhibitor of class I histone deacetylases (HDACs). Administration of exogenous beta OHB, or fasting or calorie restriction, two conditions associated with increased beta OHB abundance, all increased global histone acetylation in mouse tissues. Inhibition of HDAC by beta OHB was correlated with global changes in transcription, including that of the genes encoding oxidative stress resistance factors FOXO3A and MT2. Treatment of cells with beta OHB increased histone acetylation at the Foxo3a and Mt2 promoters, and both genes were activated by selective depletion of HDAC1 and HDAC2. Consistent with increased FOXO3A and MT2 activity, treatment of mice with beta OHB conferred substantial protection against oxidative stress.	[Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Lim, Hyungwook; Saunders, Laura R.; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Lim, Hyungwook; Saunders, Laura R.; Farese, Robert V., Jr.; Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Le Moan, Natacha; Akassoglou, Katerina] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Grueter, Carrie A.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Grueter, Carrie A.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC 27704 USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Ulrich, Scott] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Verdin, E (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	Newman, John C/L-8112-2013; Verdin, Eric/AAB-7999-2019; de Cabo, Rafael/E-7996-2010; SHIMAZU, Tadahiro/ABC-3950-2020; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; Akassoglou, Katerina/0000-0002-2632-1465; Grueter, Carrie/0000-0002-1913-2527; Verdin, Eric/0000-0003-3703-3183; de Cabo, Rafael/0000-0002-3354-2442; Hirschey, Matthew/0000-0003-4541-5376	Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, P30DK026743, R01DK056084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000212, ZIAAG000361, ZIAAG000368, ZIAAG000363] Funding Source: NIH RePORTER	Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Carroll for graphics, G. Howard and S. Ordway for editorial assistance, V. Fonseca for administrative assistance, and A. Brunet (Stanford University) for reagents. Supported by funds from the Gladstone Institutes.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kawai K, 2000, CHEM RES TOXICOL, V13, P1275, DOI 10.1021/tx000119l; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; KOESLAG JH, 1980, J PHYSIOL-LONDON, V301, P79, DOI 10.1113/jphysiol.1980.sp013190; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; OWEN OE, 1973, J CLIN INVEST, V52, P2606, DOI 10.1172/JCI107453; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	22	919	951	6	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					211	214		10.1126/science.1227166	http://dx.doi.org/10.1126/science.1227166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223453	Green Accepted			2022-12-01	WOS:000313328200046
J	Torjesen, I				Torjesen, Ingrid			Sentinel node biopsy for melanoma: unnecessary treatment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LYMPHADENECTOMY; METASTASES; RECURRENCE; DISSECTION					ingrid_torjesen@hotmail.com						Agnese DM, 2003, SURGERY, V134, P542, DOI 10.1016/S0039-6060(03)00275-7; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P1566, DOI 10.1245/s10434-008-9885-2; Campanholi LL, 2011, J LYMPHOEDEMA, V6, P30; Cancer Research UK, CANC INC STAT; Cormier JN, 2005, J CLIN ONCOL, V23, P6054, DOI 10.1200/JCO.2005.21.360; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Morton D, 2010, ANN SURG ONCOL, V17, pS22; Morton DL, 2004, BRIT J DERMATOL, V151, P308, DOI 10.1111/j.1365-2133.2004.06133.x; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Morton DL, 2012, CLIN EXP METASTASIS; Morton DL, 1990, 42 ANN M SOC SURG ON; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; National Cancer Institute, MEL; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SKIN; *OFF NAT STAT, 2003, CANC REG STAT ENGL 2; Reeves ME, 2003, ANN SURG ONCOL, V10, P27, DOI 10.1245/ASO.2003.03.020; Rosenberg SA, 2008, NAT CLIN PRACT ONCOL, V5, P1, DOI 10.1038/ncponc1022; Shamsian N, 2004, BMJ-BRIT MED J, V329, P1272; Skin Cancer Foundation, SKIN CANC FACTS; Thomas JM, 2008, NAT CLIN PRACT ONCOL, V5, P18, DOI 10.1038/ncponc1014; Thomas J Meirion, 2010, Skinmed, V8, P222; Wong SL, SENTINEL LYMPH NODE	22	25	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8645	10.1136/bmj.e8645	http://dx.doi.org/10.1136/bmj.e8645			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299845	Green Submitted			2022-12-01	WOS:000313553800010
J	Taniguchi, H; Lu, JT; Huang, ZJ				Taniguchi, Hiroki; Lu, Jiangteng; Huang, Z. Josh			The Spatial and Temporal Origin of Chandelier Cells in Mouse Neocortex	SCIENCE			English	Article							CEREBRAL-CORTEX; NEURONS; INTERNEURON; SPECIFICATION; GENERATION	Diverse gamma-aminobutyric acid-releasing interneurons regulate the functional organization of cortical circuits and derive from multiple embryonic sources. It remains unclear to what extent embryonic origin influences interneuron specification and cortical integration because of difficulties in tracking defined cell types. Here, we followed the developmental trajectory of chandelier cells (ChCs), the most distinct interneurons that innervate the axon initial segment of pyramidal neurons and control action potential initiation. ChCs mainly derive from the ventral germinal zone of the lateral ventricle during late gestation and require the homeodomain protein Nkx2.1 for their specification. They migrate with stereotyped routes and schedule and achieve specific laminar distribution in the cortex. The developmental specification of this bona fide interneuron type likely contributes to the assembly of a cortical circuit motif.	[Taniguchi, Hiroki; Lu, Jiangteng; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X	NIH [R01 MH094705]; Japan Science and Technology Agency; Brain and Behavior Research Foundation (NARSAD); Patterson Foundation; Simons Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Brain and Behavior Research Foundation (NARSAD)(NARSAD); Patterson Foundation; Simons Foundation; NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank G. Miyoshi for technical advice of fate-mapping experiments and helpful discussion. Support by NIH R01 MH094705. H.T. is a Precursory Research for Embryonic Science and Technology investigator supported by Japan Science and Technology Agency and was supported by a Brain and Behavior Research Foundation (NARSAD) Postdoctoral Fellowship. J.L. is in part supported by a Patterson Foundation Postdoctoral Fellowship. Z.J.H. is supported by the Simons Foundation and a NARSAD Distinguished Investigator award.	ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lewis DA, 2011, DEV NEUROBIOL, V71, P118, DOI 10.1002/dneu.20825; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009	20	171	173	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					70	74		10.1126/science.1227622	http://dx.doi.org/10.1126/science.1227622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23180771	Green Accepted			2022-12-01	WOS:000312985800053
J	Sinha, SK; Detsky, AS				Sinha, Samir K.; Detsky, Allan S.			Measure, Promote, and Reward Mobility to Prevent Falls in Older Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITALIZATION		[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Sinha, Samir K.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Sinha, Samir K.; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Sinha, Samir K.; Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						ASHER RAJ, 1947, BRIT MED J, V2, P967, DOI 10.1136/bmj.2.4536.967; Brown R, 2009, POLYM TEST, V28, P1, DOI 10.1016/j.polymertesting.2008.12.001; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Inouye SK, 2009, NEW ENGL J MED, V360, P2390, DOI 10.1056/NEJMp0900963; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Valkenet K, 2011, CLIN REHABIL, V25, P99, DOI 10.1177/0269215510380830	8	12	12	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2573	2574		10.1001/jama.2012.68313	http://dx.doi.org/10.1001/jama.2012.68313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268514				2022-12-01	WOS:000312916600021
J	Luga, V; Zhang, L; Viloria-Petit, AM; Ogunjimi, AA; Inanlou, MR; Chiu, E; Buchanan, M; Hosein, AN; Basik, M; Wrana, JL				Luga, Valbona; Zhang, Liang; Viloria-Petit, Alicia M.; Ogunjimi, Abiodun A.; Inanlou, Mohammad R.; Chiu, Elaine; Buchanan, Marguerite; Hosein, Abdel Nasser; Basik, Mark; Wrana, Jeffrey L.			Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration	CELL			English	Article							TUMOR INVASION; POLARITY; METASTASIS; DEGRADATION; PROGRESSION; PLASTICITY; SECRETION; MOTILITY; RHOA	Stroma in the tumor microenvironment plays a critical role in cancer progression, but how it promotes metastasis is poorly understood. Exosomes are small vesicles secreted by many cell types and enable a potent mode of intercellular communication. Here, we report that fibroblast-secreted exosomes promote breast cancer cell (BCC) protrusive activity and motility via Wnt-planar cell polarity (PCP) signaling. We show that exosome-stimulated BCC protrusions display mutually exclusive localization of the core PCP complexes, Fzd-Dvl and Vangl-Pk. In orthotopic mouse models of breast cancer, coinjection of BCCs with fibroblasts dramatically enhances metastasis that is dependent on PCP signaling in BCCs and the exosome component, Cd81 in fibroblasts. Moreover, we demonstrate that trafficking in BCCs promotes tethering of autocrine Wnt11 to fibroblast-derived exosomes. This work reveals an intercellular communication pathway whereby fibroblast exosomes mobilize autocrine Wnt-PCP signaling to drive BCC invasive behavior.	[Luga, Valbona; Zhang, Liang; Ogunjimi, Abiodun A.; Inanlou, Mohammad R.; Chiu, Elaine; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Luga, Valbona; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Viloria-Petit, Alicia M.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Buchanan, Marguerite; Hosein, Abdel Nasser; Basik, Mark] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3S 1Y7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Guelph; Lady Davis Institute; McGill University	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013	Hosein, Abdel/0000-0003-1567-6700; ZHANG, Liang/0000-0003-3100-8593	CIHR [MOP14339]; Terry Fox Research Institute; Krembil Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; Krembil Foundation	We thank Eduardo Aguiar for assistance with cloning, Katherine Huang and Payman Tehrani for help with data analysis, Douglas Holmyard for technical support with EM, Brett Larsen and Cunjie Zhang for assistance with proteomic studies, and members of the J.L.W. lab for discussion. We thank Drs. Liliana Attisano, Rod Bremner, and Helen McNeill for critical review of the manuscript. This work was supported by funds from CIHR (to J.L.W. grant MOP14339), a Terry Fox Research Institute group grant, and the Krembil Foundation. J.L.W. is the Mary Janigan Chair in Experimental Therapeutics.	Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Finak G, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1608; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; SANFORD KK, 1956, CANCER RES, V16, P162; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	30	899	937	11	267	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1542	1556		10.1016/j.cell.2012.11.024	http://dx.doi.org/10.1016/j.cell.2012.11.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260141	Bronze			2022-12-01	WOS:000312890300018
J	Boehncke, WH				Boehncke, Wolf-Henning			PERSPECTIVE Don't be superficial	NATURE			English	Editorial Material							PSORIASIS; RISK		Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland	University of Geneva	Boehncke, WH (corresponding author), Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland.	wolf-henning.boehncke@hcuge.ch						Coimbra S, 2010, J EUR ACAD DERMATOL, V24, P1386, DOI 10.1111/j.1468-3083.2010.03647.x; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Karadag AS, 2010, INT J DERMATOL, V49, P642, DOI 10.1111/j.1365-4632.2009.04358.x; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X	8	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					555	555		10.1038/492S55a	http://dx.doi.org/10.1038/492S55a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254972	Bronze, Green Published			2022-12-01	WOS:000312488200004
J	Garber, K				Garber, Ken			GENETICS Deep exploration	NATURE			English	Editorial Material							PSORIASIS											de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	4	16	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					556	557		10.1038/492S56a	http://dx.doi.org/10.1038/492S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254973	Bronze			2022-12-01	WOS:000312488200005
J	Ye, Y; Blaser, G; Horrocks, MH; Ruedas-Rama, MJ; Ibrahim, S; Zhukov, AA; Orte, A; Klenerman, D; Jackson, SE; Komander, D				Ye, Yu; Blaser, Georg; Horrocks, Mathew H.; Ruedas-Rama, Maria J.; Ibrahim, Shehu; Zhukov, Alexander A.; Orte, Angel; Klenerman, David; Jackson, Sophie E.; Komander, David			Ubiquitin chain conformation regulates recognition and activity of interacting proteins	NATURE			English	Article							FLUORESCENCE COINCIDENCE SPECTROSCOPY; LINEAR POLYUBIQUITIN CHAINS; KAPPA-B ACTIVATION; SINGLE-MOLECULE; STRUCTURAL BASIS; DIUBIQUITIN; BINDING; NMR; E2	Mechanisms of protein recognition have been extensively studied for single-domain proteins(1), but are less well characterized for dynamic multidomain systems. Ubiquitin chains represent a biologically important multidomain system that requires recognition by structurally diverse ubiquitin-interacting proteins(2,3). Ubiquitin chain conformations in isolation are often different from conformations observed in ubiquitin-interacting protein complexes, indicating either great dynamic flexibility or extensive chain remodelling upon binding. Using single-molecule fluorescence resonance energy transfer, we show that Lys 63-, Lys 48- and Met 1-linked diubiquitin exist in several distinct conformational states in solution. Lys 63- and Met 1-linked diubiquitin adopt extended 'open' and more compact 'closed' conformations, and ubiquitin-binding domains and deubiquitinases (DUBs) select pre-existing conformations. By contrast, Lys 48-linked diubiquitin adopts predominantly compact conformations. DUBs directly recognize existing conformations, but may also remodel ubiquitin chains to hydrolyse the isopeptide bond. Disruption of the Lys 48-diubiquitin interface changes conformational dynamics and affects DUB activity. Hence, conformational equilibria in ubiquitin chains provide an additional layer of regulation in the ubiquitin system, and distinct conformations observed in differently linked polyubiquitin may contribute to the specificity of ubiquitin-interacting proteins.	[Ye, Yu; Komander, David] MRC, Mol Biol Lab, Div Prot & Nucle Acids Chem, Cambridge CB2 0QH, England; [Blaser, Georg; Horrocks, Mathew H.; Ibrahim, Shehu; Zhukov, Alexander A.; Klenerman, David; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ruedas-Rama, Maria J.; Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain	MRC Laboratory Molecular Biology; University of Cambridge; University of Granada	Komander, D (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acids Chem, Cambridge CB2 0QH, England.	dk10012@cam.ac.uk; sej13@cam.ac.uk; dk@mrc-lmb.cam.ac.uk	Ruedas-Rama, Maria Jose/L-2277-2014; Orte, Angel/J-4810-2012; Ye, Yu/ABE-7107-2021; Ye, Yu/D-5727-2019	Ruedas-Rama, Maria Jose/0000-0003-0853-187X; Orte, Angel/0000-0003-1905-4183; Ye, Yu/0000-0003-0441-6399; Ye, Yu/0000-0003-0441-6399; Klenerman, David/0000-0001-7116-6954; Jackson, Sophie/0000-0002-7470-9800; Horrocks, Mathew/0000-0001-5495-5492	Medical Research Council [U105192732]; EMBO Young Investigator Program; BBSRC; Newton Trust; EMBO YIP small grant; EPSRC; Biotechnology and Biological Sciences Research Council [BB/F00219X/1] Funding Source: researchfish; Medical Research Council [MC_U105192732] Funding Source: researchfish; BBSRC [BB/F00219X/1] Funding Source: UKRI; MRC [MC_U105192732] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton Trust; EMBO YIP small grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the Komander, Jackson and Klenerman laboratories, R. Williams, S. Freund, C. Johnson, S. McLaughlin and A. Fersht for discussions. Work in the Komander laboratory is supported by the Medical Research Council (U105192732) and the EMBO Young Investigator Program. G. B. and S. I. were supported by the BBSRC, the Newton Trust and an EMBO YIP small grant to D.Ko. Work in the Klenerman laboratory is supported by EPSRC.	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clarke RW, 2007, ANAL CHEM, V79, P2771, DOI 10.1021/ac062188w; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2011, J BIOL CHEM, V286, P37496, DOI 10.1074/jbc.M111.256354; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lo Conte L, 1999, J MOL BIOL, V285, P2177; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Orte A, 2008, ANAL CHEM, V80, P8389, DOI 10.1021/ac8009092; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rohaim A, 2012, ACTA CRYSTALLOGR D, V68, P102, DOI 10.1107/S0907444911051195; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	29	129	131	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					266	270		10.1038/nature11722	http://dx.doi.org/10.1038/nature11722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201676	Green Accepted, Green Submitted			2022-12-01	WOS:000312259300045
J	Newbatt, E; Beckles, Z; Ullman, R; Lumsden, MA				Newbatt, Emma; Beckles, Zosia; Ullman, Roz; Lumsden, Mary Ann		Guideline Dev Grp	Ectopic pregnancy and miscarriage: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Newbatt, Emma; Beckles, Zosia; Ullman, Roz] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Lumsden, Mary Ann] Univ Glasgow, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Ullman, R (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	rullman@ncc-wch.org.uk	Beckles, Zosia/R-9630-2019; Ramlakhan, Shammi/ABD-5794-2020; Riggs, Elisha/K-4267-2019	Beckles, Zosia/0000-0003-4352-2266; Ramlakhan, Shammi/0000-0003-1792-0842; Riggs, Elisha/0000-0003-0799-7467	NICE	NICE	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: EN, ZB, and RU have support from NICE for the submitted work; MAL receives travel, accommodation, and meetings expenses from the Royal College of Obstetricians and Gynaecologists for sitting on multiple committees, including the Guideline Development Group; MAL's institution receives consultancy fees from Abbott Pharmaceuticals (for drugs in heavy menstrual bleeding); no other financial relationships with any organisation that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work	HESonline Hospital Episode Statistics, 2010, NHS MAT STAT 2010 11; National Institute for Health and Clinical Excellence, 2012, MANAGEMENT OUTCOME E; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Poddar A, 2011, J OBSTET GYNAECOL, V31, P640, DOI 10.3109/01443615.2011.593650	4	27	28	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e8136	10.1136/bmj.e8136	http://dx.doi.org/10.1136/bmj.e8136			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MU	23236034				2022-12-01	WOS:000312495100011
J	Xiong, W; Grillet, N; Elledge, HM; Wagner, TFJ; Zhao, B; Johnson, KR; Kazmierczak, P; Muller, U				Xiong, Wei; Grillet, Nicolas; Elledge, Heather M.; Wagner, Thomas F. J.; Zhao, Bo; Johnson, Kenneth R.; Kazmierczak, Piotr; Mueller, Ulrich			TMHS Is an Integral Component of the Mechanotransduction Machinery of Cochlear Hair Cells	CELL			English	Article							USHER-SYNDROME PROTEINS; HEARING-LOSS; TIP-LINK; MYOSIN VIIA; FAST ADAPTATION; GAMMA-SUBUNIT; ION CHANNELS; WALTZER MICE; MOUSE MODEL; CADHERIN-23	Hair cells are mechanosensors for the perception of sound, acceleration, and fluid motion. Mechanotransduction channels in hair cells are gated by tip links, which connect the stereocilia of a hair cell in the direction of their mechanical sensitivity. The molecular constituents of the mechanotransduction channels of hair cells are not known. Here, we show that mechanotransduction is impaired in mice lacking the tetraspan TMHS. TMHS binds to the tip-link component PCDH15 and regulates tip-link assembly, a process that is disrupted by deafness-causing Tmhs mutations. TMHS also regulates transducer channel conductance and is required for fast channel adaptation. TMHS therefore resembles other ion channel regulatory subunits such as the transmembrane alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor regulatory proteins (TARPs) of AMPA receptors that facilitate channel transport and regulate the properties of pore-forming channel subunits. We conclude that TMHS is an integral component of the hair cell's mechanotransduction machinery that functionally couples PCDH15 to the transduction channel.	[Xiong, Wei; Grillet, Nicolas; Elledge, Heather M.; Wagner, Thomas F. J.; Zhao, Bo; Kazmierczak, Piotr; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Johnson, Kenneth R.] Jackson Lab, Bar Harbor, ME 04609 USA	Scripps Research Institute; Jackson Laboratory	Muller, U (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umueller@scripps.edu	Xiong, Wei/AAY-5944-2020; Kaźmierczak, Piotr/AAD-7059-2021; Zhao, Bo/S-6404-2019	Xiong, Wei/0000-0002-2784-7696; Kaźmierczak, Piotr/0000-0002-4060-3055; Zhao, Bo/0000-0003-2881-5714; Grillet, Nicolas/0000-0001-8007-9246	NIH [DC005965, DC007704]; Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; Bundy Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004301, R01DC005965, R01DC007704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; Bundy Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	W.X. carried out the electrophysiological recordings, calcium imaging experiments, and the analysis of protein localization in transfected cells. W. X. and T.F.J.W. developed the electroporation technique. N.G. carried out in situ hybridizations and the analysis of hair cell morphology and tip links by SEM. W.X., N.G., T.F.J.W., and P.K. carried out immunolocalization experiments in hair cells. H. M. E. and B.Z. generated plasmid constructs and carried out co-immunoprecipitation experiments. K.R.J. provided TMHS mutant mice and generated the TMHS antibody. W. X., N.G., T.F.J.W., P. K., and U. M. contributed to the planning of the work. U. M. wrote the manuscript with help from W. X. and N.G. We thank S. W. Webb and S. R. Harkins-Perry for cloning constructs. This work was supported by the NIH (DC005965 and DC007704 to U. M.), the Dorris Neuroscience Center, the Skaggs Institute for Chemical Biology, and the Bundy Foundation (to W.X. and U.M.).	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Caberlotto E, 2011, P NATL ACAD SCI USA, V108, P5825, DOI 10.1073/pnas.1017114108; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Longo-Guess CM, 2007, MAMM GENOME, V18, P646, DOI 10.1007/s00335-007-9049-x; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Sakaguchi H, 2009, CURR OPIN OTOLARYNGO, V17, P388, DOI 10.1097/MOO.0b013e3283303472; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Shabbir MI, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039834; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004	51	160	164	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1283	1295		10.1016/j.cell.2012.10.041	http://dx.doi.org/10.1016/j.cell.2012.10.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217710	Green Accepted, Bronze			2022-12-01	WOS:000311999900017
J	Chang, CY; Furlong, LA				Chang, Christina Y.; Furlong, Lesley-Anne			Microbial Stowaways in Topical Antiseptic Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chang, Christina Y.; Furlong, Lesley-Anne] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Chang, CY (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P347; [Anonymous], 2009, ALLERGY INFECT ASS M; FDA, ARCH REC MARK WITHDR; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07	4	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2170	2173		10.1056/NEJMp1212680	http://dx.doi.org/10.1056/NEJMp1212680			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215554				2022-12-01	WOS:000311890600003
J	von der Heyden, BP; Roychoudhury, AN; Mtshali, TN; Tyliszczak, T; Myneni, SCB				von der Heyden, B. P.; Roychoudhury, A. N.; Mtshali, T. N.; Tyliszczak, T.; Myneni, S. C. B.			Chemically and Geographically Distinct Solid-Phase Iron Pools in the Southern Ocean	SCIENCE			English	Article							SPECTROSCOPY	Iron is a limiting nutrient in many parts of the oceans, including the unproductive regions of the Southern Ocean. Although the dominant fraction of the marine iron pool occurs in the form of solid-phase particles, its chemical speciation and mineralogy are challenging to characterize on a regional scale. We describe a diverse array of iron particles, ranging from 20 to 700 nanometers in diameter, in the waters of the Southern Ocean euphotic zone. Distinct variations in the oxidation state and composition of these iron particles exist between the coasts of South Africa and Antarctica, with different iron pools occurring in different frontal zones. These speciation variations can result in solubility differences that may affect the production of bioavailable dissolved iron.	[von der Heyden, B. P.; Roychoudhury, A. N.; Mtshali, T. N.] Univ Stellenbosch, Dept Earth Sci, ZA-7602 Matieland, South Africa; [von der Heyden, B. P.; Myneni, S. C. B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Mtshali, T. N.] CSIR, ZA-7600 Stellenbosch, South Africa; [Tyliszczak, T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Stellenbosch University; Princeton University; Council for Scientific & Industrial Research (CSIR) - South Africa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Roychoudhury, AN (corresponding author), Univ Stellenbosch, Dept Earth Sci, Private Bag X1, ZA-7602 Matieland, South Africa.	roy@sun.ac.za		von der Heyden, Bjorn/0000-0002-4006-9278; Roychoudhury, Alakendra/0000-0002-5627-8891	National Research Foundation, South Africa (Blue Skies Program and SANAP); Stellenbosch University VR(R) fund; NSF (chemical sciences); U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program); Princeton in Africa program	National Research Foundation, South Africa (Blue Skies Program and SANAP); Stellenbosch University VR(R) fund; NSF (chemical sciences); U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program); Princeton in Africa program	Supported by grants from National Research Foundation, South Africa (Blue Skies Program and SANAP), Stellenbosch University VR(R) fund, NSF (chemical sciences), the U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program), and the Princeton in Africa program. We thank the support staff at the Advanced Light Source for helping with data collection and sample preparation. This work benefited from discussions with F. Morel, D. Sigman, and four anonymous reviewers.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; BALISTRIERI LS, 1983, GEOCHIM COSMOCHIM AC, V47, P1091, DOI 10.1016/0016-7037(83)90239-9; Bluhm H, 2006, J ELECTRON SPECTROSC, V150, P86, DOI 10.1016/j.elspec.2005.07.005; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/ngeo964, 10.1038/NGEO964]; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chever F, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005880; Cornell R.M., 2003, IRON OXIDES STRUCTUR, DOI [DOI 10.1002/3527602097, 10.1002/3527602097, DOI 10.1002/]; de Groot FMF, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012004; FITZPATRICK RW, 1982, GEODERMA, V27, P335, DOI 10.1016/0016-7061(82)90022-2; Kraemer SM, 2004, AQUAT SCI, V66, P3, DOI 10.1007/s00027-003-0690-5; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Nishioka J, 2005, MAR CHEM, V95, P51, DOI 10.1016/j.marchem.2004.06.040; Oakes M, 2012, ATMOS CHEM PHYS, V12, P745, DOI 10.5194/acp-12-745-2012; Pollard RT, 2002, DEEP-SEA RES PT II, V49, P3289, DOI 10.1016/S0967-0645(02)00084-X; Sunda W. G., 2001, BIOGEOCHEMISTRY IRON, P41; VANDERLAAN G, 1992, J PHYS-CONDENS MAT, V4, P4189, DOI 10.1088/0953-8984/4/16/019	16	68	69	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1199	1201		10.1126/science.1227504	http://dx.doi.org/10.1126/science.1227504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197531				2022-12-01	WOS:000311666200043
J	Savage, PE				Savage, Phillip E.			Algae Under Pressure and in Hot Water	SCIENCE			English	Editorial Material							BIO-OIL; EXTRACTION; BIOMASS		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Savage, PE (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	psavage@umich.edu	Savage, Phillip/ABC-8765-2021	Savage, Phillip/0000-0002-7902-3744				Akiya N, 2002, CHEM REV, V102, P2725, DOI 10.1021/cr000668w; Berl E, 1944, SCIENCE, V99, P309, DOI 10.1126/science.99.2573.309; Biller P, 2012, BIOFUELS-UK, V3, P603, DOI 10.4155/BFS.12.42; Chakraborty M, 2012, FUEL, V95, P63, DOI 10.1016/j.fuel.2011.10.055; Duan PG, 2011, BIORESOURCE TECHNOL, V102, P1899, DOI 10.1016/j.biortech.2010.08.013; Guan QQ, 2012, ENERG FUEL, V26, P4575, DOI 10.1021/ef3007992; Heilmann SM, 2010, BIOMASS BIOENERG, V34, P875, DOI 10.1016/j.biombioe.2010.01.032; Khan MY, 2012, ENERG FUEL, V26, P6137, DOI 10.1021/ef300935z; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031; Roussis SG, 2012, ENERG FUEL, V26, P5294, DOI 10.1021/ef300798b; Savage PE, 2010, RSC ENERGY ENVIRON S, P192; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Stucki S, 2009, ENERG ENVIRON SCI, V2, P535, DOI 10.1039/b819874h; U.S. Department of Energy, 2010, NAT ALG BIOF TECHN R; Valdez PJ, 2012, BIOMASS BIOENERG, V46, P317, DOI 10.1016/j.biombioe.2012.08.009	16	77	78	1	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1039	1040		10.1126/science.1224310	http://dx.doi.org/10.1126/science.1224310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180853				2022-12-01	WOS:000311390600032
J	Cheng, JK				Cheng, Jennifer K.			Confronting the Social Determinants of Health - Obesity, Neglect, and Inequity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital	Cheng, JK (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.							Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Murtagh L, 2011, JAMA-J AM MED ASSOC, V306, P206, DOI 10.1001/jama.2011.903; Waldfogel J, 1998, ARCH PEDIAT ADOLESC, V8, P104; Wilkinson RG, 2003, SOCIAL DETERMINANTS	4	21	21	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1976	1977		10.1056/NEJMp1209420	http://dx.doi.org/10.1056/NEJMp1209420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171094				2022-12-01	WOS:000311340200004
J	Shao, W; Zhang, SZ; Tang, M; Zhang, XH; Zhou, Z; Yin, YQ; Zhou, QB; Huang, YY; Liu, YJ; Wawrousek, E; Chen, T; Li, SB; Xu, M; Zhou, JN; Hu, G; Zhou, JW				Shao, Wei; Zhang, Shu-zhen; Tang, Mi; Zhang, Xin-hua; Zhou, Zheng; Yin, Yan-qing; Zhou, Qin-bo; Huang, Yuan-yuan; Liu, Ying-jun; Wawrousek, Eric; Chen, Teng; Li, Sheng-bin; Xu, Ming; Zhou, Jiang-ning; Hu, Gang; Zhou, Jia-wei			Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alpha B-crystallin	NATURE			English	Article							HUMAN-BRAIN; INFLAMMATION; MICROGLIA; PATHWAY; INNATE; MICE	Chronic neuroinflammation is a common feature of the ageing brain and some neurodegenerative disorders. However, the molecular and cellular mechanisms underlying the regulation of innate immunity in the central nervous system remain elusive. Here we show that the astrocytic dopamine D2 receptor (DRD2) modulates innate immunity through alpha B-crystallin (CRYAB), which is known to suppress neuroinflammation(1,2). We demonstrate that knockout mice lacking Drd2 showed remarkable inflammatory response in multiple central nervous system regions and increased the vulnerability of nigral dopaminergic neurons to neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity(3). Astrocytes null for Drd2 became hyper-responsive to immune stimuli with a marked reduction in the level of CRYAB. Preferential ablation of Drd2 in astrocytes robustly activated astrocytes in the substantia nigra. Gain- or loss-of-function studies showed that CRYAB is critical for DRD2-mediated modulation of innate immune response in astrocytes. Furthermore, treatment of wildtype mice with the selective DRD2 agonist quinpirole increased resistance of the nigral dopaminergic neurons to MPTP through partial suppression of inflammation. Our study indicates that astrocytic DRD2 activation normally suppresses neuroinflammation in the central nervous system through a CRYAB-dependent mechanism, and provides a new strategy for targeting the astrocyte-mediated innate immune response in the central nervous system during ageing and disease.	[Shao, Wei; Zhang, Shu-zhen; Tang, Mi; Zhang, Xin-hua; Zhou, Zheng; Yin, Yan-qing; Zhou, Qin-bo; Huang, Yuan-yuan; Liu, Ying-jun; Zhou, Jia-wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Tang, Mi; Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, Nanjing 210029, Jiangsu, Peoples R China; [Wawrousek, Eric] NEI, NIH, Bethesda, MD 20892 USA; [Chen, Teng; Li, Sheng-bin] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710061, Shanxi, Peoples R China; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Zhou, Jiang-ning] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Xi'an Jiaotong University; University of Chicago; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, JW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.	jwzhou@ion.ac.cn	Liu, Yingjun/AAW-5353-2020; Shao, Wei/GNW-5579-2022; Zhou, JiangNing/N-3374-2013; Zhou, Zheng/AAA-8079-2020; Wawrousek, Eric/A-4547-2008	Liu, Yingjun/0000-0003-1543-1965; Shao, Wei/0000-0002-8782-4904; Zhou, Qinbo/0000-0002-7967-2138; Zhou, Jiawei/0000-0002-1844-9178; Zhang, Xin-hua/0000-0002-5702-6733	Chinese Academy of Sciences; National Basic Research Program of China [2011CBA00408, 2011CB504102]; Natural Science Foundation of China [31021063, 31123002]; Shanghai Metropolitan Fund for Research and Development; NATIONAL EYE INSTITUTE [ZICEY000458] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Metropolitan Fund for Research and Development; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Zhang and Y.J. Yan for technical assistance; L. Zhu for technical support in DNA microarray analysis; the Optical Imaging Center of ION and the Cell Biology Analysis Center of IBCB for technical support in confocal microscopy; T. L. Hagemann for providing the CRYAB construct; R. Quinlan for anti-CRYAB antibodies, Y. Q. Ding for providing the Drd1 and Drd2 gene null mice; we also thank Shanghai Research Center for Model Organisms for creating Drd2-floxed mice. This work was supported by grants from the Chinese Academy of Sciences, National Basic Research Program of China (nos 2011CBA00408 and 2011CB504102), Natural Science Foundation of China (nos 31021063 and 31123002), and Shanghai Metropolitan Fund for Research and Development.	ANTONINI A, 1993, ANN NY ACAD SCI, V695, P81, DOI 10.1111/j.1749-6632.1993.tb23033.x; Bal A, 1994, Brain Res Mol Brain Res, V23, P204; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Cai L, 2011, NEUROSCIENCE, V181, P196, DOI 10.1016/j.neuroscience.2011.02.059; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saijo K, 2010, ADV IMMUNOL, V106, P21, DOI 10.1016/S0065-2776(10)06002-5; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; Xu M, 1997, NEURON, V19, P837, DOI 10.1016/S0896-6273(00)80965-4; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	22	267	286	7	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					90	94		10.1038/nature11748	http://dx.doi.org/10.1038/nature11748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23242137				2022-12-01	WOS:000314741200040
J	Moynihan, R				Moynihan, Ray			What is disease? And why it's a healthy question	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Bewley S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6894; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; ROSENBERG CE, 1989, MILBANK Q, V67, P1, DOI 10.2307/3350182; Rosenberg CE, 2002, MILBANK Q, V80, P237, DOI 10.1111/1468-0009.t01-1-00003; Rosenberg C, 2009, LANCET, V373, P802, DOI 10.1016/S0140-6736(09)60467-0; Tikkinen KAO, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001632; Wise J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7910	10	3	3	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								f107	10.1136/bmj.f107	http://dx.doi.org/10.1136/bmj.f107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZR	23303894				2022-12-01	WOS:000313554900007
J	Hopkins, DR				Hopkins, Donald R.			Disease Eradication	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LYMPHATIC FILARIASIS ELIMINATION; JANUARY 2010-SEPTEMBER 2011; POLIOMYELITIS ERADICATION; PROGRESS; DRACUNCULIASIS; AFRICA; ONCHOCERCIASIS; TRANSMISSION; NIGERIA		Carter Ctr, Atlanta, GA 30307 USA		Hopkins, DR (corresponding author), Carter Ctr, 453 Freedom Pky, Atlanta, GA 30307 USA.	sdsulli@emory.edu						Abdelwahab Jalaa, 2011, Morbidity and Mortality Weekly Report, V60, P1482; Alexander Jim, 2011, Morbidity and Mortality Weekly Report, V60, P1523; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P195; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P341; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P417; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P309; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P199; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P321; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P25; [Anonymous], 2010, SCIENCE, V328, P850, DOI 10.1126/science.328.5980.850; [Anonymous], FIN RES REQ 2012 201; [Anonymous], 2011, MMWR-MORBID MORTAL W, V60, P1053; Cochi SL, 2011, DIS ERADICATION 21 C, V7; Djidina Mathias R., 2011, Morbidity and Mortality Weekly Report, V60, P744; Dorkenoo Ameyo, 2011, Morbidity and Mortality Weekly Report, V60, P989; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Heymann DL, 2011, TROPICAL INFECT DIS, P40; Hopkins D.R, 1998, ERADICATION INFECT D; Hopkins Donald R., 2011, Morbidity and Mortality Weekly Report, V60, P1450; HOPKINS DR, 1981, SCIENCE, V212, P495, DOI 10.1126/science.6451929; Hopkins DR, 2005, AM J TROP MED HYG, V72, P1; HOPKINS DR, 1991, B WORLD HEALTH ORGAN, V69, P533; Hopkins DR, 2009, GLOBAL HLTH MAGAZINE, V3, P14; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Molyneux DH, 2006, LANCET, V367, P966, DOI 10.1016/S0140-6736(06)68404-3; Nutman TB, 2011, TROPICAL INFECT DIS, P729; Ogbuanu I. U., 2011, Morbidity and Mortality Weekly Report, V60, P441; Ogden HG, 1987, HHS PUBLICATION; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pigman HA, 2005, CONQUERING POLIO; Richards FO, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001346; RUIZTIBEN E, 2008, INT ENCY PUBLIC HLTH, P294; Stepan Nancy Leys, 2011, ERADICATION RIDDING; WATTS SJ, 1987, AM J TROP MED HYG, V37, P119, DOI 10.4269/ajtmh.1987.37.119; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; World Health Assembly, 1997, WHA50 29 EL LYMPH FI	39	61	62	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					54	63		10.1056/NEJMra1200391	http://dx.doi.org/10.1056/NEJMra1200391			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281976				2022-12-01	WOS:000312930600005
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Conversation with a pill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8664	10.1136/bmj.e8664	http://dx.doi.org/10.1136/bmj.e8664			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284160				2022-12-01	WOS:000313236300002
J	Rosenbluh, J; Nijhawan, D; Cox, AG; Li, XN; Neal, JT; Schafer, EJ; Zack, TI; Wang, XX; Tsherniak, A; Schinzel, AC; Shao, DD; Schumacher, SE; Weir, BA; Vazquez, F; Cowley, GS; Root, DE; Mesirov, JP; Beroukhim, R; Kuo, CJ; Goessling, W; Hahn, WC				Rosenbluh, Joseph; Nijhawan, Deepak; Cox, Andrew G.; Li, Xingnan; Neal, James T.; Schafer, Eric J.; Zack, Travis I.; Wang, Xiaoxing; Tsherniak, Aviad; Schinzel, Anna C.; Shao, Diane D.; Schumacher, Steven E.; Weir, Barbara A.; Vazquez, Francisca; Cowley, Glenn S.; Root, David E.; Mesirov, Jill P.; Beroukhim, Rameen; Kuo, Calvin J.; Goessling, Wolfram; Hahn, William C.			beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis	CELL			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CELL-PROLIFERATION; SIGNALING PATHWAY; ZEBRAFISH EMBRYOS; GROWTH-CONTROL; COLON-CANCER; ORGAN SIZE; PHOSPHORYLATION; ACTIVATION	Wnt/beta-catenin signaling plays a key role in the pathogenesis of colon and other cancers; emerging evidence indicates that oncogenic beta-catenin regulates several biological processes essential for cancer initiation and progression. To decipher the role of beta-catenin in transformation, we classified beta-catenin activity in 85 cancer cell lines in which we performed genome-scale loss-of-function screens and found that beta-catenin active cancers are dependent on a signaling pathway involving the transcriptional regulator YAP1. Specifically, we found that YAP1 and the transcription factor TBX5 form a complex with beta-catenin. Phosphorylation of YAP1 by the tyrosine kinase YES1 leads to localization of this complex to the promoters of antiapoptotic genes, including BCL2L1 and BIRC5. A small-molecule inhibitor of YES1 impeded the proliferation of beta-catenin-dependent cancers in both cell lines and animal models. These observations define a beta-catenin-YAP1-TBX5 complex essential to the transformation and survival of beta-catenin-driven cancers.	[Rosenbluh, Joseph; Nijhawan, Deepak; Schafer, Eric J.; Wang, Xiaoxing; Schinzel, Anna C.; Shao, Diane D.; Weir, Barbara A.; Vazquez, Francisca; Goessling, Wolfram; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Zack, Travis I.; Schumacher, Steven E.; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Cox, Andrew G.; Schafer, Eric J.; Wang, Xiaoxing; Schinzel, Anna C.; Shao, Diane D.; Beroukhim, Rameen; Goessling, Wolfram; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Cox, Andrew G.; Goessling, Wolfram] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Schafer, Eric J.; Zack, Travis I.; Wang, Xiaoxing; Tsherniak, Aviad; Schinzel, Anna C.; Shao, Diane D.; Schumacher, Steven E.; Weir, Barbara A.; Vazquez, Francisca; Cowley, Glenn S.; Root, David E.; Mesirov, Jill P.; Beroukhim, Rameen; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Cox, Andrew G.; Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Xingnan; Neal, James T.; Kuo, Calvin J.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Zack, Travis I.] Harvard Univ, Program Biophys, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	william_hahn@dfci.harvard.edu	Vazquez, Francisca/AAA-3751-2020; Mesirov, Jill/AGF-7626-2022; Schumacher, Steven/E-9821-2013; Shao, Diane/GRO-3470-2022; Vazquez, Francisca/ABC-4620-2020	Vazquez, Francisca/0000-0002-2857-4685; Schumacher, Steven/0000-0002-6819-5647; Tsherniak, Aviad/0000-0002-3797-1877; Rosenbluh, Joseph/0000-0001-9815-8049; Goessling, Wolfram/0000-0001-9972-1569; Shao, Diane/0000-0003-2087-4082; Cox, Andrew/0000-0003-4189-9422; Kuo, Calvin/0000-0002-7427-5985; Neal, James/0000-0002-3962-8570	NIH/NCI [R01 CA140545, RC2 CA148268, U54 CA143798, U01 DK085527, U01 CA151920, R01 DK085720, U54 CA112962, R01 DK090311]; Pew Charitable Trust; Fidelity Foundation; Stanford University; DoD [W81XWH-10-1-0062]; Conquer Cancer Foundation; Sass Foundation; SPORE career development award [P50 CA127003]; NIH [F32 GM090437]; NATIONAL CANCER INSTITUTE [RC2CA148268, U01CA151920, F32CA124082, U54CA143798, P50CA127003, U54CA112962, R01CA109467, R01CA140545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085720, U01DK085527, R01DK090311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024, F32GM090437, T32GM007753] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Charitable Trust; Fidelity Foundation; Stanford University(Stanford University); DoD(United States Department of Defense); Conquer Cancer Foundation; Sass Foundation; SPORE career development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Hahn lab for helpful discussions and L. Gafney and L. Solomon for assistance with graphic arts. This work was supported in part by NIH/NCI grants R01 CA140545 (W.C.H.), RC2 CA148268 (W.C.H.), U54 CA143798 (R.B.), U01 DK085527 (C.J.K.), U01 CA151920 (C.J.K.), R01 DK085720 (C.J.K.), U54 CA112962 (A.T., J.P.M., and W.C.H.), R01 DK090311 (W.G.), the Pew Charitable Trust (W.G.), a Fidelity Foundation grant (C.J.K.), a Stanford University Dean's Fellowship (J.T.N.), a DoD breast cancer postdoctoral fellowship W81XWH-10-1-0062 (X.W.), Conquer Cancer Foundation Young Investigator Award and Sass Foundation Fellowship (D.N.), a SPORE career development award P50 CA127003 (J.R.), and an NIH F32 postdoctoral fellowship F32 GM090437 (J.R.). J.R. is a John Svenson postdoctoral fellow. W.C.H. and R.B. are consultants for Novartis Pharmaceuticals.	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nautiyal J, 2011, INT J CANCER, V128, P951, DOI 10.1002/ijc.25410; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tsai WB, 2005, DEV BIOL, V277, P129, DOI 10.1016/j.ydbio.2004.08.052; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	58	527	546	6	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1457	1473		10.1016/j.cell.2012.11.026	http://dx.doi.org/10.1016/j.cell.2012.11.026			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23245941	Green Accepted, Bronze			2022-12-01	WOS:000312890300012
J	Hughes, V				Hughes, Virginia			MICROBIOME Cultural differences	NATURE			English	Editorial Material																		Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Poulain M, 2004, EXP GERONTOL, V39, P1423, DOI 10.1016/j.exger.2004.06.016; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	5	12	13	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S14	S15		10.1038/492S14a	http://dx.doi.org/10.1038/492S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222668	Bronze			2022-12-01	WOS:000311893400008
J	Paley, MA; Kroy, DC; Odorizzi, PM; Johnnidis, JB; Dolfi, DV; Barnett, BE; Bikoff, EK; Robertson, EJ; Lauer, GM; Reiner, SL; Wherry, EJ				Paley, Michael A.; Kroy, Daniela C.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Bikoff, Elizabeth K.; Robertson, Elizabeth J.; Lauer, Georg M.; Reiner, Steven L.; Wherry, E. John			Progenitor and Terminal Subsets of CD8(+) T Cells Cooperate to Contain Chronic Viral Infection	SCIENCE			English	Article							TRANSCRIPTION FACTOR; PD-1 EXPRESSION; HIV-1 INFECTION; CUTTING EDGE; EXHAUSTION; BET; RESPONSES; ANTIGEN; CD4(+); DIFFERENTIATION	Chronic infections strain the regenerative capacity of antiviral T lymphocyte populations, leading to failure in long-term immunity. The cellular and molecular events controlling this regenerative capacity, however, are unknown. We found that two distinct states of virus-specific CD8(+) T cells exist in chronically infected mice and humans. Differential expression of the T-box transcription factors T-bet and Eomesodermin (Eomes) facilitated the cooperative maintenance of the pool of antiviral CD8(+) T cells during chronic viral infection. T-bet(hi) cells displayed low intrinsic turnover but proliferated in response to persisting antigen, giving rise to Eomes(hi) terminal progeny. Genetic elimination of either subset resulted in failure to control chronic infection, which suggests that an imbalance in differentiation and renewal could underlie the collapse of immunity in humans with chronic infections.	[Paley, Michael A.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Paley, Michael A.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Kroy, Daniela C.; Lauer, Georg M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Bikoff, Elizabeth K.; Robertson, Elizabeth J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; [Reiner, Steven L.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Lauer, Georg/J-1467-2018	Lauer, Georg/0000-0002-9792-4271; Paley, Michael/0000-0001-8724-3176	Deutsche Forschungsgemeinschaft [r3839/1-1]; NIH [T32-AI-07324, AI0663445, AI061699, AI076458, AI083022, AI078897, HHSN266200500030C, AI082630]; Dana Foundation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076458, U19AI083022, R01AI042370, R01AI076458, R01AI061699, U19AI082630, P01AI078897, T32AI007632, T32AI007324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Wherry, Reiner, and Artis labs for helpful comments and the UPenn Flow Cytometry Core for cell sorting. We thank E. Crosby for isolation of skin lymphocytes. Supported by Deutsche Forschungsgemeinschaft grant r3839/1-1 (D.C.K.); NIH grants T32-AI-07324 (M.A.P.), AI0663445 (G.M.L.), AI061699 and AI076458 (S.L.R.), AI083022, AI078897, and HHSN266200500030C (E.J.W.), and AI082630 (E.J.W. and G.M.L.); and the Dana Foundation (E.J.W. and G.M.L.). E.J.W. has a patent licensing agreement on therapeutic targeting of the PD-1 pathway (U.S. patent application no. 20070122378).	Arnold SJ, 2009, GENESIS, V47, P775, DOI 10.1002/dvg.20562; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Ciocca ML, 2012, J IMMUNOL, V188, P4145, DOI 10.4049/jimmunol.1200176; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Ribeiro-dos-Santos P, 2012, BLOOD, V119, P4928, DOI 10.1182/blood-2011-12-395186; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101	31	564	578	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1220	1225		10.1126/science.1229620	http://dx.doi.org/10.1126/science.1229620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197535	Green Accepted			2022-12-01	WOS:000311666200049
J	Merie, C; Kober, L; Olsen, PS; Andersson, C; Gislason, G; Jensen, JS; Torp-Pedersen, C				Merie, Charlotte; Kober, Lars; Olsen, Peter Skov; Andersson, Charlotte; Gislason, Gunnar; Jensen, Jan Skov; Torp-Pedersen, Christian			Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VALVULAR HEART-DISEASE; ANTITHROMBOTIC THERAPY; TASK-FORCE; ANTICOAGULATION; MANAGEMENT; OCTOGENARIANS; GUIDELINES; CARDIOLOGY; VALIDITY; REGISTRY	Context The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined. Objective To perform a nationwide study of the association of warfarin treatment with the risk of thromboembolic complications, bleeding incidents, and cardiovascular deaths after bioprosthetic AVR surgery. Design, Setting, and Participants Through a search in the Danish National Patient Registry, 4075 patients were identified who had bioprosthetic AVR surgery performed between January 1, 1997, and December 31, 2009. Concomitant comorbidity and medication were retrieved. Poisson regression models were used to determine risk. Main Outcome Measures Incidence rate ratios (IRRs) of strokes, thromboembolic events, cardiovascular deaths, and bleeding incidents by discontinuing warfarin as opposed to continued treatment 30 to 89 days, 90 to 179 days, 180 to 364 days, 365 to 729 days, and at least 730 days after surgery. Results The median duration of follow-up was 6.57 person-years. Estimated rates of events per 100 person-years in patients not treated with warfarin compared with those treated with warfarin with comparative absolute risk were 7.00 (95% CI, 4.07-12.06) vs 2.69 (95% CI, 1.49-4.87; adjusted IRR, 2.46; 95% CI, 1.09-5.55) for strokes; 13.07 (95% CI, 8.76-19.50) vs 3.97 (95% CI, 2.43-6.48; adjusted IRR, 2.93; 95% CI, 1.54-5.55) for thromboembolic events; 11.86 (95% CI, 7.81-18.01) vs 5.37 (95% CI, 3.54-8.16; adjusted IRR, 2.32; 95% CI, 1.28-4.22) for bleeding incidents; and 31.74 (95% CI, 24.69-40.79) vs 3.83 (95% CI, 2.35-6.25; adjusted IRR, 7.61; 95% CI, 4.37-13.26) for cardiovascular deaths within 30 to 89 days after surgery; and 6.50 (95% CI, 4.67-9.06) vs 2.08 (95% CI, 0.99-4.36; adjusted IRR, 3.51; 95% CI, 1.54-8.03) for cardiovascular deaths within 90 to 179 days after surgery. Conclusion Discontinuation of warfarin treatment within 6 months after bioprosthetic AVR surgery was associated with increased cardiovascular death. JAMA. 2012;308(20):2118-2125 www.jama.com	[Merie, Charlotte; Andersson, Charlotte; Gislason, Gunnar; Jensen, Jan Skov; Torp-Pedersen, Christian] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Copenhagen, Denmark; [Kober, Lars] Rigshosp, Dept Cardiol, Copenhagen Univ Hosp, Copenhagen, Denmark; [Olsen, Peter Skov] Rigshosp, Dept Cardiothorac Surg, Copenhagen Univ Hosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Merie, C (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	c.merie@mail.dk	Torp-Pedersen, Christian/E-5931-2013; Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466	Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark; Danish Agency for Science, Technology, and Innovation [FSS-11-120873]; Cardiome; sanofi-aventis; Merck; Bristol-Meyers Squibb	Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark; Danish Agency for Science, Technology, and Innovation; Cardiome; sanofi-aventis(Sanofi-Aventis); Merck(Merck & Company); Bristol-Meyers Squibb(Bristol-Myers Squibb)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kober reported receiving payment for giving lectures on unrelated issues from Servier as well as unrelated consultancy for Bayer. Dr Andersson reported receiving an independent research grant FSS-11-120873 unrelated to current study with 30 months salary and meeting expenses from the Danish Agency for Science, Technology, and Innovation. Dr Torp-Pedersen reported receiving consultancy fees for antiarrhythmic drugs from Cardiome, sanofi-aventis, Merck, and Bristol-Meyers Squibb. No other authors reported any financial disclosures.; This work was supported by the Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark.	Aramendi JL, 1998, J HEART VALVE DIS, V7, P610; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Brennan JM, 2012, J HEART VALVE DIS, V21, P78; Brown ML, 2008, J THORAC CARDIOV SUR, V135, P878, DOI 10.1016/j.jtcvs.2007.10.065; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Colli A, 2008, EUR J CARDIO-THORAC, V33, P531, DOI 10.1016/j.ejcts.2007.12.019; ElBardissi AW, 2010, J THORAC CARDIOV SUR, V139, P1137, DOI 10.1016/j.jtcvs.2009.10.064; Gaist D, 1997, DAN MED BULL, V44, P445; Gherli T, 2004, CIRCULATION, V110, P496, DOI 10.1161/01.CIR.0000137122.95108.52; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; HERAS M, 1995, J AM COLL CARDIOL, V25, P1111, DOI 10.1016/0735-1097(94)00563-6; Higgins J, 2011, J THORAC CARDIOV SUR, V142, P595, DOI 10.1016/j.jtcvs.2010.05.056; Kolh P, 2007, EUR J CARDIO-THORAC, V31, P600, DOI 10.1016/j.ejcts.2007.01.003; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Melby SJ, 2007, ANN THORAC SURG, V83, P1651, DOI 10.1016/j.athoracsur.2006.09.068; Mistiaen W, 2004, J THORAC CARDIOV SUR, V127, P1166, DOI 10.1016/j.jtcvs.2003.11.010; Nowell J, 2007, EUR J CARDIO-THORAC, V31, P578, DOI 10.1016/j.ejcts.2006.12.017; ORSZULAK TA, 1995, ANN THORAC SURG, V59, P462, DOI 10.1016/0003-4975(94)00862-2; Salem DN, 2008, CHEST, V133, p593S, DOI 10.1378/chest.08-0724; Salem DN, 2004, CHEST, V126, p457S, DOI 10.1378/chest.126.3_suppl.457S; Sundt TM, 2005, J THORAC CARDIOV SUR, V129, P1024, DOI 10.1016/j.jtcvs.2004.11.028; Thourani VH, 2011, ANN THORAC SURG, V91, P1798, DOI 10.1016/j.athoracsur.2011.02.015; Tiede DJ, 1998, MAYO CLIN PROC, V73, P665; Tjang YS, 2007, EUR J CARDIO-THORAC, V32, P469, DOI 10.1016/j.ejcts.2007.06.012; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Whitley WS, 2008, SEMIN CARDIOTHORAC V, V12, P290, DOI 10.1177/1089253208328583	27	155	157	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2118	2125		10.1001/jama.2012.54506	http://dx.doi.org/10.1001/jama.2012.54506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188028	Bronze			2022-12-01	WOS:000311537200026
J	Chistol, G; Liu, SX; Hetherington, CL; Moffitt, JR; Grimes, S; Jardine, PJ; Bustamante, C				Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Moffitt, Jeffrey R.; Grimes, Shelley; Jardine, Paul J.; Bustamante, Carlos			High Degree of Coordination and Division of Labor among Subunits in a Homomeric Ring ATPase	CELL			English	Article							HEXAMERIC HELICASE; DNA TRANSLOCATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; HYDROLYSIS; MOTOR; TRANSPORT; MCM2-7; MODEL	Ring NTPases of the ASCE superfamily perform a variety of cellular functions. An important question about the operation of these molecular machines is how the ring subunits coordinate their chemical and mechanical transitions. Here, we present a comprehensive mechanochemical characterization of a homomeric ring ATPase-the bacteriophage phi 29 packaging motor-a homopentamer that translocates double-stranded DNA in cycles composed of alternating dwells and bursts. We use high-resolution optical tweezers to determine the effect of nucleotide analogs on the cycle. We find that ATP hydrolysis occurs sequentially during the burst and that ADP release is interlaced with ATP binding during the dwell, revealing a high degree of coordination among ring subunits. Moreover, we show that the motor displays an unexpected division of labor: although all subunits of the homopentamer bind and hydrolyze ATP during each cycle, only four participate in translocation, whereas the remaining subunit plays an ATP-dependent regulatory role.	[Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Liu, Shixin; Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Moffitt, Jeffrey R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Chistol, Gheorghe/0000-0003-4868-3667; Jardine, Paul/0000-0002-1090-0550; Bustamante, Carlos/0000-0002-2970-0073	National Institutes of Health [GM071552, GM059604, DE003606]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003606, R37DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071552, R01GM059604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Dangkulwanich, T. Ishibashi, C. Kaiser, N. Liu, R. Maillard, M. Morais, and M. Sen for critical discussions. This work was supported in part by grants from the National Institutes of Health (GM071552 to C.B., GM059604 and DE003606 to S.G.) and the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract No. DE-AC02-05CH11231 (single molecule force measurement) to C.B.	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C., 2008, SINGLE MOL TECHNIQUE, P297; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; Hetherington CL, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P420, DOI 10.1016/B978-0-12-374920-8.00431-8; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kainov DE, 2008, J BIOL CHEM, V283, P3607, DOI 10.1074/jbc.M706366200; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Moffitt JR, 2010, METHOD ENZYMOL, V475, P221, DOI 10.1016/S0076-6879(10)75010-2; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel I. H, 1975, ENZYME KINETICS BEHA; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yang Q, 2004, BIOCHEMISTRY-US, V43, P289, DOI 10.1021/bi035532h; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002	46	79	79	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1017	1028		10.1016/j.cell.2012.10.031	http://dx.doi.org/10.1016/j.cell.2012.10.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178121	Green Accepted, Bronze			2022-12-01	WOS:000311423500015
J	Miyamoto, T; Slone, J; Song, XY; Amrein, H				Miyamoto, Tetsuya; Slone, Jesse; Song, Xiangyu; Amrein, Hubert			A Fructose Receptor Functions as a Nutrient Sensor in the Drosophila Brain	CELL			English	Article							BITTER TASTE RECEPTORS; NEUROPEPTIDE Y-LIKE; EXPRESSION; SUGAR; GLUCOSE; FOOD; GENE; GUSTDUCIN; BEHAVIOR; NEURONS	Internal nutrient sensors play important roles in feeding behavior, yet their molecular structure and mechanism of action are poorly understood. Using Ca2+ imaging and behavioral assays, we show that the gustatory receptor 43a (Gr43a) functions as a narrowly tuned fructose receptor in taste neurons. Remarkably, Gr43a also functions as a fructose receptor in the brain. Interestingly, hemolymph fructose levels are tightly linked to feeding status: after nutritious carbohydrate consumption, fructose levels rise several fold and reach a concentration sufficient to activate Gr43a in the brain. By using different feeding paradigms and artificial activation of Gr43a-expressing brain neurons, we show that Gr43a is both necessary and sufficient to sense hemolymph fructose and promote feeding in hungry flies but suppress feeding in satiated flies. Thus, our studies indicate that the Gr43a-expressing brain neurons function as a nutrient sensor for hemolymph fructose and assign opposing valence to feeding experiences in a satiation-dependent manner.	[Miyamoto, Tetsuya; Slone, Jesse; Song, Xiangyu; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Amrein, H (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77845 USA.	amrein@tamhsc.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Slone, Jesse/0000-0002-2478-3295	National Institute of Health [RO1-DC009014, RO1-DC005606]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009014, R01DC005606] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Drs. S. Fujii and Y. Chen for stimulating discussions while conducting these studies, and Drs. S. Waddell, R. Sitcheran, and two anonymous reviewers for comments and suggestions on the manuscript. We thank Drs. L. Looger, T. Lee, T. Kitamoto, and J. Carlson for Drosophila strains G-CaMP3.0, lexAop-rCD2GFP, Cha<SUP>7.4kb</SUP>-GAL80, and Delta Gr61a, respectively, and Dr. L.B. Vosshall for a LexA plasmid. This work was supported by grants from the National Institute of Health, RO1-DC009014 and RO1-DC005606, to H.A. T.M. conducted all experiments, except the PER analysis. J.S. and X.S. performed the PER analysis, and J.S. generated the Gr64f<SUP>GAL4</SUP> knock-in strain. T.M. and H.A. conceived the experiments and wrote the paper.	Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chapman RF., 1998, INSECTS STRUCTURE FU, DOI 10.1017/CBO9780511818202; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Harvey R. A., 2011, BIOCHEMISTRY-US; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kubli E, 2008, CURR BIOL, V18, pR210, DOI 10.1016/j.cub.2007.12.047; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nunes RD, 2008, J VECTOR ECOL, V33, P225, DOI 10.3376/1081-1710-33.2.225; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	58	272	279	6	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1113	1125		10.1016/j.cell.2012.10.024	http://dx.doi.org/10.1016/j.cell.2012.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178127	Green Accepted, Bronze			2022-12-01	WOS:000311423500022
J	Lima, MD; Li, N; de Andrade, MJ; Fang, SL; Oh, J; Spinks, GM; Kozlov, ME; Haines, CS; Suh, D; Foroughi, J; Kim, SJ; Chen, YS; Ware, T; Shin, MK; Machado, LD; Fonseca, AF; Madden, JDW; Voit, WE; Galvao, DS; Baughman, RH				Lima, Marcio D.; Li, Na; de Andrade, Monica Jung; Fang, Shaoli; Oh, Jiyoung; Spinks, Geoffrey M.; Kozlov, Mikhail E.; Haines, Carter S.; Suh, Dongseok; Foroughi, Javad; Kim, Seon Jeong; Chen, Yongsheng; Ware, Taylor; Shin, Min Kyoon; Machado, Leonardo D.; Fonseca, Alexandre F.; Madden, John D. W.; Voit, Walter E.; Galvao, Douglas S.; Baughman, Ray H.			Electrically, Chemically, and Photonically Powered Torsional and Tensile Actuation of Hybrid Carbon Nanotube Yarn Muscles	SCIENCE			English	Article							ARRAYS; DYNAMICS; SHEETS; FIBERS; SPUN	Artificial muscles are of practical interest, but few types have been commercially exploited. Typical problems include slow response, low strain and force generation, short cycle life, use of electrolytes, and low energy efficiency. We have designed guest-filled, twist-spun carbon nanotube yarns as electrolyte-free muscles that provide fast, high-force, large-stroke torsional and tensile actuation. More than a million torsional and tensile actuation cycles are demonstrated, wherein a muscle spins a rotor at an average 11,500 revolutions/minute or delivers 3% tensile contraction at 1200 cycles/minute. Electrical, chemical, or photonic excitation of hybrid yarns changes guest dimensions and generates torsional rotation and contraction of the yarn host. Demonstrations include torsional motors, contractile muscles, and sensors that capture the energy of the sensing process to mechanically actuate.	[Lima, Marcio D.; Li, Na; de Andrade, Monica Jung; Fang, Shaoli; Oh, Jiyoung; Kozlov, Mikhail E.; Haines, Carter S.; Suh, Dongseok; Ware, Taylor; Voit, Walter E.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA; [Li, Na; Chen, Yongsheng] Nankai Univ, Coll Chem, Inst Polymer Chem, Ctr Nanoscale Sci & Technol, Tianjin 300071, Peoples R China; [Spinks, Geoffrey M.; Foroughi, Javad] Univ Wollongong, Intelligent Polymer Res Inst, Australian Res Council Ctr Excellence Electromat, Wollongong, NSW 2522, Australia; [Kim, Seon Jeong; Shin, Min Kyoon] Hanyang Univ, Ctr Bioartificial Muscle, Seoul 133791, South Korea; [Kim, Seon Jeong; Shin, Min Kyoon] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Machado, Leonardo D.; Galvao, Douglas S.] Univ Estadual Campinas, Dept Appl Phys, BR-13081970 Campinas, SP, Brazil; [Fonseca, Alexandre F.] Univ Estadual Paulista, Fac Ciencias, BR-17033360 Bauru, SP, Brazil; [Madden, John D. W.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada	University of Texas System; University of Texas Dallas; Nankai University; University of Wollongong; Hanyang University; Hanyang University; Universidade Estadual de Campinas; Universidade Estadual Paulista; University of British Columbia	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Ware, Taylor/I-2812-2013; Chen, Yongsheng/D-3256-2011; Spinks, Geoffrey/T-6363-2019; de Andrade, Monica Jung/N-3963-2019; Suh, Dongseok/A-5447-2013; Spinks, Geoffrey/E-5612-2011; Lima, Marcio/G-4634-2012; Li, Na/M-9852-2015; Kim, Seon Jeong/AAR-8127-2021; Foroughi, Javad/A-1439-2012; Fonseca, Alexandre F./K-5477-2019; Voit, Walter/D-1185-2010; Baughman, Ray/A-8628-2018; Madden, John DW/B-8948-2009; Fonseca, Alexandre/H-3105-2011; Machado, Leonardo D/E-2081-2017; Galvao, Douglas/J-6017-2013; Ware, Taylor/A-7130-2017	Chen, Yongsheng/0000-0003-1448-8177; Spinks, Geoffrey/0000-0003-4656-9473; de Andrade, Monica Jung/0000-0003-0411-4008; Spinks, Geoffrey/0000-0003-4656-9473; Li, Na/0000-0002-1909-6378; Kim, Seon Jeong/0000-0002-2867-6737; Foroughi, Javad/0000-0003-1979-5213; Voit, Walter/0000-0003-0135-0531; Baughman, Ray/0000-0001-5845-5137; Madden, John DW/0000-0002-0014-4712; Fonseca, Alexandre/0000-0001-8413-9744; Machado, Leonardo D/0000-0003-1221-4228; Galvao, Douglas/0000-0003-0145-8358; Ware, Taylor/0000-0001-7996-7393; Suh, Dongseok/0000-0002-0392-3391	Air Force Office of Scientific Research [FA9550-09-1-0537, FA9550-12-1-0211]; Office of Naval Research MURI [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program (Korea) [2012-00074]; Australian Research Council; MoST [2012CB933401]; National Natural Science Foundation of China [50933003]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research MURI(MURIOffice of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program (Korea); Australian Research Council(Australian Research Council); MoST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X. Lepro for scanning electron micrograph (SEM) images of yarn cross sections; B. J. Swedlove, D. B. Hagenasr, J. M. Cruciger, C. Mozayan, and S. Rudraraju for assistance with sample preparation and measurements; and F. Goktepe and O. Goktepe for valuable discussions. Support is largely from Air Force Office of Scientific Research grants FA9550-09-1-0537 and FA9550-12-1-0211, with additional support from Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation grant AT-0029, the Creative Research Initiative Center for Bio-Artificial Muscle and the Korea-U.S. Air Force Cooperation Program grant-2012-00074 (Korea), and the Centre of Excellence funding from the Australian Research Council. N.L. and Y.C. acknowledge financial support from MoST (grant 2012CB933401) and National Natural Science Foundation of China (grant 50933003). D. S. G., L. D. M., and A. F. F. are research fellows of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo of Brazil. A provisional patent application on the topic of this manuscript has been filed by N. Li et al., "Coiled and non-coiled nanofiber yarn torsional and tensile actuators," U.S. Provisional Patent 61678340 (1 August 2012).	Carlen ET, 2002, J MICROELECTROMECH S, V11, P165, DOI 10.1109/JMEMS.2002.1007394; Chen LZ, 2011, ACS NANO, V5, P1588, DOI 10.1021/nn102251a; da Fonseca AF, 2006, J APPL PHYS, V99, DOI 10.1063/1.2194309; Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; FULLER FB, 1971, P NATL ACAD SCI USA, V68, P815, DOI 10.1073/pnas.68.4.815; Goriely A, 1997, PHYSICA D, V105, P20, DOI 10.1016/S0167-2789(96)00290-4; Hu Y, 2010, ACS NANO, V4, P3498, DOI 10.1021/nn1006013; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Jakubinek MB, 2012, CARBON, V50, P244, DOI 10.1016/j.carbon.2011.08.041; JOSEPHSON RK, 1993, ANNU REV PHYSIOL, V55, P527, DOI 10.1146/annurev.ph.55.030193.002523; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Mirfakhrai T, 2007, SMART MATER STRUCT, V16, pS243, DOI 10.1088/0964-1726/16/2/S07; Mizumoto M, 2009, J ALLOY COMPD, V482, P416, DOI 10.1016/j.jallcom.2009.04.041; Peng HS, 2009, NAT NANOTECHNOL, V4, P738, DOI [10.1038/nnano.2009.264, 10.1038/NNANO.2009.264]; Peterson D. R., 2008, BIOMECHANICS PRINCIP; Potschke P, 2008, MACROMOL RAPID COMM, V29, P244, DOI 10.1002/marc.200700637; Sellinger AT, 2010, ADV MATER, V22, P3430, DOI 10.1002/adma.200904107; Shang YY, 2012, ADV MATER, V24, P2896, DOI 10.1002/adma.201200576; Xiao L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909593; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhang XF, 2007, SMALL, V3, P244, DOI 10.1002/smll.200600368; Zhou RF, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/34/345701	26	464	486	57	840	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					928	932		10.1126/science.1226762	http://dx.doi.org/10.1126/science.1226762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161994				2022-12-01	WOS:000311083600038
J	McGourty, K; Thurston, TL; Matthews, SA; Pinaud, L; Mota, LJ; Holden, DW				McGourty, Kieran; Thurston, Teresa L.; Matthews, Sophie A.; Pinaud, Laurie; Mota, Luis Jaime; Holden, David W.			Salmonella Inhibits Retrograde Trafficking of Mannose-6-Phosphate Receptors and Lysosome Function	SCIENCE			English	Article							TRANS-GOLGI; VIRULENCE PROTEIN; TYPHIMURIUM; ENDOSOMES; SIFA; PHAGOSOMES; MECHANISM	Salmonella enterica is an intracellular bacterial pathogen that replicates within membrane-bound vacuoles through the action of effector proteins translocated into host cells. Salmonella vacuoles have characteristics of lysosomes but are reduced in hydrolytic enzymes transported by mannose-6-phosphate receptors (MPRs). We found that the effector SifA subverted Rab9-dependent retrograde trafficking of MPRs, thereby attenuating lysosome function. This required binding of SifA to its host cell target SKIP/PLEKHM2. Furthermore, SKIP regulated retrograde trafficking of MPRs in noninfected cells. Translocated SifA formed a stable complex with SKIP and Rab9 in infected cells. Sequestration of Rab9 by SifA-SKIP accounted for the effect of SifA on MPR transport and lysosome function. Growth of Salmonella increased in cells with reduced lysosomal activity and decreased in cells with higher lysosomal activity. These results suggest that Salmonella vacuoles undergo fusion with lysosomes whose potency has been reduced by SifA.	[McGourty, Kieran; Thurston, Teresa L.; Matthews, Sophie A.; Pinaud, Laurie; Mota, Luis Jaime; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, Armstrong Rd, London SW7 2AZ, England.	d.holden@imperial.ac.uk	Thurston, Teresa/AAZ-9938-2020; Mota, Luis/B-9497-2008	Thurston, Teresa/0000-0001-6139-3723; Mota, Luis/0000-0002-5592-8397	Wellcome Trust; Medical Research Council; Medical Research Council [G0800148] Funding Source: researchfish; MRC [G0800148] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Tang and members of the Holden laboratory for comments on the manuscript, S. Meresse for providing MEFs, S. Meresse and F. Randow for plasmids, and the European Conditional Mouse Mutagenesis Program Consortium for SkipPlekhm2<SUP>-/-</SUP> mice. We thank I. Dikic and D. McEwan for advice and discussions. This research was supported by a Wellcome Trust funded studentship to K. M. and grants to D. W. H. from the Medical Research Council and Wellcome Trust. The data are included in the main and the supplementary figures.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Deiwick J, 1998, J BACTERIOL, V180, P4775, DOI 10.1128/JB.180.18.4775-4780.1998; Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hang HC, 2006, ACS CHEM BIOL, V1, P713, DOI 10.1021/cb600431a; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V377, P268, DOI 10.1016/j.bbrc.2008.09.121; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925	24	119	122	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					963	967		10.1126/science.1227037	http://dx.doi.org/10.1126/science.1227037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162002	Green Accepted			2022-12-01	WOS:000311083600048
J	Sando, R; Gounko, N; Pieraut, S; Liao, LJ; Yates, J; Maximov, A				Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Liao, Lujian; Yates, John, III; Maximov, Anton			HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory	CELL			English	Article							II HISTONE DEACETYLASES; NEURONAL-ACTIVITY; GENE-EXPRESSION; MECP2 PHOSPHORYLATION; NERVOUS-SYSTEM; NUCLEAR EXPORT; NMDA RECEPTOR; CELL-DEATH; CORTEX; GROWTH	Neuronal activity influences genes involved in circuit development and information processing. However, the molecular basis of this process remains poorly understood. We found that HDAC4, a histone deacetylase that shuttles between the nucleus and cytoplasm, controls a transcriptional program essential for synaptic plasticity and memory. The nuclear import of HDAC4 and its association with chromatin is negatively regulated by NMDA receptors. In the nucleus, HDAC4 represses genes encoding constituents of central synapses, thereby affecting synaptic architecture and strength. Furthermore, we show that a truncated form of HDAC4 encoded by an allele associated with mental retardation is a gain-of-function nuclear repressor that abolishes transcription and synaptic transmission despite the loss of the deacetylase domain. Accordingly, mice carrying a mutant that mimics this allele exhibit deficits in neurotransmission, spatial learning, and memory. These studies elucidate a mechanism of experience-dependent plasticity and define the biological role of HDAC4 in the brain.	[Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Maximov, Anton] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Liao, Lujian; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Maximov, Anton] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Sando, Richard, III] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Maximov, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	amaximov@scripps.edu	Gounko, Natalia/N-4102-2019; Karakhanov, Edward/P-1660-2015	Gounko, Natalia/0000-0003-0791-9477; 	NIH [MH085776, MH067880-09, RR011823, NS057096]; Novartis Advanced Discovery Institute; Baxter Foundation; Helen Dorris Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880, R01MH085776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Advanced Discovery Institute; Baxter Foundation; Helen Dorris Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Hollis Cline, Ulrich Mueller, Ardem Patapoutian, Franck Polleux, Mark Mayford, and Kristin Baldwin for advice and critical comments; Drs. Thomas Sudhof and Martyn Goulding for mouse strains and antibodies; members of the Cline, Mueller, Polleux, Baldwin, Feeney, and McHeyzer-Williams labs for help with experiments; and Nina Torabi-Rander, TSRI DNA array, mouse transgenic, and behavioral cores for expert technical assistance. This study was supported, in part, by the NIH grants MH085776 (A. M.), MH067880-09 (J.Y.), RR011823 (J.Y.), and NS057096 (J.Y.); Novartis Advanced Discovery Institute (A. M.); The Baxter Foundation (A. M.); and Helen Dorris Postdoctoral Fellowship (S.P.).	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chao HT, 2009, P NATL ACAD SCI USA, V106, P4577, DOI 10.1073/pnas.0901518106; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Seabrooke S, 2008, DEV NEUROBIOL, V68, P379, DOI 10.1002/dneu.20595; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	57	182	189	4	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					821	834		10.1016/j.cell.2012.09.037	http://dx.doi.org/10.1016/j.cell.2012.09.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141539	Bronze, Green Accepted			2022-12-01	WOS:000310921200013
J	Taylor, JR; Stocker, R				Taylor, John R.; Stocker, Roman			Trade-Offs of Chemotactic Foraging in Turbulent Water	SCIENCE			English	Article							MICROSCALE NUTRIENT PATCHES; MICROBIAL FOOD-WEB; MARINE-BACTERIA; SIMULATION; MOTILITY; BEHAVIOR; FLUID; SEA	Bacteria play an indispensable role in marine biogeochemistry by recycling dissolved organic matter. Motile species can exploit small, ephemeral solute patches through chemotaxis and thereby gain a fitness advantage over nonmotile competitors. This competition occurs in a turbulent environment, yet turbulence is generally considered inconsequential for bacterial uptake. In contrast, we show that turbulence affects uptake by stirring nutrient patches into networks of thin filaments that motile bacteria can readily exploit. We find that chemotactic motility is subject to a trade-off between the uptake benefit due to chemotaxis and the cost of locomotion, resulting in an optimal swimming speed. A second trade-off results from the competing effects of stirring and mixing and leads to the prediction that chemotaxis is optimally favored at intermediate turbulence intensities.	[Stocker, Roman] MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 02139 USA; [Taylor, John R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Massachusetts Institute of Technology (MIT); University of Cambridge	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; 	NSF Mathematical Sciences Postdoctoral Research Fellowship; NSF [OCE-0744641-CAREER, CBET-1066566]	NSF Mathematical Sciences Postdoctoral Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	We thank W. M. Durham, R. Ferrari, M. Follows, M. Garren, F. Menolascina, S. Merrifield, T. Pedley, S. Smriga, and R. Watteaux for helpful comments and suggestions. The calculation of the resistive force coefficient for a bacterium was performed by Marcos. J.R.T. was supported by an NSF Mathematical Sciences Postdoctoral Research Fellowship. R. S. acknowledges NSF grants OCE-0744641-CAREER and CBET-1066566.	Ahmed T, 2008, BIOPHYS J, V95, P4481, DOI 10.1529/biophysj.108.134510; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Donzis DA, 2010, FLOW TURBUL COMBUST, V85, P549, DOI 10.1007/s10494-010-9271-6; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Durham WM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238102; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Gregg MC, 1996, DYNAM ATMOS OCEANS, V24, P1, DOI 10.1016/0377-0265(95)00406-8; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Grunbaum D, 2002, HYDROBIOLOGIA, V480, P175, DOI 10.1023/A:1021296103358; Hutz A, 2011, APPL ENVIRON MICROB, V77, P4412, DOI 10.1128/AEM.00490-11; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; LAZIER JRN, 1989, DEEP-SEA RES, V36, P1721, DOI 10.1016/0198-0149(89)90068-X; Marshall JS, 2010, CHEM ENG SCI, V65, P3865, DOI 10.1016/j.ces.2010.03.036; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Mitchell JG, 1996, APPL ENVIRON MICROB, V62, P3716, DOI 10.1128/AEM.62.10.3716-3721.1996; Moin P, 1998, ANNU REV FLUID MECH, V30, P539, DOI 10.1146/annurev.fluid.30.1.539; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Munoz-Garcia J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103043; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Seymour JR, 2009, AM NAT, V173, pE15, DOI 10.1086/593004; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Williams P.J.I.B., 2000, MICROBIAL ECOLOGY OC, P153; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	28	111	115	3	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					675	679		10.1126/science.1219417	http://dx.doi.org/10.1126/science.1219417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118190				2022-12-01	WOS:000310516000055
J	Tran, V; Lim, C; Xie, J; Chen, X				Vuong Tran; Lim, Cindy; Xie, Jing; Chen, Xin			Asymmetric Division of Drosophila Male Germline Stem Cell Shows Asymmetric Histone Distribution	SCIENCE			English	Article							SELF-RENEWAL; EPIGENETIC REGULATION; CHROMATIN; CENTROSOME; MEMORY; DNA; MECHANISMS; DEPOSITION; POLYCOMB	Stem cells can self-renew and generate differentiating daughter cells. It is not known whether these cells maintain their epigenetic information during asymmetric division. Using a dual-color method to differentially label "old" versus "new" histones in Drosophila male germline stem cells (GSCs), we show that preexisting canonical H3, but not variant H3.3, histones are selectively segregated to the GSC, whereas newly synthesized histones incorporated during DNA replication are enriched in the differentiating daughter cell. The asymmetric histone distribution occurs in GSCs but not in symmetrically dividing progenitor cells. Furthermore, if GSCs are genetically manipulated to divide symmetrically, this asymmetric mode is lost. This work suggests that stem cells retain preexisting canonical histones during asymmetric cell divisions, probably as a mechanism to maintain their unique molecular properties.	[Vuong Tran; Lim, Cindy; Xie, Jing; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Chen, X (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	xchen32@jhu.edu	, jxie10@live.johnshopkins.edu/B-5028-2015	, jxie10@live.johnshopkins.edu/0000-0001-9715-3369	NICHD/NIH [R21HD065089, R01HD065816]; David & Lucile Packard Foundation; American Federation of Aging Research; JHU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER	NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); American Federation of Aging Research; JHU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Prado for discussions to develop a controlled gene expression system and the FRT-MCS-SV40 Poly A-FRT plasmid; A. Talaga, A. Chin, A. Kim, and B. Weber for experimental assistance; K. Ahmad for plasmids containing H3, H2B, and H3.3 sequences; A. Nakamura for the UAS-mKO-vasa strain; S. DiNardo for the UAS-upd strain; Y. Yamashita for GSC cell cycle information and insightful suggestions; and R. Kuruvilla, K. Zhao, Y. Zheng, H. Zhao, M. Van Doren, D. Drummond-Barbosa, A. Hoyt, and Chen lab members for critical reading. Supported by NICHD/NIH grants R21HD065089 and R01HD065816, the David & Lucile Packard Foundation, American Federation of Aging Research, and JHU start-up (X.C.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ANNUNZIATO AT, 1982, J BIOL CHEM, V257, P8507; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Eun SH, 2010, CURR OPIN CELL BIOL, V22, P737, DOI 10.1016/j.ceb.2010.09.004; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; JACKSON V, 1981, J BIOL CHEM, V256, P5095; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	25	111	116	6	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					679	682		10.1126/science.1226028	http://dx.doi.org/10.1126/science.1226028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118191	Green Accepted			2022-12-01	WOS:000310516000056
J	Stocker, TF				Stocker, Thomas F.			The Closing Door of Climate Targets	SCIENCE			English	Editorial Material							CUMULATIVE CARBON EMISSIONS		[Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Stocker, TF (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Stocker, Thomas/B-1273-2013					Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Andres RJ, 2012, BIOGEOSCIENCES, V9, P1845, DOI 10.5194/bg-9-1845-2012; Bowerman NHA, 2011, PHILOS T R SOC A, V369, P45, DOI 10.1098/rsta.2010.0288; den Elzen M, 2007, GLOBAL ENVIRON CHANG, V17, P260, DOI 10.1016/j.gloenvcha.2006.10.003; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; UNFCCC, 2009, COP ACC; UNFCCC, 2010, CANC AGR	8	85	88	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					280	282		10.1126/science.1232468	http://dx.doi.org/10.1126/science.1232468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23196911				2022-12-01	WOS:000313622000031
J	Santini, E; Huynh, TN; MacAskill, AF; Carter, AG; Pierre, P; Ruggero, D; Kaphzan, H; Klann, E				Santini, Emanuela; Huynh, Thu N.; MacAskill, Andrew F.; Carter, Adam G.; Pierre, Philippe; Ruggero, Davide; Kaphzan, Hanoch; Klann, Eric			Exaggerated translation causes synaptic and behavioural aberrations associated with autism	NATURE			English	Article							PROTEIN-SYNTHESIS; INHIBITION; MEMORY; MODEL; DYSFUNCTIONS	Autism spectrum disorders (ASDs) are an early onset, heterogeneous group of heritable neuropsychiatric disorders with symptoms that include deficits in social interaction skills, impaired communication abilities, and ritualistic-like repetitive behaviours(1,2). One of the hypotheses for a common molecular mechanism underlying ASDs is altered translational control resulting in exaggerated protein synthesis(3). Genetic variants in chromosome 4q, which contains theEIF4E locus, have been described in patients with autism(4,5). Importantly, a rare single nucleotide polymorphism has been identified in autism that is associated with increased promoter activity in the EIF4E gene(6). Here we show that genetically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice(7) results in exaggerated cap-dependent translation and aberrant behaviours reminiscent of autism, including repetitive and perseverative behaviours and social interaction deficits. Moreover, these autistic-like behaviours are accompanied by synaptic pathophysiology in the medial prefrontal cortex, striatumand hippocampus. The autistic-like behaviours displayed by the eIF4E-transgenic mice are corrected by intracerebroventricular infusions of the cap-dependent translation inhibitor 4EGI-1. Our findings demonstrate a causal relationship between exaggerated cap-dependent translation, synaptic dysfunction and aberrant behaviours associated with autism.	[Santini, Emanuela; Huynh, Thu N.; MacAskill, Andrew F.; Carter, Adam G.; Kaphzan, Hanoch; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13288 Marseille, France; [Pierre, Philippe] CNRS, URM 7280, F-13288 Marseille, France; [Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, Dept Urol, San Francisco, CA 94143 USA	New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu	Huynh, Thu/I-5864-2014; MacAskill, Andrew/AFO-2061-2022	Huynh, Thu/0000-0002-7625-5101; MacAskill, Andrew/0000-0002-0196-3779; pierre, philippe/0000-0003-0863-8255	National Institutes of Health (NIH) [NS034007, NS047384, NS078718]; Department of Defense CDMRP [W81XWH-11-1-0389]; NIH [CA154916]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA154916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034007, R01NS047384, R29NS034007, R21NS078718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense CDMRP(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. LeDoux and members of his laboratory for their technical support and suggestions. We would also like to thank D. St Clair and Z. Miedzybrodzka for their comments on the manuscript. This research was supported by National Institutes of Health (NIH) grants NS034007, NS047384 and NS078718, and Department of Defense CDMRP award W81XWH-11-1-0389 (E. K.), NIH grant CA154916 (D. R.) and the Wellcome Trust (A.F.M.).	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Borgkvist A, 2006, MOL CELL NEUROSCI, V31, P293, DOI 10.1016/j.mcn.2005.09.018; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P156, DOI 10.1016/j.nbd.2011.07.018; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gingras AC, 2001, GENE DEV, V15, P2852; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Rapin I, 2008, PEDIATR CLIN N AM, V55, P1129, DOI 10.1016/j.pcl.2008.07.005; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	38	250	254	1	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					411	U158		10.1038/nature11782	http://dx.doi.org/10.1038/nature11782			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23263185	Green Accepted, Green Submitted			2022-12-01	WOS:000313615900053
J	Ardaugh, BM; Graves, SE; Redberg, RF				Ardaugh, Brent M.; Graves, Stephen E.; Redberg, Rita F.			The 510(k) Ancestry of a Metal-on-Metal Hip Implant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ardaugh, Brent M.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Graves, Stephen E.] Australian Orthopaed Assoc, Natl Joint Replacement Registry, Adelaide, SA, Australia; [Graves, Stephen E.] Flinders Univ S Australia, Dept Surg, Adelaide, SA 5001, Australia; [Redberg, Rita F.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	Boston University; Framingham Heart Study; Flinders University South Australia; University of California System; University of California San Francisco	Ardaugh, BM (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA.		Graves, Stephen E/A-9463-2016	Graves, Stephen E/0000-0002-1629-319X				Australian Orthopaedic Association National Joint Replacement Registry, 2012, REP INV PROSTH HIG S; Cabitza P, 1979, Arch Sci Med (Torino), V136, P45; Center for Devices and Radiological Health, CDRH 2012 STRAT PRIO; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; RING PA, 1983, CLIN ORTHOP RELAT R, P115	5	71	71	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					97	100		10.1056/NEJMp1211581	http://dx.doi.org/10.1056/NEJMp1211581			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301729	Bronze			2022-12-01	WOS:000313238100012
J	Webster, PJ				Webster, Peter J.			Improve weather forecasts for the developing world	NATURE			English	Editorial Material							BANGLADESH; FLOODS		Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Webster, PJ (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	pjw@eas.gatech.edu						Belanger JI, 2012, WEATHER FORECAST, V27, P757, DOI 10.1175/WAF-D-11-00083.1; Foresight, 2012, RED RISKS FUT DIS PR; Hopson TM, 2010, J HYDROMETEOROL, V11, P618, DOI 10.1175/2009JHM1006.1; Leutbecher M, 2008, J COMPUT PHYS, V227, P3515, DOI 10.1016/j.jcp.2007.02.014; Stephens GL, 2004, J CLIMATE, V17, P2213, DOI [10.1175/1520-0442(2004)017<2213:OEFTMR>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;2213:OEFTMR&gt;2.0.CO;2]; Teisberg T.J., 2009, BACKGROUND PAPER BEN; Webster PJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046346; Webster PJ, 2008, NAT GEOSCI, V1, P488, DOI 10.1038/ngeo257; Webster PJ, 2010, B AM METEOROL SOC, V91, P1493, DOI 10.1175/2010BAMS2911.1; Webster PJ, 2004, B AM METEOROL SOC, V85, P1745, DOI 10.1175/BAMS-85-11-1745	10	53	53	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					17	19		10.1038/493017a	http://dx.doi.org/10.1038/493017a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062QC	23282347				2022-12-01	WOS:000312933800010
J	Moeller, A; Kirchdoerfer, RN; Potter, CS; Carragher, B; Wilson, IA				Moeller, Arne; Kirchdoerfer, Robert N.; Potter, Clinton S.; Carragher, Bridget; Wilson, Ian A.			Organization of the Influenza Virus Replication Machinery	SCIENCE			English	Article							A VIRUS; ELECTRON-MICROSCOPY; RIBONUCLEOPROTEIN COMPLEXES; CRYSTAL-STRUCTURE; VIRAL POLYMERASE; HUMAN-CELLS; NUCLEOPROTEIN; RNA; GENERATION; BINDING	Influenza virus ribonucleoprotein complexes (RNPs) are central to the viral life cycle and in adaptation to new host species. RNPs are composed of the viral genome, viral polymerase, and many copies of the viral nucleoprotein. In vitro cell expression of all RNP protein components with four of the eight influenza virus gene segments enabled structural determination of native influenza virus RNPs by means of cryogenic electron microscopy (cryo-EM). The cryo-EM structure reveals the architecture and organization of the native RNP, defining the attributes of its largely helical structure and how polymerase interacts with nucleoprotein and the viral genome. Observations of branched-RNP structures in negative-stain electron microscopy and their putative identification as replication intermediates suggest a mechanism for viral replication by a second polymerase on the RNP template.	[Moeller, Arne; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kirchdoerfer, Robert N.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Carragher, B (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	bcarr@scripps.edu; wilson@scripps.edu		Carragher, Bridget/0000-0002-0624-5020; Moeller, Arne/0000-0003-1101-5366	National Institutes of Health [AI058113, GM095573]; National Center for Research Resources [2P41RR017573-11]; National Institute of General Medical Sciences Biomedical Technology Resource Centers [9 P41 GM103310-11]; Joint Center for Innovation in Membrane Protein Production for Structure Determination [P50GM073197]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R01GM095573, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences Biomedical Technology Resource Centers; Joint Center for Innovation in Membrane Protein Production for Structure Determination; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Webster (St. Jude Children's Research Hospital) for providing the eight plasmid system (pHW2000, the cloning vector: pHW191-PB2, pHW192-PB1, pHW193-PA, and pHW195-NP, under a material transfer agreement from St. Jude) used for recombinant RNP expression; M. Brimble and P. Harris (Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland) for synthesizing the FLAG peptide; J. Quispe for help in EM grid specimen preparation; and A. Su for helpful advice on statistical analyses. We also thank J. Martin-Benito and J. Ortin (Consejo Superior de Investigaciones Cientificas, Spain) for sending us the previously reconstructed mini-RNP map. This project has been funded in part by the National Institutes of Health AI058113 to I. A. W. and GM095573 to C. S. P and B. C. The project was also supported by grants from the National Center for Research Resources (2P41RR017573-11) and the National Institute of General Medical Sciences Biomedical Technology Resource Centers (9 P41 GM103310-11) and by the Joint Center for Innovation in Membrane Protein Production for Structure Determination (P50GM073197). This is publication 21687 from The Scripps Research Institute. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Reconstructions of the free polymerase, RNP-bound polymerase, central filament, and loop regions have been deposited in the EM Data Bank (EMDB entry numbers 2209, 2211, 2212, and 2213). Coordinates of NP protomers docked into the central filament map have been deposited in the Protein Data Bank (PDB code 2YMN) The authors report no conflicts of interest.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Fields B.N., 2007, FIELDS VIROLOGY; Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; LUO GX, 1991, J VIROL, V65, P2861, DOI 10.1128/JVI.65.6.2861-2867.1991; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; NAEVE CW, 1980, J VIROL, V34, P764, DOI 10.1128/JVI.34.3.764-771.1980; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Resa-Infante P, 2010, J VIROL, V84, P10477, DOI 10.1128/JVI.01115-10; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Shen YF, 2011, P NATL ACAD SCI USA, V108, P16515, DOI 10.1073/pnas.1113107108; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.jmb.2007.10.022; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	35	175	179	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1631	1634		10.1126/science.1227270	http://dx.doi.org/10.1126/science.1227270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180774	Green Accepted			2022-12-01	WOS:000312533100056
J	Kolev, NG; Ramey-Butler, K; Cross, GAM; Ullu, E; Tschudi, C				Kolev, Nikolay G.; Ramey-Butler, Kiantra; Cross, George A. M.; Ullu, Elisabetta; Tschudi, Christian			Developmental Progression to Infectivity in Trypanosoma brucei Triggered by an RNA-Binding Protein	SCIENCE			English	Article							TSETSE-FLY	Unraveling the intricate interactions between Trypanosoma brucei, the protozoan parasite causing African trypanosomiasis, and the tsetse (Glossina) vector remains a challenge. Metacyclic trypanosomes, which inhabit the tsetse salivary glands, transmit the disease and are produced through a complex differentiation and unknown program. By overexpressing a single RNA-binding protein, TbRBP6, in cultured noninfectious trypanosomes, we recapitulated the developmental stages that have been observed in tsetse, including the generation of infective metacyclic forms expressing the variant surface glycoprotein. Thus, events leading to acquisition of infectivity in the insect vector are now accessible to laboratory investigation, providing an opening for new intervention strategies.	[Ramey-Butler, Kiantra; Ullu, Elisabetta] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Kolev, Nikolay G.; Tschudi, Christian] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06536 USA; [Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA; [Ullu, Elisabetta] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University; Rockefeller University; Yale University	Ullu, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06536 USA.	elisabetta.ullu@yale.edu; christian.tschudi@yale.edu	Cross, George A M/B-7444-2011	Cross, George A M/0000-0003-1374-6955; Butler, Kiantra/0000-0001-6635-8601	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) [AI028798, AI043594, AI021729, AI076879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043594, R37AI021729, R21AI076879, R01AI021729, R01AI028798, R37AI028798] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Savage and S. Aksoy for assistance with the infectivity assays, J. Bangs for providing the immunofluorescence protocol and advice, D. Engman for the antibody against calflagin, and M. Chaudhuri for the antibody against alternative oxidase. Supported by grants AI028798 (E. U.), AI043594 (C. T.), AI021729 (G. A. M. C.), and AI076879 (S. Aksoy) from the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH. The sequence data from this study have been submitted to the National Center for Biotechnology Information Sequence Read Archive under accession nos. SRP002243 and SRA059559.	Bruce D, 1909, P R SOC LOND B-CONTA, V81, P405, DOI 10.1098/rspb.1909.0041; Ginger ML, 2002, EUKARYOT CELL, V1, P1000, DOI 10.1128/EC.1.6.1000-1009.2002; Rotureau B, 2012, DEVELOPMENT, V139, P1842, DOI 10.1242/dev.072611; Sharma R, 2009, TRENDS PARASITOL, V25, P517, DOI 10.1016/j.pt.2009.08.001; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x	6	126	127	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1352	1353		10.1126/science.1229641	http://dx.doi.org/10.1126/science.1229641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224556	Green Accepted			2022-12-01	WOS:000311991200069
J	Su, CY; Menuz, K; Reisert, J; Carlson, JR				Su, Chih-Ying; Menuz, Karen; Reisert, Johannes; Carlson, John R.			Non-synaptic inhibition between grouped neurons in an olfactory circuit	NATURE			English	Article							RECEPTOR NEURONS; DROSOPHILA-MELANOGASTER; CHEMOSENSORY RECEPTORS; BEHAVIORAL-RESPONSES; MOLECULAR-BASIS; PHEROMONE; SENSILLA; ORGANIZATION; MOTH; PERCEPTION	Diverse sensory organs, including mammalian taste buds and insect chemosensory sensilla, show a marked compartmentalization of receptor cells; however, the functional impact of this organization remains unclear. Here we show that compartmentalized Drosophila olfactory receptor neurons (ORNs) communicate with each other directly. The sustained response of one ORN is inhibited by the transient activation of a neighbouring ORN. Mechanistically, such lateral inhibition does not depend on synapses and is probably mediated by ephaptic coupling. Moreover, lateral inhibition in the periphery can modulate olfactory behaviour. Together, the results show that integration of olfactory information can occur via lateral interactions between ORNs. Inhibition of a sustained response by a transient response may provide a means of encoding salience. Finally, a CO2-sensitive ORN in the malaria mosquito Anopheles can also be inhibited by excitation of an adjacent ORN, suggesting a broad occurrence of lateral inhibition in insects and possible applications in insect control.	[Su, Chih-Ying; Menuz, Karen; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Reisert, Johannes] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Yale University; Monell Chemical Senses Center	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Menuz, Karen/0000-0001-8163-0941	National Institutes of Health (NIH) [NIH DC009613]; Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH) [121]; NRSA [NIH F32DC011242]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011697, R01DC004729, F32DC011242, R01DC009613] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Cardin for help with establishing the optogenetics system; Y. Zhao and E. Fikrig for providing mosquitoes; A. Tzingounis and G. Lowe for suggestions; Z. Berman and P. Graham for technical assistance; T. Koh for suggestions and for sharing reagents; and G. Thomas, F. Marion-Poll, R. Wyman and D. McCormick for comments on the manuscript. This work was funded by National Institutes of Health (NIH) grants to J. R. C. and by a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH no. 121); an NRSA postdoctoral fellowship to K. M. (NIH F32DC011242); and an NIH grant to J. R. (NIH DC009613).	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; AKERS RP, 1988, J COMP PHYSIOL A, V163, P641, DOI 10.1007/BF00603848; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BERG BG, 1995, J COMP PHYSIOL A, V177, P683, DOI 10.1007/BF00187627; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; FABER DS, 1989, PHYSIOL REV, V69, P821, DOI 10.1152/physrev.1989.69.3.821; Gaffin DD, 2002, MICROSC RES TECHNIQ, V58, P325, DOI 10.1002/jemt.10140; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jorgensen K, 2007, CHEM SENSES, V32, P863, DOI 10.1093/chemse/bjm057; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MITCHELL BK, 1987, J CHEM ECOL, V13, P2009, DOI 10.1007/BF01041728; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; OCONNELL RJ, 1985, J COMP PHYSIOL A, V156, P747, DOI 10.1007/BF00610828; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 2000, ARTHROPOD STRUCT DEV, V29, P211, DOI 10.1016/S1467-8039(00)00028-1; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Takanashi T, 2006, J EXP BIOL, V209, P4946, DOI 10.1242/jeb.02587; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vermeulen A, 2004, EUR BIOPHYS J BIOPHY, V33, P633, DOI 10.1007/s00249-004-0405-4; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	50	140	146	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					66	+		10.1038/nature11712	http://dx.doi.org/10.1038/nature11712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23172146	Green Submitted, Green Accepted			2022-12-01	WOS:000311893400046
J	Reis, S; Grennfelt, P; Klimont, Z; Amann, M; ApSimon, H; Hettelingh, JP; Holland, M; LeGall, AC; Maas, R; Posch, M; Spranger, T; Sutton, MA; Williams, M				Reis, S.; Grennfelt, P.; Klimont, Z.; Amann, M.; ApSimon, H.; Hettelingh, J. -P.; Holland, M.; LeGall, A. -C.; Maas, R.; Posch, M.; Spranger, T.; Sutton, M. A.; Williams, M.			From Acid Rain to Climate Change	SCIENCE			English	Editorial Material									[Reis, S.; Sutton, M. A.] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Grennfelt, P.] Swedish Environm Res Inst, SE-40014 Gothenburg, Sweden; [Klimont, Z.; Amann, M.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [ApSimon, H.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Hettelingh, J. -P.; Maas, R.; Posch, M.] Natl Inst Publ Hlth & Environm, NL-3721 MA Bilthoven, Netherlands; [Holland, M.] Ecometr Res & Consulting, Reading RG8 7PW, Berks, England; [LeGall, A. -C.] Natl Inst Ind Environm & Risks, F-60550 Verneuil En Halatte, France; [Spranger, T.] Fed Minist Environm Nat Conservat & Nucl Safety, D-11055 Berlin, Germany; [Williams, M.] Kings Coll London, Environm Res Grp, London SE1 9NH, England	UK Centre for Ecology & Hydrology (UKCEH); IVL Swedish Environmental Research Institute; International Institute for Applied Systems Analysis (IIASA); Imperial College London; Netherlands National Institute for Public Health & the Environment; Institut National de l'Environnement Industriel et des Risques (INERIS); University of London; King's College London	Reis, S (corresponding author), Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland.	srei@ceh.ac.uk	Klimont, Zbigniew/O-6683-2019; Reis, Stefan/E-4713-2011; Sutton, Mark/K-2700-2012; Klimont, Zbigniew/P-7641-2015	Klimont, Zbigniew/0000-0003-2630-198X; Reis, Stefan/0000-0003-2428-8320; Sutton, Mark/0000-0002-1342-2072; Klimont, Zbigniew/0000-0003-2630-198X; Williams, Martin/0000-0002-4677-6491	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; [Anonymous], 2011, NEAR TERM CLIMATE PR; Dentener F., 2010, AIR POLLUTION STUDIE; Hettelingh JP, 2007, WATER AIR SOIL POLL, V7, P379; Holland M., 2011, COST BENEFIT ANAL RE; Mills G., 2011, OZONE POLLUTION HIDD; Posch M, 2011, ENVIRON POLLUT, V159, P2223, DOI 10.1016/j.envpol.2010.11.001; Raes F, 2007, SCIENCE, V318, P1386, DOI 10.1126/science.1147873; Rafaj P., 2012, ENVC3SER20110009 IIA; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Sundqvist G, 2011, POLIT SCI ENVIRON, P195; Sutton MA, 2011, EUROPEAN NITROGEN AS; UNECE, 2009, CLEAR AIR; UNECE, 2012, PART UNECE AIR POLL	15	103	107	5	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1153	1154		10.1126/science.1226514	http://dx.doi.org/10.1126/science.1226514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197517				2022-12-01	WOS:000311666200026
J	Thomas, MK; Kremer, CT; Klausmeier, CA; Litchman, E				Thomas, Mridul K.; Kremer, Colin T.; Klausmeier, Christopher A.; Litchman, Elena			A Global Pattern of Thermal Adaptation in Marine Phytoplankton	SCIENCE			English	Article							CLIMATE-CHANGE; BIODIVERSITY LOSS; IMPACTS; PRODUCTIVITY; TERRESTRIAL	Rising ocean temperatures will alter the productivity and composition of marine phytoplankton communities, thereby affecting global biogeochemical cycles. Predicting the effects of future ocean warming on biogeochemical cycles depends critically on understanding how existing global temperature variation affects phytoplankton. Here we show that variation in phytoplankton temperature optima over 150 degrees of latitude is well explained by a gradient in mean ocean temperature. An eco-evolutionary model predicts a similar relationship, suggesting that this pattern is the result of evolutionary adaptation. Using mechanistic species distribution models, we find that rising temperatures this century will cause poleward shifts in species' thermal niches and a sharp decline in tropical phytoplankton diversity in the absence of an evolutionary response.	[Thomas, Mridul K.; Kremer, Colin T.; Klausmeier, Christopher A.; Litchman, Elena] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Thomas, Mridul K.; Litchman, Elena] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Kremer, Colin T.; Klausmeier, Christopher A.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Thomas, MK (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA.	thomasmr@msu.edu	Klausmeier, Christopher A/J-9339-2012	Thomas, Mridul/0000-0002-5089-5610; Klausmeier, Christopher/0000-0002-6987-5871; Litchman, Elena/0000-0001-7736-6332	NSF [DEB-0845932, DEB-0845825, OCE-0928819]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; Graduate Research Fellowship; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; Graduate Research Fellowship; James S. McDonnell Foundation	This research was supported by NSF (grants DEB-0845932, DEB-0845825, and OCE-0928819), including the BEACON Center for the Study of Evolution in Action (grant DBI-0939454) and a Graduate Research Fellowship to C. T. K., as well as a grant from the James S. McDonnell Foundation. K. Edwards and N. Swenson provided statistical advice, and J. Lennon, G. Mittelbach, and.. Miller provided comments on the manuscript. The trait data presented are shown in table S5, and the collated growth rate data are in table S6. Also thanks to NOAA/OAR/ESRL PSD, Boulder, CO, USA, for NOAA_OI_SST_V2 data provided at their Web site, www.esrl.noaa.gov/psd/. This is W. K. Kellogg Biological Station contribution number 1694. E. L. and M. K. T. conceived the original idea; M. K. T. collected the growth-temperature data; M. K. T. and C. T. K. analyzed the data; C. T. K. and C. A. K. developed and C. T. K. analyzed the eco-evolutionary model; M. K. T. and C. T. K. ran the mechanistic species distribution models; and M. K. T., C. T. K., and E. L. wrote and C. A. K. commented on the manuscript.	Abrams PA, 2001, ECOL LETT, V4, P166, DOI 10.1046/j.1461-0248.2001.00199.x; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; [Anonymous], 2000, SPECIAL REPORT EMISS; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett A. F., 2007, LIGHT EVOLUTION, V1, P225; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Knies JL, 2006, PLOS BIOL, V4, P1257, DOI 10.1371/journal.pbio.0040201; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; REDFIELD AC, 1958, AM SCI, V46, P205; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Solomon S., 2007, ADV CLIM CHANG RES; Stegen JC, 2012, P ROY SOC B-BIOL SCI, V279, P1051, DOI 10.1098/rspb.2011.1733; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0	33	440	447	45	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1085	1088		10.1126/science.1224836	http://dx.doi.org/10.1126/science.1224836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23112294				2022-12-01	WOS:000311390600045
J	Qaseem, A; Fihn, SD; Dallas, P; Williams, S; Owens, DK; Shekelle, P				Qaseem, Amir; Fihn, Stephan D.; Dallas, Paul; Williams, Sankey; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; OPTIMAL MEDICAL THERAPY; IN-HOSPITAL MORTALITY; INDIVIDUAL ANTIRETROVIRAL DRUGS; CONVERTING-ENZYME-INHIBITORS; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST	Description: The American College of Physicians (ACP) developed this guideline with the American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, and Society of Thoracic Surgeons to present the available evidence on the management of stable known or suspected ischemic heart disease. Methods: Literature on this topic published before November 2011 was identified by using MEDLINE, Embase, Cochrane CENTRAL, PsychINFO, AMED, and SCOPUS. Searches were limited to human studies published in English. This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system. Recommendations: The guideline includes 48 specific recommendations that address the following issues: patient education, management of proven risk factors (dyslipidemia, hypertension, diabetes, physical activity body weight, and smoking), risk factor reduction strategies of unproven benefit, medical therapy to prevent myocardial infarction and death and to relieve symptoms, alternative therapy, revascularization to improve survival and symptoms, and patient follow-up. Ann Intern Med. 2012;157:735-743.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Dept Vet Affairs, Seattle, WA USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA; Virginia Tech Caril Sch Med, Roanoke, VA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Fihn, Stephan/ABA-1040-2020		ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abrams J, 2003, ORGANIC NITRATES NIT; ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Academy of Family Physicians (AAFP), 2000, AM FAM PHYSICIAN, V62, P1712; Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 2004, N S W Public Health Bull, V15, P107; [Anonymous], 1982, NEW ENGL J MED, V307, P976; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P277; [Anonymous], 1984, HYPERTENSION, V6, pI198; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Aubry MC, 2007, J RHEUMATOL, V34, P937; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BALL SG, 1993, LANCET, V342, P821; BALSANO F, 1990, CIRCULATION, V82, P17, DOI 10.1161/01.CIR.82.1.17; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Berman DS, 2006, J NUCL CARDIOL, V13, P191, DOI 10.1016/j.nuclcard.2006.01.020; Bernheim AM, 2011, AM HEART J, V161, P740, DOI 10.1016/j.ahj.2010.12.017; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; BOMAN K, 1995, EUR J CLIN PHARMACOL, V49, P27; Bosworth HB, 2007, CONTEMP CLIN TRIALS, V28, P33, DOI 10.1016/j.cct.2006.08.006; Bottcher M, 2002, AM J CARDIOL, V89, P1019, DOI 10.1016/S0002-9149(02)02268-3; Bouzas-Mosquera A, 2010, EUR J CLIN INVEST, V40, P1122, DOI 10.1111/j.1365-2362.2010.02365.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brogden RN, 1996, DRUGS, V51, P792, DOI 10.2165/00003495-199651050-00007; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cecil WT, 2008, AM J MANAG CARE, V14, P521; Centers for Medicare & Medicaid Services, 2008, MED MED STAT SUPPL; Chae C, 1999, BETABLOCKERS; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Clayton TC, 2005, BMJ-BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Collins R, 1994, ANTIHYPERTENSIVE DRU; Critchley J, 2003, COCHRANE DB SYST REV; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daly C, 2003, EUR HEART J, V24, P534, DOI 10.1016/S0195-668X(02)00820-5; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; DICARLI MF, 1995, CIRCULATION, V92, P3436, DOI 10.1161/01.CIR.92.12.3436; DIGENIO AG, 1991, S AFR MED J, V79, P188; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Duvall WL, 2006, J NUCL CARDIOL, V13, P202, DOI 10.1016/j.nuclcard.2006.01.003; Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072; Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0; Emanuelsson H, 1999, AM HEART J, V137, P854, DOI 10.1016/S0002-8703(99)70409-6; EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435, DOI 10.1016/0735-1097(92)90599-I; EZEKOWITZ MD, 1995, AM HEART J, V129, P527, DOI 10.1016/0002-8703(95)90281-3; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026; Fihn SD, 2012, J AM COLL C IN PRESS; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Food and Drug Administration, 2008, INF HEALTHC PROF VAR; Food and Drug Administration, 2008, IMP INF CHANT VAR; Fox KM, 2003, LANCET, V362, P782; Franklin BA, 1998, CHEST, V114, P902, DOI 10.1378/chest.114.3.902; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; FRISHMAN WH, 1991, AM J CARDIOL, V67, P665, DOI 10.1016/0002-9149(91)90518-P; FROELICHER V, 1984, JAMA-J AM MED ASSOC, V252, P1291, DOI 10.1001/jama.252.10.1291; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [10.1056/NEJMoa0805796, DOI 10.1056/NEJMOA0805796]; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Ginsberg HN, 1998, ARTERIOSCL THROM VAS, V18, P441, DOI 10.1161/01.ATV.18.3.441; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gorin SS, 2004, CANCER EPIDEM BIOMAR, V13, P2012; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Goyal D, 2009, CARDIOVASC THER, V27, P10, DOI 10.1111/j.1755-5922.2008.00067.x; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6; Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hambrecht R, 1993, J AM COLL CARDIOL, V22, P468, DOI 10.1016/0735-1097(93)90051-2; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; HaufZachariou U, 1997, EUR J CLIN PHARMACOL, V52, P95, DOI 10.1007/s002280050256; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; HEBERT PR, 1993, ARCH INTERN MED, V153, P578, DOI 10.1001/archinte.153.5.578; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; HIRSH J, 1995, CHEST, V108, pS247, DOI 10.1378/chest.108.4_Supplement.247S; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; HOLMES DR, 1989, J AM COLL CARDIOL, V13, P524, DOI 10.1016/0735-1097(89)90587-1; Holubkov R, 2002, AM HEART J, V144, P826, DOI 10.1067/mhj.2002.125505; HSIEH SD, 1995, INT J OBESITY, V19, P585; Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hypertension Detection and Followup Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.242.23.2562; Innocenti F, 2011, INT J CARDIOVAS IMAG, V27, P65, DOI 10.1007/s10554-010-9655-7; Jagathesan R, 2006, J CARDIOVASC PHARM, V48, P110, DOI 10.1097/01.fjc.0000245404.20922.9f; Jeger RV, 2004, CHEST, V125, P1124, DOI 10.1378/chest.125.3.1124; Joint Commission, 2007, Jt Comm Perspect, V27, P9; Joint Commission on Accreditation of Healthcare Organizations, 2007, Jt Comm Perspect, V27, P9; Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kardas P, 2007, VASC HEALTH RISK MAN, V3, P235, DOI 10.2147/vhrm.2007.3.2.235; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; KERN MJ, 1995, J AM COLL CARDIOL, V25, P178, DOI 10.1016/0735-1097(94)00328-N; Kernis SJ, 2004, J AM COLL CARDIOL, V43, P1773, DOI 10.1016/j.jacc.2003.09.071; Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035; King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KREPP HP, 1991, CARDIOLOGY, V79, P14, DOI 10.1159/000174919; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Kwok JMF, 2002, J AM COLL CARDIOL, V39, P1475, DOI 10.1016/S0735-1097(02)01769-2; LACOSTE LL, 1994, AM J CARDIOL, V73, P1058; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; LANCASTER T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub3, DOI 10.1002/14651858.CD001292.PUB3]; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lavi S, 2007, CATHETER CARDIO INTE, V70, P525, DOI 10.1002/ccd.21154; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Martini CH, 2005, J THROMB HAEMOST, V3, P177, DOI 10.1111/j.1538-7836.2004.01080.x; Matetzky S, 2003, ARCH INTERN MED, V163, P457, DOI 10.1001/archinte.163.4.457; Matzkies FK, 2001, NEPHRON, V89, P10, DOI 10.1159/000046036; MAY GA, 1984, PHYS THER, V64, P1361, DOI 10.1093/ptj/64.9.1361; McGillion M, 2007, CAN J NURS RES, V39, P48; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McNulty PH, 2002, CATHETER CARDIO INTE, V56, P174, DOI 10.1002/ccd.10186; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Miller NH, 1995, MONOGRAPH HUMAN KINE, V2; Morrow D, 2005, CHRONIC CORONARY ART; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Moscucci M, 2001, CIRCULATION, V104, P263, DOI 10.1161/01.CIR.104.3.263; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Munzel T, 2002, CIRCULATION, V106, P170, DOI 10.1161/01.CIR.0000021663.39699.30; Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x; MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487; NARAHARA KA, 1990, AM J CARDIOL, V65, P577, DOI 10.1016/0002-9149(90)91033-3; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Heart Lung and Blood Institute, 2008, CLIN GUID ID EV TREA; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3; Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016; Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3; OLDRIDGE NB, 1989, MED SCI SPORT EXER, V21, P308; ORNISH D, 1983, JAMA-J AM MED ASSOC, V249, P54, DOI 10.1001/jama.249.1.54; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parker JD, 1998, NEW ENGL J MED, V338, P520, DOI 10.1056/NEJM199802193380807; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pazhenkottil AP, 2011, J NUCL MED, V52, P196, DOI 10.2967/jnumed.110.080580; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; Pepine CJ, 2004, HOPE PEACE UPDATE RO; Perrone-Filardi P, 2010, J NUCL CARDIOL, V17, P310, DOI 10.1007/s12350-009-9182-x; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Phillips HR, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.026; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8; Poole-Wilson PA, 2007, EUR HEART J, V28, P1928, DOI 10.1093/eurheartj/ehm198; Qaseem A, 2012, ANN INTERN MED, V157, P729, DOI 10.7326/0003-4819-157-10-201211200-00010; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Qureshi MA, 2003, J AM COLL CARDIOL, V42, P1890, DOI 10.1016/j.jacc.2003.06.014; Raftery EB, 1996, EUR HEART J, V17, P30, DOI 10.1093/eurheartj/17.suppl_B.30; Rao SV, 2004, ARCH INTERN MED, V164, P1128, DOI 10.1001/archinte.164.10.1128; Rehnqvist N, 1995, Cardiologia, V40, P301; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606; Ruggenenti P, 1997, LANCET, V349, P1857; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Savonitto S, 1996, J AM COLL CARDIOL, V27, P311, DOI 10.1016/0735-1097(95)00489-0; Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026; SCHAEFER EJ, 1995, ARTERIOSCL THROM VAS, V15, P1079, DOI 10.1161/01.ATV.15.8.1079; Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823, DOI 10.1093/ajcn/65.3.823; SCHULER G, 1992, CIRCULATION, V86, P1, DOI 10.1161/01.CIR.86.1.1; SEBRECHTS CP, 1986, AM HEART J, V112, P1217, DOI 10.1016/0002-8703(86)90351-0; Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Shaw Richard E, 2003, J Invasive Cardiol, V15, P578; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Silagy C., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000146.PUB2; Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045; Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0; Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066; Slomka PJ, 2007, J NUCL CARDIOL, V14, P44, DOI 10.1016/j.nuclcard.2006.10.021; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stead LF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002850; Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; SULLIVAN AK, 1994, BRIT MED J, V308, P883, DOI 10.1136/bmj.308.6933.883; Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Tepper David, 1999, Congest Heart Fail, V5, P184; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; TODD IC, 1992, BRIT HEART J, V68, P560; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TRESCH DD, 1985, AM HEART J, V110, P1139, DOI 10.1016/0002-8703(85)90003-1; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; TSUYA T, 1990, AM J CARDIOL, V66, P275, DOI 10.1016/0002-9149(90)90835-O; Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F., 2007, J HYPERTENS, V25, P951, DOI [10.1097/HJH.0b013-3280bad9b4, 10.1097/HJH.0b013e3280bad9b4]; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ussher M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub2; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Verma S, 2007, J AM SOC HYPERTENS, V1, P286, DOI 10.1016/j.jash.2007.05.003; VONARNIM T, 1995, J AM COLL CARDIOL, V25, P231, DOI 10.1016/0735-1097(94)00345-Q; Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9; WAYSBORT J, 1991, CARDIOLOGY, V79, P19, DOI 10.1159/000174920; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Wright JT, 2002, ARCH INTERN MED, V162, P1636, DOI 10.1001/archinte.162.14.1636; Wu CT, 2006, J AM COLL CARDIOL, V47, P654, DOI 10.1016/j.jacc.2005.09.071; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	317	46	51	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					735	+		10.7326/0003-4819-157-10-201211200-00011	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00011			31	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165665				2022-12-01	WOS:000311580000019
J	Badrinarayanan, A; Reyes-Lamothe, R; Uphoff, S; Leake, MC; Sherratt, DJ				Badrinarayanan, Anjana; Reyes-Lamothe, Rodrigo; Uphoff, Stephan; Leake, Mark C.; Sherratt, David J.			In Vivo Architecture and Action of Bacterial Structural Maintenance of Chromosome Proteins	SCIENCE			English	Article							ESCHERICHIA-COLI; ATP HYDROLYSIS; CONDENSIN; DNA; COMPLEX; COHESIN; MUKB; SMC; STOICHIOMETRY; ORGANIZATION	SMC (structural maintenance of chromosome) proteins act ubiquitously in chromosome processing. In Escherichia coli, the SMC complex MukBEF plays roles in chromosome segregation and organization. We used single-molecule millisecond multicolor fluorescence microscopy of live bacteria to reveal that a dimer of dimeric fluorescent MukBEF molecules acts as the minimal functional unit. On average, 8 to 10 of these complexes accumulated as "spots" in one to three discrete chromosome-associated regions of the cell, where they formed higher-order structures. Functional MukBEF within spots exchanged with freely diffusing complexes at a rate of one complex about every 50 seconds in reactions requiring adenosine triphosphate (ATP) hydrolysis. Thus, by functioning in pairs, MukBEF complexes may undergo multiple cycles of ATP hydrolysis without being released from DNA, analogous to the behavior of well-characterized molecular motors.	[Uphoff, Stephan; Leake, Mark C.] Univ Oxford, Dept Phys, Oxford OX1 2JD, England; [Badrinarayanan, Anjana; Reyes-Lamothe, Rodrigo; Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Leake, MC (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 2JD, England.	m.leake1@physics.ox.ac.uk; david.sherratt@bioch.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249; Badrinarayanan, Anjana/0000-0001-5520-2134; Sherratt, David/0000-0002-2104-5430; Uphoff, Stephan/0000-0002-3579-0888	New College (Oxford University); Mathworks scholarship; Royal Society; Engineering and Physical Sciences Research Council [EP/G061009]; Wellcome Trust [WT083469MA]	New College (Oxford University); Mathworks scholarship; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust)	R.R.-L. held the Todd-Bird Junior Research Fellowship of New College (Oxford University). S.U. was supported by a Mathworks scholarship. M.C.L. was supported by a Royal Society University Research Fellowship. We thank R. Oliveira for assistance with FRAP experiments and A. Kapanidis for discussions and provision of the PALM equipment. The experimental work was funded by an Engineering and Physical Sciences Research Council grant to M.C.L. (EP/G061009) and by a Wellcome Trust program grant to D.J.S. (WT083469MA). All data are presented in the supplementary materials, and bacterial strains are available on request. The authors declare that they have no competing financial interests. The project was conceived by all authors, each of whom contributed to writing the manuscript. A.B., R.R.-L., and S.U. performed the experiments, M.C.L. developed the millisecond microscopy and biophysical/analytical methods, and S.U. implemented live-cell PALM. M.C.L., A.B., and S.U. did the analysis. D.J.S. and M.C.L. contributed equally.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Gloyd M, 2011, J MOL BIOL, V412, P578, DOI 10.1016/j.jmb.2011.08.009; Gruber S, 2011, MOL MICROBIOL, V81, P855, DOI 10.1111/j.1365-2958.2011.07764.x; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Yamanaka K, 1996, MOL GEN GENET, V250, P241	26	163	163	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					528	531		10.1126/science.1227126	http://dx.doi.org/10.1126/science.1227126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112333	Green Accepted			2022-12-01	WOS:000310195800058
J	Hyster, TK; Knorr, L; Ward, TR; Rovis, T				Hyster, Todd K.; Knoerr, Livia; Ward, Thomas R.; Rovis, Tomislav			Biotinylated Rh(III) Complexes in Engineered Streptavidin for Accelerated Asymmetric C-H Activation	SCIENCE			English	Article							ARTIFICIAL METALLOENZYMES; PROTEIN; HYDROGENATION; DESIGN; EVOLUTION; CATALYST; ENZYMES; ALKYNES	Enzymes provide an exquisitely tailored chiral environment to foster high catalytic activities and selectivities, but their native structures are optimized for very specific biochemical transformations. Designing a protein to accommodate a non-native transition metal complex can broaden the scope of enzymatic transformations while raising the activity and selectivity of small-molecule catalysis. Here, we report the creation of a bifunctional artificial metalloenzyme in which a glutamic acid or aspartic acid residue engineered into streptavidin acts in concert with a docked biotinylated rhodium(III) complex to enable catalytic asymmetric carbon-hydrogen (C-H) activation. The coupling of benzamides and alkenes to access dihydroisoquinolones proceeds with up to nearly a 100-fold rate acceleration compared with the activity of the isolated rhodium complex and enantiomeric ratios as high as 93:7.	[Hyster, Todd K.; Knoerr, Livia; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland; [Hyster, Todd K.; Rovis, Tomislav] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	University of Basel; Colorado State University	Ward, TR (corresponding author), Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.	thomas.ward@unibas.ch; rovis@lamar.colostate.edu	Ward, Thomas R/K-6419-2012	Ward, Thomas R/0000-0001-8602-5468	National Institute of General Medical Sciences [GM80442]; Swiss National Science Foundation [200020-126366]; National Center of Competence in Research Nanoscale Sciences; Marie Curie Training Network [FP7-ITN-238434]; Amgen; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080442] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research Nanoscale Sciences; Marie Curie Training Network(European Commission); Amgen(Amgen); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of General Medical Sciences (GM80442), the Swiss National Science Foundation (grant 200020-126366), the National Center of Competence in Research Nanoscale Sciences, the Marie Curie Training Network (FP7-ITN-238434), Amgen, and Roche for support. We thank Johnson Matthey for a loan of rhodium salts and C. R. Cantor for the Sav gene. We thank M. J. Zimbron for providing an initial sample of [RhCp*<SUP>biotin</SUP>Cl<INF>2</INF>]<INF>2</INF> and for stimulating discussions.	Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c; Collot J, 2004, J ORGANOMET CHEM, V689, P4868, DOI 10.1016/j.jorganchem.2004.09.032; Deuss PJ, 2011, CHEM-EUR J, V17, P4680, DOI 10.1002/chem.201003646; GREEN N. M., 1970, Methods in Enzymology, V18A, P418, DOI 10.1016/0076-6879(71)18342-5; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Heinisch T, 2010, CURR OPIN CHEM BIOL, V14, P184, DOI 10.1016/j.cbpa.2009.11.026; Hyster TK, 2010, J AM CHEM SOC, V132, P10565, DOI 10.1021/ja103776u; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Lin CC, 1999, TETRAHEDRON-ASYMMETR, V10, P1887, DOI 10.1016/S0957-4166(99)00193-7; Lin YW, 2010, J AM CHEM SOC, V132, P9970, DOI 10.1021/ja103516n; Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Reetz MT, 2006, CHEM COMMUN, P4318, DOI 10.1039/b610461d; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; Reiner T, 2009, J ORGANOMET CHEM, V694, P1934, DOI 10.1016/j.jorganchem.2009.01.056; Roelfes G, 2011, CHEMCATCHEM, V3, P647, DOI 10.1002/cctc.201000413; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Skander M, 2004, J AM CHEM SOC, V126, P14411, DOI 10.1021/ja0476718; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Xu L, 2012, J ORG CHEM, V77, P3017, DOI 10.1021/jo202431q; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620	30	557	569	12	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					500	503		10.1126/science.1226132	http://dx.doi.org/10.1126/science.1226132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112327	Green Accepted			2022-12-01	WOS:000310195800050
J	Zelenitsky, DK; Therrien, F; Erickson, GM; DeBuhr, CL; Kobayashi, Y; Eberth, DA; Hadfield, F				Zelenitsky, Darla K.; Therrien, Francois; Erickson, Gregory M.; DeBuhr, Christopher L.; Kobayashi, Yoshitsugu; Eberth, David A.; Hadfield, Frank			Feathered Non-Avian Dinosaurs from North America Provide Insight into Wing Origins	SCIENCE			English	Article							THEROPOD DINOSAUR; EVOLUTIONARY ORIGIN; SOFT-TISSUE; ARCHAEOPTERYX	Previously described feathered dinosaurs reveal a fascinating record of feather evolution, although substantial phylogenetic gaps remain. Here we report the occurrence of feathers in ornithomimosaurs, a clade of non-maniraptoran theropods for which fossilized feathers were previously unknown. The Ornithomimus specimens, recovered from Upper Cretaceous deposits of Alberta, Canada, provide new insights into dinosaur plumage and the origin of the avian wing. Individuals from different growth stages reveal the presence of a filamentous feather covering throughout life and winglike structures on the forelimbs of adults. The appearance of winglike structures in older animals indicates that they may have evolved in association with reproductive behaviors. These specimens show that primordial wings originated earlier than previously thought, among non-maniraptoran theropods.	[Zelenitsky, Darla K.; DeBuhr, Christopher L.] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada; [Therrien, Francois; Eberth, David A.] Royal Tyrrell Museum Palaeontol, Drumheller, AB TOJ OYO, Canada; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan; [Hadfield, Frank] Palcoprep, Drumheller, AB TOJ OYO, Canada	University of Calgary; State University System of Florida; Florida State University; Hokkaido University	Zelenitsky, DK (corresponding author), Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada.	dkzeleni@ucalgary.ca; francois.therrien@gov.ab.ca			Royal Tyrrell Museum of Palaeontology; Natural Sciences and Engineering Research Council of Canada; University of Calgary; NSF Division of Earth Sciences [EAR 0959029]	Royal Tyrrell Museum of Palaeontology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary; NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank P. Andrew (landowner), D. Brinkman (logistical support), J. Csotonyi (artwork), D. MacLeod (specimen preparation), M. Newbrey (discussions), D. Sloan (technical illustrations), and K. Womble (graphics). Research was funded by the Royal Tyrrell Museum of Palaeontology, a Natural Sciences and Engineering Research Council of Canada Discovery grant (D.K.Z.), the University of Calgary Start-up Fund (D.K.Z.), and an NSF Division of Earth Sciences grant (EAR 0959029) (G.M.E.). TMP 1995.110.1, TMP 2008.70.1, and TMP 2009.110.1 are permanently deposited at the Royal Tyrrell Museum, Drumheller, Alberta, Canada.	BOCK WALTER J., 1965, SYST ZOOL, V14, P272, DOI 10.2307/2411681; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Cho P., 1984, Zoo Biology, V3, P133, DOI 10.1002/zoo.1430030205; Dal Sasso C, 1998, NATURE, V392, P383; Davies S.J.J.F., 2002, RATITES TINAMOUS; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Duerden J. E., 1911, AGR J UNION S AFRICA, V1, P29; Fastovsky D. E., 1989, AGE DINOSAURS, V2, P22; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; Gill F.B., 2007, ORNITHOLOGY; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner Alexander W.A., 2002, P389; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Lucas A.M., 1972, AVIAN ANATOMY INTE 1; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; WRAY R. S., 1887, P ZOOL SOC LONDON, V1887, P343; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	36	66	69	0	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					510	514		10.1126/science.1225376	http://dx.doi.org/10.1126/science.1225376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112330				2022-12-01	WOS:000310195800053
J	Wu, JX; Sun, LJ; Chen, X; Du, FH; Shi, HP; Chen, C; Chen, ZJJ				Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Shi, Heping; Chen, Chuo; Chen, Zhijian J.			Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA	SCIENCE			English	Article								Cytosolic DNA induces type I interferons and other cytokines that are important for antimicrobial defense but can also result in autoimmunity. This DNA signaling pathway requires the adaptor protein STING and the transcription factor IRF3, but the mechanism of DNA sensing is unclear. We found that mammalian cytosolic extracts synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vitro from adenosine triphosphate and guanosine triphosphate in the presence of DNA but not RNA. DNA transfection or DNA virus infection of mammalian cells also triggered cGAMP production. cGAMP bound to STING, leading to the activation of IRF3 and induction of interferon-beta. Thus, cGAMP in metazoans and functions as an endogenous second messenger that triggers interferon production in response to cytosolic DNA.	[Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Shi, Heping; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012; shi, heping/G-3238-2015; Wu, Jiaxi/K-3322-2016	Chen, Zhijian/0000-0002-8475-8251; Wu, Jiaxi/0000-0002-6976-4784; Chen, Chuo/0000-0002-3118-4901	NIH [AI-093967, GM-079554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tanaka for generating HEK293T-STING and L929-shSTING cell lines; J. Bell, B. Levine, and L. Deng for VSV, HSV-1, and VACV, respectively; R. Debose-Boyd for the PFO plasmid; and V. Sperandio for V. cholerae strain C6709. Supported by NIH grants AI-093967 (Z.J.C.) and GM-079554 (C. C.). Z.J.C. is an investigator of Howard Hughes Medical Institute.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Blumenthal SA, 2012, PERSPECT BIOL MED, V55, P236, DOI 10.1353/pbm.2012.0017; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Mossman KL, 2002, J VIROL, V76, P1995, DOI 10.1128/JVI.76.4.1995-1998.2002; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029	17	1243	1336	23	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					826	830		10.1126/science.1229963	http://dx.doi.org/10.1126/science.1229963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258412	Green Accepted			2022-12-01	WOS:000314874400051
J	Di Virgilio, M; Callen, E; Yamane, A; Zhang, WZ; Jankovic, M; Gitlin, AD; Feldhahn, N; Resch, W; Oliveira, TY; Chait, BT; Nussenzweig, A; Casellas, R; Robbiani, DF; Nussenzweig, MC				Di Virgilio, Michela; Callen, Elsa; Yamane, Arito; Zhang, Wenzhu; Jankovic, Mila; Gitlin, Alexander D.; Feldhahn, Niklas; Resch, Wolfgang; Oliveira, Thiago Y.; Chait, Brian T.; Nussenzweig, Andre; Casellas, Rafael; Robbiani, Davide F.; Nussenzweig, Michel C.			Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching	SCIENCE			English	Article							53BP1; PROTEIN; REPAIR; DAMAGE; AID; RECOMBINATION; REGULATOR; TELOMERES; SITES; FOCUS	DNA double-strand breaks (DSBs) represent a threat to the genome because they can lead to the loss of genetic information and chromosome rearrangements. The DNA repair protein p53 binding protein 1 (53BP1) protects the genome by limiting nucleolytic processing of DSBs by a mechanism that requires its phosphorylation, but whether 53BP1 does so directly is not known. Here, we identify Rap1-interacting factor 1 (Rif1) as an ATM (ataxia-telangiectasia mutated) phosphorylation-dependent interactor of 53BP1 and show that absence of Rif1 results in 5'-3' DNA-end resection in mice. Consistent with enhanced DNA resection, Rif1 deficiency impairs DNA repair in the G(1) and S phases of the cell cycle, interferes with class switch recombination in B lymphocytes, and leads to accumulation of chromosome DSBs.	[Di Virgilio, Michela; Jankovic, Mila; Gitlin, Alexander D.; Feldhahn, Niklas; Oliveira, Thiago Y.; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst HHMI, New York, NY 10065 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NCI, Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, NIH, Bethesda, MD 20892 USA; [Zhang, Wenzhu; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Oliveira, Thiago Y.] Univ Sao Paulo, Fac Med, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Oliveira, Thiago Y.] Natl Inst Sci & Technol Stem Cells & Cell Therapy, BR-14049 Ribeirao Preto, Brazil	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Universidade de Sao Paulo	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022; Di Virgilio, Michela/AAE-9298-2022; Yamane, Arito/A-2959-2013; Robbiani, Davide F./AAF-7662-2019; Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/ABF-5186-2020	Oliveira, Thiago Y/0000-0002-2654-0879; Robbiani, Davide F./0000-0001-7379-3484; Oliveira, Thiago Y/0000-0002-2654-0879; Di Virgilio, Michela/0000-0001-5189-0793; Gitlin, Alexander/0000-0002-9229-0919; Resch, Wolfgang/0000-0001-7594-5963	NIH [GM007739, AI037526, RR022220, RR00862, GM103314]; NIAMS at the NIH; NCI at the NIH; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010959, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS at the NIH; NCI at the NIH; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Nussenzweig laboratory for discussion, D. Bosque and T. Eisenreich for help in managing mouse colonies, A. Gazumyan for assistance with Igh germline and AID transcript levels analysis, and K. Yao for help with genotyping. We thank T. de Lange (The Rockefeller University, New York) for Rif1<SUP>F/F</SUP> mice; S. Buonomo (European Molecular Biology Laboratory Mouse Biology Unit, Monterotondo, Italy) for the anti-mouse Rif1 serum #1240; G. Gutierrez (NIAMS, NIH, Bethesda, MD) for Illumina sequencing; N. Zampieri (Columbia University, New York) for assistance with immunofluorescence image processing, and M. P. Rout, J. LaCava, S. Obado, and L. Hough (The Rockefeller University) for invaluable help, discussions, and protocols for cryolysis and magnetic bead-mediated immunoisolation. The data presented in the manuscript are tabulated in the main text and in the supplementary materials. Sequence data shown in Fig. 4 have been deposited in the Gene Expression Omnibus database (accession number GSE42298) at www.ncbi.nlm.nih.gov/geo/. M. D. V. was a Fellow of the American Italian Cancer Foundation, and A. D. G. was supported by NIH Medical Scientist Training Program grant GM007739. This work was supported in part by NIH grants AI037526 (M. C. N.), RR022220 (B. T. C.), RR00862 (B. T. C.), and GM103314 (B. T. C.); and by the intramural program of NIAMS at the NIH (R. C.); and the intramural research program of NCI at the NIH and Center for Cancer Research (A. N. and E. C.). M. C. N. is an HHMI Investigator.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Kumar S, 2012, CELL CYCLE, V11, P1183, DOI 10.4161/cc.11.6.19636; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180	26	293	296	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					711	715		10.1126/science.1230624	http://dx.doi.org/10.1126/science.1230624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23306439	Green Accepted			2022-12-01	WOS:000314585600047
J	Kreso, A; O'Brien, CA; van Galen, P; Gan, OI; Notta, F; Brown, AMK; Ng, K; Ma, J; Wienholds, E; Dunant, C; Pollett, A; Gallinger, S; McPherson, J; Mullighan, CG; Shibata, D; Dick, JE				Kreso, Antonija; O'Brien, Catherine A.; van Galen, Peter; Gan, Olga I.; Notta, Faiyaz; Brown, Andrew M. K.; Ng, Karen; Ma, Jing; Wienholds, Erno; Dunant, Cyrille; Pollett, Aaron; Gallinger, Steven; McPherson, John; Mullighan, Charles G.; Shibata, Darryl; Dick, John E.			Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; INITIATING CELLS; TUMOR-GROWTH; STEM-CELLS; EVOLUTION; ORIGINS; STOCHASTICITY; HETEROGENEITY; BIODIVERSITY	Intratumoral heterogeneity arises through the evolution of genetically diverse subclones during tumor progression. However, it remains unknown whether cells within single genetic clones are functionally equivalent. By combining DNA copy number alteration (CNA) profiling, sequencing, and lentiviral lineage tracking, we followed the repopulation dynamics of 150 single lentivirus-marked lineages from 10 human colorectal cancers through serial xenograft passages in mice. CNA and mutational analysis distinguished individual clones and showed that clones remained stable upon serial transplantation. Despite this stability, the proliferation, persistence, and chemotherapy tolerance of lentivirally marked lineages were variable within each clone. Chemotherapy promoted the dominance of previously minor or dormant lineages. Thus, apart from genetic diversity, tumor cells display inherent functional variability in tumor propagation potential, which contributes to both cancer growth and therapy tolerance.	[Kreso, Antonija; O'Brien, Catherine A.; van Galen, Peter; Gan, Olga I.; Notta, Faiyaz; Wienholds, Erno; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada; [Kreso, Antonija; Notta, Faiyaz; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [O'Brien, Catherine A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5L 1F4, Canada; [O'Brien, Catherine A.] Univ Toronto, Dept Surg, Toronto, ON M5L 1F4, Canada; [Brown, Andrew M. K.; Ng, Karen; McPherson, John] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Ma, Jing; Mullighan, Charles G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Dunant, Cyrille] Univ Toronto, Dept Civil Engn, Toronto, ON M5S 1A4, Canada; [Pollett, Aaron] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON M7H 2B9, Canada; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; St Jude Children's Research Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Southern California	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	McPherson, John D/D-2633-2017; Pollett, Aaron/J-2308-2016; Mullighan, Charles/H-3253-2011; Pollett, Aaron/AAQ-2540-2021; Gallinger, Steven/E-4575-2013	McPherson, John D/0000-0001-8049-9347; Pollett, Aaron/0000-0001-5121-8788; Mullighan, Charles/0000-0002-1871-1850; Pollett, Aaron/0000-0001-5121-8788; Dunant, Cyrille/0000-0001-5176-4439; van Galen, Peter/0000-0002-0735-1570; Dick, John/0000-0002-9527-8317; O'Brien, Catherine/0000-0003-0682-3879	Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; Summit Award; Canadian Institutes for Health Research; Netherlands Organisation for Scientific Research; NIH [R21 CA149990-01]; Canada Research Chair; Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC); province of Ontario; NATIONAL CANCER INSTITUTE [R21CA149990] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; Summit Award; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); province of Ontario; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Gibson, A. Khandani, and P. Penttila for experimental support and members of the Dick lab, especially M. Doedens, J. Wang, M. Milyavsky, and E. Laurenti for technical support and critical assessment of this work, as well as UHN biobank for specimens, the Clinical Applications of Core Technology (Affymetrix) Laboratory of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. Supported by Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research and a Summit Award with funds from the province of Ontario, the Canadian Institutes for Health Research, the Netherlands Organisation for Scientific Research, NIH grant R21 CA149990-01, a Canada Research Chair, the Princess Margaret Hospital Foundation, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	ABULAFI AM, 1994, BRIT J SURG, V81, P7, DOI 10.1002/bjs.1800810106; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825	30	516	542	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					543	548		10.1126/science.1227670	http://dx.doi.org/10.1126/science.1227670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23239622				2022-12-01	WOS:000314270000050
J	Granger, AJ; Shi, Y; Lu, W; Cerpas, M; Nicoll, RA				Granger, Adam J.; Shi, Yun; Lu, Wei; Cerpas, Manuel; Nicoll, Roger A.			LTP requires a reserve pool of glutamate receptors independent of subunit type	NATURE			English	Article							AMPA RECEPTOR; SYNAPTIC PLASTICITY; LONG-TERM; SURFACE EXPRESSION; GLUR1 SUBUNIT; TRAFFICKING; PHOSPHORYLATION; CAMKII; SYNAPSES; NEURONS	Long-term potentiation (LTP) of synaptic transmission is thought to be an important cellular mechanism underlying memory formation. A widely accepted model posits that LTP requires the cytoplasmic carboxyl tail (C-tail) of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor subunit GluA1. To find the minimum necessary requirement of the GluA1 C-tail for LTP in mouse CA1 hippocampal pyramidal neurons, we used a single-cell molecular replacement strategy to replace all endogenous AMPA receptors with transfected subunits. In contrast to the prevailing model, we found no requirement of the GluA1 C-tail for LTP. In fact, replacement with the GluA2 subunit showed normal LTP, as did an artificially expressed kainate receptor not normally found at these synapses. The only conditions under which LTP was impaired were those with markedly decreased AMPA receptor surface expression, indicating a requirement for a reserve pool of receptors. These results demonstrate the synapse's remarkable flexibility to potentiate with a variety of glutamate receptor subtypes, requiring a fundamental change in our thinking with regard to the core molecular events underlying synaptic plasticity.	[Granger, Adam J.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Shi, Yun; Lu, Wei; Cerpas, Manuel; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.uscf.edu	Lu, Wei/S-5617-2018; Shi, Yun/B-5623-2009; Shi, Yun S/T-8845-2018	Lu, Wei/0000-0001-6668-8432; Shi, Yun/0000-0002-8842-9818; Granger, Adam/0000-0002-3953-6764	National Science Foundation; National Institute of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Jackson, J. Levy, S. Fischbach, K. Lovero, N. Sheng, S. Shipman and M. Younger for critical discussions and reading of the manuscript; K. Bjorgen for technical help with organotypic slice cultures; and L. Subramanian from the Kriegstein laboratory for technical help with in utero electroporations. We thank P. Seeburg and R. Sprengel for the Gria1-3<SUP>fl/fl</SUP> mice. A. J. G. was supported by the National Science Foundation Graduate Research Fellowship. R. A. N. is supported by the National Institute of Health.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Coleman SK, 2003, J NEUROSCI, V23, P798; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Dargan SL, 2009, NEUROPHARMACOLOGY, V56, P121, DOI 10.1016/j.neuropharm.2008.08.016; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Granger AJ, 2011, J PHYSIOL-LONDON, V589, P4095, DOI 10.1113/jphysiol.2011.213033; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Makino Y, 2011, P NATL ACAD SCI USA, V108, P8450, DOI 10.1073/pnas.1105261108; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Navarro-Quiroga I, 2007, J NEUROSCI, V27, P5007, DOI 10.1523/JNEUROSCI.0867-07.2007; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Panicker S, 2008, P NATL ACAD SCI USA, V105, P1032, DOI 10.1073/pnas.0711313105; Patterson M, 2011, BRIT J PHARMACOL, V163, P1626, DOI 10.1111/j.1476-5381.2011.01328.x; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	42	219	222	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					495	+		10.1038/nature11775	http://dx.doi.org/10.1038/nature11775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235828	Green Accepted, Green Submitted			2022-12-01	WOS:000313871400030
J	Mizuno, K; Miyabe, I; Schalbetter, SA; Carr, AM; Murray, JM				Mizuno, Ken'Ichi; Miyabe, Izumi; Schalbetter, Stephanie A.; Carr, Antony M.; Murray, Johanne M.			Recombination-restarted replication makes inverted chromosome fusions at inverted repeats	NATURE			English	Article							BREAK-INDUCED REPLICATION; GENOMIC REARRANGEMENTS; TEMPLATE EXCHANGE; RIBOSOMAL DNA; FRAGILE SITE; MECHANISMS; DISORDERS; REPAIR	Impediments to DNA replication are known to induce gross chromosomal rearrangements (GCRs) and copy-number variations (CNVs). GCRs and CNVs underlie human genomic disorders(1) and are a feature of cancer(2). During cancer development, environmental factors and oncogene-driven proliferation promote replication stress. Resulting GCRs and CNVs are proposed to contribute to cancer development and therapy resistance(3). When stress arrests replication, the replisome remains associated with the fork DNA(stalled fork) and is protected by the inter-S-phase checkpoint. Stalled forks efficiently resume when the stress is relieved. However, if the polymerases dissociate from the fork (fork collapse) or the fork structure breaks (broken fork), replication restart can proceed either by homologous recombination or microhomology-primed re-initiation(4,5). Here we ascertain the consequences of replication with a fork restarted by homologous recombination in fission yeast. We identify a new mechanism of chromosomal rearrangement through the observation that recombination-restarted forks have a considerably high propensity to execute a U-turn at small inverted repeats (up to 1 in 40 replication events). We propose that the error-prone nature of restarted forks contributes to the generation of GCRs and gene amplification in cancer, and to non-recurrent CNVs in genomic disorders.	[Mizuno, Ken'Ichi; Miyabe, Izumi; Schalbetter, Stephanie A.; Carr, Antony M.; Murray, Johanne M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.m.carr@sussex.ac.uk	Miyabe, Izumi/K-7536-2017; Mizuno, Ken'Ichi/P-7350-2015	Miyabe, Izumi/0000-0002-4546-2837; Mizuno, Ken'Ichi/0000-0001-8115-7808; Carr, Antony Michael/0000-0002-2028-2389	Cancer Research UK (CRUK) [C9601/A9484]; Medical Research Council (MRC) [G0600233]; Biotechnology and Biological Sciences Research Council [BB/C510291/1] Funding Source: researchfish; Medical Research Council [G0600233, G1100074, G0500308] Funding Source: researchfish; Worldwide Cancer Research [10-0273] Funding Source: researchfish; MRC [G1100074, G0500308, G0600233] Funding Source: UKRI	Cancer Research UK (CRUK)(Cancer Research UK); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Hoffman, J. Baxter, M. Neale and members of the Carr and Murray laboratories for discussions. J. M. M. acknowledges Cancer Research UK (CRUK) grant C9601/A9484: A. M. C. acknowledges Medical Research Council (MRC) grant G0600233.	Arlt MF, 2012, CURR OPIN GENET DEV, V22, P204, DOI 10.1016/j.gde.2012.01.009; Blow JJ, 2011, TRENDS BIOCHEM SCI, V36, P405, DOI 10.1016/j.tibs.2011.05.002; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iraqui I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002976; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Ozeri-Galai E, 2011, MOL CELL, V43, P122, DOI 10.1016/j.molcel.2011.05.019; Pelliccia F, 2010, CANCER LETT, V299, P37, DOI 10.1016/j.canlet.2010.08.001; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; WILLIAMS WL, 1987, J MOL BIOL, V196, P743; Zuffardi O, 2009, CLIN GENET, V75, P505, DOI 10.1111/j.1399-0004.2009.01187.x	30	109	110	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					246	249		10.1038/nature11676	http://dx.doi.org/10.1038/nature11676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23178809	Green Accepted			2022-12-01	WOS:000313259600044
J	Shen, YD; Wollam, J; Magner, D; Karalay, O; Antebi, A				Shen, Yidong; Wollam, Joshua; Magner, Daniel; Karalay, Oezlem; Antebi, Adam			A Steroid Receptor-MicroRNA Switch Regulates Life Span in Response to Signals from the Gonad	SCIENCE			English	Article							STEM-CELLS; LONGEVITY; DAF-16	Although the gonad primarily functions in procreation, it also affects animal life span. Here, we show that removal of the Caenorhabditis elegans germ line triggers a switch in the regulatory state of the organism to promote longevity, co-opting components involved in larval developmental timing circuits. These components include the DAF-12 steroid receptor, which is involved in the larval stage two-to-stage three (L2-L3) transition and up-regulates members of the let-7 microRNA (miRNA) family. The miRNAs target an early larval nuclear factor lin-14 and akt-1/kinase, thereby stimulating DAF-16/FOXO signaling to extend life. Our studies suggest that metazoan life span is coupled to the gonad through elements of a developmental timer.	[Shen, Yidong; Wollam, Joshua; Magner, Daniel; Karalay, Oezlem; Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Shen, Yidong; Wollam, Joshua; Magner, Daniel; Antebi, Adam] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Antebi, Adam] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	Max Planck Society; Baylor College of Medicine; University of Cologne	Antebi, A (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany.	antebi@age.mpg.de	Shen, Yi/GRS-3602-2022		European Molecular Biology Organization; National Institute on Aging/NIH; Ellison Medical Foundation; Max Planck Society; Sybacol/Bundesministerium fur Bildung und Forschung; CECAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027498] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institute on Aging/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Max Planck Society(Max Planck Society); Sybacol/Bundesministerium fur Bildung und Forschung; CECAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Montino for technical help; M. Denzel for manuscript comments; S. Lo (Chang-Qung University) for plasmids; and I. Greenwald (Columbia University), H. Aguilaniu (ENS de Lyon), C. Kenyon (University of California San Francisco), and the Caenorhabditis Genetics Center for strains. This work was supported by an European Molecular Biology Organization fellowship (Y.S.) and the National Institute on Aging/NIH, the Ellison Medical Foundation, the Max Planck Society, Sybacol/Bundesministerium fur Bildung und Forschung, and CECAD (A. A.). Strain pha-1(e2123);arEx1273(lin-14::gfp) is available from Iva Greenwald (Columbia University) subject to a materials transfer agreement with the Howard Hughes Medical Institute.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Resnick TD, 2010, DEV DYNAM, V239, P1477, DOI 10.1002/dvdy.22260; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wollam J, 2011, AGING CELL, V10, P879, DOI 10.1111/j.1474-9726.2011.00733.x; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	21	73	77	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1472	1476		10.1126/science.1228967	http://dx.doi.org/10.1126/science.1228967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239738	Green Accepted			2022-12-01	WOS:000312250800049
J	Shah, DI; Takahashi-Makise, N; Cooney, JD; Li, LT; Schultz, IJ; Pierce, EL; Narla, A; Seguin, A; Hattangadi, SM; Medlock, AE; Langer, NB; Dailey, TA; Hurst, SN; Faccenda, D; Wiwczar, JM; Heggers, SK; Vogin, G; Chen, W; Chen, CY; Campagna, DR; Brugnara, C; Zhou, Y; Ebert, BL; Danial, NN; Fleming, MD; Ward, DM; Campanella, M; Dailey, HA; Kaplan, J; Paw, BH				Shah, Dhvanit I.; Takahashi-Makise, Naoko; Cooney, Jeffrey D.; Li, Liangtao; Schultz, Iman J.; Pierce, Eric L.; Narla, Anupama; Seguin, Alexandra; Hattangadi, Shilpa M.; Medlock, Amy E.; Langer, Nathaniel B.; Dailey, Tamara A.; Hurst, Slater N.; Faccenda, Danilo; Wiwczar, Jessica M.; Heggers, Spencer K.; Vogin, Guillaume; Chen, Wen; Chen, Caiyong; Campagna, Dean R.; Brugnara, Carlo; Zhou, Yi; Ebert, Benjamin L.; Danial, Nika N.; Fleming, Mark D.; Ward, Diane M.; Campanella, Michelangelo; Dailey, Harry A.; Kaplan, Jerry; Paw, Barry H.			Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts	NATURE			English	Article							IRON-METABOLISM; ZEBRAFISH; YEAST; FERROCHELATASE; INHIBITOR; TRANSPORT; DEFECTS; PROTEIN; CYTOSOL; ANEMIA	Defects in the availability of haem substrates or the catalytic activity of the terminal enzyme in haem biosynthesis, ferrochelatase (Fech), impair haem synthesis and thus cause human congenital anaemias(1,2). The interdependent functions of regulators of mitochondrial homeostasis and enzymes responsible for haem synthesis are largely unknown. To investigate this we used zebrafish genetic screens and cloned mitochondrial ATPase inhibitory factor 1 (atpif1) from a zebrafish mutant with profound anaemia, pinotage (pnt (tq209)). Here we describe a direct mechanism establishing that Atpif1 regulates the catalytic efficiency of vertebrate Fech to synthesize haem. The loss of Atpif1 impairs haemoglobin synthesis in zebrafish, mouse and human haematopoietic models as a consequence of diminished Fech activity and elevated mitochondrial pH. To understand the relationship between mitochondrial pH, redox potential, [2Fe-2S] clusters and Fech activity, we used genetic complementation studies of Fech constructs with or without [2Fe-2S] clusters in pnt, as well as pharmacological agents modulating mitochondrial pH and redox potential. The presence of [2Fe-2S] cluster renders vertebrate Fech vulnerable to perturbations in Atpif1-regulated mitochondrial pH and redox potential. Therefore, Atpif1 deficiency reduces the efficiency of vertebrate Fech to synthesize haem, resulting in anaemia. The identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development. An ATPIF1 deficiency may contribute to important human diseases, such as congenital sideroblastic anaemias and mitochondriopathies.	[Shah, Dhvanit I.; Cooney, Jeffrey D.; Schultz, Iman J.; Pierce, Eric L.; Narla, Anupama; Langer, Nathaniel B.; Hurst, Slater N.; Heggers, Spencer K.; Vogin, Guillaume; Chen, Wen; Chen, Caiyong; Ebert, Benjamin L.; Paw, Barry H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; [Takahashi-Makise, Naoko; Li, Liangtao; Seguin, Alexandra; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84312 USA; [Narla, Anupama; Hattangadi, Shilpa M.; Paw, Barry H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med,Div Hematol Oncol, Boston, MA 02115 USA; [Hattangadi, Shilpa M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hattangadi, Shilpa M.] MIT, Cambridge, MA 02142 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Biochem, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Mol Biol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Faccenda, Danilo; Campanella, Michelangelo] Univ London Royal Vet Coll, London NW1 0TU, England; [Faccenda, Danilo; Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London NW1 0TU, England; [Wiwczar, Jessica M.; Danial, Nika N.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Campagna, Dean R.; Fleming, Mark D.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of London; University of London Royal Veterinary College; University of London; University College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Paw, BH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA.	hdailey@uga.edu; jerry.kaplan@path.utah.edu; bpaw@rics.bwh.harvard.edu	Campanella, Michelangelo/K-8172-2016	Campanella, Michelangelo/0000-0002-6948-4184; Faccenda, Danilo/0000-0003-2827-2529; Vogin, Guillaume/0000-0002-8114-5900; Paw, Barry/0000-0002-0492-1419; Medlock, Amy/0000-0001-9402-3593; Fleming, Mark/0000-0003-0948-4024; Shah, Dhvanit/0000-0002-3173-2402	Cooley's Anemia Foundation; March of Dimes Foundation; American Heart Association; Dutch National Science Fund; Fondation Soldati pour la Recherche en Cancerologie; Burroughs Welcome Fund; NIDDK; NHLBI; Biotechnology and Biological Sciences Research Council [BB/I013695/1] Funding Source: researchfish; BBSRC [BB/I013695/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838, R56DK032303, R01DK052380, R01DK087992, P30DK072437, K01DK085217, R01DK096051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	Cooley's Anemia Foundation; March of Dimes Foundation(March of Dimes); American Heart Association(American Heart Association); Dutch National Science Fund; Fondation Soldati pour la Recherche en Cancerologie; Burroughs Welcome Fund(Burroughs Wellcome Fund); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratory (M. Cassim, A. Kaplan, G. Hildick-Smith and H. Anderson) and colleagues (S. L. Alper, K. Pepper and N. S. Trede) for critical review of the manuscript, T. C. Law for pnt adult blood characterization, H. Mulhern for help with the electron microscopy, and Christopher Lawrence and his team for the zebrafish husbandry. This research was supported in part by the Cooley's Anemia Foundation (D.I.S. and C.C.), the March of Dimes Foundation (B.H.P.), the American Heart Association (J.D.C. and A.E.M.), the Dutch National Science Fund (I.J.S.), the Fondation Soldati pour la Recherche en Cancerologie (G.V.), the Burroughs Welcome Fund (N.N.D.), the NIDDK (D.I.S., B.H.P., A.N., J.K., H.A.D. and S.M.H.) and the NHLBI (D.I.S. and B.H.P).	Anderson K. E., 2011, ONLINE METABOLIC MOL, P1; Ando C, 2008, J BIOCHEM, V144, P547, DOI 10.1093/jb/mvn100; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lanzilotta W.N., 2011, HDB METALLOPROTEINS, V4, P138; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Medlock AE, 2000, BIOCHEMISTRY-US, V39, P7461, DOI 10.1021/bi000134p; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ransom DG, 1996, DEVELOPMENT, V123, P311; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel AD, 2009, ACTA HAEMATOL-BASEL, V122, P120, DOI 10.1159/000243796; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110	30	66	73	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					608	612		10.1038/nature11536	http://dx.doi.org/10.1038/nature11536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135403	Green Submitted, Green Accepted			2022-12-01	WOS:000311339800055
J	Knight, ZA; Tan, K; Birsoy, K; Schmidt, S; Garrison, JL; Wysocki, RW; Emiliano, A; Ekstrand, MI; Friedman, JM				Knight, Zachary A.; Tan, Keith; Birsoy, Kivanc; Schmidt, Sarah; Garrison, Jennifer L.; Wysocki, Robert W.; Emiliano, Ana; Ekstrand, Mats I.; Friedman, Jeffrey M.			Molecular Profiling of Activated Neurons by Phosphorylated Ribosome Capture	CELL			English	Article							CELL-TYPES; GENE-EXPRESSION; NERVOUS-SYSTEM; GLUCOSE-HOMEOSTASIS; OSMOTIC STIMULATION; SIGNALING PATHWAY; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; MESSENGER-RNA; BODY-WEIGHT	The mammalian brain is composed of thousands of interacting neural cell types. Systematic approaches to establish the molecular identity of functional populations of neurons would advance our understanding of neural mechanisms controlling behavior. Here, we show that ribosomal protein S6, a structural component of the ribosome, becomes phosphorylated in neurons activated by a wide range of stimuli. We show that these phosphorylated ribosomes can be captured from mouse brain homogenates, thereby enriching directly for the mRNAs expressed in discrete subpopulations of activated cells. We use this approach to identify neurons in the hypothalamus regulated by changes in salt balance or food availability. We show that galanin neurons are activated by fasting and that prodynorphin neurons restrain food intake during scheduled feeding. These studies identify elements of the neural circuit that controls food intake and illustrate how the activity-dependent capture of cell-type-specific transcripts can elucidate the functional organization of a complex tissue.	[Knight, Zachary A.; Tan, Keith; Birsoy, Kivanc; Schmidt, Sarah; Garrison, Jennifer L.; Wysocki, Robert W.; Emiliano, Ana; Ekstrand, Mats I.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Knight, ZA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, 1230 York Ave, New York, NY 10021 USA.	zachary.knight@ucsf.edu; friedj@rockefeller.edu		Ekstrand, Mats/0000-0003-0019-9462; Knight, Zachary/0000-0001-7621-1478; Wysocki, Robert/0000-0001-9812-6071	JPB Foundation; NIH [DK083531]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK083531, K99DK083531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding from the JPB Foundation (J.M.F.) and NIH grant DK083531 (Z.A.K.). The authors have filed a patent related to this work. Dr. Friedman is a Founder of Envoy Therapeutics and holds equity in it and receives a retainer from the company. Envoy holds an option to license this technology from the Rockefeller University.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; BROWN MR, 1988, BRAIN RES, V452, P212, DOI 10.1016/0006-8993(88)90025-X; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Carroll I, 2004, EUR J PHARMACOL, V501, P111, DOI 10.1016/j.ejphar.2004.08.028; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Mateos-Verchere JG, 2001, EUR J PHARMACOL, V414, P225; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; GAI WP, 1990, J COMP NEUROL, V298, P265, DOI 10.1002/cne.902980302; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hahm S, 2002, J NEUROSCI, V22, P6929; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Koch C., 2001, INT ENCY SOCIAL BEHA, P2600; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Koike K, 1997, MOL BRAIN RES, V52, P326, DOI 10.1016/S0169-328X(97)00300-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Porter JP, 2004, AM J PHYSIOL-REG I, V287, pR422, DOI 10.1152/ajpregu.00537.2003; Reaux-Le Goazigo A, 2011, AM J PHYSIOL-ENDOC M, V301, pE955, DOI 10.1152/ajpendo.00090.2011; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SCHWARTZ MW, 1993, BRAIN RES BULL, V31, P361, DOI 10.1016/0361-9230(93)90228-4; SHERMAN TG, 1986, NEUROENDOCRINOLOGY, V44, P222, DOI 10.1159/000124649; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Sunn N, 2002, P NATL ACAD SCI USA, V99, P1701, DOI 10.1073/pnas.022647699; THORNTON SN, 1995, J NEUROENDOCRINOL, V7, P165, DOI 10.1111/j.1365-2826.1995.tb00743.x; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P384, DOI 10.1016/j.euroneuro.2010.06.005; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou D, 2005, REGUL PEPTIDES, V124, P53, DOI 10.1016/j.regpep.2004.06.026	49	187	190	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1126	1137		10.1016/j.cell.2012.10.039	http://dx.doi.org/10.1016/j.cell.2012.10.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178128	Bronze, Green Accepted			2022-12-01	WOS:000311423500023
J	Soufi, A; Donahue, G; Zaret, KS				Soufi, Abdenour; Donahue, Greg; Zaret, Kenneth S.			Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome	CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; HUMAN FIBROBLASTS; IN-VITRO; GENERATION; CHROMATIN; DNA; EXPRESSION	The ectopic expression of transcription factors can reprogram cell fate, yet it is unknown how the initial binding of factors to the genome relates functionally to the binding seen in the minority of cells that become reprogrammed. We report a map of Oct4, Sox2, Klf4, and c-Myc (O, S, K, and M) on the human genome during the first 48 hr of reprogramming fibroblasts to pluripotency. Three striking aspects of the initial chromatin binding events include an unexpected role for c-Myc in facilitating OSK chromatin engagement, the primacy of O, S, and K as pioneer factors at enhancers of genes that promote reprogramming, and megabase-scale chromatin domains spanned by H3K9me3, including many genes required for pluripotency, that prevent initial OSKM binding and impede the efficiency of reprogramming. We find diverse aspects of initial factor binding that must be overcome in the minority of cells that become reprogrammed.	[Soufi, Abdenour; Donahue, Greg; Zaret, Kenneth S.] Univ Penn, Dept Cell & Dev Biol, Smilow Ctr Translat Res, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Smilow Ctr Translat Res, Perelman Sch Med, Bldg 421,Rooms 131-132,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Soufi, Abdenour/0000-0002-3666-3266	NIH [R37GM36477, P01GM099134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, R37GM036477, R01GM036477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kim for iPS reagents; G. Blobel, K. Blahnik, J. Caravaca, M. Iwafuchi-Doi, and J. Kim for comments on the manuscript; and K. Kaestner and J. Schug for sequencing by the UPenn Diabetes Research Center Functional Genomics Gore (P30-DK19525). The work was supported by NIH grants R37GM36477 and P01GM099134 to K.S.Z.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024351; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	565	582	5	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					994	1004		10.1016/j.cell.2012.09.045	http://dx.doi.org/10.1016/j.cell.2012.09.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23159369	Green Accepted, Bronze			2022-12-01	WOS:000311423500013
J	Montealegre-Z, F; Jonsson, T; Robson-Brown, KA; Postles, M; Robert, D				Montealegre-Z, Fernando; Jonsson, Thorin; Robson-Brown, Kate A.; Postles, Matthew; Robert, Daniel			Convergent Evolution Between Insect and Mammalian Audition	SCIENCE			English	Article							AUDITORY RECEPTOR ORGANS; BUSH-CRICKETS; MORPHOLOGY; PHYSIOLOGY; EAR	In mammals, hearing is dependent on three canonical processing stages: (i) an eardrum collecting sound, (ii) a middle ear impedance converter, and (iii) a cochlear frequency analyzer. Here, we show that some insects, such as rainforest katydids, possess equivalent biophysical mechanisms for auditory processing. Although katydid ears are among the smallest in all organisms, these ears perform the crucial stage of air-to-liquid impedance conversion and signal amplification, with the use of a distinct tympanal lever system. Further along the chain of hearing, spectral sound analysis is achieved through dispersive wave propagation across a fluid substrate, as in the mammalian cochlea. Thus, two phylogenetically remote organisms, katydids and mammals, have evolved a series of convergent solutions to common biophysical problems, despite their reliance on very different morphological substrates.	[Montealegre-Z, Fernando; Jonsson, Thorin; Postles, Matthew; Robert, Daniel] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Robson-Brown, Kate A.] Univ Bristol, Dept Archaeol & Anthropol, Imaging Lab, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	Montealegre-Z, F (corresponding author), Lincoln Univ, Sch Life Sci, Riseholme Campus, Lincoln LN2 2LG, England.	fmontealegrez@lincoln.ac.uk; d.robert@bristol.ac.uk	Jonsson, Thorin/AAH-3490-2019	Jonsson, Thorin/0000-0002-5049-7612	Human Frontier Science Program (Cross Disciplinary Fellowship) [LT00024/2008-C]; Royal Society of London; UK-India Education and Research Initiative [SA06-169E]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I009671/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I009671/1, BB/C518522/1] Funding Source: researchfish	Human Frontier Science Program (Cross Disciplinary Fellowship)(Human Frontier Science Program); Royal Society of London(Royal Society of London); UK-India Education and Research Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was sponsored by the Human Frontier Science Program (Cross Disciplinary Fellowship LT00024/2008-C to F.M.-Z.). D. R. is supported by the Royal Society of London. This research was also partially supported by the UK-India Education and Research Initiative (grant no. SA06-169E) and the Biotechnology and Biological Sciences Research Council. We declare no conflict of interest. The Colombian Ministry of Environment granted a permit for fieldwork at Gorgona National Park (decree DTS0-G-31 11/07). All additional information regarding data generation is given in the text and the supplementary materials.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; Boistel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022080; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KALMRING K, 1993, ZOOL JAHRB ALLG ZOOL, V97, P75; LEWIS DB, 1974, J EXP BIOL, V60, P839; Montealegre-Z Fernando, 2010, Journal of Orthoptera Research, V19, P347, DOI 10.1665/034.019.0223; Muller J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000889; Nowotny M, 2010, J COMP PHYSIOL A, V196, P939, DOI 10.1007/s00359-010-0577-6; OLDFIELD BP, 1982, J COMP PHYSIOL, V147, P461, DOI 10.1007/BF00612011; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Thomassen HA, 2007, HEARING RES, V225, P25, DOI 10.1016/j.heares.2006.11.013; Udayashankar AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031008; von Bekesy G., 1960, EXPT HEARING; Windmill JFC, 2005, J EXP BIOL, V208, P157, DOI 10.1242/jeb.01332; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	19	55	58	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					968	971		10.1126/science.1225271	http://dx.doi.org/10.1126/science.1225271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162003				2022-12-01	WOS:000311083600049
J	Montano, SP; Pigli, YZ; Rice, PA				Montano, Sherwin P.; Pigli, Ying Z.; Rice, Phoebe A.			The Mu transpososome structure sheds light on DDE recombinase evolution	NATURE			English	Article							IN-VITRO TRANSPOSITION; DNA-BINDING DOMAIN; BACTERIOPHAGE-MU; PHAGE-MU; STRAND TRANSFER; CRYSTAL-STRUCTURE; COMPLEX; PROTEIN; CLPX; INTEGRATION	Studies of bacteriophage Mu transposition paved the way for understanding retroviral integration and V(D)J recombination as well as many other DNA transposition reactions. Here we report the structure of the Mu transpososome-Mu transposase (MuA) in complex with bacteriophage DNA ends and target DNA-determined from data that extend anisotropically to 5.2 angstrom, 5.2 angstrom and 3.7 angstrom resolution, in conjunction with previously determined structures of individual domains. The highly intertwined structure illustrates why chemical activity depends on formation of the synaptic complex, and reveals that individual domains have different roles when bound to different sites. The structure also provides explanations for the increased stability of the final product complex and for its preferential recognition by the ATP-dependent unfoldase ClpX. Although MuA and many other recombinases share a structurally conserved 'DDE' catalytic domain, comparisons among the limited set of available complex structures indicate that some conserved features, such as catalysis in trans and target DNA bending, arose through convergent evolution because they are important for function.	[Montano, Sherwin P.; Pigli, Ying Z.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	PRice@uchicago.edu			NIH [GM086826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Mizuuchi for initiating this project, K. K. Swinger and B. Vertessy for early crystallization efforts, and X. Yang and the staff of APS beamlines 14, 19 and 21 for assistance with data collection. This work was funded in part by NIH grant GM086826 (to P.A.R.).	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Abdelhakim AH, 2010, P NATL ACAD SCI USA, V107, P2437, DOI 10.1073/pnas.0910905106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; ALLISON RG, 1992, J BIOL CHEM, V267, P19963; Au TK, 2004, EMBO J, V23, P3408, DOI 10.1038/sj.emboj.7600344; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton BM, 2003, CHEM BIOL, V10, P463, DOI 10.1016/S1074-5521(03)00102-9; CHACONAS G, 1983, VIROLOGY, V128, P48, DOI 10.1016/0042-6822(83)90317-3; Choi W, 2010, P NATL ACAD SCI USA, V107, P10014, DOI 10.1073/pnas.0912615107; Clubb RT, 1997, J MOL BIOL, V273, P19, DOI 10.1006/jmbi.1997.1312; CRAIG NL, 2002, MOBILE DNA, V2; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Ducruix A., 1992, PREPARATION SELENOME; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Harshey RM, 2006, CRIT REV BIOCHEM MOL, V41, P387, DOI 10.1080/10409230600946015; Jiang H, 1999, EMBO J, V18, P3845, DOI 10.1093/emboj/18.13.3845; Krementsova E, 1998, J BIOL CHEM, V273, P31358, DOI 10.1074/jbc.273.47.31358; Kruklitis R, 1996, EMBO J, V15, P935, DOI 10.1002/j.1460-2075.1996.tb00428.x; KUO CF, 1991, EMBO J, V10, P1585, DOI 10.1002/j.1460-2075.1991.tb07679.x; LAVOIE BD, 1993, GENE DEV, V7, P2510, DOI 10.1101/gad.7.12b.2510; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; Mizuuchi M, 2001, EMBO J, V20, P6927, DOI 10.1093/emboj/20.23.6927; MIZUUCHI M, 1991, P NATL ACAD SCI USA, V88, P9031, DOI 10.1073/pnas.88.20.9031; Mizuuchi M, 2007, P NATL ACAD SCI USA, V104, P14622, DOI 10.1073/pnas.0706556104; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Naigamwalla DZ, 1998, J MOL BIOL, V282, P265, DOI 10.1006/jmbi.1998.2011; Namgoong SY, 1998, NUCLEIC ACIDS RES, V26, P3521, DOI 10.1093/nar/26.15.3521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SURETTE MG, 1989, J BIOL CHEM, V264, P3028; SURETTE MG, 1992, CELL, V68, P1101, DOI 10.1016/0092-8674(92)90081-M; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Tanaka Y, 2001, EMBO J, V20, P6612, DOI 10.1093/emboj/20.23.6612; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770; WU ZG, 1995, EMBO J, V14, P3835, DOI 10.1002/j.1460-2075.1995.tb00053.x; Yanagihara K, 2002, P NATL ACAD SCI USA, V99, P11317, DOI 10.1073/pnas.132403399; YANG JY, 1995, EMBO J, V14, P2374, DOI 10.1002/j.1460-2075.1995.tb07232.x; Yuan JF, 2005, GENE DEV, V19, P840, DOI 10.1101/gad.1291405; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; ZOU A, 1991, J BIOL CHEM, V266, P20476	63	83	86	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					413	+		10.1038/nature11602	http://dx.doi.org/10.1038/nature11602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23135398	Green Accepted			2022-12-01	WOS:000311031600039
J	Wu, CY; Chen, YJ; Ho, HJ; Hsu, YC; Kuo, KN; Wu, MS; Lin, JT				Wu, Chun-Ying; Chen, Yi-Ju; Ho, Hsiu J.; Hsu, Yao-Chun; Kuo, Ken N.; Wu, Ming-Shiang; Lin, Jaw-Town			Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMORTAL TIME BIAS; ANTIVIRAL THERAPY; VIRAL LOAD; LAMIVUDINE; SURVIVAL; REPLICATION; APOPTOSIS; IMPACT	Context Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection. Objective To investigate the association between nucleoside analogue use and risk of tumor recurrence in patients with hepatitis B virus (HBV)-related HCC after curative surgery. Design, Setting, and Participants A nationwide cohort study between October 2003 and September 2010. Data from the Taiwan National Health Insurance Research Database. Among 100 938 newly diagnosed HCC patients, we identified 4569 HBV-related HCC patients who received curative liver resection for HCC between October 2003 and September 2010. Main Outcome Measures The risk of first tumor recurrence was compared between patients not taking nucleoside analogues (untreated cohort, n=4051) and patients taking nucleoside analogues (treated cohort, n=518). Cumulative incidences and hazard ratios (HRs) were calculated after adjusting for competing mortality. Results The treated cohort had a higher prevalence of liver cirrhosis when compared with the untreated cohort (48.6% vs 38.7%; P<.001), but lower risk of HCC recurrence (n=106 [20.5%] vs n=1765 [43.6%]; P<.001), and lower overall death (n=55 [10.6%] vs n=1145 [28.3%]; P<.001). After adjusting for competing mortality, the treated cohort had a significantly lower 6-year HCC recurrence rate (45.6%; 95% CI, 36.5%-54.6% vs untreated, 54.6%; 95% CI, 52.5%-56.6%; P<.001). Six-year overall mortalities for treated cohorts were 29.0% (95% CI, 20.0%-38.0%) and for untreated 42.4% (95% CI, 40.0%-44.7%; P<.001). On modified Cox regression analysis, nucleoside analogue use (HR, 0.67; 95% CI, 0.55-0.81; P<.001), statin use (HR, 0.68; 95% CI, 0.53-0.87; P=.002), and nonsteroidal anti-inflammatory drugs or aspirin use (HR, 0.80; 95% CI, 0.73-0.88; P<.001) were independently associated with a reduced risk of HCC recurrence. Multivariable stratified analyses verified the association in all subgroups of patients, including those who were noncirrhotic (HR, 0.56; 95% CI, 0.42-0.76) and diabetic (HR, 0.52; 95% CI, 0.31-0.89). Conclusion Nucleoside analogue use was associated with a lower risk of HCC recurrence among patients with HBV-related HCC after liver resection. JAMA. 2012; 308(18): 1906-1913 Published online November 12, 2012. doi: 10.1001/2012.jama.11975 www.jama.com	[Wu, Chun-Ying; Chen, Yi-Ju] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Wu, Chun-Ying] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Chen, Yi-Ju] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Wu, Chun-Ying; Hsu, Yao-Chun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wu, Chun-Ying; Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Wu, Chun-Ying] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Ho, Hsiu J.; Wu, Ming-Shiang; Lin, Jaw-Town] Natl Taiwan Univ Hosp, Div Gastroenterol, Taipei, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town] I Shou Univ, Dept Internal Med, E Da Hosp, Kaohsiung, Taiwan; [Kuo, Ken N.] Taipei Med Coll, Coll Med, Taipei, Taiwan; [Kuo, Ken N.; Lin, Jaw-Town] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; Taipei Medical University; National Health Research Institutes - Taiwan; Fu Jen Catholic University	Wu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	chun@vghtc.gov.tw	Wu, Chun-Ying/AAX-5077-2021	Wu, Chun-Ying/0000-0001-5053-1801; Wu, Ming-Shiang/0000-0002-1940-6428	National Health Research Institutes; Taiwan's National Health Research Institute [PH-101-PP-23]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Taiwan's National Health Research Institute	The National Health Research Institutes provided access to the National Health Insurance Research Database (NHIRD) and financial support for the hiring of a research assistant. This work was supported by Taiwan's National Health Research Institute (PH-101-PP-23). This study is based on data from the NHIRD provided by the Bureau of National Health Insurance, Department of Health, and managed by the NHIRD, Taiwan.	Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cho YK, 2011, J GASTROEN HEPATOL, V26, P1354, DOI 10.1111/j.1440-1746.2011.06812.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Hossain MA, 2012, INT J ONCOL, V40, P1298, DOI 10.3892/ijo.2011.1304; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Jang JW, 2007, CANCER, V110, P1760, DOI 10.1002/cncr.22984; Kim BK, 2008, LIVER INT, V28, P393, DOI 10.1111/j.1478-3231.2007.01625.x; Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kuzuya T, 2007, J GASTROEN HEPATOL, V22, P1929, DOI 10.1111/j.1440-1746.2006.04707.x; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Poon RTP, 2000, J CLIN ONCOL, V18, P1094, DOI 10.1200/JCO.2000.18.5.1094; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; TONG MJ, 1971, ANN INTERN MED, V75, P687, DOI 10.7326/0003-4819-75-5-687; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Wu CY, 2011, GUT, V60, P1038, DOI 10.1136/gut.2010.224329; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	35	667	691	3	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1906	1913		10.1001/2012.jama.11975	http://dx.doi.org/10.1001/2012.jama.11975			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23162861	Bronze, Green Submitted			2022-12-01	WOS:000310952700027
J	Rando, OJ				Rando, Oliver J.			Daddy Issues: Paternal Effects on Phenotype	CELL			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; MOUSE; TRANSMISSION; ARABIDOPSIS; METHYLATION; MECHANISMS; RESPONSES; DYNAMICS	The once popular and then heretical idea that ancestral environment can affect the phenotype of future generations is coming back into vogue due to advances in the field of epigenetic inheritance. How paternal environmental conditions influence the phenotype of progeny is now a tractable question, and researchers are exploring potential mechanisms underlying such effects.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu		Rando, Oliver/0000-0003-1516-9397	NIGMS; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033664] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Thanks to N. Francis, M. Walhout, J. Shea, M. Vallaster, M. Garber, H. Florman, and B. Carone for critical reading of early drafts of this manuscript. I apologize to the many authors of relevant work left uncited due to space constraints. This work was supported by NIGMS and by the G. Harold and Leila Y. Mathers Foundation.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Avital E., 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chason RJ, 2011, TRENDS ENDOCRIN MET, V22, P412, DOI 10.1016/j.tem.2011.05.005; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Li M, 2011, EXP DIABETES RES, DOI [10.4061/2011/179819, 10.1155/2011/592408]; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nelson VR, 2010, EPIGENOMICS-UK, V2, P513, DOI [10.2217/epi.10.26, 10.2217/EPI.10.26]; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rassoulzadegan M, 2010, ORGANOGENESIS, V6, P33, DOI 10.4161/org.6.1.11094; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; van Montfoort APA, 2012, HUM REPROD UPDATE, V18, P171, DOI 10.1093/humupd/dmr047; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	48	191	197	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					702	708		10.1016/j.cell.2012.10.020	http://dx.doi.org/10.1016/j.cell.2012.10.020			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141533	Green Accepted, Bronze			2022-12-01	WOS:000310921200004
J	Raiten, JM; Neuman, MD				Raiten, Jesse M.; Neuman, Mark D.			"If I Had Only Known" - On Choice and Uncertainty in the ICU	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raiten, Jesse M.; Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Raiten, JM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA.							Mol A., 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Mol A, 2009, LANCET, V373, P1756, DOI 10.1016/S0140-6736(09)60971-5; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Neuman MD, 2012, MILBANK Q, V90, P135, DOI 10.1111/j.1468-0009.2011.00657.x; Schwarze ML, 2010, CRIT CARE MED, V38, P843, DOI 10.1097/CCM.0b013e3181cc466b	5	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1779	1781		10.1056/NEJMp1209698	http://dx.doi.org/10.1056/NEJMp1209698			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134380				2022-12-01	WOS:000310773200004
J	Wang, YF; Wang, Y; Breed, DR; Manoharan, VN; Feng, L; Hollingsworth, AD; Weck, M; Pine, DJ				Wang, Yufeng; Wang, Yu; Breed, Dana R.; Manoharan, Vinothan N.; Feng, Lang; Hollingsworth, Andrew D.; Weck, Marcus; Pine, David J.			Colloids with valence and specific directional bonding	NATURE			English	Article							ASYMMETRIC FUNCTIONALIZATION; CLUSTERS; NANOPARTICLES; PARTICLES; ANISOTROPY	The ability to design and assemble three-dimensional structures from colloidal particles is limited by the absence of specific directional bonds. As a result, complex or low-coordination structures, common in atomic and molecular systems, are rare in the colloidal domain. Here we demonstrate a general method for creating the colloidal analogues of atoms with valence: colloidal particles with chemically distinct surface patches that imitate hybridized atomic orbitals, including sp, sp(2), sp(3), sp(3)d, sp(3)d(2) and sp(3)d(3). Functionalized with DNA with single-stranded sticky ends, patches on different particles can form highly directional bonds through programmable, specific and reversible DNA hybridization. These features allow the particles to self-assemble into 'colloidal molecules' with triangular, tetrahedral and other bonding symmetries, and should also give access to a rich variety of new microstructured colloidal materials.	[Feng, Lang; Hollingsworth, Andrew D.; Pine, David J.] NYU, Ctr Soft Matter Res, New York, NY 10003 USA; [Feng, Lang; Hollingsworth, Andrew D.; Pine, David J.] NYU, Dept Phys, New York, NY 10003 USA; [Wang, Yufeng; Wang, Yu; Weck, Marcus] NYU, Inst Mol Design, New York, NY 10003 USA; [Wang, Yufeng; Wang, Yu; Weck, Marcus] NYU, Dept Chem, New York, NY 10003 USA; [Breed, Dana R.] Dow Chem Co USA, Freeport, TX 77541 USA; [Manoharan, Vinothan N.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	New York University; New York University; New York University; New York University; Dow Chemical Company; Harvard University; Harvard University	Pine, DJ (corresponding author), NYU, Ctr Soft Matter Res, New York, NY 10003 USA.	marcus.weck@nyu.edu; pine@nyu.edu	Wang, Yu/E-7358-2015; Manoharan, Vinothan N/C-1292-2008; Feng, Lang/P-7891-2014; Pine, David J/B-7740-2016	Wang, Yu/0000-0003-1286-2401; Manoharan, Vinothan N/0000-0003-0370-6095; Pine, David J/0000-0002-3304-6684; Wang, Yufeng/0000-0001-9409-7250; Weck, Marcus/0000-0002-6486-4268	MRSEC Program of the National Science Foundation [DMR-0820341]; National Science Foundation [ChE-0911460]; MRI programme of the National Science Foundation [DMR-0923251]	MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Science Foundation(National Science Foundation (NSF)); MRI programme of the National Science Foundation	We thank M. T. Elsesser, D. Kraft, and G.-R. Yi for discussions. This work was supported partially by the MRSEC Program of the National Science Foundation under award number DMR-0820341. Additional financial support was provided by the National Science Foundation (ChE-0911460). We acknowledge support from the MRI programme of the National Science Foundation under award number DMR-0923251 for the purchase of a Zeiss field emission scanning electron microscope.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Breed D. R., 2007, THESIS U CALIFORNIA; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cho YS, 2007, CHEM MATER, V19, P3183, DOI 10.1021/cm070051w; Dreyfus R, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041404; Frenkel D, 2002, SCIENCE, V296, P65, DOI 10.1126/science.1070865; Glotzer SC, 2004, SCIENCE, V306, P419, DOI 10.1126/science.1099988; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; HO KM, 1990, PHYS REV LETT, V65, P3152, DOI 10.1103/PhysRevLett.65.3152; Hong L, 2008, LANGMUIR, V24, P621, DOI 10.1021/la7030818; Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178; Johnson PM, 2005, LANGMUIR, V21, P11510, DOI 10.1021/la0518750; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Khan A., 1985, MAKROMOL CHEM, V10, P215; Kraft DJ, 2009, SOFT MATTER, V5, P3823, DOI 10.1039/b910593j; Kraft DJ, 2009, J AM CHEM SOC, V131, P1182, DOI 10.1021/ja8079803; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/NMAT2471, 10.1038/nmat2471]; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Manoharan V. N., 2004, THESIS U CALIFORNIA; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Miller MA, 2005, J PHYS CHEM B, V109, P23109, DOI 10.1021/jp0549632; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nelson DR, 2002, NANO LETT, V2, P1125, DOI 10.1021/n10202096; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; OTTEWILL RH, 1967, KOLLOID Z Z POLYM, V215, P161, DOI 10.1007/BF01520398; Pawar AB, 2010, MACROMOL RAPID COMM, V31, P150, DOI 10.1002/marc.200900614; Pawar AB, 2009, LANGMUIR, V25, P9057, DOI 10.1021/la900809b; Perro A, 2009, ANGEW CHEM INT EDIT, V48, P361, DOI 10.1002/anie.200802562; Romano F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578182; Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Sacanna S, 2011, CURR OPIN COLLOID IN, V16, P96, DOI 10.1016/j.cocis.2011.01.003; UGELSTAD J, 1979, MAKROMOL CHEM, V180, P737; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P292; Velikov KP, 2002, SCIENCE, V296, P106, DOI 10.1126/science.1067141; Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Zerrouki D, 2006, LANGMUIR, V22, P57, DOI 10.1021/la051765t; Zhang G, 2005, NANO LETT, V5, P143, DOI 10.1012/nl048121a; Zhang ZL, 2005, LANGMUIR, V21, P11547, DOI 10.1021/la0513611; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zoldesi CI, 2006, LANGMUIR, V22, P4343, DOI 10.1021/la060101w	47	783	792	13	674	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					51	U61		10.1038/nature11564	http://dx.doi.org/10.1038/nature11564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128225	Green Submitted			2022-12-01	WOS:000310434500029
J	Mali, P; Yang, LH; Esvelt, KM; Aach, J; Guell, M; DiCarlo, JE; Norville, JE; Church, GM				Mali, Prashant; Yang, Luhan; Esvelt, Kevin M.; Aach, John; Guell, Marc; DiCarlo, James E.; Norville, Julie E.; Church, George M.			RNA-Guided Human Genome Engineering via Cas9	SCIENCE			English	Article							ZINC-FINGER NUCLEASES; SYNTHETIC BIOLOGY; MAMMALIAN-CELLS; GENE CORRECTION; IN-VIVO; SYSTEMS; CLEAVAGE; BACTERIA; IMMUNITY; SPECIFICITIES	Bacteria and archaea have evolved adaptive immune defenses, termed clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems, that use short RNA to direct degradation of foreign nucleic acids. Here, we engineer the type II bacterial CRISPR system to function with custom guide RNA (gRNA) in human cells. For the endogenous AAVS1 locus, we obtained targeting rates of 10 to 25% in 293T cells, 13 to 8% in K562 cells, and 2 to 4% in induced pluripotent stem cells. We show that this process relies on CRISPR components; is sequence-specific; and, upon simultaneous introduction of multiple gRNAs, can effect multiplex editing of target loci. We also compute a genome-wide resource of similar to 190 K unique gRNAs targeting similar to 40.5% of human exons. Our results establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.	[Mali, Prashant; Yang, Luhan; Aach, John; Guell, Marc; Norville, Julie E.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Esvelt, Kevin M.; Church, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Yang, Luhan] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA; [DiCarlo, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Boston University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Güell, Marc/J-2970-2017; DiCarlo, James/AAJ-1579-2021; Wilson, Matthew H/K-3193-2013; Güell, Marc/AAB-3054-2021	Güell, Marc/0000-0003-4000-7912; DiCarlo, James/0000-0003-4728-3186; Güell, Marc/0000-0003-4000-7912; Esvelt, Kevin/0000-0001-8797-3945; Norville, Julie/0000-0001-9205-8936; church, george/0000-0001-6232-9969	NIH [P50 HG005550]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH grant P50 HG005550. We thank S. Kosuri for advice on the oligonucleotide pool designs and synthesis. G. M. C. and P. M. have filed a patent based on the findings of this study.	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; King NMP, 2008, MOL THER, V16, P432, DOI 10.1038/mt.2008.13; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	28	5915	6960	119	3806	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					823	826		10.1126/science.1232033	http://dx.doi.org/10.1126/science.1232033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287722	Green Accepted			2022-12-01	WOS:000314874400050
J	Sun, LJ; Wu, JX; Du, FH; Chen, X; Chen, ZJJ				Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.			Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway	SCIENCE			English	Article							INTRACELLULAR DNA; INNATE; IDENTIFICATION; IMMUNITY; RANGE; GENE; RNA	The presence of DNA in the cytoplasm of mammalian cells is a danger signal that triggers host immune responses such as the production of type I interferons. Cytosolic DNA induces interferons through the production of cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING. Through biochemical fractionation and quantitative mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family. Overexpression of cGAS activated the transcription factor IRF3 and induced interferon-beta in a STING-dependent manner. Knockdown of cGAS inhibited IRF3 activation and interferon-b induction by DNA transfection or DNA virus infection. cGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis. These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP.	[Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Wu, Jiaxi/K-3322-2016; Chen, Zhijian/C-6039-2012	Wu, Jiaxi/0000-0002-6976-4784; Chen, Zhijian/0000-0002-8475-8251	NIH [AI-093967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Li for helpful discussion on bioinformatics analyses. The GenBank accession numbers for human and mouse cGAS sequences are KC294566 and KC294567, respectively. Supported by NIH grant AI-093967. Z.J.C. is an investigator of Howard Hughes Medical Institute.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	21	2328	2448	62	660	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					786	791		10.1126/science.1232458	http://dx.doi.org/10.1126/science.1232458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258413	Green Accepted			2022-12-01	WOS:000314874400039
J	Maddocks, ODK; Berkers, CR; Mason, SM; Zheng, L; Blyth, K; Gottlieb, E; Vousden, KH				Maddocks, Oliver D. K.; Berkers, Celia R.; Mason, Susan M.; Zheng, Liang; Blyth, Karen; Gottlieb, Eyal; Vousden, Karen H.			Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells	NATURE			English	Article							PYRUVATE-KINASE M2; P53-INDUCIBLE REGULATOR; RETINOBLASTOMA PROTEIN; CYCLE ARREST; DNA-DAMAGE; P53; APOPTOSIS; GLYCINE; TUMORS; MICE	Cancer cells acquire distinct metabolic adaptations to survive stress associated with tumour growth and to satisfy the anabolic demands of proliferation. The tumour suppressor protein p53 (also known as TP53) influences a range of cellular metabolic processes, including glycolysis(1,2), oxidative phosphorylation(3), glutaminolysis(4,5) and anti-oxidant response(6). In contrast to its role in promoting apoptosis during DNA-damaging stress, p53 can promote cell survival during metabolic stress(7), a function that may contribute not only to tumour suppression but also to non-cancer-associated functions of p53(8). Here we show that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle. Transient p53-p21 (also known as CDKN1A) activation and cell-cycle arrest promoted cell survival by efficiently channelling depleted serine stores to glutathione synthesis, thus preserving cellular anti-oxidant capacity. Cells lacking p53 failed to complete the response to serine depletion, resulting in oxidative stress, reduced viability and severely impaired proliferation. The role of p53 in supporting cancer cell proliferation under serine starvation was translated to an in vivo model, indicating that serine depletion has a potential role in the treatment of p53-deficient tumours.	[Maddocks, Oliver D. K.; Berkers, Celia R.; Mason, Susan M.; Zheng, Liang; Blyth, Karen; Gottlieb, Eyal; Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Maddocks, Oliver/K-5410-2012; Berkers, Celia/I-3848-2016; Gottlieb, Eyal/G-6450-2010	Maddocks, Oliver/0000-0002-5551-9091; Gottlieb, Eyal/0000-0002-9770-0956; Mason, Susan/0000-0002-3327-7693; Blyth, Karen/0000-0002-9304-439X; Zheng, Liang/0000-0002-5346-4111; Berkers, Celia/0000-0003-0746-8565	Cancer Research UK; Netherlands Organisation for Scientific Research	Cancer Research UK(Cancer Research UK); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded by Cancer Research UK. C. R. B. is a recipient of a Rubicon Fellowship from the Netherlands Organisation for Scientific Research. The authors thank A. Vigneron, B. Chaneton, M. O'Prey, E. Cheung, D. Athineos, G. Kalna, G. Mackay and B. Ludwig for advice and technical assistance.	ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gruning NM, 2011, NATURE, V480, P190, DOI 10.1038/480190a; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kondoh H, 2005, CANCER RES, V65, P177; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Locasale JW, 2011, CELL CYCLE, V10, P3812, DOI 10.4161/cc.10.22.18224; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; Okamura S, 1999, ONCOL RES, V11, P281; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rose ML, 1999, CARCINOGENESIS, V20, P2075, DOI 10.1093/carcin/20.11.2075; Rose ML, 1999, CARCINOGENESIS, V20, P793, DOI 10.1093/carcin/20.5.793; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; SNELL K, 1990, ADV ENZYME REGUL, V30, P13; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	33	583	603	7	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					542	+		10.1038/nature11743	http://dx.doi.org/10.1038/nature11743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23242140	Green Accepted			2022-12-01	WOS:000313871400040
J	Lewandowski, B; De Bo, G; Ward, JW; Papmeyer, M; Kuschel, S; Aldegunde, MJ; Gramlich, PME; Heckmann, D; Goldup, SM; D'Souza, DM; Fernandes, AE; Leigh, DA				Lewandowski, Bartosz; De Bo, Guillaume; Ward, John W.; Papmeyer, Marcus; Kuschel, Sonja; Aldegunde, Maria J.; Gramlich, Philipp M. E.; Heckmann, Dominik; Goldup, Stephen M.; D'Souza, Daniel M.; Fernandes, Antony E.; Leigh, David A.			Sequence-Specific Peptide Synthesis by an Artificial Small-Molecule Machine	SCIENCE			English	Article							MULTISTEP ORGANIC-SYNTHESIS; RIBOSOME NOBEL LECTURE; CHEMICAL LIGATION; ANTIBIOTICS; ROTAXANES; CATALYSTS	The ribosome builds proteins by joining together amino acids in an order determined by messenger RNA. Here, we report on the design, synthesis, and operation of an artificial small-molecule machine that travels along a molecular strand, picking up amino acids that block its path, to synthesize a peptide in a sequence-specific manner. The chemical structure is based on a rotaxane, a molecular ring threaded onto a molecular axle. The ring carries a thiolate group that iteratively removes amino acids in order from the strand and transfers them to a peptide-elongation site through native chemical ligation. The synthesis is demonstrated with similar to 10(18) molecular machines acting in parallel; this process generates milligram quantities of a peptide with a single sequence confirmed by tandem mass spectrometry.	[Lewandowski, Bartosz; De Bo, Guillaume; Ward, John W.; Papmeyer, Marcus; Kuschel, Sonja; Leigh, David A.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Aldegunde, Maria J.; Gramlich, Philipp M. E.; Heckmann, Dominik; Goldup, Stephen M.; D'Souza, Daniel M.; Fernandes, Antony E.; Leigh, David A.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Manchester; University of Edinburgh	Leigh, DA (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	david.leigh@manchester.ac.uk	Goldup, Stephen M/M-3136-2014; Goldup, Stephen/F-1660-2011; De Bo, Guillaume/C-5861-2013; Leigh, David/K-5965-2015; Ward, John/AAF-3691-2021	Goldup, Stephen M/0000-0003-3781-0464; Goldup, Stephen/0000-0003-3781-0464; De Bo, Guillaume/0000-0003-2670-6370; Leigh, David/0000-0002-1202-4507; Ward, John/0000-0001-7186-6416; Fernandes, Antony/0000-0002-7993-2980; Lewandowski, Bartosz/0000-0002-0342-4701	Engineering and Physical Sciences Research Council (UK); Fundacja na Rzecz Nauki Polskiej; Fonds de la Recherche Scientifique; Wallonie-Bruxelles International; European Union; Deutscher Akademischer Austausch Dienst; Deutsche Akademia der Naturforscher Leopoldina; Peter und Traudl Engelhorn-Stiftung; Engineering and Physical Sciences Research Council [EP/H021620/2, EP/H021620/1] Funding Source: researchfish; EPSRC [EP/H021620/1, EP/H021620/2] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fundacja na Rzecz Nauki Polskiej; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Wallonie-Bruxelles International; European Union(European Commission); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Akademia der Naturforscher Leopoldina; Peter und Traudl Engelhorn-Stiftung; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank V. Aucagne for useful suggestions during early versions of the molecular machine design. This research was funded by the Engineering and Physical Sciences Research Council (UK). We are grateful to the following organizations for postdoctoral fellowships: Fundacja na Rzecz Nauki Polskiej (to B. L.), Fonds de la Recherche Scientifique and Wallonie-Bruxelles International (to G. D. B.), the European Union 7th Framework Marie Curie Intra European Fellowship Program (to M.J.A.), Deutscher Akademischer Austausch Dienst (to P. M. E. G. and D. H.), and Deutsche Akademia der Naturforscher Leopoldina and Peter und Traudl Engelhorn-Stiftung (to D.M.D.).	Aucagne V, 2006, J AM CHEM SOC, V128, P2186, DOI 10.1021/ja056903f; Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; Berg JM, 2006, BIOCHEMISTRY; Berna J, 2005, NAT MATER, V4, P704, DOI 10.1038/nmat1455; Blanco V, 2012, ANGEW CHEM INT EDIT, V51, P5166, DOI 10.1002/anie.201201364; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Crowley JD, 2009, CHEM SOC REV, V38, P1530, DOI 10.1039/b804243h; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Hansen FK, 2011, ORG BIOMOL CHEM, V9, P7162, DOI 10.1039/c1ob05740e; He Y, 2011, J AM CHEM SOC, V133, P9972, DOI 10.1021/ja201361t; He Y, 2010, NAT NANOTECHNOL, V5, P778, DOI [10.1038/nnano.2010.190, 10.1038/NNANO.2010.190]; Juluri BK, 2009, ACS NANO, V3, P291, DOI 10.1021/nn8002373; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; McKee ML, 2012, J AM CHEM SOC, V134, P1446, DOI 10.1021/ja2101196; McKee ML, 2010, ANGEW CHEM INT EDIT, V49, P7948, DOI 10.1002/anie.201002721; Monnereau C, 2010, J AM CHEM SOC, V132, P1529, DOI 10.1021/ja908524x; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Payne RJ, 2007, J AM CHEM SOC, V129, P13527, DOI 10.1021/ja073653p; Ramakrishnan V, 2010, ANGEW CHEM INT EDIT, V49, P4355, DOI 10.1002/anie.201001436; Schmittel M, 2012, ANGEW CHEM INT EDIT, V51, P3832, DOI 10.1002/anie.201108089; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Wang JB, 2011, SCIENCE, V331, P1429, DOI 10.1126/science.1199844; WURTHNER F, 1995, ANGEW CHEM INT EDIT, V34, P446, DOI 10.1002/anie.199504461; Yonath A, 2010, ANGEW CHEM INT EDIT, V49, P4340, DOI 10.1002/anie.201001297; Yoon HJ, 2010, SCIENCE, V330, P66, DOI 10.1126/science.1193928	30	520	527	11	580	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					189	193		10.1126/science.1229753	http://dx.doi.org/10.1126/science.1229753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307739	Green Submitted			2022-12-01	WOS:000313328200040
J	Morgan, JLW; Strumillo, J; Zimmer, J				Morgan, Jacob L. W.; Strumillo, Joanna; Zimmer, Jochen			Crystallographic snapshot of cellulose synthesis and membrane translocation	NATURE			English	Article							C-DI-GMP; ACETOBACTER-XYLINUM; STRUCTURAL BASIS; IN-VITRO; BIOSYNTHESIS; SYNTHASES; BINDING; SYSTEM; GLYCOSYLTRANSFERASES; MICROFIBRILS	Cellulose, the most abundant biological macromolecule, is an extracellular, linear polymer of glucose molecules. It represents an essential component of plant cell walls but is also found in algae and bacteria. In bacteria, cellulose production frequently correlates with the formation of biofilms, a sessile, multicellular growth form. Cellulose synthesis and transport across the inner bacterial membrane is mediated by a complex of the membrane-integrated catalytic BcsA subunit and the membrane-anchored, periplasmic BcsB protein. Here we present the crystal structure of a complex of BcsA and BcsB from Rhodobacter sphaeroides containing a translocating polysaccharide. The structure of the BcsA-BcsB translocation intermediate reveals the architecture of the cellulose synthase, demonstrates how BcsA forms a cellulose-conducting channel, and suggests a model for the coupling of cellulose synthesis and translocation in which the nascent polysaccharide is extended by one glucose molecule at a time.	[Morgan, Jacob L. W.; Strumillo, Joanna; Zimmer, Jochen] Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Strumillo, Joanna] Univ Lodz, Fac Biol & Environm Protect, PL-90231 Lodz, Poland	University of Virginia; University of Lodz	Zimmer, J (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Zimmer, Jochen/0000-0002-8423-2882; Strumillo, Joanna/0000-0001-5478-2595	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, W-31-109-Eng-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; Department of Energy [DE-FG02-09ER-20097]; NIH [1R01GM101001]; University of Virginia; University of Virginia School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101001] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia; University of Virginia School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to G. Murshudov for advice on Refmac refinement and U. and Z. Derewenda for discussions. We thank L. Tamm, M. Wiener, A. Walling and T. Rapoport for critical comments on the manuscript. X-ray diffraction data were collected at GM/CA- and Southeast Regional-Collaborative Access Team beamlines at the Advanced Photon Source (APS), Argonne National Laboratory. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, contract no. DE-AC02-06CH11357 and W-31-109-Eng-38. GM/CA at APS has been funded in whole or in part with funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The University of Georgia CCRC is supported by the Department of Energy funded Center for Plant and Microbial Complex Carbohydrates (DE-FG02-09ER-20097). J.L.W.M. is partially supported by a Peach Fellowship, University of Virginia. J.Z. is support by NIH grant 1R01GM101001 and start-up funds from the University of Virginia School of Medicine.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Daras G, 2009, NEW PHYTOL, V184, P114, DOI 10.1111/j.1469-8137.2009.02960.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimson MJ, 1996, J CELL SCI, V109, P3079; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Jahn CE, 2011, MICROBIOL-SGM, V157, P2733, DOI 10.1099/mic.0.051003-0; Kimura S, 1996, PROTOPLASMA, V194, P151, DOI 10.1007/BF01882023; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Kozmon S, 2006, J AM CHEM SOC, V128, P16921, DOI 10.1021/ja065944o; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Momany FA, 2011, CARBOHYD RES, V346, P619, DOI 10.1016/j.carres.2011.01.004; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PyMol, 2000, PYMOL MOL GRAPHICS S; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rapoport TA, 2008, FEBS J, V275, P4471, DOI 10.1111/j.1742-4658.2008.06588.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	50	361	369	27	411	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					181	U192		10.1038/nature11744	http://dx.doi.org/10.1038/nature11744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23222542	Green Accepted			2022-12-01	WOS:000313259600031
J	Plotnikov, SV; Pasapera, AM; Sabass, B; Waterman, CM				Plotnikov, Sergey V.; Pasapera, Ana M.; Sabass, Benedikt; Waterman, Clare M.			Force Fluctuations within Focal Adhesions Mediate ECM-Rigidity Sensing to Guide Directed Cell Migration	CELL			English	Article							PAXILLIN PHOSPHORYLATION; VINCULIN RECRUITMENT; MATRIX; KINASE; GROWTH; LAMELLIPODIA; CHEMOTAXIS; PHENOTYPE; DYNAMICS; ARP2/3	Cell migration toward areas of higher extracellular matrix (ECM) rigidity via a process called "durotaxis" is thought to contribute to development, immune response, and cancer metastasis. To understand how cells sample ECM rigidity to guide durotaxis, we characterized cell-generated forces on the nanoscale within single mature integrin-based focal adhesions (FAs). We found that individual FAs act autonomously, exhibiting either stable or dynamically fluctuating ("tugging") traction. We show that a FAK/phosphopaxillin/vinculin pathway is essential for high FA traction and to enable tugging FA traction over a broad range of ECM rigidities. We show that tugging FA traction is dispensable for FA maturation, chemotaxis, and haptotaxis but is critical to direct cell migration toward rigid ECM. We conclude that individual FAs dynamically sample rigidity by applying fluctuating pulling forces to the ECM to act as sensors to guide durotaxis, and that FAK/phosphopaxillin/vinculin signaling defines the rigidity range over which this dynamic sensing process operates.	[Plotnikov, Sergey V.; Pasapera, Ana M.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Sabass, Benedikt] Univ Stuttgart, Inst Theoret Phys, D-70550 Stuttgart, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Stuttgart	Waterman, CM (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	watermancm@nhlbi.nih.gov	Sabass, Benedikt/N-1431-2017	Sabass, Benedikt/0000-0002-7769-8043; Waterman, Clare/0000-0001-6142-6775; Plotnikov, Sergey/0000-0002-5561-8890	Division of Intramural Research, National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Mary Beckerle for mouse embryonic fibroblasts, Michael Davidson for mApple paxillin, William Shin for support of the Waterman Lab microscopes, Sharon Campbell and Robert Fischer for helpful suggestions, and the NHLBI flow cytometry core facility. This research was supported by the Division of Intramural Research, National Heart Lung and Blood Institute.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2011, BIOPHYS J, V101, P2131, DOI 10.1016/j.bpj.2011.09.043; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Landau L D, 1970, THEORY ELASTICITY; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Raz-Ben Aroush D, 2006, ADV MATER, V18, P1537, DOI 10.1002/adma.200600372; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	545	553	17	247	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1513	1527		10.1016/j.cell.2012.11.034	http://dx.doi.org/10.1016/j.cell.2012.11.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260139	Green Accepted, Bronze			2022-12-01	WOS:000312890300016
J	Polo, JM; Anderssen, E; Walsh, RM; Schwarz, BA; Nefzger, CM; Lim, SM; Borkent, M; Apostolou, E; Alaei, S; Cloutier, J; Bar-Nur, O; Cheloufi, S; Stadtfeld, M; Figueroa, ME; Robinton, D; Natesan, S; Melnick, A; Zhu, JF; Ramaswamy, S; Hochedlinger, K				Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Nefzger, Christian M.; Lim, Sue Mei; Borkent, Marti; Apostolou, Effie; Alaei, Sara; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Figueroa, Maria Eugenia; Robinton, Daisy; Natesan, Sridaran; Melnick, Ari; Zhu, Jinfang; Ramaswamy, Sridhar; Hochedlinger, Konrad			A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells	CELL			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; EXPRESSION; FIBROBLASTS; INDUCTION; DISCOVERY	Factor-induced reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is inefficient, complicating mechanistic studies. Here, we examined defined intermediate cell populations poised to becoming iPSCs by genome-wide analyses. We show that induced pluripotency elicits two transcriptional waves, which are driven by c-Myc/Klf4 (first wave) and Oct4/Sox2/Klf4 (second wave). Cells that become refractory to reprogramming activate the first but fail to initiate the second transcriptional wave and can be rescued by elevated expression of all four factors. The establishment of bivalent domains occurs gradually after the first wave, whereas changes in DNA methylation take place after the second wave when cells acquire stable pluripotency. This integrative analysis allowed us to identify genes that act as roadblocks during reprogramming and surface markers that further enrich for cells prone to forming iPSCs. Collectively, our data offer new mechanistic insights into the nature and sequence of molecular events inherent to cellular reprogramming.	[Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Polo, Jose M.; Nefzger, Christian M.; Lim, Sue Mei; Alaei, Sara] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Anderssen, Endre; Ramaswamy, Sridhar] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Borkent, Marti] Erasmus MC, Dept Reprod & Dev, NL-3015 GE Rotterdam, Netherlands; [Figueroa, Maria Eugenia; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY 10065 USA; [Natesan, Sridaran] Sanofi Aventis, Cambridge, MA 02139 USA; [Zhu, Jinfang] NIAID, NIH, Bethesda, MD 20892 USA; [Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Monash University; Australian Regenerative Medicine Institute; Monash University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Erasmus University Rotterdam; Erasmus MC; Cornell University; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Ramaswamy, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	sridhar@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu	Melnick, Ari/AAA-5763-2020; Apostolou, Effie/AAG-1559-2020; Bar-Nur, Ori/GWQ-5917-2022; Figueroa, Maria/AAE-8662-2019; Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745; Cheloufi, Sihem/0000-0002-1726-4796; Alaei, Sara/0000-0003-4897-6339; Stadtfeld, Matthias/0000-0002-5852-9906; Figueroa, Maria Eugenia/0000-0003-4887-4981; Polo, Jose M/0000-0002-2531-778X; Cloutier, Jennifer/0000-0003-3462-0307; Lim, Sue Mei/0000-0001-8287-5756; Nefzger, Christian/0000-0003-4631-5633	ECOR postdoctoral fellowship; Monash Larkins Program; NHMRC CDF; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA; NIH [DP2OD003266, R01HD058013]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	ECOR postdoctoral fellowship; Monash Larkins Program; NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Hochedlinger and Ramaswamy labs for helpful suggestions and critical reading of the manuscript. We thank Laura Prickett and Kat Folz-Donahue at the MGH/HSCI flow cytometry core and Flowcore Monash for expert cell sorting; Paul Lacaze, Danielle Evans, and Michelle Garred at Millenium Science for support with the Fluidigm experiments; and Lucy Dagostino from Lifetech Australia for help in miRNA assays. We are grateful to Ben Wittner for help with formatting and uploading genome-wide data. Support to J.M.P. was from an ECOR postdoctoral fellowship, Monash Larkins Program, and a NHMRC CDF. J.Z. was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA. K.H. was supported by the NIH (DP2OD003266 and R01HD058013). S.R. was supported by an HHMI Physican-Scientist Early Career Award.	Aranda-Orgilles B., 2012, CELL STEM CELL; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Hansson J., 2012, CELL REP IN PRESS; Huo J.S., 2012, BIOCH BIOPHYS ACTA; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/nmeth.1409, 10.1038/NMETH.1409]; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yang CS, 2011, STEM CELLS, V29, P1528, DOI 10.1002/stem.717	26	596	611	7	191	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1617	1632		10.1016/j.cell.2012.11.039	http://dx.doi.org/10.1016/j.cell.2012.11.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260147	Green Accepted, Bronze			2022-12-01	WOS:000312890300024
J	Clarke, PM; Walter, SJ; Hayen, A; Mallon, WJ; Heijmans, J; Studdert, DM				Clarke, Philip M.; Walter, Simon J.; Hayen, Andrew; Mallon, William J.; Heijmans, Jeroen; Studdert, David M.			Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEAGUE BASEBALL PLAYERS; PHYSICAL-ACTIVITY; LIFE EXPECTANCY; FOLLOW-UP; MORTALITY; HEALTH; EXPERIENCE; ACTORS	Objective To determine whether Olympic medallists live longer than the general population. Design Retrospective cohort study, with passive follow-up and conditional survival analysis to account for unidentified loss to follow-up. Setting and participants 15 174 Olympic athletes from nine country groups (United States, Germany, Nordic countries, Russia, United Kingdom, France, Italy, Canada, and Australia and New Zealand) who won medals in the Olympic Games held in 1896-2010. Medallists were compared with matched cohorts in the general population (by country, age, sex, and year of birth). Main outcome measures Relative conditional survival. Results More medallists than matched controls in the general population were alive 30 years after winning (relative conditional survival 1.08, 95% confidence interval 1.07 to 1.10). Medallists lived an average of 2.8 years longer than controls. Medallists in eight of the nine country groups had a significant survival advantage compared with controls. Gold, silver, and bronze medallists each enjoyed similar sized survival advantages. Medallists in endurance sports and mixed sports had a larger survival advantage over controls at 30 years (1.13, 1.09 to 1.17; 1.11, 1.09 to 1.13) than that of medallists in power sports (1.05, 1.01 to 1.08). Conclusions Olympic medallists live longer than the general population, irrespective of country, medal, or sport. This study was not designed to explain this effect, but possible explanations include genetic factors, physical activity, healthy lifestyle, and the wealth and status that come with international sporting glory.	[Clarke, Philip M.; Walter, Simon J.; Studdert, David M.] Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Mallon, William J.] Triangle Orthopaed Associates, Durham, NC USA; [Heijmans, Jeroen] Software Improvement Grp SIG, NL-3134 EB Vlaardingen, Netherlands	University of Melbourne; University of New South Wales Sydney	Studdert, DM (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia.	d.studdert@unimelb.edu.au	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Clarke, Philip/0000-0002-7555-5348; Hayen, Andrew/0000-0003-4046-8030				Alaranta A, 2006, INT J SPORTS MED, V27, P581, DOI 10.1055/s-2005-865826; Backmand H, 2003, INT J SPORTS MED, V24, P609; BEAGLEHOLE R, 1983, NEW ZEAL MED J, V96, P513; Coate D, 2012, SCAND J MED SCI SPOR, DOI [10.1111/j.1600-0838.2012.01449, DOI 10.1111/J.1600-0838.2012.01449]; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; HAKULINEN T, 1982, BIOMETRICS, V38, P933, DOI 10.2307/2529873; Homer, 1998, ILIAD; Kamper E., 1992, GOLDEN BOOK OLYMPIC; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Kujala UM, 1996, JAMA-J AM MED ASSOC, V276, P216, DOI 10.1001/jama.276.3.216; Kuss O, 2010, SCAND J MED SCI SPOR, V13, P410; Mallon B, 2011, HIST DICT OLYMPIC MO; Mallon B, 2001, TOTAL OLYMPICS COMPL; Marmot M., 2005, PSYCHOSOCIAL DETERMI; MENOTTI A, 1990, EUR J EPIDEMIOL, V6, P257, DOI 10.1007/BF00150429; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Redelmeier DA, 2001, ANN INTERN MED, V134, P955, DOI 10.7326/0003-4819-134-10-200105150-00009; Saint Onge JM, 2008, SOC SCI QUART, V89, P817; Sarna S, 1997, AGING-CLIN EXP RES, V9, P35, DOI 10.1007/BF03340126; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; SCHNOHR P, 1971, LANCET, V2, P1364; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SR Olympic Sports, 2012, OL STAT HIST; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; TALLIS GM, 1988, STAT MED, V7, P483, DOI 10.1002/sim.4780070405; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WATERBOR J, 1988, NEW ENGL J MED, V318, P1278, DOI 10.1056/NEJM198805123181917; YAMAJI K, 1977, Journal of Human Ergology, V6, P15	31	58	58	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2012	345								e8308	10.1136/bmj.e8308	http://dx.doi.org/10.1136/bmj.e8308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MZ	23241272	Green Submitted			2022-12-01	WOS:000312495700007
J	Wang, YS; Rattner, A; Zhou, YL; Williams, J; Smallwood, PM; Nathans, J				Wang, Yanshu; Rattner, Amir; Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy			Norrin/Frizzled4 Signaling in Retinal Vascular Development and Blood Brain Barrier Plasticity	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; REDUNDANT ROLES; ANGIOGENESIS; MICE; FRIZZLED-4; DISEASE; NORRIN; VEGF; PERICYTES; SOX18	Norrin/Frizzled4 (Fz4) signaling activates the canonical Wnt pathway to control retinal vascular development. Using genetically engineered mice, we show that precocious Norrin production leads to premature retinal vascular invasion and delayed Norrin production leads to characteristic defects in intraretinal vascular architecture. In genetic mosaics, wildtype endothelial cells (ECs) instruct neighboring Fz4(-/-) ECs to produce an architecturally normal mosaic vasculature, a cell nonautonomous effect. However, over the ensuing weeks, Fz4(-/-) ECs are selectively eliminated from the mosaic vasculature, implying the existence of a quality control program that targets defective ECs. In the adult retina and cerebellum, gain or loss of Norrin/Fz4 signaling results in a cell-autonomous gain or loss, respectively, of blood retina barrier and blood brain barrier function, indicating an ongoing requirement for Frizzled signaling in barrier maintenance and substantial plasticity in mature CNS vascular structure.	[Wang, Yanshu; Rattner, Amir; Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wang, Yanshu; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460; Rattner, Amir/0000-0001-9542-6212	National Eye Institute (NIH); HHMI; Johns Hopkins Brain Sciences Institute; Foundation Fighting Blindness; Ellison Medical Foundation; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	National Eye Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHMI(Howard Hughes Medical Institute); Johns Hopkins Brain Sciences Institute; Foundation Fighting Blindness(European Commission); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Hugh Cahill, Hao Chang, Alex Kolodkin, Se-Jin Lee, Max Tischfield, and Xin Ye for advice and/or helpful comments on the manuscript. This work was supported by the National Eye Institute (NIH), HHMI, the Johns Hopkins Brain Sciences Institute, the Foundation Fighting Blindness, and the Ellison Medical Foundation.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	40	226	236	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1332	1344		10.1016/j.cell.2012.10.042	http://dx.doi.org/10.1016/j.cell.2012.10.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217714	Green Accepted, Bronze			2022-12-01	WOS:000311999900021
J	Allen, AS; Sequist, TD				Allen, Adrienne S.; Sequist, Thomas D.			Pharmacy Dispensing of Electronically Discontinued Medications	ANNALS OF INTERNAL MEDICINE			English	Article							ADVERSE DRUG EVENTS; HEALTH INFORMATION-TECHNOLOGY; CARE; PERFORMANCE; SAFETY	Background: Most physician offices do not transmit orders for medication discontinuation to the pharmacy, creating the potential for errors in dispensing of previously prescribed medications. Electronic health records offer the potential to assess this patient safety concern. Objective: To assess the frequency of and potential patient harm associated with pharmacy dispensing of discontinued medications in the ambulatory setting. Design: Retrospective cohort study. Setting: Multispecialty group practice in eastern Massachusetts using an electronic health record. Patients: 30 406 adult patients with an electronic discontinuation order for antihypertensive, antiplatelet, anticoagulant, oral hypoglycemic, and statin medications between November 2008 and October 2009. Measurements: Dispensing of discontinued medications within 12 months and associated potential patient harm. Results: Among 83 902 targeted medications that were electronically discontinued, 1218 (1.5% [95% CI, 1.4% to 1.5%]) were subsequently dispensed by the pharmacy a mean of 1.0 (SD, 0.3) time during the 12-month follow-up. Among the top 10 most frequently electronically discontinued medications, the rate of subsequent dispensing by a pharmacy ranged from 0.9% for metformin to 2.5% for metoprolol. Manual chart review of 416 medication-dispensing events that were predefined as high risk according to an automated algorithm identified potential harm in 50 (12%) cases, including clinical reactions (n = 18), laboratory abnormalities (n = 17), duplicated medication classes dispensed (n = 8), and potential allergic reactions (n = 7). Limitation: Information on pharmacy dispensing was available for only 52% of medication orders. Conclusion: The dispensing of discontinued medications represents an important ambulatory patient safety concern. Electronic health records should be used to facilitate better communication between providers and pharmacies and improve medication safety. Primary Funding Source: National Institutes of Health.	[Allen, Adrienne S.] N Shore Phys Grp, Danvers, MA 01923 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard Vanguard Medical Associates	Allen, AS (corresponding author), N Shore Phys Grp, 104 Endicott St,Suite 104, Danvers, MA 01923 USA.	aallen0@partners.org			National Institutes of Health [T32HP10251-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Allen was funded by a National Institutes of Health Institutional National Research Service Award (T32HP10251-02).	Allen AS, 2011, J PATIENT SAF, V7, P122, DOI 10.1097/PTS.0b013e318223cb41; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Kaushal R, 2010, J GEN INTERN MED, V25, P530, DOI 10.1007/s11606-009-1238-8; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Nemeth Lynne S, 2010, J Patient Saf, V6, P238, DOI 10.1097/PTS.0b013e3181fe401f; Sequist TD, 2006, ARCH INTERN MED, V166, P2237, DOI 10.1001/archinte.166.20.2237; Sequist TD, 2011, MED CARE, V49, P126, DOI 10.1097/MLR.0b013e3181d5690f; Sequist TD, 2010, ANN INTERN MED, V152, P40, DOI 10.7326/0003-4819-152-1-201001050-00009	15	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					700	+		10.7326/0003-4819-157-10-201211200-00006	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	043VZ	23165661				2022-12-01	WOS:000311580000015
J	Houllier, F				Houllier, Francois			Bring more rigour to GM research	NATURE			English	Editorial Material							BT COTTON		INRA, Paris, France	INRAE	Houllier, F (corresponding author), INRA, Paris, France.	francois.houllier@paris.inra.fr						[Anonymous], FRANC OGM; Arnich N, 2011, INT J HYG ENVIR HEAL, V214, P271, DOI 10.1016/j.ijheh.2010.12.002; Joly PB, 2007, NATURE, V450, P174, DOI 10.1038/450174a; Lemaire O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000551; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050	9	5	9	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					327	327		10.1038/491327a	http://dx.doi.org/10.1038/491327a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151562	Bronze			2022-12-01	WOS:000311031600014
J	Goetz, SC; Liem, KF; Anderson, KV				Goetz, Sarah C.; Liem, Karel F., Jr.; Anderson, Kathryn V.			The Spinocerebellar Ataxia-Associated Gene Tau Tubulin Kinase 2 Controls the Initiation of Ciliogenesis	CELL			English	Article							TAU-TUBULIN KINASE; INTRAFLAGELLAR TRANSPORT PROTEINS; HEDGEHOG SIGNAL-TRANSDUCTION; NEURAL STEM-CELLS; PRIMARY CILIA; REPRESSOR FUNCTIONS; MECKEL SYNDROME; SONIC HEDGEHOG; MOUSE; MEMBRANE	The primary cilium has critical roles in human development and disease, but the mechanisms that regulate ciliogenesis are not understood. Here, we show that Tau tubulin kinase 2 (TTBK2) is a dedicated regulator of the initiation of ciliogenesis in vivo. We identified a null allele of mouse Ttbk2 based on loss of Sonic hedgehog activity, a signaling pathway that requires the primary cilium. Despite a normal basal body template, Ttbk2 mutants lack cilia. TTBK2 acts at the distal end of the basal body, where it promotes the removal of CP110, which caps the mother centriole, and promotes recruitment of IFT proteins, which build the ciliary axoneme. Dominant truncating mutations in human TTBK2 cause spinocerebellar ataxia type 11 (SCA11); these mutant proteins do not promote ciliogenesis and inhibit ciliogenesis in wild-type cells. We propose that cell-cycle regulators target TTBK2 to the basal body, where it modifies specific targets to initiate ciliogenesis.	[Goetz, Sarah C.; Liem, Karel F., Jr.; Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	k-anderson@sloankettering.edu		Anderson, Kathryn/0000-0003-1657-2161	NIH [NS044385]; American Cancer Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to P. Jallepalli and B. Tsou and their laboratories for reagents and advice on retroviral transduction. We thank James Sillibourne and Michel Bornens (Institut Curie), Brian Dynlacht (NYU), and Greg Pazour (University of Massachusetts Medical School) for antibodies. We thank the MSKCC Molecular Cytology Core Facility and the Bio-Imaging Resource Center at Rockefeller University for help with imaging; the MSKCC Electron Microscopy Core Facility for SEM; and Peter Satir and Leslie Gunther at the Analytical Imaging Center of Albert Einstein College of Medicine for assistance with TEM. We thank A. Parrish, H. Bazzi, and F. Bangs for comments on the manuscript. This work was funded by NIH Grant NS044385 to K. V. A. and an American Cancer Society Postdoctoral Fellowship to S.C.G.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Aughsteen AA, 2001, EUR J MORPHOL, V39, P277, DOI 10.1076/ejom.39.5.277.7380; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bauer P, 2010, J NEUROL NEUROSUR PS, V81, P1229, DOI 10.1136/jnnp.2009.202150; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chakravarthy B, 2010, BIOCHEM BIOPH RES CO, V401, P458, DOI 10.1016/j.bbrc.2010.09.081; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Dowdle WE, 2011, AM J HUM GENET, V89, P94, DOI 10.1016/j.ajhg.2011.06.003; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; FONTE VG, 1971, J CELL BIOL, V49, P226, DOI 10.1083/jcb.49.1.226; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Matilla-Duenas A., 2012, CEREBELLUM; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Tomizawa K, 2001, FEBS LETT, V492, P221, DOI 10.1016/S0014-5793(01)02256-6; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	56	155	159	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					847	858		10.1016/j.cell.2012.10.010	http://dx.doi.org/10.1016/j.cell.2012.10.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141541	Green Accepted, Bronze			2022-12-01	WOS:000310921200015
J	Laxminarayan, R; Arrow, K; Jamison, D; Bloom, BR				Laxminarayan, Ramanan; Arrow, Kenneth; Jamison, Dean; Bloom, Barry R.			From Financing to Fevers: Lessons of an Antimalarial Subsidy Program	SCIENCE			English	Editorial Material							MALARIA		[Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Laxminarayan, Ramanan] Princeton Univ, Washington, DC 20036 USA; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Arrow, Kenneth] Stanford Univ, Stanford, CA 94305 USA; [Jamison, Dean] Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Princeton University; Stanford University; University of Washington; University of Washington Seattle	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	bbloom@hsph.harvard.edu	Laxminarayan, Ramanan/ABD-5050-2021					Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; AMFm Expert Advisory Group, AMFM GLOB FUND AIDS; [Anonymous], IMCI HDB; [Anonymous], 2012, IND EV PHAS 1 AFF ME; Arrow KJ, 2004, SAVING LIVES BUYING; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Frost LJ, 2008, ACCESS DO GOOD HLTH; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; WHO, WHO URG REG MEAS STO; World Health Organization, 2001, ANT DRUG COMB THER; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	14	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					615	616		10.1126/science.1231010	http://dx.doi.org/10.1126/science.1231010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118173				2022-12-01	WOS:000310516000034
J	Kerkering, TM; Grifasi, ML; Baffoe-Bonnie, AW; Bansal, E; Garner, DC; Smith, JA; Demicco, DD; Schleupner, CJ; Aldoghaither, RA; Savaliya, VA				Kerkering, Thomas M.; Grifasi, Marissa L.; Baffoe-Bonnie, Anthony W.; Bansal, Ekta; Garner, Dorothy C.; Smith, Jean A.; Demicco, Deborah D.; Schleupner, Charles J.; Aldoghaither, Rabia A.; Savaliya, Vipul A.			Early Clinical Observations in Prospectively Followed Patients With Fungal Meningitis Related to Contaminated Epidural Steroid Injections	ANNALS OF INTERNAL MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBRAL PHEOHYPHOMYCOSIS; MELANIZED FUNGI; AMPHOTERICIN-B; EXSEROHILUM	Background: Administration of epidural steroid injections (ESIs) with contaminated methylprednisolone resulted in an outbreak of fungal meningitis in many locations in the United States. Objective: To characterize early clinical findings and initial response to treatment. Design: Case series with standardized observation studied from 4 October to 31 October 2012. Setting: An 800-bed hospital in Virginia. Patients: 172 patients who presented to the hospital with exposure to contaminated ESI. Intervention: Standardized approach to screening, case definition, treatment, and data collection. Measurements: Clinical findings, cerebrospinal fluid (CSF) values, magnetic resonance imaging (MRI), serum and CSF voriconazole concentrations, and clinician assessment of response to therapy. Results: Of 172 patients presenting to the hospital who had had ESI, 131 had lumbar puncture because of symptoms or signs consistent with central nervous system disease. Twenty-five (19%) had neutrophilic meningitis. All were started on voriconazole therapy alone. Three patients developed stroke during treatment. Ten patients had arachnoiditis, another had an epidural abscess, and 9 had urine retention. Fifteen continued to receive voriconazole, and 10 were switched to amphotericin B. Cerebrospinal fluid leukocyte counts began to decrease by day 13 of treatment. Findings on MRI included ventriculitis, leptomeningeal enhancement, infarction, hemorrhage, and arachnoiditis. Serum voriconazole levels varied, and CSF concentrations of voriconazole were approximately 50% those of serum. Exserohilum rostratum and Cladosporium species have been cultured. Limitations: This is an observational study of an evolving outbreak. Not all exposed patients presented for evaluation. Follow-up is too short to determine final outcomes. Conclusion: Meningitis after receipt of contaminated ESI has been diagnosed in many exposed patients presenting to 1 hospital. Most patients have improved on receipt of empirical voriconazole therapy. The full natural history and long-term sequelae of this infection are currently unknown. Primary Funding Source: None. Ann Intern Med. 2013;158:154-161.	[Kerkering, Thomas M.; Grifasi, Marissa L.; Baffoe-Bonnie, Anthony W.; Bansal, Ekta; Garner, Dorothy C.; Smith, Jean A.; Demicco, Deborah D.; Schleupner, Charles J.; Aldoghaither, Rabia A.; Savaliya, Vipul A.] Virginia Tech Caril Sch Med, Roanoke, VA 24014 USA		Kerkering, TM (corresponding author), Virginia Tech Caril Sch Med, 1906 Belleview Ave, Roanoke, VA 24014 USA.			SAVALIYA, Vipul/0000-0002-3221-4500				ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Carter E, 2004, J CLIN MICROBIOL, V42, P5419, DOI 10.1128/JCM.42.11.5419-5423.2004; Centers for Disease Control and Prevention Health Alert Network, 2012, MEN STROK ASS POT CO; da Cunha KC, 2012, ANTIMICROB AGENTS CH, V56, P4951, DOI 10.1128/AAC.00488-12; Doshi SM, 2012, AM J KIDNEY DIS, V59, P222, DOI 10.1053/j.ajkd.2011.08.029; Filizzola Marcelo J., 2003, International Journal of Infectious Diseases, V7, P282, DOI 10.1016/S1201-9712(03)90108-1; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kantarcioglu AS, 2004, MYCOSES, V47, P4, DOI 10.1046/j.1439-0507.2003.00956.x; Li DM, 2009, LANCET INFECT DIS, V9, P376, DOI 10.1016/S1473-3099(09)70131-8; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Moja M, 2000, NEURORADIOLOGY, V42, P261, DOI 10.1007/s002340050882; Pai MP, 2011, ANTIMICROB AGENTS CH, V55, P2601, DOI 10.1128/AAC.01765-10; Pettit AC, 2012, N ENGL J MED; Revankar SG, 2010, CLIN MICROBIOL REV, V23, P884, DOI 10.1128/CMR.00019-10; Revankar SG, 2004, CLIN INFECT DIS, V38, P206, DOI 10.1086/380635; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Theuretzbacher U, 2006, CLIN PHARMACOKINET, V45, P649, DOI 10.2165/00003088-200645070-00002; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Virginia Department of Health, 2012, EP UPD FUNG INF ASS	21	41	41	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					154	+		10.7326/0003-4819-158-3-201302050-00568	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00568			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23183583				2022-12-01	WOS:000314757900002
J	Oisi, Y; Ota, KG; Kuraku, S; Fujimoto, S; Kuratani, S				Oisi, Yasuhiro; Ota, Kinya G.; Kuraku, Shigehiro; Fujimoto, Satoko; Kuratani, Shigeru			Craniofacial development of hagfishes and the evolution of vertebrates	NATURE			English	Article							LETHENTERON-JAPONICUM; BDELLOSTOMA STOUTI; LAMPETRA-JAPONICA; TRIGEMINAL NERVE; NEURAL CREST; GENES; EXPRESSION; LAMPREYS; ADENOHYPOPHYSIS; ORGANIZATION	Cyclostomes, the living jawless vertebrates including hagfishes and lampreys, represent the most basal lineage of vertebrates. Although the monophyly of cyclostomes has been supported by recent molecular analyses, the phenotypic traits of hagfishes, especially the lack of some vertebrate-defining features and the reported endodermal origin of the adenohypophysis, have been interpreted as hagfishes exhibiting a more ancestral state than those of all other vertebrates. Furthermore, the adult anatomy of hagfishes cannot be compared easily with that of lampreys. Here we describe the craniofacial development of a series of staged hagfish embryos, which shows that their adenohypophysis arises ectodermally, consistent with the molecular phylogenetic data. This finding also allowed us to identify a pan-cyclostome pattern, one not shared by jawed vertebrates. Comparative analyses indicated that many of the hagfish-specific traits can be explained by changes secondarily introduced into the hagfish lineage. We also propose a possibility that the pan-cyclostome pattern may reflect the ancestral programme for the craniofacial development of all living vertebrates.	[Oisi, Yasuhiro] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; [Oisi, Yasuhiro; Fujimoto, Satoko; Kuratani, Shigeru] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan; [Ota, Kinya G.] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Yilan 26242, Taiwan; [Kuraku, Shigehiro] RIKEN Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo 6500047, Japan	Kobe University; RIKEN; RIKEN	Kuratani, S (corresponding author), RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuratani, Shigeru/J-4146-2014; Kuraku, Shigehiro/B-2801-2009	Kuratani, Shigeru/0000-0001-9717-7221; Kuraku, Shigehiro/0000-0003-1464-8388	Grants-in-Aid for Scientific Research [22128003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adachi N, 2012, EVOL DEV, V14, P234, DOI 10.1111/j.1525-142X.2012.00542.x; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BARDACK D, 1991, SCIENCE, V254, P701, DOI 10.1126/science.254.5032.701; Candiani S, 2008, BRAIN RES BULL, V75, P324, DOI 10.1016/j.brainresbull.2007.10.023; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dean B., 1899, EMBRYOLOGY BDELLOSTO, P220; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; GORBMAN A, 1983, AM ZOOL, V23, P639; GORBMAN A, 1985, EVOLUTIONARY BIOL PR, P165; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; JANVIER P., 1996, EARLY VERTEBRATES; Janvier P, 2008, ZOOL SCI, V25, P1045, DOI 10.2108/zsj.25.1045; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOYAMA H, 1987, J COMP NEUROL, V264, P437, DOI 10.1002/cne.902640402; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Kuratani S, 2008, J EXP ZOOL PART B, V310B, P294, DOI 10.1002/jez.b.21190; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Marinelli W., 1956, VERGLEICHENDE ANATOM; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; NISHIZAWA H, 1988, J COMP NEUROL, V267, P281, DOI 10.1002/cne.902670210; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Ota KG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1355; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; SONG J, 1993, ACTA ANAT, V148, P139; Soukup V., 2012, J ANAT; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Steinberg M., 1957, YB CARNEGIE I WASH, V56, P347; Stensio E.A., 1927, SKRIFTER SVALBARD NO, DOI DOI 10.3402/POLAR.V14I1.6649; Stockard CR, 1906, AM J ANAT, V5, P481, DOI 10.1002/aja.1000050405; Stockard CR, 1906, AM J ANAT, V6, P511, DOI 10.1002/aja.1000060114; STRAHAN RONALD, 1958, ACTA ZOOL [STOCKHOLM], V39, P227; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; TAHARA Y, 1988, ZOOL SCI, V5, P109; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tiecke E, 2007, DEV GENES EVOL, V217, P691, DOI 10.1007/s00427-007-0181-0; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; Uchida K, 2010, P NATL ACAD SCI USA, V107, P15832, DOI 10.1073/pnas.1002208107; von Kupffer C., 1900, STUDIEN VERGLEICHEND; WICHT H, 1995, PHILOS T ROY SOC B, V349, P119, DOI 10.1098/rstb.1995.0098; Wicht H, 1998, BIOLOGY OF HAGFISHES, P431; YALDEN DW, 1985, ZOOL J LINN SOC-LOND, V84, P291, DOI 10.1111/j.1096-3642.1985.tb01802.x	50	95	98	0	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					175	180		10.1038/nature11794	http://dx.doi.org/10.1038/nature11794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23254938				2022-12-01	WOS:000313259600030
J	Ude, S; Lassak, J; Starosta, AL; Kraxenberger, T; Wilson, DN; Jung, K				Ude, Susanne; Lassak, Juergen; Starosta, Agata L.; Kraxenberger, Tobias; Wilson, Daniel N.; Jung, Kirsten			Translation Elongation Factor EF-P Alleviates Ribosome Stalling at Polyproline Stretches	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PEPTIDE-BOND FORMATION; COLI CAD OPERON; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; TRANSFER-RNA; POSTTRANSLATIONAL MODIFICATION; PROTEIN-SYNTHESIS; POXA; IDENTIFICATION	Translation elongation factor P (EF-P) is critical for virulence in bacteria. EF-P is present in all bacteria and orthologous to archaeal and eukaryotic initiation factor 5A, yet the biological function has so far remained enigmatic. Here, we demonstrate that EF-P is an elongation factor that enhances translation of polyproline-containing proteins: In the absence of EF-P, ribosomes stall at polyproline stretches, whereas the presence of EF-P alleviates the translational stalling. Moreover, we demonstrate the physiological relevance of EF-P to fine-tune the expression of the polyproline-containing pH receptor CadC to levels necessary for an appropriate stress response. Bacterial, archaeal, and eukaryotic cells have hundreds to thousands of polyproline-containing proteins of diverse function, suggesting that EF-P and a/eIF-5A are critical for copy-number adjustment of multiple pathways across all kingdoms of life.	[Ude, Susanne; Lassak, Juergen; Starosta, Agata L.; Kraxenberger, Tobias; Wilson, Daniel N.; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Munich, Germany; [Ude, Susanne; Lassak, Juergen; Kraxenberger, Tobias; Jung, Kirsten] Univ Munich, Dept Biol 1, D-82152 Martinsried, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Wilson, DN (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Munich, Germany.	wilson@genzentrum.de; jung@lmu.de	Lassak, Jürgen Michael/Q-2128-2019; Starosta, Agata/D-9535-2017; Wilson, Daniel/AAE-8504-2019	Lassak, Jürgen Michael/0000-0003-3936-3389; Starosta, Agata/0000-0003-3915-5723; Wilson, Daniel/0000-0003-3816-3828	Excellence Cluster "Center for integrated Protein Science" Munich [Exc114/1]; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [JU270/5-3, WI3285/1-1]; AXA Postdoctoral fellowship	Excellence Cluster "Center for integrated Protein Science" Munich; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); AXA Postdoctoral fellowship	This work was supported by the Excellence Cluster "Center for integrated Protein Science" Munich (Exc114/1), the European Molecular Biology Organization young investigator program (to D.N.W.) and grants JU270/5-3 (K.J.) and WI3285/1-1 (D.N.W.) from the Deutsche Forschungsgemeinschaft. A.L.S. is funded by an AXA Postdoctoral fellowship.	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bearson SMD, 2006, APPL ENVIRON MICROB, V72, P2829, DOI 10.1128/AEM.72.4.2829-2836.2006; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	25	285	295	7	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					82	85		10.1126/science.1228985	http://dx.doi.org/10.1126/science.1228985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239623				2022-12-01	WOS:000312985800056
J	Wordsworth, R; Pierrehumbert, R				Wordsworth, Robin; Pierrehumbert, Raymond			Hydrogen-Nitrogen Greenhouse Warming in Earth's Early Atmosphere	SCIENCE			English	Article							CLIMATE; EVOLUTION; PLANETS; ARCHAEA; GA	Understanding how Earth has sustained surface liquid water throughout its history remains a key challenge, given that the Sun's luminosity was much lower in the past. Here we show that with an atmospheric composition consistent with the most recent constraints, the early Earth would have been significantly warmed by H-2-N-2 collision-induced absorption. With two to three times the present-day atmospheric mass of N-2 and a H-2 mixing ratio of 0.1, H-2-N-2 warming would be sufficient to raise global mean surface temperatures above 0 degrees C under 75% of present-day solar flux, with CO2 levels only 2 to 25 times the present-day values. Depending on their time of emergence and diversification, early methanogens may have caused global cooling via the conversion of H-2 and CO2 to CH4, with potentially observable consequences in the geological record.	[Wordsworth, Robin; Pierrehumbert, Raymond] Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA	University of Chicago	Wordsworth, R (corresponding author), Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA.	rwordsworth@uchicago.edu		Pierrehumbert, Raymond/0000-0002-5887-1197				Abbot DS, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/178; Blank CE, 2009, GEOBIOLOGY, V7, P495, DOI 10.1111/j.1472-4669.2009.00219.x; BORYSOW A, 1986, ASTROPHYS J, V303, P495, DOI 10.1086/164096; Catling DC, 2006, SCIENCE, V311, DOI 10.1126/science.1117827; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; Driese SG, 2011, PRECAMBRIAN RES, V189, P1, DOI 10.1016/j.precamres.2011.04.003; Feulner G, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000375; Goldblatt C, 2009, NAT GEOSCI, V2, P891, DOI 10.1038/NGEO692; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; House CH, 2003, GEOBIOLOGY, V1, P15, DOI 10.1046/j.1472-4669.2003.00004.x; Kasting J. F, 2012, GLOBAL OXYGEN CYCLE, P93; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Peck WH, 2001, GEOCHIM COSMOCHIM AC, V65, P4215, DOI 10.1016/S0016-7037(01)00711-6; Pierrehumbert R, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L13; Pope EC, 2012, P NATL ACAD SCI USA, V109, P4371, DOI 10.1073/pnas.1115705109; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; Sleep NH, 2001, J GEOPHYS RES-PLANET, V106, P1373, DOI 10.1029/2000JE001247; Som SM, 2012, NATURE, V484, P359, DOI 10.1038/nature10890; Stevenson DJ, 1999, NATURE, V400, P32, DOI 10.1038/21811; Tian F, 2006, SCIENCE, V311, DOI 10.1126/science.1118412; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Tian F, 2011, EARTH PLANET SC LETT, V308, P417, DOI 10.1016/j.epsl.2011.06.011; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; Wordsworth R, 2012, ICARUS, V219, P267, DOI 10.1016/j.icarus.2012.02.035; Wordsworth RD, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015053; Young GM, 1998, J GEOL, V106, P523, DOI 10.1086/516039	31	130	133	2	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					64	67		10.1126/science.1225759	http://dx.doi.org/10.1126/science.1225759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288536	Green Submitted			2022-12-01	WOS:000312985800051
J	Lane, N; Martin, WF				Lane, Nick; Martin, William F.			The Origin of Membrane Bioenergetics	CELL			English	Review							OXIDATION-REDUCTION POTENTIALS; EARLY EVOLUTION; COMPLEX; FERREDOXIN; LIFE; EMERGENCE; REDOX; CELLS; FIXATION; BACTERIA	Harnessing energy as ion gradients across membranes is as universal as the genetic code. We leverage new insights into anaerobe metabolism to propose geochemical origins that account for the ubiquity of chemiosmotic coupling, and Na+/H+ transporters in particular. Natural proton gradients acting across thin FeS walls within alkaline hydrothermal vents could drive carbon assimilation, leading to the emergence of protocells within vent pores. Protocell membranes that were initially leaky would eventually become less permeable, forcing cells dependent on natural H+ gradients to pump Na+ ions. Our hypothesis accounts for the Na+/H+ promiscuity of bioenergetic proteins, as well as the deep divergence between bacteria and archaea.	[Lane, Nick] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England; [Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany	University of London; University College London; Heinrich Heine University Dusseldorf	Lane, N (corresponding author), UCL, Res Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	nick.lane@ucl.ac.uk	Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449; Lane, Nick/0000-0002-5433-3973	UCL Provost's Venture Research Fellowship; Leverhulme Trust; European Research Council	UCL Provost's Venture Research Fellowship; Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	We thank Filipa Sousa, Mike Russell, Wolfgang Nitschke, John Allen, Peter Rich, Ana Hidalgo, Don Braben, Frank Harold, Manuela Pereira, John Baross, Volker Muller, Georg Fuchs, and Rolf Thauer for discussions and for criticisms of earlier versions of this paper. N.L. is grateful to the UCL Provost's Venture Research Fellowship and the Leverhulme Trust for funding. W.F.M. thanks the European Research Council for funding.	Amend JP, 2009, ACS SYM SER, V1025, P63; Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; Baaske P, 2007, P NATL ACAD SCI USA, V104, P9346, DOI 10.1073/pnas.0609592104; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P1638, DOI 10.1021/bi00536a026; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Batista AP, 2012, IUBMB LIFE, V64, P492, DOI 10.1002/iub.1050; Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Branciamore S, 2009, J MOL EVOL, V69, P458, DOI 10.1007/s00239-009-9278-6; Buckel W., 2012, BIOCH BIOPHYS ACTA; Chaves MRM, 2011, SEDIMENT TRANSPORT, P313; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; FUCHS G, 1986, FEMS MICROBIOL LETT, V39, P181, DOI 10.1016/0378-1097(86)90446-5; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; HARMS U, 1995, EUR J BIOCHEM, V228, P640, DOI 10.1111/j.1432-1033.1995.0640m.x; Harold F. M., 1986, VITAL FORCE STUDY BI; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Koonin EV, 2005, TRENDS GENET, V21, P647, DOI 10.1016/j.tig.2005.09.006; Lane N, 2010, BIOESSAYS, V32, P271, DOI 10.1002/bies.200900131; Lang SQ, 2010, GEOCHIM COSMOCHIM AC, V74, P941, DOI 10.1016/j.gca.2009.10.045; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; MADEN BEH, 1995, TRENDS BIOCHEM SCI, V20, P337, DOI 10.1016/S0968-0004(00)89069-6; Marreiros B.C., 2012, BIOCH BIOPHYS ACTA; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Martin WF, 2012, FEBS LETT, V586, P485, DOI 10.1016/j.febslet.2011.09.031; Mast CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.188102; MILLER SL, 1988, NATURE, V334, P609, DOI 10.1038/334609a0; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Morowitz H., 1968, ENERGY FLOW BIOL; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Nitschke W, 2009, J MOL EVOL, V69, P481, DOI 10.1007/s00239-009-9289-3; Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pohorille A, 2009, RES MICROBIOL, V160, P449, DOI 10.1016/j.resmic.2009.06.004; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Russell MJ, 2004, TRENDS BIOCHEM SCI, V29, P358, DOI 10.1016/j.tibs.2004.05.007; RUSSELL MJ, 1993, TERRA NOVA, V5, P343, DOI 10.1111/j.1365-3121.1993.tb00267.x; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Shock E, 2010, GEOFLUIDS, V10, P161, DOI 10.1111/j.1468-8123.2010.00277.x; Shock Everett L., 1998, P59; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; Surin S, 2007, FEMS MICROBIOL LETT, V269, P301, DOI 10.1111/j.1574-6968.2007.00655.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; WACHTERSHAUSER G, 1988, SYST APPL MICROBIOL, V10, P207; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; Wolthers M, 2005, GEOCHIM COSMOCHIM AC, V69, P3469, DOI 10.1016/j.gca.2005.01.027; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z	67	220	228	9	224	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1406	1416		10.1016/j.cell.2012.11.050	http://dx.doi.org/10.1016/j.cell.2012.11.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260134	Bronze			2022-12-01	WOS:000312890300008
J	Williams, C; Hoppe, HJ; Rezgui, D; Strickland, M; Forbes, BE; Grutzner, F; Frago, S; Ellis, RZ; Wattana-Amorn, P; Prince, SN; Zaccheo, OJ; Nolan, CM; Mungall, AJ; Jones, EY; Crump, MP; Hassan, AB				Williams, Christopher; Hoppe, Hans-Juergen; Rezgui, Dellel; Strickland, Madeleine; Forbes, Briony E.; Grutzner, Frank; Frago, Susana; Ellis, Rosamund Z.; Wattana-Amorn, Pakorn; Prince, Stuart N.; Zaccheo, Oliver J.; Nolan, Catherine M.; Mungall, Andrew J.; Jones, E. Yvonne; Crump, Matthew P.; Hassan, A. Bassim			An Exon Splice Enhancer Primes IGF2:IGF2R Binding Site Structure and Function Evolution	SCIENCE			English	Article							GROWTH-FACTOR-II; 6-PHOSPHATE RECEPTOR; INSIGHTS; ORIGIN	Placental development and genomic imprinting coevolved with parental conflict over resource distribution to mammalian offspring. The imprinted genes IGF2 and IGF2R code for the growth promoter insulin-like growth factor 2 (IGF2) and its inhibitor, mannose 6-phosphate (M6P)/IGF2 receptor (IGF2R), respectively. M6P/IGF2R of birds and fish do not recognize IGF2. In monotremes, which lack imprinting, IGF2 specifically bound M6P/IGF2R via a hydrophobic CD loop. We show that the DNA coding the CD loop in monotremes functions as an exon splice enhancer (ESE) and that structural evolution of binding site loops (AB, HI, FG) improved therian IGF2 affinity. We propose that ESE evolution led to the fortuitous acquisition of IGF2 binding by M6P/IGF2R that drew IGF2R into parental conflict; subsequent imprinting may then have accelerated affinity maturation.	[Hoppe, Hans-Juergen; Rezgui, Dellel; Frago, Susana; Prince, Stuart N.; Zaccheo, Oliver J.; Hassan, A. Bassim] Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Control Grp, Oxford OX1 3RE, England; [Williams, Christopher; Strickland, Madeleine; Ellis, Rosamund Z.; Wattana-Amorn, Pakorn; Crump, Matthew P.] Univ Bristol, Sch Chem, Dept Organ & Biol Chem, Bristol BS8 1TS, Avon, England; [Forbes, Briony E.; Grutzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Nolan, Catherine M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Mungall, Andrew J.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England	University of Oxford; University of Bristol; University of Adelaide; University College Dublin; British Columbia Cancer Agency; Cancer Research UK; University of Oxford; Wellcome Centre for Human Genetics	Hassan, AB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Control Grp, S Parks Rd, Oxford OX1 3RE, England.	matt.crump@bristol.ac.uk; bass.hassan@path.ox.ac.uk	Wattana-Amorn, Pakorn/GPK-6717-2022; Grutzner, Frank/ABB-2820-2021; Jones, Yvonne/N-8111-2019; Grutzner, Frank/AAD-5834-2020; Frago, Susana/L-1477-2017; Jones, Yvonne/J-2293-2016; Forbes, Briony/R-1838-2019; Wiliams, Christopher/P-4904-2015; Mungall, Andrew J./U-7067-2018; Strickland, Madeleine/L-8425-2019	Wattana-Amorn, Pakorn/0000-0002-4780-7122; Grutzner, Frank/0000-0002-3088-7314; Jones, Yvonne/0000-0002-3834-1893; Frago, Susana/0000-0002-1369-1328; Jones, Yvonne/0000-0002-3834-1893; Wiliams, Christopher/0000-0001-5806-9842; Mungall, Andrew J./0000-0002-0905-2742; Strickland, Madeleine/0000-0001-8160-070X; Hoppe, Hans/0000-0002-5107-876X; Hassan, Andrew/0000-0002-2517-6681; Forbes, Briony/0000-0003-4360-9927; Crump, Matthew/0000-0002-7868-5818	Cancer Research UK [C429, C375]; Wellcome Trust; Science Foundation Ireland; Algerian Government; National Health and Medical Research Council; Australian Research Council (ARC, Australia);  [EP1945663B];  [US20090304651A]; Cancer Research UK [9891] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Algerian Government; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC, Australia)(Australian Research Council); ; ; Cancer Research UK(Cancer Research UK)	We thank C. Graham, J. Crosby, N. Barclay, C. Ponting, E. Tsend-Ayush, S.-C. Ong, S. Murphy, and N. Proudfoot. Work supported by Cancer Research UK (A.B.H., M.P.C., and E.Y.J., C429, C375), Wellcome Trust (M.P.C. NMR facility), Science Foundation Ireland (C.M.N.), Algerian Government (D.R.), National Health and Medical Research Council and Australian Research Council (ARC, Australia; B.E.F. and F.G. are ARC Research Fellows). The research described in this manuscript is the subject of a worldwide patent application on improved affinity mutants of IGF2R domain 11 IGF2WO2007020402A, granted in Europe as EP1945663B and pending in the United States as US20090304651A. The ensembles of NMR structures and associated NMR chemical shifts have been deposited with the protein database and BioMagResBank with the following accession codes: chicken, 2L21/17110; echidna, 2L5W/17287; opossum, 2L2G/17134; domain 11<SUP>E4</SUP>, 2L2A/17128; domain 11<SUP>E4</SUP>/IGF2 complex, 2L29/17127. The authors declare that there are no competing financial interests.	Brown J, 2002, EMBO J, V21, P1054, DOI 10.1093/emboj/21.5.1054; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; CANFIELD WM, 1989, J BIOL CHEM, V264, P7100; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; HAIG D, 1991, CELL, V64, P1045; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Pask AJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r1; Renfree MB, 2009, ANNU REV GENOM HUM G, V10, P241, DOI 10.1146/annurev-genom-082908-150026; TRIVERS RL, 1974, AM ZOOL, V14, P249; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Warnecke T, 2009, BIOCHEM SOC T, V37, P756, DOI 10.1042/BST0370756; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; Xiao XS, 2007, P NATL ACAD SCI USA, V104, P18583, DOI 10.1073/pnas.0707349104; Yandell CA, 1999, J BIOL CHEM, V274, P27076, DOI 10.1074/jbc.274.38.27076; Zaccheo OJ, 2006, J MOL BIOL, V359, P403, DOI 10.1016/j.jmb.2006.03.046	24	30	31	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1209	1213		10.1126/science.1228633	http://dx.doi.org/10.1126/science.1228633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197533	Green Accepted			2022-12-01	WOS:000311666200046
J	Ellegren, H; Smeds, L; Burri, R; Olason, PI; Backstrom, N; Kawakami, T; Kunstner, A; Makinen, H; Nadachowska-Brzyska, K; Qvarnstrom, A; Uebbing, S; Wolf, JBW				Ellegren, Hans; Smeds, Linnea; Burri, Reto; Olason, Pall I.; Backstrom, Niclas; Kawakami, Takeshi; Kunstner, Axel; Makinen, Hannu; Nadachowska-Brzyska, Krystyna; Qvarnstrom, Anna; Uebbing, Severin; Wolf, Jochen B. W.			The genomic landscape of species divergence in Ficedula flycatchers	NATURE			English	Article							WILD BIRD POPULATION; FEMALE MEIOTIC DRIVE; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; HYBRID STERILITY; EVOLUTION; CONSEQUENCES; HITCHHIKING; CHICKEN	Unravelling the genomic landscape of divergence between lineages is key to understanding speciation(1). The naturally hybridizing collared flycatcher and pied flycatcher are important avian speciation models(2-7) that show pre- as well as postzygotic isolation(8,9). We sequenced and assembled the 1.1-Gb flycatcher genome, physically mapped the assembly to chromosomes using a low-density linkage map(10) and re-sequenced population samples of each species. Here we show that the genomic landscape of species differentiation is highly heterogeneous with approximately 50 'divergence islands' showing up to 50-fold higher sequence divergence than the genomic background. These non-randomly distributed islands, with between one and three regions of elevated divergence per chromosome irrespective of chromosome size, are characterized by reduced levels of nucleotide diversity, skewed allele-frequency spectra, elevated levels of linkage disequilibrium and reduced proportions of shared polymorphisms in both species, indicative of parallel episodes of selection. Proximity of divergence peaks to genomic regions resistant to sequence assembly, potentially including centromeres and telomeres, indicate that complex repeat structures may drive species divergence. A much higher background level of species divergence of the Z chromosome, and a lower proportion of shared polymorphisms, indicate that sex chromosomes and autosomes are at different stages of speciation. This study provides a roadmap to the emerging field of speciation genomics.	[Ellegren, Hans; Smeds, Linnea; Burri, Reto; Olason, Pall I.; Backstrom, Niclas; Kawakami, Takeshi; Kunstner, Axel; Makinen, Hannu; Nadachowska-Brzyska, Krystyna; Uebbing, Severin; Wolf, Jochen B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Qvarnstrom, Anna] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75263 Uppsala, Sweden	Uppsala University; Uppsala University	Ellegren, H (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	Hans.Ellegren@ebc.uu.se	Uebbing, Severin/K-5046-2012; Nadachowska-Brzyska, Krystyna/ABB-7632-2020; Wolf, Jochen/U-2243-2017; Kawakami, Takeshi/B-9060-2009	Uebbing, Severin/0000-0003-2439-6946; Nadachowska-Brzyska, Krystyna/0000-0002-8457-310X; Wolf, Jochen/0000-0002-2958-5183; Kawakami, Takeshi/0000-0002-9204-6852; Qvarnstrom, Anna/0000-0002-1178-4053; Smeds, Linnea/0000-0002-8415-9259; Kunstner, Axel/0000-0003-0692-2105	European Research Council; Knut and Alice Wallenberg Scholar Grant; Swedish Research Council; Swiss National Science Foundation [PBLAB3-134299, PBLAB1-140171]; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing (SNIC)	European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Scholar Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing (SNIC)	Financial support was obtained from a European Research Council Advanced Investigator Grant (NEXTGENMOLECOL), a Knut and Alice Wallenberg Scholar Grant, and from the Swedish Research Council to H.E. R.B. was funded by the Swiss National Science Foundation (grants PBLAB3-134299 and PBLAB1-140171). We are grateful to M. Lascoux, M. Noor and T. Slotte for helpful discussion and comments. We thank the Uppsala University SNP and SEQ Technology Platform for help with DNA sequencing, and the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX), and the associated Next generation sequencing Cluster and Storage (UPPNEX) project, funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing (SNIC), for computer resources.	Axelsson E, 2010, HEREDITY, V105, P290, DOI 10.1038/hdy.2009.193; Backstrom N, 2008, GENETICS, V179, P1479, DOI 10.1534/genetics.108.088195; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Borge T, 2005, J EVOLUTION BIOL, V18, P1416, DOI 10.1111/j.1420-9101.2005.00964.x; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Coyne J.A., 2004, SPECIATION; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Darwin C., 1859, ORIGIN SPECIES MEANS; Delany ME, 2007, CYTOGENET GENOME RES, V117, P54, DOI 10.1159/000103165; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Henikoff S, 2002, NATURE, V417, P227, DOI 10.1038/417227a; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 1997, NATURE, V387, P589; SHIELDS GF, 1982, CONDOR, V84, P45, DOI 10.2307/1367820; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Wiley C, 2009, EVOLUTION, V63, P1731, DOI 10.1111/j.1558-5646.2009.00674.x; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	30	426	434	7	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					756	760		10.1038/nature11584	http://dx.doi.org/10.1038/nature11584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103876	hybrid			2022-12-01	WOS:000311606000045
J	Baudisch, A; Vaupel, JW				Baudisch, Annette; Vaupel, James W.			Getting to the Root of Aging	SCIENCE			English	Editorial Material							SENESCENCE		[Baudisch, Annette] Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany; [Baudisch, Annette; Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany; [Vaupel, James W.] Univ So Denmark, Odense, Denmark; [Vaupel, James W.] Duke Univ, Durham, NC 27705 USA	Max Planck Society; University of Southern Denmark; Duke University	Baudisch, A (corresponding author), Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany.	baudisch@demogr.mpg.de	Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X; Vaupel, James/0000-0003-0783-3905	NIA NIH HHS [AG-031719, P01 AG031719] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG031719] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baudisch A, 2008, INEVITABLE SENESCENC; Baudisch A, 2012, GERONTOLOGY, V58, P481, DOI 10.1159/000341861; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x; Danko MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034146; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Medawar P. B., 1952, UNIQUENESS INDIVIDUA, P44; PARTRIDGE L, 1991, PHILOS T R SOC B, V332, P3, DOI 10.1098/rstb.1991.0027; Salguero-Gomez R, 2010, J ECOL, V98, P312, DOI 10.1111/j.1365-2745.2009.01616.x; Stearns S.C., 1992, pi; Turner F.B., 1987, 87RD81 SO CAL ED CO; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	18	66	66	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					618	619		10.1126/science.1226467	http://dx.doi.org/10.1126/science.1226467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118175	Green Accepted			2022-12-01	WOS:000310516000036
J	Marx, V				Marx, Vivien			READING THE SECOND GENOMIC CODE	NATURE			English	Editorial Material							CHROMATIN; CANCER; DNA											Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Cipriany BR, 2012, P NATL ACAD SCI USA, V109, P8477, DOI 10.1073/pnas.1117549109; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232	9	17	19	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					143	146		10.1038/491143a	http://dx.doi.org/10.1038/491143a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	028PM	23128234	Bronze			2022-12-01	WOS:000310434500047
J	Farrell, L				Farrell, Liam			Breaking good news	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7355	10.1136/bmj.e7355	http://dx.doi.org/10.1136/bmj.e7355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114076				2022-12-01	WOS:000310778900019
J	Palfrey, JS; Palfrey, S				Palfrey, Judith S.; Palfrey, Sean			Preventing Gun Deaths in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Palfrey, Judith S.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA; [Palfrey, Sean] Boston Med Ctr, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Boston Medical Center	Palfrey, JS (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA.							Barkin SL, 2008, PEDIATRICS, V122, pE15, DOI 10.1542/peds.2007-2611; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, JAMA; Olson LM, 2010, PED AC SOC ANN M VAN	4	27	27	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					401	403		10.1056/NEJMp1215606	http://dx.doi.org/10.1056/NEJMp1215606			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23272974				2022-12-01	WOS:000314215400003
J	Xu, K; Zhong, GS; Zhuang, XW				Xu, Ke; Zhong, Guisheng; Zhuang, Xiaowei			Actin, Spectrin, and Associated Proteins Form a Periodic Cytoskeletal Structure in Axons	SCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; ERYTHROCYTE-MEMBRANE SKELETON; INITIAL SEGMENT; CELLS; DYNAMICS; VISUALIZATION; LOCALIZATION; MICROTUBULES; ORGANIZATION; ANKYRIN(G)	Actin and spectrin play important roles in neurons, but their organization in axons and dendrites remains unclear. We used stochastic optical reconstruction microscopy to study the organization of actin, spectrin, and associated proteins in neurons. Actin formed ringlike structures that wrapped around the circumference of axons and were evenly spaced along axonal shafts with a periodicity of similar to 180 to 190 nanometers. This periodic structure was not observed in dendrites, which instead contained long actin filaments running along dendritic shafts. Adducin, an actin-capping protein, colocalized with the actin rings. Spectrin exhibited periodic structures alternating with those of actin and adducin, and the distance between adjacent actin-adducin rings was comparable to the length of a spectrin tetramer. Sodium channels in axons were distributed in a periodic pattern coordinated with the underlying actin-spectrin-based cytoskeleton.	[Xu, Ke; Zhong, Guisheng; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Xu, Ke/A-9476-2011	Xu, Ke/0000-0002-2788-194X	NIH; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Rasband for providing the beta IV-spectrin and sodium channel antibodies and M. Ericsson, B. Kasthuri, R. Schalek, G. Hao, and C. Speer for help in the preparation of hippocampal tissue slices. This work is supported in part by the NIH and the Collaborative Innovation Award from the HHMI. X.Z. is a HHMI investigator.	Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHNAPP BJ, 1982, J CELL BIOL, V94, P667, DOI 10.1083/jcb.94.3.667; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	36	749	775	7	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					452	456		10.1126/science.1232251	http://dx.doi.org/10.1126/science.1232251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23239625	Green Accepted			2022-12-01	WOS:000313960700045
J	Strugatsky, D; McNulty, R; Munson, K; Chen, CK; Soltis, SM; Sachs, G; Luecke, H				Strugatsky, David; McNulty, Reginald; Munson, Keith; Chen, Chiung-Kuang; Soltis, S. Michael; Sachs, George; Luecke, Hartmut			Structure of the proton-gated urea channel from the gastric pathogen Helicobacter pylori	NATURE			English	Article							PH; PROTEIN; COMPLEX; SYSTEM	Half the world's population is chronically infected with Helico-bacter pylori(1), causing gastritis, gastric ulcers and an increased incidence of gastric adenocarcinoma(2). Its proton-gated inner-membrane urea channel, HpUreI, is essential for survival in the acidic environment of the stomach(3). The channel is closed at neutral pH and opens at acidic pH to allow the rapid access of urea to cytoplasmic urease(4). Urease produces NH3 and CO2, neutralizing entering protons and thus buffering the periplasm to a pH of roughly 6.1 even in gastric juice at a pH below 2.0. Here we report the structure of HpUreI, revealing six protomers assembled in a hexameric ring surrounding a central bilayer plug of ordered lipids. Each protomer encloses a channel formed by a twisted bundle of six transmembrane helices. The bundle defines a previously unobserved fold comprising a two-helix hairpin motif repeated three times around the central axis of the channel, without the inverted repeat of mammalian-type urea transporters. Both the channel and the protomer interface contain residues conserved in the AmiS/UreI superfamily, suggesting the preservation of channel architecture and oligomeric state in this superfamily. Predominantly aromatic or aliphatic side chains line the entire channel and define two consecutive constriction sites in the middle of the channel. Mutation of Trp 153 in the cytoplasmic constriction site to Ala or Phe decreases the selectivity for urea in comparison with thiourea, suggesting that solute interaction with Trp 153 contributes specificity. The previously unobserved hexameric channel structure described here provides a new model for the permeation of urea and other small amide solutes in prokaryotes and archaea.	[Strugatsky, David; Munson, Keith; Sachs, George] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Strugatsky, David; Munson, Keith; Sachs, George] Greater W Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [McNulty, Reginald; Chen, Chiung-Kuang; Luecke, Hartmut] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Soltis, S. Michael] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Luecke, Hartmut] Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA; [Luecke, Hartmut] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Luecke, Hartmut] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sachs, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA.	gsachs@ucla.edu; hudel@uci.edu		McNulty, Reginald/0000-0003-2101-1377	National Institutes of Health (NIH) [R01AI78000, P30CA062203]; National Cancer Institute institutional training grant [5T32CA9054-34]; University of California Irvine Center for Biomembrane Systems; NIH [R01DK53462, R01DK58333]; US Veterans Administration; DOE Office of Biological and Environmental Research; HIN, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [T32CA009054, P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute institutional training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California Irvine Center for Biomembrane Systems; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration(US Department of Veterans Affairs); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); HIN, National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following for assistance with X-ray data collection at the Stanford Synchrotron Radiation Lightsource (T. Doukov), the Advanced Photon Source (D. Cascio & R. Rajashankar), the Advanced Light Source (J. Nix) and the Swiss Light Source (C. Schulze-Briese). We also thank J. Whitelegge for mass spectrometry characterization of potential heavy atom derivatives; D. R. Scott for the urease assays; B. Hirayama for advice on the oocyte experiments; N. Echols and T. Terwilliger for assistance with the development version of the program Phenix; A. Murzin for fold characterization; T. Silkov for pseudosymmetry analysis; and D. R. Scott, F. Tombola, V. De Souza, K. Luecke, S. Luecke and J. Lanyi for general suggestions. This work was supported by National Institutes of Health (NIH) grants R01AI78000 and P30CA062203, National Cancer Institute institutional training grant 5T32CA9054-34, the University of California Irvine Center for Biomembrane Systems (H. L.), NIH grants R01DK53462 and R01DK58333 (G. S.) and the US Veterans Administration (G. S). Portions of this research were performed at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the HIN, National Center for Research Resources, Biomedical Technology Program (P41RR001209) and the National Institute of General Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Gray LR, 2011, BIOCHEMISTRY-US, V50, P8656, DOI 10.1021/bi200887a; Hong W, 2003, J MED MICROBIOL, V52, P211, DOI 10.1099/jmm.0.05072-0; Huysmans GHM, 2012, BIOCHEM J, V445, P157, DOI 10.1042/BJ20120169; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-303; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; ORBACH E, 1980, J GEN PHYSIOL, V75, P427, DOI 10.1085/jgp.75.4.427; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; Scott DR, 2010, J BACTERIOL, V192, P94, DOI 10.1128/JB.00848-09; Scott DR, 2000, INFECT IMMUN, V68, P470, DOI 10.1128/IAI.68.2.470-477.2000; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Weeks DL, 2001, MOL MICROBIOL, V40, P1249, DOI 10.1046/j.1365-2958.2001.02466.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	33	58	63	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					255	U144		10.1038/nature11684	http://dx.doi.org/10.1038/nature11684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23222544	Green Accepted, Green Submitted			2022-12-01	WOS:000313259600046
J	Coffin, PO; Sullivan, SD				Coffin, Phillip O.; Sullivan, Sean D.			Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; NEW-YORK-CITY; SAN-FRANCISCO; NONFATAL OVERDOSE; OPIOID OVERDOSE; UNITED-STATES; METHADONE-MAINTENANCE; PROSPECTIVE COHORT; HEALTH-CARE; FOLLOW-UP	Background: Opioid overdose is a leading cause of accidental death in the United States. Objective: To estimate the cost-effectiveness of distributing naloxone, an opioid antagonist, to heroin users for use at witnessed overdoses. Design: Integrated Markov and decision analytic model using deterministic and probabilistic analyses and incorporating recurrent overdoses and a secondary analysis assuming heroin users are a net cost to society. Data Sources: Published literature calibrated to epidemiologic data. Target Population: Hypothetical 21-year-old novice U. S. heroin user and more experienced users with scenario analyses. Time Horizon: Lifetime. Perspective: Societal. Intervention: Naloxone distribution for lay administration. Outcome Measures: Overdose deaths prevented and incremental cost-effectiveness ratio (ICER). Results of Base-Case Analysis: In the probabilistic analysis, 6% of overdose deaths were prevented with naloxone distribution; 1 death was prevented for every 227 naloxone kits distributed (95% CI, 71 to 716). Naloxone distribution increased costs by $53 (CI, $3 to $156) and quality-adjusted life-years by 0.119 (CI, 0.017 to 0.378) for an ICER of $438 (CI, $48 to $1706). Results of Sensitivity Analysis: Naloxone distribution was cost-effective in all deterministic and probabilistic sensitivity and scenario analyses, and it was cost-saving if it resulted in fewer overdoses or emergency medical service activations. In a "worst-case scenario" where overdose was rarely witnessed and naloxone was rarely used, minimally effective, and expensive, the ICER was $14 000. If national drug-related expenditures were applied to heroin users, the ICER was $2429. Limitation: Limited sources of controlled data resulted in wide CIs. Conclusion: Naloxone distribution to heroin users is likely to reduce overdose deaths and is cost-effective, even under markedly conservative assumptions. Primary Funding Source: National Institute of Allergy and Infectious Diseases. Ann Intern Med. 2013;158:1-9.	[Coffin, Phillip O.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Univ Washington, Seattle, WA 98195 USA	San Francisco Department of Public Health; University of Washington; University of Washington Seattle	Coffin, PO (corresponding author), San Francisco Dept Publ Hlth, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA.	pcoffin@gmail.com	Coffin, Phillip O/G-3286-2012	Coffin, Phillip O/0000-0002-3891-6570	National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5T32AI007140-33]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases.; Grant Support: By grant 5T32AI007140-33 from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bohnert ASB, 2012, DRUG ALCOHOL DEPEN, V120, P168, DOI 10.1016/j.drugalcdep.2011.07.018; Bohnert ASB, 2009, ANN EMERG MED, V54, P618, DOI 10.1016/j.annemergmed.2009.05.004; Briggs A., 2006, DECISION MODELLING H; Bruneau J, 2004, ADDICTION, V99, P727, DOI 10.1111/j.1360-0443.2004.00713.x; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Coffin P, 2012, 19 INT AIDS C WASH D; Coffin PO, 2007, ACAD EMERG MED, V14, P616, DOI 10.1111/j.1553-2712.2007.tb01846.x; Coffin PO, 2003, ADDICTION, V98, P739, DOI 10.1046/j.1360-0443.2003.00376.x; Coffin PO, 2011, EPIDEMIOLOGIC TRENDS; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; Darke S, 2007, J URBAN HEALTH, V84, P283, DOI 10.1007/s11524-006-9156-0; Darke S, 2011, DRUG ALCOHOL DEPEN, V115, P190, DOI 10.1016/j.drugalcdep.2010.10.021; Davidson PJ, 2003, J URBAN HEALTH, V80, P261, DOI 10.1093/jurban/jtg029; Davidson PJ, 2002, ADDICTION, V97, P1511, DOI 10.1046/j.1360-0443.2002.00210.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Enteen L, 2010, J URBAN HEALTH, V87, P931, DOI 10.1007/s11524-010-9495-8; Evans JL, 2012, AM J EPIDEMIOL, V175, P302, DOI 10.1093/aje/kwr318; Evans JL, 2009, DRUG ALCOHOL DEPEN, V101, P152, DOI 10.1016/j.drugalcdep.2008.12.007; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Gossop M, 1996, BRIT MED J, V313, P402; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hakansson A, 2008, DRUG ALCOHOL DEPEN, V94, P48, DOI 10.1016/j.drugalcdep.2007.10.014; Hart A, 2011, ANN REPORT FISCAL YE, P148; Hart A, 2004, ANN REPORT JULY 2002, P30; Havens JR, 2011, DRUG ALCOHOL DEPEN, V115, P107, DOI 10.1016/j.drugalcdep.2010.11.003; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hser YI, 2002, OAS ANAL SERIES A; Huo DZ, 2006, ADDICTION, V101, P1606, DOI 10.1111/j.1360-0443.2006.01577.x; Jenkins LM, 2011, J URBAN HEALTH, V88, P118, DOI 10.1007/s11524-010-9525-6; Lankenau SE, 2012, J COMMUNITY HLTH; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Leavitt SB, 2010, PRACT PAIN MANAG, V10; Lee CP, 2009, VALUE HEALTH, V12, P80, DOI 10.1111/j.1524-4733.2008.00401.x; Lenton SR, 2000, MED J AUSTRALIA, V173, P260, DOI 10.5694/j.1326-5377.2000.tb125633.x; Mackesy-Amiti ME, 2011, ADDICTION, V106, P601, DOI 10.1111/j.1360-0443.2010.03251.x; Maxwell S, 2006, J ADDICT DIS, V25, P89, DOI 10.1300/J069v25n03_11; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; Milloy MJS, 2008, AM J DRUG ALCOHOL AB, V34, P499, DOI 10.1080/00952990802122457; Nosyk B, 2010, J CLIN EPIDEMIOL, V63, P1132, DOI 10.1016/j.jclinepi.2009.12.003; Ochoa KC, 2005, DRUG ALCOHOL DEPEN, V80, P297, DOI 10.1016/j.drugalcdep.2005.04.012; Office of National Drug Control Policy, 2004, OFF NAT DRUG CONT PO; Paone D, 2010, ILLICIT DRUG USE NEW; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Piper TM, 2008, SUBST USE MISUSE, V43, P858, DOI 10.1080/10826080701801261; Pollini RA, 2006, DRUG ALCOHOL DEPEN, V83, P104, DOI 10.1016/j.drugalcdep.2005.10.015; Pyne JM, 2011, ADDICTION, V106, P507, DOI 10.1111/j.1360-0443.2010.03299.x; Rudolph SS, 2011, RESUSCITATION, V82, P1414, DOI 10.1016/j.resuscitation.2011.06.027; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Sporer KA, 1999, ANN INTERN MED, V130, P584, DOI 10.7326/0003-4819-130-7-199904060-00019; Sporer KA, 2007, ANN EMERG MED, V49, P172, DOI 10.1016/j.annemergmed.2006.05.025; Stoove MA, 2009, DRUG ALCOHOL REV, V28, P347, DOI 10.1111/j.1465-3362.2009.00057.x; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER A; Teesson M, 2008, ADDICTION, V103, P80, DOI 10.1111/j.1360-0443.2007.02029.x; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; Tracy M, 2005, DRUG ALCOHOL DEPEN, V79, P181, DOI 10.1016/j.drugalcdep.2005.01.010; Vanagas G, 2010, MEDICINA-LITHUANIA, V46, P286, DOI 10.3390/medicina46040040; Vilke GM, 2003, ACAD EMERG MED, V10, P893, DOI 10.1111/j.1553-2712.2003.tb00636.x; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Vlahov D, 2008, SUBST USE MISUSE, V43, P413, DOI 10.1080/10826080701203013; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Walley AY, 2012, ROL NAL OP OV FAT PR; Wampler DA, 2011, PREHOSP EMERG CARE, V15, P320, DOI 10.3109/10903127.2011.569854; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101; Wu LT, 2011, SUBST ABUSE REHABIL, V2, P77, DOI 10.2147/SAR.S18969; Yokell Michael A, 2011, Med Health R I, V94, P240; Zador D, 1996, MED J AUSTRALIA, V164, P204, DOI 10.5694/j.1326-5377.1996.tb94136.x; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	73	210	212	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					1	U42		10.7326/0003-4819-158-1-201301010-00003	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277895				2022-12-01	WOS:000313119900002
J	Fugger, L; McVean, G; Bell, JI				Fugger, Lars; McVean, Gil; Bell, John I.			Genomewide Association Studies and Common Disease - Realizing Clinical Utility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fugger, Lars] Univ Oxford, Weatherall Inst Med, Oxford, England; [Fugger, Lars] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Fugger, L (corresponding author), Univ Oxford, Weatherall Inst Med, Oxford, England.			McVean, Gil/0000-0002-5012-4162	MRC [MC_UU_12010/3] Funding Source: UKRI; Medical Research Council [G1000800i] Funding Source: researchfish; Rosetrees Trust [M210] Funding Source: researchfish; Medical Research Council [G1000800I, MC_UU_12010/3] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gudjonsson JE, 2012, J AM ACAD DERMATOL, V67, P139, DOI 10.1016/j.jaad.2011.06.037; Rosenblum MD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003504; Travers ME, 2011, HUM GENET, V130, P41, DOI 10.1007/s00439-011-1023-8; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	5	26	29	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2370	2371		10.1056/NEJMp1212285	http://dx.doi.org/10.1056/NEJMp1212285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056ZP	23252523				2022-12-01	WOS:000312531600003
J	Winkelmann, R; Levermann, A; Martin, MA; Frieler, K				Winkelmann, R.; Levermann, A.; Martin, M. A.; Frieler, K.			Increased future ice discharge from Antarctica owing to higher snowfall	NATURE			English	Article							MODEL PISM-PIK; CLIMATE-CHANGE; SHEET; SHELF; BENEATH; FLOW	Anthropogenic climate change is likely to cause continuing global sea level rise(1), but some processes within the Earth system may mitigate the magnitude of the projected effect. Regional and global climate models simulate enhanced snowfall over Antarctica, which would provide a direct offset of the future contribution to global sea level rise from cryospheric mass loss(2,3) and ocean expansion(4). Uncertainties exist in modelled snowfall(5), but even larger uncertainties exist in the potential changes of dynamic ice discharge from Antarctica(1,6) and thus in the ultimate fate of the precipitation-deposited ice mass. Here we show that snowfall and discharge are not independent, but that future ice discharge will increase by up to three times as a result of additional snowfall under global warming. Our results, based on an ice-sheet model(7) forced by climate simulations through to the end of 2500 (ref. 8), show that the enhanced discharge effect exceeds the effect of surface warming as well as that of basal ice-shelf melting, and is due to the difference in surface elevation change caused by snowfall on grounded versus floating ice. Although different underlying forcings drive ice loss from basal melting versus increased snowfall, similar ice dynamical processes are nonetheless at work in both; therefore results are relatively independent of the specific representation of the transition zone. In an ensemble of simulations designed to capture ice-physics uncertainty, the additional dynamic ice loss along the coastline compensates between 30 and 65 per cent of the ice gain due to enhanced snowfall over the entire continent. This results in a dynamic ice loss of up to 1.25 metres in the year 2500 for the strongest warming scenario. The reported effect thus strongly counters a potential negative contribution to global sea level by the Antarctic Ice Sheet.	[Winkelmann, R.; Levermann, A.; Martin, M. A.; Frieler, K.] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany; [Winkelmann, R.; Levermann, A.; Martin, M. A.] Univ Potsdam, Inst Phys, D-14476 Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Winkelmann, R (corresponding author), Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany.	ricarda.winkelmann@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704; Frieler, Katja/0000-0003-4869-3013; Winkelmann, Ricarda/0000-0003-1248-3217	German Federal Ministry of Education and Research (BMBF) [01LP1171A]; German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) [11_II_093_Global_A_SIDS, 11_II_093_Global_A_LDCs]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU)	This study was supported by the German Federal Ministry of Education and Research (BMBF, grant 01LP1171A) and the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU, grant 11_II_093_Global_A_SIDS and LDCs).	Dinniman MS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004036; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Frieler K, 2012, J CLIMATE, V25, P3117, DOI 10.1175/JCLI-D-11-00199.1; Grosfeld K., 1998, ANTARCT RES SER, V75, P83; Huybrechts P, 1999, J CLIMATE, V12, P2169, DOI 10.1175/1520-0442(1999)012<2169:TDROTG>2.0.CO;2; Huybrechts P, 2011, SURV GEOPHYS, V32, P397, DOI 10.1007/s10712-011-9131-5; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; Krinner G, 2007, CLIM DYNAM, V28, P215, DOI 10.1007/s00382-006-0177-x; Larour E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021693; Le Brocq A. M., 2010, EARTH SYSTEM SCI DAT, V3, P195, DOI [10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010, DOI 10.5194/ESSDD-3-195-2010]; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2010JD015419; Martin MA, 2011, CRYOSPHERE, V5, P727, DOI 10.5194/tc-5-727-2011; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meinshausen M., 2008, ATMOS CHEM PHYS DISC, V8, P6153, DOI DOI 10.5194/ACPD-8-6153-2008; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Olbers D, 2010, OCEAN DYNAM, V60, P141, DOI 10.1007/s10236-009-0252-z; Payne AJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003733; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Schewe J, 2011, EARTH SYST DYNAM, V2, P25, DOI 10.5194/esd-2-25-2011; Schoof C, 2010, Q J MECH APPL MATH, V63, P73, DOI 10.1093/qjmam/hbp025; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Uotila P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007482; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vizcaino M, 2010, CLIM DYNAM, V34, P301, DOI 10.1007/s00382-009-0591-y; Walker RT, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034947; Williams MJM, 2001, J GEOPHYS RES-OCEANS, V106, P22383, DOI 10.1029/2000JC000236; Winkelmann R, 2011, CRYOSPHERE, V5, P715, DOI 10.5194/tc-5-715-2011; Winkelmann R., 2012, CRYOSPHERE DISCUSS, V6, P673, DOI [10.5194/tcd-6-673-2012, DOI 10.5194/TCD-6-673-2012]	31	59	60	2	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					239	+		10.1038/nature11616	http://dx.doi.org/10.1038/nature11616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235878				2022-12-01	WOS:000312259300039
J	Itakura, E; Kishi-Itakura, C; Mizushima, N				Itakura, Eisuke; Kishi-Itakura, Chieko; Mizushima, Noboru			The Hairpin-type Tail-Anchored SNARE Syntaxin 17 Targets to Autophagosomes for Fusion with Endosomes/Lysosomes	CELL			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; ATG PROTEINS; HOMOLOG; SYSTEM; TRAFFICKING; BIOGENESIS; STARVATION; TRANSPORT	The lysosome is a degradative organelle, and its fusion with other organelles is strictly regulated. In contrast to fusion with the late endosome, the mechanisms underlying autophagosome-lysosome fusion remain unknown. Here, we identify syntaxin 17 (Stx17) as the autophagosomal SNARE required for fusion with the endosome/lysosome. Stx17 localizes to the outer membrane of completed autophagosomes but not to the isolation membrane (unclosed intermediate structures); for this reason, the lysosome does not fuse with the isolation membrane. Stx17 interacts with SNAP-29 and the endosomal/lysosomal SNARE VAMP8. Depletion of Stx17 causes accumulation of autophagosomes without degradation. Stx17 has a unique C-terminal hairpin structure mediated by two tandem transmembrane domains containing glycine zipper-like motifs, which is essential for its association with the autophagosomal membrane. These findings reveal a mechanism by which the SNARE protein is available to the completed autophagosome.	[Itakura, Eisuke; Kishi-Itakura, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Itakura, Eisuke/AAY-7977-2021; Mizushima, Noboru/C-3635-2009	Itakura, Eisuke/0000-0001-7248-9333; Mizushima, Noboru/0000-0002-6258-6444	Funding Program for Next Generation World-Leading Researchers; Takeda Science Foundation; Japan Society for the Promotion of Science for Young Scientists	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Taki Nishimura (Tokyo Medical and Dental University) for help with RNAi experiments, Masaaki Komatsu (Tokyo Metropolitan Institute of Medical Science) for providing Atg3 KO MEFs, and Toshio Kitamura (The University of Tokyo) and Shoji Yamaoka (Tokyo Medical and Dental University) for the retroviral vectors and Plat-E cells, and Atsushi Miyawaki (RIKEN) for providing Venus and SECFP. We also thank Ramanujan S. Hegde and Sichen Shao (MRC Laboratory of Molecular Biology) for critical reading of this manuscript and helpful discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers, and the Takeda Science Foundation (to N.M.) and grants for a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (to E.I.).	Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brosig B, 1998, PROTEIN SCI, V7, P1052; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Renna M, 2011, J CELL SCI, V124, P469, DOI 10.1242/jcs.076489; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	51	765	786	6	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1256	1269		10.1016/j.cell.2012.11.001	http://dx.doi.org/10.1016/j.cell.2012.11.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217709	Bronze			2022-12-01	WOS:000311999900015
J	Walker, MJ; Beatson, SA				Walker, Mark J.; Beatson, Scott A.			Outsmarting Outbreaks	SCIENCE			English	Editorial Material							TRANSMISSION; EVOLUTION; MRSA		[Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Walker, Mark J./F-6940-2011; Beatson, Scott/B-6985-2013	Beatson, Scott/0000-0002-1806-3283; Walker, Mark/0000-0001-7423-2769				Ben Zakour NL, 2012, J CLIN MICROBIOL, V50, P2224, DOI 10.1128/JCM.00675-12; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362	16	11	12	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1161	1162		10.1126/science.1232327	http://dx.doi.org/10.1126/science.1232327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	045AL	23197523				2022-12-01	WOS:000311666200032
J	Langecker, M; Arnaut, V; Martin, TG; List, J; Renner, S; Mayer, M; Dietz, H; Simmel, FC				Langecker, Martin; Arnaut, Vera; Martin, Thomas G.; List, Jonathan; Renner, Stephan; Mayer, Michael; Dietz, Hendrik; Simmel, Friedrich C.			Synthetic Lipid Membrane Channels Formed by Designed DNA Nanostructures	SCIENCE			English	Article							SOLID-STATE NANOPORES; SINGLE-NUCLEOTIDE RESOLUTION; HAIRPIN MOLECULES; NANOSCALE SHAPES; ALPHA-HEMOLYSIN; FOLDING DNA; ORIGAMI; PORE	We created nanometer-scale transmembrane channels in lipid bilayers by means of self-assembled DNA-based nanostructures. Scaffolded DNA origami was used to create a stem that penetrated and spanned a lipid membrane, as well as a barrel-shaped cap that adhered to the membrane, in part via 26 cholesterol moieties. In single-channel electrophysiological measurements, we found similarities to the response of natural ion channels, such as conductances on the order of 1 nanosiemens and channel gating. More pronounced gating was seen for mutations in which a single DNA strand of the stem protruded into the channel. Single-molecule translocation experiments show that the synthetic channels can be used to discriminate single DNA molecules.	[Martin, Thomas G.; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany; [Langecker, Martin; Arnaut, Vera; List, Jonathan; Renner, Stephan; Simmel, Friedrich C.] Tech Univ Munich, Dept Phys, Lehrstuhl Bioelekt, D-85748 Garching, Germany; [Langecker, Martin; Arnaut, Vera; List, Jonathan; Renner, Stephan; Simmel, Friedrich C.] Tech Univ Munich, ZNN WSI, D-85748 Garching, Germany; [Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Michigan System; University of Michigan	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany.	dietz@tum.de; simmel@tum.de	Simmel, Friedrich/G-3281-2010; Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020	Simmel, Friedrich/0000-0003-3829-3446; Mayer, Michael/0000-0002-6148-5756; Dietz, Hendrik/0000-0003-1270-3662; List, Jonathan/0000-0001-8408-0877	Deutsche Forschungsgemeinschaft [SFB 863]; Bundesministerium fur Bildung und Forschung [13N10970]; European Research Council [GA 256270]; Technische Universitat Munchen Institute for Advanced Study; NIH [1R01GM081705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081705] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); Technische Universitat Munchen Institute for Advanced Study; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Deutsche Forschungsgemeinschaft [grant SFB 863 and Excellence Clusters NIM (Nanosystems Initiative Munich) and CIPSM (Center for Integrated Protein Science Munich)], the Bundesministerium fur Bildung und Forschung (grant 13N10970), the European Research Council (starting grant GA 256270, H. D.), the Technische Universitat Munchen Institute for Advanced Study, and NIH grant 1R01GM081705 (M. M.). We thank M. Hiller and A. Bessonov for preliminary work, G. Baaken and J. Behrends for kindly providing the MECA chips, and A. Seifert, M. Beckler, and N. Fertig for technical support with the Orbit setup. M. M., H. D., and F. C. S. designed the research; M. L., V. A., and S. R. performed electrophysiological experiments; T. G. M. prepared the synthetic DNA channels and performed TEM; J. L., V. A., and T. G. M. performed experiments with lipid vesicles; and H. D. and F. C. S. wrote the paper. All authors discussed the results and commented on the manuscript.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Baaken G, 2008, LAB CHIP, V8, P938, DOI 10.1039/b800431e; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bell NAW, 2012, NANO LETT, V12, P512, DOI 10.1021/nl204098n; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI 10.1038/NNANO.2010.237; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hille B., 2001, ION CHANNELS EXCITAB, V3; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274; Renner S, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558902; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sakmann B., 1995, SINGLE CHANNEL RECOR; Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Wei RS, 2012, ANGEW CHEM INT EDIT, V51, P4864, DOI 10.1002/anie.201200688	27	506	570	24	461	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					932	936		10.1126/science.1225624	http://dx.doi.org/10.1126/science.1225624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161995	Green Accepted			2022-12-01	WOS:000311083600039
J	Sutton, M; Nikolova, S; Boaden, R; Lester, H; McDonald, R; Roland, M				Sutton, Matt; Nikolova, Silviya; Boaden, Ruth; Lester, Helen; McDonald, Ruth; Roland, Martin			Reduced Mortality with Hospital Pay for Performance in England	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; FOR-PERFORMANCE; IMPROVEMENT	BACKGROUND Pay-for-performance programs are being adopted internationally despite little evidence that they improve patient outcomes. In 2008, a program called Advancing Quality, based on the Hospital Quality Incentive Demonstration in the United States, was introduced in all National Health Service (NHS) hospitals in the northwest region of England (population, 6.8 million). METHODS We analyzed 30-day in-hospital mortality among 134,435 patients admitted for pneumonia, heart failure, or acute myocardial infarction to 24 hospitals covered by the pay-for-performance program. We used difference-in-differences regression analysis to compare mortality 18 months before and 18 months after the introduction of the program with mortality in two comparators: 722,139 patients admitted for the same three conditions to the 132 other hospitals in England and 241,009 patients admitted for six other conditions to both groups of hospitals. RESULTS Risk-adjusted, absolute mortality for the conditions included in the pay-for-performance program decreased significantly, with an absolute reduction of 1.3 percentage points (95% confidence interval [CI], 0.4 to 2.1; P = 0.006) and a relative reduction of 6%, equivalent to 890 fewer deaths (95% CI, 260 to 1500) during the 18-month period. The largest reduction, for pneumonia, was significant (1.9 percentage points; 95% CI, 0.9 to 3.0; P<0.001), with nonsignificant reductions for acute myocardial infarction (0.6 percentage points; 95% CI, -0.4 to 1.7; P = 0.23) and heart failure (0.6 percentage points; 95% CI, -0.6 to 1.8; P = 0.30). CONCLUSIONS The introduction of pay for performance in all NHS hospitals in one region of England was associated with a clinically significant reduction in mortality. As compared with a similar U. S. program, the U. K. program had larger bonuses and a greater investment by hospitals in quality-improvement activities. Further research is needed on how implementation of pay-for-performance programs influences their effects. (Funded by the NHS National Institute for Health Research.)	[Sutton, Matt; Nikolova, Silviya] Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Boaden, Ruth] Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England; [Lester, Helen] Univ Birmingham, Birmingham, W Midlands, England; [McDonald, Ruth] Univ Nottingham, Sch Business, Nottingham NG7 2RD, England; [Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge, England	University of Manchester; University of Manchester; University of Birmingham; University of Nottingham; University of Cambridge	Sutton, M (corresponding author), Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Rm 1-304,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	matt.sutton@manchester.ac.uk	McDonald, Ruth/C-3547-2013; Boaden, Ruth/L-3443-2016	Boaden, Ruth/0000-0003-1927-6405; Roland, Martin/0000-0002-8533-3060; McDonald, Ruth/0000-0002-3488-4209; Nikolova, Silviya/0000-0002-6922-5115; Sutton, Matt/0000-0002-6635-2127	NHS National Institute for Health Research; National Health Service National Institute for Health Research; National Institute for Health Research [08/1809/250] Funding Source: researchfish	NHS National Institute for Health Research(National Institute for Health Research (NIHR)); National Health Service National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the NHS National Institute for Health Research.; Supported by the National Health Service National Institute for Health Research.	Bhattacharyya T, 2009, HEALTH AFFAIR, V28, P526, DOI 10.1377/hlthaff.28.2.526; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P26490; Damberg CL, 2009, HEALTH AFFAIR, V28, P517, DOI 10.1377/hlthaff.28.2.517; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; Healthcare Commission, ANN HLTH CHECK 2007; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Marini G, 2008, HEALTH ECON, V17, P751, DOI 10.1002/hec.1292; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ryan AM, 2011, HEALTH SERV RES, V46, P712, DOI 10.1111/j.1475-6773.2010.01224.x; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2007, JAMA-J AM MED ASSOC, V297, P700	19	145	150	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1821	1828		10.1056/NEJMsa1114951	http://dx.doi.org/10.1056/NEJMsa1114951			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134382	Green Published			2022-12-01	WOS:000310773200009
J	Wu, D; Hu, Q; Yan, Z; Chen, W; Yan, CY; Huang, X; Zhang, J; Yang, PY; Deng, HT; Wang, JW; Deng, XW; Shi, YG				Wu, Di; Hu, Qi; Yan, Zhen; Chen, Wen; Yan, Chuangye; Huang, Xi; Zhang, Jing; Yang, Panyu; Deng, Haiteng; Wang, Jiawei; Deng, XingWang; Shi, Yigong			Structural basis of ultraviolet-B perception by UVR8	NATURE			English	Article							CATION-PI INTERACTIONS; PLANT PHOTORECEPTOR DOMAIN; BLUE; CRYPTOCHROMES; PHYTOCHROME; REGULATOR; SOFTWARE; REVEALS	The Arabidopsis thaliana protein UVR8 is a photoreceptor for ultraviolet-B. Upon ultraviolet-B irradiation, UVR8 undergoes an immediate switch from homodimer to monomer, which triggers a signalling pathway for ultraviolet protection. The mechanism by which UVR8 senses ultraviolet-B remains largely unknown. Here we report the crystal structure of UVR8 at 1.8 angstrom resolution, revealing a symmetric homodimer of seven-bladed beta-propeller that is devoid of any external cofactor as the chromophore. Arginine residues that stabilize the homodimeric interface, principally Arg 286 and Arg 338, make elaborate intramolecular cation-pi interactions with surrounding tryptophan amino acids. Two of these tryptophans, Trp 285 and Trp 233, collectively serve as the ultraviolet-B chromophore. Our structural and biochemical analyses identify the molecular mechanism for UVR8-mediated ultraviolet-B perception, in which ultraviolet-B radiation results in destabilization of the intramolecular cation-pi interactions, causing disruption of the critical intermolecular hydrogen bonds mediated by Arg 286 and Arg 338 and subsequent dissociation of the UVR8 homodimer.	[Wu, Di; Hu, Qi; Yan, Zhen; Zhang, Jing; Deng, Haiteng; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Di; Hu, Qi; Yan, Zhen; Yan, Chuangye; Zhang, Jing; Deng, Haiteng; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Wen; Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Tsinghua University; Peking University	Shi, YG (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021; Deng, Xing Wang/ABF-4107-2020	Wang, Jiawei/0000-0001-9893-8539; Jan, Lily/0000-0003-3938-8498; Shi, Yigong/0000-0003-2030-168X; He, Ye/0000-0002-3936-4958; Yan, Zhiqiang/0000-0003-4714-2076; Yan, Chuangye/0000-0001-9338-8048; Deng, Haiteng/0000-0001-9496-1280; Jan, Yuh Nung/0000-0003-1367-6299; Yan, Zhen/0000-0002-1999-8451	Ministry of Science and Technology [2009CB918801, 2012CB910900]; National Natural Science Foundation; Beijing Municipal Commission of Education; Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. He and S. Huang at SSRF, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for assistance. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801 to Y.S., and 2012CB910900 to X.W.D.), the National Natural Science Foundation, and the Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; YU HT, 1992, J AM CHEM SOC, V114, P8449, DOI 10.1021/ja00048a015	40	318	366	10	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					214	U96		10.1038/nature10931	http://dx.doi.org/10.1038/nature10931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22388820				2022-12-01	WOS:000303149900029
J	Deweerdt, S				Deweerdt, Sarah			COMPARATIVE BIOLOGY Looking for a master switch	NATURE			English	Editorial Material							FIBROBLASTS; RESISTANT											Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2011, J EXP BIOL, V214, P1902, DOI 10.1242/jeb.054643; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094	6	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S10	S11		10.1038/492S10a	http://dx.doi.org/10.1038/492S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222666	Bronze			2022-12-01	WOS:000311893400006
